"","Name","MOA","Target","Disease.Area","Indication","Vendor","Purity","Id","Phase","Deprecated.ID","InChIKey","broad_id","broad_id_old","SMILES"
"1","[SAR9,MET(O2)11]-SUBSTANCE-P","tachykinin antagonist","TACR1","","","Tocris",0,"BRD-K89787693-001-01-1","Preclinical","","OUPXSLGGCPUZJJ-SARDKLJWSA-N","BRD-K89787693","","CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCS(C)(=O)=O)C(N)=O"
"2","A-1070722","glycogen synthase kinase inhibitor","GSK3A, GSK3B","","","Tocris",97.36,"BRD-K70329400-001-02-5","Preclinical","","VQPBIJGXSXEOCU-UHFFFAOYSA-N","BRD-K70329400","","COc1ccc2c(NC(=O)Nc3cccc(n3)C(F)(F)F)ccnc2c1"
"3","A-1120","retinoid receptor ligand","RBP4","","","Tocris",83.72,"BRD-K59060513-001-02-5","Preclinical","","MEAQCLPMSVEOQF-UHFFFAOYSA-N","BRD-K59060513","","OC(=O)c1ccccc1NC(=O)N1CCC(CC1)c1ccccc1C(F)(F)F"
"4","A-317491","purinergic receptor antagonist","P2RX3","","","MedChemEx, MedChemEx",98.69,"BRD-K38019854-323-01-4, BRD-K38019854-001-01-6","Preclinical","","VQGBOYBIENNKMI-LJAQVGFWSA-N","BRD-K38019854","","OC(=O)c1cc(C(O)=O)c(cc1C(O)=O)C(=O)N(Cc1cccc(Oc2ccccc2)c1)[C@H]1CCCc2ccccc12"
"6","A-33903","","","","","Maybridge",96.18,"BRD-A40302156-001-01-9","Phase 2","","MMXSDWJOQSEPSM-UHFFFAOYSA-N","BRD-A40302156","","CC(=O)NC1C(=O)Nc2ccccc2C(=N1)c1ccccc1"
"7","A-366","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","MedChemEx, Tocris, MedChemEx, MedChemEx, Tocris",87.35,"BRD-K06182768-001-06-4, BRD-K06182768-001-02-3, BRD-K06182768-001-03-1, BRD-K06182768-001-01-5, BRD-K06182768-001-04-9","Preclinical","","BKCDJTRMYWSXMC-UHFFFAOYSA-N","BRD-K06182768","","COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1"
"12","A-412997","dopamine receptor agonist","DRD4","","","Tocris",95.39,"BRD-K62066682-300-01-0","Preclinical","","JFCDMGGMCUKHST-UHFFFAOYSA-N","BRD-K62066682","","Cc1cccc(NC(=O)CN2CCC(CC2)c2ccccn2)c1"
"13","A-438079","purinergic receptor antagonist","P2RX7","","","Tocris",93.4,"BRD-K13223831-003-01-7","Preclinical","","MMPAULQSJLVKHP-UHFFFAOYSA-N","BRD-K13223831","","Clc1cccc(-c2nnnn2Cc2cccnc2)c1Cl"
"14","A-582941","nicotinic receptor agonist","CHRNA7","","","Tocris",84.25,"BRD-K79743788-001-01-2","Preclinical","","GTMRUYCIJSNXGB-GASCZTMLSA-N","BRD-K79743788","","CN1C[C@H]2CN(C[C@H]2C1)c1ccc(nn1)-c1ccccc1"
"15","A-61603","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D","","","Tocris",96.39,"BRD-K13142315-004-01-2","Preclinical","","RIRDSZBDOHSJGT-UHFFFAOYSA-N","BRD-K13142315","","CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)=C1NCCN1"
"16","A-674563","AKT inhibitor","AKT1, PKIA, PRKACA","","","Selleck",96.74,"BRD-K78177893-001-02-4","Preclinical","","BPNUQXPIQBZCMR-IBGZPJMESA-N","BRD-K78177893","","Cc1n[nH]c2ccc(cc12)-c1cncc(OC[C@@H](N)Cc2ccccc2)c1"
"17","A-7","calmodulin antagonist","","","","Tocris, Tocris",92.44,"BRD-K03301001-003-03-3, BRD-K03301001-003-02-5","Preclinical","","JLUUJHIQVIXTGT-UHFFFAOYSA-N","BRD-K03301001","","NCCCCCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12"
"19","A-769662","AMPK activator","","","","Tocris, Selleck",90.56,"BRD-K41918892-001-06-7, BRD-K41918892-001-05-9","Preclinical","","CTESJDQKVOEUOY-UHFFFAOYSA-N","BRD-K41918892","","Oc1ccccc1-c1ccc(cc1)-c1csc2[nH]c(=O)c(C#N)c(O)c12"
"21","A-784168","transient receptor potential channel antagonist","TRPV1","","","Tocris",90.02,"BRD-K87665527-001-01-3","Preclinical","","SDUAWRFBHRAFBM-UHFFFAOYSA-N","BRD-K87665527","","FC(F)(F)c1cccnc1N1CCC(=CC1)C(=O)Nc1ccc(cc1)S(=O)(=O)C(F)(F)F"
"22","A-803467","sodium channel blocker","SCN10A","","","Selleck, Tocris",97.96,"BRD-K28570407-001-02-0, BRD-K28570407-001-04-6","Preclinical","","VHKBTPQDHDSBSP-UHFFFAOYSA-N","BRD-K28570407","","COc1cc(NC(=O)c2ccc(o2)-c2ccc(Cl)cc2)cc(OC)c1"
"24","A-804598","purinergic receptor antagonist","P2RX7","","","Tocris",93.16,"BRD-K76894955-001-02-1","Preclinical","BRD-K94313941-001-01-9","PQYCRDPLPKGSME-AWEZNQCLSA-N","BRD-K76894955","BRD-K94313941","C[C@H](\N=C(\NC#N)Nc1cccc2ncccc12)c1ccccc1"
"25","A-839977","purinergic receptor antagonist","P2RX7","","","Tocris",92.75,"BRD-K60427831-001-01-0","Preclinical","","GMVNBKZQJFRFAR-UHFFFAOYSA-N","BRD-K60427831","","Clc1cccc(c1Cl)-n1nnnc1NCc1ccccc1Oc1ccccn1"
"26","A-867744","acetylcholine receptor allosteric modulator","CHRNA3, CHRNA4, CHRNA7","","","Tocris",95.81,"BRD-K33059059-001-01-0","Preclinical","","ABACVOXFUHDKNZ-UHFFFAOYSA-N","BRD-K33059059","","CCC(=O)c1cc(-c2ccc(Cl)cc2)n(c1C)-c1ccc(cc1)S(N)(=O)=O"
"27","A-887826","sodium channel blocker","SCN10A","","","Tocris",91.61,"BRD-K20239555-001-01-2","Preclinical","","JPJGFWKHSMUKFO-UHFFFAOYSA-N","BRD-K20239555","","CCCCOc1ccc(cc1Cl)-c1cncc(c1)C(=O)NCc1cccnc1N1CCOCC1"
"28","A-922500","diacylglycerol O acyltransferase inhibitor","DGAT1","","","Tocris",96.89,"BRD-K81614372-001-02-1","Preclinical","","BOZRFEQDOFSZBV-DHIUTWEWSA-N","BRD-K81614372","","OC(=O)[C@@H]1CCC[C@H]1C(=O)c1ccc(cc1)-c1ccc(NC(=O)Nc2ccccc2)cc1"
"29","A-939572","stearoyl-CoA desaturase inhibitor","SCD","","","Tocris",94.18,"BRD-K99308908-001-01-5","Preclinical","","DPYTYQFYDLYWHZ-UHFFFAOYSA-N","BRD-K99308908","","CNC(=O)c1cccc(NC(=O)N2CCC(CC2)Oc2ccccc2Cl)c1"
"30","A-967079","transient receptor potential channel antagonist","TRPA1","","","Tocris",97.41,"BRD-K70744942-001-01-2","Preclinical","","HKROEBDHHKMNBZ-CHBKHGQFSA-N","BRD-K70744942","","CCC(=N/O)\C(C)=C\c1ccc(F)cc1"
"31","A-987306","histamine receptor antagonist","ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2","","","Tocris",86.49,"BRD-K68982262-001-01-4","Preclinical","","DJKJVWJQAVGLHJ-YPMHNXCESA-N","BRD-K68982262","","Nc1nc(N2CCNCC2)c2CCC3=C([C@@H]4CCCC[C@@H]4O3)c2n1"
"32","AA-29504","GABA receptor positive allosteric modulator","GABRA1, GABRA4, GABRB3","","","Tocris",19.95,"BRD-K13944729-001-01-7","Preclinical","","SCOOTUMXCXKEAD-UHFFFAOYSA-N","BRD-K13944729","","CCOC(=O)Nc1ccc(NCc2c(C)cc(C)cc2C)cc1N"
"33","ABAFUNGIN","sterol methyltransferase inhibitor","","","","ChemImpex",92.48,"BRD-K77432251-001-01-2","Phase 3","","TYBHXIFFPVFXQW-UHFFFAOYSA-N","BRD-K77432251","","Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1"
"34","ABAMETAPIR","metalloproteinase inhibitor","MMP9","","","Sigma",92.8,"BRD-K65498798-001-01-7","Phase 3","","PTRATZCAGVBFIQ-UHFFFAOYSA-N","BRD-K65498798","","Cc1ccc(nc1)-c1ccc(C)cn1"
"35","ABC-294640","sphingosine kinase inhibitor","SPHK2","","","Enzo, Selleck",99.82,"BRD-A70814879-003-02-6, BRD-A70814879-001-01-2","Phase 1/Phase 2","","CAOTVXGYTWCKQE-UHFFFAOYSA-N","BRD-A70814879","","Clc1ccc(cc1)C12CC3CC(CC(C3)(C1)C(=O)NCc1ccncc1)C2"
"37","ABT-202","acetylcholine receptor agonist","","","","Enamine",88.87,"BRD-A29844814-300-01-5","Phase 1","","LVGMMVAWLISWJD-UHFFFAOYSA-N","BRD-A29844814","","NC1CCN(C1)c1cccnc1"
"38","ABT-239","histamine receptor antagonist","HRH1, HRH2, HRH3","","","Axon",99.38,"BRD-K22749967-046-02-3","Phase 1","","KFHYZKCRXNRKRC-MRXNPFEDSA-N","BRD-K22749967","","C[C@@H]1CCCN1CCc1cc2cc(ccc2o1)-c1ccc(cc1)C#N"
"39","ABT-491","platelet activating factor receptor antagonist","PTAFR","","","EMDBio",93.81,"BRD-K97233161-003-01-5","Phase 1","","GDLNHSUSOZEAOR-UHFFFAOYSA-N","BRD-K97233161","","CN(C)C(=O)n1cc(C(=O)c2ccc(Cn3c(C)nc4cnccc34)c(F)c2)c2c(cccc12)C#C"
"40","ABT-639","calcium channel blocker","CACNA1G, CACNA1H, CACNA1I","","","MedChemEx",96.74,"BRD-K11792081-001-01-4","Phase 2","","AGPIHNZOZNKRGT-CYBMUJFWSA-N","BRD-K11792081","","Fc1ccccc1NS(=O)(=O)c1cc(C(=O)N2CCN3CCC[C@@H]3C2)c(Cl)cc1F"
"41","ABT-702","adenosine kinase inhibitor","ADK","","","Tocris, Tocris",87.52,"BRD-K36021395-300-03-2, BRD-K36021395-300-02-4","Preclinical","","RQCXKDWOCUJWQZ-UHFFFAOYSA-N","BRD-K36021395","","Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCOCC1"
"43","ABT-724","dopamine receptor agonist","DRD4","","","Tocris",97.43,"BRD-K37714784-305-02-1","Phase 2","","FRPJGTNLZNXQEX-UHFFFAOYSA-N","BRD-K37714784","","C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1"
"44","ABT-737","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Selleck, Selleck",87.14,"BRD-K56301217-001-10-8, BRD-K56301217-001-07-4","Phase 1/Phase 2","","HPLNQCPCUACXLM-PGUFJCEWSA-N","BRD-K56301217","","CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1"
"46","ABT-751","tubulin polymerization inhibitor","TUBB","","","Selleck, Tocris, Selleck",96.81,"BRD-K91623615-001-05-0, BRD-K91623615-001-06-8, BRD-K91623615-001-04-3","Phase 2","","URCVCIZFVQDVPM-UHFFFAOYSA-N","BRD-K91623615","","COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1"
"49","AC-186","estrogen receptor agonist","ESR2","","","Tocris",94.66,"BRD-K53788420-001-01-1","Preclinical","","HSMUKSLNDJOZQG-UHFFFAOYSA-N","BRD-K53788420","","Oc1ccc(cc1)C1(CCC(F)(F)CC1)c1ccccc1F"
"50","AC-261066","retinoid receptor agonist","RARB","","","Tocris",92.33,"BRD-K31144453-001-02-2","Preclinical","","HSAOETBFVAWNRP-UHFFFAOYSA-N","BRD-K31144453","","CCCCOCCOc1nc(sc1C)-c1ccc(C(O)=O)c(F)c1"
"51","AC-264613","PAR agonist","F2RL1","","","Tocris, Tocris",95.07,"BRD-K81548480-001-01-2, BRD-K81548480-001-02-0","Preclinical","","RQKXQCSEZPQBNZ-QSBCOWLBSA-N","BRD-K81548480","","C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)c1ccccc1)c1cccc(Br)c1"
"53","AC-55541","PARP inhibitor","PARP2","","","MedChemEx",97.05,"BRD-A27911617-001-01-7","Preclinical","","UCUHFWIFSHROPY-RWPZCVJISA-N","BRD-A27911617","","C\C(=N/NC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1"
"54","AC-55649","retinoid receptor agonist","RARA, RARB","","","Tocris, Tocris",98.46,"BRD-K93176058-001-03-6, BRD-K93176058-001-04-4","Preclinical","","HXBKPYIEQLLNBK-UHFFFAOYSA-N","BRD-K93176058","","CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O"
"56","AC-710","PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFRA, PDGFRB","","","Tocris",98.87,"BRD-K15819326-001-01-6","Preclinical","","JVCWPUFNLFSKFS-UHFFFAOYSA-N","BRD-K15819326","","CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(NC(=O)Nc2cc(on2)C(C)(C)C)cc1"
"57","AC-7954-(+/-)","urotensin receptor agonist","UTS2R","","","Tocris, Tocris",95.87,"BRD-A49544621-003-02-8, BRD-A49544621-003-03-6","Preclinical","","HIVBATDUVFEJFZ-UHFFFAOYSA-N","BRD-A49544621","","CN(C)CCC1(Cc2ccccc2C(=O)O1)c1ccc(Cl)cc1"
"59","ACADESINE","AMPK activator","","","","Selleck, Tocris, Selleck",100,"BRD-K53448858-001-09-6, BRD-K53448858-001-08-8, BRD-K53448858-001-07-0","Phase 3","BRD-K04797704-001-01-9","RTRQQBHATOEIAF-UUOKFMHZSA-N","BRD-K53448858","BRD-K04797704","NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N"
"62","ACALABRUTINIB","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","MedChemEx",88.47,"BRD-K64034691-001-01-9","Phase 3","","WDENQIQQYWYTPO-IBGZPJMESA-N","BRD-K64034691","","CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(cc2)C(=O)Nc2ccccn2)c2c(N)nccn12"
"63","ACALISIB","PI3K inhibitor","PIK3CB, PIK3CD","","","MedChemEx",98.55,"BRD-K92517771-001-01-2","Phase 1","","DOCINCLJNAXZQF-LBPRGKRZSA-N","BRD-K92517771","","C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1"
"64","ACDPP","glutamate receptor antagonist","GRM5","","","Tocris",95.36,"BRD-K68633617-003-02-9","Preclinical","","RNGRUHWJJPTYNR-UHFFFAOYSA-N","BRD-K68633617","","CN(C)c1nc(N)c(nc1Cl)C(=O)Nc1cccnc1"
"65","ACECAINIDE","polarization inhibitor","SCN5A","","","MicroSource",98.41,"BRD-K07753030-003-17-6","Phase 3","","KEECCEWTUVWFCV-UHFFFAOYSA-N","BRD-K07753030","","CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1"
"66","ACEDOBEN","","","","","MicroSource",95.14,"BRD-K47195926-001-06-6","Phase 2","","QCXJEYYXVJIFCE-UHFFFAOYSA-N","BRD-K47195926","","CC(=O)Nc1ccc(cc1)C(O)=O"
"67","ACENEURAMIC-ACID","","AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1","","","OxChem",100,"BRD-K36262466-001-06-3","Phase 3","","SQVRNKJHWKZAKO-PFQGKNLYSA-N","BRD-K36262466","","CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O"
"68","ACESULFAME-POTASSIUM","","","","","Selleck, MicroSource, Selleck",88.18,"BRD-K50850824-237-02-2, BRD-K50850824-237-03-0, BRD-K50850824-237-04-8","Phase 3","","YGCFIWIQZPHFLU-UHFFFAOYSA-N","BRD-K50850824","","CC1=CC(=O)NS(=O)(=O)O1"
"71","ACETANILIDE","hydrogen peroxide decomposition inhibitor","","","","MicroSource, Selleck",96.78,"BRD-K11094367-001-10-1, BRD-K11094367-001-09-3","Preclinical","","FZERHIULMFGESH-UHFFFAOYSA-N","BRD-K11094367","","CC(=O)Nc1ccccc1"
"73","ACETRIAZOIC-ACID","","","","","MicroSource, MedChemEx",96.57,"BRD-K46416130-001-06-9, BRD-K46416130-001-07-7","Preclinical","","GNOGSFBXBWBTIG-UHFFFAOYSA-N","BRD-K46416130","","CC(=O)Nc1c(I)cc(I)c(C(O)=O)c1I"
"75","ACETYL-11-KETO-BETA-BOSWELLIC-ACID","lipoxygenase inhibitor","HSD11B1, HSD11B2","","","AnalytiCon",0,"BRD-A44696962-001-01-4","Phase 2","","HMMGKOVEOFBCAU-MFIYSICPSA-N","BRD-A44696962","","C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C"
"76","ACETYLSALICYLSALICYLIC-ACID","cyclooxygenase inhibitor","","","","Prestwick",93.66,"BRD-K46585355-001-14-3","Preclinical","","DDSFKIFGAPZBSR-UHFFFAOYSA-N","BRD-K46585355","","CC(=O)Oc1ccccc1C(=O)Oc1ccccc1C(O)=O"
"77","ACIFRAN","cholesterol inhibitor","HCAR2, HCAR3","","","Tocris, Tocris",98.05,"BRD-A29520968-001-03-5, BRD-A29520968-001-02-7","Phase 3","","DFDGRKNOFOJBAJ-UHFFFAOYSA-N","BRD-A29520968","","CC1(OC(=CC1=O)C(O)=O)c1ccccc1"
"79","ACIVICIN","gamma glutamyltransferase Inhibitors","CTPS1","","","Enzo",100,"BRD-K13050541-001-01-9","Phase 2","","QAWIHIJWNYOLBE-ZAFYKAAXSA-N","BRD-K13050541","","N[C@H]([C@@H]1CC(Cl)=NO1)C(O)=O"
"80","ACPC","glutamate receptor antagonist","","","","Enzo",85.02,"BRD-K66465025-001-05-1","Phase 1","","PAJPWUMXBYXFCZ-UHFFFAOYSA-N","BRD-K66465025","","NC1(CC1)C(O)=O"
"81","ACRYLATE","mucus protecting agent","","","","Sigma",0,"BRD-M00184283-001-01-1","Phase 3","","MNNFZYTXMPWOTA-UHFFFAOYSA-N","BRD-M00184283","","[Na].OC(=O)C=C"
"82","ACT-462206","orexin receptor antagonist","HCRTR1, HCRTR2","","","Tocris, Sigma",97.06,"BRD-K19781342-001-02-2, BRD-K19781342-001-01-4","Phase 1","","NHPQGZOBHSVTAQ-IBGZPJMESA-N","BRD-K19781342","","COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1"
"84","ACTB-1003","FGFR inhibitor, VEGFR inhibitor","KDR, TEK","","","MedChemEx",95.17,"BRD-K35936936-001-01-6","Phase 1","","GZPJCJKUZPUFAL-UHFFFAOYSA-N","BRD-K35936936","","COCc1c(CN2CCOCC2)n2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)c(F)c1"
"85","ACTINOQUINOL","","","","","MicroSource",85.47,"BRD-K08837089-236-01-6","Preclinical","","YAMVZYRZAMBCED-UHFFFAOYSA-N","BRD-K08837089","","CCOc1ccc(c2cccnc12)S(O)(=O)=O"
"86","ACY-1215","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC6, HDAC8","","","Selleck",93.15,"BRD-K82928847-001-04-7","Phase 1/Phase 2","","QGZYDVAGYRLSKP-UHFFFAOYSA-N","BRD-K82928847","","ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1"
"87","AC1NDSS5","","","","","Sigma",75.43,"BRD-K10226125-245-01-5","Phase 1","","VZXULFIUJKSVJY-UHFFFAOYSA-N","BRD-K10226125","","CCCCCCCCCCCCCCCCCC[S+](CCC)c1ccccc1C(=O)OCC"
"88","AD-5467","aldose reductase inhibitor","AKR1B1","","","Maybridge, Maybridge",88.22,"BRD-A80280426-001-02-0, BRD-A80280426-001-03-8","Phase 2","","CLDJCRWXLDLJLO-UHFFFAOYSA-N","BRD-A80280426","","CC(C)C1Oc2c(cccc2N(CC(O)=O)C1=S)C(C)C"
"90","ADAPREV","TGF beta receptor inhibitor","IGF2R, M6PR","","","TCI",59.36,"BRD-A73427433-240-01-3","Phase 3","","NBSCHQHZLSJFNQ-GASJEMHNSA-N","BRD-A73427433","","OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O"
"91","ADAPTAVIR","CC chemokine receptor antagonist","CCR5","","","Tocris",89.21,"BRD-K37151368-001-01-7","Phase 2","","AKWRNBWMGFUAMF-ZESMOPTKSA-N","BRD-K37151368","","C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O"
"92","ADAROTENE","retinoid receptor agonist","RARB, RARG","","","MedChemEx",93.85,"BRD-K00152668-001-01-5","Phase 1","","QAWBIEIZDDIEMW-FPYGCLRLSA-N","BRD-K00152668","","OC(=O)\C=C\c1ccc(cc1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2"
"93","ADATANSERIN","serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR2A","","","Enamine",87.69,"BRD-K67789209-001-01-0","Phase 2","","HPFLVTSWRFCPCV-UHFFFAOYSA-N","BRD-K67789209","","O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2"
"94","ADD-233089","benzodiazepine receptor agonist","","","","MedChemEx",98.53,"BRD-K43055376-001-01-2","Phase 1","","IQHYCZKIFIHTAI-UHFFFAOYSA-N","BRD-K43055376","","Clc1ccc(cc1)N1CC(=NC1=O)N1CCOCC1"
"95","ADELMIDROL","anti-inflammatory agent","","","","MicroSource",53.55,"BRD-K78097265-001-01-6","Phase 2/Phase 3","","PAHZPHDAJQIETD-UHFFFAOYSA-N","BRD-K78097265","","OCCNC(=O)CCCCCCCC(=O)NCCO"
"96","ADENINE","protein synthesis stimulant","ACACB, ACP1, APRT, MTAP, PECR, SRPK2","","","Selleck, MicroSource, Selleck, Selleck",97.86,"BRD-K26060080-065-05-6, BRD-K26060080-001-11-9, BRD-K26060080-003-07-3, BRD-K26060080-001-10-1","Preclinical","BRD-M27046829-065-02-5","GFFGJBXGBJISGV-UHFFFAOYSA-N","BRD-K26060080","BRD-M27046829","Nc1ncnc2[nH]cnc12"
"100","ADENOSINE-PHOSPHATE","adenosine receptor agonist","ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4","","","MicroSource",100,"BRD-A10111329-001-04-6","Launched","","UDMBCSSLTHHNCD-VTHZCTBJSA-N","BRD-A10111329","","Nc1ncnc2n(cnc12)C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O"
"101","ADENOSINE-TRIPHOSPHATE","adenosine receptor agonist","ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7","","","MicroSource, Selleck, Selleck",83.47,"BRD-A31990649-304-04-9, BRD-A31990649-304-02-3, BRD-A31990649-304-03-1","Phase 2","BRD-A76560018-304-02-3, BRD-A48310747-304-01-8","ZKHQWZAMYRWXGA-KQYNXXCUSA-N","BRD-A31990649","BRD-A76560018","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"
"104","ADIPIC-ACID","solute carrier family member inhibitor","SLC22A6","","","Enamine",100,"BRD-K10656395-001-02-1","Preclinical","","WNLRTRBMVRJNCN-UHFFFAOYSA-N","BRD-K10656395","","OC(=O)CCCCC(O)=O"
"105","ADIPORON","adiponectin receptor agonist","ADIPOR1, ADIPOR2","","","Selleck, Tocris, Selleck",98.48,"BRD-K68810443-001-01-9, BRD-K68810443-003-01-5, BRD-K68810443-001-02-7","Preclinical","","SHHUPGSHGSNPDB-UHFFFAOYSA-N","BRD-K68810443","","O=C(COc1ccc(cc1)C(=O)c1ccccc1)NC1CCN(Cc2ccccc2)CC1"
"108","ADL5859","opioid receptor agonist","OPRD1","","","Selleck, Selleck",96.95,"BRD-K39624409-003-02-6, BRD-K39624409-003-03-4","Phase 2","","OPIKUXLJQFYMSC-UHFFFAOYSA-N","BRD-K39624409","","CCN(CC)C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2cccc(O)c12"
"110","ADOPRAZINE","dopamine receptor antagonist, serotonin receptor agonist","DRD2, HTR1A","","","MedChemEx",95.25,"BRD-K34870043-001-01-8","Phase 2","","IUVSEUFHPNITEQ-UHFFFAOYSA-N","BRD-K34870043","","Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1"
"111","ADRENOSTERONE","11-beta hydroxysteroid dehydrogenase inhibitor","HSD11B1, HSD11B2","","","MedChemEx",98.71,"BRD-K17368287-001-18-3","Preclinical","","RZRPTBIGEANTGU-IRIMSJTPSA-N","BRD-K17368287","","C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O"
"112","ADX-10059","glutamate receptor negative allosteric modulator","GRM5","","","Tocris",94.68,"BRD-K77911775-003-01-8","Phase 2","","MEDCLNYIYBERKO-UHFFFAOYSA-N","BRD-K77911775","","Cc1cc(C)c(N)c(n1)C#Cc1cccc(F)c1"
"113","ADX-47273","glutamate receptor modulator","GRM5","","","Selleck",96.63,"BRD-K56543881-001-02-7","Preclinical","","VXQCCZHCFBHTTD-HNNXBMFYSA-N","BRD-K56543881","","Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1nc(no1)-c1ccc(F)cc1"
"114","AEE788","EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR","","","Selleck, Selleck, Tocris",96.82,"BRD-K40718343-001-03-4, BRD-K40718343-001-02-6, BRD-K40718343-001-04-2","Phase 1/Phase 2","","OONFNUWBHFSNBT-HXUWFJFHSA-N","BRD-K40718343","","CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1"
"117","AEG3482","HSP inducer","","","","Tocris, Tocris",97.67,"BRD-K77634909-001-03-5, BRD-K77634909-001-05-0","Preclinical","","MQUYTXDAVCOCMX-UHFFFAOYSA-N","BRD-K77634909","","NS(=O)(=O)c1nn2cc(nc2s1)-c1ccccc1"
"119","AFALANINE","dopamine receptor agonist","DRD2","","","MicroSource",98.01,"BRD-K53205568-001-02-6","Phase 3","","CBQJSKKFNMDLON-JTQLQIEISA-N","BRD-K53205568","","CC(=O)N[C@@H](Cc1ccccc1)C(O)=O"
"120","AFIMOXIFENE","estrogen receptor antagonist","ESR1, ESR2, ESRRG, PLD1, PRKCD, PRKCE, PRKCQ, PRKCZ","","","Sigma",47.39,"BRD-K04210847-001-21-9","Phase 2","","TXUZVZSFRXZGTL-QPLCGJKRSA-N","BRD-K04210847","","CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1"
"121","AFN-1252","FABI inhibitor","","","","MedChemEx",95.38,"BRD-K23791635-001-01-3","Phase 2","","QXTWSUQCXCWEHF-JXMROGBWSA-N","BRD-K23791635","","CN(Cc1oc2ccccc2c1C)C(=O)\C=C\C1=CNC2=NC(=O)CCC2=C1"
"122","AF38469","sortilin inhibitor","SORT1","","","MedChemEx",96.02,"BRD-K47816470-001-01-8","Preclinical","","JWCUSQCZMQIBMR-UHFFFAOYSA-N","BRD-K47816470","","Cc1cccc(NC(=O)c2ccc(cc2C(O)=O)C(F)(F)F)n1"
"123","AG-1024","insulin growth factor receptor inhibitor","IGF1R","","","Selleck",91.46,"BRD-K08310154-001-03-8","Preclinical","","ABBADGFSRBWENF-UHFFFAOYSA-N","BRD-K08310154","","CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O"
"124","AG-14361","PARP inhibitor","PARP1","","","Selleck, Selleck",95.36,"BRD-K00615600-001-12-9, BRD-K00615600-001-13-7","Preclinical","","SEKJSSBJKFLZIT-UHFFFAOYSA-N","BRD-K00615600","","CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23"
"126","AG-490","EGFR inhibitor, JAK inhibitor","EGFR, JAK2, JAK3","","","Selleck, Tocris, Selleck",90.64,"BRD-K47105409-001-15-2, BRD-K47105409-001-14-5, BRD-K47105409-001-13-7","Preclinical","","TUCIOBMMDDOEMM-RIYZIHGNSA-N","BRD-K47105409","","Oc1ccc(cc1O)\C=C(/C#N)C(=O)NCc1ccccc1"
"129","AG-555","tyrosine kinase inhibitor","CDK2","","","Tocris",58.16,"BRD-K34428485-001-18-4","Preclinical","","GSQOBTOAOGXIFL-LFIBNONCSA-N","BRD-K34428485","","Oc1ccc(\C=C(/C#N)C(=O)NCCCc2ccccc2)cc1O"
"130","AG-556","tyrosine kinase inhibitor","","","","Tocris",57.92,"BRD-K81048131-001-02-4","Preclinical","","GWCNJMUSWLTSCW-SFQUDFHCSA-N","BRD-K81048131","","Oc1ccc(\C=C(/C#N)C(=O)NCCCCc2ccccc2)cc1O"
"131","AGI-5198","isocitrate dehydrogenase inhibitor","IDH1","","","Selleck",98.97,"BRD-A56371469-001-03-3","Preclinical","","FNYGWXSATBUBER-UHFFFAOYSA-N","BRD-A56371469","","Cc1nccn1CC(=O)N(C(C(=O)NC1CCCCC1)c1ccccc1C)c1cccc(F)c1"
"132","AGI-6780","isocitrate dehydrogenase inhibitor","IDH2","","","Selleck",96.02,"BRD-K04691817-001-01-8","Preclinical","","CCAWRGNYALGPQH-UHFFFAOYSA-N","BRD-K04691817","","FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2-c2ccsc2)S(=O)(=O)NC2CC2)c1"
"133","AGM-1470","cell cycle inhibitor","METAP2","","","Enzo",58.76,"BRD-A78111609-001-01-2","Phase 2","","MSHZHSPISPJWHW-MIQCOGSQSA-N","BRD-A78111609","","CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl"
"134","AGMATINE","nitric oxide synthase inhibitor","ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH","","","Enzo",0,"BRD-K49738308-065-04-9","Phase 3","","QYPPJABKJHAVHS-UHFFFAOYSA-N","BRD-K49738308","","NCCCCNC(N)=N"
"135","AGN-192403","imidazoline receptor ligand","NISCH","","","Tocris, Tocris",100,"BRD-A18074780-003-02-0, BRD-A18074780-003-04-6","Preclinical","BRD-A79038507-003-02-3, BRD-A79038507-003-03-1","SHXVJSFOJHMEEQ-YDYPAMBWSA-N","BRD-A18074780","BRD-A79038507","CC(C)[C@@H]1C2CCC(C2)[C@H]1N"
"137","AGN-194310","retinoid receptor antagonist","RXRA, RXRB, RXRG","","","MedChemEx",96.23,"BRD-K70262971-001-01-9","Phase 3","","LHUPKWKWYWOMSK-UHFFFAOYSA-N","BRD-K70262971","","CCc1ccc(cc1)C1=CC(C)(C)Sc2ccc(cc12)C#Cc1ccc(cc1)C(O)=O"
"138","AGN-195183","retinoid receptor agonist","RARA","","","MedChemEx",94.51,"BRD-K32533226-001-01-3","Phase 1/Phase 2","","PNAWUIKCVQSLFG-UHFFFAOYSA-N","BRD-K32533226","","CC1(C)CCC(C)(C)c2c(Cl)c(O)c(cc12)C(=O)Nc1cc(F)c(C(O)=O)c(F)c1"
"139","AGP-103","membrane permeability inhibitor","","","","Enzo",91.5,"BRD-K91495480-001-02-2","Launched","","UKMSUNONTOPOIO-UHFFFAOYSA-N","BRD-K91495480","","CCCCCCCCCCCCCCCCCCCCCC(O)=O"
"140","AH-7614","free fatty acid receptor antagonist","FFAR4","","","Tocris",95.83,"BRD-K10852420-001-02-5","Preclinical","","OZCQEUZTOAAWDK-UHFFFAOYSA-N","BRD-K10852420","","Cc1ccc(cc1)S(=O)(=O)NC1c2ccccc2Oc2ccccc12"
"141","AH11110","adrenergic receptor ligand","ADRA1B","","","Tocris",98.96,"BRD-A64808605-003-02-7","Preclinical","","HSVZQQYIMKLNLN-UHFFFAOYSA-N","BRD-A64808605","","OC(COc1ccccc1-c1ccccc1)CC(=N)N1CCCCC1"
"142","AH6809","prostanoid receptor antagonist","PTGDR, PTGER1, PTGER2, PTGER3","","","Tocris, Tocris",96.06,"BRD-K59339270-001-03-4, BRD-K59339270-001-02-6","Preclinical","","AQFFXPQJLZFABJ-UHFFFAOYSA-N","BRD-K59339270","","CC(C)Oc1ccc2c(c1)oc1ccc(cc1c2=O)C(O)=O"
"144","AI-10-49","core binding factor inhibitor","CBFB","","","MedChemEx",92.82,"BRD-K89899948-001-01-7","Preclinical","","WJBSSBFGPKTMQQ-UHFFFAOYSA-N","BRD-K89899948","","FC(F)(F)Oc1ccc2nc([nH]c2c1)-c1ccc(OCCOCCOc2ccc(nc2)-c2nc3ccc(OC(F)(F)F)cc3[nH]2)cn1"
"145","AIM-100","tyrosine kinase inhibitor","TNK2","","","Tocris",98.41,"BRD-K85139301-001-01-3","Preclinical","","XNFHHOXCDUAYSR-SFHVURJKSA-N","BRD-K85139301","","C(Nc1ncnc2oc(c(-c3ccccc3)c12)-c1ccccc1)[C@@H]1CCCO1"
"146","AJ76-(+)","dopamine receptor antagonist","DRD2, DRD3, DRD4","","","Tocris",94.73,"BRD-K76677554-003-02-1","Preclinical","","YGHLYBIUVOLKCV-SMDDNHRTSA-N","BRD-K76677554","","CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C"
"147","AK-7","SIRT inhibitor","SIRT2","","","Tocris",96.33,"BRD-K09143580-001-01-0","Preclinical","","IYAYHZZWYNXHEQ-UHFFFAOYSA-N","BRD-K09143580","","Brc1cccc(NC(=O)c2cccc(c2)S(=O)(=O)N2CCCCCC2)c1"
"148","AKBA","lipoxygenase inhibitor","ALOX5","","","MedChemEx",90.39,"BRD-K54907283-001-01-2","Phase 3","","HMMGKOVEOFBCAU-BCDBGHSCSA-N","BRD-K54907283","","C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C"
"149","AL-8697","p38 MAPK inhibitor","MAPK14","","","Tocris",99.77,"BRD-K44731351-001-01-6","Preclinical","","ZVBTZTQYHOXIBC-UHFFFAOYSA-N","BRD-K44731351","","Cc1c(F)cc(cc1-c1c(F)cn2c(nnc2c1F)C(C)(C)C)C(=O)NC1CC1"
"150","ALAFOSFALIN","bacterial cell wall synthesis inhibitor","","","","Sigma",93.9,"BRD-K80403280-001-02-1","Phase 1","","BHAYDBSYOBONRV-IUYQGCFVSA-N","BRD-K80403280","","C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O"
"151","ALAGEBRIUM","glycosylation inhibitor","","","","OxChem",87.59,"BRD-K96029467-003-01-9","Phase 2/Phase 3","","LYLFQLCLUXOFOL-UHFFFAOYSA-N","BRD-K96029467","","Cc1sc[n+](CC(=O)c2ccccc2)c1C"
"152","ALANINE","","AARS, AARS2, ABAT, AGXT, AGXT2, GPRC6A, GPT, GPT2, KYNU, NFS1, PHYKPL, SLC1A4, SLC36A1, SLC7A8","","","Sigma",69.19,"BRD-A33317514-001-01-3","Launched","","QNAYBMKLOCPYGJ-UHFFFAOYSA-N","BRD-A33317514","","CC(N)C(O)=O"
"153","ALANTOLACTONE","apoptosis stimulant, STAT inhibitor","STAT3","","","Tocris",86.65,"BRD-K53731810-001-04-3","Preclinical","","PXOYOCNNSUAQNS-AGNJHWRGSA-N","BRD-K53731810","","C[C@H]1CCC[C@]2(C)C[C@H]3OC(=O)C(=C)[C@H]3C=C12"
"154","ALAPROCLATE","serotonin receptor antagonist","SLC6A4","","","AlfaAesar",95.15,"BRD-A14966924-003-07-7","Phase 2","","FZSPJBYOKQPKCD-UHFFFAOYSA-N","BRD-A14966924","","CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1"
"155","ALARELIN","gonadotropin releasing factor hormone receptor antagonist","GNRH1","","","MedChemEx",96.08,"BRD-K42140276-402-01-4","Launched","","QLGKMLRGKPKGKI-QWQCQAQZSA-N","BRD-K42140276","","CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1"
"156","ALDA-1","aldehyde dehydrogenase activator","ALDH2","","","Tocris",96.06,"BRD-K06890060-001-09-1","Preclinical","","NMKJFZCBCIUYHI-UHFFFAOYSA-N","BRD-K06890060","","Clc1cccc(Cl)c1C(=O)NCc1ccc2OCOc2c1"
"157","ALDOXORUBICIN","topoisomerase inhibitor","TOP2A","","","MedChemEx, MedChemEx, MedChemEx",55.08,"BRD-K68928792-001-03-2, BRD-K68928792-001-01-6, BRD-K68928792-001-02-4","Phase 3","","OBMJQRLIQQTJLR-USGQOSEYSA-N","BRD-K68928792","","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(\CO)=N\NC(=O)CCCCCN1C(=O)C=CC1=O"
"160","ALEXIDINE","phosphatidylglycerophosphatase inhibitor","PTPMT1","","","Selleck",91.99,"BRD-A27883417-300-01-6","Preclinical","","LFVVNPBBFUSSHL-UHFFFAOYSA-N","BRD-A27883417","","CCCCC(CC)C\N=C(/N)N\C(N)=N\CCCCCC\N=C(/N)N\C(N)=N\CC(CC)CCCC"
"161","ALFADOLONE-ACETATE","benzodiazepine receptor agonist","","","","Prestwick",100,"BRD-K51751936-001-09-1","Phase 2","","QRJOQYLXZPQQMX-FWROMSNXSA-N","BRD-K51751936","","CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C"
"162","ALISERTIB","Aurora kinase inhibitor","AURKA","","","Selleck",98.27,"BRD-K75295174-001-05-0","Phase 3","","ZLHFILGSQDJULK-UHFFFAOYSA-N","BRD-K75295174","","COc1cc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2OC)ccc1C(O)=O"
"163","ALIZARIN","","","","","Selleck, Selleck",92.04,"BRD-K73191876-001-12-0, BRD-K73191876-001-11-2","Preclinical","","RGCKGOZRHPZPFP-UHFFFAOYSA-N","BRD-K73191876","","Oc1ccc2C(=O)c3ccccc3C(=O)c2c1O"
"165","ALLICIN","cytokine production inhibitor","TRPA1, TRPV1","","","AKSci",0,"BRD-A60402836-001-01-0","Phase 2","","JDLKFOPOAOFWQN-UHFFFAOYSA-N","BRD-A60402836","","C=CCSS(=O)CC=C"
"166","ALLOPREGNANOLONE","GABA receptor positive allosteric modulator","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2","","","Tocris",93.1,"BRD-A03204438-001-02-0","Phase 2","","AURFZBICLPNKBZ-JMTGGFPBSA-N","BRD-A03204438","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"167","ALLOPURINOL-RIBOSIDE","anti-leishmanial agent","","","","Berry",100,"BRD-A93407926-001-01-1","Phase 2","","UKNHQPDCWMADJW-VTUMKUEMSA-N","BRD-A93407926","","OC[C@H]1O[C@H](C(O)[C@H]1O)n1[nH]cc2c1ncnc2=O"
"168","ALLYLISOTHIOCYANATE","TRPV agonist","TRPA1","","","MicroSource",0,"BRD-K33219225-001-01-9","Preclinical","","ZOJBYZNEUISWFT-UHFFFAOYSA-N","BRD-K33219225","","C=CCN=C=S"
"169","ALLYLTHIOUREA","nitrification inhibitor","","","","Selleck, MicroSource",99.28,"BRD-K89634775-001-08-1, BRD-K89634775-001-09-9","Preclinical","","HTKFORQRBXIQHD-UHFFFAOYSA-N","BRD-K89634775","","NC(S)=NCC=C"
"171","ALMOREXANT","orexin receptor antagonist","HCRTR1, HCRTR2","","","MedChemEx",90.95,"BRD-K84810405-003-01-1","Phase 3","","DKMACHNQISHMDN-RPLLCQBOSA-N","BRD-K84810405","","CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1"
"172","ALOE-EMODIN","anticancer agent","CASP8","","","Selleck",94.34,"BRD-K04851519-001-06-8","Preclinical","","YDQWDHRMZQUTBA-UHFFFAOYSA-N","BRD-K04851519","","OCc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1"
"173","ALOIN","angiogenesis inhibitor","","","","Selleck, Selleck, MicroSource",50.52,"BRD-K02074536-001-02-7, BRD-K02074536-001-03-5, BRD-K02074536-001-01-9","Preclinical","BRD-A63615100-001-03-9, BRD-A63615100-001-02-1,BRD-A82191553-001-01-4","AFHJQYHRLPMKHU-OSYMLPPYSA-N","BRD-K02074536","BRD-A63615100","OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@H]1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12"
"176","ALOPERINE","","","","","Selleck",97.73,"BRD-K96391852-001-02-8","Preclinical","","SKOLRLSBMUGVOY-GBJTYRQASA-N","BRD-K96391852","","C1CCN2C[C@H]3C[C@H](C=C4CCCN[C@@H]34)[C@H]2C1"
"177","ALOSETRON","serotonin receptor antagonist","HTR3A","","","Enzo",99.02,"BRD-K46742498-003-11-0","Withdrawn","","JSWZEAMFRNKZNL-UHFFFAOYSA-N","BRD-K46742498","","Cc1[nH]cnc1CN1CCc2c(C1=O)c1ccccc1n2C"
"178","ALOXISTATIN","protease inhibitor","CTSG","","","MedChemEx, Adooq, Selleck, Selleck",86.09,"BRD-K91188791-001-17-5, BRD-K91188791-001-15-9, BRD-K91188791-001-18-3, BRD-K91188791-001-14-2","Phase 3","BRD-A12987505-001-01-9","SRVFFFJZQVENJC-IHRRRGAJSA-N","BRD-K91188791","BRD-A12987505","CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C"
"182","ALPELISIB","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",91.09,"BRD-K54997624-001-06-0","Phase 3","","STUWGJZDJHPWGZ-LBPRGKRZSA-N","BRD-K54997624","","Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F"
"183","ALPHA-ASARONE","cytochrome P450 inhibitor, HMGCR inhibitor","HMGCR","","","Cayman",94.23,"BRD-K72536715-001-01-5","Preclinical","","RKFAZBXYICVSKP-AATRIKPKSA-N","BRD-K72536715","","COc1cc(OC)c(\C=C\C)cc1OC"
"184","ALPHA-D-GLUCOPYRANOSE","","","","","Sigma",0,"BRD-K87424134-001-01-0","Preclinical","","WQZGKKKJIJFFOK-DVKNGEFBSA-N","BRD-K87424134","","OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O"
"185","ALPHA-LINOLENIC-ACID","omega 3 fatty acid stimulant","ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1","","","Sigma, Enzo",84.81,"BRD-K33396764-001-11-1, BRD-K33396764-001-08-7","Phase 3","","DTOSIQBPPRVQHS-PDBXOOCHSA-N","BRD-K33396764","","CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O"
"187","ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-)","histamine receptor agonist","HRH3","","","Tocris",90.81,"BRD-K80028314-303-02-6","Preclinical","","XNQIOISZPFVUFG-RXMQYKEDSA-N","BRD-K80028314","","C[C@@H](N)Cc1c[nH]cn1"
"188","ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+)","histamine receptor agonist","HRH3","","","Tocris",91.26,"BRD-K28308851-303-01-8","Preclinical","","XNQIOISZPFVUFG-YFKPBYRVSA-N","BRD-K28308851","","C[C@H](N)Cc1c[nH]cn1"
"189","ALPHA-METHYLSEROTONIN","serotonin receptor agonist","HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4","","","Tocris, Tocris",64.4,"BRD-A17745711-050-06-2, BRD-A17745711-050-05-4","Preclinical","","LYPCGXKCQDYTFV-UHFFFAOYSA-N","BRD-A17745711","","CC(N)Cc1c[nH]c2ccc(O)cc12"
"191","ALPIDEM","benzodiazepine receptor agonist","GABRA1","","","Sigma",98.59,"BRD-K66896751-001-02-4","Withdrawn","","JRTIDHTUMYMPRU-UHFFFAOYSA-N","BRD-K66896751","","CCCN(CCC)C(=O)Cc1c(nc2ccc(Cl)cn12)-c1ccc(Cl)cc1"
"192","ALRESTATIN","aldose reductase inhibitor","AKR1B1","","","Tocris, MicroSource",98.57,"BRD-K35498378-001-06-1, BRD-K35498378-001-07-9","Preclinical","","GCUCIFQCGJIRNT-UHFFFAOYSA-N","BRD-K35498378","","OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23"
"194","ALS-8176","RNA polymerase inhibitor","","","","MedChemEx",95.6,"BRD-K21415491-001-01-4","Phase 1","","AWSRKKBIPSQHOJ-IBCQBUCCSA-N","BRD-K21415491","","Nc1ccn([C@@H]2O[C@@](CO)(CCl)[C@@H](O)[C@H]2F)c(=O)n1"
"195","ALTANSERIN","serotonin receptor antagonist","HTR2A","","","Tocris, Tocris",96.89,"BRD-K00610438-003-03-3, BRD-K00610438-003-02-5","Phase 2","","SMYALUSCZJXWHG-UHFFFAOYSA-N","BRD-K00610438","","Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1"
"197","ALTINICLINE","nicotinic receptor agonist","CHRNA4, CHRNB2","","","Tocris",95.59,"BRD-K52681925-050-01-6","Phase 2","","NUPUDYKEEJNZRG-LBPRGKRZSA-N","BRD-K52681925","","CN1CCC[C@H]1c1cncc(c1)C#C"
"198","ALTIRATINIB","VEGFR inhibitor, MET inhibitor","KDR, MET, TEK","","","MedChemEx",92.67,"BRD-K78627070-001-01-5","Phase 1","","GNNDEPIMDAZHRQ-UHFFFAOYSA-N","BRD-K78627070","","Fc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1"
"199","ALVESPIMYCIN","HSP inhibitor","HSP90AA1","","","Selleck, Selleck",96.5,"BRD-K83988098-003-03-4, BRD-K83988098-001-02-0","Phase 2","BRD-K23499943-003-01-6","KUFRQPKVAWMTJO-LMZWQJSESA-N","BRD-K83988098","BRD-K23499943","CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O"
"201","ALVOCIDIB","CDK inhibitor","CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM","","","Tocris, Selleck",94.16,"BRD-K87909389-003-04-2, BRD-K87909389-003-03-4","Phase 2","","BIIVYFLTOXDAOV-YVEFUNNKSA-N","BRD-K87909389","","CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl"
"203","ALX-5407","Glycine transporter 1 inhibitor","SLC6A9","","","Tocris, Tocris",98.56,"BRD-K53979406-003-03-6, BRD-K53979406-003-02-8","Phase 1","","FDORQEIHOKEJNX-HSZRJFAPSA-N","BRD-K53979406","","CN(CC[C@@H](Oc1ccc(cc1)-c1ccccc1)c1ccc(F)cc1)CC(O)=O"
"205","AM-1241","cannabinoid receptor agonist","CNR1, CNR2","","","Selleck",94.55,"BRD-A66116161-001-02-3","Preclinical","","ZUHIXXCLLBMBDW-UHFFFAOYSA-N","BRD-A66116161","","CN1CCCCC1Cn1cc(C(=O)c2cc(ccc2I)[N+]([O-])=O)c2ccccc12"
"206","AM-24","lipoxygenase inhibitor","ALOX5","","","Enamine",99.73,"BRD-K59013864-001-01-1","Phase 2","","VAPDZNUFNKUROY-UHFFFAOYSA-N","BRD-K59013864","","Oc1c(I)cc(I)cc1I"
"207","AM-251","cannabinoid receptor antagonist","CNR1, GPR18, GPR55","","","Selleck, Tocris",94.81,"BRD-K92000912-001-11-8, BRD-K92000912-001-12-6","Preclinical","","BUZAJRPLUGXRAB-UHFFFAOYSA-N","BRD-K92000912","","Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1"
"209","AM-281","cannabinoid receptor antagonist","CNR1, CNR2, GPR55","","","Tocris",95.08,"BRD-K59419204-001-02-7","Preclinical","","AJFFBPZYXRNAIC-UHFFFAOYSA-N","BRD-K59419204","","Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCOCC1"
"210","AM-404","cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist","CNR1, CNR2, FAAH, TRPV1","","","Tocris",94.19,"BRD-K55462201-001-07-3","Preclinical","","IJBZOOZRAXHERC-DOFZRALJSA-N","BRD-K55462201","","CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)Nc1ccc(O)cc1"
"211","AM-580","retinoid receptor agonist","RARA","","","Tocris, Tocris",98.56,"BRD-K06854232-001-19-9, BRD-K06854232-001-22-3","Preclinical","","SZWKGOZKRMMLAJ-UHFFFAOYSA-N","BRD-K06854232","","CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O"
"213","AM-630","cannabinoid receptor antagonist","CNR1, CNR2","","","Tocris, Tocris",97.26,"BRD-K63533170-001-03-7, BRD-K63533170-001-02-9","Preclinical","","JHOTYHDSLIUKCJ-UHFFFAOYSA-N","BRD-K63533170","","COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12"
"215","AM-92016","potassium channel blocker","GRIN1","","","Tocris, Tocris",89.71,"BRD-A11813248-003-03-2, BRD-A11813248-003-02-4","Preclinical","","BQBSHJUQVIWEFM-UHFFFAOYSA-N","BRD-A11813248","","CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1"
"217","AMBAZONE","DNA damage inducer","","","","Kemprotec, Vitas-M, Vitas-M",84,"BRD-K11244467-002-01-8, BRD-K11244467-001-09-3, BRD-K11244467-001-08-5","Phase 1","","HQDSAVMTLKVTGJ-UHFFFAOYSA-N","BRD-K11244467","","NC(=N)N=Nc1ccc(NNC(S)=N)cc1"
"220","AMD-3465","CC chemokine receptor antagonist","CXCR4","","","Tocris",65.06,"BRD-K03019184-439-01-0","Preclinical","","CWJJHESJXJQCJA-UHFFFAOYSA-N","BRD-K03019184","","C(NCc1ccccn1)c1ccc(CN2CCCNCCNCCCNCC2)cc1"
"221","AMD11070","CC chemokine receptor antagonist","CXCR4","","","MedChemEx",92.59,"BRD-K42948882-305-01-1","Phase 1/Phase 2","","WVLHHLRVNDMIAR-IBGZPJMESA-N","BRD-K42948882","","NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc12"
"222","AMELTOLIDE","anticonvulsant","","","","Vitas-M",98.29,"BRD-K48173020-001-01-8","Preclinical","","HZIWGOAXOBPQGY-UHFFFAOYSA-N","BRD-K48173020","","Cc1cccc(C)c1NC(=O)c1ccc(N)cc1"
"223","AMEZINIUM","adrenergic receptor agonist","ADRB2","","","CombiBlocks",74.42,"BRD-K51387999-067-01-6","Launched","","VXROHTDSRBRJLN-UHFFFAOYSA-O","BRD-K51387999","","COc1cc(N)cn[n+]1-c1ccccc1"
"224","AMFLUTIZOLE","xanthine oxidase inhibitor","XDH","","","Enamine",96.22,"BRD-K50813454-001-01-9","Phase 2","","KVMCEGAWQYTFKC-UHFFFAOYSA-N","BRD-K50813454","","Nc1c(snc1-c1cccc(c1)C(F)(F)F)C(O)=O"
"225","AMG-PERK-44","PERK inhibitor","EIF2AK4","","","Tocris",97.69,"BRD-K04374714-003-01-1","Preclinical","","YPPSMYLMSKHYAY-UHFFFAOYSA-N","BRD-K04374714","","Cc1ccc2cc(ccc2n1)-c1c(C)ccc(C(=O)c2c(-c3ccccc3)n(C)n(-c3ccccc3)c2=O)c1N"
"226","AMG-208","tyrosine kinase inhibitor","MET","","","MedChemEx",99.83,"BRD-K32285926-001-02-1","Phase 1","","HEAIZQNMNCHNFD-UHFFFAOYSA-N","BRD-K32285926","","COc1ccc2c(OCc3nnc4ccc(nn34)-c3ccccc3)ccnc2c1"
"227","AMG-232","MDM inhibitor","MDM2","","","MedChemEx",98.92,"BRD-K64925568-001-01-8","Phase 1/Phase 2","","DRLCSJFKKILATL-YWCVFVGNSA-N","BRD-K64925568","","CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1"
"228","AMG-319","PI3K inhibitor","PIK3CD","","","MedChemEx",98.62,"BRD-K21077415-001-01-5","Phase 2","","KWRYMZHCQIOOEB-LBPRGKRZSA-N","BRD-K21077415","","C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1"
"229","AMG-337","MET inhibitor","MET","","","MedChemEx",92.73,"BRD-K27061362-001-01-6","Phase 2","","DWHXUGDWKAIASB-CQSZACIVSA-N","BRD-K27061362","","COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(cn34)-c3cnn(C)c3)c(=O)c2c1"
"230","AMG-487","CC chemokine receptor antagonist","","","","MedChemEx",98.21,"BRD-K90239174-001-01-8","Phase 2","","WQTKNBPCJKRYPA-OAQYLSRUSA-N","BRD-K90239174","","CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1"
"231","AMG-487-(+/-)","CC chemokine receptor antagonist","CXCR3","","","Tocris",97.4,"BRD-A01307728-001-01-4","Phase 2","","WQTKNBPCJKRYPA-UHFFFAOYSA-N","BRD-A01307728","","CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)C(C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1"
"232","AMG-517","TRPV antagonist","TRPV1","","","Selleck",97.4,"BRD-K34185671-001-02-8","Phase 1","","YUTIXVXZQIQWGY-UHFFFAOYSA-N","BRD-K34185671","","CC(=O)Nc1nc2c(Oc3cc(ncn3)-c3ccc(cc3)C(F)(F)F)cccc2s1"
"233","AMG-548","MAP kinase inhibitor","MAPK11, MAPK12, MAPK13, MAPK14","","","Tocris, Tocris",87.61,"BRD-K86673452-001-01-7, BRD-K86673452-001-02-5","Phase 1","","RQVKVJIRFKVPBF-VWLOTQADSA-N","BRD-K86673452","","Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O"
"235","AMG-837","free fatty acid receptor agonist","FFAR1","","","MedChemEx",97.49,"BRD-K43802723-340-01-9","Phase 1","BRD-M56591481-002-01-8","ZOPNBMMVVZRSGH-NRFANRHFSA-N","BRD-K43802723","BRD-M56591481","CC#C[C@@H](CC(O)=O)c1ccc(OCc2cccc(c2)-c2ccc(cc2)C(F)(F)F)cc1"
"236","AMG-925","CDK inhibitor, FLT3 inhibitor","CDK4, CDK6, FLT3","","","MedChemEx",94.57,"BRD-K97452254-001-01-3","Phase 1","","BBUVDDPUURMFOX-SAABIXHNSA-N","BRD-K97452254","","C[C@H]1CC[C@@H](CC1)n1c2cnccc2c2cnc(Nc3ccc4CN(CCc4n3)C(=O)CO)nc12"
"237","AMG-9810","TRPV antagonist","TRPV1","","","Tocris, Tocris",98.34,"BRD-K01995783-001-01-6, BRD-K01995783-001-02-4","Preclinical","","GZTFUVZVLYUPRG-IZZDOVSWSA-N","BRD-K01995783","","CC(C)(C)c1ccc(cc1)\C=C\C(=O)Nc1ccc2OCCOc2c1"
"239","AMG319","PI3K inhibitor","PIK3CD","","","Selleck",99.26,"BRD-A58947127-001-01-6","Phase 2","","KWRYMZHCQIOOEB-UHFFFAOYSA-N","BRD-A58947127","","CC(Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1"
"240","AMG458","MET inhibitor","MET","","","Selleck, Selleck",93.71,"BRD-K21782625-001-02-4, BRD-K21782625-001-03-2","Preclinical","","GLBZSOQDAOLMGC-UHFFFAOYSA-N","BRD-K21782625","","COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1"
"242","AMG900","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck",92.61,"BRD-K21728777-001-02-3","Phase 1","","IVUGFMLRJOCGAS-UHFFFAOYSA-N","BRD-K21728777","","Cc1csc(c1)-c1nnc(Nc2ccc(Oc3ncccc3-c3ccnc(N)n3)cc2)c2ccccc12"
"243","AMI-1","protein arginine N-methyltransferase inhibitor","PRMT1","","","ChemBridge",83.1,"BRD-K75114721-304-02-6","Preclinical","","PCGISRHGYLRXSR-UHFFFAOYSA-N","BRD-K75114721","","Oc1cc(cc2cc(NC(=O)Nc3ccc4c(O)cc(cc4c3)S(O)(=O)=O)ccc12)S(O)(=O)=O"
"244","AMIBEGRON","adrenergic receptor agonist","ADRB3","","","Tocris, Sigma",97.85,"BRD-K24610819-003-02-6, BRD-K24610819-003-01-8","Phase 3","","RDJQCOBTKKAQAH-FPOVZHCZSA-N","BRD-K24610819","","CCOC(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c1cccc(Cl)c1"
"246","AMIFLAMINE","monoamine oxidase inhibitor","MAOA, SLC6A2","","","Enamine",69.64,"BRD-A19401019-001-01-3","Phase 1","","HFQMYSHATTXRTC-UHFFFAOYSA-N","BRD-A19401019","","CC(N)Cc1ccc(cc1C)N(C)C"
"247","AMINEPTINE","dopamine receptor agonist","SLC6A2, SLC6A4","","","MedChemEx",97.45,"BRD-K24219278-001-01-6","Withdrawn","","ONNOFKFOZAJDHT-UHFFFAOYSA-N","BRD-K24219278","","OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12"
"248","AMINOGUANIDINE","nitric oxide synthase inhibitor","NOS2","","","MicroSource, Tocris",100,"BRD-K25114078-003-08-1, BRD-K25114078-003-07-3","Phase 3","","HAMNKKUPIHEESI-UHFFFAOYSA-N","BRD-K25114078","","NNC(N)=N"
"250","AMINOLEVULINIC-ACID-BENZYL-ESTER","","","","","ChemImpex",94.33,"BRD-K59998349-003-01-4","Phase 1","","AFFZCQDLQIEQGB-UHFFFAOYSA-N","BRD-K59998349","","NCC(=O)CCC(=O)OCc1ccccc1"
"251","AMINOMETHYLTRANSFERASE","nitric oxide synthase inhibitor","NOS2","","","Tocris",92.48,"BRD-A28318179-003-08-5","Preclinical","","BATVOUKHGLKDGQ-UHFFFAOYSA-N","BRD-A28318179","","CC1CCN=C(N)S1"
"252","AMINOPTERIN","dihydrofolate reductase inhibitor","DHFR, SLC46A1","","","MicroSource, Sigma",0,"BRD-K87544030-001-02-8, BRD-K87544030-001-01-0","Phase 3","BRD-A86736466-001-05-9","TVZGACDUOSZQKY-LBPRGKRZSA-N","BRD-K87544030","BRD-A86736466","Nc1nc(N)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1"
"254","AMINOPURVALANOL-A","CDK inhibitor, tyrosine kinase inhibitor","CDK1, CDK2, CDK5, CDK6","","","Tocris, Tocris",94.83,"BRD-K07762753-001-05-1, BRD-K07762753-001-04-4","Preclinical","","RAMROQQYRRQPDL-HNNXBMFYSA-N","BRD-K07762753","","CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1"
"256","AMINOTHIADIAZOLE","inosine monophosphate dehydrogenase inhibitor","ADORA3, IMPDH1","","","Enamine, Vitas-M",0,"BRD-K94837153-001-02-8, BRD-K94837153-001-01-0","Phase 2","","QUKGLNCXGVWCJX-UHFFFAOYSA-N","BRD-K94837153","","Nc1nncs1"
"258","AMINOTHIAZOLE","cyclin D inhibitor","NOS2","","","MicroSource, Selleck, Selleck",98.31,"BRD-K13421763-001-06-2, BRD-K13421763-001-05-4, BRD-K13421763-001-07-0","Preclinical","","RAIPHJJURHTUIC-UHFFFAOYSA-N","BRD-K13421763","","Nc1nccs1"
"261","AMIPRILOSE","CD antagonist","","","","Prestwick",96.74,"BRD-K97643133-003-09-3","Phase 3","","YXBQLONCIPUQKO-UJPOAAIJSA-N","BRD-K97643133","","CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO"
"262","AMITIFADINE","serotonin transporter (SERT) inhibitor","SLC6A2, SLC6A3, SLC6A4","","","TygerSci",97.84,"BRD-A68942014-003-01-7","Phase 3","","BSMNRYCSBFHEMQ-UHFFFAOYSA-N","BRD-A68942014","","Clc1ccc(cc1Cl)C12CC1CNC2"
"263","AMMONIUM-PERFLUOROCAPRYLATE","Pim kinase inhibitor","PIM1","","","Enamine",54.3,"BRD-K32531356-001-01-9","Phase 1","","SNGREZUHAYWORS-UHFFFAOYSA-N","BRD-K32531356","","OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F"
"264","AMN-082","glutamate receptor modulator","GRM7","","","Tocris, Tocris",91.79,"BRD-K23335153-300-02-5, BRD-K23335153-300-03-3","Preclinical","","DTZDSNQYNPNCPK-UHFFFAOYSA-N","BRD-K23335153","","C(CNC(c1ccccc1)c1ccccc1)NC(c1ccccc1)c1ccccc1"
"266","AMONAFIDE","topoisomerase inhibitor","TOP2A, TOP2B","","","Selleck",90.78,"BRD-K56334280-001-05-1","Phase 3","","UPALIKSFLSVKIS-UHFFFAOYSA-N","BRD-K56334280","","CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23"
"267","AMPA-(RS)","glutamate receptor agonist","GRIN1","","","Tocris, Tocris",86.94,"BRD-A34716233-004-03-5, BRD-A34716233-001-02-3","Preclinical","","UUDAMDVQRQNNHZ-UHFFFAOYSA-N","BRD-A34716233","","Cc1onc(O)c1CC(N)C(O)=O"
"269","AMPA-(S)","glutamate receptor agonist","GRIN1","","","Tocris",87.14,"BRD-K92493880-001-03-0","Preclinical","","UUDAMDVQRQNNHZ-YFKPBYRVSA-N","BRD-K92493880","","Cc1onc(O)c1C[C@H](N)C(O)=O"
"270","AMPALEX","glutamate receptor agonist","GRIA1, GRIA2, GRIA3, GRIA4","","","MedChemEx",99.54,"BRD-K24771047-001-01-6","Phase 2","","ANDGGVOPIJEHOF-UHFFFAOYSA-N","BRD-K24771047","","O=C(N1CCCCC1)c1ccc2nccnc2c1"
"271","AMPYRONE","cyclooxygenase inhibitor","","","","Prestwick",70.49,"BRD-K20484910-001-14-7","Preclinical","","RLFWWDJHLFCNIJ-UHFFFAOYSA-N","BRD-K20484910","","Cc1c(N)c(=O)n(-c2ccccc2)n1C"
"272","AMTHAMINE","histamine receptor agonist","HRH2","","","Tocris",90.06,"BRD-K39670393-303-02-1","Preclinical","","LHVRFUVVRXGZPV-UHFFFAOYSA-N","BRD-K39670393","","Cc1nc(N)sc1CCN"
"273","AMUVATINIB","FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor","KIT, MET","","","Selleck",97.82,"BRD-K66538826-001-07-2","Phase 2","","FOFDIMHVKGYHRU-UHFFFAOYSA-N","BRD-K66538826","","S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12"
"274","AMYGDALIN","caspase activator","CASP3","","","Selleck, Selleck",95.98,"BRD-K03504028-001-07-6, BRD-K03504028-001-08-4","Phase 2","BRD-K11478426-001-01-4","XUCIJNAGGSZNQT-JHSLDZJXSA-N","BRD-K03504028","BRD-K11478426","OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O"
"276","AMYL-NITRITE","atrial natriuretic peptide receptor agonist","NPR1","","","Sigma",0,"BRD-K03326591-001-01-4","Preclinical","","CSDTZUBPSYWZDX-UHFFFAOYSA-N","BRD-K03326591","","CCCCCO[N+][O-]"
"277","AMYLEINE","local anesthetic","","","","Prestwick",96.77,"BRD-A09062839-003-10-0","Preclinical","","FDMBBCOBEAVDAO-UHFFFAOYSA-N","BRD-A09062839","","CCC(C)(CN(C)C)OC(=O)c1ccccc1"
"278","AMYLENE-HYDRATE","local anesthetic","","","","Sigma, MicroSource",0,"BRD-K93502141-001-02-4, BRD-K93502141-001-01-6","Preclinical","","MSXVEPNJUHWQHW-UHFFFAOYSA-N","BRD-K93502141","","CCC(C)(C)O"
"280","AMZ30","protein phosphatase inhibitor","","","","MedChemEx",88.11,"BRD-K00256256-001-06-1","Preclinical","","GUCUORSUHTZMBW-YBFXNURJSA-N","BRD-K00256256","","[O-][N+](=O)c1cccc(c1)S(=O)(=O)n1cccc1\C=C(/C#N)S(=O)(=O)c1ccc(F)cc1"
"281","AM679","cannabinoid receptor agonist, lipoxygenase inhibitor","ALOX5AP, CNR1, CNR2","","","MedChemEx",96.62,"BRD-K88443722-001-01-7","Preclinical","","VYXWHVDEWWHDLH-LJAQVGFWSA-N","BRD-K88443722","","COc1cnc(nc1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OC[C@@H]4Cc5ccccc5N4C(C)=O)ccc23)cc1"
"282","ANA-12","tropomyosin receptor kinase inhibitor","NTRK2","","","Tocris",96.82,"BRD-A19609491-001-01-8","Preclinical","","TUSCYCAIGRVBMD-UHFFFAOYSA-N","BRD-A19609491","","O=C(Nc1ccccc1C(=O)NC1CCCCNC1=O)c1cc2ccccc2s1"
"283","ANABASINE","acetylcholine receptor agonist","","","","Enzo",90.14,"BRD-A24284985-001-09-9","Preclinical","","MTXSIJUGVMTTMU-UHFFFAOYSA-N","BRD-A24284985","","C1CCC(NC1)c1cccnc1"
"284","ANACETRAPIB","cholesteryl ester transfer protein inhibitor","CETP","","","Selleck",97.01,"BRD-K44366189-001-01-9","Phase 3","","MZZLGJHLQGUVPN-WZQKQDCOSA-N","BRD-K44366189","","COc1cc(F)c(cc1-c1ccc(cc1CN1[C@H](C)[C@H](OC1=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C"
"285","ANAMORELIN","growth hormone secretagogue receptor agonist","GHSR","","","MedChemEx",90.17,"BRD-K01174345-001-01-9","Phase 3","","VQPFSIRUEPQQPP-MXBOTTGLSA-N","BRD-K01174345","","CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(C)N"
"286","ANANDAMIDE","cannabinoid receptor agonist","CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1","","","Enzo",97.08,"BRD-K42352790-001-05-3","Phase 2","","LGEQQWMQCRIYKG-DOFZRALJSA-N","BRD-K42352790","","CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO"
"287","ANDARINE","androgen receptor modulator","AR","","","Selleck",97.04,"BRD-K82164249-001-03-5","Phase 1","","YVXVTLGIDOACBJ-SFHVURJKSA-N","BRD-K82164249","","CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc(c(c2)C(F)(F)F)[N+]([O-])=O)cc1"
"288","ANDROGRAPHOLIDE","tumor necrosis factor production inhibitor","NFKB1","","","Selleck",96.85,"BRD-A86619021-001-04-8","Phase 2","BRD-A63236097-001-01-3","BOJKULTULYSRAS-JAAXSKLYSA-N","BRD-A86619021","BRD-A63236097","C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CCC12"
"289","ANDROSTENONE","steroid","","","","SantaCruz",100,"BRD-A64011898-001-01-0","Preclinical","","HFVMLYAGWXSTQI-UHFFFAOYSA-N","BRD-A64011898","","CC12CCC3C(CCC4CC(=O)CCC34C)C1CC=C2"
"290","ANDROSTERONE","androgen receptor agonist","","","","Prestwick",100,"BRD-K12329651-001-18-8","Preclinical","","QGXBDMJGAMFCBF-HLUDHZFRSA-N","BRD-K12329651","","C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O"
"291","ANETHOLE","glutathione transferase stimulant","","","","MedChemEx, MicroSource, MedChemEx",0,"BRD-K49060658-001-08-0, BRD-K49060658-001-05-6, BRD-K49060658-001-07-2","Launched","","RUVINXPYWBROJD-ONEGZZNKSA-N","BRD-K49060658","","COc1ccc(cc1)\C=C\C"
"294","ANETHOLE-TRITHIONE","glutathione transferase stimulant","","","","MedChemEx, Enzo",97.57,"BRD-K92490248-001-06-6, BRD-K92490248-001-04-1","Launched","","KYLIZBIRMBGUOP-UHFFFAOYSA-N","BRD-K92490248","","COc1ccc(cc1)-c1cc(=S)ss1"
"296","ANGUIDINE","protein synthesis inhibitor","SLC5A1","","","Enzo",100,"BRD-K45724504-001-01-6","Phase 2","","AUGQEEXBDZWUJY-ZLJUKNTDSA-N","BRD-K45724504","","CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1"
"297","ANIRACETAM","glutamate receptor agonist","DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A","","","Tocris, Tocris, Selleck",97.89,"BRD-K88611939-001-25-7, BRD-K88611939-001-23-2, BRD-K88611939-001-22-4","Launched","","ZXNRTKGTQJPIJK-UHFFFAOYSA-N","BRD-K88611939","","COc1ccc(cc1)C(=O)N1CCCC1=O"
"300","ANISODAMINE","lipid peroxidase inhibitor","ADRA1A","","","MicroSource",86.1,"BRD-A29623586-001-01-3","Phase 3","","WTQYWNWRJNXDEG-GZPFGDLZSA-N","BRD-A29623586","","CN1C2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1"
"301","ANISOMYCIN","DNA synthesis inhibitor","NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1","","","Tocris",87.39,"BRD-K91370081-001-25-1","Preclinical","","YKJYKKNCCRKFSL-RDBSUJKOSA-N","BRD-K91370081","","COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1"
"302","ANLOTINIB","VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor","KDR, PDGFRB","","","MedChemEx",98.2,"BRD-K36949735-001-01-1","Phase 2/Phase 3","","KSMZEXLVHXZPEF-UHFFFAOYSA-N","BRD-K36949735","","COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1"
"303","ANPIRTOLINE","serotonin receptor agonist","HTR1B","","","Tocris, Tocris",93.59,"BRD-K55424922-003-03-6, BRD-K55424922-003-02-8","Phase 1","","GGALEXMXDMUMDM-UHFFFAOYSA-N","BRD-K55424922","","Clc1cccc(SC2CCNCC2)n1"
"305","ANR-94","A1 adenosine receptor antagonist","ADORA2A","","","Tocris",96.91,"BRD-K31170746-001-01-6","Preclinical","","QUGDTMONBLMLLD-UHFFFAOYSA-N","BRD-K31170746","","CCOc1nc2c(N)ncnc2n1CC"
"306","ANSAMITOCIN-P-3","apoptosis stimulant","","","","MedChemEx, MedChemEx, MedChemEx",85.5,"BRD-K53252847-001-03-9, BRD-K53252847-001-02-1, BRD-K53252847-001-01-3","Preclinical","","OPQNCARIZFLNLF-UMXLAOKQSA-N","BRD-K53252847","","CO[C@@H]1C=C\C=C(C)/Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2"
"309","ANTAGONIST-G","neuropeptide receptor antagonist","MAPK8","","","Tocris",77.63,"BRD-K25863791-001-01-8","Phase 1","","CUCSSYAUKKIDJV-FAXBSAIASA-N","BRD-K25863791","","CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O"
"310","ANTALARMIN","corticosteroid releasing factor receptor antagonist","CRHR1","","","Tocris",95.23,"BRD-K01363385-003-01-5","Preclinical","","IXPROWGEHNVJOY-UHFFFAOYSA-N","BRD-K01363385","","CCCCN(CC)c1nc(C)nc2n(c(C)c(C)c12)-c1c(C)cc(C)cc1C"
"311","ANTHRANILIC-ACID","","","","","Enamine",97.76,"BRD-K75167327-001-01-6","Preclinical","","XKZLSYWCDJZTMW-UHFFFAOYSA-N","BRD-K75167327","","OC(=O)c1ccccc1NC(=O)C12CC3CC(CC(C3)C1)C2"
"312","ANTHRAQUINONE","CDC inhibitor","CDC25B","","","Vitas-M",83.65,"BRD-K15957397-001-04-2","Preclinical","","RZVHIXYEVGDQDX-UHFFFAOYSA-N","BRD-K15957397","","O=C1c2ccccc2C(=O)c2ccccc12"
"313","ANTIMONY-POTASSIUM","","","","","MicroSource",0,"BRD-A53836783-409-01-6","Phase 2","","JFVMOLRNQCNLCH-UHFFFAOYSA-L","BRD-A53836783","","OC(=O)C1O[Sb]2OC(C(O[Sb]3OC1C(=O)O3)C(O)=O)C(=O)O2"
"314","ANTIMONYL","","","","","MedChemEx",0,"BRD-A74328360-409-01-0","Phase 1","BRD-U39828521-000-01-2","ZCIXFSVENQDMCK-UHFFFAOYSA-J","BRD-A74328360","BRD-U39828521","O=C1O[SbH]23OC1C1O[SbH]4(OC(C(O2)C(=O)O3)C(=O)O4)OC1=O"
"315","ANTIMYCIN-A","ATP synthase inhibitor","CYCS","","","Prestwick",32.64,"BRD-A67709388-001-05-4","Preclinical","","UIFFUZWRFRDZJC-KSVNMYRZSA-N","BRD-A67709388","","CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)C(NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O"
"316","ANTIOXINE","","","","","Enamine, Sigma",0,"BRD-K15541734-001-01-2, BRD-K15541734-001-02-0","Launched","","RECUKUPTGUEGMW-UHFFFAOYSA-N","BRD-K15541734","","CC(C)c1ccc(C)c(O)c1"
"318","AN2718","leucyl-tRNA synthetase inhibitor","","","","Enamine, Enamine",96.45,"BRD-K21920947-001-02-1, BRD-K21920947-001-01-3","Phase 1","","HMAFTPZYFJFEHK-UHFFFAOYSA-N","BRD-K21920947","","OB1OCc2cc(Cl)ccc12"
"320","AP-18","transient receptor potential channel antagonist","TRPA1","","","Tocris",91.72,"BRD-K32143970-001-01-9","Preclinical","","MHTJEUOFLVQMCL-NJHPPEEMSA-N","BRD-K32143970","","CC(=C/c1ccc(Cl)cc1)\C(C)=N\O"
"321","APABETALONE","apolipoprotein expression enhancer","BRD3","","","Selleck",96.24,"BRD-K20001883-001-02-7","Phase 3","","NETXMUIMUZJUTB-UHFFFAOYSA-N","BRD-K20001883","","COc1cc(OC)c2c(c1)[nH]c(nc2=O)-c1cc(C)c(OCCO)c(C)c1"
"322","APAFANT","platelet activating factor receptor antagonist","PTAFR","","","Tocris, Tocris",98.5,"BRD-K28115081-001-02-7, BRD-K28115081-001-03-5","Phase 3","","JGPJQFOROWSRRS-UHFFFAOYSA-N","BRD-K28115081","","Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl"
"324","APATINIB","RET tyrosine kinase inhibitor","CSK, KDR, KIT, RET","","","Selleck, Selleck",97.58,"BRD-K25244359-066-02-6, BRD-K25244359-066-03-4","Phase 3","","WPEWQEMJFLWMLV-UHFFFAOYSA-N","BRD-K25244359","","O=C(Nc1ccc(cc1)C1(CCCC1)C#N)c1cccnc1NCc1ccncc1"
"326","APC-100","anti-inflammatory agent, androgen receptor antagonist","AR","","","Sigma",93.42,"BRD-K07449869-001-01-5","Phase 1/Phase 2","","SEBPXHSZHLFWRL-UHFFFAOYSA-N","BRD-K07449869","","Cc1c(C)c2OC(C)(C)CCc2c(C)c1O"
"327","APCK-110","KIT inhibitor","KIT, STAT3","","","Tocris",95.57,"BRD-K72748448-001-01-0","Preclinical","","CAMGZGMEPKFVMF-UHFFFAOYSA-N","BRD-K72748448","","COc1cc(OC)cc(c1)-c1ccc2c(n[nH]c2n1)-c1ccc(F)cc1"
"328","APD597","glucose dependent insulinotropic receptor agonist","GPR119","","","MedChemEx",96.93,"BRD-K86226872-001-01-6","Phase 1","","WPDCHTSXOPUOII-UHFFFAOYSA-N","BRD-K86226872","","COc1c(Nc2ccc(nc2C)S(C)(=O)=O)ncnc1OC1CCN(CC1)C(=O)OC(C)C"
"329","APD668","glucose dependent insulinotropic receptor agonist","GPR119","","","MedChemEx",98.92,"BRD-K10859802-001-01-0","Phase 1","","XTRUQJBVQBUKSQ-UHFFFAOYSA-N","BRD-K10859802","","CC(C)OC(=O)N1CCC(CC1)Oc1ncnc2n(ncc12)-c1ccc(cc1F)S(C)(=O)=O"
"330","APHIDICOLIN","RNA synthesis inhibitor","","","","Enzo",98.81,"BRD-K85140930-001-12-7","Phase 1","","NOFOAYPPHIUXJR-APNQCZIXSA-N","BRD-K85140930","","C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO"
"331","API-001","sigma receptor antagonist","SIGMAR1","","","MedChemEx",96.83,"BRD-K26325692-003-01-3","Phase 2","","DGPGXHRHNRYVDH-UHFFFAOYSA-N","BRD-K26325692","","Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1"
"332","API-1","AKT inhibitor","AKT1, AKT2, AKT3","","","Tocris",87.32,"BRD-K97840621-001-01-5","Preclinical","","SPBWHPXCWJLQRU-FITJORAGSA-N","BRD-K97840621","","NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c2c1=O"
"333","APIGENIN","casein kinase inhibitor, cell proliferation inhibitor","AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1","","","Tocris, Selleck",96.49,"BRD-K01493881-001-29-4, BRD-K01493881-001-28-6","Preclinical","","KZNIFHPLKGYRTM-UHFFFAOYSA-N","BRD-K01493881","","Oc1ccc(cc1)-c1cc(=O)c2c(O)cc(O)cc2o1"
"335","APOCYNIN","NADPH oxidase inhibitor","NOX4","","","Selleck",94.64,"BRD-K64990520-001-08-4","Phase 1","","DFYRUELUNQRZTB-UHFFFAOYSA-N","BRD-K64990520","","COc1cc(ccc1O)C(C)=O"
"336","APOPTOSIS-ACTIVATOR-II","carboxylesterase inhibitor","BCHE, CES1","","","Tocris, Selleck, Tocris",97.54,"BRD-K15164005-001-06-4, BRD-K15164005-001-04-9, BRD-K15164005-001-05-6","Preclinical","","KGRJPLRFGLMQMV-UHFFFAOYSA-N","BRD-K15164005","","Clc1ccc(CN2C(=O)C(=O)c3ccccc23)cc1Cl"
"339","APR-246","p53 activator","TP53","","","Adooq",97.6,"BRD-A09004963-001-01-3","Phase 1/Phase 2","","BGBNULCRKBVAKL-UHFFFAOYSA-N","BRD-A09004963","","COCC1(CO)N2CCC(CC2)C1=O"
"340","APRATASTAT","matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor","ADAM17, MMP1, MMP13, MMP9","","","Sigma",85.75,"BRD-K06883221-001-01-9","Phase 2","","MAVDNGWEBZTACC-HNNXBMFYSA-N","BRD-K06883221","","CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(OCC#CCO)cc1"
"341","APRICITABINE","nucleoside reverse transcriptase inhibitor","","","","Key",98.8,"BRD-K55172746-001-01-3","Phase 3","","RYMCFYKJDVMSIR-RNFRBKRXSA-N","BRD-K55172746","","Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1"
"342","APTIGANEL","glutamate receptor antagonist","GRIN1","","","Tocris, EMDBio",99.3,"BRD-K63919159-003-08-8, BRD-K63919159-003-07-0","Phase 3","","BFNCJMURTMZBTE-UHFFFAOYSA-N","BRD-K63919159","","CCc1cccc(c1)N(C)C(=N)Nc1cccc2ccccc12"
"344","APTO-253","krüppel-like factor expression enhancer","KLF4","","","MedChemEx",90.27,"BRD-K68003372-001-01-6","Phase 1","","NIRXBXIPHUTNNI-UHFFFAOYSA-N","BRD-K68003372","","Cc1[nH]c2ccc(F)cc2c1-c1nc2c([nH]1)c1cccnc1c1ncccc21"
"345","APY-29","serine/threonine kinase inhibitor","ERN1","","","Tocris",94.48,"BRD-K17511755-001-01-7","Preclinical","","WJNBSTLIALIIEW-UHFFFAOYSA-N","BRD-K17511755","","C1CC1c1cc(Nc2ccnc(Nc3ccc4nc[nH]c4c3)n2)[nH]n1"
"346","APY0201","phosphoinositide dependent kinase inhibitor","IL12A, IL12B, PIKFYVE","","","MedChemEx",88.96,"BRD-K38627885-001-01-9","Preclinical","","RFZQYGBLRIKROZ-PCLIKHOPSA-N","BRD-K38627885","","Cc1cccc(\C=N\Nc2cc(N3CCOCC3)n3nc(cc3n2)-c2ccncc2)c1"
"347","AP1903","","","","","MedChemEx",89.09,"BRD-K28383148-001-01-4","Phase 1/Phase 2","","GQLCLPLEEOUJQC-ZTQDTCGGSA-N","BRD-K28383148","","CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc(c2)[C@@H](CCc2ccc(OC)c(OC)c2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)c2cc(OC)c(OC)c(OC)c2)c1)c1cc(OC)c(OC)c(OC)c1"
"348","AP26113","ALK tyrosine kinase receptor inhibitor","ALK, EGFR","","","Selleck",90.42,"BRD-K56032964-001-02-1","Phase 2","","OVDSPTSBIQCAIN-UHFFFAOYSA-N","BRD-K56032964","","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N(C)C"
"349","AQ-RA741","acetylcholine receptor antagonist","CHRM2","","","Tocris, Tocris",94.68,"BRD-K81729199-001-02-8, BRD-K81729199-001-03-6","Preclinical","","BCUGCHZRMKTPMU-UHFFFAOYSA-N","BRD-K81729199","","CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1"
"351","AR-A014418","glycogen synthase kinase inhibitor","GSK3B","","","Tocris, Selleck",96.97,"BRD-K67860401-001-07-2, BRD-K67860401-001-05-6","Preclinical","","YAEMHJKFIIIULI-UHFFFAOYSA-N","BRD-K67860401","","COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1"
"353","AR-C155858","monocarboxylate transporter inhibitor","SLC16A1, SLC16A7","","","MedChemEx",93.13,"BRD-K42325600-001-01-8","Preclinical","","ISIVOJWVBJIOFM-ZDUSSCGKSA-N","BRD-K42325600","","CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(C(=O)N3C[C@H](O)CO3)c2c(=O)n(C)c1=O"
"354","AR-12","phosphoinositide dependent kinase inhibitor","PDPK1","","","Selleck, Adooq, Selleck, Tocris",92.43,"BRD-K90497590-001-05-9, BRD-K90497590-001-07-5, BRD-K90497590-001-04-2, BRD-K90497590-001-08-3","Phase 1","","YULUCECVQOCQFQ-UHFFFAOYSA-N","BRD-K90497590","","NCC(=O)Nc1ccc(cc1)-n1nc(cc1-c1ccc2c(ccc3ccccc23)c1)C(F)(F)F"
"358","AR-42","HDAC inhibitor","HDAC1","","","Selleck",94.12,"BRD-K13167095-001-02-9","Phase 1","","LAMIXXKAWNLXOC-INIZCTEOSA-N","BRD-K13167095","","CC(C)[C@H](C(=O)Nc1ccc(cc1)C(=O)NO)c1ccccc1"
"359","ARACHIDONIC-ACID","cytochrome P450 inhibitor","CLCN2, KCNJ4, KCNK10, KCNK18, KCNK2, PRKCZ, PTGS1, TRPC6, TRPM2","","","Sigma, Enzo",50.81,"BRD-K03070961-001-10-1, BRD-K03070961-001-08-5","Phase 1","","YZXBAPSDXZZRGB-DOFZRALJSA-N","BRD-K03070961","","CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O"
"361","ARBUTIN","melanin inhibitor","TYR","","","Selleck",100,"BRD-K08037784-001-12-6","Phase 2/Phase 3","","BJRNKVDFDLYUGJ-RMPHRYRLSA-N","BRD-K08037784","","OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O"
"362","ARC-239","adrenergic receptor antagonist","ADRA2A, ADRA2B, ADRA2C","","","Tocris",96.55,"BRD-K93188295-300-02-2","Preclinical","","JFNKXGOEOQCXDM-UHFFFAOYSA-N","BRD-K93188295","","COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1"
"363","ARCTIGENIN","MEK inhibitor","CHUK, MAP2K1","","","Tocris, Tocris",98.04,"BRD-K53523901-001-05-1, BRD-K53523901-001-04-4","Preclinical","","NQWVSMVXKMHKTF-JKSUJKDBSA-N","BRD-K53523901","","COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O"
"365","ARCYRIAFLAVIN-A","CDK inhibitor","CCND1, CDK4","","","Tocris, Tocris",87.14,"BRD-K72726508-001-02-1, BRD-K72726508-001-03-9","Preclinical","","KAJXOWFGKYKMMZ-UHFFFAOYSA-N","BRD-K72726508","","O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21"
"367","ARDEPARIN","thrombin inhibitor","SERPINC1, SERPIND1","","","MedChemEx",0,"BRD-A83644949-236-01-6","Withdrawn","","HTTJABKRGRZYRN-UHFFFAOYSA-N","BRD-A83644949","","CC(=O)NC1C(O)OC(COS(O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4OS(O)(=O)=O)C(O)=O)C(OS(O)(=O)=O)C3NS(O)(=O)=O)C(O)C2OS(O)(=O)=O)C(O)=O)C1O"
"368","ARECAIDINE-BUT-2-YNYL-ESTER","acetylcholine receptor agonist","CHRM2","","","Tocris",87.97,"BRD-K63792901-075-02-1","Preclinical","","LBFWTPRSXIRKMZ-UHFFFAOYSA-N","BRD-K63792901","","CC#CCOC(=O)C1=CCCN(C)C1"
"369","ARECAIDINE-PROPARGYL-ESTER","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","","","Tocris, Tocris",84.89,"BRD-K23922020-075-03-7, BRD-K23922020-075-02-9","Preclinical","","SPHRJZBOFYIKMC-UHFFFAOYSA-N","BRD-K23922020","","CN1CCC=C(C1)C(=O)OCC#C"
"371","ARECOLINE","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","","","Selleck, MicroSource",99.05,"BRD-K88646909-004-15-4, BRD-K88646909-004-16-2","Phase 1","","HJJPJSXJAXAIPN-UHFFFAOYSA-N","BRD-K88646909","","COC(=O)C1=CCCN(C)C1"
"373","ARGLABIN","farnesyltransferase inhibitor","FNTA, NFKB1","","","MedChemEx",97.88,"BRD-K62734952-001-01-0","Launched","","UVJYAKBJSGRTHA-CUZKYEQNSA-N","BRD-K62734952","","CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13"
"374","AROFYLLINE","phosphodiesterase inhibitor","PDE4A","","","Maybridge",98.45,"BRD-K33852358-001-09-9","Phase 3","","GVTLDPJNRVMCAL-UHFFFAOYSA-N","BRD-K33852358","","CCCn1c(=O)n(-c2ccc(Cl)cc2)c2[nH]cnc2c1=O"
"375","ARQ-092","AKT inhibitor","AKT2","","","MedChemEx",97.73,"BRD-K60171656-001-01-6","Phase 1","","HNFMVVHMKGFCMB-UHFFFAOYSA-N","BRD-K60171656","","Nc1ncccc1-c1nc2ccc(nc2n1-c1ccc(cc1)C1(N)CCC1)-c1ccccc1"
"376","ARQ-621","kinesin-like spindle protein inhibitor","KIF11","","","Selleck",80.29,"BRD-K43436647-001-01-7","Phase 1","","UPJSUQWHUVLLNW-XMMPIXPASA-N","BRD-K43436647","","NCCCN([C@H](CC#C)c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)C(=O)c1cccc(Cl)c1F"
"377","ARRY-334543","EGFR inhibitor","ERBB2","","","Selleck",93.75,"BRD-K46386702-001-02-1","Phase 2","","UWXSAYUXVSFDBQ-CYBMUJFWSA-N","BRD-K46386702","","C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1"
"378","ARSANILIC-ACID","","LYZ","","","MicroSource",100,"BRD-K24179883-001-16-7","Phase 1","","XKNKHVGWJDPIRJ-UHFFFAOYSA-N","BRD-K24179883","","Nc1ccc(cc1)[As](O)(O)=O"
"379","ARUNDIC-ACID","astrocyte modulating agent","PTGS2, S100B","","","Tocris",17.19,"BRD-K49223707-001-01-0","Phase 2/Phase 3","","YCYMCMYLORLIJX-SNVBAGLBSA-N","BRD-K49223707","","CCCCCC[C@@H](CCC)C(O)=O"
"380","ARV-825","bromodomain inhibitor","BRD4","","","MedChemEx",94.44,"BRD-A00047421-001-01-7","Preclinical","","RWLOGRLTDKDANT-TYIYNAFKSA-N","BRD-A00047421","","Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1"
"381","AS-1269574","glucose dependent insulinotropic receptor agonist","GPR119","","","Tocris",97.58,"BRD-K07656463-001-01-5","Preclinical","","DUKPGOOUJNUIOI-UHFFFAOYSA-N","BRD-K07656463","","Cc1cc(NCCO)nc(n1)-c1ccc(Br)cc1"
"382","AS-1892802","rho associated kinase inhibitor","ROCK1","","","Tocris",98.94,"BRD-K27051047-001-01-0","Preclinical","","WDTFYYZHMRBVHK-LJQANCHMSA-N","BRD-K27051047","","OC[C@@H](NC(=O)Nc1ccc(cc1)-c1ccncc1)c1ccccc1"
"383","AS-1949490","SHIP2 phosphatase inhibitor","INPP5D","","","Tocris, Tocris",98.99,"BRD-K61936403-001-01-7, BRD-K61936403-001-02-5","Preclinical","","RFZPGNRLOKVZJY-AWEZNQCLSA-N","BRD-K61936403","","C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1"
"385","AS-2034178","free fatty acid receptor agonist","FFAR1","","","Tocris",94.69,"BRD-K75254015-001-01-9","Preclinical","","VENOXIKBBUVHRY-UHFFFAOYSA-N","BRD-K75254015","","OC(=O)CCc1ccc(NCc2cccc3N(CCOc4ccccc4)CCCc23)cc1F"
"386","AS-2444697","interleukin inhibitor","IRAK4","","","Tocris",92.16,"BRD-K73565918-003-01-4","Preclinical","","JANBIXNDYNRYQP-UHFFFAOYSA-N","BRD-K73565918","","Cc1cc(ccn1)-c1nc(co1)C(=O)Nc1cn(nc1C(N)=O)C1CCOCC1"
"387","AS-252424","PI3K inhibitor","PIK3CG","","","Selleck, Selleck",82.97,"BRD-K14988953-001-04-4, BRD-K14988953-001-03-6","Preclinical","","OYYVWNDMOQPMGE-SDQBBNPISA-N","BRD-K14988953","","Oc1cc(F)ccc1-c1ccc(\C=C2/SC(=O)NC2=O)o1"
"389","AS-604850","PI3K inhibitor","PIK3CA, PIK3CG","","","Selleck",94.13,"BRD-K63915849-001-03-7","Preclinical","","SRLVNYDXMUGOFI-YWEYNIOJSA-N","BRD-K63915849","","FC1(F)Oc2ccc(cc2O1)\C=C1/SC(=O)NC1=O"
"390","AS-703026","MEK inhibitor","MAP2K1, MAP2K2","","","Selleck",97.03,"BRD-K89014967-001-04-3","Phase 2","","VIUAUNHCRHHYNE-JTQLQIEISA-N","BRD-K89014967","","OC[C@@H](O)CNC(=O)c1ccncc1Nc1ccc(I)cc1F"
"391","AS-77","potassium channel blocker","KCNA3, KCNA5, KCNN4","","","MedChemEx",99.13,"BRD-K62427771-001-01-0","Preclinical","","KINMYBBFQRSVLL-UHFFFAOYSA-N","BRD-K62427771","","O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1"
"392","ASA-404","angiogenesis inhibitor","","","","Selleck",95.25,"BRD-K27938825-001-02-4","Phase 3","","XGOYIMQSIKSOBS-UHFFFAOYSA-N","BRD-K27938825","","Cc1ccc2c(oc3c(CC(O)=O)cccc3c2=O)c1C"
"393","ASARALDEHYDE","cyclooxygenase inhibitor","PTGS2","","","Selleck",95.62,"BRD-K88219015-001-10-8","Preclinical","","IAJBQAYHSQIQRE-UHFFFAOYSA-N","BRD-K88219015","","COc1cc(OC)c(C=O)cc1OC"
"394","ASC-J9","androgen receptor enhancer","AR","","","MedChemEx, MedChemEx, Adooq",91.45,"BRD-K30331124-001-01-7, BRD-K30331124-001-03-3, BRD-K30331124-001-02-5","Phase 2","","HMJSBVCDPKODEX-NXZHAISVSA-N","BRD-K30331124","","COc1ccc(cc1OC)\C=C\C(=O)CC(=O)\C=C\c1ccc(OC)c(OC)c1"
"397","ASCOMYCIN","calcineurin inhibitor","FKBP1A","","","Selleck",82.5,"BRD-A72381333-001-01-0","Preclinical","","ZDQSOHOQTUFQEM-AMASXYNMSA-N","BRD-A72381333","","CCC1\C=C(C)\CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)C(O)CC1=O)C(\C)=C\C1CCC(O)C(C1)OC"
"398","ASIATIC-ACID","apoptosis stimulant","PYGM","","","Selleck, Selleck",92.85,"BRD-K35079116-001-02-5, BRD-K35079116-001-03-3","Preclinical","BRD-K88350560-001-01-9","JXSVIVRDWWRQRT-UYDOISQJSA-N","BRD-K35079116","BRD-K88350560","C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O"
"400","ASP-2535","glycine transporter inhibitor","SLC6A9","","","Tocris, Tocris",98.79,"BRD-K07150325-001-02-5, BRD-K07150325-001-01-7","Phase 1","","FQGLDGKVKDPVLO-UHFFFAOYSA-N","BRD-K07150325","","CC(C)c1nnc(-c2ccc(nc2)-c2ccccc2)n1-c1cccc2nonc12"
"402","ASPARTAME","","TAS1R2, TRPV1","","","MicroSource, Selleck, Sigma, Selleck",85.8,"BRD-K78841970-001-12-0, BRD-K78841970-001-13-8, BRD-K78841970-001-14-6, BRD-K78841970-001-11-2","Launched","","IAOZJIPTCAWIRG-QWRGUYRKSA-N","BRD-K78841970","","COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O"
"406","ASP3026","ALK tyrosine kinase receptor inhibitor","ALK","","","MedChemEx, Tocris",94.84,"BRD-K06542892-001-01-9, BRD-K06542892-001-02-7","Phase 1","","MGGBYMDAPCCKCT-UHFFFAOYSA-N","BRD-K06542892","","COc1cc(ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1"
"408","AST-1306","EGFR inhibitor","EGFR, ERBB2","","","Selleck",97.14,"BRD-K26838195-075-04-9","Phase 1","","MVZGYPSXNDCANY-UHFFFAOYSA-N","BRD-K26838195","","Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=O)C=C)cc34)cc2Cl)c1"
"409","ASTAXANTHIN","antioxidant","","","","Cayman",26.68,"BRD-K51832961-001-01-4","Launched","","MQZIGYBFDRPAKN-UWFIBFSHSA-N","BRD-K51832961","","CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C"
"410","ASTEMIZOLE","histamine receptor antagonist","HRH1, KCNH1, KCNH2","","","Tocris, MicroSource, Tocris",98.54,"BRD-K37249724-001-24-0, BRD-K37249724-001-25-7, BRD-K37249724-001-28-1","Withdrawn","","GXDALQBWZGODGZ-UHFFFAOYSA-N","BRD-K37249724","","COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1"
"413","ASTRAGALOSIDE-A","antiinflammatory agent","","","","Selleck",100,"BRD-K08188887-001-02-4","Preclinical","BRD-K56653660-001-01-3","QMNWISYXSJWHRY-AUJDEUPOSA-N","BRD-K08188887","BRD-K56653660","CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]1[C@@H](O)C[C@@]2(C)[C@@H]3C[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C4(C)C"
"414","ASUNAPREVIR","HCV inhibitor","","","","MedChemEx",97.98,"BRD-K87028197-001-01-3","Phase 3","","XRWSZZJLZRKHHD-WVWIJVSJSA-N","BRD-K87028197","","COc1cnc(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)c2cc(Cl)ccc12"
"415","ASYMMETRICAL-DIMETHYLARGININE","nitric oxide synthase inhibitor","NOS2, NOS3","","","EMDBio",100,"BRD-K36269323-300-02-6","Phase 1","","YDGMGEXADBMOMJ-LURJTMIESA-N","BRD-K36269323","","CN(C)C(=N)NCCC[C@H](N)C(O)=O"
"416","AT-1015","serotonin receptor antagonist","HTR2A","","","Tocris",77.53,"BRD-K06496777-003-01-4","Preclinical","","BSPMYKLEFGUTSI-UHFFFAOYSA-N","BRD-K06496777","","O=CN1CCC(CC1)C(=O)NCCN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12"
"417","AT-7519","CDK inhibitor","CDK1, CDK2, CDK4, CDK5, CDK6, CDK9","","","Selleck",92.34,"BRD-K13390322-001-06-3","Phase 2","","OVPNQJVDAFNBDN-UHFFFAOYSA-N","BRD-K13390322","","Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1"
"418","AT-9283","Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A","","","Selleck",90.54,"BRD-K24576554-001-04-8","Phase 2","","LOLPPWBBNUVNQZ-UHFFFAOYSA-N","BRD-K24576554","","O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1"
"419","ATB-346","cyclooxygenase inhibitor","PTGER2","","","MedChemEx, MedChemEx",94.79,"BRD-A52551912-001-02-9, BRD-A52551912-001-01-1","Phase 2","","YCNMAPLPQYQJFC-UHFFFAOYSA-N","BRD-A52551912","","COc1ccc2cc(ccc2c1)C(C)C(=O)Oc1ccc(cc1)C(N)=S"
"421","ATENOLOL-(+)","adrenergic receptor antagonist","","","","Selleck",81.19,"BRD-K68075732-001-11-8","Preclinical","","METKIMKYRPQLGS-GFCCVEGCSA-N","BRD-K68075732","","CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1"
"422","ATENOLOL-(-)","adrenergic receptor antagonist","","","","Sigma, Tocris",92.98,"BRD-K44993696-001-13-1, BRD-K44993696-001-12-3","Phase 2","","METKIMKYRPQLGS-LBPRGKRZSA-N","BRD-K44993696","","CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1"
"424","ATGLISTATIN","adipose triglyceride lipase inhibitor","","","","Selleck, Selleck",89.13,"BRD-K43363084-001-01-3, BRD-K43363084-001-02-1","Preclinical","","AWOPBSAJHCUSAS-UHFFFAOYSA-N","BRD-K43363084","","CN(C)C(=O)Nc1cccc(c1)-c1ccc(cc1)N(C)C"
"426","ATIPRIMOD","JAK inhibitor, STAT inhibitor","JAK2, STAT3","","","Tocris",98.03,"BRD-K38527262-300-01-0","Phase 2","","SERHTTSLBVGRBY-UHFFFAOYSA-N","BRD-K38527262","","CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1"
"427","ATIZORAM","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4C, PDE4D","","","Cayman",97.53,"BRD-K76614248-001-01-2","Phase 2","","LITNEAPWQHVPOK-FFSVYQOJSA-N","BRD-K76614248","","COc1ccc(cc1O[C@H]1C[C@@H]2CC[C@H]1C2)C1CNC(=O)NC1"
"428","ATN-161","integrin antagonist","ITGA5, ITGAV, ITGB1, ITGB3","","","MedChemEx, MedChemEx",93.15,"BRD-K00521308-019-03-5, BRD-K00521308-019-01-9","Phase 2","","MMHDBUJXLOFTLC-WOYTXXSLSA-N","BRD-K00521308","","CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O"
"430","ATPA","glutamate receptor agonist","GRIA2, GRIK1","","","Tocris, Tocris",95.4,"BRD-A65145453-001-07-9, BRD-A65145453-001-06-1","Preclinical","","PIXJURSCCVBKRF-UHFFFAOYSA-N","BRD-A65145453","","CC(C)(C)c1onc(O)c1CC(N)C(O)=O"
"432","ATRASENTAN","endothelin receptor antagonist","EDNRA","","","MedChemEx",97.8,"BRD-K16295392-003-01-3","Phase 3","","MOTJMGVDPWRKOC-QPVYNBJUSA-N","BRD-K16295392","","CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(OC)cc1)C(O)=O)c1ccc2OCOc2c1"
"433","ATROPINE-OXIDE","acetylcholine receptor antagonist","","","","MicroSource",0,"BRD-A70067498-001-01-8","Preclinical","BRD-U06139252-000-01-8","HGWPFSBHDACWNL-UHFFFAOYSA-N","BRD-A70067498","BRD-U06139252","C[N+]1([O-])C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1"
"434","AT13148","protein kinase inhibitor","AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3","","","MedChemEx, MedChemEx, MedChemEx, Selleck",91.13,"BRD-K32127727-001-01-8, BRD-K32127727-001-02-6, BRD-K32127727-001-03-4, BRD-K32127727-001-04-2","Phase 1","BRD-A77091532-001-01-9","IIRWNGPLJQXWFJ-KRWDZBQOSA-N","BRD-K32127727","BRD-A77091532","NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(cc1)-c1cn[nH]c1"
"438","AT13387","HSP antagonist","HSP90AA1","","","Selleck, Selleck",88.58,"BRD-K58435339-001-06-3, BRD-K58435339-001-03-0","Phase 2","","IFRGXKKQHBVPCQ-UHFFFAOYSA-N","BRD-K58435339","","CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O"
"440","AT7867","AKT inhibitor","AKT2, GSK3B, PKIA, PRKACA","","","Selleck, Selleck",92.8,"BRD-K12040459-001-07-8, BRD-K12040459-001-06-0","Preclinical","","LZMOSYUFVYJEPY-UHFFFAOYSA-N","BRD-K12040459","","Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1"
"442","AURORA-A-INHIBITOR-I","Aurora kinase inhibitor","AURKA","","","Selleck, Tocris",99.42,"BRD-K53561341-001-07-5, BRD-K53561341-001-09-1","Preclinical","","AKSIZPIFQAYJGF-UHFFFAOYSA-N","BRD-K53561341","","CCN1CCN(CC1)C(=O)Cc1ccc(Nc2ncc(F)c(Nc3ccc(cc3)C(=O)Nc3ccccc3Cl)n2)cc1"
"444","AUTOTAXIN-MODULATOR-1","autotaxin inhibitor","ENPP2","","","MedChemEx",97.37,"BRD-A94640958-001-01-7","Preclinical","","PZASAAIJIFDWSB-RQDPYJAVSA-N","BRD-A94640958","","C[C@@H](N1C2CCC1CC(C2)C(O)=O)c1ccc2ccc(O[C@H]3CC[C@H](CC3)C(F)(F)F)c(c2c1)C(F)(F)F"
"445","AV-412","protein tyrosine kinase inhibitor","EGFR, ERBB2","","","MedChemEx",94.87,"BRD-K23190681-001-01-1","Phase 1","","ZAJXXUDARPGGOC-UHFFFAOYSA-N","BRD-K23190681","","CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C"
"446","AV-608","tachykinin antagonist","TACR1","","","MedChemEx",99.39,"BRD-K96615647-001-01-2","Phase 2","","NXLUTEDAEFXMQR-BJKOFHAPSA-N","BRD-K96615647","","FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1Cc1ccc(Cl)cc1)NC(=O)c1ccnc2ccccc12"
"447","AVAGACESTAT","gamma secretase inhibitor","PSEN1","","","Selleck",96.39,"BRD-K83720053-001-03-8","Phase 2","","XEAOPVUAMONVLA-QGZVFWFLSA-N","BRD-K83720053","","NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)-c1ncon1)S(=O)(=O)c1ccc(Cl)cc1"
"448","AVASIMIBE","ACAT inhibitor","CES1","","","Selleck, Selleck",96.76,"BRD-K67901620-001-03-8, BRD-K67901620-001-02-0","Phase 3","","PTQXTEKSNBVPQJ-UHFFFAOYSA-N","BRD-K67901620","","CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C"
"450","AVE-0991","angiotensin receptor agonist","MRGPRX1","","","MedChemEx",93.56,"BRD-K36154108-001-01-7","Preclinical","","QTOZBSNPDCWHPV-UHFFFAOYSA-N","BRD-K36154108","","CCNC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(C=O)c(OC)nc2-c2ccccc2)cc1"
"451","AVL-292","Bruton's tyrosine kinase (BTK) inhibitor","BTK, YES1","","","Selleck",95.48,"BRD-K87782578-001-01-4","Phase 2","","KXBDTLQSDKGAEB-UHFFFAOYSA-N","BRD-K87782578","","COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1"
"452","AVN-944","inosine monophosphate dehydrogenase inhibitor","IMPDH1, IMPDH2","","","MedChemEx",99.41,"BRD-K62196610-001-01-6","Phase 2","","GYCPCOJTCINIFZ-OXJNMPFZSA-N","BRD-K62196610","","CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1"
"453","AVRIDINE","immunostimulant","","","","Sigma",0,"BRD-K26665484-001-01-8","Preclinical","","WXNRAKRZUCLRBP-UHFFFAOYSA-N","BRD-K26665484","","CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO"
"454","AY-9944","hedgehog pathway modulator","","","","Tocris",88.67,"BRD-K77012840-300-01-6","Preclinical","","RZRPZWGIOOZIBE-IYARVYRRSA-N","BRD-K77012840","","Clc1ccccc1CNC[C@H]1CC[C@H](CNCc2ccccc2Cl)CC1"
"455","AZ-10417808","caspase inhibitor","CASP3","","","Tocris, Tocris",97.36,"BRD-K36258877-001-03-1, BRD-K36258877-001-04-9","Preclinical","","VUBILPOZTRGZJK-UHFFFAOYSA-N","BRD-K36258877","","[O-][N+](=O)c1cc(C(=O)NCC=C)c2nc(Nc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1"
"457","AZ-10606120","purinergic receptor antagonist","P2RX7","","","Tocris",94.2,"BRD-K09907507-300-01-4","Preclinical","","FQMZXMVHHKXGTM-UHFFFAOYSA-N","BRD-K09907507","","OCCNCCNc1ccc2c(NC(=O)CC34CC5CC(CC(C5)C3)C4)cccc2n1"
"458","AZ-12080282","hedgehog pathway inhibitor","DHH","","","Tocris",97.72,"BRD-K05973499-300-01-0","Preclinical","","KMSKKYBHDQYHMC-UHFFFAOYSA-N","BRD-K05973499","","Cc1ccc(cc1NC(=O)c1ccc(OCc2ccccn2)cc1)-c1ncc[nH]1"
"459","AZ-628","RAF inhibitor","BRAF, RAF1","","","Selleck, Selleck, Selleck, Tocris",98.18,"BRD-K05804044-001-12-8, BRD-K05804044-001-06-0, BRD-K05804044-001-09-4, BRD-K05804044-001-14-4","Preclinical","","ZGBGPEDJXCYQPH-UHFFFAOYSA-N","BRD-K05804044","","Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1"
"463","AZACYCLONOL","histamine receptor antagonist","HRH1","","","Selleck, Selleck",93.2,"BRD-K97061094-001-20-6, BRD-K97061094-001-21-4","Preclinical","","ZMISODWVFHHWNR-UHFFFAOYSA-N","BRD-K97061094","","OC(C1CCNCC1)(c1ccccc1)c1ccccc1"
"465","AZAGUANINE-8","purine antagonist","PNP","","","Selleck, Selleck",84.14,"BRD-K53114651-001-11-9, BRD-K53114651-001-12-7","Preclinical","","LPXQRXLUHJKZIE-UHFFFAOYSA-N","BRD-K53114651","","Nc1nc2[nH]nnc2c(=O)[nH]1"
"467","AZALOMYCIN-B","bacterial 50S ribosomal subunit inhibitor","","","","Selleck",77.98,"BRD-K96104201-001-01-5","Preclinical","","OSERMIPXNLXAPD-UBZOKEKOSA-N","BRD-K96104201","","CC[C@@H]1[C@@H](C)O[C@](O)(C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1)[C@@H](C)[C@H](O)[C@H](C)[C@@H]1OC(=O)\C=C\C=C\[C@@H](C)[C@H](OC(=O)\C=C\C=C\[C@@H]1C)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](CC)[C@@H](C)O1"
"468","AZAPROPAZONE","cyclooxygenase inhibitor","PTGS2","","","Prestwick",0,"BRD-A70182876-001-10-8","Withdrawn","","MPHPHYZQRGLTBO-UHFFFAOYSA-N","BRD-A70182876","","CCCC1C(=O)N2N(C1=O)c1cc(C)ccc1N=C2N(C)C"
"469","AZASERINE","purine antagonist","","","","MicroSource",36.32,"BRD-A67065070-001-04-7","Preclinical","","MZZGOOYMKKIOOX-UHFFFAOYSA-N","BRD-A67065070","","NC(COC(=O)C=[N+]=[N-])C(O)=O"
"470","AZD1080","glycogen synthase kinase inhibitor","GSK3A, GSK3B","","","MedChemEx, MedChemEx, Selleck, Selleck",71.86,"BRD-K61041538-001-05-5, BRD-K61041538-001-04-8, BRD-K61041538-001-01-4, BRD-K61041538-001-03-0","Phase 1","","BLTVBQXJFVRPFK-UHFFFAOYSA-N","BRD-K61041538","","Oc1[nH]c2ccc(cc2c1-c1ccc(CN2CCOCC2)cn1)C#N"
"474","AZD1208","Pim kinase inhibitor","PIM1, PIM2, PIM3","","","MedChemEx",88.58,"BRD-K21908111-001-01-8","Phase 1","","MCUJKPPARUPFJM-UWCCDQBKSA-N","BRD-K21908111","","N[C@@H]1CCCN(C1)c1c(cccc1-c1ccccc1)\C=C1/SC(=O)NC1=O"
"475","AZD1283","purinergic receptor antagonist","P2RY12","","","MedChemEx",99.81,"BRD-K77060810-001-01-5","Preclinical","","NEMHKCNXXRQYRF-UHFFFAOYSA-N","BRD-K77060810","","CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1"
"476","AZD1446","acetylcholine receptor agonist","CHRNA4, CHRNB2","","","Key",81.54,"BRD-A44188509-001-01-2","Phase 2","","GTUIQNHJSXQMKW-UHFFFAOYSA-N","BRD-A44188509","","Clc1ccc(o1)C(=O)N1CC2CNCC2C1"
"477","AZD1480","JAK inhibitor","JAK1, JAK2, JAK3","","","Tocris, MedChemEx",98.38,"BRD-K65928735-001-06-8, BRD-K65928735-001-04-3","Phase 1","","PDOQBOJDRPLBQU-QMMMGPOBSA-N","BRD-K65928735","","C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1"
"479","AZD1981","CRTH receptor antagonist","PTGDR2","","","Selleck",95.7,"BRD-K83186168-001-01-8","Phase 2","","JWYIGNODXSRKGP-UHFFFAOYSA-N","BRD-K83186168","","CC(=O)Nc1cccc2n(CC(O)=O)c(C)c(Sc3ccc(Cl)cc3)c12"
"480","AZD2014","mTOR inhibitor","MTOR","","","Selleck",95.64,"BRD-K99113996-001-02-0","Phase 2","","JUSFANSTBFGBAF-IRXDYDNUSA-N","BRD-K99113996","","CNC(=O)c1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C"
"481","AZD2461","PARP inhibitor","","","","Selleck",98.71,"BRD-K85014146-001-02-5","Phase 1","","HYNBNUYQTQIHJK-UHFFFAOYSA-N","BRD-K85014146","","COC1CCN(CC1)C(=O)c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F"
"482","AZD2858","glycogen synthase kinase inhibitor","GSK3B","","","Selleck",94.49,"BRD-K85849709-001-01-5","Preclinical","","FHCSBLWRGCOVPT-UHFFFAOYSA-N","BRD-K85849709","","CN1CCN(CC1)S(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1cccnc1"
"483","AZD3264","IKK inhibitor","IKBKB","","","MedChemEx",90.52,"BRD-K14287049-001-01-3","Preclinical","","NMFIXEFNQPDISY-ZDUSSCGKSA-N","BRD-K14287049","","Cc1noc(C)c1-c1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)c(O[C@H]2CCNC2)c1"
"484","AZD3463","ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor","ALK, IGF1R","","","Selleck, Selleck",94.52,"BRD-K24593301-001-01-5, BRD-K24593301-001-02-3","Preclinical","","GCYIGMXOIWJGBU-UHFFFAOYSA-N","BRD-K24593301","","COc1cc(ccc1Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12)N1CCC(N)CC1"
"486","AZD3514","androgen receptor modulator","AR","","","Selleck",96.18,"BRD-K84996356-001-01-1","Phase 1","","JMEYDSHPKCSIJC-UHFFFAOYSA-N","BRD-K84996356","","CC(=O)N1CCN(CCOc2ccc(cc2)C2CCN(CC2)C2=Nn3c(CC2)nnc3C(F)(F)F)CC1"
"487","AZD3759","EGFR inhibitor","EGFR","","","MedChemEx",98.14,"BRD-K41626799-001-01-1","Phase 1","","MXDSJQHFFDGFDK-CYBMUJFWSA-N","BRD-K41626799","","COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C"
"488","AZD3839","beta-secretase inhibitor","BACE1","","","Selleck",0,"BRD-A54654253-001-01-8","Phase 1","","QXKYWSDUVAJHNZ-CGAIIQECSA-N","BRD-A54654253","","NC1N[C@](c2cccc(F)c12)(c1ccnc(c1)C(F)F)c1cccc(c1)-c1cncnc1"
"489","AZD3965","monocarboxylate transporter inhibitor","SLC16A1","","","MedChemEx",97.59,"BRD-K25210703-001-01-9","Phase 1","","PRNXOFBDXNTIFG-FQEVSTJZSA-N","BRD-K25210703","","CC(C)n1c2sc(Cc3c(C)[nH]nc3C(F)(F)F)c(C(=O)N3C[C@](C)(O)CO3)c2c(=O)n(C)c1=O"
"490","AZD3988","diacylglycerol kinase inhibitor","DGAT1","","","Tocris",97.67,"BRD-K73984371-001-01-1","Preclinical","","NGEBYTLALFOQKI-HDJSIYSDSA-N","BRD-K73984371","","OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(NC(=O)c2nnc(Nc3ccc(F)c(F)c3)o2)cc1"
"491","AZD4282","glutamate receptor antagonist","AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9","","","Enzo",0,"BRD-K72369578-001-04-1","Phase 1","","DHMQDGOQFOQNFH-UHFFFAOYSA-N","BRD-K72369578","","NCC(O)=O"
"492","AZD4547","FGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR","","","Selleck",92.48,"BRD-K28392481-001-05-1","Phase 2/Phase 3","","VRQMAABPASPXMW-HDICACEKSA-N","BRD-K28392481","","COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1"
"493","AZD5069","CC chemokine receptor antagonist","CXCR2","","","MedChemEx",98.58,"BRD-K34801930-001-01-9","Phase 2","","QVKPEMXUBULFBM-FZMZJTMJSA-N","BRD-K34801930","","C[C@H](Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(F)c2F)n1)[C@@H](O)CO"
"494","AZD5363","AKT inhibitor","AKT1, AKT2, AKT3","","","Selleck",94.65,"BRD-K99023089-001-03-7","Phase 2","","JDUBGYFRJFOXQC-KRWDZBQOSA-N","BRD-K99023089","","NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1"
"495","AZD5438","CDK inhibitor","KCNH2","","","Selleck, Tocris, Selleck",97.1,"BRD-K72414522-001-08-3, BRD-K72414522-001-10-9, BRD-K72414522-001-06-7","Phase 1","","WJRRGYBTGDJBFX-UHFFFAOYSA-N","BRD-K72414522","","CC(C)n1c(C)ncc1-c1ccnc(Nc2ccc(cc2)S(C)(=O)=O)n1"
"498","AZD5582","XIAP inhibitor","BIRC2, BIRC3, XIAP","","","MedChemEx",91.6,"BRD-K88767641-001-01-7","Preclinical","","WLMCRYCCYXHPQF-ZVMUOSSASA-N","BRD-K88767641","","CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@@H](Cc2ccccc12)OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1"
"499","AZD6482","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck, Tocris",99.6,"BRD-K58772419-001-07-0, BRD-K58772419-001-08-8","Phase 1","","IRTDIKMSKMREGO-OAHLLOKOSA-N","BRD-K58772419","","C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1"
"501","AZD6738","ATR kinase inhibitor","ATR","","","Selleck",97.61,"BRD-A36013532-001-01-3","Phase 1/Phase 2","","OHUHVTCQTUDPIJ-RNHBAAACSA-N","BRD-A36013532","","C[C@@H]1COCCN1c1cc(nc(n1)-c1ccnc2[nH]ccc12)C1(CC1)S(C)(=N)=O"
"502","AZD6765","glutamate receptor antagonist","GRIN1","","","Enamine",84.3,"BRD-A94033181-001-01-4","Phase 2","","FWUQWDCOOWEXRY-UHFFFAOYSA-N","BRD-A94033181","","NC(Cc1ccccn1)c1ccccc1"
"503","AZD7545","pyruvate dehydrogenase kinase inhibitor","PDK1","","","Selleck",93.48,"BRD-A87435144-001-01-6","Phase 1","","DTDZLJHKVNTQGZ-UHFFFAOYSA-N","BRD-A87435144","","CN(C)C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(NC(=O)C(C)(O)C(F)(F)F)c(Cl)c1"
"504","AZD7687","diacylglycerol O acyltransferase inhibitor","DGAT1","","","MedChemEx",99.55,"BRD-K31495718-001-01-1","Phase 1","","YXFNPRHZMOGREC-SHTZXODSSA-N","BRD-K31495718","","Cc1nc(C)c(nc1C(N)=O)-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1"
"505","AZD7762","CHK inhibitor","CHEK1, CHEK2","","","Selleck, Selleck, Tocris",94.21,"BRD-K86525559-001-07-8, BRD-K86525559-001-04-5, BRD-K86525559-003-01-7","Phase 1","","IAYGCINLNONXHY-LBPRGKRZSA-N","BRD-K86525559","","NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1"
"508","AZD8055","mTOR inhibitor","MTOR","","","Selleck",97.5,"BRD-K69932463-001-10-6","Phase 1","","KVLFRAWTRWDEDF-IRXDYDNUSA-N","BRD-K69932463","","COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C"
"509","AZD8186","PI3K inhibitor","PIK3CB, PIK3CD","","","Adooq, Selleck",99.82,"BRD-K47289408-001-01-5, BRD-K47289408-001-02-3","Phase 1","BRD-A57210235-001-01-9","LMJFJIDLEAWOQJ-CQSZACIVSA-N","BRD-K47289408","BRD-A57210235","C[C@@H](Nc1cc(F)cc(F)c1)c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C"
"511","AZD8330","MEK inhibitor","","","","Selleck, Selleck",86.39,"BRD-K37687095-001-07-7, BRD-K37687095-001-06-9","Phase 1","","RWEVIPRMPFNTLO-UHFFFAOYSA-N","BRD-K37687095","","Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O"
"513","AZD8835","PI3K inhibitor","PIK3CA, PIK3CD","","","MedChemEx",97.11,"BRD-K82894950-001-01-0","Phase 1","","ZGRDYKFVDCFJCZ-UHFFFAOYSA-N","BRD-K82894950","","CCn1nc(nc1-c1cnc(N)c(n1)-c1nnc(o1)C(C)(C)C)C1CCN(CC1)C(=O)CCO"
"514","AZD8931","EGFR inhibitor","EGFR, ERBB2, ERBB3","","","Selleck",96.79,"BRD-K98572433-001-02-9","Phase 2","","DFJSJLGUIXFDJP-UHFFFAOYSA-N","BRD-K98572433","","CNC(=O)CN1CCC(CC1)Oc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC"
"515","AZD9272","glutamate receptor antagonist","GRM5","","","Tocris",97.51,"BRD-K61043483-001-01-5","Preclinical","","RBSPCALDSNXWEP-UHFFFAOYSA-N","BRD-K61043483","","Fc1ccc(nc1)-c1noc(n1)-c1cc(F)cc(c1)C#N"
"516","AZD9496","estrogen receptor agonist","ESR1","","","MedChemEx, MedChemEx",97.14,"BRD-K73235735-001-02-7, BRD-K73235735-050-01-6","Phase 1","","DFBDRVGWBHBJNR-BBNFHIFMSA-N","BRD-K73235735","","C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(C)(C)F)c1c(F)cc(\C=C\C(O)=O)cc1F"
"518","AZD9668","elastase inhibitor","ELANE","","","MedChemEx",98.48,"BRD-K31476763-001-01-5","Phase 2","","QNQZWEGMKJBHEM-UHFFFAOYSA-N","BRD-K31476763","","Cc1c(cc(C(=O)NCc2ccc(cn2)S(C)(=O)=O)c(=O)n1-c1cccc(c1)C(F)(F)F)-c1ccnn1C"
"519","AZELIRAGON","RAGE receptor antagonist","AGER","","","MedChemEx",90.27,"BRD-K51899933-001-02-6","Phase 3","","KJNNWYBAOPXVJY-UHFFFAOYSA-N","BRD-K51899933","","CCCCc1nc(cn1-c1ccc(Oc2ccc(Cl)cc2)cc1)-c1ccc(OCCCN(CC)CC)cc1"
"520","AZIMILIDE","potassium channel blocker","KCNA5, KCNE1, KCNH2, KCNQ1","","","MedChemEx",97.19,"BRD-K38913877-300-01-9","Phase 3","","MREBEPTUUMTTIA-PCLIKHOPSA-N","BRD-K38913877","","CN1CCN(CCCCN2C(=O)CN(\N=C\c3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1"
"521","AZM-475271","src inhibitor","SRC","","","Tocris",93.7,"BRD-K51329597-001-01-3","Preclinical","","WPOXAFXHRJYEIC-UHFFFAOYSA-N","BRD-K51329597","","COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1"
"522","AZODICARBONAMIDE","DNA synthesis inhibitor","","","","AMS, MatrixSci",0,"BRD-K87036601-001-02-4, BRD-K87036601-001-01-6","Phase 2","","XOZUGNYVDXMRKW-AATRIKPKSA-N","BRD-K87036601","","NC(=O)\N=N\C(N)=O"
"524","AZOMYCIN-(2-NITROIMIDAZOLE)","protein synthesis inhibitor","","","","Selleck, Selleck",96.5,"BRD-K26824830-001-02-0, BRD-K26824830-001-03-8","Preclinical","","YZEUHQHUFTYLPH-UHFFFAOYSA-N","BRD-K26824830","","[O-][N+](=O)c1ncc[nH]1"
"526","AZ191","DYRK inhibitor","DYRK1B","","","Selleck, Tocris",92.78,"BRD-K80935598-001-01-1, BRD-K80935598-001-02-9","Preclinical","","ZYVXTMKTGDARKR-UHFFFAOYSA-N","BRD-K80935598","","COc1cc(ccc1Nc1nccc(n1)-c1cn(C)c2cnccc12)N1CCN(C)CC1"
"528","AZ20","ATR kinase inhibitor","ATR, MTOR","","","Tocris, Selleck",98.44,"BRD-K42436189-001-03-8, BRD-K42436189-001-01-2","Preclinical","","SCGCBAAYLFTIJU-CQSZACIVSA-N","BRD-K42436189","","C[C@@H]1COCCN1c1cc(nc(n1)-c1cccc2[nH]ccc12)C1(CC1)S(C)(=O)=O"
"530","AZ3146","monopolar spindle 1 kinase inhibitor","","","","Selleck, Selleck, Tocris",93.84,"BRD-K59146805-001-04-5, BRD-K59146805-001-03-7, BRD-K59146805-001-05-2","Preclinical","","YUKWVHPTFRQHMF-UHFFFAOYSA-N","BRD-K59146805","","COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2n(C)c(=O)n(C3CCCC3)c2n1"
"533","AZ505","histone lysine methyltransferase inhibitor","SMYD2","","","MedChemEx, MedChemEx",97.71,"BRD-K76244476-362-02-5, BRD-K76244476-362-01-7","Preclinical","","LIBVHXXKHSODII-UHFFFAOYSA-N","BRD-K76244476","","Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc2ccc(Cl)c(Cl)c2)c2OCC(=O)Nc12"
"535","AZ5104","EGFR inhibitor","EGFR","","","Selleck",79.95,"BRD-K81958169-001-01-1","Preclinical","","IQNVEOMHJHBNHC-UHFFFAOYSA-N","BRD-K81958169","","COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1c[nH]c2ccccc12"
"536","AZ960","JAK inhibitor","JAK2","","","Selleck, Selleck",94.66,"BRD-K64888243-001-04-5, BRD-K64888243-001-03-7","Preclinical","","SUNXHXDJOIXABJ-NSHDSACASA-N","BRD-K64888243","","C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(F)cc1C#N)c1ccc(F)cc1"
"538","A0001","","","","","Sigma, Enzo",40.81,"BRD-K57865272-001-02-0, BRD-K57865272-001-01-2","Phase 2","","LTVDFSLWFKLJDQ-IEOSBIPESA-N","BRD-K57865272","","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O"
"540","A12B4C3","polynucleotide kinase/phosphatase inhibitor","PNKP","","","Tocris",89.26,"BRD-A30000356-001-01-9","Preclinical","","KVHGJAKTBPFFNV-UHFFFAOYSA-N","BRD-A30000356","","CCCCCCCCCCC(O)C1C=CC2C(N1Nc1ccc(cc1)[N+]([O-])=O)C(=O)N(C2=O)c1ccccc1"
"541","A205804","ICAM1 expression inhibitor","ICAM1, SELE","","","Tocris, Tocris, Selleck",98.68,"BRD-K77627880-001-04-0, BRD-K77627880-001-05-7, BRD-K77627880-001-03-2","Preclinical","","QQGWEXFLMJGCAL-UHFFFAOYSA-N","BRD-K77627880","","Cc1ccc(Sc2cncc3sc(cc23)C(N)=O)cc1"
"544","A61603","adrenergic receptor agonist","ADRA1A","","","Tocris",80.43,"BRD-A83650191-004-02-8","Preclinical","","OQFCXJDXHCDLHX-UHFFFAOYSA-N","BRD-A83650191","","CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)C1=NCCN1"
"545","A66","PI3K inhibitor","PIK3CA","","","Selleck, Tocris",94.01,"BRD-K49055432-001-04-2, BRD-K49055432-001-07-5","Preclinical","","HBPXWEPKNBHKAX-NSHDSACASA-N","BRD-K49055432","","Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(n1)C(C)(C)C"
"547","A740003","purinergic receptor antagonist","P2RX7","","","Tocris, Tocris",97.5,"BRD-A78952587-001-01-5, BRD-A78952587-001-02-3","Preclinical","","PUHSRMSFDASMAE-UHFFFAOYSA-N","BRD-A78952587","","COc1ccc(CC(=O)NC(N\C(Nc2cccc3ncccc23)=N\C#N)C(C)(C)C)cc1OC"
"549","A77636","dopamine receptor agonist","CALY","","","Tocris",39.87,"BRD-K72226571-003-01-2","Preclinical","","QLJOSZATCBCBDR-KLONBWLYSA-N","BRD-K72226571","","NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)[C@@]12CC3CC(CC(C3)C1)C2"
"550","A922500","diacylglycerol O acyltransferase inhibitor","DGAT1","","","Selleck",92.69,"BRD-K28861668-001-01-9","Preclinical","","BOZRFEQDOFSZBV-PKTZIBPZSA-N","BRD-K28861668","","OC(=O)[C@H]1CCC[C@H]1C(=O)c1ccc(cc1)-c1ccc(NC(=O)Nc2ccccc2)cc1"
"551","BACLOFEN-(R)","benzodiazepine receptor agonist","GABBR1, GABBR2","","","Selleck, Selleck",96.78,"BRD-K62353271-001-04-7, BRD-K62353271-001-02-1","Preclinical","","KPYSYYIEGFHWSV-QMMMGPOBSA-N","BRD-K62353271","","NC[C@H](CC(O)=O)c1ccc(Cl)cc1"
"553","BADGE","PPAR receptor antagonist","PPARG","","","Tocris",94.12,"BRD-A16694057-001-06-8","Preclinical","","LCFVJGUPQDGYKZ-UHFFFAOYSA-N","BRD-A16694057","","CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1"
"554","BAFETINIB","Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor","ABL1, BCR, LYN","","","Selleck",91.07,"BRD-A75975749-001-01-4","Phase 2","","ZOPBZHLJXQAQON-UHFFFAOYSA-N","BRD-A75975749","","CN(C)C1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3ncc(cn3)-c3cncnc3)c2)C1"
"555","BAG-956","phosphoinositide dependent kinase inhibitor","PIK3CG","","","Tocris",97.92,"BRD-K00652956-001-01-5","Preclinical","","GVPAGJWVBUZHNQ-UHFFFAOYSA-N","BRD-K00652956","","Cc1nc2cnc3ccc(cc3c2n1-c1ccc(cc1)C(C)(C)C#N)C#Cc1cccnc1"
"556","BAICALEIN","lipoxygenase inhibitor","ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH","","","Selleck, Selleck, Tocris",97.14,"BRD-K72327355-001-15-4, BRD-K72327355-001-13-9, BRD-K72327355-001-14-7","Preclinical","","FXNFHKRTJBSTCS-UHFFFAOYSA-N","BRD-K72327355","","Oc1cc2oc(cc(=O)c2c(O)c1O)-c1ccccc1"
"559","BAICALIN","beta glucuronidase inhibitor","PREP","","","Selleck, Selleck",87.7,"BRD-K49962337-001-02-9, BRD-K49962337-001-01-1","Launched","BRD-K99455969-001-02-8, BRD-K98733875-001-01-4","IKIIZLYTISPENI-ZFORQUDYSA-N","BRD-K49962337","BRD-K99455969","O[C@H]1[C@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O"
"561","BAKUCHIOL","DNA polymerase inhibitor","HIF1A","","","MedChemEx, Enzo",89.43,"BRD-K09785578-001-02-0, BRD-K09785578-001-01-2","Phase 2","","LFYJSSARVMHQJB-QIXNEVBVSA-N","BRD-K09785578","","CC(C)=CCC[C@@](C)(C=C)\C=C\c1ccc(O)cc1"
"563","BALAGLITAZONE","insulin sensitizer, PPAR receptor partial agonist","PPARG","","","MedChemEx",96.17,"BRD-A00147595-001-01-5","Phase 3","","IETKPTYAGKZLKY-UHFFFAOYSA-N","BRD-A00147595","","Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O"
"564","BALAPIRAVIR","RNA polymerase inhibitor","","","","MedChemEx",95.37,"BRD-K47976015-001-01-2","Phase 2","","VKXWOLCNTHXCLF-DXEZIKHYSA-N","BRD-K47976015","","CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)n1ccc(N)nc1=O)N=[N+]=[N-]"
"565","BALICATIB","cathepsin inhibitor","CTSK","","","Tocris, MedChemEx",97.04,"BRD-K27204852-001-02-7, BRD-K27204852-001-01-9","Phase 2","","LLCRBOWRJOUJAE-UHFFFAOYSA-N","BRD-K27204852","","CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N"
"567","BAM7","BAX activator","BAX","","","Selleck",97.43,"BRD-K07442505-001-03-6","Preclinical","","KOCVKGYKBLJEPK-LYBHJNIJSA-N","BRD-K07442505","","CCOc1ccccc1N\N=C1C(=O)N(N=C\1C)c1nc(cs1)-c1ccccc1"
"568","BAN-ORL-24","nociceptin/orphanin FQ receptor antagonist","OPRL1","","","MedChemEx, Tocris, Tocris",83.83,"BRD-K47049295-300-03-1, BRD-K47049295-300-01-5, BRD-K47049295-300-02-3","Preclinical","","MAKMQGKJURAJEN-RUZDIDTESA-N","BRD-K47049295","","O=C(NCCCN1CCC2(CC1)OCc1ccccc21)[C@H]1CCCN1Cc1ccccc1"
"571","BARASERTIB","Aurora kinase inhibitor","AURKA, AURKB","","","MedChemEx",89.07,"BRD-K31928526-001-02-1","Phase 2/Phase 3","","GBJVVSCPOBPEIT-UHFFFAOYSA-N","BRD-K31928526","","CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O"
"572","BARASERTIB-HQPA","Aurora kinase inhibitor","AURKB","","","Selleck, Selleck",96.94,"BRD-K63923597-001-11-8, BRD-K63923597-001-10-0","Phase 2/Phase 3","","QYZOGCMHVIGURT-UHFFFAOYSA-N","BRD-K63923597","","CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1"
"574","BARDOXOLONE","nuclear factor erythroid derived, like (NRF2) activator","NOS2, PPARG","","","MedChemEx",85.92,"BRD-K20545304-001-01-6","Phase 1","","TXGZJQLMVSIZEI-UQMAOPSPSA-N","BRD-K20545304","","CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O"
"575","BARDOXOLONE-METHYL","nuclear factor erythroid derived, like (NRF2) activator","PPARG, STAT3","","","Selleck",90.44,"BRD-K69694239-001-02-2","Phase 3","BRD-K22848513-001-01-9","WPTTVJLTNAWYAO-KPOXMGGZSA-N","BRD-K69694239","BRD-K22848513","COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2"
"576","BARICITINIB","JAK inhibitor","JAK1, JAK2","","","Selleck",97.35,"BRD-K53581288-001-02-9","Phase 3","","XUZMWHLSFXCVMG-UHFFFAOYSA-N","BRD-K53581288","","CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12"
"577","BARIUM-6-O-PHOSPHONATO-D-GLUCOSE","","GPI","","","TCI",0,"BRD-K67760597-240-01-5","Preclinical","","VFRROHXSMXFLSN-SLPGGIOYSA-N","BRD-K67760597","","O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C=O"
"578","BASIC-FUCHSIN","","","","","SantaCruz",0,"BRD-K26362911-003-01-1","Preclinical","","YDCMWLQSPFTWCS-UHFFFAOYSA-N","BRD-K26362911","","CC1=CC(C=CC1=N)=C(c1ccc(N)cc1)c1ccc(N)cc1"
"579","BASIMGLURANT","glutamate receptor antagonist","GRM5","","","MedChemEx",99.2,"BRD-K62387885-001-01-9","Phase 2","","UPZWINBEAHDTLA-UHFFFAOYSA-N","BRD-K62387885","","Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1"
"580","BATIMASTAT","matrix metalloprotease inhibitor","ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8","","","Selleck, Selleck",91.11,"BRD-K82818427-001-04-8, BRD-K82818427-001-02-2","Phase 3","BRD-K25361343-001-01-6","XFILPEOLDIKJHX-QYZOEREBSA-N","BRD-K82818427","BRD-K25361343","CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO"
"582","BAVISANT","histamine receptor antagonist","HRH3","","","MedChemEx",99.79,"BRD-K79595931-312-01-3","Phase 2","","BGBVSGSIXIIREO-UHFFFAOYSA-N","BRD-K79595931","","O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1"
"583","BAX-CHANNEL-BLOCKER","cytochrome C release inhibitor","BAX","","","Tocris, Tocris",94.54,"BRD-A18763547-300-06-3, BRD-A18763547-300-05-5","Preclinical","","KUUJEXLRLIPQQJ-UHFFFAOYSA-N","BRD-A18763547","","OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12"
"585","BAY-K-8644-(+/-)","L-type calcium channel activator","","","","Tocris",92.92,"BRD-A05457250-001-08-4","Preclinical","","ZFLWDHHVRRZMEI-UHFFFAOYSA-N","BRD-A05457250","","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C(F)(F)F)[N+]([O-])=O"
"586","BAY-K-8644-(S)-(-)","L-type calcium channel activator","CACNA1C","","","Tocris",90.62,"BRD-K14329163-001-03-9","Preclinical","","ZFLWDHHVRRZMEI-ZDUSSCGKSA-N","BRD-K14329163","","COC(=O)C1=C(C)NC(C)=C([C@H]1c1ccccc1C(F)(F)F)[N+]([O-])=O"
"587","BAY-W-9798","antioxidant","","","","Vitas-M",98.03,"BRD-K44471774-001-01-8","Phase 2","","AVFYPHPSIBAAME-UHFFFAOYSA-N","BRD-K44471774","","COC(=O)C1=C(C)N(C)C(C)=C(C1c1ccc(cc1)C(F)(F)F)C(=O)OC"
"588","BAY-11-7082","NFkB pathway inhibitor","RELA","","","Tocris, Selleck, Selleck",100,"BRD-K15025317-001-15-1, BRD-K15025317-001-14-4, BRD-K15025317-001-17-7","Preclinical","","DOEWDSDBFRHVAP-KRXBUXKQSA-N","BRD-K15025317","","Cc1ccc(cc1)S(=O)(=O)\C=C\C#N"
"591","BAY-11-7085","NFkB pathway inhibitor","NFKBIA","","","Tocris",91.4,"BRD-K48684885-001-04-2","Preclinical","","VHKZGNPOHPFPER-ONNFQVAWSA-N","BRD-K48684885","","CC(C)(C)c1ccc(cc1)S(=O)(=O)\C=C\C#N"
"592","BAY-41-2272","guanylyl cyclase activator","GUCY1A3, GUCY1B3","","","Tocris",96.5,"BRD-K32033120-001-01-1","Preclinical","","ATOAHNRJAXSBOR-UHFFFAOYSA-N","BRD-K32033120","","Nc1nc(ncc1C1CC1)-c1nn(Cc2ccccc2F)c2ncccc12"
"593","BAY-60-6583","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",92.52,"BRD-K32952627-001-01-0","Preclinical","","ZTYHZMAZUWOXNC-UHFFFAOYSA-N","BRD-K32952627","","NC(=O)CSc1nc(N)c(C#N)c(-c2ccc(OCC3CC3)cc2)c1C#N"
"594","BAY-60-7550","phosphodiesterase inhibitor","PDE2A","","","MedChemEx",93.86,"BRD-K86932920-001-02-9","Preclinical","","MYTWFJKBZGMYCS-NQIIRXRSSA-N","BRD-K86932920","","COc1ccc(Cc2nn3c(nc(C)c3c(=O)[nH]2)[C@@H](CCCc2ccccc2)[C@@H](C)O)cc1OC"
"595","BAY-61-3606","syk inhibitor","SYK","","","MedChemEx",91.87,"BRD-K53281329-300-01-5","Preclinical","","JWQOJVOKBAAAAR-UHFFFAOYSA-N","BRD-K53281329","","COc1ccc(cc1OC)-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1"
"596","BAY-85-8050","","","","","AlfaAesar",100,"BRD-A11731518-001-01-7","Phase 1","","JPSHPWJJSVEEAX-UHFFFAOYSA-N","BRD-A11731518","","NC(CC(F)C(O)=O)C(O)=O"
"597","BAY-87-2243","hypoxia inducible factor inhibitor","HIF1A","","","MedChemEx",96.05,"BRD-K70463136-001-01-5","Phase 1","","CDJNNOJINJAXPV-UHFFFAOYSA-N","BRD-K70463136","","Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1"
"598","BAZ2-ICR","bromodomain inhibitor","ZNF215","","","Tocris",86.63,"BRD-K66830666-001-01-9","Preclinical","","RRZVGDGTWNQAPW-UHFFFAOYSA-N","BRD-K66830666","","Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(cc2)C#N)cn1"
"599","BC-11","urokinase inhibitor","PLAU","","","Tocris",78.51,"BRD-K14646328-004-01-6","Preclinical","","KDQVMGQHPAKJAN-UHFFFAOYSA-N","BRD-K14646328","","NC(=N)SCc1ccc(cc1)B(O)O"
"600","BCI-540","glutamate receptor agonist","","","","MedChemEx",99.63,"BRD-K23672206-001-01-4","Phase 2","","PSPGQHXMUKWNDI-UHFFFAOYSA-N","BRD-K23672206","","Cc1oc2nc3CCCCc3c(NC(=O)CN3CCCC3=O)c2c1C"
"601","BCTC","TRPV antagonist","TRPV1","","","Tocris",89.31,"BRD-K66541497-001-01-7","Preclinical","","ROGUAPYLUCHQGK-UHFFFAOYSA-N","BRD-K66541497","","CC(C)(C)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2Cl)cc1"
"602","BCX-1470","serine protease inhibitor, complement inhibitor","CFD","","","MedChemEx",94.08,"BRD-K90472149-066-01-0","Phase 1","","OTGQTQBPQCRNRG-UHFFFAOYSA-N","BRD-K90472149","","NC(=N)c1cc2ccc(OC(=O)c3cccs3)cc2s1"
"603","BD-1008","sigma receptor antagonist","","","","Tocris",91,"BRD-K17008822-303-02-1","Preclinical","","ASGIQUHBAVIOTI-UHFFFAOYSA-N","BRD-K17008822","","CN(CCN1CCCC1)CCc1ccc(Cl)c(Cl)c1"
"604","BD-1047","adrenergic receptor antagonist","SIGMAR1","","","Tocris, Tocris",91.49,"BRD-K36864847-303-03-3, BRD-K36864847-303-02-5","Preclinical","","MGVRNMUKTZOQOW-UHFFFAOYSA-N","BRD-K36864847","","CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1"
"606","BD-1063","sigma receptor antagonist","SIGMAR1","","","Tocris",96.05,"BRD-K29668683-300-02-2","Preclinical","","SUIZRDJCBVPASY-UHFFFAOYSA-N","BRD-K29668683","","CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1"
"607","BE-2254","adrenergic receptor antagonist","ADRA1A","","","Biotrend, Tocris",32.4,"BRD-A24429032-003-03-2, BRD-A24429032-003-02-4","Phase 2","","PZZOEXPDTYIBPI-UHFFFAOYSA-N","BRD-A24429032","","Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1"
"609","BEFURALINE","","","","","Enamine",96.8,"BRD-K99077012-001-01-9","Phase 2","","SRIJFPBZWUFLFD-UHFFFAOYSA-N","BRD-K99077012","","O=C(N1CCN(Cc2ccccc2)CC1)c1cc2ccccc2o1"
"610","BEGACESTAT","gamma secretase inhibitor","PSEN1","","","Tocris, Sigma",89.43,"BRD-K58319700-001-02-9, BRD-K58319700-001-01-1","Phase 1","","PSXOKXJMVRSARX-SCSAIBSYSA-N","BRD-K58319700","","OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F"
"612","BEMESETRON","serotonin receptor antagonist","HTR3A, HTR3B","","","Tocris, Tocris",96.71,"BRD-A85587465-001-04-1, BRD-A85587465-001-03-3","Phase 3","","MNJNPLVXBISNSX-UHFFFAOYSA-N","BRD-A85587465","","CN1C2CCC1CC(C2)OC(=O)c1cc(Cl)cc(Cl)c1"
"614","BENAXIBINE","","","","","Vitas-M",97.7,"BRD-A90642009-001-03-2","Phase 1","","HLDUHCYBUVVDOT-UHFFFAOYSA-N","BRD-A90642009","","OC1COC(Nc2ccc(cc2)C(O)=O)C(O)C1O"
"615","BENETHAMINE","","","","","Enamine",99.27,"BRD-K13473780-001-02-1","Preclinical","BRD-M11305712-001-07-7","UPABQMWFWCMOFV-UHFFFAOYSA-N","BRD-K13473780","BRD-M11305712","C(Cc1ccccc1)NCc1ccccc1"
"616","BENFLUOREX","gluconeogenesis inhibitor","HMGCR","","","MicroSource",98.31,"BRD-A22305049-003-13-6","Withdrawn","","CJAVTWRYCDNHSM-UHFFFAOYSA-N","BRD-A22305049","","CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1"
"617","BENFLURALIN","","CYP1A1, CYP1A2, CYP2B6, CYP3A4, ESR1, MMP1, SULT2A1, UGT1A1","","","Sigma",97.41,"BRD-K33903083-001-03-5","Phase 3","","SMDHCQAYESWHAE-UHFFFAOYSA-N","BRD-K33903083","","CCCCN(CC)c1c(cc(cc1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O"
"618","BENURESTAT","urease inhibitor","","","","MicroSource",92.03,"BRD-K88553858-001-02-7","Phase 1","","JFZGBMJPJZDNNT-UHFFFAOYSA-N","BRD-K88553858","","ONC(=O)CNC(=O)c1ccc(Cl)cc1"
"619","BENZAMIL","sodium channel blocker","ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1","","","Tocris, Enzo",97.72,"BRD-K87158025-003-08-7, BRD-K87158025-001-01-6","Phase 2","BRD-K97688263-001-03-7","KXDROGADUISDGY-UHFFFAOYSA-N","BRD-K87158025","BRD-K97688263","NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N"
"621","BENZENEMETHANOL,-2,5-DIMETHYL-[[(1-METHYLETHYL)AMINO]METHYL]","","","","","Enamine",83.87,"BRD-A98083480-001-01-3","Preclinical","","PHFWPIKQCFQPJY-UHFFFAOYSA-N","BRD-A98083480","","CC(C)NCC(O)c1cc(C)ccc1C"
"622","BENZO[D]THIAZOLE-2(3H)-THIONE","","","","","Ark",95.36,"BRD-K55160477-001-04-7","Phase 1","","YXIWHUQXZSMYRE-UHFFFAOYSA-N","BRD-K55160477","","Sc1nc2ccccc2s1"
"623","BENZOCLIDINE","","","","","MicroSource",35.21,"BRD-A45929034-001-09-5","Preclinical","","AHKAOMZZTQULDS-UHFFFAOYSA-N","BRD-A45929034","","O=C(OC1CN2CCC1CC2)c1ccccc1"
"624","BENZOFENAC","","","","","Sigma",99.01,"BRD-K26556907-001-01-8","Phase 1","","DFHBBMJTBBLQSA-UHFFFAOYSA-N","BRD-K26556907","","OC(=O)Cc1ccc(OCc2ccccc2)c(Cl)c1"
"625","BENZOIN","","CES1","","","Enamine",99.28,"BRD-A55748233-001-08-7","Preclinical","","ISAOCJYIOMOJEB-UHFFFAOYSA-N","BRD-A55748233","","OC(C(=O)c1ccccc1)c1ccccc1"
"626","BENZOQUINONIUM-DIBROMIDE","cholinergic receptor antagonist","CHRNA1","","","Tocris",91.5,"BRD-K18772613-303-02-4","Preclinical","","YERABYSOHUZTPQ-UHFFFAOYSA-P","BRD-K18772613","","CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)Cc2ccccc2)=CC1=O)Cc1ccccc1"
"627","BENZOTRIPT","CCK receptor antagonist","CCKAR, CCKBR","","","Enamine",99.39,"BRD-A87983072-001-01-1","Phase 1","","QJERBBQXOMUURJ-UHFFFAOYSA-N","BRD-A87983072","","OC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1"
"628","BENZOXIQUINE","antiinfective drug","","","","MicroSource",99.67,"BRD-K70327191-001-02-2","Preclinical","","BHKPHCKISVSDGV-UHFFFAOYSA-N","BRD-K70327191","","O=C(Oc1cccc2cccnc12)c1ccccc1"
"629","BENZOYLPAS","","","","","MicroSource, Vitas-M",97.57,"BRD-K20431737-001-08-1, BRD-K20431737-001-09-9","Preclinical","","GNZCRYWFWKFIDM-UHFFFAOYSA-N","BRD-K20431737","","OC(=O)c1ccc(NC(=O)c2ccccc2)cc1O"
"631","BENZYL-ISOTHIOCYANATE","methylazoxymethanol acetate inhibitor","","","","MicroSource",2.87,"BRD-K80253852-001-04-4","Preclinical","","MDKCFLQDBWCQCV-UHFFFAOYSA-N","BRD-K80253852","","S=C=NCc1ccccc1"
"632","BENZYLDIMETHYLHEXADECYLAMMONIUM","cationic surfactant","","","","Acros",98.49,"BRD-K23403298-003-01-9","Preclinical","","QDYLMAYUEZBUFO-UHFFFAOYSA-N","BRD-K23403298","","CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1"
"633","BENZYLDIMETHYLOCTYLAMMONIUM","","","","","Sigma",96.76,"BRD-K11576103-003-01-1","Preclinical","","SHFLYPPECXRCFO-UHFFFAOYSA-N","BRD-K11576103","","CCCCCCCC[N+](C)(C)Cc1ccccc1"
"634","BERBERINE","LDL receptor activator","LDLR","","","MicroSource, Selleck",95.66,"BRD-K14796088-003-26-8, BRD-K14796088-003-25-0","Phase 2/Phase 3","","YBHILYKTIRIUTE-UHFFFAOYSA-N","BRD-K14796088","","COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC"
"636","BERGAPTEN","","","","","MicroSource, Selleck",96.13,"BRD-K12968785-001-13-3, BRD-K12968785-001-12-5","Preclinical","","BGEBZHIAGXMEMV-UHFFFAOYSA-N","BRD-K12968785","","COc1c2ccoc2cc2oc(=O)ccc12"
"638","BERGENIN","interleukin inhibitor","IL1B, TNF","","","MicroSource, Selleck",97.98,"BRD-K04176066-001-09-1, BRD-K04176066-001-08-3","Preclinical","BRD-K18550767-001-03-6","YWJXCIXBAKGUKZ-HJJNZUOJSA-N","BRD-K04176066","BRD-K18550767","COc1c(O)cc2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c2c1O"
"640","BET-BAY-002","bromodomain inhibitor","","","","MedChemEx",97.66,"BRD-K72735080-001-01-0","Preclinical","","AGYIAWHWIUZNSD-INIZCTEOSA-N","BRD-K72735080","","Cc1nnc(C[C@@H]2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc23)o1"
"641","BETA-AMYLOID-SYNTHESIS-INHIBITOR","beta amyloid synthesis inhibitor","APP","","","Maybridge",94.44,"BRD-K38687824-001-02-5","Preclinical","","GYNDFOLSPPBBIK-UHFFFAOYSA-N","BRD-K38687824","","Oc1cccc(Nc2ccc(Nc3cccc(O)c3)nn2)c1"
"642","BETA-CAROTENE","","","","","Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K74225533-001-10-4, BRD-K74225533-001-08-8, BRD-K74225533-001-12-0, BRD-K74225533-001-09-6","Launched","BRD-K34538779-001-01-1","OENHQHLEOONYIE-JLTXGRSLSA-N","BRD-K74225533","BRD-K34538779","CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C"
"646","BETA-CCB","benzodiazepine receptor ligand","GABRA1, GABRG2","","","Tocris",98.04,"BRD-K87349602-001-03-8","Launched","","WGNGIELOOKACSB-UHFFFAOYSA-N","BRD-K87349602","","CCCCOC(=O)c1cc2c(cn1)[nH]c1ccccc21"
"647","BETA-ELEMENE","apoptosis stimulant","MMP2, MMP9","","","Sigma",0,"BRD-K21045639-001-01-2","Launched","","OPFTUNCRGUEPRZ-QLFBSQMISA-N","BRD-K21045639","","CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C"
"648","BETA-FUNALTREXAMINE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","","","Tocris, Tocris",95.83,"BRD-K95110148-003-02-3, BRD-K95110148-003-01-5","Preclinical","","PQKHESYTSKMWFP-WZJCLRDWSA-N","BRD-K95110148","","COC(=O)\C=C\C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45"
"650","BETA-GLYCEROPHOSPHORIC-ACID","","","","","Vitas-M",0,"BRD-K39061174-001-01-0","Preclinical","","DHCLVCXQIBBOPH-UHFFFAOYSA-N","BRD-K39061174","","OCC(CO)OP(O)(O)=O"
"651","BETA-HYDROXY-BETA-METHYLBUTYRATE","protein synthesis stimulant","MTOR","","","CombiBlocks",97.1,"BRD-M02899238-238-01-6","Phase 2/Phase 3","","KORPMXSVHOHPMS-UHFFFAOYSA-N","BRD-M02899238","","CC(C)(O)CC(O)=O.CC(C)(O)CC(O)=O"
"652","BETA-HYDROXYBUTYRATE","","HCAR2","","","Vitas-M",0,"BRD-A41387824-001-06-0","Phase 1","","WHBMMWSBFZVSSR-UHFFFAOYSA-N","BRD-A41387824","","CC(O)CC(O)=O"
"653","BETA-LAPACHONE","topoisomerase inhibitor","TOP1","","","MedChemEx, MedChemEx, Selleck, Selleck",82.91,"BRD-K28061410-001-07-4, BRD-K28061410-001-09-0, BRD-K28061410-001-05-8, BRD-K28061410-001-06-6","Phase 2","","QZPQTZZNNJUOLS-UHFFFAOYSA-N","BRD-K28061410","","CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O"
"657","BETA-NAPHTHOL","","","","","MicroSource",90.98,"BRD-K21164796-001-02-8","Preclinical","","JWAZRIHNYRIHIV-UHFFFAOYSA-N","BRD-K21164796","","Oc1ccc2ccccc2c1"
"658","BETP","glucagon-like peptide receptor positive allosteric modulator","GLP1R","","","Tocris",98.36,"BRD-A60153876-001-01-0","Preclinical","","NTDFYGSSDDMNHI-UHFFFAOYSA-N","BRD-A60153876","","CCS(=O)c1nc(cc(n1)C(F)(F)F)-c1cccc(OCc2ccccc2)c1"
"659","BETULINIC-ACID","apoptosis stimulant, NFkB pathway inhibitor","GPBAR1","","","Tocris, Selleck, Selleck",96.07,"BRD-K45401373-001-21-7, BRD-K45401373-001-20-9, BRD-K45401373-001-22-5","Phase 1/Phase 2","BRD-K15168723-001-01-7, BRD-K38744518-001-01-7","QGJZLNKBHJESQX-FZFNOLFKSA-N","BRD-K45401373","BRD-K15168723","CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O"
"662","BEVIRIMAT-DIMEGLUMINE","HIV capsid assembly inhibitor","","","","MedChemEx",87.82,"BRD-K16898998-001-01-6","Phase 2","","YJEJKUQEXFSVCJ-WRFMNRASSA-N","BRD-K16898998","","CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O"
"663","BF2.649","histamine receptor antagonist","HRH3","","","Tocris, Tocris",97,"BRD-K21673112-003-02-1, BRD-K21673112-003-01-3","Phase 3","","NNACHAUCXXVJSP-UHFFFAOYSA-N","BRD-K21673112","","Clc1ccc(CCCOCCCN2CCCCC2)cc1"
"665","BGT226","PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CG","","","Selleck, Selleck",98.31,"BRD-K29415052-050-05-5, BRD-K29415052-050-04-8","Phase 1/Phase 2","","BMMXYEBLEBULND-UHFFFAOYSA-N","BRD-K29415052","","COc1ccc(cn1)-c1ccc2ncc3n(C)c(=O)n(-c4ccc(N5CCNCC5)c(c4)C(F)(F)F)c3c2c1"
"667","BHQ","ATPase inhibitor","ATP2A1","","","Tocris",1.34,"BRD-K95603879-001-07-5","Preclinical","","JZODKRWQWUWGCD-UHFFFAOYSA-N","BRD-K95603879","","CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C"
"668","BI-D1870","ribosomal protein inhibitor","RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6","","","MedChemEx, Selleck, Selleck",84.09,"BRD-A81370665-001-06-9, BRD-A81370665-001-04-4, BRD-A81370665-001-03-6","Preclinical","","DTEKTGDVSARYDS-UHFFFAOYSA-N","BRD-A81370665","","CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12"
"671","BI-224436","HIV integrase inhibitor","","","","MedChemEx",93.15,"BRD-K53422148-001-01-8","Phase 1","","MIXIIJCBELCMCZ-VWLOTQADSA-N","BRD-K53422148","","Cc1nc2ccccc2c(-c2ccc3OCCc4ccnc2c34)c1[C@H](OC(C)(C)C)C(O)=O"
"672","BI-2536","PLK inhibitor","BRD4, PLK1, PLK2, PLK3","","","Selleck",97.91,"BRD-K64890080-001-13-8","Phase 2","","XQVVPGYIWAGRNI-JOCHJYFZSA-N","BRD-K64890080","","CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O"
"673","BI-78D3","JNK inhibitor","MAPK8","","","Tocris, Tocris",94.21,"BRD-K73982490-001-02-9, BRD-K73982490-001-03-7","Preclinical","","QFRLDZGQEZCCJZ-UHFFFAOYSA-N","BRD-K73982490","","Oc1nnc(Sc2ncc(s2)[N+]([O-])=O)n1-c1ccc2OCCOc2c1"
"675","BI-847325","MEK inhibitor, Aurora kinase inhibitor","AURKA, AURKB, AURKC, MAP2K1, MAP2K2","","","Selleck, Selleck",93.33,"BRD-K37492701-001-02-9, BRD-K37492701-001-01-1","Phase 1","","FLBNLJLONKAPLR-BYYHNAKLSA-N","BRD-K37492701","","CCNC(=O)C#Cc1ccc2c(NC(=O)\C2=C(\Nc2ccc(CN(C)C)cc2)c2ccccc2)c1"
"677","BIBN4096","calcitonin antagonist","CALCA, CALCRL, RAMP1","","","MedChemEx, MedChemEx, MedChemEx",86.32,"BRD-K43927145-001-01-2, BRD-K43927145-001-02-0, BRD-K43927145-001-03-8","Phase 2","","ITIXDWVDFFXNEG-JHOUSYSJSA-N","BRD-K43927145","","NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)C(=O)N1CCN(CC1)c1ccncc1"
"680","BIBR-1532","telomerase inhibitor","TERT","","","Tocris, Selleck",94.94,"BRD-K04623885-001-10-9, BRD-K04623885-001-07-5","Preclinical","","PGFQXGLPJUCTOI-WYMLVPIESA-N","BRD-K04623885","","C\C(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1"
"682","BIBU-1361","EGFR inhibitor","EGFR","","","Tocris, Tocris",96.69,"BRD-K49294207-300-03-8, BRD-K49294207-300-04-6","Preclinical","","JUGSLZCFNSTKBN-UHFFFAOYSA-N","BRD-K49294207","","CCN(CC)CC1CCN(CC1)c1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1"
"684","BIBX-1382","EGFR inhibitor","EGFR, ERBB2","","","Tocris, Tocris",94.43,"BRD-K70914287-300-02-8, BRD-K70914287-300-03-6","Phase 1","","FTFRZXFNZVCRSK-UHFFFAOYSA-N","BRD-K70914287","","CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1"
"686","BICIFADINE","serotonin receptor antagonist, dopamine reuptake inhibitor","DRD2, SLC6A2, SLC6A4","","","Tocris",95.01,"BRD-A24208517-003-01-8","Phase 3","","OFYVIGTWSQPCLF-UHFFFAOYSA-N","BRD-A24208517","","Cc1ccc(cc1)C12CC1CNC2"
"687","BICUCULLINE-(+)","GABA receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1","","","Tocris, Selleck",97.77,"BRD-A07870296-001-07-4, BRD-A07870296-001-06-6","Preclinical","","IYGYMKDQCDOMRE-QRWMCTBCSA-N","BRD-A07870296","","CN1CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21"
"689","BICUCULLINE-METHOCHLORIDE-(-)","GABA receptor antagonist","","","","Tocris, Tocris, Tocris",97.84,"BRD-A57798559-004-02-3, BRD-A57798559-003-02-5, BRD-A57798559-005-02-0","Preclinical","","WDIQXKYUSINZME-MUMRKEEXSA-N","BRD-A57798559","","C[N+]1(C)CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21"
"692","BICYCLOL","NFkB pathway inhibitor","HSPA1A, HSPB1","","","Sigma",98.42,"BRD-K16546375-001-01-4","Launched","","KXMTXZACPVCDMH-UHFFFAOYSA-N","BRD-K16546375","","COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO"
"693","BIFENDATE","","","","","AKSci",99.86,"BRD-K26581543-001-01-6","Launched","","JMZOMFYRADAWOG-UHFFFAOYSA-N","BRD-K26581543","","COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC"
"694","BIIB021","HSP inhibitor","HSP90AA1","","","Selleck, Tocris",97.64,"BRD-K51967704-001-03-6, BRD-K51967704-001-04-4","Phase 2","","QULDDKSCVCJTPV-UHFFFAOYSA-N","BRD-K51967704","","COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C"
"696","BILOBALIDE","GABA receptor modulator","GLRA1, GLRA2, GLRB, HTR3A, HTR3B","","","Selleck",98.12,"BRD-A41714661-001-02-0","Preclinical","BRD-A35837007-001-01-2","MOLPUWBMSBJXER-ISSLQHLCSA-N","BRD-A41714661","BRD-A35837007","CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)C[C@@]22C(=O)O[C@@H]3OC(=O)[C@H](O)C123"
"697","BIMU-8","serotonin receptor agonist","HTR4","","","Tocris",96.53,"BRD-A62743154-003-01-5","Preclinical","","AFOFVIBWSLOHFR-GOOCMWNKSA-N","BRD-A62743154","","CC(C)n1c2ccccc2n(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C)c1=O"
"698","BINA","glutamate receptor positive allosteric modulator","GRM2","","","Tocris",99.13,"BRD-A13293292-001-02-6","Preclinical","","KMKBEESNZAPKMP-UHFFFAOYSA-N","BRD-A13293292","","Cc1c2C(=O)C(Cc2cc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1C)C1CCCC1"
"699","BINDARIT","NFkB pathway inhibitor","CCL2, CCL7, CCL8","","","Selleck",97.84,"BRD-K36467523-001-02-8","Phase 2","","MTHORRSSURHQPZ-UHFFFAOYSA-N","BRD-K36467523","","CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O"
"700","BIO-1211","integrin antagonist","ITGA4, ITGB1","","","Tocris",93.1,"BRD-K03399463-001-01-6","Phase 2","","NVVGCQABIHSJSQ-KFZSMJGVSA-N","BRD-K03399463","","CC(C)C[C@H](NC(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O"
"701","BIO-5192","integrin inhibitor","ITGA4, ITGB1","","","Tocris",98.15,"BRD-K21318844-001-01-4","Preclinical","","MNQBPRHHZPXCKZ-ZDCRTTOTSA-N","BRD-K21318844","","CC(C)C[C@H](N(C)C(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1S(=O)(=O)c1cc(Cl)cc(Cl)c1)C(O)=O"
"702","BIOTIN","vitamin B","ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6","","","MicroSource, Selleck",100,"BRD-K89210380-001-14-5, BRD-K89210380-001-13-7","Launched","BRD-A36603537-001-13-1, BRD-K95496960-001-01-7","YBJHBAHKTGYVGT-ZKWXMUAHSA-N","BRD-K89210380","BRD-A36603537","OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12"
"704","BIPENAMOL","dipeptidyl peptidase inhibitor","CTSC","","","Sigma",81.11,"BRD-K47690382-001-03-0","Phase 2","","HLAFSNJRKZLMPT-UHFFFAOYSA-N","BRD-K47690382","","NCc1ccccc1Sc1ccccc1CO"
"705","BIRINAPANT","XIAP inhibitor","BIRC2, XIAP","","","Selleck, Selleck",95.44,"BRD-K71221037-001-01-6, BRD-K71221037-001-02-4","Phase 2","","PKWRMUKBEYJEIX-DXXQBUJASA-N","BRD-K71221037","","CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC"
"707","BIRT-377","lymphocyte function-associated antigen negative modulator","ICAM1","","","Tocris",97.8,"BRD-K64880136-001-02-6","Preclinical","","FJNJHZQMQRVZEE-GOSISDBHSA-N","BRD-K64880136","","CN1C(=O)N(C(=O)[C@@]1(C)Cc1ccc(Br)cc1)c1cc(Cl)cc(Cl)c1"
"708","BIS(MALTOLATO)OXOVANADIUM(IV)","tyrosine phosphatase inhibitor","PTPN1","","","Carbosynth",79.05,"BRD-K16180792-001-01-7","Phase 2","","XUOLEICXAPEOSI-UHFFFAOYSA-L","BRD-K16180792","","Cc1occc(=O)c1O[V](=O)Oc1c(C)occc1=O"
"709","BISINDOLYLMALEIMIDE-IX","PKC inhibitor","AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1","","","Selleck, Tocris, Tocris, Selleck",95.99,"BRD-K06543683-066-02-1, BRD-K06543683-066-05-4, BRD-K06543683-066-03-9, BRD-K06543683-066-04-7","Preclinical","","DSXXEELGXBCYNQ-UHFFFAOYSA-N","BRD-K06543683","","Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCSC(N)=N)c3ccccc23)c2ccccc12"
"713","BISMUTH(III)-TRIFLUOROMETHANESULFONATE","direct substitution catalyst","","","","AlfaAesar",99.14,"BRD-M56276249-001-01-1","Preclinical","","BQFARKYNYLKHRD-UHFFFAOYSA-N","BRD-M56276249","","[Bi].OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F"
"714","BISMUTH-OXALATE","","","","","MPBio",0,"BRD-M02179497-001-01-1","Preclinical","","PEBMBOMJLWXKFI-UHFFFAOYSA-N","BRD-M02179497","","[Bi].[Bi].OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O"
"715","BISMUTH-SUBGALLATE","nitric oxide synthase inhibitor","NOS1","","","Sigma",0,"BRD-K65978409-001-01-9","Launched","","JAONZGLTYYUPCT-UHFFFAOYSA-K","BRD-K65978409","","O[Bi]1Oc2cc(cc(O)c2O1)C(O)=O"
"716","BISOCTRIZOLE","","","","","MicroSource",0,"BRD-K00228584-396-01-8","Phase 2","","FQUNFJULCYSSOP-UHFFFAOYSA-N","BRD-K00228584","","CC(C)(C)CC(C)(C)c1cc(Cc2cc(cc(c2O)-n2nc3ccccc3n2)C(C)(C)CC(C)(C)C)c(O)c(c1)-n1nc2ccccc2n1"
"717","BISPHENOL-A","synthetic estrogen","AR, ESR1, ESR2, ESRRG, PPARG","","","Sigma",95.98,"BRD-K41494493-001-13-8","Phase 1","","IISBACLAFKSPIT-UHFFFAOYSA-N","BRD-K41494493","","CC(C)(c1ccc(O)cc1)c1ccc(O)cc1"
"718","BITHIONOL","autotaxin inhibitor","ESR1, ESR2, MCL1","","","MicroSource",97.59,"BRD-K39120595-304-04-7","Withdrawn","","JFIOVJDNOJYLKP-UHFFFAOYSA-N","BRD-K39120595","","Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O"
"719","BITOPERTIN","glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9","","","MedChemEx",99.57,"BRD-K13756951-001-01-4","Phase 3","","YUUGYIUSCYNSQR-LBPRGKRZSA-N","BRD-K13756951","","C[C@H](Oc1ccc(cc1C(=O)N1CCN(CC1)c1ncc(cc1F)C(F)(F)F)S(C)(=O)=O)C(F)(F)F"
"720","BITOSCANATE","anthelmintic agent","","","","MicroSource",0,"BRD-K77548206-001-02-9","Preclinical","","OMWQUXGVXQELIX-UHFFFAOYSA-N","BRD-K77548206","","S=C=Nc1ccc(cc1)N=C=S"
"721","BIX-01294","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","MedChemEx, Selleck, Selleck, Tocris",97.03,"BRD-K26818574-001-06-3, BRD-K26818574-305-04-3, BRD-K26818574-305-07-6, BRD-K26818574-305-08-4","Preclinical","","OSXFATOLZGZLSK-UHFFFAOYSA-N","BRD-K26818574","","COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1"
"725","BIX-02188","MEK inhibitor","MAP2K5","","","Selleck, Selleck",94.2,"BRD-K20290250-001-02-1, BRD-K20290250-001-01-3","Preclinical","BRD-K50394339-001-04-5, BRD-K50394339-001-03-7","FSZPIAXLCCQFCM-FCQUAONHSA-N","BRD-K20290250","BRD-K50394339","CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(N)=O)c1"
"727","BIX-02189","MEK inhibitor","MAP2K5, MAPK7","","","Tocris, Selleck",98.67,"BRD-K73368362-001-08-3, BRD-K73368362-001-07-5","Preclinical","","HOMJAAIVTDVQJA-IZHYLOQSSA-N","BRD-K73368362","","CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1"
"729","BL-5583","hypercalcaemic agent","","","","Enamine",99.35,"BRD-K75282704-001-02-4","Preclinical","","DYSJMQABFPKAQM-UHFFFAOYSA-N","BRD-K75282704","","OC(=O)c1cc2ccccc2s1"
"730","BLEBBISTATIN-(+/-)","ATPase inhibitor","MYH2","","","Tocris",98.19,"BRD-A75817871-001-06-7","Preclinical","","LZAXPYOBKSJSEX-UHFFFAOYSA-N","BRD-A75817871","","Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c1ccccc1"
"731","BLEBBISTATIN-(-)","ATPase inhibitor","","","","Selleck",94.77,"BRD-K61295575-001-03-6","Preclinical","","LZAXPYOBKSJSEX-GOSISDBHSA-N","BRD-K61295575","","Cc1ccc2N=C3N(CC[C@@]3(O)C(=O)c2c1)c1ccccc1"
"732","BLEOMYCETIN","EGFR expression inhibitor","","","","InterBioScreen",0,"BRD-A94813917-001-01-0","Phase 2","","QYOAUOAXCQAEMW-OUNSJABCSA-N","BRD-A94813917","","C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCCNCCCCN"
"733","BLU9931","FGFR inhibitor","FGFR4","","","MedChemEx",93.5,"BRD-K72898849-001-01-8","Preclinical","","TXEBNKKOLVBTFK-UHFFFAOYSA-N","BRD-K72898849","","COc1cc(OC)c(Cl)c(-c2ccc3nc(Nc4c(C)cccc4NC(=O)C=C)ncc3c2)c1Cl"
"734","BML-190","cannabinoid receptor inverse agonist","CNR2","","","Selleck, Tocris",98.01,"BRD-K94379058-001-05-0, BRD-K94379058-001-06-8","Preclinical","","BJSDNVVWJYDOLK-UHFFFAOYSA-N","BRD-K94379058","","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)N3CCOCC3)c2c1"
"736","BML-284","WNT agonist","","","","MedChemEx",97.93,"BRD-K42624714-001-04-1","Preclinical","","FABQUVYDAXWUQP-UHFFFAOYSA-N","BRD-K42624714","","COc1cccc(c1)-c1cc(NCc2ccc3OCOc3c2)nc(N)n1"
"737","BMS-CCR2-22","CC chemokine receptor antagonist","CCR2","","","Tocris",98.16,"BRD-K15119094-001-01-1","Preclinical","","IBPXYDUJQWENPM-XZOQPEGZSA-N","BRD-K15119094","","CSc1ccc(cc1)C(=O)N[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)NC(C)C)C(F)(F)F"
"738","BMS-182874","endothelin receptor antagonist","EDNRA","","","Tocris, Tocris",78.23,"BRD-K56509348-003-03-9, BRD-K56509348-003-02-1","Phase 2","","MJRGSRRZKSJHOE-UHFFFAOYSA-N","BRD-K56509348","","CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1onc(C)c1C"
"740","BMS-191011","potassium channel activator","KCNMA1","","","Tocris, Tocris",95.41,"BRD-K95609758-001-03-7, BRD-K95609758-001-04-5","Preclinical","","QKOWACXSXTXRKA-UHFFFAOYSA-N","BRD-K95609758","","Oc1ccc(Cl)cc1Cn1nc(oc1=O)-c1ccc(cc1)C(F)(F)F"
"742","BMS-191095","KATP activator, potassium channel agonist","","","","MedChemEx",96.19,"BRD-K01231377-001-01-8","Phase 1","","SMIKIPXIDLITMP-LEWJYISDSA-N","BRD-K01231377","","CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N(Cc1ncc[nH]1)c1ccc(Cl)cc1)C#N"
"743","BMS-265246","CDK inhibitor","CDK1, CDK2","","","MedChemEx, Selleck",97.16,"BRD-K62814476-001-04-1, BRD-K62814476-001-03-3","Preclinical","","SCFMWQIQBVZOQR-UHFFFAOYSA-N","BRD-K62814476","","CCCCOc1c(cnc2[nH]ncc12)C(=O)c1c(F)cc(C)cc1F"
"745","BMS-299897","gamma secretase inhibitor","","","","EMDBio",97.26,"BRD-K02950022-001-02-9","Phase 1","","IZAOBRWCUGOKNH-OAHLLOKOSA-N","BRD-K02950022","","C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1)c1ccc(F)cc1CCCC(O)=O"
"746","BMS-309403","fatty acid binding protein inhibitor","FABP4","","","Tocris",96.68,"BRD-K87956243-001-01-9","Preclinical","","SJRVJRYZAQYCEE-UHFFFAOYSA-N","BRD-K87956243","","CCc1c(c(nn1-c1ccccc1-c1cccc(OCC(O)=O)c1)-c1ccccc1)-c1ccccc1"
"747","BMS-345541","IKK inhibitor","CHUK, IKBKB","","","Selleck, Tocris",96.97,"BRD-K13566078-001-02-3, BRD-K13566078-003-06-0","Preclinical","","PSPFQEBFYXJZEV-UHFFFAOYSA-N","BRD-K13566078","","Cc1cnc2c(NCCN)nc3ccc(C)cc3n12"
"749","BMS-387032","CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9","","","Selleck, Selleck",92.86,"BRD-K43389698-001-09-9, BRD-K43389698-001-07-3","Phase 1","","OUSFTKFNBAZUKL-UHFFFAOYSA-N","BRD-K43389698","","CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"
"751","BMS-470539","melanocortin receptor agonist","MC1R","","","Tocris",81.93,"BRD-K22000702-300-01-4","Preclinical","","GULVVTHHUIIMRL-WUFINQPMSA-N","BRD-K22000702","","CCCC(=O)C1(CCN(CC1)C(=O)[C@@H](Cc1ccc(OC)cc1)NC(=O)[C@@H](N)Cc1cncn1C)c1ccccc1"
"752","BMS-536924","IGF-1 inhibitor","AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB","","","MedChemEx, Tocris",92.53,"BRD-K34581968-001-04-6, BRD-K34581968-001-05-3","Preclinical","","ZWVZORIKUNOTCS-OAQYLSRUSA-N","BRD-K34581968","","Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1"
"754","BMS-566419","inosine monophosphate dehydrogenase inhibitor","IMPDH1, IMPDH2","","","Tocris",94.41,"BRD-K56932272-001-01-1","Preclinical","","XEVJUIZOZCFECP-UHFFFAOYSA-N","BRD-K56932272","","CCN1CCN(CC1)c1ccc(cn1)C(C)(C)NC(=O)c1cc2[nH]c3ccccc3c(=O)c2cc1F"
"755","BMS-587101","integrin antagonist","ITGAL, ITGB2","","","Key",92.65,"BRD-K20093108-001-02-3","Phase 2","","NXNKJLOEGWSJGI-BKMJKUGQSA-N","BRD-K20093108","","CN1C(=O)N(C(=O)[C@]11CN(Cc2cc(cs2)C(O)=O)C[C@H]1c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1"
"756","BMS-599626","EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4","","","Selleck, Tocris",97.06,"BRD-K07106112-003-03-8, BRD-K07106112-300-01-2","Phase 1","","LUJZZYWHBDHDQX-QFIPXVFZSA-N","BRD-K07106112","","Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12"
"758","BMS-626529","HIV attachment inhibitor","","","","MedChemEx",98.85,"BRD-K97883416-001-01-4","Phase 3","","QRPZBKAMSFHVRW-UHFFFAOYSA-N","BRD-K97883416","","COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12"
"759","BMS-649","retinoid receptor agonist","RXRA","","","Tocris, Tocris",99.1,"BRD-K25991633-001-01-9, BRD-K25991633-001-02-7","Preclinical","","ZZUKALQMHNSWTK-UHFFFAOYSA-N","BRD-K25991633","","CC1(C)CCC(C)(C)c2cc(ccc12)C1(OCCO1)c1ccc(cc1)C(O)=O"
"761","BMS-688521","leukocyte function-associated antigen receptor antagonist, ICAM1 antagonist","ICAM1","","","Key",99.64,"BRD-K85649978-001-02-1","Preclinical","","LILGMDXLRPEBNH-HFZDXXHNSA-N","BRD-K85649978","","CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1"
"762","BMS-690514","EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR","","","MedChemEx, MedChemEx",94.59,"BRD-K76239644-001-02-6, BRD-K76239644-001-01-8","Phase 2","","CSGQVNMSRKWUSH-IAGOWNOFSA-N","BRD-K76239644","","COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1"
"764","BMS-707035","HIV integrase inhibitor","","","","Selleck",96.62,"BRD-K49555808-001-03-9","Phase 2","","VNIWZCGZPBJWBI-UHFFFAOYSA-N","BRD-K49555808","","Cn1c(nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O)N1CCCCS1(=O)=O"
"765","BMS-754807","IGF-1 inhibitor","AKT1, IGF1R","","","MedChemEx, Selleck, Selleck",96.93,"BRD-K13049116-001-04-0, BRD-K13049116-001-03-2, BRD-K13049116-001-05-7","Phase 2","BRD-K47200824-001-01-8","LQVXSNNAFNGRAH-QHCPKHFHSA-N","BRD-K13049116","BRD-K47200824","C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1"
"768","BMS-777607","AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor","AXL, MERTK, MET, MST1R, TYRO3","","","Selleck",98.03,"BRD-K40738845-001-05-0","Phase 1/Phase 2","","VNBRGSXVFBYQNN-UHFFFAOYSA-N","BRD-K40738845","","CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1"
"769","BMS-806","HIV attachment inhibitor","","","","Selleck, Selleck",97.42,"BRD-K55773932-001-03-8, BRD-K55773932-001-02-0","Phase 1","","OKGPFTLYBPQBIX-CQSZACIVSA-N","BRD-K55773932","","COc1cc[nH]c2ncc(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)c12"
"771","BMS-817378","c-Met inhibitor, VEGFR inhibitor","KDR, MET","","","MedChemEx",96.68,"BRD-K81026553-234-01-8","Phase 1","","KXDZWUPUSDCGDD-UHFFFAOYSA-N","BRD-K81026553","","Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl"
"772","BMS-833923","smoothened receptor antagonist","SMO","","","MedChemEx, Selleck, Selleck",94.83,"BRD-K33245965-001-03-4, BRD-K33245965-001-01-8, BRD-K33245965-001-02-6","Phase 2","","KLRRGBHZCJLIEL-UHFFFAOYSA-N","BRD-K33245965","","CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1"
"775","BMS-863233","CDC inhibitor","CDC7, PIM1","","","MedChemEx, MedChemEx",89,"BRD-K12511835-003-01-2, BRD-K12511835-003-02-0","Phase 1/Phase 2","","JJWLXRKVUJDJKG-VIFPVBQESA-N","BRD-K12511835","","Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1"
"777","BMS-927711","calcitonin antagonist","CALCA","","","MedChemEx",95.12,"BRD-K55781385-001-01-7","Phase 2","","KRNAOFGYEFKHPB-ANJVHQHFSA-N","BRD-K55781385","","N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F"
"778","BMS-983970","notch signaling inhibitor","","","","MedChemEx",96.07,"BRD-K22316123-001-01-9","Phase 1","","RANYIWAZSQWERN-WLENULPWSA-N","BRD-K22316123","","NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cccc(F)c2NC1=O"
"779","BMS-986020","lysophosphatidic acid receptor antagonist","LPAR1","","","MedChemEx, MedChemEx, MedChemEx",96.92,"BRD-K23952234-236-02-6, BRD-K23952234-236-03-4, BRD-K23952234-236-01-8","Phase 2","","LNDDRUPAICPXIN-GOSISDBHSA-N","BRD-K23952234","","C[C@@H](OC(=O)Nc1c(C)noc1-c1ccc(cc1)-c1ccc(CC(O)=O)cc1)c1ccccc1"
"782","BMY-14802","sigma receptor antagonist","HTR1A","","","Tocris",95.41,"BRD-A15435692-003-02-3","Phase 2","","ZXUYYZPJUGQHLQ-UHFFFAOYSA-N","BRD-A15435692","","OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1"
"783","BMY-45778","IP1 prostacyclin receptor agonist","PTGIR","","","Tocris",87.31,"BRD-K84895041-001-02-4","Preclinical","","DSRSEEYZGWTODH-UHFFFAOYSA-N","BRD-K84895041","","OC(=O)COc1cccc(c1)-c1ocnc1-c1nc(c(o1)-c1ccccc1)-c1ccccc1"
"784","BMY-7378","adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A","","","Selleck, Tocris",97.28,"BRD-K31054881-300-03-9, BRD-K31054881-300-04-7","Preclinical","","AYYCFGDXLUPJAQ-UHFFFAOYSA-N","BRD-K31054881","","COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1"
"786","BNC105","tubulin polymerization inhibitor","","","","MedChemEx, MedChemEx",94.71,"BRD-K20468903-001-01-6, BRD-K20468903-001-02-4","Phase 2","","RADMJHVVIZTENA-UHFFFAOYSA-N","BRD-K20468903","","COc1ccc2c(C(=O)c3cc(OC)c(OC)c(OC)c3)c(C)oc2c1O"
"788","BNTX","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","","","Tocris, Tocris, Tocris",94.95,"BRD-A55484088-050-03-3, BRD-A55484088-050-04-1, BRD-A55484088-050-02-5","Preclinical","","WXOUFNFMPVMGFZ-WLNGDWEISA-N","BRD-A55484088","","Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)\C(C[C@@]35O)=C\c1ccccc1"
"791","BONAPHTHONE","","","","","Vitas-M, AMS",14.06,"BRD-K34149328-001-01-3, BRD-K34149328-001-02-1","Phase 3","","MXWZRRPNVLCHMY-UHFFFAOYSA-N","BRD-K34149328","","Brc1ccc2C(=O)C(=O)C=Cc2c1"
"793","BORNYL-ACETATE","","","","","Vitas-M, MicroSource",0,"BRD-A41385909-001-02-1, BRD-A41385909-001-01-3","Preclinical","","KGEKLUUHTZCSIP-UHFFFAOYSA-N","BRD-A41385909","","CC(=O)OC1CC2CCC1(C)C2(C)C"
"795","BORONOPHENYLALANINE","","","","","Sigma, Acros",99.4,"BRD-K50122911-001-01-2, BRD-K50122911-001-02-0","Phase 2","BRD-K70071822-001-01-5","NFIVJOSXJDORSP-QMMMGPOBSA-N","BRD-K50122911","BRD-K70071822","N[C@@H](Cc1ccc(cc1)B(O)O)C(O)=O"
"797","BP-554","serotonin receptor agonist","HTR1A","","","Tocris, Tocris",94.12,"BRD-K45479396-050-02-3, BRD-K45479396-050-01-5","Preclinical","","VUSNBQDZGKZEDL-UHFFFAOYSA-N","BRD-K45479396","","C(COc1ccc2OCOc2c1)CN1CCN(CC1)c1ccccc1"
"799","BP-897","dopamine receptor agonist","ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B","","","Prestwick",91.72,"BRD-K17378184-300-05-9","Phase 2","","MNHDKMDLOJSCGN-UHFFFAOYSA-N","BRD-K17378184","","COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1"
"800","BQ-123","endothelin receptor antagonist","EDNRA","","","Selleck",95.45,"BRD-A59961917-001-01-0","Phase 2","","VYCMAAOURFJIHD-UHFFFAOYSA-N","BRD-A59961917","","CC(C)CC1NC(=O)C(NC(=O)C2CCCN2C(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O)C(C)C"
"801","BQ-788","endothelin receptor antagonist","EDNRB","","","MedChemEx, MedChemEx",87.22,"BRD-K02490038-236-03-8, BRD-K02490038-236-01-2","Phase 1","","LPAHKJMGDSJDRG-DJYQTOCQSA-N","BRD-K02490038","","CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C(O)=O"
"803","BQU57","Ras GTPase inhibitor","RALA, RALB","","","MedChemEx, MedChemEx",91.26,"BRD-A40257118-001-02-0, BRD-A40257118-001-01-2","Preclinical","","IJCMHHSFXFMZAI-UHFFFAOYSA-N","BRD-A40257118","","Cc1nn(C)c2OC(N)=C(C#N)C(c12)c1ccc(cc1)C(F)(F)F"
"805","BRD-7389","ribosomal protein inhibitor","RPS6KA1, RPS6KA2, RPS6KA3","","","Tocris",72.56,"BRD-K15107389-001-03-6","Preclinical","","XASCINRGTHLHGM-UHFFFAOYSA-N","BRD-K15107389","","O=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23"
"806","BRD-9876","kinesin inhibitor","KIF11","","","Tocris",90.59,"BRD-K89329876-001-07-8","Preclinical","","MKILROQBJOOZKC-UHFFFAOYSA-N","BRD-K89329876","","CC(C)(C)c1ccc2cc(C#N)c(cc2c1)C#N"
"807","BRD4770","histone lysine methyltransferase inhibitor","EHMT2","","","MedChemEx, MedChemEx",99.57,"BRD-K72264770-001-03-2, BRD-K72264770-001-04-0","Preclinical","","UCGWYCMPZXDHNR-UHFFFAOYSA-N","BRD-K72264770","","COC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c3ccccc3)nc2c1"
"809","BREFELDIN-A","protein synthesis inhibitor","ARF1, CYTH2","","","Tocris, Selleck, Tocris",97.85,"BRD-K77841042-001-15-8, BRD-K77841042-001-11-7, BRD-K77841042-001-14-1","Preclinical","BRD-A84228258-001-05-1, BRD-A84228258-001-04-4","KQNZDYYTLMIZCT-KQPMLPITSA-N","BRD-K77841042","BRD-A84228258","C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1"
"812","BREMELANOTIDE","melanocortin receptor agonist","MC1R, MC2R, MC3R, MC4R, MC5R","","","MedChemEx",91.49,"BRD-K06328344-015-01-7","Phase 3","","FFHBJDQSGDNCIV-MFVUMRCOSA-N","BRD-K06328344","","CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)C(O)=O"
"813","BREQUINAR","dihydroorotate dehydrogenase inhibitor","DHODH","","","EMDBio",98.43,"BRD-K96123349-236-02-8","Phase 2","","PHEZJEYUWHETKO-UHFFFAOYSA-N","BRD-K96123349","","Cc1c(nc2ccc(F)cc2c1C(O)=O)-c1ccc(cc1)-c1ccccc1F"
"814","BRETAZENIL","GABA benzodiazepine site receptor partial agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6","","","Tocris, Tocris",98.49,"BRD-K96936751-001-01-4, BRD-K96936751-001-02-2","Phase 2","","LWUDDYHYYNNIQI-ZDUSSCGKSA-N","BRD-K96936751","","CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21"
"816","BRICICLIB","cyclin D inhibitor","CCND1","","","MedChemEx",94.31,"BRD-K05531427-001-01-7","Phase 1","","LXENKEWVEVKKGV-BQYQJAHWSA-N","BRD-K05531427","","COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(OP(O)(O)=O)c2)c(OC)c1"
"817","BRILLIANT-GREEN","","","","","Acros",90.42,"BRD-K60348325-065-09-9","Launched","","HXCILVUBKWANLN-UHFFFAOYSA-N","BRD-K60348325","","CCN(CC)c1ccc(cc1)C(c1ccccc1)=C1C=CC(C=C1)=[N+](CC)CC"
"818","BRIVANIB","FGFR inhibitor, VEGFR inhibitor","CYP3A4, FGFR1, FLT1, KCNH2, KDR","","","Selleck",97.4,"BRD-K28428262-001-04-1","Phase 3","","WCWUXEGQKLTGDX-LLVKDONJSA-N","BRD-K28428262","","C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C"
"819","BRIVANIB-ALANINATE","FGFR inhibitor, VEGFR inhibitor","FGFR3","","","Selleck, MedChemEx, Selleck",73.46,"BRD-K57187269-001-03-2, BRD-K57187269-001-04-0, BRD-K57187269-001-02-4","Phase 3","","LTEJRLHKIYCEOX-OCCSQVGLSA-N","BRD-K57187269","","C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N"
"822","BRL-15572","serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6","","","Selleck, Selleck, Tocris",98.84,"BRD-A51829654-300-03-6, BRD-A51829654-300-02-8, BRD-A51829654-003-07-7","Preclinical","","QJHCTHPYUOXOGM-UHFFFAOYSA-N","BRD-A51829654","","OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1"
"825","BRL-26314","cholesterol inhibitor","LPL","","","Sigma",97.68,"BRD-A57806482-001-01-4","Phase 1","","SAOHCSVJQIAGDD-UHFFFAOYSA-N","BRD-A57806482","","OC(=O)C(Cc1ccccc1)NCc1ccc(Cl)cc1"
"826","BRL-37344","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Tocris, Tocris",92.21,"BRD-K07507905-236-03-4, BRD-K07507905-236-02-6","Phase 2","","ZGGNJJJYUVRADP-ACJLOTCBSA-N","BRD-K07507905","","C[C@H](Cc1ccc(OCC(O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1"
"828","BRL-44408","adrenergic receptor antagonist","ADRA2A, ADRA2B, ADRA2C","","","Tocris",12.04,"BRD-A67949680-050-01-7","Preclinical","","SGOFAUSEYBZKDQ-UHFFFAOYSA-N","BRD-A67949680","","CC1N(CC2=NCCN2)Cc2ccccc12"
"829","BRL-50481","phosphodiesterase inhibitor","PDE7A, PDE7B","","","Tocris, Tocris",98.33,"BRD-K84266862-001-03-2, BRD-K84266862-001-04-0","Preclinical","","IFIUFCJFLGCQPH-UHFFFAOYSA-N","BRD-K84266862","","CN(C)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O"
"831","BRL-52537","opioid receptor agonist","OPRK1","","","Tocris",95.52,"BRD-A37347161-003-02-6","Preclinical","","GHCCBWMZKJQGLS-UHFFFAOYSA-N","BRD-A37347161","","Clc1ccc(CC(=O)N2CCCCC2CN2CCCC2)cc1Cl"
"832","BRL-54443","serotonin receptor agonist","HTR1E, HTR1F","","","Selleck, Tocris",96.5,"BRD-K17868609-001-04-3, BRD-K17868609-001-05-0","Preclinical","","WKNFADCGOAHBPG-UHFFFAOYSA-N","BRD-K17868609","","CN1CCC(CC1)c1c[nH]c2ccc(O)cc12"
"834","BROLITENE","muscle relaxant","RYR1","","","ChemBridge, Vitas-M",0,"BRD-K76021681-001-01-4, BRD-K76021681-001-02-2","Launched","","OSCTXCOERRNGLW-VOTSOKGWSA-N","BRD-K76021681","","OCCNC(=O)\C=C\c1ccccc1"
"836","BROMEBRIC-ACID","purine antagonist, DNA synthesis inhibitor","","","","Sigma",91.08,"BRD-K17874929-236-02-0","Preclinical","","UPZFHUODAYGHDZ-TWGQIWQCSA-N","BRD-K17874929","","COc1ccc(cc1)C(=O)C(\Br)=C\C(O)=O"
"837","BROMFENAC","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Selleck",96.65,"BRD-K47679368-236-01-7","Withdrawn","","ZBPLOVFIXSTCRZ-UHFFFAOYSA-N","BRD-K47679368","","Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1"
"838","BROMINDIONE","anticoagulant","","","","MicroSource",0,"BRD-K50490982-001-08-2","Phase 2","","NPUZIGSOEWMFKK-UHFFFAOYSA-N","BRD-K50490982","","Brc1ccc(cc1)C1C(=O)c2ccccc2C1=O"
"839","BROMOSPORINE","bromodomain inhibitor","","","","Selleck, Tocris",98.35,"BRD-K44665581-001-01-8, BRD-K44665581-001-02-6","Preclinical","","UYBRROMMFMPJAN-UHFFFAOYSA-N","BRD-K44665581","","CCOC(=O)Nc1cc(nn2c(C)nnc12)-c1ccc(C)c(NS(C)(=O)=O)c1"
"841","BRONOPOL","","","","","MicroSource",0,"BRD-K33457401-001-01-1","Launched","","LVDKZNITIUWNER-UHFFFAOYSA-N","BRD-K33457401","","OCC(Br)(CO)[N+]([O-])=O"
"842","BROPIRIMINE","interferon inducer","","","","LifeChem",99.22,"BRD-K17500877-001-02-1","Phase 3","","CIUUIPMOFZIWIZ-UHFFFAOYSA-N","BRD-K17500877","","Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1"
"843","BROXALDINE","","","","","MicroSource",96.22,"BRD-K36222532-001-01-8","Preclinical","","IJTPLVAAROHGGB-UHFFFAOYSA-N","BRD-K36222532","","Cc1ccc2c(Br)cc(Br)c(OC(=O)c3ccccc3)c2n1"
"844","BROXATEROL","adrenergic receptor agonist","ADRB2","","","Enamine",98.05,"BRD-A08316590-001-01-3","Phase 3","","JBRBWHCVRGURBA-UHFFFAOYSA-N","BRD-A08316590","","CC(C)(C)NCC(O)c1cc(Br)no1"
"845","BROXURIDINE","antimetabolite","","","","MedChemEx",94.39,"BRD-K79095980-001-09-6","Phase 2","","WOVKYSAHUYNSMH-RRKCRQDMSA-N","BRD-K79095980","","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(Br)c(=O)[nH]c1=O"
"846","BROXYQUINOLINE","antiprotozoal agent","","","","MicroSource, Selleck, Selleck",99.49,"BRD-K23301018-001-10-9, BRD-K23301018-001-09-1, BRD-K23301018-001-11-7","Phase 1","","ZDASUJMDVPTNTF-UHFFFAOYSA-N","BRD-K23301018","","Oc1c(Br)cc(Br)c2cccnc12"
"849","BRUCEANTIN","protein synthesis inhibitor","","","","MedChemEx",87.66,"BRD-A36057565-001-01-0","Phase 2","","KMCZIPGKKBSLEX-JLNWNYEJSA-N","BRD-A36057565","","COC(=O)[C@]12OC[C@@]34[C@H]1[C@@H](OC(=O)\C=C(/C)C(C)C)C(=O)O[C@@H]3C[C@H]1C(C)C(=O)C(=O)C[C@]1(C)[C@H]4[C@@H](O)[C@@H]2O"
"850","BRUCINE","glycine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","","","MicroSource, Selleck, Selleck",95.02,"BRD-A41995253-001-04-5, BRD-A41995253-330-01-4, BRD-A41995253-330-02-2","Preclinical","","RRKTZKIUPZVBMF-PLNGPGDESA-N","BRD-A41995253","","COc1cc2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)c2cc1OC"
"853","BRYOSTATIN-1","protein kinase C inhibitor","PRKCE","","","EMDBio",0,"BRD-K47405978-001-02-5","Phase 2","BRD-A77494669-001-01-0","MJQUEDHRCUIRLF-YAWXWKATSA-N","BRD-K47405978","BRD-A77494669","CCC\C=C\C=C\C(=O)O[C@H]1\C(C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C\C(C[C@@H](O4)\C=C/C(C)(C)[C@]1(O)O2)=C\C(=O)OC)O3)[C@@H](C)O)=C\C(=O)OC"
"854","BS-181","CDK inhibitor","CDK7","","","Selleck, Selleck, Tocris",96.53,"BRD-K31313613-003-05-9, BRD-K31313613-003-04-2, BRD-K31313613-300-01-8","Preclinical","","DNYBIOICMDTDAP-UHFFFAOYSA-N","BRD-K31313613","","CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12"
"857","BTB06584","ATPase inhibitor","ATP5F1","","","Selleck, Selleck",0,"BRD-K37933329-001-01-6, BRD-K37933329-001-02-4","Preclinical","","WNDWKKPBLAKXMI-UHFFFAOYSA-N","BRD-K37933329","","[O-][N+](=O)c1ccc(cc1OC(=O)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1"
"859","BTB1","mitotic kinesin inhibitor","KIF18A","","","Tocris",95.56,"BRD-K89000287-001-01-1","Preclinical","","VZDUQPHKUBZMLW-UHFFFAOYSA-N","BRD-K89000287","","[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)c1ccccc1"
"860","BTS","","","","","Tocris, Tocris",98.75,"BRD-K64178227-001-10-8, BRD-K64178227-001-09-0","Preclinical","","WTHKAJZQYNKTCJ-UHFFFAOYSA-N","BRD-K64178227","","Cc1ccc(cc1)S(=O)(=O)NCc1ccccc1"
"862","BTS-54505","dopamine reuptake inhibitor","SLC6A2, SLC6A3, SLC6A4","","","Tocris, Tocris",94.8,"BRD-A68304895-003-02-2, BRD-A68304895-003-03-0","Withdrawn","","WQSACWZKKZPCHN-UHFFFAOYSA-N","BRD-A68304895","","CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1"
"864","BTS-72664","GABA receptor antagonist","GABBR1","","","Key",98.2,"BRD-A65793993-001-01-6","Phase 1","","FCEPUTGEUCVRRI-UHFFFAOYSA-N","BRD-A65793993","","CC(Oc1ccc(Cl)cc1)c1ccnc2ncnn12"
"865","BTT-3033","integrin inhibitor","ITGA2, ITGB1","","","Tocris",98.48,"BRD-K01492390-001-01-9","Preclinical","","NSLIQOPYDUKWTA-UHFFFAOYSA-N","BRD-K01492390","","CN(c1ccc(NC(=O)Nc2ccccc2)cc1)S(=O)(=O)c1cnn(c1)-c1ccc(F)cc1"
"866","BTZ043-RACEMATE","DPRE1 inhibitor","","","","Selleck",98.56,"BRD-A53037217-001-02-0","Preclinical","","GTUIRORNXIOHQR-UHFFFAOYSA-N","BRD-A53037217","","CC1COC2(CCN(CC2)c2nc(=O)c3cc(cc([N+]([O-])=O)c3s2)C(F)(F)F)O1"
"867","BU-224","imidazoline receptor ligand","MAOA, MAOB","","","Tocris",98.23,"BRD-K55344148-003-02-6","Preclinical","","OSUVWJGCKQEMHK-UHFFFAOYSA-N","BRD-K55344148","","C1CN=C(N1)c1ccc2ccccc2n1"
"868","BU-239","imidazoline receptor ligand, imidazoline receptor agonist","","","","Tocris",95.93,"BRD-K11696279-003-02-3","Preclinical","","MQSSFHXQKUSFIW-UHFFFAOYSA-N","BRD-K11696279","","C1CN=C(N1)c1cnc2ccccc2n1"
"869","BUCETIN","analgesic agent","","","","MicroSource",98.09,"BRD-A88684804-001-04-3","Withdrawn","","LIAWQASKBFCRNR-UHFFFAOYSA-N","BRD-A88684804","","CCOc1ccc(NC(=O)CC(C)O)cc1"
"870","BUFEXAMAC","cyclooxygenase inhibitor","HDAC10, HDAC6","","","MicroSource, Selleck",95.88,"BRD-K36660044-001-24-2, BRD-K36660044-001-23-4","Withdrawn","","MXJWRABVEGLYDG-UHFFFAOYSA-N","BRD-K36660044","","CCCCOc1ccc(CC(=O)NO)cc1"
"872","BUPARLISIB","PI3K inhibitor","PIK3CA, PIK3CG","","","Selleck, Selleck",98.65,"BRD-K42191735-001-08-7, BRD-K42191735-001-05-3","Phase 3","","CWHUFRVAEUJCEF-UHFFFAOYSA-N","BRD-K42191735","","Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F"
"874","BUPARVAQUONE","antiprotozoal agent","","","","MedChemEx",96.77,"BRD-A07947329-001-01-4","Launched","","OMMKCJLAGTXGLC-UHFFFAOYSA-N","BRD-A07947329","","CC(C)(C)C1CCC(CC2C(=O)C(=O)c3ccccc3C2=O)CC1"
"875","BUPICOMIDE","adrenergic receptor antagonist","ADRB1","","","Enamine",95.4,"BRD-K51700582-001-01-2","Phase 1","","VKSPIPWLHGKJQO-UHFFFAOYSA-N","BRD-K51700582","","CCCCc1ccc(nc1)C(N)=O"
"876","BURAMATE","antiepileptic","","","","MicroSource",65.99,"BRD-K30360804-001-01-3","Preclinical","","YFLRYAVDPKONNX-UHFFFAOYSA-N","BRD-K30360804","","OCCOC(=O)NCc1ccccc1"
"877","BUTABINDIDE","tripeptidyl peptidase inhibitor","TPP2","","","Tocris",0.47,"BRD-K40581315-034-01-5","Preclinical","","HAQIRIMIVLFYIX-ZFWWWQNUSA-N","BRD-K40581315","","CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@@H](N)CC"
"878","BUTACLAMOL","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A","","","Enzo",98.69,"BRD-K23082237-003-01-5","Phase 2","","ZZJYIKPMDIWRSN-TZBSWOFLSA-N","BRD-K23082237","","CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34"
"879","BUTAMBEN","sodium channel blocker","","","","MicroSource",99.12,"BRD-K27217864-001-22-3","Withdrawn","","IUWVALYLNVXWKX-UHFFFAOYSA-N","BRD-K27217864","","CCCCOC(=O)c1ccc(N)cc1"
"880","BUTEIN","EGFR inhibitor, src inhibitor","ACE","","","Selleck, Selleck",88.13,"BRD-K17497770-001-03-6, BRD-K17497770-001-04-4","Preclinical","","AYMYWHCQALZEGT-ORCRQEGFSA-N","BRD-K17497770","","Oc1ccc(C(=O)\C=C\c2ccc(O)c(O)c2)c(O)c1"
"882","BUTHIONINE-SULFOXIMINE","glutathione transferase inhibitor","GCLM","","","Enzo",94.36,"BRD-A47706533-001-02-6","Phase 1","","KJQFBVYMGADDTQ-CVSPRKDYSA-N","BRD-A47706533","","CCCCS(=N)(=O)CC[C@H](N)C(O)=O"
"883","BUTIBUFEN","cyclooxygenase inhibitor","","","","Carbosynth",95.48,"BRD-A46136514-001-01-2","Withdrawn","","UULSXYSSHHRCQK-UHFFFAOYSA-N","BRD-A46136514","","CCC(C(O)=O)c1ccc(CC(C)C)cc1"
"884","BUTOFILOLOL","adrenergic receptor antagonist","","","","Sigma",96.62,"BRD-A27274504-001-01-6","Phase 2","","NMBNQRJDEPOXCP-UHFFFAOYSA-N","BRD-A27274504","","CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C"
"885","BUTYL-PARABEN","DNA synthesis inhibitor","","","","MicroSource",98.43,"BRD-K08287586-001-14-3","Preclinical","","QFOHBWFCKVYLES-UHFFFAOYSA-N","BRD-K08287586","","CCCCOC(=O)c1ccc(O)cc1"
"886","BUTYLATED-HYDROXYANISOLE","antioxidant","","","","MicroSource",88.92,"BRD-K93035859-001-07-6","Preclinical","","MRBKEAMVRSLQPH-UHFFFAOYSA-N","BRD-K93035859","","COc1ccc(O)c(c1)C(C)(C)C"
"887","BUTYLATED-HYDROXYTOLUENE","carbonic anhydrase inhibitor","CA2","","","MicroSource",97.99,"BRD-K53153417-001-10-4","Phase 1","","NLZUEZXRPGMBCV-UHFFFAOYSA-N","BRD-K53153417","","Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C"
"888","BU226","imidazoline receptor ligand","","","","Tocris",97.75,"BRD-K56115039-003-02-1","Preclinical","","ZXRSVNHYTSSFMN-UHFFFAOYSA-N","BRD-K56115039","","C1CN=C(N1)c1cc2ccccc2cn1"
"889","BVD-523","MAP kinase inhibitor","","","","MedChemEx",99.21,"BRD-K28965160-001-01-1","Phase 1/Phase 2","","KSERXGMCDHOLSS-LJQANCHMSA-N","BRD-K28965160","","CC(C)Nc1cc(-c2c[nH]c(c2)C(=O)N[C@H](CO)c2cccc(Cl)c2)c(Cl)cn1"
"890","BVT-2733","11-beta hydroxysteroid dehydrogenase inhibitor","HSD17B1","","","MedChemEx",96.59,"BRD-K01742705-001-01-7","Preclinical","","YDPRNGAPPNPYQQ-UHFFFAOYSA-N","BRD-K01742705","","CN1CCN(CC1)C(=O)Cc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1"
"891","BVT-948","tyrosine phosphatase inhibitor","PTPN1, PTPN11, PTPN2","","","Tocris, Tocris",94.31,"BRD-K68567222-001-01-2, BRD-A22713669-001-04-3","Preclinical","BRD-A22713669-001-02-7","LLPBUXODFQZPFH-UHFFFAOYSA-N","BRD-K68567222","BRD-A22713669","CC1(C)C(=O)NC2=C1C(=O)C(=O)c1ccccc21"
"892","BVT-948","tyrosine phosphatase inhibitor","PTPN1, PTPN11, PTPN2","","","Tocris, Tocris",94.31,"BRD-K68567222-001-01-2, BRD-A22713669-001-04-3","Preclinical","BRD-A22713669-001-02-7","LLPBUXODFQZPFH-UHFFFAOYSA-N","BRD-K68567222","BRD-A22713669","CC1(C)C2C(=NC1=O)c1ccccc1C(=O)C2=O"
"893","BVT-948","tyrosine phosphatase inhibitor","PTPN1, PTPN11, PTPN2","","","Tocris, Tocris",94.31,"BRD-K68567222-001-01-2, BRD-A22713669-001-04-3","Preclinical","BRD-A22713669-001-02-7","AJVXVYTVAAWZAP-UHFFFAOYSA-N","BRD-K68567222","BRD-A22713669","CC1(C)C(=O)NC2=C1C(=O)C(=O)c1ccccc21"
"894","BVT-948","tyrosine phosphatase inhibitor","PTPN1, PTPN11, PTPN2","","","Tocris, Tocris",94.31,"BRD-K68567222-001-01-2, BRD-A22713669-001-04-3","Preclinical","BRD-A22713669-001-02-7","AJVXVYTVAAWZAP-UHFFFAOYSA-N","BRD-K68567222","BRD-A22713669","CC1(C)C2C(=NC1=O)c1ccccc1C(=O)C2=O"
"895","BW-A4C","lipoxygenase inhibitor","ALOX5","","","Sigma",87.05,"BRD-K80194255-001-01-9","Phase 1","","CEUDWZXMLMKPNN-SOFGYWHQSA-N","BRD-K80194255","","CC(=O)N(O)C\C=C\c1cccc(Oc2ccccc2)c1"
"896","BW-B70C","lipoxygenase inhibitor","ALOX5","","","Tocris",51.53,"BRD-A55946879-001-03-7","Preclinical","","UAIYNMRLUHHRMF-AATRIKPKSA-N","BRD-A55946879","","CC(\C=C\c1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O"
"897","BW-180C","opioid receptor agonist","OPRD1, OPRM1","","","Enzo",84.55,"BRD-K57927309-001-01-7","Phase 2","","ZHUJMSMQIPIPTF-IMNFJDCFSA-N","BRD-K57927309","","CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O"
"898","BW-373U86","opioid receptor agonist","OPRD1","","","Tocris",96.77,"BRD-K74990253-001-02-8","Preclinical","","LBLDMHBSVIVJPM-YZIHRLCOSA-N","BRD-K74990253","","CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(O)c1"
"899","BW-616U","monoamine oxidase inhibitor","MAOA","","","Enamine",97.3,"BRD-K07061232-001-01-8","Preclinical","","MLPSDBJCWIYSEA-UHFFFAOYSA-N","BRD-K07061232","","CNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1"
"900","BW-723C86","serotonin receptor agonist","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",88.95,"BRD-A17428743-003-10-8, BRD-A17428743-003-09-0","Preclinical","","ALFGDCNSEBJYSP-UHFFFAOYSA-N","BRD-A17428743","","CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12"
"902","BX-795","IKK inhibitor","CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1","","","MedChemEx, Selleck, Selleck, MedChemEx",94.52,"BRD-K47983010-001-15-3, BRD-K47983010-001-09-6, BRD-K47983010-001-12-0, BRD-K47983010-001-14-6","Preclinical","","VAVXGGRQQJZYBL-UHFFFAOYSA-N","BRD-K47983010","","Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1"
"906","BX-912","pyruvate dehydrogenase kinase inhibitor","CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1","","","Selleck",95.26,"BRD-K49669041-001-08-4","Preclinical","","DMMILYKXNCVKOJ-UHFFFAOYSA-N","BRD-K49669041","","Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1"
"907","BYK-204165","PARP inhibitor","PARP1","","","Tocris, Tocris",98.46,"BRD-K61665160-001-01-5, BRD-K61665160-001-02-3","Preclinical","","BTYSIDSTHDDAJW-LCYFTJDESA-N","BRD-K61665160","","Cn1cccc1\C=C1/C(=O)NC(=O)c2ccccc12"
"909","C-021","CC chemokine receptor antagonist","CCR4","","","Tocris",97.39,"BRD-K98179423-300-01-3","Preclinical","","WYVBISCFCHREDA-UHFFFAOYSA-N","BRD-K98179423","","COc1cc2nc(nc(NC3CCCCCC3)c2cc1OC)N1CCC(CC1)N1CCCCC1"
"910","C-1","protein kinase inhibitor","PRKCA","","","Tocris, Tocris",98.34,"BRD-K72462751-001-03-5, BRD-K72462751-001-02-7","Preclinical","","UPTYCYWTFGTCCG-UHFFFAOYSA-N","BRD-K72462751","","O=S(=O)(N1CCNCC1)c1cccc2cnccc12"
"912","C-751","","","","","Key",98.92,"BRD-K15337272-001-01-3","Preclinical","","KLWYPRNPRNPORS-UHFFFAOYSA-N","BRD-K15337272","","CCOC(=O)c1c[nH]cn1"
"913","CABALETTA","pharmacological chaperone","","","","Enzo",97.42,"BRD-K54028654-001-02-6","Phase 2","","HDTRYLNUVZCQOY-LIZSDCNHSA-N","BRD-K54028654","","OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O"
"914","CABOTEGRAVIR","HIV integrase inhibitor","","","","MedChemEx, Selleck",97.41,"BRD-K76819217-001-02-2, BRD-K76819217-001-01-4","Phase 2/Phase 3","BRD-A95114378-001-01-4, BRD-A07738941-001-01-5","WCWSTNLSLKSJPK-LKFCYVNXSA-N","BRD-K76819217","BRD-A95114378","C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12"
"916","CACCINH-A01","calcium-activated chloride channel inhibitor","CLCA1","","","Tocris",93.54,"BRD-A90751343-001-01-0","Preclinical","","ACLUEOBQFRYTQS-UHFFFAOYSA-N","BRD-A90751343","","CC(C)(C)C1CCc2c(C1)sc(NC(=O)c1ccco1)c2C(O)=O"
"917","CAFESTOL","pregnane X receptor agonist","","","","Enzo",95.32,"BRD-K46741531-001-02-4","Launched","","DNJVYWXIDISQRD-HWUKTEKMSA-N","BRD-K46741531","","C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3"
"918","CAFFEIC-ACID","HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF","","","Selleck, Selleck",88.37,"BRD-K09900591-001-26-7, BRD-K09900591-001-25-9","Preclinical","","QAIPRVGONGVQAS-DUXPYHPUSA-N","BRD-K09900591","","OC(=O)\C=C\c1ccc(O)c(O)c1"
"920","CAFFEIC-ACID-PHENETHYL-ESTER","HIV integrase inhibitor","RELA","","","Tocris, Selleck",96.26,"BRD-K96188950-001-16-9, BRD-K96188950-001-15-1","Preclinical","","SWUARLUWKZWEBQ-VQHVLOKHSA-N","BRD-K96188950","","Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O"
"922","CALCIFEDIOL","vitamin D receptor agonist","VDR","","","Adooq, MedChemEx, Selleck, Selleck",93.33,"BRD-K77175907-001-08-0, BRD-K77175907-002-01-3, BRD-K77175907-001-06-4, BRD-K77175907-001-10-6","Launched","BRD-K34907920-001-01-6","JWUBBDSIWDLEOM-DTOXIADCSA-N","BRD-K77175907","BRD-K34907920","C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C"
"926","CALCIUM-GLUCEPTATE","","","","","MicroSource, Selleck",100,"BRD-K35952844-238-02-0, BRD-K35952844-238-01-2","Launched","BRD-M41172429-238-02-8, BRD-K74392481-001-01-3","KWMLJOLKUYYJFJ-VFUOTHLCSA-N","BRD-K35952844","BRD-M41172429","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O"
"928","CALCIUM-LEVOFOLINATE","","","","","Selleck, Selleck",100,"BRD-K97009491-238-03-8, BRD-K97009491-238-02-0","Launched","","VVIAGPKUTFNRDU-STQMWFEESA-N","BRD-K97009491","","Nc1nc(=O)c2N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1"
"930","CALHEX-231","calcium sensing receptor negative allosteric modulator","CASR","","","Tocris",93.49,"BRD-K19811997-003-01-3","Preclinical","","YTFUQWWKTIWYEY-CQLNOVPUSA-N","BRD-K19811997","","C[C@@H](N[C@H]1CCCC[C@@H]1NC(=O)c1ccc(Cl)cc1)c1cccc2ccccc12"
"931","CALPEPTIN","calpain inhibitor","","","","Tocris, Tocris",79.34,"BRD-K26134695-001-04-4, BRD-K26134695-001-03-6","Preclinical","","PGGUOGKHUUUWAF-ROUUACIJSA-N","BRD-K26134695","","CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O"
"933","CAMICINAL","motilin receptor agonist","MLNR","","","MedChemEx",85.54,"BRD-K23248433-001-01-8","Phase 2","","RZKDEGZIFSJVNA-IBGZPJMESA-N","BRD-K23248433","","C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc3cccc(F)c3)cc2)CCN1"
"934","CAMKII-IN-1","calcium/calmodulin dependent protein kinase inhibitor","AKT1, CAMK2A, CAMK4, MYLK","","","MedChemEx, MedChemEx",96.28,"BRD-K35772771-001-02-1, BRD-K35772771-001-01-3","Preclinical","","LGUUETDTMQTHML-UHFFFAOYSA-N","BRD-K35772771","","Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2CCN(Cc3ccccc3)Cc12"
"936","CAMPHOR-(+)","","TRPV1","","","MedChemEx",0,"BRD-K10034334-001-03-3","Phase 2","","DSSYKIVIOFKYAU-XCBNKYQSSA-N","BRD-K10034334","","CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2"
"937","CAMPHOR-(1R)","TRPV activator","","","","MicroSource",0,"BRD-K15714472-001-04-5","Phase 1","","DSSYKIVIOFKYAU-GMSGAONNSA-N","BRD-K15714472","","CC1(C)[C@@H]2CC[C@]1(C)C(=O)C2"
"938","CAMPTOTHECIN","topoisomerase inhibitor","TOP1","","","Selleck, Selleck, Tocris",89.88,"BRD-K37890730-001-17-7, BRD-K37890730-001-15-1, BRD-K37890730-001-16-9","Phase 3","","VSJKWCGYPAHWDS-FQEVSTJZSA-N","BRD-K37890730","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O"
"941","CANERTINIB","EGFR inhibitor","AKT1, EGFR, ERBB2, ERBB4","","","Selleck",95.13,"BRD-K50168500-001-07-9","Phase 3","","OMZCMEYTWSXEPZ-UHFFFAOYSA-N","BRD-K50168500","","Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl"
"942","CANRENONE","mineralocorticoid receptor antagonist","NR3C2","","","MicroSource",82.77,"BRD-A20644369-001-08-6","Withdrawn","","UJVLDDZCTMKXJK-GMTJQTPWSA-N","BRD-A20644369","","C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]21CCC(=O)O1"
"943","CAPADENOSON","adenosine receptor agonist","ADORA1","","","MedChemEx",99.55,"BRD-K97025174-001-01-4","Phase 2","","CITWCLNVRIKQAF-UHFFFAOYSA-N","BRD-K97025174","","Nc1nc(SCc2csc(n2)-c2ccc(Cl)cc2)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N"
"944","CAPOBENIC-ACID","","","","","MicroSource",52.98,"BRD-K04282412-001-16-3","Preclinical","","MPTXLVRHYGBOQY-UHFFFAOYSA-N","BRD-K04282412","","COc1cc(cc(OC)c1OC)C(=O)NCCCCCC(O)=O"
"945","CAPRYLIC-ACID","","","","","Enamine, Enamine",8.98,"BRD-K35170555-001-09-5, BRD-K35170555-001-12-9","Launched","","WWZKQHOCKIZLMA-UHFFFAOYSA-N","BRD-K35170555","","CCCCCCCC(O)=O"
"947","CAPSAZEPINE","TRPV agonist","TRPV1, TRPV4","","","Tocris, Tocris",92.83,"BRD-K44849676-001-11-3, BRD-K44849676-001-10-5","Preclinical","","DRCMAZOSEIMCHM-UHFFFAOYSA-N","BRD-K44849676","","Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1"
"949","CAPTAMINE","","","","","MicroSource",0,"BRD-K81645907-001-01-1","Preclinical","","DENMGZODXQRYAR-UHFFFAOYSA-N","BRD-K81645907","","CN(C)CCS"
"950","CAPTAN","","","","","AKSci",0,"BRD-A79857384-001-03-6","Phase 1","","LDVVMCZRFWMZSG-UHFFFAOYSA-N","BRD-A79857384","","ClC(Cl)(Cl)SN1C(=O)C2CC=CCC2C1=O"
"951","CARACEMIDE","ribonucleotide reductase inhibitor","RRM1","","","Enamine",0,"BRD-K62790656-001-01-1","Phase 2","","JURAJLFHWXNPHG-UHFFFAOYSA-N","BRD-K62790656","","CNC(=O)ON(C(C)=O)C(=O)NC"
"952","CARBARIL","acetylcholinesterase inhibitor","","","","MicroSource",54.75,"BRD-K54208592-001-09-4","Launched","","CVXBEEMKQHEXEN-UHFFFAOYSA-N","BRD-K54208592","","CNC(=O)Oc1cccc2ccccc12"
"953","CARBOXYAMIDOTRIAZOLE","calcium channel blocker","CXCL8","","","Sigma",99.81,"BRD-K68408772-001-05-4","Phase 3","","WNRZHQBJSXRYJK-UHFFFAOYSA-N","BRD-K68408772","","NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N"
"954","CARBOXYLOSARTAN","angiotensin antagonist","AGTR1","","","Cayman",98.87,"BRD-K23533833-001-01-9","Phase 1","","ZEUXAIYYDDCIRX-UHFFFAOYSA-N","BRD-K23533833","","CCCCc1nc(Cl)c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"955","CARBOXYPYRIDINE-DISULFIDE","","","","","Sigma",98.3,"BRD-K26530649-001-01-6","Phase 2","","GSASOFRDSIKDSN-UHFFFAOYSA-N","BRD-K26530649","","OC(=O)c1ccc(SSc2ccc(cn2)C(O)=O)nc1"
"956","CARDIOGENOL-C","cardiomyogenesis inducer","","","","Tocris, Tocris",95.96,"BRD-K99174507-003-02-0, BRD-K99174507-003-03-8","Preclinical","","LKBSMPFEKIBRGC-UHFFFAOYSA-N","BRD-K99174507","","COc1ccc(Nc2nccc(NCCO)n2)cc1"
"958","CARDIONOGEN-1","WNT signaling inhibitor","CTNNB1","","","Tocris",91.85,"BRD-K50905564-001-07-7","Preclinical","","SWTUPSNBTSPBIH-UHFFFAOYSA-N","BRD-K50905564","","C1CCC(CC1)c1nn2c(nnc2s1)-c1ccco1"
"959","CAREBASTINE","histamine receptor antagonist","HRH1","","","ChemImpex",98.51,"BRD-K49554218-001-01-0","Phase 1","","XGHOVGYJHWQGCC-UHFFFAOYSA-N","BRD-K49554218","","CC(C)(C(O)=O)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1"
"960","CARICOTAMIDE","NADPH quinone oxidoreductase inhibitor","NQO2","","","Enamine",0,"BRD-K90215590-001-01-4","Phase 2","","WEJRSYKFMCUCRQ-UHFFFAOYSA-N","BRD-K90215590","","NC(=O)CN1C=CCC(=C1)C(N)=O"
"961","CARIPORIDE","sodium/hydrogen exchanger inhibitor","SLC9A1","","","SantaCruz",97.4,"BRD-K21670884-001-01-9","Phase 3","","IWXNYAIICFKCTM-UHFFFAOYSA-N","BRD-K21670884","","CC(C)c1ccc(cc1S(C)(=O)=O)C(=O)N=C(N)N"
"962","CARMOTEROL","adrenergic receptor agonist","ADRB2","","","BidePharm",24.66,"BRD-K25095405-001-01-5","Phase 2","BRD-A25157829-001-01-3","IHOXNOQMRZISPV-YJYMSZOUSA-N","BRD-K25095405","BRD-A25157829","COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3nc(O)ccc23)cc1"
"963","CARMOXIROLE","dopamine receptor agonist","DRD2","","","Tocris, Tocris",91.82,"BRD-K82484965-003-03-5, BRD-K82484965-003-04-3","Phase 2","","AFSOIHMEOKEZJF-UHFFFAOYSA-N","BRD-K82484965","","OC(=O)c1ccc2[nH]cc(CCCCN3CCC(=CC3)c3ccccc3)c2c1"
"965","CARNITINE-(D/L)","","","","","MicroSource, Selleck",100,"BRD-A89594340-003-12-3, BRD-A89594340-003-11-5","Phase 3","","PHIQHXFUZVPYII-UHFFFAOYSA-O","BRD-A89594340","","C[N+](C)(C)CC(O)CC(O)=O"
"967","CARNOSINE","antiglycating agent","","","","SantaCruz",0,"BRD-A96051074-001-02-2","Phase 2","","CQOVPNPJLQNMDC-UHFFFAOYSA-N","BRD-A96051074","","NCCC(=O)NC(Cc1cnc[nH]1)C(O)=O"
"968","CAROXAZONE","monoamine oxidase inhibitor","MAOA, MAOB","","","Enamine",97.63,"BRD-K92129045-001-01-6","Withdrawn","","KYCBWEZLKCTALM-UHFFFAOYSA-N","BRD-K92129045","","NC(=O)CN1Cc2ccccc2OC1=O"
"969","CARSALAM","analgesic agent","","","","MicroSource",99.02,"BRD-K13238618-001-05-9","Preclinical","","OAYRYNVEFFWSHK-UHFFFAOYSA-N","BRD-K13238618","","O=c1[nH]c(=O)c2ccccc2o1"
"970","CARZENIDE","","CA1, CA12, CA14, CA2, CA6, CA9","","","MicroSource",92.92,"BRD-K09295674-001-09-8","Preclinical","","UCAGLBKTLXCODC-UHFFFAOYSA-N","BRD-K09295674","","NS(=O)(=O)c1ccc(cc1)C(O)=O"
"971","CASANTHRANOL-VARIANT","","","","","MicroSource",0,"BRD-K12413266-001-01-3","Launched","","CPUHNROBVJNNPW-VVBPCJSVSA-N","BRD-K12413266","","OC[C@H]1O[C@@H](O[C@@H]2c3cccc(O)c3C(=O)c3c(O)cc(CO)cc23)[C@H](O)[C@H](O)[C@H]1O"
"972","CASIN","GTPase inhibitor","CDC42","","","Tocris",87.75,"BRD-A25043798-001-01-2","Preclinical","","RXIUMAOXORBRCY-UHFFFAOYSA-N","BRD-A25043798","","OCCNC1CCCc2c1[nH]c1ccc(cc21)-c1ccccc1"
"973","CASTANOSPERMINE","glucosidase inhibitor","GAA, GBA","","","Tocris, Tocris",100,"BRD-K20897876-001-11-8, BRD-K20897876-001-10-0","Phase 2","","JDVVGAQPNNXQDW-TVNFTVLESA-N","BRD-K20897876","","O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12"
"975","CATHARANTHINE","tubulin polymerization inhibitor","","","","Selleck, Selleck",82.42,"BRD-K92377961-001-03-7, BRD-K92377961-001-02-9","Preclinical","","CMKFQVZJOWHHDV-NQZBTDCJSA-N","BRD-K92377961","","CCC1=C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@](C2)([C@@H]13)C(=O)OC"
"977","CATHEPSIN-INHIBITOR-1","cathepsin inhibitor","CTSB, CTSL, CTSV","","","Selleck",97.25,"BRD-K40269473-001-02-2","Preclinical","","MZRVIHRERYCHBL-HNNXBMFYSA-N","BRD-K40269473","","Cn1nc(cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N)C(C)(C)C"
"978","CAY10505","PI3K inhibitor","PIK3CG","","","Selleck, Selleck",92.14,"BRD-K40366680-001-04-1, BRD-K40366680-001-03-3","Preclinical","","UFBTYTGRUBUUIL-KPKJPENVSA-N","BRD-K40366680","","Fc1ccc(cc1)-c1ccc(\C=C2\SC(=O)NC2=O)o1"
"980","CB-03-01","androgen receptor antagonist","AR","","","MedChemEx, MedChemEx",85.47,"BRD-K41779183-001-01-2, BRD-K41779183-001-02-0","Phase 3","","GPNHMOZDMYNCPO-PDUMRIMRSA-N","BRD-K41779183","","CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO"
"982","CB-10-277","DNA synthesis inhibitor","","","","Vitas-M",99.53,"BRD-K59929863-001-01-9","Phase 1","","GUAZPUYTLMUTMA-ZHACJKMWSA-N","BRD-K59929863","","CN(C)\N=N\c1ccc(cc1)C(O)=O"
"983","CB-5083","valosin-containing protein inhibitor","VCP","","","MedChemEx, ApexBio",96.62,"BRD-K49048664-001-02-0, BRD-K49048664-001-01-2","Phase 1","","RDALZZCKQFLGJP-UHFFFAOYSA-N","BRD-K49048664","","Cc1cc2c(cccc2n1-c1nc2CCOCc2c(NCc2ccccc2)n1)C(N)=O"
"985","CB-839","glutaminase inhibitor","GLS","","","Broad Institute, MedChemEx",94.65,"BRD-K58070273-001-03-3, BRD-K58070273-001-04-1","Phase 1/Phase 2","","PRAAPINBUWJLGA-UHFFFAOYSA-N","BRD-K58070273","","FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3nnc(NC(=O)Cc4ccccn4)s3)nn2)c1"
"987","CBIPES","glutamate receptor positive allosteric modulator","GRM2","","","Tocris",98.08,"BRD-K34675210-003-01-4","Preclinical","","HDVYXILCBYGKGU-UHFFFAOYSA-N","BRD-K34675210","","CCS(=O)(=O)N(Cc1cccnc1)c1cccc(c1)-c1ccc(cc1)C#N"
"988","CBS,-N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE","","","","","AKSci",98.95,"BRD-K64191834-001-03-1","Preclinical","","DEQZTKGFXNUBJL-UHFFFAOYSA-N","BRD-K64191834","","C1CCC(CC1)NSc1nc2ccccc2s1"
"989","CBS-1114","lipoxygenase inhibitor","ALOX5","","","Vitas-M",50.58,"BRD-K91874254-001-01-4","Phase 1","","ZOBKPJRHDMKXQG-UHFFFAOYSA-N","BRD-K91874254","","N=C(NNc1ccccc1)c1ccccc1"
"990","CC-115","mTOR inhibitor, DNA protein kinase inhibitor","MTOR","","","MedChemEx, MedChemEx, MedChemEx",93.43,"BRD-K16755045-003-01-7, BRD-K16755045-001-01-1, BRD-K16755045-003-02-5","Phase 1","","GMYLVKUGJMYTFB-UHFFFAOYSA-N","BRD-K16755045","","CCN1C(=O)CN=C2NC=C(N=C12)c1ccc(nc1C)-c1nnc[nH]1"
"993","CC-223","mTOR inhibitor","MTOR","","","MedChemEx, MedChemEx",84.46,"BRD-K88737571-001-02-2, BRD-K88737571-001-01-4","Phase 1/Phase 2","","UFKLYTOEMRFKAD-SHTZXODSSA-N","BRD-K88737571","","CO[C@H]1CC[C@@H](CC1)N1C(=O)CNc2ncc(nc12)-c1ccc(nc1)C(C)(C)O"
"995","CC-401","JNK inhibitor","MAPK8","","","MedChemEx",96.72,"BRD-K45746021-003-01-9","Phase 1","","XDJCLCLBSGGNKS-UHFFFAOYSA-N","BRD-K45746021","","C(CN1CCCCC1)Oc1cccc(c1)-c1n[nH]c2ccc(cc12)-c1ncn[nH]1"
"996","CC-930","JNK inhibitor","","","","MedChemEx",94.72,"BRD-K48213016-001-01-8","Phase 2","","IBGLGMOPHJQDJB-IHRRRGAJSA-N","BRD-K48213016","","O[C@H]1CC[C@@H](CC1)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CCOC3)c2n1"
"997","CCG-1423","apoptosis stimulant","RHOC, SRF","","","Tocris",87.77,"BRD-A79726147-001-01-5","Preclinical","","DSMXVSGJIDFLKP-UHFFFAOYSA-N","BRD-A79726147","","CC(ONC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(=O)Nc1ccc(Cl)cc1"
"998","CCG-50014","G protein signaling inhibitor","RGS4, RGS8","","","Tocris, Selleck, Selleck",97.23,"BRD-K08893438-001-06-4, BRD-K08893438-001-04-9, BRD-K08893438-001-03-1","Preclinical","","QUIIIYITNGOFEI-UHFFFAOYSA-N","BRD-K08893438","","Cc1ccc(cc1)-n1sc(=O)n(Cc2ccc(F)cc2)c1=O"
"1001","CCG-63802","G protein signaling inhibitor","RGS4","","","MedChemEx, MedChemEx",3.27,"BRD-K26970495-001-02-7, BRD-K26970495-001-01-9","Preclinical","","VFSVKVQMZDJFQX-NBVRZTHBSA-N","BRD-K26970495","","Cc1cccc(Oc2nc3c(C)cccn3c(=O)c2\C=C(/C#N)c2nc3ccccc3s2)c1"
"1003","CCG-63808","G protein signaling inhibitor","RGS4","","","MedChemEx, MedChemEx",8.02,"BRD-K68474505-001-02-7, BRD-K68474505-001-01-9","Preclinical","","IPZHFKHGSYRBNT-DTQAZKPQSA-N","BRD-K68474505","","Cc1cccn2c1nc(Oc1ccc(F)cc1)c(\C=C(/C#N)c1nc3ccccc3s1)c2=O"
"1005","CCMI","acetylcholine receptor allosteric modulator","CHRNA7","","","Tocris, Tocris",93.64,"BRD-K16338837-001-01-8, BRD-K16338837-001-02-6","Preclinical","BRD-K19859123-001-01-3","VMAKIACTLSBBIY-UHFFFAOYSA-N","BRD-K16338837","BRD-K19859123","Cc1cc(on1)C(=CNc1ccc(Cl)cc1)C(=O)Nc1ccc(Cl)cc1"
"1007","CCMQ","homoquinolinic acid binding inhibitor","","","","Tocris",65.42,"BRD-K06159959-001-02-0","Preclinical","","IFXJDEHFADWURH-UHFFFAOYSA-N","BRD-K06159959","","OC(=O)Cc1cc2ccccc2nc1C(O)=O"
"1008","CCT-031374","WNT signaling inhibitor","CTNNB1","","","Tocris",89.63,"BRD-K90999434-004-01-7","Preclinical","","JPCYSKNELCOPKJ-UHFFFAOYSA-N","BRD-K90999434","","O=C(CN1C2=NCCN2c2ccccc12)c1ccc(cc1)-c1ccccc1"
"1009","CCT018159","HSP inhibitor","HSP90AA1, HSP90AB1","","","Tocris, Tocris",96.84,"BRD-K65503129-001-06-3, BRD-K65503129-001-07-1","Preclinical","","OWPMENVYXDJDOW-UHFFFAOYSA-N","BRD-K65503129","","CCc1cc(-c2n[nH]c(C)c2-c2ccc3OCCOc3c2)c(O)cc1O"
"1011","CCT128930","AKT inhibitor","PKIA, PRKACA","","","Selleck",96.82,"BRD-K76406695-001-02-9","Preclinical","","RZIDZIGAXXNODG-UHFFFAOYSA-N","BRD-K76406695","","NC1(Cc2ccc(Cl)cc2)CCN(CC1)c1ncnc2[nH]ccc12"
"1012","CCT129202","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck, Selleck",82.82,"BRD-K57136142-001-03-2, BRD-K57136142-001-02-4","Preclinical","","QYKHWEFPFAGNEV-UHFFFAOYSA-N","BRD-K57136142","","CN(C)c1ccc(cc1)-c1nc2c(N3CCN(CC(=O)Nc4nccs4)CC3)c(Cl)cnc2[nH]1"
"1014","CCT137690","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck, Selleck, Tocris",97.74,"BRD-K03289018-001-02-7, BRD-K03289018-001-03-5, BRD-K03289018-001-04-3","Preclinical","","GFLQCBTXTRCREJ-UHFFFAOYSA-N","BRD-K03289018","","CN1CCN(CC1)c1ccc(cc1)-c1nc2c(N3CCN(Cc4cc(C)on4)CC3)c(Br)cnc2[nH]1"
"1017","CC4","nicotinic receptor agonist","CHRNB2","","","Tocris",82.66,"BRD-K17751100-001-01-1","Preclinical","","LEXDAVFCJPDCNA-VNTMZGSJSA-N","BRD-K17751100","","O=c1cccc2[C@@H]3C[C@@H](CN(CCN4C[C@@H]5C[C@H](C4)c4cccc(=O)n4C5)C3)Cn12"
"1018","CD-1530","retinoid receptor agonist","RARG","","","Tocris",92.54,"BRD-K09619322-001-03-8","Preclinical","BRD-K25737009-001-04-6","VCQGNUWOMLYNNG-UHFFFAOYSA-N","BRD-K09619322","BRD-K25737009","OC(=O)c1ccc(cc1)-c1ccc2cc(O)c(cc2c1)C12CC3CC(CC(C3)C1)C2"
"1019","CD-437","retinoid receptor agonist","RARG","","","Tocris, Tocris",94.37,"BRD-K28907958-001-05-0, BRD-K28907958-001-04-3","Preclinical","","LDGIHZJOIQSHPB-UHFFFAOYSA-N","BRD-K28907958","","OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2"
"1021","CDBA","","","","","EMDBio",97.04,"BRD-A08079565-001-01-8","Phase 3","","WHGYBXFWUBPSRW-UHFFFAOYSA-N","BRD-A08079565","","OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O"
"1022","CDK1-5-INHIBITOR","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3B","","","Tocris",97.23,"BRD-K87932577-001-02-4","Preclinical","","DWHVZCLBMTZRQM-UHFFFAOYSA-N","BRD-K87932577","","Nc1n[nH]c2nc3ccccc3nc12"
"1023","CDK9-IN-6","CDK inhibitor","CDK9","","","MedChemEx",96.73,"BRD-K43914553-001-01-5","Preclinical","","XWQVQSXLXAXOPJ-ACRUOGEOSA-N","BRD-K43914553","","COC[C@H](C)N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCC2(CCOCC2)C#N)n1"
"1024","CDPPB","glutamate receptor positive allosteric modulator","GRM5","","","Tocris",96.82,"BRD-K02213468-001-02-3","Preclinical","","BKUIZWILNWHFHD-UHFFFAOYSA-N","BRD-K02213468","","O=C(Nc1cc(nn1-c1ccccc1)-c1ccccc1)c1cccc(c1)C#N"
"1025","CEBRANOPADOL","opioid receptor agonist","OPRL1, OPRM1","","","MedChemEx",95.64,"BRD-K48141473-001-01-7","Phase 3","","CSMVOZKEWSOFER-RQNOJGIXSA-N","BRD-K48141473","","CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1"
"1026","CEDIRANIB","KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB","","","Selleck",90.12,"BRD-K86930074-001-05-0","Phase 3","","XXJWYDDUDKYVKI-UHFFFAOYSA-N","BRD-K86930074","","COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1"
"1027","CEDROL","","","","","Vitas-M",0,"BRD-A61188230-001-01-6","Phase 2","","SVURIXNDRWRAFU-UHFFFAOYSA-N","BRD-A61188230","","CC1CCC2C(C)(C)C3CC12CCC3(C)O"
"1028","CEDROL-(+)","sedative","","","","Sigma",0,"BRD-K96362839-001-01-9","Phase 2","","SVURIXNDRWRAFU-OGMFBOKVSA-N","BRD-K96362839","","C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O"
"1029","CEFOSELIS","bacterial cell wall synthesis inhibitor","","","","Selleck, MedChemEx, AKSci, Selleck",99.54,"BRD-K72339976-065-03-9, BRD-K72339976-065-01-3, BRD-K72339976-065-04-7, BRD-K72339976-065-02-1","Launched","BRD-K37910175-065-03-0, BRD-K20284063-065-01-8, BRD-K02689172-065-01-8","ZINFAXPQMLDEEJ-GFVOIPPFSA-N","BRD-K72339976","BRD-K37910175","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"1033","CEFOTIAM-CILEXETIL","bacterial cell wall synthesis inhibitor","","","","SantaCruz, SantaCruz",23.99,"BRD-A76661185-300-02-4, BRD-A76661185-300-01-6","Launched","","VVFDMWZLBPUKTD-UHFFFAOYSA-N","BRD-A76661185","","CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12"
"1035","CEFOZOPRAN","bacterial cell wall synthesis inhibitor","","","","MedChemEx",90.83,"BRD-K46970505-003-01-9","Launched","","QDUIJCOKQCCXQY-WHJQOFBOSA-O","BRD-K46970505","","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccn4ncccc34)=C(N2C1=O)C(O)=O)c1nsc(N)n1"
"1036","CENTAZOLONE","monoamine oxidase inhibitor","","","","Enamine",95.67,"BRD-K31329721-001-08-2","Phase 1","","CZXUQBVMAUWSBX-UHFFFAOYSA-N","BRD-K31329721","","Nn1cnc2cc3ccccc3cc2c1=O"
"1037","CENTPROPAZINE","inositol monophosphatase inhibitor","","","","Enamine, Enamine",95.61,"BRD-A28958257-001-02-0, BRD-A28958257-001-01-2","Phase 3","","ZQPXSRTZFYHSFB-UHFFFAOYSA-N","BRD-A28958257","","CCC(=O)c1ccc(OCC(O)CN2CCN(CC2)c2ccccc2)cc1"
"1039","CEP-32496","RAF inhibitor","BRAF, RAF1","","","Selleck",97.13,"BRD-K20722021-001-02-1","Phase 1/Phase 2","","DKNUPRMJNUQNHR-UHFFFAOYSA-N","BRD-K20722021","","COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC"
"1040","CEP-33779","JAK inhibitor","JAK2","","","Selleck, Selleck",86.12,"BRD-K37237504-001-02-7, BRD-K37237504-001-03-5","Preclinical","","RFZKSQIFOZZIAQ-UHFFFAOYSA-N","BRD-K37237504","","CN1CCN(CC1)c1cccc(Nc2nc3c(cccn3n2)-c2ccc(cc2)S(C)(=O)=O)c1"
"1042","CEP-37440","ALK tyrosine kinase receptor inhibitor","ALK","","","MedChemEx",97.19,"BRD-K72827473-001-01-0","Phase 1","","BCSHRERPHLTPEE-NRFANRHFSA-N","BRD-K72827473","","CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl"
"1043","CEPHALOMANNINE","DNA polymerase inhibitor","","","","MedChemEx, Selleck, Selleck",94.06,"BRD-K68904758-001-04-3, BRD-K68904758-001-02-7, BRD-K68904758-001-03-5","Preclinical","BRD-A70157906-001-01-3, BRD-K99571587-001-01-6","DBXFAPJCZABTDR-WBYYIXQISA-N","BRD-K68904758","BRD-A70157906","C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)c1ccccc1"
"1046","CEPHALOSPORIN-C-ZN","bacterial cell wall synthesis inhibitor","","","","MicroSource",0,"BRD-A44936478-001-01-1","Preclinical","BRD-M47474198-001-01-5","TVMXJQZBKOMFQK-XLCFFBBVSA-L","BRD-A44936478","BRD-M47474198","CC(=O)OCC1=C2N3C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O[Zn]OC2=O)C3=O"
"1047","CEPHARANTHINE","NFkB pathway inhibitor","","","","Selleck, MicroSource, Selleck",95.81,"BRD-K96194081-001-12-8, BRD-K96194081-001-10-2, BRD-K96194081-001-11-0","Phase 2","BRD-K78936063-001-01-9","YVPXVXANRNDGTA-WDYNHAJCSA-N","BRD-K96194081","BRD-K78936063","COc1ccc2C[C@H]3N(C)CCc4cc(OC)c(Oc5c6OCOc6cc6CCN(C)[C@@H](Cc7ccc(Oc1c2)cc7)c56)cc34"
"1050","CETABEN","cholesterol inhibitor, ACAT inhibitor","PPARA","","","Adooq",55.82,"BRD-K86954340-001-01-7","Phase 2","","QXWKHSSBFQDQPR-UHFFFAOYSA-N","BRD-K86954340","","CCCCCCCCCCCCCCCCNc1ccc(cc1)C(O)=O"
"1051","CETILISTAT","triacylglycerol lipase inhibitor","PNLIP","","","Key, TCI",17.4,"BRD-K94863486-001-02-2, BRD-K94863486-001-01-4","Phase 3","","MVCQKIKWYUURMU-UHFFFAOYSA-N","BRD-K94863486","","CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1"
"1053","CEVIPABULIN","microtubule stimulant, tubulin polymerization inhibitor","TUBB","","","MedChemEx",89.67,"BRD-A02473266-001-01-1","Phase 1","","ZUZPCOQWSYNWLU-UHFFFAOYSA-N","BRD-A02473266","","CNCCCOc1cc(F)c(c(F)c1)-c1c(Cl)nc2ncnn2c1NC(C)C(F)(F)F"
"1054","CE3F4","rap guanine nucleotide exchange factor inhibitor","RAPGEF3","","","Tocris",98.53,"BRD-A47940219-001-01-4","Preclinical","","ZZLQPWXVZCPUGC-UHFFFAOYSA-N","BRD-A47940219","","CC1CCc2c(cc(Br)c(F)c2Br)N1C=O"
"1055","CFM-1571","guanylate cyclase activator","","","","Tocris, Tocris",95.4,"BRD-K64341947-003-02-4, BRD-K64341947-003-03-2","Preclinical","","YZCSJBGQLATPMH-UHFFFAOYSA-N","BRD-K64341947","","COc1ccc(NC(=O)c2cc(OCCCN(C)C)nn2Cc2ccccc2)cc1"
"1057","CFM-2","glutamate receptor antagonist","","","","Tocris",89.65,"BRD-K42859542-001-03-3","Preclinical","","MJKADKZSYQWGLL-UHFFFAOYSA-N","BRD-K42859542","","COc1cc2CC(=O)NN=C(c3ccc(N)cc3)c2cc1OC"
"1058","CFTRINH-172","chloride channel blocker","CFTR","","","Tocris, Tocris, Selleck",90.25,"BRD-K72004355-001-02-7, BRD-K72004355-001-03-5, BRD-K72004355-001-01-9","Preclinical","","JIMHYXZZCWVCMI-RIYZIHGNSA-N","BRD-K72004355","","OC(=O)c1ccc(cc1)\C=C1\SC(=S)N(C1=O)c1cccc(c1)C(F)(F)F"
"1061","CF102","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",98.78,"BRD-K52396582-001-06-7","Phase 2","","IPSYPUKKXMNCNQ-PFHKOEEOSA-N","BRD-K52396582","","CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)nc(Cl)nc12"
"1062","CG-400549","FABI inhibitor","","","","Astatech, Astatech",95.34,"BRD-K48888725-001-02-7, BRD-K48888725-001-01-9","Phase 2","","YCLREGRRHGLOAK-UHFFFAOYSA-N","BRD-K48888725","","Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O"
"1064","CGH2466","adenosine receptor antagonist","ADORA1, ADORA2B, ADORA3","","","Tocris, Tocris",94.17,"BRD-K82028950-300-03-7, BRD-K82028950-300-02-9","Preclinical","","BEPGKLOHQTXUHX-UHFFFAOYSA-N","BRD-K82028950","","Nc1nc(c(s1)-c1ccncc1)-c1ccc(Cl)c(Cl)c1"
"1066","CGK-733","ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR","","","Tocris, Tocris, Selleck, Selleck",97.37,"BRD-A50737080-001-03-0, BRD-A50737080-001-06-3, BRD-A50737080-001-02-2, BRD-A50737080-001-05-5","Preclinical","","HLCDNLNLQNYZTK-UHFFFAOYSA-N","BRD-A50737080","","[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F"
"1070","CGM097","MDM inhibitor","MDM2","","","MedChemEx, MedChemEx",86.88,"BRD-K79584249-001-02-1, BRD-K79584249-001-01-3","Phase 1","","CLRSLRWKONPSRQ-IIPSPAQQSA-N","BRD-K79584249","","COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c1ccc(cc1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1"
"1072","CGP-12177","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Tocris",96.6,"BRD-A40084411-003-07-7","Phase 1","","UMQUQWCJKFOUGV-UHFFFAOYSA-N","BRD-A40084411","","CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12"
"1073","CGP-13501","GABA receptor modulator","GABBR1","","","Tocris",91.07,"BRD-K95851186-001-07-8","Preclinical","","XGWATTXMMMANFJ-UHFFFAOYSA-N","BRD-K95851186","","CC(C)(Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)C=O"
"1074","CGP-20712A","adrenergic receptor antagonist","ADRB1, ADRB3","","","Sigma",97.65,"BRD-A31575449-066-07-8","Preclinical","","GKJZEKSHCJELPL-UHFFFAOYSA-N","BRD-A31575449","","Cn1cc(nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(c2)C(N)=O)cc1)C(F)(F)F"
"1075","CGP-37157","mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor","SLC8A1","","","Tocris, Tocris",99.24,"BRD-A35623999-001-06-5, BRD-A35623999-001-05-7","Preclinical","","KQEPIRKXSUIUTH-UHFFFAOYSA-N","BRD-A35623999","","Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1"
"1077","CGP-37849","glutamate receptor antagonist","GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio",0,"BRD-A90272038-001-02-5, BRD-A90272038-001-01-7","Phase 1","","BDYHNCZIGYIOGJ-DUXPYHPUSA-N","BRD-A90272038","","C\C(CP(O)(O)=O)=C/C(N)C(O)=O"
"1079","CGP-52411","EGFR inhibitor","EGFR","","","Tocris, Tocris",94.09,"BRD-K13087974-001-02-5, BRD-K13087974-001-03-3","Preclinical","","AAALVYBICLMAMA-UHFFFAOYSA-N","BRD-K13087974","","O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc12"
"1081","CGP-53353","EGFR inhibitor, PKC inhibitor","EGFR, PRKCB","","","Tocris, Tocris",94.62,"BRD-K32292990-001-03-6, BRD-K32292990-001-04-4","Preclinical","","RONQPWQYDRPRGG-UHFFFAOYSA-N","BRD-K32292990","","Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1"
"1083","CGP-54626","GABA receptor antagonist","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8","","","Tocris, Tocris",93.07,"BRD-A74208568-003-02-3, BRD-A74208568-003-01-5","Preclinical","","JGGVBBYJRQOPPA-BBRMVZONSA-N","BRD-A74208568","","C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)c1ccc(Cl)c(Cl)c1"
"1085","CGP-55845","GABA receptor antagonist","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8","","","Tocris, Tocris",97.05,"BRD-A89672324-001-04-8, BRD-A89672324-001-03-0","Preclinical","","ZODSPDOOCZZEIM-BBRMVZONSA-N","BRD-A89672324","","C[C@H](NC[C@H](O)CP(O)(=O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1"
"1087","CGP-57380","MAP kinase inhibitor","AURKB, LCK, MKNK1, MKNK2, SGK1","","","Tocris, Selleck, Tocris",92.47,"BRD-K42500029-001-04-3, BRD-K42500029-001-03-5, BRD-K42500029-001-06-8","Preclinical","","UQPMANVRZYYQMD-UHFFFAOYSA-N","BRD-K42500029","","Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12"
"1090","CGP-60474","CDK inhibitor","CDK1, CDK2","","","Tocris",98.36,"BRD-K79090631-001-22-3","Preclinical","","IYNDTACKOAXKBJ-UHFFFAOYSA-N","BRD-K79090631","","OCCCNc1cc(ccn1)-c1ccnc(Nc2cccc(Cl)c2)n1"
"1091","CGP-71683","neuropeptide receptor antagonist","NPY5R","","","Tocris, Tocris",98.57,"BRD-K34321528-003-01-2, BRD-K34321528-003-02-0","Preclinical","","UULIGRNKXHCLQN-WGSAOQKQSA-N","BRD-K34321528","","Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12"
"1093","CGP-74514","CDK inhibitor","CDK1","","","Tocris",95.63,"BRD-K56239177-300-01-3","Preclinical","","UTBSBSOBZHXMHI-LSDHHAIUSA-N","BRD-K56239177","","CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc12"
"1094","CGP-78608","glutamate receptor antagonist","","","","Tocris",0,"BRD-K60946979-003-01-7","Preclinical","","DPFHVUSPVHRVFL-YFKPBYRVSA-N","BRD-K60946979","","C[C@@H](NCc1cc(Br)cc2[nH]c(=O)c(=O)[nH]c12)P(O)(O)=O"
"1095","CGP-7930","GABA receptor modulator","GABBR1","","","Tocris, Tocris",96.35,"BRD-K65786282-001-08-3, BRD-K65786282-001-07-5","Preclinical","","XLWJPQQFJNGUPA-UHFFFAOYSA-N","BRD-K65786282","","CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C"
"1097","CGS-15943","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",96.89,"BRD-K49049886-001-08-7","Preclinical","","MSJODEOZODDVGW-UHFFFAOYSA-N","BRD-K49049886","","Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1"
"1098","CGS-20625","benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6","","","Tocris, Tocris",94.19,"BRD-K68103045-001-02-9, BRD-K68103045-001-03-7","Phase 1","","XRUUVUYJUULCBQ-UHFFFAOYSA-N","BRD-K68103045","","COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O"
"1100","CGS-21680","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Selleck",94.58,"BRD-K12614344-003-01-8","Preclinical","","PAOANWZGLPPROA-VDNWNZSNSA-N","BRD-K12614344","","CCNC(=O)[C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12"
"1101","CGS-9896","GABA receptor antagonist","GABRA1, GABRB2, GABRG2","","","ChemDiv",96.33,"BRD-K54093161-001-01-8","Preclinical","","QCBUAKLOWCOUCR-UHFFFAOYSA-N","BRD-K54093161","","Clc1ccc(cc1)-n1[nH]c2c(cnc3ccccc23)c1=O"
"1102","CH-170","","","","","Enamine",99.18,"BRD-K24820488-001-01-7","Phase 1","","JBXSBZBZASARMY-UHFFFAOYSA-N","BRD-K24820488","","Cc1nc(Cn2cnc3n(C)c(=O)n(C)c(=O)c23)no1"
"1103","CH-5183284","fibroblast growth factor inhibitor","FGFR1, FGFR2, FGFR3","","","Cayman, Selleck",98.42,"BRD-K11683436-001-02-5, BRD-K11683436-001-01-7","Phase 1","","BEMNJULZEQTDJY-UHFFFAOYSA-N","BRD-K11683436","","Cc1nc2ccc(cc2[nH]1)-n1ncc(C(=O)c2cc3ccccc3[nH]2)c1N"
"1105","CHC","monocarboxylate transporter inhibitor","SLC16A1","","","Tocris",89.98,"BRD-K60302405-001-08-6","Preclinical","","AFVLVVWMAFSXCK-VMPITWQZSA-N","BRD-K60302405","","OC(=O)C(\C#N)=C\c1ccc(O)cc1"
"1106","CHF5074","gamma secretase modulator","PSEN1","","","MedChemEx",92.25,"BRD-K34508702-001-02-4","Phase 2","","LIYLTQQDABRNRX-UHFFFAOYSA-N","BRD-K34508702","","OC(=O)C1(CC1)c1ccc(c(F)c1)-c1ccc(Cl)c(Cl)c1"
"1107","CHICAGO-SKY-BLUE-6B","glutamate inhibitor, macrophage migration inhibiting factor inhibitor","MIF","","","Prestwick",76.61,"BRD-K56483981-342-06-4","Preclinical","","OHMJKMNGYYWCHB-HVMBLDELSA-N","BRD-K56483981","","COc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(\N=N\c2ccc3c(cc(c(N)c3c2O)S(O)(=O)=O)S(O)(=O)=O)c(OC)c1"
"1108","CHIDAMIDE","HDAC inhibitor","HDAC10, HDAC3","","","MedChemEx",91.41,"BRD-K28537285-001-01-8","Launched","","WXHHICFWKXDFOW-BJMVGYQFSA-N","BRD-K28537285","","Nc1ccc(F)cc1NC(=O)c1ccc(CNC(=O)\C=C\c2cccnc2)cc1"
"1109","CHIR-124","CHK inhibitor","CHEK1","","","Selleck",95.19,"BRD-K02241333-001-02-7","Preclinical","","MOVBBVMDHIRCTG-LJQANCHMSA-N","BRD-K02241333","","Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1"
"1110","CHIR-98014","glycogen synthase kinase inhibitor","GSK3A, GSK3B","","","Selleck",94.71,"BRD-K42973005-001-04-0","Preclinical","","MDZCSIDIPDZWKL-UHFFFAOYSA-N","BRD-K42973005","","Nc1nc(NCCNc2ncc(c(n2)-c2ccc(Cl)cc2Cl)-n2ccnc2)ccc1[N+]([O-])=O"
"1111","CHIR-99021","glycogen synthase kinase inhibitor","CDK1, GSK3A, GSK3B, MAPK1","","","Selleck, Tocris",95.6,"BRD-K16189898-003-03-3, BRD-K16189898-001-21-9","Preclinical","","AQGNHMOJWBZFQQ-UHFFFAOYSA-N","BRD-K16189898","","Cc1c[nH]c(n1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl"
"1113","CHLORALOSE","","","","","MicroSource",96.81,"BRD-A98174560-001-02-1","Preclinical","","OJYGBLRPYBAHRT-YCNXOVPFSA-N","BRD-A98174560","","OCC(O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl"
"1114","CHLORAZANIL","","","","","MicroSource",98.95,"BRD-K21452876-003-01-8","Preclinical","BRD-K44275059-003-01-5","YRZQHIVOIFJEEE-UHFFFAOYSA-N","BRD-K21452876","BRD-K44275059","Nc1ncnc(Nc2ccc(Cl)cc2)n1"
"1115","CHLORFENSON","other antifungal","","","","Sigma",0,"BRD-K89409436-001-01-4","Phase 2","","RZXLPPRPEOUENN-UHFFFAOYSA-N","BRD-K89409436","","Clc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)cc1"
"1116","CHLORINDANOL","","","","","MicroSource",93.98,"BRD-K01653460-001-01-1","Preclinical","","ATAJVFBUUIBIEO-UHFFFAOYSA-N","BRD-K01653460","","Oc1ccc(Cl)c2CCCc12"
"1117","CHLORINDIONE","","","","","MicroSource",96.83,"BRD-K61802864-001-08-8","Preclinical","","NJDUWAXIURWWLN-UHFFFAOYSA-N","BRD-K61802864","","Clc1ccc(cc1)C1C(=O)c2ccccc2C1=O"
"1118","CHLORISONDAMINE-DIIODIDE","acetylcholine receptor antagonist","CHRNA1","","","Tocris",0,"BRD-K18030938-302-02-7","Preclinical","","IXWDUZLHWJKVPX-UHFFFAOYSA-N","BRD-K18030938","","C[N+](C)(C)CC[N+]1(C)Cc2c(C1)c(Cl)c(Cl)c(Cl)c2Cl"
"1119","CHLORMEZANONE","GABA receptor modulator","GABRA1, TSPO","","","MicroSource, Tocris, Selleck",98.9,"BRD-A20348246-001-15-8, BRD-A20348246-001-14-1, BRD-A20348246-001-13-3","Withdrawn","","WEQAYVWKMWHEJO-UHFFFAOYSA-N","BRD-A20348246","","CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O"
"1122","CHLOROPHYLLIDE-CU-COMPLEX-NA-SALT","","","","","MicroSource",0,"BRD-A63866086-314-01-7","Preclinical","BRD-A09283158-314-01-5,BRD-U54521177-000-01-0","CAIDFDPKOGBHAT-UHFFFAOYSA-K","BRD-A63866086","BRD-A09283158","CCc1c(C)c2=Cc3c(C=C)c(C)c4C=c5c(C)c(CCC(O)=O)c6=C7C(C(O)=O)C(=O)c8c(C)c9C=c1n2[Cu](n34)(n9c78)n56"
"1123","CHLOROPHYLLIN-COPPER","cytochrome P450 inhibitor","","","","MedChemEx",20.18,"BRD-A92960111-314-01-2","Phase 1","BRD-U98640356-000-01-9","ZDOYGJNADZJRFB-UHFFFAOYSA-L","BRD-A92960111","BRD-U98640356","CCC1=C(C)\C2=C\c3c(C=C)c(C)c4\C=C5/N=C(C(CCC(O)=O)C5C)/C(CC(O)=O)=c5/c(C(O)=O)c(C)/c(=C/C1=N/2)n5[Cu]n34"
"1124","CHLOROTHYMOL","","","","","Enamine",0,"BRD-K04358951-001-01-0","Launched","","KFZXVMNBUMVKLN-UHFFFAOYSA-N","BRD-K04358951","","CC(C)c1cc(Cl)c(C)cc1O"
"1125","CHLOROXOQUINOLINE","","","","","Alinda",97.87,"BRD-K83335125-001-07-0","Launched","","XMFXTXKSWIDMER-UHFFFAOYSA-N","BRD-K83335125","","Oc1ccnc2cc(Cl)ccc12"
"1126","CHLORPHENSIN-CARBAMATE","muscle relaxant","","","","Prestwick",98.03,"BRD-A39230911-001-10-2","Preclinical","","SKPLBLUECSEIFO-UHFFFAOYSA-N","BRD-A39230911","","NC(=O)OCC(O)COc1ccc(Cl)cc1"
"1127","CHLORPROPHAM","antiviral","","","","Sigma",99.36,"BRD-K59590127-001-04-5","Phase 1","","CWJSHJJYOPWUGX-UHFFFAOYSA-N","BRD-K59590127","","CC(C)OC(=O)Nc1cccc(Cl)c1"
"1128","CHLORPYRIFOS","acetylcholinesterase inhibitor","ACHE","","","MicroSource",79.39,"BRD-K08303368-001-10-0","Launched","","SBPBAQFWLVIOKP-UHFFFAOYSA-N","BRD-K08303368","","CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl"
"1129","CHOLESTEROL","","RORA","","","MicroSource",0,"BRD-A42883684-001-04-1","Preclinical","","HVYWMOMLDIMFJA-RJLWFLQPSA-N","BRD-A42883684","","CC(C)CCCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C"
"1130","CHOLINE","acetylcholine precursor","ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2","","","MicroSource, Selleck",100,"BRD-K77300776-001-01-7, BRD-K77300776-001-02-5","Phase 3","BRD-M07056525-001-05-3, BRD-M07056525-001-04-6","OEYIOHPDSNJKLS-UHFFFAOYSA-N","BRD-K77300776","BRD-M07056525","C[N+](C)(C)CCO"
"1132","CHOLINE-ALFOSCERATE","acetylcholine precursor","GM2A","","","MedChemEx",100,"BRD-A72390365-001-15-2","Launched","","SUHOQUVVVLNYQR-MRVPVSSYSA-O","BRD-A72390365","","C[N+](C)(C)CCOP(O)(=O)OC[C@H](O)CO"
"1133","CHPG","glutamate receptor agonist","GRM5","","","Tocris",0,"BRD-A19381518-001-02-1","Preclinical","","UNIDAFCQFPGYJJ-UHFFFAOYSA-N","BRD-A19381518","","NC(C(O)=O)c1cc(O)ccc1Cl"
"1134","CHR-6494","serine/threonine kinase inhibitor","GSG2","","","MedChemEx, Tocris",99.14,"BRD-K76259716-001-01-9, BRD-K76259716-019-01-1","Preclinical","","CZZCAOGIEGXMBZ-UHFFFAOYSA-N","BRD-K76259716","","CCCNc1ccc2ncc(-c3ccc4[nH]ncc4c3)n2n1"
"1136","CHROMANOL-(+/-)","potassium channel blocker","","","","Tocris",98.74,"BRD-M02075109-001-01-1","Preclinical","","VCIPBXUEKWCJAU-DZYJZKBLSA-N","BRD-M02075109","","CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)Oc2ccc(cc12)C#N.CCS(=O)(=O)N(C)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N"
"1137","CHROMANOL-293B-(-)-[3R,4S]","potassium channel blocker","","","","Tocris",99.19,"BRD-K27911943-001-02-8","Preclinical","","HVSJHHXUORMCGK-UONOGXRCSA-N","BRD-K27911943","","CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)Oc2ccc(cc12)C#N"
"1138","CHROMOCARB","antispasmodic","","","","MicroSource, Selleck",97.77,"BRD-K94720315-001-10-4, BRD-K94720315-001-09-6","Launched","","RVMGXWBCQGAWBR-UHFFFAOYSA-N","BRD-K94720315","","OC(=O)c1cc(=O)c2ccccc2o1"
"1140","CHRYSIN","breast cancer resistance protein inhibitor","AKR1B1, CDK6, CYP19A1, CYP1B1","","","Selleck",96.12,"BRD-K22861715-001-17-4","Phase 1","","RTIXKCRFFJGDFG-UHFFFAOYSA-N","BRD-K22861715","","Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccccc1"
"1141","CHRYSOPHANIC-ACID","EGFR inhibitor","EGFR, MTOR","","","Selleck",96.2,"BRD-K59284035-001-07-9","Preclinical","","LQGUBLBATBMXHT-UHFFFAOYSA-N","BRD-K59284035","","Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1"
"1142","CHUANXIONGZINE","","","","","Enzo",97.8,"BRD-K25691735-001-09-5","Phase 2","","FINHMKGKINIASC-UHFFFAOYSA-N","BRD-K25691735","","Cc1nc(C)c(C)nc1C"
"1143","CH223191","aryl hydrocarbon receptor antagonist","AHR","","","Tocris",97.94,"BRD-K22314899-001-02-4","Preclinical","","LKTNEXPODAWWFM-GHVJWSGMSA-N","BRD-K22314899","","Cc1cc(ccc1NC(=O)c1ccnn1C)\N=N\c1ccccc1C"
"1144","CH5132799","PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck, Selleck",93.07,"BRD-K28352084-001-02-3, BRD-K28352084-001-03-1","Phase 1","","JEGHXKRHKHPBJD-UHFFFAOYSA-N","BRD-K28352084","","CS(=O)(=O)N1CCc2c1nc(nc2-c1cnc(N)nc1)N1CCOCC1"
"1146","CH55","retinoid receptor binder","RARA, RARB","","","Tocris, Tocris",92.13,"BRD-K71487808-001-03-6, BRD-K71487808-001-02-8","Preclinical","","FOUVTBKPJRMLPE-FMIVXFBMSA-N","BRD-K71487808","","CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)\C=C\c1ccc(cc1)C(O)=O"
"1148","CI-844","","","","","ChemImpex",98.44,"BRD-K83022601-001-01-0","Phase 2","","KDGUIKPOZGYLQJ-UHFFFAOYSA-N","BRD-K83022601","","O(c1ccccc1)c1cccnc1"
"1149","CI-923","acetylcholine receptor antagonist","","","","Sigma",86.83,"BRD-A50016482-001-01-7","Phase 1","","MJRICTKAEYTJAV-UHFFFAOYSA-N","BRD-A50016482","","CCNC(C)CN1CCc2c(C1)c(=O)oc1ccccc21"
"1150","CI-966","GAT inhibitor","SLC6A1","","","Tocris, Tocris",98.04,"BRD-K67680372-003-03-4, BRD-K67680372-003-02-6","Phase 1","","CMHQDSBIBSKHFP-UHFFFAOYSA-N","BRD-K67680372","","OC(=O)C1=CCCN(CCOC(c2ccc(cc2)C(F)(F)F)c2ccc(cc2)C(F)(F)F)C1"
"1152","CI-976","ACAT inhibitor","ACAT1, CES1","","","Tocris, Tocris",98.32,"BRD-K88544581-001-06-1, BRD-K88544581-001-08-7","Phase 1","","WAFNZAURAWBNDZ-UHFFFAOYSA-N","BRD-K88544581","","CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC"
"1154","CIAFTALAN-ZINC","reactive oxygen species stimulant","","","","Sigma",22.93,"BRD-K01423020-001-01-2","Phase 1","","PODBBOVVOGJETB-UHFFFAOYSA-N","BRD-K01423020","","[Zn]1n2c3\N=C4/N=C(c5ccccc45)/N=c4\n1\c(=N/C1=N/C(c5ccccc15)=N\c2c1ccccc31)c1ccccc41"
"1155","CIANIDANOL","fatty acid synthase inhibitor","PTGS1","","","MicroSource",98.72,"BRD-K58736316-001-09-5","Withdrawn","","PFTAWBLQPZVEMU-DZGCQCFKSA-N","BRD-K58736316","","O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1"
"1156","CIBENZOLINE","sodium channel blocker","","","","Sigma",98.93,"BRD-K34251960-036-01-6","Launched","","AMRFVEMXRRPNJH-UHFFFAOYSA-N","BRD-K34251960","","C1C(=C2NCCN2)C1(c1ccccc1)c1ccccc1"
"1157","CICLOPROFEN","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Enamine",95.97,"BRD-A94965935-001-01-6","Preclinical","","LRXFKKPEBXIPMW-UHFFFAOYSA-N","BRD-A94965935","","CC(C(O)=O)c1ccc-2c(Cc3ccccc-23)c1"
"1158","CID-16020046","G protein-coupled receptor antagonist","GPR55","","","Tocris",98.4,"BRD-A59391172-001-07-7","Preclinical","","VGUQVYZXABOXCX-UHFFFAOYSA-N","BRD-A59391172","","Cc1ccc(cc1)-c1[nH]nc2C(=O)N(C(c12)c1cccc(O)c1)c1ccc(cc1)C(O)=O"
"1159","CID-2011756","protein kinase inhibitor","PKD1","","","Tocris",98.57,"BRD-K92781136-001-08-9","Preclinical","","XQJWTJLJEYIUDZ-UHFFFAOYSA-N","BRD-K92781136","","Clc1cccc(c1)-c1ccc(o1)C(=O)Nc1ccc(CN2CCOCC2)cc1"
"1160","CID-2745687","G protein-coupled receptor antagonist","GPR35","","","Tocris",90.54,"BRD-K06405316-001-03-3","Preclinical","","CYNLZIBKERMMOA-AWQFTUOYSA-N","BRD-K06405316","","COC(=O)c1cnn(c1\C=N\N=C(/S)NC(C)(C)C)-c1ccc(F)cc1F"
"1161","CID-5458317","MAP kinase phosphatase inhibitor","MAPK3","","","EMDBio",96.86,"BRD-A08840375-001-01-3","Preclinical","","XJDKPLZUXCIMIS-HMMYKYKNSA-N","BRD-A08840375","","O=C1c2ccccc2C(NC2CCCCC2)\C1=C/c1ccccc1"
"1162","CIGLITAZONE","PPAR receptor agonist","PPARG","","","Tocris",96.7,"BRD-A93000692-001-08-1","Phase 2","","YZFWTZACSRHJQD-UHFFFAOYSA-N","BRD-A93000692","","CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1"
"1163","CILASTATIN","dehydropeptidase inhibitor","DPEP1","","","AvaChem, Tocris",0,"BRD-K85518562-236-08-9, BRD-K85518562-236-09-7","Launched","BRD-K62370608-001-02-9, BRD-K26556168-236-01-4","DHSUYTOATWAVLW-WFVMDLQDSA-N","BRD-K85518562","BRD-K62370608","CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@H](N)C(O)=O"
"1165","CILENGITIDE","integrin antagonist","ITGAV, ITGB3","","","Selleck",96.22,"BRD-K57252450-001-02-5","Phase 3","","AMLYAMJWYAIXIA-VWNVYAMZSA-N","BRD-K57252450","","CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O"
"1166","CILOMILAST","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4D","","","Selleck",91.79,"BRD-K38473998-001-02-0","Phase 3","","CFBUZOUXXHZCFB-UHFFFAOYSA-N","BRD-K38473998","","COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N"
"1167","CILOSTAMIDE","phosphodiesterase inhibitor","PDE3A, PDE3B","","","Tocris, Tocris",95.91,"BRD-K28578425-001-09-6, BRD-K28578425-001-07-0","Preclinical","","UIAYVIIHMORPSJ-UHFFFAOYSA-N","BRD-K28578425","","CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1"
"1169","CIM-0216","transient receptor potential channel agonist","TRPM3","","","Tocris",90.64,"BRD-A75514485-001-01-9","Preclinical","","KSEXDSJYVSEVGF-UHFFFAOYSA-N","BRD-A75514485","","Cc1cc(NC(=O)C(N2CCCc3ccccc23)c2ccccc2)no1"
"1170","CIMATEROL","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Tocris",89.76,"BRD-A65440446-001-04-1","Preclinical","","BUXRLJCGHZZYNE-UHFFFAOYSA-N","BRD-A65440446","","CC(C)NCC(O)c1ccc(N)c(c1)C#N"
"1171","CINACIGUAT","guanylate cyclase activator","GUCY1A3, GUCY1B3","","","MedChemEx",97.86,"BRD-K73440166-001-01-3","Phase 2","","WPYWMXNXEZFMAK-UHFFFAOYSA-N","BRD-K73440166","","OC(=O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(cc1)C(O)=O"
"1172","CINALUKAST","leukotriene receptor antagonist","CYSLTR1","","","Tocris, Tocris, Tocris",92.06,"BRD-K53720352-001-05-7, BRD-K53720352-001-04-0, BRD-K53720352-001-03-2","Phase 2","","BZMKNPGKXJAIDV-VAWYXSNFSA-N","BRD-K53720352","","CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C2CCC2)c1)C(O)=O"
"1175","CINANSERIN","serotonin receptor antagonist","HTR2A","","","Tocris",96.6,"BRD-K40901640-003-01-6","Preclinical","","RSUVYMGADVXGOU-BUHFOSPRSA-N","BRD-K40901640","","CN(C)CCCSc1ccccc1NC(=O)\C=C\c1ccccc1"
"1176","CINCHONIDINE","P glycoprotein inhibitor","","","","MicroSource, Selleck",93.36,"BRD-K39079086-001-06-8, BRD-K39079086-001-07-6","Phase 1","BRD-A54537387-001-02-2","KMPWYEUPVWOPIM-KODHJQJWSA-N","BRD-K39079086","BRD-A54537387","O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccccc12"
"1178","CINCHONINE","P glycoprotein inhibitor","CYP2D6","","","MicroSource",86.78,"BRD-K14693417-001-04-0","Preclinical","","KMPWYEUPVWOPIM-YXUGBTPSSA-N","BRD-K14693417","","O[C@@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccccc12"
"1179","CINEPAZET","vasodilator","","","","Sigma",95.1,"BRD-K00531707-001-01-3","Launched","","XDUOTWNXVDBCDY-VOTSOKGWSA-N","BRD-K00531707","","CCOC(=O)CN1CCN(CC1)C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1"
"1180","CINEPAZIDE","calcium channel activator","","","","Selleck, Selleck",99.15,"BRD-K46839850-050-04-2, BRD-K46839850-050-05-9","Withdrawn","","RCUDFXMNPQNBDU-VOTSOKGWSA-N","BRD-K46839850","","COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCN(CC(=O)N2CCCC2)CC1"
"1182","CINFLUMIDE","muscle relaxant","","","","Enamine",89.23,"BRD-K25154476-001-01-4","Phase 2","","NCOOUEIQXVWKTO-QPJJXVBHSA-N","BRD-K25154476","","Fc1cccc(c1)\C=C\C(=O)NC1CC1"
"1183","CINNAMALDEHYDE","aldose reductase inhibitor, TRPV agonist","TRPA1","","","Otava",0,"BRD-K38088841-001-01-7","Preclinical","","KJPRLNWUNMBNBZ-UHFFFAOYSA-N","BRD-K38088841","","O=CC=Cc1ccccc1"
"1184","CINOCTRAMIDE","","","","","MicroSource",0,"BRD-K08699567-001-01-9","Preclinical","BRD-K15901271-001-01-7","MDGVCMGGLSOVIQ-MDZDMXLPSA-N","BRD-K08699567","BRD-K15901271","COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCCCCCC1"
"1185","CINPA-1","CAR antagonist","NR1H4, NR1I3, PPARG","","","Tocris",93.64,"BRD-K24570280-001-01-8","Preclinical","","AYQBYSPEGRYKFA-UHFFFAOYSA-N","BRD-K24570280","","CCOC(=O)Nc1ccc2CCc3ccccc3N(C(=O)CN(CC)CC)c2c1"
"1186","CINROMIDE","","","","","MicroSource",99.12,"BRD-K66241279-001-01-8","Phase 3","","LDCXGZCEMNMWIL-VOTSOKGWSA-N","BRD-K66241279","","CCNC(=O)\C=C\c1cccc(Br)c1"
"1187","CINTRIAMIDE","","","","","MicroSource",97.46,"BRD-K24507548-001-01-8","Preclinical","","LRLKZVMLJBNNPE-SNAWJCMRSA-N","BRD-K24507548","","COc1cc(cc(OC)c1OC)\C=C\C(N)=O"
"1188","CIPEMASTAT","metalloproteinase inhibitor","ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9","","","Tocris",86.65,"BRD-K95362002-001-01-1","Phase 3","","GFUITADOEPNRML-SJORKVTESA-N","BRD-K95362002","","CN1C(=O)N(C[C@@H]([C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)NO)C(=O)C1(C)C"
"1189","CIPROXIFAN","histamine receptor antagonist","ADRA2A, ADRA2C, HRH3, HRH4, HTR3A","","","Selleck",94.57,"BRD-K01767299-050-02-1","Preclinical","","ACQBHJXEAYTHCY-UHFFFAOYSA-N","BRD-K01767299","","O=C(C1CC1)c1ccc(OCCCc2c[nH]cn2)cc1"
"1190","CIQ","glutamate receptor potentiator","GRIN2C, GRIN2D","","","Tocris",98.05,"BRD-A35425966-001-02-3","Preclinical","","VYMILMYEENZHAR-UHFFFAOYSA-N","BRD-A35425966","","COc1ccc(OCC2N(CCc3cc(OC)c(OC)cc23)C(=O)c2cccc(Cl)c2)cc1"
"1191","CIRAZOLINE","adrenergic receptor agonist","ADRA1A","","","Tocris, Tocris",92.59,"BRD-K54142781-003-13-4, BRD-K54142781-003-11-8","Preclinical","","YAORIDZYZDUZCM-UHFFFAOYSA-N","BRD-K54142781","","C(Oc1ccccc1C1CC1)C1=NCCN1"
"1193","CIS-ACONITIC-ACID","","ACO2","","","Enamine",0,"BRD-K71756122-001-02-5","Preclinical","","GTZCVFVGUGFEME-IWQZZHSRSA-N","BRD-K71756122","","OC(=O)C\C(=C\C(O)=O)C(O)=O"
"1194","CIS-ACPD","glutamate receptor agonist","GRM2, GRM3, GRM6, GRM7, GRM8","","","Tocris",100,"BRD-M29936662-001-02-0","Preclinical","","DXLSPTHQGVGVTN-ATXZCBKLSA-N","BRD-M29936662","","N[C@]1(CC[C@@H](C1)C(O)=O)C(O)=O.N[C@@]1(CC[C@H](C1)C(O)=O)C(O)=O"
"1195","CIS-EXO-CAMPHANEDIOL-2,3","nitric oxide stimulant","NOS3","","","Sigma",0,"BRD-K41962502-001-01-8","Phase 1","","AYEOSGBMQHXVER-AZQAYCESSA-N","BRD-K41962502","","CC1(C)[C@H]2CC[C@]1(C)[C@@H](O)[C@H]2O"
"1196","CIS-UROCANIC ACID","serotonin receptor agonist","HTR2A","","","Sigma",96.8,"BRD-K25146005-001-01-0","Phase 2","","LOIYMIARKYCTBW-UPHRSURJSA-N","BRD-K25146005","","OC(=O)\C=C/c1c[nH]cn1"
"1197","CIS-UROCANIC-ACID","serotonin receptor agonist","HTR2A","","","Enamine, Enamine",100,"BRD-K52670952-003-02-2, BRD-K52670952-003-01-4","Phase 2","","LOIYMIARKYCTBW-OWOJBTEDSA-N","BRD-K52670952","","OC(=O)\C=C\c1c[nH]cn1"
"1199","CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID","","","","","Enzo",96.02,"BRD-K80025777-001-01-4","Launched","","JBYXPOFIGCOSSB-GOJKSUSPSA-N","BRD-K80025777","","CCCCCC\C=C\C=C/CCCCCCCC(O)=O"
"1200","CISAPRIDE","serotonin receptor agonist","HTR2A, HTR3A, HTR4, KCNH2","","","MicroSource, Tocris, Tocris",98.57,"BRD-A12896037-001-04-3, BRD-K06895174-001-03-6, BRD-K06895174-001-02-8","Withdrawn","","DCSUBABJRXZOMT-UHFFFAOYSA-N","BRD-A12896037","","COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC"
"1201","CISAPRIDE","serotonin receptor agonist","HTR2A, HTR3A, HTR4, KCNH2","","","MicroSource, Tocris, Tocris",98.57,"BRD-A12896037-001-04-3, BRD-K06895174-001-03-6, BRD-K06895174-001-02-8","Withdrawn","","DCSUBABJRXZOMT-UHFFFAOYSA-N","BRD-A12896037","","CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c1cc(Cl)c(N)cc1OC"
"1203","CISAPRIDE","serotonin receptor agonist","HTR2A, HTR3A, HTR4, KCNH2","","","MicroSource, Tocris, Tocris",98.57,"BRD-A12896037-001-04-3, BRD-K06895174-001-03-6, BRD-K06895174-001-02-8","Withdrawn","","DCSUBABJRXZOMT-IRLDBZIGSA-N","BRD-A12896037","","COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC"
"1204","CISAPRIDE","serotonin receptor agonist","HTR2A, HTR3A, HTR4, KCNH2","","","MicroSource, Tocris, Tocris",98.57,"BRD-A12896037-001-04-3, BRD-K06895174-001-03-6, BRD-K06895174-001-02-8","Withdrawn","","DCSUBABJRXZOMT-IRLDBZIGSA-N","BRD-A12896037","","CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c1cc(Cl)c(N)cc1OC"
"1206","CITCO","constitutive androstane receptor (CAR) agonist","NR1I3","","","Tocris, Tocris",94.15,"BRD-K53263234-001-05-2, BRD-K53263234-001-06-0","Preclinical","","ZQWBOKJVVYNKTL-AUEPDCJTSA-N","BRD-K53263234","","Clc1ccc(cc1)-c1nc2sccn2c1\C=N\OCc1ccc(Cl)c(Cl)c1"
"1208","CITIOLONE","lipotropic, mucolytic agent","","","","MicroSource",94.67,"BRD-A57957888-001-08-0","Preclinical","","NRFJZTXWLKPZAV-UHFFFAOYSA-N","BRD-A57957888","","CC(=O)NC1CCSC1=O"
"1209","CITRIC-ACID","coagulation factor inhibitor","AKR1B1, ANG, APRT, BHMT, C8G, CA4, CPB1, CS, CTDSP1, GNMT, HGS, HS3ST3A1, IL4I1, ITPA, LSM6, MDH2, MIF, PDE5A, PKD2L1, PLEKHA1, RNASE1, RNASE3, SRC, TNFSF13B, UCK2","","","Sigma",0,"BRD-K76792669-001-08-1","Preclinical","BRD-M87682871-001-01-8","KRKNYBCHXYNGOX-UHFFFAOYSA-N","BRD-K76792669","BRD-M87682871","OC(=O)CC(O)(CC(O)=O)C(O)=O"
"1210","CJ-033466","serotonin receptor agonist","HTR4","","","Tocris",87.64,"BRD-K21306330-001-01-0","Preclinical","","ISKHMDNIWXPUGR-UHFFFAOYSA-N","BRD-K21306330","","CC(C)CN1CCC(CNC(=O)c2cc(Cl)c(N)n3cc(C)nc23)CC1"
"1211","CK-636","actin related protein inhibitor","ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5","","","Selleck, Selleck",84.46,"BRD-K81572616-001-01-9, BRD-K81572616-001-02-7","Preclinical","","ACAKNPKRLPMONU-UHFFFAOYSA-N","BRD-K81572616","","Cc1[nH]c2ccccc2c1CCNC(=O)c1cccs1"
"1213","CKD-712","NFkB pathway inhibitor","JAK2, STAT1","","","MedChemEx, MedChemEx",93.15,"BRD-A26458246-004-02-1, BRD-A26458246-004-01-3","Phase 1","","YGCQFKVNIBDJFW-UHFFFAOYSA-N","BRD-A26458246","","Oc1cc2CCNC(Cc3cccc4ccccc34)c2cc1O"
"1215","CKI-7","casein kinase inhibitor","CSNK1G2","","","Tocris",93.33,"BRD-K34303607-300-02-2","Preclinical","","OGKYMFFYOWUTKV-UHFFFAOYSA-N","BRD-K34303607","","NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12"
"1216","CL-218872","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2","","","Tocris, Tocris",98.21,"BRD-K00662280-001-10-2, BRD-K00662280-001-09-4","Phase 1","","GUOQUXNJZHGPQF-UHFFFAOYSA-N","BRD-K00662280","","Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F"
"1218","CL-225385","","","","","Enamine",96.85,"BRD-K87573013-001-01-0","Phase 2","","ZJRCIQAMTAINCB-UHFFFAOYSA-N","BRD-K87573013","","O=C(CC#N)c1ccccc1"
"1219","CLINAFLOXACIN","bacterial DNA gyrase inhibitor","","","","MicroSource, Selleck, Selleck, Selleck",98.71,"BRD-A93964801-003-03-3, BRD-A93964801-001-14-4, BRD-A93964801-003-02-5, BRD-A93964801-001-15-1","Phase 3","","QGPKADBNRMWEQR-UHFFFAOYSA-N","BRD-A93964801","","NC1CCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1"
"1223","CLIOQUINOL","chelating agent","OPRK1","","","MicroSource",91.44,"BRD-K09255212-001-16-6","Withdrawn","","QCDFBFJGMNKBDO-UHFFFAOYSA-N","BRD-K09255212","","Oc1c(I)cc(Cl)c2cccnc12"
"1224","CLOBENPROPIT","histamine receptor antagonist","HRH1, HRH2, HRH3, HRH4","","","Tocris",96.33,"BRD-K71430621-303-02-3","Preclinical","","UCAIEVHKDLMIFL-UHFFFAOYSA-N","BRD-K71430621","","Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1"
"1225","CLOBUTINOL","antitussive","","","","Prestwick",96.04,"BRD-A43809092-003-02-1","Withdrawn","","KVHHQGIIZCJATJ-UHFFFAOYSA-N","BRD-A43809092","","CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1"
"1226","CLOFIBRIC-ACID","PPAR receptor agonist","PPARA","","","MicroSource, Tocris, Selleck",98.95,"BRD-K19111024-001-20-9, BRD-K19111024-001-19-1, BRD-K19111024-001-18-3","Launched","","TXCGAZHTZHNUAI-UHFFFAOYSA-N","BRD-K19111024","","CC(C)(Oc1ccc(Cl)cc1)C(O)=O"
"1229","CLOFILIUM","potassium channel blocker","KCNA5, KCNH1","","","Sigma, Prestwick",46.21,"BRD-K02680176-075-12-9, BRD-K02680176-075-11-1","Phase 2","","WPSYTTKBGAZSCX-UHFFFAOYSA-N","BRD-K02680176","","CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1"
"1231","CLOMESONE","DNA inhibitor","","","","Enamine",0,"BRD-K39230570-001-01-1","Phase 1","","SEHSPJCWCBQHPF-UHFFFAOYSA-N","BRD-K39230570","","CS(=O)(=O)CS(=O)(=O)OCCCl"
"1232","CLOPROSTENOL-(+/-)","prostaglandin receptor agonist","PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R","","","Tocris",93.34,"BRD-K17850764-236-11-9","Launched","","VJGGHXVGBSZVMZ-QIZQQNKQSA-N","BRD-K17850764","","O[C@@H](COc1cccc(Cl)c1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O"
"1233","CLORANOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","","","Sigma",97.23,"BRD-A04971881-003-01-3","Launched","","XYCMOTOFHFTUIU-UHFFFAOYSA-N","BRD-A04971881","","CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl"
"1234","CLORGILINE","monoamine oxidase inhibitor","MAOA","","","Selleck, MicroSource",97.37,"BRD-K73251053-003-21-4, BRD-K73251053-003-22-2","Phase 2","","BTFHLQRNAMSNLC-UHFFFAOYSA-N","BRD-K73251053","","CN(CCCOc1ccc(Cl)cc1Cl)CC#C"
"1236","CLOXYQUIN","potassium channel activator","KCNK18","","","MicroSource",94.72,"BRD-K46982791-001-09-4","Preclinical","","CTQMJYWDVABFRZ-UHFFFAOYSA-N","BRD-K46982791","","Oc1ccc(Cl)c2cccnc12"
"1237","CL316243","adrenergic receptor agonist","ADRB3, UCP1, UCP2, UCP3","","","Tocris",96.36,"BRD-K06467130-304-02-7","Phase 2","","JEDJMKTVUPSHFW-ABAIWWIYSA-N","BRD-K06467130","","C[C@H](Cc1ccc2OC(Oc2c1)(C(O)=O)C(O)=O)NC[C@H](O)c1cccc(Cl)c1"
"1238","CMPD-1","p38 MAPK inhibitor","GNRHR, MAPK14","","","Tocris, Tocris",96.43,"BRD-K54095730-001-03-1, BRD-K54095730-001-04-9","Preclinical","","ODYAQBDIXCVKAE-UHFFFAOYSA-N","BRD-K54095730","","Oc1ccc(NC(=O)CCCc2ccc(cc2)-c2ccccc2F)cc1"
"1240","CNQX","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Tocris, Tocris",97.7,"BRD-K19438463-304-01-2, BRD-K19438463-001-05-5","Phase 1","","RPXVIAFEQBNEAX-UHFFFAOYSA-N","BRD-K19438463","","[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N"
"1242","CNX-2006","EGFR inhibitor","EGFR","","","MedChemEx",88.48,"BRD-K24869513-001-02-1","Preclinical","","BFSRTTWIPACGMI-UHFFFAOYSA-N","BRD-K24869513","","COc1cc(NC2CN(CCF)C2)ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F"
"1243","CNX-774","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Selleck",96.11,"BRD-K48443249-001-01-0","Preclinical","","VVLHQJDAUIPZFH-UHFFFAOYSA-N","BRD-K48443249","","CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1"
"1244","CO-101244","glutamate receptor antagonist","GRIN2B","","","Tocris, Tocris",94.77,"BRD-K55677650-003-02-9, BRD-K55677650-003-03-7","Preclinical","","VKMFDKYCIKEDMR-UHFFFAOYSA-N","BRD-K55677650","","Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1"
"1246","CO-102862","","SCN4A, SCN9A","","","Tocris",97.69,"BRD-K70912147-001-01-8","Phase 1","","MHUUDVZSPFRUSK-RQZCQDPDSA-N","BRD-K70912147","","NC(=O)N\N=C\c1ccc(Oc2ccc(F)cc2)cc1"
"1247","COENZYME-A","","ACAT2, CRAT, CS, DBI, HMGCR, KAT2A, KAT2B, KAT5","","","ChemImpex",0,"BRD-A67956599-002-01-3","Launched","","RGJOEKWQDUBAIZ-IBOSZNHHSA-N","BRD-A67956599","","CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS"
"1248","COENZYME-I","","AASS, ACADS, ADH1A, ADH1B, ADH1C, ADH4, ADH5, ADH7, AKR1B1, AKR1C1, AKR1C2, AKR1C3, AKR1C4, ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, ALDH2, ALDH3A1, ALDH3A2, ALDH3B1, ALDH3B2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDH9A1, AMT, BDH1, BLVRA, BLVRB, CDO1, CYB5R3, CYP17A1, CYP4A11, DHCR7, DHFR, DLAT, DLD, EHHADH, GAPDH, GAPDHS, GLUD1, GLUD2, GPD1, GSR, H6PD, HADH, HADHA, HIBADH, HMGCR, HMOX1, HMOX2, HPGD, HSD11B1, HSD11B2, HSD17B1, HSD17B10, HSD17B2, HSD17B3, HSD17B4, HSD17B7, HSD17B8, HSD3B1, HSD3B2, IDH3A, IDH3B, IDH3G, IMPDH1, IMPDH2, LDHA, LDHAL6A, LDHAL6B, LDHB, LDHC, MDH1, MDH2, ME1, ME2, ME3, MSMO1, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MTHFD1, MTHFD2, NDUFA1, NDUFA10, NDUFA11, NDUFA12, NDUFA13, NDUFA2, NDUFA3, NDUFA4, NDUFA4L2, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFA9, NDUFAB1, NDUFB1, NDUFB10, NDUFB2, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB7, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NNT, NQO2, NSDHL, OGDH, PDHA1, PDHA2, PDHB, PHGDH, PYCR1, PYCR2, QDPR, RDH5, SORD, TSTA3, TYR, UGDH","","","Apollo, SantaCruz",0,"BRD-A84188517-304-01-1, BRD-A84188517-304-02-9","Phase 2","BRD-A45839132-304-01-2","BOPGDPNILDQYTO-NNYOXOHSSA-N","BRD-A84188517","BRD-A45839132","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"
"1250","COENZYME-Q10","","","","","Sigma, Selleck, Selleck",0,"BRD-K75043328-001-05-9, BRD-K75043328-001-04-2, BRD-K75043328-001-03-4","Launched","","ACTIUHUUMQJHFO-UPTCCGCDSA-N","BRD-K75043328","","COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O"
"1253","COLFORSIN","adenylyl cyclase activator","ADCY2, ADCY5","","","MicroSource",100,"BRD-A55416093-001-06-4","Phase 2","","OHCQJHSOBUTRHG-VDCUXWMXSA-N","BRD-A55416093","","CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C"
"1254","COLFORSIN-DAPROATE","adenylyl cyclase activator","","","","EMDBio",100,"BRD-K19388745-003-01-7","Launched","","RSOZZQTUMVBTMR-XGUNBQNXSA-N","BRD-K19388745","","CN(C)CCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C"
"1255","COMBRETASTATIN-A-4","tubulin polymerization inhibitor","","","","ChemDiv",87.15,"BRD-K61195623-001-01-4","Phase 2","","HVXBOLULGPECHP-WAYWQWQTSA-N","BRD-K61195623","","COc1ccc(cc1O)\C=C/c1cc(OC)c(OC)c(OC)c1"
"1256","COMPOUND-W","beta-secretase inhibitor","BACE1","","","Tocris",98.85,"BRD-K98143539-001-02-2","Preclinical","","JOSXKPZXMVHRKU-UHFFFAOYSA-N","BRD-K98143539","","OC(=O)c1cc(Oc2ccc(cc2)[N+]([O-])=O)cc(Oc2ccc(cc2)[N+]([O-])=O)c1"
"1257","COMPOUND-401","DNA dependent protein kinase inhibitor","MTOR, PRKDC","","","Tocris",99.02,"BRD-K19655798-001-01-9","Preclinical","","BVRDQVRQVGRNHG-UHFFFAOYSA-N","BRD-K19655798","","O=c1cc(nc2c3ccccc3ccn12)N1CCOCC1"
"1258","COMPOUND-58112","","","","","Sigma",97.83,"BRD-K76139886-003-01-3","Preclinical","","CUYLJVJMQPPTOS-UHFFFAOYSA-N","BRD-K76139886","","COc1cccc(CN2C[Si](C)(C)O[Si](C)(C)C2)c1"
"1259","COPPER-HISTIDINE","","HAL, HARS, HDC, SLC15A3, SLC15A4, SLC38A3, SLC38A5","","","Enzo",93.67,"BRD-K36449075-001-01-0","Phase 3","","HNDVDQJCIGZPNO-RXMQYKEDSA-N","BRD-K36449075","","N[C@H](Cc1c[nH]cn1)C(O)=O"
"1260","COR-170","cannabinoid receptor inverse agonist","CNR2","","","Tocris",98.6,"BRD-K74965187-001-01-3","Preclinical","","MSJISJDTJJYBFT-UHFFFAOYSA-N","BRD-K74965187","","CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)c2cc(ccc12)-c1ccccc1"
"1261","CORDYCEPIN","DNA inhibitor","","","","Tocris, Tocris",98.83,"BRD-K65428967-001-08-4, BRD-K65428967-001-09-2","Phase 1/Phase 2","","OFEZSBMBBKLLBJ-BAJZRUMYSA-N","BRD-K65428967","","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)C[C@H]1O"
"1263","COROSOLIC-ACID","PKC inhibitor, protein tyrosine kinase inhibitor","HSD11B1, PTPN1","","","MedChemEx",96.17,"BRD-K27885593-001-06-8","Phase 2","","HFGSQOYIOKBQOW-ZSDYHTTISA-N","BRD-K27885593","","C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O"
"1264","CORTICOSTERONE","mineralocorticoid receptor agonist","HSD11B1, NCOA1, NR3C2","","","Prestwick, Tocris",98.1,"BRD-K73589401-001-23-6, BRD-K73589401-001-25-1","Preclinical","","OMFXVFTZEKFJBZ-HJTSIMOOSA-N","BRD-K73589401","","C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO"
"1266","CORTODOXONE","androgen receptor antagonist","AR","","","Vitas-M, MedChemEx, Sigma",94.37,"BRD-K43736954-001-22-3, BRD-K32891457-001-16-3, BRD-K32891457-001-15-5","Phase 3","BRD-A95717758-001-07-1","MFYSYFVPBJMHGN-ZPOLXVRWSA-N","BRD-K43736954","BRD-A95717758","C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"1267","CORTODOXONE","androgen receptor antagonist","AR","","","Vitas-M, MedChemEx, Sigma",94.37,"BRD-K43736954-001-22-3, BRD-K32891457-001-16-3, BRD-K32891457-001-15-5","Phase 3","BRD-A95717758-001-07-1","MFYSYFVPBJMHGN-ZPOLXVRWSA-N","BRD-K43736954","BRD-A95717758","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"1269","CORTODOXONE","androgen receptor antagonist","AR","","","Vitas-M, MedChemEx, Sigma",94.37,"BRD-K43736954-001-22-3, BRD-K32891457-001-16-3, BRD-K32891457-001-15-5","Phase 3","BRD-A95717758-001-07-1","WHBHBVVOGNECLV-OBQKJFGGSA-N","BRD-K43736954","BRD-A95717758","C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"1270","CORTODOXONE","androgen receptor antagonist","AR","","","Vitas-M, MedChemEx, Sigma",94.37,"BRD-K43736954-001-22-3, BRD-K32891457-001-16-3, BRD-K32891457-001-15-5","Phase 3","BRD-A95717758-001-07-1","WHBHBVVOGNECLV-OBQKJFGGSA-N","BRD-K43736954","BRD-A95717758","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"1272","COSTUNOLIDE","telomerase inhibitor","","","","Selleck, Tocris, Selleck",89.25,"BRD-K26833429-001-04-4, BRD-K26833429-001-03-6, BRD-K26833429-001-02-8","Preclinical","BRD-K44887666-001-02-4","HRYLQFBHBWLLLL-AHNJNIBGSA-N","BRD-K26833429","BRD-K44887666","C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1"
"1275","COT-INHIBITOR-1","MAPK-interacting kinase inhibitor","MAP3K8","","","MedChemEx",90.4,"BRD-K98710228-001-01-6","Preclinical","","ZWFKJFUFYPOTKL-UHFFFAOYSA-N","BRD-K98710228","","Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cn(CCN5CCCCCC5)nn4)cc23)C#N)cc1Cl"
"1276","COT-INHIBITOR-2","MAPK-interacting kinase inhibitor","MAP3K8","","","MedChemEx, MedChemEx",93.1,"BRD-K49468759-001-05-9, BRD-K49468759-001-04-2","Preclinical","","PHNZIIMWDVXPGG-UHFFFAOYSA-N","BRD-K49468759","","CCN1CCC(CC1)n1cc(CNc2cc(Cl)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1"
"1278","COTININE","nicotine metabolite","","","","MicroSource",97.89,"BRD-K94144010-001-13-9","Phase 2","","UIKROCXWUNQSPJ-VIFPVBQESA-N","BRD-K94144010","","CN1[C@@H](CCC1=O)c1cccnc1"
"1279","COUMOPHOS","cholinesterase inhibitor","","","","MicroSource",89.12,"BRD-K41567533-001-08-3","Preclinical","","BXNANOICGRISHX-UHFFFAOYSA-N","BRD-K41567533","","CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1"
"1280","CP-316819","glycogen phosphorylase inhibitor","PYGL","","","Tocris",95.8,"BRD-K53913008-001-01-5","Preclinical","","WEQLRDLTRCEUHG-PKOBYXMFSA-N","BRD-K53913008","","CON(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1"
"1281","CP-339818","potassium channel blocker","KCNA3","","","Tocris",99.19,"BRD-K52113681-003-02-1","Preclinical","","MMGAVKCAGQCFHS-UHFFFAOYSA-N","BRD-K52113681","","CCCCCN=c1ccn(Cc2ccccc2)c2ccccc12"
"1282","CP-376395","corticosteroid releasing factor receptor antagonist","CRHR1","","","Key, Tocris",98.61,"BRD-K31394475-001-01-9, BRD-K31394475-003-01-5","Phase 1","","VIZBSVDBNLAVAW-UHFFFAOYSA-N","BRD-K31394475","","CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C"
"1284","CP-471474","matrix metalloprotease inhibitor","MMP1, MMP13, MMP2, MMP3, MMP9","","","Tocris",75.47,"BRD-K33234937-001-01-7","Preclinical","","QCOQJYRPDUMCNP-UHFFFAOYSA-N","BRD-K33234937","","CC(C)(NS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)C(=O)NO"
"1285","CP-532623","cholesteryl ester transfer protein inhibitor","CETP","","","Sigma",98.71,"BRD-K36611520-001-01-6","Phase 1","","TUPKOWFPVAXQFP-OFNKIYASSA-N","BRD-K36611520","","CC[C@@H]1C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(C)=O)c2cc(ccc2N1C(=O)OC(C)C)C(F)(F)F"
"1286","CP-640186","acetyl-CoA carboxylase inhibitor","ACACA, ACACB","","","MedChemEx",89.9,"BRD-K26921335-003-01-2","Preclinical","","LDQKDRLEMKIYMC-XMMPIXPASA-N","BRD-K26921335","","O=C([C@@H]1CCCN(C1)C1CCN(CC1)C(=O)c1c2ccccc2cc2ccccc12)N1CCOCC1"
"1287","CP-673451","PDGFR tyrosine kinase receptor inhibitor","KIT, PDGFRA, PDGFRB","","","Selleck, Selleck",91.79,"BRD-K43621685-001-02-5, BRD-K43621685-001-03-3","Preclinical","","DEEOXSOLTLIWMG-UHFFFAOYSA-N","BRD-K43621685","","COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1"
"1289","CP-724714","EGFR inhibitor, protein tyrosine kinase inhibitor","ERBB2","","","Selleck",97.14,"BRD-K76908866-001-07-6","Phase 2","","LLVZBTWPGQVVLW-SNAWJCMRSA-N","BRD-K76908866","","COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1"
"1290","CP-775146","PPAR receptor agonist","PPARA","","","Tocris",97.47,"BRD-K96843359-001-02-6","Preclinical","","OISHBINQIFNIPV-JOCHJYFZSA-N","BRD-K96843359","","CC(C)c1ccc(CC(=O)N2CCC[C@H](C2)c2cccc(OC(C)(C)C(O)=O)c2)cc1"
"1291","CP-91149","glycogen phosphorylase inhibitor","PYGL","","","Selleck",97.92,"BRD-K19171642-001-02-3","Preclinical","","HINJNZFCMLSBCI-PKOBYXMFSA-N","BRD-K19171642","","CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1"
"1292","CP-93129","serotonin receptor agonist","HTR1A","","","Tocris",87.99,"BRD-K81876028-300-02-0","Preclinical","","PJYVGMRFPFNZCT-UHFFFAOYSA-N","BRD-K81876028","","O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1"
"1293","CP-94253","serotonin receptor agonist","HTR1B","","","Tocris, Tocris",92.31,"BRD-K33860217-003-04-0, BRD-K33860217-003-03-2","Preclinical","","KWQWBZIGHIOKIO-UHFFFAOYSA-N","BRD-K33860217","","CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1"
"1295","CP-945,598","cannabinoid receptor antagonist","CNR1","","","MedChemEx",98.78,"BRD-K09090949-001-01-9","Phase 3","","UNAZAADNBYXMIV-UHFFFAOYSA-N","BRD-K09090949","","CCNC1(CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1)C(N)=O"
"1296","CP-99994","tachykinin antagonist","TACR1","","","Tocris",94.58,"BRD-K09946180-300-01-6","Phase 2","","DTQNEFOKTXXQKV-HKUYNNGSSA-N","BRD-K09946180","","COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1"
"1297","CPA-INHIBITOR","carboxypeptidase inhibitor","CPA1, CPA2","","","MedChemEx",95.18,"BRD-A69126730-001-01-3","Preclinical","","PONANXDRJJIGPG-UHFFFAOYSA-N","BRD-A69126730","","ON(CC(Cc1ccccc1)C(O)=O)C(=O)Cc1ccccc1"
"1298","CPCCOET","glutamate receptor antagonist","GRM1","","","Tocris, Tocris",96.83,"BRD-A05729358-001-03-8, BRD-A05729358-001-02-0","Preclinical","","FXCTZFMSAHZQTR-KAMYIIQDSA-N","BRD-A05729358","","CCOC(=O)C12CC1\C(=N/O)c1ccccc1O2"
"1300","CPI-0610","bromodomain inhibitor","BRD4","","","MedChemEx",97.89,"BRD-K19871656-001-01-3","Phase 1","","GCWIQUVXWZWCLE-INIZCTEOSA-N","BRD-K19871656","","Cc1noc2[C@H](CC(N)=O)N=C(c3ccc(Cl)cc3)c3ccccc3-c12"
"1301","CPI-1189","tumor necrosis factor release inhibitor","TNF","","","ChemDiv",98.62,"BRD-K11073688-001-01-6","Phase 2","","DJKNRCWSXSZACF-UHFFFAOYSA-N","BRD-K11073688","","CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C"
"1302","CPI-169","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx",93.82,"BRD-K97181972-001-01-9","Preclinical","","LHGUZCKPFXXVPV-GOSISDBHSA-N","BRD-K97181972","","CCS(=O)(=O)N1CCC(CC1)[C@@H](C)n1c(C)c(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c2ccccc12"
"1303","CPI-203","bromodomain inhibitor","BRD4","","","Tocris, MedChemEx",94.7,"BRD-K15811707-001-02-0, BRD-K15811707-001-01-2","Preclinical","","QECMENZMDBOLDR-AWEZNQCLSA-N","BRD-K15811707","","Cc1sc-2c(c1C)C(=N[C@@H](CC(N)=O)c1nnc(C)n-21)c1ccc(Cl)cc1"
"1305","CPI-360","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx",94.64,"BRD-K18319422-001-01-7","Preclinical","","PFPSFENQCNMITC-MRXNPFEDSA-N","BRD-K18319422","","COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCOCC2)c2ccccc12"
"1306","CPI-613","pyruvate dehydrogenase inhibitor","PDHA1","","","Selleck",95.51,"BRD-A06916187-001-02-9","Phase 2","","ZYRLHJIMTROTBO-UHFFFAOYSA-N","BRD-A06916187","","OC(=O)CCCCC(CCSCc1ccccc1)SCc1ccccc1"
"1307","CPP","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio, AMS",93.04,"BRD-K66094457-001-02-3, BRD-K66094457-001-01-5, BRD-A60832661-001-01-8","Phase 2","","CUVGUPIVTLGRGI-SSDOTTSWSA-N","BRD-K66094457","","OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1"
"1309","CPP","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio, AMS",93.04,"BRD-K66094457-001-02-3, BRD-K66094457-001-01-5, BRD-A60832661-001-01-8","Phase 2","","CUVGUPIVTLGRGI-SSDOTTSWSA-N","BRD-K66094457","","OC(=O)C1CN(CCCP(O)(O)=O)CCN1"
"1310","CPP","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio, AMS",93.04,"BRD-K66094457-001-02-3, BRD-K66094457-001-01-5, BRD-A60832661-001-01-8","Phase 2","","CUVGUPIVTLGRGI-UHFFFAOYSA-N","BRD-K66094457","","OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1"
"1312","CPP","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio, AMS",93.04,"BRD-K66094457-001-02-3, BRD-K66094457-001-01-5, BRD-A60832661-001-01-8","Phase 2","","CUVGUPIVTLGRGI-UHFFFAOYSA-N","BRD-K66094457","","OC(=O)C1CN(CCCP(O)(O)=O)CCN1"
"1313","CPSI-1306-(+/-)","macrophage migration inhibiting factor inhibitor","MIF","","","Tocris",96.78,"BRD-A81603255-001-01-0","Preclinical","","GUWOSEVHCSNYFK-UHFFFAOYSA-N","BRD-A81603255","","Fc1ccc(C2=NOC(CC(=O)N3CCOCC3)C2)c(F)c1"
"1314","CREATINE","","CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8","","","Vitas-M",100,"BRD-K19615002-001-02-3","Launched","","CVSVTCORWBXHQV-UHFFFAOYSA-N","BRD-K19615002","","CN(CC(O)=O)C(N)=N"
"1315","CREATININE","","","","","Selleck, MicroSource",100,"BRD-K13495773-001-11-4, BRD-K13495773-001-12-2","Preclinical","","DDRJAANPRJIHGJ-UHFFFAOYSA-N","BRD-K13495773","","CN1CC(=O)NC1=N"
"1317","CREATINOL-PHOSPHATE","","","","","CombiBlocks, CombiBlocks",100,"BRD-K42991124-001-04-8, BRD-K42991124-001-03-0","Launched","","FOIPWTMKYXWFGC-UHFFFAOYSA-N","BRD-K42991124","","CN(CCOP(O)(O)=O)C(N)=N"
"1319","CRENOLANIB","PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFRA, PDGFRB","","","Selleck, Selleck",91.35,"BRD-K22127577-001-03-7, BRD-K22127577-001-02-9","Phase 2","","DYNHJHQFHQTFTP-UHFFFAOYSA-N","BRD-K22127577","","CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1"
"1321","CRESOL","","","","","MicroSource",78.99,"BRD-K56940914-001-04-2","Launched","","IWDCLRJOBJJRNH-UHFFFAOYSA-N","BRD-K56940914","","Cc1ccc(O)cc1"
"1322","CRESOPIRINE","","","","","MicroSource",94.31,"BRD-K58648841-001-04-7","Preclinical","","XRBMKGUDDJPAMH-UHFFFAOYSA-N","BRD-K58648841","","CC(=O)Oc1c(C)cccc1C(O)=O"
"1323","CRIDANIMOD","progesterone receptor agonist","PGR","","","ChemDiv, Sigma",98.36,"BRD-K97939847-001-11-2, BRD-K97939847-001-12-0","Launched","","UOMKBIIXHQIERR-UHFFFAOYSA-N","BRD-K97939847","","OC(=O)Cn1c2ccccc2c(=O)c2ccccc12"
"1325","CRISABOROLE","phosphodiesterase inhibitor","PDE4B","","","MedChemEx",93.42,"BRD-K43230258-001-01-4","Phase 3","","USZAGAREISWJDP-UHFFFAOYSA-N","BRD-K43230258","","OB1OCc2cc(Oc3ccc(cc3)C#N)ccc12"
"1326","CRIZOTINIB-(S)","MTH1 inhibitor","NUDT1","","","Selleck, Selleck",91.61,"BRD-K40308497-001-02-0, BRD-K40308497-001-01-2","Preclinical","BRD-A75349800-001-01-8","KTEIFNKAUNYNJU-LBPRGKRZSA-N","BRD-K40308497","BRD-A75349800","C[C@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl"
"1328","CROCONAZOLE","bacterial cell wall synthesis inhibitor","","","","AKSci",0,"BRD-K73701464-003-01-3","Launched","","WHPAGCJNPTUGGD-UHFFFAOYSA-N","BRD-K73701464","","Clc1cccc(COc2ccccc2C(=C)n2ccnc2)c1"
"1329","CROMAKALIM","","KCNJ8","","","Tocris",99.22,"BRD-M89827113-001-01-5","Phase 2","","BVMDRSUIADWFLV-PNSAJKJISA-N","BRD-M89827113","","CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N.CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N1CCCC1=O)C#N"
"1330","CRT0044876","","","","","Selleck",96.56,"BRD-K02816415-001-01-9","Preclinical","","BIUCOFQROHIAEO-UHFFFAOYSA-N","BRD-K02816415","","OC(=O)c1cc2cccc([N+]([O-])=O)c2[nH]1"
"1331","CRYPTOTANSHINONE","acetylcholinesterase inhibitor, STAT inhibitor","STAT3","","","MedChemEx, MedChemEx, Selleck, Selleck",66.48,"BRD-K33336844-001-11-1, BRD-K33336844-001-10-3, BRD-K33336844-001-09-5, BRD-K33336844-001-12-9","Preclinical","BRD-K53562481-001-01-6","GVKKJJOMQCNPGB-JTQLQIEISA-N","BRD-K33336844","BRD-K53562481","C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C"
"1335","CRYSTAL-VIOLET","other antibiotic","","","","Selleck, Selleck, MicroSource",86.06,"BRD-K60025295-003-07-4, BRD-K60025295-003-05-8, BRD-K60025295-003-06-6","Launched","","LGLFFNDHMLKUMI-UHFFFAOYSA-N","BRD-K60025295","","CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C"
"1338","CR8-(R)","CDK inhibitor","CCNA2","","","Tocris, Tocris",96.87,"BRD-K40331046-305-01-5, BRD-K40331046-305-02-3","Preclinical","","HOCBJBNQIQQQGT-LJQANCHMSA-N","BRD-K40331046","","CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1"
"1340","CS-110266","dopamine receptor agonist","SLC6A3","","","Tocris, Tocris",94.58,"BRD-K15519488-050-02-1, BRD-K15519488-050-01-3","Preclinical","","RGSVXQJPSWZXOP-UHFFFAOYSA-N","BRD-K15519488","","C1CCN(CC1)C1(CCCCC1)c1cc2ccccc2s1"
"1342","CS-917","fructose biphosphate inhibitor","FBP1","","","MedChemEx, MedChemEx",92.89,"BRD-K35601925-001-01-9, BRD-K35601925-001-02-7","Phase 2","","XJMYIJPPDSZOPN-UHFFFAOYSA-N","BRD-K35601925","","CC(C)Cc1sc(N)nc1-c1ccc(o1)P(O)(O)=O"
"1344","CT-7758","integrin antagonist","ITGA4","","","MedChemEx",96.91,"BRD-K40870905-001-01-7","Phase 2","","KYHVWHYLKOHLKA-FQEVSTJZSA-N","BRD-K40870905","","OC(=O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C11CCCCC1"
"1345","CTEP","glutamate receptor antagonist","GRM5","","","Selleck",96.37,"BRD-K30572193-001-02-0","Preclinical","","GOHCTCOGYKAJLZ-UHFFFAOYSA-N","BRD-K30572193","","Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1"
"1346","CTS-1027","metalloproteinase inhibitor","MMP1, MMP13, MMP2, MMP3, MMP9","","","MedChemEx, MedChemEx",97.14,"BRD-K53508936-001-02-8, BRD-K53508936-001-01-0","Phase 2","","ROSNVSQTEGHUKU-UHFFFAOYSA-N","BRD-K53508936","","ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1"
"1348","CTS21166","beta-secretase inhibitor","BACE1","","","EMDBio",78.39,"BRD-K89071957-001-01-1","Phase 1","","NIOCOJFPGCXNKL-ZKZXETMPSA-N","BRD-K89071957","","CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O"
"1349","CU-CPT-4A","toll-like receptor inhibitor","TLR3","","","Tocris",91.08,"BRD-K58234744-001-01-0","Preclinical","","IAASQMCXDRISAV-CYBMUJFWSA-N","BRD-K58234744","","OC(=O)[C@@H](Cc1ccccc1)NC(=O)c1sc2cc(F)ccc2c1Cl"
"1350","CU-T12-9","toll-like receptor agonist","TLR1, TLR2","","","Tocris",94.4,"BRD-K89462779-001-01-8","Preclinical","","LITXVDAFEYLWQE-UHFFFAOYSA-N","BRD-K89462779","","CNc1ccc(cc1-n1cnc(c1)-c1ccc(cc1)C(F)(F)F)[N+]([O-])=O"
"1351","CUDC-101","EGFR inhibitor","EGFR, ERBB2","","","Selleck",94.69,"BRD-K41278234-001-03-0","Phase 1","","PLIVFNIUGLLCEK-UHFFFAOYSA-N","BRD-K41278234","","COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO"
"1352","CUDC-427","apoptosis inhibitor","XIAP","","","MedChemEx, MedChemEx",86.1,"BRD-K69351586-001-02-8, BRD-K69351586-001-01-0","Phase 1","","HSHPBORBOJIXSQ-HARLFGEKSA-N","BRD-K69351586","","CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1sc(nc1-c1ccccc1)-c1ncco1"
"1354","CUDC-907","PI3K inhibitor","HDAC2, PIK3R1","","","Selleck",91.24,"BRD-K77638923-001-02-0","Phase 2","","JOWXJLIFIIOYMS-UHFFFAOYSA-N","BRD-K77638923","","COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1"
"1355","CUR-61414","smoothened receptor antagonist","DHH, IHH, SMO","","","Cayman",97.61,"BRD-K69624312-001-01-1","Phase 1","","WPHXYKUPFJRJDK-AHWVRZQESA-N","BRD-K69624312","","COc1cccc(CN([C@H]2C[C@H](N(Cc3ccc4OCOc4c3)C2)C(=O)N2CCNCC2)C(=O)CC(C)(C)C)c1"
"1356","CURCUMIN","cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH","","","Selleck, Selleck, Enzo",91.77,"BRD-K07572174-001-39-4, BRD-K07572174-001-38-6, BRD-K07572174-001-43-6","Launched","BRD-K69690935-001-03-5","VFLDPWHFBUODDF-FCXRPNKRSA-N","BRD-K07572174","BRD-K69690935","COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1"
"1359","CURCUMOL","JAK inhibitor","JAK1, JAK2, JAK3","","","Selleck, Selleck",82.1,"BRD-K41933240-001-02-4, BRD-K41933240-001-03-2","Phase 1","BRD-K07241895-001-01-4","QRMPRVXWPCLVNI-YYFQZIEXSA-N","BRD-K41933240","BRD-K07241895","CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C"
"1361","CUTAMESINE","sigma receptor agonist","SIGMAR1","","","MedChemEx, Tocris",95.88,"BRD-K90777969-300-01-2, BRD-K90777969-300-02-0","Phase 2","","UVSWWUWQVAQPJR-UHFFFAOYSA-N","BRD-K90777969","","COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC"
"1363","CV-1808","adenosine receptor agonist","ADORA2A","","","Tocris",95.83,"BRD-K49197823-001-09-8","Preclinical","","SCNILGOVBBRMBK-SDBHATRESA-N","BRD-K49197823","","Nc1nc(Nc2ccccc2)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"1364","CVT-10216","aldehyde dehydrogenase inhibitor","ALDH2","","","Sigma, Tocris",96.71,"BRD-K60659193-001-01-0, BRD-K60659193-001-02-8","Phase 1","","YYOOFJZTRCPVFD-UHFFFAOYSA-N","BRD-K60659193","","CS(=O)(=O)Nc1ccc(cc1)-c1coc2cc(OCc3cccc(c3)C(O)=O)ccc2c1=O"
"1366","CW-008","PKA activator","PRKACA","","","Tocris",92.05,"BRD-K84068331-001-01-9","Preclinical","","KCIMKTNQCUDTFI-UHFFFAOYSA-N","BRD-K84068331","","COc1ccn2ncc(-c3nc4[nH]nc(NC(=O)c5ccc(F)cc5)c4cc3F)c2c1"
"1367","CX-4945","casein kinase inhibitor","CSNK2A1, CSNK2A2, DAPK3, HIPK3","","","Selleck",98.07,"BRD-K81458380-001-04-9","Phase 1/Phase 2","","MUOKSQABCJCOPU-UHFFFAOYSA-N","BRD-K81458380","","OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21"
"1368","CX-516","glutamate receptor modulator","","","","Tocris",98.29,"BRD-K25140590-001-03-0","Phase 2/Phase 3","","BXBNADAPIHHXJQ-UHFFFAOYSA-N","BRD-K25140590","","O=C(N1CCCCC1)c1ccc2OCOc2c1"
"1369","CX-5461","RNA polymerase inhibitor","","","","MedChemEx",96.98,"BRD-K12787259-001-04-3","Phase 1","","XGPBJCHFROADCK-UHFFFAOYSA-N","BRD-K12787259","","CN1CCCN(CC1)c1ccc2c(n1)n1c3ccccc3sc1c(C(=O)NCc1cnc(C)cn1)c2=O"
"1370","CYACETACIDE","","","","","MicroSource",93.04,"BRD-K39371216-001-01-3","Preclinical","","HPHBOJANXDKUQD-UHFFFAOYSA-N","BRD-K39371216","","NNC(=O)CC#N"
"1371","CYANOPINDOLOL","adrenergic receptor antagonist","ADRB1, HTR1A, HTR1D","","","Tocris",96.81,"BRD-A47884604-051-01-2","Phase 2","BRD-M87382116-051-02-3","QXIUMMLTJVHILT-UHFFFAOYSA-N","BRD-A47884604","BRD-M87382116","CC(C)(C)NCC(O)COc1cccc2[nH]c(cc12)C#N"
"1372","CYCLAMIC-ACID","","","","","MicroSource, MicroSource, Selleck",100,"BRD-K50785021-001-04-7, BRD-K50785021-001-03-9, BRD-K50785021-001-02-1","Preclinical","BRD-M61995960-001-03-2","HCAJEUSONLESMK-UHFFFAOYSA-N","BRD-K50785021","BRD-M61995960","OS(=O)(=O)NC1CCCCC1"
"1375","CYCLIC-AMP","","CNGA3, HCN2, PRKAR1A, PRKAR2B, TRPM7","","","ChemDiv",100,"BRD-A41840684-001-01-8","Preclinical","","IVOMOUWHDPKRLL-UHFFFAOYSA-N","BRD-A41840684","","Nc1ncnc2n(cnc12)C1OC2COP(O)(=O)OC2C1O"
"1376","CYCLOCREATINE","creatine kinase substrate","","","","Sigma",96.8,"BRD-K14379200-001-04-7","Phase 1","","AMHZIUVRYRVYBA-UHFFFAOYSA-N","BRD-K14379200","","OC(=O)CN1CCNC1=N"
"1377","CYCLOCYTIDINE","DNA synthesis inhibitor, RNA synthesis inhibitor","","","","MicroSource, Selleck",99.31,"BRD-K67536197-003-11-4, BRD-K67536197-003-10-6","Preclinical","BRD-K67536197-001-02-7,BRD-K81021983-003-02-6, BRD-K80834753-003-01-3","BBDAGFIXKZCXAH-CCXZUQQUSA-N","BRD-K67536197","BRD-K67536197","OC[C@H]1O[C@@H]2[C@@H](Oc3nc(=N)ccn23)[C@@H]1O"
"1379","CYCLOHEXIMIDE","protein synthesis inhibitor","RPL3","","","Sigma, MicroSource",89.23,"BRD-K36055864-001-20-0, BRD-K36055864-001-19-2","Preclinical","","YPHMISFOHDHNIV-FSZOTQKASA-N","BRD-K36055864","","C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1"
"1381","CYCLOPIAZONIC-ACID","ATPase inhibitor","ATP2A1","","","Tocris, Tocris",99.1,"BRD-A10420615-001-05-1, BRD-A10420615-001-04-4","Preclinical","BRD-K93666001-001-01-8","TZCOBUQKVNFIQF-ARUUDZKJSA-N","BRD-A10420615","BRD-K93666001","CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O"
"1383","CYCLOVIROBUXIN-D","calcium channel modulator","","","","Selleck, Selleck",100,"BRD-K27799744-001-02-8, BRD-K27799744-001-03-6","Preclinical","BRD-K35479987-001-01-5","GMNAPBAUIVITMI-ABNIRSKTSA-N","BRD-K27799744","BRD-K35479987","CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](NC)C4(C)C"
"1385","CYC116","Aurora kinase inhibitor","AURKA, AURKB, KDR","","","Selleck, Selleck",93.87,"BRD-K64866502-001-04-7, BRD-K64866502-001-03-9","Phase 1","","GPSZYOIFQZPWEJ-UHFFFAOYSA-N","BRD-K64866502","","Cc1nc(N)sc1-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1"
"1387","CYM-50260","sphingosine 1 phosphate receptor agonist","S1PR4","","","Tocris",96.41,"BRD-K69877120-001-01-7","Preclinical","","FHPOTBQOUBMMCI-UHFFFAOYSA-N","BRD-K69877120","","FCc1ccc(OCCOc2ccc(Cl)cc2Cl)c(Cl)n1"
"1388","CYM-50358","sphingosine 1-phosphate receptor antagonist","S1PR4","","","Tocris",97.71,"BRD-K80666802-003-01-0","Preclinical","","QWJOPXDAQCDRRM-UHFFFAOYSA-N","BRD-K80666802","","Cc1cc(CN)cc(C)c1NC(=O)c1ccc(o1)-c1cc(Cl)ccc1Cl"
"1389","CYM-50769","neuropeptide receptor antagonist","NPBWR1","","","Tocris",98.77,"BRD-K27732927-001-03-6","Preclinical","","QHVSQUYCVUHYKT-UHFFFAOYSA-N","BRD-K27732927","","COc1ccc(Oc2c(Cl)cnn(C3c4ccccc4-c4ccccc34)c2=O)cc1"
"1390","CYM-5442","sphingosine 1 phosphate receptor agonist","S1PR1","","","Tocris",97.43,"BRD-A43005764-003-01-5","Preclinical","","NUIKTBLZSPQGCP-UHFFFAOYSA-N","BRD-A43005764","","CCOc1ccc(cc1OCC)-c1nc(no1)-c1cccc2C(CCc12)NCCO"
"1391","CYM-5520","sphingosine 1 phosphate receptor agonist","S1PR2","","","Tocris",96.49,"BRD-K29151923-001-01-5","Preclinical","","FMYGNANMYYHBSU-UHFFFAOYSA-N","BRD-K29151923","","Cc1cc(C(=O)Cn2cc(ccc2=O)C#N)c(C)n1Cc1ccccc1"
"1392","CYM-5541","sphingosine 1 phosphate receptor agonist","S1PR3","","","Tocris",93.59,"BRD-K75940276-001-03-3","Preclinical","","NDKGACIWVAOUQH-UHFFFAOYSA-N","BRD-K75940276","","O=C(N(C1CCCCC1)C1CCCCC1)c1cc(on1)C1CC1"
"1393","CYPERMETHRIN","","","","","MicroSource",42.23,"BRD-A62798249-001-04-4","Launched","","KAATUXNTWXVJKI-UHFFFAOYSA-N","BRD-A62798249","","CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1"
"1394","CYROMAZINE","","","","","Selleck, MicroSource",99.31,"BRD-K36711084-001-01-2, BRD-K36711084-001-02-0","Launched","","LVQDKIWDGQRHTE-UHFFFAOYSA-N","BRD-K36711084","","Nc1nc(N)nc(NC2CC2)n1"
"1396","CYT-997","tubulin polymerization inhibitor","TUBB","","","Selleck",96.56,"BRD-K23363278-001-02-1","Phase 2","","MTJHLONVHHPNSI-IBGZPJMESA-N","BRD-K23363278","","CCC[C@H](Nc1nc(ncc1C)-c1ccc(NC(=O)NCC)c(OC)c1)c1cccnc1"
"1397","CYTOCHALASIN-B","microtubule inhibitor","ACTB","","","Enzo",95.57,"BRD-K47000838-001-01-6","Phase 2","","GBOGMAARMMDZGR-FFXRSMCQSA-N","BRD-K47000838","","C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]22OC(=O)\C=C/[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C"
"1398","CYTOCHLOR","","","","","Berry",100,"BRD-K48988407-001-01-2","Phase 1","","NGGRGTWYSXYVDK-FSDSQADBSA-N","BRD-K48988407","","Nc1nc(=O)n(cc1Cl)[C@H]1C[C@@H](O)[C@@H](CO)O1"
"1399","CYT387","","JAK1, JAK2, JAK3","","","Selleck, Selleck",94.44,"BRD-K87737963-001-07-8, BRD-K87737963-001-06-0","Phase 3","","ZVHNDZWQTBEVRY-UHFFFAOYSA-N","BRD-K87737963","","O=C(NCC#N)c1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1"
"1401","CY208-243","dopamine receptor agonist","CALY","","","Tocris, Tocris",66.95,"BRD-K79353516-001-05-0, BRD-K79353516-001-04-3","Phase 2","","WRNKIDLXXXIELU-IEBWSBKVSA-N","BRD-K79353516","","CN1Cc2ccccc2[C@H]2[C@H]1Cc1c[nH]c3cccc2c13"
"1403","CZC-54252","leucine rich repeat kinase inhibitor","LRRK2","","","Tocris",96.05,"BRD-K87021635-003-02-2","Preclinical","","CLGWUCNXOBLWFM-UHFFFAOYSA-N","BRD-K87021635","","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1)N1CCOCC1"
"1404","CZC24832","PI3K inhibitor","PIK3CG","","","Selleck, Tocris",98.69,"BRD-K01377300-001-01-1, BRD-K01377300-001-02-9","Preclinical","","RXRZPHQBTHQXSV-UHFFFAOYSA-N","BRD-K01377300","","CC(C)(C)NS(=O)(=O)c1cncc(c1)-c1cc(F)c2nc(N)nn2c1"
"1406","C106","","","","","Enzo",0,"BRD-M12328004-001-01-8","Phase 3","","GEGPCGHEPLKDLY-UHFFFAOYSA-N","BRD-M12328004","","CN1CCCC1c1cccnc1.Cc1ccc(cc1)C(=O)OC(C(OC(=O)c1ccc(C)cc1)C(O)=O)C(O)=O"
"1407","C11-ACETATE","","ABAT, ACE, AKR1C3, CA2, CELA1, ESR2, FFAR2, FFAR3, HPRT1, LTA4H, MMP12, NOS1, NOS3, PLA2G1B, PTPN1, SOD1, TXN","","","SantaCruz",0,"BRD-K83914624-415-01-3","Phase 3","","GRTBAGCGDOYUBE-UHFFFAOYSA-N","BRD-K83914624","","[Y+3]"
"1408","C34","toll-like receptor inhibitor","TLR4","","","Tocris",100,"BRD-K43167535-001-01-3","Preclinical","","KMIQMFHPUJUDMC-HHARLNAUSA-N","BRD-K43167535","","CC(C)O[C@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O"
"1409","C646","histone acetyltransferase inhibitor","EP300","","","Selleck, Selleck",88.71,"BRD-K73383190-001-03-1, BRD-K73383190-001-02-3","Preclinical","BRD-K68548958-001-04-6, BRD-K19202888-001-01-1","HEKJYZZSCQBJGB-UHFFFAOYSA-N","BRD-K73383190","BRD-K68548958","CC1=NN(C(=O)C1=Cc1ccc(o1)-c1cc(C)c(C)cc1[N+]([O-])=O)c1ccc(cc1)C(O)=O"
"1411","D-(+)-MALTOSE","","AMY2B, MGAM","","","MicroSource",100,"BRD-K74377520-001-01-7","Preclinical","","GUBGYTABKSRVRQ-QUYVBRFLSA-N","BRD-K74377520","","OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O"
"1412","D-ALPHA-TOCOPHERYL-SUCCINATE","","","","","SantaCruz",93.52,"BRD-K64636206-001-02-7","Launched","","IELOKBJPULMYRW-NJQVLOCASA-N","BRD-K64636206","","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(O)=O)c(C)c(C)c2O1"
"1413","D-DELTA-TOCOPHEROL","","","","","Acros",91.79,"BRD-K04657451-001-01-0","Launched","","GZIFEOYASATJEH-VHFRWLAGSA-N","BRD-K04657451","","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1"
"1414","D-LIMONENE","","","","","Sigma, MicroSource",0,"BRD-K20879694-001-01-7, BRD-K20879694-001-02-5","Phase 1","BRD-A81494260-001-02-5","XMGQYMWWDOXHJM-JTQLQIEISA-N","BRD-K20879694","BRD-A81494260","CC(=C)[C@@H]1CCC(C)=CC1"
"1416","D-PHENYLALANINE","enkephalinase inhibitor","CCBL1, CRH, HCAR3","","","MicroSource, Selleck, Selleck",100,"BRD-K00911807-003-01-2, BRD-K00911807-001-03-2, BRD-K00911807-001-04-0","Preclinical","","COLNVLDHVKWLRT-MRVPVSSYSA-N","BRD-K00911807","","N[C@H](Cc1ccccc1)C(O)=O"
"1419","D-SERINE","glutamate receptor agonist","GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3","","","Enzo",100,"BRD-K71822263-001-03-2","Launched","","MTCFGRXMJLQNBG-UWTATZPHSA-N","BRD-K71822263","","N[C@H](CO)C(O)=O"
"1420","D-4476","TGF beta receptor inhibitor","CSNK1A1, CSNK1D, TGFB1","","","Tocris, Tocris",96.91,"BRD-K09132007-001-07-5, BRD-K09132007-001-11-7","Preclinical","","DPDZHVCKYBCJHW-UHFFFAOYSA-N","BRD-K09132007","","NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1"
"1422","D-64131","microtubule inhibitor","TUBB","","","Tocris",98.74,"BRD-K26997899-001-02-2","Preclinical","","ICMIJSRDISNKOC-UHFFFAOYSA-N","BRD-K26997899","","COc1ccc2[nH]c(cc2c1)C(=O)c1ccccc1"
"1423","D-7193","","","","","ChemImpex",0,"BRD-K32372024-001-01-0","Phase 2","","YTPQSLLEROSACP-YUMQZZPRSA-N","BRD-K32372024","","CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(O)=O)C(O)=O"
"1424","DAA-1106","benzodiazepine receptor agonist","TSPO","","","MedChemEx",98.31,"BRD-K01080633-001-01-9","Preclinical","","DCRZYADKQRHHSF-UHFFFAOYSA-N","BRD-K01080633","","COc1ccc(OC)c(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c1"
"1425","DACINOSTAT","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","","","Selleck, Selleck",87.84,"BRD-K56957086-001-09-7, BRD-K56957086-001-06-3","Phase 1","","BWDQBBCUWLSASG-MDZDMXLPSA-N","BRD-K56957086","","OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(\C=C\C(=O)NO)cc1"
"1427","DACOMITINIB","EGFR inhibitor","EGFR, ERBB2, ERBB4","","","Selleck",95.48,"BRD-K57169635-001-04-5","Phase 3","","LVXJQMNHJWSHET-AATRIKPKSA-N","BRD-K57169635","","COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN1CCCCC1"
"1428","DAIDZEIN","estrogen receptor agonist","ESRRA, ESRRB, ESRRG, TRPC5","","","Tocris, Selleck, Enzo, Selleck, Tocris",97.99,"BRD-K42095107-001-22-1, BRD-K42095107-001-21-3, BRD-K42095107-001-18-9, BRD-K42095107-001-16-3, BRD-K42095107-001-17-1","Phase 2","","ZQSIJRDFPHDXIC-UHFFFAOYSA-N","BRD-K42095107","","Oc1ccc(cc1)-c1coc2cc(O)ccc2c1=O"
"1433","DALARGIN","opioid receptor agonist","OPRM1","","","InterBioScreen",79.63,"BRD-A89196962-300-01-7","Phase 2","","GDPHPXYFLPDZGH-VSZNVKCOSA-N","BRD-A89196962","","CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O"
"1434","DALCETRAPIB","cholesteryl ester transfer protein inhibitor","CETP","","","Selleck, Selleck",95.55,"BRD-K18849474-001-04-4, BRD-K18849474-001-03-6","Phase 3","","YZQLWPMZQVHJED-UHFFFAOYSA-N","BRD-K18849474","","CCC(CC)CC1(CCCCC1)C(=O)Nc1ccccc1SC(=O)C(C)C"
"1436","DALTROBAN","thromboxane receptor antagonist","TBXA2R","","","Sigma",94.94,"BRD-K26813177-001-03-2","Phase 3","","IULOBWFWYDMECP-UHFFFAOYSA-N","BRD-K26813177","","OC(=O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1"
"1437","DAMINOZIDE","KDM2A inhibitor","KDM2A, KDM7A, PHF8","","","Tocris",63.13,"BRD-K83452553-001-05-8","Preclinical","","NOQGZXFMHARMLW-UHFFFAOYSA-N","BRD-K83452553","","CN(C)NC(=O)CCC(O)=O"
"1438","DANEGAPTIDE","gap junction modulator","","","","MedChemEx",85.91,"BRD-K35589454-003-01-1","Phase 2","","BIZKIHUJGMSVFD-MNOVXSKESA-N","BRD-K35589454","","NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)c1ccccc1"
"1439","DANIRIXIN","CC chemokine receptor antagonist","CXCR2","","","MedChemEx",94.48,"BRD-K13769342-001-01-5","Phase 2","","NGYNBSHYFOFVLS-LBPRGKRZSA-N","BRD-K13769342","","Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(c1O)S(=O)(=O)[C@H]1CCCNC1"
"1440","DANOPREVIR","HCV inhibitor","","","","Selleck",94.01,"BRD-K08111240-001-02-8","Phase 2","","ZVTDLPBHTSMEJZ-JSZLBQEHSA-N","BRD-K08111240","","CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1Cc2cccc(F)c2C1)C(=O)NS(=O)(=O)C1CC1"
"1441","DANTRON","laxative","","","","MicroSource",95.61,"BRD-K10065684-001-07-4","Withdrawn","","QBPFLULOKWLNNW-UHFFFAOYSA-N","BRD-K10065684","","Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12"
"1442","DANUSERTIB","Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK","","","Selleck, Selleck",91.1,"BRD-K07881437-001-04-6, BRD-K07881437-001-03-8","Phase 2","","XKFTZKGMDDZMJI-HSZRJFAPSA-N","BRD-K07881437","","CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1"
"1444","DAPHNETIN","protein kinase inhibitor","","","","Selleck",91.06,"BRD-K61269089-001-05-5","Preclinical","","ATEFPOUAMCWAQS-UHFFFAOYSA-N","BRD-K61269089","","Oc1ccc2ccc(=O)oc2c1O"
"1445","DAPIVIRINE","non-nucleoside reverse transcriptase inhibitor","CYP3A4, CYP3A5","","","Selleck",97.99,"BRD-K12885236-001-02-7","Phase 3","","ILAYIAGXTHKHNT-UHFFFAOYSA-N","BRD-K12885236","","Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1"
"1446","DAPRODUSTAT","hypoxia inducible factor inhibitor","EGLN1","","","MedChemEx",93.43,"BRD-K06455935-001-01-3","Phase 3","","RUEYEZADQJCKGV-UHFFFAOYSA-N","BRD-K06455935","","OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O"
"1447","DAPT","gamma secretase inhibitor","","","","Tocris, Selleck, Tocris",96.31,"BRD-K47177710-001-03-1, BRD-K47177710-001-02-3, BRD-K47177710-001-04-9","Preclinical","","DWJXYEABWRJFSP-XOBRGWDASA-N","BRD-K47177710","","C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1"
"1450","DARAPLADIB","phospholipase inhibitor","PLA2G7","","","MedChemEx",93.01,"BRD-K19085898-001-01-8","Phase 3","","WDPFJWLDPVQCAJ-UHFFFAOYSA-N","BRD-K19085898","","CCN(CC)CCN(Cc1ccc(cc1)-c1ccc(cc1)C(F)(F)F)C(=O)Cn1c2CCCc2c(=O)nc1SCc1ccc(F)cc1"
"1451","DARGLITAZONE","PPAR receptor antagonist","PPARG","","","Cayman",96.02,"BRD-K82908348-001-01-9","Phase 2","","BUWFKENPFXXWGV-UHFFFAOYSA-N","BRD-K82908348","","Cc1oc(nc1CCC(=O)c1ccc(Cc2sc(O)nc2O)cc1)-c1ccccc1"
"1452","DARUSENTAN","endothelin receptor antagonist","EDNRA","","","Key",98.96,"BRD-K54863166-001-01-9","Phase 3","","FEJVSJIALLTFRP-LJQANCHMSA-N","BRD-K54863166","","COc1cc(OC)nc(O[C@H](C(O)=O)C(OC)(c2ccccc2)c2ccccc2)n1"
"1453","DAU-5884","acetylcholine receptor antagonist","CHRM3","","","Tocris, Tocris",97.49,"BRD-K31633810-003-03-6, BRD-K31633810-003-02-8","Preclinical","","NWXCDQHBVVPPTL-WDNDVIMCSA-N","BRD-K31633810","","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1Cc2ccccc2NC1=O"
"1455","DAUCOSTEROL","apoptosis stimulant","","","","MedChemEx",89.9,"BRD-K14276241-001-01-2","Phase 2","","NPJICTMALKLTFW-OFUAXYCQSA-N","BRD-K14276241","","CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)C"
"1456","DAZMEGREL","thromboxane synthase inhibitor","TBXAS1","","","Vitas-M",98.91,"BRD-K20738689-001-01-2","Phase 2","","DEQLGSOHGTZKFB-UHFFFAOYSA-N","BRD-K20738689","","Cc1c(Cn2ccnc2)c2ccccc2n1CCC(O)=O"
"1457","DAZOXIBEN","thromboxane synthase inhibitor","TBXAS1","","","AKSci",95.24,"BRD-K82767007-001-01-1","Phase 2","","XQGZSYKGWHUSDH-UHFFFAOYSA-N","BRD-K82767007","","OC(=O)c1ccc(OCCn2ccnc2)cc1"
"1458","DBEQ","ATPase inhibitor","CASP3","","","Tocris, Selleck",96.56,"BRD-K59204667-001-05-6, BRD-K59204667-001-03-1","Preclinical","","QAIMUUJJAJBPCL-UHFFFAOYSA-N","BRD-K59204667","","C(Nc1nc(NCc2ccccc2)c2ccccc2n1)c1ccccc1"
"1460","DBPR108","dipeptidyl peptidase inhibitor","DPP4","","","MedChemEx",95.35,"BRD-K83020231-001-01-2","Phase 1","","VQKSCYBKUIDZEI-STQMWFEESA-N","BRD-K83020231","","CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N"
"1461","DC-260126","free fatty acid receptor antagonist","FFAR1","","","Tocris",94.07,"BRD-K10596918-001-01-9","Preclinical","","CNGHPXKWPGIDSK-UHFFFAOYSA-N","BRD-K10596918","","CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1"
"1462","DCC-2618","PDGFR tyrosine kinase receptor inhibitor, KIT inhibitor","KIT, PDGFRA","","","MedChemEx",97.17,"BRD-K49246350-001-01-1","Phase 1","","WWOXKWLDMLMYQY-UHFFFAOYSA-N","BRD-K49246350","","Cn1cc(cn1)-c1cc(Oc2cc(F)c(NC(=O)C3(CC3)C(=O)Nc3ccccc3)cc2F)ccn1"
"1463","DCEBIO","potassium channel activator","KCNN2, KCNN3, KCNN4","","","Tocris, Tocris, Tocris",99.43,"BRD-K89299012-001-08-6, BRD-K89299012-001-07-8, BRD-K89299012-001-06-0","Preclinical","","LKHRMULASXZCLG-UHFFFAOYSA-N","BRD-K89299012","","CCn1c(O)nc2cc(Cl)c(Cl)cc12"
"1466","DCPIB","chloride channel blocker, gap junction modulator, glutamate inhibitor","SLC1A2","","","Tocris",88.14,"BRD-A39255369-001-03-1","Preclinical","","KHKGTPJPBOQECW-UHFFFAOYSA-N","BRD-A39255369","","CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1"
"1467","DDR1-IN-1","discoidin domain receptor inhibitor","DDR1, DDR2","","","Tocris",92.41,"BRD-K61845293-300-01-9","Preclinical","","AOZPVMOOEJAZGK-UHFFFAOYSA-N","BRD-K61845293","","CCN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Oc3ccc4NC(=O)Cc4c3)c2)CC1"
"1468","DECAMETHOXINE","antiseptic","","","","Innovapharm",0,"BRD-A56320380-300-01-6","Phase 2","","ZADGGFKUEYIBJC-UHFFFAOYSA-N","BRD-A56320380","","CC(C)C1CCC(C)CC1OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC1CC(C)CCC1C(C)C"
"1469","DECERNOTINIB","JAK inhibitor","JAK3","","","MedChemEx",97.54,"BRD-A95300432-001-01-3","Phase 2/Phase 3","","ASUGUQWIHMTFJL-UHFFFAOYSA-N","BRD-A95300432","","CCC(C)(Nc1ccnc(n1)-c1c[nH]c2ncccc12)C(=O)NCC(F)(F)F"
"1470","DEFACTINIB","focal adhesion kinase inhibitor","PTK2","","","MedChemEx, MedChemEx",98.24,"BRD-K43578482-001-02-2, BRD-K43578482-001-01-4","Phase 2","","FWLMVFUGMHIOAA-UHFFFAOYSA-N","BRD-K43578482","","CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1"
"1472","DEFOROLIMUS","mTOR inhibitor","MTOR","","","Selleck, Selleck",89.39,"BRD-K62304154-001-03-4, BRD-K62304154-001-04-2","Phase 3","BRD-K09078998-001-01-4","BUROJSBIWGDYCN-GAUTUEMISA-N","BRD-K62304154","BRD-K09078998","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O"
"1474","DEHYDROACETIC-ACID","","","","","MicroSource",86.69,"BRD-A17300716-001-01-5","Preclinical","","PGRHXDWITVMQBC-UHFFFAOYSA-N","BRD-A17300716","","CC(=O)C1C(=O)OC(C)=CC1=O"
"1475","DEHYDROCHOLATE","","","","","MicroSource",85.01,"BRD-A64125466-236-04-6","Preclinical","","OHXPGWPVLFPUSM-NDGTYXLASA-N","BRD-A64125466","","C[C@H](CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)CC1CC3=O"
"1476","DEHYDROCHOLATE-ACID","","","","","MicroSource",91.75,"BRD-A11551002-001-04-6","Preclinical","","OHXPGWPVLFPUSM-IWYXHJQRSA-N","BRD-A11551002","","CC(CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)C[C@H]1CC3=O"
"1477","DEHYDROCORYDALINE","acetylcholinesterase inhibitor","ACHE","","","MedChemEx, MedChemEx",91.32,"BRD-K67186445-001-01-3, BRD-K67186445-001-02-1","Phase 3","","RFKQJTRWODZPHF-UHFFFAOYSA-N","BRD-K67186445","","COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC"
"1479","DEHYDROEPIANDROSTERONE","protein synthesis stimulant","ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1","","","MicroSource, Selleck",100,"BRD-K41256143-001-13-5, BRD-K41256143-001-12-7","Launched","BRD-A79445307-001-01-8, BRD-K85833139-001-01-9","FMGSKLZLMKYGDP-USOAJAOKSA-N","BRD-K41256143","BRD-A79445307","C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O"
"1481","DELANZOMIB","proteasome inhibitor","CMA1, CTSG, CYP3A4, ELANE","","","MedChemEx, MedChemEx, Selleck, Selleck",89.99,"BRD-K59325863-001-04-4, BRD-K59325863-001-01-0, BRD-K59325863-001-03-6, BRD-K59325863-001-02-8","Phase 1/Phase 2","BRD-K84591635-001-02-1, BRD-K84591635-001-01-3","SJFBTAPEPRWNKH-CCKFTAQKSA-N","BRD-K59325863","BRD-K84591635","CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(n1)-c1ccccc1)[C@@H](C)O)B(O)O"
"1485","DELIVERT","angiotensin receptor agonist","AGTR1, AGTR2","","","MedChemEx",88.91,"BRD-K45503887-001-01-1","Launched","","CZGUSIXMZVURDU-FCWOTDAASA-N","BRD-K45503887","","CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O"
"1486","DELPHINIDIN","membrane permeability inhibitor","GLO1","","","Cayman, Cayman",0,"BRD-K79107392-003-02-2, BRD-K79107392-003-01-4","Phase 2","","JKHRCGUTYDNCLE-UHFFFAOYSA-O","BRD-K79107392","","Oc1cc(O)c2cc(O)c([o+]c2c1)-c1cc(O)c(O)c(O)c1"
"1488","DELTA-TOCOTRIENOL","HMGCR inhibitor","HMGCR","","","AnalytiCon",0.25,"BRD-K85776940-001-01-9","Phase 1","","ODADKLYLWWCHNB-LDYBVBFYSA-N","BRD-K85776940","","CC(C)=CCC\C(C)=C\CC\C(C)=C\CC[C@]1(C)CCc2cc(O)cc(C)c2O1"
"1489","DELTARASIN","phosphodiesterase inhibitor","KRAS","","","Tocris",98.28,"BRD-K90830492-305-01-4","Preclinical","","LTZKEDSUXKTTTC-KXQOOQHDSA-N","BRD-K90830492","","C(Oc1ccc(cc1)-c1nc2ccccc2n1Cc1ccccc1)[C@H](C1CCNCC1)n1c(nc2ccccc12)-c1ccccc1"
"1490","DENATONIUM-BENZOATE","","","","","MicroSource",81.39,"BRD-K34122555-057-11-5","Preclinical","","ZFQMTVNLDNXRNQ-UHFFFAOYSA-O","BRD-K34122555","","CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1"
"1491","DEOXYARBUTIN","tyrosinase inhibitor","","","","Selleck, Selleck",62.84,"BRD-A62562325-001-03-3, BRD-A62562325-001-02-5","Preclinical","","GFBCWCDNXDKFRH-UHFFFAOYSA-N","BRD-A62562325","","Oc1ccc(OC2CCCCO2)cc1"
"1493","DEOXYCORTICOSTERONE-ACETATE","progestogen hormone","NR3C2","","","MicroSource, Selleck, Selleck, Selleck",98.53,"BRD-K24556098-001-19-1, BRD-K24556098-001-17-5, BRD-K24556098-001-18-3, BRD-K24556098-001-16-7","Preclinical","BRD-A75402480-001-04-6, BRD-K54733518-001-01-9","VPGRYOFKCNULNK-ACXQXYJUSA-N","BRD-K24556098","BRD-A75402480","CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"1497","DEOXYEPINEPHRINE","adrenergic receptor agonist, dopamine receptor agonist","ADRA1A, DRD1, DRD2","","","Enzo",83.38,"BRD-K33151569-003-09-7","Preclinical","","NGKZFDYBISXGGS-UHFFFAOYSA-N","BRD-K33151569","","CNCCc1ccc(O)c(O)c1"
"1498","DEPTROPINE","histamine receptor antagonist","HRH1","","","Prestwick",96.68,"BRD-A65797496-048-09-3","Preclinical","","ZWPODSUQWXAZNC-YOFSQIOKSA-N","BRD-A65797496","","CN1[C@H]2CC[C@@H]1CC(C2)OC1c2ccccc2CCc2ccccc12"
"1499","DEQUALINIUM","PKC inhibitor","KCNN1, KCNN3","","","MicroSource, Selleck",95.31,"BRD-K77685957-300-09-1, BRD-K77685957-300-08-3","Launched","","PCSWXVJAIHCTMO-UHFFFAOYSA-P","BRD-K77685957","","Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc12"
"1501","DESMETHYLCLOZAPINE","acetylcholine receptor agonist","HTR2C","","","Tocris",67.09,"BRD-K10042277-001-05-0","Phase 2","","JNNOSTQEZICQQP-UHFFFAOYSA-N","BRD-K10042277","","Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1"
"1502","DESOXYCORTONE","mineralocorticoid receptor agonist","NR3C1, NR3C2","","","Prestwick",98.09,"BRD-K98521173-001-19-4","Preclinical","","ZESRJSPZRDMNHY-YFWFAHHUSA-N","BRD-K98521173","","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO"
"1503","DESOXYPEGANINE","acetylcholinesterase inhibitor, monoamine oxidase inhibitor","ACHE","","","Enzo",93.52,"BRD-K13819402-003-10-2","Phase 1","","WUFQLZTXIWKION-UHFFFAOYSA-N","BRD-K13819402","","C1CN2Cc3ccccc3N=C2C1"
"1504","DEXFENFLURAMINE","serotonin receptor agonist","HTR2C, SLC6A4","","","Prestwick",92.42,"BRD-K58626373-003-07-8","Withdrawn","","DBGIVFWFUFKIQN-VIFPVBQESA-N","BRD-K58626373","","CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F"
"1505","DEXFOSFOSERINE","membrane integrity inhibitor","CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2","","","Sigma, MicroSource",0,"BRD-K30019776-001-01-9, BRD-K30019776-003-01-5","Preclinical","","BZQFBWGGLXLEPQ-REOHCLBHSA-N","BRD-K30019776","","N[C@@H](COP(O)(O)=O)C(O)=O"
"1507","DEXLOXIGLUMIDE","CCK receptor antagonist","CCKAR","","","AdvChemBlocks",96.36,"BRD-K07609981-001-01-7","Phase 3","","QNQZBKQEIFTHFZ-GOSISDBHSA-N","BRD-K07609981","","CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1"
"1508","DEXMEDETOMIDINE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","","","Tocris, Selleck, Selleck",98.01,"BRD-K18423410-003-03-3, BRD-K18423410-003-02-5, BRD-K18423410-001-02-9","Launched","","CUHVIMMYOGQXCV-NSHDSACASA-N","BRD-K18423410","","C[C@H](c1cnc[nH]1)c1cccc(C)c1C"
"1511","DEXNIGULDIPINE","calmodulin antagonist","ADORA3","","","Tocris",92.38,"BRD-K44309363-003-02-1","Phase 2","","SVJMLYUFVDMUHP-MGBGTMOVSA-N","BRD-K44309363","","COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1"
"1512","DFB","glutamate receptor agonist","GRM5","","","Tocris",98.04,"BRD-K82002057-001-01-2","Preclinical","","YYMCVDNIIFNDJK-BEQMOXJMSA-N","BRD-K82002057","","Fc1cccc(c1)\C=N\N=C\c1cccc(F)c1"
"1513","DG-172","PPAR receptor inverse agonist","PPARD","","","Tocris",79.69,"BRD-K75748943-300-01-3","Preclinical","","ZJMDTBBCNMGFMS-SAPNQHFASA-N","BRD-K75748943","","CN1CCN(CC1)c1ccc(cc1)\C=C(/C#N)c1ccccc1Br"
"1514","DH-97","melatonin receptor antagonist","MTNR1B","","","Tocris, Tocris",96,"BRD-K06014311-001-03-8, BRD-K06014311-001-02-0","Preclinical","","HDOIPCLEKCEANF-UHFFFAOYSA-N","BRD-K06014311","","CCCCC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12"
"1516","DHBP","ryanodine receptor blocker","","","","Tocris",0,"BRD-K41262162-303-02-2","Preclinical","","XJGZGUSMZSXHJI-UHFFFAOYSA-N","BRD-K41262162","","CCCCCCC[n+]1ccc(cc1)-c1cc[n+](CCCCCCC)cc1"
"1517","DIACETAMATE","","","","","MicroSource",98.65,"BRD-K93611241-001-02-2","Preclinical","","UJAOSPFULOFZRR-UHFFFAOYSA-N","BRD-K93611241","","CC(=O)Nc1ccc(OC(C)=O)cc1"
"1518","DIADENOSINE-TETRAPHOSPHATE","adenosine kinase inhibitor","P2RY13, P2RY2","","","Enzo",99.35,"BRD-A15035311-001-01-8","Phase 1","","YOAHKNVSNCMZGQ-GMKVLROZSA-N","BRD-A15035311","","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C(O)C2O)n2cnc3c(N)ncnc23)C(O)C1O"
"1519","DIANHYDROGALACTITOL","DNA alkylating agent","","","","MedChemEx",0,"BRD-K68502831-001-01-2","Phase 1","","AAFJXZWCNVJTMK-GUCUJZIJSA-N","BRD-K68502831","","O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1"
"1520","DIARYLPROPIONITRILE","estrogen receptor agonist","ESR2","","","Tocris",94.36,"BRD-A27143604-001-02-0","Preclinical","","GHZHWDWADLAOIQ-UHFFFAOYSA-N","BRD-A27143604","","Oc1ccc(CC(C#N)c2ccc(O)cc2)cc1"
"1521","DIAVERIDINE","dihydrofolate reductase inhibitor","","","","MicroSource",99.41,"BRD-K97464279-001-03-5","Launched","","LDBTVAXGKYIFHO-UHFFFAOYSA-N","BRD-K97464279","","COc1ccc(Cc2cnc(N)nc2N)cc1OC"
"1522","DIAZOOXONORLEUCINE","glutamate receptor antagonist","","","","ChemImpex",0,"BRD-K38458514-001-01-8","Phase 2","","LHGVYNDAWRBWGL-YFKPBYRVSA-O","BRD-K38458514","","N[C@@H](CCC(=O)C=[N+]=N)C(O)=O"
"1523","DIBENZEPINE","norepinephrine reputake inhibitor","","","","Selleck",96.96,"BRD-K79145749-003-02-2","Preclinical","","QPGGEKPRGVJKQB-UHFFFAOYSA-N","BRD-K79145749","","CN(C)CCN1c2ccccc2N(C)c2ccccc2C1=O"
"1524","DIBENZOTHIOPHENE","","","","","MicroSource, Selleck, Selleck",99.86,"BRD-K46863940-001-05-4, BRD-K46863940-001-04-7, BRD-K46863940-001-06-2","Preclinical","","IYYZUPMFVPLQIF-UHFFFAOYSA-N","BRD-K46863940","","c1ccc2c(c1)sc1ccccc21"
"1527","DIBUTYL-PHTHALATE","","TRPA1","","","MicroSource",99.18,"BRD-K73477617-001-08-5","Preclinical","","DOIRQSBPFJWKBE-UHFFFAOYSA-N","BRD-K73477617","","CCCCOC(=O)c1ccccc1C(=O)OCCCC"
"1528","DICHLORISONE-ACETATE","","","","","MicroSource, Selleck, Selleck",91.61,"BRD-K54187111-001-09-2, BRD-K54187111-001-07-6, BRD-K54187111-001-08-4","Phase 2","BRD-A40195998-001-02-7","YNNURTVKPVJVEI-GSLJADNHSA-N","BRD-K54187111","BRD-A40195998","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@]12C"
"1531","DICHLOROACETATE","pyruvate dehydrogenase kinase inhibitor","PDK1","","","Tocris, Sigma",96.5,"BRD-M97302542-001-03-6, BRD-M97302542-001-04-4","Phase 3","","FLWQSOHPGISTPX-UHFFFAOYSA-N","BRD-M97302542","","[Na].OC(=O)C(Cl)Cl"
"1533","DICHLOROPHEN","anticestodal agent","","","","Sigma, MicroSource",92.97,"BRD-K62326629-001-20-8, BRD-K62326629-001-19-0","Launched","","MDNWOSOZYLHTCG-UHFFFAOYSA-N","BRD-K62326629","","Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O"
"1535","DICHLORVOS","acetylcholinesterase inhibitor","","","","MicroSource",0,"BRD-K23779958-001-05-8","Launched","","OEBRKCOSUFCWJD-UHFFFAOYSA-N","BRD-K23779958","","COP(=O)(OC)OC=C(Cl)Cl"
"1536","DICLOFENSINE","dopamine reuptake inhibitor","DRD1, MAOA, MAOB","","","MedChemEx",97.06,"BRD-A51078674-003-01-0","Phase 3","","ZJDCGVDEEHWEIG-UHFFFAOYSA-N","BRD-A51078674","","COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1"
"1537","DICLORALUREA","","","","","MicroSource",0,"BRD-A41657926-001-03-0","Preclinical","","PPJXIHLNYDVTDI-UHFFFAOYSA-N","BRD-A41657926","","OC(NC(=O)NC(O)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl"
"1538","DICYCLOHEXYLAMINE","","","","","Vitas-M",96.38,"BRD-K57091285-001-07-7","Preclinical","","XBPCUCUWBYBCDP-UHFFFAOYSA-N","BRD-K57091285","","C1CCC(CC1)NC1CCCCC1"
"1539","DIDEOXYADENOSINE","nucleoside reverse transcriptase inhibitor","","","","Berry",97.9,"BRD-K84794093-001-07-5","Phase 1","","WVXRAFOPTSTNLL-NKWVEPMBSA-N","BRD-K84794093","","Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](CO)O1"
"1540","DIETHYLSTILBESTROL","estrogen receptor agonist","ESR1, ESR2, ESRRB, ESRRG","","","MicroSource, Selleck",92.99,"BRD-K45330754-001-22-5, BRD-K45330754-001-21-7","Withdrawn","","RGLYKWWBQGJZGM-ISLYRVAYSA-N","BRD-K45330754","","CC\C(c1ccc(O)cc1)=C(\CC)c1ccc(O)cc1"
"1542","DIFENPIRAMIDE","cyclooxygenase inhibitor, prostaglandin inhibitor","","","","Enamine",85.55,"BRD-K96206066-001-07-9","Launched","","PWHROYKAGRUWDQ-UHFFFAOYSA-N","BRD-K96206066","","O=C(Cc1ccc(cc1)-c1ccccc1)Nc1ccccn1"
"1543","DIGITOXIGENIN","ATPase inhibitor","ATP1A1","","","Prestwick",93.94,"BRD-K18518344-001-15-9","Preclinical","","XZTUSOXSLKTKJQ-CESUGQOBSA-N","BRD-K18518344","","C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1"
"1544","DIGITOXIN","ATPase inhibitor","ATP1A1","","","MicroSource",97.65,"BRD-A93236127-001-04-5","Launched","","WDJUZGPOPHTGOT-KSVSUYAUSA-N","BRD-A93236127","","C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C"
"1545","DIGOXIGENIN","steroid","","","","Selleck",97.81,"BRD-K18619710-001-14-4","Preclinical","","SHIBSTMRCDJXLN-KCZCNTNESA-N","BRD-K18619710","","C[C@@]12[C@H](CC[C@]1(O)[C@@H]1CC[C@@H]3C[C@@H](O)CC[C@]3(C)[C@H]1C[C@H]2O)C1=CC(=O)OC1"
"1546","DIHOMO-GAMMA-LINOLENIC-ACID","prostanoid receptor agonist","PTGS1, PTGS2","","","Sigma, Sigma, Enzo",81.2,"BRD-K20152659-001-10-3, BRD-K20152659-001-07-9, BRD-K20152659-001-04-6","Phase 2","","HOBAELRKJCKHQD-QNEBEIHSSA-N","BRD-K20152659","","CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O"
"1549","DIHYDREXIDINE","dopamine receptor agonist","DRD1, DRD2, DRD3, DRD4, DRD5","","","Tocris",67.11,"BRD-K31471398-003-01-5","Phase 2","","BGOQGUHWXBGXJW-RHSMWYFYSA-N","BRD-K31471398","","Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O"
"1550","DIHYDROERGOCRISTINE","adrenergic receptor antagonist, prolactin inhibitor","ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7","","","Tocris, Tocris",96.31,"BRD-K97440753-066-19-9, BRD-K97440753-066-18-1","Launched","","DEQITUUQPICUMR-HJPBWRTMSA-N","BRD-K97440753","","CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O"
"1552","DIHYDROMYRICETIN","","","","","MedChemEx, MedChemEx, Selleck, Selleck",80.78,"BRD-K01614093-001-05-9, BRD-K01614093-001-04-2, BRD-K01614093-001-02-6, BRD-K01614093-001-03-4","Preclinical","","KJXSIXMJHKAJOD-LSDHHAIUSA-N","BRD-K01614093","","O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1cc(O)c(O)c(O)c1"
"1556","DIHYDROSTREPTOMYCIN","bacterial 30S ribosomal subunit inhibitor","","","","MicroSource",96.53,"BRD-A67363467-001-01-3","Withdrawn","","ASXBYYWOLISCLQ-DAOCWCMRSA-N","BRD-A67363467","","CN[C@H]1C(O)C(O)C(CO)OC1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)OC(C)[C@]1(O)CO"
"1557","DIHYDROXYPHENYLGLYCINE","glutamate receptor agonist","GRM1, GRM5","","","Tocris",0,"BRD-A20589515-001-02-9","Preclinical","","HOOWCUZPEFNHDT-UHFFFAOYSA-N","BRD-A20589515","","NC(C(O)=O)c1cc(O)cc(O)c1"
"1558","DIIODOTHYROPROPIONIC-ACID","thyroid hormone stimulant","","","","Sigma",3.17,"BRD-K36802417-001-01-7","Phase 2","","WONYMNWUJVKVII-UHFFFAOYSA-N","BRD-K36802417","","OC(=O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1"
"1559","DILAZEP","adenosine reuptake inhibitor","SLC29A1","","","MicroSource, Tocris",92.84,"BRD-K48722258-300-11-0, BRD-K48722258-300-10-2","Launched","","QVZCXCJXTMIDME-UHFFFAOYSA-N","BRD-K48722258","","COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1"
"1561","DIMAPRIT","histamine receptor agonist","HRH2, HRH3, HRH4","","","Selleck, Tocris",100,"BRD-K23541596-300-07-2, BRD-K23541596-300-08-0","Preclinical","","OLHQOJYVQUNWPL-UHFFFAOYSA-N","BRD-K23541596","","CN(C)CCCSC(N)=N"
"1563","DIMESNA","tubulin polymerization inhibitor","","","","MicroSource, Selleck",100,"BRD-K30126819-304-03-5, BRD-K30126819-304-02-7","Phase 3","","BYUKOOOZTSTOOH-UHFFFAOYSA-N","BRD-K30126819","","OS(=O)(=O)CCSSCCS(O)(=O)=O"
"1565","DIMETHADIONE","oxazolidine antiepileptic","","","","MicroSource",0,"BRD-K43687498-001-09-8","Preclinical","","JYJFNDQBESEHJQ-UHFFFAOYSA-N","BRD-K43687498","","CC1(C)OC(=O)NC1=O"
"1566","DIMETHINDENE-(S)-(+)","acetylcholine receptor antagonist","HRH1","","","Tocris, Tocris",90.39,"BRD-K83192048-050-03-5, BRD-K83192048-050-02-7","Preclinical","","MVMQESMQSYOVGV-OAHLLOKOSA-N","BRD-K83192048","","C[C@@H](C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1"
"1568","DIMETHYL-ISOSORBIDE","cosmetic moisturizer","","","","AMS",0,"BRD-A17224697-001-01-0","Preclinical","","MEJYDZQQVZJMPP-UHFFFAOYSA-N","BRD-A17224697","","COC1COC2C(COC12)OC"
"1569","DIMETRIDAZOLE","bacterial DNA inhibitor","","","","MicroSource",96.89,"BRD-K72728560-001-01-4","Launched","BRD-U80626937-000-01-6","IBXPYPUJPLLOIN-UHFFFAOYSA-N","BRD-K72728560","BRD-U80626937","Cc1ncc(n1C)[N+]([O-])=O"
"1570","DIMINAZENE-ACETURATE","angiotensin converting enzyme activator","AOC1, PRDX5, PRSS1","","","MicroSource, Selleck, Selleck",87.59,"BRD-K92848252-001-01-9, BRD-K92848252-001-02-7, BRD-K92848252-001-03-5","Phase 3","BRD-M65846159-001-02-6, BRD-M65846159-001-01-8, BRD-M65846159-001-03-4","XNYZHCFCZNMTFY-UHFFFAOYSA-N","BRD-K92848252","BRD-M65846159","NC(=N)c1ccc(N\N=N\c2ccc(cc2)C(N)=N)cc1"
"1573","DIMPYLATE","acetylcholinesterase inhibitor","ACHE","","","MicroSource",89.72,"BRD-K60567437-001-10-2","Launched","","FHIVAFMUCKRCQO-UHFFFAOYSA-N","BRD-K60567437","","CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C"
"1574","DINACICLIB","CDK inhibitor","CDK1, CDK2, CDK5, CDK9","","","Selleck",96.78,"BRD-K13662825-001-07-5","Phase 3","","PIMQWRZWLQKKBJ-SFHVURJKSA-N","BRD-K13662825","","CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO"
"1575","DINOPROSTONE","prostanoid receptor agonist","CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, TBXA2R","","","Tocris, Cayman",98.3,"BRD-K26521938-001-07-2, BRD-K26521938-001-09-8","Withdrawn","","XEYBRNLFEZDVAW-ARSRFYASSA-N","BRD-K26521938","","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O"
"1577","DIOSCIN","apoptosis stimulant","CXCR3","","","Selleck",100,"BRD-K37723606-001-01-5","Preclinical","","VNONINPVFQTJOC-OXSREHLTSA-N","BRD-K37723606","","C[C@@H]1[C@@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](CC[C@]5(C)[C@@H]4CC[C@]23C)O[C@@H]2O[C@@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1"
"1578","DIOSGENIN","steroid","","","","Selleck",95.08,"BRD-K28690501-001-02-1","Preclinical","BRD-K15864401-001-01-0","WQLVFSAGQJTQCK-VKROHFNGSA-N","BRD-K28690501","BRD-K15864401","C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@@H](C)CO1"
"1579","DIOXYBENZONE","topical sunscreen agent","","","","MicroSource",96.11,"BRD-K22193694-001-13-6","Preclinical","","MEZZCSHVIGVWFI-UHFFFAOYSA-N","BRD-K22193694","","COc1ccc(C(=O)c2ccccc2O)c(O)c1"
"1580","DIPEPTAMIN","","","","","ChemImpex, ChemImpex",0,"BRD-K11595419-001-02-2, BRD-K11595419-001-01-4","Launched","","HJCMDXDYPOUFDY-WHFBIAKZSA-N","BRD-K11595419","","C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O"
"1582","DIPERODON","local anesthetic","","","","Selleck, MicroSource",98.2,"BRD-A30693873-003-11-0, BRD-A30693873-003-12-8","Preclinical","","YUGZHQHSNYIFLG-UHFFFAOYSA-N","BRD-A30693873","","O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1"
"1584","DIPHENCYPRONE","immunostimulant","","","","Vitas-M, Sigma",98.43,"BRD-K51730347-001-05-6, BRD-K51730347-001-06-4","Phase 2","","HCIBTBXNLVOFER-UHFFFAOYSA-N","BRD-K51730347","","O=c1c(c1-c1ccccc1)-c1ccccc1"
"1586","DIPHENYLENEIODONIUM","nitric oxide synthase inhibitor","NOS2, NOS3","","","Tocris",100,"BRD-K65814004-003-02-9","Preclinical","","QFXKXRXFBRLLPQ-UHFFFAOYSA-N","BRD-K65814004","","[I+]1c2ccccc2-c2ccccc12"
"1587","DIPHENYLGUANIDINE","","","","","Vitas-M",85.15,"BRD-K12362304-001-07-3","Preclinical","","OWRCNXZUPFZXOS-UHFFFAOYSA-N","BRD-K12362304","","N=C(Nc1ccccc1)Nc1ccccc1"
"1588","DIPRAGLURANT","glutamate receptor negative allosteric modulator","GRM5","","","MedChemEx",94.48,"BRD-K64838454-001-01-0","Phase 2","","LZXMUJCJAWVHPZ-UHFFFAOYSA-N","BRD-K64838454","","Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1"
"1589","DIPT","dopamine reuptake inhibitor, serotonin reuptake inhibitor","HTR1A, HTR2A, HTR2C","","","Cayman",88.49,"BRD-K75385383-001-01-5","Launched","","ZRVAAGAZUWXRIP-UHFFFAOYSA-N","BRD-K75385383","","CC(C)N(CCc1c[nH]c2ccccc12)C(C)C"
"1590","DIROXIMEL-FUMARATE","anti-inflammatory agent","","","","WuXi",97.29,"BRD-K87386013-001-01-7","Phase 3","","YIMYDTCOUQIDMT-SNAWJCMRSA-N","BRD-K87386013","","COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O"
"1591","DISODIUM SEBACATE","","HBA1, HBB","","","Sigma",68.1,"BRD-K66672047-304-01-3","Phase 1","","CXMXRPHRNRROMY-UHFFFAOYSA-N","BRD-K66672047","","OC(=O)CCCCCCCCC(O)=O"
"1592","DITIOCARB-SODIUM-TRIHYDRATE","immunostimulant","CA1, CA2, CA4","","","Enamine, Enamine",0,"BRD-K40654626-236-02-3, BRD-K40654626-236-01-5","Phase 3","","LMBWSYZSUOEYSN-UHFFFAOYSA-N","BRD-K40654626","","CCN(CC)C(S)=S"
"1594","DITOLYLGUANIDINE","sigma receptor agonist","GRIN1, GRIN2A, GRIN2B, SIGMAR1","","","Tocris",89.42,"BRD-K33459542-001-07-4","Preclinical","","OPNUROKCUBTKLF-UHFFFAOYSA-N","BRD-K33459542","","Cc1ccccc1NC(=N)Nc1ccccc1C"
"1595","DIXANTHOGEN","","","","","MicroSource",0,"BRD-K05919151-001-01-6","Preclinical","","FVIGODVHAVLZOO-UHFFFAOYSA-N","BRD-K05919151","","CCOC(=S)SSC(=S)OCC"
"1596","DIZOCILPINE-(+)","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, Tocris, Selleck",98.82,"BRD-K58930050-050-16-6, BRD-K58930050-050-15-8, BRD-K58930050-001-05-2","Preclinical","","LBOJYSIDWZQNJS-CVEARBPZSA-N","BRD-K58930050","","C[C@]12N[C@H](Cc3ccccc13)c1ccccc21"
"1599","DIZOCILPINE-(-)","glutamate receptor antagonist","","","","Tocris, Selleck",99.01,"BRD-K23163214-050-15-1, BRD-K23163214-051-01-9","Phase 1","","LBOJYSIDWZQNJS-JKSUJKDBSA-N","BRD-K23163214","","C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21"
"1601","DMAB-ANABASEINE","adrenergic receptor agonist","CHRNA7","","","Tocris, Tocris",90.18,"BRD-K26573499-300-02-1, BRD-K26573499-300-03-9","Preclinical","","KHUUTHZSRXABAC-DTQAZKPQSA-N","BRD-K26573499","","CN(C)c1ccc(cc1)\C=C1CCCN=C/1c1cccnc1"
"1603","DMEOB","","GRM5","","","Tocris",98.09,"BRD-K36775483-001-01-4","Preclinical","BRD-K77961099-001-01-6","FBNPHFBYHYNMHC-JYFOCSDGSA-N","BRD-K36775483","BRD-K77961099","COc1cccc(c1)\C=N\N=C\c1cccc(OC)c1"
"1604","DMH1","ALK tyrosine kinase receptor inhibitor","ACVR1","","","Selleck, Tocris",98.8,"BRD-K39381259-001-01-0, BRD-K39381259-001-02-8","Preclinical","","JMIFGARJSWXZSH-UHFFFAOYSA-N","BRD-K39381259","","CC(C)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12"
"1606","DMH4","VEGFR inhibitor","KDR","","","Tocris",96.96,"BRD-K40575944-001-01-5","Preclinical","","SKZQZGSPYYHTQG-UHFFFAOYSA-N","BRD-K40575944","","C(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1"
"1607","DMNB","DNA dependent protein kinase inhibitor","","","","Tocris",94.25,"BRD-K03564313-001-03-3","Preclinical","","YWSPWKXREVSQCA-UHFFFAOYSA-N","BRD-K03564313","","COc1cc(C=O)c(cc1OC)[N+]([O-])=O"
"1608","DMP-543","acetylcholine release enhancer","","","","Tocris, Tocris",98.35,"BRD-K89274813-001-02-3, BRD-K89274813-001-03-1","Phase 2","","MUJBUUDUXGDXLW-UHFFFAOYSA-N","BRD-K89274813","","Fc1cc(CC2(Cc3ccnc(F)c3)c3ccccc3C(=O)c3ccccc23)ccn1"
"1610","DMP-777","elastase inhibitor","MPO","","","MedChemEx",85.68,"BRD-K54936858-001-01-6","Phase 2","","ZSDCIRYNTCVTMF-GIGWZHCTSA-N","BRD-K54936858","","CCC[C@@H](NC(=O)N1[C@@H](Oc2ccc(cc2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)c1ccc2OCOc2c1"
"1611","DMPS","chelating agent","","","","Vitas-M",0,"BRD-A22971209-001-01-0","Phase 1","","JLVSRWOIZZXQAD-UHFFFAOYSA-N","BRD-A22971209","","OS(=O)(=O)CC(S)CS"
"1612","DMSO","control vehicle","","","","Sigma",0,"BRD-M56212252-001-01-0","Preclinical","BRD-K08970894-001-03-4","CETRZFQIITUQQL-UHFFFAOYSA-N","BRD-M56212252","BRD-K08970894","CS(C)=O.CS(C)=O"
"1613","DNQX","glutamate receptor antagonist","GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B","","","Tocris, Tocris, Tocris",95.86,"BRD-K64400208-001-09-1, BRD-K64400208-304-01-6, BRD-K64400208-001-08-3","Preclinical","","RWVIMCIPOAXUDG-UHFFFAOYSA-N","BRD-K64400208","","[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+]([O-])=O"
"1616","DOCEBENONE","lipoxygenase inhibitor","ALOX5","","","Enzo",62.9,"BRD-K08290224-001-14-5","Phase 2","","WDEABJKSGGRCQA-UHFFFAOYSA-N","BRD-K08290224","","CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O"
"1617","DOCONEXENT","PPAR receptor agonist","FFAR1, PTGS1, PTGS2","","","Sigma, MicroSource",56.12,"BRD-K39965020-001-12-5, BRD-K39965020-001-09-1","Launched","","MBMBGCFOFBJSGT-KUBAVDMBSA-N","BRD-K39965020","","CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O"
"1619","DOCONEXENT-ETHYL-ESTER","omega 3 fatty acid stimulant","","","","Cayman",0,"BRD-K61937613-001-01-1","Launched","","ITNKVODZACVXDS-YNUSHXQLSA-N","BRD-K61937613","","CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC"
"1620","DODECYL-SULFATE","","LYZ","","","Sigma",0,"BRD-K05680146-001-01-2","Preclinical","","MOTZDAYCYVMXPC-UHFFFAOYSA-N","BRD-K05680146","","CCCCCCCCCCCCOS(O)(=O)=O"
"1621","DOFEQUIDAR","MRP inhibitor, P glycoprotein inhibitor","ABCB1","","","MedChemEx",98.23,"BRD-A14941520-051-01-0","Phase 3","","KLWUUPVJTLHYIM-UHFFFAOYSA-N","BRD-A14941520","","OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1"
"1622","DOFETILIDE","potassium channel blocker","KCNH1, KCNH2, KCNJ12, KCNK2","","","Tocris, Selleck, Selleck",93.46,"BRD-K86887724-001-12-2, BRD-K86887724-001-10-6, BRD-K86887724-001-09-8","Withdrawn","","IXTMWRCNAAVVAI-UHFFFAOYSA-N","BRD-K86887724","","CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1"
"1625","DOLASTATIN-10","tubulin polymerization inhibitor","TUBB","","","MedChemEx",94.05,"BRD-K78567475-001-01-4","Phase 2","","OFDNQWIFNXBECV-VFSYNPLYSA-N","BRD-K78567475","","CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C"
"1626","DOMIPHEN","","","","","Selleck",93.67,"BRD-K30431096-004-01-3","Preclinical","","YXUPZGKORWTXID-UHFFFAOYSA-N","BRD-K30431096","","CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1"
"1627","DONITRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6","","","Tocris",92.52,"BRD-K31092604-003-03-5","Phase 2","","SOHCKWZVTCTQBG-UHFFFAOYSA-N","BRD-K31092604","","NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12"
"1628","DORAMAPIMOD","p38 MAPK inhibitor","MAPK11, MAPK12, MAPK13, MAPK14","","","Selleck, Selleck",93.78,"BRD-K74065929-001-08-0, BRD-K74065929-001-07-2","Phase 2","","MVCOAUNKQVWQHZ-UHFFFAOYSA-N","BRD-K74065929","","Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C"
"1630","DORSOMORPHIN","AMPK inhibitor","ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC","","","Tocris",91.96,"BRD-K54233340-300-05-1","Preclinical","","XHBVYDAKJHETMP-UHFFFAOYSA-N","BRD-K54233340","","C(CN1CCCCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccncc1"
"1631","DOVITINIB","EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB","","","Selleck, Selleck, Selleck, Selleck, Selleck, Selleck",96.83,"BRD-K85402309-001-07-4, BRD-K85402309-389-03-2, BRD-K85402309-001-06-6, BRD-K85402309-389-04-0, BRD-K85402309-043-01-9, BRD-K85402309-406-01-8","Phase 3","","PIQCTGMSNWUMAF-UHFFFAOYSA-N","BRD-K85402309","","CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O"
"1637","DPC-681","HIV protease inhibitor","","","","MedChemEx",97.55,"BRD-K37087535-001-01-1","Phase 1","","PNIFFZXGBAYVMQ-RKKDRKJOSA-N","BRD-K37087535","","CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1"
"1638","DPCPX","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",99.02,"BRD-K01824921-001-18-5","Phase 1","","FFBDFADSZUINTG-UHFFFAOYSA-N","BRD-K01824921","","CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCCC1"
"1639","DPI-201106","sodium channel activator","ADRB2","","","Enzo",94.82,"BRD-A64553394-001-04-4","Phase 2","","BYBYHCOEAFHGJL-UHFFFAOYSA-N","BRD-A64553394","","OC(COc1cccc2[nH]c(cc12)C#N)CN1CCN(CC1)C(c1ccccc1)c1ccccc1"
"1640","DPO-1","potassium channel blocker","KCNA5","","","Tocris",98.66,"BRD-K99922388-001-02-0","Preclinical","","BPCNGVCAHAIZEE-COPCDDAFSA-N","BRD-K99922388","","CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1P(=O)(c1ccccc1)c1ccccc1"
"1641","DPPE","histamine receptor antagonist","ABCB1, HRH1","","","Tocris",92.86,"BRD-K80315159-051-02-0","Phase 3","","NFIXBCVWIPOYCD-UHFFFAOYSA-N","BRD-K80315159","","CCN(CC)CCOc1ccc(Cc2ccccc2)cc1"
"1642","DQP-1105","glutamate receptor antagonist","GRIN2C, GRIN2D","","","Tocris",93.59,"BRD-A67976398-001-01-6","Preclinical","","MVYNQMRZRULRIE-UHFFFAOYSA-N","BRD-A67976398","","Cc1ccc2[nH]c(=O)c(C3=NN(C(C3)c3ccc(Br)cc3)C(=O)CCC(O)=O)c(-c3ccccc3)c2c1"
"1643","DR-2313","PARP inhibitor","PARP1, PARP3","","","Tocris",64.58,"BRD-K94920105-001-03-9","Preclinical","","HRYKZAKEAVZGJD-UHFFFAOYSA-N","BRD-K94920105","","Cc1nc(=O)c2CSCCc2[nH]1"
"1644","DR-4485","serotonin receptor antagonist","HTR7","","","Tocris",98.04,"BRD-A39794701-003-01-6","Preclinical","","SBTRHJHOLCAPFT-UHFFFAOYSA-N","BRD-A39794701","","Clc1ccc(cc1)C1=CCN(CCCCC23CCCc4c2c(NC3=O)ccc4Cl)CC1"
"1645","DRF053-(R)","CDK inhibitor","CSNK1A1","","","Tocris, Tocris",94.78,"BRD-K25486274-300-01-0, BRD-K25486274-300-02-8","Preclinical","","LWANFAFTTOKZAX-QGZVFWFLSA-N","BRD-K25486274","","CC[C@H](CO)Nc1nc(Nc2cccc(c2)-c2ccccn2)c2ncn(C(C)C)c2n1"
"1647","DROLOXIFENE","selective estrogen receptor modulator (SERM)","ESR1","","","LKT",82.82,"BRD-K38477637-001-01-0","Phase 3","","ZQZFYGIXNQKOAV-OCEACIFDSA-N","BRD-K38477637","","CC\C(=C(\c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1"
"1648","DROXINOSTAT","HDAC inhibitor","HDAC6, HDAC8","","","Selleck",90.2,"BRD-K11558771-001-13-9","Preclinical","","JHSXDAWGLCZYSM-UHFFFAOYSA-N","BRD-K11558771","","Cc1cc(Cl)ccc1OCCCC(=O)NO"
"1649","DSR-6434","toll-like receptor agonist","TLR7","","","Tocris",90.78,"BRD-K46384285-001-01-3","Preclinical","","SSZHESNDOMBSRV-UHFFFAOYSA-N","BRD-K46384285","","CCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(OCCN(C)C)nc3)c2n1"
"1650","DS2-(806622)","","","","","Tocris, Tocris",89.78,"BRD-K09619578-001-01-3, BRD-K09619578-001-02-1","Preclinical","","AZKMWHRDICVYEI-UHFFFAOYSA-N","BRD-K09619578","","Clc1ccc(cc1)C(=O)Nc1c(nc2ccccn12)-c1cccs1"
"1652","DU-728","structural glycoprotein antagonist","ITGA2B, ITGB3","","","MedChemEx",100,"BRD-K08859203-001-01-9","Phase 1","","NNRFRJQMBSBXGO-CIUDSAMLSA-N","BRD-K08859203","","N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O"
"1653","DUP-697","cyclooxygenase inhibitor","PTGS2","","","Tocris, Tocris",97.02,"BRD-K06221026-001-07-6, BRD-K06221026-001-06-8","Phase 1","","AJFTZWGGHJXZOB-UHFFFAOYSA-N","BRD-K06221026","","CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1"
"1655","DVD-111","","","","","MedChemEx",99.45,"BRD-K22520627-001-01-7","Phase 2","","PJNSMUBMSNAEEN-AWEZNQCLSA-N","BRD-K22520627","","CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1"
"1656","DYNASORE","dynamin inhibitor","DNM1, DNM1L, DNM2","","","Selleck, Selleck",89.1,"BRD-K87718015-001-01-9, BRD-K87718015-001-02-7","Preclinical","","SYNDQCRDGGCQRZ-VXLYETTFSA-N","BRD-K87718015","","Oc1ccc(\C=N\NC(=O)c2cc3ccccc3cc2O)cc1O"
"1658","DYNOLE-34-2","dynamin inhibitor","DNM1","","","Tocris",45.25,"BRD-K23479488-001-01-3","Preclinical","","MYIMRONQBLZJFI-DYTRJAOYSA-N","BRD-K23479488","","CCCCCCCCNC(=O)C(=C\c1cn(CCCN(C)C)c2ccccc12)\C#N"
"1659","DY131","estrogen-related receptor agonist","ESRRB, ESRRG","","","Tocris, Tocris",88.82,"BRD-K58343622-001-01-6, BRD-K58343622-001-02-4","Preclinical","","WLKOCYWYAWBGKY-CPNJWEJPSA-N","BRD-K58343622","","CCN(CC)c1ccc(cc1)\C=N\NC(=O)c1ccc(O)cc1"
"1661","D609","phospholipase inhibitor","","","","MedChemEx, MedChemEx, Tocris, Enzo",86.67,"BRD-A77118605-237-09-5, BRD-A77118605-237-08-7, BRD-A77118605-237-06-1, BRD-A77118605-237-07-9","Preclinical","","PWLXJBSAUKKGCM-UHFFFAOYSA-N","BRD-A77118605","","SC(=S)OC1CC2CC1C1CCCC21"
"1665","E-2012","gamma secretase modulator","APH1A, APH1B, PSENEN","","","MedChemEx, Sigma",90.8,"BRD-K50564936-001-01-6, BRD-K69144501-001-01-1","Phase 1","","PUOAETJYKQITMO-LANLRWRYSA-N","BRD-K50564936","","COc1cc(ccc1-n1cnc(C)c1)\C=C1/CCCN([C@@H](C)c2ccc(F)cc2)C1=O"
"1666","E-2012","gamma secretase modulator","APH1A, APH1B, PSENEN","","","MedChemEx, Sigma",90.8,"BRD-K50564936-001-01-6, BRD-K69144501-001-01-1","Phase 1","","PUOAETJYKQITMO-LANLRWRYSA-N","BRD-K50564936","","CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC"
"1667","E-2012","gamma secretase modulator","APH1A, APH1B, PSENEN","","","MedChemEx, Sigma",90.8,"BRD-K50564936-001-01-6, BRD-K69144501-001-01-1","Phase 1","","QWDCYFDDFPWISL-JEBPEJKESA-N","BRD-K50564936","","COc1cc(ccc1-n1cnc(C)c1)\C=C1/CCCN([C@@H](C)c2ccc(F)cc2)C1=O"
"1668","E-2012","gamma secretase modulator","APH1A, APH1B, PSENEN","","","MedChemEx, Sigma",90.8,"BRD-K50564936-001-01-6, BRD-K69144501-001-01-1","Phase 1","","QWDCYFDDFPWISL-JEBPEJKESA-N","BRD-K50564936","","CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC"
"1669","E-4031","potassium channel blocker","KCNH1, KCNH2","","","Tocris, Tocris",96.27,"BRD-K41713976-300-03-4, BRD-K41713976-300-02-6","Phase 1","","SRUISGSHWFJION-UHFFFAOYSA-N","BRD-K41713976","","Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1"
"1671","E-64","cysteine protease inhibitor, calpain inhibitor","CTSS","","","Selleck, Selleck",88.95,"BRD-K06273313-001-07-9, BRD-K06273313-001-08-7","Preclinical","BRD-A08545410-311-02-6,BRD-M28128163-312-02-0","LTLYEAJONXGNFG-HBNTYKKESA-N","BRD-K06273313","BRD-A08545410","CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCN=C(N)N"
"1673","EACT","calcium-activated chloride channel inhibitor","ANO1","","","Tocris",96.51,"BRD-K53030960-001-01-4","Preclinical","","ZUXNHFFVQWADJL-UHFFFAOYSA-N","BRD-K53030960","","COCCN(C(=O)c1cc(OC)c(OC)c(OC)c1)c1nc(cs1)-c1ccccc1"
"1674","EB-47","PARP inhibitor","PARP1","","","Tocris",95.65,"BRD-K66998413-300-01-6","Preclinical","","DDFLFKTXUWPNMV-LFALDJFMSA-N","BRD-K66998413","","Nc1ncnc2n(cnc12)[C@H]1O[C@H]([C@H](O)[C@@H]1O)C(=O)N1CCN(CC(=O)Nc2cccc3C(=O)NCc23)CC1"
"1675","EBPC","aldose reductase inhibitor","AKR1B1","","","Tocris",91.11,"BRD-A96485169-001-14-3","Preclinical","","FQMSSTZJKSWSMP-UHFFFAOYSA-N","BRD-A96485169","","CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1=O"
"1676","EBROTIDINE","histamine receptor antagonist","HRH2","","","MedChemEx, MedChemEx, MedChemEx",83.9,"BRD-K22421059-001-03-1, BRD-K22421059-001-01-5, BRD-K22421059-001-02-3","Withdrawn","","ZQHFZHPUZXNPMF-UHFFFAOYSA-N","BRD-K22421059","","NC(=N)Nc1nc(CSCCN\C=N\S(=O)(=O)c2ccc(Br)cc2)cs1"
"1679","EBSELEN","cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor","ALB","","","MicroSource",90.35,"BRD-K29359156-001-30-1","Phase 2/Phase 3","","DYEFUKCXAQOFHX-UHFFFAOYSA-N","BRD-K29359156","","O=c1n([se]c2ccccc12)-c1ccccc1"
"1680","EC-144","HSP inhibitor","HSP90AA1, HSP90AB1","","","Tocris",96.8,"BRD-K41705163-001-01-1","Preclinical","","VOASEWXFCTZRDF-UHFFFAOYSA-N","BRD-K41705163","","COc1c(C)cnc(Cn2cc(C#CCC(C)(C)O)c3c(Cl)nc(N)nc23)c1C"
"1681","EC-23","retinoid receptor agonist","RARA, RARB, RARG","","","Sigma, Tocris",98.05,"BRD-K81004638-001-01-7, BRD-K81004638-001-02-5","Preclinical","","OQVLOWLEEHYBJH-UHFFFAOYSA-N","BRD-K81004638","","CC1(C)CCC(C)(C)c2cc(ccc12)C#Cc1ccc(cc1)C(O)=O"
"1683","ECABAPIDE","","","","","Enamine",87.95,"BRD-K47371940-001-01-6","Phase 3","","JTAGHJPZEDNHHA-UHFFFAOYSA-N","BRD-K47371940","","CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1"
"1684","ECHINOMYCIN","DNA intercalating agent","","","","EMDBio",78.32,"BRD-A68969091-001-12-7","Phase 2","BRD-M14664499-001-01-6","AUJXLBOHYWTPFV-UHFFFAOYSA-N","BRD-A68969091","BRD-M14664499","CSC1SCC2N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C(=O)C1N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1"
"1685","ECTOINE-ZWITTERION","","","","","Sigma",98.7,"BRD-K60902958-001-01-9","Preclinical","","FPZMPGPGYQUWQS-YFKPBYRVSA-N","BRD-K60902958","","OC(=O)[C@@H]1CCNC(=C)N1"
"1686","EDAGLITAZONE","PPAR receptor agonist","PPARG","","","Tocris",99.08,"BRD-A25182582-001-01-8","Phase 2","","HAAXAFNSRADSMK-UHFFFAOYSA-N","BRD-A25182582","","Cc1oc(nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12)-c1ccccc1"
"1687","EDELFOSINE","phospholipase inhibitor","","","","Cayman, Enzo",100,"BRD-A30403214-001-04-1, BRD-A30403214-001-03-3","Phase 2","","MHFRGQHAERHWKZ-HHHXNRCGSA-O","BRD-A30403214","","CCCCCCCCCCCCCCCCCCOC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC"
"1689","EDITOL","","","","","MicroSource",91.55,"BRD-A78588743-001-03-4","Preclinical","","NSOXQYCFHDMMGV-UHFFFAOYSA-N","BRD-A78588743","","CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O"
"1690","EDTMP","chelating agent","","","","Vitas-M",0,"BRD-K54542929-001-01-7","Preclinical","","NFDRPXJGHKJRLJ-UHFFFAOYSA-N","BRD-K54542929","","OP(O)(=O)CN(CCN(CP(O)(O)=O)CP(O)(O)=O)CP(O)(O)=O"
"1691","EED226","polycomb protein inhibitor","EED","","","MedChemEx",96.75,"BRD-K19002914-001-01-3","Preclinical","","DYIRSNMPIZZNBK-UHFFFAOYSA-N","BRD-K19002914","","CS(=O)(=O)c1ccc(cc1)-c1cnc(NCc2ccco2)n2cnnc12"
"1692","EFAPROXIRAL","haemoglobin oxygen release stimulant","HBA1, HBB","","","Selleck",97.94,"BRD-K37355418-236-01-6","Phase 3","","BNFRJXLZYUTIII-UHFFFAOYSA-N","BRD-K37355418","","Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(O)=O)cc2)c1"
"1693","EFAROXAN","adrenergic receptor antagonist","ADORA2A","","","Tocris, MicroSource",98.28,"BRD-A10739734-003-09-8, BRD-A10739734-003-10-6","Phase 2","","RATZLMXRALDSJW-UHFFFAOYSA-N","BRD-A10739734","","CCC1(Cc2ccccc2O1)C1=NCCN1"
"1695","EFATUTAZONE","PPAR receptor agonist","PPARG","","","MedChemEx",95.58,"BRD-A24560335-300-01-2","Phase 2","","JCYNMRJCUYVDBC-UHFFFAOYSA-N","BRD-A24560335","","Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N"
"1696","EFLOXATE","vasodilator","","","","MicroSource",97.67,"BRD-K55166090-001-09-0","Preclinical","","ZVXBAHLOGZCFTP-UHFFFAOYSA-N","BRD-K55166090","","CCOC(=O)COc1ccc2c(c1)oc(cc2=O)-c1ccccc1"
"1697","EFONIDIPINE-MONOETHANOLATE","L-type calcium channel blocker, T-type calcium channel blocker","CACNA1C, CACNA1G","","","Tocris, Tocris, Tocris",95.91,"BRD-M92675308-003-06-3, BRD-M92675308-003-07-1, BRD-M92675308-003-05-5","Launched","BRD-A39845846-003-01-2,BRD-M92675308-003-03-0","DUUFLTUTPZFOAH-UHFFFAOYSA-N","BRD-M92675308","BRD-A39845846","CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1"
"1700","EGF816","EGFR inhibitor","EGFR","","","MedChemEx, MedChemEx",92.84,"BRD-K22514639-001-05-7, BRD-K22514639-001-04-0","Phase 2","","IOMMMLWIABWRKL-WUTDNEBXSA-N","BRD-K22514639","","CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)n1c(NC(=O)c2ccnc(C)c2)nc2cccc(Cl)c12"
"1702","EGLUMETAD","glutamate receptor agonist","GRM2, GRM3, GRM6, GRM8","","","MedChemEx, EMDBio",100,"BRD-K65359424-001-02-1, BRD-K65359424-001-01-3","Phase 2","","VTAARTQTOOYTES-RGDLXGNYSA-N","BRD-K65359424","","N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O"
"1704","EG00229","neuropilin receptor antagonist","NRP1","","","MedChemEx, Tocris",96.86,"BRD-K50653584-019-01-4, BRD-K50653584-001-01-2","Preclinical","","ZWWMEDURALZMEV-NSHDSACASA-N","BRD-K50653584","","NC(=N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(O)=O"
"1706","EHOP-016","Ras GTPase inhibitor","RAC1, RAC3","","","Selleck",93.91,"BRD-K32289541-001-01-0","Preclinical","","AFTZZRFCMOAFCR-UHFFFAOYSA-N","BRD-K32289541","","CCn1c2ccccc2c2cc(Nc3ccnc(NCCCN4CCOCC4)n3)ccc12"
"1707","EIPA","transient receptor potential polycystic inhibitor, sodium/hydrogen exchanger inhibitor","ADRA2A, ASIC1, PKD2L1","","","Tocris",65.7,"BRD-K88120876-001-09-8","Preclinical","","QDERNBXNXJCIQK-UHFFFAOYSA-N","BRD-K88120876","","CCN(C(C)C)c1nc(N)c(nc1Cl)C(=O)N=C(N)N"
"1708","EIT-HYDROBROMIDE","nitric oxide synthase inhibitor","NOS2, NOS3","","","Tocris",90.43,"BRD-K81623406-004-08-3","Preclinical","","VFIZBHJTOHUOEK-UHFFFAOYSA-N","BRD-K81623406","","CCSC(N)=N"
"1709","EI1","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx",93.04,"BRD-K91535048-001-01-2","Preclinical","","PFHDWRIVDDIFRP-UHFFFAOYSA-N","BRD-K91535048","","CCC(CC)n1ccc2c(cc(cc12)C#N)C(=O)NCc1c(C)cc(C)[nH]c1=O"
"1710","ELACRIDAR","P glycoprotein inhibitor","ABCB1","","","MedChemEx, MedChemEx, Selleck",94.19,"BRD-K88807631-001-03-9, BRD-K88807631-001-01-3, BRD-K88807631-001-02-1","Phase 1","","OSFCMRGOZNQUSW-UHFFFAOYSA-N","BRD-K88807631","","COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC"
"1713","ELACTOCIN","exportin antagonist","XPO1","","","EMDBio",0,"BRD-K63876426-001-01-6","Phase 1","","YACHGFWEQXFSBS-ZNDZZNGASA-N","BRD-K63876426","","CCC(\C=C\[C@H]1OC(=O)C=C[C@@H]1C)=C\[C@H](C)C\C=C\C(C)=C\[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C\C(C)=C\C(O)=O"
"1714","ELAFIBRANOR","PPAR receptor agonist","PPARA, PPARD","","","MedChemEx",92.97,"BRD-K03165895-001-01-9","Phase 3","","AFLFKFHDSCQHOL-IZZDOVSWSA-N","BRD-K03165895","","CSc1ccc(cc1)C(=O)\C=C\c1cc(C)c(OC(C)(C)C(O)=O)c(C)c1"
"1715","ELAGOLIX","gonadotropin releasing factor hormone receptor antagonist","GNRHR","","","MedChemEx",81.73,"BRD-K55808645-001-01-4","Phase 3","","HEAUOKZIVMZVQL-VWLOTQADSA-N","BRD-K55808645","","COc1cccc(c1F)-c1c(C)n(Cc2c(F)cccc2C(F)(F)F)c(=O)n(C[C@H](NCCCC(O)=O)c2ccccc2)c1=O"
"1716","ELEMENE","VEGFR inhibitor","","","","Enamine",0,"BRD-K79565391-001-01-8","Phase 2","","OPFTUNCRGUEPRZ-RBSFLKMASA-N","BRD-K79565391","","CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C1)C(C)=C"
"1717","ELESCLOMOL","oxidative stress inducer","HSPA1A","","","Selleck",90.7,"BRD-K82135108-001-04-3","Phase 3","","BKJIXTWSNXCKJH-UHFFFAOYSA-N","BRD-K82135108","","CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1"
"1718","ELINOGREL","purinergic receptor antagonist","P2RY12","","","Tocris, Tocris",13.9,"BRD-K59271229-001-02-3, BRD-K59271229-001-01-5","Phase 2","","LGSDFTPAICUONK-UHFFFAOYSA-N","BRD-K59271229","","CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F"
"1720","ELIPRODIL","glutamate receptor antagonist","GRIN1, GRIN2B","","","Tocris",87.72,"BRD-A61392169-001-02-7","Phase 3","","GGUSQTSTQSHJAH-UHFFFAOYSA-N","BRD-A61392169","","OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1"
"1721","ELLAGIC-ACID","glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor","CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK","","","Selleck, MicroSource, Selleck",98.25,"BRD-K30466858-001-10-4, BRD-K30466858-001-09-6, BRD-K30466858-001-08-8","Phase 2","","AFSDNFLWKVMVRB-UHFFFAOYSA-N","BRD-K30466858","","Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O"
"1724","ELN-441958","bradykinin receptor antagonist","BDKRB1","","","MedChemEx",97.7,"BRD-K50699835-001-01-2","Preclinical","","ARYQHSWJGHCGJS-UHFFFAOYSA-N","BRD-K50699835","","Clc1cccc2CN(C(=O)c12)c1cccc(c1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1"
"1725","ELTANOLONE","membrane integrity inhibitor","GABRA1, GABRB2, GABRG2","","","Enzo",100,"BRD-K18172896-001-02-5","Phase 3","","AURFZBICLPNKBZ-SYBPFIFISA-N","BRD-K18172896","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"1726","ELTOPRAZINE","serotonin receptor agonist","HTR1A, HTR1B","","","MedChemEx, MedChemEx, MedChemEx",97.53,"BRD-K86171477-001-01-3, BRD-K86171477-001-03-9, BRD-K86171477-001-02-1","Phase 2","","WVLHGCRWEHCIOT-UHFFFAOYSA-N","BRD-K86171477","","C1CN(CCN1)c1cccc2OCCOc12"
"1729","EMBELIN","HCV inhibitor, XIAP inhibitor","XIAP","","","Tocris, Selleck, Selleck",94.95,"BRD-K86727142-001-12-4, BRD-K86727142-001-11-6, BRD-K86727142-001-13-2","Preclinical","","FNQDSLSOLMXCMU-UHFFFAOYSA-N","BRD-K86727142","","CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O"
"1732","EMD-1214063","hepatocyte growth factor receptor inhibitor","MET","","","MedChemEx",95.6,"BRD-K97963946-001-01-3","Phase 1","","AHYMHWXQRWRBKT-UHFFFAOYSA-N","BRD-K97963946","","CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1"
"1733","EMD-386088","serotonin receptor agonist","HTR6","","","Tocris, Tocris",90.04,"BRD-K47659338-003-02-8, BRD-K47659338-003-03-6","Preclinical","","BPPGPYJBCVXILI-UHFFFAOYSA-N","BRD-K47659338","","Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1"
"1735","EMD-53998","phosphodiesterase inhibitor","TNNC1","","","EMDBio",97.01,"BRD-A65248799-001-01-7","Phase 1","","IZLRMTJLQCLMKF-UHFFFAOYSA-N","BRD-A65248799","","COc1ccc(cc1OC)C(=O)N1CCCc2cc(ccc12)C1=NNC(=O)SC1C"
"1736","EMD-66684","angiotensin receptor antagonist","AGTR1","","","Tocris, Tocris",99.17,"BRD-K88759641-003-03-6, BRD-K88759641-003-02-8","Preclinical","","CQVJTTOZTTVVBK-UHFFFAOYSA-N","BRD-K88759641","","CCCCc1nc2ccn(CC(=O)N(C)C)c(=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"1738","EMETINE","protein synthesis inhibitor","RPS2","","","MicroSource, Selleck",98.73,"BRD-A25687296-300-04-3, BRD-K03067624-001-02-3","Phase 2","","AUVVAXYIELKVAI-VXNUJMKFSA-N","BRD-A25687296","","CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc12"
"1739","EMETINE","protein synthesis inhibitor","RPS2","","","MicroSource, Selleck",98.73,"BRD-A25687296-300-04-3, BRD-K03067624-001-02-3","Phase 2","","AUVVAXYIELKVAI-VXNUJMKFSA-N","BRD-A25687296","","CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12"
"1740","EMETINE","protein synthesis inhibitor","RPS2","","","MicroSource, Selleck",98.73,"BRD-A25687296-300-04-3, BRD-K03067624-001-02-3","Phase 2","","AUVVAXYIELKVAI-CKBKHPSWSA-N","BRD-A25687296","","CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc12"
"1741","EMETINE","protein synthesis inhibitor","RPS2","","","MicroSource, Selleck",98.73,"BRD-A25687296-300-04-3, BRD-K03067624-001-02-3","Phase 2","","AUVVAXYIELKVAI-CKBKHPSWSA-N","BRD-A25687296","","CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12"
"1742","EMODIN","11-beta hydroxysteroid dehydrogenase inhibitor","CSNK2A1","","","Selleck",92.43,"BRD-K58685305-001-20-4","Preclinical","","RHMXXJGYXNZAPX-UHFFFAOYSA-N","BRD-K58685305","","Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1"
"1743","EMOXIPIN","","","","","Vitas-M",95.96,"BRD-K28982731-001-01-6","Phase 2","","JPGDYIGSCHWQCC-UHFFFAOYSA-N","BRD-K28982731","","CCc1nc(C)ccc1O"
"1744","ENCIPRAZINE","GABA receptor modulator","GABRA1","","","Key",97.6,"BRD-A62197763-001-01-1","Phase 3","","KSQCNASWXSCJTD-UHFFFAOYSA-N","BRD-A62197763","","COc1ccccc1N1CCN(CC(O)COc2cc(OC)c(OC)c(OC)c2)CC1"
"1745","ENDO-IWR-1","PARP inhibitor","TNKS, TNKS2","","","Tocris, Selleck, Tocris",97.96,"BRD-K61314889-001-05-1, BRD-K61314889-001-04-4, BRD-K61314889-001-06-9","Preclinical","BRD-M14816435-001-01-9, BRD-K27544219-001-01-6, BRD-M14816435-001-02-7","ZGSXEXBYLJIOGF-ALFLXDJESA-N","BRD-K61314889","BRD-M14816435","O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O"
"1748","ENDOXIFEN","estrogen receptor antagonist","ESR1","","","MedChemEx, Selleck",52.03,"BRD-K62752296-003-01-3, BRD-K62752296-003-02-1","Phase 2","BRD-K91486246-003-01-4","MHJBZVSGOZTKRH-IZHYLOQSSA-N","BRD-K62752296","BRD-K91486246","CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCNC)cc1"
"1750","ENFLURANE","membrane permeability inhibitor","ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4","","","Apollo",0,"BRD-A51831848-001-01-7","Launched","","JPGQOUSTVILISH-UHFFFAOYSA-N","BRD-A51831848","","FC(F)OC(F)(F)C(F)Cl"
"1751","ENILURACIL","dihydropyrimidine dehydrogenase inhibitor","AOX1, DPYD, XDH","","","Sigma",0,"BRD-K26425819-001-01-3","Phase 3","","JOZGNYDSEBIJDH-UHFFFAOYSA-N","BRD-K26425819","","Oc1ncc(C#C)c(O)n1"
"1752","ENISAMIUM-IODIDE","","","","","Vitas-M",96.66,"BRD-K10029415-005-06-9","Launched","","QOEJDHLJOKRPJG-UHFFFAOYSA-O","BRD-K10029415","","C[n+]1ccc(cc1)C(=O)NCc1ccccc1"
"1753","ENMD-2076","Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC","","","Selleck",96.02,"BRD-K68488863-001-04-9","Phase 2","","BLQYVHBZHAISJM-CMDGGOBGSA-N","BRD-K68488863","","CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(\C=C\c2ccccc2)n1"
"1754","ENOCITABINE","DNA synthesis inhibitor","CMPK1, RRM1, TYMS","","","AKSci, Carbosynth",97.2,"BRD-K32007074-001-02-9, BRD-K32007074-001-01-1","Launched","BRD-A77582494-001-01-3","SAMRUMKYXPVKPA-VFKOLLTISA-N","BRD-K32007074","BRD-A77582494","CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1"
"1756","ENPROFYLLINE","phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B","","","Enzo",98.71,"BRD-K35007173-001-07-5","Phase 3","","SIQPXVQCUCHWDI-UHFFFAOYSA-N","BRD-K35007173","","CCCn1c2nc[nH]c2c(=O)[nH]c1=O"
"1757","ENTINOSTAT","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC9","","","Selleck, Selleck",88.78,"BRD-K77908580-001-10-4, BRD-K77908580-001-09-6","Phase 3","","INVTYAOGFAGBOE-UHFFFAOYSA-N","BRD-K77908580","","Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1"
"1759","ENTRECTINIB","ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1","","","Selleck",87.23,"BRD-K39009484-001-01-4","Phase 2","","HAYYBYPASCDWEQ-UHFFFAOYSA-N","BRD-K39009484","","CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1"
"1760","ENZASTAURIN","PKC inhibitor","AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG","","","Selleck",96.13,"BRD-K79404599-001-09-3","Phase 3","","AXRCEOKUDYDWLF-UHFFFAOYSA-N","BRD-K79404599","","Cn1cc(C2=C(C(=O)NC2=O)c2cn(C3CCN(Cc4ccccn4)CC3)c3ccccc23)c2ccccc12"
"1761","EN460","endoplasmic reticulum oxidation inhibitor","ERO1A","","","MedChemEx, MedChemEx",49.85,"BRD-K86063171-001-03-7, BRD-K86063171-001-02-9","Preclinical","","RSLFQCNAOMQAIH-WJDWOHSUSA-N","BRD-K86063171","","OC(=O)c1cc(ccc1Cl)N1N=C(\C(=C\c2ccc(o2)-c2ccccc2)C1=O)C(F)(F)F"
"1763","EO-1428","p38 MAPK inhibitor","MAPK11, MAPK14","","","Tocris, Tocris",94.29,"BRD-K42452249-001-02-5, BRD-K42452249-001-03-3","Preclinical","","HDCLCHNAEZNGNV-UHFFFAOYSA-N","BRD-K42452249","","Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl"
"1765","EPACADOSTAT","indoleamine 2,3-dioxygenase inhibitor","IDO1","","","MedChemEx, Selleck",97.41,"BRD-K79450420-001-03-4, BRD-K79450420-001-02-6","Phase 3","BRD-A15458132-001-01-9, BRD-K67385813-001-01-5","FBKMWOJEPMPVTQ-UHFFFAOYSA-N","BRD-K79450420","BRD-A15458132","NS(=O)(=O)NCCNc1nonc1\C(Nc1ccc(F)c(Br)c1)=N\O"
"1767","EPEREZOLID","bacterial 30S ribosomal subunit inhibitor","","","","MedChemEx",91.48,"BRD-K47554101-001-01-2","Phase 1","","SIMWTRCFFSTNMG-AWEZNQCLSA-N","BRD-K47554101","","CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCN(CC2)C(=O)CO)c(F)c1"
"1768","EPIANDROSTERONE","steroid","G6PD","","","Selleck",100,"BRD-K42756753-001-01-9","Preclinical","","QGXBDMJGAMFCBF-DBQFFBIKSA-N","BRD-K42756753","","C[C@]12CC[C@@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O"
"1769","EPICATECHIN-GALLATE-(-)","bacterial DNA gyrase inhibitor","BACE1, FASN","","","AnalytiCon, MedChemEx",96.2,"BRD-K50660797-001-04-4, BRD-K50660797-001-05-1","Phase 2","","LSHVYAFMTMFKBA-TZIWHRDSSA-N","BRD-K50660797","","Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1ccc(O)c(O)c1"
"1771","EPIGALLOCATECHIN-GALLATE-(-)","bacterial DNA gyrase inhibitor","ELANE, EP300, FASN, KAT2B, MMP14, MMP2","","","MedChemEx, MedChemEx, Selleck, Selleck",81.58,"BRD-K55591206-001-20-7, BRD-K55591206-001-22-3, BRD-K55591206-001-19-9, BRD-K55591206-001-18-1","Phase 2/Phase 3","","WMBWREPUVVBILR-WIYYLYMNSA-N","BRD-K55591206","","Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1cc(O)c(O)c(O)c1"
"1775","EPITIOSTANOL","androgen receptor agonist","AR","","","Prestwick",90.16,"BRD-K02314383-001-01-3","Launched","","OBMLHUPNRURLOK-XGRAFVIBSA-N","BRD-K02314383","","C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O"
"1776","EPOMEDIOL","cholesterol inhibitor","CYP7A1","","","TimTec",0,"BRD-A59329714-001-01-5","Launched","","JSNQSLSBBZFGBM-UHFFFAOYSA-N","BRD-A59329714","","CC1(C)OC2(C)C(O)CC1CC2O"
"1777","EPOTHILONE-A","microtubule stabilizing agent","","","","Selleck",97.44,"BRD-K71823332-001-03-7","Preclinical","BRD-K87031376-001-01-0","HESCAJZNRMSMJG-KKQRBIROSA-N","BRD-K71823332","BRD-K87031376","C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1"
"1778","EPOTHILONE-B","microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","","","Selleck",96.96,"BRD-K68164687-001-01-6","Phase 3","","QXRSDHAAWVKZLJ-AXCXJGFASA-N","BRD-K68164687","","C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1"
"1779","EPOTHILONE-D","microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","","","MedChemEx",97.71,"BRD-K52762805-001-01-2","Phase 2","","XOZIUKBZLSUILX-GIQCAXHBSA-N","BRD-K52762805","","C[C@H]1CCC\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1"
"1780","EPPTB","trace amine associated receptor antagonist","TAAR1","","","Tocris",95.64,"BRD-K42536037-001-01-3","Preclinical","","KLFVWQCQUXXLOU-UHFFFAOYSA-N","BRD-K42536037","","CCOc1cccc(NC(=O)c2ccc(N3CCCC3)c(c2)C(F)(F)F)c1"
"1781","EPRODISATE","antiamyloidogenic agent, amyloid protein inhibitor","SAA1","","","MicroSource, MedChemEx, Sigma",95.43,"BRD-K11463116-304-01-9, BRD-K11463116-304-03-5, BRD-K11463116-304-02-7","Phase 3","","MGNVWUDMMXZUDI-UHFFFAOYSA-N","BRD-K11463116","","OS(=O)(=O)CCCS(O)(=O)=O"
"1784","EPZ-5676","histone lysine methyltransferase inhibitor","DOT1L","","","Selleck, Selleck",95.25,"BRD-K26531771-001-01-4, BRD-K26531771-001-02-2","Phase 1","BRD-K63457253-001-01-3","LXFOLMYKSYSZQS-LURJZOHASA-N","BRD-K26531771","BRD-K63457253","CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1"
"1786","EPZ004777","histone lysine methyltransferase inhibitor","DOT1L","","","Selleck, Selleck, Selleck",94.61,"BRD-K69070623-003-01-7, BRD-K69070623-001-01-1, BRD-K69070623-001-02-9","Preclinical","","WXRGFPHDRFQODR-ICLZECGLSA-N","BRD-K69070623","","CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(N)ncnc12"
"1789","EPZ005687","histone lysine methyltransferase inhibitor","EZH2","","","Selleck",95.53,"BRD-K57754230-001-02-7","Preclinical","","ZOIBZSZLMJDVDQ-UHFFFAOYSA-N","BRD-K57754230","","Cc1cc(C)c(CNC(=O)c2cc(cc3n(ncc23)C2CCCC2)-c2ccc(CN3CCOCC3)cc2)c(=O)[nH]1"
"1790","EPZ011989","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx",95.82,"BRD-K87468701-001-01-0","Preclinical","","XQFINGFCBFHOPE-WXUXXXNLSA-N","BRD-K87468701","","CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C#CCN1CCOCC1"
"1791","EPZ015666","protein arginine N-methyltransferase inhibitor","PRMT5","","","MedChemEx",95.64,"BRD-K70446295-001-01-7","Preclinical","","ZKXZLIFRWWKZRY-KRWDZBQOSA-N","BRD-K70446295","","O[C@@H](CNC(=O)c1cc(NC2COC2)ncn1)CN1CCc2ccccc2C1"
"1792","EPZ020411","protein arginine N-methyltransferase inhibitor","PRMT6","","","MedChemEx, MedChemEx",90.26,"BRD-K33586289-003-02-8, BRD-K33586289-003-01-0","Preclinical","","QMDKVNSQXPVCRD-RQNOJGIXSA-N","BRD-K33586289","","CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@@H](C2)OCCC2CCOCC2)cc1"
"1794","EQUILIN","estrogen receptor agonist","HSD17B1","","","MicroSource",86.71,"BRD-A88080608-001-04-2","Preclinical","","WKRLQDKEXYKHJB-UHFFFAOYSA-N","BRD-A88080608","","CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O"
"1795","EQUOL","estrogen receptor agonist","ESR1, ESR2","","","Selleck, Selleck",94.51,"BRD-K54847683-001-04-0, BRD-K54847683-001-03-2","Launched","","ADFCQWZHKCXPAJ-GFCCVEGCSA-N","BRD-K54847683","","Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1"
"1797","ER-27319","mediator release inhibitor, SYK inhibitor","SYK","","","Tocris, Tocris, Tocris",95.64,"BRD-K11927976-050-04-5, BRD-K11927976-050-02-9, BRD-K11927976-050-03-7","Preclinical","","CFPDEQBPNROZDC-UHFFFAOYSA-N","BRD-K11927976","","Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O"
"1800","ER-50891","retinoid receptor antagonist","RARA","","","Tocris",66.53,"BRD-K18347943-001-01-8","Preclinical","","LSGNKLDHMQVTEK-UHFFFAOYSA-N","BRD-K18347943","","CC(C)c1cccc2c(cc(nc12)-c1ccc([nH]1)-c1ccc(cc1)C(O)=O)-c1ccccc1"
"1801","ERASTIN","ion channel antagonist","VDAC2","","","Selleck, Selleck",98.74,"BRD-A25004090-001-08-4, BRD-A25004090-001-09-2","Preclinical","","BKQFRNYHFIQEKN-UHFFFAOYSA-N","BRD-A25004090","","CCOc1ccccc1-n1c(=O)c2ccccc2nc1C(C)N1CCN(CC1)C(=O)COc1ccc(Cl)cc1"
"1803","ERBSTATIN-ANALOG","EGFR inhibitor, tyrosine kinase inhibitor","EGFR","","","Tocris",63.51,"BRD-K35573744-001-06-8","Preclinical","","BQCNSTFWSKOWMA-GORDUTHDSA-N","BRD-K35573744","","COC(=O)\C=C\c1cc(O)ccc1O"
"1804","ERCALCITRIOL","vitamin D receptor agonist","VDR","","","MedChemEx, MedChemEx",92.34,"BRD-K84163249-001-03-5, BRD-K84163249-001-01-9","Phase 1","","ZGLHBRQAEXKACO-XJRQOBMKSA-N","BRD-K84163249","","C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"1806","ERDAFITINIB","FGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4","","","MedChemEx",95.96,"BRD-K84868168-001-01-0","Phase 2","","OLAHOMJCDNXHFI-UHFFFAOYSA-N","BRD-K84868168","","COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1"
"1807","ERGOSTEROL","vitamin D precursor","","","","Selleck, Selleck",0,"BRD-K03039262-001-03-7, BRD-K03039262-001-04-5","Preclinical","BRD-K09161066-001-01-5","DNVPQKQSNYMLRS-APGDWVJJSA-N","BRD-K03039262","BRD-K09161066","CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"1809","ERK5-IN-1","MAP kinase inhibitor","MAPK7","","","MedChemEx",85.1,"BRD-K64857848-001-06-4","Preclinical","","DDTPGANIPBKTNU-UHFFFAOYSA-N","BRD-K64857848","","COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1"
"1810","ERTEBEREL","estrogen receptor agonist","ESR1, ESR2","","","Selleck",97.54,"BRD-K80608265-001-01-6","Phase 2","","XIESSJVMWNJCGZ-VKJFTORMSA-N","BRD-K80608265","","Oc1ccc(cc1)[C@@H]1Oc2ccc(O)cc2[C@@H]2CCC[C@H]12"
"1811","ERYTHRITOL","","","","","Selleck, Selleck",92.41,"BRD-K79315489-001-07-8, BRD-K79315489-001-08-6","Launched","","UNXHWFMMPAWVPI-ZXZARUISSA-N","BRD-K79315489","","OC[C@H](O)[C@H](O)CO"
"1813","ERYTHROSINE","coloring agent","","","","MicroSource",92.82,"BRD-K14920963-304-02-7","Preclinical","","LAINPTZBIXYTIZ-UHFFFAOYSA-N","BRD-K14920963","","OC(=O)c1ccccc1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12"
"1814","ESAPRAZOLE","","","","","Enamine, Enamine",89.47,"BRD-K92426617-001-05-5, BRD-K92426617-001-06-3","Phase 2","","RTFADALJKSFJDZ-UHFFFAOYSA-N","BRD-K92426617","","O=C(CN1CCNCC1)NC1CCCCC1"
"1816","ESCULIN","antioxidant","","","","Selleck",90.89,"BRD-K36270037-001-01-7","Phase 1","","XHCADAYNFIFUHF-JSFFLRCESA-N","BRD-K36270037","","OC[C@H]1O[C@@H](Oc2cc3ccc(=O)oc3cc2O)[C@@H](O)[C@@H](O)[C@@H]1O"
"1817","ESEROLINE-(-)","acetylcholinesterase inhibitor","OPRD1, OPRM1","","","Prestwick",0,"BRD-K13629382-051-06-6","Preclinical","BRD-K76359782-051-03-7","HKGWQUVGHPDEBZ-OLZOCXBDSA-N","BRD-K13629382","BRD-K76359782","CN1CC[C@]2(C)[C@H]1N(C)c1ccc(O)cc21"
"1818","ESI-09","EPAC inhibitor","RAPGEF3, RAPGEF4","","","MedChemEx, Tocris",96.93,"BRD-K77139516-001-01-4, BRD-K77139516-001-02-2","Preclinical","","DXEATJQGQHDURZ-DEDYPNTBSA-N","BRD-K77139516","","CC(C)(C)c1cc(no1)C(=O)C(\C#N)=N\Nc1cccc(Cl)c1"
"1820","ESTETROL","selective estrogen receptor modulator (SERM)","ESR1","","","Sigma",86.38,"BRD-K75445017-001-01-1","Phase 3","","AJIPIJNNOJSSQC-NYLIRDPKSA-N","BRD-K75445017","","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O"
"1821","ESTRADIOL-BENZOATE","contraceptive agent","ESR1","","","MicroSource",97.72,"BRD-A74765037-001-01-1","Preclinical","","UYIFTLBWAOGQBI-YSHINGEJSA-N","BRD-A74765037","","C[C@]12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C1CC[C@@H]2O"
"1822","ESTRONE","estrogen receptor agonist, estrogenic hormone","ESR1, ESR2","","","Selleck, MicroSource, Selleck",91.87,"BRD-K81839095-001-25-1, BRD-K81839095-001-30-1, BRD-K81839095-001-29-3","Launched","BRD-A37959677-001-04-5, BRD-K15236393-001-01-1","DNXHEGUUPJUMQT-CBZIJGRNSA-N","BRD-K81839095","BRD-A37959677","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O"
"1825","ETAFENONE","calcium channel blocker","","","","Vitas-M",98.74,"BRD-K84971356-001-01-4","Launched","","OEGDFSLNGABBKJ-UHFFFAOYSA-N","BRD-K84971356","","CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1"
"1826","ETANIDAZOLE","bacterial cell wall synthesis inhibitor","","","","Prestwick",97.03,"BRD-K96042922-001-09-8","Phase 3","","WCDWBPCFGJXFJZ-UHFFFAOYSA-N","BRD-K96042922","","OCCNC(=O)Cn1ccnc1[N+]([O-])=O"
"1827","ETAZOLATE","phosphodiesterase inhibitor","GABRB3, PDE4A","","","Tocris",91.67,"BRD-K64755930-003-03-2","Phase 2","","OPQRBXUBWHDHPQ-UHFFFAOYSA-N","BRD-K64755930","","CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C"
"1828","ETC-1002","AMPK inhibitor","ACLY","","","MedChemEx",98.6,"BRD-K63177377-001-01-8","Phase 3","","HYHMLYSLQUKXKP-UHFFFAOYSA-N","BRD-K63177377","","CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O"
"1829","ETC-159","porcupine inhibitor, beta catenin inhibitor","PORCN","","","MedChemEx",97.74,"BRD-K54264768-001-01-2","Phase 1","","QTRXIFVSTWXRJJ-UHFFFAOYSA-N","BRD-K54264768","","Cn1c2ncn(CC(=O)Nc3ccc(nn3)-c3ccccc3)c2c(=O)n(C)c1=O"
"1830","ETEBENECID","uricosuric blocker","","","","MicroSource",98.34,"BRD-K24443618-001-10-2","Preclinical","","UACOQEQOBAQRDQ-UHFFFAOYSA-N","BRD-K24443618","","CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O"
"1831","ETEROBARB","anticonvulsant","","","","Vitas-M",94.62,"BRD-K64834129-001-19-6","Phase 2","","DACOQFZGGLCXMA-UHFFFAOYSA-N","BRD-K64834129","","CCC1(C(=O)N(COC)C(=O)N(COC)C1=O)c1ccccc1"
"1832","ETHACRIDINE-LACTATE-MONOHYDRATE","DNA intercalating agent","","","","Selleck, MicroSource, Selleck",87.55,"BRD-K24715592-406-01-3, BRD-K24715592-043-02-2, BRD-K24715592-406-02-1","Preclinical","","CIKWKGFPFXJVGW-UHFFFAOYSA-N","BRD-K24715592","","CCOc1ccc2nc3cc(N)ccc3c(N)c2c1"
"1835","ETHAMIVAN","respiratory stimulant","","","","Sigma, MicroSource",87.48,"BRD-K38055836-001-22-9, BRD-K38055836-001-21-1","Preclinical","","BQJODPIMMWWMFC-UHFFFAOYSA-N","BRD-K38055836","","CCN(CC)C(=O)c1ccc(O)c(OC)c1"
"1837","ETHIMIZOL","","","","","MedChemEx",99.78,"BRD-K19672466-001-02-3","Phase 1","","RYRFAMRQBZNEPX-UHFFFAOYSA-N","BRD-K19672466","","CCn1cnc(C(=O)NC)c1C(=O)NC"
"1838","ETHISTERONE","progestogen hormone","TYR","","","MicroSource, Selleck, Selleck",97.2,"BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9","Launched","BRD-K00456604-001-01-7","CHNXZKVNWQUJIB-UHFFFAOYSA-N","BRD-A29111201","BRD-K00456604","CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C"
"1839","ETHISTERONE","progestogen hormone","TYR","","","MicroSource, Selleck, Selleck",97.2,"BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9","Launched","BRD-K00456604-001-01-7","CHNXZKVNWQUJIB-UHFFFAOYSA-N","BRD-A29111201","BRD-K00456604","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C"
"1841","ETHISTERONE","progestogen hormone","TYR","","","MicroSource, Selleck, Selleck",97.2,"BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9","Launched","BRD-K00456604-001-01-7","CHNXZKVNWQUJIB-CEGNMAFCSA-N","BRD-A29111201","BRD-K00456604","CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C"
"1842","ETHISTERONE","progestogen hormone","TYR","","","MicroSource, Selleck, Selleck",97.2,"BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9","Launched","BRD-K00456604-001-01-7","CHNXZKVNWQUJIB-CEGNMAFCSA-N","BRD-A29111201","BRD-K00456604","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C"
"1844","ETHOXYQUIN","antioxidant","","","","Prestwick",42.49,"BRD-K56792340-001-13-2","Preclinical","","DECIPOUIJURFOJ-UHFFFAOYSA-N","BRD-K56792340","","CCOc1ccc2NC(C)(C)C=C(C)c2c1"
"1845","ETHYL-PARABEN","","","","","MicroSource",99.39,"BRD-K02464583-001-02-2","Preclinical","","NUVBSKCKDOMJSU-UHFFFAOYSA-N","BRD-K02464583","","CCOC(=O)c1ccc(O)cc1"
"1846","ETHYL-PYRUVATE","tumor necrosis factor production inhibitor","HMGB1, TNF","","","Sigma",0,"BRD-K47738867-001-01-5","Phase 2","","XXRCUYVCPSWGCC-UHFFFAOYSA-N","BRD-K47738867","","CCOC(=O)C(C)=O"
"1847","ETHYL-VANILLIN","","","","","MicroSource",97.9,"BRD-K82104468-001-05-0","Preclinical","","CBOQJANXLMLOSS-UHFFFAOYSA-N","BRD-K82104468","","CCOc1cc(C=O)ccc1O"
"1848","ETHYL-2-(CARBAMOYLOXY)BENZOATE","","","","","Enamine",0,"BRD-K21892374-001-01-6","Phase 1","","JFMIIMPCFQKAAD-UHFFFAOYSA-N","BRD-K21892374","","CCOC(=O)c1ccccc1OC(N)=O"
"1849","ETHYLNOREPINEPHRINE","bronchodilator","","","","MicroSource",95.14,"BRD-A68509429-003-03-9","Preclinical","","LENNRXOJHWNHSD-UHFFFAOYSA-N","BRD-A68509429","","CCC(N)C(O)c1ccc(O)c(O)c1"
"1850","ETICLOPRIDE","dopamine receptor antagonist","DRD2, DRD3, DRD4","","","Tocris",95.14,"BRD-K50417881-003-17-4","Preclinical","","AADCDMQTJNYOSS-LBPRGKRZSA-N","BRD-K50417881","","CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC"
"1851","ETIFENIN","renal function diagnostic agent","","","","Prestwick",46.68,"BRD-K63979671-001-10-1","Preclinical","","WNIDXAKKFOKNEF-UHFFFAOYSA-N","BRD-K63979671","","CCc1cccc(CC)c1NC(=O)CN(CC(O)=O)CC(O)=O"
"1852","ETILEVODOPA","dopamine receptor agonist","DRD3","","","Enamine, Sigma",95.55,"BRD-K90982969-003-01-8, BRD-K90982969-001-01-2","Phase 3","","NULMGOSOSZBEQL-QMMMGPOBSA-N","BRD-K90982969","","CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1"
"1854","ETOFYLLINE-CLOFIBRATE","platelet aggregation inhibitor","PPARA","","","Enamine",99.43,"BRD-K49840922-001-05-1","Launched","","KYAKGJDISSNVPZ-UHFFFAOYSA-N","BRD-K49840922","","Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O"
"1855","ETOMOXIR","carnitine palmitoyltransferase inhibitor","CPT1A","","","MedChemEx",98.66,"BRD-K32405725-001-02-8","Phase 2","","DZLOHEOHWICNIL-QGZVFWFLSA-N","BRD-K32405725","","CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1"
"1856","ETOSALAMIDE","anti-inflammatory agent","","","","MicroSource",95.92,"BRD-K60914966-001-01-4","Preclinical","","XBNRCMFFZFCWMH-UHFFFAOYSA-N","BRD-K60914966","","CCOCCOc1ccccc1C(N)=O"
"1857","ETOXYBAMIDE","","","","","Sigma",69.8,"BRD-K51364817-001-01-4","Phase 2","","MFHPPMMWHSHDSI-UHFFFAOYSA-N","BRD-K51364817","","OCCCC(=O)NCCO"
"1858","ETP-45658","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Tocris",97.88,"BRD-K15858023-001-01-0","Preclinical","","BJVRNXSHJLDZJR-UHFFFAOYSA-N","BRD-K15858023","","Cn1ncc2c(nc(nc12)-c1cccc(O)c1)N1CCOCC1"
"1859","ETP-46464","ATR kinase inhibitor","","","","Selleck",97.1,"BRD-K24556407-001-02-3","Preclinical","","DPLMXAYKJZOTKO-UHFFFAOYSA-N","BRD-K24556407","","CC(C)(C#N)c1ccc(cc1)N1C(=O)OCc2cnc3ccc(cc3c12)-c1cnc2ccccc2c1"
"1860","ETRETINATE","protein synthesis inhibitor","RARA, RARB, RARG, RXRA, RXRB, RXRG","","","MedChemEx, Prestwick, MedChemEx, MedChemEx",87.97,"BRD-K49076555-001-05-6, BRD-K49076555-001-01-5, BRD-K49076555-001-03-1, BRD-K49076555-001-04-9","Withdrawn","","HQMNCQVAMBCHCO-DJRRULDNSA-N","BRD-K49076555","","CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\c1c(C)cc(OC)c(C)c1C"
"1864","EUCATROPINE","acetylcholine receptor antagonist","","","","Prestwick",54.26,"BRD-A37942872-003-20-6","Preclinical","","QSAVEGSLJISCDF-UHFFFAOYSA-N","BRD-A37942872","","CC1CC(CC(C)(C)N1C)OC(=O)C(O)c1ccccc1"
"1865","EUK-134","catalase stimulant","APP, SOD2","","","Selleck, Selleck",0,"BRD-K19741031-001-02-2, BRD-K19741031-001-01-4","Preclinical","BRD-U78472365-000-01-0, BRD-U78671345-000-01-2","QCAWBJDECIOVBU-UHFFFAOYSA-K","BRD-K19741031","BRD-U78472365","COc1cccc2C=[N+]3CC[N+]4=Cc5cccc(OC)c5O[Mn]34(Cl)Oc12"
"1867","EUPATILIN","mucus protecting agent","","","","MedChemEx, Astatech",94.26,"BRD-K47031502-001-02-4, BRD-K47031502-001-01-6","Launched","","DRRWBCNQOKKKOL-UHFFFAOYSA-N","BRD-K47031502","","COc1ccc(cc1OC)-c1cc(=O)c2c(O)c(OC)c(O)cc2o1"
"1869","EVACETRAPIB","cholesteryl ester transfer protein inhibitor","CETP","","","Selleck, Selleck",94.86,"BRD-K16551357-001-02-4, BRD-K16551357-001-03-2","Phase 3","","IHIUGIVXARLYHP-YBXDKENTSA-N","BRD-K16551357","","Cc1cc(C)c2N(C[C@H]3CC[C@@H](CC3)C(O)=O)CCC[C@H](N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)c3nnn(C)n3)c2c1"
"1871","EVANS-BLUE","glutamate receptor negative allosteric modulator","GRIA1, PTPN1","","","MicroSource",92.8,"BRD-K24548560-342-02-1","Launched","","COXVTLYNGOIATD-HVMBLDELSA-N","BRD-K24548560","","Cc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(c(C)c1)\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O"
"1872","EVATANEPAG","prostaglandin inhibitor","PTGER2, PTGER4","","","MedChemEx",95.91,"BRD-K11452913-001-01-9","Phase 2","","WOHRHWDYFNWPNG-UHFFFAOYSA-N","BRD-K11452913","","CC(C)(C)c1ccc(CN(Cc2cccc(OCC(O)=O)c2)S(=O)(=O)c2cccnc2)cc1"
"1873","EVODIAMINE","ATPase inhibitor, TRPV agonist","TRPV1","","","Selleck, Selleck",98.92,"BRD-A68631409-001-05-4, BRD-A68631409-001-06-2","Preclinical","","TXDUTHBFYKGSAH-UHFFFAOYSA-N","BRD-A68631409","","CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12"
"1875","EVP-6124","acetylcholine receptor agonist","CHRNA7","","","MedChemEx",95.74,"BRD-K71603915-003-01-8","Phase 3","","SSRDSYXGYPJKRR-ZDUSSCGKSA-N","BRD-K71603915","","Clc1cccc2cc(sc12)C(=O)N[C@H]1CN2CCC1CC2"
"1876","EVP4593","NFkB pathway inhibitor","","","","Selleck, MedChemEx, Selleck",87.46,"BRD-K68395654-001-03-1, BRD-K68395654-001-06-4, BRD-K68395654-001-05-6","Preclinical","","IBAKVEUZKHOWNG-UHFFFAOYSA-N","BRD-K68395654","","Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1"
"1879","EW-7197","TGF beta receptor inhibitor","ACVR1B, TGFBR1","","","Selleck",89.86,"BRD-K74396648-001-01-4","Phase 1","","FJCDSQATIJKQKA-UHFFFAOYSA-N","BRD-K74396648","","Cc1cccc(n1)-c1[nH]c(CNc2ccccc2F)nc1-c1ccc2ncnn2c1"
"1880","EX-527","SIRT inhibitor","SIRT1","","","Selleck, Selleck",94.26,"BRD-A73908300-001-09-1, BRD-A73908300-001-06-7","Phase 2","","FUZYTVDVLBBXDL-UHFFFAOYSA-N","BRD-A73908300","","NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21"
"1882","EXALAMIDE","membrane permeability inhibitor","","","","MicroSource",98.99,"BRD-K12609457-001-03-1","Launched","","CKSJXOVLXUMMFF-UHFFFAOYSA-N","BRD-K12609457","","CCCCCCOc1ccccc1C(N)=O"
"1883","EXAMORELIN","growth hormone releasing factor agonist","GHRHR, GHSR","","","Sigma",85.7,"BRD-K35304636-001-01-0","Phase 2","","RVWNMGKSNGWLOL-GIIHNPQRSA-N","BRD-K35304636","","C[C@H](NC(=O)[C@@H](Cc1c(C)[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O"
"1884","EXATECAN-MESYLATE","topoisomerase inhibitor","TOP1","","","MedChemEx, MedChemEx",87.61,"BRD-K92150287-066-02-0, BRD-K92150287-066-01-2","Phase 3","","ZVYVPGLRVWUPMP-FYSMJZIKSA-N","BRD-K92150287","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45"
"1886","EXHERIN","cadherin antagonist","CDH2","","","MedChemEx",94.47,"BRD-K81795818-019-01-4","Phase 2","","FQVLRGLGWNWPSS-BXBUPLCLSA-N","BRD-K81795818","","CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O"
"1887","EXIFONE","nootropic agent","TYR","","","Sigma, Enzo",95.11,"BRD-K65716359-001-04-7, BRD-K65716359-001-02-1","Withdrawn","","XEDWWPGWIXPVRQ-UHFFFAOYSA-N","BRD-K65716359","","Oc1ccc(C(=O)c2cc(O)c(O)c(O)c2)c(O)c1O"
"1889","EXISULIND","phosphodiesterase inhibitor","PDE5A","","","LKT",96.77,"BRD-K37708699-001-01-4","Phase 3","","MVGSNCBCUWPVDA-MFOYZWKCSA-N","BRD-K37708699","","CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)(=O)=O"
"1890","EXO-IWR-1","WNT signaling inhibitor negative control","TNKS","","","Tocris",91.1,"BRD-K96155658-001-01-5","Preclinical","","ZGSXEXBYLJIOGF-BTYSMDAFSA-N","BRD-K96155658","","O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@H]3C[C@H](C=C3)[C@H]2C1=O"
"1891","EXO-1","ARF inhibitor","","","","Tocris, Tocris",99.03,"BRD-K78633253-001-11-1, BRD-K78633253-001-10-3","Preclinical","","KIAPWMKFHIKQOZ-UHFFFAOYSA-N","BRD-K78633253","","COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1"
"1893","EZATIOSTAT","glutathione transferase inhibitor","GSTP1","","","MedChemEx, MedChemEx, MedChemEx",88.92,"BRD-K98963219-001-03-8, BRD-K98963219-001-02-0, BRD-K98963219-001-01-2","Phase 2","","GWEJFLVSOGNLSS-WPFOTENUSA-N","BRD-K98963219","","CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1"
"1896","EZUTROMID","utrophin enhancer","UTRN","","","Vitas-M",77.14,"BRD-K25570267-001-01-4","Phase 2","","WRIPKYOZKAJHRL-UHFFFAOYSA-N","BRD-K25570267","","CCN(CC)c1ccc(cc1)-n1nc2cc(C)c(N)cc2n1"
"1897","E7449","PARP inhibitor","PARP1, PARP2, TNKS, TNKS2","","","MedChemEx, MedChemEx, MedChemEx",94.48,"BRD-K05444225-001-03-3, BRD-K05444225-001-02-5, BRD-K05444225-001-01-7","Phase 1/Phase 2","","JLFSBHQQXIAQEC-UHFFFAOYSA-N","BRD-K05444225","","O=c1[nH][nH]c2nc(CN3Cc4ccccc4C3)nc3cccc1c23"
"1900","F-11440","serotonin receptor agonist","HTR1A","","","MedChemEx",92.26,"BRD-K87948281-001-01-9","Phase 2","","NMYAHEULKSYAPP-UHFFFAOYSA-N","BRD-K87948281","","Cn1c(=O)cnn(CCCCN2CCN(CC2)c2ncccn2)c1=O"
"1901","FAGOMINE","glucosidase inhibitor","GLB1","","","MedChemEx",99.3,"BRD-K61536264-001-01-3","Phase 2","","YZNNBIPIQWYLDM-HSUXUTPPSA-N","BRD-K61536264","","OC[C@H]1NCC[C@@H](O)[C@@H]1O"
"1902","FAMPROFAZONE","cyclooxygenase inhibitor","","","","Selleck, MicroSource",95.25,"BRD-A08255417-001-13-9, BRD-A08255417-001-14-7","Preclinical","","GNUXVOXXWGNPIV-UHFFFAOYSA-N","BRD-A08255417","","CC(Cc1ccccc1)N(C)Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C"
"1904","FANANSERIN","dopamine receptor antagonist, serotonin receptor antagonist","HTR2A","","","Tocris, Tocris",93.07,"BRD-K08998509-001-02-4, BRD-K08998509-001-03-2","Phase 2","","VGIGHGMPMUCLIQ-UHFFFAOYSA-N","BRD-K08998509","","Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1"
"1906","FANETIZOLE","neutrophil superoxide production","","","","Enamine",94.26,"BRD-K60798049-001-03-8","Phase 3","","WEEYMMXMBFJUAI-UHFFFAOYSA-N","BRD-K60798049","","C(Cc1ccccc1)Nc1nc(cs1)-c1ccccc1"
"1907","FARNESYL-THIOSALICYLIC-ACID-AMIDE","Ras GTPase inhibitor","HRAS","","","Cayman",96.81,"BRD-K14590126-001-01-6","Phase 1","","GZTMFRUGZMZCRD-CFBAGHHKSA-N","BRD-K14590126","","CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(N)=O"
"1908","FAVIPIRAVIR","RNA polymerase inhibitor","","","","AdvChemBlocks",95.67,"BRD-K04264130-001-01-4","Phase 3","","ZCGNOVWYSGBHAU-UHFFFAOYSA-N","BRD-K04264130","","NC(=O)c1nc(F)cnc1O"
"1909","FCE-22250","DNA directed DNA polymerase inhibitor","","","","Vitas-M",15.69,"BRD-A10991937-001-01-1","Phase 1","","JEGGQYICWGMXOZ-GMPMKFSHSA-N","BRD-A10991937","","COC1\C=C\OC2(C)Oc3c(C2=O)c2c(O)c(\C=N\N=C\N4CCCCC4)c(NC(=O)\C(C)=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c(O)c2c(O)c3C"
"1910","FDCYD","DNA methyltransferase inhibitor","","","","SantaCruz",94.9,"BRD-K18157228-001-01-7","Phase 2","","IDYKCXHJJGMAEV-RRKCRQDMSA-N","BRD-K18157228","","Nc1nc(=O)n(cc1F)[C@H]1C[C@H](O)[C@@H](CO)O1"
"1911","FELBINAC-ETHYL","cyclooxygenase inhibitor","PTGS1, PTGS2","","","AMS",47.98,"BRD-K26404903-001-01-5","Launched","","NPPJLSILDPVHCM-UHFFFAOYSA-N","BRD-K26404903","","CCOC(=O)Cc1ccc(cc1)-c1ccccc1"
"1912","FENACLON","","","","","MicroSource",88.3,"BRD-K08791496-001-01-0","Preclinical","","BITWVVLBVUMFHU-UHFFFAOYSA-N","BRD-K08791496","","ClCCC(=O)NCCc1ccccc1"
"1913","FENBUFEN","cyclooxygenase inhibitor","PTGS1, PTGS2","","","MicroSource",99.5,"BRD-K12513978-001-24-1","Launched","","ZPAKPRAICRBAOD-UHFFFAOYSA-N","BRD-K12513978","","OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1"
"1914","FENCLONINE-(+/-)","tryptophan hydroxylase inhibitor","PAH, TPH1, TPH2","","","MicroSource",89.42,"BRD-A81615860-003-01-7","Preclinical","","NIGWMJHCCYYCSF-UHFFFAOYSA-N","BRD-A81615860","","NC(Cc1ccc(Cl)cc1)C(O)=O"
"1915","FENDILINE","calcium channel blocker","HTR2B","","","MicroSource",97.49,"BRD-A71033472-003-23-9","Preclinical","","NMKSAYKQLCHXDK-UHFFFAOYSA-N","BRD-A71033472","","CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1"
"1916","FENOBAM","glutamate receptor antagonist","GRM5","","","Tocris, Tocris",94.73,"BRD-K41160163-001-06-8, BRD-K41160163-001-07-6","Phase 2","","DWPQODZAOSWNHB-UHFFFAOYSA-N","BRD-K41160163","","CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1"
"1918","FENOTEROL","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","MicroSource",92.58,"BRD-A97104540-004-15-0","Withdrawn","","LSLYOANBFKQKPT-UHFFFAOYSA-N","BRD-A97104540","","CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1"
"1919","FENOXAPROP-P-ETHYL","","NOS2, NOS3","","","MedChemEx",94.27,"BRD-K44777569-001-01-7","Preclinical","","PQKBPHSEKWERTG-LLVKDONJSA-N","BRD-K44777569","","CCOC(=O)[C@@H](C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1"
"1920","FENRETINIDE","apoptosis stimulant, retinoid receptor agonist","RARA","","","MedChemEx, MedChemEx, Adooq, Tocris",82.51,"BRD-K89085489-001-24-0, BRD-K89085489-001-23-2, BRD-K89085489-001-22-4, BRD-K89085489-001-19-0","Phase 3","","AKJHMTWEGVYYSE-FXILSDISSA-N","BRD-K89085489","","CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)Nc1ccc(O)cc1"
"1924","FENTHION","cholinesterase inhibitor","","","","MicroSource",78.04,"BRD-K67217586-001-08-0","Launched","","PNVJTZOFSHSLTO-UHFFFAOYSA-N","BRD-K67217586","","COP(=S)(OC)Oc1ccc(SC)c(C)c1"
"1925","FERB-033","EGFR inhibitor","ERBB2","","","Tocris, Tocris",94.02,"BRD-K61642990-001-01-0, BRD-K61642990-001-02-8","Preclinical","","LRRMQNGSYOUANY-OMCISZLKSA-N","BRD-K61642990","","O\N=C\c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O"
"1927","FERROSTATIN-1","ferroptosis inhibitor","","","","Selleck, Tocris, Selleck",83.4,"BRD-K97375133-001-01-3, BRD-K97375133-001-03-9, BRD-K97375133-001-02-1","Preclinical","","UJHBVMHOBZBWMX-UHFFFAOYSA-N","BRD-K97375133","","CCOC(=O)c1ccc(NC2CCCCC2)c(N)c1"
"1930","FERULIC-ACID","antioxidant","CA1, CA12, CA14, CA2, CA4, CA6, CA9","","","MedChemEx, MedChemEx, Selleck, Selleck",95.29,"BRD-K66295376-236-02-6, BRD-K66295376-236-01-8, BRD-K66295376-001-13-1, BRD-K66295376-001-12-3","Phase 2","","KSEBMYQBYZTDHS-HWKANZROSA-N","BRD-K66295376","","COc1cc(\C=C\C(O)=O)ccc1O"
"1934","FEXARAMINE","FXR agonist","NR1H4","","","Tocris, Tocris",85.86,"BRD-K08864679-001-02-2, BRD-K08864679-001-03-0","Preclinical","","VLQTUNDJHLEFEQ-KGENOOAVSA-N","BRD-K08864679","","COC(=O)\C=C\c1cccc(c1)N(Cc1ccc(cc1)-c1ccc(cc1)N(C)C)C(=O)C1CCCCC1"
"1936","FEXINIDAZOLE","","","","","Ark",99.04,"BRD-K37069697-001-01-3","Phase 2/Phase 3","","MIWWSGDADVMLTG-UHFFFAOYSA-N","BRD-K37069697","","CSc1ccc(OCc2ncc(n2C)[N+]([O-])=O)cc1"
"1937","FG-2216","hypoxia inducible factor prolyl hydroxylase inhibitor","EGLN1, EGLN2, HIF1A","","","MedChemEx",96.03,"BRD-K56807945-001-01-2","Phase 2","","OUQVKRKGTAUJQA-UHFFFAOYSA-N","BRD-K56807945","","OC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O"
"1938","FG-4592","hypoxia inducible factor prolyl hydroxylase inhibitor","EGLN2","","","Selleck, Selleck",93.33,"BRD-K14385366-001-04-4, BRD-K14385366-001-02-8","Phase 3","","YOZBGTLTNGAVFU-UHFFFAOYSA-N","BRD-K14385366","","Cc1nc(C(=O)NCC(O)=O)c(O)c2ccc(Oc3ccccc3)cc12"
"1940","FG-7142","GABA benzodiazepine site receptor inverse agonist","","","","Tocris, Tocris",97.73,"BRD-K61951118-001-08-7, BRD-K61951118-001-07-9","Preclinical","","QMCOPDWHWYSJSA-UHFFFAOYSA-N","BRD-K61951118","","CNC(=O)c1cc2c(cn1)[nH]c1ccccc21"
"1942","FGIN-1-27","inositol monophosphatase inhibitor","TSPO","","","Tocris, Tocris",96.53,"BRD-K09778810-001-11-4, BRD-K09778810-001-10-6","Preclinical","","VUWXAQFLTSBUDB-UHFFFAOYSA-N","BRD-K09778810","","CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1"
"1944","FGIN-1-43","benzodiazepine receptor agonist","TSPO","","","Tocris, Tocris",98.62,"BRD-K66093087-001-04-9, BRD-K66093087-001-03-1","Preclinical","","XTZUPNNVXIMWAR-UHFFFAOYSA-N","BRD-K66093087","","CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccc(Cl)cc12)-c1ccc(Cl)cc1"
"1946","FH-535","PPAR receptor antagonist, WNT signaling inhibitor","PPARD, PPARG","","","Tocris",93.75,"BRD-K48112880-001-02-3","Preclinical","","AXNUEXXEQGQWPA-UHFFFAOYSA-N","BRD-K48112880","","Cc1cc(ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl)[N+]([O-])=O"
"1947","FH1","hepatocyte function enhancer","","","","Selleck, Tocris",97.97,"BRD-K44777625-001-03-5, BRD-K44777625-001-05-0","Preclinical","","OEXMNSOPAKOPEF-UHFFFAOYSA-N","BRD-K44777625","","CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1"
"1949","FIACITABINE","DNA synthesis inhibitor","","","","MedChemEx",99.3,"BRD-K07160047-001-01-3","Phase 2","","GIMSJJHKKXRFGV-BYPJNBLXSA-N","BRD-K07160047","","Nc1nc(=O)n(cc1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F"
"1950","FIDARESTAT","aldose reductase inhibitor","AKR1B1","","","Vitas-M",88.01,"BRD-A63752151-001-01-2","Phase 3","","WAAPEIZFCHNLKK-UHFFFAOYSA-N","BRD-A63752151","","NC(=O)C1CC2(NC(=O)NC2=O)c2cc(F)ccc2O1"
"1951","FILANESIB","kinesin inhibitor, kinesin-like spindle protein inhibitor","KIF11","","","MedChemEx, MedChemEx",85.47,"BRD-K37379014-001-01-2, BRD-K37379014-001-02-0","Phase 3","","LLXISKGBWFTGEI-FQEVSTJZSA-N","BRD-K37379014","","CON(C)C(=O)N1N=C(S[C@@]1(CCCN)c1ccccc1)c1cc(F)ccc1F"
"1953","FILGOTINIB","JAK inhibitor","JAK1, JAK2, JAK3, TYK2","","","MedChemEx",96.83,"BRD-K16803204-001-01-6","Phase 2","","RIJLVEAXPNLDTC-UHFFFAOYSA-N","BRD-K16803204","","O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1"
"1954","FIPEXIDE","psychoactive drug","","","","MicroSource",98.95,"BRD-K37688416-003-13-1","Withdrawn","","BFUJHVVEMMWLHC-UHFFFAOYSA-N","BRD-K37688416","","Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1"
"1955","FIPI","phospholipase inhibitor","PLD1, PLD2","","","Tocris",97.57,"BRD-K61560897-003-01-4","Preclinical","","LHABRXRGDLASIH-UHFFFAOYSA-N","BRD-K61560897","","Fc1ccc2[nH]c(cc2c1)C(=O)NCCN1CCC(CC1)n1c2ccccc2[nH]c1=O"
"1956","FIPRONIL","chloride channel blocker, GABA gated chloride channel blocker","","","","MicroSource",96.39,"BRD-A50675702-001-07-1","Launched","","ZOCSXAVNDGMNBV-UHFFFAOYSA-N","BRD-A50675702","","Nc1c(c(nn1-c1c(Cl)cc(cc1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F"
"1957","FIRATEGRAST","integrin antagonist","ITGA4","","","MedChemEx",99.31,"BRD-K17513304-001-01-9","Phase 2","","YLFZHHDVRSYTKT-NRFANRHFSA-N","BRD-K17513304","","CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(O)=O)cc2)c(OC)c1"
"1958","FISETIN","Aurora kinase inhibitor","CDK6, FASN","","","Selleck, Selleck",84.91,"BRD-K31836715-001-05-0, BRD-K31836715-001-06-8","Preclinical","","XHEFDIBZLJXQHF-UHFFFAOYSA-N","BRD-K31836715","","Oc1ccc2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O"
"1960","FIT","opioid receptor agonist","OPRD1","","","Tocris",8.53,"BRD-K17896185-001-02-0","Preclinical","","VDKBIFPJULZUPU-UHFFFAOYSA-N","BRD-K17896185","","CCC(=O)N(C1CCN(CCc2ccc(cc2)N=C=S)CC1)c1ccccc1"
"1961","FK-33-824","opioid receptor agonist","OPRM1","","","Enzo",81.78,"BRD-A01907367-001-01-7","Phase 2","","HYZHONGSQNXMPH-WFZMTUIASA-N","BRD-A01907367","","C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)CCS(C)=O"
"1962","FK-3311","cyclooxygenase inhibitor","PTGS2","","","MedChemEx",94.36,"BRD-K38350380-001-01-8","Phase 2","","DIIYLGZNZGPXRR-UHFFFAOYSA-N","BRD-K38350380","","CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1"
"1963","FK-866","niacinamide phosphoribosyltransferase inhibitor","NAMPT","","","Enzo",92.65,"BRD-K58550667-001-08-7","Phase 2","","KPBNHDGDUADAGP-VAWYXSNFSA-N","BRD-K58550667","","O=C(NCCCCC1CCN(CC1)C(=O)c1ccccc1)\C=C\c1cccnc1"
"1964","FK-888","tachykinin antagonist","TACR1, TACR2","","","Tocris, Tocris",97.91,"BRD-K83508485-001-02-7, BRD-K83508485-001-03-5","Phase 2","","BFNKQTIJVFGCKQ-PDJGWCFMSA-N","BRD-K83508485","","CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12"
"1966","FK-962","somatostatin receptor agonist","","","","Enamine",98.54,"BRD-K80607346-001-01-1","Phase 2","","VBHVOHJOTMCSBQ-UHFFFAOYSA-N","BRD-K80607346","","CC(=O)N1CCC(CC1)NC(=O)c1ccc(F)cc1"
"1967","FLAVIN-ADENINE-DINUCLEOTIDE","","ACAD8, ACADM, ACADS, ACOX1, AIFM1, CYB5R1, CYB5R3, DAO, DLD, DPYD, ERO1LB, FDXR, GCDH, GFER, GSR, IL4I1, IVD, MAOA, MAOB, NOS1, NQO1, NQO2, POR, TXNRD1, XDH","","","Vitas-M",0,"BRD-A86545589-001-01-5","Preclinical","","VWWQXMAJTJZDQX-UHFFFAOYSA-N","BRD-A86545589","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(CC(O)C(O)C(O)COP(O)(=O)OP(O)(=O)OCC3OC(C(O)C3O)n3cnc4c(N)ncnc34)c2cc1C"
"1968","FLI-06","notch signaling inhibitor","","","","Selleck, Tocris, Selleck",97.33,"BRD-A44500574-001-01-8, BRD-A44500574-001-03-4, BRD-A44500574-001-02-6","Preclinical","","SWWVFYHSSOWZMF-UHFFFAOYSA-N","BRD-A44500574","","CC1=C(C(c2ccc(cc2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1"
"1971","FLINDOKALNER","potassium channel agonist","KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5","","","Tocris, Sigma",98.77,"BRD-K56740996-001-02-1, BRD-K56740996-001-01-3","Phase 3","","ULYONBAOIMCNEH-HNNXBMFYSA-N","BRD-K56740996","","COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(ccc12)C(F)(F)F"
"1973","FLOSEQUINAN","phosphodiesterase inhibitor","","","","Key",99.63,"BRD-A79643124-001-01-9","Withdrawn","","UYGONJYYUKVHDD-UHFFFAOYSA-N","BRD-A79643124","","Cn1cc(S(C)=O)c(=O)c2ccc(F)cc12"
"1974","FLUFENAMIC-ACID","chloride channel blocker","AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5","","","MicroSource, Selleck",99.37,"BRD-K44067360-001-30-3, BRD-K44067360-001-29-5","Preclinical","","LPEPZBJOKDYZAD-UHFFFAOYSA-N","BRD-K44067360","","OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F"
"1976","FLUMATINIB","Bcr-Abl kinase inhibitor","ABL1, PDGFRB","","","MedChemEx",94.43,"BRD-K68870568-066-01-5","Phase 3","","BJCJYEYYYGBROF-UHFFFAOYSA-N","BRD-K68870568","","CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1"
"1977","FLUMECINOL","","","","","Enamine",97.8,"BRD-A44181516-001-01-8","Launched","","DVASNQYQOZHAJN-UHFFFAOYSA-N","BRD-A44181516","","CCC(O)(c1ccccc1)c1cccc(c1)C(F)(F)F"
"1978","FLUMETHASONE-PIVALATE","glucocorticoid receptor agonist","NR3C1, SERPINA6","","","MicroSource",96.12,"BRD-A50064262-001-04-7","Launched","","JWRMHDSINXPDHB-DCPWPRNHSA-N","BRD-A50064262","","C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C"
"1979","FLUMEXADOL","","","","","Enamine, Enamine",29.46,"BRD-A43518428-001-01-9, BRD-A43518428-001-02-7","Preclinical","","GXPYCYWPUGKQIJ-UHFFFAOYSA-N","BRD-A43518428","","FC(F)(F)c1cccc(c1)C1CNCCO1"
"1981","FLUNIXIN-MEGLUMIN","prostanoid receptor antagonist","","","","MicroSource, Selleck",99.53,"BRD-K99984802-100-13-5, BRD-K99984802-100-12-7","Launched","","NOOCSNJCXJYGPE-UHFFFAOYSA-N","BRD-K99984802","","Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F"
"1983","FLUOROMETHYLCHOLINE","","","","","MatrixSci",100,"BRD-K51199656-003-01-4","Launched","","PBVFROWIWWGIFK-UHFFFAOYSA-N","BRD-K51199656","","C[N+](C)(CF)CCO"
"1984","FLUPRAZINE","serotonin receptor agonist","HTR1A, HTR1B","","","Enamine",92.16,"BRD-K44091134-001-01-9","Phase 1","","CHQKHXJPWDSTPY-UHFFFAOYSA-N","BRD-K44091134","","NC(=O)NCCN1CCN(CC1)c1cccc(c1)C(F)(F)F"
"1985","FLURIZAN","gamma secretase inhibitor","APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2","","","Tocris",95.1,"BRD-K75410565-001-02-9","Phase 3","","SYTBZMRGLBWNTM-SNVBAGLBSA-N","BRD-K75410565","","C[C@@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1"
"1986","FLUROFAMIDE","urease inhibitor","","","","Tocris, Tocris, Tocris",73.24,"BRD-K67445247-001-04-7, BRD-K67445247-001-03-9, BRD-K67445247-001-02-1","Preclinical","","QWZFVMCWPLMLTL-UHFFFAOYSA-N","BRD-K67445247","","NP(N)(=O)NC(=O)c1ccc(F)cc1"
"1989","FLUROTHYL","","","","","MicroSource, TCI",0,"BRD-K14763542-001-02-3, BRD-K14763542-001-03-1","Preclinical","","KGPPDNUWZNWPSI-UHFFFAOYSA-N","BRD-K14763542","","FC(F)(F)COCC(F)(F)F"
"1991","FLUROXENE","local anesthetic","","","","MedChemEx, MicroSource",0,"BRD-K56908511-001-02-0, BRD-K56908511-001-01-2","Preclinical","","DLEGDLSLRSOURQ-UHFFFAOYSA-N","BRD-K56908511","","FC(F)(F)COC=C"
"1993","FMOC-L-LEUCINE","PPAR receptor agonist","","","","Sigma",99.78,"BRD-K15327298-001-05-5","Phase 2","","CBPJQFCAFFNICX-IBGZPJMESA-N","BRD-K15327298","","CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O"
"1994","FORETINIB","VEGFR inhibitor","FLT1, FLT4, KDR, MET","","","Selleck",93.68,"BRD-K03449891-001-08-6","Phase 2","","CXQHYVUVSFXTMY-UHFFFAOYSA-N","BRD-K03449891","","COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1"
"1995","FORMONONETIN","alcohol dehydrogenase inhibitor","ADH1C, SLC5A2","","","Selleck",96.93,"BRD-K55567017-001-12-3","Preclinical","","HKQYGTCOTHHOMP-UHFFFAOYSA-N","BRD-K55567017","","COc1ccc(cc1)-c1coc2cc(O)ccc2c1=O"
"1996","FORODESINE","purinergic receptor antagonist","PNP","","","MedChemEx, MedChemEx",100,"BRD-K16505263-003-01-1, BRD-K16505263-003-02-9","Phase 2","","IWKXDMQDITUYRK-KUBHLMPHSA-N","BRD-K16505263","","OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c1c[nH]c2c1[nH]cnc2=O"
"1998","FOROPAFANT","platelet activating factor receptor antagonist","PTAFR","","","Sigma",97.36,"BRD-K57774929-001-01-3","Phase 3","","VVBFISAUNSXQGZ-UHFFFAOYSA-N","BRD-K57774929","","CC(C)c1cc(C(C)C)c(-c2csc(n2)N(CCN(C)C)Cc2cccnc2)c(c1)C(C)C"
"1999","FORSKOLIN","adenylyl cyclase activator","ADCY2, ADCY5, GNAS","","","Tocris, Selleck, Tocris",100,"BRD-K09602097-001-13-6, BRD-K09602097-001-23-5, BRD-K09602097-001-20-1","Launched","BRD-K77830450-001-05-7,BRD-K62498766-001-01-8","OHCQJHSOBUTRHG-KGGHGJDLSA-N","BRD-K09602097","BRD-K77830450","CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C"
"2002","FOSBRETABULIN","tubulin polymerization inhibitor, VE-cadherin antagonist","CDH5","","","MedChemEx, MedChemEx, MedChemEx, MedChemEx",90.79,"BRD-K68399195-304-02-9, BRD-K06814349-304-01-9, BRD-K06814349-304-02-7, BRD-K68399195-304-01-1","Phase 3","","WDOGQTQEKVLZIJ-UHFFFAOYSA-N","BRD-K68399195","","COc1ccc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1OP(O)(O)=O"
"2003","FOSBRETABULIN","tubulin polymerization inhibitor, VE-cadherin antagonist","CDH5","","","MedChemEx, MedChemEx, MedChemEx, MedChemEx",90.79,"BRD-K68399195-304-02-9, BRD-K06814349-304-01-9, BRD-K06814349-304-02-7, BRD-K68399195-304-01-1","Phase 3","","WDOGQTQEKVLZIJ-UHFFFAOYSA-N","BRD-K68399195","","COc1ccc(cc1OP(O)(O)=O)\C=C/c1cc(OC)c(OC)c(OC)c1"
"2006","FOSBRETABULIN","tubulin polymerization inhibitor, VE-cadherin antagonist","CDH5","","","MedChemEx, MedChemEx, MedChemEx, MedChemEx",90.79,"BRD-K68399195-304-02-9, BRD-K06814349-304-01-9, BRD-K06814349-304-02-7, BRD-K68399195-304-01-1","Phase 3","","WDOGQTQEKVLZIJ-WAYWQWQTSA-N","BRD-K68399195","","COc1ccc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1OP(O)(O)=O"
"2007","FOSBRETABULIN","tubulin polymerization inhibitor, VE-cadherin antagonist","CDH5","","","MedChemEx, MedChemEx, MedChemEx, MedChemEx",90.79,"BRD-K68399195-304-02-9, BRD-K06814349-304-01-9, BRD-K06814349-304-02-7, BRD-K68399195-304-01-1","Phase 3","","WDOGQTQEKVLZIJ-WAYWQWQTSA-N","BRD-K68399195","","COc1ccc(cc1OP(O)(O)=O)\C=C/c1cc(OC)c(OC)c(OC)c1"
"2010","FOSFOSAL","phosphodiesterase inhibitor","PTGS1, PTGS2","","","MicroSource, Sigma",84.64,"BRD-K28687144-001-07-9, BRD-K28687144-001-08-7","Launched","","FFKUDWZICMJVPA-UHFFFAOYSA-N","BRD-K28687144","","OC(=O)c1ccccc1OP(O)(O)=O"
"2012","FOSFRUCTOSE","fructose diphosphate stimulant","PKLR","","","SantaCruz",0,"BRD-A19086570-314-01-0","Phase 3","","RNBGYGVWRKECFJ-VRPWFDPXSA-N","BRD-A19086570","","O[C@@H]1[C@@H](COP(O)(O)=O)OC(O)(COP(O)(O)=O)[C@H]1O"
"2013","FOSINOPRILAT","angiotensin converting enzyme inhibitor","ACE","","","AvaChem",61.88,"BRD-A33506612-001-01-2","Launched","","WOIWWYDXDVSWAZ-RTWAWAEBSA-N","BRD-A33506612","","OC(=O)[C@@H]1C[C@H](CN1C(=O)CP(O)(=O)CCCCc1ccccc1)C1CCCCC1"
"2014","FOXY-5","WNT5a peptide mimetic","WNT5A","","","Tocris",99.26,"BRD-K13005598-001-02-3","Phase 1","","WFZPJYYCTSHDJI-ATIWLJMLSA-N","BRD-K13005598","","CSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O"
"2015","FPA-124","AKT inhibitor","","","","Tocris, Tocris",0,"BRD-M17926088-001-02-1, BRD-M17926088-001-01-3","Preclinical","","HZRXQEVFXXQYFS-VBPDOGLUSA-L","BRD-M17926088","","Cl[Cu]Cl.NC(=S)N\N=C\c1coc2ccccc2c1=O"
"2017","FPH1-(BRD-6125)","hepatocyte function enhancer","","","","Selleck",96.07,"BRD-K61250484-001-02-3","Preclinical","","WAOBCCBUTHNTFO-UHFFFAOYSA-N","BRD-K61250484","","Cc1ccc(Cl)cc1N(CC(=O)Nc1c(F)cccc1F)S(C)(=O)=O"
"2018","FPL-12495","glutamate receptor antagonist","","","","Enamine",92.23,"BRD-A09368919-001-01-7","Phase 1","","JINQHBRSXWQJAZ-UHFFFAOYSA-N","BRD-A09368919","","CC(N)(Cc1ccccc1)c1ccccc1"
"2019","FPL-55712","leukotriene receptor antagonist","","","","Tocris",97.14,"BRD-A96456596-001-02-2","Phase 1","","LMQBMWHHGVZWMR-UHFFFAOYSA-N","BRD-A96456596","","CCCc1c(OCC(O)COc2ccc3c(oc(cc3=O)C(O)=O)c2CCC)ccc(C(C)=O)c1O"
"2020","FPL-62064","cyclooxygenase inhibitor, lipoxygenase inhibitor","","","","Astatech",86.14,"BRD-K59875992-001-01-8","Phase 2","","WKLGNFJHVJIZPK-UHFFFAOYSA-N","BRD-K59875992","","COc1ccc(Nc2ccn(n2)-c2ccccc2)cc1"
"2021","FPL-64176","calcium channel activator","CACNA1C, CACNA1S","","","Tocris, Tocris",98.96,"BRD-K78959463-001-15-7, BRD-K78959463-001-13-2","Preclinical","","MDMWHKZANMNXTF-UHFFFAOYSA-N","BRD-K78959463","","COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1"
"2023","FPS-ZM1","RAGE receptor antagonist","AGER","","","MedChemEx",97.01,"BRD-K87691185-001-01-2","Preclinical","","XDFKWGIBQMHSOH-UHFFFAOYSA-N","BRD-K87691185","","Clc1ccc(cc1)C(=O)N(Cc1ccccc1)C1CCCCC1"
"2024","FR-122047","cyclooxygenase inhibitor","","","","Tocris",98.1,"BRD-K30990140-003-02-4","Preclinical","","UBHKJRYGKOSQDJ-UHFFFAOYSA-N","BRD-K30990140","","COc1ccc(cc1)-c1nc(sc1-c1ccc(OC)cc1)C(=O)N1CCN(C)CC1"
"2025","FR-139317","endothelin receptor antagonist","EDNRA","","","Tocris, Tocris",97.59,"BRD-K19318328-001-02-1, BRD-K19318328-001-01-3","Phase 1","","LIOKMIQQPDDTNO-UPRLRBBYSA-N","BRD-K19318328","","CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](Cc1cn(C)c2ccccc12)C(=O)N[C@H](Cc1ccccn1)C(O)=O"
"2027","FR-180204","MAP kinase inhibitor","MAPK1, MAPK3","","","Tocris, Tocris",85.02,"BRD-K68756823-001-07-1, BRD-K68756823-001-10-5","Preclinical","","XVECMUKVOMUNLE-UHFFFAOYSA-N","BRD-K68756823","","Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1"
"2029","FRAX486","serine/threonine kinase inhibitor","PAK1, PAK2, PAK3, PAK4","","","MedChemEx, Tocris",92.66,"BRD-K57243773-001-01-6, BRD-K57243773-001-02-4","Preclinical","","DHKFOIHIUYFSOF-UHFFFAOYSA-N","BRD-K57243773","","CCn1c2nc(Nc3ccc(N4CCNCC4)c(F)c3)ncc2cc(-c2ccc(Cl)cc2Cl)c1=O"
"2031","FRENTIZOLE","immunosuppressant","","","","MedChemEx",87.55,"BRD-K07202345-001-19-4","Phase 1","","JHBWYQRKOUBPCA-UHFFFAOYSA-N","BRD-K07202345","","COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1"
"2032","FRUQUINTINIB","VEGFR inhibitor","KDR","","","MedChemEx",97.88,"BRD-K70504253-001-01-3","Phase 3","","BALLNEJQLSTPIO-UHFFFAOYSA-N","BRD-K70504253","","CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12"
"2033","FTAXILIDE","","","","","MicroSource",66.74,"BRD-K05724540-001-08-5","Preclinical","","LLECMGGNFBKPRH-UHFFFAOYSA-N","BRD-K05724540","","Cc1cccc(C)c1NC(=O)c1ccccc1C(O)=O"
"2034","FURALTADONE","bacterial DNA inhibitor","","","","MicroSource, Selleck, Selleck",99.01,"BRD-A67514145-001-02-9, BRD-A67514145-003-05-8, BRD-A67514145-003-06-6","Launched","","YVQVOQKFMFRVGR-VGOFMYFVSA-N","BRD-A67514145","","[O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1"
"2037","FURAMIDINE","protein arginine N-methyltransferase inhibitor","PRMT1","","","Tocris",76.91,"BRD-K77758223-300-01-1","Preclinical","","ZJHZBDRZEZEDGB-UHFFFAOYSA-N","BRD-K77758223","","NC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(N)=N"
"2038","FUREGRELATE","thromboxane synthase inhibitor","TBXAS1","","","Cayman",98.91,"BRD-K55529781-236-03-8","Phase 1","","VHWFITPGPFLBGT-UHFFFAOYSA-N","BRD-K55529781","","OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1"
"2039","FURSULTIAMINE","vitamin B","","","","Prestwick",99.61,"BRD-A71157293-003-10-0","Launched","","JTLXCMOFVBXEKD-FOWTUZBSSA-N","BRD-A71157293","","C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCO)SSCC1CCCO1"
"2040","F351","TGF beta receptor inhibitor","TGFB1","","","Carbosynth",95.15,"BRD-K41267922-001-01-4","Phase 2","","NETTXQJYJRFTFS-UHFFFAOYSA-N","BRD-K41267922","","Cc1ccc(=O)n(c1)-c1ccc(O)cc1"
"2041","G-CARYOPHYLLENE","acetylcholinesterase inhibitor","ACHE","","","Sigma",0,"BRD-K26878113-001-01-6","Preclinical","","NPNUFJAVOOONJE-GFUGXAQUSA-N","BRD-K26878113","","C\C1=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1"
"2042","G-1","G protein-coupled receptor agonist","GPER1","","","Tocris",97.15,"BRD-K62696033-001-01-4","Preclinical","","VHSVKVWHYFBIFJ-HKZYLEAXSA-N","BRD-K62696033","","CC(=O)c1ccc2N[C@H]([C@H]3CC=C[C@H]3c2c1)c1cc2OCOc2cc1Br"
"2043","G-15","estrogen receptor antagonist","GPER1","","","Tocris",94.06,"BRD-M30288325-001-01-4","Preclinical","","LBBDCJLRQXMUAE-FWHYVADDSA-N","BRD-M30288325","","Brc1cc2OCOc2cc1[C@H]1Nc2ccccc2[C@H]2C=CC[C@@H]12.Brc1cc2OCOc2cc1[C@@H]1Nc2ccccc2[C@@H]2C=CC[C@H]12"
"2044","GABA-LINOLEAMIDE","benzodiazepine receptor agonist","","","","Enzo",0,"BRD-K46254452-001-01-5","Phase 2","","YGFYZZQGVSUXJE-HZJYTTRNSA-N","BRD-K46254452","","CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCCC(O)=O"
"2045","GABAZINE","GABA receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2","","","Tocris, Tocris",98.53,"BRD-K79905821-004-04-4, BRD-K79905821-004-03-6","Preclinical","","ACVGNKYJVGNLIL-UHFFFAOYSA-N","BRD-K79905821","","COc1ccc(cc1)-c1ccc(=N)n(CCCC(O)=O)n1"
"2047","GABOXADOL","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3","","","Tocris, MicroSource, Tocris",100,"BRD-K89104321-003-16-3, BRD-K89104321-003-15-5, BRD-K89104321-003-14-8","Phase 3","","ZXRVKCBLGJOCEE-UHFFFAOYSA-N","BRD-K89104321","","Oc1noc2CNCCc12"
"2050","GALETERONE","androgen receptor modulator","AR, CYP17A1","","","Selleck",96.55,"BRD-A07986123-001-02-8","Phase 3","","PAFKTGFSEFKSQG-BLYLLKCRSA-N","BRD-A07986123","","C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1cnc2ccccc12"
"2051","GALLIC-ACID","beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist","CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP","","","MicroSource",98.82,"BRD-K77345217-001-05-0","Preclinical","","LNTHITQWFMADLM-UHFFFAOYSA-N","BRD-K77345217","","OC(=O)c1cc(O)c(O)c(O)c1"
"2052","GALLIUM-TRIQUINOLIN-8-OLATE","","","","","Sigma",0,"BRD-K46648676-001-01-8","Phase 1","","KWQNQSDKCINQQP-UHFFFAOYSA-K","BRD-K46648676","","O([Ga](Oc1cccc2cccnc12)Oc1cccc2cccnc12)c1cccc2cccnc12"
"2053","GAMBOGIC-ACID","caspase activator","BCL2","","","MedChemEx, MedChemEx, Enzo",81.89,"BRD-K08542803-001-01-5, BRD-K08542803-001-02-3, BRD-K08542803-001-03-1","Phase 2","BRD-A76999758-001-01-1","GEZHEQNLKAOMCA-RRZNCOCZSA-N","BRD-K08542803","BRD-A76999758","CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C"
"2056","GAMMA-AMINOBUTYRIC-ACID","benzodiazepine receptor agonist","GABBR1, GABBR2, GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2, GATM, KCTD12, KCTD16, KCTD8, SLC6A1","","","MicroSource",100,"BRD-K77245796-003-01-6","Preclinical","","BTCSSZJGUNDROE-UHFFFAOYSA-N","BRD-K77245796","","NCCCC(O)=O"
"2057","GAMMA-LINOLENIC-ACID","cyclooxygenase inhibitor, prostanoid receptor agonist","PTGS1, PTGS2","","","Sigma, Cayman, Enzo",87.22,"BRD-K18059238-001-13-8, BRD-K18059238-001-11-2, BRD-K18059238-001-10-4","Phase 2","","VZCCETWTMQHEPK-QNEBEIHSSA-N","BRD-K18059238","","CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O"
"2060","GANAXOLONE","GABA receptor modulator","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6","","","Tocris",100,"BRD-K28217197-001-01-4","Phase 3","","PGTVWKLGGCQMBR-FLBATMFCSA-N","BRD-K28217197","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C"
"2061","GANETESPIB","HSP inhibitor","HSP90AA1","","","Selleck",97.3,"BRD-K38852836-001-02-1","Phase 3","","RVAQIUULWULRNW-UHFFFAOYSA-N","BRD-K38852836","","CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3n(C)ccc3c2)c(O)cc1O"
"2062","GANGLIOSIDE-GM1","","","","","EMDBio",85.28,"BRD-A30703952-201-01-2","Phase 2","","QPJBWNIQKHGLAU-MRSLTSNLSA-N","BRD-A30703952","","CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(OC4OC(CO)C(O)C(O)C4O)C3NC(C)=O)C(OC3(CC(O)C(NC(C)=O)C(O3)C(O)C(O)CO)C(O)=O)C2O)C(O)C1O)[C@H](O)\C=C\CCCCCCCCCCCCC"
"2063","GANT-58","GLI antagonist","GLI1","","","Tocris",96.49,"BRD-K64451768-001-05-4","Preclinical","","USWLOKMMUTWFMD-UHFFFAOYSA-N","BRD-K64451768","","c1cc(ccn1)-c1sc(c(c1-c1ccncc1)-c1ccncc1)-c1ccncc1"
"2064","GANT-61","GLI antagonist","GLI1, GLI2","","","Tocris",89.02,"BRD-K09485525-001-03-9","Preclinical","","KVQOGDQTWWCZFX-UHFFFAOYSA-N","BRD-K09485525","","CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1"
"2065","GASTRODIN","","","","","Selleck",100,"BRD-K81613478-001-01-8","Phase 2","","PUQSUZTXKPLAPR-OBPIAQAESA-N","BRD-K81613478","","OC[C@@H]1O[C@@H](Oc2ccc(CO)cc2)[C@H](O)[C@@H](O)[C@@H]1O"
"2066","GATIFLOXACIN","bacterial DNA gyrase inhibitor","","","","MicroSource, Selleck",93.99,"BRD-A74980173-213-01-1, BRD-A74980173-001-11-9","Withdrawn","","XUBOMFCQGDBHNK-UHFFFAOYSA-N","BRD-A74980173","","COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1"
"2068","GAVESTINEL","glutamate receptor antagonist","GLRB","","","Tocris, Tocris, Tocris",92.51,"BRD-K81981783-236-01-1, BRD-K81981783-236-02-9, BRD-K81981783-236-03-7","Phase 3","","WZBNEZWCNKUOSM-VOTSOKGWSA-N","BRD-K81981783","","OC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1\C=C\C(=O)Nc1ccccc1"
"2071","GBR-12783","dopamine uptake inhibitor","","","","Tocris",97.13,"BRD-K92015269-300-01-2","Preclinical","","XFBDGHFDKJITGC-JLHYYAGUSA-N","BRD-K92015269","","C(CN1CCN(C\C=C\c2ccccc2)CC1)OC(c1ccccc1)c1ccccc1"
"2072","GBR-12935","dopamine uptake inhibitor","AGTR1, SLC6A3","","","Tocris",97.4,"BRD-K50135270-300-02-3","Preclinical","","RAQPOZGWANIDQT-UHFFFAOYSA-N","BRD-K50135270","","C(CN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)Cc1ccccc1"
"2073","GBR-13069","dopamine uptake inhibitor","SLC6A3","","","Tocris",95.51,"BRD-K92577649-300-01-2","Preclinical","","DASHZBBQOARCMQ-QPJJXVBHSA-N","BRD-K92577649","","Fc1ccc(cc1)C(OCCN1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1"
"2074","GDC-0068","AKT inhibitor","AKT1, AKT2, AKT3, PRKG1","","","Selleck",96.67,"BRD-K71480163-001-01-4","Phase 2","","GRZXWCHAXNAUHY-AHRSYUTCSA-N","BRD-K71480163","","CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1"
"2075","GDC-0152","XIAP inhibitor","BIRC2, BIRC3, BIRC7, XIAP","","","Selleck",94.69,"BRD-K68938568-001-01-7","Phase 1","","WZRFLSDVFPIXOV-LRQRDZAKSA-N","BRD-K68938568","","CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1"
"2076","GDC-0349","Pim kinase inhibitor","PIK3CA","","","Selleck, Selleck",89.78,"BRD-K43187018-001-02-5, BRD-K43187018-001-03-3","Phase 1","","RGJOJUGRHPQXGF-INIZCTEOSA-N","BRD-K43187018","","CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1"
"2078","GDC-0623","MEK inhibitor","","","","MedChemEx, MedChemEx, MedChemEx, Selleck",92.75,"BRD-K46908090-001-03-0, BRD-K46908090-001-01-4, BRD-K46908090-001-04-8, BRD-K46908090-001-02-2","Phase 1","","RFWVETIZUQEJEF-UHFFFAOYSA-N","BRD-K46908090","","OCCONC(=O)c1ccc2cncn2c1Nc1ccc(I)cc1F"
"2082","GDC-0810","selective estrogen receptor destabilizer","ESR1","","","MedChemEx",96.35,"BRD-K61923022-001-02-4","Phase 2","","BURHGPHDEVGCEZ-KJGLQBJMSA-N","BRD-K61923022","","CC\C(=C(\c1ccc(\C=C\C(O)=O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl"
"2083","GDC-0834","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","MedChemEx, MedChemEx",90.56,"BRD-A30984645-001-02-3, BRD-A30984645-001-01-5","Phase 1","","CDOOFZZILLRUQH-UHFFFAOYSA-N","BRD-A30984645","","CN1CCN(C)C(=O)C1c1ccc(Nc2nc(cn(C)c2=O)-c2cccc(NC(=O)c3cc4CCCCc4s3)c2C)cc1"
"2085","GDC-0879","RAF inhibitor","BRAF","","","Selleck, Selleck, Tocris",97.55,"BRD-K67578145-001-09-7, BRD-K67578145-001-12-1, BRD-K67578145-001-10-5","Preclinical","BRD-K14399170-001-01-7","DEZZLWQELQORIU-RELWKKBWSA-N","BRD-K67578145","BRD-K14399170","OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CC\C2=N/O)c1"
"2088","GDC-0941","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",95.23,"BRD-K52911425-001-09-8","Phase 2","","LHNIIDJUOCFXAP-UHFFFAOYSA-N","BRD-K52911425","","CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1"
"2089","GDC-0980","mTOR inhibitor, PI3K inhibitor","FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK","","","Selleck, Selleck",94.13,"BRD-K23228615-001-02-8, BRD-K23228615-001-03-6","Phase 2","","YOVVNQKCSKSHKT-HNNXBMFYSA-N","BRD-K23228615","","C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1"
"2091","GDC-0994","MAP kinase inhibitor","MAPK1, MAPK3","","","Selleck",98.7,"BRD-A20830788-001-01-9","Phase 1","","RZUOCXOYPYGSKL-UHFFFAOYSA-N","BRD-A20830788","","Cn1nccc1Nc1nccc(n1)-c1ccn(C(CO)c2ccc(Cl)c(F)c2)c(=O)c1"
"2092","GEDUNIN","HSP inhibitor","HSP90AA1","","","Tocris",95.65,"BRD-K02703275-001-07-5","Preclinical","","YJXDGWUNRYLINJ-BHAPSIHVSA-N","BRD-K02703275","","CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)c1ccoc1"
"2093","GELDANAMYCIN","HSP inhibitor","HSP90AA1, HSP90AB1","","","Selleck, Selleck",76.5,"BRD-K43570081-001-02-4, BRD-K43570081-001-04-0","Preclinical","BRD-K82847623-001-01-5,BRD-A77524860-001-03-7","QTQAWLPCGQOSGP-PHLMVCJGSA-N","BRD-K43570081","BRD-K82847623","CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C\[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O"
"2095","GEMCADIOL","antilipemic","","","","Sigma",92.2,"BRD-K43890836-001-01-6","Phase 2","","DJKWDKJYFYUEBQ-UHFFFAOYSA-N","BRD-K43890836","","CC(C)(CO)CCCCCCC(C)(C)CO"
"2096","GEMCITABINE-ELAIDATE","DNA synthesis inhibitor, apoptosis inhibitor","CMPK1, RRM1, TYMS","","","MedChemEx",94.93,"BRD-K09456915-001-01-2","Phase 1","","HESSNRGIEVBPRB-QDDPNBLJSA-N","BRD-K09456915","","CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O"
"2097","GENIPIN","choleretic agent","","","","MedChemEx, Selleck, Selleck",99.08,"BRD-K28824103-001-03-6, BRD-K28824103-001-04-4, BRD-K28824103-001-02-8","Preclinical","BRD-K70886785-001-01-1","AZKVWQKMDGGDSV-BCMRRPTOSA-N","BRD-K28824103","BRD-K70886785","COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO"
"2100","GENIPOSIDE","GLP receptor agonist","GLP1R","","","Selleck, Selleck",97.9,"BRD-K57275767-001-02-4, BRD-K57275767-001-03-2","Preclinical","BRD-K35205465-001-01-5","IBFYXTRXDNAPMM-BVTMAQQCSA-N","BRD-K57275767","BRD-K35205465","COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1CC=C2CO"
"2102","GENIPOSIDIC-ACID","cyclooxygenase inhibitor","","","","Selleck, Selleck",86.68,"BRD-K73771095-001-03-3, BRD-K73771095-001-02-5","Preclinical","BRD-K02342990-001-01-9","ZJDOESGVOWAULF-OGJQONSISA-N","BRD-K73771095","BRD-K02342990","OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3CC=C(CO)[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O"
"2104","GENISTEIN","tyrosine kinase inhibitor","CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5","","","Selleck, Tocris, Tocris, MicroSource",97.71,"BRD-K43797669-001-28-8, BRD-K43797669-001-29-6, BRD-K43797669-001-31-2, BRD-K43797669-001-30-4","Phase 2/Phase 3","","TZBJGXHYKVUXJN-UHFFFAOYSA-N","BRD-K43797669","","Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O"
"2108","GENTIOPICRIN","glutamate receptor downregulator","GRIN2B","","","Sigma",97.46,"BRD-K33131085-001-07-2","Phase 3","","DUAGQYUORDTXOR-GPQRQXLASA-N","BRD-K33131085","","OC[C@H]1O[C@@H](O[C@@H]2OC=C3C(=O)OCC=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O"
"2109","GENZ-123346","glucosylceramidase inhibitor","UGCG","","","MedChemEx, MedChemEx",85.93,"BRD-K70693421-001-01-1, BRD-K70693421-001-02-9","Preclinical","","JMNXWOFCUJJYEO-HYBUGGRVSA-N","BRD-K70693421","","CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1"
"2111","GENZ-644282","topoisomerase inhibitor","TOP1","","","MedChemEx",97.15,"BRD-K99475619-001-01-2","Phase 1","","BAORCAMWLWRZQG-UHFFFAOYSA-N","BRD-K99475619","","CNCCn1c2c(cnc3cc4OCOc4cc23)c2cc(OC)c(OC)cc2c1=O"
"2112","GEPON","","","","","InterBioScreen",99.2,"BRD-A56754222-001-01-2","Phase 1","","HTQONPPEZULJKY-CXRHXLISSA-N","BRD-A56754222","","CC(C)[C@@H](NC(=O)C(NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)C(CCC(O)=O)NC(=O)[C@H](N)C(C)O)C(C)O)C(=O)N[C@H](CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"2113","GERANYL-FARNESYLACETATE","mucin production enhancer","","","","Adooq, AKSci",49.56,"BRD-K02780233-001-02-5, BRD-K02780233-001-01-7","Phase 2","","ZPACYDRSPFRDHO-ROBAGEODSA-N","BRD-K02780233","","CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(=O)OC\C=C(/C)CCC=C(C)C"
"2115","GF109203X","PKC inhibitor","PDPK1, PIM1, PRKCI, PRKCZ","","","Tocris, Tocris",88.34,"BRD-K31342827-001-13-8, BRD-K31342827-001-15-3","Preclinical","","QMGUOJYZJKLOLH-UHFFFAOYSA-N","BRD-K31342827","","CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc12"
"2117","GGSTOP","gamma glutamyltransferase Inhibitors","GGT1","","","Tocris",15.75,"BRD-A25625670-001-01-9","Preclinical","","NTFPDEDRMYYPAC-UHFFFAOYSA-N","BRD-A25625670","","COP(=O)(CCC(N)C(O)=O)Oc1cccc(CC(O)=O)c1"
"2118","GGTI-298","GGTase inhibitor","CDKN1A","","","EMDBio",38.97,"BRD-K19669037-001-01-1","Preclinical","","XVWPFYDMUFBHBF-CLOONOSVSA-N","BRD-K19669037","","COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12"
"2119","GIDAZEPAM","GABA benzodiazepine site receptor agonist","","","","Enamine",88.96,"BRD-K22588750-001-07-0","Launched","","XLGCMZLSEXRBSG-UHFFFAOYSA-N","BRD-K22588750","","NNC(=O)CN1c2ccc(Br)cc2C(=NCC1=O)c1ccccc1"
"2120","GILTERITINIB","FLT3 inhibitor","FLT3","","","MedChemEx",90.94,"BRD-K72280606-001-01-2","Phase 3","","GYQYAJJFPNQOOW-UHFFFAOYSA-N","BRD-K72280606","","CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(CC3)N3CCN(C)CC3)c(OC)c2)nc1NC1CCOCC1"
"2121","GINKGOLIDE-A","GABA receptor antagonist","GLRA1, GLRB","","","Selleck",100,"BRD-A95121829-001-08-9","Preclinical","BRD-A94702766-001-01-7","FPUXKXIZEIDQKW-MALVTOHRSA-N","BRD-A95121829","BRD-A94702766","C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O"
"2122","GINKGOLIDE-B","platelet activating factor receptor antagonist","GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B","","","Tocris, Selleck, Tocris",100,"BRD-A08430411-001-01-9, BRD-A59001851-001-02-1, BRD-A59001851-001-01-3","Phase 3","BRD-A82395837-001-01-9","SQOJOAFXDQDRGF-REVVDZANSA-N","BRD-A08430411","BRD-A82395837","C[C@@H]1C(=O)OC2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O"
"2123","GINKGOLIDE-B","platelet activating factor receptor antagonist","GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B","","","Tocris, Selleck, Tocris",100,"BRD-A08430411-001-01-9, BRD-A59001851-001-02-1, BRD-A59001851-001-01-3","Phase 3","BRD-A82395837-001-01-9","SQOJOAFXDQDRGF-REVVDZANSA-N","BRD-A08430411","BRD-A82395837","C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O"
"2125","GINKGOLIDE-B","platelet activating factor receptor antagonist","GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B","","","Tocris, Selleck, Tocris",100,"BRD-A08430411-001-01-9, BRD-A59001851-001-02-1, BRD-A59001851-001-01-3","Phase 3","BRD-A82395837-001-01-9","SQOJOAFXDQDRGF-IWNUMIARSA-N","BRD-A08430411","BRD-A82395837","C[C@@H]1C(=O)OC2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O"
"2126","GINKGOLIDE-B","platelet activating factor receptor antagonist","GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B","","","Tocris, Selleck, Tocris",100,"BRD-A08430411-001-01-9, BRD-A59001851-001-02-1, BRD-A59001851-001-01-3","Phase 3","BRD-A82395837-001-01-9","SQOJOAFXDQDRGF-IWNUMIARSA-N","BRD-A08430411","BRD-A82395837","C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O"
"2128","GINSENOSIDE-C-K","NFkB pathway inhibitor, nitric oxide synthase inhibitor","PTGS2","","","MedChemEx",99.5,"BRD-K01942833-001-01-8","Preclinical","","FVIZARNDLVOMSU-IRFFNABBSA-N","BRD-K01942833","","CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C"
"2129","GINSENOSIDE-RD","calcium channel blocker","","","","MedChemEx",100,"BRD-A84810646-001-01-6","Phase 3","","RLDVZILFNVRJTL-HIOAYSDNSA-N","BRD-A84810646","","CC(C)=CCCC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C"
"2130","GINSENOSIDE-RG3","angiogenesis inhibitor, apoptosis stimulant","KCNH2","","","MedChemEx",99.4,"BRD-A44511856-001-01-4","Launched","","RWXIFXNRCLMQCD-QIRRTGJGSA-N","BRD-A44511856","","CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C"
"2131","GIVINOSTAT","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","","","Selleck",92.76,"BRD-K13810148-311-03-2","Phase 2","","YALNUENQHAQXEA-UHFFFAOYSA-N","BRD-K13810148","","CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(cc3)C(=O)NO)ccc2c1"
"2132","GKA-50","glucokinase activator","GCK","","","Tocris",93.93,"BRD-K03827870-001-01-3","Preclinical","","OCBMECSFDVUYQN-ROUUACIJSA-N","BRD-K03827870","","COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(c1)C(=O)Nc1ccc(cn1)C(O)=O"
"2133","GKT137831","NADPH oxidase inhibitor","NOX1, NOX4","","","MedChemEx, MedChemEx, Selleck",90,"BRD-K79710622-001-03-7, BRD-K79710622-001-01-1, BRD-K79710622-001-02-9","Phase 2","","RGYQPQARIQKJKH-UHFFFAOYSA-N","BRD-K79710622","","CN(C)c1cccc(c1)-c1n(C)c(=O)cc2[nH]n(-c3ccccc3Cl)c(=O)c12"
"2136","GK921","transglutaminase inhibitor","TGM2","","","MedChemEx, MedChemEx",94.48,"BRD-K38272302-001-02-7, BRD-K38272302-001-01-9","Preclinical","","MNYJJHBAEYKXEG-UHFFFAOYSA-N","BRD-K38272302","","C(CN1CCCC1)Oc1nc2cccnc2nc1C#Cc1ccccc1"
"2138","GLAFENINE","DeltaF508-CFTR Correctors","CFTR","","","MicroSource, Selleck",98.69,"BRD-A38076815-001-04-0, BRD-A38076815-003-10-3","Withdrawn","","GWOFUCIGLDBNKM-UHFFFAOYSA-N","BRD-A38076815","","OCC(O)COC(=O)c1ccccc1Nc1ccnc2cc(Cl)ccc12"
"2140","GLASDEGIB","hedgehog pathway inhibitor","SMO","","","MedChemEx",90.62,"BRD-K34341643-001-01-4","Phase 2","","SFNSLLSYNZWZQG-VQIMIIECSA-N","BRD-K34341643","","CN1CC[C@H](C[C@@H]1c1nc2ccccc2[nH]1)NC(=O)Nc1ccc(cc1)C#N"
"2141","GLPG0492","androgen receptor modulator","AR","","","MedChemEx",95.84,"BRD-K15893360-001-01-8","Phase 1","","VAJGULUVTFDTAS-GOSISDBHSA-N","BRD-K15893360","","CN1C(=O)N(C(=O)[C@@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F"
"2142","GLPG0492-R-ENANTIOMER","androgen receptor modulator","AR","","","MedChemEx",90.37,"BRD-K04643927-001-01-6","Phase 1","","VAJGULUVTFDTAS-SFHVURJKSA-N","BRD-K04643927","","CN1C(=O)N(C(=O)[C@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F"
"2143","GLUCARIC-ACID","","","","","Sigma",0,"BRD-K60150658-432-01-5","Phase 1","","DSLZVSRJTYRBFB-LLEIAEIESA-N","BRD-K60150658","","O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O"
"2144","GLUCONOLACTONE","","LCT","","","MicroSource",0,"BRD-K04288422-001-04-4","Launched","","PHOQVHQSTUBQQK-KLVWXMOXSA-N","BRD-K04288422","","OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O"
"2145","GLUTATHIONE","antioxidant","ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12","","","MicroSource",0,"BRD-K69346723-001-04-8","Phase 3","","RWSXRVCMGQZWBV-WDSKDSINSA-N","BRD-K69346723","","N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O"
"2146","GLUTATHIONE-MONOISOPROPYL-ESTER","lipid peroxidase inhibitor","","","","ChemImpex, Sigma",79.96,"BRD-K58937086-001-01-4, BRD-K58937086-001-02-2","Phase 2","","MVNCPACIPXNJIW-IUCAKERBSA-N","BRD-K58937086","","CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O"
"2148","GLY-GLN","","","","","Ark",100,"BRD-K85066592-001-01-6","Phase 2","","PNMUAGGSDZXTHX-BYPYZUCNSA-N","BRD-K85066592","","NCC(=O)N[C@@H](CCC(N)=O)C(O)=O"
"2149","GLYCEROL-MONOLAURATE","beta lactamase inhibitor","","","","Sigma",98.1,"BRD-A10773072-001-03-4","Launched","","ARIWANIATODDMH-UHFFFAOYSA-N","BRD-A10773072","","CCCCCCCCCCCC(=O)OCC(O)CO"
"2150","GLYCITEIN","tumor necrosis factor release inhibitor","TNF","","","Cayman",97.95,"BRD-K78303961-001-02-3","Phase 3","","DXYUAIFZCFRPTH-UHFFFAOYSA-N","BRD-K78303961","","COc1cc2c(cc1O)occ(-c1ccc(O)cc1)c2=O"
"2151","GMX1778","NAMPT inhibitor","NAMPT","","","MedChemEx",96.98,"BRD-K69832040-001-01-9","Phase 1/Phase 2","","BOIPLTNGIAPDBY-UHFFFAOYSA-N","BRD-K69832040","","Clc1ccc(OCCCCCCN\C(NC#N)=N\c2ccncc2)cc1"
"2152","GNF-2","Bcr-Abl kinase inhibitor","ABL1, BCR","","","Selleck, Tocris",96.55,"BRD-K97056771-001-13-1, BRD-K97056771-001-14-9","Preclinical","","WEVYNIUIFUYDGI-UHFFFAOYSA-N","BRD-K97056771","","NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1"
"2154","GNF-5","Bcr-Abl kinase inhibitor","ABL1, BCR","","","Tocris",99.44,"BRD-K87632963-001-03-0","Preclinical","","IIQUYGWWHIHOCF-UHFFFAOYSA-N","BRD-K87632963","","OCCNC(=O)c1cccc(c1)-c1ncnc(Nc2ccc(cc2)OC(F)(F)F)c1"
"2155","GNF-5837","growth factor receptor inhibitor","NTRK1, NTRK2, NTRK3","","","Tocris",75.24,"BRD-K19975102-001-01-2","Preclinical","","YYDUWLSETXNJJT-MTJSOVHGSA-N","BRD-K19975102","","Cc1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)cc1Nc1ccc2c(NC(=O)\C2=C/c2ccc[nH]2)c1"
"2156","GNF-7","protein kinase inhibitor, glucokinase inhibitor","GCK, TNK2","","","Tocris",90.81,"BRD-K69075588-001-01-3","Preclinical","","SZNYUUZOQHNEKB-UHFFFAOYSA-N","BRD-K69075588","","CN1C(=O)N(Cc2cnc(Nc3ccc(C)nc3)nc12)c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C"
"2157","GNTI","opioid receptor antagonist","OPRK1, OPRM1","","","Tocris",0,"BRD-K64748124-300-01-7","Preclinical","BRD-A80271098-300-01-4","VLNHDKDBGWXJEE-GYHUNEDQSA-N","BRD-K64748124","BRD-A80271098","NC(=N)Nc1ccc2[nH]c3c(C[C@@]4(O)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC3CC3)c67)c2c1"
"2158","GO-6983","protein kinase inhibitor","PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ","","","Selleck, Selleck",93.45,"BRD-K36984403-001-02-7, BRD-K36984403-001-03-5","Preclinical","","LLJJDLHGZUOMQP-UHFFFAOYSA-N","BRD-K36984403","","COc1ccc2n(CCCN(C)C)cc(C3=C(C(=O)NC3=O)c3c[nH]c4ccccc34)c2c1"
"2160","GOLGICIDE-A","ARF inhibitor","GBF1","","","Tocris",96.27,"BRD-A57886255-001-01-1","Preclinical","","NJZHEQOUHLZCOX-FTLRAWMYSA-N","BRD-A57886255","","Fc1cc(F)c2NC([C@@H]3CC=C[C@@H]3c2c1)c1cccnc1"
"2161","GOLVATINIB","VEGFR inhibitor","KDR, MET","","","Selleck",91.39,"BRD-K69001009-001-02-8","Phase 2","","UQRCJCNVNUFYDX-UHFFFAOYSA-N","BRD-K69001009","","CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1"
"2162","GOSSYPOL","BCL inhibitor, MCL1 inhibitor","BCL2","","","Selleck, Tocris, Tocris, Selleck, Selleck, Selleck",96.16,"BRD-K19295594-015-13-5, BRD-K19295594-001-16-8, BRD-K19295594-001-17-6, BRD-K19295594-001-15-0, BRD-K19295594-015-14-3, BRD-K19295594-015-12-7","Phase 2","","QBKSWRVVCFFDOT-UHFFFAOYSA-N","BRD-K19295594","","CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O"
"2168","GPBAR-A","G protein coupled receptor agonist","GPBAR1","","","Tocris",96.41,"BRD-K67397687-001-01-3","Preclinical","","ZIXNJVGTAXRKAP-UHFFFAOYSA-N","BRD-K67397687","","Fc1ccccc1-c1ccnc2OCC(=O)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)Cc12"
"2169","GPI-1046","FKBP inhibitor","FKBP1A","","","Key",97.78,"BRD-K44869961-001-01-6","Preclinical","","OQAHHWOPVDDWHD-INIZCTEOSA-N","BRD-K44869961","","CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1"
"2170","GPI-688","glycogen phosphorylase inhibitor","","","","Tocris",93.41,"BRD-A90201073-001-01-2","Preclinical","","UICNBXVDHCBKCE-PUODRLBUSA-N","BRD-A90201073","","OC[C@H](O)CN1C(=O)C(Cc2ccccc12)NC(=O)c1cc2cc(Cl)sc2[nH]1"
"2171","GPP-78","NAMPT inhibitor","NAMPT","","","Tocris",98.04,"BRD-K83289131-003-01-0","Preclinical","","SJOLTIOPWDLDEB-UHFFFAOYSA-N","BRD-K83289131","","O=C(CCCCCCCn1cc(nn1)-c1cccnc1)Nc1ccccc1-c1ccccc1"
"2172","GPR120-MODULATOR-1","G protein-coupled receptor modulator","FFAR4","","","MedChemEx",96.16,"BRD-K19409553-001-01-6","Preclinical","","FONSSTYHKIFEBM-UHFFFAOYSA-N","BRD-K19409553","","Cc1cc(OCc2nc(cs2)-c2ccccc2Cl)ccc1OCC(O)=O"
"2173","GP1A","cannabinoid receptor agonist","CNR2","","","Tocris",97.02,"BRD-K65285700-001-02-3","Preclinical","","FNOMTMVRTBHRET-UHFFFAOYSA-N","BRD-K65285700","","Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1"
"2174","GP2A","cannabinoid receptor agonist","CNR2","","","Tocris",98.53,"BRD-K34608650-001-02-4","Preclinical","","SPEFJYZGXZENAF-UHFFFAOYSA-N","BRD-K34608650","","Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1"
"2175","GR-103691","dopamine receptor antagonist","DRD3","","","Tocris",85.45,"BRD-K50891186-001-04-4","Preclinical","","JARNORYOPMINDY-UHFFFAOYSA-N","BRD-K50891186","","COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccc(cc2)C(C)=O)CC1"
"2176","GR-113808","serotonin receptor antagonist","HTR4","","","Tocris",94.87,"BRD-K49945136-001-10-0","Preclinical","","MOZPSIXKYJUTKI-UHFFFAOYSA-N","BRD-K49945136","","Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12"
"2177","GR-127935","serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6","","","Tocris",89.38,"BRD-K11911061-003-11-9","Preclinical","","YDBCEBYHYKAFRX-UHFFFAOYSA-N","BRD-K11911061","","COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1"
"2178","GR-135531","melatonin receptor agonist","","","","Tocris",90.72,"BRD-K83023055-001-02-7","Preclinical","","MPZVHKLZCUEJFO-UHFFFAOYSA-N","BRD-K83023055","","COC(=O)Nc1ccc2[nH]cc(CCNC(C)=O)c2c1"
"2179","GR-144053","integrin antagonist","ITGA2B, ITGB3","","","Tocris",94.59,"BRD-K12120659-305-02-2","Preclinical","","QGEGSJUSWLLZLH-UHFFFAOYSA-N","BRD-K12120659","","NC(=N)c1ccc(cc1)N1CCN(CC1)C1CCN(CC(O)=O)CC1"
"2180","GR-159897","tachykinin antagonist","TAC1, TACR2","","","Tocris, Tocris",92.73,"BRD-K52394958-001-03-5, BRD-K52394958-001-02-7","Preclinical","","BANYJBHWTOJQDU-GDLZYMKVSA-N","BRD-K52394958","","COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1"
"2182","GR-235","estrogen receptor agonist, FXR antagonist, progesterone receptor agonist","NR1H4","","","Tocris",55.9,"BRD-K26674531-001-02-1","Launched","","WDXRGPWQVHZTQJ-OSJVMJFVSA-N","BRD-K26674531","","C\C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"2183","GR-79236","adenosine receptor agonist","ADORA1, ADORA2A","","","Tocris",98.53,"BRD-K40578143-001-02-6","Phase 1","","GYWXTRVEUURNEW-TVDBPQCTSA-N","BRD-K40578143","","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12"
"2184","GRAMINE","norepinephrine reputake inhibitor","","","","Selleck",90.98,"BRD-K26005076-001-12-8","Preclinical","","OCDGBSUVYYVKQZ-UHFFFAOYSA-N","BRD-K26005076","","CN(C)Cc1c[nH]c2ccccc12"
"2185","GRAZOPREVIR","HCV inhibitor","","","","MedChemEx, MedChemEx",98.76,"BRD-K24943235-237-01-3, BRD-K24943235-001-01-3","Launched","","OBMNJSNZOWALQB-NCQNOWPTSA-N","BRD-K24943235","","COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C"
"2187","GR125487","serotonin receptor antagonist","HTR4","","","Tocris",95.42,"BRD-K62594868-082-08-6","Preclinical","","SSPCCAYAIDNNJX-UHFFFAOYSA-N","BRD-K62594868","","COc1[nH]c2ccc(F)cc2c1C(=O)OCC1CCN(CCNS(C)(=O)=O)CC1"
"2188","GR46611","serotonin receptor agonist","HTR1D","","","Tocris, Tocris",91.27,"BRD-K98155362-001-08-5, BRD-K98155362-001-07-7","Preclinical","","LBVZWEWTNUDWNS-YRNVUSSQSA-N","BRD-K98155362","","COc1ccc(CNC(=O)\C=C\c2ccc3[nH]cc(CCN(C)C)c3c2)cc1"
"2190","GS-143","ubiquitin ligase inhibitor","BTRC, NFKBIA","","","Tocris",67.28,"BRD-K99916169-001-01-9","Preclinical","","IZPMWFSVTDOCDI-HAVVHWLPSA-N","BRD-K99916169","","OC(=O)c1ccc(cc1)N1N=C(Cc2ccccc2)\C(=C/c2ccc(o2)-c2ccccc2F)C1=O"
"2191","GS-39783","GABA receptor modulator","GABBR1","","","Tocris",98.14,"BRD-K75478907-001-02-3","Preclinical","","GSGVDKOCBKBMGG-UHFFFAOYSA-N","BRD-K75478907","","CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O"
"2192","GS-6201","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",99.12,"BRD-K68453341-001-01-1","Phase 1","","KOYXXLLNCXWUNF-UHFFFAOYSA-N","BRD-K68453341","","CCCn1c(=O)n(CC)c2nc([nH]c2c1=O)-c1cnn(Cc2cccc(c2)C(F)(F)F)c1"
"2193","GS-9620","toll-like receptor agonist","TLR7","","","MedChemEx, MedChemEx",86.83,"BRD-K73585091-001-02-3, BRD-K73585091-001-01-5","Phase 2","","VFOKSTCIRGDTBR-UHFFFAOYSA-N","BRD-K73585091","","CCCCOc1nc(N)c2NC(=O)CN(Cc3cccc(CN4CCCC4)c3)c2n1"
"2195","GS-9973","syk inhibitor","SYK","","","MedChemEx, Selleck, MedChemEx, Selleck",92.11,"BRD-K76719364-001-06-6, BRD-K76719364-001-01-7, BRD-K76719364-001-04-1, BRD-K76719364-001-02-5","Phase 2","","XSMSNFMDVXXHGJ-UHFFFAOYSA-N","BRD-K76719364","","C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1"
"2199","GSK-J1","histone demethylase inhibitor","KDM6B","","","MedChemEx, Tocris",94.8,"BRD-K32847255-001-01-1, BRD-K32847255-001-02-9","Preclinical","","AVZCPICCWKMZDT-UHFFFAOYSA-N","BRD-K32847255","","OC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1"
"2201","GSK-J2","histone demethylase inhibitor","","","","MedChemEx, Tocris",95.52,"BRD-K82484347-001-01-2, BRD-K82484347-001-02-0","Preclinical","","LJIFOCRGDDQFJF-UHFFFAOYSA-N","BRD-K82484347","","OC(=O)CCNc1cc(nc(n1)-c1cccnc1)N1CCc2ccccc2CC1"
"2203","GSK-J4","histone lysine demethylase inhibitor","KDM6A, KDM6B","","","Selleck, Tocris",94.39,"BRD-K98203492-003-04-1, BRD-K98203492-001-02-9","Preclinical","","WBKCKEHGXNWYMO-UHFFFAOYSA-N","BRD-K98203492","","CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1"
"2205","GSK-J5","histone demethylase control","","","","Tocris",95.18,"BRD-K55438324-001-01-8","Preclinical","","LQPGVGSKBNXQDU-UHFFFAOYSA-N","BRD-K55438324","","CCOC(=O)CCNc1cc(nc(n1)-c1cccnc1)N1CCc2ccccc2CC1"
"2206","GSK-LSD-1","histone lysine demethylase inhibitor","KDM1A","","","Tocris",37.79,"BRD-K33521504-300-02-4","Preclinical","","BASFYRLYJAZPPL-UONOGXRCSA-N","BRD-K33521504","","C1[C@@H](NC2CCNCC2)[C@@H]1c1ccccc1"
"2207","GSK-0660","PPAR receptor antagonist","PPARD","","","Tocris, Tocris",96.98,"BRD-K98684188-001-02-9, BRD-K98684188-001-03-7","Preclinical","","NDFKBGWLUHKMFY-UHFFFAOYSA-N","BRD-K98684188","","COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC"
"2209","GSK-1562590","urotensin receptor antagonist","UTS2R","","","Tocris",93.97,"BRD-K36697397-003-01-1","Preclinical","","QDUMEBKFKOODFN-SANMLTNESA-N","BRD-K36697397","","CN([C@@H](CN1CCCC1)c1ccc(cc1)-c1cccc(c1)C(N)=O)C(=O)CN1C(=O)COc2cc(Cl)c(Cl)cc12"
"2210","GSK-2193874","transient receptor potential channel antagonist","TRPV4","","","Tocris",92.6,"BRD-K90737788-001-01-9","Preclinical","","UIVOZBSCHXCGPS-UHFFFAOYSA-N","BRD-K90737788","","FC(F)(F)c1cccc(c1)-c1nc2cc(Br)ccc2c(C(=O)NC2(CC2)c2ccccc2)c1CN1CCC(CC1)N1CCCCC1"
"2211","GSK-2837808A","lactate dehydrogenase inhibitor","LDHA","","","Tocris",92.69,"BRD-K50679358-001-01-1","Preclinical","","RZBCPMYJIARMGV-UHFFFAOYSA-N","BRD-K50679358","","COc1ncc(-c2ccc3c(Nc4cc(Oc5cc(F)cc(F)c5)cc(c4)C(O)=O)c(cnc3c2)S(=O)(=O)NC2CC2)c(OC)n1"
"2212","GSK-3-INHIBITOR-IX","glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B","","","Tocris, Selleck",95.08,"BRD-K04923131-001-15-4, BRD-K04923131-001-14-7","Preclinical","","DDLZLOKCJHBUHD-UJZLGWIISA-N","BRD-K04923131","","O\N=C1/C(Nc2ccccc12)=C1/C(=O)Nc2cc(Br)ccc12"
"2214","GSK-37647","free fatty acid receptor agonist","FFAR4","","","Tocris",98.11,"BRD-K26514105-001-01-7","Preclinical","","FQUAFMNPXPXOJE-UHFFFAOYSA-N","BRD-K26514105","","COc1ccc(cc1)S(=O)(=O)Nc1c(C)cc(C)cc1C"
"2215","GSK1059615","PI3K inhibitor","PIK3CG","","","Selleck, Selleck",82.73,"BRD-K06750613-001-07-3, BRD-K06750613-001-04-0","Phase 1","","QDITZBLZQQZVEE-YBEGLDIGSA-N","BRD-K06750613","","O=C1NC(=O)\C(S1)=C\c1ccc2nccc(-c3ccncc3)c2c1"
"2217","GSK1070916","Aurora kinase inhibitor","AURKA, AURKB, AURKC, CYP2D6, CYP3A4","","","Selleck",96.68,"BRD-K36740062-001-06-6","Phase 1","","QTBWCSQGBMPECM-UHFFFAOYSA-N","BRD-K36740062","","CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1"
"2218","GSK1292263","glucose dependent insulinotropic receptor agonist","GRPR","","","Selleck",97.16,"BRD-K60341624-001-02-2","Phase 2","","AYJRTVVIBJSSKN-UHFFFAOYSA-N","BRD-K60341624","","CC(C)c1noc(n1)N1CCC(COc2ccc(nc2)-c2ccc(cc2)S(C)(=O)=O)CC1"
"2219","GSK163090","serotonin receptor antagonist","HTR1A, HTR1B, HTR1D","","","MedChemEx",98.29,"BRD-K69669039-001-01-8","Phase 2","","ANGUXJDGJCHGOG-UHFFFAOYSA-N","BRD-K69669039","","Cc1ccc2c(cccc2n1)N1CCN(CCc2cccc(c2)N2CCNC2=O)CC1"
"2220","GSK1838705A","insulin growth factor receptor inhibitor","ALK, IGF1R, INSR, RPS6KA1","","","Selleck, Selleck, Tocris",94.21,"BRD-K06749501-001-02-1, BRD-K06749501-001-03-9, BRD-K06749501-001-05-4","Preclinical","","HZTYDQRUAWIZRE-UHFFFAOYSA-N","BRD-K06749501","","CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3N(CCc3cc2OC)C(=O)CN(C)C)nc2[nH]ccc12"
"2223","GSK1904529A","IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR","","","Selleck",93.1,"BRD-K04833372-001-06-2","Preclinical","","MOSKATHMXWSZTQ-UHFFFAOYSA-N","BRD-K04833372","","CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O"
"2224","GSK2110183","AKT inhibitor","AKT1, AKT2, AKT3","","","MedChemEx",86.22,"BRD-K25412176-001-01-9","Phase 2","","AFJRDFWMXUECEW-LBPRGKRZSA-N","BRD-K25412176","","Cn1ncc(Cl)c1-c1cc(sc1Cl)C(=O)N[C@H](CN)Cc1cccc(F)c1"
"2225","GSK2126458","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",95.25,"BRD-K07972848-001-02-0","Phase 1","","CGBJSGAELGCMKE-UHFFFAOYSA-N","BRD-K07972848","","COc1ncc(cc1NS(=O)(=O)c1ccc(F)cc1F)-c1ccc2nccc(-c3ccnnc3)c2c1"
"2226","GSK2190915","lipoxygenase inhibitor","ALOX5AP","","","MedChemEx",97.5,"BRD-K15691453-236-01-6","Phase 2","","DFQGDHBGRSTTHX-UHFFFAOYSA-N","BRD-K15691453","","CCOc1ccc(cn1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OCc4ccc(C)cn4)ccc23)cc1"
"2227","GSK2194069","fatty acid synthase inhibitor","FASN","","","Tocris",98.51,"BRD-K95123482-001-01-6","Preclinical","","AQTPWCUIYUOEMG-INIZCTEOSA-N","BRD-K95123482","","O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(cc2)-c2ccc3occc3c2)C1"
"2228","GSK2256294A","epoxide hydolase inhibitor","EPHX2","","","MedChemEx",96.85,"BRD-K62738477-001-01-7","Phase 1","","LQHDJQIMETZMPH-ZBFHGGJFSA-N","BRD-K62738477","","CNc1nc(C)nc(N[C@H]2CCC[C@H](C2)C(=O)NCc2ccc(cc2C(F)(F)F)C#N)n1"
"2229","GSK2330672","bile acid transporter inhibitor","SLC10A2","","","MedChemEx",96.72,"BRD-K05858796-001-01-7","Phase 2","","CZGVOBIGEBDYTP-VSGBNLITSA-N","BRD-K05858796","","CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(O)=O)CC(O)=O)c(OC)cc2[C@H](N1)c1ccccc1"
"2230","GSK2334470","phosphoinositide dependent kinase inhibitor","AURKA, AURKB, PDPK1","","","Tocris",86.72,"BRD-K70642949-001-04-5","Preclinical","","QLPHOXTXAKOFMU-WBVHZDCISA-N","BRD-K70642949","","CNc1nc(cc(n1)-c1ccc2c(N)n[nH]c2c1)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1"
"2231","GSK256066","phosphodiesterase inhibitor","PDE4A","","","Selleck",92.4,"BRD-K37590257-001-02-8","Phase 2","","JFHROPTYMMSOLG-UHFFFAOYSA-N","BRD-K37590257","","COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c2cccc(c2)C(=O)N(C)C)C(N)=O)c1"
"2232","GSK2578215A","leucine rich repeat kinase inhibitor","LRRK2","","","Tocris",98.57,"BRD-K30185465-001-03-0","Preclinical","","WCIGMFCFPXZRMQ-UHFFFAOYSA-N","BRD-K30185465","","Fc1cc(ccn1)-c1ccc(OCc2ccccc2)c(c1)C(=O)Nc1cccnc1"
"2233","GSK2606414","protein kinase inhibitor","EIF2AK3, MYLK2","","","MedChemEx, MedChemEx, Tocris",90.4,"BRD-K81689258-001-04-8, BRD-K81689258-001-02-2, BRD-K81689258-001-03-0","Preclinical","","SIXVRXARNAVBTC-UHFFFAOYSA-N","BRD-K81689258","","Cn1cc(-c2ccc3N(CCc3c2)C(=O)Cc2cccc(c2)C(F)(F)F)c2c(N)ncnc12"
"2236","GSK2636771","PI3K inhibitor","PIK3CB","","","Selleck, Selleck",91.39,"BRD-K49215523-001-04-2, BRD-K49215523-001-05-9","Phase 2","","XTKLTGBKIDQGQL-UHFFFAOYSA-N","BRD-K49215523","","Cc1nc2c(cc(cc2n1Cc1cccc(c1C)C(F)(F)F)N1CCOCC1)C(O)=O"
"2238","GSK2656157","PERK inhibitor","","","","Selleck",95.49,"BRD-K41104902-001-01-3","Preclinical","","PRWSIEBRGXYXAJ-UHFFFAOYSA-N","BRD-K41104902","","Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1"
"2239","GSK269962","rho associated kinase inhibitor","ROCK1, ROCK2","","","Tocris",98.12,"BRD-K89464729-001-03-1","Preclinical","","YOVNFNXUCOWYSG-UHFFFAOYSA-N","BRD-K89464729","","CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)-c1nonc1N"
"2240","GSK2801","bromodomain inhibitor","BAZ2A, BAZ2B","","","MedChemEx",97.85,"BRD-K48062199-001-01-8","Preclinical","","KHWCPNJRJCNVRI-UHFFFAOYSA-N","BRD-K48062199","","CCCOc1ccn2c(cc(-c3ccccc3S(C)(=O)=O)c2c1)C(C)=O"
"2241","GSK2816126","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx, MedChemEx",88.86,"BRD-K21867462-001-02-9, BRD-K21867462-001-03-7","Phase 1","","FKSFKBQGSFSOSM-QFIPXVFZSA-N","BRD-K21867462","","CC[C@H](C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCNCC1)C(=O)NCc1c(C)cc(C)[nH]c1=O"
"2243","GSK2830371","protein phosphatase inhibitor","PPM1D","","","MedChemEx, Tocris",93.44,"BRD-K17472821-001-01-2, BRD-K17472821-001-02-0","Preclinical","","IVDUVEGCMXCMSO-FQEVSTJZSA-N","BRD-K17472821","","Cc1ncc(Cl)cc1NCc1ccc(s1)C(=O)N[C@@H](CC1CCCC1)C(=O)NC1CC1"
"2245","GSK2838232","HIV gag inhibitor","","","","MedChemEx, MedChemEx",81.68,"BRD-K08398903-001-02-9, BRD-K08398903-001-01-1","Phase 1","","MEOWKUXNVNJAMY-PZFKGGKESA-N","BRD-K08398903","","CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)Cc1ccc(Cl)cc1"
"2247","GSK2879552","histone lysine demethylase inhibitor","KDM1A","","","MedChemEx",97.24,"BRD-K09223495-001-01-4","Phase 1","","LRULVYSBRWUVGR-FCHUYYIVSA-N","BRD-K09223495","","OC(=O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1"
"2248","GSK3787","PPAR receptor antagonist","PPARD","","","Tocris, Selleck",95.61,"BRD-K03155172-001-03-0, BRD-K03155172-001-02-2","Preclinical","","JFUIMTGOQCQTPF-UHFFFAOYSA-N","BRD-K03155172","","FC(F)(F)c1ccc(nc1)S(=O)(=O)CCNC(=O)c1ccc(Cl)cc1"
"2250","GSK429286A","rho associated kinase inhibitor","ROCK1","","","MedChemEx, Selleck, Tocris",96.54,"BRD-A10523515-001-11-1, BRD-A10523515-001-07-9, BRD-A10523515-001-10-3","Preclinical","","OLIIUAHHAZEXEX-UHFFFAOYSA-N","BRD-A10523515","","CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F"
"2253","GSK461364","PLK inhibitor","PLK1","","","Selleck",94.3,"BRD-K92428232-001-10-6","Phase 1","","ZHJGWYRLJUCMRT-QGZVFWFLSA-N","BRD-K92428232","","C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F"
"2254","GSK503","histone lysine methyltransferase inhibitor","EZH2","","","MedChemEx",94.9,"BRD-K72293620-001-01-7","Preclinical","","HRDQQHUKUIKFHT-UHFFFAOYSA-N","BRD-K72293620","","CC(C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCN(C)CC1)C(=O)NCc1c(C)cc(C)[nH]c1=O"
"2255","GSK650394","serum/glucocorticoid regulated kinase inhibitor","SGK1, SGK2","","","MedChemEx, Tocris, Tocris",97.46,"BRD-K14991967-001-04-2, BRD-K14991967-001-02-6, BRD-K14991967-001-03-4","Preclinical","","WVSBGSNVCDAMCF-UHFFFAOYSA-N","BRD-K14991967","","OC(=O)c1ccc(cc1C1CCCC1)-c1c[nH]c2ncc(cc12)-c1ccccc1"
"2258","GSK690693","AKT inhibitor","AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX","","","Selleck, Selleck, Tocris",94.6,"BRD-K25325018-001-05-6, BRD-K25325018-001-02-3, BRD-K25325018-001-06-4","Phase 1","BRD-K29174426-001-01-9","KGPGFQWBCSZGEL-ZDUSSCGKSA-N","BRD-K25325018","BRD-K29174426","CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N"
"2261","GSK9027","glucocorticoid receptor agonist","NR3C1","","","Tocris",96.16,"BRD-K29328421-001-01-6","Preclinical","","DXBJGDVBQPEMOB-UHFFFAOYSA-N","BRD-K29328421","","Fc1ccc(cc1)-n1ncc2cc(ccc12)-c1ccc(NS(=O)(=O)Cc2ccccc2)cc1C(F)(F)F"
"2262","GSK923295","centromere associated protein inhibitor","CENPE","","","MedChemEx",88.45,"BRD-K89015388-001-01-7","Phase 1","","WHMXDBPHBVLYRC-OFVILXPXSA-N","BRD-K89015388","","CC(C)Oc1ccc(cc1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)Cc1ccc(cc1)-c1cn2cccc([C@H](C)O)c2n1"
"2263","GTP-14564","FLT3 inhibitor, tyrosine kinase inhibitor","CSF1R, FLT3, KIT, PDGFRB","","","Tocris, Tocris",98.68,"BRD-K16664969-001-04-1, BRD-K16664969-001-03-3","Preclinical","","DZQLVVLATXPWBK-UHFFFAOYSA-N","BRD-K16664969","","c1ccc(cc1)-c1n[nH]c2c1oc1ccccc21"
"2265","GTS21","cholinergic receptor agonist","CHRNA7","","","ChemDiv",98.14,"BRD-K14235254-001-01-2","Phase 1/Phase 2","","RPYWXZCFYPVCNQ-RVDMUPIBSA-N","BRD-K14235254","","COc1ccc(\C=C2CCCN=C/2c2cccnc2)c(OC)c1"
"2266","GUACETISAL","immunosuppressant","","","","AvaChem",96.88,"BRD-K00739965-001-01-9","Launched","","HSJFYRYGGKLQBT-UHFFFAOYSA-N","BRD-K00739965","","COc1ccccc1OC(=O)c1ccccc1OC(C)=O"
"2267","GUAIACOL","local anesthetic","CA2","","","MicroSource",0,"BRD-K96282009-001-08-8","Launched","","LHGVFZTZFXWLCP-UHFFFAOYSA-N","BRD-K96282009","","COc1ccccc1O"
"2268","GUANIDINOETHYLDISULFIDE-BICARBONATE","nitric oxide synthase inhibitor","NOS2","","","TygerSci",0,"BRD-K69191882-065-01-6","Phase 2","","IRMTXMJNHRISQH-UHFFFAOYSA-N","BRD-K69191882","","NC(N)=NCCSSCCN=C(N)N"
"2269","GUANIDINOPROPIONIC-ACID","creatine kinase inhibitor","CKM","","","Sigma",0,"BRD-K50781608-001-02-1","Phase 2","","KMXXSJLYVJEBHI-UHFFFAOYSA-N","BRD-K50781608","","NC(N)=NCCC(O)=O"
"2270","GUANOSINE","","PNP","","","Selleck",92.38,"BRD-K92976206-001-01-5","Preclinical","","NYHBQMYGNKIUIF-HAVMAKPUSA-N","BRD-K92976206","","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O"
"2271","GUE-1654","oxoeicosanoid receptor modulator","OXER1","","","Tocris",96.81,"BRD-K18745919-001-01-3","Preclinical","","UFOBDFMYJABXGK-UHFFFAOYSA-N","BRD-K18745919","","CSc1nc2ccc3nc(NC(=O)C(c4ccccc4)c4ccccc4)sc3c2s1"
"2272","GUVACINE","GABA uptake inhibitor","SLC6A1, SLC6A11, SLC6A12, SLC6A13","","","Tocris",100,"BRD-K01980392-003-11-6","Preclinical","","QTDZOWFRBNTPQR-UHFFFAOYSA-N","BRD-K01980392","","OC(=O)C1=CCCNC1"
"2273","GW-0742","PPAR receptor agonist","PPARD","","","Tocris, Selleck, Tocris",94.54,"BRD-K82983861-001-05-0, BRD-K82983861-001-04-3, BRD-K82983861-001-06-8","Preclinical","","HWVNEWGKWRGSRK-UHFFFAOYSA-N","BRD-K82983861","","Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F"
"2276","GW-1100","G protein-coupled receptor agonist","FFAR1","","","MedChemEx",93.14,"BRD-K23614267-001-01-2","Preclinical","","PTPNCCWOTBBVJR-UHFFFAOYSA-N","BRD-K23614267","","CCOC(=O)c1ccc(cc1)-n1cc(Cc2cnc(OCC)nc2)c(=O)nc1SCc1ccc(F)cc1"
"2277","GW-1929","PPAR receptor agonist","PPARG","","","Tocris",75.23,"BRD-A15415227-003-02-9","Preclinical","","QTQMRBZOBKYXCG-UHFFFAOYSA-N","BRD-A15415227","","CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1"
"2278","GW-2580","cFMS kinase inhibitor","CSF1R","","","Selleck",94.93,"BRD-K24242599-001-02-8","Preclinical","","MYQAUKPBNJWPIE-UHFFFAOYSA-N","BRD-K24242599","","COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1"
"2279","GW-311616","leukocyte elastase inhibitor, elastase inhibitor","ELANE","","","MedChemEx",97.39,"BRD-K37864785-001-01-0","Phase 1","","NDNKNUMSTIMSHQ-URZKGLGPSA-N","BRD-K37864785","","CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O"
"2280","GW-3965","LXR agonist","NR1H2, NR1H3","","","Tocris, Tocris, Selleck",97.64,"BRD-K33818169-003-04-6, BRD-K33818169-003-05-3, BRD-K33818169-003-03-8","Preclinical","","NAXSRXHZFIBFMI-UHFFFAOYSA-N","BRD-K33818169","","OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1"
"2283","GW-405833","cannabinoid receptor agonist","CNR2","","","Tocris",95.83,"BRD-K10705233-001-02-2","Preclinical","","FSFZRNZSZYDVLI-UHFFFAOYSA-N","BRD-K10705233","","COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1"
"2284","GW-4064","FXR agonist","NR1H4","","","Tocris, Selleck",94.31,"BRD-K88186167-001-05-5, BRD-K88186167-001-04-8","Preclinical","","BYTNEISLBIENSA-MDZDMXLPSA-N","BRD-K88186167","","CC(C)c1onc(c1COc1ccc(\C=C\c2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl"
"2286","GW-438014A","neuropeptide receptor antagonist","NPY5R","","","Tocris",96.45,"BRD-K13039700-066-01-2","Preclinical","","CDUDZZGLFOFINU-UHFFFAOYSA-N","BRD-K13039700","","O=C(Nc1nc2ccccc2n1CCc1ccccc1)c1ccccc1"
"2287","GW-441756","growth factor receptor inhibitor","NTRK1","","","Tocris, Selleck",96.24,"BRD-K41312087-001-02-7, BRD-K41312087-001-01-9","Preclinical","","NXNQLECPAXXYTR-LCYFTJDESA-N","BRD-K41312087","","Cn1cc(\C=C2/C(=O)Nc3cccnc23)c2ccccc12"
"2289","GW-501516","PPAR receptor agonist","PPARA, PPARD","","","MedChemEx, MedChemEx",95.38,"BRD-K14880289-001-03-0, BRD-K14880289-001-02-2","Phase 2","","YDBLKRPLXZNVNB-UHFFFAOYSA-N","BRD-K14880289","","Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F"
"2291","GW-5074","RAF inhibitor, leucine rich repeat kinase inhibitor","NTRK1, RAF1","","","Selleck, Tocris, Selleck",58.05,"BRD-K39520573-001-03-8, BRD-K39520573-001-04-6, BRD-K39520573-001-02-0","Preclinical","BRD-K07859598-001-13-8, BRD-K07859598-001-12-0, BRD-K93653303-001-01-1","LMXYVLFTZRPNRV-UHFFFAOYSA-N","BRD-K39520573","BRD-K07859598","Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br"
"2294","GW-542573X","calcium channel activator","KCNN1","","","Tocris",91.84,"BRD-K36485341-001-01-2","Preclinical","","SAXGSDIZIYFNKD-UHFFFAOYSA-N","BRD-K36485341","","COc1ccccc1NC(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C"
"2295","GW-583340","EGFR inhibitor","EGFR, ERBB2","","","Tocris, Tocris",93.17,"BRD-K79930101-300-04-5, BRD-K79930101-300-03-7","Preclinical","","MNNXRVSQOABRRP-UHFFFAOYSA-N","BRD-K79930101","","CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1"
"2297","GW-627368","prostanoid receptor antagonist","PTGER4","","","Tocris",99.49,"BRD-K50005760-001-01-1","Preclinical","","XREWXJVMYAXCJV-UHFFFAOYSA-N","BRD-K50005760","","CCOc1c2CN(C(=O)c2c(OCC)c2ccccc12)c1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1"
"2298","GW-6471","PPAR receptor antagonist","PPARA","","","Tocris, Tocris",97.24,"BRD-K20828910-001-01-2, BRD-K20828910-001-02-0","Preclinical","","TYEFSRMOUXWTDN-DYQICHDWSA-N","BRD-K20828910","","CCC(=O)NC[C@H](Cc1ccc(OCCc2nc(oc2C)-c2ccccc2)cc1)N\C(C)=C/C(=O)c1ccc(cc1)C(F)(F)F"
"2300","GW-7647","PPAR receptor agonist","PPARA","","","Tocris, Tocris",97.97,"BRD-K96263742-001-15-5, BRD-K96263742-001-14-8","Preclinical","","PKNYXWMTHFMHKD-UHFFFAOYSA-N","BRD-K96263742","","CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O"
"2302","GW-788388","ALK tyrosine kinase receptor inhibitor","LCK, MAPK14, TGFBR1","","","Selleck, Tocris",95,"BRD-K78086729-001-02-7, BRD-K78086729-001-03-5","Preclinical","","SAGZIBJAQGBRQA-UHFFFAOYSA-N","BRD-K78086729","","O=C(NC1CCOCC1)c1ccc(cc1)-c1cc(ccn1)-c1c[nH]nc1-c1ccccn1"
"2304","GW-803430","melanin inhibitor","KCNH2, MCHR1","","","Tocris",93.27,"BRD-K65576800-001-01-6","Phase 1","","MWULMTACIBZPGN-UHFFFAOYSA-N","BRD-K65576800","","COc1cc(ccc1OCCN1CCCC1)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1"
"2305","GW-842166","cannabinoid receptor agonist","CNR2","","","Selleck",97.52,"BRD-K26823213-001-02-9","Phase 2","","TWQYWUXBZHPIIV-UHFFFAOYSA-N","BRD-K26823213","","FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1"
"2306","GW-843682X","PLK inhibitor","PLK1, PLK3","","","Tocris, Tocris",98.98,"BRD-K90382497-001-10-7, BRD-K90382497-001-13-1","Preclinical","","JSKUWFIZUALZLX-UHFFFAOYSA-N","BRD-K90382497","","COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC"
"2308","GW-9508","free fatty acid receptor agonist, G protein-coupled receptor agonist","FFAR1, FFAR4","","","Tocris, Tocris, Selleck",94.14,"BRD-K71534238-001-11-8, BRD-K71534238-001-12-6, BRD-K71534238-001-10-0","Preclinical","","DGENZVKCTGIDRZ-UHFFFAOYSA-N","BRD-K71534238","","OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1"
"2311","GW-9662","PPAR receptor antagonist","NCOA2, PPARG, RXRA","","","Selleck, Tocris",98.73,"BRD-K93258693-001-16-5, BRD-K93258693-001-17-3","Preclinical","","DNTSIBUQMRRYIU-UHFFFAOYSA-N","BRD-K93258693","","[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccccc1"
"2313","GYKI-52466","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Tocris, Tocris",71.41,"BRD-K24240364-003-09-6, BRD-K24240364-003-08-8","Preclinical","","LFBZZHVSGAHQPP-UHFFFAOYSA-N","BRD-K24240364","","CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1"
"2315","GYNOSTEMMA-EXTRACT","calcium channel modulator","","","","Selleck, Selleck",2.21,"BRD-K58775955-001-02-4, BRD-K58775955-001-03-2","Preclinical","BRD-K75189747-001-01-2","ZTQSADJAYQOCDD-HUGMCNGHSA-N","BRD-K58775955","BRD-K75189747","CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C"
"2317","GZD824","Bcr-Abl kinase inhibitor","ABL1, BCR","","","Selleck",96.55,"BRD-K35329391-334-01-7","Preclinical","","TZKBVRDEOITLRB-UHFFFAOYSA-N","BRD-K35329391","","CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1"
"2318","G007-LK","tankyrase inhibitor","TNKS, TNKS2","","","MedChemEx",97.94,"BRD-K12198961-001-01-8","Preclinical","","HIWVLHPKZNBSBE-OUKQBFOZSA-N","BRD-K12198961","","CS(=O)(=O)c1ccc(nc1)-c1nnc(\C=C\c2nnc(o2)-c2ccc(cc2)C#N)n1-c1ccccc1Cl"
"2319","H-89","PKA inhibitor","GSG2, PKIA, PRKACA","","","Tocris, Selleck, Tocris",97.93,"BRD-K27737647-300-04-8, BRD-K27737647-300-03-0, BRD-K27737647-300-08-9","Preclinical","","ZKZXNDJNWUTGDK-NSCUHMNNSA-N","BRD-K27737647","","Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1"
"2322","HA-1004","calcium channel blocker","","","","Enzo",98.82,"BRD-K05434375-001-06-5","Phase 2","","MZNDNBFMSVMUCX-UHFFFAOYSA-N","BRD-K05434375","","NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12"
"2323","HA-130","autotaxin inhibitor","ENPP2","","","Tocris",90.3,"BRD-K64452997-001-01-4","Preclinical","","VTNKMYWFWQTEHE-XKZIYDEJSA-N","BRD-K64452997","","OB(O)c1cccc(COc2ccc(\C=C3/SC(=O)N(Cc4ccc(F)cc4)C3=O)cc2)c1"
"2324","HA-14-1","BCL inhibitor","BCL2","","","Tocris",0,"BRD-A13807286-001-07-0","Preclinical","","SXJDCULZDFWMJC-UHFFFAOYSA-N","BRD-A13807286","","CCOC(=O)C(C#N)C1c2cc(Br)ccc2OC(N)=C1C(=O)OCC"
"2325","HA-966-(R)-(+)","glutamate receptor agonist","GRIA1","","","Tocris",100,"BRD-K58046914-001-03-8","Preclinical","","HCKUBNLZMKAEIN-GSVOUGTGSA-N","BRD-K58046914","","N[C@@H]1CCN(O)C1=O"
"2326","HA-966-(S)-(-)","glutamate receptor antagonist","GRIA1","","","Tocris",100,"BRD-K41304947-001-03-2","Preclinical","","HCKUBNLZMKAEIN-VKHMYHEASA-N","BRD-K41304947","","N[C@H]1CCN(O)C1=O"
"2327","HALAZONE","","","","","MicroSource",0,"BRD-K68091065-001-04-7","Launched","","XPDVQPODLRGWPL-UHFFFAOYSA-N","BRD-K68091065","","OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl"
"2328","HALOPEMIDE","phospholipase inhibitor","PLD1, PLD2","","","Sigma",97.2,"BRD-K50055394-001-03-6","Phase 2","","NBHPRWLFLUBAIE-UHFFFAOYSA-N","BRD-K50055394","","Oc1nc2cc(Cl)ccc2n1C1CCN(CCNC(=O)c2ccc(F)cc2)CC1"
"2329","HARMANE","monoamine oxidase inhibitor","MAOA, MAOB","","","Tocris",97.3,"BRD-K12630395-001-14-9","Preclinical","","PSFDQSOCUJVVGF-UHFFFAOYSA-N","BRD-K12630395","","Cc1nccc2c3ccccc3[nH]c12"
"2330","HARRINGTONINE","protein synthesis inhibitor","","","","Enzo",87.81,"BRD-K96358241-001-01-9","Phase 3","","HAVJATCHLFRDHY-JZTSUELASA-N","BRD-K96358241","","COC(=O)C[C@@](O)(CCC(C)(C)O)C(=O)O[C@H]1[C@@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC"
"2331","HA14-1","BCL inhibitor","BCL2","","","Selleck, Selleck",95.14,"BRD-K18163608-001-02-3, BRD-K18163608-001-05-6","Preclinical","","SXJDCULZDFWMJC-AAEUAGOBSA-N","BRD-K18163608","","CCOC(=O)[C@@H](C#N)[C@@H]1c2cc(Br)ccc2OC(N)=C1C(=O)OCC"
"2333","HC-030031","TRPA1 channel blocker","TRPA1","","","Selleck",98.24,"BRD-K73815512-001-02-5","Phase 1","","HEQDZPHDVAOBLN-UHFFFAOYSA-N","BRD-K73815512","","CC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1"
"2334","HC-067047","transient receptor potential channel antagonist","TRPV4","","","Tocris",93.91,"BRD-K03391209-001-02-0","Preclinical","","NCZYSQOTAYFTNM-UHFFFAOYSA-N","BRD-K03391209","","Cc1c(cc(-c2ccccc2)n1CCCN1CCOCC1)C(=O)Nc1cccc(c1)C(F)(F)F"
"2335","HECLIN","ubiquitin ligase inhibitor","NEDD4, SMURF2, WWP1","","","Tocris",91.97,"BRD-K49788188-001-01-0","Preclinical","","SPTWXRJNCFIDRQ-ZHACJKMWSA-N","BRD-K49788188","","CCc1ccc(\C=C\C(=O)Nc2ccc(cc2)C(C)=O)o1"
"2336","HEMADO","","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",96.56,"BRD-K34672903-001-02-5, BRD-K34672903-001-01-7","Preclinical","","KOCIMZNSNPOGOP-IWCJZZDYSA-N","BRD-K34672903","","CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1"
"2338","HEMATOXYLIN","","","","","Selleck, Selleck",94.58,"BRD-K78342372-001-03-2, BRD-K78342372-001-02-4","Preclinical","","WZUVPPKBWHMQCE-XJKSGUPXSA-N","BRD-K78342372","","Oc1cc2C[C@@]3(O)COc4c(ccc(O)c4O)[C@H]3c2cc1O"
"2340","HEMOGLOBIN-MODULATORS-1","hemoglobin modulator","","","","MedChemEx",96.07,"BRD-K43639297-001-01-9","Phase 3","","FWCVZAQENIZVMY-UHFFFAOYSA-N","BRD-K43639297","","CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O"
"2341","HEMOMEX-S","","PPARG","","","MedChemEx",90.75,"BRD-K15231341-001-01-5","Launched","","SHCBCKBYTHZQGZ-CJPZEJHVSA-N","BRD-K15231341","","CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C"
"2342","HER2-INHIBITOR-1","EGFR inhibitor","","","","Selleck",62.06,"BRD-K89709433-001-02-8","Preclinical","","QVMNYGOVNWWFKF-UHFFFAOYSA-N","BRD-K89709433","","Cc1cc(Nc2ncnc3ccc(cc23)-c2ccc(CNCCS(C)(=O)=O)o2)ccc1Oc1ccn2ncnc2c1"
"2343","HESPERADIN","Aurora kinase inhibitor","AURKB","","","Selleck, Tocris",96.66,"BRD-K58122457-001-02-2, BRD-K58122457-003-01-0","Preclinical","","GLDSKRNGVVYJAB-DQSJHHFOSA-N","BRD-K58122457","","CCS(=O)(=O)Nc1ccc2NC(=O)\C(c2c1)=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1"
"2345","HESPERETIN","ACAT inhibitor","DGAT1, MTTP, SOAT1, SOAT2","","","Selleck",98.16,"BRD-K30553453-001-13-2","Launched","","AIONOLUJZLIMTK-AWEZNQCLSA-N","BRD-K30553453","","COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1"
"2346","HESPERIDIN","flavanone glycoside","CACNA1B","","","Selleck, Selleck, Selleck",90.46,"BRD-K38903228-001-11-9, BRD-K38903228-001-13-5, BRD-K38903228-001-12-7","Launched","BRD-K43382661-001-02-2,BRD-M12718521-001-02-2, BRD-K53229386-001-04-2,BRD-K93633846-001-01-7, BRD-K43382661-001-01-4,BRD-M45990714-001-01-7","QUQPHWDTPGMPEX-QJBIFVCTSA-N","BRD-K38903228","BRD-K43382661","COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1"
"2349","HEXAMETHONIUM","cholinergic receptor antagonist","CHRNA2, CHRNA3, CHRNA4, CHRNA6","","","MicroSource, Selleck, Selleck",96.93,"BRD-K10598093-303-06-1, BRD-K10598093-303-05-3, BRD-K10598093-303-07-9","Preclinical","","VZJFGSRCJCXDSG-UHFFFAOYSA-N","BRD-K10598093","","C[N+](C)(C)CCCCCC[N+](C)(C)C"
"2352","HEXAMETHYLENEBISACETAMIDE","AKT inhibitor, differentiation inducer, NFKB pathway inhibitor","AKT1","","","Sigma",87.14,"BRD-K04710043-001-17-8","Phase 2","","BNQSTAOJRULKNX-UHFFFAOYSA-N","BRD-K04710043","","CC(=O)NCCCCCCNC(C)=O"
"2353","HEXASODIUM-PHYTATE","","","","","TCI",0,"BRD-K70007857-001-01-7","Phase 2","","IMQLKJBTEOYOSI-GPIVLXJGSA-N","BRD-K70007857","","OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O"
"2354","HEXESTROL","synthetic estrogen","AKR1C1, ESR1, ESR2","","","MicroSource, Selleck, Selleck",88.97,"BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8","Launched","","PBBGSZCBWVPOOL-UHFFFAOYSA-N","BRD-A01078468","","CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1"
"2355","HEXESTROL","synthetic estrogen","AKR1C1, ESR1, ESR2","","","MicroSource, Selleck, Selleck",88.97,"BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8","Launched","","PBBGSZCBWVPOOL-UHFFFAOYSA-N","BRD-A01078468","","CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1"
"2357","HEXESTROL","synthetic estrogen","AKR1C1, ESR1, ESR2","","","MicroSource, Selleck, Selleck",88.97,"BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8","Launched","","PBBGSZCBWVPOOL-HDICACEKSA-N","BRD-A01078468","","CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1"
"2358","HEXESTROL","synthetic estrogen","AKR1C1, ESR1, ESR2","","","MicroSource, Selleck, Selleck",88.97,"BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8","Launched","","PBBGSZCBWVPOOL-HDICACEKSA-N","BRD-A01078468","","CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1"
"2360","HEXONIC-ACID","","","","","Sigma",90.83,"BRD-A63267145-001-01-0","Preclinical","BRD-M98748937-001-01-6","RGHNJXZEOKUKBD-UHFFFAOYSA-N","BRD-A63267145","BRD-M98748937","OCC(O)C(O)C(O)C(O)C(O)=O"
"2361","HEXYLENE-GLYCOL","","AKR1C3, CTPS1, DLG4, HSP90AA1, NOS3, PGF, PLA2G1B, PTPN1, SELP","","","MicroSource",15.17,"BRD-A14234430-001-01-4","Preclinical","","SVTBMSDMJJWYQN-UHFFFAOYSA-N","BRD-A14234430","","CC(O)CC(C)(C)O"
"2362","HIGENAMINE","adrenergic receptor agonist","ADRB2","","","Accela",94.65,"BRD-A55204514-003-01-2","Phase 1","","WZRCQWQRFZITDX-UHFFFAOYSA-N","BRD-A55204514","","Oc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1"
"2363","HIPPURIC-ACID","","","","","CombiBlocks",97.62,"BRD-K62914667-001-13-9","Preclinical","","QIAFMBKCNZACKA-UHFFFAOYSA-N","BRD-K62914667","","OC(=O)CNC(=O)c1ccccc1"
"2364","HJC-0350","GTPase inhibitor","RAPGEF4","","","Tocris",95.86,"BRD-K34411045-001-01-9","Preclinical","","AFZWZVLPIMHLSE-UHFFFAOYSA-N","BRD-K34411045","","Cc1cc(C)n(c1)S(=O)(=O)c1c(C)cc(C)cc1C"
"2365","HKI-357","EGFR inhibitor","EGFR","","","Tocris, Tocris",98.23,"BRD-K58811567-001-01-9, BRD-K58811567-001-02-7","Phase 1","","NERXPXBELDBEPZ-RMKNXTFCSA-N","BRD-K58811567","","CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C"
"2367","HLCL-61","protein arginine N-methyltransferase inhibitor","PRMT5","","","MedChemEx",95.62,"BRD-K73746696-003-01-8","Preclinical","","FIOIJUCPVZEPFX-UHFFFAOYSA-N","BRD-K73746696","","CCn1c2ccccc2c2cc(CNCc3ccccc3OC)ccc12"
"2368","HMN-214","PLK inhibitor","PLK1","","","Selleck",90.91,"BRD-K70511574-001-06-9","Phase 1","","OCKHRKSTDPOHEN-BQYQJAHWSA-N","BRD-K70511574","","COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1\C=C\c1cc[n+]([O-])cc1"
"2369","HOMIDIUM","","","","","MicroSource",69.09,"BRD-K28354016-004-11-7","Preclinical","","QTANTQQOYSUMLC-UHFFFAOYSA-O","BRD-K28354016","","CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12"
"2370","HOMOQUINOLINIC-ACID","glutamate receptor agonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris",100,"BRD-K30519779-001-03-1","Preclinical","","HQPMJFFEXJELOQ-UHFFFAOYSA-N","BRD-K30519779","","OC(=O)Cc1cccnc1C(O)=O"
"2371","HOMOSALATE","HSP inducer","","","","MicroSource",85.67,"BRD-A34751532-001-06-9","Preclinical","","WSSJONWNBBTCMG-UHFFFAOYSA-N","BRD-A34751532","","CC1CC(CC(C)(C)C1)OC(=O)c1ccccc1O"
"2372","HOMOVERATRYLAMINE","dopamine analog","","","","Prestwick",66.18,"BRD-K59570838-003-01-9","Preclinical","","ANOUKFYBOAKOIR-UHFFFAOYSA-N","BRD-K59570838","","COc1ccc(CCN)cc1OC"
"2373","HONOKIOL","AKT inhibitor","ALOX5, PTGS1, PTGS2","","","Selleck",97.8,"BRD-K98493452-001-14-9","Phase 3","","FVYXIJYOAGAUQK-UHFFFAOYSA-N","BRD-K98493452","","Oc1ccc(cc1CC=C)-c1cc(CC=C)ccc1O"
"2374","HORDENINE","","","","","Selleck, Selleck",88.33,"BRD-K93631643-001-03-2, BRD-K93631643-001-02-4","Preclinical","","KUBCEEMXQZUPDQ-UHFFFAOYSA-N","BRD-K93631643","","CN(C)CCc1ccc(O)cc1"
"2376","HQK-1001","","","","","Enamine, Enamine",0,"BRD-K44963273-001-07-7, BRD-K44963273-001-06-9","Phase 2","","VUAXHMVRKOTJKP-UHFFFAOYSA-N","BRD-K44963273","","CCC(C)(C)C(O)=O"
"2378","HTH-01-015","protein kinase inhibitor","NUAK1","","","Tocris",86.89,"BRD-K58726989-001-01-9","Preclinical","","CHSDJDLAKKAWCI-UHFFFAOYSA-N","BRD-K58726989","","CN1c2cc3ccccc3cc2C(=O)N(C)c2c(C)nc(Nc3cnn(c3)C3CCNCC3)nc12"
"2379","HTMT","histamine receptor agonist","HRH4","","","Tocris, Tocris",86.57,"BRD-A66435872-332-02-6, BRD-A66435872-332-01-8","Preclinical","","PMKJGGBYYNEYPA-UHFFFAOYSA-N","BRD-A66435872","","CC(CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)NCCc1c[nH]cn1"
"2381","HUPERZINE-A","acetylcholinesterase inhibitor","ACHE","","","MedChemEx, Selleck, Selleck",86.35,"BRD-K62240499-001-05-9, BRD-K62240499-001-04-2, BRD-K62240499-001-06-7","Phase 2","BRD-K45888792-001-03-6, BRD-K97618845-001-03-1, BRD-K45888792-001-02-8","ZRJBHWIHUMBLCN-YQEJDHNASA-N","BRD-K62240499","BRD-K45888792","C\C=C1/[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)CC(C)=C2"
"2384","HYDRASTINE-(1R,-9S)","tyrosine hydroxylase inhibitor","","","","MicroSource",99.03,"BRD-K02715688-001-02-1","Preclinical","","JZUTXVTYJDCMDU-MOPGFXCFSA-N","BRD-K02715688","","COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3cc12"
"2385","HYDRASTININE","haemostatic agent","","","","MicroSource, Selleck",92.64,"BRD-A57900429-003-06-6, BRD-A57900429-003-05-8","Preclinical","","YOJQZPVUNUQTDF-UHFFFAOYSA-N","BRD-A57900429","","CN1CCc2cc3OCOc3cc2C1O"
"2387","HYDROCORTISONE-HEMISUCCINATE","","","","","MicroSource",96.14,"BRD-A07000685-001-04-4","Phase 2/Phase 3","","VWQWXZAWFPZJDA-PILPDLGISA-N","BRD-A07000685","","C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O"
"2388","HYDROXYFASUDIL","rho associated kinase inhibitor","PKIA, PRKACA, ROCK1","","","Tocris",97.11,"BRD-K77793136-003-03-0","Preclinical","","ZAVGJDAFCZAWSZ-UHFFFAOYSA-N","BRD-K77793136","","Oc1nccc2c(cccc12)S(=O)(=O)N1CCCNCC1"
"2389","HYDROXYPROGESTERONE-ACETATE","progesterone receptor agonist","PGR","","","Sigma",94,"BRD-K92902018-001-01-9","Launched","","VTHUYJIXSMGYOQ-KOORYGTMSA-N","BRD-K92902018","","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O"
"2390","HYDROXYPROPYL-BETA-CYCLODEXTRIN","","","","","Cayman",98.32,"BRD-A01412266-001-01-0","Phase 2","","ODLHGICHYURWBS-LKONHMLTSA-N","BRD-A01412266","","CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O"
"2391","HYDROXYSTILBAMIDINE","","","","","Enzo",93.1,"BRD-K62186992-334-02-8","Launched","","TUESWZZJYCLFNL-DAFODLJHSA-N","BRD-K62186992","","NC(=N)c1ccc(cc1)\C=C\c1ccc(cc1O)C(N)=N"
"2392","HYDROXYTACRINE-MALEATE-(R,S)","cholinesterase inhibitor","ACHE","","","Prestwick",92.87,"BRD-A98299281-050-09-6","Preclinical","","HLVVITIHAZBPKB-UHFFFAOYSA-N","BRD-A98299281","","Nc1c2C(O)CCCc2nc2ccccc12"
"2393","HYDROXYTOLUIC-ACID","","","","","MicroSource",99.14,"BRD-K75608666-001-08-3","Preclinical","","WHSXTWFYRGOBGO-UHFFFAOYSA-N","BRD-K75608666","","Cc1cccc(C(O)=O)c1O"
"2394","HYGROMYCIN-B","polypeptide synthesis inhibitor","","","","Selleck",100,"BRD-A67101513-001-03-7","Preclinical","BRD-A26049141-001-01-2","ONCSSPOCYKWCTO-WOZJRPKHSA-N","BRD-A67101513","BRD-A26049141","CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H]3OC4(O[C@@H]3[C@@H]2O)O[C@H](C(N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O"
"2395","HYMECROMONE","monoamine oxidase inhibitor","MAOA, MAOB","","","MicroSource, Selleck",95.22,"BRD-K46424862-001-15-8, BRD-K46424862-001-14-1","Phase 2","","HSHNITRMYYLLCV-UHFFFAOYSA-N","BRD-K46424862","","Cc1cc(=O)oc2cc(O)ccc12"
"2397","HYODEOXYCHOLIC-ACID","atherosclerosis formation inhibitor","","","","Selleck",96.92,"BRD-K44009692-001-02-3","Phase 1","BRD-K49031386-001-01-5","DGABKXLVXPYZII-SIBKNCMHSA-N","BRD-K44009692","BRD-K49031386","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"2398","HYPERICIN","tyrosine kinase inhibitor","","","","Enzo",87.7,"BRD-K29673530-001-05-4","Phase 2","","BTXNYTINYBABQR-UHFFFAOYSA-N","BRD-K29673530","","Cc1cc(O)c2c3c1c1c(C)cc(O)c4c1c1c3c3c(c(O)cc(O)c3c2=O)c2c(O)cc(O)c(c12)c4=O"
"2399","HYPERIN","aldose reductase inhibitor","ACE, AKR1B1","","","ChemDiv",96.75,"BRD-A63780829-001-11-4","Preclinical","","OVSQVDMCBVZWGM-UHFFFAOYSA-N","BRD-A63780829","","OCC1OC(Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)c(O)c2)C(O)C(O)C1O"
"2400","HYPOESTOXIDE","IKK inhibitor","IKBKB, IL1B, TNF","","","EMDBio",97.42,"BRD-A51571244-001-01-9","Phase 1","","HNPAHGHFONBTLV-UOAZVOCOSA-N","BRD-A51571244","","CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C"
"2401","HYPOXANTHINE","PARP inhibitor","PNP","","","Selleck",96.41,"BRD-K03739921-001-06-8","Preclinical","","FDGQSTZJBFJUBT-UHFFFAOYSA-N","BRD-K03739921","","O=c1[nH]cnc2nc[nH]c12"
"2402","H2L-5765834","lysophosphatidic acid receptor antagonist","LPAR1, LPAR3","","","Tocris",95.78,"BRD-K26439554-001-01-3","Preclinical","","HFYPTENHTPNXGP-UHFFFAOYSA-N","BRD-K26439554","","OC(=O)c1ccc2C(=O)N(C(=O)c2c1)c1cccc(Oc2ccc(cc2)[N+]([O-])=O)c1"
"2403","I-BET-762","bromodomain inhibitor","BRD2, BRD3, BRD4","","","Selleck",97.76,"BRD-K08109215-001-06-4","Phase 2","","AAAQFGUYHFJNHI-SFHVURJKSA-N","BRD-K08109215","","CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12"
"2404","I-BET151","bromodomain inhibitor","BRD2, BRD3, BRD4","","","Selleck, Tocris",96.17,"BRD-K36363294-001-04-2, BRD-K36363294-300-01-4","Preclinical","","VUVUVNZRUGEAHB-CYBMUJFWSA-N","BRD-K36363294","","COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C"
"2406","I-BRD9","bromodomain inhibitor","BRD9","","","Tocris, MedChemEx",95.93,"BRD-K04972057-001-02-9, BRD-K04972057-001-01-1","Preclinical","","WRUWGLUCNBMGPS-UHFFFAOYSA-N","BRD-K04972057","","CCn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1"
"2408","I-BZA","","","","","Enamine",89.11,"BRD-K14762862-001-01-9","Phase 2","","HRVWCNMOEFNEON-UHFFFAOYSA-N","BRD-K14762862","","CCN(CC)CCNC(=O)c1ccc(I)cc1"
"2409","I-BZA2","","","","","ChemBridge",98.45,"BRD-K71698503-003-01-6","Phase 3","","WNSWOZIBBVUJBI-UHFFFAOYSA-N","BRD-K71698503","","CCN(CC)CCNC(=O)c1ccccc1I"
"2410","I-CBP-112","bromodomain inhibitor","CREBBP, EP300","","","Tocris",81.05,"BRD-K57090026-001-02-4","Preclinical","","YKNAKDFZAWQEEO-IBGZPJMESA-N","BRD-K57090026","","CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]1CCCN(C)C1)-c1ccc(OC)c(OC)c1"
"2411","IB-MECA","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",96.28,"BRD-K31135544-001-07-0","Phase 3","","HUJXGQILHAUCCV-MOROJQBDSA-N","BRD-K31135544","","CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12"
"2412","IBC-293","hydroxycarboxylic acid receptor agonist","HCAR3","","","Tocris",96.09,"BRD-K15196155-001-02-3","Preclinical","","RUTVRAJKELSHCC-UHFFFAOYSA-N","BRD-K15196155","","CC(C)n1nnc2cc(ccc12)C(O)=O"
"2413","IBMX","phosphodiesterase inhibitor","ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A","","","Tocris",95.56,"BRD-K94979336-001-20-0","Preclinical","","APIXJSLKIYYUKG-UHFFFAOYSA-N","BRD-K94979336","","CC(C)Cn1c2[nH]cnc2c(=O)n(C)c1=O"
"2414","IBOTENIC-ACID","glutamate receptor agonist","GRIN1","","","Tocris",0,"BRD-A04628621-001-02-6","Phase 1","","IRJCBFDCFXCWGO-UHFFFAOYSA-N","BRD-A04628621","","NC(C(O)=O)c1cc(O)no1"
"2415","IBROLIPIM","lipoprotein lipase activator","LPL","","","Sigma",96.6,"BRD-K62490786-001-01-1","Phase 2","","KPRTURMJVWXURQ-UHFFFAOYSA-N","BRD-K62490786","","CCOP(=O)(Cc1ccc(cc1)C(=O)Nc1ccc(Br)cc1C#N)OCC"
"2416","IBUPROFEN-(S)","cyclooxygenase inhibitor","ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD","","","Tocris, MicroSource",99.44,"BRD-K14965640-001-13-2, BRD-K14965640-001-12-4","Preclinical","","HEFNNWSXXWATRW-JTQLQIEISA-N","BRD-K14965640","","CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O"
"2418","IBUPROFEN-PICONOL","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Enamine, Enamine",95.32,"BRD-A75224450-001-01-6, BRD-A75224450-001-02-4","Launched","","ACEWLPOYLGNNHV-UHFFFAOYSA-N","BRD-A75224450","","CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1"
"2420","IBUTAMOREN","growth hormone secretagogue receptor agonist","GHR, GHSR","","","MedChemEx, Tocris",94.74,"BRD-K44771174-066-01-0, BRD-K44771174-066-02-8","Phase 2","","UMUPQWIGCOZEOY-JOCHJYFZSA-N","BRD-K44771174","","CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CN(c3ccccc23)S(C)(=O)=O)CC1"
"2422","ICA-069673","voltage-gated potassium channel activator","KCNQ2, KCNQ3","","","Tocris",87.74,"BRD-K59839632-001-01-0","Preclinical","","IIBSHMFXVWTQSJ-UHFFFAOYSA-N","BRD-K59839632","","Fc1ccc(cc1F)C(=O)Nc1cnc(Cl)nc1"
"2423","ICA-110381","voltage-gated potassium channel activator","KCNQ2","","","Tocris",92.75,"BRD-K71686520-001-01-4","Preclinical","","FOYOGIUAMYSVIT-UHFFFAOYSA-N","BRD-K71686520","","Clc1ccc(cc1)C(=O)Nc1ccc(Cl)nc1"
"2424","ICA-121431","sodium channel blocker","SCN1A, SCN3A","","","Tocris",97.46,"BRD-K03149601-001-02-6","Preclinical","","URSQNPPONHUJDL-UHFFFAOYSA-N","BRD-K03149601","","O=C(Nc1ccc(cc1)S(=O)(=O)Nc1nccs1)C(c1ccccc1)c1ccccc1"
"2425","ICARIIN","phosphodiesterase inhibitor","PDE5A","","","Selleck, Selleck",90.67,"BRD-K65639003-001-10-8, BRD-K65639003-001-09-0","Phase 3","BRD-A06210771-001-02-9, BRD-A88583207-001-01-6","TZJALUIVHRYQQB-XLRXWWTNSA-N","BRD-K65639003","BRD-A06210771","COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c2c(=O)c1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O"
"2427","ICARITIN","PPAR receptor antagonist","PDE5A","","","MedChemEx, MedChemEx",88.81,"BRD-K24476327-001-02-1, BRD-K24476327-001-01-3","Phase 2","","TUUXBSASAQJECY-UHFFFAOYSA-N","BRD-K24476327","","COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O)cc(O)c2c(=O)c1O"
"2429","ICG-001","beta-catenin inhibitor","CTNNB1","","","Selleck",95.2,"BRD-K94455792-001-01-8","Preclinical","","HQWTUOLCGKIECB-LOYHVIPDSA-N","BRD-K94455792","","Oc1ccc(C[C@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc2ccccc2)cc1"
"2430","ICI-118,551","adrenergic receptor antagonist","ADRB2, ADRB3","","","Tocris",97.18,"BRD-K74603273-003-01-1","Phase 2","","VFIDUCMKNJIJTO-XJKSGUPXSA-N","BRD-K74603273","","CC(C)N[C@@H](C)[C@H](O)COc1ccc(C)c2CCCc12"
"2431","ICI-162846","histamine receptor antagonist","HRH2","","","Tocris",91.43,"BRD-K11071038-001-01-7","Phase 1","","ALCSGJCIESECFD-UHFFFAOYSA-N","BRD-K11071038","","NC(=O)CCCCn1ccc(n1)\N=C(/N)NCC(F)(F)F"
"2432","ICI-185,282","thromboxane receptor antagonist","","","","Tocris",96.78,"BRD-K29133151-001-03-2","Phase 1","","ZWAVGFSZMACJHA-PMNBYGLBSA-N","BRD-K29133151","","OC(=O)CCC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)C(F)(F)F"
"2433","ICI-192605","thromboxane receptor antagonist","TBXA2R","","","Tocris, Tocris",96.71,"BRD-K59433843-001-02-5, BRD-K59433843-001-01-7","Phase 2","","WHUIENZXNGAHQI-GKZDNZBASA-N","BRD-K59433843","","OC(=O)CC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl"
"2435","ICI-199441","opioid receptor agonist","CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R","","","Tocris, Tocris",97.12,"BRD-K73290745-003-03-4, BRD-K73290745-003-02-6","Preclinical","","AEJOEPSMZCEYJN-HXUWFJFHSA-N","BRD-K73290745","","CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccc(Cl)c(Cl)c1"
"2437","ICI-215,001","adrenergic receptor agonist","ADRB3","","","Tocris",98.33,"BRD-K52487250-003-01-2","Preclinical","","MXWICZOXPUWAHY-HNNXBMFYSA-N","BRD-K52487250","","O[C@@H](CNCCOc1ccc(OCC(O)=O)cc1)COc1ccccc1"
"2438","ICI-63197","phosphodiesterase inhibitor","","","","Tocris, Tocris",97.43,"BRD-K52219182-001-03-2, BRD-K52219182-001-02-4","Preclinical","","UQDVRVNMIJAGRK-UHFFFAOYSA-N","BRD-K52219182","","CCCn1c2nc(N)nn2cc(C)c1=O"
"2440","ICI-89406","adrenergic receptor antagonist","ADRB1, ADRB2","","","Tocris",88.81,"BRD-A03359064-001-02-3","Phase 1","","HTLWRKRZKFAAAH-UHFFFAOYSA-N","BRD-A03359064","","OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N"
"2441","ICILIN","TRPV agonist","TRPA1, TRPM8","","","Tocris",10.14,"BRD-K48869804-001-09-6","Phase 1","","RCEFMOGVOYEGJN-UHFFFAOYSA-N","BRD-K48869804","","Oc1ccccc1N1CC=C(NC1=O)c1cccc(c1)[N+]([O-])=O"
"2442","ICOMUCRET","mucin production enhancer","LTB4R2","","","Enzo",44,"BRD-K41234004-001-03-1","Phase 3","","JSFATNQSLKRBCI-VAEKSGALSA-N","BRD-K41234004","","CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O"
"2443","ICRT-14","WNT signaling inhibitor, beta catenin inhibitor","CTNNB1, TCF4","","","Tocris",89.36,"BRD-K18634484-001-01-4","Preclinical","","NCSHZXNGQYSKLR-UNOMPAQXSA-N","BRD-K18634484","","Cc1cc(\C=C2/SC(=O)N(C2=O)c2ccccc2)c(C)n1-c1cccnc1"
"2444","IC261","casein kinase inhibitor","CSNK1A1, CSNK1D, CSNK1E, CSNK1G2","","","MedChemEx, MedChemEx",74.58,"BRD-K09638361-001-02-2, BRD-K09638361-001-03-0","Preclinical","","JBJYTZXCZDNOJW-JLHYYAGUSA-N","BRD-K09638361","","COc1cc(OC)c(\C=C2\C(=O)Nc3ccccc23)c(OC)c1"
"2446","ID-1101","insulin sensitizer","INS","","","Sigma",78.9,"BRD-K90305467-001-01-3","Phase 1","","OSCCDBFHNMXNME-YUPRTTJUSA-N","BRD-K90305467","","C[C@H](O)[C@H](C)[C@H](N)C(O)=O"
"2447","ID-8","","","","","Selleck, Tocris",97.87,"BRD-K39166528-001-01-0, BRD-K39166528-001-02-8","Preclinical","","VVZNWYXIOADGSW-UHFFFAOYSA-N","BRD-K39166528","","COc1ccc(cc1)-n1c(C)c([N+]([O-])=O)c2ccc(O)cc12"
"2449","IDALOPIRDINE","serotonin receptor antagonist","HTR6","","","MedChemEx",95.12,"BRD-K79102359-003-01-6","Phase 3","","YBAWYTYNMZWMMJ-UHFFFAOYSA-N","BRD-K79102359","","FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1"
"2450","IDASANUTLIN","MDM inhibitor","MDM2, TP53","","","MedChemEx",97.79,"BRD-K62627508-001-01-5","Phase 3","","TVTXCJFHQKSQQM-LJQIRTBHSA-N","BRD-K62627508","","COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1c1cccc(Cl)c1F)c1ccc(Cl)cc1F)C(O)=O"
"2451","IDAZOXAN","adrenergic receptor antagonist","ADRA2A","","","Tocris, MicroSource",84.32,"BRD-A18696154-003-21-8, BRD-A18696154-003-22-6","Phase 3","","HPMRFMKYPGXPEP-UHFFFAOYSA-N","BRD-A18696154","","C1CN=C(N1)C1COc2ccccc2O1"
"2453","IDAZOXANE","adrenergic receptor antagonist","ADRA2A, ADRA2B, ADRA2C","","","AMS",96.56,"BRD-K70759443-001-01-4","Preclinical","","CSKKSNNRKWZLAM-UHFFFAOYSA-N","BRD-K70759443","","C1CNC(N1)=C1COc2ccccc2O1"
"2454","IDO5L","indoleamine 2,3-dioxygenase inhibitor","IDO1","","","MedChemEx",88.63,"BRD-K22356203-001-01-8","Preclinical","","HGXSLPIXNPASGZ-UHFFFAOYSA-N","BRD-K22356203","","Nc1nonc1\C(NO)=N/c1ccc(F)c(Cl)c1"
"2455","IDRA-21","glutamate receptor positive allosteric modulator","GRIA1, GRIA2, GRIA3, GRIA4","","","Tocris, Tocris",97.41,"BRD-A14344385-001-04-0, BRD-A14344385-001-03-2","Preclinical","","VZRNTCHTJRLTMU-UHFFFAOYSA-N","BRD-A14344385","","CC1Nc2ccc(Cl)cc2S(=O)(=O)N1"
"2457","IDRAMANTONE","","","","","MicroSource",23.73,"BRD-A57877027-001-01-7","Preclinical","","TZBDEVBNMSLVKT-UHFFFAOYSA-N","BRD-A57877027","","OC12CC3CC(C1)C(=O)C(C3)C2"
"2458","IDRONOXIL","XIAP inhibitor","ENOX2, SPHK1","","","Sigma",81.54,"BRD-K74671368-001-01-8","Phase 3","","ZZUBHVMHNVYXRR-UHFFFAOYSA-N","BRD-K74671368","","Oc1ccc(cc1)C1=Cc2ccc(O)cc2OC1"
"2459","IEM1460","glutamate receptor antagonist","GRIA2","","","Tocris, Tocris",98.63,"BRD-K13829090-303-03-7, BRD-K13829090-303-02-9","Preclinical","","IWYZMMIPAJDJBN-UHFFFAOYSA-N","BRD-K13829090","","C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2"
"2461","IEM1754","glutamate receptor antagonist","GRIA1","","","Selleck, Selleck",95.33,"BRD-K80060353-303-03-9, BRD-K80060353-303-02-1","Preclinical","","UWWMQHVWAYFCDT-UHFFFAOYSA-N","BRD-K80060353","","NCCCCCNCC12CC3CC(CC(C3)C1)C2"
"2463","IFENPRODIL","adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B","","","MicroSource, Selleck, Tocris, Selleck",99,"BRD-A24191444-046-01-3, BRD-A24191444-046-02-1, BRD-A24191444-045-10-6, BRD-A24191444-046-03-9","Launched","BRD-M01603234-046-01-4, BRD-M20547247-322-01-0, BRD-M01603234-046-02-2","UYNVMODNBIQBMV-UHFFFAOYSA-N","BRD-A24191444","BRD-M01603234","CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1"
"2467","IGMESINE","sigma receptor agonist","SIGMAR1","","","Tocris",95.83,"BRD-A48376327-003-01-5","Phase 2","","VCZSWYIFCKGTJI-JLHYYAGUSA-N","BRD-A48376327","","CCC(C\C=C\c1ccccc1)(N(C)CC1CC1)c1ccccc1"
"2468","IKK-16","IKK inhibitor","IKBKB","","","Tocris, Tocris, Selleck",95.29,"BRD-K14618467-003-02-6, BRD-K14618467-003-03-4, BRD-K14618467-001-04-6","Preclinical","","BWZJBXAPRCVCKQ-UHFFFAOYSA-N","BRD-K14618467","","O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1"
"2471","IKK-2-INHIBITOR","IKK inhibitor, SYK inhibitor","IKBKB","","","Tocris, Selleck, Selleck",93.53,"BRD-K26373640-001-06-9, BRD-K26373640-001-05-1, BRD-K26373640-001-07-7","Preclinical","","BMUACLADCKCNKZ-UHFFFAOYSA-N","BRD-K26373640","","NC(=O)c1sc(cc1N)-c1ccsc1"
"2474","IKK-2-INHIBITOR-V","IKK inhibitor, NFkB pathway inhibitor","IKBKB","","","Tocris, Selleck",97.99,"BRD-K74305673-001-07-0, BRD-K74305673-001-06-2","Phase 1","","CHILCFMQWMQVAL-UHFFFAOYSA-N","BRD-K74305673","","Oc1ccc(Cl)cc1C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F"
"2476","ILEPCIMIDE","anticonvulsant","","","","Enamine",87.77,"BRD-K43873574-001-01-8","Phase 3","","BLPUOQGPBJPXRL-UHFFFAOYSA-N","BRD-K43873574","","O=C(C=Cc1ccc2OCOc2c1)N1CCCCC1"
"2477","ILOMASTAT","matrix metalloprotease inhibitor","ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9","","","Selleck, Selleck",94.49,"BRD-K51662849-001-05-4, BRD-K51662849-001-08-8","Phase 3","","NITYDPDXAAFEIT-DYVFJYSZSA-N","BRD-K51662849","","CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO"
"2479","IMEGLIMIN","gluconeogenesis inhibitor","","","","MedChemEx, MedChemEx",97.85,"BRD-K55822903-003-02-6, BRD-K55822903-003-01-8","Phase 2","","GFICWFZTBXUVIG-SCSAIBSYSA-N","BRD-K55822903","","C[C@@H]1N=C(N)NC(=N1)N(C)C"
"2481","IMETIT","histamine receptor agonist","HRH3, HRH4","","","Tocris",90.26,"BRD-K33183200-303-02-4","Preclinical","","PEHSVUKQDJULKE-UHFFFAOYSA-N","BRD-K33183200","","NC(=N)SCCc1c[nH]cn1"
"2482","IMEXON","apoptosis stimulant, ribonucleotide reductase inhibitor","RRM1, RRM2","","","MicroSource",100,"BRD-A78195072-001-06-2","Phase 2","","BIXBBIPTYBJTRY-UHFFFAOYSA-N","BRD-A78195072","","N=C1NC(=O)N2CC12"
"2483","IMIDACLOPRID","acetylcholine receptor antagonist","CHRFAM7A","","","SantaCruz",99.22,"BRD-K76609936-001-08-4","Launched","","YWTYJOPNNQFBPC-UHFFFAOYSA-N","BRD-K76609936","","[O-][N+](=O)NC1=NCCN1Cc1ccc(Cl)nc1"
"2484","IMIDUREA","other antibiotic","","","","Prestwick",0,"BRD-A65444648-001-11-4","Preclinical","","ZCTXEAQXZGPWFG-UHFFFAOYSA-N","BRD-A65444648","","OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O"
"2485","IMILOXAN","adrenergic receptor antagonist","ADRA2A, ADRA2B","","","Tocris",97.18,"BRD-A10903566-003-07-7","Phase 1","","UXABARREKCJULM-UHFFFAOYSA-N","BRD-A10903566","","CCn1ccnc1CC1COc2ccccc2O1"
"2486","IMMEPIP","histamine receptor agonist","HRH3, HRH4","","","Tocris",91.38,"BRD-K25906698-303-02-7","Preclinical","","MCNGUYXRBCIGOV-UHFFFAOYSA-N","BRD-K25906698","","C(C1CCNCC1)c1c[nH]cn1"
"2487","IMMETHRIDINE","histamine receptor agonist","HRH3","","","Tocris, Tocris",97.64,"BRD-K49519092-303-02-2, BRD-K49519092-303-03-0","Phase 1","","DFVSGZHJSIEEQQ-UHFFFAOYSA-N","BRD-K49519092","","C(c1cnc[nH]1)c1ccncc1"
"2489","IMPENTAMINE","histamine receptor antagonist","HRH3","","","Tocris",70.44,"BRD-K20049318-303-02-1","Preclinical","","MZCJWLAXZRFUPI-UHFFFAOYSA-N","BRD-K20049318","","NCCCCCc1cnc[nH]1"
"2490","IMREG-1","","","","","ChemImpex",97.29,"BRD-K00926464-001-01-8","Phase 3","","HIINQLBHPIQYHN-JTQLQIEISA-N","BRD-K00926464","","N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(O)=O"
"2491","INC-280","c-Met inhibitor","MET","","","Selleck",95.03,"BRD-K81016934-001-02-0","Phase 2","","LIOLIMKSCNQPLV-UHFFFAOYSA-N","BRD-K81016934","","CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1"
"2492","INCA-6","calcineurin inhibitor","NFATC1","","","Tocris, Tocris",58.26,"BRD-K33308633-001-02-4, BRD-K33308633-001-03-2","Preclinical","","GCHPUOHXXCNSQL-UHFFFAOYSA-N","BRD-K33308633","","O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc12"
"2494","INCB-003284","CC chemokine receptor antagonist","","","","EMDBio",83.66,"BRD-K28059174-334-01-2","Phase 2","","NXZNYBUBXWWKCP-JMOWIOHXSA-N","BRD-K28059174","","COc1ccc(cn1)C1(O)CCC(CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F"
"2495","INCB-024360","indoleamine 2,3-dioxygenase inhibitor","IDO1","","","MedChemEx",95.87,"BRD-K79450420-001-01-8","Phase 2","","FBKMWOJEPMPVTQ-UHFFFAOYSA-N","BRD-K79450420","","NS(=O)(=O)NCCNc1nonc1\C(Nc1ccc(F)c(Br)c1)=N\O"
"2496","INCB-3284","CC chemokine receptor antagonist","CCR2","","","MedChemEx",92.32,"BRD-K67628093-001-01-9","Phase 2","","NXZNYBUBXWWKCP-DNRQZRRGSA-N","BRD-K67628093","","COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F"
"2497","INDALPINE","selective serotonin reuptake inhibitor (SSRI)","SLC6A4","","","Sigma",90.29,"BRD-K64973364-001-01-4","Withdrawn","","SADQVAVFGNTEOD-UHFFFAOYSA-N","BRD-K64973364","","C(Cc1c[nH]c2ccccc12)C1CCNCC1"
"2498","INDATRALINE","norepinephrine transporter inhibitor","MAOA, MAOB","","","Tocris, Tocris",96.95,"BRD-K01649396-003-08-9, BRD-K01649396-003-07-1","Preclinical","","SVFXPTLYMIXFRX-XJKSGUPXSA-N","BRD-K01649396","","CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1"
"2500","INDELOXAZINE","norepinephrine reuptake inhibitor, serotonin reuptake inhibitor","","","","Sigma",99.26,"BRD-A59747053-003-01-3","Withdrawn","","MADRVGBADLFHMO-UHFFFAOYSA-N","BRD-A59747053","","C(Oc1cccc2C=CCc12)C1CNCCO1"
"2501","INDIBULIN","tubulin polymerization inhibitor","","","","Vitas-M",97.78,"BRD-K74057757-001-01-9","Phase 1/Phase 2","","SOLIIYNRSAWTSQ-UHFFFAOYSA-N","BRD-K74057757","","Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c3ccccc23)cc1"
"2502","INDIPLON","benzodiazepine receptor agonist","GABRA1","","","Tocris, Tocris",99.26,"BRD-K90948141-001-01-4, BRD-K90948141-001-02-2","Phase 3","","CBIAWPMZSFFRGN-UHFFFAOYSA-N","BRD-K90948141","","CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1"
"2504","INDIRUBIN","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A","","","Selleck",99.41,"BRD-K17894950-001-14-3","Phase 2/Phase 3","","CRDNMYFJWFXOCH-YPKPFQOOSA-N","BRD-K17894950","","O=C1Nc2ccccc2\C1=C1\Nc2ccccc2C1=O"
"2505","INDIRUBIN-3-MONOXIME","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B","","","Tocris",97.67,"BRD-K19136521-001-08-9","Preclinical","","HBDSHCUSXQATPO-BGBJRWHRSA-N","BRD-K19136521","","O\N=C1c2ccccc2NC/1=C1\C(=O)Nc2ccccc12"
"2506","INDISULAM","CDK inhibitor","CA1, CA12, CA14, CA2, CA6, CA7, CA9","","","Sigma",98.25,"BRD-K17610631-001-03-3","Phase 2","","SETFNECMODOHTO-UHFFFAOYSA-N","BRD-K17610631","","NS(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1cccc2c(Cl)c[nH]c12"
"2507","INDIUM(III)-ISOPROPOXIDE","","","","","AlfaAesar",0,"BRD-M08274809-001-01-7","Preclinical","","JUUUERJZVKCDOT-UHFFFAOYSA-N","BRD-M08274809","","[In].CC(C)O.CC(C)O.CC(C)O"
"2508","INDIUM-TRI(2-PROPANOLATE)","","","","","AlfaAesar",0,"BRD-K42332878-001-01-9","Preclinical","","OVZUSPADPSOQQN-UHFFFAOYSA-N","BRD-K42332878","","CC(C)O[In](OC(C)C)OC(C)C"
"2509","INDOCYANINE-GREEN","contrast agent","SLCO1B1","","","MedChemEx, Sigma, MedChemEx",92.75,"BRD-K80762071-236-01-7, BRD-K80762071-236-02-5, BRD-K80762071-236-03-3","Launched","","BDBMLMBYCXNVMC-UHFFFAOYSA-O","BRD-K80762071","","CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12"
"2512","INDOLE-3-CARBINOL","aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor","AHR","","","Selleck",96.69,"BRD-K01815685-001-15-5","Phase 2/Phase 3","","IVYPNXXAYMYVSP-UHFFFAOYSA-N","BRD-K01815685","","OCc1c[nH]c2ccccc12"
"2513","INDOLE-3-PYRUBATE","melatonin receptor agonist","","","","Sigma",0,"BRD-K09109825-001-07-3","Phase 2","","RSTKLPZEZYGQPY-UHFFFAOYSA-N","BRD-K09109825","","OC(=O)C(=O)Cc1c[nH]c2ccccc12"
"2514","INDOPROFEN","cyclooxygenase inhibitor, prostanoid receptor antagonist","CXCR1, CXCR2, PTGS1, PTGS2","","","MicroSource",99.31,"BRD-A44090213-001-25-6","Withdrawn","","RJMIEHBSYVWVIN-UHFFFAOYSA-N","BRD-A44090213","","CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O"
"2515","INDOXIMOD","indoleamine 2,3-dioxygenase inhibitor","IDO1","","","Cayman",98.79,"BRD-K93255255-001-02-1","Phase 2","","ZADWXFSZEAPBJS-SNVBAGLBSA-N","BRD-K93255255","","Cn1cc(C[C@@H](N)C(O)=O)c2ccccc12"
"2516","INH1","Hec1 inhibitor","NDC80","","","Tocris",98.19,"BRD-K70177501-003-01-4","Preclinical","","JPMOKRWIYQGMJL-UHFFFAOYSA-N","BRD-K70177501","","Cc1ccc(c(C)c1)-c1csc(NC(=O)c2ccccc2)n1"
"2517","INIMUR","other antifungal","","","","MedChemEx, MedChemEx",86.95,"BRD-A71407503-001-01-8, BRD-A71407503-001-02-6","Launched","","SRQKTCXJCCHINN-NYYWCZLTSA-N","BRD-A71407503","","CSCC1CN(\N=C\c2ccc(o2)[N+]([O-])=O)C(=O)O1"
"2519","INIPARIB","PARP inhibitor","PARP1","","","Selleck",97.59,"BRD-K11153516-001-05-5","Phase 3","","MDOJTZQKHMAPBK-UHFFFAOYSA-N","BRD-K11153516","","NC(=O)c1ccc(I)c(c1)[N+]([O-])=O"
"2520","INOSINE","neurotrophic agent","PARP1, PNP","","","Selleck, Selleck, MicroSource",94.71,"BRD-K79612754-001-20-9, BRD-K79612754-001-19-1, BRD-K79612754-001-21-7","Launched","BRD-K14210676-001-01-5, BRD-A28787076-001-04-8","UGQMRVRMYYASKQ-KQYNXXCUSA-N","BRD-K79612754","BRD-K14210676","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12"
"2523","INOSITOL","insulin sensitizer","CDIPT, GBA","","","MicroSource",98.26,"BRD-K52618540-001-09-9","Launched","","CDAISMWEOUEBRE-GPIVLXJGSA-N","BRD-K52618540","","O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O"
"2524","INS316","purinergic receptor antagonist","","","","Enzo",0,"BRD-A29125379-314-01-7","Phase 2","","PGAVKCOVUIYSFO-AYZDMWBASA-N","BRD-A29125379","","OC1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H](C1O)n1ccc(=O)[nH]c1=O"
"2525","INT-747","FXR agonist","","","","MedChemEx",98.9,"BRD-K30968378-001-01-9","Phase 3","","ZXERDUOLZKYMJM-ZWECCWDJSA-N","BRD-K30968378","","CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12"
"2526","INT-767","FXR agonist","GPBAR1","","","MedChemEx",98.4,"BRD-K33067152-236-01-1","Phase 1","","XGIYOABXZNJOHV-APIYUPOTSA-N","BRD-K33067152","","CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCOS(O)(=O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12"
"2527","INTEGRIN-ANTAGONIST-1","integrin antagonist","ITGAV, ITGB6","","","MedChemEx",93.77,"BRD-K88165431-003-01-4","Phase 1","","ZMXBIIQMSGOIRZ-RCZVLFRGSA-N","BRD-K88165431","","Cc1cc(C)n(n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCC2=CC=C3CCCN=C3N2)C1)CC(O)=O"
"2528","IODOANTIPYRINE","","","","","AlfaAesar",98.81,"BRD-K69216798-001-01-9","Preclinical","","ZZOBLCHCPLOXCE-UHFFFAOYSA-N","BRD-K69216798","","Cc1c(I)c(=O)n(-c2ccccc2)n1C"
"2529","IODODEXETIMIDE","acetylcholine receptor antagonist","","","","MedChemEx",96.72,"BRD-A46813902-001-01-6","Phase 2","","WJLRTFJPHDSXAF-UHFFFAOYSA-N","BRD-A46813902","","Ic1ccc(CN2CCC(CC2)C2(CCC(=O)NC2=O)c2ccccc2)cc1"
"2530","IODOPHENPROPIT","histamine receptor antagonist","HRH3, HRH4","","","Tocris",95.9,"BRD-K51918615-303-02-9","Preclinical","","UBHYDQAARZKHEZ-UHFFFAOYSA-N","BRD-K51918615","","Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1"
"2531","IOPANIC-ACID","thyroid hormone inhibitor","","","","MicroSource",98.49,"BRD-A42628519-001-12-4","Preclinical","","OIRFJRBSRORBCM-UHFFFAOYSA-N","BRD-A42628519","","CCC(Cc1c(I)cc(I)c(N)c1I)C(O)=O"
"2532","IOTHALAMIC-ACID-D3","radiopaque medium","","","","Toronto",0,"BRD-K98250023-001-01-0","Preclinical","","UXIGWFXRQKWHHA-UHFFFAOYSA-N","BRD-K98250023","","CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I"
"2533","IOWH032","CFTR channel antagonist","CFTR","","","Selleck",98.44,"BRD-K84892605-001-01-1","Phase 2","","DSFNLJXHXBIKDS-UHFFFAOYSA-N","BRD-K84892605","","Oc1c(Br)cc(cc1Br)-c1noc(n1)C(=O)NCc1ccc(Oc2ccccc2)cc1"
"2534","IOX1","histone demethylase inhibitor","EGLN1, KDM3A, KDM4C, KDM6B","","","MedChemEx, Tocris",87.15,"BRD-K70751730-001-10-4, BRD-K70751730-001-11-2","Preclinical","","JGRPKOGHYBAVMW-UHFFFAOYSA-N","BRD-K70751730","","OC(=O)c1ccc(O)c2ncccc12"
"2536","IOX2","hypoxia inducible factor inhibitor","EGLN1, KDM2A, KDM5C","","","Selleck, Tocris",97.26,"BRD-K98251413-001-04-0, BRD-K98251413-001-06-5","Preclinical","","CAOSCCRYLYQBES-UHFFFAOYSA-N","BRD-K98251413","","OC(=O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O"
"2538","IPA-3","p21 activated kinase inhibitor","PAK1","","","Tocris, Selleck, Selleck",70.81,"BRD-K38727704-001-02-4, BRD-K38727704-001-01-6, BRD-K38727704-001-03-2","Preclinical","","RFAXLXKIAKIUDT-UHFFFAOYSA-N","BRD-K38727704","","Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12"
"2541","IPAG","","","","","Tocris",95.16,"BRD-K82421491-001-02-6","Preclinical","","UUKPIWYXWLJPJF-UHFFFAOYSA-N","BRD-K82421491","","Ic1ccc(NC(=N)NC2C3CC4CC(C3)CC2C4)cc1"
"2542","IPI-145","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",95.49,"BRD-K93468883-001-02-0","Phase 3","","SJVQHLPISAIATJ-ZDUSSCGKSA-N","BRD-K93468883","","C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1"
"2543","IPIDACRINE","acetylcholinesterase inhibitor","ACHE","","","ChemDiv",98.46,"BRD-K66896231-001-08-1","Phase 3","","YLUSMKAJIQOXPV-UHFFFAOYSA-N","BRD-K66896231","","Nc1c2CCCc2nc2CCCCc12"
"2544","IPRONIAZID","monoamine oxidase inhibitor","MAOA, MAOB","","","MicroSource",98.08,"BRD-K88568253-011-19-9","Withdrawn","","NYMGNSNKLVNMIA-UHFFFAOYSA-N","BRD-K88568253","","CC(C)NNC(=O)c1ccncc1"
"2545","IPSAPIRONE","serotonin receptor agonist","HTR1A","","","Tocris",93.81,"BRD-K90574421-001-03-5","Phase 3","","TZJUVVIWVWFLCD-UHFFFAOYSA-N","BRD-K90574421","","O=C1N(CCCCN2CCN(CC2)c2ncccn2)S(=O)(=O)c2ccccc12"
"2546","IRL-2500","endothelin receptor antagonist","EDNRB","","","Tocris",94.23,"BRD-K98357249-001-02-9","Preclinical","","UZDORQWMYRRLQV-JHOUSYSJSA-N","BRD-K98357249","","CN([C@H](Cc1ccc(cc1)-c1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O)C(=O)c1cc(C)cc(C)c1"
"2547","IROSUSTAT","steroid sulfatase inhibitor","CA2, STS","","","Sigma",0,"BRD-K87777313-001-02-2","Phase 2","","DSLPMJSGSBLWRE-UHFFFAOYSA-N","BRD-K87777313","","NS(=O)(=O)Oc1ccc2c3CCCCCc3c(=O)oc2c1"
"2548","ISAMOLTANE","adrenergic receptor antagonist","HTR1A, HTR1B","","","Tocris",89.47,"BRD-A26845397-051-01-9","Phase 1","BRD-M60365050-051-02-7","XVTVPGKWYHWYAD-UHFFFAOYSA-N","BRD-A26845397","BRD-M60365050","CC(C)NCC(O)COc1ccccc1-n1cccc1"
"2549","ISAVUCONAZOLE","cytochrome P450 inhibitor","CYP3A4","","","MedChemEx",98.14,"BRD-A17009129-001-01-3","Phase 3","","DDFOUSQFMYRUQK-XLEXHMCLSA-N","BRD-A17009129","","C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)C(O)(Cn1cncn1)c1cc(F)ccc1F"
"2550","ISAXONINE","nerve growth factor agonist","","","","MicroSource",81.09,"BRD-K95957366-001-02-6","Withdrawn","","FTCYIGBVOHNHCD-UHFFFAOYSA-N","BRD-K95957366","","CC(C)Nc1ncccn1"
"2551","ISBUFYLLINE","phosphodiesterase inhibitor","","","","Vitas-M",97.28,"BRD-K06762493-001-08-1","Phase 2","","WHUWQSQEVISUMC-UHFFFAOYSA-N","BRD-K06762493","","CC(C)Cn1cnc2n(C)c(=O)n(C)c(=O)c12"
"2552","ISO-1","macrophage migration inhibiting factor inhibitor","MIF","","","Tocris",83.05,"BRD-A94055480-001-01-5","Preclinical","","AIXMJTYHQHQJLU-UHFFFAOYSA-N","BRD-A94055480","","COC(=O)CC1CC(=NO1)c1ccc(O)cc1"
"2553","ISOBUTAMBEN","local anesthetic","","","","MicroSource",99.03,"BRD-K96714749-001-01-0","Preclinical","","PUYOAVGNCWPANW-UHFFFAOYSA-N","BRD-K96714749","","CC(C)COC(=O)c1ccc(N)cc1"
"2554","ISOBUTYRAMIDE","gene expression stimulant","HBE1, HBG1","","","Otava",0,"BRD-K54057105-001-01-2","Phase 2","","WFKAJVHLWXSISD-UHFFFAOYSA-N","BRD-K54057105","","CC(C)C(N)=O"
"2555","ISODIBUT","aldehyde reductase inhibitor","","","","Enamine, Sigma",99.18,"BRD-K60241851-001-10-1, BRD-K60241851-001-11-9","Phase 2","","ZHXRDXTYPCPBTI-UHFFFAOYSA-N","BRD-K60241851","","OC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23"
"2557","ISOFLOXYTHEPIN","dopamine receptor antagonist","","","","Specs",85.83,"BRD-A07704283-001-01-3","Phase 2","","XDBMBHVYXPBOPL-UHFFFAOYSA-N","BRD-A07704283","","CC(C)c1ccc2Sc3cc(F)ccc3CC(N3CCN(CCO)CC3)c2c1"
"2558","ISOFLUPREDONE-ACETATE","","NR3C1","","","Prestwick",91.96,"BRD-K29173907-001-09-2","Preclinical","","ZOCUOMKMBMEYQV-GSLJADNHSA-N","BRD-K29173907","","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C"
"2559","ISOGUVACINE","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3","","","Tocris",100,"BRD-K66480997-003-10-0","Preclinical","","KRVDMABBKYMBHG-UHFFFAOYSA-N","BRD-K66480997","","OC(=O)C1=CCNCC1"
"2560","ISOLEUCINE","","ACADSB, BCAT1, BCAT2, IARS, IARS2","","","Enamine",89.82,"BRD-A02232681-001-01-8","Launched","","AGPKZVBTJJNPAG-UHFFFAOYSA-N","BRD-A02232681","","CCC(C)C(N)C(O)=O"
"2561","ISOLIQUIRITIGENIN","guanylate cyclase activator","GABBR1","","","Selleck",90.32,"BRD-K33583600-001-16-1","Preclinical","","DXDRHHKMWQZJHT-FPYGCLRLSA-N","BRD-K33583600","","Oc1ccc(cc1)\C=C\C(=O)c1ccc(O)cc1O"
"2562","ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,","","","","","Prestwick",98.3,"BRD-A75140635-003-10-9","Preclinical","","HMYJLVDKPJHJCF-UHFFFAOYSA-N","BRD-A75140635","","COc1cc2CCNC(C)c2cc1OC"
"2563","ISOSTEVIOL","","","","","ChemDiv",100,"BRD-A96529864-001-01-3","Phase 2","","KFVUFODCZDRVSS-LBWIARQKSA-N","BRD-A96529864","","C[C@]12C[C@@]3(CC1=O)CC[C@H]1[C@@](C)(CCC[C@@]1(C)C(O)=O)C3CC2"
"2564","ISOTIQUIMIDE","","","","","Enamine",92.3,"BRD-A02933148-001-01-8","Phase 1","","PWPWEYFVLITGNU-UHFFFAOYSA-N","BRD-A02933148","","Cc1ccnc2C(CCCc12)C(N)=S"
"2565","ISOVALERAMIDE","alcohol dehydrogenase inhibitor","","","","PrincetonBio, Selleck, MicroSource, Selleck",79.17,"BRD-K90069354-001-04-5, BRD-K90069354-001-01-1, BRD-K90069354-001-02-9, BRD-K90069354-001-03-7","Phase 2","","SANOUVWGPVYVAV-UHFFFAOYSA-N","BRD-K90069354","","CC(C)CC(N)=O"
"2569","ISOXEPAC","anti-inflammatory agent","","","","Ark",99.77,"BRD-K92116564-001-01-4","Phase 2","","QFGMXJOBTNZHEL-UHFFFAOYSA-N","BRD-K92116564","","OC(=O)Cc1ccc2OCc3ccccc3C(=O)c2c1"
"2570","ISOXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","","","MicroSource, Selleck",97.77,"BRD-A75552914-001-16-8, BRD-A75552914-001-15-0","Withdrawn","","SPTMROWPYQRZSX-UHFFFAOYSA-N","BRD-A75552914","","CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O"
"2572","ISPINESIB","kinesin inhibitor","KIF11","","","Selleck, Tocris, Selleck",88.16,"BRD-K64881305-001-05-2, BRD-K64881305-001-06-0, BRD-K64881305-001-03-7","Phase 2","","QJZRFPJCWMNVAV-HHHXNRCGSA-N","BRD-K64881305","","CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1nc2cc(Cl)ccc2c(=O)n1Cc1ccccc1"
"2575","ISRIB","eukaryotic translation initiation factor inhibitor, PERK inhibitor","EIF2A, EIF2AK3","","","MedChemEx",90.08,"BRD-K12826175-001-02-4","Preclinical","","HJGMCDHQPXTGAV-IYARVYRRSA-N","BRD-K12826175","","Clc1ccc(OCC(=O)N[C@H]2CC[C@@H](CC2)NC(=O)COc2ccc(Cl)cc2)cc1"
"2576","ISTAROXIME","ATPase inhibitor","ATP1A1","","","MedChemEx",97.6,"BRD-K95412502-003-01-5","Phase 2","","MPYLDWFDPHRTEG-PAAYLBSLSA-N","BRD-K95412502","","C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O"
"2577","ISX-9","neural stem cell inducer","NEUROD1","","","Tocris",89.11,"BRD-K53903639-001-04-7","Preclinical","","SYENTKHGMVKGAQ-UHFFFAOYSA-N","BRD-K53903639","","O=C(NC1CC1)c1cc(on1)-c1cccs1"
"2578","ITACITINIB","JAK inhibitor","JAK1","","","MedChemEx",96.17,"BRD-K67482377-001-01-8","Phase 2","","KTBSXLIQKWEBRB-UHFFFAOYSA-N","BRD-K67482377","","Fc1c(ccnc1C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12"
"2579","ITD-1","TGF beta receptor inhibitor","TGFBR2","","","Tocris",93.59,"BRD-A56690687-001-01-6","Preclinical","","ULFUJLFTRWWLPO-UHFFFAOYSA-N","BRD-A56690687","","CCOC(=O)C1=C(C)NC2=C(C1c1ccc(cc1)-c1ccccc1)C(=O)CC(C)(C)C2"
"2580","ITE","aryl hydrocarbon receptor agonist","AHR","","","Tocris",97.76,"BRD-K60298136-001-03-3","Preclinical","","KDDXOGDIPZSCTM-UHFFFAOYSA-N","BRD-K60298136","","COC(=O)c1csc(n1)C(=O)c1c[nH]c2ccccc12"
"2581","ITI214","phosphodiesterase inhibitor","PDE1A","","","MedChemEx",95.75,"BRD-K77987496-011-01-9","Phase 1","","BBIPVJCGIASXJB-PKTZIBPZSA-N","BRD-K77987496","","CN1C2=N[C@@H]3CCC[C@@H]3N2c2nn(Cc3ccc(cc3)-c3cccc(F)n3)c(Nc3ccccc3)c2C1=O"
"2582","ITX3","GEF inhibitor","TRIO","","","MedChemEx, MedChemEx",84.43,"BRD-K36515744-001-03-5, BRD-K36515744-001-02-7","Preclinical","","SJMYMKPBODEZSH-DEDYPNTBSA-N","BRD-K36515744","","Cc1cc(\C=c2\sc3nc4ccccc4n3c2=O)c(C)n1-c1ccccc1"
"2584","IT1T","CC chemokine receptor antagonist","CXCR4","","","Tocris",77.71,"BRD-K73499906-300-01-0","Preclinical","","OOSUDWRRWZVFEB-UHFFFAOYSA-N","BRD-K73499906","","CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C3CCCCC3)=CSC2=N1"
"2585","IU1","ubiquitin C-terminal hydrolase inhibitor","USP14","","","Tocris, Selleck, Selleck",87.3,"BRD-K45841694-001-12-5, BRD-K45841694-001-11-7, BRD-K45841694-001-10-9","Preclinical","","JUWDSDKJBMFLHE-UHFFFAOYSA-N","BRD-K45841694","","Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1"
"2588","IWP-L6","porcupine inhibitor","PORCN","","","Selleck",95.25,"BRD-K53234107-001-01-6","Preclinical","","QESQGTFWEQMCMH-UHFFFAOYSA-N","BRD-K53234107","","O=C(CSc1nc2CCSc2c(=O)n1-c1ccccc1)Nc1ccc(cn1)-c1ccccc1"
"2589","JAK3-INHIBITOR-V","JAK inhibitor","JAK3","","","Tocris",0,"BRD-K95676198-001-05-9","Preclinical","","FOTCGZPFSUWZBN-UHFFFAOYSA-N","BRD-K95676198","","C=CC(=O)c1ccc2ccccc2c1"
"2590","JDTIC","opioid receptor antagonist","OPRK1","","","MedChemEx",91.5,"BRD-K95837862-300-01-7","Phase 1","","ZLVXBBHTMQJRSX-VMGNSXQWSA-N","BRD-K95837862","","CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c1cccc(O)c1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1"
"2591","JHW-007","dopamine uptake inhibitor","SLC6A3","","","Tocris",89.23,"BRD-K32892871-003-01-7","Preclinical","","HZEVDVGPBUFIAW-JKHIJQBDSA-N","BRD-K32892871","","CCCCN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(c1ccc(F)cc1)c1ccc(F)cc1"
"2592","JIB04","histone lysine demethylase inhibitor","KDM4E","","","Selleck, Selleck, Tocris",85.22,"BRD-K76180386-001-01-6, BRD-K76180386-001-02-4, BRD-K76180386-001-03-2","Preclinical","","YHHFKWKMXWRVTJ-OQKWZONESA-N","BRD-K76180386","","Clc1ccc(N\N=C(/c2ccccc2)c2ccccn2)nc1"
"2595","JK-184","hedgehog pathway inhibitor","","","","Tocris, Tocris, Tocris",81.15,"BRD-K38860038-001-03-8, BRD-K38860038-001-01-2, BRD-K38860038-001-02-0","Preclinical","","ROYXIPOUVGDTAO-UHFFFAOYSA-N","BRD-K38860038","","CCOc1ccc(Nc2nc(cs2)-c2c(C)nc3ccccn23)cc1"
"2598","JLK-6","gamma secretase inhibitor","PSEN1","","","Tocris",0,"BRD-K22010301-001-04-6","Preclinical","","AMDGKLWVCUXONP-UHFFFAOYSA-N","BRD-K22010301","","COc1oc(=O)c2cc(N)ccc2c1Cl"
"2599","JNJ-10191584","histamine receptor antagonist","HRH4","","","Tocris, Tocris",99.26,"BRD-K15086322-050-01-3, BRD-K15086322-050-02-1","Preclinical","","MOIWSUQWIOVGRH-UHFFFAOYSA-N","BRD-K15086322","","CN1CCN(CC1)C(=O)c1nc2ccc(Cl)cc2[nH]1"
"2601","JNJ-10397049","orexin receptor antagonist","HCRTR1, HCRTR2","","","Tocris",90.72,"BRD-K61721596-001-02-8","Preclinical","","RBKIJGLHFFQHBE-IRXDYDNUSA-N","BRD-K61721596","","CC1(C)OC[C@H](NC(=O)Nc2ccc(Br)cc2Br)[C@@H](O1)c1ccccc1"
"2602","JNJ-16259685","glutamate receptor antagonist","GRM1","","","Tocris, Tocris",97.98,"BRD-K25596805-001-01-8, BRD-K25596805-001-02-6","Preclinical","","QOTAQTRFJWLFCR-XFHMXUHZSA-N","BRD-K25596805","","CO[C@H]1CC[C@H](CC1)C(=O)c1ccc2nc3OCCCc3cc2c1"
"2604","JNJ-1661010","FAAH inhibitor","FAAH","","","Selleck, Tocris",96.42,"BRD-K47376733-001-08-1, BRD-K47376733-001-09-9","Preclinical","","BHBOSTKQCZEAJM-UHFFFAOYSA-N","BRD-K47376733","","O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1"
"2606","JNJ-17203212","TRPV antagonist","TRPV1","","","Tocris, Tocris",94.57,"BRD-K51770398-001-01-9, BRD-K51770398-001-02-7","Preclinical","","JFRYYGVYCWYIDQ-UHFFFAOYSA-N","BRD-K51770398","","FC(F)(F)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2C(F)(F)F)nc1"
"2608","JNJ-26481585","HDAC inhibitor","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2","","","Selleck",91.72,"BRD-K83837640-001-04-8","Phase 2","","PAWIYAYFNXQGAP-UHFFFAOYSA-N","BRD-K83837640","","Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12"
"2609","JNJ-26990990","anticonvulsant","","","","Enamine",93.07,"BRD-K24864897-001-01-0","Phase 2","","AWSKBQNOSRREEY-UHFFFAOYSA-N","BRD-K24864897","","NS(=O)(=O)NCc1csc2ccccc12"
"2610","JNJ-27141491","CC chemokine receptor antagonist","CCR2","","","Tocris",87.73,"BRD-K41895652-001-01-8","Preclinical","","SYARXICKXVXWNA-LBPRGKRZSA-N","BRD-K41895652","","CC[C@@H](c1ccc(F)c(F)c1)n1c(C(=O)OC)c([nH]c1=S)-c1ccno1"
"2611","JNJ-37822681","dopamine receptor antagonist","DRD2","","","Enamine",89,"BRD-K31802667-001-01-9","Phase 2","","UVUYWJWYRLJHEN-UHFFFAOYSA-N","BRD-K31802667","","Fc1ccc(CN2CCC(CC2)Nc2ccc(nn2)C(F)(F)F)cc1F"
"2612","JNJ-38877605","tyrosine kinase inhibitor","MET","","","Selleck",97.35,"BRD-K02123250-001-06-7","Phase 1","","JRWCBEOAFGHNNU-UHFFFAOYSA-N","BRD-K02123250","","Cn1cc(cn1)-c1ccc2nnc(n2n1)C(F)(F)c1ccc2ncccc2c1"
"2613","JNJ-40411813","glutamate receptor positive allosteric modulator","GRM2","","","MedChemEx",95.69,"BRD-K55029398-001-01-6","Phase 2","","HYOGJHCDLQSAHX-UHFFFAOYSA-N","BRD-K55029398","","CCCCn1ccc(N2CCC(CC2)c2ccccc2)c(Cl)c1=O"
"2614","JNJ-42041935","hypoxia inducible factor prolyl hydroxylase inhibitor","PDK2","","","MedChemEx",97.43,"BRD-K01036220-001-01-0","Preclinical","","FXHHASJVTYRJHH-UHFFFAOYSA-N","BRD-K01036220","","OC(=O)c1cnn(c1)-c1nc2cc(Cl)c(OC(F)(F)F)cc2[nH]1"
"2615","JNJ-42165279","FAAH inhibitor","FAAH","","","MedChemEx",94.84,"BRD-K70330032-001-01-1","Phase 2","","YWGYNGCRVZLMCS-UHFFFAOYSA-N","BRD-K70330032","","FC1(F)Oc2ccc(CN3CCN(CC3)C(=O)Nc3cnccc3Cl)cc2O1"
"2616","JNJ-47965567","purinergic receptor antagonist","P2RX7","","","Tocris",93.76,"BRD-K83547600-001-01-7","Preclinical","","XREFXUCWSYMIOG-UHFFFAOYSA-N","BRD-K83547600","","O=C(NCC1(CCOCC1)N1CCN(CC1)c1ccccc1)c1cccnc1Sc1ccccc1"
"2617","JNJ-63533054","G protein-coupled receptor agonist","GPR139","","","MedChemEx",98.12,"BRD-K19482962-001-01-8","Preclinical","","MWDVCHRYCKXEBY-LBPRGKRZSA-N","BRD-K19482962","","C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1"
"2618","JNJ-7706621","CDK inhibitor","AURKA, AURKB, CDK1, CDK2","","","Selleck",93.95,"BRD-K11636097-001-03-1","Preclinical","","KDKUVYLMPJIGKA-UHFFFAOYSA-N","BRD-K11636097","","Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F"
"2619","JNJ-7777120","histamine receptor antagonist","HRH4","","","Tocris, Selleck",97.84,"BRD-K17774839-001-03-7, BRD-K17774839-001-02-9","Preclinical","","HUQJRYMLJBBEDO-UHFFFAOYSA-N","BRD-K17774839","","CN1CCN(CC1)C(=O)c1cc2cc(Cl)ccc2[nH]1"
"2621","JQ1-(+)","bromodomain inhibitor","BRD4, BRDT","","","Selleck, Tocris",97.16,"BRD-K54606188-001-13-1, BRD-K54606188-001-16-4","Preclinical","BRD-K17588104-001-03-9","DNVXATUJJDPFDM-KRWDZBQOSA-N","BRD-K54606188","BRD-K17588104","Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n-21)c1ccc(Cl)cc1"
"2623","JTC-801","opioid receptor antagonist","OPRL1","","","Tocris, Tocris, Selleck",96.79,"BRD-K17705806-003-04-4, BRD-K17705806-003-06-9, BRD-K17705806-003-03-6","Phase 2","","VTGBZWHPJFMTKS-UHFFFAOYSA-N","BRD-K17705806","","CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1"
"2626","JTE-013","lysophospholipid receptor antagonist","P2RY10, S1PR2","","","Tocris, Tocris",74.8,"BRD-K43330982-001-02-3, BRD-K43330982-001-03-1","Preclinical","","RNSLRQNDXRSASX-UHFFFAOYSA-N","BRD-K43330982","","CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc2n(C)nc(C)c12"
"2628","JTE-607","cytokine production inhibitor","IL10, IL1B, IL6, TNF","","","Tocris, Tocris",98.12,"BRD-K81405859-300-01-4, BRD-K81405859-300-02-2","Phase 2","","IPSSXIMJJXSJQB-FQEVSTJZSA-N","BRD-K81405859","","CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c(OCCN2CCN(C)CC2)c(Cl)c1O"
"2630","JTE-907","cannabinoid receptor inverse agonist","CNR2","","","Tocris, Tocris",98.31,"BRD-K63150726-001-02-1, BRD-K63150726-001-03-9","Phase 1","","GRAJFFFXJYFVOC-UHFFFAOYSA-N","BRD-K63150726","","CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12"
"2632","JW-55","tankyrase inhibitor","TNKS, TNKS2","","","Tocris",96.32,"BRD-K53328210-001-04-4","Preclinical","","ZJZWZIXSGNFWQQ-UHFFFAOYSA-N","BRD-K53328210","","COc1ccc(cc1)C1(CNC(=O)c2ccc(NC(=O)c3ccco3)cc2)CCOCC1"
"2633","JW-642","monoacylglycerol lipase inhibitor","MGLL","","","Tocris",92.32,"BRD-K48424871-001-03-1","Preclinical","","AVSCNEOUWSVZEY-UHFFFAOYSA-N","BRD-K48424871","","FC(F)(F)C(OC(=O)N1CCN(Cc2cccc(Oc3ccccc3)c2)CC1)C(F)(F)F"
"2634","JW-67","Wnt pathway inhibitor","APC, AXIN1, GSK3B","","","Tocris",96.58,"BRD-K24554037-001-08-3","Preclinical","","BTXRSHKJNDFHGA-UHFFFAOYSA-N","BRD-K24554037","","O=C1Nc2ccccc2C11OCC2(CO1)COC1(OC2)C(=O)Nc2ccccc12"
"2635","JW-74","WNT signaling inhibitor, tankyrase inhibitor","TNKS, TNKS2","","","PrincetonBio, Tocris",99.87,"BRD-K75664313-001-02-6, BRD-K75664313-001-03-4","Preclinical","","KRIKILRRJCIWNB-UHFFFAOYSA-N","BRD-K75664313","","COc1ccc(cc1)-n1c(SCc2nc(no2)-c2ccc(C)cc2)nnc1-c1ccncc1"
"2637","JX-401","p38 MAPK inhibitor","MAPK14","","","Tocris, Tocris",98.22,"BRD-K05464208-001-05-7, BRD-K05464208-001-08-1","Preclinical","","OMGLGPKQUFSRNN-UHFFFAOYSA-N","BRD-K05464208","","COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1"
"2639","JZL-184","monoacylglucerol lipase inhibitor","MGLL","","","Tocris, Selleck",96.24,"BRD-K45446451-001-06-8, BRD-K45446451-001-05-0","Preclinical","","SEGYOKHGGFKMCX-UHFFFAOYSA-N","BRD-K45446451","","OC(C1CCN(CC1)C(=O)Oc1ccc(cc1)[N+]([O-])=O)(c1ccc2OCOc2c1)c1ccc2OCOc2c1"
"2641","JZL-195","FAAH inhibitor, monoacylglycerol lipase inhibitor","FAAH, MGLL","","","Tocris",98.35,"BRD-K38875233-001-03-9","Preclinical","","QNYRAEKLMNDRFY-UHFFFAOYSA-N","BRD-K38875233","","[O-][N+](=O)c1ccc(OC(=O)N2CCN(Cc3cccc(Oc4ccccc4)c3)CC2)cc1"
"2642","K-MAP","","","","","ChemBridge",92.13,"BRD-A45906415-001-01-9","Phase 2","","VXMVXDITZWJXJN-UHFFFAOYSA-N","BRD-A45906415","","OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C(O)C1O"
"2643","K-RAS(G12C)-INHIBITOR-12","K-ras inhibitor","KRAS","","","MedChemEx, MedChemEx",82.19,"BRD-K90756851-001-01-1, BRD-K90756851-001-02-9","Preclinical","","JFIFBWVNHLXJFY-UHFFFAOYSA-N","BRD-K90756851","","Oc1cc(Cl)c(I)cc1NCC(=O)N1CCN(CC1)C(=O)C=C"
"2645","K-RAS(G12C)-INHIBITOR-6","K-ras inhibitor","","","","Selleck, Selleck",94.21,"BRD-K26305185-001-01-3, BRD-K26305185-001-02-1","Preclinical","","ZPXCEHMKUTXHRZ-UHFFFAOYSA-N","BRD-K26305185","","SCCCC(=O)NC1CCN(CC1)C(=O)COc1ccc(Cl)cc1Cl"
"2647","K-STROPHANTHIDIN","ATPase inhibitor","ATP1A1","","","Enzo",69.82,"BRD-A55312468-001-04-7","Phase 2","","ODJLBQGVINUMMR-VJHNTTCYSA-N","BRD-A55312468","","C[C@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CCC2C1=CC(=O)OC1"
"2648","K-247","","","","","ChemBridge",62.72,"BRD-A74648924-001-02-3","Phase 1","","QNUBRHYSSHJWDH-UHFFFAOYSA-N","BRD-A74648924","","OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C1O"
"2649","K-858","kinesin-like spindle protein inhibitor","KIF11","","","Tocris",98.42,"BRD-A67748489-001-10-0","Preclinical","","JEFVYQYZCAVNTP-UHFFFAOYSA-N","BRD-A67748489","","CC(=O)NC1=NN(C(C)=O)C(C)(S1)c1ccccc1"
"2650","KAEMPFEROL","bone resorption inhibitor, estrogen-related receptor inverse agonist","AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1","","","Tocris, Selleck, Selleck",97.71,"BRD-K12807006-001-18-5, BRD-K12807006-001-17-7, BRD-K12807006-001-19-3","Preclinical","","IYRMWMYZSQPJKC-UHFFFAOYSA-N","BRD-K12807006","","Oc1ccc(cc1)-c1oc2cc(O)cc(O)c2c(=O)c1O"
"2653","KAINIC-ACID","kainate receptor agonist","GRIA1, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5","","","Tocris",100,"BRD-K52459018-001-09-1","Preclinical","","VLSMHEGGTFMBBZ-OOZYFLPDSA-N","BRD-K52459018","","CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O"
"2654","KAKONEIN","GABA receptor antagonist, serotonin receptor antagonist","","","","Vitas-M",97.6,"BRD-A07815743-001-01-1","Phase 2","","HKEAFJYKMMKDOR-UHFFFAOYSA-N","BRD-A07815743","","OCC1OC(C(O)C(O)C1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O"
"2655","KARTOGENIN","chondrocyte differentiation stimulator","FLNA","","","Tocris",71.07,"BRD-K27584835-001-01-6","Preclinical","","SLUINPGXGFUMLL-UHFFFAOYSA-N","BRD-K27584835","","OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)-c1ccccc1"
"2656","KB-R7943","sodium/calcium exchange inhibitor","SLC8A1, TRPC3, TRPC5, TRPC6","","","Tocris, Tocris",92.36,"BRD-K17743697-066-04-4, BRD-K17743697-066-03-6","Preclinical","","UMJUNUMSJDTYTM-UHFFFAOYSA-N","BRD-K17743697","","NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1"
"2658","KB-SRC-4","src inhibitor","SRC","","","Tocris",98.82,"BRD-K88154110-001-01-0","Preclinical","","UHIZYQVRKSWIFO-UHFFFAOYSA-N","BRD-K88154110","","Nc1ncnc2n(nc(-c3ccc(Cl)cc3)c12)-c1cccc(c1)-c1cnnn1Cc1cccc(c1)-c1ccccc1"
"2659","KBG","neprilysin inhibitor","MME","","","SantaCruz",97.5,"BRD-A00376169-001-01-6","Phase 2","","FOLRUCXBTYDAQK-SFZUHQLGSA-N","BRD-A00376169","","OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)c1ccccc1"
"2660","KD-023","ACAT inhibitor","ACACA, ACACB","","","EMDBio",100,"BRD-K71164191-001-01-0","Phase 2","","CZRCFAOMWRAFIC-UHFFFAOYSA-N","BRD-K71164191","","CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O"
"2661","KD025","rho associated kinase inhibitor","ROCK2","","","MedChemEx",97.3,"BRD-K88506063-001-01-8","Phase 2","","GKHIVNAUVKXIIY-UHFFFAOYSA-N","BRD-K88506063","","CC(C)NC(=O)COc1cccc(c1)-c1nc(Nc2ccc3[nH]ncc3c2)c2ccccc2n1"
"2662","KENPAULLONE","CDK inhibitor, glycogen synthase kinase inhibitor","CCNB1, CDK1, CDK5, GSK3B","","","Tocris, Tocris",96.42,"BRD-K37312348-001-17-6, BRD-K37312348-001-15-0","Preclinical","","QQUXFYAWXPMDOE-UHFFFAOYSA-N","BRD-K37312348","","Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1"
"2664","KETOROLAC","cyclooxygenase inhibitor","PTGS1, PTGS2","","","MicroSource, Selleck, Selleck",95.72,"BRD-A40639672-234-18-0, BRD-A40639672-234-17-2, BRD-A40639672-001-01-9","Launched","","OZWKMVRBQXNZKK-UHFFFAOYSA-N","BRD-A40639672","","OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1"
"2667","KEVETRIN","p53 activator","","","","MedChemEx",95.3,"BRD-K61339991-003-01-8","Phase 1","","PRDJGNVQBVXXEO-UHFFFAOYSA-N","BRD-K61339991","","NC(=N)SCCCC#N"
"2668","KF-38789","P selectin inhibitor","SELP","","","Tocris, Tocris",92.1,"BRD-A54927599-001-16-9, BRD-A54927599-001-17-7","Preclinical","","NHFIAAAMCYVRIW-UHFFFAOYSA-N","BRD-A54927599","","COc1ccc(C2CC(=NCCS2)c2c(O)cc(C)oc2=O)c(OC)c1"
"2670","KG-5","RAF inhibitor","BRAF, FLT3, KIT, PDGFRB","","","Tocris",96.24,"BRD-K90747162-001-01-4","Preclinical","","CMYHZFCJPORPHY-UHFFFAOYSA-N","BRD-K90747162","","CSc1nc(N)cc(Oc2ccc(cc2)-c2nnc(Nc3cccc(c3)C(F)(F)F)[nH]2)n1"
"2671","KH-CB19","CDC inhibitor","CLK1, CLK3, DYRK1A","","","MedChemEx",27.29,"BRD-K01673854-001-02-1","Preclinical","","CXJCGSPAPOTTSF-VURMDHGXSA-N","BRD-K01673854","","CCOC(=O)c1c(\C(=C/N)C#N)c2ccc(Cl)c(Cl)c2n1C"
"2672","KHELLIN","vasodilator","","","","MicroSource, Sigma",99.43,"BRD-K80353807-001-24-6, BRD-K80353807-001-25-3","Phase 2","","HSMPDPBYAYSOBC-UHFFFAOYSA-N","BRD-K80353807","","COc1c2ccoc2c(OC)c2oc(C)cc(=O)c12"
"2674","KHK-IN-1","hexokinase inhibitor","KHK","","","MedChemEx",93.66,"BRD-K84605263-003-01-6","Preclinical","","HFLMLZKGLUEWBU-UHFFFAOYSA-N","BRD-K84605263","","CSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1"
"2675","KHS-101","neural stem cell inducer","TACC3","","","Tocris",97.05,"BRD-K78978711-003-01-3","Preclinical","","DGRJOOOHPBSAHD-UHFFFAOYSA-N","BRD-K78978711","","CC(C)CNc1ccnc(NCc2csc(n2)-c2ccccc2)n1"
"2676","KI-16425","lysophosphatidic acid receptor antagonist","LPAR1, LPAR3","","","Selleck",96.73,"BRD-A25569250-001-03-3","Preclinical","","LLIFMNUXGDHTRO-UHFFFAOYSA-N","BRD-A25569250","","CC(OC(=O)Nc1c(C)noc1-c1ccc(CSCCC(O)=O)cc1)c1ccccc1Cl"
"2677","KI-20227","c-Fms inhibitor","CSF1R, KDR, KIT, PDGFRB","","","Tocris",97.77,"BRD-A88787317-001-01-0","Preclinical","","SHPFDGWALWEPGS-UHFFFAOYSA-N","BRD-A88787317","","COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1"
"2678","KI-8751","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","KDR","","","Tocris, Selleck, Tocris",96.63,"BRD-K47150025-001-06-1, BRD-K47150025-001-05-3, BRD-K47150025-001-09-5","Preclinical","","LFKQSJNCVRGFCC-UHFFFAOYSA-N","BRD-K47150025","","COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC"
"2681","KIFUNENSINE","mannosidase inhibitor","MAN1B1, MAN2A1","","","EMDBio",100,"BRD-K02898090-001-02-7","Phase 1","","OIURYJWYVIAOCW-PQMKYFCFSA-N","BRD-K02898090","","OC[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H]2NC(=O)C(=O)N12"
"2682","KI16198","lipoprotein antagonist","LPA","","","Selleck",96.6,"BRD-A94323479-001-02-8","Preclinical","","HHVJBROTJWPHHX-UHFFFAOYSA-N","BRD-A94323479","","COC(=O)CCSCc1ccc(cc1)-c1onc(C)c1NC(=O)OC(C)c1ccccc1Cl"
"2683","KL-001","proteasome inhibitor","CRY1, CRY2","","","Tocris",98.65,"BRD-A94580299-001-10-4","Preclinical","","OQAFDLPAPSSOHY-UHFFFAOYSA-N","BRD-A94580299","","CS(=O)(=O)N(CC(O)Cn1c2ccccc2c2ccccc12)Cc1ccco1"
"2684","KML29","monoacylglucerol lipase inhibitor","MGLL","","","MedChemEx",96.99,"BRD-K46734292-001-03-6","Preclinical","","SXHQLPHDBLTFPM-UHFFFAOYSA-N","BRD-K46734292","","OC(C1CCN(CC1)C(=O)OC(C(F)(F)F)C(F)(F)F)(c1ccc2OCOc2c1)c1ccc2OCOc2c1"
"2685","KN-62","calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist","AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1","","","MedChemEx",96.68,"BRD-A81177136-001-12-7","Preclinical","","RJVLFQBBRSMWHX-UHFFFAOYSA-N","BRD-A81177136","","CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12"
"2686","KN-93","calcium/calmodulin dependent protein kinase inhibitor","CAMK2A","","","MedChemEx, MedChemEx, MedChemEx",98.69,"BRD-K93480852-003-01-0, BRD-K93480852-001-06-3, BRD-K93480852-001-05-5","Preclinical","","LLLQTDSSHZREGW-AATRIKPKSA-N","BRD-K93480852","","COc1ccc(cc1)S(=O)(=O)N(CCO)c1ccccc1CN(C)C\C=C\c1ccc(Cl)cc1"
"2689","KO143","BCRP inhibitor","ABCB1, ABCC1","","","Tocris, MedChemEx",97.42,"BRD-K64642496-001-04-0, BRD-K64642496-001-03-2","Preclinical","","NXNRAECHCJZNRF-JBACZVJFSA-N","BRD-K64642496","","COc1ccc2c3C[C@@H]4N([C@@H](CC(C)C)c3[nH]c2c1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O"
"2691","KP-1212","","","","","Berry",100,"BRD-K46690591-001-01-2","Phase 2","","LAOLDMMWVYDDID-HSUXUTPPSA-N","BRD-K46690591","","NC1=NC(=O)N(CN1)[C@H]1C[C@@H](O)[C@@H](CO)O1"
"2692","KPT-185","exportin antagonist","XPO1","","","Selleck",95.93,"BRD-K71467466-001-02-3","Preclinical","","NLNGWFLRRRYNIL-PLNGDYQASA-N","BRD-K71467466","","COc1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)OC(C)C)n1"
"2693","KPT-276","exportin antagonist","XPO1","","","Selleck",95.86,"BRD-K75352575-001-01-3","Preclinical","","JCHAWRDHMUSLMM-UPHRSURJSA-N","BRD-K75352575","","FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(n1)\C=C/C(=O)N1CC(F)(F)C1"
"2694","KRCA-0008","ALK inihibitor","ALK","","","Tocris",89.08,"BRD-K40604024-001-01-6","Preclinical","","TXDIRJCYNAWBOS-UHFFFAOYSA-N","BRD-K40604024","","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccc(cc2OC)N2CCN(CC2)C(C)=O)n1)N1CCN(CC1)C(C)=O"
"2695","KRN-633","VEGFR inhibitor","FLT1, FLT4, KDR","","","Selleck",93.55,"BRD-K90993449-001-02-7","Preclinical","","VPBYZLCHOKSGRX-UHFFFAOYSA-N","BRD-K90993449","","CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl"
"2696","KS-176","BCRP inhibitor","ABCG2","","","Tocris",96.94,"BRD-K81053848-001-01-0","Preclinical","","LTWQQWSXYYXVGA-UHFFFAOYSA-N","BRD-K81053848","","OCCc1ccc(NC(=O)c2ccccc2NC(=O)c2ccc(cc2)[N+]([O-])=O)cc1"
"2697","KT-433","uricosuric agent","","","","Sigma",97.5,"BRD-K66437909-001-01-0","Phase 2","","XSDFWTIKVXKOGJ-UHFFFAOYSA-N","BRD-K66437909","","CCc1oc2ccccc2c1C(=O)c1ccc(OCC(O)=O)cc1"
"2698","KU-0063794","mTOR inhibitor","MTOR","","","Selleck, Selleck",95.33,"BRD-K67566344-001-08-3, BRD-K67566344-001-07-5","Preclinical","","RFSMUFRPPYDYRD-CALCHBBNSA-N","BRD-K67566344","","COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1"
"2700","KU-55933","ATM kinase inhibitor","ATM, PRKDC","","","Tocris, Selleck",98.75,"BRD-K25311561-001-10-7, BRD-K25311561-001-09-9","Preclinical","","XRKYMMUGXMWDAO-UHFFFAOYSA-N","BRD-K25311561","","O=c1cc(oc(c1)-c1cccc2Sc3ccccc3Sc12)N1CCOCC1"
"2702","KU-60019","ATM kinase inhibitor","ATM","","","Selleck, Selleck, Tocris",96.77,"BRD-K36016295-001-05-2, BRD-K36016295-001-04-5, BRD-K36016295-001-06-0","Preclinical","","SCELLOWTHJGVIC-BGYRXZFFSA-N","BRD-K36016295","","C[C@H]1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)C[C@@H](C)O1"
"2705","KUROMANIN","ribosyl cyclase inhibitor","CD38","","","MedChemEx",98.1,"BRD-K51337109-003-01-3","Preclinical","","RKWHWFONKJEUEF-GQUPQBGVSA-O","BRD-K51337109","","OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O"
"2706","KU14R","imidazoline receptor antagonist","","","","Tocris, Tocris",98.56,"BRD-A38747044-001-03-1, BRD-A38747044-001-02-3","Preclinical","","JCWVNNMJXQJVNC-UHFFFAOYSA-N","BRD-A38747044","","CCC1(Cc2ccccc2O1)c1ncc[nH]1"
"2708","KW-2449","Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor","ABL1, AURKA, AURKB, FLT3","","","Selleck",93.46,"BRD-K21718444-001-06-8","Phase 1","","YYLKKYCXAOBSRM-JXMROGBWSA-N","BRD-K21718444","","O=C(N1CCNCC1)c1ccc(cc1)\C=C\c1n[nH]c2ccccc12"
"2709","KW-2478","HSP inhibitor","","","","Selleck",92.87,"BRD-K41213548-001-02-0","Phase 1/Phase 2","","VFUXSYAXEKYYMB-UHFFFAOYSA-N","BRD-K41213548","","CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC"
"2710","KW-3902","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",98.8,"BRD-A95683721-001-03-8","Phase 3","","PJBFVWGQFLYWCB-UHFFFAOYSA-N","BRD-A95683721","","CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)C12CC3CC1CC(C2)C3"
"2711","KX2-391","src inhibitor, tubulin polymerization inhibitor","SRC","","","Selleck",96.52,"BRD-K29968218-001-03-2","Phase 2","","HUNGUWOZPQBXGX-UHFFFAOYSA-N","BRD-K29968218","","O=C(Cc1ccc(cn1)-c1ccc(OCCN2CCOCC2)cc1)NCc1ccccc1"
"2712","KYNURENIC-ACID","glutamate receptor antagonist","GPR35, GRIN1, GRIN2A, GRIN2B","","","Tocris, Tocris",98.64,"BRD-K85872723-001-17-5, BRD-K85872723-001-15-9","Preclinical","","HCZHHEIFKROPDY-UHFFFAOYSA-N","BRD-K85872723","","OC(=O)c1cc(O)c2ccccc2n1"
"2714","KY02111","Wnt pathway inhibitor","DKK1","","","Selleck, Tocris",97.58,"BRD-K13302470-001-02-7, BRD-K13302470-001-03-5","Preclinical","","LXFKEVQQSKQXPR-UHFFFAOYSA-N","BRD-K13302470","","COc1ccc(CCC(=O)Nc2nc3ccc(Cl)cc3s2)cc1OC"
"2716","K02288","bone morphogenic protein inhibitor","BMP1","","","MedChemEx, Selleck, Tocris",99.48,"BRD-K58568447-001-03-7, BRD-K58568447-001-01-1, BRD-K58568447-001-02-9","Preclinical","","CJLMANFTWLNAKC-UHFFFAOYSA-N","BRD-K58568447","","COc1cc(cc(OC)c1OC)-c1cc(cnc1N)-c1cccc(O)c1"
"2719","K145","sphingosine kinase inhibitor","SPHK2","","","MedChemEx",87.48,"BRD-K12106308-003-01-9","Preclinical","","MPZXLTZVPUSTFY-SOFYXZRVSA-N","BRD-K12106308","","CCCCOc1ccc(CC\C=C2/SC(=O)N(CCN)C2=O)cc1"
"2720","L-(+)-RHAMNOSE-MONOHYDRATE","","","","","Selleck",100,"BRD-A86354194-002-01-7","Preclinical","","SHZGCJCMOBCMKK-CBPJZXOFSA-N","BRD-A86354194","","C[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O"
"2721","L-ALANINE","","","","","Sigma",0,"BRD-K25125382-001-02-5","Launched","","QNAYBMKLOCPYGJ-REOHCLBHSA-N","BRD-K25125382","","C[C@H](N)C(O)=O"
"2722","L-ASCORBYL-6-PALMITATE","","","","","Selleck, MicroSource, Selleck",36.17,"BRD-A45419686-001-02-3, BRD-A45419686-001-04-9, BRD-A45419686-001-03-1","Preclinical","BRD-A14985772-001-03-3","CYJPUZLKFAUFHF-PRZWFREHSA-N","BRD-A45419686","BRD-A14985772","CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(=O)C1O"
"2725","L-ASPARAGINE","","ASNS, ASRGL1, NARS, NARS2, SLC1A5, SLC38A3","","","Sigma",0,"BRD-K06665116-001-02-6","Phase 3","","DCXYFEDJOCDNAF-REOHCLBHSA-N","BRD-K06665116","","N[C@@H](CC(N)=O)C(O)=O"
"2726","L-ASPARAGINE-N-HYDROXY","","","","","Sigma",98.6,"BRD-K82178523-001-01-6","Preclinical","","ZBYVTTSIVDYQSO-REOHCLBHSA-N","BRD-K82178523","","N[C@@H](CC(=O)NO)C(O)=O"
"2727","L-ASPARTIC-ACID","metallic radical formation stimulant","ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13","","","Sigma, Enzo",98.1,"BRD-K97163964-001-04-1, BRD-K97163964-001-03-3","Launched","","CKLJMWTZIZZHCS-REOHCLBHSA-N","BRD-K97163964","","N[C@@H](CC(O)=O)C(O)=O"
"2729","L-CYSTEINE","","CARS, CARS2, CBS, CDO-1, CDO1, CSAD, CTH, GCLC, GCLM, GOT1, GSS, MGMT, NFS1, SLC19A3","","","Sigma",0,"BRD-K00795468-001-02-1","Launched","","XUJNEKJLAYXESH-REOHCLBHSA-N","BRD-K00795468","","N[C@@H](CS)C(O)=O"
"2730","L-CYSTEINESULFINIC-ACID","glutamate receptor agonist","GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2","","","Tocris",0,"BRD-A25800195-001-02-2","Preclinical","","ADVPTQAUNPRNPO-REOHCLBHSA-N","BRD-A25800195","","N[C@@H](CS(O)=O)C(O)=O"
"2731","L-CYSTINE","","CTNS, SLC3A1, SLC7A11, SLC7A9","","","Enamine, Enamine, Sigma",0,"BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3","Launched","","LEVWYRKDKASIDU-UHFFFAOYSA-N","BRD-A15397381","","NC(CSSCC(N)C(O)=O)C(O)=O"
"2733","L-CYSTINE","","CTNS, SLC3A1, SLC7A11, SLC7A9","","","Enamine, Enamine, Sigma",0,"BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3","Launched","","LEVWYRKDKASIDU-UHFFFAOYSA-N","BRD-A15397381","","N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O"
"2734","L-CYSTINE","","CTNS, SLC3A1, SLC7A11, SLC7A9","","","Enamine, Enamine, Sigma",0,"BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3","Launched","","LEVWYRKDKASIDU-IMJSIDKUSA-N","BRD-A15397381","","NC(CSSCC(N)C(O)=O)C(O)=O"
"2736","L-CYSTINE","","CTNS, SLC3A1, SLC7A11, SLC7A9","","","Enamine, Enamine, Sigma",0,"BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3","Launched","","LEVWYRKDKASIDU-IMJSIDKUSA-N","BRD-A15397381","","N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O"
"2737","L-ERGOTHIONEINE","free radical scavenger","","","","Enzo",100,"BRD-K26341917-001-01-3","Phase 2","","SSISHJJTAXXQAX-ZETCQYMHSA-O","BRD-K26341917","","C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(O)=O"
"2738","L-GLUTAMIC-ACID","glutamate receptor agonist","AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT","","","Sigma",98.26,"BRD-K62309135-001-05-2","Launched","BRD-M12235055-001-06-2","WHUUTDBJXJRKMK-VKHMYHEASA-N","BRD-K62309135","BRD-M12235055","N[C@@H](CCC(O)=O)C(O)=O"
"2739","L-HYDROXYPROLINE","","","","","Enamine",0,"BRD-A12454076-001-01-9","Launched","","PMMYEEVYMWASQN-UHFFFAOYSA-N","BRD-A12454076","","OC1CNC(C1)C(O)=O"
"2740","L-LEUCINE","","BCAT1, BCAT2, LARS, LARS2, LCMT1, LCMT2","","","Sigma",58.9,"BRD-K12853841-001-02-2","Phase 3","","ROHFNLRQFUQHCH-YFKPBYRVSA-N","BRD-K12853841","","CC(C)C[C@H](N)C(O)=O"
"2741","L-LYSINE","serotonin receptor agonist","GPRC6A, KARS, SLC7A1, SLC7A2, SLC7A3, SLC7A4","","","Sigma",0,"BRD-K86016185-001-01-3","Phase 2","","KDXKERNSBIXSRK-YFKPBYRVSA-N","BRD-K86016185","","NCCCC[C@H](N)C(O)=O"
"2742","L-METHIONINE","voltage-gated calcium channel ligand","","","","Sigma",97.7,"BRD-K06502269-001-02-6","Launched","","FFEARJCKVFRZRR-BYPYZUCNSA-N","BRD-K06502269","","CSCC[C@H](N)C(O)=O"
"2743","L-MIMOSINE","dopamine beta hydroxylase inhibitor, eukaryotic translation initiation factor inhibitor","DBH, EIF5A","","","Sigma",50.1,"BRD-K98151021-001-01-2","Preclinical","","BLYDGIISUNWHLF-YFKPBYRVSA-N","BRD-K98151021","","N[C@@H](CN1CC(=O)C(=O)C=C1)C(O)=O"
"2744","L-MONOMETHYLARGININE","nitric oxide synthase inhibitor","NOS1, NOS2","","","Tocris",0,"BRD-K20946707-001-01-9","Phase 3","","NTWVQPHTOUKMDI-YFKPBYRVSA-N","BRD-K20946707","","CN[C@@H](CCCNC(N)=N)C(O)=O"
"2745","L-NAME","nitric oxide synthase inhibitor","NOS3","","","Tocris, Tocris",96.03,"BRD-K33141550-003-06-5, BRD-K33141550-003-05-7","Phase 2/Phase 3","","KCWZGJVSDFYRIX-YFKPBYRVSA-N","BRD-K33141550","","COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O"
"2747","L-NIL","nitric oxide synthase inhibitor","NOS1, NOS2, NOS3","","","Tocris",97.43,"BRD-K60036103-003-01-6","Preclinical","","ONYFNWIHJBLQKE-ZETCQYMHSA-N","BRD-K60036103","","CC(=N)NCCCC[C@H](N)C(O)=O"
"2748","L-PROLINE","glutamate receptor agonist","EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7","","","Sigma",99.2,"BRD-K01666412-001-02-0","Launched","","ONIBWKKTOPOVIA-BYPYZUCNSA-N","BRD-K01666412","","OC(=O)[C@@H]1CCCN1"
"2749","L-QUISQUALIC-ACID","glutamate receptor agonist","FOLH1, GRIA2, GRIK1, GRIK2, GRM1, GRM2, GRM3, GRM5, GRM7, GRM8","","","Tocris",100,"BRD-K92404805-001-07-0","Preclinical","","ASNFTDCKZKHJSW-REOHCLBHSA-N","BRD-K92404805","","N[C@@H](Cn1oc(=O)[nH]c1=O)C(O)=O"
"2750","L-THEANINE","glutamate receptor antagonist","","","","Enzo",100,"BRD-A08715367-001-01-7","Launched","","DATAGRPVKZEWHA-UHFFFAOYSA-N","BRD-A08715367","","CCNC(=O)CCC(N)C(O)=O"
"2751","L-THREONINE","","TARS, TARS2, THNSL1","","","Sigma",0,"BRD-K75508643-001-02-6","Phase 2","","AYFVYJQAPQTCCC-GBXIJSLDSA-N","BRD-K75508643","","C[C@@H](O)[C@H](N)C(O)=O"
"2752","L-152804","neuropeptide receptor antagonist","NPY5R","","","Tocris, Tocris",92.68,"BRD-A42553870-001-15-0, BRD-A42553870-001-14-3","Preclinical","","XQDXIHYKAGHZRX-UHFFFAOYSA-N","BRD-A42553870","","CC1(C)CC(=O)C(C2c3ccccc3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1"
"2754","L-161982","prostanoid receptor antagonist","PTGER4","","","Tocris, Tocris",98.41,"BRD-K39733634-001-02-6, BRD-K39733634-001-03-4","Preclinical","","MMDNKTXNUZFVKD-UHFFFAOYSA-N","BRD-K39733634","","CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C"
"2756","L-165041","PPAR receptor agonist","PPARD","","","Tocris, Tocris",98.7,"BRD-K98372770-001-09-0, BRD-K98372770-001-08-2","Preclinical","BRD-K40656405-001-03-1, BRD-K40656405-001-02-3","HBBVCKCCQCQCTJ-UHFFFAOYSA-N","BRD-K98372770","BRD-K40656405","CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O"
"2758","L-168049","glucagon receptor antagonist","GCGR","","","Tocris, Tocris",94.42,"BRD-K18036262-001-02-8, BRD-K18036262-001-03-6","Preclinical","","HHBOWXZOLYQFNY-UHFFFAOYSA-N","BRD-K18036262","","CCCOc1ccc(Br)cc1-c1cc([nH]c1-c1ccncc1)-c1ccc(Cl)cc1"
"2760","L-365260","CCK receptor antagonist","CCKAR, CCKBR, KCNQ1","","","Tocris",98.98,"BRD-K34277641-001-01-2","Phase 2","","KDFQABSFVYLGPM-QFIPXVFZSA-N","BRD-K34277641","","CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2cccc(C)c2)C1=O)c1ccccc1"
"2761","L-368899","oxytocin receptor antagonist","AVPR1A, AVPR2, OXTR","","","Tocris, Tocris",84.47,"BRD-A43930669-003-02-8, BRD-A43930669-003-03-6","Phase 1","","MWIASLNTAGRGGA-WVJGRJQASA-N","BRD-A43930669","","Cc1ccccc1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C"
"2763","L-655,708","GABA receptor inverse agonist","GABRA1, GABRA2, GABRA3, GABRA5, GABRG2","","","Tocris, Tocris",98.39,"BRD-K13474508-001-02-0, BRD-K13474508-001-01-2","Preclinical","","YKYOQIXTECBVBB-AWEZNQCLSA-N","BRD-K13474508","","CCOC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc-21"
"2765","L-655240","thromboxane receptor antagonist","PTGES","","","Tocris, Tocris",98.81,"BRD-K89402695-001-03-1, BRD-K89402695-001-02-3","Phase 1","","JLPYLHLUHJOPNL-UHFFFAOYSA-N","BRD-K89402695","","Cc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(F)cc12"
"2767","L-670596","prostanoid receptor antagonist","","","","Tocris",98.01,"BRD-A85472596-001-02-2","Preclinical","","GMJWAIMJHBTYPD-UHFFFAOYSA-N","BRD-A85472596","","CS(=O)(=O)c1ccc(Cn2c3C(CC(O)=O)CCCc3c3cc(F)cc(F)c23)cc1"
"2768","L-689560","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, Tocris",95.13,"BRD-K74284736-001-03-1, BRD-K74284736-001-02-3","Preclinical","","UCKHICKHGAOGAP-UONOGXRCSA-N","BRD-K74284736","","OC(=O)[C@H]1C[C@H](NC(=O)Nc2ccccc2)c2c(Cl)cc(Cl)cc2N1"
"2770","L-690330","inositol monophosphatase inhibitor","IMPA1","","","Tocris",0,"BRD-K28470988-001-04-6","Preclinical","","JKOCAAWWDVHWKB-UHFFFAOYSA-N","BRD-K28470988","","CC(Oc1ccc(O)cc1)(P(O)(O)=O)P(O)(O)=O"
"2771","L-693403","sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1","","","Tocris",96.18,"BRD-K83322645-050-01-9","Preclinical","","GSXJSGMDWKPVBY-UHFFFAOYSA-N","BRD-K83322645","","C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1"
"2772","L-694247","serotonin receptor agonist","HTR1A, HTR1B, HTR1D","","","Tocris",29.3,"BRD-K18816859-001-02-2","Preclinical","","HKXMQLISPYELRD-UHFFFAOYSA-N","BRD-K18816859","","CS(=O)(=O)Nc1ccc(Cc2noc(n2)-c2ccc3[nH]cc(CCN)c3c2)cc1"
"2773","L-701252","glutamate receptor antagonist","GRIN1","","","Tocris",97.91,"BRD-K10176267-001-03-3","Preclinical","","MXEFWCFPCLDOOG-UHFFFAOYSA-N","BRD-K10176267","","Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12"
"2774","L-701324","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, Tocris",98.44,"BRD-K08109516-001-08-6, BRD-K08109516-001-07-8","Preclinical","","FLVRDMUHUXVRET-UHFFFAOYSA-N","BRD-K08109516","","Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12"
"2776","L-732,138","tachykinin antagonist","TACR1, TACR2","","","Tocris, Tocris",97.96,"BRD-K37952347-001-02-2, BRD-K37952347-001-01-4","Preclinical","","BYYQYXVAWXAYQC-LJQANCHMSA-N","BRD-K37952347","","CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F"
"2778","L-733060","tachykinin antagonist","TACR1","","","Tocris",96.09,"BRD-K15791587-003-02-5","Preclinical","","FCDRFVCGMLUYPG-ROUUACIJSA-N","BRD-K15791587","","FC(F)(F)c1cc(CO[C@H]2CCCN[C@H]2c2ccccc2)cc(c1)C(F)(F)F"
"2779","L-741742","dopamine receptor antagonist","DRD3, DRD4, SCN1A, SCN3A","","","Tocris",97.25,"BRD-K13211965-003-02-8","Preclinical","","QDMAKDIDFJTXEL-UHFFFAOYSA-N","BRD-K13211965","","Cc1c(noc1-c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1"
"2780","L-745870","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7","","","Tocris, Tocris",93.03,"BRD-K05528470-305-03-0, BRD-K05528470-305-02-2","Preclinical","","OGJGQVFWEPNYSB-UHFFFAOYSA-N","BRD-K05528470","","Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1"
"2782","L-755507","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Tocris, Tocris",76.05,"BRD-K39359968-001-01-8, BRD-K39359968-001-02-6","Preclinical","","NYYJKMXNVNFOFQ-MHZLTWQESA-N","BRD-K39359968","","CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1"
"2784","L-760735","tachykinin antagonist","TACR1","","","Tocris",72.75,"BRD-K30425481-003-01-0","Preclinical","","USRYEHHMJIRICK-ZNZBMKLDSA-N","BRD-K30425481","","C[C@@H](O[C@H]1OCCN(Cc2nn[nH]c2CN(C)C)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F"
"2785","L-778123","farnesyltransferase inhibitor","FNTA, FNTB, PGGT1B","","","MedChemEx",96.05,"BRD-K10958118-003-01-5","Phase 1","","JNUGFGAVPBYSHF-UHFFFAOYSA-N","BRD-K10958118","","Clc1cccc(c1)N1CCN(Cc2cncn2Cc2ccc(cc2)C#N)CC1=O"
"2786","L-798,106","prostanoid receptor antagonist","PTGER3","","","Tocris, Tocris",99.28,"BRD-K43905307-001-01-2, BRD-K43905307-001-02-0","Preclinical","","ODTKFNUPVBULRJ-NTCAYCPXSA-N","BRD-K43905307","","COc1ccc(Br)cc1S(=O)(=O)NC(=O)\C=C\c1ccccc1Cc1ccc2ccccc2c1"
"2788","L-838417","GABA receptor partial agonist","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris",97.33,"BRD-K46647427-001-02-0","Preclinical","","BQDUNOMMYOKHEP-UHFFFAOYSA-N","BRD-K46647427","","Cn1ncnc1COc1nn2c(nnc2cc1C(C)(C)C)-c1cc(F)ccc1F"
"2789","LANATOSIDE-C","cardiac glycoside","","","","MicroSource",98.52,"BRD-A64242993-001-05-6","Preclinical","","JAYAGJDXJIDEKI-YBYZECQXSA-N","BRD-A64242993","","C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](OC(C)=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)C(CCC3C2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1"
"2790","LAPPACONITE","sodium channel blocker","","","","Selleck",90.14,"BRD-A05906449-004-01-1","Phase 2","","NWBWCXBPKTTZNQ-BBLNFATASA-N","BRD-A05906449","","CCN1C[C@@]2(CC[C@@H](OC)[C@@]34[C@H]5C[C@H]6[C@H](OC)[C@]5(O)[C@](O)(C[C@@H]6OC)[C@H](C[C@H]23)C14)OC(=O)c1ccccc1NC(C)=O"
"2791","LAQUINIMOD","immunosuppressant","CXCL2","","","Selleck, Selleck",86.53,"BRD-K60918217-001-02-0, BRD-K60918217-001-03-8","Phase 3","","GKWPCEFFIHSJOE-UHFFFAOYSA-N","BRD-K60918217","","CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1"
"2793","LATREPIRDINE","glutamate receptor antagonist","HRH1, HTR6","","","ChemDiv, Tocris, Adooq",95.21,"BRD-K55703048-001-07-7, BRD-K55703048-300-02-4, BRD-K55703048-300-01-6","Phase 3","","JNODQFNWMXFMEV-UHFFFAOYSA-N","BRD-K55703048","","CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1"
"2796","LATRUNCULIN-B","actin polymerization inhibitor","ACTA1, MKL1, SPIRE2","","","EMDBio",31.64,"BRD-K61292460-001-02-3","Phase 1","","NSHPHXHGRHSMIK-JRIKCGFMSA-N","BRD-K61292460","","C[C@H]1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]2CSC(=O)N2)OC(=O)\C=C(C)/CC\C=C/1"
"2797","LAURIC-ACID","bacterial permeability inducer","GPR84, HNF4A, LTF, LY96, PLA2G2A, TLR4","","","Enzo",58.87,"BRD-K67375056-001-07-9","Phase 3","","POULHZVOKOAJMA-UHFFFAOYSA-N","BRD-K67375056","","CCCCCCCCCCCC(O)=O"
"2798","LAURIC-DIETHANOLAMIDE","","","","","Enamine",97.68,"BRD-K11548689-001-01-6","Preclinical","","AOMUHOFOVNGZAN-UHFFFAOYSA-N","BRD-K11548689","","CCCCCCCCCCCC(=O)N(CCO)CCO"
"2799","LAUROCAPRAM","","","","","InterBioScreen",94.26,"BRD-K35698076-001-01-2","Phase 3","","AXTGDCSMTYGJND-UHFFFAOYSA-N","BRD-K35698076","","CCCCCCCCCCCCN1CCCCCC1=O"
"2800","LAZABEMIDE","monoamine oxidase inhibitor","MAOB","","","Tocris, Tocris",89.6,"BRD-K51486818-003-02-8, BRD-K51486818-003-03-6","Phase 3","","JZXRLKWWVNUZRB-UHFFFAOYSA-N","BRD-K51486818","","NCCNC(=O)c1ccc(Cl)cn1"
"2802","LB-100","protein phosphatase inhibitor","","","","MedChemEx, MedChemEx, MedChemEx",61.4,"BRD-A49767491-001-01-8, BRD-A73709786-001-01-3, BRD-A73709786-001-02-1","Phase 1","","JUQMLSGOTNKJKI-MFQSTILNSA-N","BRD-A49767491","","CN1CCN(CC1)C(=O)C1[C@H]2CC[C@H](O2)C1C(O)=O"
"2803","LB-100","protein phosphatase inhibitor","","","","MedChemEx, MedChemEx, MedChemEx",61.4,"BRD-A49767491-001-01-8, BRD-A73709786-001-01-3, BRD-A73709786-001-02-1","Phase 1","","JUQMLSGOTNKJKI-MFQSTILNSA-N","BRD-A49767491","","CN1CCN(CC1)C(=O)C1C2CCC(O2)C1C(O)=O"
"2805","LB-100","protein phosphatase inhibitor","","","","MedChemEx, MedChemEx, MedChemEx",61.4,"BRD-A49767491-001-01-8, BRD-A73709786-001-01-3, BRD-A73709786-001-02-1","Phase 1","","JUQMLSGOTNKJKI-UHFFFAOYSA-N","BRD-A49767491","","CN1CCN(CC1)C(=O)C1[C@H]2CC[C@H](O2)C1C(O)=O"
"2806","LB-100","protein phosphatase inhibitor","","","","MedChemEx, MedChemEx, MedChemEx",61.4,"BRD-A49767491-001-01-8, BRD-A73709786-001-01-3, BRD-A73709786-001-02-1","Phase 1","","JUQMLSGOTNKJKI-UHFFFAOYSA-N","BRD-A49767491","","CN1CCN(CC1)C(=O)C1C2CCC(O2)C1C(O)=O"
"2808","LB42708","farnesyltransferase inhibitor","","","","Tocris, Selleck, Selleck",96.49,"BRD-K18834913-001-03-7, BRD-K18834913-001-01-1, BRD-K18834913-001-02-9","Preclinical","","GUUIRIMAQGOLHT-UHFFFAOYSA-N","BRD-K18834913","","Brc1ccc(Cn2cncc2Cn2cc(C(=O)N3CCOCC3)c(c2)-c2cccc3ccccc23)cc1"
"2811","LCL-161","XIAP inhibitor","BIRC2, XIAP","","","MedChemEx",95.17,"BRD-K08248804-001-01-8","Phase 2","","UFPFGVNKHCLJJO-SSKFGXFMSA-N","BRD-K08248804","","CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)C(=O)c1ccc(F)cc1"
"2812","LCQ908","diacylglycerol O acyltransferase inhibitor","DGAT1","","","MedChemEx",89,"BRD-K20008181-001-01-3","Phase 3","","GXALXAKNHIROPE-QAQDUYKDSA-N","BRD-K20008181","","OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)-c1ccc(Nc2ccc(nc2)C(F)(F)F)cn1"
"2813","LDC1267","protein tyrosine kinase inhibitor","AXL, MERTK, TYRO3","","","MedChemEx",98.38,"BRD-K44715996-001-01-0","Preclinical","","ISPBCAXOSOLFME-UHFFFAOYSA-N","BRD-K44715996","","CCOc1cn(nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1)-c1ccc(F)cc1C"
"2814","LDN-209929","haspin kinase inhibitor","GSG2","","","Tocris",0,"BRD-K61795638-300-01-0","Preclinical","","XMMAOXMYUGQGJD-UHFFFAOYSA-N","BRD-K61795638","","COc1ccc2nc3ccc(Cl)cc3c(SCCCN)c2c1"
"2815","LDN-212854","bone morphogenic protein inhibitor","ABL1, ACVR1, RIPK2","","","Selleck, Selleck",97.26,"BRD-K59831625-001-01-6, BRD-K59831625-001-02-4","Preclinical","","BBDGBGOVJPEFBT-UHFFFAOYSA-N","BRD-K59831625","","C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12"
"2817","LDN-27219","tissue transglutaminase inhibitor","TGM2","","","Tocris",88.89,"BRD-K51485109-001-01-4","Preclinical","","WLBUICQBNZXIDJ-UHFFFAOYSA-N","BRD-K51485109","","NNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1"
"2818","LDN-57444","ubiquitin C-terminal hydrolase inhibitor","","","","MedChemEx, Selleck, Selleck",99.35,"BRD-K94485812-001-03-7, BRD-K94485812-001-01-1, BRD-K94485812-001-02-9","Preclinical","BRD-K20203690-001-02-2","OPQRFPHLZZPCCH-LTGZKZEYSA-N","BRD-K94485812","BRD-K20203690","CC(=O)O\N=C1\C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc12"
"2821","LDN193189","bone morphogenic protein inhibitor","ACVR1, BMPR1A","","","MedChemEx",85.57,"BRD-K04853698-376-01-4","Preclinical","","CDOVNWNANFFLFJ-UHFFFAOYSA-N","BRD-K04853698","","C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12"
"2822","LE-135","retinoid receptor agonist","RARB","","","Tocris, Tocris",95.85,"BRD-K06593056-001-05-5, BRD-K06593056-001-04-8","Preclinical","","YZZAIQOVMHVWBS-UHFFFAOYSA-N","BRD-K06593056","","CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C"
"2824","LEMBOREXANT","orexin receptor antagonist","HCRTR1, HCRTR2","","","MedChemEx",96.65,"BRD-K78666663-001-01-6","Phase 3","","MUGXRYIUWFITCP-PGRDOPGGSA-N","BRD-K78666663","","Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc2ccc(F)cn2)c2cccc(F)c2)c(C)n1"
"2825","LERISETRON","serotonin receptor antagonist","HTR3A","","","LifeChem",91.67,"BRD-K62398570-300-01-2","Phase 3","","PWWDCRQZITYKDV-UHFFFAOYSA-N","BRD-K62398570","","C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1"
"2826","LERSIVIRINE","non-nucleoside reverse transcriptase inhibitor","","","","MedChemEx",96.3,"BRD-K03289534-001-01-4","Phase 2","","MCPUZZJBAHRIPO-UHFFFAOYSA-N","BRD-K03289534","","CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N"
"2827","LESTAURTINIB","FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor","FLT3, NTRK1","","","EMDBio",97.47,"BRD-A27376179-001-01-3","Phase 3","","UIARLYUEJFELEN-DMVVYWCZSA-N","BRD-A27376179","","C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13"
"2828","LETEPRINIM","nerve growth factor agonist","","","","Sigma",97.65,"BRD-K21612934-001-01-1","Phase 2","","JMPOIZCOJJMTHI-UHFFFAOYSA-N","BRD-K21612934","","OC(=O)c1ccc(NC(=O)CCn2cnc3c(O)ncnc23)cc1"
"2829","LETERMOVIR","CMV terminase inhibitor","","","","MedChemEx",96.6,"BRD-K94288301-001-01-7","Phase 3","","FWYSMLBETOMXAG-QHCPKHFHSA-N","BRD-K94288301","","COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2[C@H](CC(O)=O)N1c1cc(ccc1OC)C(F)(F)F"
"2830","LEUCOMETHYLENE-BLUE","nitric oxide production inhibitor, tau aggregation inhibitor","MAPT","","","MedChemEx",0,"BRD-K27460187-334-01-8","Phase 3","","QTWZICCBKBYHDM-UHFFFAOYSA-N","BRD-K27460187","","CN(C)c1ccc2Nc3ccc(cc3Sc2c1)N(C)C"
"2831","LEUCYLLEUCINE-METHYL-ESTER","","","","","ChemImpex",100,"BRD-K81136890-003-01-6","Phase 2","","AJMOLNFDYWTVQW-QWRGUYRKSA-N","BRD-K81136890","","COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C"
"2832","LEVAMISOLE","acetylcholine receptor agonist","ALPL, ALPPL2, CHRNA3","","","MicroSource, Selleck",99.45,"BRD-K73107279-003-12-5, BRD-K73107279-003-11-7","Withdrawn","","HLFSDGLLUJUHTE-SNVBAGLBSA-N","BRD-K73107279","","C1CN2C[C@@H](N=C2S1)c1ccccc1"
"2834","LEVCROMAKALIM","potassium channel activator","KCNJ5","","","Tocris, Sigma",99.04,"BRD-K24526313-001-17-7, BRD-K24526313-001-18-5","Phase 3","","TVZCRIROJQEVOT-CABCVRRESA-N","BRD-K24526313","","CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N"
"2836","LEVO-PHENCYNONATE","acetylcholine receptor antagonist","CHRM1","","","ChemPacific",87.3,"BRD-A64698388-003-01-7","Launched","","ROZOEEGFKDFEFP-UHFFFAOYSA-N","BRD-A64698388","","CN1CC2CCCC(C1)C2OC(=O)C(O)(C1CCCC1)c1ccccc1"
"2837","LEVOBUNOLOL-(+)","adrenergic receptor antagonist","","","","Prestwick",99.32,"BRD-K73323637-003-10-9","Preclinical","","IXHBTMCLRNMKHZ-GFCCVEGCSA-N","BRD-K73323637","","CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12"
"2838","LEVOBUNOLOL-(+/-)","adrenergic receptor antagonist","","","","MicroSource",98.4,"BRD-A46876182-003-02-8","Preclinical","","IXHBTMCLRNMKHZ-UHFFFAOYSA-N","BRD-A46876182","","CC(C)(C)NCC(O)COc1cccc2C(=O)CCCc12"
"2839","LEVOMEQUITAZINE","histamine receptor antagonist","HRH1","","","Vitas-M",96.71,"BRD-A67616246-001-07-9","Phase 2","","HOKDBMAJZXIPGC-UHFFFAOYSA-N","BRD-A67616246","","C(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12"
"2840","LFM-A13","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Tocris",94.77,"BRD-A30655177-001-14-0","Preclinical","","BQLDGDMKDYAGNE-UHFFFAOYSA-N","BRD-A30655177","","CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br"
"2841","LGK-974","porcupine inhibitor","PORCN","","","Selleck",97.22,"BRD-K16810791-001-01-0","Phase 2","","XXYGTCZJJLTAGH-UHFFFAOYSA-N","BRD-K16810791","","Cc1cc(ccn1)-c1ncc(CC(=O)Nc2ccc(cn2)-c2cnccn2)cc1C"
"2842","LGX818","RAF inhibitor","BRAF","","","Selleck",96.4,"BRD-A56085258-001-01-8","Phase 3","","CMJCXYNUCSMDBY-UHFFFAOYSA-N","BRD-A56085258","","COC(=O)NC(C)CNc1nccc(n1)-c1cn(nc1-c1cc(Cl)cc(NS(C)(=O)=O)c1F)C(C)C"
"2843","LH846","casein kinase inhibitor","CSNK1D","","","MedChemEx, Tocris",97.64,"BRD-K47409078-001-01-8, BRD-K47409078-001-02-6","Preclinical","","DYHAMRNAHTWYKY-UHFFFAOYSA-N","BRD-K47409078","","Cc1cc2sc(NC(=O)Cc3ccccc3)nc2cc1Cl"
"2845","LIAROZOLE","cytochrome P450 inhibitor","CYP19A1, CYP26A1","","","Tocris",88.88,"BRD-A57133765-300-01-7","Phase 2/Phase 3","","UGFHIPBXIWJXNA-UHFFFAOYSA-N","BRD-A57133765","","Clc1cccc(c1)C(c1ccc2nc[nH]c2c1)n1ccnc1"
"2846","LICARBAZEPINE","voltage-gated sodium channel blocker","SCN5A","","","Tocris, Tocris",98.65,"BRD-A22642447-001-02-7, BRD-A22642447-001-01-9","Phase 3","","BMPDWHIDQYTSHX-UHFFFAOYSA-N","BRD-A22642447","","NC(=O)N1c2ccccc2CC(O)c2ccccc12"
"2848","LICOCHALCONE-A","topoisomerase inhibitor","PTPN1","","","Enzo",90.29,"BRD-K26011976-001-01-0","Phase 3","","KAZSKMJFUPEHHW-UHFFFAOYSA-N","BRD-K26011976","","COc1cc(O)c(cc1C=CC(=O)c1ccc(O)cc1)C(C)(C)C=C"
"2849","LICOFELONE","cyclooxygenase inhibitor, lipoxygenase inhibitor","ALOX5, PLA2G2E, PTGS2","","","Adooq, Selleck, Selleck",43.46,"BRD-K08439945-001-03-9, BRD-K08439945-001-01-3, BRD-K08439945-001-02-1","Phase 3","","UAWXGRJVZSAUSZ-UHFFFAOYSA-N","BRD-K08439945","","CC1(C)Cc2c(c(c(CC(O)=O)n2C1)-c1ccc(Cl)cc1)-c1ccccc1"
"2852","LIDOFLAZINE","calcium channel blocker","SCN1A, SCN3A, SLC29A1","","","Prestwick",97.89,"BRD-K62996583-001-10-3","Launched","","ZBIAKUMOEKILTF-UHFFFAOYSA-N","BRD-K62996583","","Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1"
"2853","LIGUSTILIDE","tumor necrosis factor production inhibitor","TNF","","","MedChemEx",87.42,"BRD-K48875051-001-01-0","Preclinical","","IQVQXVFMNOFTMU-FLIBITNWSA-N","BRD-K48875051","","CCC\C=C1OC(=O)C2=C/1CCC=C2"
"2854","LIMKI-3","LIM kinase inhibitor","LIMK1","","","Tocris",98.06,"BRD-K75373031-001-01-7","Preclinical","","IVUGBSGLHRJSSP-UHFFFAOYSA-N","BRD-K75373031","","CC(C)C(=O)Nc1ncc(s1)-c1cc(nn1-c1c(Cl)cccc1Cl)C(F)F"
"2855","LIMONIN","HIV protease inhibitor","","","","Selleck",92.68,"BRD-K05906022-001-05-1","Preclinical","BRD-K64094723-001-01-5","KBDSLGBFQAGHBE-MSGMIQHVSA-N","BRD-K05906022","BRD-K64094723","CC1(C)O[C@H]2CC(=O)OC[C@@]22[C@H]1CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@@]123)c1ccoc1"
"2856","LINALOOL","anticonvulsant","","","","InterBioScreen",0,"BRD-A43082461-001-06-3","Phase 1","","CDOSHBSSFJOMGT-UHFFFAOYSA-N","BRD-A43082461","","CC(C)=CCCC(C)(O)C=C"
"2857","LINIFANIB","PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK","","","Selleck",90.79,"BRD-K99749624-001-07-0","Phase 3","","MPVGZUGXCQEXTM-UHFFFAOYSA-N","BRD-K99749624","","Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1"
"2858","LINOLEIC-ACID","oxidative stress inducer","FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8","","","Sigma",0,"BRD-K08973992-001-06-2","Phase 3","","OYHQOLUKZRVURQ-HZJYTTRNSA-N","BRD-K08973992","","CCCCC\C=C/C\C=C/CCCCCCCC(O)=O"
"2859","LINOPIRDINE","potassium channel blocker","KCNQ2, KCNQ3, KCNQ4, KCNQ5","","","Tocris, Tocris",98.43,"BRD-K59332007-300-03-5, BRD-K59332007-300-02-7","Phase 3","","YEJCDKJIEMIWRQ-UHFFFAOYSA-N","BRD-K59332007","","O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1"
"2861","LINSITINIB","IGF-1 inhibitor","IGF1R, INSR, INSRR","","","Selleck, Selleck",88.41,"BRD-K86118762-001-01-8, BRD-K86118762-001-05-9","Phase 3","","PKCDDUHJAFVJJB-VLZXCDOPSA-N","BRD-K86118762","","C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12"
"2863","LIOTHYRONINE-(ISOMER)","","","","","MicroSource",94.02,"BRD-K46428823-001-02-5","Preclinical","","AUYYCJSJGJYCDS-GFCCVEGCSA-N","BRD-K46428823","","N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O"
"2864","LIPOAMIDE","","","","","MicroSource",70.53,"BRD-A14440173-001-03-4","Preclinical","","FCCDDURTIIUXBY-UHFFFAOYSA-N","BRD-A14440173","","NC(=O)CCCCC1CCSS1"
"2865","LIRIMILAST","phosphodiesterase inhibitor","","","","Enamine",87.13,"BRD-K31339321-001-03-6","Phase 2","","YPFLFUJKZDAXRA-UHFFFAOYSA-N","BRD-K31339321","","CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(oc2c1)C(=O)c1ccc(Cl)cc1Cl"
"2866","LISOFYLLINE","interleukin receptor antagonist, STAT inhibitor","","","","Enzo",99.2,"BRD-A05334458-001-02-8","Phase 2","","NSMXQKNUPPXBRG-UHFFFAOYSA-N","BRD-A05334458","","CC(O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O"
"2867","LITHIUM-ACETOACETATE","","","","","SantaCruz",0,"BRD-K73234506-235-02-1","Preclinical","","WDJHALXBUFZDSR-UHFFFAOYSA-N","BRD-K73234506","","CC(=O)CC(O)=O"
"2868","LITHOCHOLIC-ACID","FXR antagonist, vitamin D receptor agonist","GPBAR1, NR1H4, NR1I2, VDR","","","Selleck",95.71,"BRD-K04497194-001-02-1","Preclinical","","SMEROWZSTRWXGI-JKTPOEMPSA-N","BRD-K04497194","","C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"2869","LITRONESIB","kinesin-like spindle protein inhibitor","KIF11","","","MedChemEx",94.34,"BRD-K83029223-001-01-3","Phase 2","","YVAFBXLHPINSIK-QHCPKHFHSA-N","BRD-K83029223","","CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)c1ccccc1"
"2870","LIXIVAPTAN","vasopressin receptor antagonist","AVPR2","","","Carbosynth",89.39,"BRD-K59391348-001-01-7","Phase 3","","PPHTXRNHTVLQED-UHFFFAOYSA-N","BRD-K59391348","","Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc23)c(Cl)c1"
"2871","LM-22A4","tropomyosin receptor kinase inhibitor","NTRK2","","","Tocris",98.29,"BRD-K70404782-001-01-6","Preclinical","","RGWJKANXFYJKHN-UHFFFAOYSA-N","BRD-K70404782","","OCCNC(=O)c1cc(cc(c1)C(=O)NCCO)C(=O)NCCO"
"2872","LMI070","survival motor neuron protein modulator","SMN1","","","MedChemEx",96.89,"BRD-K08532119-001-01-5","Phase 1/Phase 2","","STWTUEAWRAIWJG-UHFFFAOYSA-N","BRD-K08532119","","CC1(C)CC(CC(C)(C)N1)Oc1ccc(nn1)-c1ccc(cc1O)-c1cn[nH]c1"
"2873","LMK-235","HDAC inhibitor","HDAC4, HDAC5","","","Tocris",82.85,"BRD-K49921286-001-02-6","Preclinical","","VRYZCEONIWEUAV-UHFFFAOYSA-N","BRD-K49921286","","Cc1cc(C)cc(c1)C(=O)NOCCCCCC(=O)NO"
"2874","LM11A-31","neurotrophic agent","NGFR","","","Enamine",94.1,"BRD-A04649065-001-01-7","Phase 1","","YNMUTYLWSRFTPX-UHFFFAOYSA-N","BRD-A04649065","","CCC(C)C(N)C(=O)NCCN1CCOCC1"
"2875","LOBENDAZOLE","anthelmintic agent","","","","MicroSource",93.92,"BRD-K15834839-001-02-3","Preclinical","","OKOVSTKGUBOSTB-UHFFFAOYSA-N","BRD-K15834839","","CCOC(=O)Nc1nc2ccccc2[nH]1"
"2876","LOFEMIZOLE","cyclooxygenase inhibitor","","","","AMS",98.71,"BRD-K06388517-001-01-2","Phase 3","","MBKWNJVQSFBLQI-UHFFFAOYSA-N","BRD-K06388517","","Cc1nc[nH]c1-c1ccc(Cl)cc1"
"2877","LOMEGUATRIB","O6-alkylguanine-DNA alkyltransferase inhibitor","MGMT","","","Selleck, Tocris",97.23,"BRD-K27955832-001-02-9, BRD-K27955832-001-05-2","Phase 2","","JUJPKFNFCWJBCX-UHFFFAOYSA-N","BRD-K27955832","","Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1"
"2879","LOMETREXOL","glycinamide ribonucleotide formyltransferase inhibitor","GART, MTHFD1","","","Cayman",66.91,"BRD-K66036108-001-01-9","Phase 2","","ZUQBAQVRAURMCL-DOMZBBRYSA-N","BRD-K66036108","","Nc1nc(O)c2C[C@@H](CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1"
"2880","LONAFARNIB","farnesyltransferase inhibitor","FNTA, HRAS, KRAS, NRAS","","","Selleck",97.47,"BRD-K41599323-001-02-3","Phase 3","","DHMTURDWPRKSOA-RUZDIDTESA-N","BRD-K41599323","","NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1"
"2881","LONIDAMINE","glucokinase inhibitor","GCK","","","Tocris, MicroSource, Selleck, Tocris",98.47,"BRD-K78513633-001-16-5, BRD-K78513633-001-15-7, BRD-K78513633-001-13-2, BRD-K78513633-001-14-0","Launched","","WDRYRZXSPDWGEB-UHFFFAOYSA-N","BRD-K78513633","","OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12"
"2885","LORECLEZOLE","benzodiazepine receptor agonist","GABRB2, GABRB3","","","Tocris",98.11,"BRD-K09659835-003-01-4","Phase 2","","XGLHZTBDUXXHOM-WMZJFQQLSA-N","BRD-K09659835","","Cl\C(=C/n1cncn1)c1ccc(Cl)cc1Cl"
"2886","LOREDIPLON","GABA receptor modulator","GABRA1","","","MedChemEx",97.58,"BRD-K42066335-001-01-0","Phase 2","","NQPOCLFSADOXBR-UHFFFAOYSA-N","BRD-K42066335","","CN(C(C)=O)c1cc(ccc1F)-c1ccnc2c(cnn12)C(=O)c1cccs1"
"2887","LORGLUMIDE","CCK receptor antagonist","CCKAR, CCKBR","","","MicroSource",99.07,"BRD-A29854054-236-12-6","Phase 1","","IEKOTSCYBBDIJC-UHFFFAOYSA-N","BRD-A29854054","","CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1"
"2888","LORLATINIB","ALK tyrosine kinase receptor inhibitor","ALK","","","Tocris, MedChemEx",98.73,"BRD-K99879819-001-03-9, BRD-K99879819-001-02-1","Phase 2","","IIXWYSCJSQVBQM-LLVKDONJSA-N","BRD-K99879819","","C[C@H]1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N"
"2890","LOSMAPIMOD","p38 MAPK inhibitor","MAPK14","","","MedChemEx",96.05,"BRD-K56195681-001-01-0","Phase 3","","KKYABQBFGDZVNQ-UHFFFAOYSA-N","BRD-K56195681","","Cc1c(F)cc(cc1-c1ccc(cn1)C(=O)NCC(C)(C)C)C(=O)NC1CC1"
"2891","LOXISTATIN-ACID","cysteine peptidase inhibitor","CTSB","","","Selleck, Selleck",98.39,"BRD-K21937671-001-10-0, BRD-K21937671-001-09-2","Preclinical","BRD-A44872635-001-01-8","SCMSYZJDIQPSDI-SRVKXCTJSA-N","BRD-K21937671","BRD-A44872635","CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O"
"2893","LOXO-101","tropomyosin receptor kinase inhibitor","NTRK1, NTRK2, NTRK3","","","MedChemEx",96.12,"BRD-K36574127-001-01-3","Phase 2","","NYNZQNWKBKUAII-KBXCAEBGSA-N","BRD-K36574127","","O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F"
"2894","LPA2-ANTAGONIST-1","lysophosphatidic acid receptor antagonist","LPAR2","","","MedChemEx",97.22,"BRD-K32322923-001-01-7","Preclinical","","BPRNMVDTWIHULJ-AWEZNQCLSA-N","BRD-K32322923","","C[C@@H](CN1CCN(CC1)S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ncnc2c(C)csc12"
"2895","LRRK2-IN-1","leucine rich repeat kinase inhibitor","LRRK2","","","Tocris, MedChemEx",98.57,"BRD-K01436366-001-22-2, BRD-K01436366-001-20-6","Preclinical","","IWMCPJZTADUIFX-UHFFFAOYSA-N","BRD-K01436366","","COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1"
"2897","LSN-2463359","glutamate receptor positive allosteric modulator","GRM5","","","Tocris",96.1,"BRD-K79337272-001-01-6","Preclinical","","STAFRSGTRKNXHF-UHFFFAOYSA-N","BRD-K79337272","","CC(C)NC(=O)c1ccc(cn1)C#Cc1ccncc1"
"2898","LTA","","","","","Enamine",94.91,"BRD-K52914072-001-01-5","Phase 2","","RCORNHOUCUDCAC-UHFFFAOYSA-N","BRD-K52914072","","N=C(Nc1ccccc1)c1cccs1"
"2899","LTB4","leukocyte activator","LTB4R, LTB4R2","","","Enzo",8.37,"BRD-K53124401-001-03-8","Phase 2","","VNYSSYRCGWBHLG-AMOLWHMGSA-N","BRD-K53124401","","CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O"
"2900","LU-AA-47070","adenosine receptor antagonist","ADORA2A","","","Tocris",88.17,"BRD-K83970940-001-01-0","Phase 2","","MSWIQSFUBYCFJE-PGMHBOJBSA-N","BRD-K83970940","","CC(C)(C)CC(=O)Nc1c(F)cc(cc1F)C(=O)\N=c1/sccn1COP(O)(O)=O"
"2901","LUCITANIB","FGFR inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET","","","MedChemEx",91.38,"BRD-K31309378-001-01-5","Phase 2","","CUDVHEFYRIWYQD-UHFFFAOYSA-N","BRD-K31309378","","CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12"
"2902","LUF-5834","adenosine receptor agonist","ADORA2A, ADORA2B","","","Tocris",98.27,"BRD-K67079690-001-01-2","Preclinical","","OFHKDLYFKPBXER-UHFFFAOYSA-N","BRD-K67079690","","Nc1nc(SCc2ncc[nH]2)c(C#N)c(-c2ccc(O)cc2)c1C#N"
"2903","LUMATEPERONE","serotonin receptor antagonist, dopamine receptor modulator","DRD2, HTR2A","","","MedChemEx, MedChemEx",81.32,"BRD-K10031916-075-02-1, BRD-K10031916-075-01-3","Phase 3","","HOIIHACBCFLJET-SFTDATJTSA-N","BRD-K10031916","","CN1CCN2[C@H]3CCN(CCCC(=O)c4ccc(F)cc4)C[C@H]3c3cccc1c23"
"2905","LUMIRACOXIB","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Selleck, MicroSource",97.35,"BRD-K26901728-001-05-4, BRD-K26901728-001-06-2","Withdrawn","","KHPKQFYUPIUARC-UHFFFAOYSA-N","BRD-K26901728","","Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1"
"2907","LUPANINE","sodium channel blocker","INS","","","ChemDiv",97.57,"BRD-A92826379-001-01-5","Phase 1","","JYIJIIVLEOETIQ-RFPFOJJUSA-N","BRD-A92826379","","O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3"
"2908","LUTEOLIN","glucosidase inhibitor","TOP1","","","Selleck",92.4,"BRD-K05236810-001-19-0","Phase 2","","IQPNAANSBPBGFQ-UHFFFAOYSA-N","BRD-K05236810","","Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccc(O)c(O)c1"
"2909","LUZINDOLE","melatonin receptor antagonist","MTNR1A, MTNR1B","","","Tocris, Tocris",89.41,"BRD-K67013324-001-04-9, BRD-K67013324-001-03-1","Preclinical","","WVVXBPKOIZGVNS-UHFFFAOYSA-N","BRD-K67013324","","CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12"
"2911","LXR-623","LXR agonist","AR, NR1H2, NR1H3, NR1I2, NR3C1","","","MedChemEx",99.59,"BRD-K54520417-001-01-2","Phase 1","","KYWWJENKIMRJBI-UHFFFAOYSA-N","BRD-K54520417","","Fc1ccc(cc1)-c1n(Cc2ccc(F)cc2Cl)nc2c(cccc12)C(F)(F)F"
"2912","LX1031","tryptophan hydroxylase inhibitor","TPH1","","","MedChemEx",93.2,"BRD-K32101625-001-01-6","Phase 2","","XNMUICFMGGQSMZ-WIOPSUGQSA-N","BRD-K32101625","","COc1cccc(c1)-c1ccc(cc1)[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F"
"2913","LX7101","LIM kinase inhibitor, rho associated kinase inhibitor","LIMK2, ROCK1, ROCK2","","","MedChemEx, MedChemEx",81.88,"BRD-K21038058-001-02-7, BRD-K21038058-001-01-9","Phase 1/Phase 2","","PWPNYABQEOGNNC-UHFFFAOYSA-N","BRD-K21038058","","CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(CC2)c2ncnc3[nH]cc(C)c23)c1"
"2915","LY-404187","glutamate receptor positive allosteric modulator","GRIA1, GRIA2, GRIA3, GRIA4","","","Tocris",90.87,"BRD-A50062753-001-01-3","Preclinical","","HOQAVGZLYRYHSO-UHFFFAOYSA-N","BRD-A50062753","","CC(CNS(=O)(=O)C(C)C)c1ccc(cc1)-c1ccc(cc1)C#N"
"2916","LYCOPENE","free radical scavenger","","","","AKSci",0,"BRD-K37083340-001-02-3","Phase 3","","OAIJSZIZWZSQBC-GYZMGTAESA-N","BRD-K37083340","","CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(/C)CCC=C(C)C"
"2917","LYLAMINE","cannabinoid receptor agonist","CNR1","","","Tocris",69.31,"BRD-K62289640-003-02-7","Preclinical","","JVVXZOOGOGPDRZ-SLFFLAALSA-N","BRD-K62289640","","CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1"
"2918","LYPRESSIN","vasopressin receptor agonist","AVPR1A, AVPR1B, AVPR2","","","Apollo",70.31,"BRD-K93331255-001-02-0","Launched","","BJFIDCADFRDPIO-DZCXQCEKSA-N","BRD-K93331255","","NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O"
"2919","LY2090314","glycogen synthase kinase inhibitor","GSK3B","","","MedChemEx",98.37,"BRD-K78055238-001-01-8","Phase 2","","HRJWTAWVFDCTGO-UHFFFAOYSA-N","BRD-K78055238","","Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1"
"2920","LY2109761","TGF beta receptor inhibitor","TGFBR1, TGFBR2","","","Selleck",98.4,"BRD-K47557313-001-02-7","Preclinical","","IHLVSLOZUHKNMQ-UHFFFAOYSA-N","BRD-K47557313","","C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c(nn2CCCc12)-c1ccccn1"
"2921","LY2140023","glutamate receptor agonist","GRM3","","","Selleck, Selleck",100,"BRD-K49519144-001-04-6, BRD-K49519144-001-03-8","Phase 3","","AVDUGNCTZRCAHH-MDASVERJSA-N","BRD-K49519144","","N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O"
"2923","LY215490","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4, GRIK1","","","MedChemEx",100,"BRD-K34313798-001-01-6","Phase 1","","ZXFRFPSZAKNPQQ-YTWAJWBKSA-N","BRD-K34313798","","OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1"
"2924","LY2157299","TGF beta receptor inhibitor","TGFBR1","","","Selleck",97.81,"BRD-K78118466-001-03-3","Phase 2/Phase 3","","IVRXNBXKWIJUQB-UHFFFAOYSA-N","BRD-K78118466","","Cc1cccc(n1)-c1nn2CCCc2c1-c1ccnc2ccc(cc12)C(N)=O"
"2925","LY2183240","FAAH inhibitor, FAAH reuptake inhibitor","FAAH","","","Tocris, Tocris",95.78,"BRD-K37865504-001-04-1, BRD-K37865504-001-05-8","Preclinical","","GZNIYOXWFCDBBJ-UHFFFAOYSA-N","BRD-K37865504","","CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1"
"2927","LY2228820","p38 MAPK inhibitor","MAPK14","","","Selleck, Selleck",94.21,"BRD-K59227464-334-03-2, BRD-K59227464-334-02-4","Phase 2","","XPPBBJCBDOEXDN-UHFFFAOYSA-N","BRD-K59227464","","CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C"
"2929","LY223982","leukotriene receptor antagonist","LTB4R","","","Cayman",95.19,"BRD-K35367061-001-01-1","Phase 2","","SYZSSLLFRVDRHL-QPJJXVBHSA-N","BRD-K35367061","","COc1ccc(\C=C\CCCCOc2ccc(cc2CCC(O)=O)C(=O)c2cccc(c2)C(O)=O)cc1"
"2930","LY225910","CCK receptor antagonist","CCKBR","","","Tocris, Tocris",98.13,"BRD-K33864865-001-03-3, BRD-K33864865-001-02-5","Preclinical","","KUECXUACQOYKNB-UHFFFAOYSA-N","BRD-K33864865","","CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O"
"2932","LY231617","lipid peroxidase inhibitor","","","","Otava",90.52,"BRD-K85804405-003-01-3","Preclinical","","WQNYIWJBDGLKEB-UHFFFAOYSA-N","BRD-K85804405","","CCNCc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C"
"2933","LY2334737","antitumor agent, ribonucleotide reductase inhibitor","","","","MedChemEx",95.83,"BRD-K04993719-001-01-7","Phase 1","","MEOYFIHNRBNEPI-UXIGCNINSA-N","BRD-K04993719","","CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1"
"2934","LY2365109","Glycine transporter 1 inhibitor","SLC6A9","","","Tocris, Tocris",97.65,"BRD-K13888115-003-02-2, BRD-K13888115-003-03-0","Preclinical","","FKPLJWGRBCQLTL-UHFFFAOYSA-N","BRD-K13888115","","CN(CCOc1ccc(cc1C(C)(C)C)-c1ccc2OCOc2c1)CC(O)=O"
"2936","LY2452473","androgen receptor modulator","AR","","","Sigma",82.38,"BRD-K90171280-001-01-4","Phase 2","","IHIWYQYVBNODSV-KRWDZBQOSA-N","BRD-K90171280","","CC(C)OC(=O)N[C@@H]1Cc2c(C1)c1cc(ccc1n2Cc1ccccn1)C#N"
"2937","LY255283","leukotriene receptor antagonist","LTB4R, LTB4R2","","","Tocris, Tocris",97.51,"BRD-K92492521-001-02-9, BRD-K92492521-001-03-7","Preclinical","","WCGXJPFHTHQNJL-UHFFFAOYSA-N","BRD-K92492521","","CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nnn[nH]1"
"2939","LY2584702","ribosomal protein inhibitor","RPS6KB1","","","Adooq, Selleck",98.81,"BRD-K21833260-075-02-9, BRD-K21833260-075-01-1","Phase 1","","FYXRSVDHGLUMHB-UHFFFAOYSA-N","BRD-K21833260","","Cn1cc(nc1C1CCN(CC1)c1ncnc2[nH]ncc12)-c1ccc(F)c(c1)C(F)(F)F"
"2941","LY2603618","CHK inhibitor","CHEK1","","","Selleck, Selleck",86.32,"BRD-K14109347-001-05-9, BRD-K14109347-001-03-4","Phase 2","","SYYBDNPGDKKJDU-ZDUSSCGKSA-N","BRD-K14109347","","Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1"
"2943","LY2606368","CHK inhibitor","CHEK1","","","MedChemEx, MedChemEx",97.06,"BRD-K20463415-300-01-4, BRD-K20463415-001-01-8","Phase 2","","DOTGPNHGTYJDEP-UHFFFAOYSA-N","BRD-K20463415","","COc1cccc(OCCCN)c1-c1cc(Nc2cnc(cn2)C#N)n[nH]1"
"2945","LY2608204","glucokinase activator","GCK","","","MedChemEx, Selleck, Selleck",94.33,"BRD-K12068470-001-03-3, BRD-K12068470-001-02-5, BRD-K12068470-001-04-1","Phase 2","BRD-K69247090-001-01-9","QIIVJLHCZUTGSD-CUBQBAPOSA-N","BRD-K12068470","BRD-K69247090","O=C(Nc1ncc(SCCN2CCCC2)s1)[C@@]1(C[C@H]1C1CCCCC1)c1ccc(cc1)S(=O)(=O)C1CC1"
"2948","LY266097","serotonin receptor antagonist","HTR2B","","","Tocris",94.79,"BRD-A64004759-003-01-9","Preclinical","","NJLHHCITDFZZSE-UHFFFAOYSA-N","BRD-A64004759","","COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)c(Cl)c1OC"
"2949","LY2784544","JAK inhibitor","JAK2, JAK3","","","Selleck",91.48,"BRD-K25630527-001-03-8","Phase 2","","SQSZANZGUXWJEA-UHFFFAOYSA-N","BRD-K25630527","","Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1"
"2950","LY2801653","MET inhibitor","MET","","","MedChemEx",99.53,"BRD-K18961567-001-01-1","Phase 2","","QHADVLVFMKEIIP-UHFFFAOYSA-N","BRD-K18961567","","Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1"
"2951","LY2811376","beta-secretase inhibitor","BACE1","","","Selleck",96.96,"BRD-K94534639-001-02-5","Phase 1","","MJQMRGWYPNIERM-HNNXBMFYSA-N","BRD-K94534639","","C[C@]1(CCSC(N)=N1)c1cc(c(F)cc1F)-c1cncnc1"
"2952","LY2857785","CDK inhibitor","CDK9","","","MedChemEx",91.94,"BRD-K15382985-001-01-7","Preclinical","","LHIUZPIDLZYPRL-MXVIHJGJSA-N","BRD-K15382985","","CC(C)c1n(C)nc2ccc(cc12)-c1ccnc(N[C@H]2CC[C@@H](CC2)NC2CCOCC2)n1"
"2953","LY2874455","FGFR antagonist","FGFR1, FGFR2, FGFR3, FGFR4, KDR","","","MedChemEx",90.03,"BRD-K17203476-001-01-9","Phase 1","","GKJCVYLDJWTWQU-CXLRFSCWSA-N","BRD-K17203476","","C[C@@H](Oc1ccc2[nH]nc(\C=C\c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl"
"2954","LY288513","CCK receptor antagonist","CCKBR","","","Tocris",4.58,"BRD-K24675965-001-04-1","Preclinical","","LMUQHXHWJWQXSD-PMACEKPBSA-N","BRD-K24675965","","Brc1ccc(NC(=O)N2NC(=O)[C@H]([C@@H]2c2ccccc2)c2ccccc2)cc1"
"2955","LY2886721","beta-secretase inhibitor","BACE1","","","Selleck",97.19,"BRD-K17953908-001-01-7","Phase 1/Phase 2","","NIDRNVHMMDAAIK-MGNBDDOMSA-N","BRD-K17953908","","NC1=N[C@]2(COC[C@@H]2CS1)c1cc(NC(=O)c2ccc(F)cn2)ccc1F"
"2956","LY294002","mTOR inhibitor, PI3K inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Tocris",96.09,"BRD-K27305650-001-16-6, BRD-K27305650-003-03-0, BRD-K27305650-003-02-2","Preclinical","","CZQHHVNHHHRRDU-UHFFFAOYSA-N","BRD-K27305650","","O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1"
"2959","LY2979165","glutamate receptor agonist","GRM2","","","MedChemEx, MedChemEx",97.2,"BRD-K68220839-413-02-8, BRD-K68220839-413-01-0","Phase 1","","BBGHHIUQOKQCBW-LDZWZCGGSA-N","BRD-K68220839","","C[C@H](N)C(=O)N[C@]1(C[C@@H](Sc2nnc[nH]2)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O"
"2961","LY3000328","cathepsin inhibitor","CTSS","","","MedChemEx",96.06,"BRD-K21070437-001-01-4","Phase 1","","NDEBZCZEAVMSQF-GOTSBHOMSA-N","BRD-K21070437","","CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c1ccc(F)cc1)N1CCN(CC1)C1COC1"
"2962","LY3009120","RAF inhibitor","BRAF, RAF1","","","MedChemEx, Selleck",95.74,"BRD-K38385169-001-04-5, BRD-K38385169-001-03-7","Phase 1","","HHCBMISMPSAZBF-UHFFFAOYSA-N","BRD-K38385169","","CNc1ncc2cc(c(C)nc2n1)-c1cc(NC(=O)NCCC(C)(C)C)c(F)cc1C"
"2964","LY3023414","PI3K inhibitor, mTOR inhibitor","MTOR","","","MedChemEx",96.51,"BRD-K82967180-001-01-6","Phase 2","","ACCFLVVUVBJNGT-AWEZNQCLSA-N","BRD-K82967180","","CO[C@@H](C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O"
"2965","LY303511","casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","BRD2, BRD3, BRD4","","","Tocris, Tocris",95.92,"BRD-K22385716-001-02-5, BRD-K22385716-001-03-3","Preclinical","","NGAGMBNBKCDCDJ-UHFFFAOYSA-N","BRD-K22385716","","O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1"
"2967","LY310762","serotonin receptor antagonist","HTR1D","","","MedChemEx",97.19,"BRD-K41194171-003-09-7","Preclinical","","KDXISMANFPJVJY-UHFFFAOYSA-N","BRD-K41194171","","CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12"
"2968","LY320135","cannabinoid receptor antagonist","CNR1","","","Tocris",98.54,"BRD-K78637815-001-02-2","Preclinical","","RYNSGDFWBJWWSZ-UHFFFAOYSA-N","BRD-K78637815","","COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N"
"2969","LY344864","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7","","","Tocris, Tocris",86.9,"BRD-K95899059-003-02-8, BRD-K95899059-003-03-6","Preclinical","","GKWHICIUSVVNGX-MRXNPFEDSA-N","BRD-K95899059","","CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1"
"2971","LY364947","TGF beta receptor inhibitor, p38 MAPK inhibitor","TGFBR1","","","Tocris, Selleck, Tocris",96.57,"BRD-K06234293-001-04-2, BRD-K06234293-001-03-4, BRD-K06234293-001-05-9","Preclinical","","IBCXZJCWDGCXQT-UHFFFAOYSA-N","BRD-K06234293","","c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1"
"2974","LY393558","serotonin receptor antagonist","HTR1B, HTR1D, HTR2A, HTR2B","","","Tocris",15.46,"BRD-K08534264-001-01-4","Preclinical","","QUSLYAPLTMMCFE-UHFFFAOYSA-N","BRD-K08534264","","CC(C)N1Cc2cc(ccc2N(CCN2CCC(=CC2)c2c[nH]c3cc(F)ccc23)S1(=O)=O)S(C)(=O)=O"
"2975","LY411575","gamma secretase inhibitor","","","","Selleck",97.33,"BRD-K20013301-001-02-6","Preclinical","","ULSSJYNJIZWPSB-CVRXJBIPSA-N","BRD-K20013301","","C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O"
"2976","LY450108","glutamate receptor modulator","","","","MedChemEx",94.81,"BRD-K54538117-001-01-7","Phase 1","","ACOXQYLJOQAHST-ZDUSSCGKSA-N","BRD-K54538117","","C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(NC(=O)c2cc(F)cc(F)c2)cc1"
"2977","LY456236","glutamate receptor antagonist","GRM1","","","Tocris, Tocris",97.15,"BRD-K87696786-003-04-4, BRD-K87696786-003-05-1","Preclinical","","XPJOMFBGKIABQW-UHFFFAOYSA-N","BRD-K87696786","","COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1"
"2979","M-CHLOROPHENYLBIGUANIDE","","HTR3A, HTR3B","","","Tocris",93.77,"BRD-K36965586-003-08-8","Preclinical","","DIHXJZHAIHGSAW-UHFFFAOYSA-N","BRD-K36965586","","NC(=N)NC(=N)Nc1cccc(Cl)c1"
"2980","M-THP","","","","","FrontierSci",88.76,"BRD-K91147684-001-01-5","Phase 1","","ZUELZXZJXUXJCH-UHFFFAOYSA-N","BRD-K91147684","","Oc1cccc(c1)-c1c2ccc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2"
"2981","M-14157","ATP-sensitive potassium channel antagonist","KCNQ1","","","Enzo",0,"BRD-A96977263-001-03-7","Phase 2","","LMHJFKYQYDSOQO-UHFFFAOYSA-N","BRD-A96977263","","CCCCCC(O)CCCC(O)=O"
"2982","M-25","smoothened receptor antagonist","DHH, IHH, SMO","","","Tocris",98.33,"BRD-K51265828-001-01-0","Preclinical","","WATNXVHKRRTUFK-UHFFFAOYSA-N","BRD-K51265828","","CCCC(CCC)C(=O)NCc1ccc2n(ncc2c1)-c1ccccc1OC"
"2983","M-3M3FBS","","PLCB2, PLCB3, PLCD1, PLCG1, PLCG2","","","Tocris, Tocris",98.86,"BRD-K09635314-001-04-2, BRD-K09635314-001-03-4","Preclinical","","ZIIUUSVHCHPIQD-UHFFFAOYSA-N","BRD-K09635314","","Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F"
"2985","M-344","HDAC inhibitor","","","","Selleck, Selleck, Tocris",97.25,"BRD-K45528773-001-07-2, BRD-K45528773-001-06-4, BRD-K45528773-001-08-0","Preclinical","","MXWDSZWTBOCWBK-UHFFFAOYSA-N","BRD-K45528773","","CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO"
"2988","MABUTEROL","adrenergic receptor agonist","ADRB2","","","Sigma",98.26,"BRD-A13116749-003-01-6","Launched","","JSJCTEKTBOKRST-UHFFFAOYSA-N","BRD-A13116749","","CC(C)(C)NCC(O)c1cc(Cl)c(N)c(c1)C(F)(F)F"
"2989","MACELIGNAN","antioxidant, antiinflammatory agent","","","","MedChemEx",97.67,"BRD-K94948151-001-07-4","Preclinical","","QDDILOVMGWUNGD-UONOGXRCSA-N","BRD-K94948151","","COc1cc(C[C@H](C)[C@H](C)Cc2ccc3OCOc3c2)ccc1O"
"2990","MADRASIN","cell splicing inhibitor","","","","PrincetonBio",93.78,"BRD-K48905682-001-11-1","Preclinical","","QQJIYKXTEMDJFM-UHFFFAOYSA-N","BRD-K48905682","","COc1ccc2c(C)nc(Nc3nc(C)c(C)c(O)n3)nc2c1"
"2991","MAGNOLOL","PPAR receptor agonist","GABRA1, PPARG","","","Selleck",93.11,"BRD-K26168087-001-09-7","Preclinical","","VVOAZFWZEDHOOU-UHFFFAOYSA-N","BRD-K26168087","","Oc1ccc(CC=C)cc1-c1cc(CC=C)ccc1O"
"2992","MALIC-ACID","","CS, ME2, PKD2L1","","","Enamine, Enamine",100,"BRD-A18396475-001-16-1, BRD-A18396475-001-15-3","Launched","","BJEPYKJPYRNKOW-UHFFFAOYSA-N","BRD-A18396475","","OC(CC(O)=O)C(O)=O"
"2994","MANDELIC-ACID","","","","","Enamine",0,"BRD-A91448670-001-06-4","Launched","","IWYDHOAUDWTVEP-UHFFFAOYSA-N","BRD-A91448670","","OC(C(O)=O)c1ccccc1"
"2995","MARIBAVIR","cytomegalovirus inhibitor, protein kinase inhibitor","PYGM","","","MedChemEx",94.38,"BRD-K59524082-001-01-3","Phase 3","","KJFBVJALEQWJBS-XUXIUFHCSA-N","BRD-K59524082","","CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O"
"2996","MARIMASTAT","matrix metalloprotease inhibitor","MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9","","","MedChemEx",92.47,"BRD-K21396683-001-04-8","Phase 3","","OCSMOTCMPXTDND-OUAUKWLOSA-N","BRD-K21396683","","CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C"
"2997","MATRINE","opioid receptor agonist","OPRK1","","","Selleck",92.78,"BRD-K25312248-001-01-5","Phase 2","","ZSBXGIUJOOQZMP-COMQUAJESA-N","BRD-K25312248","","O=C1CCC[C@@H]2[C@@H]3CCCN4CCC[C@H](CN12)[C@@H]34"
"2998","MAVOGLURANT","glutamate receptor antagonist","GRM5","","","MedChemEx",93,"BRD-K07790550-001-01-6","Phase 2","","ZFPZEYHRWGMJCV-ZHALLVOQSA-N","BRD-K07790550","","COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1"
"2999","MAYTANSINOL-ISOBUTYRATE","","","","","MedChemEx",78.12,"BRD-K15898725-001-01-7","Preclinical","","OPQNCARIZFLNLF-JBHFWYGFSA-N","BRD-K15898725","","CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2"
"3000","MBX-2982","glucose dependent insulinotropic receptor agonist","GPR119","","","MedChemEx",98.92,"BRD-K32218650-001-01-6","Phase 2","","NFTMKHWBOINJGM-UHFFFAOYSA-N","BRD-K32218650","","CCc1cnc(nc1)N1CCC(CC1)c1nc(COc2ccc(cc2)-n2cnnn2)cs1"
"3001","MC-1","","AADAT, ABAT, AGXT, AGXT2, ALAS1, AZIN2, BCAT1, BCAT2, CBS, CCBL1, CCBL2, CSAD, CTH, DDC, FTCD, GAD1, GAD2, GADL1, GCAT, GLDC, GOT1, GOT2, GPT, GPT2, HDC, IGSF10, KYNU, MOCOS, NFS1, OAT, ODC1, PDXDC1, PDXP, PHYKPL, PNPO, PROSC, PSAT1, PYGB, PYGL, PYGM, SCLY, SDS, SDSL, SEPSECS, SGPL1, SHMT1, SHMT2, SPTLC1, SPTLC2, SPTLC3, SRR, TAT, THNSL1","","","Vitas-M, Sigma",0,"BRD-K50712474-001-02-7, BRD-K50712474-002-02-5","Phase 3","","NGVDGCNFYWLIFO-UHFFFAOYSA-N","BRD-K50712474","","Cc1ncc(COP(O)(O)=O)c(C=O)c1O"
"3003","MCC950","NOD like receptor inhibitor","NLRP3","","","MedChemEx, MedChemEx",37.23,"BRD-K55418700-001-03-0, BRD-K55418700-001-02-2","Preclinical","","HUUSXLKCTQDPGL-UHFFFAOYSA-N","BRD-K55418700","","CC(C)(O)c1coc(c1)S(=O)(=O)NC(=O)Nc1c2CCCc2cc2CCCc12"
"3005","MCN-5652-(+/-)","selective serotonin reuptake inhibitor (SSRI)","","","","Tocris",26.5,"BRD-K31168993-001-02-8","Preclinical","","YVKDUIAAPBKHMJ-MOPGFXCFSA-N","BRD-K31168993","","CSc1ccc(cc1)[C@H]1CN2CCC[C@H]2c2ccccc12"
"3006","MCOPPB","nociceptin/orphanin FQ (NOP) receptor agonist","OPRL1","","","Tocris",96.23,"BRD-K73276278-305-01-1","Preclinical","","CYYNMPPFEJPBJD-OAQYLSRUSA-N","BRD-K73276278","","CC1(CCCCCCC1)N1CCC(CC1)n1c(nc2ccccc12)[C@@H]1CCCNC1"
"3007","MCPP","serotonin receptor agonist","HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6","","","Enzo",95.44,"BRD-K75844781-003-08-0","Phase 2","","VHFVKMTVMIZMIK-UHFFFAOYSA-N","BRD-K75844781","","Clc1cccc(c1)N1CCNCC1"
"3008","MC1568","HDAC inhibitor","HDAC2","","","Selleck, MedChemEx, Selleck",89.02,"BRD-K24031866-001-02-1, BRD-K24031866-001-03-9, BRD-K24031866-001-01-3","Preclinical","BRD-K94335714-001-07-4, BRD-K94335714-001-06-6","QQDIFLSJMFDTCQ-FIFLTTCUSA-N","BRD-K24031866","BRD-K94335714","Cn1c(\C=C\C(=O)NO)ccc1\C=C\C(=O)c1cccc(F)c1"
"3011","MD-920","NFkB pathway inhibitor","AADACL2","","","Enzo",96.77,"BRD-K92758126-001-18-8","Phase 1","","IXORZMNAPKEEDV-OBDJNFEBSA-N","BRD-K92758126","","C[C@@]12[C@H]3[C@H](C(O)=O)[C@@]45CC(=C)[C@@](O)(C4)CC[C@H]5[C@]3(OC1=O)C=C[C@@H]2O"
"3012","MDIVI-1","dynamin inhibitor","DNM1","","","Selleck, Selleck",97.44,"BRD-K61128465-001-09-9, BRD-K61128465-001-10-7","Preclinical","","NZJKEVWTYMOYOR-UHFFFAOYSA-N","BRD-K61128465","","COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O"
"3014","MDL-11939","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",98.53,"BRD-A62057054-001-04-9, BRD-A62057054-001-03-1","Phase 2","","AXNGJCOYCMDPQG-UHFFFAOYSA-N","BRD-A62057054","","OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1"
"3016","MDL-27531","glycine receptor agonist","","","","Otava",84.16,"BRD-K50888640-001-01-6","Preclinical","","DPGDRICHXKQXEN-UHFFFAOYSA-N","BRD-K50888640","","Cn1c(nnc1S(C)(=O)=O)-c1ccccc1"
"3017","MDL-29951","glutamate receptor antagonist","FBP1","","","MedChemEx",96.68,"BRD-K59753853-001-02-3","Preclinical","","KNBSYZNKEAWABY-UHFFFAOYSA-N","BRD-K59753853","","OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(O)=O"
"3018","MDL-72832","serotonin receptor agonist","HTR1A","","","Tocris",96.3,"BRD-A17453586-003-02-3","Preclinical","","HCVRCHQFYYZPHT-UHFFFAOYSA-N","BRD-A17453586","","O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2O1"
"3019","MDL-73005EF","serotonin receptor antagonist","HTR1A","","","Tocris",96.76,"BRD-A50764878-003-02-8","Phase 1","","BVMYCHKQPGEOSI-UHFFFAOYSA-N","BRD-A50764878","","O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1"
"3020","MDMS","DNA inhibitor","","","","Enamine",0,"BRD-K70840370-001-01-9","Phase 2","","IQLZWWDXNXZGPK-UHFFFAOYSA-N","BRD-K70840370","","CS(=O)(=O)OCOS(C)(=O)=O"
"3021","ME-0328","PPAR receptor antagonist","PARP3","","","Tocris",97.84,"BRD-K24283677-001-01-9","Preclinical","","QIHBWVVVRYYYRO-ZDUSSCGKSA-N","BRD-K24283677","","C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1"
"3022","MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE","","","","","Prestwick",93.45,"BRD-K29713308-077-04-1","Preclinical","BRD-M45580279-077-05-4","FQQIIPAOSKSOJM-UHFFFAOYSA-N","BRD-K29713308","BRD-M45580279","CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1"
"3023","MECARBINATE","","","","","Selleck",97.97,"BRD-K28405228-001-06-7","Preclinical","","YTBNTDMBGXAOCG-UHFFFAOYSA-N","BRD-K28405228","","CCOC(=O)c1c(C)n(C)c2ccc(O)cc12"
"3024","MECLINERTANT","neurotensin receptor antagonist","NTSR1, NTSR2","","","Sigma",98.44,"BRD-K25075681-001-02-0","Phase 2/Phase 3","","DYLJVOXRWLXDIG-UHFFFAOYSA-N","BRD-K25075681","","COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O"
"3025","MEDICA-16","ATP citrase lyase inhibitor","FFAR1","","","Cayman",98.1,"BRD-K92908289-001-01-8","Phase 2","","HYSMCRNFENOHJH-UHFFFAOYSA-N","BRD-K92908289","","CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O"
"3026","MEDORINONE","","","","","Key",97.74,"BRD-K40715924-001-01-1","Phase 1","","OCCZJXAHSUCJSA-UHFFFAOYSA-N","BRD-K40715924","","Cc1nccc2[nH]c(=O)ccc12"
"3027","MEFEXAMIDE","psychoactive drug","","","","MicroSource",99.12,"BRD-K20655524-003-12-0","Preclinical","","HUNIPYLVUPMFCZ-UHFFFAOYSA-N","BRD-K20655524","","CCN(CC)CCNC(=O)COc1ccc(OC)cc1"
"3028","MEGLITINIDE","potassium channel blocker","CCR2","","","Enamine",99.32,"BRD-K51324732-001-01-0","Phase 2","","SWLAMJPTOQZTAE-UHFFFAOYSA-N","BRD-K51324732","","COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)C(O)=O"
"3029","MEGLUMINE","excipient","","","","MicroSource, Selleck, Selleck",100,"BRD-K28595280-001-04-5, BRD-K28595280-001-03-7, BRD-K28595280-001-05-2","Launched","","MBBZMMPHUWSWHV-BDVNFPICSA-N","BRD-K28595280","","CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"3032","MEGLUTOL","HMGCR inhibitor","HMGCR","","","MicroSource",0,"BRD-K00495673-001-05-2","Launched","","NPOAOTPXWNWTSH-UHFFFAOYSA-N","BRD-K00495673","","CC(O)(CC(O)=O)CC(O)=O"
"3033","MEISOINDIGO","STAT inhibitor","STAT3","","","MedChemEx",97.04,"BRD-K14529030-001-01-9","Phase 3","","QNOCRUSVMMAKSC-CCEZHUSRSA-N","BRD-K14529030","","CN1C(=O)\C(c2ccccc12)=C1\C(=O)Nc2ccccc12"
"3034","MEK1-2-INHIBITOR","MEK inhibitor","MAP2K2","","","Tocris, Selleck",95.74,"BRD-K12244279-001-05-8, BRD-K12244279-001-04-1","Preclinical","","JLOXTZFYJNCPIS-FYWRMAATSA-N","BRD-K12244279","","N\C(Sc1ccc(N)cc1)=C(\C#N)c1ccccc1C(F)(F)F"
"3036","MEK162","MEK inhibitor","MAP2K1, MAP2K2","","","Selleck",94.6,"BRD-K82244583-001-01-3","Phase 3","","ACWZRVQXLIRSDF-UHFFFAOYSA-N","BRD-K82244583","","Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO"
"3037","MELENGESTROL-ACETATE","progesterone receptor agonist","","","","MicroSource",86.88,"BRD-A42746051-001-02-9","Preclinical","","UDKABVSQKJNZBH-PQQMIVRBSA-N","BRD-A42746051","","CC(=O)O[C@]1(C(C)=O)C(=C)CC2C3C=C(C)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C"
"3038","MELPHALAN-N-OXIDE","hypoxia inducible factor inhibitor","HIF1A","","","Adooq",67.76,"BRD-K36394566-300-01-0","Phase 1","","GSKQMLGAUOTSKT-LBPRGKRZSA-N","BRD-K36394566","","N[C@@H](Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O"
"3039","MELUADRINE","","","","","MedChemEx",98.2,"BRD-A07164067-001-01-2","Preclinical","","LIXBJWRFCNRAPA-UHFFFAOYSA-N","BRD-A07164067","","CC(C)(C)NCC(O)c1ccc(O)cc1Cl"
"3040","MENADIONE-BISULFITE","vitamin K","GGCX, VKORC1, VKORC1L1","","","Sigma",98.12,"BRD-A19777893-236-01-9","Phase 2","","WIXFIQKTHUVFDI-UHFFFAOYSA-N","BRD-A19777893","","CC1(CC(=O)c2ccccc2C1=O)S(O)(=O)=O"
"3041","MEPARFYLON","","","","","MicroSource",0,"BRD-A11662333-001-03-3","Preclinical","","QXLPXWSKPNOQLE-UHFFFAOYSA-N","BRD-A11662333","","CCC(C)(O)C#C"
"3042","MEPAZINE","MALT1 inhibitor (JH)","MALT1","","","ChemDiv",90.48,"BRD-A82772293-001-03-2","Phase 2","","CBHCDHNUZWWAPP-UHFFFAOYSA-N","BRD-A82772293","","CN1CCCC(CN2c3ccccc3Sc3ccccc23)C1"
"3043","MEPIROXOL","","","","","Selleck, MicroSource",98.37,"BRD-K78299798-001-02-2, BRD-K78299798-001-03-0","Preclinical","","LQYJAVWWKTWWKN-UHFFFAOYSA-N","BRD-K78299798","","OCc1ccc[n+]([O-])c1"
"3045","MEPREDNISONE","","NR3C1","","","Selleck, Selleck",0.53,"BRD-K18207669-001-02-4, BRD-K81190290-001-01-3","Launched","BRD-K79233274-001-01-5","PIDANAQULIKBQS-RNUIGHNZSA-N","BRD-K18207669","BRD-K79233274","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"3046","MEPREDNISONE","","NR3C1","","","Selleck, Selleck",0.53,"BRD-K18207669-001-02-4, BRD-K81190290-001-01-3","Launched","BRD-K79233274-001-01-5","PIDANAQULIKBQS-RNUIGHNZSA-N","BRD-K18207669","BRD-K79233274","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"3047","MEPREDNISONE","","NR3C1","","","Selleck, Selleck",0.53,"BRD-K18207669-001-02-4, BRD-K81190290-001-01-3","Launched","BRD-K79233274-001-01-5","XTLSVXWJVRKFIP-RNUIGHNZSA-N","BRD-K18207669","BRD-K79233274","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"3048","MEPREDNISONE","","NR3C1","","","Selleck, Selleck",0.53,"BRD-K18207669-001-02-4, BRD-K81190290-001-01-3","Launched","BRD-K79233274-001-01-5","XTLSVXWJVRKFIP-RNUIGHNZSA-N","BRD-K18207669","BRD-K79233274","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"3049","MEPRYLCAINE","local anesthetic","","","","MicroSource",83.5,"BRD-K65417056-003-10-1","Preclinical","","VXJABHHJLXLNMP-UHFFFAOYSA-N","BRD-K65417056","","CCCNC(C)(C)COC(=O)c1ccccc1"
"3050","MERBARONE","topoisomerase inhibitor","TOP2A","","","EMDBio",100,"BRD-K45152786-001-08-4","Phase 2","","JARCFMKMOFFIGZ-UHFFFAOYSA-N","BRD-K45152786","","O=C(Nc1ccccc1)C1C(=O)NC(=S)NC1=O"
"3051","MERCAPTOSUCCINIC-ACID","","","","","Enamine, Enamine",100,"BRD-A43435802-001-01-2, BRD-A43435802-001-02-0","Launched","","NJRXVEJTAYWCQJ-UHFFFAOYSA-N","BRD-A43435802","","OC(=O)CC(S)C(O)=O"
"3053","MERICITABINE","HCV inhibitor","","","","MedChemEx",98,"BRD-K69726595-001-01-2","Phase 2","","MLESJYFEMSJZLZ-MAAOGQSESA-N","BRD-K69726595","","CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C"
"3054","MERIMEPODIB","inosine monophosphate dehydrogenase inhibitor","IMPDH1","","","MedChemEx",98.21,"BRD-K09372874-001-01-0","Phase 2","","JBPUGFODGPKTDW-SFHVURJKSA-N","BRD-K09372874","","COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1"
"3055","MESULERGINE","dopamine receptor agonist","HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7","","","Enzo",94.81,"BRD-K91336023-003-01-0","Phase 2","","JLVHTNZNKOSCNB-YSVLISHTSA-N","BRD-K91336023","","CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1"
"3056","META-CRESYL-ACETATE","","","","","MicroSource",0,"BRD-K33442414-001-02-6","Preclinical","","OTGAHJPFNKQGAE-UHFFFAOYSA-N","BRD-K33442414","","CC(=O)Oc1cccc(C)c1"
"3057","METACETAMOL","analgesic agent","","","","MicroSource",99.02,"BRD-K16474819-001-09-6","Preclinical","","QLNWXBAGRTUKKI-UHFFFAOYSA-N","BRD-K16474819","","CC(=O)Nc1cccc(O)c1"
"3058","METACRESOL","","INS","","","MicroSource",96.37,"BRD-K22518984-001-01-8","Launched","","RLSSMJSEOOYNOY-UHFFFAOYSA-N","BRD-K22518984","","Cc1cccc(O)c1"
"3059","METAFOLIN","","AMT","","","MedChemEx, MedChemEx, MedChemEx",67.8,"BRD-K28580965-238-03-9, BRD-K28580965-238-01-3, BRD-K28580965-238-02-1","Launched","","ZNOVTXRBGFNYRX-STQMWFEESA-N","BRD-K28580965","","CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12"
"3062","METAMIZOLE","cyclooxygenase inhibitor, opioid receptor agonist","PTGS1","","","MicroSource",93.08,"BRD-K76812510-236-14-8","Withdrawn","","LVWZTYCIRDMTEY-UHFFFAOYSA-N","BRD-K76812510","","CN(CS(O)(=O)=O)c1c(C)n(C)n(-c2ccccc2)c1=O"
"3063","METAPHIT","phencyclidine receptor acylator","","","","Tocris",12.3,"BRD-K95701999-001-02-3","Preclinical","","FGSGBQAQSPSRJK-UHFFFAOYSA-N","BRD-K95701999","","S=C=Nc1cccc(c1)C1(CCCCC1)N1CCCCC1"
"3064","METATINIB","Bcr-Abl kinase inhibitor","ABL1, BCR","","","Selleck",98.07,"BRD-K27182532-001-02-3","Phase 1","","PDYXPCKITKHFOZ-UHFFFAOYSA-N","BRD-K27182532","","Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl"
"3065","METAZOSIN","adrenergic receptor antagonist","ADRA1A","","","Sigma",98.7,"BRD-A78277353-001-01-9","Phase 2","","YEOTYALSMRNXLJ-UHFFFAOYSA-N","BRD-A78277353","","COC(C)C(=O)N1CCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1"
"3066","METENKEPHALIN","immunostimulant","OPRD1","","","MPBio",91.27,"BRD-A38218502-001-01-2","Phase 2","","YFGBQHOOROIVKG-UHFFFAOYSA-N","BRD-A38218502","","CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(O)=O"
"3067","METERGOLINE","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",94,"BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5","Launched","","WZHJKEUHNJHDLS-QTGUNEKASA-N","BRD-K56699285","","CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13"
"3068","METERGOLINE","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",94,"BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5","Launched","","WZHJKEUHNJHDLS-QTGUNEKASA-N","BRD-K56699285","","CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13"
"3070","METERGOLINE","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",94,"BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5","Launched","","WZHJKEUHNJHDLS-STDCAVTESA-N","BRD-K56699285","","CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13"
"3071","METERGOLINE","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",94,"BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5","Launched","","WZHJKEUHNJHDLS-STDCAVTESA-N","BRD-K56699285","","CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13"
"3073","METHANESULFONYL-FLUORIDE","acetylcholinesterase inhibitor","ACHE","","","Sigma",0,"BRD-K53896891-001-01-2","Phase 2","","KNWQLFOXPQZGPX-UHFFFAOYSA-N","BRD-K53896891","","CS(F)(=O)=O"
"3074","METHAPYRILENE","histamine receptor antagonist","HRH1","","","MicroSource, Selleck",93.74,"BRD-K47323024-003-25-1, BRD-K47323024-003-24-4","Withdrawn","","HNJJXZKZRAWDPF-UHFFFAOYSA-N","BRD-K47323024","","CN(C)CCN(Cc1cccs1)c1ccccn1"
"3076","METHIAZOLE","anthelmintic agent","","","","Prestwick",95.06,"BRD-K02764365-001-13-6","Preclinical","","SXJIZQPZESTWLD-UHFFFAOYSA-N","BRD-K02764365","","COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1"
"3077","METHICILLIN","bacterial cell wall synthesis inhibitor","","","","Sigma, MicroSource",85.33,"BRD-K34388247-236-09-0, BRD-K34388247-236-08-2","Launched","","RJQXTJLFIWVMTO-TYNCELHUSA-N","BRD-K34388247","","COc1cccc(OC)c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O"
"3079","METHIONINE","","BHMT, BHMT2, METAP2, MTR, MTRR","","","Sigma",47.29,"BRD-A39515206-001-01-9","Launched","","FFEARJCKVFRZRR-UHFFFAOYSA-N","BRD-A39515206","","CSCCC(N)C(O)=O"
"3080","METHIOPRIL","angiotensin converting enzyme inhibitor","ACE","","","ChemDiv",97.96,"BRD-A32172948-001-07-6","Phase 2","","JHFOAISYWJRTIM-UHFFFAOYSA-N","BRD-A32172948","","CC1CCCC(N1C(=O)CCSC(C)=O)C(O)=O"
"3081","METHOPRENE-(S)","","","","","MicroSource",86.73,"BRD-K34591242-001-04-3","Preclinical","","NFGXHKASABOEEW-GYMWBFJFSA-N","BRD-K34591242","","COC(C)(C)CCC[C@H](C)C\C=C\C(C)=C\C(=O)OC(C)C"
"3082","METHOXYAMINE","DNA repair enzyme inhibitor","APEX1","","","Otava",0,"BRD-K79277568-003-04-7","Phase 2","","GMPKIPWJBDOURN-UHFFFAOYSA-N","BRD-K79277568","","CON"
"3083","METHYL-NICOTINATE","","","","","Vitas-M, Sigma",0,"BRD-K10132944-001-01-1, BRD-K10132944-001-02-9","Phase 2","","YNBADRVTZLEFNH-UHFFFAOYSA-N","BRD-K10132944","","COC(=O)c1cccnc1"
"3085","METHYLATROPINE-NITRATE","acetylcholine receptor antagonist","CHRM1","","","MicroSource",96.89,"BRD-A52460047-001-01-3","Preclinical","BRD-M17130441-001-03-0","PIPAJLPNWZMYQA-UHFFFAOYSA-N","BRD-A52460047","BRD-M17130441","C[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1"
"3086","METHYLBENZETHONIUM-CHLORIDE","other antibiotic","","","","MicroSource",64.12,"BRD-K46531780-003-18-9","Preclinical","","UQOOPIMXBSPVJI-UHFFFAOYSA-N","BRD-K46531780","","Cc1cc(ccc1OCCOCC[N+](C)(C)Cc1ccccc1)C(C)(C)CC(C)(C)C"
"3087","METHYLLYCACONITINE","acetylcholine receptor antagonist","CHRNA7","","","Tocris, Tocris, Tocris",93.67,"BRD-K43192255-048-02-8, BRD-K43192255-048-01-0, BRD-K43192255-048-03-6","Preclinical","BRD-A29043702-048-02-2, BRD-A29043702-048-03-0, BRD-A29043702-048-01-4,BRD-A32164164-048-02-2","XLTANAWLDBYGFU-VTLKBQQISA-N","BRD-K43192255","BRD-A29043702","CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14"
"3090","METIPRANOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","","","Aronis",96.55,"BRD-A99388803-001-01-5","Withdrawn","","BQIPXWYNLPYNHW-UHFFFAOYSA-N","BRD-A99388803","","CC(C)NCC(O)COc1cc(C)c(OC(C)=O)c(C)c1C"
"3091","METITEPINE","anti-HCVE2","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",98.47,"BRD-A07932845-050-16-6, BRD-A07932845-066-11-3, BRD-A07932845-050-15-8","Preclinical","","RLJFTICUTYVZDG-UHFFFAOYSA-N","BRD-A07932845","","CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1"
"3094","METOXIBUTROPATE","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Specs",96.65,"BRD-A71725768-001-01-3","Launched","","FVRWRGBTEHAPDI-UHFFFAOYSA-N","BRD-A71725768","","COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1"
"3095","METRIFONATE","acetylcholinesterase inhibitor","ACHE","","","MedChemEx, MicroSource, MedChemEx",58.32,"BRD-A22101059-001-15-5, BRD-A22101059-001-13-0, BRD-A22101059-001-14-8","Phase 3","","NFACJZMKEDPNKN-UHFFFAOYSA-N","BRD-A22101059","","COP(=O)(OC)C(O)C(Cl)(Cl)Cl"
"3098","MEVALONIC-D,-L-ACID-LACTONE","","","","","Prestwick",0,"BRD-A05674712-001-06-0","Preclinical","","JYVXNLLUYHCIIH-UHFFFAOYSA-N","BRD-A05674712","","CC1(O)CCOC(=O)C1"
"3099","MEVASTATIN","HMGCR inhibitor","HMGCR","","","Tocris, MicroSource, Selleck, Selleck, Tocris",93.53,"BRD-K94441233-001-15-5, BRD-K94441233-001-17-1, BRD-K94441233-001-16-3, BRD-K94441233-001-13-0, BRD-K94441233-001-12-2","Preclinical","BRD-A83177971-001-04-0, BRD-K31414443-001-01-4","AJLFOPYRIVGYMJ-INTXDZFKSA-N","BRD-K94441233","BRD-A83177971","CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12"
"3104","MEXENEONE","","","","","MicroSource",97.2,"BRD-K18613660-001-05-5","Preclinical","","MJVGBKJNTFCUJM-UHFFFAOYSA-N","BRD-K18613660","","COc1ccc(C(=O)c2ccc(C)cc2)c(O)c1"
"3105","ME0328","PARP inhibitor","PARP3","","","Selleck",99.08,"BRD-A63444178-001-01-5","Preclinical","","QIHBWVVVRYYYRO-UHFFFAOYSA-N","BRD-A63444178","","CC(NC(=O)CCc1nc(=O)c2ccccc2[nH]1)c1ccccc1"
"3106","MF-101","estrogen receptor agonist","CYP19A1, XDH","","","InterBioScreen",98,"BRD-K34328244-001-01-4","Phase 3","","FURUXTVZLHCCNA-AWEZNQCLSA-N","BRD-K34328244","","Oc1ccc(cc1)[C@@H]1CC(=O)c2ccc(O)cc2O1"
"3107","MG-132","proteasome inhibitor","PSMB1","","","Selleck, Selleck, Selleck",86.03,"BRD-K60230970-001-17-5, BRD-K60230970-001-13-4, BRD-K60230970-001-16-7","Preclinical","","TZYWCYJVHRLUCT-VABKMULXSA-N","BRD-K60230970","","CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O"
"3110","MG-624","acetylcholine receptor antagonist","CHRNA7","","","Tocris, Tocris",93.43,"BRD-K03128577-005-07-0, BRD-K03128577-005-06-2","Preclinical","","YIMFXBPXUPTIEJ-OUKQBFOZSA-N","BRD-K03128577","","CC[N+](CC)(CC)CCOc1ccc(\C=C\c2ccccc2)cc1"
"3112","MGCD-265","VEGFR inhibitor","AXL, MET","","","Selleck",92.2,"BRD-K56277358-001-07-5","Preclinical","","UFICVEHDQUKCEA-UHFFFAOYSA-N","BRD-K56277358","","Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1"
"3113","MI-14","PI4K inhibitor","PI4KB","","","Tocris",92.97,"BRD-K26726854-001-01-0","Preclinical","","PSTAJIONBVMKLA-UHFFFAOYSA-N","BRD-K26726854","","CN(C)S(=O)(=O)c1cccc(c1)-c1c(C)nc2c(NCCNC(C)=O)cc(Cl)nn12"
"3114","MIBAMPATOR","glutamate receptor modulator","GRIA1","","","MedChemEx",99.84,"BRD-K42981054-001-01-9","Phase 2","","ULRDYYKSPCRXAJ-KRWDZBQOSA-N","BRD-K42981054","","CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)-c1ccc(CCNS(C)(=O)=O)cc1"
"3115","MIBEFRADIL","T-type calcium channel blocker","ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4","","","Tocris, Tocris",97.32,"BRD-K09549677-300-03-4, BRD-K09549677-300-04-2","Withdrawn","","HBNPJJILLOYFJU-VMPREFPWSA-N","BRD-K09549677","","COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C"
"3117","MIDAFOTEL","glutamate receptor antagonist","GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, EMDBio",100,"BRD-K45163704-001-02-3, BRD-K45163704-001-01-5","Phase 3","","VZXMZMJSGLFKQI-ABVWVHJUSA-N","BRD-K45163704","","OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1"
"3119","MIFOBATE","PPAR receptor antagonist","PPARG","","","Tocris",92.75,"BRD-A72066420-001-04-5","Phase 2","","VQHUQHAPWMNBLP-UHFFFAOYSA-N","BRD-A72066420","","COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC"
"3120","MILACEMIDE","monoamine oxidase inhibitor","MAOB","","","Enamine",92.25,"BRD-K64338723-001-01-6","Phase 3","","GJNNXIYZWIZFRH-UHFFFAOYSA-N","BRD-K64338723","","CCCCCNCC(N)=O"
"3121","MIMOSINE","DNA replication inhibitor","CCL2, SHMT1, SHMT2, TYR","","","Enzo",0,"BRD-K67642028-001-03-6","Preclinical","","WZNJWVWKTVETCG-YFKPBYRVSA-N","BRD-K67642028","","N[C@@H](Cn1ccc(=O)c(O)c1)C(O)=O"
"3122","MINAPRINE","serotonin reuptake inhibitor","ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4","","","MicroSource",99.62,"BRD-K02867583-300-08-9","Withdrawn","","LDMWSLGGVTVJPG-UHFFFAOYSA-N","BRD-K02867583","","Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1"
"3123","MINERVAL","FAAH inhibitor","","","","Sigma",98.8,"BRD-A74347210-001-01-7","Phase 1/Phase 2","","JBSOOFITVPOOSY-KTKRTIGZSA-N","BRD-A74347210","","CCCCCCCC\C=C/CCCCCCC(O)C(O)=O"
"3124","MIRA-1","apoptosis stimulant","","","","Tocris",0,"BRD-K39706510-001-03-9","Preclinical","","YXEWPGYLMHXLPS-UHFFFAOYSA-N","BRD-K39706510","","CCC(=O)OCN1C(=O)C=CC1=O"
"3125","MIRIN","MRE11A exonuclease inhibitor","MRE11A","","","Tocris",89.76,"BRD-K55420858-001-02-8","Preclinical","","YBHQCJILTOVLHD-YVMONPNESA-N","BRD-K55420858","","NC1=NC(=O)\C(S1)=C\c1ccc(O)cc1"
"3126","MISONIDAZOLE","","","","","Cayman",96.47,"BRD-A16263897-001-06-6","Phase 3","","OBBCSXFCDPPXOL-UHFFFAOYSA-N","BRD-A16263897","","COCC(O)Cn1ccnc1[N+]([O-])=O"
"3127","MITOFLAXONE","antitumor agent","VWF","","","Specs",98.8,"BRD-K35882976-001-04-7","Phase 2","","TZZNWMJZDWYJAZ-UHFFFAOYSA-N","BRD-K35882976","","OC(=O)Cc1cccc2c1oc(cc2=O)-c1ccccc1"
"3128","MIVOBULIN","microtubule inhibitor","","","","Sigma",80.61,"BRD-K39576764-071-01-6","Preclinical","","ZAKKIVMLUCPABA-UHFFFAOYSA-N","BRD-K39576764","","CCOC(=O)Nc1cc2NC(C)=C(Nc2c(N)n1)c1ccccc1"
"3129","MIZORIBINE","immunosuppressant, inosine monophosphate dehydrogenase inhibitor","IMPDH1","","","Selleck, MicroSource, Selleck",100,"BRD-K88061624-001-21-4, BRD-K88061624-001-20-6, BRD-K88061624-001-22-2","Launched","BRD-K05218031-001-01-9","HZQDCMWJEBCWBR-UUOKFMHZSA-N","BRD-K88061624","BRD-K05218031","NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O"
"3132","MJ-15","cannabinoid receptor antagonist","CNR1","","","Tocris",92.68,"BRD-K71315565-001-01-6","Preclinical","","PJEIKJFNEFJFLA-UHFFFAOYSA-N","BRD-K71315565","","Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NCc1cccnc1"
"3133","MK-0354","niacin receptor agonist","HCAR2, HCAR3","","","MedChemEx",94.22,"BRD-K91405252-001-01-9","Phase 2","","LTQYSJKGRPGMPO-UHFFFAOYSA-N","BRD-K91405252","","C1Cc2[nH]nc(-c3nnn[nH]3)c2C1"
"3134","MK-0752","gamma secretase inhibitor","","","","Selleck",93.39,"BRD-K18850819-001-04-6","Phase 1/Phase 2","","XCGJIFAKUZNNOR-QCKZDCLWSA-N","BRD-K18850819","","OC(=O)CC[C@H]1CC[C@@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1"
"3135","MK-0773","androgen receptor modulator","AR","","","MedChemEx",97.69,"BRD-K38868394-001-01-3","Phase 2","","GBEUKTWTUSPHEE-JWJWXJQQSA-N","BRD-K38868394","","CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCc5nc6cccnc6[nH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O"
"3136","MK-0812","CC chemokine receptor antagonist","CCR2","","","MedChemEx",97.78,"BRD-K14175878-001-01-6","Phase 2","","MTMDXAIUENDNDL-RJSMDTJLSA-N","BRD-K14175878","","CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F"
"3137","MK-0893","glucagon receptor antagonist","GCGR","","","MedChemEx",98.42,"BRD-K16732600-001-01-7","Phase 2","","DNTVJEMGHBIUMW-IBGZPJMESA-N","BRD-K16732600","","COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1"
"3138","MK-1775","WEE1 kinase inhibitor","WEE1","","","Selleck",91.74,"BRD-K54256913-001-08-7","Phase 2","","BKWJAKQVGHWELA-UHFFFAOYSA-N","BRD-K54256913","","CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1"
"3139","MK-2048","HIV integrase inhibitor","","","","Selleck, Selleck",61.42,"BRD-K03128512-001-03-6, BRD-K03128512-001-02-8","Preclinical","BRD-K66135050-001-01-7","JSRREMIKIHJGAA-JTQLQIEISA-N","BRD-K03128512","BRD-K66135050","CCN1C[C@H](C)n2c(c(O)c3c2c(nn(Cc2ccc(F)c(Cl)c2)c3=O)C(=O)NC)C1=O"
"3141","MK-2206","AKT inhibitor","AKT1, AKT2, AKT3","","","Selleck",97.67,"BRD-K68065987-300-09-1","Phase 2","","ULDXWLCXEDXJGE-UHFFFAOYSA-N","BRD-K68065987","","NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1"
"3142","MK-2295","TRPV antagonist","TRPV1","","","DuPont",97.5,"BRD-K43316319-001-01-8","Phase 2","","VTANGSDRFFLTSQ-UHFFFAOYSA-N","BRD-K43316319","","FC(F)(F)c1ccc(Nc2ncnc3cc(ccc23)-c2ncccc2C(F)(F)F)cc1"
"3143","MK-2461","FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB","","","Selleck",93.34,"BRD-K56405753-001-02-4","Phase 1/Phase 2","","JGEBLDKNWBUGRZ-HXUWFJFHSA-N","BRD-K56405753","","CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1"
"3144","MK-2894","prostaglandin inhibitor","PTGER4","","","MedChemEx",92.79,"BRD-K27983781-001-01-4","Preclinical","","QJZQFVRFJCGDKF-UHFFFAOYSA-N","BRD-K27983781","","Cc1sc(C)c(C(=O)NC2(CC2)c2ccc(cc2)C(O)=O)c1Cc1ccc(cc1)C(F)(F)F"
"3145","MK-3207","calcitonin antagonist","CALCA","","","MedChemEx",98.79,"BRD-K66911501-003-01-2","Phase 2","","AZAANWYREOQRFB-SETSBSEESA-N","BRD-K66911501","","Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31"
"3146","MK-3697","orexin receptor antagonist","HCRTR2","","","MedChemEx",97.36,"BRD-K95828359-001-01-0","Phase 2","","VSOUDUXMPUHJEU-UHFFFAOYSA-N","BRD-K95828359","","COc1ccc(CNC(=O)c2cc(ncc2-c2nccs2)-c2cncc(C)c2)nc1OC"
"3147","MK-5046","bombesin receptor agonist","BRS3, GRPR, NMBR","","","MedChemEx",90.83,"BRD-K03886848-001-01-8","Preclinical","","UJINBEQCDMOAHM-SFHVURJKSA-N","BRD-K03886848","","O[C@@](Cc1nc(CC2(CC2)C(F)(F)F)c[nH]1)(c1ccc(cc1)-n1cccn1)C(F)(F)F"
"3148","MK-5108","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck",92.91,"BRD-K53665955-001-03-0","Phase 1","","LCVIRAZGMYMNNT-VVONHTQRSA-N","BRD-K53665955","","OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F"
"3149","MK-571","leukotriene receptor antagonist","ABCC2, CYSLTR1","","","MedChemEx",94.07,"BRD-A73679382-236-01-8","Phase 2","","AXUZQJFHDNNPFG-UXBLZVDNSA-N","BRD-A73679382","","CN(C)C(=O)CCSC(SCCC(O)=O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1"
"3150","MK-6096","orexin receptor antagonist","HCRTR1, HCRTR2","","","MedChemEx",97.98,"BRD-K03894385-001-01-1","Phase 2","","NPFDWHQSDBWQLH-QZTJIDSGSA-N","BRD-K03894385","","C[C@@H]1CC[C@@H](COc2ccc(F)cn2)CN1C(=O)c1cc(C)ccc1-c1ncccn1"
"3151","MK-8033","c-Met inhibitor","MET","","","MedChemEx",91.91,"BRD-K55512740-001-01-6","Phase 1","","VMJFTOSOFDEKTM-UHFFFAOYSA-N","BRD-K55512740","","Cn1cc(cn1)-c1cnc2ccc3ccc(CS(=O)(=O)NCc4ccccn4)cc3c(=O)c2c1"
"3152","MK-8245","stearoyl-CoA desaturase inhibitor","SCD","","","Selleck",96.51,"BRD-K29656036-001-02-5","Phase 2","","UJEAABFSXKCSGI-UHFFFAOYSA-N","BRD-K29656036","","OC(=O)Cn1nnc(n1)-c1cc(no1)N1CCC(CC1)Oc1cc(F)ccc1Br"
"3153","MK-8745","Aurora kinase inhibitor","AURKA","","","Selleck",93.7,"BRD-K25279140-001-01-5","Preclinical","","YCRFPWKUUNKNDN-UHFFFAOYSA-N","BRD-K25279140","","Fc1c(Cl)cccc1C(=O)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1"
"3154","MKT-077","HSP inhibitor","","","","Tocris, Cayman",49.21,"BRD-K61695967-003-02-1, BRD-K61695967-003-01-3","Phase 1","","QLYHOWIZHHZGPV-XUTLUUPISA-N","BRD-K61695967","","CCn1\c(=C/c2cccc[n+]2CC)s\c(=C2\Sc3ccccc3N2C)c1=O"
"3156","MK2-IN-1","MAP kinase inhibitor","MAPKAPK2","","","MedChemEx",91.11,"BRD-K90316462-003-01-1","Preclinical","","LIPNXDIBECKOMJ-UHFFFAOYSA-N","BRD-K90316462","","Clc1ccc(cc1)-c1ccc(o1)C(=O)N(Cc1ccccn1)c1ccc(cc1)N1CCNCC1"
"3157","ML-10302","serotonin receptor partial agonist","HTR3A, HTR3B, HTR4","","","Tocris",94.1,"BRD-K69343602-003-01-3","Preclinical","","RVFIAQAAZUEPPE-UHFFFAOYSA-N","BRD-K69343602","","COc1cc(N)c(Cl)cc1C(=O)OCCN1CCCCC1"
"3158","ML-141","GTPase inhibitor","CDC42","","","Tocris",88.19,"BRD-A28422330-001-10-1","Preclinical","","QBNZBMVRFYREHK-UHFFFAOYSA-N","BRD-A28422330","","COc1ccc(cc1)C1CC(=NN1c1ccc(cc1)S(N)(=O)=O)c1ccccc1"
"3159","ML-179","liver receptor homolog inverse agonist","NR5A2","","","Tocris",96.66,"BRD-K77547509-001-03-3","Preclinical","","MFABFKUNLDYKGH-UHFFFAOYSA-N","BRD-K77547509","","FC(F)(F)c1cccc(c1)N1CCN(CC1)c1cc(=O)n(C2CCCCC2)c(=O)[nH]1"
"3160","ML-193","G protein-coupled receptor antagonist","GPR55","","","Tocris",99.09,"BRD-K27539181-001-08-5","Preclinical","","HTSLEZOTMYUPLU-UHFFFAOYSA-N","BRD-K27539181","","Cc1noc(NS(=O)(=O)c2ccc(NC(=O)c3cc(nc4c(C)cc(C)cc34)-c3ccccn3)cc2)c1C"
"3161","ML-213","potassium channel activator","KCNQ4","","","Tocris",97.46,"BRD-A12633378-001-07-0","Preclinical","","SIQGKPGBLYKQBB-UHFFFAOYSA-N","BRD-A12633378","","Cc1cc(C)c(NC(=O)C2CC3CCC2C3)c(C)c1"
"3162","ML-218","T-type calcium channel binder","CACNA1G, CACNA1H, CACNA1I","","","Tocris",93.41,"BRD-K92995792-003-02-9","Preclinical","","GSJIGYLGKSBYBC-OSYLJGHBSA-N","BRD-K92995792","","CC(C)(C)CCN1C[C@H]2[C@H](CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1"
"3163","ML-228","hypoxia inducible factor activator","HIF1A","","","Tocris",97.16,"BRD-K44432556-001-05-5","Preclinical","","QNRODODTMXCRKU-UHFFFAOYSA-N","BRD-K44432556","","C(Nc1nc(nnc1-c1ccccc1)-c1ccccn1)c1ccc(cc1)-c1ccccc1"
"3164","ML-277","potassium channel activator","KCNQ1","","","Tocris",97.08,"BRD-K60020910-001-02-5","Preclinical","","OXQNLLVUVDAEHC-OAQYLSRUSA-N","BRD-K60020910","","COc1ccc(cc1)-c1csc(NC(=O)[C@H]2CCCCN2S(=O)(=O)c2ccc(C)cc2)n1"
"3165","ML-281","serine/threonine kinase inhibitor","STK33","","","Tocris",98.78,"BRD-K48188942-001-03-7","Preclinical","","HWOYIOLMBQSTQS-UHFFFAOYSA-N","BRD-K48188942","","CC(C)c1ccc(NC(=O)c2cccs2)c(c1)-c1nc2ccccc2[nH]c1=O"
"3166","ML-297","inward rectifier potassium channel activator","KCNJ3","","","Tocris",72.69,"BRD-K51137250-001-02-6","Preclinical","","IEKSMUSSYJUQMY-UHFFFAOYSA-N","BRD-K51137250","","Cc1cc(NC(=O)Nc2ccc(F)c(F)c2)n(n1)-c1ccccc1"
"3167","ML-298","phospholipase inhibitor","PLD2","","","Tocris",86.04,"BRD-K24600306-003-01-9","Preclinical","","XAPVAKKLQGLNOY-UHFFFAOYSA-N","BRD-K24600306","","Fc1cccc(c1)N1CNC(=O)C11CCN(CCNC(=O)c2ccc(F)c(F)c2)CC1"
"3168","ML-323","ubiquitin specific protease inhibitor","USP1","","","MedChemEx",96.64,"BRD-K93942811-001-01-3","Preclinical","","VUIRVWPJNKZOSS-UHFFFAOYSA-N","BRD-K93942811","","CC(C)c1ccccc1-c1ncc(C)c(NCc2ccc(cc2)-n2ccnn2)n1"
"3169","ML-3403","MAP kinase inhibitor","CYP3A4, MAPK11, MAPK12, MAPK14","","","Tocris",96.63,"BRD-A29014990-001-02-3","Preclinical","","VXPWQNBKEIVYIS-UHFFFAOYSA-N","BRD-A29014990","","CSc1nc(c([nH]1)-c1ccnc(NC(C)c2ccccc2)c1)-c1ccc(F)cc1"
"3170","ML-348","lysophospholipase inhibitor","LYPLA1","","","Tocris",97.3,"BRD-K81044214-001-06-4","Preclinical","","OXKNHBBDOIMFFQ-UHFFFAOYSA-N","BRD-K81044214","","FC(F)(F)c1ccc(Cl)c(NC(=O)CN2CCN(CC2)C(=O)c2ccco2)c1"
"3171","ML-365","potassium channel blocker","KCNK3, KCNK9","","","Tocris",98.91,"BRD-K02160913-001-02-7","Preclinical","","UTAJHKSGYJSZBR-UHFFFAOYSA-N","BRD-K02160913","","COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1"
"3172","ML-786","RAF inhibitor","BRAF, RAF1","","","Tocris",91.56,"BRD-K52644305-300-01-3","Preclinical","","GXEGTVQATHKFDH-OAQYLSRUSA-N","BRD-K52644305","","CC(C)(N)c1cc(cc(c1)C(F)(F)F)C(=O)N[C@@H]1CCc2ccc(OC3=C4CCC(=O)N=C4NC=C3)cc2C1"
"3173","ML-9","myosin light chain kinase inhibitor","TRPC6","","","Tocris, Tocris",98.37,"BRD-K68402494-003-03-5, BRD-K68402494-003-04-3","Preclinical","","OZSMSRIUUDGTEP-UHFFFAOYSA-N","BRD-K68402494","","Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1"
"3175","MLN-8054","Aurora kinase inhibitor","AURKA","","","Selleck",93.63,"BRD-K83963101-001-06-9","Phase 1","","HHFBDROWDBDFBR-UHFFFAOYSA-N","BRD-K83963101","","OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1"
"3176","MLN0128","mTOR inhibitor","MTOR, PIK3CA, PIK3CD, PIK3CG","","","Selleck",97.29,"BRD-K59317601-001-05-5","Phase 2","","GYLDXIAOMVERTK-UHFFFAOYSA-N","BRD-K59317601","","CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc12"
"3177","MLN1117","PI3K inhibitor","PIK3CA","","","MedChemEx",97.33,"BRD-K73877023-001-01-9","Phase 1/Phase 2","","BLGWHBSBBJNKJO-UHFFFAOYSA-N","BRD-K73877023","","Nc1nc2cc(ccc2o1)-c1ccc2ncc(C(=O)N3CCOCC3)n2c1"
"3178","MLN2480","RAF inhibitor","","","","MedChemEx",94.36,"BRD-K43410529-001-02-3","Phase 1","","VWMJHAFYPMOMGF-ZCFIWIBFSA-N","BRD-K43410529","","C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(s1)C(=O)Nc1cc(c(Cl)cn1)C(F)(F)F"
"3179","MLN9708","proteasome inhibitor","","","","MedChemEx, MedChemEx",17.51,"BRD-K15203492-001-01-1, BRD-K15203492-001-02-9","Phase 3","","MBOMYENWWXQSNW-AWEZNQCLSA-N","BRD-K15203492","","CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(O)=O)(CC(O)=O)O1"
"3181","ML130","NOD1 inhibitor","","","","Tocris, Selleck",96.19,"BRD-K89306950-001-13-3, BRD-K89306950-001-12-5","Preclinical","","SRFABRWQVPCPRG-UHFFFAOYSA-N","BRD-K89306950","","Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12"
"3183","ML133","potassium channel blocker","","","","Selleck",97.57,"BRD-K33743361-003-02-6","Preclinical","","GIFYKGIODMXYNT-UHFFFAOYSA-N","BRD-K33743361","","COc1ccc(CNCc2cccc3ccccc23)cc1"
"3184","ML161","protease-activated receptor inhibitor","","","","Tocris, Selleck",98.28,"BRD-K59036917-001-17-5, BRD-K59036917-001-16-7","Preclinical","","DFOVLSMXPWPCFH-UHFFFAOYSA-N","BRD-K59036917","","CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1"
"3186","ML167","CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B","","","Selleck",90.04,"BRD-K64835161-001-02-8","Preclinical","","ROCFOIBAEVAOLQ-UHFFFAOYSA-N","BRD-K64835161","","Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1"
"3187","ML204","transient receptor potential channel antagonist","TRPC4, TRPC5","","","MedChemEx",97.27,"BRD-K80021413-001-08-8","Preclinical","","USYRQXDHKXGTCK-UHFFFAOYSA-N","BRD-K80021413","","Cc1cc(nc2ccccc12)N1CCCCC1"
"3188","ML314","neurotensin agonist","NTSR1","","","MedChemEx",96.62,"BRD-K92606079-001-02-0","Preclinical","","SWEOAXMICIJCQC-UHFFFAOYSA-N","BRD-K92606079","","COc1ccccc1N1CCN(CC1)c1nc(nc2cc(OC)c(OC)cc12)C1CC1"
"3189","ML324","histone lysine demethylase inhibitor","KDM4A","","","MedChemEx",86.85,"BRD-K25611237-001-02-1","Preclinical","","QDBVSOZTVKXUES-UHFFFAOYSA-N","BRD-K25611237","","CN(C)CCCNC(=O)c1ccc(cc1)-c1cc(O)c2ncccc2c1"
"3190","ML347","ALK tyrosine kinase receptor inhibitor","ACVR1, ACVRL1, BMPR1A","","","Selleck, Tocris",99.36,"BRD-K33892651-001-02-4, BRD-K33892651-001-03-2","Preclinical","","FVRYPYDPKSZGNS-UHFFFAOYSA-N","BRD-K33892651","","COc1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12"
"3192","MM-102","WDR5/MLL interaction inhibitor","","","","Selleck",91.66,"BRD-K68474068-001-01-8","Preclinical","","RZKSQRIPRKWVBU-MHZLTWQESA-N","BRD-K68474068","","CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NC1(CCCC1)C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1"
"3193","MM-11253","retinoid receptor antagonist","RARG","","","Tocris",98.06,"BRD-K98353094-001-01-6","Preclinical","","DPVGXUNWCVEIGT-UHFFFAOYSA-N","BRD-K98353094","","CC1(C)CCC(C)(C)c2cc(ccc12)C1(SCCS1)c1ccc2cc(ccc2c1)C(O)=O"
"3194","MMPX","phosphodiesterase inhibitor","","","","Tocris",99.04,"BRD-K56077740-001-09-2","Preclinical","","NBLBCGUCPBXKOV-UHFFFAOYSA-N","BRD-K56077740","","COCc1nc2n(CC(C)C)c(=O)n(C)c(=O)c2[nH]1"
"3195","MM77","serotonin receptor antagonist","HTR1A","","","Tocris",75.74,"BRD-K50293352-300-02-1","Preclinical","","MQHOGPLXAXSQAJ-UHFFFAOYSA-N","BRD-K50293352","","COc1ccccc1N1CCN(CCCCN2C(=O)CCC2=O)CC1"
"3196","MN-64","tankyrase inhibitor","TNKS","","","MedChemEx",96.16,"BRD-K16183658-001-01-4","Preclinical","","PYTOHIUBXSJKQH-UHFFFAOYSA-N","BRD-K16183658","","CC(C)c1ccc(cc1)-c1cc(=O)c2ccccc2o1"
"3197","MNITMT","lymphocyte inhibitor","","","","Tocris",98.32,"BRD-K63151507-001-02-4","Preclinical","","NMBDIMPYACLUDE-UHFFFAOYSA-N","BRD-K63151507","","Cn1cnnc1Sc1c(ncn1C)[N+]([O-])=O"
"3198","MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)","src inhibitor, syk inhibitor","SRC, SYK","","","Selleck, Selleck",93.21,"BRD-K42205652-001-02-7, BRD-K42205652-001-05-0","Preclinical","","KFLWBZPSJQPRDD-ONEGZZNKSA-N","BRD-K42205652","","[O-][N+](=O)\C=C\c1ccc2OCOc2c1"
"3200","MOCETINOSTAT","HDAC inhibitor","HDAC1, HDAC11, HDAC2, HDAC3","","","Selleck, MedChemEx, Selleck",96.2,"BRD-K16485616-001-12-1, BRD-K16485616-001-13-9, BRD-K16485616-001-08-9","Phase 2","","HRNLUBSXIHFDHP-UHFFFAOYSA-N","BRD-K16485616","","Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1"
"3203","MODALINE","","","","","MicroSource",98.29,"BRD-K25317177-065-01-4","Preclinical","","BJHCGMHPEKLROM-UHFFFAOYSA-N","BRD-K25317177","","Cc1nccnc1N1CCCCC1"
"3204","MOFEGILINE","monoamine oxidase inhibitor","MAOA, MAOB","","","MedChemEx, MedChemEx",88.73,"BRD-K52598503-003-01-1, BRD-K52598503-003-02-9","Phase 1","","VXLBSYHAEKDUSU-JXMROGBWSA-N","BRD-K52598503","","NC\C(CCc1ccc(F)cc1)=C\F"
"3206","MOGUISTEINE","ATP-sensitive potassium channel inhibitor","","","","Selleck",97.02,"BRD-A87673115-001-04-1","Phase 2","","WSYVIAQNTFPTBI-UHFFFAOYSA-N","BRD-A87673115","","CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC"
"3207","MOLIDUSTAT","hypoxia inducible factor inhibitor","EGLN2","","","MedChemEx, MedChemEx",90.41,"BRD-K01291782-001-02-9, BRD-K01291782-001-01-1","Phase 2","","IJMBOKOTALXLKS-UHFFFAOYSA-N","BRD-K01291782","","O=c1c(c[nH]n1-c1cc(ncn1)N1CCOCC1)-n1ccnn1"
"3209","MONASTROL","kinesin inhibitor","KIF11","","","Tocris, Tocris",97.94,"BRD-A78377521-001-06-3, BRD-A78377521-001-05-5","Preclinical","","LOBCDGHHHHGHFA-UHFFFAOYSA-N","BRD-A78377521","","CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1"
"3211","MONENSIN","bacterial permeability inducer","","","","Selleck, MicroSource, Selleck",83.47,"BRD-A06627858-236-01-4, BRD-A06627858-236-03-0, BRD-A06627858-236-02-2","Launched","BRD-A61543962-236-02-6, BRD-A09919099-236-01-1, BRD-A43972623-236-01-3","GAOZTHIDHYLHMS-SMJJDZSHSA-N","BRD-A06627858","BRD-A61543962","CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C"
"3214","MONOSODIUM-ALPHA-LUMINOL","","","","","Enamine, MedChemEx",97.04,"BRD-K52559566-001-01-1, BRD-K52559566-001-02-9","Launched","","HWYHZTIRURJOHG-UHFFFAOYSA-N","BRD-K52559566","","Nc1cccc2c1c(=O)[nH][nH]c2=O"
"3216","MONOSTEARIN","","","","","TCI",92.85,"BRD-A31454688-001-01-6","Preclinical","","VBICKXHEKHSIBG-UHFFFAOYSA-N","BRD-A31454688","","CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO"
"3217","MORIN","cytochrome P450 inhibitor","ADORA2A, ESR2, FASN, MCL1, SLC22A12","","","Selleck, Selleck",100,"BRD-K11590034-002-02-6, BRD-K11590034-002-03-4","Preclinical","","YXOLAZRVSSWPPT-UHFFFAOYSA-N","BRD-K11590034","","Oc1ccc(c(O)c1)-c1oc2cc(O)cc(O)c2c(=O)c1O"
"3219","MORINIDAZOLE","other antibiotic","CYP51A1","","","MedChemEx",85.47,"BRD-A40546373-001-01-8","Launched","","GAZGHCHCYRSPIV-UHFFFAOYSA-N","BRD-A40546373","","Cc1ncc(n1CC(O)CN1CCOCC1)[N+]([O-])=O"
"3220","MOTESANIB","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT1, FLT4, KDR, KIT","","","Selleck, MedChemEx, MedChemEx, Selleck, MedChemEx",95.52,"BRD-K99616396-316-05-3, BRD-K99616396-001-06-9, BRD-K99616396-001-05-1, BRD-K99616396-316-04-6, BRD-K99616396-316-06-1","Phase 3","","RAHBGWKEPAQNFF-UHFFFAOYSA-N","BRD-K99616396","","CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12"
"3225","MOTOLIMOD","toll-like receptor agonist","TLR8","","","MedChemEx",87.75,"BRD-K11785681-001-01-2","Phase 1/Phase 2","","QSPOQCXMGPDIHI-UHFFFAOYSA-N","BRD-K11785681","","CCCN(CCC)C(=O)C1=Cc2ccc(cc2N=C(N)C1)-c1ccc(cc1)C(=O)N1CCCC1"
"3226","MOXISYLYTE","adrenergic receptor antagonist","","","","MicroSource",95.95,"BRD-K81144366-003-19-7","Withdrawn","","VRYMTAVOXVTQEF-UHFFFAOYSA-N","BRD-K81144366","","CC(C)c1cc(OC(C)=O)c(C)cc1OCCN(C)C"
"3227","MPEP","glutamate receptor antagonist","GRM1, GRM4, GRM5","","","Tocris, Selleck, Tocris",97.59,"BRD-K60690191-003-11-2, BRD-K60690191-001-03-3, BRD-K60690191-003-09-6","Preclinical","","NEWKHUASLBMWRE-UHFFFAOYSA-N","BRD-K60690191","","Cc1cccc(n1)C#Cc1ccccc1"
"3230","MPI-0479605","mitotic kinase inhibitor","TTK","","","MedChemEx, Selleck, MedChemEx, Selleck",94.28,"BRD-K45551181-001-03-9, BRD-K45551181-001-01-3, BRD-K45551181-001-04-7, BRD-K45551181-001-02-1","Preclinical","","OVJBNYKNHXJGSA-UHFFFAOYSA-N","BRD-K45551181","","Cc1cc(ccc1Nc1nc(NC2CCCCC2)c2[nH]cnc2n1)N1CCOCC1"
"3234","MPS-BAY-2A","monopolar spindle 1 kinase inhibitor","TTK","","","Tocris",94.23,"BRD-K18530250-001-01-6","Preclinical","","MDYKTGNHXNTATG-UHFFFAOYSA-N","BRD-K18530250","","CC(C)CNc1nc(cn2c(cnc12)-c1ccc(cc1)C(=O)NC1CC1)-c1cccc2ncccc12"
"3235","MPS1-IN-1","monopolar spindle 1 kinase inhibitor","TTK","","","Tocris",85.19,"BRD-K94853001-300-01-7","Preclinical","","NMJMRSQTDLRCRQ-UHFFFAOYSA-N","BRD-K94853001","","COc1cc(ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1)N1CCC(O)CC1"
"3236","MPS1-IN-5","protein kinase inhibitor","","","","MedChemEx",94.51,"BRD-K43812936-001-01-9","Preclinical","","NRJKIOCCERLIDG-GOSISDBHSA-N","BRD-K43812936","","COc1cc(ccc1Nc1nc2ccc(cn2n1)-c1ccc(NC(=O)[C@H](C)c2ccc(F)cc2)cc1)S(C)(=O)=O"
"3237","MR-16728","acetylcholine release enhancer","","","","Tocris",93.83,"BRD-A30590053-003-02-9","Preclinical","","AGKAAJMNNVUNDK-UHFFFAOYSA-N","BRD-A30590053","","O=C(NCCCN1CCCCCC1)C(C1CCCCC1)c1ccccc1"
"3238","MR-948","thromboxane synthase inhibitor","TBXAS1","","","Enamine",98.9,"BRD-K84883208-001-01-1","Phase 1","","LQQIZTXSZOYPPS-UHFFFAOYSA-N","BRD-K84883208","","OCCc1ccc(OCCn2ccnc2)cc1"
"3239","MRK-016","GABA receptor inverse agonist","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris, Tocris",98.16,"BRD-K44022883-001-01-7, BRD-K44022883-001-02-5","Phase 1","","QYSYOGCIDRANAR-UHFFFAOYSA-N","BRD-K44022883","","Cc1cc(no1)-c1nncc2c(c(OCc3ncnn3C)nn12)C(C)(C)C"
"3241","MRK-409","benzodiazepine receptor agonist","","","","Tocris, Sigma",99.45,"BRD-K57416838-001-02-9, BRD-K57416838-001-01-1","Phase 1","","GOIFCXRIFSYPFG-UHFFFAOYSA-N","BRD-K57416838","","Cn1ncnc1COc1nn2c(nnc2cc1C1CCC1)-c1c(F)cccc1F"
"3243","MRK-560","gamma secretase inhibitor","APP","","","Tocris",90.05,"BRD-K68795758-001-01-1","Preclinical","","WDZVWDXOIGQJIO-UJKQEGAGSA-N","BRD-K68795758","","Fc1ccc(F)c(c1)[C@]1(CC[C@@H](CC1)NS(=O)(=O)C(F)(F)F)S(=O)(=O)c1ccc(Cl)cc1"
"3244","MRS-1220","adenosine receptor antagonist","ADORA2B, ADORA3","","","Tocris, Tocris",92.13,"BRD-K37618799-001-04-8, BRD-K37618799-001-03-0","Preclinical","","TWWFAXQOKNBUCR-UHFFFAOYSA-N","BRD-K37618799","","Clc1ccc2nc(NC(=O)Cc3ccccc3)n3nc(nc3c2c1)-c1ccco1"
"3246","MRS-3777","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",96.4,"BRD-M86143595-034-03-4","Preclinical","","ZYVKEIQGOGHCFB-UHFFFAOYSA-N","BRD-M86143595","","C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12.C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12"
"3247","MRS1334","adenosine receptor antagonist","ADORA3","","","Tocris",83.79,"BRD-A06784547-001-02-6","Preclinical","","QFLOJAMZLQXHFS-UHFFFAOYSA-N","BRD-A06784547","","CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C1C#Cc1ccccc1)C(=O)OCc1ccc(cc1)[N+]([O-])=O"
"3248","MRS1845","calcium channel blocker","","","","Tocris",95.21,"BRD-A78093359-001-06-3","Preclinical","","BITHABUTZRAUGT-UHFFFAOYSA-N","BRD-A78093359","","CCOC(=O)C1=C(C)N(CC#C)C(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC"
"3249","MRS2578","purinergic receptor antagonist","P2RY6","","","Selleck, Selleck",21.98,"BRD-K91135178-001-03-9, BRD-K91135178-001-02-1","Preclinical","","QOHNRGHTJPFMSL-UHFFFAOYSA-N","BRD-K91135178","","S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S)c1"
"3251","MRS3777","adenosine receptor antagonist","ADORA2A","","","Tocris",97.24,"BRD-K10575656-034-01-0","Preclinical","BRD-M86143595-034-02-6","OGCQBCHLFMBCCE-UHFFFAOYSA-N","BRD-K10575656","BRD-M86143595","C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12"
"3252","MSX-122","CC chemokine receptor antagonist","CXCR4","","","MedChemEx",93.92,"BRD-K25143390-001-01-0","Phase 1","","PXZXYRKDDXKDTK-UHFFFAOYSA-N","BRD-K25143390","","C(Nc1ncccn1)c1ccc(CNc2ncccn2)cc1"
"3253","MTPG","glutamate receptor antagonist","GRM2, GRM3","","","Tocris",93.8,"BRD-A28329383-001-02-1","Preclinical","","OZBFBAYESADVDX-UHFFFAOYSA-N","BRD-A28329383","","CC(N)(C(O)=O)c1ccc(cc1)-c1nnn[nH]1"
"3254","MUBRITINIB","protein tyrosine kinase inhibitor","EGFR, ERBB2","","","Tocris, Tocris, Selleck",96.61,"BRD-K19061412-001-03-2, BRD-K19061412-001-04-0, BRD-K19061412-001-02-4","Phase 1","","ZTFBIUXIQYRUNT-MDWZMJQESA-N","BRD-K19061412","","FC(F)(F)c1ccc(\C=C\c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1"
"3257","MUSCIMOL","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3","","","Tocris",97.75,"BRD-K60441002-001-04-8","Phase 1","","ZJQHPWUVQPJPQT-UHFFFAOYSA-N","BRD-K60441002","","NCc1cc(O)no1"
"3258","MUT056399","FABI inhibitor","","","","MedChemEx",93.76,"BRD-K72078047-001-01-7","Phase 1","","QUHARGDBJJUOEB-UHFFFAOYSA-N","BRD-K72078047","","CCc1cc(O)c(Oc2ccc(cc2F)C(N)=O)cc1F"
"3259","MY-5445","phosphodiesterase inhibitor, platelet aggregation inhibitor","PDE5A","","","Tocris, Tocris",99.38,"BRD-K90524085-001-08-6, BRD-K90524085-001-07-8","Preclinical","","CEHQLKSLMFIHBF-UHFFFAOYSA-N","BRD-K90524085","","Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1"
"3261","MYRICETIN","androgen receptor agonist, cytochrome P450 inhibitor","PIK3CG","","","Selleck, Selleck",94.44,"BRD-K43149758-001-22-7, BRD-K43149758-001-23-5","Preclinical","","IKMDFBPHZNJCSN-UHFFFAOYSA-N","BRD-K43149758","","Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O"
"3263","MYRICITRIN","PKC inhibitor","NOS1, PRKCA","","","Selleck",94.75,"BRD-K29834313-001-01-4","Preclinical","","DCYOADKBABEMIQ-FLCVNNLFSA-N","BRD-K29834313","","C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1O"
"3264","MYRISTYL-NICOTINATE","topical sunscreen agent","","","","Accela",0,"BRD-K88153212-001-01-9","Phase 1","","TVGLGJWCZSCAEM-UHFFFAOYSA-N","BRD-K88153212","","CCCCCCCCCCCCCCOC(=O)c1cccnc1"
"3265","M8-B","transient receptor potential channel antagonist","TRPM8","","","Tocris",93.81,"BRD-K90410034-003-01-1","Preclinical","","UOGGWHBYFVBUIY-UHFFFAOYSA-N","BRD-K90410034","","COc1cc(CN(CCN)C(=O)c2cccs2)ccc1OCc1ccccc1"
"3266","N-(2-CHLOROPHENYL)-2-({(2E)-2-[1-(2-PYRIDINYL)ETHYLIDENE]HYDRAZINO}CARBOTHIOYL)HYDRAZINECARBOTHIOAMIDE","","","","","Key",20.21,"BRD-K57027742-001-01-1","Preclinical","","AHKBRSQVOSQELW-UHFFFAOYSA-N","BRD-K57027742","","Clc1ccccc1NC(=S)NNC(=S)NNC(=C)c1ccccn1"
"3267","N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE","sigma receptor ligand","","","","Tocris",98.14,"BRD-K78844995-001-02-6","Preclinical","","WCMWVYQHPUQKHW-UHFFFAOYSA-N","BRD-K78844995","","Ic1ccc(cc1)C(=O)NCCN1CCCCC1"
"3268","N-ACETYL-D-GLUCOSAMINE","","B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP","","","Vitas-M",100,"BRD-K80653534-001-01-7","Phase 2/Phase 3","","MBLBDJOUHNCFQT-LXGUWJNJSA-N","BRD-K80653534","","CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO"
"3269","N-ACETYL-TYROSINE","","","","","Enamine",96.39,"BRD-A24857382-001-03-4","Launched","","CAHKINHBCWCHCF-UHFFFAOYSA-N","BRD-A24857382","","CC(=O)NC(Cc1ccc(O)cc1)C(O)=O"
"3270","N-ACETYLCARNOSINE","","","","","AKSci",100,"BRD-K52523550-001-01-5","Phase 2","","BKAYIFDRRZZKNF-VIFPVBQESA-N","BRD-K52523550","","CC(=O)NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O"
"3271","N-ACETYLGLYCYL-D-GLUTAMIC-ACID","glutamate receptor agonist","","","","Tocris, Tocris",100,"BRD-K28121004-001-02-9, BRD-K28121004-001-01-1","Preclinical","","CQTYJLQESPLSOP-ZCFIWIBFSA-N","BRD-K28121004","","CC(=O)NCC(=O)N[C@H](CCC(O)=O)C(O)=O"
"3273","N-ACETYLMANNOSAMINE","","CHIT1","","","Vitas-M",100,"BRD-A92872453-001-01-8","Phase 1","","OVRNDRQMDRJTHS-PNALHPDYSA-N","BRD-A92872453","","CC(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O"
"3274","N-ACETYLTRYPTAMINE","melatonin receptor agonist","","","","Tocris, Tocris",98.63,"BRD-K73700643-001-13-8, BRD-K73700643-001-11-2","Preclinical","","NVUGEQAEQJTCIX-UHFFFAOYSA-N","BRD-K73700643","","CC(=O)NCCc1c[nH]c2ccccc12"
"3276","N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE","histamine receptor agonist","HRH4","","","Tocris",100,"BRD-K64422603-300-02-7","Phase 3","","PHSPJQZRQAJPPF-UHFFFAOYSA-N","BRD-K64422603","","CNCCc1cnc[nH]1"
"3277","N-BENZYLNALTRINDOLE","opioid receptor antagonist","","","","Tocris",92.01,"BRD-A33514596-003-01-2","Preclinical","","PSPANKCQVWSVHM-OSLYBJCVSA-N","BRD-A33514596","","Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1c(C[C@@]35O)c2ccccc2n1Cc1ccccc1"
"3278","N-CYANOPYRROLIDINE","","CTSK","","","Maybridge",0,"BRD-K90042229-001-01-1","Preclinical","","QJRYYOWARFCJQZ-UHFFFAOYSA-N","BRD-K90042229","","N#CN1CCCC1"
"3279","N-DEMETHYLANTIPYRINE","","","","","Sigma",26.35,"BRD-K84517077-001-01-3","Preclinical","","KZQYIMCESJLPQH-UHFFFAOYSA-N","BRD-K84517077","","Cc1cc(=O)n([nH]1)-c1ccccc1"
"3280","N-HYDROXYNICOTINAMIDE","","","","","Sigma",96.8,"BRD-K28030264-001-02-7","Preclinical","","IYCHDNQCHLMLJZ-UHFFFAOYSA-N","BRD-K28030264","","ONC(=O)c1cccnc1"
"3281","N-METHYL-(-)EPHEDRINE-[1R,2S]","","","","","MicroSource",82.42,"BRD-K82236108-001-04-9","Preclinical","","FMCGSUUBYTWNDP-ONGXEEELSA-N","BRD-K82236108","","C[C@@H]([C@H](O)c1ccccc1)N(C)C"
"3282","N-METHYLFORMAMIDE","","","","","Sigma",0,"BRD-K33445938-001-01-8","Phase 2","","ATHHXGZTWNVVOU-UHFFFAOYSA-N","BRD-K33445938","","CNC=O"
"3283","N-METHYLLIDOCAINE-IODIDE","antiarrhythmic medication","","","","Tocris",98.14,"BRD-K60060639-005-02-2","Preclinical","","HFRFLLYLVAKRMZ-UHFFFAOYSA-O","BRD-K60060639","","CC[N+](C)(CC)CC(=O)Nc1c(C)cccc1C"
"3284","N-METHYLPYRROLIDONE","","","","","Sigma",0,"BRD-K52732207-001-01-9","Phase 1","","SECXISVLQFMRJM-UHFFFAOYSA-N","BRD-K52732207","","CN1CCCC1=O"
"3285","N-METHYLQUIPAZINE","serotonin receptor agonist","HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4","","","Tocris",98.26,"BRD-K62056274-332-01-8","Preclinical","","HOMWNUXPSJQSSU-UHFFFAOYSA-N","BRD-K62056274","","CN1CCN(CC1)c1ccc2ccccc2n1"
"3286","N-MPPP","opioid receptor agonist","","","","Tocris",97.35,"BRD-K93806173-003-01-8","Preclinical","","OVZWUDZIAAHNFG-HXUWFJFHSA-N","BRD-K93806173","","CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccccc1"
"3287","N-OXYDIETHYLENEBENZOTHIAZOLE-2-SULFENAMIDE","","","","","Enamine",3.71,"BRD-K97360717-001-09-2","Preclinical","","MHKLKWCYGIBEQF-UHFFFAOYSA-N","BRD-K97360717","","C1CN(CCO1)Sc1nc2ccccc2s1"
"3288","N-SALICOYLAMINOPHENOL","ribonucleotide reductase inhibitor","","","","CombiBlocks",99.07,"BRD-K39693230-001-01-2","Preclinical","","LGCMKPRGGJRYGM-UHFFFAOYSA-N","BRD-K39693230","","Oc1ccc(NC(=O)c2ccccc2O)cc1"
"3289","NAB-2","ubiquitin ligase transport promoter","NEDD4","","","Tocris",97.08,"BRD-K36804890-001-01-9","Preclinical","","CZSLEMCYYGEGKP-UHFFFAOYSA-N","BRD-K36804890","","Cc1ccc(C)c(c1)-n1cnc2cc(ccc12)C(=O)NCc1ccccc1Cl"
"3290","NADIDE","electron acceptor","AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2","","","MicroSource",86.18,"BRD-A11132253-001-08-2","Launched","","BAWFJGJZGIEFAR-NNYOXOHSSA-O","BRD-A11132253","","NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"
"3291","NADPH","","AASS, DPYD, GHSR, TXNRD1","","","MedChemEx, MedChemEx",70,"BRD-M06409173-001-02-7, BRD-M06409173-001-01-9","Preclinical","","PTKRUDMLGIIORX-ITGWJZMWSA-N","BRD-M06409173","","NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"
"3293","NAFADOTRIDE","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Tocris",86.99,"BRD-A71262238-001-08-4","Preclinical","","IDZASIQMRGPBCQ-UHFFFAOYSA-N","BRD-A71262238","","CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC"
"3294","NAFAMOSTAT","serine protease inhibitor","ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7","","","Selleck, Tocris, Selleck",89.75,"BRD-K06674495-334-04-0, BRD-K06674495-334-05-7, BRD-K06674495-334-03-2","Launched","","MQQNFDZXWVTQEH-UHFFFAOYSA-N","BRD-K06674495","","NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N"
"3297","NALOXONE-BENZOYLHYDRAZONE","opioid receptor antagonist","OPRK1, OPRM1","","","Tocris, Tocris, Tocris",80.29,"BRD-K70898774-001-05-0, BRD-K70898774-001-04-3, BRD-K70898774-001-03-5","Preclinical","BRD-K58239851-001-01-8","AKXCFAYOTIEFOH-XTNAHFASSA-N","BRD-K70898774","BRD-K58239851","Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)\C(CC[C@@]35O)=N\NC(=O)c1ccccc1"
"3300","NALTRIBEN","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","","","Tocris, Tocris",94.38,"BRD-A19102171-066-02-2, BRD-A19102171-066-01-4","Preclinical","","ZHVWWEYETMPAMX-OOGIKFLQSA-N","BRD-A19102171","","Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1oc2ccccc2c1C[C@@]35O"
"3302","NALTRINDOLE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","","","Tocris, Tocris",97.6,"BRD-A47342814-003-02-6, BRD-A47342814-003-01-8","Preclinical","","WIYUZYBFCWCCQJ-OOGIKFLQSA-N","BRD-A47342814","","Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2ccccc2c1C[C@@]35O"
"3304","NAMPT-IN-1","","","","","MedChemEx",97.45,"BRD-K18280217-001-01-0","Preclinical","","QHHSCLARESIWBH-UHFFFAOYSA-N","BRD-K18280217","","CC(C)(O)CS(=O)(=O)Nc1ccc2CN(CCc2c1)C(=O)COc1cccnc1"
"3305","NAN-190","serotonin receptor agonist","ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F","","","Tocris",91.6,"BRD-K69195780-004-08-4","Preclinical","","SJDOMIRMMUGQQK-UHFFFAOYSA-N","BRD-K69195780","","COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1"
"3306","NANCHANGMYCIN","other antibiotic","","","","Selleck",98.79,"BRD-A73871920-236-03-6","Preclinical","BRD-A68478444-236-01-8","FELYAZAWTURXNF-CDKYLCCUSA-N","BRD-A73871920","BRD-A68478444","CO[C@H]1CCC(O[C@H]2CC(O[C@]3(O[C@H](C[C@@H]3C)C3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)[C@@H]2C)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C(O)=O)O2)O[C@@H]1C"
"3307","NANDROLONE-DECANOATE","androgenic steroid","AR","","","MedChemEx, MedChemEx",89,"BRD-K78352627-001-02-6, BRD-K78352627-001-01-8","Phase 1","","JKWKMORAXJQQSR-MOPIKTETSA-N","BRD-K78352627","","CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C"
"3309","NAPABUCASIN","STAT inhibitor","STAT3","","","MedChemEx, Tocris",89.62,"BRD-K22064724-001-01-8, BRD-K22064724-001-02-6","Phase 3","","DPHUWDIXHNQOSY-UHFFFAOYSA-N","BRD-K22064724","","CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O"
"3311","NAPHTHOQUINE-PHOSPHATE","antimalarial agent","","","","MedChemEx, MedChemEx, MedChemEx",79.04,"BRD-K13664493-316-02-5, BRD-K13664493-316-01-7, BRD-K13664493-316-03-3","Launched","","VEVMYTDOWUQLGI-UHFFFAOYSA-N","BRD-K13664493","","CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O"
"3314","NAPIRIMUS","immunosuppressant","","","","Enamine",98.99,"BRD-K91234829-001-01-7","Phase 1","","CNUPQURTHORUGH-UHFFFAOYSA-N","BRD-K91234829","","Cn1cc(cc1C(O)=O)C(=O)c1cccc2ccccc12"
"3315","NARINGENIN","aromatase inhibitor, TRPV antagonist","CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1","","","Selleck",96.02,"BRD-K08832567-001-11-5","Phase 1","","FTVWIRXFELQLPI-ZDUSSCGKSA-N","BRD-K08832567","","Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1"
"3316","NARINGENINIC-ACID","","HCAR2, PTGR1","","","Vitas-M, Sigma",97.59,"BRD-K87122641-001-08-1, BRD-K87122641-001-10-7","Phase 1","","NGSWKAQJJWESNS-ZZXKWVIFSA-N","BRD-K87122641","","OC(=O)\C=C\c1ccc(O)cc1"
"3318","NARINGIN","cytochrome P450 inhibitor","SLCO1A2","","","Selleck",92.64,"BRD-K02953697-001-09-2","Preclinical","BRD-K80718324-001-01-2","DFPMSGMNTNDNHN-ZPHOTFPESA-N","BRD-K02953697","BRD-K80718324","C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c3C(=O)C[C@H](Oc3c2)c2ccc(O)cc2)[C@H](O)[C@H](O)[C@H]1O"
"3319","NARINGIN-DIHYDROCHALCONE","cytochrome P450 inhibitor","","","","Selleck",91.24,"BRD-K13511380-001-01-4","Preclinical","","CWBZAESOUBENAP-WMKOAESCSA-N","BRD-K13511380","","C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c(C(=O)CCc3ccc(O)cc3)c(O)c2)[C@H](O)[C@H](O)[C@H]1O"
"3320","NARLAPREVIR","HCV inhibitor","","","","MedChemEx",95.2,"BRD-K38287497-001-01-2","Phase 2/Phase 3","","RICZEKWVNZFTNZ-LFGITCQGSA-N","BRD-K38287497","","CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1"
"3321","NASTORAZEPIDE","CCK receptor antagonist","CCKBR","","","MedChemEx",97.38,"BRD-K17295893-001-01-0","Phase 2","","VIJCCFFEBCOOIE-JOCHJYFZSA-N","BRD-K17295893","","CC(C)(C)C(=O)CN1c2ccccc2N(C[C@@H](NC(=O)Nc2cccc(c2)C(O)=O)C1=O)C1CCCCC1"
"3322","NAV-26","voltage-gated sodium channel blocker","SCN9A","","","Tocris",97.97,"BRD-A84202322-001-01-7","Preclinical","","ICGMZCVSHDKQTE-UHFFFAOYSA-N","BRD-A84202322","","FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCOCC3)C(=O)c3ccccc23)cc1"
"3323","NAVARIXIN","CC chemokine receptor antagonist","CXCR1, CXCR2","","","MedChemEx",93.85,"BRD-K82850175-001-01-1","Phase 2","","RXIUEIPPLAFSDF-CYBMUJFWSA-N","BRD-K82850175","","CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1"
"3324","NAVITOCLAX","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Selleck, Selleck",94.7,"BRD-K82746043-001-19-3, BRD-K82746043-001-15-1","Phase 2","","JLYAXFNOILIKPP-KXQOOQHDSA-N","BRD-K82746043","","CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1"
"3326","NBI-27914","corticosteroid releasing factor receptor antagonist","CRHR1","","","Tocris, Tocris",97.59,"BRD-K61177364-003-03-7, BRD-K61177364-003-02-9","Preclinical","","KNADXBVKFAUMCR-UHFFFAOYSA-N","BRD-K61177364","","CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl"
"3328","NBI-74330-(+/-)","CC chemokine receptor antagonist","CXCR3","","","Tocris",98.26,"BRD-A86523169-001-01-0","Preclinical","","XMRGQUDUVGRCBS-UHFFFAOYSA-N","BRD-A86523169","","CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)C(C)N(Cc1cccnc1)C(=O)Cc1ccc(F)c(c1)C(F)(F)F"
"3329","NBQX","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B","","","Tocris, Tocris, Tocris",98.85,"BRD-K11796549-001-05-2, BRD-K11796549-304-01-9, BRD-K11796549-001-04-5","Preclinical","","UQNAFPHGVPVTAL-UHFFFAOYSA-N","BRD-K11796549","","NS(=O)(=O)c1cccc2c1c(cc1[nH]c(=O)c(=O)[nH]c21)[N+]([O-])=O"
"3332","NCS-382","GABA receptor antagonist","GABBR1, GABBR2, SLC52A2","","","Tocris",97.2,"BRD-A85025557-001-02-5","Preclinical","","UADPGHINQMWEAG-CSKARUKUSA-N","BRD-A85025557","","OC1c2ccccc2CCC\C1=C/C(O)=O"
"3333","NDT-9513727","complement antagonist","C5AR1","","","Tocris",91.92,"BRD-K17539220-001-01-5","Preclinical","","ITACCRHKSPSKKL-UHFFFAOYSA-N","BRD-K17539220","","CCCCn1c(CN(Cc2ccc3OCOc3c2)Cc2ccc3OCOc3c2)c(nc1-c1ccccc1)-c1ccccc1"
"3334","NE-100","sigma receptor antagonist","SIGMAR1","","","Tocris, Tocris",92.52,"BRD-K11443721-003-01-6, BRD-K11443721-003-02-4","Phase 2","","YBLIQJGXRLZBCZ-UHFFFAOYSA-N","BRD-K11443721","","CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1"
"3336","NEBRACETAM","acetylcholine receptor agonist","CHRM1","","","Enamine",98.57,"BRD-A51355958-003-01-9","Phase 3","","LCAFGJGYCUMTGS-UHFFFAOYSA-N","BRD-A51355958","","NCC1CN(Cc2ccccc2)C(=O)C1"
"3337","NECA","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1","","","Tocris, Tocris",98.69,"BRD-K14395568-001-17-1, BRD-K14395568-001-16-3","Launched","","JADDQZYHOWSFJD-FLNNQWSLSA-N","BRD-K14395568","","CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12"
"3339","NECROSTATIN-1","RIPK inhibitor","RIPK1","","","Tocris, Tocris, Selleck, Selleck",94.54,"BRD-A36318220-001-09-6, BRD-A36318220-001-12-0, BRD-A36318220-001-08-8, BRD-A36318220-001-11-2","Preclinical","","TXUWMXQFNYDOEZ-UHFFFAOYSA-N","BRD-A36318220","","CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O"
"3343","NECROSTATIN-2","necroptosis inhibitor, RIPK inhibitor","RIPK2","","","MedChemEx",98.11,"BRD-K68851986-001-01-6","Preclinical","","WIKGAEMMNQTUGL-SNVBAGLBSA-N","BRD-K68851986","","CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O"
"3344","NEDAPLATIN","DNA inhibitor","","","","MedChemEx, MedChemEx",0,"BRD-K38820178-001-01-6, BRD-K73469236-001-01-8","Launched","BRD-U66818247-000-01-2, BRD-K34751753-318-01-8,BRD-U48121946-000-01-8","DVUJFSXMTBOIKW-UHFFFAOYSA-M","BRD-K38820178","BRD-U66818247","N[Pt++]1(N)OCC(=O)O1"
"3345","NEDAPLATIN","DNA inhibitor","","","","MedChemEx, MedChemEx",0,"BRD-K38820178-001-01-6, BRD-K73469236-001-01-8","Launched","BRD-U66818247-000-01-2, BRD-K34751753-318-01-8,BRD-U48121946-000-01-8","DVUJFSXMTBOIKW-UHFFFAOYSA-M","BRD-K38820178","BRD-U66818247","N[Pt]1(N)OCC(=O)O1"
"3346","NEDAPLATIN","DNA inhibitor","","","","MedChemEx, MedChemEx",0,"BRD-K38820178-001-01-6, BRD-K73469236-001-01-8","Launched","BRD-U66818247-000-01-2, BRD-K34751753-318-01-8,BRD-U48121946-000-01-8","GRHLMSBCOPRFNA-UHFFFAOYSA-M","BRD-K38820178","BRD-U66818247","N[Pt++]1(N)OCC(=O)O1"
"3347","NEDAPLATIN","DNA inhibitor","","","","MedChemEx, MedChemEx",0,"BRD-K38820178-001-01-6, BRD-K73469236-001-01-8","Launched","BRD-U66818247-000-01-2, BRD-K34751753-318-01-8,BRD-U48121946-000-01-8","GRHLMSBCOPRFNA-UHFFFAOYSA-M","BRD-K38820178","BRD-U66818247","N[Pt]1(N)OCC(=O)O1"
"3348","NEFAZODONE","adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4","","","Tocris, MicroSource",97.09,"BRD-K90789829-003-12-4, BRD-K90789829-001-07-8","Withdrawn","","VRBKIVRKKCLPHA-UHFFFAOYSA-N","BRD-K90789829","","CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1"
"3350","NEFIRACETAM","acetylcholine receptor agonist, benzodiazepine receptor agonist","CHRM1","","","Tocris, MicroSource, Selleck",99.27,"BRD-K65678996-001-09-7, BRD-K65678996-001-05-5, BRD-K65678996-001-04-8","Phase 3","","NGHTXZCKLWZPGK-UHFFFAOYSA-N","BRD-K65678996","","Cc1cccc(C)c1NC(=O)CN1CCCC1=O"
"3353","NEMORUBICIN","topoisomerase inhibitor","TOP1, TOP2A","","","MedChemEx",90.61,"BRD-K51911221-001-01-2","Phase 2","","CTMCWCONSULRHO-UHQPFXKFSA-N","BRD-K51911221","","CO[C@@H]1CN(CCO1)[C@H]1C[C@H](O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5cccc(OC)c5C(=O)c4c(O)c23)C(=O)CO)O[C@@H](C)[C@H]1O"
"3354","NEO-GILURYTMAL","","","","","InterBioScreen",83.33,"BRD-A53539450-004-01-7","Launched","","UAUHEPXILIZYCU-CQSZUQOFSA-N","BRD-A53539450","","CCC[N+]12[C@H]3C[C@]45C(O)C3[C@@H](CC1[C@@H]4N(C)c1ccccc51)[C@H](CC)[C@H]2O"
"3355","NEOHESPERIDIN","","","","","Selleck",95.17,"BRD-K96299080-001-02-7","Preclinical","BRD-K49617926-001-01-8","TWAZWVPPDIUVOD-UZRWAPQLSA-N","BRD-K96299080","BRD-K49617926","COc1cc(O)cc(c1)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O1"
"3356","NEOHESPERIDIN-DIHYDROCHALCONE","","","","","Selleck",94.52,"BRD-K61032563-001-02-9","Preclinical","BRD-K33395461-001-01-0","ITVGXXMINPYUHD-CUVHLRMHSA-N","BRD-K61032563","BRD-K33395461","COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O)cc1O"
"3357","NEPICASTAT","dopamine beta hydroxylase inhibitor","DBH","","","MedChemEx, Sigma, MedChemEx",91.33,"BRD-K09126848-003-03-5, BRD-K09126848-003-02-7, BRD-K09126848-003-01-9","Phase 2","","YZZVIKDAOTXDEB-JTQLQIEISA-N","BRD-K09126848","","NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1"
"3360","NERATINIB","EGFR inhibitor","EGFR, ERBB2, KDR","","","Selleck",90.19,"BRD-K85606544-001-09-1","Phase 3","","JWNPDZNEKVCWMY-VQHVLOKHSA-N","BRD-K85606544","","CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C"
"3361","NERBACADOL","cyclooxygenase inhibitor","","","","Enamine",85.08,"BRD-K43647122-001-01-3","Phase 3","","ZWNGSOLJLMBZFZ-UHFFFAOYSA-N","BRD-K43647122","","Cc1oncc1C(=O)N1CCCCC1"
"3362","NESBUVIR","RNA polymerase inhibitor","","","","MedChemEx",98.31,"BRD-K79989959-001-01-4","Phase 2","","WTDWVLJJJOTABN-UHFFFAOYSA-N","BRD-K79989959","","CNC(=O)c1c(oc2cc(N(CCO)S(C)(=O)=O)c(cc12)C1CC1)-c1ccc(F)cc1"
"3363","NEURODAZINE","neurogenesis of non-pluripotent C2C12 myoblast inducer","","","","Tocris, Tocris",85.65,"BRD-K22631935-001-02-7, BRD-K22631935-001-03-5","Preclinical","","FEEOFPAEDSMOTO-UHFFFAOYSA-N","BRD-K22631935","","COc1ccc(cc1)-c1nc([nH]c1-c1ccc(OC)cc1)-c1ccc(o1)-c1cccc(Cl)c1"
"3365","NEUROPATHIAZOL","neural stem cell inducer","BMP2, LIF","","","Tocris",83.16,"BRD-K28567778-001-02-7","Preclinical","","MGKYEWWFHSESJN-UHFFFAOYSA-N","BRD-K28567778","","CCOC(=O)c1ccc(cc1)N(C)c1csc(n1)-c1ccccc1"
"3366","NEXTURASTAT-A","HDAC inhibitor","HDAC1, HDAC6","","","Selleck",91.37,"BRD-K70402238-001-02-8","Preclinical","","JZWXMCPARMXZQV-UHFFFAOYSA-N","BRD-K70402238","","CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc1ccccc1"
"3367","NFKB-ACTIVATION-INHIBITOR-II","NFkB pathway inhibitor","RELA","","","Selleck, Selleck",76.84,"BRD-K83354763-001-03-7, BRD-K83354763-001-06-0","Preclinical","","YMFNPBSZFWXMAD-UHFFFAOYSA-N","BRD-K83354763","","Cc1ccc(NCCCc2ccccc2)c(N)c1"
"3369","NG-NITRO-ARGININE","nitric oxide synthase inhibitor","NOS1, NOS2, NOS3","","","ChemDiv, Sigma",98.3,"BRD-K89223384-001-04-5, BRD-K89223384-001-05-2","Phase 1","","MRAUNPAHJZDYCK-BYPYZUCNSA-N","BRD-K89223384","","N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O"
"3371","NGB-2904","dopamine receptor antagonist","DRD3","","","Tocris, Tocris",96.62,"BRD-K05181084-003-03-7, BRD-K05181084-003-04-5","Preclinical","","YJPWVCIGSHWNON-UHFFFAOYSA-N","BRD-K05181084","","Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl"
"3373","NGD-94-1","dopamine receptor antagonist","DRD4","","","Tocris",97.29,"BRD-K28639661-001-01-6","Phase 1","","OTVQCHUIPJYASM-UHFFFAOYSA-N","BRD-K28639661","","C(N1CCN(CC1)c1ncccn1)c1cnc([nH]1)-c1ccccc1"
"3374","NGD-98-2","corticosteroid releasing factor receptor antagonist","CRHR1","","","Tocris",69.89,"BRD-K81779590-003-01-6","Preclinical","","PSUFQBRCUSJTDO-UHFFFAOYSA-N","BRD-K81779590","","CCC(CC)Nc1nc(C)c(nc1OC)-c1ccc(OC(F)(F)F)cc1OC"
"3375","NHI-2","lactate dehydrogenase inhibitor","LDHA","","","Tocris",81.23,"BRD-K05653025-001-01-5","Preclinical","","YPPFWRWCZNXINO-UHFFFAOYSA-N","BRD-K05653025","","COC(=O)c1cc2c(cc(cc2n1O)-c1ccccc1)C(F)(F)F"
"3376","NH125","eukaryotic translation elongation factor 2 inhibitor","","","","Tocris, Selleck",97.8,"BRD-K31086665-005-01-2, BRD-K31086665-005-04-6","Preclinical","BRD-K70344361-005-01-4","ZZXUNAFAKNKXFW-UHFFFAOYSA-N","BRD-K31086665","BRD-K70344361","CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C"
"3378","NI-57","bromodomain inhibitor","BRD1, BRPF1, BRPF3","","","Tocris",97.87,"BRD-K03042257-001-01-2","Preclinical","","UEMQPCYDWCSVCU-UHFFFAOYSA-N","BRD-K03042257","","COc1cc(ccc1S(=O)(=O)Nc1ccc2n(C)c(=O)c(C)cc2c1)C#N"
"3379","NIALAMIDE","monoamine oxidase inhibitor","COMT, MAOA, MAOB","","","MicroSource, Selleck",95.02,"BRD-K12102668-001-25-5, BRD-K12102668-001-24-8","Withdrawn","","NOIIUHRQUVNIDD-UHFFFAOYSA-N","BRD-K12102668","","O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1"
"3381","NIBENTAN","potassium channel blocker","","","","Vitas-M",96.69,"BRD-A85876464-001-01-5","Phase 2","","YRFYIORBFFGPPZ-UHFFFAOYSA-N","BRD-A85876464","","CCN(CC)CCCCC(NC(=O)c1ccc(cc1)[N+]([O-])=O)c1ccccc1"
"3382","NICARAVEN","free radical scavenger","","","","Selleck",96.43,"BRD-A86871940-001-01-9","Phase 3","","KTXBOOWDLPUROC-UHFFFAOYSA-N","BRD-A86871940","","CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1"
"3383","NICOTINYL-ALCOHOL-TARTRATE","","","","","MicroSource",88.02,"BRD-K76600340-045-04-9","Launched","","MVQVNTPHUGQQHK-UHFFFAOYSA-N","BRD-K76600340","","OCc1cccnc1"
"3384","NIDA-41020","cannabinoid receptor antagonist","CNR1","","","Tocris",97.58,"BRD-K17617556-001-01-3","Preclinical","","KWDBQJRWPWTGPF-UHFFFAOYSA-N","BRD-K17617556","","COc1ccc(cc1)-c1c(C)c(nn1-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1"
"3385","NIFENALOL","adrenergic receptor antagonist","ADRB1, ADRB2","","","Enamine",87.38,"BRD-A21280314-001-06-8","Launched","","UAORFCGRZIGNCI-UHFFFAOYSA-N","BRD-A21280314","","CC(C)NCC(O)c1ccc(cc1)[N+]([O-])=O"
"3386","NIFURSOL","bacterial DNA inhibitor","","","","MicroSource",96.23,"BRD-K85757157-001-01-7","Launched","","XXUXXCZCUGIGPP-WLRTZDKTSA-N","BRD-K85757157","","Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O"
"3387","NIGULDIPINE-(S)-(+)","adrenergic receptor antagonist","ADRA1A","","","Tocris, Tocris",94.55,"BRD-K59333713-003-03-8, BRD-K59333713-003-02-0","Preclinical","","SVJMLYUFVDMUHP-XIFFEERXSA-N","BRD-K59333713","","COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1"
"3389","NIKETHAMIDE","immunostimulant","","","","MicroSource",96.18,"BRD-K91544578-001-03-8","Withdrawn","","NCYVXEGFNDZQCU-UHFFFAOYSA-N","BRD-K91544578","","CCN(CC)C(=O)c1cccnc1"
"3390","NIMUSTINE","DNA alkylating agent","","","","MicroSource, Sigma",37.86,"BRD-K13240081-001-06-1, BRD-K13240081-003-06-7","Launched","","VFEDRRNHLBGPNN-UHFFFAOYSA-N","BRD-K13240081","","Cc1ncc(CNC(=O)N(CCCl)[N+][O-])c(N)n1"
"3392","NISIN","bacterial cell wall synthesis inhibitor","","","","Cayman",0,"BRD-A41063939-001-01-0","Phase 1","BRD-U59029435-000-01-7","NVNLLIYOARQCIX-GSJOZIGCSA-N","BRD-A41063939","BRD-U59029435","CCC(C)C(N)C(=O)N\C(=C/C)C(=O)NC1CSCC(NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(NC1=O)C(C)CC)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C2CCCN2C1=O)C(=O)NC(CCCCN)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC1=O)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC1C(C)SCC2NC(=O)C(NC(=O)C(C)NC1=O)C(C)SCC(NC(=O)C(Cc1c[nH]cn1)NC2=O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O"
"3393","NISOXETINE","norepinephrine reuptake inhibitor","SLC6A2, SLC6A3, SLC6A4","","","Tocris",98.12,"BRD-A95696066-003-13-8","Phase 1","","ITJNARMNRKSWTA-UHFFFAOYSA-N","BRD-A95696066","","CNCCC(Oc1ccccc1OC)c1ccccc1"
"3394","NITECAPONE","catechol O methyltransferase inhibitor","COMT","","","Cayman",31.32,"BRD-K75551531-001-01-3","Phase 2","","UPMRZALMHVUCIN-UHFFFAOYSA-N","BRD-K75551531","","CC(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C(C)=O"
"3395","NITHIAMIDE","bacterial DNA inhibitor","","","","MicroSource, Selleck, Selleck",100,"BRD-K39467894-001-05-9, BRD-K39467894-001-04-2, BRD-K39467894-001-06-7","Preclinical","","UJRRDDHEMZLWFI-UHFFFAOYSA-N","BRD-K39467894","","CC(=O)Nc1ncc(s1)[N+]([O-])=O"
"3398","NITROCARAMIPHEN","cholinergic receptor antagonist","CHRM1","","","Tocris",92.79,"BRD-K28453807-003-11-2","Preclinical","","NSHMVLOWOAQFTP-UHFFFAOYSA-N","BRD-K28453807","","CCN(CC)CCOC(=O)C1(CCCC1)c1ccc(cc1)[N+]([O-])=O"
"3399","NITROMIDE","","","","","MicroSource",99.72,"BRD-K76381435-001-08-6","Launched","","UUKWKUSGGZNXGA-UHFFFAOYSA-N","BRD-K76381435","","NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O"
"3400","NITROSODIMETHYLUREA","DNA synthesis inhibitor","","","","Enamine",0,"BRD-K08927448-001-01-9","Preclinical","","BHMHNSQLZKUIMD-UHFFFAOYSA-N","BRD-K08927448","","CNC(=O)N(C)[N+][O-]"
"3401","NK-252","NRF2 activator","NFE2L2","","","Tocris",71.07,"BRD-K47441935-001-01-4","Preclinical","","FNSCFQXZZNCDAI-UHFFFAOYSA-N","BRD-K47441935","","O=C(NCc1ccccn1)Nc1nnc(o1)-c1ccco1"
"3402","NKP-1339","HSP inhibitor","","","","MedChemEx, MedChemEx",76.7,"BRD-K74796838-236-01-7, BRD-K81645297-236-01-1","Phase 1","BRD-U77299140-000-01-0, BRD-U52007923-000-01-9","KNLORLKZMHLRBH-UHFFFAOYSA-J","BRD-K74796838","BRD-U77299140","Cl[Ru+3](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1"
"3403","NKP-1339","HSP inhibitor","","","","MedChemEx, MedChemEx",76.7,"BRD-K74796838-236-01-7, BRD-K81645297-236-01-1","Phase 1","BRD-U77299140-000-01-0, BRD-U52007923-000-01-9","KNLORLKZMHLRBH-UHFFFAOYSA-J","BRD-K74796838","BRD-U77299140","Cl[Ru](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1"
"3404","NKP-1339","HSP inhibitor","","","","MedChemEx, MedChemEx",76.7,"BRD-K74796838-236-01-7, BRD-K81645297-236-01-1","Phase 1","BRD-U77299140-000-01-0, BRD-U52007923-000-01-9","HZRCCSSSNUKHQG-UHFFFAOYSA-J","BRD-K74796838","BRD-U77299140","Cl[Ru+3](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1"
"3405","NKP-1339","HSP inhibitor","","","","MedChemEx, MedChemEx",76.7,"BRD-K74796838-236-01-7, BRD-K81645297-236-01-1","Phase 1","BRD-U77299140-000-01-0, BRD-U52007923-000-01-9","HZRCCSSSNUKHQG-UHFFFAOYSA-J","BRD-K74796838","BRD-U77299140","Cl[Ru](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1"
"3406","NKY-80","adenylyl cyclase inhibitor","ADCY5","","","Tocris",92.62,"BRD-A75015151-001-07-7","Preclinical","","SOJUSNIBPPMLCC-UHFFFAOYSA-N","BRD-A75015151","","Nc1ncc2C(=O)CC(Cc2n1)c1ccco1"
"3407","NLG919","indoleamine 2,3-dioxygenase inhibitor","IDO1","","","MedChemEx, MedChemEx, Selleck, Selleck",79.93,"BRD-A62133859-001-03-7, BRD-A62133859-001-04-5, BRD-A62133859-001-01-1, BRD-A62133859-001-02-9","Phase 1","","YTRRAUACYORZLX-UHFFFAOYSA-N","BRD-A62133859","","OC(CC1c2ccccc2-c2cncn12)C1CCCCC1"
"3411","NMDA","glutamate receptor agonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, Selleck",100,"BRD-K62414032-001-13-8, BRD-K62414032-001-12-0","Preclinical","BRD-A02508087-001-02-9","HOKKHZGPKSLGJE-GSVOUGTGSA-N","BRD-K62414032","BRD-A02508087","CN[C@H](CC(O)=O)C(O)=O"
"3413","NMS-E973","HSP inhibitor","","","","Selleck",96.76,"BRD-K58770988-001-01-8","Preclinical","BRD-K29587137-001-01-2","YLQODGGPIHWTHR-UHFFFAOYSA-N","BRD-K58770988","BRD-K29587137","CN1CCC(CC1)NC(=O)c1cc(on1)-c1c(O)cc(O)cc1Oc1ccc(cc1)[N+]([O-])=O"
"3414","NMS-P715","protein kinase inhibitor","","","","MedChemEx",96.6,"BRD-K54170555-001-01-8","Preclinical","","JFOAJUGFHDCBJJ-UHFFFAOYSA-N","BRD-K54170555","","CCc1cccc(CC)c1NC(=O)c1nn(C)c-2c1CCc1cnc(Nc3ccc(cc3OC(F)(F)F)C(=O)NC3CCN(C)CC3)nc-21"
"3415","NMS-1286937","PLK inhibitor","FLT3, PLK1, PLK2, PLK3","","","MedChemEx",96.61,"BRD-K83699324-001-01-1","Phase 1","","QHLVBNKYJGBCQJ-UHFFFAOYSA-N","BRD-K83699324","","CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1"
"3416","NMS-873","ATPase inhibitor","VCP","","","MedChemEx, Selleck",98.64,"BRD-K26253904-001-03-1, BRD-K26253904-001-01-5","Preclinical","","UJGTUKMAJVCBIS-UHFFFAOYSA-N","BRD-K26253904","","Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(cc1)S(C)(=O)=O"
"3418","NM107","RNA polymerase inhibitor","","","","LifeChem",100,"BRD-A66966115-001-01-0","Phase 2","","PPUDLEUZKVJXSZ-UHFFFAOYSA-N","BRD-A66966115","","CC1(O)C(O)C(CO)OC1n1ccc(N)nc1=O"
"3419","NNC-05-2090","GABA uptake inhibitor, GAT inhibitor","SLC6A12","","","Tocris, Tocris",98.12,"BRD-K85015012-003-02-9, BRD-K85015012-003-03-7","Preclinical","","XZZYCJOGZYEPPW-UHFFFAOYSA-N","BRD-K85015012","","COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc23)CC1"
"3421","NNC-55-0396","T-type calcium channel blocker","CATSPER1, CATSPER2, CATSPER3, CATSPER4","","","Tocris, Tocris",97.64,"BRD-K78122587-300-04-3, BRD-K78122587-300-02-7","Preclinical","","VHHVPDKNKPNKHY-JDXGNMNLSA-N","BRD-K78122587","","CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1"
"3423","NNC-63-0532","opioid receptor agonist","OPRL1","","","Tocris, Tocris",97.28,"BRD-K72904818-001-02-9, BRD-K72904818-001-01-1","Preclinical","BRD-K36009368-001-03-4, BRD-K36009368-001-02-6","AQMPIDSGLFVVPL-UHFFFAOYSA-N","BRD-K72904818","BRD-K36009368","COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O"
"3425","NNC-711","GABA uptake inhibitor","SIGMAR1, SLC6A1","","","Tocris, Tocris",99.12,"BRD-K42221274-003-08-5, BRD-K42221274-003-07-7","Preclinical","","NGNALWDRPKNJGR-UHFFFAOYSA-N","BRD-K42221274","","OC(=O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1"
"3427","NO-ASA","cyclooxygenase inhibitor","PTGS2","","","Enzo",2.28,"BRD-K08807999-001-02-4","Phase 2","","IOJUJUOXKXMJNF-UHFFFAOYSA-N","BRD-K08807999","","CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+]([O-])=O)c1"
"3428","NOBILETIN","MEK inhibitor","MAP2K1","","","Selleck",97.88,"BRD-K06753942-001-14-5","Preclinical","","MRIAQLRQZPPODS-UHFFFAOYSA-N","BRD-K06753942","","COc1ccc(cc1OC)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1"
"3429","NOCODAZOLE","tubulin polymerization inhibitor","HPGDS","","","Tocris, MicroSource, Selleck, Tocris",95.61,"BRD-K12539581-001-25-2, BRD-K12539581-001-23-7, BRD-K12539581-001-21-1, BRD-K12539581-001-22-9","Preclinical","","KYRVNWMVYQXFEU-UHFFFAOYSA-N","BRD-K12539581","","COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1"
"3433","NOLATREXED","thymidylate synthase inhibitor","TYMS","","","AvaChem",95.58,"BRD-K36636143-001-01-0","Phase 3","","XHWRWCSCBDLOLM-UHFFFAOYSA-N","BRD-K36636143","","Cc1ccc2nc(N)nc(O)c2c1Sc1ccncc1"
"3434","NOMIFENSINE","dopamine uptake inhibitor, noradrenaline uptake inhibitor","DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3","","","Selleck, MicroSource, Selleck",97.52,"BRD-A29644307-050-16-2, BRD-A29644307-050-17-0, BRD-A29644307-050-18-8","Withdrawn","","XXPANQJNYNUNES-UHFFFAOYSA-N","BRD-A29644307","","CN1CC(c2ccccc2)c2cccc(N)c2C1"
"3437","NOR-BINALTORPHIMINE-DIHYDROCHLORIDE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","","","Tocris, Tocris",77.38,"BRD-K36381762-300-03-5, BRD-K36381762-300-02-7","Preclinical","","APSUXPSYBJVPPS-YAUKWVCOSA-N","BRD-K36381762","","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2[C@@H]4Oc6c7c(C[C@H]8N(CC9CC9)CC[C@@]47[C@@]8(O)Cc2c1C[C@@]35O)ccc6O"
"3439","NORCYCLOBENZAPRINE","adrenergic receptor agonist, serotonin receptor antagonist","","","","Prestwick",97.82,"BRD-K63165456-001-10-8","Preclinical","","XECQQDXTQRYYBH-UHFFFAOYSA-N","BRD-K63165456","","CNCCC=C1c2ccccc2C=Cc2ccccc12"
"3440","NORFLUOXETINE","selective serotonin reuptake inhibitor (SSRI)","HTR2B","","","Cayman",95.93,"BRD-A79769222-001-01-3","Phase 1","","WIQRCHMSJFFONW-UHFFFAOYSA-N","BRD-A79769222","","NCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1"
"3441","NORNICOTINE","acetylcholine receptor agonist","","","","Enzo",83.34,"BRD-A24543851-001-05-7","Preclinical","","MYKUKUCHPMASKF-UHFFFAOYSA-N","BRD-A24543851","","C1CNC(C1)c1cccnc1"
"3442","NORVANCOMYCIN","","","","","MedChemEx",65.08,"BRD-A08791201-003-01-4","Preclinical","","NUAQIRUAZSJTAI-UHFFFAOYSA-N","BRD-A08791201","","CC(C)CC(N)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(O)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1)c(Cl)c2"
"3443","NOV-002","","GSR, GSTM2","","","InterBioScreen",94.9,"BRD-K11411329-001-01-3","Phase 3","","YPZRWBKMTBYPTK-USZNOCQGSA-N","BRD-K11411329","","N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O"
"3444","NPC-01","steroid","","","","Sigma",93.36,"BRD-K58277159-001-01-7","Phase 3","","WSCUHXPGYUMQEX-KCZNZURUSA-N","BRD-K58277159","","C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O"
"3445","NPC-15199","ICAM1 antagonist","PPARG","","","Tocris",78.5,"BRD-K65275554-001-04-7","Phase 2","","CBPJQFCAFFNICX-LJQANCHMSA-N","BRD-K65275554","","CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O"
"3446","NPPB","chloride channel blocker","ANO1, CLCN2, CLCN7, TRPA1","","","Tocris, Tocris",98.44,"BRD-K89272762-001-13-5, BRD-K89272762-001-12-7","Preclinical","","WBSMIPAMAXNXFS-UHFFFAOYSA-N","BRD-K89272762","","OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+]([O-])=O"
"3448","NPS-2143","calcium receptor antagonist","CASR","","","Tocris, Selleck",98.14,"BRD-K75506300-003-01-2, BRD-K75506300-001-01-6","Preclinical","","PZUJQWHTIRWCID-HXUWFJFHSA-N","BRD-K75506300","","CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N"
"3450","NPY-5RA972","neuropeptide receptor antagonist","NPY5R","","","Tocris, Tocris",95.24,"BRD-K95600043-001-01-5, BRD-K95600043-001-02-3","Preclinical","","ZNFMHLDBJPAFEQ-UHFFFAOYSA-N","BRD-K95600043","","CC(C)n1c2ccccc2c2c(C)c(NC(=O)N3CCOCC3)ccc12"
"3452","NQDI-1","caspase inhibitor","CASP3","","","MedChemEx",96.79,"BRD-K61918008-001-07-1","Preclinical","","UFJGFNHRMPMALC-UHFFFAOYSA-N","BRD-K61918008","","CCOC(=O)c1c(O)nc2cccc3C(=O)c4ccccc4-c1c23"
"3453","NS-018","JAK inhibitor","JAK1, JAK2, JAK3, TYK2","","","MedChemEx",92.62,"BRD-K21865955-003-01-5","Phase 1/Phase 2","","UQTPDWDAYHAZNT-AWEZNQCLSA-N","BRD-K21865955","","C[C@H](Nc1cc(cc(Nc2cnccn2)n1)-c1cnn(C)c1)c1ccc(F)cc1"
"3454","NS-11021","calcium-activated potassium channel activator","KCNMA1","","","Tocris",0,"BRD-K94342292-001-01-3","Preclinical","","MDKAFDIKYQMOMF-UHFFFAOYSA-N","BRD-K94342292","","FC(F)(F)c1cc(NC(=S)Nc2ccc(Br)cc2-c2nnn[nH]2)cc(c1)C(F)(F)F"
"3455","NS-1643","voltage-gated potassium channel activator","KCNH2, KCNH6, KCNMA1","","","Tocris",91.34,"BRD-K73738482-001-02-5","Preclinical","","NJFVQMRYJZHGME-UHFFFAOYSA-N","BRD-K73738482","","Oc1ccc(cc1NC(=O)Nc1cc(ccc1O)C(F)(F)F)C(F)(F)F"
"3456","NS-19504","calcium-activated potassium channel activator","KCNMA1","","","Tocris",84.54,"BRD-K03808106-001-01-9","Preclinical","","HGWLTZOMQZIUBW-UHFFFAOYSA-N","BRD-K03808106","","Nc1ncc(Cc2ccc(Br)cc2)s1"
"3457","NS-309","calcium-activated potassium channel activator","KCNN1, KCNN2, KCNN3, KCNN4","","","Tocris",92.67,"BRD-K37602296-001-01-6","Preclinical","","CVOUSAVHMDXCKG-UHFFFAOYSA-N","BRD-K37602296","","ON=C1C(=O)Nc2c1ccc(Cl)c2Cl"
"3458","NS-3623","voltage-gated potassium channel activator","KCNH2","","","Tocris",86.42,"BRD-K24434292-001-02-1","Preclinical","","JXPULDIATMTIIN-UHFFFAOYSA-N","BRD-K24434292","","FC(F)(F)c1cccc(NC(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)c1"
"3459","NS-3861","acetylcholine receptor agonist","CHRNA3, CHRNB4","","","Tocris",89.71,"BRD-A23155040-051-01-7","Preclinical","","ZJCNRVHZJADROC-UHFFFAOYSA-N","BRD-A23155040","","CN1C2CCC1C=C(C2)c1sccc1Br"
"3460","NS-5806","voltage-gated potassium channel activator","KCND3","","","Tocris",85.92,"BRD-K93314017-001-01-7","Preclinical","","UZWJWROOLOOCPQ-UHFFFAOYSA-N","BRD-K93314017","","FC(F)(F)c1cc(NC(=O)Nc2c(Br)cc(Br)cc2-c2nnn[nH]2)cc(c1)C(F)(F)F"
"3461","NS-8","potassium channel agonist","KCNMA1","","","Enamine",40.47,"BRD-K22667752-001-01-3","Phase 2","","KVDWOQGDMAEJLM-UHFFFAOYSA-N","BRD-K22667752","","Cc1c([nH]c(N)c1C#N)-c1ccccc1F"
"3462","NS-8593","calcium-activated potassium channel modulator","KCNN1, KCNN2, KCNN3","","","Tocris",97.22,"BRD-K34624869-003-01-6","Preclinical","","XZIZUQSOFMLIIR-CQSZACIVSA-N","BRD-K34624869","","C1C[C@@H](Nc2nc3ccccc3[nH]2)c2ccccc2C1"
"3463","NS-9283","acetylcholine receptor allosteric modulator","CHRNA4","","","Tocris",97.98,"BRD-K40176866-001-01-6","Preclinical","","HGFXDSQLRSWUBO-UHFFFAOYSA-N","BRD-K40176866","","N#Cc1cccc(c1)-c1nc(no1)-c1cccnc1"
"3464","NSC-23766","Ras GTPase inhibitor","","","","Tocris, Tocris, Selleck, Selleck",95.29,"BRD-A80213327-305-08-3, BRD-A80213327-305-13-3, BRD-A80213327-305-07-5, BRD-A80213327-305-11-7","Preclinical","","DEFBCZWQLILOJF-UHFFFAOYSA-N","BRD-A80213327","","CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1"
"3468","NSC-319726","p53 activator","","","","Selleck, Tocris, Selleck",84.67,"BRD-K99170882-001-04-3, BRD-K99170882-001-06-8, BRD-K99170882-001-05-0","Preclinical","","XDHBUMNIQRLHGO-UKTHLTGXSA-N","BRD-K99170882","","C\C(c1ccccn1)=N/NC(=S)N1CCC1"
"3471","NSC-3852","HDAC inhibitor","HDAC1","","","Tocris",96.22,"BRD-K13169950-001-14-4","Preclinical","","RZWRYPGAUIOOMK-UHFFFAOYSA-N","BRD-K13169950","","Oc1ccc([N+][O-])c2cccnc12"
"3472","NSC-405020","matrix metalloprotease inhibitor","MMP1","","","Tocris, Selleck",97.07,"BRD-A67975844-001-02-6, BRD-A67975844-001-01-8","Preclinical","","ARDYECYBETXQFD-UHFFFAOYSA-N","BRD-A67975844","","CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1"
"3474","NSC-4644","ACAT inhibitor, sterol regulatory element binding protein (SREBP) inhibitor","PYGM","","","Enzo",100,"BRD-K64874225-001-04-7","Phase 2","","FVWJYYTZTCVBKE-ROUWMTJPSA-N","BRD-K64874225","","CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12"
"3475","NSC-625987","CDK inhibitor","CDK2, CDK4","","","Tocris",0.34,"BRD-K62949423-001-03-1","Preclinical","","KFAKESMKRPNZTM-UHFFFAOYSA-N","BRD-K62949423","","COc1ccc(OC)c2c1[nH]c1ccccc1c2=S"
"3476","NSC-632839","ubiquitin specific protease inhibitor","SENP2, USP1, USP2, USP7","","","Tocris, Tocris",90.63,"BRD-K81197548-003-01-4, BRD-K81197548-003-02-2","Preclinical","","PKCYYPHSCUSQDK-AYKLPDECSA-N","BRD-K81197548","","Cc1ccc(cc1)\C=C1/CNC\C(C1=O)=C/c1ccc(C)cc1"
"3478","NSC-663284","CDC inhibitor","CDC25A, CDC25B, CDC25C","","","Tocris, Tocris",96.21,"BRD-K03109492-001-03-0, BRD-K03109492-001-02-2","Preclinical","","BMKPVDQDJQWBPD-UHFFFAOYSA-N","BRD-K03109492","","ClC1=C(NCCN2CCOCC2)C(=O)c2ncccc2C1=O"
"3480","NSC-697923","ubiquitin-conjugating enzyme inhibitor","UBE2N","","","Selleck, Tocris",92.89,"BRD-K20605374-001-05-4, BRD-K20605374-001-06-2","Preclinical","","GAUHIPWCDXOLCZ-UHFFFAOYSA-N","BRD-K20605374","","Cc1ccc(cc1)S(=O)(=O)c1ccc(o1)[N+]([O-])=O"
"3482","NSC-95397","CDC inhibitor","CDC25A, CDC25B","","","Tocris",9.25,"BRD-K68143200-001-11-7","Preclinical","","MAASHDQFQDDECQ-UHFFFAOYSA-N","BRD-K68143200","","OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O"
"3483","NSC-9965","acetylcholine receptor antagonist","CHRNA4, CHRNB2","","","Enzo",95.89,"BRD-K49811169-004-06-6","Preclinical","","ALSKYCOJJPXPFS-BBRMVZONSA-N","BRD-K49811169","","CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1"
"3484","NSC5844","CC chemokine receptor agonist","CCR1","","","MedChemEx",96.41,"BRD-K73799155-001-01-5","Preclinical","","SSXYXSMMVMVYEV-UHFFFAOYSA-N","BRD-K73799155","","C(CNc1ccnc2cc(Cl)ccc12)Nc1ccnc2cc(Cl)ccc12"
"3485","NSC636819","histone demethylase inhibitor","KDM4A, KDM4B","","","Tocris",90.48,"BRD-K61120504-001-01-6","Preclinical","","YYZPXBXVBQSBDG-IJIVKGSJSA-N","BRD-K61120504","","[O-][N+](=O)c1cc(c(\C=C\c2ccc(Cl)c(Cl)c2)cc1\C=C\c1ccc(Cl)c(Cl)c1)[N+]([O-])=O"
"3486","NSI-189","neurotrophic agent","","","","MedChemEx",99.38,"BRD-K74371986-001-01-7","Phase 2","","DYTOQURYRYYNOR-UHFFFAOYSA-N","BRD-K74371986","","CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1"
"3487","NTNCB","neuropeptide receptor antagonist","NPY5R","","","Tocris",97.68,"BRD-A40413915-003-01-2","Preclinical","","ISSSVYKMIIAPTH-YGQOYYDZSA-N","BRD-A40413915","","[O-][N+](=O)c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1"
"3488","NTRC-824","neurotensin receptor antagonist","NTSR2","","","Tocris",93.63,"BRD-K07788774-001-01-0","Preclinical","","SOOLLEBJNGCDOZ-FQEVSTJZSA-N","BRD-K07788774","","CC(C)C[C@H](NC(=O)Cn1cc(C(=O)C(F)(F)F)c2cc(NS(=O)(=O)c3ccc(C)cc3)ccc12)C(O)=O"
"3489","NTZDPA","PPAR receptor agonist","PPARG","","","Tocris, Tocris",98,"BRD-K54708045-001-03-9, BRD-K54708045-001-02-1","Preclinical","","VUPOTURDKDMIGQ-UHFFFAOYSA-N","BRD-K54708045","","OC(=O)c1n(Cc2ccc(Cl)cc2)c2ccc(Cl)cc2c1Sc1ccccc1"
"3491","NT157","IGF-1 inhibitor","IGF1R","","","MedChemEx, MedChemEx",66.42,"BRD-K54098378-001-02-4, BRD-K54098378-001-01-6","Preclinical","","NIPUPOUEGOSAAO-OWOJBTEDSA-N","BRD-K54098378","","Oc1cc(CNC(=S)\C=C\c2cc(O)c(O)c(Br)c2)cc(O)c1O"
"3493","NU-1025","PARP inhibitor","PARP1","","","Tocris, Tocris",95.84,"BRD-K48692744-001-02-0, BRD-K48692744-001-03-8","Preclinical","","YJDAOHJWLUNFLX-UHFFFAOYSA-N","BRD-K48692744","","Cc1nc2c(O)cccc2c(=O)[nH]1"
"3495","NU-2058","cyclin D inhibitor","CCNA2, CDK2","","","Tocris",91.61,"BRD-K20976221-001-12-0","Preclinical","","MWGXGTJJAOZBNW-UHFFFAOYSA-N","BRD-K20976221","","Nc1nc(OCC2CCCCC2)c2[nH]cnc2n1"
"3496","NU-7026","DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","PRKDC","","","MedChemEx, Tocris, Selleck",99.72,"BRD-K09537769-001-06-5, BRD-K09537769-001-04-0, BRD-K09537769-001-03-2","Preclinical","","KKTZALUTXUZPSN-UHFFFAOYSA-N","BRD-K09537769","","O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1"
"3499","NU-7441","DNA dependent protein kinase inhibitor","PRKDC","","","Selleck",98.03,"BRD-K00337317-001-06-6","Preclinical","","JAMULYFATHSZJM-UHFFFAOYSA-N","BRD-K00337317","","O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1"
"3500","NUCLOMEDONE","immunosuppressant","","","","InterBioScreen",93.86,"BRD-A96466199-001-01-4","Phase 3","","QSKVYHYMQQQAFS-UHFFFAOYSA-N","BRD-A96466199","","Clc1ccc(CC2C(=O)N=C3SCCN3C2=O)cc1"
"3501","NUTLIN-3","MDM inhibitor","MDM2, TP53","","","Selleck, Selleck, Tocris",95.55,"BRD-A12230535-001-11-7, BRD-A12230535-001-06-7, BRD-K73255294-001-02-8","Preclinical","","BDUHCSBCVGXTJM-UHFFFAOYSA-N","BRD-A12230535","","COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1"
"3503","NUTLIN-3","MDM inhibitor","MDM2, TP53","","","Selleck, Selleck, Tocris",95.55,"BRD-A12230535-001-11-7, BRD-A12230535-001-06-7, BRD-K73255294-001-02-8","Preclinical","","BDUHCSBCVGXTJM-UHFFFAOYSA-N","BRD-A12230535","","COc1ccc(C2=N[C@@H]([C@@H](N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1"
"3504","NUTLIN-3","MDM inhibitor","MDM2, TP53","","","Selleck, Selleck, Tocris",95.55,"BRD-A12230535-001-11-7, BRD-A12230535-001-06-7, BRD-K73255294-001-02-8","Preclinical","","BDUHCSBCVGXTJM-IZLXSDGUSA-N","BRD-A12230535","","COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1"
"3506","NUTLIN-3","MDM inhibitor","MDM2, TP53","","","Selleck, Selleck, Tocris",95.55,"BRD-A12230535-001-11-7, BRD-A12230535-001-06-7, BRD-K73255294-001-02-8","Preclinical","","BDUHCSBCVGXTJM-IZLXSDGUSA-N","BRD-A12230535","","COc1ccc(C2=N[C@@H]([C@@H](N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1"
"3507","NU6027","CDK inhibitor","CCNA2, CDK2","","","Selleck",93.48,"BRD-K03294269-001-08-0","Preclinical","","DGWXOLHKVGDQLN-UHFFFAOYSA-N","BRD-K03294269","","Nc1nc(N)c([N+][O-])c(OCC2CCCCC2)n1"
"3508","NVP-ADW742","insulin growth factor receptor inhibitor","IGF1R","","","Selleck, Selleck, Tocris",96.14,"BRD-K15179513-001-04-2, BRD-K15179513-001-03-4, BRD-K15179513-001-05-9","Preclinical","","LSFLAQVDISHMNB-AFARHQOCSA-N","BRD-K15179513","","Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@H]1C[C@H](CN2CCCC2)C1"
"3511","NVP-AEW541","IGF-1 inhibitor","IGF1R, INSR","","","Selleck",94.66,"BRD-K24696047-001-02-3","Preclinical","","AECDBHGVIIRMOI-GRGXKFILSA-N","BRD-K24696047","","Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1"
"3512","NVP-AUY922","HSP inhibitor","HSP90AA1, HSP90AB1","","","Selleck, MedChemEx, Selleck",96.22,"BRD-K41859756-001-08-4, BRD-K41859756-001-09-2, BRD-K41859756-001-06-8","Phase 2","","NDAZATDQFDPQBD-UHFFFAOYSA-N","BRD-K41859756","","CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O"
"3515","NVP-BEZ235","mTOR inhibitor, PI3K inhibitor","ATR, MTOR, PIK3CA, PIK3CD, PIK3CG","","","Selleck, Selleck",98.67,"BRD-K12184916-001-19-6, BRD-K12184916-001-15-4","Phase 2","","JOGKUKXHTYWRGZ-UHFFFAOYSA-N","BRD-K12184916","","Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1"
"3517","NVP-BGJ398","FGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, KDR","","","LCLabs, MedChemEx, Selleck, MedChemEx, Selleck",89.82,"BRD-K42728290-001-09-1, BRD-K42728290-001-11-7, BRD-K42728290-001-06-7, BRD-K42728290-001-08-3, BRD-K42728290-001-07-5","Phase 2","","QADPYRIHXKWUSV-UHFFFAOYSA-N","BRD-K42728290","","CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1"
"3522","NVP-BHG712","ephrin inhibitor","EPHB4","","","Selleck",98.2,"BRD-K79259477-001-04-9","Preclinical","","ZCCPLJOKGAACRT-UHFFFAOYSA-N","BRD-K79259477","","Cc1ccc(cc1Nc1nc(nc2n(C)ncc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F"
"3523","NVP-BSK805","JAK inhibitor","JAK2","","","Selleck, Selleck",92.69,"BRD-K02017404-300-07-0, BRD-K02017404-300-06-2","Preclinical","","IBPVXAOOVUAOKJ-UHFFFAOYSA-N","BRD-K02017404","","Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1"
"3525","NVP-BVU972","MET inhibitor","MET","","","Selleck",98.35,"BRD-K77943374-001-02-8","Preclinical","","RNCNPRCUHHDYPC-UHFFFAOYSA-N","BRD-K77943374","","Cn1cc(cn1)-c1ccc2ncc(Cc3ccc4ncccc4c3)n2n1"
"3526","NVP-DPP728","dipeptidyl peptidase inhibitor","DPP4","","","Tocris",92.57,"BRD-K77396579-300-01-0","Phase 2","","VFFZWMWTUSXDCB-ZDUSSCGKSA-N","BRD-K77396579","","O=C(CNCCNc1ccc(cn1)C#N)N1CCC[C@H]1C#N"
"3527","NVP-HSP990","HSP inhibitor","HSP90AA1, HSP90AB1","","","MedChemEx",94.87,"BRD-K67915505-001-01-2","Phase 1","","WSMQUUGTQYPVPD-OAHLLOKOSA-N","BRD-K67915505","","COc1cccc(n1)-c1cc(F)ccc1[C@H]1Cc2nc(N)nc(C)c2C(=O)N1"
"3528","NVP-TAE226","protein tyrosine kinase inhibitor","PTK2","","","Selleck, Selleck",95.2,"BRD-K21025364-001-04-9, BRD-K21025364-001-05-6","Preclinical","","UYJNQQDJUOUFQJ-UHFFFAOYSA-N","BRD-K21025364","","CNC(=O)c1ccccc1Nc1nc(Nc2ccc(cc2OC)N2CCOCC2)ncc1Cl"
"3530","NVP-TAE684","ALK tyrosine kinase receptor inhibitor","ALK, INSR","","","Selleck",90.97,"BRD-K50140147-001-10-1","Preclinical","","QQWUGDVOUVUTOY-UHFFFAOYSA-N","BRD-K50140147","","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1"
"3531","NVP-TNKS656","tankyrase inhibitor","TNKS2","","","MedChemEx",93.82,"BRD-K87454346-001-01-1","Preclinical","","DYGBNAYFDZEYBA-UHFFFAOYSA-N","BRD-K87454346","","COc1ccc(cc1)C(=O)C1CCN(CC(=O)N(CC2CC2)Cc2nc3CCOCc3c(=O)[nH]2)CC1"
"3532","NVP-231","ceramidase inhibitor","CERK","","","Tocris, MedChemEx",96.82,"BRD-K01573278-001-03-9, BRD-K01573278-001-02-1","Preclinical","","MVSSJPGNLQPWSW-UHFFFAOYSA-N","BRD-K01573278","","O=C(Nc1nc2ccc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2s1)c1ccccc1"
"3534","NVS-PAK1-1","p21 activated kinase inhibitor","PAK1","","","MedChemEx",99.03,"BRD-K28132190-001-02-0","Preclinical","","OINGHOPGNMYCAB-INIZCTEOSA-N","BRD-K28132190","","CC(C)NC(=O)N1CC[C@@H](C1)NC1=Nc2cc(F)ccc2N(CC(F)F)c2ccc(Cl)cc12"
"3535","NXY-059","free radical scavenger","","","","Tocris, Selleck",91.94,"BRD-K46133855-304-03-8, BRD-K46133855-304-02-0","Phase 3","","OVTCHWSLKGENKP-GHXNOFRVSA-N","BRD-K46133855","","CC(C)(C)[N+](\[O-])=C\c1ccc(cc1S(O)(=O)=O)S(O)(=O)=O"
"3537","N20C","glutamate receptor antagonist","","","","Tocris",95.35,"BRD-K41143549-003-02-4","Preclinical","","BYGXICRJQZKUPA-UHFFFAOYSA-N","BRD-K41143549","","NC(=O)CNCCC(c1ccccc1)c1ccccc1"
"3538","N6-CYCLOPENTYLADENOSINE","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1","","","Tocris",97.75,"BRD-K60150510-001-15-6","Preclinical","","SQMWSBKSHWARHU-SDBHATRESA-N","BRD-K60150510","","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)ncnc12"
"3539","N6-METHYLADENOSINE","","","","","Selleck",97.73,"BRD-K81807412-001-10-6","Preclinical","","VQAYFKKCNSOZKM-IOSLPCCCSA-N","BRD-K81807412","","CNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"3540","N6022","alcohol dehydrogenase inhibitor","ADH5","","","MedChemEx",96.42,"BRD-K82522873-001-01-1","Phase 1/Phase 2","","YVPGZQLRPAGKLA-UHFFFAOYSA-N","BRD-K82522873","","Cc1cc(ccc1-n1c(CCC(O)=O)ccc1-c1ccc(cc1)-n1ccnc1)C(N)=O"
"3541","O-ACETYL-L-SERINE","","PTGS1","","","Astatech",96.8,"BRD-K63247785-001-01-5","Preclinical","","VZXPDPZARILFQX-BYPYZUCNSA-N","BRD-K63247785","","CC(=O)OC[C@H](N)C(O)=O"
"3542","O-MERCAPTO-BENZOIC-ACID","","","","","Enamine",97.04,"BRD-K36998189-001-03-5","Preclinical","","NBOMNTLFRHMDEZ-UHFFFAOYSA-N","BRD-K36998189","","OC(=O)c1ccccc1S"
"3543","O-1918","cannabinoid receptor antagonist","","","","Tocris, Tocris",95.81,"BRD-K18316707-001-02-7, BRD-K18316707-001-03-5","Preclinical","","ICHJMVMWPKLUKT-JKSUJKDBSA-N","BRD-K18316707","","COc1cc(C)cc(OC)c1[C@@H]1C=C(C)CC[C@H]1C(C)=C"
"3545","O-3M3FBS","phospholipase activator","","","","Tocris, Tocris",98.98,"BRD-K46384212-001-03-7, BRD-K46384212-001-02-9","Preclinical","","SKJJIFRWCCSXGL-UHFFFAOYSA-N","BRD-K46384212","","Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1ccccc1C(F)(F)F"
"3547","OAC1","Oct activator","","","","Selleck, Tocris",94.83,"BRD-K10878147-001-02-2, BRD-K10878147-001-03-0","Preclinical","","HWJRIFZDXJKJJN-UHFFFAOYSA-N","BRD-K10878147","","O=C(Nc1cc2cc[nH]c2cn1)c1ccccc1"
"3549","OAC2","Oct activator","POU5F1","","","MedChemEx",96.28,"BRD-K18305454-001-07-4","Preclinical","","JCAFGYWSIWYMOX-UHFFFAOYSA-N","BRD-K18305454","","O=C(Nc1ccc2[nH]ccc2c1)c1ccccc1"
"3550","OBATOCLAX","BCL inhibitor","BCL2","","","Selleck, Selleck",89.43,"BRD-K15600710-066-05-8, BRD-K15600710-066-04-1","Phase 3","","RFTSSZJZXOSICM-GRSHGNNSSA-N","BRD-K15600710","","COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1"
"3552","OCHROMYCINONE","STAT inhibitor","STAT3","","","AnalytiCon",0,"BRD-K92524032-001-02-1","Phase 1","","ZAWXOCUFQSQDJS-VIFPVBQESA-N","BRD-K92524032","","C[C@@H]1CC(=O)c2c(C1)ccc1C(=O)c3c(O)cccc3C(=O)c21"
"3553","OCINAPLON","GABA receptor modulator","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris",99.66,"BRD-K92581468-001-01-6","Phase 3","","OQJFBUOFGHPMSR-UHFFFAOYSA-N","BRD-K92581468","","O=C(c1cnn2c(ccnc12)-c1ccncc1)c1ccccn1"
"3554","OCO-1112","cholesterol inhibitor","","","","Enamine",98.74,"BRD-K22097830-001-01-9","Phase 2","","ODLDHXPJRGNTPC-UHFFFAOYSA-N","BRD-K22097830","","CC(C)c1ccc(cc1)C(=O)NCCOc1ccc(cc1)C(O)=O"
"3555","OCTADECAN-1-OL","","","","","Ark",0,"BRD-K20501889-001-02-0","Preclinical","","GLDOVTGHNKAZLK-UHFFFAOYSA-N","BRD-K20501889","","CCCCCCCCCCCCCCCCCCO"
"3556","OCTAMETHYLTRISILOXANE","","","","","Sigma",0,"BRD-K73201113-001-01-3","Preclinical","","CXQXSVUQTKDNFP-UHFFFAOYSA-N","BRD-K73201113","","C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C"
"3557","OCTENIDINE","membrane integrity inhibitor","","","","TCI",99.2,"BRD-K04568635-300-01-4","Launched","","ZVXNYZWXUADSRV-UHFFFAOYSA-N","BRD-K04568635","","CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(cc2)=NCCCCCCCC)cc1"
"3558","OCTODRINE","antitumor agent","","","","MicroSource",21.54,"BRD-A37873789-001-01-9","Preclinical","","QNIVIMYXGGFTAK-UHFFFAOYSA-N","BRD-A37873789","","CC(C)CCCC(C)N"
"3559","OCTOPAMINE","trace amine associated receptor agonist","F10, TAAR1","","","Tocris, MicroSource, Selleck, Selleck",100,"BRD-A14240607-003-25-3, BRD-A14240607-003-26-1, BRD-A14240607-003-27-9, BRD-A14240607-003-24-6","Preclinical","","QHGUCRYDKWKLMG-UHFFFAOYSA-N","BRD-A14240607","","NCC(O)c1ccc(O)cc1"
"3563","OC000459","CRTH receptor antagonist","PTGDR2","","","MedChemEx, Selleck, Selleck",93.19,"BRD-K36463073-001-03-9, BRD-K36463073-001-01-3, BRD-K36463073-001-02-1","Phase 2","","FATGTHLOZSXOBC-UHFFFAOYSA-N","BRD-K36463073","","Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(O)=O"
"3566","ODANACATIB","cathepsin inhibitor","CTSK","","","Selleck",97.87,"BRD-K22822991-001-02-3","Phase 3","","FWIVDMJALNEADT-SFTDATJTSA-N","BRD-K22822991","","CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N"
"3567","ODM-201","androgen receptor antagonist","AR","","","MedChemEx, Selleck",98.62,"BRD-A44971162-001-01-9, BRD-A44971162-001-02-7","Phase 3","BRD-A01259528-001-01-9","BLIJXOOIHRSQRB-PXYINDEMSA-N","BRD-A44971162","BRD-A01259528","C[C@@H](Cn1ccc(n1)-c1ccc(C#N)c(Cl)c1)NC(=O)c1cc([nH]n1)C(C)O"
"3569","ODQ","guanylyl cyclase inhibitor","GUCY1A2, GUCY1A3, GUCY1B3","","","Tocris, Tocris",70.01,"BRD-K26015241-001-04-4, BRD-K26015241-001-03-6","Preclinical","","LZMHWZHOZLVYDL-UHFFFAOYSA-N","BRD-K26015241","","O=c1onc2cnc3ccccc3n12"
"3571","OF-1","bromodomain inhibitor","BRD1","","","Tocris",86.25,"BRD-K92658264-001-01-8","Preclinical","","YUNQZQREIHWDQT-UHFFFAOYSA-N","BRD-K92658264","","COc1cc2n(C)c(=O)n(C)c2cc1NS(=O)(=O)c1ccc(Br)cc1C"
"3572","OG-L002","histone lysine demethylase inhibitor","KDM1A","","","Selleck, Selleck",85.35,"BRD-K26349472-001-02-1, BRD-K26349472-001-01-3","Preclinical","BRD-A46597779-001-01-5","DSOJSZXQRJGBCW-CABCVRRESA-N","BRD-K26349472","BRD-A46597779","N[C@H]1C[C@@H]1c1ccc(cc1)-c1cccc(O)c1"
"3574","OGLEMILAST","phosphodiesterase inhibitor","","","","MedChemEx",96.52,"BRD-K92303087-001-01-6","Phase 2","","OKFDRAHPFKMAJH-UHFFFAOYSA-N","BRD-K92303087","","CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1"
"3575","OICR-9429","WDR5/MLL interaction inhibitor","WDR5","","","Tocris",93.82,"BRD-K94083718-001-01-9","Preclinical","","DJOVLOYCGXNVPI-UHFFFAOYSA-N","BRD-K94083718","","CN1CCN(CC1)c1ccc(cc1NC(=O)c1c[nH]c(=O)cc1C(F)(F)F)-c1cccc(CN2CCOCC2)c1"
"3576","OLDA","TRPV agonist","GPR119","","","Tocris",96.21,"BRD-K95523387-001-09-6","Preclinical","","QQBPLXNESPTPNU-KTKRTIGZSA-N","BRD-K95523387","","CCCCCCCC\C=C/CCCCCCCC(=O)NCCc1ccc(O)c(O)c1"
"3577","OLEAMIDE","cannabinoid receptor agonist","HTR7, PLA2G2A","","","Tocris",100,"BRD-K06644925-001-03-0","Preclinical","","FATBGEAMYMYZAF-KTKRTIGZSA-N","BRD-K06644925","","CCCCCCCC\C=C/CCCCCCCC(N)=O"
"3578","OLEANDRIN","Na/K-ATPase inhibitor","","","","MedChemEx",94.48,"BRD-K98006098-001-01-6","Phase 1","","JLPDBLFIVFSOCC-XYXFTTADSA-N","BRD-K98006098","","CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O"
"3579","OLEANOLIC-ACID","G protein-coupled receptor agonist","GPBAR1","","","Selleck, Selleck",90.67,"BRD-K90647725-001-07-3, BRD-K90647725-001-06-5","Preclinical","BRD-A00113255-001-02-6, BRD-A65785035-001-01-2","MIJYXULNPSFWEK-GTOFXWBISA-N","BRD-K90647725","BRD-A00113255","CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O"
"3581","OLEOYLETHANOLAMIDE","cannabinoid receptor agonist, glucose dependent insulinotropic receptor agonist, potassium channel blocker, PPAR receptor agonist","CNR1, GPR119, GPR55, PPARA","","","Tocris",97.64,"BRD-K66956375-001-11-3","Preclinical","","BOWVQLFMWHZBEF-KTKRTIGZSA-N","BRD-K66956375","","CCCCCCCC\C=C/CCCCCCCC(=O)NCCO"
"3582","OLESOXIME","apoptosis stimulant","","","","MedChemEx, MedChemEx, MedChemEx",69.73,"BRD-K18210059-001-01-8, BRD-A33931310-001-02-5, BRD-K18210059-001-02-6","Phase 2/Phase 3","BRD-A33931310-001-01-7","QNTASHOAVRSLMD-SIWSWZRQSA-N","BRD-K18210059","BRD-A33931310","CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C\C(CC[C@]4(C)[C@H]3CC[C@]12C)=N\O"
"3583","OLESOXIME","apoptosis stimulant","","","","MedChemEx, MedChemEx, MedChemEx",69.73,"BRD-K18210059-001-01-8, BRD-A33931310-001-02-5, BRD-K18210059-001-02-6","Phase 2/Phase 3","BRD-A33931310-001-01-7","QNTASHOAVRSLMD-SIWSWZRQSA-N","BRD-K18210059","BRD-A33931310","CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@]4(C)[C@H]3CC[C@]12C)=NO"
"3585","OLESOXIME","apoptosis stimulant","","","","MedChemEx, MedChemEx, MedChemEx",69.73,"BRD-K18210059-001-01-8, BRD-A33931310-001-02-5, BRD-K18210059-001-02-6","Phase 2/Phase 3","BRD-A33931310-001-01-7","QNTASHOAVRSLMD-SHLKSLFASA-N","BRD-K18210059","BRD-A33931310","CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C\C(CC[C@]4(C)[C@H]3CC[C@]12C)=N\O"
"3586","OLESOXIME","apoptosis stimulant","","","","MedChemEx, MedChemEx, MedChemEx",69.73,"BRD-K18210059-001-01-8, BRD-A33931310-001-02-5, BRD-K18210059-001-02-6","Phase 2/Phase 3","BRD-A33931310-001-01-7","QNTASHOAVRSLMD-SHLKSLFASA-N","BRD-K18210059","BRD-A33931310","CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@]4(C)[C@H]3CC[C@]12C)=NO"
"3588","OLEUROPEIN","estrogen receptor agonist","GPER1","","","Selleck",85.99,"BRD-A00842753-001-01-9","Phase 2","","RFWGABANNQMHMZ-DXNYSGJVSA-N","BRD-A00842753","","COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)\C(=C/C)C1CC(=O)OCCc1ccc(O)c(O)c1"
"3589","OLIGOMYCIN-A","ATP synthase inhibitor, ATPase inhibitor","ATP5A1","","","Selleck",94.2,"BRD-A81541225-001-06-8","Preclinical","BRD-K52536804-001-01-1","MNULEGDCPYONBU-VVXVDZGXSA-N","BRD-A81541225","BRD-K52536804","CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)\C=C\[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C\1)[C@H]2C"
"3590","OLMUTINIB","EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR","","","MedChemEx, MedChemEx",91.76,"BRD-K60421517-001-02-2, BRD-K60421517-001-01-4","Launched","","FDMQDKQUTRLUBU-UHFFFAOYSA-N","BRD-K60421517","","CN1CCN(CC1)c1ccc(Nc2nc(Oc3cccc(NC(=O)C=C)c3)c3sccc3n2)cc1"
"3592","OLOMOUCINE","CDK inhibitor","CDK1, CDK2, CDK5, MAPK1","","","Tocris",97.73,"BRD-K82731415-001-07-0","Preclinical","","GTVPOLSIJWJJNY-UHFFFAOYSA-N","BRD-K82731415","","Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12"
"3593","OLTIPRAZ","nuclear factor erythroid derived, like (NRF2) activator","ANG","","","MicroSource, MicroSource",97.51,"BRD-K86972824-001-01-4, BRD-K86972824-001-02-2","Phase 3","","CKNAQFVBEHDJQV-UHFFFAOYSA-N","BRD-K86972824","","Cc1c(ssc1=S)-c1cnccn1"
"3595","OLVANIL","TRPV agonist","CNR1, GPR119, TRPV1","","","Tocris, Tocris",94.57,"BRD-K31560319-001-02-3, BRD-K31560319-001-01-5","Preclinical","","OPZKBPQVWDSATI-KHPPLWFESA-N","BRD-K31560319","","CCCCCCCC\C=C/CCCCCCCC(=O)NCc1ccc(O)c(OC)c1"
"3597","OMADACYCLINE","bacterial 30S ribosomal subunit inhibitor","","","","MedChemEx",59.45,"BRD-A72591750-066-01-1","Phase 3","","OVIWLBQFYMOVOF-NPGXJKJDSA-N","BRD-A72591750","","CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(CNCC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C"
"3598","OMARIGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","","","MedChemEx, MedChemEx",94.52,"BRD-K14171291-001-01-4, BRD-K14171291-001-02-2","Launched","","MKMPWKUAHLTIBJ-ISTRZQFTSA-N","BRD-K14171291","","CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]1CO[C@@H]([C@@H](N)C1)c1cc(F)ccc1F"
"3600","OMDM-2","FAAH inhibitor","GPR119","","","Tocris",92.27,"BRD-K48830578-001-01-9","Preclinical","","ICDMLAQPOAVWNH-HAAQQRBASA-N","BRD-K48830578","","CCCCCCCC\C=C/CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1"
"3601","OMECAMTIV-MECARBIL","cardiac myosin activator","MYBPC3","","","Selleck",94.66,"BRD-K36680103-001-01-6","Phase 2","","RFUBTTPMWSKEIW-UHFFFAOYSA-N","BRD-K36680103","","COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1"
"3602","OMEGA-(4-IODOPHENYL)PENTADECANOIC ACID","","","","","Sigma",13.69,"BRD-K53156781-001-01-4","Preclinical","","YAONEUNUMVOKNQ-UHFFFAOYSA-N","BRD-K53156781","","OC(=O)CCCCCCCCCCCCCCc1ccc(I)cc1"
"3603","OMEGA-3-ACID-ESTERS","cholesterol inhibitor","","","","MicroSource, MedChemEx, MedChemEx",71.9,"BRD-K31139048-001-02-4, BRD-K31139048-001-03-2, BRD-K31139048-001-04-0","Launched","","SSQPWTVBQMWLSZ-AAQCHOMXSA-N","BRD-K31139048","","CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC"
"3606","OMEPRAZOLE-SULFIDE","ATPase inhibitor","","","","AKSci",92.79,"BRD-K69035426-001-01-3","Phase 1","","XURCIPRUUASYLR-UHFFFAOYSA-N","BRD-K69035426","","COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1"
"3607","ON-01500","apoptosis stimulant","","","","Enamine",74.35,"BRD-K55790047-001-01-8","Preclinical","","KUTAVMCJCVADGZ-BQYQJAHWSA-N","BRD-K55790047","","COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(N)c2)c(OC)c1"
"3608","ONCRASIN-1","apoptosis stimulant","","","","Tocris",99.67,"BRD-K43449605-001-01-0","Preclinical","","ZDRQMXCSSAPUMM-UHFFFAOYSA-N","BRD-K43449605","","Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1"
"3609","ONC201","AKT inhibitor, MAP kinase inhibitor","TNFSF10","","","Cayman",96.29,"BRD-K58529924-001-01-5","Phase 2","","VLULRUCCHYVXOH-UHFFFAOYSA-N","BRD-K58529924","","Cc1ccccc1CN1C2=NCCN2C2=C(CN(Cc3ccccc3)CC2)C1=O"
"3610","ONO-AE3-208","prostanoid receptor antagonist","PTGER4","","","Tocris",96.3,"BRD-A80567330-001-01-7","Preclinical","","MTDIMKNAJUQTIO-UHFFFAOYSA-N","BRD-A80567330","","CC(C(=O)Nc1cc(ccc1CCCC(O)=O)C#N)c1ccc(F)c2ccccc12"
"3611","ONO-4059","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Selleck",97.08,"BRD-A13689093-001-01-8","Phase 1","","KSUDUUBCXJUFRL-UHFFFAOYSA-N","BRD-A13689093","","Nc1ncnc2n(C3CCCN(C3)C(=O)C=C)c(=O)n(-c3ccc(Oc4ccccc4)cc3)c12"
"3612","ONO-4817","matrix metalloprotease inhibitor","MMP8","","","Sigma",97.35,"BRD-K58894520-001-01-1","Phase 1","","HDWWQELUBWGQGA-WMZOPIPTSA-N","BRD-K58894520","","CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(Oc2ccccc2)cc1"
"3613","ONO-8130","prostanoid receptor antagonist","PTGER1","","","Tocris",92,"BRD-K76725781-001-01-9","Preclinical","","IOXMDBQCUCDLAF-UHFFFAOYSA-N","BRD-K76725781","","CC(C)CN(c1cc2CCCc2cc1OCc1ccc(cc1)C(O)=O)S(=O)(=O)c1nc(C)cs1"
"3614","ONX-0914","proteasome inhibitor","","","","Selleck",93.85,"BRD-K60446698-001-01-2","Preclinical","","WQAVPPWWLLVGFK-FRDWYVIJSA-N","BRD-K60446698","","COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@]2(C)CO2)cc1"
"3615","ON123300","CDK inhibitor","CDK4, NUAK1, PDGFRB","","","MedChemEx, MedChemEx",91.24,"BRD-K88554883-001-01-6, BRD-K88554883-001-03-2","Preclinical","","VADOZMZXXRBXNY-UHFFFAOYSA-N","BRD-K88554883","","CN1CCN(CC1)c1ccc(Nc2ncc3cc(C#N)c(=O)n(C4CCCC4)c3n2)cc1"
"3617","OPC-21268","vasopressin receptor antagonist","AVPR1A, AVPR2, OXTR","","","Tocris, Sigma",96.93,"BRD-K19426040-001-02-9, BRD-K19426040-001-01-1","Phase 1","","KSNUCNRMDYJBKT-UHFFFAOYSA-N","BRD-K19426040","","CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2ccccc12"
"3619","OPICAPONE","catechol O methyltransferase inhibitor","COMT","","","MedChemEx, MedChemEx",94.71,"BRD-K66192203-001-01-4, BRD-K66192203-001-02-2","Phase 3","","ASOADIZOVZTJSR-UHFFFAOYSA-N","BRD-K66192203","","Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(n1)-c1cc(O)c(O)c(c1)[N+]([O-])=O"
"3621","OPROZOMIB","proteasome inhibitor","","","","Selleck",94.08,"BRD-A36331462-001-02-1","Phase 1/Phase 2","","SWZXEVABPLUDIO-QNLBTCDKSA-N","BRD-A36331462","","COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C1(C)CO1"
"3622","OR-486","catechol O methyltransferase inhibitor","COMT","","","Tocris",0,"BRD-K18602506-001-08-0","Preclinical","","VDCDWNDTNSWDFJ-UHFFFAOYSA-N","BRD-K18602506","","Oc1cc(cc(c1O)[N+]([O-])=O)[N+]([O-])=O"
"3623","ORANTINIB","FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB","","","Selleck, Tocris, Tocris, Selleck",92.22,"BRD-K55966568-001-09-6, BRD-K55966568-001-06-2, BRD-K55966568-001-10-4, BRD-K55966568-001-05-4","Phase 3","","NHFDRBXTEDBWCZ-ZROIWOOFSA-N","BRD-K55966568","","Cc1[nH]c(\C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O"
"3627","ORE1001","angiotensin converting enzyme inhibitor","ACE2","","","EMDBio",94.22,"BRD-K67068943-001-01-0","Phase 1/Phase 2","","NTCCRGGIJNDEAB-IRXDYDNUSA-N","BRD-K67068943","","CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(O)=O)C(O)=O"
"3628","ORG-12962","serotonin receptor agonist","HTR2A, HTR2B, HTR2C","","","Key",91.07,"BRD-K07409305-001-01-1","Phase 2","","QZYYPQAYSFBKPW-UHFFFAOYSA-N","BRD-K07409305","","FC(F)(F)c1ccc(nc1Cl)N1CCNCC1"
"3629","ORG-25543","glycine transporter inhibitor","GLRB, SLC6A5","","","Tocris",97.69,"BRD-K32853922-003-01-8","Preclinical","","ZCYOBMASPXQBSZ-UHFFFAOYSA-N","BRD-K32853922","","COc1cc(cc(OC)c1OCc1ccccc1)C(=O)NCC1(CCCC1)N(C)C"
"3630","ORG-26576","glutamate receptor modulator","","","","AMS",98.64,"BRD-K40002998-001-01-5","Phase 2","","FIKUEZUFASUKAH-QMMMGPOBSA-N","BRD-K40002998","","O=C1N2CCC[C@H]2COc2ncccc12"
"3631","ORG-27569","cannabinoid receptor modulator","CNR1","","","Selleck",90.91,"BRD-K57597776-001-01-2","Preclinical","","AHFZDNYNXFMRFQ-UHFFFAOYSA-N","BRD-K57597776","","CCc1c([nH]c2ccc(Cl)cc12)C(=O)NCCc1ccc(cc1)N1CCCCC1"
"3632","ORG-9768","adrenergic receptor antagonist","ADRA2A","","","Enamine",93.42,"BRD-K41434598-003-01-9","Phase 1","","JOLKQWPKJFRPOU-UHFFFAOYSA-N","BRD-K41434598","","CC1(CN)Cc2ccccc2C1"
"3633","ORIDONIN","BCL inhibitor","BCL2","","","Selleck, Selleck",92.98,"BRD-K23925186-001-02-8, BRD-K23925186-001-01-0","Preclinical","BRD-A09838294-001-02-2, BRD-K35776642-001-02-9,BRD-A99499647-001-01-0","VPZCKRKZFRCZMX-QRTGZHHDSA-N","BRD-K23925186","BRD-A09838294","O[C@@H]1[C@H]2CC[C@@H]3[C@@]45CO[C@](O)(C[C@@H]4C(C)(C)CC[C@@H]5O)[C@@]13C(=O)C2=C"
"3635","ORNITHINE","NFkB pathway modulator","ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4","","","MicroSource",0,"BRD-A13561534-003-02-0","Launched","","AHLPHDHHMVZTML-UHFFFAOYSA-N","BRD-A13561534","","NCCCC(N)C(O)=O"
"3636","OROTIC-ACID","","DHODH","","","MicroSource, Selleck",100,"BRD-K32572029-001-05-1, BRD-K32572029-001-04-4","Phase 2","","PXQPEWDEAKTCGB-UHFFFAOYSA-N","BRD-K32572029","","OC(=O)c1cc(=O)[nH]c(=O)[nH]1"
"3638","ORPHANIN-FQ","opioid receptor agonist","OPRL1, OPRM1","","","Enzo",63.03,"BRD-K05717154-001-01-1","Phase 1","","PULGYDLMFSFVBL-SMFNREODSA-N","BRD-K05717154","","CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O"
"3639","ORTERONEL","androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor","CYP17A1","","","Selleck",97.87,"BRD-K00674894-001-01-4","Phase 3","BRD-A12409803-001-04-7","OZPFIJIOIVJZMN-GOSISDBHSA-N","BRD-K00674894","BRD-A12409803","CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12"
"3640","ORY-1001","histone lysine demethylase inhibitor","KDM1A","","","MedChemEx, Selleck",92.83,"BRD-K59711701-300-02-1, BRD-K59711701-300-01-3","Phase 1/Phase 2","","ALHBJBCQLJZYON-PFSRBDOWSA-N","BRD-K59711701","","NC1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1"
"3642","OSEMOZOTAN","serotonin receptor agonist","HTR1A","","","Sigma",98.16,"BRD-K60371362-001-01-7","Phase 2/Phase 3","","MEEQBDCQPIZMLY-HNNXBMFYSA-N","BRD-K60371362","","C(CNC[C@H]1COc2ccccc2O1)COc1ccc2OCOc2c1"
"3643","OSI-027","mTOR inhibitor","MTOR","","","Selleck, Selleck",91.53,"BRD-K87124298-001-03-4, BRD-K87124298-001-04-2","Phase 1","","JROFGZPOBKIAEW-HAQNSBGRSA-N","BRD-K87124298","","COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12"
"3645","OSI-420","EGFR inhibitor","EGFR","","","Selleck",96.28,"BRD-K73309154-003-02-8","Preclinical","","KOQIAZNBAWFSQM-UHFFFAOYSA-N","BRD-K73309154","","COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCO"
"3646","OSI-930","KIT inhibitor, VEGFR inhibitor","KDR, KIT","","","Selleck, Selleck",86.5,"BRD-K25340465-001-11-1, BRD-K25340465-001-07-9","Phase 1","","FGTCROZDHDSNIO-UHFFFAOYSA-N","BRD-K25340465","","FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1"
"3648","OSTARINE","androgen receptor modulator","AR","","","Selleck",97.85,"BRD-K29735307-001-02-9","Phase 3","","JNGVJMBLXIUVRD-SFHVURJKSA-N","BRD-K29735307","","C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F"
"3649","OSTHOL","calcium channel blocker","","","","Selleck",98.35,"BRD-K78294846-001-12-4","Preclinical","","MBRLOUHOWLUMFF-UHFFFAOYSA-N","BRD-K78294846","","COc1ccc2ccc(=O)oc2c1CC=C(C)C"
"3650","OT-R-ANTAGONIST-1","oxytocin receptor antagonist","AVPR1A, OXTR","","","MedChemEx",98.05,"BRD-K42009284-001-01-1","Preclinical","","IBXGJPAYWMFXSF-UEEONYLUSA-N","BRD-K42009284","","CO\N=C1\C[C@H](N(C1)C(=O)c1ccc(cc1)-c1ccccc1C)C(=O)NC[C@@H](O)c1ccccc1"
"3651","OTAMIXABAN","coagulation factor inhibitor","F10","","","MedChemEx",95.95,"BRD-K80082640-001-01-0","Phase 3","","PFGVNLZDWRZPJW-OPAMFIHVSA-N","BRD-K80082640","","COC(=O)[C@H](Cc1cccc(c1)C(N)=N)[C@@H](C)NC(=O)c1ccc(cc1)-c1cc[n+]([O-])cc1"
"3652","OTENZEPAD","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","","","Tocris, Tocris",92.55,"BRD-A00520476-001-08-2, BRD-A00520476-001-07-4","Phase 3","","UBRKDAVQCKZSPO-UHFFFAOYSA-N","BRD-A00520476","","CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12"
"3654","OTS167","maternal embryonic leucine zipper kinase inhibitor","MELK","","","MedChemEx",93.78,"BRD-K53417444-003-03-1","Phase 1","","DKZYXHCYPUVGAF-JCNLHEQBSA-N","BRD-K53417444","","CN(C)C[C@H]1CC[C@@H](CC1)Nc1c(cnc2ccc(nc12)-c1cc(Cl)c(O)c(Cl)c1)C(C)=O"
"3655","OTS514","TOPK inhibitor","","","","MedChemEx",93.47,"BRD-K38018935-001-01-1","Preclinical","","OETLNMOJNONWOY-LBPRGKRZSA-N","BRD-K38018935","","C[C@@H](CN)c1ccc(cc1)-c1c(O)cc(C)c2[nH]c(=O)c3sccc3c12"
"3656","OTX015","bromodomain inhibitor","BRD2, BRD3, BRD4","","","Selleck, Selleck",98.65,"BRD-K43471985-001-05-5, BRD-K43471985-001-03-0","Phase 1/Phase 2","BRD-A53775886-001-01-7","GNMUEVRJHCWKTO-FQEVSTJZSA-N","BRD-K43471985","BRD-A53775886","Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1"
"3658","OXA-06","rho associated kinase inhibitor","ROCK1, ROCK2","","","Tocris",96.59,"BRD-K98736329-300-01-5","Preclinical","","XUIUXXQVHPEQNM-UHFFFAOYSA-N","BRD-K98736329","","Fc1ccccc1CNCc1ccc(cc1)-c1ccnc2[nH]ccc12"
"3659","OXACYCLOHEXADECAN-2-ONE","protein kinase inhibitor","","","","Sigma",0,"BRD-K36982194-001-01-6","Preclinical","","FKUPPRZPSYCDRS-UHFFFAOYSA-N","BRD-K36982194","","O=C1CCCCCCCCCCCCCCO1"
"3660","OXALOACETATE","glutamate release inhibitor","CS, SPR","","","Sigma, Enamine",0,"BRD-K61279411-001-03-8, BRD-K61279411-001-02-0","Phase 2/Phase 3","","KHPXUQMNIQBQEV-UHFFFAOYSA-N","BRD-K61279411","","OC(=O)CC(=O)C(O)=O"
"3662","OXANTEL","anthelmintic agent","","","","MicroSource",36.2,"BRD-K66019333-096-02-0","Phase 3","","VRYKTHBAWRESFI-VOTSOKGWSA-N","BRD-K66019333","","CN1CCCN=C1\C=C\c1cccc(O)c1"
"3663","OXF-BD-02","bromodomain inhibitor","BRD4","","","Tocris",93.12,"BRD-A73891132-001-01-0","Preclinical","","FEQUIPXIENTMJN-UHFFFAOYSA-N","BRD-A73891132","","Cc1noc(C)c1-c1cc(O)cc(c1)C(O)c1ccccc1"
"3664","OXFENICINE","carnitine palmitoyltransferase inhibitor","CPT1A, CPT1B","","","Enamine, Vitas-M",98,"BRD-K30373577-001-01-1, BRD-A86525947-001-01-4","Phase 1","","LJCWONGJFPCTTL-SSDOTTSWSA-N","BRD-K30373577","","N[C@@H](C(O)=O)c1ccc(O)cc1"
"3665","OXFENICINE","carnitine palmitoyltransferase inhibitor","CPT1A, CPT1B","","","Enamine, Vitas-M",98,"BRD-K30373577-001-01-1, BRD-A86525947-001-01-4","Phase 1","","LJCWONGJFPCTTL-SSDOTTSWSA-N","BRD-K30373577","","NC(C(O)=O)c1ccc(O)cc1"
"3666","OXFENICINE","carnitine palmitoyltransferase inhibitor","CPT1A, CPT1B","","","Enamine, Vitas-M",98,"BRD-K30373577-001-01-1, BRD-A86525947-001-01-4","Phase 1","","LJCWONGJFPCTTL-UHFFFAOYSA-N","BRD-K30373577","","N[C@@H](C(O)=O)c1ccc(O)cc1"
"3667","OXFENICINE","carnitine palmitoyltransferase inhibitor","CPT1A, CPT1B","","","Enamine, Vitas-M",98,"BRD-K30373577-001-01-1, BRD-A86525947-001-01-4","Phase 1","","LJCWONGJFPCTTL-UHFFFAOYSA-N","BRD-K30373577","","NC(C(O)=O)c1ccc(O)cc1"
"3668","OXIDOPAMINE","neurotoxin","","","","MicroSource",0,"BRD-K41809988-003-09-3","Preclinical","","DIVDFFZHCJEHGG-UHFFFAOYSA-N","BRD-K41809988","","NCCc1cc(O)c(O)cc1O"
"3669","OXINIACIC-ACID","","","","","Vitas-M, MicroSource",100,"BRD-K20417253-001-02-7, BRD-K20417253-001-01-9","Preclinical","","FJCFFCXMEXZEIM-UHFFFAOYSA-N","BRD-K20417253","","OC(=O)c1ccc[n+]([O-])c1"
"3671","OXIPEROMIDE","dopamine receptor antagonist","","","","Enamine",86.05,"BRD-K78096648-001-05-7","Phase 2","","NVDBBGBUTKLRSN-UHFFFAOYSA-N","BRD-K78096648","","Oc1nc2ccccc2n1C1CCN(CCOc2ccccc2)CC1"
"3672","OXIRACETAM","acetylcholine receptor agonist","","","","MedChemEx",100,"BRD-K50677762-001-01-5","Launched","","IHLAQQPQKRMGSS-SCSAIBSYSA-N","BRD-K50677762","","NC(=O)CN1C[C@H](O)CC1=O"
"3673","OXOLINIC-ACID","bacterial DNA gyrase inhibitor","","","","MicroSource",95.97,"BRD-K73394555-237-01-1","Preclinical","","KYGZCKSPAKDVKC-UHFFFAOYSA-N","BRD-K73394555","","CCn1cc(C(O)=O)c(=O)c2cc3OCOc3cc12"
"3674","OXONIC-ACID","uricase inhibitor","","","","AKSci, Sigma",0,"BRD-K31468676-237-01-8, BRD-K31468676-237-02-6","Preclinical","BRD-K13516279-237-01-7","RYYCJUAHISIHTL-UHFFFAOYSA-N","BRD-K31468676","BRD-K13516279","OC(=O)c1nc(=O)[nH]c(=O)[nH]1"
"3676","OXOTREMORINE-M","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","","","Tocris, Tocris",97.04,"BRD-K01942991-005-09-0, BRD-K01942991-005-08-2","Preclinical","","CANZROMYQDHYHR-UHFFFAOYSA-N","BRD-K01942991","","C[N+](C)(C)CC#CCN1CCCC1=O"
"3678","OXOTREMORINE-SESQUIFUMARATE","cholinergic receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","","","Tocris, Tocris",69.87,"BRD-K21936341-051-04-0, BRD-K21936341-051-03-2","Preclinical","BRD-M50913522-361-03-7, BRD-M50913522-361-02-9","RSDOPYMFZBJHRL-UHFFFAOYSA-N","BRD-K21936341","BRD-M50913522","O=C1CCCN1CC#CCN1CCCC1"
"3680","OXYMATRINE","","","","","Selleck",90.8,"BRD-A57833392-001-01-7","Launched","","XVPBINOPNYFXID-WEFVWUPKSA-N","BRD-A57833392","","[O-][N+]12CCC[C@@H]3CN4[C@H](CCCC4=O)[C@H](CCC1)[C@@H]23"
"3681","OXYPHENBUTAZONE","cyclooxygenase inhibitor","PLA2G2E, PTGS1, PTGS2","","","MicroSource",69.64,"BRD-A33749298-001-18-3","Withdrawn","","HFHZKZSRXITVMK-UHFFFAOYSA-N","BRD-A33749298","","CCCCC1C(=O)N(N(C1=O)c1ccc(O)cc1)c1ccccc1"
"3682","OXYPURINOL","xanthine oxidase inhibitor","XDH","","","AlfaAesar",95,"BRD-K31841515-001-07-8","Phase 2/Phase 3","","HXNFUBHNUDHIGC-UHFFFAOYSA-N","BRD-K31841515","","O=c1[nH]c2n[nH]cc2c(=O)[nH]1"
"3683","OZANIMOD","sphingosine 1 phosphate receptor agonist","S1PR1","","","MedChemEx",98.03,"BRD-K46625559-001-01-8","Phase 3","","XRVDGNKRPOAQTN-FQEVSTJZSA-N","BRD-K46625559","","CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2[C@H](CCc12)NCCO"
"3684","OZOLINONE","diuretic","","","","Sigma",78.8,"BRD-A72297358-001-01-8","Phase 3","","NQFBZYYUAFJYNS-FPLPWBNLSA-N","BRD-A72297358","","CN1C(=O)C(S\C1=C/C(O)=O)N1CCCCC1"
"3685","O4I1","Oct inducer","POU5F1","","","Tocris",0,"BRD-K53849769-001-01-0","Preclinical","","QJEJLARVLKHYFW-UHFFFAOYSA-N","BRD-K53849769","","COc1ccc(COc2ccc(CC#N)cc2)cc1"
"3686","O6-BENZYLGUANINE","O6-alkylguanine-DNA alkyltransferase inhibitor","MGMT","","","CombiBlocks",98.19,"BRD-K92041145-001-09-5","Phase 3","","KRWMERLEINMZFT-UHFFFAOYSA-N","BRD-K92041145","","Nc1nc(OCc2ccccc2)c2[nH]cnc2n1"
"3687","P-DIMETHYLINAMYL-BENZOATE","","","","","Enamine",26.63,"BRD-K42336459-001-01-7","Preclinical","","LXTZRIBXKVRLOA-UHFFFAOYSA-N","BRD-K42336459","","CCCCCOC(=O)c1ccc(cc1)N(C)C"
"3688","PA-452","retinoid receptor antagonist","RXRA","","","Tocris",96.7,"BRD-K11428250-001-01-0","Preclinical","","JJUUTJCZMGZJDZ-UHFFFAOYSA-N","BRD-K11428250","","CCCCCCOc1cc2c(cc1N(C)c1ncc(cn1)C(O)=O)C(C)(C)CCC2(C)C"
"3689","PA-824","nitric oxide donor","FASN","","","Selleck",96.87,"BRD-K96671969-001-03-1","Phase 3","","ZLHZLMOSPGACSZ-NSHDSACASA-N","BRD-K96671969","","[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(OC(F)(F)F)cc1"
"3690","PAC-1","caspase activator","CASP3","","","Tocris, Tocris, Selleck",96.8,"BRD-K92991072-001-05-6, BRD-K92991072-001-06-4, BRD-K92991072-001-04-9","Phase 1","","YQNRVGJCPCNMKT-LFVJCYFKSA-N","BRD-K92991072","","Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1"
"3693","PACOCF3","phospholipase inhibitor","PLA2G4A","","","Tocris",0,"BRD-K05677083-001-05-4","Preclinical","","MAHYXYTYTLCTQD-UHFFFAOYSA-N","BRD-K05677083","","CCCCCCCCCCCCCCCC(=O)C(F)(F)F"
"3694","PACRITINIB","FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3","","","MedChemEx, Selleck, Selleck",90.7,"BRD-K19034817-001-04-8, BRD-K19034817-001-01-4, BRD-K19034817-001-02-2","Phase 3","","HWXVIOGONBBTBY-ONEGZZNKSA-N","BRD-K19034817","","C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COC\C=C\COCc1c2)c3"
"3697","PAEONIFLORIN","anticonvulsant","","","","Selleck, Selleck",80.79,"BRD-K83631119-001-02-1, BRD-K83631119-001-03-9","Preclinical","BRD-K77265172-001-01-2","YKRGDOXKVOZESV-WRJNSLSBSA-N","BRD-K83631119","BRD-K77265172","C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@H]3C[C@]21O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O"
"3699","PAEONOL","anti-inflammatory agent","","","","Selleck",94.76,"BRD-K94239562-001-05-5","Preclinical","","UILPJVPSNHJFIK-UHFFFAOYSA-N","BRD-K94239562","","COc1ccc(C(C)=O)c(O)c1"
"3700","PAFURAMIDINE","DNA synthesis inhibitor","","","","MedChemEx",94.73,"BRD-K68805147-001-01-8","Phase 3","","UKOQVLAXCBRRGH-UHFFFAOYSA-N","BRD-K68805147","","CONC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(=N)NOC"
"3701","PALIFOSFAMIDE","DNA alkylating agent","","","","MedChemEx, MedChemEx",0,"BRD-K12047401-001-01-5, BRD-K12047401-001-02-3","Phase 3","","BKCJZNIZRWYHBN-UHFFFAOYSA-N","BRD-K12047401","","OP(=O)(NCCCl)NCCCl"
"3703","PALMATINE-CHLORIDE","dopamine synthesis inhibitor","CYP3A4","","","Selleck",92.35,"BRD-K58466253-003-14-0","Preclinical","","QUCQEUCGKKTEBI-UHFFFAOYSA-N","BRD-K58466253","","COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4cc3-c2cc1OC"
"3704","PALMITOLEIC-ACID","","","","","Sigma",97.5,"BRD-K91356052-001-04-0","Preclinical","","SECPZKHBENQXJG-FPLPWBNLSA-N","BRD-K91356052","","CCCCCC\C=C/CCCCCCCC(O)=O"
"3705","PALMITOYLCARNITINE","protein kinase inhibitor","","","","Tocris",100,"BRD-A77577770-003-08-9","Preclinical","","XOMRRQXKHMYMOC-UHFFFAOYSA-O","BRD-A77577770","","CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C"
"3706","PALMITOYLETHANOLAMIDE","cannabinoid receptor agonist","CNR2, GPR119, GPR55","","","MicroSource, Tocris",96.53,"BRD-K68095457-001-11-9, BRD-K68095457-001-10-1","Launched","","HXYVTAGFYLMHSO-UHFFFAOYSA-N","BRD-K68095457","","CCCCCCCCCCCCCCCC(=O)NCCO"
"3708","PALOMID-529","AKT inhibitor, mTOR inhibitor","MTOR","","","Selleck",94.07,"BRD-A50998626-001-02-1","Phase 1","","YEAHTLOYHVWAKW-UHFFFAOYSA-N","BRD-A50998626","","COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1"
"3709","PALOSURAN","urotensin receptor antagonist","UTS2R","","","MedChemEx",98.46,"BRD-K07682953-001-01-8","Phase 2","","WYJCYXOCHXWTHG-UHFFFAOYSA-N","BRD-K07682953","","Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1"
"3710","PALOVAROTENE","retinoid receptor agonist","RARG","","","MedChemEx",85.97,"BRD-K83794243-001-01-8","Phase 2","","YTFHCXIPDIHOIA-DHZHZOJOSA-N","BRD-K83794243","","CC1(C)CCC(C)(C)c2cc(\C=C\c3ccc(cc3)C(O)=O)c(Cn3cccn3)cc12"
"3711","PANTETHINE","coenzyme A precursor","","","","Sigma, MedChemEx, MedChemEx, MicroSource",97.01,"BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4","Launched","","DJWYOLJPSHDSAL-ROUUACIJSA-N","BRD-K68764924","","CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO"
"3714","PANTETHINE","coenzyme A precursor","","","","Sigma, MedChemEx, MedChemEx, MicroSource",97.01,"BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4","Launched","","DJWYOLJPSHDSAL-ROUUACIJSA-N","BRD-K68764924","","CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO"
"3715","PANTETHINE","coenzyme A precursor","","","","Sigma, MedChemEx, MedChemEx, MicroSource",97.01,"BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4","Launched","","DJWYOLJPSHDSAL-UHFFFAOYSA-N","BRD-K68764924","","CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO"
"3718","PANTETHINE","coenzyme A precursor","","","","Sigma, MedChemEx, MedChemEx, MicroSource",97.01,"BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4","Launched","","DJWYOLJPSHDSAL-UHFFFAOYSA-N","BRD-K68764924","","CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO"
"3719","PANTOTHENIC-ACID","coenzyme A precursor","","","","Selleck, MicroSource, Selleck",86.63,"BRD-K29392254-001-02-2, BRD-K29392254-236-01-6, BRD-K29392254-001-03-0","Launched","","GHOKWGTUZJEAQD-ZETCQYMHSA-N","BRD-K29392254","","CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O"
"3722","PAOPA","dopamine receptor modulator","DRD2","","","Tocris",69.39,"BRD-K18573821-001-02-4","Preclinical","","QXHVGEXNEZRSGG-JGVFFNPUSA-N","BRD-K18573821","","NC(=O)CN1CC[C@@H](NC(=O)[C@@H]2CCCN2)C1=O"
"3723","PARA-TOLUENESULFONAMIDE","","CA12, CA2, CA6, CA9","","","Enamine",97.72,"BRD-K62412084-001-07-1","Phase 3","","LMYRWZFENFIFIT-UHFFFAOYSA-N","BRD-K62412084","","Cc1ccc(cc1)S(N)(=O)=O"
"3724","PARACHLOROPHENOL","antiinfective drug","","","","MicroSource",89.27,"BRD-K40992116-001-09-7","Launched","","WXNZTHHGJRFXKQ-UHFFFAOYSA-N","BRD-K40992116","","Oc1ccc(Cl)cc1"
"3725","PARAXANTHINE","adenosine receptor antagonist","","","","Enzo",97.98,"BRD-K24084088-001-11-3","Phase 1","","QUNWUDVFRNGTCO-UHFFFAOYSA-N","BRD-K24084088","","Cn1cnc2[nH]c(=O)n(C)c(=O)c12"
"3726","PARBENDAZOLE","tubulin polymerization inhibitor","TUBB","","","Prestwick",98.82,"BRD-K02407574-001-09-7","Preclinical","","YRWLZFXJFBZBEY-UHFFFAOYSA-N","BRD-K02407574","","CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1"
"3727","PARDOPRUNOX","serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7","","","MedChemEx",95.88,"BRD-K11851476-003-01-7","Phase 3","","YVPUUUDAZYFFQT-UHFFFAOYSA-N","BRD-K11851476","","CN1CCN(CC1)c1cccc2[nH]c(=O)oc12"
"3728","PARETHOXYCAINE","local anesthetic","","","","ChemBridge",91.8,"BRD-K54799382-003-08-4","Preclinical","","OWWVHQUOYSPNNE-UHFFFAOYSA-N","BRD-K54799382","","CCOc1ccc(cc1)C(=O)OCCN(CC)CC"
"3729","PAROXYPROPIONE","gonadotropin inhibitor","","","","MicroSource",93.24,"BRD-K07441213-001-18-9","Launched","","RARSHUDCJQSEFJ-UHFFFAOYSA-N","BRD-K07441213","","CCC(=O)c1ccc(O)cc1"
"3730","PARTHENOLIDE","NFkB pathway inhibitor","","","","Tocris, Tocris",96.19,"BRD-K98548675-001-06-7, BRD-K98548675-001-05-9","Phase 1","","KTEXNACQROZXEV-SLXBATTESA-N","BRD-K98548675","","C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1"
"3732","PARTHENOLIDE-(-)","NFkB pathway inhibitor","HDAC1","","","Selleck",96.2,"BRD-K34851558-001-02-3","Preclinical","","KTEXNACQROZXEV-QLIGOWBFSA-N","BRD-K34851558","","C\C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1"
"3733","PARTHENOLIDE-(ALTERNATE-STEREO)","NFkB pathway inhibitor","IKBKB, RELA","","","Prestwick",97.8,"BRD-K28120222-001-08-4","Preclinical","","KTEXNACQROZXEV-PVLRGYAZSA-N","BRD-K28120222","","C\C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1"
"3734","PCA-4248","platelet activating factor receptor antagonist","PTAFR","","","Tocris, Tocris",91.88,"BRD-A29289453-001-05-4, BRD-A29289453-001-04-7","Phase 1","","DHCNAWNKZMNTIS-UHFFFAOYSA-N","BRD-A29289453","","COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1"
"3736","PCI-24781","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC6","","","Selleck",90.76,"BRD-K12867552-001-04-7","Phase 1/Phase 2","","MAUCONCHVWBMHK-UHFFFAOYSA-N","BRD-K12867552","","CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO"
"3737","PCI-29732","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Tocris",0,"BRD-K71223042-001-01-5","Preclinical","","GMJUPMONHWAZCP-UHFFFAOYSA-N","BRD-K71223042","","Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCC1"
"3738","PCI-34051","HDAC inhibitor","HDAC1, HDAC10, HDAC6, HDAC8","","","Selleck, Selleck, Tocris",88.28,"BRD-K88742110-001-07-9, BRD-K88742110-001-08-7, BRD-K88742110-001-09-5","Preclinical","","AJRGHIGYPXNABY-UHFFFAOYSA-N","BRD-K88742110","","COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1"
"3741","PCO-400","potassium channel activator","KCNJ8","","","Enzo",32.31,"BRD-K52721684-001-03-0","Phase 1","","WJBHHTPFTVKZCV-CVEARBPZSA-N","BRD-K52721684","","CC1(C)Oc2ccc(cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N"
"3742","PD-0325901","MEK inhibitor","MAP2K1","","","Selleck",95.2,"BRD-K49865102-001-08-4","Phase 2","","SUDAHWBOROXANE-SECBINFHSA-N","BRD-K49865102","","OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F"
"3743","PD-102807","acetylcholine receptor antagonist","CHRM4","","","Tocris, Tocris",88.27,"BRD-A89337244-001-03-7, BRD-A89337244-001-02-9","Preclinical","","VDDUJINYXKGZLV-UHFFFAOYSA-N","BRD-A89337244","","CCOC(=O)c1c(C)[nH]c2ccc3OC4N(CCc5cc(OC)ccc45)Cc3c12"
"3745","PD-118057","potassium channel activator","KCNH2","","","Sigma",94.44,"BRD-K34657753-001-01-9","Preclinical","","ZCQOSCDABPVAFB-UHFFFAOYSA-N","BRD-K34657753","","OC(=O)c1ccccc1Nc1ccc(CCc2ccc(Cl)c(Cl)c2)cc1"
"3746","PD-123319","angiotensin antagonist","AGTR2","","","Selleck, Tocris",95.92,"BRD-K34713073-001-01-3, BRD-K34713073-362-01-9","Phase 1","","YSTVFDAKLDMYCR-NDEPHWFRSA-N","BRD-K34713073","","CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)cc1C"
"3748","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-GXTWGEPZSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@@H]1COc1ccc(O)cc21"
"3749","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-GXTWGEPZSA-N","BRD-K20260086","","CCCN1CCO[C@@H]2[C@@H]1COc1ccc(O)cc21"
"3750","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-GXTWGEPZSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@H]1COc1ccc(O)cc21"
"3751","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-JSGCOSHPSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@@H]1COc1ccc(O)cc21"
"3752","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-JSGCOSHPSA-N","BRD-K20260086","","CCCN1CCO[C@@H]2[C@@H]1COc1ccc(O)cc21"
"3753","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-JSGCOSHPSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@H]1COc1ccc(O)cc21"
"3754","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-TZMCWYRMSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@@H]1COc1ccc(O)cc21"
"3755","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-TZMCWYRMSA-N","BRD-K20260086","","CCCN1CCO[C@@H]2[C@@H]1COc1ccc(O)cc21"
"3756","PD-128907","dopamine receptor agonist","DRD2, DRD3","","","Selleck, Selleck, Tocris",91.59,"BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1","Preclinical","","YOILXOMTHPUMRG-TZMCWYRMSA-N","BRD-K20260086","","CCCN1CCO[C@H]2[C@H]1COc1ccc(O)cc21"
"3757","PD-153035","EGFR inhibitor","EGFR, KDR","","","MedChemEx",98.35,"BRD-K26603252-003-04-9","Phase 1","","LSPANGZZENHZNJ-UHFFFAOYSA-N","BRD-K26603252","","COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC"
"3758","PD-156707","endothelin receptor antagonist","EDNRA, EDNRB","","","Sigma",71.03,"BRD-K13826399-236-01-7","Preclinical","","OFCTYBMKKTVKCR-QQTULTPQSA-N","BRD-K13826399","","COc1ccc(cc1)C(=O)C(\Cc1cc(OC)c(OC)c(OC)c1)=C(/C(O)=O)c1ccc2OCOc2c1"
"3759","PD-158780","EGFR inhibitor","EGFR","","","Tocris, Tocris",69.87,"BRD-K48735772-001-03-0, BRD-K48735772-001-04-8","Preclinical","","KFHMLBXBRCITHF-UHFFFAOYSA-N","BRD-K48735772","","CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1"
"3761","PD-160170","neuropeptide receptor antagonist","NPY1R","","","Tocris, Tocris",97.6,"BRD-K12079898-001-02-6, BRD-K12079898-001-03-4","Preclinical","","YUVNGBZROXQYQH-UHFFFAOYSA-N","BRD-K12079898","","CC(C)c1ccccc1S(=O)(=O)c1cc(N)c2ncccc2c1[N+]([O-])=O"
"3763","PD-161570","FGFR inhibitor","FGFR1","","","Tocris, Tocris",86.49,"BRD-K97152684-001-01-9, BRD-K97152684-001-02-7","Preclinical","","MKVMEJKNLUWFSQ-UHFFFAOYSA-N","BRD-K97152684","","CCN(CC)CCCCNc1ncc2cc(c(NC(=O)NC(C)(C)C)nc2n1)-c1c(Cl)cccc1Cl"
"3765","PD-166285","src inhibitor","EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1","","","Tocris",93.87,"BRD-K93217218-300-01-5","Preclinical","","IFPPYSWJNWHOLQ-UHFFFAOYSA-N","BRD-K93217218","","CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1"
"3766","PD-166793","collagenase inhibitor, metalloproteinase inhibitor","MMP13, MMP2, MMP3","","","Tocris, Tocris",98.52,"BRD-K60984070-001-01-0, BRD-K60984070-001-02-8","Preclinical","","GJOCABIDMCKCEG-INIZCTEOSA-N","BRD-K60984070","","CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O"
"3768","PD-168077","dopamine receptor agonist","DRD2","","","Tocris",20.24,"BRD-K47761761-050-07-8","Preclinical","","DNULYRGWTFLJQL-UHFFFAOYSA-N","BRD-K47761761","","Cc1cccc(c1)C(=O)NCN1CCN(CC1)c1ccccc1C#N"
"3769","PD-168393","EGFR inhibitor","EGFR, ERBB2, SRC","","","Selleck",96.19,"BRD-K17702546-001-03-2","Preclinical","","HTUBKQUPEREOGA-UHFFFAOYSA-N","BRD-K17702546","","Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1"
"3770","PD-168568","dopamine receptor antagonist","DRD2, DRD4","","","Tocris",96.65,"BRD-A82013137-300-01-1","Preclinical","","WQEPZBNLBWDIRZ-UHFFFAOYSA-N","BRD-A82013137","","Cc1ccc(cc1C)N1CCN(CCC2NC(=O)c3ccccc23)CC1"
"3771","PD-173074","FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","","","Selleck, Selleck, Tocris",94.27,"BRD-K97764662-001-20-7, BRD-K97764662-001-17-3, BRD-K97764662-001-21-5","Preclinical","","DXCUKNQANPLTEJ-UHFFFAOYSA-N","BRD-K97764662","","CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1"
"3774","PD-173212","calcium channel blocker","CACNA1B","","","Tocris",91.84,"BRD-K04426574-001-02-0","Preclinical","","GCDHMGROXQUFNR-HEVIKAOCSA-N","BRD-K04426574","","CC(C)C[C@H](N(C)Cc1ccc(cc1)C(C)(C)C)C(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)NC(C)(C)C"
"3775","PD-184352","MEK inhibitor","MAP2K1, MAP3K1, MAP3K2","","","Selleck",96.78,"BRD-K05104363-001-10-0","Phase 2","","GFMMXOIFOQCCGU-UHFFFAOYSA-N","BRD-K05104363","","Fc1ccc(C(=O)NOCC2CC2)c(Nc2ccc(I)cc2Cl)c1F"
"3776","PD-198306","MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2","","","Tocris",93.92,"BRD-K88677950-001-03-9","Preclinical","","UHAXDAKQGVISBZ-UHFFFAOYSA-N","BRD-K88677950","","Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1"
"3777","PD-318088","MEK inhibitor","MAP2K1","","","Selleck",95.69,"BRD-A57798112-001-03-7","Preclinical","","XXSSGBYXSKOLAM-UHFFFAOYSA-N","BRD-A57798112","","OCC(O)CONC(=O)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F"
"3778","PD-407824","PKC inhibitor","WEE1","","","Tocris, Tocris",92.11,"BRD-K82823804-001-04-1, BRD-K82823804-001-05-8","Preclinical","","IAUZTOZLTFSMIE-UHFFFAOYSA-N","BRD-K82823804","","Oc1ccc2[nH]c3cc(c4C(=O)NC(=O)c4c3c2c1)-c1ccccc1"
"3780","PD-81723","adenosine receptor agonist","ADORA1","","","Tocris",10.23,"BRD-K77951111-001-04-5","Preclinical","","KKDKAWKYGCUOGR-UHFFFAOYSA-N","BRD-K77951111","","Cc1sc(N)c(C(=O)c2cccc(c2)C(F)(F)F)c1C"
"3781","PD-98059","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Tocris",94.02,"BRD-K62810658-001-11-4, BRD-K62810658-001-15-5, BRD-K62810658-001-12-2","Preclinical","","QFWCYNPOPKQOKV-UHFFFAOYSA-N","BRD-K62810658","","COc1cccc(-c2cc(=O)c3ccccc3o2)c1N"
"3784","PDE10-IN-1","phosphodiesterase inhibitor","PDE10A","","","MedChemEx",96.99,"BRD-K38145871-001-01-8","Preclinical","","ZLHNYULRKIEGAY-HZPDHXFCSA-N","BRD-K38145871","","Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1"
"3785","PDP-EA","FAAH activator","FAAH","","","Tocris",96.07,"BRD-K26358347-001-01-7","Preclinical","","BIOVSNWTCKRADD-UHFFFAOYSA-N","BRD-K26358347","","CCCCCCCCCCCCCCCc1cccc(OCC(=O)NCCO)c1"
"3786","PD1-PDL-INHIBITOR-1","programmed death ligand inhibitor","CD274","","","MedChemEx",97.25,"BRD-K04032780-001-01-8","Preclinical","","ZBOYJODMIAUJHH-SANMLTNESA-N","BRD-K04032780","","COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CN1CCCC[C@H]1C(O)=O"
"3787","PEFICITINIB","JAK inhibitor","JAK1, JAK2, JAK3","","","MedChemEx, Selleck",98.78,"BRD-K21225231-001-01-2, BRD-A14577621-001-01-5","Phase 3","BRD-A59435073-001-01-5","DREIJXJRTLTGJC-ZKVNVPQCSA-N","BRD-K21225231","BRD-A59435073","NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2"
"3788","PEFICITINIB","JAK inhibitor","JAK1, JAK2, JAK3","","","MedChemEx, Selleck",98.78,"BRD-K21225231-001-01-2, BRD-A14577621-001-01-5","Phase 3","BRD-A59435073-001-01-5","DREIJXJRTLTGJC-ZKVNVPQCSA-N","BRD-K21225231","BRD-A59435073","NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1C2C[C@@H]3C[C@H]1C[C@@](O)(C3)C2"
"3789","PEFICITINIB","JAK inhibitor","JAK1, JAK2, JAK3","","","MedChemEx, Selleck",98.78,"BRD-K21225231-001-01-2, BRD-A14577621-001-01-5","Phase 3","BRD-A59435073-001-01-5","DREIJXJRTLTGJC-ZQPGVAGSSA-N","BRD-K21225231","BRD-A59435073","NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2"
"3790","PEFICITINIB","JAK inhibitor","JAK1, JAK2, JAK3","","","MedChemEx, Selleck",98.78,"BRD-K21225231-001-01-2, BRD-A14577621-001-01-5","Phase 3","BRD-A59435073-001-01-5","DREIJXJRTLTGJC-ZQPGVAGSSA-N","BRD-K21225231","BRD-A59435073","NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1C2C[C@@H]3C[C@H]1C[C@@](O)(C3)C2"
"3791","PELANSERIN","serotonin receptor antagonist","HTR2A","","","Enamine",91.31,"BRD-K96436774-001-01-8","Phase 2","","WPKPLSFHHBBLRY-UHFFFAOYSA-N","BRD-K96436774","","O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(CC1)c1ccccc1"
"3792","PELITINIB","EGFR inhibitor","EGFR","","","Selleck",92.07,"BRD-K08799216-001-05-3","Phase 2","","WVUNYSQLFKLYNI-AATRIKPKSA-N","BRD-K08799216","","CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C"
"3793","PENICILLAMINE-(RACEMIC)","","","","","MicroSource",0,"BRD-A16376407-213-01-1","Preclinical","","VVNCNSJFMMFHPL-UHFFFAOYSA-N","BRD-A16376407","","CC(C)(S)C(N)C(O)=O"
"3794","PENTACOSANOIC-ACID","","","","","Cayman",100,"BRD-K48996094-001-01-3","Preclinical","","MWMPEAHGUXCSMY-UHFFFAOYSA-N","BRD-K48996094","","CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O"
"3795","PENTETIC-ACID","chelating agent","PGD","","","MicroSource",99.18,"BRD-K40621224-001-06-7","Phase 2","","QPCDCPDFJACHGM-UHFFFAOYSA-N","BRD-K40621224","","OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O"
"3796","PENTOBARBITAL","barbiturate antiepileptic, GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","","","Prestwick",91.76,"BRD-A44448661-001-04-8","Withdrawn","","WEXRUCMBJFQVBZ-UHFFFAOYSA-N","BRD-A44448661","","CCCC(C)C1(CC)C(=O)NC(=O)NC1=O"
"3797","PENTYLENETETRAZOL","GABA receptor antagonist","","","","MedChemEx, Tocris, MicroSource",76.62,"BRD-K57718010-001-12-7, BRD-K57718010-001-10-1, BRD-K57718010-001-11-9","Withdrawn","","CWRVKFFCRWGWCS-UHFFFAOYSA-N","BRD-K57718010","","C1CCc2nnnn2CC1"
"3800","PEPSTATIN","aspartic protease inhibitor","CTSB, CTSD, CTSL, REN","","","Enzo",94.54,"BRD-K13571841-001-14-4","Preclinical","","FAXGPCHRFPCXOO-LXTPJMTPSA-N","BRD-K13571841","","CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O"
"3801","PERETINOIN","retinoid receptor agonist","RXRA","","","MedChemEx, MedChemEx",85.75,"BRD-K99431849-001-01-7, BRD-K99431849-001-02-5","Phase 3","","UUBHZHZSIKRVIV-KCXSXWJSSA-N","BRD-K99431849","","CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(C)=C\C(O)=O"
"3803","PERFLUAMINE","","","","","Oakwood",0,"BRD-K16758059-001-01-8","Launched","","JAJLKEVKNDUJBG-UHFFFAOYSA-N","BRD-K16758059","","FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F"
"3804","PERGOLIDE","dopamine receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","","","Selleck, Selleck",93,"BRD-K60770992-066-26-8, BRD-K60770992-066-25-0","Withdrawn","BRD-K38689957-066-01-5","YEHCICAEULNIGD-MZMPZRCHSA-N","BRD-K60770992","BRD-K38689957","CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13"
"3806","PERIFOSINE","AKT inhibitor","AKT1","","","MedChemEx, MedChemEx, MedChemEx",98.4,"BRD-A89082344-001-07-9, BRD-A89082344-001-06-1, BRD-A89082344-001-08-7","Phase 3","","SZFPYBIJACMNJV-UHFFFAOYSA-O","BRD-A89082344","","CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1"
"3809","PERILLYL-ALCOHOL","apoptosis stimulant, farnesyltransferase inhibitor","FNTA","","","Enamine, Enamine",0,"BRD-A13323580-001-05-5, BRD-A13323580-001-04-8","Phase 2","","NDTYTMIUWGWIMO-UHFFFAOYSA-N","BRD-A13323580","","CC(=C)C1CCC(CO)=CC1"
"3811","PERINDOPRILAT","angiotensin converting enzyme inhibitor","ACE","","","MicroSource",3.67,"BRD-K00768353-001-01-8","Phase 2","","ODAIHABQVKJNIY-PEDHHIEDSA-N","BRD-K00768353","","CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(O)=O"
"3812","PERUVOSIDE","cardiac glycoside","","","","Enzo",70.11,"BRD-A72716251-001-01-5","Phase 1","","PMTSPAGBAFCORP-WTGLOUSHSA-N","BRD-A72716251","","CO[C@H]1[C@@H](O)C(C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)C1O"
"3813","PERZINFOTEL","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B","","","Sigma",97,"BRD-K04643877-001-03-2","Phase 2","","BDABGOLMYNHHTR-UHFFFAOYSA-N","BRD-K04643877","","OP(O)(=O)CCN1CCCNc2c1c(=O)c2=O"
"3814","PETCM","caspase activator","CASP3","","","Tocris",93.77,"BRD-A93477898-001-04-2","Preclinical","","NGTDJJKTGRNNAU-UHFFFAOYSA-N","BRD-A93477898","","OC(Cc1ccncc1)C(Cl)(Cl)Cl"
"3815","PEVONEDISTAT","nedd activating enzyme inhibitor","NAE1, UBA3","","","MedChemEx",94.15,"BRD-K67844266-003-01-9","Phase 2","","MPUQHZXIXSTTDU-QXGSTGNESA-N","BRD-K67844266","","NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12"
"3816","PEXIDARTINIB","tyrosine kinase inhibitor","CSF1R, FLT3, KIT","","","MedChemEx",94.45,"BRD-K54519451-001-02-9","Phase 3","","JGWRKYUXBBNENE-UHFFFAOYSA-N","BRD-K54519451","","FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1"
"3817","PEXMETINIB","TIE tyrosine kinase inhibitor, MAP kinase inhibitor","MAPK14, TEK","","","Selleck, Selleck",99.4,"BRD-K53405000-001-02-8, BRD-K53405000-001-01-0","Phase 1","","LNMRSSIMGCDUTP-UHFFFAOYSA-N","BRD-K53405000","","Cc1ccc(cc1)-n1nc(cc1NC(=O)NCc1cc(F)ccc1Oc1ccc2n(CCO)ncc2c1)C(C)(C)C"
"3819","PF-02545920","phosphodiesterase inhibitor","PDE10A","","","Selleck",95.3,"BRD-K31519811-001-02-2","Phase 2","","AZEXWHKOMMASPA-UHFFFAOYSA-N","BRD-K31519811","","Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1"
"3820","PF-03049423","phosphodiesterase inhibitor","PDE5A","","","Key",97.3,"BRD-K07070922-001-01-4","Phase 2","","MNLNAGRCHNMKKJ-UHFFFAOYSA-N","BRD-K07070922","","CCCOCCn1c2cc(ncc2nc(N2CCN(CCO)CC2)c1=O)-c1ccc(OC)nc1"
"3821","PF-03084014","gamma secretase inhibitor","","","","MedChemEx",91.79,"BRD-K61691541-001-01-1","Phase 2","","VFCRKLWBYMDAED-REWPJTCUSA-N","BRD-K61691541","","CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(cn1)C(C)(C)CNCC(C)(C)C"
"3822","PF-03758309","p21 activated kinase inhibitor","PAK4","","","MedChemEx",95.43,"BRD-K37764012-001-04-1","Phase 1","","AYCPARAPKDAOEN-LJQANCHMSA-N","BRD-K37764012","","CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1"
"3823","PF-03814735","Aurora kinase inhibitor","AURKA, AURKB","","","MedChemEx, Tocris",99.4,"BRD-K68747584-001-02-0, BRD-K68747584-001-03-8","Phase 1","","RYYNGWLOYLRZLK-RBUKOAKNSA-N","BRD-K68747584","","CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(c(NC4CCC4)n3)C(F)(F)F)ccc21"
"3825","PF-03882845","","","","","Sigma",87.47,"BRD-K51041191-001-01-4","Phase 1","","ONEWULDKRWPYMP-QHCPKHFHSA-N","BRD-K51041191","","OC(=O)c1ccc2C3=C(CCc2c1)[C@H](C1CCCC1)N(N3)c1ccc(C#N)c(Cl)c1"
"3826","PF-04136309","CC chemokine receptor antagonist","","","","MedChemEx",97.35,"BRD-K94420399-001-01-9","Phase 2","","ZNSVOHSYDRPBGI-LXWOLXCRSA-N","BRD-K94420399","","O[C@]1(CC[C@@H](CC1)N[C@H]1CCN(C1)C(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc(cn1)-c1ncccn1"
"3827","PF-04217903","c-Met inhibitor","MET","","","Selleck",97.26,"BRD-K73319509-001-08-0","Phase 1","","PDMUGYOXRHVNMO-UHFFFAOYSA-N","BRD-K73319509","","OCCn1cc(cn1)-c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1"
"3828","PF-04418948","prostaglandin inhibitor","PTGER2","","","Tocris, Selleck",99.27,"BRD-K54871792-001-02-2, BRD-K54871792-001-01-4","Phase 1","","LWJGMYMNSNVCEM-UHFFFAOYSA-N","BRD-K54871792","","COc1ccc2cc(OCC3(CN(C3)C(=O)c3ccc(F)cc3)C(O)=O)ccc2c1"
"3830","PF-04447943","phosphodiesterase inhibitor","PDE9A","","","MedChemEx",97.37,"BRD-K50031829-001-01-6","Phase 2","","IWXUVYOOUMLUTQ-CZUORRHYSA-N","BRD-K50031829","","C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2n(ncc2c(=O)[nH]1)C1CCOCC1"
"3831","PF-04457845","FAAH inhibitor","FAAH","","","MedChemEx",99.1,"BRD-K86816506-001-01-8","Phase 2","","BATCTBJIJJEPHM-UHFFFAOYSA-N","BRD-K86816506","","FC(F)(F)c1ccc(Oc2cccc(C=C3CCN(CC3)C(=O)Nc3cccnn3)c2)nc1"
"3832","PF-04620110","diacylglycerol O acyltransferase inhibitor","DGAT1","","","MedChemEx",99.59,"BRD-K30550578-001-01-3","Phase 1","","GEVVQZHMFVFGLN-HDJSIYSDSA-N","BRD-K30550578","","Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12"
"3833","PF-04691502","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA","","","Selleck",96.68,"BRD-K07310275-001-02-5","Phase 2","","XDLYKKIQACFMJG-WKILWMFISA-N","BRD-K07310275","","COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O"
"3834","PF-04885614","voltage-gated sodium channel blocker","SCN10A","","","Tocris",84.39,"BRD-K92435527-001-01-4","Preclinical","","AGORGFNWYAUYSU-UHFFFAOYSA-N","BRD-K92435527","","CC(C)(N)c1nc(c[nH]1)-c1ccc(OC(F)(F)F)cc1"
"3835","PF-04937319","glucokinase activator","GCK","","","Sigma",97.36,"BRD-K27755542-001-01-6","Phase 2","","MASKQITXHVYVFL-UHFFFAOYSA-N","BRD-K27755542","","CN(C)C(=O)c1ncc(Oc2cc(cc3oc(C)cc23)C(=O)Nc2cnc(C)cn2)cn1"
"3836","PF-05190457","growth hormone secretagogue receptor inverse agonist","GHSR","","","Sigma",87.74,"BRD-K02554563-001-01-6","Phase 2","","ZIUDADZJCKGWKR-AREMUKBSSA-N","BRD-K02554563","","Cc1cn2cc(CC(=O)N3CCC4(CN(C4)[C@@H]4CCc5cc(ccc45)-c4cc(C)ncn4)CC3)nc2s1"
"3837","PF-05212384","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA","","","Key, Selleck, Selleck",97.48,"BRD-K07955840-001-04-9, BRD-K07955840-001-02-3, BRD-K07955840-001-03-1","Phase 2","","DWZAEMINVBZMHQ-UHFFFAOYSA-N","BRD-K07955840","","CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1"
"3840","PF-06447475","serine/threonine kinase inhibitor","LRRK2","","","MedChemEx, Tocris",99.15,"BRD-K83114366-001-01-0, BRD-K83114366-001-02-8","Preclinical","","BHTWDJBVZQBRKP-UHFFFAOYSA-N","BRD-K83114366","","N#Cc1cccc(c1)-c1c[nH]c2ncnc(N3CCOCC3)c12"
"3842","PF-06463922","ALK tyrosine kinase receptor inhibitor","ALK, FES, ROS1","","","Selleck",98.98,"BRD-A23124853-001-01-4","Phase 2","","IIXWYSCJSQVBQM-UHFFFAOYSA-N","BRD-A23124853","","CC1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N"
"3843","PF-3274167","oxytocin receptor antagonist","AVPR1A, OXTR","","","MedChemEx",96.73,"BRD-K31417912-001-01-9","Phase 2","","HNIFCPBQMKPRCX-UHFFFAOYSA-N","BRD-K31417912","","COCc1nnc(N2CC(C2)Oc2ccc(F)cc2Cl)n1-c1ccc(OC)nc1"
"3844","PF-3845","FAAH inhibitor","FAAH","","","Tocris, Selleck",96.31,"BRD-K68997413-001-06-9, BRD-K68997413-001-05-1","Preclinical","","NBOJHRYUGLRASX-UHFFFAOYSA-N","BRD-K68997413","","FC(F)(F)c1ccc(Oc2cccc(CC3CCN(CC3)C(=O)Nc3cccnc3)c2)nc1"
"3846","PF-429242","SREBP inhibitor","MBTPS1","","","Tocris",91.17,"BRD-K11821338-300-01-8","Preclinical","","XKPJTOHUPQWSOJ-HSZRJFAPSA-N","BRD-K11821338","","CCN(CC)Cc1ccc(cc1)C(=O)N(CCc1ccccc1OC)[C@@H]1CCNC1"
"3847","PF-431396","focal adhesion kinase inhibitor","PTK2, PTK2B","","","Tocris",97.24,"BRD-K93788137-001-04-1","Preclinical","","POJZIZBONPAWIV-UHFFFAOYSA-N","BRD-K93788137","","CN(c1ccccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O"
"3848","PF-4708671","ribosomal protein inhibitor","RPS6KB1","","","Selleck, Tocris",98.79,"BRD-K14711741-001-02-1, BRD-K14711741-001-05-4","Preclinical","","FBLPQCAQRNSVHB-UHFFFAOYSA-N","BRD-K14711741","","CCc1cncnc1N1CCN(CC1)Cc1nc2cc(ccc2[nH]1)C(F)(F)F"
"3850","PF-477736","CHK inhibitor","CHEK1, CHEK2","","","Selleck, Tocris, Selleck",91.23,"BRD-K03063480-001-06-6, BRD-K03063480-001-07-4, BRD-K03063480-001-05-8","Phase 1","","NDEXUOWTGYUVGA-LJQANCHMSA-N","BRD-K03063480","","Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O"
"3853","PF-4800567","casein kinase inhibitor","CSNK1D, CSNK1E","","","Tocris",98.53,"BRD-K43428468-003-04-0","Preclinical","","AUMDBEHGJRZSOO-UHFFFAOYSA-N","BRD-K43428468","","Nc1ncnc2n(nc(COc3cccc(Cl)c3)c12)C1CCOCC1"
"3854","PF-4981517","cytochrome P450 inhibitor","CYP3A4","","","Selleck",96.16,"BRD-K78318619-001-02-7","Preclinical","","WDWIMDKOXZZYHH-FQEVSTJZSA-N","BRD-K78318619","","Cc1ccc(cc1)-c1c(cnn1C)-c1nn(C)c2ncnc(N3CC[C@@H](C3)N3CCCCC3)c12"
"3855","PF-5274857","smoothened receptor antagonist","SMO","","","Selleck, Tocris",93.06,"BRD-K40302533-001-02-9, BRD-K40302533-003-01-7","Preclinical","","BBVNTTZIOTWDSV-UHFFFAOYSA-N","BRD-K40302533","","Cc1cnc(c(C)c1)-c1cc(ncc1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O"
"3857","PF-562271","focal adhesion kinase inhibitor","PTK2, PTK2B","","","Selleck, Selleck, Selleck, Selleck",93.6,"BRD-K99545815-003-01-0, BRD-K99545815-074-02-9, BRD-K99545815-074-03-7, BRD-K99545815-001-06-3","Phase 1","","MZDKLVOWGIOKTN-UHFFFAOYSA-N","BRD-K99545815","","CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O"
"3861","PF-573228","focal adhesion kinase inhibitor","CDK1, CDK2, CDK7, GSK3B, IKBKB","","","Selleck, Tocris",96.83,"BRD-K79239947-001-06-8, BRD-K79239947-001-07-6","Preclinical","","HESLKTSGTIBHJU-UHFFFAOYSA-N","BRD-K79239947","","CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1"
"3863","PF-670462","casein kinase inhibitor","CSNK1D, CSNK1E","","","MedChemEx, Tocris",97.92,"BRD-K96295391-300-01-7, BRD-K96295391-300-02-5","Preclinical","","WUDBUIUHVNECTM-UHFFFAOYSA-N","BRD-K96295391","","Nc1nccc(n1)-c1c(ncn1C1CCCCC1)-c1ccc(F)cc1"
"3865","PF-750","FAAH inhibitor","FAAH","","","Tocris",92.71,"BRD-K83213911-001-07-7","Preclinical","","BIODYGOZWZNCAG-UHFFFAOYSA-N","BRD-K83213911","","O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1"
"3866","PF-8380","autotaxin inhibitor","ENPP2","","","MedChemEx, MedChemEx",87.86,"BRD-K50865540-001-02-3, BRD-K50865540-001-01-5","Preclinical","","JMSUDQYHPSNBSN-UHFFFAOYSA-N","BRD-K50865540","","Clc1cc(Cl)cc(COC(=O)N2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)c1"
"3868","PF-915275","11-beta hydroxysteroid dehydrogenase inhibitor","HSD11B1","","","Tocris, MedChemEx",98.29,"BRD-K18289362-001-02-2, BRD-K18289362-001-01-4","Phase 1","","ZESFDAKNYJQYKO-UHFFFAOYSA-N","BRD-K18289362","","Nc1cccc(NS(=O)(=O)c2ccc(cc2)-c2ccc(cc2)C#N)n1"
"3870","PFI-1","bromodomain inhibitor","BRD4","","","Selleck, Selleck, Tocris",91.99,"BRD-K13094524-001-04-2, BRD-K13094524-001-07-5, BRD-K13094524-001-09-1","Preclinical","","TXZPMHLMPKIUGK-UHFFFAOYSA-N","BRD-K13094524","","COc1ccccc1S(=O)(=O)Nc1ccc2NC(=O)N(C)Cc2c1"
"3873","PFI-3","bromodomain inhibitor","PBRM1, SMARCA4","","","Tocris",90.87,"BRD-K61524559-001-01-3","Preclinical","","INAICWLVUAKEPB-QSTFCLMHSA-N","BRD-K61524559","","Oc1ccccc1C(=O)\C=C\N1C[C@H]2C[C@@H]1CN2c1ccccn1"
"3874","PFI-4","bromodomain inhibitor","BRPF1","","","Tocris",83.46,"BRD-K13106865-001-01-7","Preclinical","","QCIJLRJBZDBVDB-UHFFFAOYSA-N","BRD-K13106865","","COc1ccccc1C(=O)Nc1cc2n(C)c(=O)n(C)c2cc1N1CCCC1"
"3875","PFK-015","phosphofructokinase inhibitor","PFKFB3","","","MedChemEx, MedChemEx",94.52,"BRD-K95573441-001-02-0, BRD-K95573441-001-01-2","Phase 1","","UJJUKZPBUMCSJZ-BQYQJAHWSA-N","BRD-K95573441","","O=C(\C=C\c1ccc2ccccc2n1)c1ccncc1"
"3877","PFK-158","phosphofructokinase inhibitor","PFKFB3","","","MedChemEx",90.57,"BRD-K28010364-001-01-0","Phase 1","","IAJOMYABKVAZCN-AATRIKPKSA-N","BRD-K28010364","","FC(F)(F)c1ccc2ccc(\C=C\C(=O)c3ccncc3)nc2c1"
"3878","PG-9","acetylcholine receptor agonist","","","","Tocris",92.7,"BRD-A70268693-050-01-2","Preclinical","","GHDWIFTUSXQYGK-UHFFFAOYSA-N","BRD-A70268693","","CC(C(=O)OC1CC2CCC(C1)N2C)c1ccc(Br)cc1"
"3879","PGL5001","JNK inhibitor","MAPK10, MAPK8, MAPK9","","","MedChemEx, MedChemEx, MedChemEx",90.93,"BRD-A53813595-001-01-8, BRD-A53813595-001-03-4, BRD-A53813595-001-02-6","Phase 2","","XCPPIJCBCWUBNT-UHFFFAOYSA-N","BRD-A53813595","","N#CC(c1nc2ccccc2s1)c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1"
"3882","PH-797804","p38 MAPK inhibitor","MAPK11, MAPK14","","","Selleck",97.63,"BRD-K95880107-001-02-4","Phase 2","","KCAJXIDMCNPGHZ-UHFFFAOYSA-N","BRD-K95880107","","CNC(=O)c1ccc(C)c(c1)-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O"
"3883","PHA-568487","nicotinic receptor agonist","CHRNA7","","","Tocris",79.3,"BRD-K48053228-051-01-7","Preclinical","","LUVXHMJTVXZFPD-ZDUSSCGKSA-N","BRD-K48053228","","O=C(N[C@H]1CN2CCC1CC2)c1ccc2OCCOc2c1"
"3884","PHA-665752","c-Met inhibitor","MET","","","Tocris, Selleck, Selleck, Tocris",97.63,"BRD-K95435023-001-07-7, BRD-K95435023-001-08-5, BRD-K95435023-001-10-1, BRD-K95435023-001-09-3","Preclinical","BRD-K55218890-001-01-8","OYONTEXKYJZFHA-SSHUPFPWSA-N","BRD-K95435023","BRD-K55218890","Cc1[nH]c(\C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1"
"3888","PHA-680632","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck",90.32,"BRD-K09443272-001-03-3","Preclinical","","OBWNXGOQPLDDPS-UHFFFAOYSA-N","BRD-K09443272","","CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1"
"3889","PHA-767491","CDC inhibitor","CDK1, RPS6KB1","","","Selleck, Tocris",96.2,"BRD-K50000283-001-04-4, BRD-K50000283-003-02-4","Preclinical","","DKXHSOUZPMHNIZ-UHFFFAOYSA-N","BRD-K50000283","","O=C1NCCc2[nH]c(cc12)-c1ccncc1"
"3891","PHA-793887","CDK inhibitor","CDK1, CDK2, CDK4, CDK5, CDK7, CDK9","","","Selleck, Selleck",91.57,"BRD-K64800655-001-09-0, BRD-K64800655-001-07-4","Phase 1","","HUXYBQXJVXOMKX-UHFFFAOYSA-N","BRD-K64800655","","CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C"
"3893","PHA-848125","CDK inhibitor, growth factor receptor inhibitor","CDK2, CDK4, CDK7, NTRK1","","","Selleck",96.58,"BRD-K60997853-001-02-3","Phase 2","","RXZMYLDMFYNEIM-UHFFFAOYSA-N","BRD-K60997853","","CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21"
"3894","PHCCC","glutamate receptor agonist","GRM1, GRM4","","","Tocris, Tocris",96.49,"BRD-A59709458-001-02-6, BRD-A59709458-001-01-8","Preclinical","","FPXPIEZPAXSELW-CYVLTUHYSA-N","BRD-A59709458","","O\N=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1"
"3896","PHENACETIN","cyclooxygenase inhibitor","PTGS1","","","MicroSource, Selleck",99.33,"BRD-K38323065-001-19-9, BRD-K38323065-001-18-1","Withdrawn","","CPJSUEIXXCENMM-UHFFFAOYSA-N","BRD-K38323065","","CCOc1ccc(NC(C)=O)cc1"
"3898","PHENETHICILLIN","bacterial cell wall synthesis inhibitor","","","","Prestwick",55.17,"BRD-A66025870-237-06-9","Launched","","NONJJLVGHLVQQM-JHXYUMNGSA-N","BRD-A66025870","","CC(Oc1ccccc1)C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O"
"3899","PHENETHYL-ISOTHIOCYANATE","anticancer agent","CYP2E1","","","Sigma",0,"BRD-K56700933-001-03-9","Phase 2","","IZJDOKYDEWTZSO-UHFFFAOYSA-N","BRD-K56700933","","S=C=NCCc1ccccc1"
"3900","PHENFORMIN","AMPK activator","KCNJ8, PRKAA1","","","MicroSource, MicroSource, Selleck",97.99,"BRD-K11399644-003-10-5, BRD-K11399644-003-11-3, BRD-K11399644-003-09-7","Withdrawn","","ICFJFFQQTFMIBG-UHFFFAOYSA-N","BRD-K11399644","","NC(=N)NC(=N)NCCc1ccccc1"
"3903","PHENOLPHTHALEIN","indicator dye","UGT1A9","","","MicroSource",98.24,"BRD-K19227686-001-18-6","Withdrawn","","KJFMBFZCATUALV-UHFFFAOYSA-N","BRD-K19227686","","Oc1ccc(cc1)C1(OC(=O)c2ccccc12)c1ccc(O)cc1"
"3904","PHENOLSULFONPHTHALEIN","","","","","MicroSource",91.1,"BRD-K79892937-001-02-5","Launched","","BELBBZDIHDAJOR-UHFFFAOYSA-N","BRD-K79892937","","Oc1ccc(cc1)C1(OS(=O)(=O)c2ccccc12)c1ccc(O)cc1"
"3905","PHENOTHIAZINE","dopamine receptor antagonist","","","","MicroSource, Selleck, Selleck",88.33,"BRD-K59597909-001-19-2, BRD-K59597909-001-17-6, BRD-K59597909-001-20-0","Preclinical","","WJFKNYWRSNBZNX-UHFFFAOYSA-N","BRD-K59597909","","N1c2ccccc2Sc2ccccc12"
"3908","PHENSERINE","acetylcholinesterase inhibitor, beta amyloid synthesis inhibitor","ACHE, BCHE","","","Sigma, Enzo",83.49,"BRD-K46580984-001-03-6, BRD-K46580984-001-02-8","Phase 3","","PBHFNBQPZCRWQP-QUCCMNQESA-N","BRD-K46580984","","CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21"
"3910","PHENYLACETYLGLUTAMINE","DNA methylase inhibitor, protein synthesis inhibitor","","","","Cayman",89.95,"BRD-K70592483-001-01-0","Phase 2","","JFLIEFSWGNOPJJ-JTQLQIEISA-N","BRD-K70592483","","NC(=O)CC[C@H](NC(=O)Cc1ccccc1)C(O)=O"
"3911","PHENYLBUTAZONE","cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2","","","Selleck, Selleck, MicroSource",98.14,"BRD-K10843433-001-23-5, BRD-K10843433-001-21-9, BRD-K10843433-001-22-7","Withdrawn","","VYMDGNCVAMGZFE-UHFFFAOYSA-N","BRD-K10843433","","CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1"
"3914","PHENYLETHYL-ALCOHOL","","","","","MicroSource",0,"BRD-K42371134-001-06-6","Preclinical","","WRMNZCZEMHIOCP-UHFFFAOYSA-N","BRD-K42371134","","OCCc1ccccc1"
"3915","PHENYLMERCURIC-ACETATE","other antifungal","","","","MicroSource",0,"BRD-K74193284-001-04-8","Preclinical","","XEBWQGVWTUSTLN-UHFFFAOYSA-M","BRD-K74193284","","CC(=O)O[Hg]c1ccccc1"
"3916","PHENYLMETHYLSULFONYL-FLUORIDE","serine protease inhibitor","","","","Selleck, Selleck",0,"BRD-K33422401-001-06-4, BRD-K33422401-001-05-6","Preclinical","","YBYRMVIVWMBXKQ-UHFFFAOYSA-N","BRD-K33422401","","FS(=O)(=O)Cc1ccccc1"
"3918","PHIKAN-083","p53 stabilizing agent","TP53","","","Tocris",85.55,"BRD-K44400149-003-01-1","Preclinical","","LBPNOEAFWYTTEB-UHFFFAOYSA-N","BRD-K44400149","","CCn1c2ccccc2c2cc(CNC)ccc12"
"3919","PHLORETIN","sodium/glucose cotransporter inhibitor","AQP9, CLCN3, SLC23A1","","","Selleck",95.59,"BRD-K15563106-001-18-0","Launched","","VGEREEWJJVICBM-UHFFFAOYSA-N","BRD-K15563106","","Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1"
"3920","PHLORIZIN","sodium/glucose cotransporter inhibitor","SLC5A1, SLC5A11, SLC5A2, SLC5A3","","","Selleck",97.41,"BRD-K24601397-001-01-1","Preclinical","","IOUVKUPGCMBWBT-BVJIBDCISA-N","BRD-K24601397","","OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H](O)[C@@H]1O"
"3921","PHLOROGLUCIN","","","","","Vitas-M",98.67,"BRD-K00405906-001-01-9","Launched","","QCDYQQDYXPDABM-UHFFFAOYSA-N","BRD-K00405906","","Oc1cc(O)cc(O)c1"
"3922","PHORTRESS","aryl hydrocarbon receptor ligand","AHR","","","Key",92.95,"BRD-K74558903-300-01-5","Phase 1","","LFDOEFHQLNGBQQ-HNNXBMFYSA-N","BRD-K74558903","","Cc1cc(ccc1NC(=O)[C@@H](N)CCCCN)-c1nc2cc(F)ccc2s1"
"3923","PHP-501","GABA receptor antagonist","GABRA1, GABRB2, GABRG2","","","Tocris",79.59,"BRD-K07460388-019-01-6","Preclinical","","UHEYIOPHTBWBQN-UHFFFAOYSA-N","BRD-K07460388","","On1ncc(C2CCNCC2)c1-c1cccc(c1)-c1ccccc1"
"3924","PHT-427","AKT inhibitor, pyruvate dehydrogenase inhibitor","AKT2, PDPK1","","","Selleck, Tocris, Selleck",96.76,"BRD-K59745944-001-03-8, BRD-K59745944-001-04-6, BRD-K59745944-001-02-0","Preclinical","","BYWWNRBKPCPJMG-UHFFFAOYSA-N","BRD-K59745944","","CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1"
"3927","PHTHALYLSULFACETAMIDE","","","","","MedChemEx, Selleck, MicroSource, Selleck",94.32,"BRD-K77115421-001-05-9, BRD-K77115421-001-02-6, BRD-K77115421-001-03-4, BRD-K77115421-001-04-2","Preclinical","","SNWQKAWITMVCQW-UHFFFAOYSA-N","BRD-K77115421","","CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2C(O)=O)cc1"
"3931","PHTPP","estrogen receptor antagonist","ESR2","","","Tocris, Tocris",93.41,"BRD-K76568384-001-02-2, BRD-K76568384-001-03-0","Preclinical","","AEZPAUSGTAHLOQ-UHFFFAOYSA-N","BRD-K76568384","","Oc1ccc(cc1)-c1c(nn2c(cc(nc12)C(F)(F)F)C(F)(F)F)-c1ccccc1"
"3933","PHYSOSTIGMINE-SALICYLATE","acetylcholinesterase inhibitor","","","","Selleck, Selleck",93.77,"BRD-K25650355-059-19-7, BRD-K25650355-059-18-9","Phase 3","BRD-A37052580-059-07-6","PIJVFDBKTWXHHD-HIFRSBDPSA-N","BRD-K25650355","BRD-A37052580","CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1"
"3935","PHYTOSPHINGOSINE","","","","","Enzo",77.82,"BRD-K05048137-001-03-9","Phase 1","","AERBNCYCJBRYDG-KSZLIROESA-N","BRD-K05048137","","CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO"
"3936","PI-103","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","","","Tocris, Selleck",96.2,"BRD-K67868012-003-02-3, BRD-K67868012-001-07-6","Preclinical","","TUVCWJQQGGETHL-UHFFFAOYSA-N","BRD-K67868012","","Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1"
"3938","PI-828","PI3K inhibitor","","","","Tocris, Tocris, Tocris",93.17,"BRD-K97365803-001-04-7, BRD-K97365803-001-02-1, BRD-K97365803-001-03-9","Preclinical","","WUKMIBOGGXMBAC-UHFFFAOYSA-N","BRD-K97365803","","Nc1ccc(cc1)-c1cccc2c1oc(cc2=O)N1CCOCC1"
"3941","PIBENZIMOL","DNA inhibitor","","","","Vitas-M, MedChemEx",93.13,"BRD-K79132813-001-09-0, BRD-K17026858-001-01-2","Phase 2","","VEZJRJGLFIXQHG-UHFFFAOYSA-N","BRD-K79132813","","c1ccc2[nH]c(nc2c1)-c1nc2ccccc2[nH]1"
"3942","PIBENZIMOL","DNA inhibitor","","","","Vitas-M, MedChemEx",93.13,"BRD-K79132813-001-09-0, BRD-K17026858-001-01-2","Phase 2","","VEZJRJGLFIXQHG-UHFFFAOYSA-N","BRD-K79132813","","CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1ccc2nc([nH]c2c1)-c1ccc(O)cc1"
"3943","PIBENZIMOL","DNA inhibitor","","","","Vitas-M, MedChemEx",93.13,"BRD-K79132813-001-09-0, BRD-K17026858-001-01-2","Phase 2","","INAAIJLSXJJHOZ-UHFFFAOYSA-N","BRD-K79132813","","c1ccc2[nH]c(nc2c1)-c1nc2ccccc2[nH]1"
"3944","PIBENZIMOL","DNA inhibitor","","","","Vitas-M, MedChemEx",93.13,"BRD-K79132813-001-09-0, BRD-K17026858-001-01-2","Phase 2","","INAAIJLSXJJHOZ-UHFFFAOYSA-N","BRD-K79132813","","CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1ccc2nc([nH]c2c1)-c1ccc(O)cc1"
"3945","PIBOSEROD","serotonin receptor antagonist","HTR2B, HTR4","","","MedChemEx, MedChemEx",96.02,"BRD-K02750403-001-02-2, BRD-K02750403-001-01-4","Phase 2","","KVCSJPATKXABRQ-UHFFFAOYSA-N","BRD-K02750403","","CCCCN1CCC(CNC(=O)c2c3OCCCn3c3ccccc23)CC1"
"3947","PICARTAMIDE","H+/K+-ATPase inhibitor","ATP4A","","","Enamine",98.26,"BRD-A71765060-001-01-4","Phase 2","","ITNLONMDUMHEOK-UHFFFAOYSA-N","BRD-A71765060","","CNC(=S)C1(CCCS1)c1ccccn1"
"3948","PICEATANNOL","SYK inhibitor","ATP5A1, ATP5B, ATP5C1, IRF3","","","Selleck, Selleck, Tocris",88.28,"BRD-K91509126-001-25-1, BRD-K91509126-001-23-6, BRD-K91509126-001-24-4","Preclinical","","CDRPUGZCRXZLFL-OWOJBTEDSA-N","BRD-K91509126","","Oc1cc(O)cc(c1)\C=C\c1ccc(O)c(O)c1"
"3951","PICLAMILAST","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4C, PDE4D","","","Enamine, Tocris",99.07,"BRD-K47642186-001-01-3, BRD-K47642186-001-02-1","Phase 2","","RRRUXBQSQLKHEL-UHFFFAOYSA-N","BRD-K47642186","","COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl"
"3953","PICOLAMINE","","","","","MicroSource",98.78,"BRD-K68653965-001-01-1","Preclinical","","HDOUGSFASVGDCS-UHFFFAOYSA-N","BRD-K68653965","","NCc1cccnc1"
"3954","PICOLINIC-ACID","chelating agent","","","","Vitas-M, Enamine, Enamine",99.23,"BRD-K01029106-001-01-4, BRD-K60612034-001-07-9, BRD-K60612034-001-08-7","Phase 2","BRD-M54429190-001-01-7","CBDQOLKNTOMMTL-UHFFFAOYSA-K","BRD-K01029106","BRD-M54429190","O=C(O[Cr](OC(=O)c1ccccn1)OC(=O)c1ccccn1)c1ccccn1"
"3955","PICOLINIC-ACID","chelating agent","","","","Vitas-M, Enamine, Enamine",99.23,"BRD-K01029106-001-01-4, BRD-K60612034-001-07-9, BRD-K60612034-001-08-7","Phase 2","BRD-M54429190-001-01-7","CBDQOLKNTOMMTL-UHFFFAOYSA-K","BRD-K01029106","BRD-M54429190","OC(=O)c1ccccn1"
"3957","PICOLINIC-ACID","chelating agent","","","","Vitas-M, Enamine, Enamine",99.23,"BRD-K01029106-001-01-4, BRD-K60612034-001-07-9, BRD-K60612034-001-08-7","Phase 2","BRD-M54429190-001-01-7","SIOXPEMLGUPBBT-UHFFFAOYSA-N","BRD-K01029106","BRD-M54429190","O=C(O[Cr](OC(=O)c1ccccn1)OC(=O)c1ccccn1)c1ccccn1"
"3958","PICOLINIC-ACID","chelating agent","","","","Vitas-M, Enamine, Enamine",99.23,"BRD-K01029106-001-01-4, BRD-K60612034-001-07-9, BRD-K60612034-001-08-7","Phase 2","BRD-M54429190-001-01-7","SIOXPEMLGUPBBT-UHFFFAOYSA-N","BRD-K01029106","BRD-M54429190","OC(=O)c1ccccn1"
"3960","PICONOL","","","","","MicroSource",88.45,"BRD-K28492574-001-01-6","Preclinical","","SHNUBALDGXWUJI-UHFFFAOYSA-N","BRD-K28492574","","OCc1ccccn1"
"3961","PICROTIN","GABA receptor antagonist","GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB","","","SantaCruz",100,"BRD-A91822151-001-05-0","Phase 2","","RYEFFICCPKWYML-UHFFFAOYSA-N","BRD-A91822151","","CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C"
"3962","PICROTOXININ","GABA receptor antagonist","GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B","","","Selleck",100,"BRD-K36461289-001-05-8","Preclinical","","PIMZUZSSNYHVCU-KBLUICEQSA-N","BRD-K36461289","","CC(=C)[C@@H]1[C@H]2OC(=O)[C@H]1[C@]1(O)C[C@H]3O[C@]33C(=O)O[C@H]2[C@]13C"
"3963","PIFITHRIN-ALPHA","TP53 inhibitor","TP53","","","Selleck, Selleck, Tocris",29.69,"BRD-K66874953-004-07-0, BRD-K66874953-004-09-6, BRD-K66874953-004-08-8","Preclinical","","OLTZHXYLLRJLST-UHFFFAOYSA-N","BRD-K66874953","","Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N"
"3966","PIFITHRIN-CYCLIC","TP53 inhibitor","TP53","","","Tocris",94.97,"BRD-K31792052-004-02-7","Preclinical","","IMUKUMUNZJILCG-UHFFFAOYSA-N","BRD-K31792052","","Cc1ccc(cc1)-c1cn2c3CCCCc3sc2n1"
"3967","PIFITHRIN-MU","HSP inhibitor","HSPA1A, TP53","","","Tocris, Selleck, Selleck",95.11,"BRD-K96799727-001-06-6, BRD-K96799727-001-05-8, BRD-K96799727-001-07-4","Preclinical","","ZZUZYEMRHCMVTB-UHFFFAOYSA-N","BRD-K96799727","","NS(=O)(=O)C#Cc1ccccc1"
"3970","PIK-293","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",96.54,"BRD-K30977212-001-02-8","Preclinical","","KQDBVHKNIYROHU-UHFFFAOYSA-N","BRD-K30977212","","Cc1ccccc1-n1c(Cn2ncc3c(N)ncnc23)nc2cccc(C)c2c1=O"
"3971","PIK-294","PI3K inhibitor","PIK3CB, PIK3CD, PIK3CG","","","Selleck",97.97,"BRD-K50631926-001-02-3","Preclinical","","WFSLJOPRIJSOJR-UHFFFAOYSA-N","BRD-K50631926","","Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc23)nc2cccc(C)c2c1=O"
"3972","PIK-75","DNA protein kinase inhibitor, PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","","","Selleck",98,"BRD-K49371609-003-03-8","Preclinical","","QTHCAAFKVUWAFI-DJKKODMXSA-N","BRD-K49371609","","CN(\N=C\c1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O"
"3973","PIK-93","PI3K inhibitor","PI4KB, PIK3C3, PIK3CG","","","Selleck",91.02,"BRD-K29395450-001-06-8","Preclinical","","JFVNFXCESCXMBC-UHFFFAOYSA-N","BRD-K29395450","","CC(=O)Nc1nc(C)c(s1)-c1ccc(Cl)c(c1)S(=O)(=O)NCCO"
"3974","PIKAMILONE","","","","","Enamine",98.59,"BRD-K56691760-001-01-2","Phase 1","","NAJVRARAUNYNDX-UHFFFAOYSA-N","BRD-K56691760","","OC(=O)CCCNC(=O)c1cccnc1"
"3975","PILARALISIB","PI3K inhibitor","","","","MedChemEx",95.08,"BRD-K49456274-001-01-9","Phase 2","","QINPEPAQOBZPOF-UHFFFAOYSA-N","BRD-K49456274","","COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1"
"3976","PIM-1-INHIBITOR-2","Pim kinase inhibitor","PIM1","","","Tocris, Tocris",86.98,"BRD-K48832421-001-01-4, BRD-K48832421-001-02-2","Preclinical","","AQVFETGXIRKVAQ-UHFFFAOYSA-N","BRD-K48832421","","Nc1nccc(n1)-c1ccc2noc(-c3ccc(Cl)cc3)c2c1"
"3978","PIMAVANSERIN","serotonin receptor inverse agonist","DRD2, HTR2A","","","MedChemEx",88.73,"BRD-K83405785-001-01-5","Launched","","RKEWSXXUOLRFBX-UHFFFAOYSA-N","BRD-K83405785","","CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1"
"3979","PIMONIDAZOLE","","","","","Cayman",94.99,"BRD-A67521319-001-01-6","Phase 3","","WVWOOAYQYLJEFD-UHFFFAOYSA-N","BRD-A67521319","","OC(CN1CCCCC1)Cn1ccnc1[N+]([O-])=O"
"3980","PINANEDIOL","","","","","Sigma",0,"BRD-K69885552-001-01-7","Preclinical","","MOILFCKRQFQVFS-BDNRQGISSA-N","BRD-K69885552","","CC1(C)[C@@H]2C[C@H]1[C@@](C)(O)[C@@H](O)C2"
"3981","PINCAINIDE","antiarrhythmic","","","","Enamine",96.6,"BRD-K90727284-001-05-0","Phase 1","","RJOUHGWLHPOQSA-UHFFFAOYSA-N","BRD-K90727284","","Cc1cccc(C)c1NC(=O)CN1CCCCCC1"
"3982","PINDOLOL-(-)","adrenergic receptor antagonist, serotonin receptor antagonist","HTR1A","","","Tocris",71.68,"BRD-K95598440-001-09-3","Preclinical","","JZQKKSLKJUAGIC-NSHDSACASA-N","BRD-K95598440","","CC(C)NC[C@H](O)COc1cccc2[nH]ccc12"
"3983","PINITOL","gamma secretase inhibitor","","","","InterBioScreen",100,"BRD-A69275535-001-01-5","Phase 2","","DSCFFEYYQKSRSV-LNEVVHJTSA-N","BRD-A69275535","","COC1C(O)[C@@H](O)C(O)C(O)[C@H]1O"
"3984","PINOCEMBRIN","cytochrome P450 inhibitor","CYP1B1","","","Enzo",0,"BRD-K94689771-001-09-0","Phase 2","","URFCJEUYXNAHFI-ZDUSSCGKSA-N","BRD-K94689771","","Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c1ccccc1"
"3985","PIPERAZINEDIONE","DNA synthesis inhibitor","","","","Enamine",97.3,"BRD-K95941975-001-01-5","Phase 2","","BXRNXXXXHLBUKK-UHFFFAOYSA-N","BRD-K95941975","","O=C1CNC(=O)CN1"
"3986","PIPERINE","monoamine oxidase inhibitor","MAOA, MAOB, TRPV1","","","Selleck, MicroSource, Selleck",97.26,"BRD-K59522102-001-13-8, BRD-K59522102-001-14-6, BRD-K59522102-001-15-3","Phase 1","","MXXWOMGUGJBKIW-YPCIICBESA-N","BRD-K59522102","","O=C(\C=C\C=C\c1ccc2OCOc2c1)N1CCCCC1"
"3989","PIPOTIAZINE-PALMITATE","dopamine receptor antagonist, serotonin receptor antagonist","DRD1, DRD2, HTR1A, HTR2A","","","Sigma",75.11,"BRD-K48429278-001-01-3","Launched","","KTOYYUONFQWSMW-UHFFFAOYSA-N","BRD-K48429278","","CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(cc23)S(=O)(=O)N(C)C)CC1"
"3990","PIRENPERONE","serotonin receptor antagonist","HTR2A, HTR7","","","Prestwick",98.26,"BRD-K25224017-001-25-0","Preclinical","","HXCNRYXBZNHDNE-UHFFFAOYSA-N","BRD-K25224017","","Cc1nc2ccccn2c(=O)c1CCN1CCC(CC1)C(=O)c1ccc(F)cc1"
"3991","PIRICAPIRON","dopamine receptor antagonist, serotonin receptor antagonist","HTR2A","","","Vitas-M",93.51,"BRD-A04203391-001-08-3","Phase 2","","NCMIPRCQUMYAEC-UHFFFAOYSA-N","BRD-A04203391","","CC1(C)C2CCC1(C)C(=O)N(CCCCN1CCN(CC1)c1ccccn1)C2=O"
"3992","PIRINIXIC-ACID","PPAR receptor agonist","PPARA","","","Tocris, Selleck, Tocris",97.87,"BRD-K01902415-001-13-3, BRD-K01902415-001-10-9, BRD-K01902415-001-11-7","Preclinical","","SZRPDCCEHVWOJX-UHFFFAOYSA-N","BRD-K01902415","","Cc1cccc(Nc2cc(Cl)nc(SCC(O)=O)n2)c1C"
"3995","PIRODAVIR","","","","","MedChemEx",98.34,"BRD-K22261391-001-01-2","Phase 2","","KCHIOGFOPPOUJC-UHFFFAOYSA-N","BRD-K22261391","","CCOC(=O)c1ccc(OCCC2CCN(CC2)c2ccc(C)nn2)cc1"
"3996","PIROMIDIC-ACID","bacterial DNA gyrase inhibitor","","","","MicroSource, Selleck, Selleck",96.79,"BRD-K37682401-213-01-1, BRD-K37682401-001-08-5, BRD-K37682401-001-09-3","Phase 2","","RCIMBBZXSXFZBV-UHFFFAOYSA-N","BRD-K37682401","","CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCCC1"
"3999","PIROXIMONE","phosphodiesterase inhibitor","PDE3A","","","Enamine",99.6,"BRD-K71977764-001-01-2","Phase 2","","OQGWJZOWLHWFME-UHFFFAOYSA-N","BRD-K71977764","","CCc1[nH]c(O)nc1C(=O)c1ccncc1"
"4000","PIRQUINOZOL","histamine release inhibitor","","","","Enamine",98.69,"BRD-K63651590-001-01-3","Phase 1","","XLUKOGNIEDDIMV-UHFFFAOYSA-N","BRD-K63651590","","OCc1cc2c3ccccc3[nH]c(=O)n2n1"
"4001","PIT","purinergic receptor antagonist","P2RY1","","","Tocris",24.71,"BRD-K43978949-075-02-5","Preclinical","","LXEZPPZLNVOLDI-UHFFFAOYSA-N","BRD-K43978949","","[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1"
"4002","PIVANEX","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC8","","","Sigma",0,"BRD-K20504455-001-01-0","Phase 2","","GYKLFBYWXZYSOW-UHFFFAOYSA-N","BRD-K20504455","","CCCC(=O)OCOC(=O)C(C)(C)C"
"4003","PI3K-IN-2","PI3K inhibitor","","","","MedChemEx",94.14,"BRD-K62374002-001-01-5","Phase 2","","ADGGYDAFIHSYFI-UHFFFAOYSA-N","BRD-K62374002","","Nc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F"
"4004","PI4KIII-BETA-INHIBITOR-1","PI4K inhibitor","PI4K2B","","","MedChemEx",94.57,"BRD-K75528696-001-01-2","Preclinical","","PLUYFBRIGUAKBR-UHFFFAOYSA-N","BRD-K75528696","","COc1ccc(cc1S(=O)(=O)Nc1ccc(O)cc1)-c1sc(NC(=O)C(C)(C)C)nc1C"
"4005","PJ-34","PARP inhibitor","EEF2, PARP1, PARP15, PARP3","","","Selleck, Selleck, Tocris",95.18,"BRD-K11853856-001-01-7, BRD-K11853856-001-02-5, BRD-K11853856-003-02-1","Preclinical","","UYJZZVDLGDDTCL-UHFFFAOYSA-N","BRD-K11853856","","CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1"
"4008","PK-THPP","potassium channel blocker","KCNK9","","","Tocris",97.46,"BRD-K44043890-001-01-4","Preclinical","","CJZGRIRZVHNUSM-UHFFFAOYSA-N","BRD-K44043890","","CCCC(=O)C1CCN(CC1)c1ncnc2CCN(Cc12)C(=O)c1ccc(cc1)-c1ccccc1"
"4009","PK-11195","benzodiazepine receptor antagonist","TSPO","","","Tocris, Tocris",98.79,"BRD-A41451487-001-12-0, BRD-A41451487-001-11-2","Phase 1","","RAVIZVQZGXBOQO-UHFFFAOYSA-N","BRD-A41451487","","CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)-c1ccccc1Cl"
"4011","PK-44","dipeptidyl peptidase inhibitor","DPP4","","","Tocris",84.96,"BRD-K04035716-011-01-9","Preclinical","","LIPWZZYFIVYJSI-MRVPVSSYSA-N","BRD-K04035716","","N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1n[nH]c2c(F)c(F)ccc12"
"4012","PKI-166","EGFR inhibitor","EGFR","","","Sigma",90.82,"BRD-K10115470-001-01-8","Phase 1","","XRYJULCDUUATMC-CYBMUJFWSA-N","BRD-K10115470","","C[C@@H](Nc1ncnc2[nH]c(cc12)-c1ccc(O)cc1)c1ccccc1"
"4013","PKI-179","mTOR inhibitor, PI3K inhibitor","MTOR","","","EMDBio",97.09,"BRD-A28467416-002-01-0","Phase 1","","WXUUCRLKXQMWRY-UHFFFAOYSA-N","BRD-A28467416","","O=C(Nc1ccncc1)Nc1ccc(cc1)-c1nc(nc(n1)N1CCOCC1)N1C2CCC1COC2"
"4014","PLECONARIL","","","","","MedChemEx, SantaCruz",91.31,"BRD-K27625831-001-02-9, BRD-K27625831-001-01-1","Phase 3","","KQOXLKOJHVFTRN-UHFFFAOYSA-N","BRD-K27625831","","Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1"
"4016","PLINABULIN","tubulin polymerization inhibitor","","","","MedChemEx, MedChemEx, Adooq",78.21,"BRD-K99498722-001-02-6, BRD-K99498722-001-04-2, BRD-K99498722-001-03-4","Phase 3","","UNRCMCRRFYFGFX-TYPNBTCFSA-N","BRD-K99498722","","CC(C)(C)c1[nH]cnc1\C=c1/[nH]c(=O)\c(=C\c2ccccc2)[nH]c1=O"
"4019","PLOVAMER-ACETATE","","TAT, TH, YARS, YARS2","","","Sigma, EMDBio",98.02,"BRD-A20781140-001-02-5, BRD-A20781140-001-01-7","Phase 2","","OUYCCCASQSFEME-UHFFFAOYSA-N","BRD-A20781140","","NC(Cc1ccc(O)cc1)C(O)=O"
"4021","PLURISIN-#1","stearoyl-CoA desaturase inhibitor","SCD","","","Selleck, Tocris, Selleck",85.97,"BRD-K99149715-001-01-6, BRD-K99149715-001-03-2, BRD-K99149715-001-02-4","Preclinical","","HUDWXDLBWRHCKO-UHFFFAOYSA-N","BRD-K99149715","","O=C(NNc1ccccc1)c1ccncc1"
"4024","PLX-4720","RAF inhibitor","BRAF, KDR","","","Selleck",97.49,"BRD-K16478699-001-09-2","Preclinical","","YZDJQTHVDDOVHR-UHFFFAOYSA-N","BRD-K16478699","","CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F"
"4025","PLX-647","receptor tyrosine protein kinase inhibitor","CSF1R, KIT","","","Tocris",71.86,"BRD-K79294107-300-01-6","Preclinical","","NODCQQSEMCESEC-UHFFFAOYSA-N","BRD-K79294107","","FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1"
"4026","PLX8394","serine/threonine kinase inhibitor","BRAF","","","MedChemEx",96.23,"BRD-K53723268-001-01-3","Phase 1/Phase 2","","YYACLQUDUDXAPA-MRXNPFEDSA-N","BRD-K53723268","","F[C@@H]1CCN(C1)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2cnc(nc2)C2CC2)c1F"
"4027","PMPA","glutamate receptor antagonist","FOLH1","","","Tocris",0,"BRD-A74387232-001-02-5","Preclinical","","ISEYJGQFXSTPMQ-UHFFFAOYSA-N","BRD-A74387232","","OC(=O)CCC(CP(O)(O)=O)C(O)=O"
"4028","PNU-120596","acetylcholine receptor agonist","CHRNA7","","","Tocris, Tocris, Selleck",98.45,"BRD-K71731651-001-04-3, BRD-K71731651-001-05-0, BRD-K71731651-001-03-5","Preclinical","","CEIIEALEIHQDBX-UHFFFAOYSA-N","BRD-K71731651","","COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl"
"4031","PNU-142633","serotonin receptor agonist","HTR1D","","","Tocris",97.37,"BRD-K81616657-001-01-4","Phase 2","","PNTVCCRNJOGKGA-QFIPXVFZSA-N","BRD-K81616657","","CNC(=O)c1ccc2[C@H](CCN3CCN(CC3)c3ccc(cc3)C(N)=O)OCCc2c1"
"4032","PNU-177864","dopamine receptor antagonist","DRD3","","","Tocris",92.27,"BRD-K04635846-003-01-6","Preclinical","","JGGQWSXZZQPZTR-UHFFFAOYSA-N","BRD-K04635846","","CCCNCCc1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1"
"4033","PNU-22394","serotonin receptor agonist","HTR2A, HTR2B, HTR2C, MAOA, MAOB","","","Tocris",87.68,"BRD-K16551401-003-03-4","Phase 2","","ZBXDOQWPGBISAR-UHFFFAOYSA-N","BRD-K16551401","","Cn1c2CCNCCc2c2ccccc12"
"4034","PNU-282987","cholinergic receptor agonist","CHRNA7","","","Tocris, Tocris",95.1,"BRD-K28863208-001-02-0, BRD-K28863208-001-03-8","Preclinical","","WECKJONDRAUFDD-ZDUSSCGKSA-N","BRD-K28863208","","Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2"
"4036","PNU-37883","ATP-sensitive potassium channel antagonist","","","","Tocris, Tocris",97.78,"BRD-K12769093-003-02-1, BRD-K12769093-003-01-3","Preclinical","","GKCGWXNLOYTUNC-UHFFFAOYSA-N","BRD-K12769093","","C1CCC(CC1)N\C(N1CCOCC1)=N\C12CC3CC(CC(C3)C1)C2"
"4038","PNU-74654","beta-catenin inhibitor","CTNNB1, TCF4","","","Tocris, Tocris",96.85,"BRD-K30707190-001-04-1, BRD-K30707190-001-05-8","Preclinical","","JJEDWBQZCRESJL-DEDYPNTBSA-N","BRD-K30707190","","Cc1ccc(\C=N\NC(=O)c2ccccc2Oc2ccccc2)o1"
"4040","PNU-89843","benzodiazepine receptor agonist","GABBR1","","","Tocris",7.39,"BRD-K84507776-003-01-4","Preclinical","","UADIKEUOAMACNA-UHFFFAOYSA-N","BRD-K84507776","","Cc1cc2c(nc(nc2n1C)N1CCCC1)N1CCCC1"
"4041","POLYDATIN","ICAM1 expression inhibitor","ICAM1","","","Selleck, Selleck",93.06,"BRD-K43236057-001-07-1, BRD-K43236057-001-09-7","Phase 2","BRD-K94506759-001-01-9","HSTZMXCBWJGKHG-CUYWLFDKSA-N","BRD-K43236057","BRD-K94506759","OC[C@H]1O[C@@H](Oc2cc(O)cc(\C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O"
"4043","POLYINOSINE","immunostimulant","ADSSL1, HPRT1, IMPDH2, PYGM","","","Sigma",98.8,"BRD-A67531813-001-01-6","Preclinical","","GRSZFWQUAKGDAV-UHFFFAOYSA-N","BRD-A67531813","","OC1C(COP(O)(O)=O)OC(C1O)n1cnc2c(O)ncnc12"
"4044","PONESIMOD","sphingosine 1 phosphate receptor agonist","S1PR1","","","MedChemEx",95,"BRD-K44030614-001-01-6","Phase 3","","LPAUOXUZGSBGDU-STDDISTJSA-N","BRD-K44030614","","CCC\N=C1/S\C(=C/c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C"
"4045","POZANICLINE","acetylcholine receptor antagonist","CHRNA4, CHRNB2","","","Sigma",98.79,"BRD-K79803033-300-01-3","Phase 2","","YRVIKLBSVVNSHF-JTQLQIEISA-N","BRD-K79803033","","Cc1ncccc1OC[C@@H]1CCCN1"
"4046","POZIOTINIB","EGFR inhibitor","EGFR, ERBB2, ERBB4","","","Adooq, Selleck",99.66,"BRD-K50010139-001-02-3, BRD-K50010139-001-01-5","Phase 2","","LPFWVDIFUFFKJU-UHFFFAOYSA-N","BRD-K50010139","","COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC1CCN(CC1)C(=O)C=C"
"4048","PP-1","src inhibitor","HCK, RET","","","Selleck, Tocris",99.39,"BRD-K47598052-001-14-1, BRD-K47598052-001-15-8","Preclinical","","ZVPDNRVYHLRXLX-UHFFFAOYSA-N","BRD-K47598052","","Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)C"
"4050","PP-121","protein tyrosine kinase inhibitor","ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC","","","Selleck, Tocris",97.69,"BRD-K81801188-001-02-8, BRD-K81801188-001-05-1","Preclinical","","NVRXTLZYXZNATH-UHFFFAOYSA-N","BRD-K81801188","","C1CCC(C1)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc12"
"4052","PP-2","src inhibitor","ABL1, LCK, LYN, RIPK2, SRC","","","Selleck, Tocris, Tocris",99.23,"BRD-K95785537-001-22-3, BRD-K95785537-001-24-9, BRD-K95785537-001-23-1","Preclinical","","PBBRWFOVCUAONR-UHFFFAOYSA-N","BRD-K95785537","","CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12"
"4055","PPT","estrogen receptor agonist","ESR1","","","Tocris, Tocris",96.1,"BRD-K00312224-001-10-3, BRD-K00312224-001-09-5","Preclinical","","IOTXSIGGFRQYKW-UHFFFAOYSA-N","BRD-K00312224","","CCCc1c(nn(c1-c1ccc(O)cc1)-c1ccc(O)cc1)-c1ccc(O)cc1"
"4057","PPY-A","Abl kinase inhibitor","ABL1, BCR","","","Tocris",99.07,"BRD-K72514671-001-01-4","Preclinical","","GYQRHHQPEMOLKH-UHFFFAOYSA-N","BRD-K72514671","","COc1ccccc1-c1c[nH]c2ncc(cc12)-c1cncc(c1)C(=O)N(C)C"
"4058","PP242","mTOR inhibitor","MTOR, PASK","","","Selleck, Tocris, Selleck",89.25,"BRD-K87112191-001-04-5, BRD-K87112191-001-06-0, BRD-K87112191-001-05-2","Preclinical","","MFAQYJIYDMLAIM-UHFFFAOYSA-N","BRD-K87112191","","CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc12"
"4061","PQ-401","IGF-1 inhibitor","IGF1R","","","Selleck, Tocris, Tocris",97.12,"BRD-K67537649-001-03-7, BRD-K67537649-001-04-5, BRD-K67537649-001-05-2","Preclinical","","YBLWOZUPHDKFOT-UHFFFAOYSA-N","BRD-K67537649","","COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12"
"4064","PR-619","DUB inhibitor","","","","Selleck, Selleck",93,"BRD-K54395039-001-01-7, BRD-K54395039-001-02-5","Preclinical","","ZXOBLNBVNROVLC-UHFFFAOYSA-N","BRD-K54395039","","Nc1nc(N)c(SC#N)cc1SC#N"
"4066","PRACTOLOL","adrenergic receptor antagonist","ADRB1","","","Prestwick, Sigma",87.63,"BRD-A41304429-001-14-8, BRD-A41304429-001-17-1","Withdrawn","","DURULFYMVIFBIR-UHFFFAOYSA-N","BRD-A41304429","","CC(C)NCC(O)COc1ccc(NC(C)=O)cc1"
"4068","PRAMIRACETAM","acetylcholine receptor agonist","","","","Selleck",91.48,"BRD-K21123171-001-02-9","Launched","","ZULJGOSFKWFVRX-UHFFFAOYSA-N","BRD-K21123171","","CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C"
"4069","PRANIDIPINE","calcium channel blocker","CACNA1C","","","AKSci",98.76,"BRD-A68083442-001-01-6","Phase 2","","XTFPDGZNWTZCMF-DHZHZOJOSA-N","BRD-A68083442","","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1"
"4070","PRASTERONE-ACETATE","","","","","MicroSource",83.3,"BRD-A20758144-001-04-5","Preclinical","","NCMZQTLCXHGLOK-KJBVPOJVSA-N","BRD-A20758144","","CC(=O)O[C@H]1CC[C@]2(C)C3CC[C@@]4(C)C(CCC4=O)C3CC=C2C1"
"4071","PRAVADOLINE","cyclooxygenase inhibitor","CNR1, CNR2","","","Cayman",99.34,"BRD-K46209126-001-06-4","Preclinical","","MEUQWHZOUDZXHH-UHFFFAOYSA-N","BRD-K46209126","","COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2ccccc12"
"4072","PRE-084","sigma receptor agonist","SIGMAR1","","","Tocris, Tocris",97.96,"BRD-K57304726-003-07-7, BRD-K57304726-003-06-9","Preclinical","","RQHKZUBCUZVZEF-UHFFFAOYSA-N","BRD-K57304726","","O=C(OCCN1CCOCC1)C1(CCCCC1)c1ccccc1"
"4074","PRECLAMOL","dopamine receptor agonist","DRD2","","","SantaCruz",91.07,"BRD-K02908048-003-06-4","Phase 2","","HTSNFXAICLXZMA-ZDUSSCGKSA-N","BRD-K02908048","","CCCN1CCC[C@@H](C1)c1cccc(O)c1"
"4075","PREDNISOLONE-HEMISUCCINATE","glucocorticoid receptor agonist","NR3C1","","","MicroSource",95.56,"BRD-A78391468-001-02-8","Preclinical","","APGDTXUMTIZLCJ-PILPDLGISA-N","BRD-A78391468","","C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O"
"4076","PREDNISOLONE-TEBUTATE","anti-inflammatory agent","","","","MicroSource",96.64,"BRD-A53151380-001-01-2","Launched","","HUMXXHTVHHLNRO-VZWGUQLYSA-N","BRD-A53151380","","CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C"
"4077","PREGNANOLONE","GABA receptor positive allosteric modulator","","","","Tocris",97.4,"BRD-A03204438-001-01-2","Phase 2","","AURFZBICLPNKBZ-JMTGGFPBSA-N","BRD-A03204438","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"4078","PREGNENOLONE","glutamate receptor modulator","CYP17A1, SULT2B1","","","MicroSource, Selleck",98.34,"BRD-K43880410-001-15-1, BRD-K43880410-001-14-4","Launched","BRD-A35054627-001-09-7, BRD-K52183142-001-01-3","ORNBQBCIOKFOEO-QGVNFLHTSA-N","BRD-K43880410","BRD-A35054627","CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"4080","PREGNENOLONE-SUCCINATE","GABA receptor negative allosteric modulator","","","","MicroSource",99.33,"BRD-A35912562-001-02-8","Preclinical","","OZZAYJQNMKMUSD-NNEZGNMOSA-N","BRD-A35912562","","CC(=O)[C@H]1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)CCC(O)=O"
"4081","PRELADENANT","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","MedChemEx",94.31,"BRD-K46290096-001-01-1","Phase 3","","DTYWJKSSUANMHD-UHFFFAOYSA-N","BRD-K46290096","","COCCOc1ccc(cc1)N1CCN(CCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)CC1"
"4082","PRENYLAMINE","calcium channel blocker","CALM1, MYLK2","","","Prestwick",98.19,"BRD-A10662413-043-11-2","Withdrawn","","IFFPICMESYHZPQ-UHFFFAOYSA-N","BRD-A10662413","","CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1"
"4083","PRESATOVIR","RSV fusion inhibitor","","","","MedChemEx",95.26,"BRD-K45906612-001-01-8","Phase 2","","GOFXWTVKPWJNGD-UWJYYQICSA-N","BRD-K45906612","","Cc1cn2nc(cc2nc1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)c1cc(Cl)ccc1NS(C)(=O)=O"
"4084","PRIMA1","TP53 inhibitor","ACHE","","","Tocris, Tocris",100,"BRD-K15318909-001-12-1, BRD-K15318909-001-10-5","Preclinical","","RFBVBRVVOPAAFS-UHFFFAOYSA-N","BRD-K15318909","","OCC1(CO)N2CCC(CC2)C1=O"
"4086","PRINABEREL","estrogen receptor agonist","ESR2, NCOA1","","","MedChemEx",94.73,"BRD-K87316765-001-01-4","Phase 2","","MQIMZDXIAHJKQP-UHFFFAOYSA-N","BRD-K87316765","","Oc1cc(C=C)c2oc(nc2c1)-c1ccc(O)c(F)c1"
"4087","PRIRALFINAMIDE","sodium channel blocker","CACNA1B","","","Tocris, AMS",98.67,"BRD-K01662324-066-01-1, BRD-K01662324-001-01-8","Phase 3","","BHJIBOFHEFDSAU-LBPRGKRZSA-N","BRD-K01662324","","C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O"
"4089","PRITELIVIR","helicase primase inhibitor","","","","MedChemEx",98.06,"BRD-K25204779-001-01-1","Phase 2","","IVZKZONQVYTCKC-UHFFFAOYSA-N","BRD-K25204779","","CN(C(=O)Cc1ccc(cc1)-c1ccccn1)c1nc(C)c(s1)S(N)(=O)=O"
"4090","PROACIPIMOX","cholesterol inhibitor","","","","Enamine",97.66,"BRD-K53605365-001-01-4","Phase 1","","KKKHJYGCTVKQEM-UHFFFAOYSA-N","BRD-K53605365","","COCc1c[n+]([O-])c(C)cn1"
"4091","PROADIFEN","nitric oxide synthase inhibitor","NOS1","","","Selleck, Selleck, MicroSource",93.97,"BRD-K46317332-003-16-0, BRD-K46317332-003-18-6, BRD-K46317332-003-17-8","Preclinical","","SNTQPLDRUZOSDP-UHFFFAOYSA-N","BRD-K46317332","","CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1"
"4094","PROCODAZOLE","immunostimulant","","","","Selleck, MicroSource",98.53,"BRD-K54824716-001-03-2, BRD-K54824716-001-04-0","Preclinical","","XYWJNTOURDMTPI-UHFFFAOYSA-N","BRD-K54824716","","OC(=O)CCc1nc2ccccc2[nH]1"
"4096","PROCYANIDIN-B-2","","","","","SantaCruz, SantaCruz",81.99,"BRD-K72093555-001-02-8, BRD-K72093555-001-01-0","Phase 2","","XFZJEEAOWLFHDH-UKWJTHFESA-N","BRD-K72093555","","O[C@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4cc(O)cc(O)c34)c3ccc(O)c(O)c3)c2O[C@@H]1c1ccc(O)c(O)c1"
"4098","PROCYSTEINE","glutathione synthase stimulant","","","","Sigma",93.1,"BRD-K92413528-001-06-9","Phase 3","","BMLMGCPTLHPWPY-REOHCLBHSA-N","BRD-K92413528","","OC(=O)[C@@H]1CSC(=O)N1"
"4099","PROFLAVINE-HEMISULFATE","topical anesthetic","F2","","","MicroSource",87.04,"BRD-K68408467-065-01-8","Phase 2","","WDVSHHCDHLJJJR-UHFFFAOYSA-N","BRD-K68408467","","Nc1ccc2cc3ccc(N)cc3nc2c1"
"4100","PROGLUMIDE","CCK receptor antagonist","CCKAR, CCKBR","","","MicroSource",99.55,"BRD-A44863528-001-13-2","Withdrawn","","DGMKFQYCZXERLX-UHFFFAOYSA-N","BRD-A44863528","","CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1"
"4101","PROLYLLEUCYLGLYCINAMIDE","melanocyte-stimulating hormone release inhibitor","","","","Pharmeks",32.9,"BRD-A09911125-001-01-4","Phase 2","","NOOJLZTTWSNHOX-UHFFFAOYSA-N","BRD-A09911125","","CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O"
"4102","PRONETHALOL","adrenergic receptor antagonist","","","","MicroSource, Tocris",98.15,"BRD-A87715314-003-15-1, BRD-A87715314-003-14-4","Withdrawn","","HRSANNODOVBCST-UHFFFAOYSA-N","BRD-A87715314","","CC(C)NCC(O)c1ccc2ccccc2c1"
"4104","PROPIDIUM-IODIDE","","ACHE","","","Prestwick",37.12,"BRD-K14821965-302-05-2","Preclinical","","ZDWVWKDAWBGPDN-UHFFFAOYSA-O","BRD-K14821965","","CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12"
"4105","PROPIOLACTONE","","","","","MicroSource",1.17,"BRD-K76867903-001-03-8","Launched","","VEZXCJBBBCKRPI-UHFFFAOYSA-N","BRD-K76867903","","O=C1CCO1"
"4106","PROPOXUR","","","","","MicroSource",93.11,"BRD-K08231299-001-08-1","Launched","","ISRUGXGCCGIOQO-UHFFFAOYSA-N","BRD-K08231299","","CNC(=O)Oc1ccccc1OC(C)C"
"4107","PROPRANOLOL-(R)","adrenergic receptor antagonist","ADRB2, ADRB3","","","Tocris",98.07,"BRD-K92830582-003-10-5","Preclinical","","AQHHHDLHHXJYJD-CQSZACIVSA-N","BRD-K92830582","","CC(C)NC[C@@H](O)COc1cccc2ccccc12"
"4108","PROPRANOLOL-(S)","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1","","","Tocris, MicroSource",97.96,"BRD-K13994703-003-15-8, BRD-K13994703-003-16-6","Preclinical","","AQHHHDLHHXJYJD-AWEZNQCLSA-N","BRD-K13994703","","CC(C)NC[C@H](O)COc1cccc2ccccc12"
"4110","PROPYL-BENZOATE","","","","","Enamine",0,"BRD-K15329706-001-01-6","Launched","","UDEWPOVQBGFNGE-UHFFFAOYSA-N","BRD-K15329706","","CCCOC(=O)c1ccccc1"
"4111","PROPYLENE-GLYCOL","","F13A1","","","Sigma",0,"BRD-A19232309-001-08-6","Launched","","DNIAPMSPPWPWGF-UHFFFAOYSA-N","BRD-A19232309","","CC(O)CO"
"4112","PROPYLPARABEN","","","","","ChemDiv",0,"BRD-K60783397-001-09-5","Launched","","QELSKZZBTMNZEB-UHFFFAOYSA-N","BRD-K60783397","","CCCOC(=O)c1ccc(O)cc1"
"4113","PROQUAZONE","cyclooxygenase inhibitor","PTGS1, PTGS2","","","AMS",97,"BRD-K54339150-001-01-8","Launched","","JTIGKVIOEQASGT-UHFFFAOYSA-N","BRD-K54339150","","CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1"
"4114","PROTOPORPHYRIN-IX","heme oxygenase inhibitor","HMOX1","","","MicroSource",18.86,"BRD-K26813314-001-08-5","Preclinical","","KSFOVUSSGSKXFI-UHFFFAOYSA-N","BRD-K26813314","","Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(O)=O"
"4115","PROXODOLOL","adrenergic receptor antagonist","","","","InterBioScreen",97.24,"BRD-A29944538-003-08-3","Launched","","CEDZURSVVKNCSL-UHFFFAOYSA-N","BRD-A29944538","","Cc1noc(COc2ccccc2OCC(O)CNC(C)(C)C)n1"
"4116","PROXYFAN","histamine receptor modulator","HRH3","","","Tocris, Tocris",97.13,"BRD-K77171813-034-01-8, BRD-K77171813-034-02-6","Preclinical","","WNWALBVQAAIULR-UHFFFAOYSA-N","BRD-K77171813","","C(COCc1ccccc1)Cc1cnc[nH]1"
"4118","PRT062070","JAK inhibitor, syk inhibitor","SYK","","","MedChemEx, MedChemEx, MedChemEx",89.15,"BRD-K25835157-001-02-2, BRD-K25835157-001-04-8, BRD-K25835157-001-01-4","Phase 1","","BGLPECHZZQDNCD-UHFFFAOYSA-N","BRD-K25835157","","CCS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc(C(N)=O)c(NC3CC3)n2)cc1"
"4121","PRT062607","syk inhibitor","FGR, MAP3K9, SYK","","","Selleck, Selleck",94.89,"BRD-K53734668-003-04-6, BRD-K53734668-003-02-0","Phase 2","BRD-K98804570-003-01-7","TXGKRVFSSHPBAJ-JKSUJKDBSA-N","BRD-K53734668","BRD-K98804570","N[C@H]1CCCC[C@H]1Nc1ncc(C(N)=O)c(Nc2cccc(c2)-n2nccn2)n1"
"4123","PRT4165","polycomb repressive complex inhibitor","PRC1","","","MedChemEx, MedChemEx, Tocris",62.32,"BRD-K32456483-001-02-3, BRD-K32456483-001-04-9, BRD-K32456483-001-03-1","Preclinical","","OMHZFEWYVFWVLI-UHFFFAOYSA-N","BRD-K32456483","","O=C1C(=Cc2cccnc2)C(=O)c2ccccc12"
"4126","PRUVANSERIN","serotonin receptor antagonist","HTR2A, HTR2C","","","Tocris, Sigma",98.48,"BRD-K43837174-003-02-1, BRD-K43837174-003-01-3","Phase 2","","AQRLDDAFYYAIJP-UHFFFAOYSA-N","BRD-K43837174","","Fc1ccc(CCN2CCN(CC2)C(=O)c2cccc3c(c[nH]c23)C#N)cc1"
"4128","PRX-08066","serotonin receptor antagonist","HTR2B","","","Selleck",97.22,"BRD-K16757695-050-02-5","Phase 2","","IENZFHBNCRQMNP-UHFFFAOYSA-N","BRD-K16757695","","Fc1ccc(CN2CCC(CC2)Nc2ncnc3sc(Cl)cc23)cc1C#N"
"4129","PSB-06126","NTPDase inhibitor","ENTPD3","","","Tocris",97.04,"BRD-K71266197-236-02-7","Preclinical","","ZHQRPIRGSWEALJ-UHFFFAOYSA-N","BRD-K71266197","","Nc1c2C(=O)c3ccccc3C(=O)c2c(Nc2cccc3ccccc23)cc1S(O)(=O)=O"
"4130","PSB-11","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA3","","","Tocris, Tocris",97.61,"BRD-K10177585-003-03-2, BRD-K10177585-003-02-4","Preclinical","","RGDHRCXUMURWBJ-LLVKDONJSA-N","BRD-K10177585","","CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1"
"4132","PSB-1115","adenosine receptor antagonist","ADORA1, ADORA2B, ADORA3","","","Tocris, Tocris",96.91,"BRD-K49027941-001-02-9, BRD-K49027941-001-01-1","Preclinical","","UYDRRQPGDSIMNU-UHFFFAOYSA-N","BRD-K49027941","","CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O"
"4134","PSB-36","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",98.41,"BRD-A70407468-001-03-8, BRD-A70407468-001-02-0","Preclinical","","CIBIXJYFYPFMTN-UHFFFAOYSA-N","BRD-A70407468","","CCCCn1c(=O)n(CCCO)c2nc([nH]c2c1=O)C12CC3CC1CC(C2)C3"
"4136","PSB-603","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris",98.46,"BRD-K05419687-001-01-0","Preclinical","","OVHCTHHFOHMNFV-UHFFFAOYSA-N","BRD-K05419687","","CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(Cl)cc1"
"4137","PSI-6130","RNA polymerase inhibitor","","","","MedChemEx",100,"BRD-K07798980-001-01-9","Phase 1","","NYPIRLYMDJMKGW-VPCXQMTMSA-N","BRD-K07798980","","C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O"
"4138","PSI-7976","HCV inhibitor","","","","MedChemEx",98.58,"BRD-K05674516-001-01-7","Preclinical","","TTZHDVOVKQGIBA-YBSJRAAASA-N","BRD-K05674516","","CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1"
"4139","PSN-375963","glucose dependent insulinotropic receptor agonist","GPR119","","","Tocris, Tocris",65.92,"BRD-K25524093-003-01-7, BRD-K25524093-003-02-5","Preclinical","","OAVLEYPTWABFLF-UHFFFAOYSA-N","BRD-K25524093","","CCCCC1CCC(CC1)c1nc(no1)-c1ccncc1"
"4141","PSNCBAM-1","cannabinoid receptor modulator","CNR1","","","Tocris",88.92,"BRD-K33502629-001-01-0","Preclinical","","HDAYFSFWIPRJSO-UHFFFAOYSA-N","BRD-K33502629","","Clc1ccc(NC(=O)Nc2cccc(c2)-c2cccc(n2)N2CCCC2)cc1"
"4142","PS178990","androgen receptor modulator","AR","","","MedChemEx",98.09,"BRD-K99092662-001-01-1","Phase 1","","KEJORAMIZFOODM-PWSUYJOCSA-N","BRD-K99092662","","Cc1c(ccc(C#N)c1Cl)N1C(=O)[C@@H]2[C@H](O)CCN2C1=O"
"4143","PT-2385","hypoxia inducible factor inhibitor","EPAS1","","","MedChemEx",96.9,"BRD-K20850787-001-01-6","Phase 1","","ONBSHRSJOPSEGS-INIZCTEOSA-N","BRD-K20850787","","CS(=O)(=O)c1ccc(Oc2cc(F)cc(c2)C#N)c2CC(F)(F)[C@@H](O)c12"
"4144","PTC-209","BMI-1 inhibitor","","","","MedChemEx, Selleck, Selleck",85.87,"BRD-K83834509-001-03-7, BRD-K83834509-001-01-1, BRD-K83834509-001-02-9","Preclinical","","XVOOCQSWCCRVDY-UHFFFAOYSA-N","BRD-K83834509","","COc1cc(Br)c(Nc2nc(cs2)-c2c(C)nc3ncccn23)c(Br)c1"
"4147","PTEROSTILBENE","cyclooxygenase inhibitor, PPAR receptor agonist","PTGS2","","","Enzo",85.05,"BRD-K53097745-001-01-5","Phase 2/Phase 3","","VLEUZFDZJKSGMX-UHFFFAOYSA-N","BRD-K53097745","","COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1"
"4148","PU-H71","HSP inhibitor","HSP90AA1","","","MedChemEx",95.73,"BRD-K36529613-001-02-6","Phase 1","","SUPVGFZUWFMATN-UHFFFAOYSA-N","BRD-K36529613","","CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12"
"4149","PUERARIN","serotonin receptor antagonist","","","","Selleck",97.51,"BRD-K89048337-001-06-9","Phase 2","BRD-K85867784-001-02-3","HKEAFJYKMMKDOR-VPRICQMDSA-N","BRD-K89048337","BRD-K85867784","OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O"
"4150","PUMOSETRAG","serotonin receptor agonist","HTR3A, HTR4","","","Sigma",98.08,"BRD-K44164034-003-01-1","Phase 2","","AFUWQWYPPZFWCO-LBPRGKRZSA-N","BRD-K44164034","","Oc1c(cnc2ccsc12)C(=O)N[C@H]1CN2CCC1CC2"
"4151","PURMORPHAMINE","smoothened receptor agonist","SMO","","","Selleck, Tocris, Selleck",94.09,"BRD-K73397362-001-06-6, BRD-K73397362-001-08-2, BRD-K73397362-001-07-4","Preclinical","","FYBHCRQFSFYWPY-UHFFFAOYSA-N","BRD-K73397362","","C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12"
"4154","PUROMYCIN","protein synthesis inhibitor","NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1","","","MicroSource",96.37,"BRD-A28970875-300-04-9","Preclinical","","RXWNCPJZOCPEPQ-DYKMBDCPSA-N","BRD-A28970875","","COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)OC([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1"
"4155","PURVALANOL-A","CDK inhibitor","CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC","","","Tocris, Tocris",95.85,"BRD-K50836978-001-03-3, BRD-K50836978-001-02-5","Preclinical","","PMXCMJLOPOFPBT-HNNXBMFYSA-N","BRD-K50836978","","CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1"
"4157","PURVALANOL-B","tyrosine kinase inhibitor","CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2","","","Tocris, Tocris",97.82,"BRD-K41564320-001-03-8, BRD-K41564320-001-02-0","Preclinical","","ZKDXRFMOHZVXSG-HNNXBMFYSA-N","BRD-K41564320","","CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1"
"4159","PUTRESCINE","tissue transglutaminase inhibitor","AMD1, KCNJ4, ODC1","","","Sigma",0,"BRD-K75282878-300-05-3","Phase 2","","KIDHWZJUCRJVML-UHFFFAOYSA-N","BRD-K75282878","","NCCCCN"
"4160","PX-12","thioredoxin inhibitor","TXN, TXNRD1","","","MedChemEx",95.68,"BRD-A56592690-001-04-3","Phase 2","","BPBPYQWMFCTCNG-UHFFFAOYSA-N","BRD-A56592690","","CCC(C)SSc1ncc[nH]1"
"4161","PX-478","hypoxia inducible factor inhibitor","","","","Selleck",88.15,"BRD-A26835809-300-01-3","Phase 1","","GSKQMLGAUOTSKT-UHFFFAOYSA-N","BRD-A26835809","","NC(Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O"
"4162","PYM50028","neurotrophic agent","","","","Enzo",100,"BRD-K62277907-001-01-6","Phase 2","","GMBQZIIUCVWOCD-WWASVFFGSA-N","BRD-K62277907","","C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@H](C)CO1"
"4163","PYR-41","ubiquitin activating enzyme inhibitor","","","","Selleck, Selleck",33.17,"BRD-K66101666-001-01-5, BRD-K66101666-001-02-3","Preclinical","","ARGIPZKQJGFSGQ-LCYFTJDESA-N","BRD-K66101666","","CCOC(=O)c1ccc(cc1)N1NC(=O)\C(=C\c2ccc(o2)[N+]([O-])=O)C1=O"
"4165","PYRANTEL-TARTRATE","acetylcholine receptor agonist","CHRNA1","","","Prestwick, MedChemEx, MedChemEx",79.67,"BRD-K20672254-046-03-9, BRD-K20672254-096-05-9, BRD-K20672254-046-04-7","Preclinical","","YSAUAVHXTIETRK-AATRIKPKSA-N","BRD-K20672254","","CN1CCCN=C1\C=C\c1cccs1"
"4168","PYRAZINOYLGUANIDINE","diuretic","","","","Enamine",95.97,"BRD-K61693562-300-01-7","Phase 1","","WNBSDCKJFDZMHT-UHFFFAOYSA-N","BRD-K61693562","","NC(=N)NC(=O)c1cnccn1"
"4169","PYRAZOLANTHRONE","JNK inhibitor","MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK","","","Selleck, Tocris",97.4,"BRD-K01567962-001-23-0, BRD-K01567962-001-24-8","Preclinical","","ACPOUJIDANTYHO-UHFFFAOYSA-N","BRD-K01567962","","O=C1c2ccccc2-c2n[nH]c3cccc1c23"
"4171","PYRAZOLOACRIDINE","topoisomerase inhibitor","TOP1, TOP2A","","","Sigma",13.26,"BRD-K42607789-001-01-2","Phase 2","","HZCWPKGYTCJSEB-UHFFFAOYSA-N","BRD-K42607789","","COc1ccc2[nH]c3c(ccc4n(CCCN(C)C)nc(c34)c2c1)[N+]([O-])=O"
"4172","PYRETHRINS","","","","","MicroSource",0,"BRD-K79856453-001-01-6","Launched","","KKHJGHLRPBEIBW-NNRAVPRJSA-N","BRD-K79856453","","CC(C)=C[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(C\C=C/C=C)=C2)C1(C)C"
"4173","PYRIDOXAL-ISONICOTINOYL-HYDRAZONE","apoptosis stimulant","","","","Cayman",93.7,"BRD-K42019693-001-01-5","Phase 2","","BQYIXOPJPLGCRZ-REZTVBANSA-N","BRD-K42019693","","Cc1ncc(CO)c(\C=N\NC(=O)c2ccncc2)c1O"
"4174","PYRIDOXAMINE","AGE inhibitor","","","","Sigma",98.7,"BRD-K96669468-300-01-1","Phase 3","","NHZMQXZHNVQTQA-UHFFFAOYSA-N","BRD-K96669468","","Cc1ncc(CO)c(CN)c1O"
"4175","PYRINTEGRIN","integrin signaling activator","","","","Tocris",89.51,"BRD-K94659840-001-01-7","Preclinical","","QRJTZIJWDLJKQO-UHFFFAOYSA-N","BRD-K94659840","","Oc1ccc2N(CCCc2c1)c1ccnc(Nc2ccc(cc2)S(=O)(=O)NCC2CC2)n1"
"4176","PYRITHYLDIONE","psychoactive drug","","","","MicroSource",97.73,"BRD-K36116267-001-15-3","Withdrawn","","NZASCBIBXNPDMH-UHFFFAOYSA-N","BRD-K36116267","","CCC1(CC)C(=O)NC=CC1=O"
"4177","PYRONARIDINE","antimalarial agent","","","","MicroSource, Vitas-M",86.56,"BRD-K73132780-411-01-3, BRD-K73132780-001-01-2","Phase 3","","DJUFPMUQJKWIJB-UHFFFAOYSA-N","BRD-K73132780","","COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1"
"4179","PYROXAMIDE","HDAC inhibitor","HDAC1","","","Cayman, Cayman, Tocris",95.74,"BRD-K11663430-001-04-9, BRD-K11663430-001-02-3, BRD-K11663430-001-03-1","Phase 1","","PTJGLFIIZFVFJV-UHFFFAOYSA-N","BRD-K11663430","","ONC(=O)CCCCCCC(=O)Nc1cccnc1"
"4182","PYRROLIDINE-DITHIOCARBAMATE","NFkB pathway inhibitor","HSD11B1, RELA","","","Tocris",0,"BRD-K80970344-201-08-6","Preclinical","","VSWDORGPIHIGNW-UHFFFAOYSA-N","BRD-K80970344","","SC(=S)N1CCCC1"
"4183","PYRVINIUM","androgen receptor antagonist","","","","Enamine",63.11,"BRD-M55114534-096-01-9","Launched","","PVWVKJZCXALBAI-UHFFFAOYSA-N","BRD-M55114534","","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1"
"4184","PYRVINIUM-PAMOATE","androgen receptor antagonist","AR","","","Sigma, MicroSource",64.19,"BRD-M55114534-373-01-2, BRD-K39479472-096-04-7","Launched","","PVWVKJZCXALBAI-UHFFFAOYSA-N","BRD-M55114534","","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1"
"4185","PYRVINIUM-PAMOATE","androgen receptor antagonist","AR","","","Sigma, MicroSource",64.19,"BRD-M55114534-373-01-2, BRD-K39479472-096-04-7","Launched","","PVWVKJZCXALBAI-UHFFFAOYSA-N","BRD-M55114534","","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1"
"4186","PYRVINIUM-PAMOATE","androgen receptor antagonist","AR","","","Sigma, MicroSource",64.19,"BRD-M55114534-373-01-2, BRD-K39479472-096-04-7","Launched","","QMHSXPLYMTVAMK-UHFFFAOYSA-N","BRD-M55114534","","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1"
"4187","PYRVINIUM-PAMOATE","androgen receptor antagonist","AR","","","Sigma, MicroSource",64.19,"BRD-M55114534-373-01-2, BRD-K39479472-096-04-7","Launched","","QMHSXPLYMTVAMK-UHFFFAOYSA-N","BRD-M55114534","","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1"
"4188","P22077","ubiquitin specific protease inhibitor","USP7","","","Tocris, Selleck",97.13,"BRD-K97714174-001-02-1, BRD-K97714174-001-01-3","Preclinical","","RMAMGGNACJHXHO-UHFFFAOYSA-N","BRD-K97714174","","CC(=O)c1cc(c(Sc2ccc(F)cc2F)s1)[N+]([O-])=O"
"4190","P276-00","CDK inhibitor","CDK1, CDK4, CDK9","","","Selleck",91.42,"BRD-K51791723-003-01-7","Phase 2","","QLUYMIVVAYRECT-OCCSQVGLSA-N","BRD-K51791723","","CN1CC[C@H]([C@@H]1CO)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl"
"4191","P5091","ubiquitin specific protease inhibitor","USP7","","","Selleck",97.85,"BRD-K13606314-001-01-3","Preclinical","","LKZLGMAAKNEGCH-UHFFFAOYSA-N","BRD-K13606314","","CC(=O)c1cc(c(Sc2cccc(Cl)c2Cl)s1)[N+]([O-])=O"
"4192","P7C3","NAMPT inhibitor","NAMPT","","","Tocris",88.39,"BRD-A09487507-001-02-1","Preclinical","","FZHHRERIIVOATI-UHFFFAOYSA-N","BRD-A09487507","","OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12"
"4193","Q-203","ATP synthase inhibitor","","","","Enamine",89.92,"BRD-K59853741-001-01-9","Phase 1","","OJICYBSWSZGRFB-UHFFFAOYSA-N","BRD-K59853741","","CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(cc1)N1CCC(CC1)c1ccc(OC(F)(F)F)cc1"
"4194","QUAZINONE","phosphodiesterase inhibitor","PDE3A, PDE3B","","","AMS",96.97,"BRD-K63631219-001-01-6","Phase 2","","XIXXNJFWPAVKFR-UHFFFAOYSA-N","BRD-K63631219","","Cc1c(O)nc2Nc3cccc(Cl)c3Cn12"
"4195","QUIFLAPON","leukotriene synthesis inhibitor","ALOX5, ALOX5AP","","","MedChemEx",97.94,"BRD-K39503511-001-03-9","Phase 2","","NZOONKHCNQFYCI-UHFFFAOYSA-N","BRD-K39503511","","CC(C)(C)Sc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12"
"4196","QUINELORANE","dopamine receptor agonist","DRD2, DRD3","","","Enzo",97.42,"BRD-K13261168-300-01-0","Phase 3","","TUFADSGTJUOBEH-ZWNOBZJWSA-N","BRD-K13261168","","CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12"
"4197","QUINOLINIC-ACID","glutamate receptor agonist","","","","Tocris",94.44,"BRD-K51885093-001-11-2","Preclinical","","GJAWHXHKYYXBSV-UHFFFAOYSA-N","BRD-K51885093","","OC(=O)c1cccnc1C(O)=O"
"4198","QUINPIROL-(-)","dopamine receptor agonist","DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",94.33,"BRD-K26548821-003-11-3, BRD-K26548821-003-10-5","Phase 2","","FTSUPYGMFAPCFZ-ZWNOBZJWSA-N","BRD-K26548821","","CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@@H]12"
"4200","QUIPAZINE","serotonin receptor agonist","","","","MicroSource, Selleck, Tocris",92.6,"BRD-K77925998-050-14-3, BRD-K77925998-364-01-5, BRD-K77925998-332-04-6","Preclinical","","XRXDAJYKGWNHTQ-UHFFFAOYSA-N","BRD-K77925998","","C1CN(CCN1)c1ccc2ccccc2n1"
"4203","QUIZARTINIB","FLT3 inhibitor","CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET","","","Selleck",95.17,"BRD-K93918653-001-08-9","Phase 3","","CVWXJKQAOSCOAB-UHFFFAOYSA-N","BRD-K93918653","","CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1"
"4204","QX-222","sodium channel blocker","","","","Tocris",98.05,"BRD-K40782193-003-02-9","Preclinical","","QYUXPWDVDMSTKR-UHFFFAOYSA-O","BRD-K40782193","","Cc1cccc(C)c1NC(=O)C[N+](C)(C)C"
"4205","QX-314","sodium channel blocker","MAPK14, TGFBR1","","","Tocris, Tocris",97.7,"BRD-K56596464-003-02-6, BRD-K56596464-004-10-7","Preclinical","","PYEBKOFMWAMBFV-UHFFFAOYSA-O","BRD-K56596464","","CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C"
"4207","R-1479","HCV inhibitor","","","","MedChemEx",96.79,"BRD-K28442028-001-01-3","Phase 1","","ODLGMSQBFONGNG-JVZYCSMKSA-N","BRD-K28442028","","Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@H]2O)c(=O)n1"
"4208","R-1485","serotonin receptor antagonist","HTR6","","","Tocris",95.77,"BRD-K96418224-300-01-8","Phase 1","","UPROBLPRPWYJGN-UHFFFAOYSA-N","BRD-K96418224","","Fc1ccccc1S(=O)(=O)N1CCOc2c(cccc12)N1CCNCC1"
"4209","R-268712","serine/threonine kinase inhibitor","TGFBR1","","","Tocris",91.85,"BRD-K83904070-001-01-1","Preclinical","","JQGOCCALXFSRHZ-UHFFFAOYSA-N","BRD-K83904070","","Cc1cccc(n1)-c1n[nH]cc1-c1ccc(F)c(c1)-c1cnn(CCO)c1"
"4210","R-428","AXL kinase inhibitor","AXL","","","MedChemEx",88.26,"BRD-K14870255-001-02-3","Phase 1","","KXMZDGSRSGHMMK-VWLOTQADSA-N","BRD-K14870255","","Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1"
"4211","R-59022","diacylglycerol kinase inhibitor, protein kinase inhibitor","DGKA","","","Tocris, Tocris",97.41,"BRD-K54665485-001-07-9, BRD-K54665485-001-08-7","Preclinical","","MFVJXLPANKSLLD-UHFFFAOYSA-N","BRD-K54665485","","Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccccc1)c1ccc(F)cc1"
"4213","R-96544","serotonin receptor antagonist","HTR2A","","","Tocris, Tocris",96.58,"BRD-K15588452-003-03-5, BRD-K15588452-003-02-7","Preclinical","","AFZLABYDOCWQBQ-WOJBJXKFSA-N","BRD-K15588452","","COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1"
"4215","RAC-BHFF","GABA receptor positive allosteric modulator","GABBR1","","","Tocris",0,"BRD-A11069678-001-01-8","Preclinical","","RVNOANDLZIIFHB-UHFFFAOYSA-N","BRD-A11069678","","CC(C)(C)c1cc2c(OC(=O)C2(O)C(F)(F)F)c(c1)C(C)(C)C"
"4216","RACLOPRIDE","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Tocris, Tocris",96.6,"BRD-K04111260-001-12-6, BRD-K04111260-001-10-0","Launched","","WAOQONBSWFLFPE-VIFPVBQESA-N","BRD-K04111260","","CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC"
"4218","RACTOPAMINE","adrenergic receptor agonist","","","","Selleck, MicroSource",93.48,"BRD-A86414188-003-01-5, BRD-A86414188-003-02-3","Launched","","YJQZYXCXBBCEAQ-UHFFFAOYSA-N","BRD-A86414188","","CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1"
"4220","RADAFAXINE","dopamine-norepinephrine reuptake inhibitor","SLC6A3","","","MedChemEx",92.33,"BRD-K13394247-003-01-4","Phase 2","","RCOBKSKAZMVBHT-TVQRCGJNSA-N","BRD-K13394247","","C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1"
"4221","RADEZOLID","bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","","","","MedChemEx",94.62,"BRD-K84683831-001-01-0","Phase 2","","BTTNOGHPGJANSW-IBGZPJMESA-N","BRD-K84683831","","CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(F)c1)-c1ccc(CNCc2cnn[nH]2)cc1"
"4222","RAF265","RAF inhibitor, VEGFR inhibitor","BRAF","","","Selleck",94.35,"BRD-K93123848-001-04-1","Phase 2","","YABJJWZLRMPFSI-UHFFFAOYSA-N","BRD-K93123848","","Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2cc(Oc3ccnc(c3)-c3ncc([nH]3)C(F)(F)F)ccc12"
"4223","RANIRESTAT","aldose reductase inhibitor","AKR1B1","","","MedChemEx",96.29,"BRD-K50489389-001-01-8","Phase 3","","QCVNMNYRNIMDKV-QGZVFWFLSA-N","BRD-K50489389","","Fc1cc(Br)ccc1CN1C(=O)c2cccn2[C@@]2(CC(=O)NC2=O)C1=O"
"4224","RAPASTINEL","glutamate receptor agonist","","","","MedChemEx",0,"BRD-K02206208-001-01-4","Phase 2","","GIBQQARAXHVEGD-BSOLPCOYSA-N","BRD-K02206208","","C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O"
"4225","RAUWOLSCINE","adrenergic receptor antagonist","ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B","","","Tocris, Tocris",88.44,"BRD-K77474816-003-14-1, BRD-K77474816-003-13-3","Preclinical","BRD-A65053077-003-01-0","BLGXFZZNTVWLAY-DIRVCLHFSA-N","BRD-K77474816","BRD-A65053077","COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12"
"4227","RAVOXERTINIB","ERK1 and ERK2 phosphorylation inhibitor","MAPK1, MAPK3","","","Adooq",98.38,"BRD-K86309810-001-01-5","Phase 1","","RZUOCXOYPYGSKL-GOSISDBHSA-N","BRD-K86309810","","Cn1nccc1Nc1nccc(n1)-c1ccn([C@H](CO)c2ccc(Cl)c(F)c2)c(=O)c1"
"4228","RAVUCONAZOLE","sterol demethylase inhibitor","","","","Cayman",98.93,"BRD-K03503561-001-01-4","Phase 2","","OPAHEYNNJWPQPX-RCDICMHDSA-N","BRD-K03503561","","C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@](O)(Cn1cncn1)c1ccc(F)cc1F"
"4229","RBC8","Ral GTPase inhibitor","RALA, RALB","","","Tocris, MedChemEx, MedChemEx",84.72,"BRD-A67036568-001-02-1, BRD-A67036568-001-03-9, BRD-A67036568-001-01-3","Preclinical","","CLMQBVUFKIKYLU-UHFFFAOYSA-N","BRD-A67036568","","COc1ccc(OC)c(c1)C1c2c(OC(N)=C1C#N)[nH]nc2-c1ccc2ccccc2c1"
"4232","REBASTINIB","Bcr-Abl kinase inhibitor, TIE tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BCR, FGR, FLT3, HCK, LYN, SRC","","","Selleck, MedChemEx, MedChemEx, Selleck",96.77,"BRD-K76694128-001-05-0, BRD-K76694128-001-06-8, BRD-K76694128-001-07-6, BRD-K76694128-001-04-3","Phase 1","","WVXNSAVVKYZVOE-UHFFFAOYSA-N","BRD-K76694128","","CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1"
"4236","REC-15/2615","adrenergic receptor antagonist","ADRA1A","","","Tocris",58.81,"BRD-K84924479-300-01-1","Phase 2","","ZZMFJJDBKSYGRM-UHFFFAOYSA-N","BRD-K84924479","","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C"
"4237","REFAMETINIB","MEK inhibitor","MAP2K1, MAP2K2","","","MedChemEx",95.47,"BRD-K85751432-001-03-3","Phase 2","","RDSACQWTXKSHJT-NSHDSACASA-N","BRD-K85751432","","COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1"
"4238","RELCOVAPTAN","vasopressin receptor antagonist","AVPR1A, AVPR1B, AVPR2, OXTR","","","Tocris, Tocris",98.48,"BRD-K96720755-001-02-6, BRD-K96720755-001-03-4","Phase 2","","CEBYCSRFKCEUSW-NAYZPBBASA-N","BRD-K96720755","","COc1ccc(cc1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(c2cc(Cl)ccc12)c1ccccc1Cl"
"4240","RELEBACTAM","beta lactamase inhibitor","","","","MedChemEx",86.36,"BRD-K63018010-001-01-7","Phase 3","","SMOBCLHAZXOKDQ-ZJUUUORDSA-N","BRD-K63018010","","OS(=O)(=O)ON1[C@H]2CN([C@@H](CC2)C(=O)NC2CCNCC2)C1=O"
"4241","REMACEMIDE","glutamate receptor antagonist","GRIN1","","","Tocris",97.95,"BRD-A36074203-003-07-6","Phase 3","","YSGASDXSLKIKOD-UHFFFAOYSA-N","BRD-A36074203","","CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1"
"4242","REMIMAZOLAM","benzodiazepine receptor agonist","GABBR1","","","MedChemEx",92.64,"BRD-K89413285-074-01-5","Phase 3","","CYHWMBVXXDIZNZ-KRWDZBQOSA-N","BRD-K89413285","","COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc12"
"4243","REMODELIN","transferase inhibitor","NAT10","","","Tocris",76.13,"BRD-K75349868-001-01-5","Preclinical","","XAEJIFARBQJLML-UHFFFAOYSA-N","BRD-K75349868","","N#Cc1ccc(cc1)-c1csc(NN=C2CCCC2)n1"
"4244","REMOXIPRIDE","dopamine receptor antagonist","DRD2, DRD3, DRD4, HTR2A, SIGMAR1","","","Tocris",98.31,"BRD-K54094468-003-11-1","Withdrawn","","GUJRSXAPGDDABA-NSHDSACASA-N","BRD-K54094468","","CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC"
"4245","REPARIXIN","CC chemokine receptor antagonist","CXCR1, CXCR2","","","MedChemEx",99.13,"BRD-K58486055-001-02-7","Phase 3","","KQDRVXQXKZXMHP-LLVKDONJSA-N","BRD-K58486055","","CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O"
"4246","REPSOX","TGF beta receptor inhibitor","TGFBR1","","","Selleck, Tocris",98.05,"BRD-K80480517-001-02-4, BRD-K80480517-001-04-0","Preclinical","","LBPKYPYHDKKRFS-UHFFFAOYSA-N","BRD-K80480517","","Cc1cccc(n1)-c1n[nH]cc1-c1ccc2ncccc2n1"
"4248","RESATORVID","toll-like receptor antagonist","TLR4","","","MedChemEx, MedChemEx",96.53,"BRD-K61567297-001-02-7, BRD-K61567297-001-01-9","Phase 3","","LEEIJTHMHDMWLJ-CQSZACIVSA-N","BRD-K61567297","","CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl"
"4250","RESIBUFOGENIN","Na/K-ATPase inhibitor","","","","MedChemEx",87.34,"BRD-K25970317-001-01-6","Phase 2","","ATLJNLYIJOCWJE-CWMZOUAVSA-N","BRD-K25970317","","C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@]11O[C@@H]1C[C@@H]2c1ccc(=O)oc1"
"4251","RESIQUIMOD","toll-like receptor agonist","TLR7, TLR8","","","MedChemEx, Tocris",99.64,"BRD-K76210423-001-01-6, BRD-K76210423-001-02-4","Phase 3","","BXNMTOQRYBFHNZ-UHFFFAOYSA-N","BRD-K76210423","","CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O"
"4253","RESMINOSTAT","HDAC inhibitor","HDAC1, HDAC3, HDAC6, HDAC8","","","Selleck, Selleck",91.59,"BRD-K28822270-001-01-1, BRD-K28822270-001-03-7","Phase 2","","FECGNJPYVFEKOD-VMPITWQZSA-N","BRD-K28822270","","CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)\C=C\C(=O)NO"
"4255","RESORCINOL-MONOACETATE","antiseptic","","","","MicroSource, MedChemEx",70.52,"BRD-K85603128-001-03-5, BRD-K85603128-001-04-3","Launched","","ZZPKZRHERLGEKA-UHFFFAOYSA-N","BRD-K85603128","","CC(=O)Oc1cccc(O)c1"
"4257","RESVERATROL","cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2","","","Selleck, MedChemEx, Selleck, Tocris, Tocris",95.03,"BRD-K80738081-001-44-3, BRD-K80738081-001-46-8, BRD-K80738081-001-42-7, BRD-K80738081-001-43-5, BRD-K80738081-001-47-6","Launched","","LUKBXSAWLPMMSZ-OWOJBTEDSA-N","BRD-K80738081","","Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1"
"4262","RETASPIMYCIN","HSP inhibitor","HSP90AA1","","","MedChemEx, MedChemEx",0,"BRD-K67935717-003-02-8, BRD-K67935717-003-01-0","Phase 3","","OAKGNIRUXAZDQF-TXHRRWQRSA-N","BRD-K67935717","","CO[C@H]1C[C@H](C)Cc2c(O)c(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)cc(O)c2NCC=C"
"4264","RETINYL-ACETATE","","","","","MicroSource, Sigma",0,"BRD-K65331431-001-06-2, BRD-K65331431-001-08-8","Launched","","QGNJRVVDBSJHIZ-QHLGVNSISA-N","BRD-K65331431","","CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C"
"4266","RETINYL-PALMITATE","","","","","MicroSource, Sigma",0,"BRD-K80595380-001-07-2, BRD-K80595380-001-09-8","Launched","","VYGQUTWHTHXGQB-FFHKNEKCSA-N","BRD-K80595380","","CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C"
"4268","REV-5901","leukotriene receptor antagonist, lipoxygenase inhibitor","ALOX5","","","Enzo",94.05,"BRD-A68281735-001-18-6","Phase 2","","JRLOEMCOOZSCQP-UHFFFAOYSA-N","BRD-A68281735","","CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1"
"4269","REVERSAN","MRP inhibitor","ABCC1","","","Tocris",96.72,"BRD-K79700588-001-09-7","Preclinical","","JTRXWCLQFAZHGP-UHFFFAOYSA-N","BRD-K79700588","","O=C(NCCCN1CCOCC1)c1cnn2c(cc(nc12)-c1ccccc1)-c1ccccc1"
"4270","REVERSINE","Aurora kinase inhibitor","AURKB, INCENP, MAP2K1","","","MedChemEx, MedChemEx",83.16,"BRD-K77286328-001-03-7, BRD-K77286328-001-06-0","Preclinical","","ZFLJHSQHILSNCM-UHFFFAOYSA-N","BRD-K77286328","","C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12"
"4272","RGB-286638","CDK inhibitor","CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9","","","MedChemEx, MedChemEx",93.17,"BRD-K20986415-001-02-6, BRD-K20986415-001-01-8","Phase 1","","XLSYZSRXVVCHLS-UHFFFAOYSA-N","BRD-K20986415","","COCCN1CCN(Cc2ccc(cc2)-c2n[nH]c3-c4cccc(NC(=O)NN5CCOCC5)c4C(=O)c23)CC1"
"4274","RGFP966","HDAC inhibitor","HDAC3","","","Selleck",91.29,"BRD-K61688984-001-02-9","Preclinical","","BLVQHYHDYFTPDV-VCABWLAWSA-N","BRD-K61688984","","Nc1cc(F)ccc1NC(=O)\C=C\c1cnn(C\C=C\c2ccccc2)c1"
"4275","RG108","DNA methyltransferase inhibitor","DNMT1, DNMT3B","","","Selleck, Tocris",98.82,"BRD-K89391146-001-08-0, BRD-K89391146-001-09-8","Preclinical","","HPTXLHAHLXOAKV-INIZCTEOSA-N","BRD-K89391146","","OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O"
"4277","RG1530","FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2","","","MedChemEx, MedChemEx, MedChemEx, Tocris",58.63,"BRD-K32942258-001-04-1, BRD-K32942258-001-02-5, BRD-K32942258-001-01-7, BRD-K32942258-001-03-3","Phase 1","","UOVCGJXDGOGOCZ-UHFFFAOYSA-N","BRD-K32942258","","COc1cc2N=C3NNC(C)=C3N=C(c3ccccc3Cl)c2cc1F"
"4281","RG2833","HDAC inhibitor","HDAC1, HDAC3","","","MedChemEx, Selleck",95.29,"BRD-K02389548-001-04-1, BRD-K02389548-001-02-5","Phase 1","","VOPDXHFYDJAYNS-UHFFFAOYSA-N","BRD-K02389548","","Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc1ccccc1N"
"4283","RG4733","gamma secretase inhibitor","PSEN1","","","MedChemEx",98.56,"BRD-K22024824-001-03-7","Phase 2","","OJPLJFIFUQPSJR-INIZCTEOSA-N","BRD-K22024824","","CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2ccccc2NC1=O"
"4284","RG7112","MDM inhibitor","MDM2","","","Selleck",99.27,"BRD-A78210457-001-01-5","Phase 1","","QBGKPEROWUKSBK-UHFFFAOYSA-N","BRD-A78210457","","CCOc1cc(ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C"
"4285","RHC-80267","triacylglycerol lipase inhibitor","DAGLA, DAGLB","","","Tocris, Tocris",95.7,"BRD-K56047318-001-07-1, BRD-K56047318-001-06-3","Preclinical","","RXSVYGIGWRDVQC-UHFFFAOYSA-N","BRD-K56047318","","O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1"
"4287","RHEIN","","HSP90AA1","","","Selleck",97.12,"BRD-K27335680-001-10-0","Phase 1","","FCDLCPWAQCPTKC-UHFFFAOYSA-N","BRD-K27335680","","OC(=O)c1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1"
"4288","RHEOCHRYSIDIN","protein tyrosine kinase inhibitor","PTPN1","","","Selleck",86.96,"BRD-K67772619-001-05-1","Preclinical","","FFWOKTFYGVYKIR-UHFFFAOYSA-N","BRD-K67772619","","COc1cc(O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1"
"4289","RHODAMINE-123","","","","","Cayman",93.16,"BRD-K47169076-003-01-6","Phase 1","","ZWODABSNRKVFCK-UHFFFAOYSA-N","BRD-K47169076","","COC(=O)c1ccccc1-c1c2ccc(N)cc2[o+]c2cc(N)ccc12"
"4290","RI-1","","RAD51","","","Selleck",90.39,"BRD-K79555887-001-01-0","Preclinical","","MWSUIZKGNWELRF-UHFFFAOYSA-N","BRD-K79555887","","ClC1=C(N2CCOCC2)C(=O)N(C1=O)c1ccc(Cl)c(Cl)c1"
"4291","RIBITOL","","","","","Selleck",100,"BRD-K49313711-001-05-4","Preclinical","","HEBKCHPVOIAQTA-ZXFHETKHSA-N","BRD-K49313711","","OC[C@H](O)[C@H](O)[C@H](O)CO"
"4292","RIBOFLAVIN-5-PHOSPHATE-SODIUM","","BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1","","","MedChemEx, MicroSource, Sigma",10.28,"BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8","Launched","","FVTCRASFADXXNN-SCRDCRAPSA-N","BRD-K09229706","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C"
"4293","RIBOFLAVIN-5-PHOSPHATE-SODIUM","","BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1","","","MedChemEx, MicroSource, Sigma",10.28,"BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8","Launched","","FVTCRASFADXXNN-SCRDCRAPSA-N","BRD-K09229706","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)COP(O)(O)=O)c2cc1C"
"4295","RIBOFLAVIN-5-PHOSPHATE-SODIUM","","BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1","","","MedChemEx, MicroSource, Sigma",10.28,"BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8","Launched","","FVTCRASFADXXNN-MBNYWOFBSA-N","BRD-K09229706","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C"
"4296","RIBOFLAVIN-5-PHOSPHATE-SODIUM","","BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1","","","MedChemEx, MicroSource, Sigma",10.28,"BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8","Launched","","FVTCRASFADXXNN-MBNYWOFBSA-N","BRD-K09229706","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)COP(O)(O)=O)c2cc1C"
"4298","RICINOLEIC-ACID","prostanoid receptor agonist","PTGER3","","","TCI",51.56,"BRD-K33682646-001-02-7","Launched","","WBHHMMIMDMUBKC-QJWNTBNXSA-N","BRD-K33682646","","CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O"
"4299","RIFAMYCIN-SV","RNA synthesis inhibitor","","","","Enzo",77.86,"BRD-K13277760-001-01-2","Phase 3","","BZOQTGADCSFWHV-RECYQVEJSA-N","BRD-K13277760","","CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C\[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]([C@H]1C)C(=O)OC)c(O)c2c(O)c3C"
"4300","RIGOSERTIB","cell cycle inhibitor, PLK inhibitor","PLK1","","","Selleck, MedChemEx, Selleck",94.32,"BRD-K55187425-236-06-0, BRD-K55187425-236-07-8, BRD-K55187425-236-05-2","Phase 3","","OWBFCJROIKNMGD-BQYQJAHWSA-N","BRD-K55187425","","COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1"
"4303","RIMCAZOLE","sigma receptor antagonist","SIGMAR1","","","Tocris",96.68,"BRD-K70490179-300-01-2","Phase 1","","GUDVQJXODNJRIJ-CALCHBBNSA-N","BRD-K70490179","","C[C@H]1CN(CCCn2c3ccccc3c3ccccc23)C[C@@H](C)N1"
"4304","RIMONABANT","cannabinoid receptor antagonist","CNR1, GPR55","","","Selleck",96.88,"BRD-K13296708-001-05-8","Withdrawn","","JZCPYUJPEARBJL-UHFFFAOYSA-N","BRD-K13296708","","Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1"
"4305","RIODIPINE","calcium channel blocker","","","","Sigma",97.87,"BRD-K36379990-001-01-1","Phase 2","","AZVFIZVKGSPGPK-UHFFFAOYSA-N","BRD-K36379990","","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1OC(F)F)C(=O)OC"
"4306","RIODOXOL","other antibiotic","","","","Vitas-M, Vitas-M",31.26,"BRD-K48963429-001-01-9, BRD-K48963429-001-02-7","Launched","","XKFZYVWWXHCHIX-UHFFFAOYSA-N","BRD-K48963429","","Oc1c(I)cc(I)c(O)c1I"
"4308","RIPAZEPAM","benzodiazepine receptor agonist","GABRA1","","","Sigma",99.45,"BRD-K57427145-001-01-6","Phase 2","","YFHYNLHGFKXAIQ-UHFFFAOYSA-N","BRD-K57427145","","CCn1nc(C)c2NC(=O)CN=C(c12)c1ccccc1"
"4309","RITA","MDM inhibitor","MDM2","","","Selleck, Selleck",87.3,"BRD-K00317371-001-05-3, BRD-K00317371-001-06-1","Preclinical","","KZENBFUSKMWCJF-UHFFFAOYSA-N","BRD-K00317371","","OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1"
"4311","RITANSERIN","serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris, MicroSource, Tocris",98.51,"BRD-K40887525-001-23-5, BRD-K40887525-001-22-7, BRD-K40887525-001-21-9","Phase 3","","JUQLTPCYUFPYKE-UHFFFAOYSA-N","BRD-K40887525","","Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1"
"4314","RIVANICLINE","acetylcholine receptor agonist","CHRNA4, CHRNB2, CXCL8","","","Enzo",94.98,"BRD-K79966802-034-01-2","Phase 2","","JUOSGGQXEBBCJB-GORDUTHDSA-N","BRD-K79966802","","CNCC\C=C\c1cccnc1"
"4315","RKI-1447","rho associated kinase inhibitor","CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2","","","Selleck, Tocris",98.46,"BRD-K19333160-001-01-3, BRD-K19333160-300-01-9","Preclinical","","GDVRVPIXWXOKQO-UHFFFAOYSA-N","BRD-K19333160","","Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1"
"4317","RLX","","","","","Vitas-M",0,"BRD-K28773847-001-07-7","Preclinical","","HTLIIBRHXAULMB-UHFFFAOYSA-N","BRD-K28773847","","O=c1n2CCCCCc2nc2ccccc12"
"4318","RN-1","histone demethylase inhibitor","KDM1A","","","Tocris",85.64,"BRD-K41415459-300-01-6","Preclinical","","YAMSXCOVJUUMCT-FCHUYYIVSA-N","BRD-K41415459","","CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1c1ccc(OCc2ccccc2)cc1"
"4319","RN-1734","TRPV antagonist","TRPV4","","","Tocris, Tocris",91.99,"BRD-K95581532-001-02-3, BRD-K95581532-001-01-5","Preclinical","","IHYZMEAZAIFMTN-UHFFFAOYSA-N","BRD-K95581532","","CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl"
"4321","RN-1747","TRPV agonist","TRPV4","","","Tocris, Tocris",96.27,"BRD-K45519571-001-02-6, BRD-K45519571-001-01-8","Preclinical","","ZNLVYSJQUMALEO-UHFFFAOYSA-N","BRD-K45519571","","[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)N1CCN(Cc2ccccc2)CC1"
"4323","RO-04-5595","","GRIN2B","","","Tocris, Tocris",90.63,"BRD-A63546914-003-03-8, BRD-A63546914-003-02-0","Preclinical","","DSTWURHEHMZWEI-UHFFFAOYSA-N","BRD-A63546914","","COc1cc2CCN(C)C(CCc3ccc(Cl)cc3)c2cc1O"
"4325","RO-08-2750","","NGF","","","Tocris",93.42,"BRD-K00486786-001-02-2","Preclinical","","JDEMVNYMYPJJIM-UHFFFAOYSA-N","BRD-K00486786","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O"
"4326","RO-10-5824","dopamine receptor agonist","DRD4","","","Tocris, Tocris",88.47,"BRD-K79684402-300-02-8, BRD-K79684402-300-03-6","Preclinical","","KABDATZAOUSYES-UHFFFAOYSA-N","BRD-K79684402","","Cc1ncc(CN2CCC(=CC2)c2ccccc2)c(N)n1"
"4328","RO-106-9920","NFkB pathway inhibitor","","","","Tocris, Tocris",94.47,"BRD-A53134341-001-04-0, BRD-A53134341-001-03-2","Preclinical","","JFSXSNSCPNFCDM-UHFFFAOYSA-N","BRD-A53134341","","O=S(c1ccccc1)c1ccc2nnnn2n1"
"4330","RO-1138452","prostanoid receptor antagonist","PTGIR","","","Tocris",95.11,"BRD-K77220725-003-01-5","Preclinical","","GYYRMJMXXLJZAB-UHFFFAOYSA-N","BRD-K77220725","","CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1"
"4331","RO-15-4513","","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2","","","Tocris",87.5,"BRD-K82823076-001-02-6","Preclinical","","CFSOJZTUTOQNIA-UHFFFAOYSA-N","BRD-K82823076","","CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-]"
"4332","RO-19-4605","","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris, Tocris",98.3,"BRD-K80778372-001-03-3, BRD-K80778372-001-02-5","Preclinical","","ZIGMMUKDYCABPW-UHFFFAOYSA-N","BRD-K80778372","","CN1Cc2c(ncn2-c2ccsc2C1=O)C(=O)OC(C)(C)C"
"4334","RO-20-1724","phosphodiesterase inhibitor","PDE3A, PDE4A, PDE4B, PDE4C, PDE4D","","","Tocris, Tocris",98.13,"BRD-A07207424-001-14-0, BRD-A07207424-001-13-2","Preclinical","","PDMUULPVBYQBBK-UHFFFAOYSA-N","BRD-A07207424","","CCCCOc1cc(CC2CNC(=O)N2)ccc1OC"
"4336","RO-25-6981","","GRIN2B","","","Tocris, Tocris",97.03,"BRD-K51541829-050-02-8, BRD-K51541829-050-01-0","Preclinical","","WVZSEUPGUDIELE-HTAPYJJXSA-N","BRD-K51541829","","C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1"
"4338","RO-28-1675","glucokinase activator","GCK","","","MedChemEx",99.65,"BRD-K21672174-001-03-0","Preclinical","","NEQSWPCDHDQINX-MRXNPFEDSA-N","BRD-K21672174","","CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1"
"4339","RO-3","purinergic receptor antagonist","P2RX3","","","Tocris",96.35,"BRD-K00354853-001-01-2","Preclinical","","PYNPWUIBJMVRIG-UHFFFAOYSA-N","BRD-K00354853","","COc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C"
"4340","RO-3306","CDK inhibitor","CDK1","","","Tocris",94.61,"BRD-K78373679-001-03-7","Preclinical","","XOLMRFUGOINFDQ-YBEGLDIGSA-N","BRD-K78373679","","O=C1N=C(NCc2cccs2)S\C1=C/c1ccc2ncccc2c1"
"4341","RO-48-8071","oxidosqualene cyclase inhibitor","LSS","","","Tocris, MedChemEx",96.64,"BRD-K55192287-051-02-9, BRD-K55192287-051-01-1","Preclinical","","CMYCCJYVZIMDFU-UHFFFAOYSA-N","BRD-K55192287","","CN(CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1)CC=C"
"4343","RO-4987655","MEK inhibitor","MAP2K1","","","MedChemEx",96.87,"BRD-K64538373-001-01-4","Phase 1","","FIMYFEGKMOCQKT-UHFFFAOYSA-N","BRD-K64538373","","OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F"
"4344","RO-5126766","RAF inhibitor, MEK inhibitor","BRAF, MAP2K1, MAP2K2, RAF1","","","MedChemEx, MedChemEx, Selleck",96.39,"BRD-K82804538-001-03-6, BRD-K82804538-001-02-8, BRD-K82804538-001-01-0","Phase 1","","LMMJFBMMJUMSJS-UHFFFAOYSA-N","BRD-K82804538","","CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F"
"4347","RO-60-0175","","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",88.51,"BRD-K28007504-051-02-0, BRD-K28007504-051-01-2","Preclinical","","XJJZQXUGLLXTHO-ZETCQYMHSA-N","BRD-K28007504","","C[C@H](N)Cn1ccc2cc(F)c(Cl)cc12"
"4349","RO-61-8048","kynurenine 3-monooxygenase inhibitor","KMO","","","Tocris, MedChemEx",98.09,"BRD-K12639498-001-02-1, BRD-K12639498-001-01-3","Preclinical","","NDPBMCKQJOZAQX-UHFFFAOYSA-N","BRD-K12639498","","COc1ccc(cc1OC)S(=O)(=O)Nc1nc(cs1)-c1cccc(c1)[N+]([O-])=O"
"4351","RO-67-7476","glutamate receptor positive allosteric modulator","GRM1","","","Tocris",90.92,"BRD-K91333421-001-01-9","Preclinical","","DAEHFYNGSSBGSS-KRWDZBQOSA-N","BRD-K91333421","","Cc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1c1ccc(F)cc1"
"4352","RO-90-7501","","APP","","","Tocris, Tocris",90.66,"BRD-K58299615-001-03-5, BRD-K58299615-001-04-3","Preclinical","","PAGZCEHLFCJSPV-UHFFFAOYSA-N","BRD-K58299615","","Nc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(N)cc2[nH]1"
"4354","RO-9187","HCV inhibitor","","","","MedChemEx",98.79,"BRD-K57284066-001-01-6","Preclinical","","ODLGMSQBFONGNG-XZMZPDFPSA-N","BRD-K57284066","","Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O)c(=O)n1"
"4355","ROBALZOTAN","serotonin receptor antagonist","HTR1A","","","Tocris",90.01,"BRD-K26169680-003-01-9","Phase 2","","MQTUXRKNJYPMCG-CYBMUJFWSA-N","BRD-K26169680","","NC(=O)c1ccc(F)c2OC[C@@H](Cc12)N(C1CCC1)C1CCC1"
"4356","ROCILETINIB","EGFR inhibitor","EGFR","","","Selleck",98.26,"BRD-K33610132-001-02-9","Phase 3","","HUFOZJXAKZVRNJ-UHFFFAOYSA-N","BRD-K33610132","","COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O"
"4357","ROFECOXIB","cyclooxygenase inhibitor","ELN, PTGS2","","","MicroSource, MedChemEx, Sigma, Selleck, Selleck",98.36,"BRD-K21733600-001-15-8, BRD-K21733600-001-24-0, BRD-K21733600-001-23-2, BRD-K21733600-001-19-0, BRD-K21733600-001-14-1","Withdrawn","","RZJQGNCSTQAWON-UHFFFAOYSA-N","BRD-K21733600","","CS(=O)(=O)c1ccc(cc1)C1=C(C(=O)OC1)c1ccccc1"
"4362","ROLIPRAM","phosphodiesterase inhibitor","","","","Tocris, MicroSource, Tocris, Selleck",98.11,"BRD-A34255068-001-38-6, BRD-A34255068-001-34-5, BRD-A34255068-001-33-7, BRD-A34255068-001-32-9","Phase 3","","HJORMJIFDVBMOB-UHFFFAOYSA-N","BRD-A34255068","","COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1"
"4366","ROLIPRAM-R(-)","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4C, PDE4D, PDE5A","","","Tocris, Tocris",97.48,"BRD-K75516118-001-04-1, BRD-K75516118-001-03-3","Preclinical","","HJORMJIFDVBMOB-LBPRGKRZSA-N","BRD-K75516118","","COc1ccc(cc1OC1CCCC1)[C@@H]1CNC(=O)C1"
"4368","ROLIPRAM-S(+)","phosphodiesterase inhibitor","","","","Selleck, Tocris",98.17,"BRD-K65856711-001-03-6, BRD-K65856711-001-04-4","Preclinical","","HJORMJIFDVBMOB-GFCCVEGCSA-N","BRD-K65856711","","COc1ccc(cc1OC1CCCC1)[C@H]1CNC(=O)C1"
"4370","ROLITETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","","","","MicroSource, Selleck, Selleck",2.99,"BRD-A62336573-001-03-1, BRD-A62336573-001-04-9, BRD-A62336573-001-02-3","Launched","","PLDZOHPIBZVDLQ-KOQYWDHLSA-N","BRD-A62336573","","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O"
"4373","ROLZIRACETAM","","","","","Sigma",97.8,"BRD-K38564664-001-01-1","Phase 2","","IEZDOKQWPWZVQF-UHFFFAOYSA-N","BRD-K38564664","","O=C1CCC2CCC(=O)N12"
"4374","ROQUINIMEX","angiogenesis inhibitor, tumor necrosis factor production inhibitor","","","","Tocris",96.21,"BRD-K03384561-001-02-7","Phase 3","","SGOOQMRIPALTEL-UHFFFAOYSA-N","BRD-K03384561","","CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1"
"4375","ROSAMICIN","protein synthesis inhibitor","","","","Vitas-M",58.91,"BRD-A38799180-001-01-0","Phase 2","","IUPCWCLVECYZRV-ZRDIBKRKSA-N","BRD-A38799180","","CCC1OC(=O)CC(O)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(CC=O)CC(C)C(=O)\C=C\C2(C)OC2C1C"
"4376","ROSCOVITINE","CDK inhibitor","CDK2, CDK9","","","Selleck, Selleck",97.94,"BRD-K07691486-001-19-7, BRD-K07691486-001-15-5","Phase 2","","BTIHMVBBUGXLCJ-OAHLLOKOSA-N","BRD-K07691486","","CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1"
"4378","ROSIGLITAZONE","insulin sensitizer, PPAR receptor agonist","ACSL4, FFAR1, PPARG, TRPC5, TRPM3","","","Selleck, Selleck, Selleck, MicroSource, Tocris",98.94,"BRD-A97437073-050-13-7, BRD-A97437073-003-14-4, BRD-A97437073-001-08-0, BRD-A97437073-050-14-5, BRD-A97437073-001-09-8","Withdrawn","","YASAKCUCGLMORW-UHFFFAOYSA-N","BRD-A97437073","","CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1"
"4383","ROSMARINIC-ACID","GABA transaminase inhibitor","MCL1, TYR","","","Tocris",94.08,"BRD-K20313525-001-04-6","Launched","","DOUMFZQKYFQNTF-WUTVXBCWSA-N","BRD-K20313525","","OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c(O)c1"
"4384","ROSTAFUROXINE","ATPase inhibitor","ATP1A1","","","Tocris, MedChemEx",98.28,"BRD-K11672787-001-02-3, BRD-K11672787-001-01-5","Phase 2","","AEAPORIZZWBIEX-DTBDINHYSA-N","BRD-K11672787","","C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)c1ccoc1"
"4386","ROTUNDINE","serotonin receptor agonist","DRD1, DRD2, DRD3, HTR1A","","","Selleck",90.41,"BRD-K35719256-001-02-6","Launched","","AEQDJSLRWYMAQI-KRWDZBQOSA-N","BRD-K35719256","","COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC"
"4387","RP-001","sphingosine 1 phosphate receptor agonist","S1PR1","","","Tocris",94.54,"BRD-A29148886-003-01-4","Preclinical","","WNDDDFYFTSGSEC-UHFFFAOYSA-N","BRD-A29148886","","CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2C(CCc12)NCCC(O)=O"
"4388","RP67580","","","","","Tocris",44.82,"BRD-K40767677-001-01-1","Preclinical","","RQPUEHDQLXIPNI-LOSJGSFVSA-N","BRD-K40767677","","COc1ccccc1C=C(N)N1C[C@H]2[C@@H](C1)C(CCC2=O)(c1ccccc1)c1ccccc1"
"4389","RQ-00203078","transient receptor potential channel antagonist","TRPM8","","","Tocris",93.37,"BRD-K87973152-001-01-3","Preclinical","","IJGQFZYYEHCCIZ-UHFFFAOYSA-N","BRD-K87973152","","OC(=O)c1ccc(cc1)S(=O)(=O)N(Cc1ccc(OC(F)(F)F)cc1)c1ncc(cc1Cl)C(F)(F)F"
"4390","RRX-001","glucose 6-phosphate dehydrogenase inhibitor","G6PD","","","MedChemEx, MedChemEx",0,"BRD-K06894065-001-02-3, BRD-K06894065-001-01-5","Phase 2","","JODKFOVZURLVTG-UHFFFAOYSA-N","BRD-K06894065","","[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O"
"4392","RS-0481","immunostimulant","","","","Enamine",94.07,"BRD-A00055058-001-01-0","Phase 2","","MEXWLVVJOPSWLN-UHFFFAOYSA-N","BRD-A00055058","","CC(NC(=O)C1CSCN1C(=O)c1ccccc1)c1ccccc1"
"4393","RS-100329","adrenergic receptor antagonist","ADRA1A, ADRA1D","","","Tocris",97.46,"BRD-K08640512-003-02-3","Preclinical","","RCOBWVAGWYRNHZ-UHFFFAOYSA-N","BRD-K08640512","","Cc1c[nH]c(=O)n(CCCN2CCN(CC2)c2ccccc2OCC(F)(F)F)c1=O"
"4394","RS-102221","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris, Tocris",97.64,"BRD-K87048468-003-03-5, BRD-K87048468-003-04-3, BRD-K87048468-003-02-7","Preclinical","","HZZZZODVDSHQRG-UHFFFAOYSA-N","BRD-K87048468","","COc1cc(OC)c(cc1NS(=O)(=O)c1ccc(cc1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O"
"4397","RS-102895","CCR antagonist","CCR2","","","Tocris, Tocris",97.44,"BRD-K83063356-003-03-3, BRD-K83063356-003-02-5","Preclinical","","HIDWEYPGMLIQSN-UHFFFAOYSA-N","BRD-K83063356","","FC(F)(F)c1ccc(CCN2CCC3(CC2)OC(=O)Nc2ccccc32)cc1"
"4399","RS-127445","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Selleck",95.44,"BRD-K90825648-001-02-0","Phase 1","","ZZZQXCUPAJFVBN-UHFFFAOYSA-N","BRD-K90825648","","CC(C)c1cc(nc(N)n1)-c1ccc(F)c2ccccc12"
"4400","RS-16566","serotonin receptor antagonist","","","","Tocris",98.66,"BRD-K80725821-300-02-9","Preclinical","","OGXMGJGFLBSEJW-HNNXBMFYSA-N","BRD-K80725821","","CC(C)n1cnc2c(cc(Cl)cc12)C(=O)N[C@H]1CN2CCC1CC2"
"4401","RS-17053","adrenergic receptor antagonist","ADRA1A, ADRA1D","","","Tocris, Tocris",96.88,"BRD-K76840893-003-03-3, BRD-K76840893-003-02-5","Preclinical","","XLZHXAXXJVKTFM-UHFFFAOYSA-N","BRD-K76840893","","CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1"
"4403","RS-23597-190","serotonin receptor antagonist","HTR4","","","Tocris",98.28,"BRD-K01868942-003-02-7","Preclinical","","RLSGBCUXLRMTPF-UHFFFAOYSA-N","BRD-K01868942","","COc1cc(N)c(Cl)cc1C(=O)OCCCN1CCCCC1"
"4404","RS-39604","serotonin receptor antagonist","HTR4","","","Tocris",98.29,"BRD-K20742498-003-02-9","Preclinical","","BKVIWGRFRKLFIO-UHFFFAOYSA-N","BRD-K20742498","","COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1"
"4405","RS-45041-190","imidazoline receptor agonist","","","","Tocris",96.87,"BRD-K26160755-003-02-6","Preclinical","","IVCMOOBKRRDNHX-UHFFFAOYSA-N","BRD-K26160755","","Clc1cccc2CN(Cc12)C1=NCCN1"
"4406","RS-504393","CC chemokine receptor antagonist","CCL2, CCR2","","","Tocris",96.5,"BRD-K87510569-001-02-8","Preclinical","","ODNICNWASXKNNQ-UHFFFAOYSA-N","BRD-K87510569","","Cc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1"
"4407","RS-56812","serotonin receptor partial agonist","HTR3A","","","Tocris",98.66,"BRD-K20714604-003-02-9","Preclinical","","ZNAPADWWBWFMCQ-HNNXBMFYSA-N","BRD-K20714604","","Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc12"
"4408","RS-67333","serotonin receptor partial agonist","HTR4","","","Tocris",97.37,"BRD-K46142322-003-02-4","Preclinical","","JBHLYIVFFLNISJ-UHFFFAOYSA-N","BRD-K46142322","","CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1"
"4409","RS-67506","serotonin receptor partial agonist","HTR4","","","Tocris",96.93,"BRD-K50018155-003-02-1","Preclinical","","UATDVRSFFGFTAI-UHFFFAOYSA-N","BRD-K50018155","","COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1"
"4410","RS-79948","adrenergic receptor antagonist","ADRA2A","","","Tocris",97.72,"BRD-K86600316-003-02-0","Preclinical","","UMGBFFAJXFXOIL-MNEFBYGVSA-N","BRD-K86600316","","CCS(=O)(=O)N1CCC[C@@H]2CN3CCc4cc(OC)ccc4[C@@H]3C[C@H]12"
"4411","RSV604","RSV replication inhibitor","","","","MedChemEx",98.22,"BRD-K30159788-001-01-9","Phase 2","","MTPVBMVUENFFLL-HXUWFJFHSA-N","BRD-K30159788","","Fc1ccccc1NC(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O"
"4412","RTA-408","nitric oxide production inhibitor","NFE2L2","","","MedChemEx, MedChemEx, Selleck",90.95,"BRD-K56211775-001-02-0, BRD-K56211775-001-01-2, BRD-K56211775-001-03-8","Phase 2","BRD-A96383502-001-01-3","RJCWBNBKOKFWNY-IDPLTSGASA-N","BRD-K56211775","BRD-A96383502","CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2"
"4415","RU-SKI-43","hedgehog pathway inhibitor","HHAT","","","Tocris",92.1,"BRD-A33603104-003-01-8","Preclinical","","AEENEMOEBJOKGN-UHFFFAOYSA-N","BRD-A33603104","","CCC(C)CNCC(=O)N1CCc2sccc2C1COc1cccc(C)c1"
"4416","RU-24969","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6","","","MedChemEx, MedChemEx, Tocris",64.03,"BRD-K00234327-001-04-8, BRD-K00234327-001-03-0, BRD-K00234327-036-05-1","Phase 1","BRD-M08478673-036-02-1","KRVMLPUDAOWOGN-UHFFFAOYSA-N","BRD-K00234327","BRD-M08478673","COc1ccc2[nH]cc(C3=CCNCC3)c2c1"
"4419","RU-28318","cytochrome P450 inhibitor","NR3C2","","","Tocris",92.75,"BRD-K37687387-237-01-7","Phase 2","","DNHCHRGCTVRAFT-JEHIOXJOSA-N","BRD-K37687387","","CCC[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)CCC(O)=O)[C@H]12"
"4420","RU-42173","adrenergic receptor agonist","ADRB2","","","Enzo",9.01,"BRD-K85285268-003-01-1","Phase 2","","ZSTCZWJCLIRCOJ-DGCLKSJQSA-N","BRD-K85285268","","CC(C)N[C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O"
"4421","RU-58841","androgen receptor antagonist","AR","","","MedChemEx",97.49,"BRD-K62762455-001-01-3","Phase 2","","ARBYGDBJECGMGA-UHFFFAOYSA-N","BRD-K62762455","","CC1(C)N(CCCCO)C(=O)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F"
"4422","RUBITECAN","topoisomerase inhibitor","TOP1","","","Sigma",94.03,"BRD-K79821389-001-03-5","Phase 3","","VHXNKPBCCMUMSW-FQEVSTJZSA-N","BRD-K79821389","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc([N+]([O-])=O)c4cc3Cn1c2=O"
"4423","RUCAPARIB","PARP inhibitor","PARP1, PARP2","","","Selleck, Selleck",94.42,"BRD-K88560311-011-07-1, BRD-K88560311-011-06-3","Phase 3","","HMABYWSNWIZPAG-UHFFFAOYSA-N","BRD-K88560311","","CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23"
"4425","RUCINOL","tyrosinase inhibitor","TYR","","","TCI",98.99,"BRD-K61036791-001-01-6","Phase 1","","CSHZYWUPJWVTMQ-UHFFFAOYSA-N","BRD-K61036791","","CCCCc1ccc(O)cc1O"
"4426","RUTAECARPINE","cyclooxygenase inhibitor","PTGS2","","","Selleck",97.45,"BRD-K94723713-001-10-6","Preclinical","","ACVGWSKVRYFWRP-UHFFFAOYSA-N","BRD-K94723713","","O=c1n2CCc3c([nH]c4ccccc34)-c2nc2ccccc12"
"4427","RUXOLITINIB-(S)","JAK inhibitor","JAK1, JAK2","","","Selleck",97.97,"BRD-K19601669-001-03-5","Preclinical","","HFNKQEVNSGCOJV-HNNXBMFYSA-N","BRD-K19601669","","N#CC[C@@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12"
"4428","RWJ-21757","toll-like receptor agonist","TLR7","","","Tocris, Tocris, Sigma",84.99,"BRD-K00091711-001-01-2, BRD-K00091711-001-03-8, BRD-K00091711-001-02-0","Phase 1","","VDCRFBBZFHHYGT-IOSLPCCCSA-N","BRD-K00091711","","Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)n(CC=C)c2c(=O)[nH]1"
"4431","RWJ-50271","integrin inhibitor","ICAM1","","","Tocris",97.8,"BRD-K94623186-001-01-5","Preclinical","","HOFGTYCLOKDAES-UHFFFAOYSA-N","BRD-K94623186","","Cc1c(cnn1-c1nc(cs1)-c1cccc(c1)C(F)(F)F)C(=O)NCCCO"
"4432","RWJ-67657","MAP kinase inhibitor","MAPK14, PTGS2","","","Cayman, Tocris",93.32,"BRD-K07074923-001-01-5, BRD-K07074923-001-02-3","Phase 1","","QSUSKMBNZQHHPA-UHFFFAOYSA-N","BRD-K07074923","","OCCC#Cc1nc(c(-c2ccncc2)n1CCCc1ccccc1)-c1ccc(F)cc1"
"4434","RX-3117","DNA synthesis inhibitor, CDK inhibitor","CDK2, DNMT1","","","MedChemEx, MedChemEx",83.1,"BRD-K66213167-001-02-0, BRD-K66213167-001-01-2","Phase 1/Phase 2","","QLLGKCJUPWYJON-HLTSFMKQSA-N","BRD-K66213167","","Nc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1"
"4436","RX-821002","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","","","Tocris, Tocris",97.1,"BRD-A65597028-003-08-1, BRD-A65597028-003-07-3","Preclinical","","HQGWKNGAKBPTBX-UHFFFAOYSA-N","BRD-A65597028","","COC1(COc2ccccc2O1)C1=NCCN1"
"4438","RYUVIDINE","histone lysine methyltransferase inhibitor","CDK2, CDK4","","","Tocris, Tocris",95.12,"BRD-K06426971-001-02-7, BRD-K06426971-001-03-5","Preclinical","","HFPLHASLIOXVGS-UHFFFAOYSA-N","BRD-K06426971","","Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O"
"4440","R112","syk inhibitor","SYK","","","MedChemEx",94.95,"BRD-K23902832-001-01-7","Preclinical","","TVKGTSHBQZEFEE-UHFFFAOYSA-N","BRD-K23902832","","Oc1cccc(Nc2ncc(F)c(Nc3cccc(O)c3)n2)c1"
"4441","R306465","HDAC inhibitor","","","","AdvChemBlocks",82.42,"BRD-K86687746-001-01-3","Phase 1","","MUTBJZVSRNUIHA-UHFFFAOYSA-N","BRD-K86687746","","ONC(=O)c1cnc(nc1)N1CCN(CC1)S(=O)(=O)c1ccc2ccccc2c1"
"4442","R406","SYK inhibitor","RET, SYK","","","Selleck, Selleck, Selleck",97.72,"BRD-K20285085-074-04-5, BRD-K20285085-074-03-7, BRD-K20285085-001-07-1","Phase 1","","NHHQJBCNYHBUSI-UHFFFAOYSA-N","BRD-K20285085","","COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC"
"4445","R547","CDK inhibitor","CDK1, CDK2, CDK4, CDK7","","","Selleck",95.54,"BRD-K52233191-001-02-4","Phase 1","","JRNJNYBQQYBCLE-UHFFFAOYSA-N","BRD-K52233191","","COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N"
"4446","S-ISOPROPYLISOTHIOUREA","nitric oxide synthase inhibitor","NOS3","","","Tocris",94.16,"BRD-K10673031-004-02-0","Preclinical","","XSSNABKEYXKKMK-UHFFFAOYSA-N","BRD-K10673031","","CC(C)SC(N)=N"
"4447","S-METHYLCYSTEINE","","CTSD, MGMT","","","Ark, Ark",100,"BRD-K63123526-001-02-0, BRD-K63123526-001-01-2","Phase 1","","IDIDJDIHTAOVLG-VKHMYHEASA-N","BRD-K63123526","","CSC[C@H](N)C(O)=O"
"4449","S-NITROSOGLUTATHIONE","nitric oxide stimulant","PTPN1","","","Cayman, Cayman",0,"BRD-K94780074-001-07-5, BRD-K94780074-001-06-7","Phase 1","","HYHSBSXUHZOYLX-WDSKDSINSA-N","BRD-K94780074","","N[C@@H](CCC(=O)N[C@@H](CS[N+][O-])C(=O)NCC(O)=O)C(O)=O"
"4451","S-SULFO-L-CYSTEINE-SODIUM-SALT","glutamate receptor agonist","","","","Tocris",90.28,"BRD-K59527975-236-01-8","Preclinical","","NOKPBJYHPHHWAN-REOHCLBHSA-N","BRD-K59527975","","N[C@@H](CSS(O)(=O)=O)C(O)=O"
"4452","S-TRITYL-L-CYSTEINE","mitotic kinesin inhibitor","","","","Tocris",18.45,"BRD-K09774593-001-01-7","Preclinical","","DLMYFMLKORXJPO-HXUWFJFHSA-N","BRD-K09774593","","N[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(O)=O"
"4453","S-07662","CAR antagonist","NR1I3","","","Tocris",94.26,"BRD-K37635256-001-01-4","Preclinical","","UITFWLJMEZPXOF-UHFFFAOYSA-N","BRD-K37635256","","Cc1oc2ccccc2c1CNC(=O)NCc1cccs1"
"4454","S-111","PARP inhibitor","PARP1","","","MedChemEx",100,"BRD-K60005752-001-01-9","Phase 2","","PYXFVCFISTUSOO-HKUCOEKDSA-N","BRD-K60005752","","CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C"
"4455","S-14506","serotonin receptor agonist","HTR1A","","","Tocris, Tocris",99.32,"BRD-K46766488-003-03-8, BRD-K46766488-003-02-0","Preclinical","","IFMQODYDAUKKEN-UHFFFAOYSA-N","BRD-K46766488","","COc1ccc2cccc(N3CCN(CCNC(=O)c4ccc(F)cc4)CC3)c2c1"
"4457","SA-47","FAAH inhibitor","FAAH","","","Tocris",93.41,"BRD-K99819791-001-01-1","Preclinical","","HSYCMGWPPRTNKH-UHFFFAOYSA-N","BRD-K99819791","","CNC(=O)COC(=O)NCCC1CCN(CC1)c1cccc(C)n1"
"4458","SACCHARIN","DNA polymerase inhibitor","CA1, CA12, CA2, CA9","","","MicroSource",98.63,"BRD-K46493214-001-06-7","Launched","","CVHZOJJKTDOEJC-UHFFFAOYSA-N","BRD-K46493214","","O=C1NS(=O)(=O)c2ccccc12"
"4459","SACLOFEN","GABA receptor antagonist","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8","","","Tocris",97.13,"BRD-A24122750-001-03-7","Preclinical","","JYLNVJYYQQXNEK-UHFFFAOYSA-N","BRD-A24122750","","NCC(CS(O)(=O)=O)c1ccc(Cl)cc1"
"4460","SAFFLOWER-YELLOW","anti-inflammatory agent","","","","MedChemEx",0,"BRD-A96503329-001-01-7","Preclinical","","UHZGYDZTDCTJBO-DKEBXYRSSA-N","BRD-A96503329","","OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)[C@]1(O)C(=O)C(\C=C2/C(=O)C(C(=O)\C=C\c3ccc(O)cc3)C(=O)[C@@](O)(C3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C2=O)C(=O)C(C(=O)\C=C\c2ccc(O)cc2)C1=O"
"4461","SAFINGOL","PKC inhibitor","TRPM3","","","Enzo",100,"BRD-K93944989-001-08-0","Phase 1","","OTKJDMGTUTTYMP-ZWKOTPCHSA-N","BRD-K93944989","","CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO"
"4462","SAFRANAL","benzodiazepine receptor agonist","GABBR1","","","Sigma",0,"BRD-K90582192-001-01-9","Phase 2","","SGAWOGXMMPSZPB-UHFFFAOYSA-N","BRD-K90582192","","CC1=C(C=O)C(C)(C)CC=C1"
"4463","SAG","smoothened receptor agonist","SMO, TRPC6","","","Tocris",90.09,"BRD-K99433989-001-01-3","Preclinical","","VFSUUTYAEQOIMW-YHBQERECSA-N","BRD-K99433989","","CN[C@H]1CC[C@@H](CC1)N(Cc1cccc(c1)-c1ccncc1)C(=O)c1sc2ccccc2c1Cl"
"4464","SALAZODINE","","","","","Aronis",90.31,"BRD-K15045219-001-01-8","Phase 2","","YFUATOCFMCWUEH-UHFFFAOYSA-N","BRD-K15045219","","COc1ccc(NS(=O)(=O)c2ccc(cc2)N=Nc2ccc(O)c(c2)C(O)=O)nn1"
"4465","SALICIN","anti-inflammatory agent","","","","MicroSource, Selleck",99.21,"BRD-K64614248-001-12-3, BRD-K64614248-001-11-5","Phase 1","","NGFMICBWJRZIBI-UJPOAAIJSA-N","BRD-K64614248","","OC[C@H]1O[C@@H](Oc2ccccc2CO)[C@H](O)[C@@H](O)[C@@H]1O"
"4467","SALICYL-ALCOHOL","","","","","MicroSource",94.96,"BRD-K08493205-001-04-9","Preclinical","","CQRYARSYNCAZFO-UHFFFAOYSA-N","BRD-K08493205","","OCc1ccccc1O"
"4468","SALICYLANILIDE","other antibiotic","","","","MicroSource, Selleck",99.27,"BRD-K83036479-001-09-2, BRD-K83036479-001-08-4","Preclinical","","WKEDVNSFRWHDNR-UHFFFAOYSA-N","BRD-K83036479","","Oc1ccccc1C(=O)Nc1ccccc1"
"4470","SALIDROSIDE","beta amyloid protein neurotoxicity inhibitor","APP","","","Selleck, Selleck",97.85,"BRD-K66030860-001-04-4, BRD-K66030860-001-03-6","Preclinical","","ILRCGYURZSFMEG-RKQHYHRCSA-N","BRD-K66030860","","OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O"
"4472","SALIRASIB","mTOR inhibitor","TRPA1","","","MedChemEx",91.85,"BRD-K98453471-001-01-7","Phase 2","","WUILNKCFCLNXOK-CFBAGHHKSA-N","BRD-K98453471","","CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(O)=O"
"4473","SALSOLINOL-1-CARBOXYLIC-ACID","","","","","Tocris",0,"BRD-A49952467-001-02-4","Preclinical","","XHGLVMDBZZZXDP-UHFFFAOYSA-N","BRD-A49952467","","CC1(NCCc2cc(O)c(O)cc12)C(O)=O"
"4474","SALUBRINAL","eukaryotic translation initiation factor inhibitor","EIF2S1","","","Tocris, Tocris, Selleck, Selleck",97.81,"BRD-A45107007-001-03-4, BRD-A45107007-001-06-7, BRD-A45107007-001-05-9, BRD-A45107007-001-02-6","Preclinical","","LCOIAYJMPKXARU-VAWYXSNFSA-N","BRD-A45107007","","ClC(Cl)(Cl)C(NC(=O)\C=C\c1ccccc1)NC(=S)Nc1cccc2cccnc12"
"4478","SALVIANOLIC-ACID-B","metalloproteinase inhibitor, EGFR inhibitor","MMP9","","","AvaChem",95.4,"BRD-K18898553-001-01-1","Phase 2","","SNKFFCBZYFGCQN-PDVBOLEISA-N","BRD-K18898553","","OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c2O[C@H]([C@H](C(=O)O[C@H](Cc3ccc(O)c(O)c3)C(O)=O)c12)c1ccc(O)c(O)c1"
"4479","SALVINORIN-A","opioid receptor agonist","OPRD1, OPRK1, OPRM1","","","Enzo",96.14,"BRD-K19284129-001-02-6","Phase 1","","OBSYBRPAKCASQB-AGQYDFLVSA-N","BRD-K19284129","","COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1"
"4480","SAL003","eukaryotic translation initiation factor inhibitor","EIF2A","","","Tocris, Tocris, Selleck",95.48,"BRD-A45869167-001-11-8, BRD-A45869167-001-12-6, BRD-A45869167-001-10-0","Preclinical","","TVNBASWNLOIQML-IZZDOVSWSA-N","BRD-A45869167","","Clc1ccc(cc1)NC(=S)NC(C(Cl)(Cl)Cl)NC(=O)\C=C\c1ccccc1"
"4483","SANAZOLE","","","","","Asinex",98.04,"BRD-K37747025-001-08-2","Phase 1","","YKDRHKCETNMLHL-UHFFFAOYSA-N","BRD-K37747025","","COCCNC(=O)Cn1cnc(n1)[N+]([O-])=O"
"4484","SANGIVAMYCIN","DNA inhibitor","","","","EMDBio",99.32,"BRD-A64064900-001-02-3","Phase 1","","OBZJZDHRXBKKTJ-HUNIYLEFSA-N","BRD-A64064900","","NC(=O)c1cn(C2OC(CO)[C@H](O)[C@@H]2O)c2ncnc(N)c12"
"4485","SANGUINARIUM-CHLORIDE","apoptosis stimulant","CASP3","","","MicroSource, Sigma",92.68,"BRD-K66898851-003-02-5, BRD-K66898851-003-03-3","Phase 1","","INVGWHRKADIJHF-UHFFFAOYSA-N","BRD-K66898851","","C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12"
"4487","SANT-1","smoothened receptor antagonist","SHH, SMO","","","Selleck, Tocris, Tocris",96.37,"BRD-K99741577-001-01-7, BRD-K99741577-001-02-5, BRD-K99741577-001-03-3","Preclinical","","FOORCIAZMIWALX-JJIBRWJFSA-N","BRD-K99741577","","Cc1nn(c(C)c1\C=N\N1CCN(Cc2ccccc2)CC1)-c1ccccc1"
"4490","SANT-2","smoothened receptor antagonist","SHH, SMO","","","Tocris, Tocris",98.44,"BRD-K35781423-001-01-6, BRD-K35781423-001-02-4","Preclinical","","VQOJFGFKIVFMDH-UHFFFAOYSA-N","BRD-K35781423","","CCOc1cc(cc(OCC)c1OCC)C(=O)Nc1ccc(Cl)c(c1)-c1nc2ccccc2[nH]1"
"4492","SAR-245409","PI3K inhibitor","MTOR, PIK3CG","","","Selleck",95.59,"BRD-K75308783-001-07-0","Phase 1/Phase 2","","HJSSPYJVWLTYHG-UHFFFAOYSA-N","BRD-K75308783","","COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1"
"4493","SARACATINIB","src inhibitor","ABL1, LCK, SRC, YES1","","","Selleck",93.33,"BRD-K19540840-001-09-4","Phase 2/Phase 3","","OUKYUETWWIPKQR-UHFFFAOYSA-N","BRD-K19540840","","CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1"
"4494","SARAFLOXACIN","bacterial DNA gyrase inhibitor","","","","MicroSource, Selleck",92.94,"BRD-K08525451-003-06-0, BRD-K08525451-003-05-2","Launched","","XBHBWNFJWIASRO-UHFFFAOYSA-N","BRD-K08525451","","OC(=O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O"
"4496","SARCOSINE","Glycine transporter 1 inhibitor","SLC6A9","","","Enamine",86.26,"BRD-K51263939-001-08-6","Phase 2","","FSYKKLYZXJSNPZ-UHFFFAOYSA-N","BRD-K51263939","","CNCC(O)=O"
"4497","SARI-59-801","","","","","Sigma",93.49,"BRD-A92448440-001-01-3","Phase 1","","GMGOZCSXMVXXRS-UHFFFAOYSA-N","BRD-A92448440","","CCc1noc(C)c1-c1[nH]c2ccccc2c1C(O)CN(C)C"
"4498","SAROGLITAZAR","PPAR receptor agonist","PPARA, PPARG","","","Synnovator",51.78,"BRD-K79878800-001-01-0","Phase 3","","MRWFZSLZNUJVQW-DEOSSOPVSA-N","BRD-K79878800","","CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(O)=O"
"4499","SAR131675","VEGFR inhibitor","FLT4","","","Selleck",94.88,"BRD-K38904395-001-02-3","Preclinical","","PFMPOBVAYMTUOX-GOSISDBHSA-N","BRD-K38904395","","CCn1c(N)c(C(=O)NC)c(=O)c2ccc(nc12)C#C[C@@](C)(O)COC"
"4500","SAR405","PI3K inhibitor","PIK3C3","","","MedChemEx",93.1,"BRD-K72868067-001-02-4","Preclinical","","SPDQRCUBFSRAFI-DOMZBBRYSA-N","BRD-K72868067","","C[C@@H]1COCCN1c1cc(=O)n2CC[C@H](N(Cc3cncc(Cl)c3)c2n1)C(F)(F)F"
"4501","SAR405838","MDM inhibitor","MDM2","","","MedChemEx, MedChemEx, Selleck",87.15,"BRD-K86736469-001-02-1, BRD-K86736469-001-01-3, BRD-A16035238-001-01-7","Phase 1","","IDKAKZRYYDCJDU-HEVVSWJASA-N","BRD-K86736469","","CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N[C@H]1CC[C@H](O)CC1"
"4503","SAR405838","MDM inhibitor","MDM2","","","MedChemEx, MedChemEx, Selleck",87.15,"BRD-K86736469-001-02-1, BRD-K86736469-001-01-3, BRD-A16035238-001-01-7","Phase 1","","IDKAKZRYYDCJDU-HEVVSWJASA-N","BRD-K86736469","","CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1"
"4504","SAR405838","MDM inhibitor","MDM2","","","MedChemEx, MedChemEx, Selleck",87.15,"BRD-K86736469-001-02-1, BRD-K86736469-001-01-3, BRD-A16035238-001-01-7","Phase 1","","IDKAKZRYYDCJDU-UHFFFAOYSA-N","BRD-K86736469","","CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N[C@H]1CC[C@H](O)CC1"
"4506","SAR405838","MDM inhibitor","MDM2","","","MedChemEx, MedChemEx, Selleck",87.15,"BRD-K86736469-001-02-1, BRD-K86736469-001-01-3, BRD-A16035238-001-01-7","Phase 1","","IDKAKZRYYDCJDU-UHFFFAOYSA-N","BRD-K86736469","","CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1"
"4507","SAR407899","rho associated kinase inhibitor","ROCK1","","","MedChemEx, MedChemEx",94.32,"BRD-K56912469-003-02-0, BRD-K56912469-003-01-2","Phase 2","","IPEXHQGMTHOKQV-UHFFFAOYSA-N","BRD-K56912469","","O=c1[nH]ccc2cc(OC3CCNCC3)ccc12"
"4509","SATRAPLATIN","DNA alkylating agent","","","","MedChemEx, MedChemEx",98.12,"BRD-M31395033-201-01-5, BRD-K42497885-001-01-1","Phase 3","BRD-U22164625-000-01-6, BRD-K50134774-416-01-3,BRD-U84587623-000-01-5","JFAHBAVHONXXFG-UHFFFAOYSA-J","BRD-M31395033","BRD-U22164625","NC1CCCCC1.CC(=O)O[Pt+4](C)(C)(Cl)(Cl)OC(C)=O"
"4510","SATRAPLATIN","DNA alkylating agent","","","","MedChemEx, MedChemEx",98.12,"BRD-M31395033-201-01-5, BRD-K42497885-001-01-1","Phase 3","BRD-U22164625-000-01-6, BRD-K50134774-416-01-3,BRD-U84587623-000-01-5","JFAHBAVHONXXFG-UHFFFAOYSA-J","BRD-M31395033","BRD-U22164625","CC(=O)O[Pt](N)(Cl)(Cl)(NC1CCCCC1)OC(C)=O"
"4511","SATRAPLATIN","DNA alkylating agent","","","","MedChemEx, MedChemEx",98.12,"BRD-M31395033-201-01-5, BRD-K42497885-001-01-1","Phase 3","BRD-U22164625-000-01-6, BRD-K50134774-416-01-3,BRD-U84587623-000-01-5","JWTNVKZACPRKPF-UHFFFAOYSA-J","BRD-M31395033","BRD-U22164625","NC1CCCCC1.CC(=O)O[Pt+4](C)(C)(Cl)(Cl)OC(C)=O"
"4512","SATRAPLATIN","DNA alkylating agent","","","","MedChemEx, MedChemEx",98.12,"BRD-M31395033-201-01-5, BRD-K42497885-001-01-1","Phase 3","BRD-U22164625-000-01-6, BRD-K50134774-416-01-3,BRD-U84587623-000-01-5","JWTNVKZACPRKPF-UHFFFAOYSA-J","BRD-M31395033","BRD-U22164625","CC(=O)O[Pt](N)(Cl)(Cl)(NC1CCCCC1)OC(C)=O"
"4513","SAVOLITINIB","c-Met inhibitor","MET","","","MedChemEx, MedChemEx",97.52,"BRD-K98028353-001-02-8, BRD-K98028353-001-01-0","Phase 2","","XYDNMOZJKOGZLS-NSHDSACASA-N","BRD-K98028353","","C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(nc12)-c1cnn(C)c1"
"4515","SB-200646","serotonin receptor antagonist","HTR2B, HTR2C","","","Tocris, Tocris",94.81,"BRD-K77677632-003-03-4, BRD-K77677632-003-02-6","Preclinical","","OJZZJTLBYXHUSJ-UHFFFAOYSA-N","BRD-K77677632","","Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12"
"4517","SB-202190","p38 MAPK inhibitor","AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1","","","Tocris, Tocris, Selleck",94.52,"BRD-K54330070-001-19-6, BRD-K54330070-001-16-2, BRD-K54330070-001-15-4","Preclinical","","QHKYPYXTTXKZST-UHFFFAOYSA-N","BRD-K54330070","","Oc1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1"
"4520","SB-203186","serotonin receptor antagonist","HTR4","","","Tocris",98.69,"BRD-K27141178-003-07-3","Preclinical","","YGKPIROTKVQCCU-UHFFFAOYSA-N","BRD-K27141178","","O=C(OCCN1CCCCC1)c1c[nH]c2ccccc12"
"4521","SB-203580","p38 MAPK inhibitor","AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF","","","Selleck, Selleck, Selleck, Tocris, Tocris, Tocris",98.22,"BRD-A37704979-001-12-3, BRD-A37704979-001-13-1, BRD-A37704979-001-09-9, BRD-A37704979-001-15-6, BRD-A37704979-001-10-7, BRD-A37704979-003-02-0","Preclinical","","CDMGBJANTYXAIV-UHFFFAOYSA-N","BRD-A37704979","","CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1"
"4527","SB-205384","GABA receptor modulator","GABRA3, GABRA5, GABRA6","","","Tocris, Tocris",96.8,"BRD-A22707317-001-11-6, BRD-A22707317-001-10-8","Preclinical","","JDTZAGLGBRRCJT-UHFFFAOYSA-N","BRD-A22707317","","CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N"
"4529","SB-206553","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",94.17,"BRD-K36395411-003-03-0, BRD-K36395411-003-02-2","Preclinical","","QJQORSLQNXDVGE-UHFFFAOYSA-N","BRD-K36395411","","Cn1ccc2cc3N(CCc3cc12)C(=O)Nc1cccnc1"
"4531","SB-216641","serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","","","Tocris",92.18,"BRD-K30867024-003-03-3","Preclinical","","JRNUKVFYILMMLX-UHFFFAOYSA-N","BRD-K30867024","","COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1OCCN(C)C"
"4532","SB-216763","glycogen synthase kinase inhibitor","CCNA2, CDK2, GSK3A, GSK3B","","","Selleck, Tocris",98.45,"BRD-K59184148-001-21-6, BRD-K59184148-001-22-4","Preclinical","","JCSGFHVFHSKIJH-UHFFFAOYSA-N","BRD-K59184148","","Cn1cc(C2=C(C(=O)NC2=O)c2ccc(Cl)cc2Cl)c2ccccc12"
"4534","SB-218078","CHK inhibitor","CHEK1","","","Tocris, Tocris",96.54,"BRD-A06352508-001-03-7, BRD-A06352508-001-05-2","Preclinical","","OTPNDVKVEAIXTI-UHFFFAOYSA-N","BRD-A06352508","","O=C1NC(=O)c2c1c1c3ccccc3n3C4CCC(O4)n4c5ccccc5c2c4c13"
"4536","SB-218795","tachykinin antagonist","TACR3","","","Tocris, Tocris",95.63,"BRD-K61097567-001-09-3, BRD-K61097567-001-08-5","Preclinical","","IUMQXQJZIHWLIN-HSZRJFAPSA-N","BRD-K61097567","","COC(=O)[C@H](NC(=O)c1cc(nc2ccccc12)-c1ccccc1)c1ccccc1"
"4538","SB-221284","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris",96.67,"BRD-K14807180-001-02-5","Preclinical","","OQZOXHCRSXYSPM-UHFFFAOYSA-N","BRD-K14807180","","CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F"
"4539","SB-222200","tachykinin antagonist","TACR3","","","Tocris, Tocris",99.49,"BRD-K04414442-001-09-1, BRD-K04414442-001-08-3","Preclinical","","MQNYRKWJSMQECI-QFIPXVFZSA-N","BRD-K04414442","","CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c1ccccc1)c1ccccc1"
"4541","SB-225002","CC chemokine receptor antagonist","CXCR2","","","Tocris, Tocris",97.9,"BRD-K61323504-001-04-0, BRD-K61323504-001-06-5","Preclinical","","MQBZVUNNWUIPMK-UHFFFAOYSA-N","BRD-K61323504","","Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O"
"4543","SB-228357","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris, Tocris",97.89,"BRD-K15424032-001-04-4, BRD-K15424032-001-03-6","Preclinical","","RRJLJKRFFRZRAF-UHFFFAOYSA-N","BRD-K15424032","","COc1cc2CCN(C(=O)Nc3cc(F)cc(c3)-c3cccnc3)c2cc1C(F)(F)F"
"4545","SB-2343","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","MedChemEx",96.34,"BRD-K98795921-001-01-7","Phase 1","","QYBGBLQCOOISAR-UHFFFAOYSA-N","BRD-K98795921","","CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1"
"4546","SB-239063","p38 MAPK inhibitor","MAPK11, MAPK14, PTGS2","","","Tocris",94.91,"BRD-K82091397-001-03-0","Preclinical","","ZQUSFAUAYSEREK-WKILWMFISA-N","BRD-K82091397","","COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1"
"4547","SB-242235","p38 MAPK inhibitor","HSPB1, MAPK14","","","MedChemEx",88.4,"BRD-K19412355-001-01-0","Phase 1","","PDTYLGXVBIWRIM-UHFFFAOYSA-N","BRD-K19412355","","COc1nccc(n1)-c1c(ncn1C1CCNCC1)-c1ccc(F)cc1"
"4548","SB-243213","serotonin receptor inverse agonist","HTR2A, HTR2B, HTR2C, HTR6","","","Tocris",94.92,"BRD-K99968849-300-01-4","Phase 1","","ZETBBVYSBABLHL-UHFFFAOYSA-N","BRD-K99968849","","Cc1cc2CCN(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2cc1C(F)(F)F"
"4549","SB-258585","serotonin receptor antagonist","HTR6","","","Tocris",94,"BRD-K80639402-003-02-9","Preclinical","","BDHMSYNBSBZCAF-UHFFFAOYSA-N","BRD-K80639402","","COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1"
"4550","SB-268262","calcitonin antagonist","CALCA","","","Tocris",95.7,"BRD-A91031770-001-01-8","Preclinical","","YXHLPJQQPOMPGE-UHFFFAOYSA-N","BRD-A91031770","","CN(C(=O)c1ccc(c(c1)[N+]([O-])=O)S(=O)c1nccs1)c1ccccc1C"
"4551","SB-269970","serotonin receptor antagonist","HTR7","","","Tocris, Selleck, Tocris",97.96,"BRD-K24201553-003-12-3, BRD-K24201553-003-10-7, BRD-K24201553-003-11-5","Preclinical","","HWKROQUZSKPIKQ-MRXNPFEDSA-N","BRD-K24201553","","CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1"
"4554","SB-271046","serotonin receptor antagonist","HTR6","","","Tocris, Selleck",94.47,"BRD-K82467063-003-01-5, BRD-K82467063-001-02-7","Phase 1","","LOCQRDBFWSXQQI-UHFFFAOYSA-N","BRD-K82467063","","COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1"
"4556","SB-297006","CC chemokine receptor antagonist","CCR3","","","Tocris",91,"BRD-K16107558-001-01-4","Preclinical","","BEZXGSZPWXRHIN-INIZCTEOSA-N","BRD-K16107558","","CCOC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1ccccc1"
"4557","SB-328437","CCR antagonist","","","","Tocris, Tocris",97.21,"BRD-K78720403-001-01-6, BRD-K78720403-001-02-4","Preclinical","","VMFGCGRAIBLAFY-IBGZPJMESA-N","BRD-K78720403","","COC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1cccc2ccccc12"
"4559","SB-334867","orexin receptor antagonist","HCRTR1, HCRTR2","","","Tocris, Tocris",99.08,"BRD-K41567364-001-05-3, BRD-K41567364-001-04-6","Preclinical","","AKMNUCBQGHFICM-UHFFFAOYSA-N","BRD-K41567364","","Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1"
"4561","SB-366791","TRPV antagonist","TRPV1","","","Tocris, Tocris",99.59,"BRD-K61536336-001-02-5, BRD-K61536336-001-01-7","Preclinical","","RYAMDQKWNKKFHD-JXMROGBWSA-N","BRD-K61536336","","COc1cccc(NC(=O)\C=C\c2ccc(Cl)cc2)c1"
"4563","SB-399885","serotonin receptor antagonist","HTR6","","","Tocris",96.08,"BRD-K03988082-001-01-7","Preclinical","","ATKZKAYWARYLBW-UHFFFAOYSA-N","BRD-K03988082","","COc1ccc(cc1N1CCNCC1)S(=O)(=O)Nc1cc(Cl)cc(Cl)c1OC"
"4564","SB-408124","orexin receptor antagonist","HCRTR1, HCRTR2","","","Tocris, Selleck, Tocris, Selleck",95.35,"BRD-K53913732-001-07-5, BRD-K53913732-001-06-7, BRD-K53913732-001-05-9, BRD-K53913732-001-04-2","Preclinical","","JTARFZSNUAGHRB-UHFFFAOYSA-N","BRD-K53913732","","CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1"
"4568","SB-415286","glycogen synthase kinase inhibitor","GSK3A, GSK3B, RPS6KB1","","","Selleck, Selleck, Tocris",91.95,"BRD-K76805682-001-17-5, BRD-K76805682-001-15-9, BRD-K76805682-001-16-7","Preclinical","","PQCXVIPXISBFPN-UHFFFAOYSA-N","BRD-K76805682","","Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl"
"4571","SB-431542","TGF beta receptor inhibitor","ACVR1C, TGFBR1","","","Selleck, Tocris, Tocris",98.92,"BRD-K67298865-001-08-2, BRD-K67298865-001-10-8, BRD-K67298865-001-09-0","Preclinical","","FHYUGAJXYORMHI-UHFFFAOYSA-N","BRD-K67298865","","NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1"
"4574","SB-452533","TRPV antagonist","TRPV1","","","Tocris",91.86,"BRD-K03665769-001-01-1","Preclinical","","IFJYEGJUQIBBQV-UHFFFAOYSA-N","BRD-K03665769","","CCN(CCNC(=O)Nc1ccccc1Br)c1cccc(C)c1"
"4575","SB-505124","ALK tyrosine kinase receptor inhibitor","TGFBR1","","","Selleck",98.07,"BRD-K40109029-001-02-9","Preclinical","","WGZOTBUYUFBEPZ-UHFFFAOYSA-N","BRD-K40109029","","Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2OCOc2c1)C(C)(C)C"
"4576","SB-525334","TGF beta receptor inhibitor","TGFBR1","","","Selleck, Tocris",95.92,"BRD-K37720887-001-07-8, BRD-K37720887-001-08-6","Preclinical","","DKPQHFZUICCZHF-UHFFFAOYSA-N","BRD-K37720887","","Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C"
"4578","SB-590885","RAF inhibitor","BRAF","","","Selleck, Selleck, Selleck",87.33,"BRD-K78809024-001-03-2, BRD-K78809024-001-05-7, BRD-K78809024-001-02-4","Preclinical","BRD-K01253243-001-03-0","MLSAQOINCGAULQ-QFMPWRQOSA-N","BRD-K78809024","BRD-K01253243","CN(C)CCOc1ccc(cc1)-c1nc(c([nH]1)-c1ccc2c(CC\C2=N/O)c1)-c1ccncc1"
"4581","SB-612111","nociceptin/orphanin FQ (NOP) receptor antagonist","OPRL1","","","Tocris",88.92,"BRD-K08333979-003-01-3","Preclinical","","OHRDCQFCAWLDBP-SBUREZEXSA-N","BRD-K08333979","","Cc1cccc2[C@@H](O)C[C@@H](CN3CCC(CC3)c3c(Cl)cccc3Cl)CCc12"
"4582","SB-657510","urotensin receptor antagonist","UTS2R","","","Tocris, Tocris",95.89,"BRD-K95292280-001-01-3, BRD-K95292280-001-02-1","Preclinical","","KQCZCINJGIRLCD-CYBMUJFWSA-N","BRD-K95292280","","COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(Cl)c(O[C@@H]2CCN(C)C2)c1"
"4584","SB-683698","integrin antagonist","ITGA4, ITGAV, ITGB1, ITGB7","","","MedChemEx",95.84,"BRD-K24968862-001-01-0","Phase 1","","DRSJLVGDSNWQBI-SFHVURJKSA-N","BRD-K24968862","","COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(O)=O)cc1"
"4585","SB-705498","TRPV antagonist","TRPV1","","","Selleck",98.38,"BRD-K65991129-001-02-9","Phase 2","","JYILLRHXRVTRSH-GFCCVEGCSA-N","BRD-K65991129","","FC(F)(F)c1ccc(nc1)N1CC[C@H](C1)NC(=O)Nc1ccccc1Br"
"4586","SB-706375","urotensin receptor antagonist","UTS2R","","","Tocris",98.2,"BRD-K68633027-001-01-9","Preclinical","","BPOWQJYAMDEAFF-CYBMUJFWSA-N","BRD-K68633027","","COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(c(O[C@@H]2CCN(C)C2)c1)C(F)(F)F"
"4587","SB-742457","serotonin receptor antagonist","HTR6","","","Selleck, Selleck",89.14,"BRD-K78941306-001-03-2, BRD-K78941306-001-02-4","Phase 3","","JJZFWROHYSMCMU-UHFFFAOYSA-N","BRD-K78941306","","O=S(=O)(c1ccccc1)c1cnc2c(cccc2c1)N1CCNCC1"
"4589","SB-743921","kinesin-like spindle protein inhibitor","KIF11","","","Selleck, Tocris",95.39,"BRD-K68532323-003-02-8, BRD-K68532323-003-05-1","Phase 1/Phase 2","","PGXYIBJJCLWJST-MUUNZHRXSA-N","BRD-K68532323","","CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1"
"4591","SB-747651A","kinase inhibitor","AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1","","","Tocris",97.46,"BRD-K49597925-300-01-9","Preclinical","","MBCJUIJWPYUEBX-UHFFFAOYSA-N","BRD-K49597925","","CCn1c(nc2cncc(CNC3CCNCC3)c12)-c1nonc1N"
"4592","SB-756050","G protein-coupled receptor agonist","GPBAR1","","","Enamine",99.59,"BRD-K45168550-001-01-9","Phase 1","","GJUFPAZNBPFNRI-UHFFFAOYSA-N","BRD-K45168550","","COc1ccc(cc1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc(OC)c(OC)c1"
"4593","SB-772077B","rho associated kinase inhibitor","ROCK1, ROCK2","","","Tocris",96.19,"BRD-K49110935-300-01-9","Preclinical","","PHWHNHYZZNJPLB-QMMMGPOBSA-N","BRD-K49110935","","CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)-c1nonc1N"
"4594","SB-939","HDAC inhibitor","HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9","","","Selleck, Selleck",96.34,"BRD-K86797399-001-05-1, BRD-K86797399-001-04-4","Phase 2","","JHDKZFFAIZKUCU-ZRDIBKRKSA-N","BRD-K86797399","","CCCCc1nc2cc(ccc2n1CCN(CC)CC)\C=C\C(=O)NO"
"4596","SBE-13","PLK inhibitor","PLK1","","","Tocris",98.45,"BRD-K71667152-003-09-8","Preclinical","","XNPRQBVQOJZMMA-UHFFFAOYSA-N","BRD-K71667152","","COc1ccc(CCNCc2ccc(OCc3ccc(Cl)nc3)c(OC)c2)cc1OC"
"4597","SBHA","HDAC inhibitor","HDAC1, HDAC3","","","Tocris",63.62,"BRD-K54729176-001-02-8","Preclinical","","IDQPVOFTURLJPT-UHFFFAOYSA-N","BRD-K54729176","","ONC(=O)CCCCCCC(=O)NO"
"4598","SC-10","protein kinase activator","PRKCA","","","Tocris",97.54,"BRD-K05361803-001-03-9","Preclinical","","MJMJERJFCHYXEM-UHFFFAOYSA-N","BRD-K05361803","","CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12"
"4599","SC-12267","dihydroorotate dehydrogenase inhibitor","IL17A","","","MedChemEx",98.78,"BRD-K40797222-001-01-8","Phase 2","","XPRDUGXOWVXZLL-UHFFFAOYSA-N","BRD-K40797222","","COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1"
"4600","SC-144","P glycoprotein inhibitor","","","","Selleck, Tocris, Selleck",98.43,"BRD-K55305701-001-01-2, BRD-K55305701-003-01-8, BRD-K55305701-001-02-0","Preclinical","","UEADAWQSJOWXBK-UHFFFAOYSA-N","BRD-K55305701","","Fc1ccc2c(c1)nc(NNC(=O)c1cnccn1)c1cccn21"
"4603","SC-19220","prostanoid receptor antagonist","PTGER1","","","Tocris, Tocris",95.92,"BRD-K52512893-001-09-7, BRD-K52512893-001-08-9","Preclinical","","KNURFLJTOUGOOQ-UHFFFAOYSA-N","BRD-K52512893","","CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc12"
"4605","SC-236","cyclooxygenase inhibitor","PTGS2","","","Tocris",98.26,"BRD-K76365178-001-01-5","Preclinical","","NSQNZEUFHPTJME-UHFFFAOYSA-N","BRD-K76365178","","NS(=O)(=O)c1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F"
"4606","SC-51089","prostanoid receptor antagonist","PTGER1","","","Tocris",88.12,"BRD-K62715847-003-01-4","Preclinical","","XDJPQOUDGROSEU-UHFFFAOYSA-N","BRD-K62715847","","Clc1ccc2Oc3ccccc3CN(C(=O)NNC(=O)CCc3ccncc3)c2c1"
"4607","SC-560","cyclooxygenase inhibitor","PTGS1","","","Tocris, Tocris",98.01,"BRD-K14767410-001-03-1, BRD-K14767410-001-02-3","Preclinical","","PQUGCKBLVKJMNT-UHFFFAOYSA-N","BRD-K14767410","","COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F"
"4609","SC-9","protein tyrosine kinase activator","PRKCA","","","Tocris, Tocris",98.46,"BRD-K25875056-001-03-8, BRD-K25875056-001-02-0","Preclinical","","YUXMTDYHFPRPLG-UHFFFAOYSA-N","BRD-K25875056","","Clc1cccc2c(cccc12)S(=O)(=O)NCCCCCCc1ccccc1"
"4611","SCH-202676","G protein-coupled receptor modulator","CHRM1, CHRM2, DRD1, DRD2","","","Tocris, Tocris",46.4,"BRD-K29562203-004-09-1, BRD-K29562203-004-08-3","Preclinical","","FFUBTEITUNMMOK-UHFFFAOYSA-N","BRD-K29562203","","CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1"
"4613","SCH-221510","nociceptin/orphanin FQ (NOP) receptor agonist","OPRL1","","","Tocris",92.09,"BRD-A06700447-001-01-5","Preclinical","","LOSJNRBXNQTUNT-UHFFFAOYSA-N","BRD-A06700447","","Cc1ccccc1C(N1C2CCC1CC(O)(C2)c1ccccc1)c1ccccc1C"
"4614","SCH-23390","dopamine receptor antagonist","DRD1, DRD5, HTR2C, KCNJ4, KCNJ6","","","Tocris",96.81,"BRD-K45435259-003-11-1","Preclinical","","GOTMKOSCLKVOGG-OAHLLOKOSA-N","BRD-K45435259","","CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1"
"4615","SCH-28080","ATPase inhibitor","ATP4A","","","Tocris",95.57,"BRD-K55748775-001-02-2","Phase 1","","PYKJFEPAUKAXNN-UHFFFAOYSA-N","BRD-K55748775","","Cc1nc2c(OCc3ccccc3)cccn2c1CC#N"
"4616","SCH-51344","MTH1 inhibitor","NUDT1","","","Tocris",83.63,"BRD-K02460719-001-01-9","Preclinical","","YWEGXZZAORIRQR-UHFFFAOYSA-N","BRD-K02460719","","COc1ccc2[nH]c3nnc(C)c3c(NCCOCCO)c2c1"
"4617","SCH-58261","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",99.01,"BRD-K81225797-001-02-3, BRD-K81225797-001-03-1","Preclinical","","UTLPKQYUXOEJIL-UHFFFAOYSA-N","BRD-K81225797","","Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1"
"4619","SCH-900776","CHK inhibitor","CDK2, CHEK1","","","Selleck, Selleck",85.42,"BRD-K75009076-001-02-1, BRD-K75009076-001-01-3","Phase 2","","GMIZZEXBPRLVIV-SECBINFHSA-N","BRD-K75009076","","Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1"
"4621","SCHISANDRIN-B","antioxidant","ATR","","","Selleck",97.81,"BRD-K86294588-001-01-9","Preclinical","","RTZKSTLPRTWFEV-STQMWFEESA-N","BRD-K86294588","","COc1cc2C[C@H](C)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC"
"4622","SCHISANDROL-B","lipid peroxidase inhibitor","","","","MedChemEx, MedChemEx",97.81,"BRD-K18878288-001-06-4, BRD-K18878288-001-07-2","Phase 3","","ZWRRJEICIPUPHZ-MYODQAERSA-N","BRD-K18878288","","COc1cc2C[C@](C)(O)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC"
"4624","SCLAREOL","","","","","Selleck",98.63,"BRD-A23127772-001-02-3","Preclinical","","XVULBTBTFGYVRC-ANXRZQSGSA-N","BRD-A23127772","","CC(O)(CC[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C)C=C"
"4625","SCLAREOLIDE","other antifungal","","","","Selleck, Selleck",83.52,"BRD-K72925150-001-10-3, BRD-K72925150-001-11-1","Launched","BRD-K35504063-001-01-7","IMKJGXCIJJXALX-SHUKQUCYSA-N","BRD-K72925150","BRD-K35504063","C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2"
"4627","SCMC-LYS","mucolytic agent","GSTP1","","","ChemImpex, ChemImpex",83.3,"BRD-K33809398-001-02-6, BRD-K33809398-001-01-8","Launched","","GBFLZEXEOZUWRN-VKHMYHEASA-N","BRD-K33809398","","N[C@@H](CSCC(O)=O)C(O)=O"
"4629","SCOPINE","","","","","Selleck, Selleck",100,"BRD-K75923785-003-02-1, BRD-K75923785-001-02-5","Launched","","FIMXSEMBHGTNKT-RZVDLVGDSA-N","BRD-K75923785","","CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21"
"4631","SCOPOLAMINE-N-OXIDE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI","","","Prestwick",93.9,"BRD-A49906757-004-09-8","Preclinical","","GSYQNAMOFFWAPF-PPOBMCMBSA-N","BRD-A49906757","","C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"4632","SCP-1","analgesic agent","","","","Vitas-M",88.92,"BRD-K20548681-001-01-3","Phase 1","","PUPNJSIFIXXJCH-UHFFFAOYSA-N","BRD-K20548681","","Oc1ccc(NC(=O)CN2C(=O)c3ccccc3S2(=O)=O)cc1"
"4633","SCRIPTAID","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","","","Tocris, Selleck",94.21,"BRD-K22503835-001-12-8, BRD-K22503835-001-11-0","Preclinical","","JTDYUFSDZATMKU-UHFFFAOYSA-N","BRD-K22503835","","ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23"
"4635","SCS","","","","","Tocris, Tocris",95.27,"BRD-K78496197-001-04-7, BRD-K78496197-001-03-9","Preclinical","","OMCYEZUIYGPHDJ-OQLLNIDSSA-N","BRD-K78496197","","Oc1ccccc1\C=N\NC(=O)c1ccccc1O"
"4637","SD-169","p38 MAPK inhibitor","MAPK14","","","EMDBio",97.83,"BRD-K91904471-001-02-4","Preclinical","","GQMYQEAXTITUAE-UHFFFAOYSA-N","BRD-K91904471","","NC(=O)c1ccc2[nH]ccc2c1"
"4638","SD-208","TGF beta receptor inhibitor","TGFBR1","","","Tocris, Tocris",97.15,"BRD-K24566386-001-01-9, BRD-K24566386-001-03-5","Preclinical","","BERLXWPRSBJFHO-UHFFFAOYSA-N","BRD-K24566386","","Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1"
"4640","SD-2590","matrix metalloprotease inhibitor","MMP1, MMP13, MMP2","","","Tocris",93.08,"BRD-K51102532-003-01-8","Preclinical","","NXUHVWMBPOFLMA-UHFFFAOYSA-N","BRD-K51102532","","COCCN1CCC(CC1)(C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1"
"4641","SDM25N","opioid receptor antagonist","OPRD1","","","Tocris, Tocris, Tocris",93.48,"BRD-A75769826-003-04-7, BRD-A75769826-003-03-9, BRD-A75769826-003-02-1","Preclinical","","ZFMVWAWSKLAVOE-OOGIKFLQSA-N","BRD-A75769826","","CC(=C)CN1CC[C@@]23[C@H]4Oc5c2c(CC1[C@]3(O)Cc1c4[nH]c2ccccc12)ccc5O"
"4644","SDZ-NKT-343","tachykinin antagonist","TACR1","","","Tocris, Tocris",97.81,"BRD-K65820248-001-01-8, BRD-K65820248-001-02-6","Phase 1","","PCVSIMQAFWRUEC-JDXGNMNLSA-N","BRD-K65820248","","CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1CCCN1C(=O)Nc1ccccc1[N+]([O-])=O"
"4646","SDZ-SER-082","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","","","Tocris",13.89,"BRD-K31339597-051-02-0","Preclinical","","YASBOGFWAMXINH-TZMCWYRMSA-N","BRD-K31339597","","CN1CC[C@@H]2CN3CCc4cccc([C@@H]2C1)c34"
"4647","SDZ-WAG-994","adenosine receptor agonist","ADORA1","","","Tocris, Tocris",89.51,"BRD-K39558284-001-01-2, BRD-K39558284-001-02-0","Phase 2","","JAKAFSGZUXCHLF-LSCFUAHRSA-N","BRD-K39558284","","CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCCC3)ncnc12"
"4649","SDZ-205-557","serotonin receptor antagonist","HTR3A, HTR3B","","","Tocris",97.71,"BRD-K15868788-003-07-7","Preclinical","","FFNWMBDISAYHDC-UHFFFAOYSA-N","BRD-K15868788","","CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC"
"4650","SDZ-21009","adrenergic receptor antagonist, serotonin receptor antagonist","HTR1A, HTR1B","","","Tocris",91.78,"BRD-A15530910-001-02-1","Preclinical","","SJYFDORQYYEJLB-UHFFFAOYSA-N","BRD-A15530910","","CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1"
"4651","SDZ-220-040","glutamate receptor antagonist","GRIN1","","","Tocris",0,"BRD-K82266792-001-02-1","Preclinical","","NYZFUZCCDOSQBG-AWEZNQCLSA-N","BRD-K82266792","","N[C@@H](Cc1cc(cc(CP(O)(O)=O)c1O)-c1ccc(Cl)cc1Cl)C(O)=O"
"4652","SDZ-220-581","glutamate receptor antagonist","GRIN1","","","Tocris, Tocris",98.62,"BRD-K27168049-001-03-6, BRD-K27168049-001-02-8","Preclinical","","VBRJFXSFCYEZMQ-HNNXBMFYSA-N","BRD-K27168049","","N[C@@H](Cc1cc(CP(O)(O)=O)cc(c1)-c1ccccc1Cl)C(O)=O"
"4654","SE-METHYLSELENOCYSTEINE","","","","","Sigma, Acros",100,"BRD-K74227499-001-02-9, BRD-K74227499-001-01-1","Phase 2","","XDSSPSLGNGIIHP-VKHMYHEASA-N","BRD-K74227499","","C[Se]C[C@H](N)C(O)=O"
"4656","SECLAZONE","anti-inflammatory agent","","","","Enamine",99.72,"BRD-A53472930-001-01-7","Phase 1","","XWXVKXXKKLBDDJ-UHFFFAOYSA-N","BRD-A53472930","","Clc1ccc2OC3CCON3C(=O)c2c1"
"4657","SECOISOLARICIRESINOL-(-)","","","","","Sigma",97.1,"BRD-K91733562-001-05-0","Preclinical","","PUETUDUXMCLALY-HOTGVXAUSA-N","BRD-K91733562","","COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O"
"4658","SECOISOLARICIRESINOL-DIGLUCOSIDE","antioxidant","","","","AvaChem",94.67,"BRD-K77320845-001-01-2","Phase 2","","SBVBJPHMDABKJV-PGCJWIIOSA-N","BRD-K77320845","","COc1cc(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Cc2ccc(O)c(OC)c2)ccc1O"
"4659","SECURININE","GABA receptor antagonist, TP53 activator","GABRA1","","","MicroSource",94.32,"BRD-K49071277-001-04-7","Preclinical","","SWZMSZQQJRKFBP-WZRBSPASSA-N","BRD-K49071277","","O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31"
"4660","SELENOMETHIONINE","","","","","Sigma, Ark, MicroSource",100,"BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2","Launched","","RJFAYQIBOAGBLC-UHFFFAOYSA-N","BRD-A18774709","","C[Se]CCC(N)C(O)=O"
"4661","SELENOMETHIONINE","","","","","Sigma, Ark, MicroSource",100,"BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2","Launched","","RJFAYQIBOAGBLC-UHFFFAOYSA-N","BRD-A18774709","","C[Se]CC[C@H](N)C(O)=O"
"4663","SELENOMETHIONINE","","","","","Sigma, Ark, MicroSource",100,"BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2","Launched","","RJFAYQIBOAGBLC-BYPYZUCNSA-N","BRD-A18774709","","C[Se]CCC(N)C(O)=O"
"4664","SELENOMETHIONINE","","","","","Sigma, Ark, MicroSource",100,"BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2","Launched","","RJFAYQIBOAGBLC-BYPYZUCNSA-N","BRD-A18774709","","C[Se]CC[C@H](N)C(O)=O"
"4666","SELEXIPAG","platelet aggregation inhibitor, IP1 prostacyclin receptor agonist","PTGIR","","","Tocris, MedChemEx",95.84,"BRD-K21191422-001-02-3, BRD-K21191422-001-01-5","Phase 3","","QXWZQTURMXZVHJ-UHFFFAOYSA-N","BRD-K21191422","","CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1"
"4668","SELFOTEL","glutamate receptor antagonist","GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Enzo",56.69,"BRD-K48738253-001-02-4","Phase 3","","LPMRCCNDNGONCD-NTSWFWBYSA-N","BRD-K48738253","","OC(=O)[C@H]1C[C@@H](CP(O)(O)=O)CCN1"
"4669","SELINEXOR","exportin antagonist","XPO1","","","Selleck",91.58,"BRD-K21361524-001-01-1","Phase 2/Phase 3","","DEVSOMFAQLZNKR-RJRFIUFISA-N","BRD-K21361524","","FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)NNc2cnccn2)n1"
"4670","SELUMETINIB","MEK inhibitor","MAP2K1","","","Selleck, Selleck",97.15,"BRD-K57080016-001-19-1, BRD-K57080016-001-15-9","Phase 3","","CYOHGALHFOKKQC-UHFFFAOYSA-N","BRD-K57080016","","Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO"
"4672","SEMAGACESTAT","gamma secretase inhibitor","PSEN1","","","Selleck",94.1,"BRD-K81957469-001-01-0","Phase 3","","PKXWXXPNHIWQHW-MAZHCROVSA-N","BRD-K81957469","","CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1c2ccccc2CCN(C)C1=O"
"4673","SEMAPIMOD","cytokine production inhibitor, p38 MAPK inhibitor","MAPK14","","","Enamine",86.13,"BRD-K21237892-376-01-3","Phase 2","","UPKULXKXQDCEPE-UHFFFAOYSA-N","BRD-K21237892","","NC(=N)NNC(=C)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)C(=C)NNC(N)=N)C(=C)NNC(N)=N)cc(c1)C(=C)NNC(N)=N"
"4674","SEMAXANIB","VEGFR inhibitor","FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET","","","Tocris, Selleck, Selleck, Tocris",96.75,"BRD-K63504947-001-15-4, BRD-K63504947-001-14-7, BRD-K63504947-001-16-2, BRD-K63504947-001-17-0","Phase 3","","WUWDLXZGHZSWQZ-WQLSENKSSA-N","BRD-K63504947","","Cc1cc(C)c(\C=C2/C(=O)Nc3ccccc23)[nH]1"
"4678","SEMUSTINE","DNA alkylating agent","","","","MicroSource, Sigma",0,"BRD-K13281575-001-13-4, BRD-K13281575-001-14-2","Phase 3","","FVLVBPDQNARYJU-UHFFFAOYSA-N","BRD-K13281575","","CC1CCC(CC1)NC(=O)N(CCCl)[N+][O-]"
"4680","SEN-1269","beta amyloid inhibitor","APP","","","Tocris",97.39,"BRD-K70614402-001-01-0","Preclinical","","MFPAAKZZUIRMKR-UHFFFAOYSA-N","BRD-K70614402","","CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1"
"4681","SENICAPOC","intermediate conductance potassium channel blocker","KCNN4","","","MedChemEx",99.76,"BRD-K21295289-001-01-6","Phase 3","","SCTZUZTYRMOMKT-UHFFFAOYSA-N","BRD-K21295289","","NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1"
"4682","SENNOSIDE-PROTONATED","","","","","Vitas-M",40,"BRD-A53504839-001-01-9","Preclinical","","QFJIQUOMKJNYLI-UHFFFAOYSA-N","BRD-A53504839","","OCC1OC(Oc2cccc3c(-c4c5cccc(OC6OC(CO)C(O)C(O)C6O)c5c(O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4c(O)c23)C(O)=O)C(O)C(O)C1O"
"4683","SEOCALCITOL","vitamin D receptor agonist","VDR","","","MedChemEx, MedChemEx",92.75,"BRD-K28456624-001-02-9, BRD-K28456624-001-01-1","Phase 3","","LVLLALCJVJNGQQ-SEODYNFXSA-N","BRD-K28456624","","CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"4685","SEP-227900","D-Amino Acid Oxidase Inhibitor","DAO","","","Enamine",94.51,"BRD-K49504902-001-01-6","Phase 1","","MMAIBGHDBYQYDI-UHFFFAOYSA-N","BRD-K49504902","","OC(=O)c1cc2occc2[nH]1"
"4686","SERDEMETAN","MDM inhibitor","MDM2","","","Selleck, Selleck",94.54,"BRD-K65924316-001-07-2, BRD-K65924316-001-03-1","Phase 1","","CEGSUKYESLWKJP-UHFFFAOYSA-N","BRD-K65924316","","C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1"
"4688","SERTINDOLE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2","","","Prestwick",93.27,"BRD-K69116396-001-04-1","Withdrawn","","GZKLJWGUPQBVJQ-UHFFFAOYSA-N","BRD-K69116396","","Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12"
"4689","SESAMIN","NFkB pathway inhibitor","","","","Selleck, Selleck",99.85,"BRD-K11631773-001-11-6, BRD-K11631773-001-10-8","Preclinical","BRD-K04837843-001-01-5","PEYUIKBAABKQKQ-AFHBHXEDSA-N","BRD-K11631773","BRD-K04837843","C1Oc2ccc(cc2O1)[C@H]1OC[C@H]2[C@@H]1CO[C@@H]2c1ccc2OCOc2c1"
"4691","SETIPIPRANT","prostaglandin inhibitor","PTGDR2","","","MedChemEx",96.5,"BRD-K24497734-001-01-6","Phase 3","","IHAXLPDVOWLUOS-UHFFFAOYSA-N","BRD-K24497734","","OC(=O)Cn1c2CCN(Cc2c2cc(F)ccc12)C(=O)c1cccc2ccccc12"
"4692","SEW-2871","lysophospholipid receptor agonist","S1PR1","","","Tocris",98.71,"BRD-K15601958-001-03-9","Preclinical","","OYMNPJXKQVTQTR-UHFFFAOYSA-N","BRD-K15601958","","FC(F)(F)c1sc(cc1-c1ccccc1)-c1nc(no1)-c1cccc(c1)C(F)(F)F"
"4693","SF-11","neuropeptide receptor antagonist","MCOLN3, NPY2R","","","Tocris",88.14,"BRD-K42629487-001-08-6","Preclinical","","PMEQBGAGFZDWQX-UHFFFAOYSA-N","BRD-K42629487","","CCOc1ccc(cc1)NC(=S)N1CCC(CC1)C(O)(c1ccccc1)c1ccccc1"
"4694","SGC-CBP30","bromodomain inhibitor","CREBBP, EP300","","","Selleck, Tocris",97.84,"BRD-K24821794-001-01-4, BRD-K24821794-001-04-8","Preclinical","","GEPYBHCJBORHCE-SFHVURJKSA-N","BRD-K24821794","","COc1ccc(CCc2nc3cc(ccc3n2C[C@H](C)N2CCOCC2)-c2c(C)noc2C)cc1Cl"
"4696","SGC-0946","histone lysine methyltransferase inhibitor","","","","Selleck, Tocris",95.72,"BRD-K69577666-001-01-3, BRD-K69577666-001-03-9","Preclinical","","IQCKJUKAQJINMK-HUBRGWSESA-N","BRD-K69577666","","CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(Br)c2c(N)ncnc12"
"4698","SGC-707","protein arginine N-methyltransferase inhibitor","PRMT3","","","Tocris",85.34,"BRD-K86718786-001-01-7","Preclinical","","DMIDPTCQPIJYFE-UHFFFAOYSA-N","BRD-K86718786","","O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1"
"4699","SGI-1027","DNA methyltransferase inhibitor","DNMT1, DNMT3A, DNMT3B","","","Selleck",90.51,"BRD-K61228301-001-01-2","Preclinical","","QSYLKMKIVWJAAK-UHFFFAOYSA-N","BRD-K61228301","","Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1"
"4700","SGI-1776","Pim kinase inhibitor","FLT3, PIM1, PIM2, PIM3","","","Selleck",96.84,"BRD-K80700417-001-04-2","Phase 1","","MHXGEROHKGDZGO-UHFFFAOYSA-N","BRD-K80700417","","CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1"
"4701","SGX523","hepatocyte growth factor receptor inhibitor","MET","","","Selleck",98.41,"BRD-K19477839-001-07-6","Phase 1","","BCZUAADEACICHN-UHFFFAOYSA-N","BRD-K19477839","","Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4ncccc4c3)n2n1"
"4702","SHA-68","neuropeptide receptor antagonist","NPSR1","","","Tocris",96.69,"BRD-A63344375-001-01-8","Preclinical","","SFRQIPRTNYHJHP-UHFFFAOYSA-N","BRD-A63344375","","Fc1ccc(CNC(=O)N2CCN3C(C2)C(OC3=O)(c2ccccc2)c2ccccc2)cc1"
"4703","SHIKIMIC-ACID","","","","","Selleck",94.86,"BRD-A92096630-001-02-8","Preclinical","","JXOHGGNKMLTUBP-INWUZDNDSA-N","BRD-A92096630","","O[C@@H]1CC(=CC(O)C1O)C(O)=O"
"4704","SHP099","protein tyrosine kinase inhibitor","PTPN11","","","MedChemEx",50.02,"BRD-K00818915-003-01-8","Preclinical","","YGUFCDOEKKVKJK-UHFFFAOYSA-N","BRD-K00818915","","CC1(N)CCN(CC1)c1cnc(c(N)n1)-c1cccc(Cl)c1Cl"
"4705","SIB-1553A","acetylcholine receptor agonist","CHRNB4","","","Tocris",94.8,"BRD-A79052425-003-01-5","Phase 2","","NVZGJSVPOOILDI-UHFFFAOYSA-N","BRD-A79052425","","CN1CCCC1CCSc1ccc(O)cc1"
"4706","SIB-1757","glutamate receptor antagonist","GRM5","","","Tocris",89.43,"BRD-K98157055-001-10-9","Preclinical","","LOCPVWIREQIGNQ-UHFFFAOYSA-N","BRD-K98157055","","Cc1ccc(O)c(N=Nc2ccccc2)n1"
"4707","SIB-1893","glutamate receptor antagonist","GRM4, GRM5","","","Tocris",0,"BRD-K14561059-001-05-9","Preclinical","","SISOFUCTXZKSOQ-ZHACJKMWSA-N","BRD-K14561059","","Cc1cccc(\C=C\c2ccccc2)n1"
"4708","SIBUTRAMINE","serotonin–norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4","","","MicroSource, MedChemEx",82.55,"BRD-A23359898-003-10-0, BRD-A23359898-003-11-8","Withdrawn","","UNAANXDKBXWMLN-UHFFFAOYSA-N","BRD-A23359898","","CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1"
"4710","SID-7969543","steroidogenic factor antagonist","NR5A1","","","Tocris, Tocris",96.71,"BRD-A43885598-001-08-1, BRD-A43885598-001-09-9","Preclinical","","KWMBIIQCLUIHDI-UHFFFAOYSA-N","BRD-A43885598","","CCOC(=O)C(C)Oc1cccc2c1ccn(CC(=O)Nc1ccc3OCCOc3c1)c2=O"
"4712","SIGUAZODAN","phosphodiesterase inhibitor","PDE3A","","","Tocris, Tocris",97.8,"BRD-A62071884-001-06-1, BRD-A62071884-001-04-6","Phase 1","","NUHPODZZKHQQET-UHFFFAOYSA-N","BRD-A62071884","","CN\C(NC#N)=N/c1ccc(cc1)C1=NNC(=O)CC1C"
"4714","SILYMARIN","","","","","Selleck, Selleck",50.9,"BRD-A06629414-001-02-3, BRD-A06629414-001-03-1","Launched","","FDQAOULAVFHKBX-UHFFFAOYSA-N","BRD-A06629414","","COc1cc(ccc1O)C1Oc2ccc(cc2OC1CO)C1Oc2cc(O)cc(O)c2C(=O)C1O"
"4716","SINEFUNGIN","DNA methyltransferase inhibitor, RNA synthesis inhibitor","CARM1","","","Sigma",94.6,"BRD-K91100918-001-03-8","Preclinical","","LMXOHSDXUQEUSF-YECHIGJVSA-N","BRD-K91100918","","N[C@@H](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12"
"4717","SINOMENINE","angiogenesis inhibitor","","","","Selleck",92.76,"BRD-K83459933-001-05-4","Preclinical","","INYYVPJSBIVGPH-QHRIQVFBSA-N","BRD-K83459933","","COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O"
"4718","SIPATRIGINE","voltage-gated sodium channel blocker","CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A","","","Tocris, Tocris",98.09,"BRD-K53195974-001-02-7, BRD-K53195974-001-01-9","Phase 2","","PDOCBJADCWMDGL-UHFFFAOYSA-N","BRD-K53195974","","CN1CCN(CC1)c1ncc(c(N)n1)-c1cc(Cl)cc(Cl)c1Cl"
"4720","SIPONIMOD","sphingosine phosphate receptor modulator","S1PR1","","","MedChemEx, Selleck",95.03,"BRD-K62384160-001-02-0, BRD-K62384160-001-01-2","Phase 3","","KIHYPELVXPAIDH-HNSNBQBZSA-N","BRD-K62384160","","CCc1cc(ccc1CN1CC(C1)C(O)=O)C(\C)=N\OCc1ccc(C2CCCCC2)c(c1)C(F)(F)F"
"4722","SIRAMESINE","sigma receptor antagonist","ADRA1A, ADRA1B, ADRA1D","","","MedChemEx",87.3,"BRD-K51333959-003-01-3","Phase 2","","XWAONOGAGZNUSF-UHFFFAOYSA-N","BRD-K51333959","","Fc1ccc(cc1)-n1cc(CCCCN2CCC3(CC2)OCc2ccccc32)c2ccccc12"
"4723","SIRREAL-2","SIRT inhibitor","SIRT2","","","Tocris",97.17,"BRD-K16472653-001-01-6","Preclinical","","MENNDDDTIIZDDN-UHFFFAOYSA-N","BRD-K16472653","","Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc4ccccc34)s2)n1"
"4724","SIRTINOL","SIRT inhibitor","SIRT1, SIRT2","","","Tocris, Selleck, Selleck",11.06,"BRD-A23747351-001-06-8, BRD-A23747351-001-07-6, BRD-A23747351-001-05-0","Preclinical","","UXJFDYIHRJGPFS-WPWMEQJKSA-N","BRD-A23747351","","CC(NC(=O)c1ccccc1\N=C\c1c(O)ccc2ccccc12)c1ccccc1"
"4727","SIS3","serine/threonine kinase inhibitor","SMAD3, TGFBR1","","","Tocris",85.23,"BRD-K38905597-003-01-4","Preclinical","","IJYPHMXWKKKHGT-VAWYXSNFSA-N","BRD-K38905597","","COc1cc2CCN(Cc2cc1OC)C(=O)\C=C\c1c(-c2ccccc2)n(C)c2ncccc12"
"4728","SITAXENTAN","endothelin receptor antagonist","EDNRA","","","MedChemEx, MedChemEx, Selleck, Selleck",93.75,"BRD-K63806092-236-05-9, BRD-K63806092-236-03-4, BRD-K63806092-236-02-6, BRD-K63806092-236-04-2","Withdrawn","","PHWXUGHIIBDVKD-UHFFFAOYSA-N","BRD-K63806092","","Cc1noc(NS(=O)(=O)c2ccsc2C(=O)Cc2cc3OCOc3cc2C)c1Cl"
"4732","SITOSTEROL","","","","","Selleck, Selleck",0,"BRD-K79402892-001-06-7, BRD-K79402892-001-07-5","Preclinical","BRD-K16553588-001-01-3","KZJWDPNRJALLNS-VJSFXXLFSA-N","BRD-K79402892","BRD-K16553588","CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C"
"4734","SJ-172550","MDM inhibitor","MDM4","","","MedChemEx, Tocris, MedChemEx",6.12,"BRD-K35945299-001-04-2, BRD-K35945299-001-03-4, BRD-K35945299-001-02-6","Preclinical","","RKKFQJXGAQWHBZ-LICLKQGHSA-N","BRD-K35945299","","CCOc1cc(\C=C2C(=O)N(N=C\2C)c2ccccc2)cc(Cl)c1OCC(=O)OC"
"4737","SK&F-10047-(+)","sigma receptor agonist","SIGMAR1","","","Tocris",95.87,"BRD-A47364545-003-02-6","Phase 1","","LGQCVMYAEFTEFN-VUOHQMJNSA-N","BRD-A47364545","","C[C@H]1C2Cc3ccc(O)cc3[C@@]1(C)CCN2CC=C"
"4738","SKA-31","potassium channel activator","KCNN4","","","Tocris, Tocris",92.73,"BRD-K67304264-001-08-5, BRD-K67304264-001-10-1","Preclinical","","FECQXVPRUCCUIL-UHFFFAOYSA-N","BRD-K67304264","","Nc1nc2c(ccc3ccccc23)s1"
"4740","SKEPINONE-L","p38 MAPK inhibitor","MAPK14","","","Selleck",97.68,"BRD-K83607951-001-02-2","Preclinical","","HXMGCTFLLWPVFM-GOSISDBHSA-N","BRD-K83607951","","OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1"
"4741","SKF-38393","dopamine receptor agonist","CALY, DRD1, DRD5","","","Tocris",90.13,"BRD-A88548664-004-02-7","Preclinical","","JUDKOGFHZYMDMF-UHFFFAOYSA-N","BRD-A88548664","","Oc1cc2CCNCC(c3ccccc3)c2cc1O"
"4742","SKF-77434","dopamine receptor agonist","DRD1","","","Tocris",89,"BRD-A64227845-004-09-3","Preclinical","","QBUVZVXIRYFENV-UHFFFAOYSA-N","BRD-A64227845","","Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O"
"4743","SKF-81297","dopamine receptor agonist","DRD1, DRD5","","","Tocris, Tocris",94.79,"BRD-A09828896-004-12-8, BRD-A09828896-004-11-0","Preclinical","","GHWJEDJMOVUXEC-UHFFFAOYSA-N","BRD-A09828896","","Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1"
"4745","SKF-83566","dopamine receptor antagonist","DRD1, DRD5","","","Tocris, Tocris",97.41,"BRD-A52588987-004-09-0, BRD-A52588987-004-08-2","Preclinical","","XFTVOHWWEQGXLS-UHFFFAOYSA-N","BRD-A52588987","","CN1CCc2cc(Br)c(O)cc2C(C1)c1ccccc1"
"4747","SKF-86002","p38 MAPK inhibitor","ALOX5, MAPK14","","","Tocris",93.26,"BRD-K96809896-300-02-3","Preclinical","","YOELZIQOLWZLQC-UHFFFAOYSA-N","BRD-K96809896","","Fc1ccc(cc1)-c1nc2SCCn2c1-c1ccncc1"
"4748","SKF-89976A","GABA uptake inhibitor","SLC6A1","","","Tocris, Tocris",97.09,"BRD-A49046702-003-09-1, BRD-A49046702-003-08-3","Preclinical","","TXQKSMSLZVKQBI-UHFFFAOYSA-N","BRD-A49046702","","OC(=O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1"
"4750","SKF-91488","histamine N-methyltransferase inhibitor","HNMT","","","Tocris, Tocris",74.58,"BRD-K49776472-300-03-2, BRD-K49776472-300-02-4","Preclinical","","UFYJLJINUGVUHO-UHFFFAOYSA-N","BRD-K49776472","","CN(C)CCCCSC(N)=N"
"4752","SKF-96365","calcium channel blocker","CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2","","","Tocris",98.58,"BRD-A72703248-003-04-9","Preclinical","","HLMBXBGDBBCYII-UHFFFAOYSA-N","BRD-A72703248","","COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1"
"4753","SKI-II","sphingosine kinase inhibitor","SPHK1","","","Tocris, Selleck, Selleck",94.83,"BRD-K20755323-001-06-7, BRD-K20755323-001-05-9, BRD-K20755323-001-07-5","Preclinical","","ZFGXZJKLOFCECI-UHFFFAOYSA-N","BRD-K20755323","","Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1"
"4756","SKLB1002","VEGFR inhibitor","KDR","","","Selleck",97.72,"BRD-K29895144-001-01-0","Preclinical","","RQVGFDBMONQTBC-UHFFFAOYSA-N","BRD-K29895144","","COc1cc2ncnc(Sc3nnc(C)s3)c2cc1OC"
"4757","SLV-319-(+/-)","cannabinoid receptor antagonist","CNR1, DRD2, HTR1A","","","Tocris",98.47,"BRD-A54228901-001-01-7","Phase 2","","AXJQVVLKUYCICH-UHFFFAOYSA-N","BRD-A54228901","","C\N=C(\NS(=O)(=O)c1ccc(Cl)cc1)N1CC(C(=N1)c1ccc(Cl)cc1)c1ccccc1"
"4758","SLV-320","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",91.33,"BRD-K34445261-001-02-2, BRD-K34445261-001-01-4","Phase 2","","RBZNJGHIKXAKQE-HDJSIYSDSA-N","BRD-K34445261","","O[C@H]1CC[C@@H](CC1)Nc1nc(nc2[nH]ccc12)-c1ccccc1"
"4760","SM-108","","","","","Ark, Ark",100,"BRD-K70053378-001-02-9, BRD-K70053378-001-01-1","Phase 2","","UEWSIIBPZOBMBL-UHFFFAOYSA-N","BRD-K70053378","","NC(=O)c1[nH]cnc1O"
"4762","SM-164","XIAP inhibitor","BIRC2, BIRC3, XIAP","","","MedChemEx, MedChemEx",85.5,"BRD-K06191411-001-02-5, BRD-K06191411-001-01-7","Preclinical","","LGYDZXNSSLRFJS-IOQQVAQYSA-N","BRD-K06191411","","CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H](c1cn(CCCCc2ccc(CCCCn3cc(nn3)[C@@H](NC(=O)[C@@H]3CC[C@@H]4CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N34)c3ccccc3)cc2)nn1)c1ccccc1"
"4764","SM-21","sigma receptor antagonist","PGRMC1","","","Tocris",93.13,"BRD-A92933783-050-01-6","Preclinical","","WTPAXDRULIZRDJ-UHFFFAOYSA-N","BRD-A92933783","","CCC(Oc1ccc(Cl)cc1)C(=O)OC1CC2CCC(C1)N2C"
"4765","SMER-28","autophagy inducer","SNCA","","","Tocris",96.8,"BRD-K08478539-001-13-8","Preclinical","","BCPOLXUSCUFDGE-UHFFFAOYSA-N","BRD-K08478539","","Brc1ccc2ncnc(NCC=C)c2c1"
"4766","SMI-4A","Pim kinase inhibitor","PIM1","","","Selleck",95.67,"BRD-K70159787-001-01-1","Preclinical","","NGJLOFCOEOHFKQ-VMPITWQZSA-N","BRD-K70159787","","FC(F)(F)c1cccc(c1)\C=C1\SC(=O)NC1=O"
"4767","SN-2","transient receptor potential channel agonist","MCOLN3","","","Tocris",97.71,"BRD-A64319165-001-07-0","Preclinical","","WKLZNTYMDOPBSE-UHFFFAOYSA-N","BRD-A64319165","","Cc1cc(C)c(C2=NOC3C4CCC(C4)C23)c(C)c1"
"4768","SN-6","sodium/calcium exchange inhibitor","","","","Tocris, Tocris",92.27,"BRD-A14316475-001-02-3, BRD-A14316475-001-03-1","Preclinical","","ZVYIJXLMBWCGHP-UHFFFAOYSA-N","BRD-A14316475","","CCOC(=O)C1CSC(N1)Cc1ccc(OCc2ccc([N+]([O-])=O)cc2)cc1"
"4770","SNAP","nitric oxide donor","PTPN1","","","Cayman, Cayman",40.86,"BRD-A67006024-001-05-5, BRD-A67006024-001-04-8","Phase 2","","ZIIQCSMRQKCOCT-UHFFFAOYSA-N","BRD-A67006024","","CC(=O)NC(C(O)=O)C(C)(C)S[N+][O-]"
"4772","SNAP-5089","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CACNA1C, CACNA1D","","","Tocris",64.33,"BRD-A21428877-003-02-7","Preclinical","","FIIXCJGBCCCOQQ-UHFFFAOYSA-N","BRD-A21428877","","COC(=O)C1=C(C)NC(C)=C(C1c1ccc(cc1)[N+]([O-])=O)C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1"
"4773","SNAP-94847","","ADRA1A, DRD2","","","Tocris, Tocris",97.3,"BRD-K49702221-003-01-6, BRD-K49702221-003-02-4","Preclinical","","VMLZFUVIKCGATC-UHFFFAOYSA-N","BRD-K49702221","","CC(C)C(=O)Nc1ccc(C)c(c1)C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1"
"4775","SNC-80","","OPRD1","","","Tocris, Tocris",96.73,"BRD-K29546239-001-04-9, BRD-K29546239-001-02-3","Preclinical","","KQWVAUSXZDRQPZ-UMTXDNHDSA-N","BRD-K29546239","","CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(OC)c1"
"4777","SNG-1153","selective estrogen receptor modulator (SERM)","ESR1","","","MedChemEx",93.39,"BRD-K75016267-001-01-7","Preclinical","","OXHMDMVBLQNMGP-UHFFFAOYSA-N","BRD-K75016267","","CC(C)=CCc1c(O)cc(O)c2c1oc(-c1ccc(cc1)C(F)(F)F)c(O)c2=O"
"4778","SNS-314","Aurora kinase inhibitor","AURKA, AURKB, AURKC","","","Selleck, Tocris",96.75,"BRD-K71512533-066-02-8, BRD-K71512533-066-03-6","Phase 1","","FAYAUAZLLLJJGH-UHFFFAOYSA-N","BRD-K71512533","","Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1"
"4780","SNX-2112","HSP inhibitor","","","","Selleck",97.02,"BRD-K71281111-001-04-3","Phase 1","","ZFVRYNYOPQZKDG-MQMHXKEQSA-N","BRD-K71281111","","CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)C(F)(F)F)C(=O)C1"
"4781","SNX-5422","HSP inhibitor","HSP90AA1","","","MedChemEx, Selleck, Selleck",89.48,"BRD-K73197500-001-04-8, BRD-K73197500-001-02-2, BRD-K73197500-001-03-0","Phase 1/Phase 2","","AVDSOVJPJZVBTC-CTYIDZIISA-N","BRD-K73197500","","CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@@H](CC3)OC(=O)CN)c2)C(F)(F)F)C(=O)C1"
"4784","SOBETIROME","thyroid hormone receptor agonist","THRA, THRB","","","MedChemEx, Tocris",96.15,"BRD-K85406984-001-01-0, BRD-K85406984-001-02-8","Phase 1","","QNAZTOHXCZPOSA-UHFFFAOYSA-N","BRD-K85406984","","CC(C)c1cc(Cc2c(C)cc(OCC(O)=O)cc2C)ccc1O"
"4786","SODIUM-ASCORBATE","","","","","Selleck, Selleck",0,"BRD-A67265925-236-01-8, BRD-A67265925-236-02-6","Launched","","SXZYCXMUPBBULW-FORAYFFESA-N","BRD-A67265925","","OC[C@H](O)[C@H]1OC(=O)C(O)C1O"
"4788","SODIUM-BUTYRATE","HDAC inhibitor","BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8","","","Selleck, Selleck",0,"BRD-K05878375-236-05-7, BRD-K05878375-236-06-5","Phase 2","","FERIUCNNQQJTOY-UHFFFAOYSA-N","BRD-K05878375","","CCCC(O)=O"
"4790","SODIUM-DANSHENSU","","","","","Selleck, Selleck",100,"BRD-A93699261-236-02-6, BRD-A93699261-236-03-4","Preclinical","","PAFLSMZLRSPALU-UHFFFAOYSA-N","BRD-A93699261","","OC(Cc1ccc(O)c(O)c1)C(O)=O"
"4792","SODIUM-DODECYL-SULFATE","","ALB, LYZ","","","Enamine, Sigma",98.3,"BRD-M58433298-001-01-6, BRD-M58433298-001-02-4","Preclinical","","ISYOIFGRKUYTGX-UHFFFAOYSA-N","BRD-M58433298","","[Na].CCCCCCCCCCCCOS(O)(=O)=O"
"4794","SODIUM-GLUCOHEPTONATE","","","","","TCI",100,"BRD-K35952844-236-01-6","Launched","","KWMLJOLKUYYJFJ-VFUOTHLCSA-N","BRD-K35952844","","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O"
"4795","SODIUM-GLUCONATE","","","","","MicroSource, Selleck, Selleck",0,"BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5","Launched","BRD-M54096567-001-02-7","RGHNJXZEOKUKBD-SQOUGZDYSA-N","BRD-K93201765","BRD-M54096567","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O"
"4796","SODIUM-GLUCONATE","","","","","MicroSource, Selleck, Selleck",0,"BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5","Launched","BRD-M54096567-001-02-7","RGHNJXZEOKUKBD-SQOUGZDYSA-N","BRD-K93201765","BRD-M54096567","[Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O"
"4798","SODIUM-GLUCONATE","","","","","MicroSource, Selleck, Selleck",0,"BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5","Launched","BRD-M54096567-001-02-7","MPPJUDJABRMYJR-ZBHRUSISSA-N","BRD-K93201765","BRD-M54096567","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O"
"4799","SODIUM-GLUCONATE","","","","","MicroSource, Selleck, Selleck",0,"BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5","Launched","BRD-M54096567-001-02-7","MPPJUDJABRMYJR-ZBHRUSISSA-N","BRD-K93201765","BRD-M54096567","[Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O"
"4801","SODIUM-GUALENATE","antacid","","","","AKSci",99.62,"BRD-K80043866-236-01-1","Launched","","VIZXMHCBZLGUET-UHFFFAOYSA-N","BRD-K80043866","","CC(C)c1ccc(C)c2c(cc(C)c2c1)S(O)(=O)=O"
"4802","SODIUM-ORTHOVANADATE","","","","","Selleck, Selleck",5.51,"BRD-K60600693-314-02-4, BRD-K60600693-314-03-2","Preclinical","","WQEVDHBJGNOKKO-UHFFFAOYSA-K","BRD-K60600693","","O[V](O)(O)=O"
"4804","SODIUM-TANSHINONE-II-A-SULFONATE","potassium channel activator","","","","Ark",93.63,"BRD-K84798689-236-02-9","Phase 2","","UJCACMLMPLLRGW-UHFFFAOYSA-N","BRD-K84798689","","Cc1c2c(oc1S(O)(=O)=O)-c1ccc3c(CCCC3(C)C)c1C(=O)C2=O"
"4805","SOLAMARGINE","apoptosis inhibitor","","","","MedChemEx",99.5,"BRD-A65562236-001-01-2","Phase 3","","MBWUSSKCCUMJHO-UHFFFAOYSA-N","BRD-A65562236","","CC1C2C(CC3C4CC=C5CC(CCC5(C)C4CCC23C)OC2OC(CO)C(OC3OC(C)C(O)C(O)C3O)C(O)C2OC2OC(C)C(O)C(O)C2O)OC11CCC(C)CN1"
"4806","SOLCITINIB","JAK inhibitor","JAK1","","","MedChemEx",97.64,"BRD-K69215269-001-01-1","Phase 1","","MPYACSQFXVMWNO-UHFFFAOYSA-N","BRD-K69215269","","CC1(C)CN(C1)C(=O)c1ccc(cc1)-c1cccc2nc(NC(=O)C3CC3)nn12"
"4807","SOLITHROMYCIN","protein synthesis inhibitor","","","","MedChemEx",96.7,"BRD-K32256160-001-01-9","Phase 3","","IXXFZUPTQVDPPK-ZAWHAJPISA-N","BRD-K32256160","","CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(nn3)-c3cccc(N)c3)C(=O)O[C@]12C)OC"
"4808","SOMANTADINE","antiviral","","","","ChemBridge",97.8,"BRD-K85764479-003-01-0","Phase 1","","OWKXRDQRMTVCEX-UHFFFAOYSA-N","BRD-K85764479","","CC(C)(N)CC12CC3CC(CC(C3)C1)C2"
"4809","SOPHOCARPINE","","","","","Vitas-M, Selleck, Selleck",96.27,"BRD-K66845263-001-03-0, BRD-K66845263-001-04-8, BRD-K66845263-001-02-2","Phase 3","BRD-K10999968-001-01-4","AAGFPTSOPGCENQ-JLNYLFASSA-N","BRD-K66845263","BRD-K10999968","O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34"
"4812","SORBIC-ACID","","","","","Enamine",0,"BRD-K55892330-001-01-8","Preclinical","","WSWCOQWTEOXDQX-UHFFFAOYSA-N","BRD-K55892330","","CC=CC=CC(O)=O"
"4813","SORBINIL","aldose reductase inhibitor","AKR1B1","","","Key",98.08,"BRD-A89164055-001-03-3","Phase 3","","LXANPKRCLVQAOG-UHFFFAOYSA-N","BRD-A89164055","","Fc1ccc2OCCC3(NC(=O)NC3=O)c2c1"
"4814","SORBITAN-MONOSTEARATE","","","","","InterBioScreen",0,"BRD-A70197423-001-01-3","Preclinical","","HVUMOYIDDBPOLL-XGKPLOKHSA-N","BRD-A70197423","","CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O"
"4815","SORBITOL","mucolytic agent","","","","Selleck, MicroSource",100,"BRD-K66035042-001-10-1, BRD-K36513555-001-02-0","Launched","","FBPFZTCFMRRESA-JGWLITMVSA-N","BRD-K66035042","","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"4816","SORBITOL","mucolytic agent","","","","Selleck, MicroSource",100,"BRD-K66035042-001-10-1, BRD-K36513555-001-02-0","Launched","","FBPFZTCFMRRESA-JGWLITMVSA-N","BRD-K66035042","","OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO"
"4817","SORBITOL","mucolytic agent","","","","Selleck, MicroSource",100,"BRD-K66035042-001-10-1, BRD-K36513555-001-02-0","Launched","","FBPFZTCFMRRESA-ZXXMMSQZSA-N","BRD-K66035042","","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"4818","SORBITOL","mucolytic agent","","","","Selleck, MicroSource",100,"BRD-K66035042-001-10-1, BRD-K36513555-001-02-0","Launched","","FBPFZTCFMRRESA-ZXXMMSQZSA-N","BRD-K66035042","","OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO"
"4819","SOTAGLIFLOZIN","sodium/glucose cotransporter inhibitor","SLC5A1, SLC5A2","","","MedChemEx",95.58,"BRD-K05850076-001-01-5","Phase 3","","QKDRXGFQVGOQKS-CRSSMBPESA-N","BRD-K05850076","","CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1"
"4820","SOTRASTAURIN","PKC inhibitor","PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ","","","Selleck",96.57,"BRD-K16761703-001-03-8","Phase 2","","OAVGBZOFDPFGPJ-UHFFFAOYSA-N","BRD-K16761703","","CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1"
"4821","SP-100030","NFkB pathway inhibitor","JUN, NFKB1","","","Tocris",62.11,"BRD-K71900389-001-01-9","Preclinical","","GHMKQBWHPQMXSH-UHFFFAOYSA-N","BRD-K71900389","","FC(F)(F)c1cc(NC(=O)c2cnc(Cl)nc2C(F)(F)F)cc(c1)C(F)(F)F"
"4822","SP-141","ubiquitin ligase inhibitor","MDM2","","","Tocris",96.64,"BRD-K28571773-001-01-6","Preclinical","","AABFWJDLCCDJJN-UHFFFAOYSA-N","BRD-K28571773","","COc1ccc2[nH]c3c(nccc3c2c1)-c1cccc2ccccc12"
"4823","SP-420","","","","","MedChemEx",85.18,"BRD-K23005288-001-01-8","Phase 1","","YASYAEVZKXPYIZ-MRXNPFEDSA-N","BRD-K23005288","","COCCOCCOc1ccc(C2=N[C@](C)(CS2)C(O)=O)c(O)c1"
"4824","SPARFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","","","Selleck, MicroSource, Selleck",91.61,"BRD-K07612980-001-04-6, BRD-K07612980-001-07-9, BRD-K07612980-001-05-3","Withdrawn","BRD-A26423207-001-01-0","DZZWHBIBMUVIIW-DTORHVGOSA-N","BRD-K07612980","BRD-A26423207","C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(N)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1"
"4827","SPARFOSATE","aspartate carbamoyltransferase inhibitor","CA2, CA4, CAD","","","AMS",0,"BRD-A81539525-433-01-5","Phase 3","","ZZKNRXZVGOYGJT-UHFFFAOYSA-N","BRD-A81539525","","OC(=O)CC(NC(=O)CP(O)(O)=O)C(O)=O"
"4828","SPARTEINE-SULFATE","","","","","MicroSource",100,"BRD-K32847234-065-04-6","Launched","","SLRCCWJSBJZJBV-NMWPEEMBSA-N","BRD-K32847234","","C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1"
"4829","SPAUTIN-1","deubiquitinase inhibitor","USP10, USP13","","","Tocris",93.94,"BRD-K84964099-001-02-9","Preclinical","","AWIVHRPYFSSVOG-UHFFFAOYSA-N","BRD-K84964099","","Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1"
"4830","SPERMIDINE","glutamate receptor modulator","KCNJ4, TXNRD1","","","Tocris",100,"BRD-K40438880-305-06-6","Preclinical","","ATHGHQPFGPMSJY-UHFFFAOYSA-N","BRD-K40438880","","NCCCCNCCCN"
"4831","SPERMINE","","CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5","","","Enzo",100,"BRD-K18375018-376-02-3","Preclinical","","PFNFFQXMRSDOHW-UHFFFAOYSA-N","BRD-K18375018","","NCCCNCCCCNCCCN"
"4832","SPHINGOSYLPHOSPHORYLCHOLINE","gene expression stimulant","GPR12","","","EMDBio",100,"BRD-A35379661-001-04-6","Preclinical","","JLVSPVFPBBFMBE-HXSWCURESA-O","BRD-A35379661","","CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(=O)OCC[N+](C)(C)C"
"4833","SPIRADOLINE","opioid receptor agonist","OPRK1","","","Enzo",97.66,"BRD-K28192623-066-08-1","Phase 2","","NYKCGQQJNVPOLU-ONTIZHBOSA-N","BRD-K28192623","","CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1"
"4834","SPIROBROMIN","","","","","MatrixSci",0,"BRD-K96684644-300-01-7","Phase 1","","JXEICPOBKSQAIU-UHFFFAOYSA-N","BRD-K96684644","","BrCCC(=O)N1CC[N+]2(CC1)CC[N+]1(CCN(CC1)C(=O)CCBr)CC2"
"4835","SPIROXATRINE","serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B","","","Tocris",91.05,"BRD-A72483914-001-03-7","Preclinical","","JVGBTTIJPBFLTE-UHFFFAOYSA-N","BRD-A72483914","","O=C1NCN(c2ccccc2)C11CCN(CC2COc3ccccc3O2)CC1"
"4836","SPIZOFURONE","","","","","Sigma",97.9,"BRD-K94934625-001-01-5","Withdrawn","","SETMGIIITGNLAS-UHFFFAOYSA-N","BRD-K94934625","","CC(=O)c1ccc2OC3(CC3)C(=O)c2c1"
"4837","SPLITOMYCIN","SIRT inhibitor","SIRT1","","","Tocris",38.94,"BRD-K27710560-001-07-5","Preclinical","","ISFPDBUKMJDAJH-UHFFFAOYSA-N","BRD-K27710560","","O=C1CCc2c(O1)ccc1ccccc21"
"4838","SPP-86","receptor tyrosine protein kinase inhibitor","RET","","","Tocris",98.51,"BRD-K63253858-001-01-5","Preclinical","","JQOIRTDBHMDWMT-UHFFFAOYSA-N","BRD-K63253858","","CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc12"
"4839","SPP301","endothelin receptor antagonist","EDNRA","","","MedChemEx",99.69,"BRD-K19203487-001-01-4","Phase 3","","YBWLTKFZAOSWSM-UHFFFAOYSA-N","BRD-K19203487","","COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(nc1OC)-c1ccncc1"
"4840","SQ-109","bacterial cell wall synthesis inhibitor","FDFT1","","","MedChemEx, MedChemEx",97.97,"BRD-A08772153-001-01-6, BRD-A08772153-001-02-4","Phase 3","","JFIBVDBTCDTBRH-UNRAVDGJSA-N","BRD-A08772153","","CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2"
"4842","SQ-22536","adenylyl cyclase inhibitor","ADCY1","","","Tocris, Tocris",98.05,"BRD-A56987319-001-12-9, BRD-A56987319-001-13-7","Preclinical","","UKHMZCMKHPHFOT-UHFFFAOYSA-N","BRD-A56987319","","Nc1ncnc2n(cnc12)C1CCCO1"
"4844","SR-1078","retinoid receptor agonist","RORA, RORC","","","Tocris",90.05,"BRD-K26501486-001-01-3","Preclinical","","DUXWIYXHHGNUJU-UHFFFAOYSA-N","BRD-K26501486","","OC(C(F)(F)F)(C(F)(F)F)c1ccc(cc1)NC(=O)c1ccc(cc1)C(F)(F)F"
"4845","SR-11302","","","","","Tocris",0,"BRD-K16229414-001-01-0","Preclinical","","RQANARBNMTXCDM-DKOHIBGUSA-N","BRD-K16229414","","CC(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)c1ccc(C)cc1)=C/C(O)=O"
"4846","SR-140333","neurokinin receptor antagonist","TACR1","","","Tocris",94.45,"BRD-K60931454-003-01-3","Phase 2","","RPDFDSQFBCJTDY-GAQXSTBRSA-N","BRD-K60931454","","CC(C)Oc1cccc(CC(=O)N2CCC[C@@](CC[N+]34CCC(CC3)(CC4)c3ccccc3)(C2)c2ccc(Cl)c(Cl)c2)c1"
"4847","SR-1664","PPAR receptor ligand","PPARG","","","Tocris",94.36,"BRD-K62814487-001-03-0","Preclinical","","IIJDFXNUWZTHIM-NRFANRHFSA-N","BRD-K62814487","","C[C@H](NC(=O)c1ccc2n(Cc3ccc(cc3)-c3ccccc3C(O)=O)c(C)c(C)c2c1)c1ccc(cc1)[N+]([O-])=O"
"4848","SR-2211","retinoid receptor inverse agonist","RORC","","","Tocris",92.59,"BRD-K11641193-001-02-6","Preclinical","","KVHKWAZUPPBMLL-UHFFFAOYSA-N","BRD-K11641193","","OC(c1ccc(c(F)c1)-c1ccc(CN2CCN(Cc3ccncc3)CC2)cc1)(C(F)(F)F)C(F)(F)F"
"4849","SR-2640","leukotriene receptor antagonist","CYSLTR1","","","Tocris, Tocris",94.07,"BRD-K62562723-003-03-5, BRD-K62562723-003-02-7","Phase 2","","LMPZHLXYBWGGNT-UHFFFAOYSA-N","BRD-K62562723","","OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1"
"4851","SR-27897","CCK receptor antagonist","CCKAR","","","Tocris, Tocris",99.12,"BRD-K35629949-001-02-0, BRD-K35629949-001-03-8","Phase 2","","ILNRQFBVVQUOLP-UHFFFAOYSA-N","BRD-K35629949","","OC(=O)Cn1c(cc2ccccc12)C(=O)Nc1nc(cs1)-c1ccccc1Cl"
"4853","SR-3306","JNK inhibitor","MAPK10, MAPK8, MAPK9","","","MedChemEx",95.06,"BRD-K60952143-001-01-0","Preclinical","","QDMXVKKPYBGIAS-UHFFFAOYSA-N","BRD-K60952143","","Cc1ccc(cn1)-c1ncn(n1)-c1ccc(Nc2nccc(n2)-c2cccc(c2)N2CCOCC2)cc1"
"4854","SR-33805","calcium channel blocker","","","","Tocris, Tocris",97.8,"BRD-K43002771-034-02-4, BRD-K43002771-034-01-6","Phase 1","","GCVFQRRBTCHIPK-UHFFFAOYSA-N","BRD-K43002771","","COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c2c(C(C)C)c3ccccc3n2C)cc1OC"
"4856","SR-3576","JNK inhibitor","MAPK10","","","Tocris",99.49,"BRD-K50378376-001-01-8","Preclinical","","MTFAYLZZDJGFGV-UHFFFAOYSA-N","BRD-K50378376","","COc1cc(NC(=O)c2cccc(c2)-n2cc(NC(=O)Nc3cccc(C)c3)cn2)cc(OC)c1OC"
"4857","SR-3677","rho associated kinase inhibitor","ROCK2","","","Tocris",79.6,"BRD-A86468475-300-01-3","Preclinical","","OQWZIAVXCYIZNN-UHFFFAOYSA-N","BRD-A86468475","","CN(C)CCOc1cc(ccc1NC(=O)C1COc2ccccc2O1)-c1cn[nH]c1"
"4858","SR-57227A","serotonin receptor agonist","HTR3A","","","Tocris",95.89,"BRD-K09397065-003-06-1","Phase 2","","WPVVMKYQOMJPIN-UHFFFAOYSA-N","BRD-K09397065","","NC1CCN(CC1)c1cccc(Cl)n1"
"4859","SR-59230A","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","","","Tocris, Tocris",95.68,"BRD-K35430135-003-03-1, BRD-K35430135-003-02-3","Preclinical","","VFDHMSXXELYMRW-ICSRJNTNSA-N","BRD-K35430135","","CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc12"
"4861","SR-95639A","acetylcholine receptor agonist","CHRM1","","","Prestwick",98.78,"BRD-K19309090-300-05-5","Preclinical","","RUTYAHFAKWVMNH-UHFFFAOYSA-N","BRD-K19309090","","C(CN1CCOCC1)Nc1cc2CCCc3ccccc3-c2nn1"
"4862","SRC-KINASE-INHIBITOR-I","src inhibitor","CSK, LCK, RIPK2","","","Tocris, Tocris",98.18,"BRD-K50495309-001-02-0, BRD-K50495309-001-03-8","Preclinical","","DMWVGXGXHPOEPT-UHFFFAOYSA-N","BRD-K50495309","","COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC"
"4864","SRPIN340","serine arginine protein kinase inhibitor","SRPK1, SRPK2","","","Tocris, Selleck",98.5,"BRD-K62621335-001-02-5, BRD-K62621335-001-01-7","Preclinical","","DWFGGOFPIISJIT-UHFFFAOYSA-N","BRD-K62621335","","FC(F)(F)c1ccc(N2CCCCC2)c(NC(=O)c2ccncc2)c1"
"4866","SRT1720","SIRT activator","SIRT1","","","Selleck",93.47,"BRD-K95926480-003-03-6","Preclinical","","IASPBORHOMBZMY-UHFFFAOYSA-N","BRD-K95926480","","O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1"
"4867","SRT2104","SIRT activator","SIRT1","","","MedChemEx, Selleck",99.71,"BRD-K48452630-001-02-6, BRD-K48452630-001-01-8","Phase 2","","LAMQVIQMVKWXOC-UHFFFAOYSA-N","BRD-K48452630","","Cc1nc(sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1)-c1cccnc1"
"4869","SSR-180711","acetylcholine receptor agonist","CHRNA7","","","Tocris",94.22,"BRD-K02782351-003-01-5","Phase 2","","RXLOZRCLQMJJLC-UHFFFAOYSA-N","BRD-K02782351","","Brc1ccc(OC(=O)N2CCN3CCC2CC3)cc1"
"4870","SSR128129E","","","","","Selleck",95.43,"BRD-K65890018-236-01-1","Preclinical","","SNMCWIDCSPHZRD-UHFFFAOYSA-N","BRD-K65890018","","COc1c(C)c(C(=O)c2ccc(N)c(c2)C(O)=O)n2ccccc12"
"4871","ST-1859","antiamyloidogenic agent","","","","Enamine",94.72,"BRD-K73524797-001-01-1","Phase 1","","ZPANWZBSGMDWON-UHFFFAOYSA-N","BRD-K73524797","","Oc1ccc2ccccc2c1Cc1c(O)ccc2ccccc12"
"4872","ST-2825","myeloid differentiation primary response inhibitor","MYD88","","","MedChemEx",97.03,"BRD-K68470841-001-01-0","Preclinical","","HBLHLJXFIPCEMW-ZJSFPPFMSA-N","BRD-K68470841","","NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)Cc3ccc(NC(=O)COc4ccc(Cl)cc4Cl)cc3)C(=O)N12"
"4873","ST-91","adrenergic receptor agonist","","","","Tocris, Tocris",93.75,"BRD-K18905250-003-02-4, BRD-K18905250-003-03-2","Preclinical","","IALHTUPVRAQZFI-UHFFFAOYSA-N","BRD-K18905250","","CCc1cccc(CC)c1N=C1NCCN1"
"4875","STA-5326","interleukin synthesis inhibitor","IL12A","","","MedChemEx",98.13,"BRD-K41783120-001-02-8","Phase 2","","HSKAZIJJKRAJAV-KOEQRZSOSA-N","BRD-K41783120","","Cc1cccc(\C=N\Nc2cc(nc(OCCc3ccccn3)n2)N2CCOCC2)c1"
"4876","STATTIC","","","","","Selleck",95.9,"BRD-K17061841-001-03-5","Preclinical","","ZRRGOUHITGRLBA-UHFFFAOYSA-N","BRD-K17061841","","[O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1"
"4877","STAT3-INHIBITOR-VI","STAT inhibitor","STAT3","","","Selleck, MedChemEx, Tocris, Selleck, MedChemEx",96.39,"BRD-K40853697-001-17-1, BRD-K40853697-001-20-5, BRD-K40853697-001-19-7, BRD-K40853697-001-12-2, BRD-K40853697-001-18-9","Preclinical","","HWNUSGNZBAISFM-UHFFFAOYSA-N","BRD-K40853697","","Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1"
"4882","STEMREGENIN-1","aryl hydrocarbon receptor antagonist","AHR","","","Selleck",95.36,"BRD-K36739687-001-03-0","Preclinical","","BGFHMYJZJZLMHW-UHFFFAOYSA-N","BRD-K36739687","","CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)-c1csc2ccccc12"
"4883","STEPRONIN","mucolytic agent","","","","AKSci",98.87,"BRD-A04506385-001-01-2","Launched","","JNYSEDHQJCOWQU-UHFFFAOYSA-N","BRD-A04506385","","CC(SC(=O)c1cccs1)C(=O)NCC(O)=O"
"4884","STETADERM","","","","","Sigma",96.74,"BRD-K93900986-001-15-0","Launched","","BFZHCUBIASXHPK-QJSKAATBSA-N","BRD-K93900986","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@]12C"
"4885","STF-083010","serine/threonine kinase inhibitor","ERN1","","","MedChemEx, MedChemEx",1.02,"BRD-K13049524-001-04-6, BRD-K13049524-001-03-8","Preclinical","","TVIVJHZHPKNDAQ-MHWRWJLKSA-N","BRD-K13049524","","Oc1ccc2ccccc2c1\C=N\S(=O)(=O)c1cccs1"
"4887","STF-118804","NAMPT inhibitor","NAMPT","","","Selleck, Tocris",96.03,"BRD-K39171998-001-01-1, BRD-K39171998-001-04-5","Preclinical","","DLFCEZOMHBPDGI-UHFFFAOYSA-N","BRD-K39171998","","Cc1oc(nc1CS(=O)(=O)c1ccc(C)cc1)-c1ccc(cc1)C(=O)NCc1cccnc1"
"4889","STF-31","NAMPT inhibitor","NAMPT, SLC2A1","","","Tocris",95.84,"BRD-K22477529-001-02-7","Preclinical","","NGQPRVWTFNBUHA-UHFFFAOYSA-N","BRD-K22477529","","CC(C)(C)c1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)C(=O)Nc1cccnc1"
"4890","STF-62247","autophagy inducer","","","","Selleck, Selleck",89.5,"BRD-K85479953-001-12-1, BRD-K85479953-001-11-3","Preclinical","","KATNUHQNJGNLPW-UHFFFAOYSA-N","BRD-K85479953","","Cc1cccc(Nc2nc(cs2)-c2ccncc2)c1"
"4892","STIGMASTEROL","","","","","Selleck, Selleck",0,"BRD-K41422683-001-02-2, BRD-K41422683-001-05-5","Preclinical","BRD-K84424780-001-01-0","HCXVJBMSMIARIN-PHZDYDNGSA-N","BRD-K41422683","BRD-K84424780","CC[C@H](\C=C\[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C"
"4894","STOBADINE","adrenergic receptor antagonist","ADRA1A","","","Enamine, ChemBridge, Enamine",67.37,"BRD-A85069489-300-01-4, BRD-A85069489-001-01-8, BRD-K33839500-001-01-0","Phase 2","","CYJQCYXRNNCURD-UHFFFAOYSA-N","BRD-A85069489","","CN1CCC2Nc3ccc(C)cc3C2C1"
"4896","STOBADINE","adrenergic receptor antagonist","ADRA1A","","","Enamine, ChemBridge, Enamine",67.37,"BRD-A85069489-300-01-4, BRD-A85069489-001-01-8, BRD-K33839500-001-01-0","Phase 2","","CYJQCYXRNNCURD-UHFFFAOYSA-N","BRD-A85069489","","CN1CC[C@H]2Nc3ccc(C)cc3[C@H]2C1"
"4897","STOBADINE","adrenergic receptor antagonist","ADRA1A","","","Enamine, ChemBridge, Enamine",67.37,"BRD-A85069489-300-01-4, BRD-A85069489-001-01-8, BRD-K33839500-001-01-0","Phase 2","","CYJQCYXRNNCURD-DGCLKSJQSA-N","BRD-A85069489","","CN1CCC2Nc3ccc(C)cc3C2C1"
"4899","STOBADINE","adrenergic receptor antagonist","ADRA1A","","","Enamine, ChemBridge, Enamine",67.37,"BRD-A85069489-300-01-4, BRD-A85069489-001-01-8, BRD-K33839500-001-01-0","Phase 2","","CYJQCYXRNNCURD-DGCLKSJQSA-N","BRD-A85069489","","CN1CC[C@H]2Nc3ccc(C)cc3[C@H]2C1"
"4900","STRYCHNINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB","","","MicroSource",97.36,"BRD-A09094913-065-01-0","Preclinical","","QMGVPVSNSZLJIA-OFYMUHMXSA-N","BRD-A09094913","","O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1c1ccccc61"
"4901","SU-11274","hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor","MET","","","Selleck, Tocris",96.9,"BRD-K02965346-001-07-5, BRD-K02965346-001-06-7","Preclinical","BRD-K59067695-001-02-0","FPYJSJDOHRDAMT-KQWNVCNZSA-N","BRD-K02965346","BRD-K59067695","CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1"
"4903","SU-16F","PDGFR tyrosine kinase receptor inhibitor","PDGFRB","","","Tocris",89.66,"BRD-K91106808-001-02-0","Preclinical","","APYYTEJNOZQZNA-MOSHPQCFSA-N","BRD-K91106808","","Cc1[nH]c(\C=C2/C(=O)Nc3cc(ccc23)-c2ccccc2)c(C)c1CCC(O)=O"
"4904","SU-4312","PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor","KDR, PDGFRB","","","Tocris",67.6,"BRD-K20287671-001-06-9","Preclinical","","UAKWLVYMKBWHMX-PTNGSMBKSA-N","BRD-K20287671","","CN(C)c1ccc(cc1)\C=C1/C(=O)Nc2ccccc12"
"4905","SUBSTANCE-P","neurokinin receptor antagonist","TACR1, TACR2, TACR3","","","Tocris",87.35,"BRD-K23106423-001-01-0","Phase 1","","ADNPLDHMAVUMIW-CUZNLEPHSA-N","BRD-K23106423","","CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O"
"4906","SUCCINIC-ACID","","ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE","","","Enamine",100,"BRD-K45238818-001-02-6","Launched","","KDYFGRWQOYBRFD-UHFFFAOYSA-N","BRD-K45238818","","OC(=O)CCC(O)=O"
"4907","SUCCINYLSULFATHIAZOLE","dihydrofolate reductase inhibitor","DHFR","","","MicroSource",96.18,"BRD-K01950558-001-14-7","Phase 2","","SKVLYVHULOWXTD-UHFFFAOYSA-N","BRD-K01950558","","OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1"
"4908","SUCRALOSE","","","","","MicroSource, Selleck",100,"BRD-K58968598-001-02-8, BRD-K58968598-001-03-6","Launched","BRD-K23414802-001-01-9","BAQAVOSOZGMPRM-QBMZZYIRSA-N","BRD-K58968598","BRD-K23414802","OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl"
"4910","SUCROSE","","ACTA1, ATOX1, C22orf28, LYZ","","","Sigma",99.8,"BRD-K74724920-001-02-4","Launched","","CZMRCDWAGMRECN-UGDNZRGBSA-N","BRD-K74724920","","OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O"
"4911","SUCROSE-OCTAACETATE","","","","","Acros",100,"BRD-K01294196-001-01-5","Preclinical","","ZIJKGAXBCRWEOL-SAXBRCJISA-N","BRD-K01294196","","CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O"
"4912","SUDAN-IV","","","","","Vitas-M",79.18,"BRD-K65989725-001-01-3","Preclinical","","RCTGMCJBQGBLKT-UHFFFAOYSA-N","BRD-K65989725","","Cc1ccccc1N=Nc1ccc(N=Nc2c(O)ccc3ccccc23)c(C)c1"
"4913","SULBENTINE","other antifungal","","","","MicroSource",94.5,"BRD-K72384124-001-08-0","Preclinical","BRD-K73698987-001-01-3","QFVAWNPSRQWSDU-UHFFFAOYSA-N","BRD-K72384124","BRD-K73698987","S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1"
"4914","SULFABENZAMIDE","bacterial antifolate","","","","MicroSource",98.4,"BRD-K59983611-001-21-9","Launched","","PBCZLFBEBARBBI-UHFFFAOYSA-N","BRD-K59983611","","Nc1ccc(cc1)S(=O)(=O)NC(=O)c1ccccc1"
"4915","SULFACARBAMIDE","","","","","MicroSource",91.78,"BRD-K13486660-001-01-0","Withdrawn","","WVAKABMNNSMCDK-UHFFFAOYSA-N","BRD-K13486660","","NC(=O)NS(=O)(=O)c1ccc(N)cc1"
"4916","SULFAMETHOXYPYRIDAZINE","bacterial antifolate","","","","Selleck, MicroSource",97.84,"BRD-K00938507-001-16-0, BRD-K00938507-001-17-8","Withdrawn","","VLYWMPOKSSWJAL-UHFFFAOYSA-N","BRD-K00938507","","COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1"
"4918","SULFANILATE-ZINC","","","","","MicroSource",0,"BRD-K04254814-001-01-8","Preclinical","BRD-M62362637-001-02-9","RIUORJCWAHCMSA-UHFFFAOYSA-L","BRD-K04254814","BRD-M62362637","Nc1ccc(cc1)S(=O)(=O)O[Zn]OS(=O)(=O)c1ccc(N)cc1"
"4919","SULFANITRAN","","","","","MicroSource",78.09,"BRD-K76845197-001-05-4","Launched","","GWBPFRGXNGPPMF-UHFFFAOYSA-N","BRD-K76845197","","CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)[N+]([O-])=O"
"4920","SULFAPYRIDINE","PABA antagonist","","","","Selleck, MicroSource",98.64,"BRD-K41406082-001-15-4, BRD-K41406082-001-16-2","Launched","","GECHUMIMRBOMGK-UHFFFAOYSA-N","BRD-K41406082","","Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1"
"4922","SULFATHIAZOLE","dihydropteroate synthase inhibitor","","","","MicroSource, Selleck",98.28,"BRD-K14705039-001-16-4, BRD-K14705039-001-15-6","Launched","","JNMRHUJNCSQMMB-UHFFFAOYSA-N","BRD-K14705039","","Nc1ccc(cc1)S(=O)(=O)Nc1nccs1"
"4924","SULFORAPHANE","anticancer agent, aryl hydrocarbon receptor antagonist","NFE2L2","","","EMDBio",95.09,"BRD-A58955223-001-03-8","Phase 2","","SUVMJBTUFCVSAD-UHFFFAOYSA-N","BRD-A58955223","","CS(=O)CCCCN=C=S"
"4925","SULMAZOLE","adenosine receptor antagonist","","","","Prestwick",98.4,"BRD-A22081593-001-11-1","Phase 1","","XMFCOYRWYYXZMY-UHFFFAOYSA-N","BRD-A22081593","","COc1cc(ccc1-c1nc2ncccc2[nH]1)S(C)=O"
"4926","SULOCTIDIL","adrenergic receptor antagonist","","","","MicroSource",95.54,"BRD-A34205397-001-04-5","Withdrawn","","BFCDFTHTSVTWOG-UHFFFAOYSA-N","BRD-A34205397","","CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1"
"4927","SULPHADIMETHOXINE","dihydropteroate synthetase inhibitor","","","","Selleck, MicroSource",97.65,"BRD-K71125014-001-26-3, BRD-K71125014-001-27-1","Launched","","ZZORFUFYDOWNEF-UHFFFAOYSA-N","BRD-K71125014","","COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1"
"4929","SUMANIROLE","dopamine receptor agonist","DRD2","","","Sigma",82.4,"BRD-K30485548-050-01-6","Phase 3","","RKZSNTNMEFVBDT-MRVPVSSYSA-N","BRD-K30485548","","CN[C@@H]1Cc2cccc3nc(O)n(C1)c23"
"4930","SUN-B-8155","calcitonin agonist","CALCR","","","Tocris, Tocris",52.27,"BRD-K36274133-001-02-0, BRD-K36274133-001-01-2","Preclinical","","SGJLINMLDNLWOS-CXUHLZMHSA-N","BRD-K36274133","","C\C(=N/c1ccccc1N)c1c(C)cc(=O)n(O)c1O"
"4932","SUN-11602","fibroblast growth factor mimetic","FGFR1","","","Tocris",49.28,"BRD-K71250460-001-01-1","Preclinical","","KCODNOOPOPTZMO-UHFFFAOYSA-N","BRD-K71250460","","CN(C1CCN(Cc2ccc(cc2)C(N)=O)CC1)C(=O)CNc1c(C)c(C)c(N)c(C)c1C"
"4933","SUPROFEN","cyclooxygenase inhibitor","PTGS1, PTGS2","","","MicroSource, Selleck",97.91,"BRD-A34006693-001-15-4, BRD-A34006693-001-14-7","Withdrawn","","MDKGKXOCJGEUJW-UHFFFAOYSA-N","BRD-A34006693","","CC(C(O)=O)c1ccc(cc1)C(=O)c1cccs1"
"4935","SURITOZOLE","GABA receptor inverse agonist","GABBR1","","","Enamine",91.89,"BRD-K98557884-001-01-6","Phase 2","","IWDUZEHNLHFBRZ-UHFFFAOYSA-N","BRD-K98557884","","Cn1nc(-c2cccc(F)c2)n(C)c1=S"
"4936","SUTEZOLID","protein synthesis inhibitor","","","","MedChemEx",91.81,"BRD-K86670086-001-02-5","Phase 2","","FNDDDNOJWPQCBZ-ZDUSSCGKSA-N","BRD-K86670086","","CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCSCC2)c(F)c1"
"4937","SU014813","PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","KDR","","","MedChemEx",94.85,"BRD-K75911534-001-01-6","Phase 2","","CTNPALGJUAXMMC-HKJBKDEOSA-N","BRD-K75911534","","Cc1[nH]c(\C=C2\C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1"
"4938","SU3327","JNK inhibitor","MAPK8","","","Tocris, Tocris",94.58,"BRD-K32730239-001-01-0, BRD-K32730239-001-02-8","Preclinical","","NQQBNZBOOHHVQP-UHFFFAOYSA-N","BRD-K32730239","","Nc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1"
"4940","SU9516","CDK inhibitor","CDK1, CDK2, CDK4, CDK5","","","MedChemEx, Tocris",87.43,"BRD-K94883909-001-17-7, BRD-K94883909-001-18-5","Preclinical","","QNUKRWAIZMBVCU-WCIBSUBMSA-N","BRD-K94883909","","COc1ccc2NC(=O)\C(=C/c3c[nH]cn3)c2c1"
"4942","SWAINSONINE","alpha mannosidase inhibitor","MAN2A1","","","Enzo",97.53,"BRD-K15170068-001-03-2","Phase 2","","FXUAIOOAOAVCGD-WCTZXXKLSA-N","BRD-K15170068","","O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O"
"4943","SX-011","MAP kinase inhibitor","MAPK14","","","Tocris, Tocris",97.88,"BRD-K45385835-001-03-2, BRD-K45385835-001-02-4","Preclinical","","GUTYHDCSDBBMGW-UHFFFAOYSA-N","BRD-K45385835","","CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(cc12)C(=O)N1CCC(Cc2ccc(F)cc2)CC1"
"4945","SYM-2081","kainate receptor antagonist","GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2","","","Enzo",0,"BRD-K72106461-001-02-1","Preclinical","","KRKRAOXTGDJWNI-DMTCNVIQSA-N","BRD-K72106461","","C[C@H](C[C@H](N)C(O)=O)C(O)=O"
"4946","SYM-2206","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Tocris, Tocris",95.25,"BRD-A77218119-001-04-3, BRD-A77218119-001-03-5","Preclinical","","OFUDZKKOKPGXOH-UHFFFAOYSA-N","BRD-A77218119","","CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C"
"4948","SYMCLOSENE","","","","","MicroSource",0,"BRD-K33642804-001-01-1","Preclinical","","YRIZYWQGELRKNT-UHFFFAOYSA-N","BRD-K33642804","","Cln1c(=O)n(Cl)c(=O)n(Cl)c1=O"
"4949","SYNEPHRINE","adrenergic receptor agonist","ADRA1A","","","Selleck, Selleck, Selleck, MicroSource, Selleck",100,"BRD-A04327189-003-02-5, BRD-A04327189-003-03-3, BRD-A04327189-001-16-9, BRD-A04327189-001-15-1, BRD-A04327189-001-14-4","Launched","","YRCWQPVGYLYSOX-UHFFFAOYSA-N","BRD-A04327189","","CNCC(O)c1ccc(O)cc1"
"4954","S1P1-AGONIST-III","sphingosine kinase inhibitor","S1PR1","","","Tocris, MedChemEx, MedChemEx",94.83,"BRD-K12745498-001-02-6, BRD-K12745498-001-03-4, BRD-K12745498-001-01-8","Preclinical","","MLDQTQOMWDNTNN-UHFFFAOYSA-N","BRD-K12745498","","COc1ccncc1C(=O)NC(=O)Nc1ccc(-c2ccccc2)c(c1)C(F)(F)F"
"4957","S18986","glutamate receptor modulator","GRIA1, GRIA2, GRIA3, GRIA4","","","EMDBio",93.79,"BRD-K02501528-001-01-1","Phase 2","","MNTIJYGEITVWHU-SNVBAGLBSA-N","BRD-K02501528","","O=S1(=O)N[C@H]2CCCN2c2ccccc12"
"4958","S26948","PPAR receptor agonist","PPARG","","","Tocris, Tocris",98.35,"BRD-K48826825-001-01-8, BRD-K48826825-001-02-6","Preclinical","","NSMJEHGOMXSLCW-UHFFFAOYSA-N","BRD-K48826825","","COC(=O)C(Cc1ccc(OCCn2c3ccc(cc3sc2=O)C(=O)c2ccccc2)cc1)C(=O)OC"
"4960","S4","carbonic anhydrase inhibitor","CA12, CA9","","","Tocris",26.89,"BRD-K96798615-001-01-4","Preclinical","","HGVHSNXRZYOTPD-UHFFFAOYSA-N","BRD-K96798615","","Cc1cc(C)cc(NC(=O)Nc2ccc(OS(N)(=O)=O)cc2)c1"
"4961","T-0070907","PPAR receptor antagonist","PPARG","","","Tocris, Tocris, Selleck",98.04,"BRD-K31843556-001-04-1, BRD-K31843556-001-05-8, BRD-K31843556-001-03-3","Preclinical","","FRPJSHKMZHWJBE-UHFFFAOYSA-N","BRD-K31843556","","[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccncc1"
"4964","T-0156","phosphodiesterase inhibitor","PDE5A","","","Tocris, Tocris",98.39,"BRD-K63516691-003-03-8, BRD-K63516691-003-02-0","Preclinical","","JEMJAABFSYOLAP-UHFFFAOYSA-N","BRD-K63516691","","COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1"
"4966","T-0901317","LXR agonist","NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB","","","Tocris, Tocris, Selleck",96.75,"BRD-K23383398-001-09-9, BRD-K23383398-001-10-7, BRD-K23383398-001-08-1","Preclinical","","SGIWFELWJPNFDH-UHFFFAOYSA-N","BRD-K23383398","","OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F"
"4969","T-5224","AP inhibitor","JUN","","","MedChemEx",92.03,"BRD-K84925803-001-01-9","Phase 2","","DALCQQSLNPLQFZ-UHFFFAOYSA-N","BRD-K84925803","","OC(=O)CCc1cc(ccc1OCc1ccc2c(O)noc2c1)C(=O)c1ccc(OC2CCCC2)cc1O"
"4970","T-5601640","LIM kinase inhibitor","LIMK2","","","Tocris",99.12,"BRD-K83492904-001-01-9","Preclinical","","XVOKFRPKSAWELK-UHFFFAOYSA-N","BRD-K83492904","","Cc1cc(on1)C(=O)Nc1cccc(c1)C(=O)Nc1cccc(c1)C(F)(F)F"
"4971","T-62","adenosine receptor modulator","ADORA2A","","","Enamine, Enamine",63.41,"BRD-K09001147-001-02-4, BRD-K09001147-001-01-6","Phase 2","","OTZVBZFYMFTYKH-UHFFFAOYSA-N","BRD-K09001147","","Nc1sc2CCCCc2c1C(=O)c1ccc(Cl)cc1"
"4973","TA-01","casein kinase inhibitor, MAP kinase inhibitor","CSNK1D, CSNK1E, MAPK14","","","MedChemEx",96.68,"BRD-K79856806-001-01-0","Preclinical","","TWPJJJZCYVFUOA-UHFFFAOYSA-N","BRD-K79856806","","Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1c(F)cccc1F"
"4974","TABIMORELIN","growth hormone secretagogue receptor agonist","GHSR","","","Tocris",92.38,"BRD-K53600683-051-01-5","Phase 2","BRD-M26279695-051-02-4","WURGZWOTGMLDJP-ZCYANPAGSA-N","BRD-K53600683","BRD-M26279695","CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)\C=C\CC(C)(C)N"
"4975","TACEDINALINE","HDAC inhibitor","HDAC1","","","Selleck, Tocris",96.91,"BRD-K52313696-001-12-3, BRD-K52313696-001-14-9","Phase 3","","VAZAPHZUAVEOMC-UHFFFAOYSA-N","BRD-K52313696","","CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N"
"4977","TAFENOQUINE","antimalarial agent","","","","Sigma",82.25,"BRD-A78965079-036-01-8","Phase 3","","LBHLFPGPEGDCJG-UHFFFAOYSA-N","BRD-A78965079","","COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1"
"4978","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UHFFFAOYSA-N","BRD-A73556557","","OCC(O)C(O)C(O)C(=O)CO"
"4979","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UHFFFAOYSA-N","BRD-A73556557","","OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO"
"4980","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UHFFFAOYSA-N","BRD-A73556557","","OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O"
"4982","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UHFFFAOYSA-N","BRD-A73556557","","OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO"
"4983","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UYFOZJQFSA-N","BRD-A73556557","","OCC(O)C(O)C(O)C(=O)CO"
"4984","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UYFOZJQFSA-N","BRD-A73556557","","OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO"
"4985","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UYFOZJQFSA-N","BRD-A73556557","","OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O"
"4987","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-UYFOZJQFSA-N","BRD-A73556557","","OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO"
"4988","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","LKDRXBCSQODPBY-ARQDHWQXSA-N","BRD-A73556557","","OCC(O)C(O)C(O)C(=O)CO"
"4989","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","LKDRXBCSQODPBY-ARQDHWQXSA-N","BRD-A73556557","","OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO"
"4990","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","LKDRXBCSQODPBY-ARQDHWQXSA-N","BRD-A73556557","","OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O"
"4992","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","LKDRXBCSQODPBY-ARQDHWQXSA-N","BRD-A73556557","","OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO"
"4993","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-PQLUHFTBSA-N","BRD-A73556557","","OCC(O)C(O)C(O)C(=O)CO"
"4994","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-PQLUHFTBSA-N","BRD-A73556557","","OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO"
"4995","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-PQLUHFTBSA-N","BRD-A73556557","","OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O"
"4997","TAGATOSE","phosphorylase inhibitor","PYGL","","","Enamine, Sigma, TCI, EMDBio, Sigma",100,"BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9","Phase 3","","BJHIKXHVCXFQLS-PQLUHFTBSA-N","BRD-A73556557","","OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO"
"4998","TAK-063","phosphodiesterase inhibitor","PDE10A","","","MedChemEx",96.14,"BRD-K57155378-001-01-1","Phase 2","","KVHRYLNQDWXAGI-UHFFFAOYSA-N","BRD-K57155378","","COc1cn(nc(-c2ccnn2-c2ccccc2)c1=O)-c1ccc(cc1F)-n1cccn1"
"4999","TAK-220","CC chemokine receptor antagonist","CCR5","","","MedChemEx",96.9,"BRD-K38793468-001-01-4","Phase 1","","ASSJTMUEFHUKMJ-UHFFFAOYSA-N","BRD-K38793468","","CC(=O)N1CCC(CC1)C(=O)N(CCCN1CCC(Cc2ccc(cc2)C(N)=O)CC1)c1ccc(C)c(Cl)c1"
"5000","TAK-285","EGFR inhibitor","ERBB2","","","Selleck",92.87,"BRD-K80343549-001-02-6","Phase 1","","ZYQXEVJIFYIBHZ-UHFFFAOYSA-N","BRD-K80343549","","CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12"
"5001","TAK-593","VEGFR inhibitor","PDGFRA","","","MedChemEx",94.1,"BRD-K67262033-001-01-0","Phase 1","","DZFZXPPHBWCXPQ-UHFFFAOYSA-N","BRD-K67262033","","Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1"
"5002","TAK-632","RAF inhibitor","BRAF","","","Selleck",97.83,"BRD-K31866293-001-01-6","Preclinical","","OJFKUJDRGJSAQB-UHFFFAOYSA-N","BRD-K31866293","","Fc1ccc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2C#N)cc1NC(=O)Cc1cccc(c1)C(F)(F)F"
"5003","TAK-715","p38 MAPK inhibitor","MAPK14","","","Tocris, Selleck",98.88,"BRD-K52751261-001-08-7, BRD-K52751261-001-06-1","Phase 2","BRD-K03865741-001-01-0","HEKAIDKUDLCBRU-UHFFFAOYSA-N","BRD-K52751261","BRD-K03865741","CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1"
"5005","TAK-733","MEK inhibitor","MAP2K1","","","Selleck, Selleck",91.47,"BRD-K26667523-001-02-5, BRD-K26667523-001-03-3","Phase 1","","RCLQNICOARASSR-SECBINFHSA-N","BRD-K26667523","","Cn1c2ncn(C[C@@H](O)CO)c(=O)c2c(Nc2ccc(I)cc2F)c(F)c1=O"
"5007","TAK-875","insulin secretagogue","FFAR1","","","Selleck",97.03,"BRD-K58501140-002-01-0","Phase 3","BRD-M64443684-002-02-5","BZCALJIHZVNMGJ-HSZRJFAPSA-N","BRD-K58501140","BRD-M64443684","Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3[C@H](CC(O)=O)COc3c2)c1"
"5008","TAK-901","Aurora kinase inhibitor","AURKB","","","Selleck",94.01,"BRD-K01683783-001-02-6","Phase 1","","WKDACQVEJIVHMZ-UHFFFAOYSA-N","BRD-K01683783","","CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12"
"5009","TAK-960","PLK inhibitor","PLK1","","","MedChemEx, Tocris",98.58,"BRD-K48059512-001-01-4, BRD-K48059512-003-01-0","Phase 1","","GWRSATNRNFYMDI-UHFFFAOYSA-N","BRD-K48059512","","COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1"
"5011","TALABOSTAT","dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor","DPP4","","","MedChemEx, MedChemEx, MedChemEx",67.55,"BRD-K37419961-066-03-8, BRD-K37419961-066-02-0, BRD-K37419961-066-01-2","Phase 3","","FKCMADOPPWWGNZ-YUMQZZPRSA-N","BRD-K37419961","","CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O"
"5014","TALADEGIB","smoothened receptor antagonist","DHH, IHH, SMO","","","MedChemEx",98.77,"BRD-K50498985-001-03-3","Phase 2","","SZBGQDXLNMELTB-UHFFFAOYSA-N","BRD-K50498985","","CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F"
"5015","TALAMPANEL","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","MedChemEx, Tocris",93,"BRD-K80359953-001-01-3, BRD-K80359953-001-02-1","Phase 2","","JACAAXNEHGBPOQ-LLVKDONJSA-N","BRD-K80359953","","C[C@@H]1Cc2cc3OCOc3cc2C(=NN1C(C)=O)c1ccc(N)cc1"
"5017","TALAROZOLE","cytochrome P450 inhibitor","CYP26A1","","","MedChemEx",94.65,"BRD-A95755460-001-01-3","Phase 2","","SNFYYXUGUBUECJ-UHFFFAOYSA-N","BRD-A95755460","","CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1"
"5018","TALAZOPARIB","PARP inhibitor","PARP2","","","Selleck",97.61,"BRD-K95142244-001-01-5","Phase 3","","HWGQMRYQVZSGDQ-HZPDHXFCSA-N","BRD-K95142244","","Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1"
"5019","TALC","","","","","Selleck, Selleck",0,"BRD-M92352362-002-02-3, BRD-M92352362-002-03-1","Launched","","XBPUDTAATCFDRE-UHFFFAOYSA-N","BRD-M92352362","","O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O"
"5021","TALMAPIMOD","p38 MAPK inhibitor","MAPK11, MAPK14","","","Tocris, Tocris, MedChemEx",98.07,"BRD-K17555800-003-01-5, BRD-K17555800-003-02-3, BRD-K17555800-001-01-9","Phase 2","","ZMELOYOKMZBMRB-DLBZAZTESA-N","BRD-K17555800","","C[C@H]1CN([C@H](C)CN1Cc1ccc(F)cc1)C(=O)c1cc2c(cn(C)c2cc1Cl)C(=O)C(=O)N(C)C"
"5024","TALNETANT","tachykinin antagonist","TACR2, TACR3","","","MedChemEx",98.57,"BRD-K47095176-001-01-6","Phase 2","","BIAVGWDGIJKWRM-FQEVSTJZSA-N","BRD-K47095176","","CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1"
"5025","TALOPRAM","adrenergic inhibitor","SLC6A2","","","Tocris",92.77,"BRD-A02532772-003-01-7","Phase 2","","LJBBMCNHIUJBDU-UHFFFAOYSA-N","BRD-A02532772","","CNCCCC1(OC(C)(C)c2ccccc12)c1ccccc1"
"5026","TALTOBULIN","tubulin polymerization inhibitor","","","","MedChemEx",96.83,"BRD-K87512222-019-01-7","Phase 1","","CNTMOLDWXSVYKD-PSRNMDMQSA-N","BRD-K87512222","","CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C(C)C)\C=C(/C)C(O)=O)C(C)(C)C)C(C)(C)c1ccccc1"
"5027","TAME","","","","","Selleck",91.82,"BRD-K72231366-001-02-3","Preclinical","","FKMJXALNHKIDOD-LBPRGKRZSA-N","BRD-K72231366","","COC(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1ccc(C)cc1"
"5028","TANAPROGET","progesterone receptor agonist","PGR","","","MedChemEx, MedChemEx",97.58,"BRD-K99604664-001-02-9, BRD-K99604664-001-01-1","Phase 2","","PYVFWTPEBMRKSR-UHFFFAOYSA-N","BRD-K99604664","","Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N"
"5030","TANDUTINIB","FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB","","","MicroSource, Selleck",94.36,"BRD-K89162000-001-07-2, BRD-K89162000-001-06-4","Phase 2","","UXXQOJXBIDBUAC-UHFFFAOYSA-N","BRD-K89162000","","COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1"
"5032","TANESPIMYCIN","HSP inhibitor","HSP90AA1","","","Selleck, Selleck",97.71,"BRD-K81473043-001-14-6, BRD-K81473043-001-19-5","Phase 3","BRD-K34504123-001-01-6","AYUNIORJHRXIBJ-TXHRRWQRSA-N","BRD-K81473043","BRD-K34504123","CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O"
"5034","TANGERITIN","cell cycle inhibitor","","","","Selleck",97.49,"BRD-K25186396-001-09-6","Preclinical","","ULSUXBXHSYSGDT-UHFFFAOYSA-N","BRD-K25186396","","COc1ccc(cc1)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1"
"5035","TANSHINONE-I","AP inhibitor","IFNG","","","Selleck, Selleck",87.49,"BRD-K34073885-001-07-7, BRD-K34073885-001-09-3","Phase 2","","AIGAZQPHXLWMOJ-UHFFFAOYSA-N","BRD-K34073885","","Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12"
"5037","TANSHINONE-IIA","anti-inflammatory agent, interleukin inhibitor","IL1B, NR1I2, TNF","","","Selleck, Selleck",78.69,"BRD-K00141480-001-15-4, BRD-K00141480-001-14-7","Phase 2/Phase 3","","HYXITZLLTYIPOF-UHFFFAOYSA-N","BRD-K00141480","","Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C"
"5039","TAPRENEPAG","prostaglandin receptor agonist","PTGER2","","","MedChemEx",96.08,"BRD-K88854110-001-01-5","Phase 2","","MFFBXYNKZHTCEY-UHFFFAOYSA-N","BRD-K88854110","","OC(=O)COc1cccc(CN(Cc2ccc(cc2)-n2cccn2)S(=O)(=O)c2cccnc2)c1"
"5040","TARAFENACIN","acetylcholine receptor antagonist","CHRM3","","","MedChemEx",99.28,"BRD-K59390331-045-01-5","Phase 2","BRD-M06471014-001-01-2","UXZDMXYRRQJIBJ-IBGZPJMESA-N","BRD-K59390331","BRD-M06471014","Fc1cccc(c1)N(Cc1cc(F)c(F)c(F)c1)C(=O)O[C@H]1CN2CCC1CC2"
"5041","TARANABANT","cannabinoid receptor inverse agonist","CNR1","","","MedChemEx",98.67,"BRD-K35169477-001-01-9","Phase 3","","QLYKJCMUNUWAGO-GAJHUEQPSA-N","BRD-K35169477","","C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc1ccc(Cl)cc1)c1cccc(c1)C#N"
"5042","TARGININE","nitric oxide synthase inhibitor","NOS3","","","Cayman",100,"BRD-K59506194-015-04-9","Phase 3","","NTNWOCRCBQPEKQ-YFKPBYRVSA-N","BRD-K59506194","","CNC(=N)NCCC[C@H](N)C(O)=O"
"5043","TARIQUIDAR","P glycoprotein inhibitor","ABCB1","","","Selleck, Selleck",95.08,"BRD-K09353376-001-02-1, BRD-K09353376-001-03-9","Phase 3","","LGGHDPFKSSRQNS-UHFFFAOYSA-N","BRD-K09353376","","COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cnc5ccccc5c4)cc3)Cc2cc1OC"
"5045","TARTARIC-ACID","antioxidant","ATP6V1C1, B3GAT1, DDX6, HIF1AN, TREM1","","","MicroSource",0,"BRD-K36474365-001-06-6","Launched","","FEWJPZIEWOKRBE-JCYAYHJZSA-N","BRD-K36474365","","O[C@H]([C@@H](O)C(O)=O)C(O)=O"
"5046","TAS-103","topoisomerase inhibitor","TOP1","","","MedChemEx",91.54,"BRD-K09426783-300-01-0","Phase 1","","ROWSTIYZUWEOMM-UHFFFAOYSA-N","BRD-K09426783","","CN(C)CCNc1nc2cc(O)ccc2c2-c3ccccc3C(=O)c12"
"5047","TASELISIB","PI3K inhibitor","PIK3CA","","","MedChemEx",98.4,"BRD-K44844162-001-01-6","Phase 3","","BEUQXVWXFDOSAQ-UHFFFAOYSA-N","BRD-K44844162","","CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O"
"5048","TASISULAM","apoptosis stimulant","","","","Selleck",97.55,"BRD-K42495768-001-01-7","Phase 3","","WWONFUQGBVOKOF-UHFFFAOYSA-N","BRD-K42495768","","Clc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)s2)c(Cl)c1"
"5049","TASQUINIMOD","angiogenesis inhibitor, S100A9 inhibitor","HDAC4","","","MedChemEx",99.3,"BRD-K14653796-001-01-1","Phase 3","","ONDYALNGTUAJDX-UHFFFAOYSA-N","BRD-K14653796","","COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12"
"5050","TASULDINE","mucolytic agent","","","","Vitas-M, Labotest",98.77,"BRD-K10415035-001-03-6, BRD-K10415035-001-04-4","Phase 3","","HMCTXMOKMWELFJ-UHFFFAOYSA-N","BRD-K10415035","","C(Sc1ncccn1)c1cccnc1"
"5052","TAUROCHOLATE","G protein-coupled receptor agonist","CEL, FABP6, SLCO1C1","","","Enzo",100,"BRD-K81062487-001-05-8","Phase 1","","WBWWGRHZICKQGZ-HZAMXZRMSA-N","BRD-K81062487","","C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C"
"5053","TAXIFOLIN","opioid receptor antagonist","ADIPOR2","","","Selleck, Selleck",97.48,"BRD-K94649603-001-10-6, BRD-K94649603-001-11-4","Phase 2","","CXQWRCVTCMQVQX-LSDHHAIUSA-N","BRD-K94649603","","O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1ccc(O)c(O)c1"
"5055","TAZEMETOSTAT","histone lysine methyltransferase inhibitor","EZH2","","","Selleck, Selleck",93.46,"BRD-K11215326-001-02-9, BRD-K11215326-001-03-7","Phase 2","","NSQSAUGJQHDYNO-UHFFFAOYSA-N","BRD-K11215326","","CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCOCC2)cc1"
"5057","TBA-354","","","","","MedChemEx",96.43,"BRD-K56405978-001-01-5","Phase 1","","ZXSGSFMORAILEY-HNNXBMFYSA-N","BRD-K56405978","","[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(nc1)-c1ccc(OC(F)(F)F)cc1"
"5058","TBOA-(DL)","excitatory amino acid transporter inhibitor","SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7","","","Tocris, Tocris, Tocris",91,"BRD-M77041484-001-03-4, BRD-M77041484-001-02-6, BRD-M77041484-001-01-8","Preclinical","","CSEZCYBVEGIYNG-MFBWXLJUSA-N","BRD-M77041484","","N[C@@H]([C@H](OCc1ccccc1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCc1ccccc1)C(O)=O)C(O)=O"
"5061","TC-A-2317","Aurora kinase inhibitor","AURKA","","","Tocris",86.6,"BRD-A12147465-003-01-4","Preclinical","","XHHRGYCOEVNAKV-UHFFFAOYSA-N","BRD-A12147465","","CC(CCCC(C)(C)O)Nc1nc(Nc2cc(C)[nH]n2)cc(C)c1C#N"
"5062","TC-ASK-10","MAP kinase inhibitor","MAP3K5, MAP3K6","","","Tocris",95.66,"BRD-K29660062-300-01-2","Preclinical","","SMJAMOAYGIVKRI-UHFFFAOYSA-N","BRD-K29660062","","CC(C)(C)c1ccc(cc1)C(=O)Nc1cn2cc(ccc2n1)-n1ccnc1"
"5063","TC-E-5002","histone demethylase inhibitor","KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8","","","Tocris, Tocris",96.52,"BRD-K15256258-001-01-3, BRD-K15256258-001-02-1","Preclinical","","NEHSERYKENINRH-UHFFFAOYSA-N","BRD-K15256258","","ON(CCC(O)=O)C(=O)CCCCCCCCC1CC1"
"5065","TC-E-5006","gamma secretase modulator","APP","","","Tocris",96.44,"BRD-A66521565-001-01-8","Preclinical","","ONYWALXTZFPKAS-UHFFFAOYSA-N","BRD-A66521565","","CC(C(O)=O)c1ccc(C(N2CCC(C)CC2)c2ccc(F)cc2)c(c1)-c1ccc(cc1)C(F)(F)F"
"5066","TC-F-2","FAAH inhibitor","FAAH","","","Tocris",96.64,"BRD-K26041695-001-02-5","Preclinical","","NXTBLPPTZRPJCA-IBGZPJMESA-N","BRD-K26041695","","CCn1c2ccccc2n([C@H]2CCCN(C2)c2nccc(n2)-c2cc3ccccc3o2)c1=O"
"5067","TC-FPR-43","formyl peptide receptor agonist","FPR2","","","Tocris",97.83,"BRD-K16497916-001-01-6","Preclinical","","PAEBEUZTAPIOIO-UHFFFAOYSA-N","BRD-K16497916","","CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C"
"5068","TC-G-1000","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","","","Tocris",77.34,"BRD-K27010807-050-01-3","Preclinical","","RLKWQKZPCMICPS-UHFFFAOYSA-N","BRD-K27010807","","Cc1sc(C)c2c1CCC=C2c1c[nH]cn1"
"5069","TC-G-1004","adenosine receptor antagonist","ADORA2A","","","Tocris",90.59,"BRD-K76989898-001-01-1","Preclinical","","JENSDTKXNVHSSN-UHFFFAOYSA-N","BRD-K76989898","","COC1CCN(CC1)c1cccc(n1)-c1cc(NC(C)=O)nc(n1)-n1nc(C)cc1C"
"5070","TC-G-1005","G protein-coupled receptor agonist","GPBAR1","","","Tocris",87.66,"BRD-K16939217-001-01-3","Preclinical","","JQULIQJSYPZQMA-UHFFFAOYSA-N","BRD-K16939217","","Cc1ccc(C)c(Oc2ccncc2C(=O)N2CCN(C3CC3)c3ccccc23)c1"
"5071","TC-G-1008","G protein-coupled receptor agonist","GPR39","","","Tocris",98.28,"BRD-K87199310-001-01-4","Preclinical","","DRSZMILOMUPIBJ-UHFFFAOYSA-N","BRD-K87199310","","CNc1nc(NCc2ccc(NS(C)(=O)=O)cc2Cl)cc(n1)-c1ccccn1"
"5072","TC-H-106","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC8","","","Tocris",89.32,"BRD-K45044657-001-02-2","Preclinical","","WTKBRPXPNAKVEQ-UHFFFAOYSA-N","BRD-K45044657","","Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1"
"5073","TC-I-15","integrin inhibitor","ITGA2, ITGB1","","","Tocris",96.07,"BRD-K17621556-001-01-5","Preclinical","","XKLHCUGVLCGKKX-RBUKOAKNSA-N","BRD-K17621556","","CC1(C)SCN([C@@H]1C(=O)N[C@@H](CNC(=O)NCc1ccccc1)C(O)=O)S(=O)(=O)c1ccccc1"
"5074","TC-I-2000","transient receptor potential channel antagonist","TRPM8","","","Tocris",96.49,"BRD-A83792282-001-01-6","Preclinical","","ADCDUDFEGFKKQH-UHFFFAOYSA-N","BRD-A83792282","","Fc1ccc(NC(=O)N2CCc3ccccc3C2c2ccc(cc2)C(F)(F)F)cc1"
"5075","TC-I-2014","transient receptor potential channel antagonist","TRPM8","","","Tocris",94.45,"BRD-K05262258-001-01-3","Preclinical","","VSMFCZZEKTVDHM-UHFFFAOYSA-N","BRD-K05262258","","FC(F)(F)c1ccccc1-c1cc(c2[nH]c(nc2c1)C1=NOC2(C1)CCCCC2)C(F)(F)F"
"5076","TC-LPA5-4","lysophosphatidic acid receptor antagonist","LPAR5","","","Tocris",96.94,"BRD-K32031961-001-01-7","Preclinical","","BNALUYKEGYUHQC-UHFFFAOYSA-N","BRD-K32031961","","COc1cccc(c1)-n1nc(cc1-c1ccc(C2CCCCC2)c(Cl)c1)C(O)=O"
"5077","TC-MPS1-12","monopolar spindle 1 kinase inhibitor","TTK","","","Tocris",98.5,"BRD-K76792630-001-01-2","Preclinical","","XDEFNAWAKYQBQY-UHFFFAOYSA-N","BRD-K76792630","","CC(C)(C)Nc1nc(Nc2ccc(cc2)C(N)=O)cc(N)c1C#N"
"5078","TC-N-1752","sodium channel blocker","SCN9A","","","Tocris",98.27,"BRD-K78161388-001-01-2","Preclinical","","QLKAFHZJICDACE-UHFFFAOYSA-N","BRD-K78161388","","CC(=O)Nc1cccc(Nc2ncnc(n2)N2CCC(CC2)OCc2ccc(OC(F)(F)F)cc2)c1C"
"5079","TC-NTR1-17","neurotensin agonist","NTSR1","","","Tocris",98.19,"BRD-K79608170-001-02-1","Preclinical","","ZQUSYVORYNBGLG-FQEVSTJZSA-N","BRD-K79608170","","COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)N[C@@H](CC(C)C)C(O)=O"
"5080","TC-O-9311","G protein-coupled receptor agonist","GPR139","","","Tocris",86.77,"BRD-K54297077-001-01-8","Preclinical","","KPTMSQHTGZMEFU-UHFFFAOYSA-N","BRD-K54297077","","COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1cccc2ccccc12"
"5081","TC-OT-39","oxytocin receptor agonist, vasopressin receptor agonist","AVPR1A, OXT","","","Tocris",96.28,"BRD-K55013981-001-01-3","Preclinical","","KSNHHKZYKYNBEI-NDEPHWFRSA-N","BRD-K55013981","","CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12"
"5082","TC-S-7003","src inhibitor","LCK","","","Tocris",94.27,"BRD-K34362291-001-01-5","Preclinical","","BHJJWVDKNXABFS-UHFFFAOYSA-N","BRD-K34362291","","CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1"
"5083","TC-S-7004","DYRK inhibitor","DYRK1A, DYRK1B","","","Tocris",95.75,"BRD-K89517477-001-01-4","Preclinical","","CQKBSRPVZZLCJE-UHFFFAOYSA-N","BRD-K89517477","","COc1ncc2cc(C(=O)Nc3cc(ccc3Cl)C(=O)NCc3cccc(Cl)c3)c(=O)[nH]c2n1"
"5084","TC-S-7005","PLK inhibitor","PLK2","","","Tocris",99.07,"BRD-K89584803-001-01-9","Preclinical","","DAAGOCSHXCDWDY-ZDUSSCGKSA-N","BRD-K89584803","","C[C@H](Nc1cc2c(noc2cn1)-c1ccc2OCOc2c1)c1ccccc1"
"5085","TC-S-7006","MAP kinase inhibitor","MAP3K8","","","Tocris",88.42,"BRD-K51776215-001-02-5","Preclinical","","NMEUKWOOQOHUNA-UHFFFAOYSA-N","BRD-K51776215","","Fc1ccc(Nc2c(cnc3cnc(NCc4cccnc4)cc23)C#N)cc1Cl"
"5086","TC-S-7009","hypoxia inducible factor inhibitor","EPAS1","","","Tocris",96.72,"BRD-K21894922-001-01-9","Preclinical","","CDQUJZKBRAFWNG-UHFFFAOYSA-N","BRD-K21894922","","[O-][N+](=O)c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12"
"5087","TC-SP-14","sphingosine 1 phosphate receptor agonist","S1PR1","","","Tocris",86.12,"BRD-K87461578-001-01-5","Preclinical","","GVXGVDIXINMAAL-UHFFFAOYSA-N","BRD-K87461578","","OC(=O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1"
"5088","TCID","","","","","Selleck, Selleck",55.04,"BRD-K27536248-001-01-7, BRD-K27536248-001-02-5","Preclinical","","IDLAOWFFKWRNHB-UHFFFAOYSA-N","BRD-K27536248","","Clc1c2C(=O)CC(=O)c2c(Cl)c(Cl)c1Cl"
"5090","TCN-238","glutamate receptor positive allosteric modulator","GRM4","","","Tocris",90.73,"BRD-K77915400-001-01-6","Preclinical","","LNUXNUNUGIHCPA-VOTSOKGWSA-N","BRD-K77915400","","Nc1nccc(\C=C\c2ccccc2)n1"
"5091","TCN201","glutamate receptor antagonist","GRIN2A","","","Tocris, Tocris",97.03,"BRD-K09787262-001-02-7, BRD-K09787262-001-01-9","Preclinical","","FYIBXBFDXNPBSF-UHFFFAOYSA-N","BRD-K09787262","","Fc1ccc(cc1Cl)S(=O)(=O)NCc1ccc(cc1)C(=O)NNC(=O)c1ccccc1"
"5093","TCS-HDAC6-20B","HDAC inhibitor","HDAC6","","","Tocris",100,"BRD-K68358632-001-01-0","Preclinical","","DQZMLPMCOMRJOR-MOVGKWKRSA-N","BRD-K68358632","","CC(C)C(=O)SCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)NC12CC3CC(CC(C3)C1)C2"
"5094","TCS-OX2-29","orexin receptor antagonist","HCRTR2","","","Tocris",84.85,"BRD-K29424831-003-02-1","Preclinical","","COFVZFLCAOUMJT-OAQYLSRUSA-N","BRD-K29424831","","COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H](NCc1ccncc1)C(C)(C)C"
"5095","TCS-PIM-1-1","Pim kinase inhibitor","PIM1","","","Tocris",96.33,"BRD-K08902330-001-01-3","Preclinical","","SVSYJTYGPLVUOZ-UHFFFAOYSA-N","BRD-K08902330","","Oc1ccc(Br)cc1-c1cc(-c2ccccc2)c(C#N)c(=O)[nH]1"
"5096","TCS-21311","JAK inhibitor","JAK3","","","Tocris",94.18,"BRD-K49461364-001-02-8","Preclinical","","CLGRAWDGLMENOD-UHFFFAOYSA-N","BRD-K49461364","","CC(C)(O)C(=O)N1CCN(CC1)c1ccc(c(c1)C1=C(C(=O)NC1=O)c1c[nH]c2ccccc12)C(F)(F)F"
"5097","TCS-2210","neural stem cell inducer","","","","Tocris",87.06,"BRD-K19958299-001-01-1","Preclinical","","ZOFZKGFBKISZRI-UHFFFAOYSA-N","BRD-K19958299","","ONC(=O)c1ccc2[nH]c(=O)c(CCCc3ccccc3)nc2c1"
"5098","TCS-2314","integrin inhibitor","ITGA4, ITGB1","","","Tocris",97.08,"BRD-K55216666-001-01-4","Preclinical","","ITXAAOWFOURIHK-DEOSSOPVSA-N","BRD-K55216666","","Cc1ccccc1NC(=O)Nc1ccc(CC(=O)N2CCOC[C@H]2C(=O)N2CCC(CC(O)=O)CC2)cc1"
"5099","TCS-3035","G protein-coupled receptor agonist","GPR35","","","Tocris",58.4,"BRD-K81935556-001-01-0","Preclinical","","WXMCOLGPDOYHNK-UITAMQMPSA-N","BRD-K81935556","","OC(=O)COc1ccc(cc1)\C=C1/SC(=O)NC1=O"
"5100","TCS-359","FLT3 inhibitor","FLT3","","","Tocris, Selleck, Tocris, Selleck",93.25,"BRD-K81376179-001-04-8, BRD-K81376179-001-03-0, BRD-K81376179-001-06-3, BRD-K81376179-001-05-5","Preclinical","","FSPQCTGGIANIJZ-UHFFFAOYSA-N","BRD-K81376179","","COc1ccc(cc1OC)C(=O)Nc1sc2CCCCc2c1C(N)=O"
"5104","TCS-5861528","transient receptor potential channel antagonist","TRPA1","","","Tocris",97.49,"BRD-A16560607-001-02-5","Preclinical","","ZUTUWJYMCADJHD-UHFFFAOYSA-N","BRD-A16560607","","CCC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1"
"5105","TCS2002","glycogen synthase kinase inhibitor","GSK3B","","","Tocris, Tocris",98.33,"BRD-A50028488-001-01-6, BRD-A50028488-001-02-4","Preclinical","","RCKYSTKYIVULEK-UHFFFAOYSA-N","BRD-A50028488","","Cc1nnc(o1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2c1"
"5107","TC1","beta-secretase inhibitor","BACE1","","","Tocris",95.78,"BRD-A13964793-001-02-6","Preclinical","","FYGREZKTJIXWIH-UHFFFAOYSA-N","BRD-A13964793","","OC12C3C4C5C3C(C3C5CC4C13)N2CCc1cccc(F)c1"
"5108","TC2559","acetylcholine receptor agonist","CHRNA4","","","Tocris, Tocris",75.02,"BRD-K24227647-364-02-3, BRD-K24227647-364-01-5","Preclinical","","HFZDMKMXPGRKCK-GQCTYLIASA-N","BRD-K24227647","","CCOc1cncc(\C=C\CCNC)c1"
"5110","TECALCET","calcium-sensing receptor agonist","CASR","","","Tocris, Cayman",96,"BRD-K41662846-003-02-3, BRD-K41662846-003-01-5","Phase 2","","ZVQUCWXZCKWZBP-CQSZACIVSA-N","BRD-K41662846","","COc1cccc(c1)[C@@H](C)NCCCc1ccccc1Cl"
"5112","TECASTEMIZOLE","histamine receptor antagonist","KCNH2","","","ChemPacific",91.7,"BRD-K48195801-001-01-6","Phase 3","","SFOVDSLXFUGAIV-UHFFFAOYSA-N","BRD-K48195801","","Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1"
"5113","TECOVIRIMAT","orthopoxvirus egress inhibitor","","","","MedChemEx",98.79,"BRD-K24312986-001-01-2","Phase 3","","CSKDFZIMJXRJGH-VWLPUNTISA-N","BRD-K24312986","","FC(F)(F)c1ccc(cc1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O"
"5114","TEGASEROD","serotonin receptor partial agonist","HTR2A, HTR2B, HTR2C, HTR4","","","MicroSource, MedChemEx, Tocris",95.01,"BRD-K88743730-050-03-3, BRD-K88743730-050-04-1, BRD-K88743730-050-05-8","Withdrawn","","IKBKZGMPCYNSLU-RGVLZGJSSA-N","BRD-K88743730","","CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12"
"5117","TEGOBUVIR","HCV inhibitor, protease inhibitor","","","","MedChemEx",95.88,"BRD-K26701552-001-01-8","Phase 3","","XBEQSQDCBSKCHJ-UHFFFAOYSA-N","BRD-K26701552","","Fc1ccccc1-c1nc2ccn(Cc3ccc(nn3)-c3ccc(cc3C(F)(F)F)C(F)(F)F)cc2n1"
"5118","TEICOPLANIN","bacterial cell wall synthesis inhibitor","","","","MedChemEx",56.59,"BRD-K07712545-001-01-8","Launched","","BJNLLBUOHPVGFT-VPMXZCLFSA-N","BRD-K07712545","","CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl"
"5119","TEICOPLANIN-A2-1","bacterial cell wall synthesis inhibitor","","","","MicroSource",46.55,"BRD-A09761158-001-02-1","Launched","","YMWQIYMUNZBOOV-AQQDCCNYSA-N","BRD-A09761158","","CCCCC\C=C\CCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(CC4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@H](NC1=O)C(O)=O)c5)cc3Cl"
"5120","TEIJIN-COMPOUND-1","CC chemokine receptor antagonist","CCR2","","","Tocris",98.07,"BRD-K51528698-003-01-4","Preclinical","","BAOQJSULMWXFRK-GOSISDBHSA-N","BRD-K51528698","","FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]1CCN(Cc2ccc(Cl)cc2)C1"
"5121","TELATINIB","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","KDR","","","Selleck",93.51,"BRD-K84564571-001-02-4","Phase 2","","QFCXANHHBCGMAS-UHFFFAOYSA-N","BRD-K84564571","","CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1"
"5122","TELCAGEPANT","calcitonin antagonist","CALCRL, RAMP1","","","MedChemEx",96.64,"BRD-K91159026-001-01-7","Phase 3","","CGDZXLJGHVKVIE-DNVCBOLYSA-N","BRD-K91159026","","Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F"
"5123","TELENZEPINE","acetylcholine receptor antagonist","CHRM1","","","MicroSource, Tocris",98.14,"BRD-K06147391-003-03-5, BRD-K06147391-300-06-8","Phase 3","","VSWPGAIWKHPTKX-UHFFFAOYSA-N","BRD-K06147391","","CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc3ccccc23)CC1"
"5125","TELMESTEINE","mucolytic agent","","","","TCI",96.9,"BRD-A05523972-001-01-5","Launched","","XBJWOGLKABXFJE-UHFFFAOYSA-N","BRD-A05523972","","CCOC(=O)N1CSCC1C(O)=O"
"5126","TELOTRISTAT","tryptophan hydroxylase inhibitor","TPH1","","","MedChemEx",94.93,"BRD-K63178091-001-01-1","Launched","","NCLGDOBQAWBXRA-PGRDOPGGSA-N","BRD-K63178091","","Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F"
"5127","TEMAZEPAM","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO","","","MicroSource",98.97,"BRD-A93093700-001-02-9","Withdrawn","","SEQDDYPDSLOBDC-UHFFFAOYSA-N","BRD-A93093700","","CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1"
"5128","TEMEFOS","cholinesterase inhibitor","","","","MicroSource",46.31,"BRD-K51805276-001-09-3","Launched","","WWJZWCUNLNYYAU-UHFFFAOYSA-N","BRD-K51805276","","COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1"
"5129","TEMPOL","free radical scavenger","","","","Selleck, Acros, Selleck",100,"BRD-K95053546-001-03-5, BRD-K95053546-001-02-7, BRD-K95053546-001-01-9","Phase 2","BRD-U44097393-000-01-2","CSGAUKGQUCHWDP-UHFFFAOYSA-N","BRD-K95053546","BRD-U44097393","CC1(C)CC(O)CC(C)(C)N1O"
"5132","TENATOPRAZOLE","ATPase inhibitor","IDO1","","","MicroSource",95.62,"BRD-A42270467-001-04-4","Phase 2","","ZBFDAUIVDSSISP-UHFFFAOYSA-N","BRD-A42270467","","COc1ccc2[nH]c(nc2n1)S(=O)Cc1ncc(C)c(OC)c1C"
"5133","TENIDAP","cyclooxygenase inhibitor","KCNJ4, PTGS1","","","Tocris, Tocris",95.02,"BRD-A87479750-001-02-7, BRD-A87479750-001-03-5","Phase 3","","IGPDWKCUDHIIRL-UHFFFAOYSA-N","BRD-A87479750","","NC(=O)N1C(=O)C(C(=O)c2cccs2)c2cc(Cl)ccc12"
"5135","TENILSETAM","AGE inhibitor","","","","LifeChem, Enamine",59.54,"BRD-A41835910-001-01-4, BRD-A41835910-001-02-2","Phase 3","","BBACKDMGYMXYLE-UHFFFAOYSA-N","BRD-A41835910","","O=C1NCCNC1c1cccs1"
"5137","TENOFOVIR-ALAFENAMIDE","nucleoside reverse transcriptase inhibitor","","","","Selleck",93.68,"BRD-A25988899-001-01-6","Preclinical","","LDEKQSIMHVQZJK-UHFFFAOYSA-N","BRD-A25988899","","CC(C)OC(=O)C(C)NP(=O)(COC(C)Cn1cnc2c(N)ncnc12)Oc1ccccc1"
"5138","TENOVIN-1","SIRT inhibitor, TP53 activator","SIRT1","","","Selleck, Selleck, Tocris",95.56,"BRD-K05977823-001-04-6, BRD-K05977823-001-03-8, BRD-K05977823-001-05-3","Preclinical","","WOWJIWFCOPZFGV-UHFFFAOYSA-N","BRD-K05977823","","CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1"
"5141","TENOVIN-6","SIRT inhibitor","SIRT1, SIRT2, SIRT3","","","Selleck, Selleck",93,"BRD-K13949769-001-01-7, BRD-K13949769-003-01-3","Preclinical","","BVJSXSQRIUSRCO-UHFFFAOYSA-N","BRD-K13949769","","CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1"
"5143","TENYLIDONE","","","","","MicroSource",71.2,"BRD-K91298281-001-01-3","Preclinical","","KHXBULXCCPIELT-DCIPZJNNSA-N","BRD-K91298281","","O=C1\C(CCC\C1=C/c1cccs1)=C\c1cccs1"
"5144","TEPP-46","pyruvate kinase isozyme activator","PKM","","","MedChemEx, MedChemEx",97.55,"BRD-A18279961-001-02-0, BRD-A18279961-001-01-2","Preclinical","","ZWKJWVSEDISQIS-UHFFFAOYSA-N","BRD-A18279961","","Cn1c2cc(sc2c2cnn(Cc3cccc(N)c3)c(=O)c12)S(C)=O"
"5146","TERAMEPROCOL","lipoxygenase inhibitor","BIRC5, CDK1","","","Sigma",99.1,"BRD-K76788410-001-01-6","Phase 1/Phase 2","","ORQFDHFZSMXRLM-IYBDPMFKSA-N","BRD-K76788410","","COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC"
"5147","TERCIPRAZINE","","","","","PrincetonBio",94.14,"BRD-A11725667-001-01-8","Phase 1","","SDKXUWMRKYQIFU-UHFFFAOYSA-N","BRD-A11725667","","OC(COC1(CCCCC1)C#C)CN1CCN(CC1)c1cccc(c1)C(F)(F)F"
"5148","TERFENADINE","histamine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2","","","MicroSource, Tocris, Selleck",97.86,"BRD-A06352418-001-25-9, BRD-A06352418-001-27-5, BRD-A06352418-001-24-2","Withdrawn","","GUGOEEXESWIERI-UHFFFAOYSA-N","BRD-A06352418","","CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1"
"5151","TERGURIDE","dopamine receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","","","Kemprotec",94.68,"BRD-A89207210-001-01-6","Launched","","JOAHPSVPXZTVEP-NXVRBGIVSA-N","BRD-A89207210","","CCN(CC)C(=O)N[C@H]1CC2C(Cc3c[nH]c4cccc2c34)N(C)C1"
"5152","TERODILINE","cholinergic receptor antagonist","","","","Sigma",97.58,"BRD-A33479817-003-03-7","Phase 3","","UISARWKNNNHPGI-UHFFFAOYSA-N","BRD-A33479817","","CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C"
"5153","TEROXIRONE","DNA inhibitor","","","","ChemDiv",100,"BRD-A39935389-001-05-9","Phase 1","","OUPZKGBUJRBPGC-UHFFFAOYSA-N","BRD-A39935389","","O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1"
"5154","TERPENE","","","","","MicroSource",0,"BRD-K93396439-002-01-2","Preclinical","","RBNWAMSGVWEHFP-UHFFFAOYSA-N","BRD-K93396439","","CC(C)(O)C1CCC(C)(O)CC1"
"5155","TERREIC-ACID-(-)","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Tocris",0,"BRD-A64228451-001-08-4","Preclinical","","NYFMSQHOGRWGFD-OOEDRKFMSA-N","BRD-A64228451","","CC1C(=O)[C@H]2O[C@H]2C(=O)C1=O"
"5156","TERUTROBAN","prostanoid receptor antagonist","TBXA2R","","","MedChemEx",95.89,"BRD-K43975632-001-01-1","Phase 3","","HWEOXFSBSQIWSY-MRXNPFEDSA-N","BRD-K43975632","","Cc1ccc2C[C@@H](CCc2c1CCC(O)=O)NS(=O)(=O)c1ccc(Cl)cc1"
"5157","TESAGLITAZAR","insulin sensitizer, PPAR receptor agonist","PPARA, PPARG","","","Tocris, Cayman",96.97,"BRD-K15507868-001-04-5, BRD-K15507868-001-03-7","Phase 3","","CXGTZJYQWSUFET-IBGZPJMESA-N","BRD-K15507868","","CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O"
"5159","TESTOSTERONE-PROPIONATE","androgen receptor agonist","AR","","","MicroSource",96.91,"BRD-A48720949-001-04-0","Launched","","PDMMFKSKQVNJMI-PPRDLICTSA-N","BRD-A48720949","","CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C"
"5160","TETRADECYLTHIOACETIC-ACID","lipid peroxidase inhibitor","","","","Enzo",97.74,"BRD-K47539947-001-03-7","Phase 2","","IPBCWPPBAWQYOO-UHFFFAOYSA-N","BRD-K47539947","","CCCCCCCCCCCCCCSCC(O)=O"
"5161","TETRAETHYLENEPENTAMINE","superoxide dismutase inhibitor","SOD1, SOD2","","","Selleck, Selleck",99.86,"BRD-K41298358-395-02-6, BRD-K41298358-395-03-4","Phase 2/Phase 3","","FAGUFWYHJQFNRV-UHFFFAOYSA-N","BRD-K41298358","","NCCNCCNCCNCCN"
"5163","TETRAHYDROFOLIC-ACID","","ALDH1L1, AMT, ATIC, FOLR2, FTCD, MTFMT, MTHFD1, MTHFD2, MTHFR, MTR, SHMT1, SHMT2","","","Sigma",0,"BRD-A36978621-001-01-9","Launched","","MSTNYGQPCMXVAQ-KIYNQFGBSA-N","BRD-A36978621","","Nc1nc(O)c2NC(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1"
"5164","TETRAHYDROPAPAVERINE","","","","","Selleck",97.58,"BRD-A91831168-003-02-5","Preclinical","","YXWQTVWJNHKSCC-UHFFFAOYSA-N","BRD-A91831168","","COc1ccc(CC2NCCc3cc(OC)c(OC)cc23)cc1OC"
"5165","TETRAHYDROURIDINE","cytidine deaminase inhibitor","CDA","","","EMDBio",100,"BRD-A86248581-001-01-4","Phase 2","","UCKYOOZPSJFJIZ-XVKVHKPRSA-N","BRD-A86248581","","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O"
"5166","TETRAMETHYLTHIURAM-MONOSULFIDE","","","","","AKSci",94.7,"BRD-K36889451-001-01-1","Preclinical","","REQPQFUJGGOFQL-UHFFFAOYSA-N","BRD-K36889451","","CN(C)C(=S)SC(=S)N(C)C"
"5167","TETRANDRINE","calcium channel blocker","SLC6A3","","","Selleck, Selleck",97.19,"BRD-K08078237-001-19-8, BRD-K08078237-001-20-6","Preclinical","BRD-K59640580-001-07-1","WVTKBKWTSCPRNU-KYJUHHDHSA-N","BRD-K08078237","BRD-K59640580","COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(Oc5cc6[C@H](Cc7ccc(Oc1c2)cc7)N(C)CCc6cc5OC)c34"
"5169","TETRAZOL-5-YL-GLYCINE-(RS)","glutamate receptor agonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris",0,"BRD-A14757586-001-03-2","Preclinical","","UKBRUIZWQZHXFL-UHFFFAOYSA-N","BRD-A14757586","","NC(C(O)=O)c1nnn[nH]1"
"5170","TETRINDOLE","monoamine oxidase inhibitor","MAOA","","","Tocris, Tocris",93.92,"BRD-A52660433-066-03-9, BRD-A52660433-066-02-1","Phase 3","","AUXCHYJDVJZEPG-UHFFFAOYSA-N","BRD-A52660433","","C1CCC(CC1)c1ccc2n3CCNC4CCCc(c34)c2c1"
"5172","TETROQUINONE","","","","","MicroSource",0,"BRD-K90177246-001-05-5","Preclinical","","GQPHQLHUIDOQTA-UHFFFAOYSA-N","BRD-K90177246","","OC1C(=O)C(=O)C(O)C(=O)C1=O"
"5173","TFC-007","prostaglandin inhibitor","HPGDS","","","Tocris",95.55,"BRD-K57708067-001-01-3","Preclinical","","NLSSUSRERAMBTA-UHFFFAOYSA-N","BRD-K57708067","","O=C(Nc1ccc(cc1)N1CCC(CC1)C(=O)N1CCOCC1)c1cnc(Oc2ccccc2)nc1"
"5174","TG-003","CLK inhibitor","CLK1, CLK4, DYRK1A, DYRK1B","","","Selleck",96.35,"BRD-K97072811-001-11-4","Preclinical","","BGVLELSCIHASRV-QPEQYQDCSA-N","BRD-K97072811","","CCN1\C(Sc2ccc(OC)cc12)=C\C(C)=O"
"5175","TG-02","CDK inhibitor, FLT3 inhibitor, JAK inhibitor","CDK1, CDK2, CDK7, CDK9, FLT3, JAK2","","","MedChemEx",96.17,"BRD-K14560436-001-01-4","Phase 1","","VXBAJLGYBMTJCY-NSCUHMNNSA-N","BRD-K14560436","","CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2"
"5176","TG-100572","src inhibitor, VEGFR inhibitor","KDR, SRC","","","MedChemEx",89.41,"BRD-K18424115-003-01-3","Preclinical","","AQSSMEORRLJZLU-UHFFFAOYSA-N","BRD-K18424115","","Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(O)ccc1Cl"
"5177","TG-100713","PI3K inhibitor","","","","Selleck",92.96,"BRD-K46392623-001-02-5","Preclinical","","UOORQSPLBHUQDQ-UHFFFAOYSA-N","BRD-K46392623","","Nc1nc(N)c2nc(cnc2n1)-c1cccc(O)c1"
"5178","TG-100801","src inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, SRC","","","MedChemEx",89.33,"BRD-K12735121-001-01-4","Phase 2","","JMGXJHWTVBGOKG-UHFFFAOYSA-N","BRD-K12735121","","Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl"
"5179","TG-101209","JAK inhibitor","JAK2, JAK3","","","Selleck",94.67,"BRD-K39841531-001-02-1","Preclinical","","JVDOKQYTTYUYDV-UHFFFAOYSA-N","BRD-K39841531","","CN1CCN(CC1)c1ccc(Nc2ncc(C)c(Nc3cccc(c3)S(=O)(=O)NC(C)(C)C)n2)cc1"
"5180","TG-101348","FLT3 inhibitor, JAK inhibitor","BRD4, JAK1, JAK2, JAK3, TYK2","","","Selleck, Selleck",91.26,"BRD-K12502280-001-11-4, BRD-K12502280-001-08-0","Phase 3","","JOOXLOJCABQBSG-UHFFFAOYSA-N","BRD-K12502280","","Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C"
"5182","TGR-1202","PI3K inhibitor","","","","MedChemEx",94.1,"BRD-K52579889-001-01-9","Phase 3","","IUVCFHHAEHNCFT-INIZCTEOSA-N","BRD-K52579889","","CC(C)Oc1ccc(cc1F)-c1nn([C@@H](C)c2oc3ccc(F)cc3c(=O)c2-c2cccc(F)c2)c2ncnc(N)c12"
"5183","TGX-221","PI3K inhibitor","PIK3CB, PIK3CD","","","Selleck, Selleck",91.18,"BRD-A41692738-001-10-0, BRD-A41692738-001-07-6","Preclinical","","CPRAGQJXBLMUEL-UHFFFAOYSA-N","BRD-A41692738","","CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1"
"5185","TG100-115","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","","","Selleck",94.74,"BRD-K64785675-001-04-0","Phase 1/Phase 2","","UJIAQDJKSXQLIT-UHFFFAOYSA-N","BRD-K64785675","","Nc1nc(N)c2nc(-c3cccc(O)c3)c(nc2n1)-c1cccc(O)c1"
"5186","TH-302","DNA alkylating agent","","","","MedChemEx",88.37,"BRD-K20958582-001-01-4","Phase 3","","UGJWRPJDTDGERK-UHFFFAOYSA-N","BRD-K20958582","","Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+]([O-])=O"
"5187","THALIBLASTINE","DNA inhibitor","","","","InterBioScreen",0,"BRD-K87548127-300-01-1","Phase 2","","ZCTJIMXXSXQXRI-KYJUHHDHSA-N","BRD-K87548127","","COc1cc(C[C@@H]2N(C)CCc3cc(OC)c(OC)cc23)c(Oc2cc3C[C@@H]4N(C)CCc5cc(OC)c(OC)c(-c3cc2OC)c45)cc1OC"
"5188","THALIDOMIDE","tumor necrosis factor production inhibitor","CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF","","","Tocris, Selleck",99,"BRD-A93255169-001-28-3, BRD-A93255169-001-27-5","Launched","","UEJJHQNACJXSKW-UHFFFAOYSA-N","BRD-A93255169","","O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12"
"5190","THEOBROMINE","phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE4B","","","Selleck, MicroSource",98.78,"BRD-K34888156-001-11-2, BRD-K34888156-213-01-4","Launched","","YAPQBXQYLJRXSA-UHFFFAOYSA-N","BRD-K34888156","","Cn1cnc2n(C)c(=O)[nH]c(=O)c12"
"5192","THIAMET-G","GLCNAC phosphotransferase inhibitor","MGEA5","","","Tocris, Selleck",95.3,"BRD-K38380126-001-02-2, BRD-K38380126-001-01-4","Preclinical","","PPAIMZHKIXDJRN-FMDGEEDCSA-N","BRD-K38380126","","CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1"
"5194","THIAMINE-PYROPHOSPHATE","","","","","ChemImpex",0,"BRD-A09994331-003-02-4","Launched","","AYEKOFBPNLCAJY-UHFFFAOYSA-O","BRD-A09994331","","Cc1c(CCOP(O)(=O)OP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N"
"5195","THIAZOVIVIN","rho associated kinase inhibitor","","","","Selleck",96.94,"BRD-K03164761-001-02-1","Preclinical","","DOBKQCZBPPCLEG-UHFFFAOYSA-N","BRD-K03164761","","O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1"
"5196","THIOCTIC-ACID","reducing agent","ACHE, LIAS, LIPT1, PTGS2, SLC5A6","","","MicroSource",94.83,"BRD-A16347691-001-13-1","Launched","","AGBQKNBQESQNJD-UHFFFAOYSA-N","BRD-A16347691","","OC(=O)CCCCC1CCSS1"
"5197","THIODIGLYCOL","","","","","MicroSource",95.75,"BRD-K54521836-001-02-1","Preclinical","","YODZTKMDCQEPHD-UHFFFAOYSA-N","BRD-K54521836","","OCCSCCO"
"5198","THIOMERSAL","other antibiotic","OXCT1","","","MicroSource",95.81,"BRD-K61443650-236-13-1","Launched","","HXQVQGWHFRNKMS-UHFFFAOYSA-M","BRD-K61443650","","CC[Hg]Sc1ccccc1C(O)=O"
"5199","THIOPERAMIDE","histamine receptor antagonist","HRH3, HRH4","","","Tocris, Tocris",98.59,"BRD-K63874012-001-03-7, BRD-K63874012-001-02-9","Preclinical","","QKDDJDBFONZGBW-UHFFFAOYSA-N","BRD-K63874012","","S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1"
"5201","THIOPHANATE","","","","","Sigma, MicroSource",94.28,"BRD-K90168339-001-09-4, BRD-K90168339-001-08-6","Preclinical","","QGHREAKMXXNCOA-UHFFFAOYSA-N","BRD-K90168339","","COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC"
"5203","THIORIDAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2","","","Selleck, MicroSource",91.42,"BRD-A84481105-003-31-3, BRD-A84481105-003-32-1","Withdrawn","","KLBQZWRITKRQQV-UHFFFAOYSA-N","BRD-A84481105","","CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1"
"5205","THIORPHAN","membrane metalloendopeptidase inhibitor","MME","","","Sigma, Enzo",38.61,"BRD-A56012032-001-15-5, BRD-A56012032-001-14-8","Phase 1","","LJJKNPQAGWVLDQ-UHFFFAOYSA-N","BRD-A56012032","","OC(=O)CNC(=O)C(CS)Cc1ccccc1"
"5207","THONZONIUM","ATPase inhibitor","","","","MicroSource, Selleck",94.95,"BRD-K13387373-004-15-2, BRD-K13387373-004-14-5","Launched","","IOYZYMQFUSNATM-UHFFFAOYSA-N","BRD-K13387373","","CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1"
"5209","THREO-2-METHYLISOCITRATE-(DL)","isocitrate lyase substrate","","","","MedChemEx",93.35,"BRD-M01344114-348-01-0","Preclinical","","KTKGACLAXAFYNU-BWELSHISSA-N","BRD-M01344114","","CC(O)([C@@H](CC(O)=O)C(O)=O)C(O)=O.CC(O)([C@H](CC(O)=O)C(O)=O)C(O)=O"
"5210","THYMOL","GABA receptor positive allosteric modulator","TRPA1","","","Enamine",0,"BRD-K17458574-001-07-7","Launched","","MGSRCZKZVOBKFT-UHFFFAOYSA-N","BRD-K17458574","","CC(C)c1ccc(C)cc1O"
"5211","THYMOL-IODIDE","","","","","SantaCruz",50.02,"BRD-K36617478-001-01-5","Preclinical","","SHOKWSLXDAIZPP-UHFFFAOYSA-N","BRD-K36617478","","CC(C)c1cc(c(C)cc1OI)-c1cc(C(C)C)c(OI)cc1C"
"5212","THZ1","CDK inhibitor","CDK7","","","MedChemEx",90.84,"BRD-K66401437-001-03-3","Preclinical","","OBJNFLYHUXWUPF-IZZDOVSWSA-N","BRD-K66401437","","CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1"
"5213","THZ1-R","CDK inhibitor","CDK7","","","MedChemEx",90.43,"BRD-K02135007-001-01-8","Preclinical","","TUERFPPIPKZNKE-UHFFFAOYSA-N","BRD-K02135007","","CN(C)CCCC(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1"
"5214","THZ2","CDK inhibitor","CDK7","","","MedChemEx",90.03,"BRD-K95902121-001-01-0","Preclinical","","FONRCZUZCHXWBD-VGOFMYFVSA-N","BRD-K95902121","","CN(C)C\C=C\C(=O)Nc1cccc(c1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1"
"5215","TH588","MTH1 inhibitor","NUDT1","","","MedChemEx",97.39,"BRD-K01054709-001-01-3","Preclinical","","PNMYJIOQIAEYQL-UHFFFAOYSA-N","BRD-K01054709","","Nc1nc(NC2CC2)cc(n1)-c1cccc(Cl)c1Cl"
"5216","TIC10","AKT inhibitor, TRAIL modulator","AKT1, MAPK1","","","Selleck, Selleck",98.82,"BRD-K01115818-001-01-0, BRD-K19939891-001-05-4","Phase 2","","DJNVPMWOJIZWOG-UHFFFAOYSA-N","BRD-K01115818","","Cc1ccccc1CN1CC2=C(CCN(Cc3ccccc3)C2=O)N2CCN=C12"
"5217","TIC10","AKT inhibitor, TRAIL modulator","AKT1, MAPK1","","","Selleck, Selleck",98.82,"BRD-K01115818-001-01-0, BRD-K19939891-001-05-4","Phase 2","","DJNVPMWOJIZWOG-UHFFFAOYSA-N","BRD-K01115818","","Cc1ccccc1CN1C2=NCCN2C(=O)C2=C1CCN(Cc1ccccc1)C2"
"5218","TIC10","AKT inhibitor, TRAIL modulator","AKT1, MAPK1","","","Selleck, Selleck",98.82,"BRD-K01115818-001-01-0, BRD-K19939891-001-05-4","Phase 2","","RSAQARAFWMUYLL-UHFFFAOYSA-N","BRD-K01115818","","Cc1ccccc1CN1CC2=C(CCN(Cc3ccccc3)C2=O)N2CCN=C12"
"5219","TIC10","AKT inhibitor, TRAIL modulator","AKT1, MAPK1","","","Selleck, Selleck",98.82,"BRD-K01115818-001-01-0, BRD-K19939891-001-05-4","Phase 2","","RSAQARAFWMUYLL-UHFFFAOYSA-N","BRD-K01115818","","Cc1ccccc1CN1C2=NCCN2C(=O)C2=C1CCN(Cc1ccccc1)C2"
"5220","TIDEGLUSIB","glycogen synthase kinase inhibitor","GSK3B","","","Selleck, Selleck",96.84,"BRD-K81330143-001-02-2, BRD-K81330143-001-04-8","Phase 2","","PMJIHLSCWIDGMD-UHFFFAOYSA-N","BRD-K81330143","","O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1"
"5222","TIENILIC-ACID","sodium/potassium/chloride transporter inhibitor, cytochrome P450 inhibitor","CYP2C9, SLC12A1","","","Sigma",99.16,"BRD-K34098590-001-02-1","Withdrawn","","AGHANLSBXUWXTB-UHFFFAOYSA-N","BRD-K34098590","","OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl"
"5223","TIE2-KINASE-INHIBITOR","TIE tyrosine kinase inhibitor","KDR, MAPK14","","","Selleck",93.18,"BRD-A92800748-001-05-5","Preclinical","","SINQIEAULQKUPD-UHFFFAOYSA-N","BRD-A92800748","","COc1ccc2cc(ccc2c1)-c1nc([nH]c1-c1ccncc1)-c1ccc(cc1)S(C)=O"
"5224","TIFENAZOXIDE","ATP-sensitive potassium channel agonist","ABCC8, KCNJ11","","","Sigma",94.29,"BRD-K20568871-001-01-1","Phase 1","","KYSFUHHFTIGRJN-UHFFFAOYSA-N","BRD-K20568871","","CC1(CC1)NC1=NS(=O)(=O)c2sc(Cl)cc2N1"
"5225","TIMOFIBRATE","cholesterol inhibitor, lipase clearing factor inhibitor","LPL","","","Enamine",98.06,"BRD-A64406146-001-01-2","Phase 2","","QSNOWCXXECLALL-UHFFFAOYSA-N","BRD-A64406146","","CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(O)=O"
"5226","TIMONACIC","antioxidant","ANXA5","","","MicroSource",100,"BRD-A38592941-001-02-7","Launched","","DZLNHFMRPBPULJ-UHFFFAOYSA-N","BRD-A38592941","","OC(=O)C1CSCN1"
"5227","TIOGUANINE","purine antagonist","","","","Prestwick",100,"BRD-K75649340-001-13-1","Phase 2","","OTDJAMXESTUWLO-UUOKFMHZSA-N","BRD-K75649340","","Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1"
"5228","TIOTIDINE","histamine receptor antagonist","HRH2","","","Tocris, Tocris",97.92,"BRD-K15071410-001-03-7, BRD-K15071410-001-01-1","Phase 2","","YDDXVAXDYKBWDX-UHFFFAOYSA-N","BRD-K15071410","","CN\C(NCCSCc1csc(N=C(N)N)n1)=N/C#N"
"5230","TIOXOLONE","carbonic anhydrase inhibitor","CA2","","","MicroSource, Selleck",93.15,"BRD-K41876534-001-13-7, BRD-K41876534-001-12-9","Preclinical","","SLYPOVJCSQHITR-UHFFFAOYSA-N","BRD-K41876534","","Oc1ccc2sc(=O)oc2c1"
"5232","TIPIFARNIB","farnesyltransferase inhibitor","FNTA, FNTB","","","Selleck",96.02,"BRD-K62965247-001-04-9","Phase 3","","PLHJCIYEEKOWNM-HHHXNRCGSA-N","BRD-K62965247","","Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1"
"5233","TIPLAXTININ","plasminogen activator inhibitor","SERPINE1","","","Tocris, MedChemEx",91.15,"BRD-K30882994-001-02-4, BRD-K30882994-001-01-6","Phase 1","","ODXQFEWQSHNQNI-UHFFFAOYSA-N","BRD-K30882994","","OC(=O)C(=O)c1cn(Cc2ccccc2)c2ccc(cc12)-c1ccc(OC(F)(F)F)cc1"
"5235","TIPRENOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","","","Enamine",96.46,"BRD-A73566563-001-01-6","Phase 2","","CSUNLSYSEQIDMO-UHFFFAOYSA-N","BRD-A73566563","","CSc1ccccc1OCC(O)CNC(C)C"
"5236","TIRACIZINE","sodium channel blocker","SCN5A","","","ChemDiv",98.01,"BRD-K75250001-001-01-3","Withdrawn","","KJAMZCVTJDTESW-UHFFFAOYSA-N","BRD-K75250001","","CCOC(=O)Nc1ccc2CCc3ccccc3N(C(=O)CN(C)C)c2c1"
"5237","TIRAPAZAMINE","DNA inhibitor","","","","Adooq, MedChemEx",95.16,"BRD-K92968657-001-02-4, BRD-K92968657-001-01-6","Phase 3","BRD-K75058612-001-01-1","ORYDPOVDJJZGHQ-UHFFFAOYSA-N","BRD-K92968657","BRD-K75058612","Nc1n[n+]([O-])c2ccccc2[n+]1[O-]"
"5239","TIRASEMTIV","troponin activator","","","","MedChemEx",99.62,"BRD-K51087630-001-01-6","Phase 2","","RSQGZEAXODVTOL-UHFFFAOYSA-N","BRD-K51087630","","CCC(CC)n1c2nc(cnc2[nH]c1=O)C#C"
"5240","TITANOCENE-DICHLORIDE","apoptosis stimulant","","","","Oakwood",98.9,"BRD-K60284353-001-01-3","Phase 2","","XKLWATAZDMHTSH-UHFFFAOYSA-L","BRD-K60284353","","Cl[Ti](Cl)(C1C=CC=C1)C1C=CC=C1"
"5241","TIVANTINIB","tyrosine kinase inhibitor","MET","","","MedChemEx",98.79,"BRD-K33379087-001-07-5","Phase 3","","UCEQXRCJXIVODC-PMACEKPBSA-N","BRD-K33379087","","O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23"
"5242","TIVOZANIB","VEGFR inhibitor","FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB","","","Selleck",97.41,"BRD-K53414658-001-08-2","Phase 3","","SPMVMDHWKHCIDT-UHFFFAOYSA-N","BRD-K53414658","","COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC"
"5243","TMC-353121","RSV fusion inhibitor","","","","MedChemEx",93.17,"BRD-K66097663-001-01-8","Phase 2","","DKORMNNYNRPTBJ-UHFFFAOYSA-N","BRD-K66097663","","Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1"
"5244","TMC647055","RNA polymerase inhibitor","","","","MedChemEx",97.37,"BRD-K49659468-436-01-2","Phase 2","","UOBYJVFBFSLCTQ-UHFFFAOYSA-N","BRD-K49659468","","COc1ccc2-c3c(C4CCCCC4)c4ccc5cc4n3CC(=Cc2c1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O"
"5245","TMN-355","cyclophilin inhibitor","PPIA","","","Tocris",94.31,"BRD-K24527118-001-01-6","Preclinical","","SFNLLCUAISZNRV-UHFFFAOYSA-N","BRD-K24527118","","Fc1cccc(Cl)c1C(=O)NC(=O)NC1c2ccccc2-c2ccccc12"
"5246","TMPH","","","","","Tocris, Tocris",100,"BRD-K49119234-003-02-6, BRD-K49119234-003-03-4","Preclinical","","PWWKJRFUJIFGGD-UHFFFAOYSA-N","BRD-K49119234","","CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1"
"5248","TMS","","","","","Tocris, Tocris",89.41,"BRD-K96233303-001-02-7, BRD-K96233303-001-01-9","Preclinical","","JDBCWSHYEQUBLW-AATRIKPKSA-N","BRD-K96233303","","COc1ccc(\C=C\c2cc(OC)cc(OC)c2)c(OC)c1"
"5250","TNP-470","methionine aminopeptidase inhibitor","","","","Sigma",75.74,"BRD-K53597484-001-02-7","Phase 2","","MSHZHSPISPJWHW-PVDLLORBSA-N","BRD-K53597484","","CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl"
"5251","TODRALAZINE","antihypertensive agent","","","","MicroSource",89.59,"BRD-K68553471-003-12-3","Launched","","WGZDBVOTUVNQFP-UHFFFAOYSA-N","BRD-K68553471","","CCOC(=O)NNc1nncc2ccccc12"
"5252","TOLAMOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","","","Sigma",94.9,"BRD-A60498477-001-01-2","Phase 3","","SKQDKFOTIPJUSV-UHFFFAOYSA-N","BRD-A60498477","","Cc1ccccc1OCC(O)CNCCOc1ccc(cc1)C(N)=O"
"5253","TOLCAPONE","catechol O methyltransferase inhibitor","COMT","","","Selleck, Selleck",99.4,"BRD-K10852020-001-04-5, BRD-K10852020-001-05-2","Withdrawn","","MIQPIUSUKVNLNT-UHFFFAOYSA-N","BRD-K10852020","","Cc1ccc(cc1)C(=O)c1cc(O)c(O)c(c1)[N+]([O-])=O"
"5255","TOLIMIDONE","src activator","LYN, SRC","","","Axon, Tocris",99.28,"BRD-K41772907-001-01-2, BRD-K41772907-001-02-0","Phase 2","","HJQILFPVRNHTIG-UHFFFAOYSA-N","BRD-K41772907","","Cc1cccc(Oc2cnc(=O)[nH]c2)c1"
"5257","TOLONIDINE","adrenergic receptor antagonist","ADRA2A","","","Enamine",98.87,"BRD-K82687598-001-01-6","Launched","","KWBTZIFLQYYPTH-UHFFFAOYSA-N","BRD-K82687598","","Cc1ccc(NC2=NCCN2)c(Cl)c1"
"5258","TOLRESTAT","aldose reductase inhibitor","AKR1A1, AKR1B1, AKR1B10","","","MedChemEx, MedChemEx, MedChemEx",89.37,"BRD-K85693895-001-01-1, BRD-K85693895-001-02-9, BRD-K85693895-001-03-7","Withdrawn","","LUBHDINQXIHVLS-UHFFFAOYSA-N","BRD-K85693895","","COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O"
"5261","TOMELUKAST","leukotriene receptor antagonist","CYSLTR1","","","Enzo",94.74,"BRD-K74765201-001-16-7","Phase 3","","MWYHLEQJTQJHSS-UHFFFAOYSA-N","BRD-K74765201","","CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O"
"5262","TONABERSAT","gap junction modulator, nitric oxide production inhibitor","","","","MedChemEx",99.82,"BRD-K36970462-001-01-6","Phase 2","","XLIIRNOPGJTBJD-ROUUACIJSA-N","BRD-K36970462","","CC(=O)c1ccc2OC(C)(C)[C@@H](O)[C@@H](NC(=O)c3ccc(F)c(Cl)c3)c2c1"
"5263","TORCETRAPIB","cholesteryl ester transfer protein inhibitor","CETP","","","Tocris, Selleck",96.12,"BRD-K55675242-001-02-2, BRD-K55675242-001-03-0","Phase 3","BRD-K64622987-001-01-4","CMSGWTNRGKRWGS-NQIIRXRSSA-N","BRD-K55675242","BRD-K64622987","CCOC(=O)N1[C@H](CC)C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c2cc(ccc12)C(F)(F)F"
"5265","TORCITABINE","DNA polymerase inhibitor","DCK, TK2","","","MedChemEx",100,"BRD-K91822704-003-07-2","Phase 2","","CKTSBUTUHBMZGZ-SHYZEUOFSA-N","BRD-K91822704","","Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1"
"5266","TORIN-1","mTOR inhibitor","MTOR","","","Selleck, Selleck",95.98,"BRD-K40175214-001-11-6, BRD-K40175214-001-13-2","Preclinical","","AKCRNFFTGXBONI-UHFFFAOYSA-N","BRD-K40175214","","CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1"
"5268","TORIN-2","mTOR inhibitor","MTOR","","","Selleck, Tocris",97.22,"BRD-K68174511-001-06-6, BRD-K68174511-001-08-2","Preclinical","","GUXXEUUYCAYESJ-UHFFFAOYSA-N","BRD-K68174511","","Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4cccc(c4)C(F)(F)F)c3c2c1"
"5270","TOSEDOSTAT","peptidase inhibitor","ANPEP, LAP3, NPEPPS","","","Selleck, Tocris, Tocris, Selleck",93.96,"BRD-K92241597-001-09-4, BRD-K92241597-001-06-0, BRD-K92241597-001-11-0, BRD-K92241597-001-05-2","Phase 2","","FWFGIHPGRQZWIW-SQNIBIBYSA-N","BRD-K92241597","","CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1"
"5274","TOYOCAMYCIN","serine/threonine kinase inhibitor","ERN1","","","Sigma",99.13,"BRD-K26420709-001-01-7","Phase 1","","XOKJUSAYZUAMGJ-WOUKDFQISA-N","BRD-K26420709","","Nc1ncnc2n(cc(C#N)c12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"5275","TOZADENANT","adenosine receptor antagonist","ADORA2A","","","MedChemEx",96.14,"BRD-K93045741-001-01-0","Phase 3","","XNBRWUQWSKXMPW-UHFFFAOYSA-N","BRD-K93045741","","COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12"
"5276","TOZASERTIB","Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor","AURKA, AURKB, AURKC, LCK","","","Selleck, Selleck",97.69,"BRD-K59369769-001-23-7, BRD-K59369769-001-20-3","Phase 2","","GCIKSSRWRFVXBI-UHFFFAOYSA-N","BRD-K59369769","","CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1"
"5278","TP-003","GABA receptor inverse agonist","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris",94.29,"BRD-K87941707-001-01-0","Preclinical","","SJMMDWXJSSJHOQ-UHFFFAOYSA-N","BRD-K87941707","","CC(C)(O)c1ccn2c(cnc2c1F)-c1ccc(F)c(c1)-c1ccc(F)cc1C#N"
"5279","TP-0903","AXL kinase inhibitor","AXL","","","MedChemEx",96.12,"BRD-K84034737-001-01-1","Preclinical","","YUAALFPUEOYPNX-UHFFFAOYSA-N","BRD-K84034737","","CN(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl"
"5280","TPCA-1","IKK inhibitor","IKBKB","","","Tocris, Tocris, Selleck",98.3,"BRD-K51575138-001-15-7, BRD-K51575138-001-13-2, BRD-K51575138-001-12-4","Preclinical","","SAYGKHKXGCPTLX-UHFFFAOYSA-N","BRD-K51575138","","NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1"
"5283","TPPS4","","","","","Vitas-M",82.5,"BRD-K39805756-001-01-6","Phase 1","","PBHVCRIXMXQXPD-UHFFFAOYSA-N","BRD-K39805756","","OS(=O)(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc([nH]2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc1[nH]2"
"5284","TRACAZOLATE","GABA receptor modulator","GABRA1","","","Tocris",98.96,"BRD-K34154330-003-06-4","Phase 2","","PCTRYMLLRKWXGF-UHFFFAOYSA-N","BRD-K34154330","","CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12"
"5285","TRAM-34","potassium channel antagonist","KCNN4","","","MedChemEx, MedChemEx",0,"BRD-K30071764-001-03-0, BRD-K30071764-001-02-2","Preclinical","","KBFUQFVFYYBHBT-UHFFFAOYSA-N","BRD-K30071764","","Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1"
"5287","TRAM-39","calcium-activated potassium channel activator","KCNN4","","","Tocris",93.57,"BRD-K81341251-001-01-9","Preclinical","","JHNRTPKGSCVKKC-UHFFFAOYSA-N","BRD-K81341251","","Clc1ccccc1C(C#N)(c1ccccc1)c1ccccc1"
"5288","TRAMIPROSATE","beta amyloid protein neurotoxicity inhibitor","APP","","","MicroSource",100,"BRD-K82234479-001-09-4","Phase 3","","SNKZJIOFVMKAOJ-UHFFFAOYSA-N","BRD-K82234479","","NCCCS(O)(=O)=O"
"5289","TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID","","","","","Cayman",95.61,"BRD-K26222048-001-01-7","Launched","","GKJZMAHZJGSBKD-NMMTYZSQSA-N","BRD-K26222048","","CCCCC\C=C/C=C/CCCCCCCCC(O)=O"
"5290","TRANS-2-UNDECENOIC-ACID","","","","","AlfaAesar",90.54,"BRD-K42959922-001-01-5","Preclinical","","IGBBVTAVILYDIO-MDZDMXLPSA-N","BRD-K42959922","","CCCCCCCC\C=C\C(O)=O"
"5291","TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID","","","","","Key",94.05,"BRD-K75080769-001-01-6","Preclinical","","XWVBOPKUSVZZPJ-UHFFFAOYSA-N","BRD-K75080769","","OC(=O)C1CCC(CC1)c1cc2cccnc2c(n1)-c1cccc(F)c1"
"5292","TRANS-4-HYDROXYCROTONIC-ACID","gamma hydroxybutyric acid ligand","","","","Tocris",0,"BRD-K91614056-001-02-2","Preclinical","","RMQJECWPWQIIPW-OWOJBTEDSA-N","BRD-K91614056","","OC\C=C\C(O)=O"
"5293","TRANS-4-METHOXYCINNAMIC-ACID","","","","","Vitas-M",96.49,"BRD-K26273521-001-07-3","Preclinical","","AFDXODALSZRGIH-QPJJXVBHSA-N","BRD-K26273521","","COc1ccc(cc1)\C=C\C(O)=O"
"5294","TRAP-101","nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist","OPRL1","","","Tocris, Tocris",97.83,"BRD-K69837166-003-02-0, BRD-K69837166-003-03-8","Preclinical","","DCRGHMJXEBSRQG-UHFFFAOYSA-N","BRD-K69837166","","CCn1c2ccccc2n(C2=C(CO)CN(CC3CCCCCCC3)CC2)c1=O"
"5296","TRAXOPRODIL","glutamate receptor antagonist","GRIN2B","","","EMDBio",93.36,"BRD-K38158531-001-02-1","Phase 2","","QEMSVZNTSXPFJA-HNAYVOBHSA-N","BRD-K38158531","","C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(CC1)c1ccccc1"
"5297","TREBENZOMINE","","","","","Sigma",53.54,"BRD-A20686268-001-01-4","Phase 2","","FDJAKSHVOONYHX-UHFFFAOYSA-N","BRD-A20686268","","CC1Oc2ccccc2CC1N(C)C"
"5298","TREMORINE","acetylcholine receptor agonist","","","","Prestwick",100,"BRD-K08619838-300-05-7","Preclinical","","JSUAJTLKVREZHV-UHFFFAOYSA-N","BRD-K08619838","","C(C#CCN1CCCC1)N1CCCC1"
"5299","TREQUINSIN","phosphodiesterase inhibitor","PDE5A","","","Tocris, Tocris",96.03,"BRD-K84663978-003-02-9, BRD-K84663978-003-03-7","Phase 1","","MCMSJVMUSBZUCN-YYDJUVGSSA-N","BRD-K84663978","","COc1cc2CCn3c(c\c(=N/c4c(C)cc(C)cc4C)n(C)c3=O)-c2cc1OC"
"5301","TRETAZICAR","DNA replication inhibitor","NQO2","","","Sigma",92.47,"BRD-K08748705-001-08-2","Phase 2","","WOCXQMCIOTUMJV-UHFFFAOYSA-N","BRD-K08748705","","NC(=O)c1cc(N2CC2)c(cc1[N+]([O-])=O)[N+]([O-])=O"
"5302","TRIACETIN","","","","","MicroSource",85.32,"BRD-K92844263-001-09-8","Launched","","URAYPUMNDPQOKB-UHFFFAOYSA-N","BRD-K92844263","","CC(=O)OCC(COC(C)=O)OC(C)=O"
"5303","TRIAPINE","ribonucleotide reductase inhibitor","RRM1, RRM2","","","MedChemEx, Selleck, Selleck",99.17,"BRD-K01669786-001-03-0, BRD-K01669786-001-01-4, BRD-K01669786-001-02-2","Phase 2","","XMYKNCNAZKMVQN-NYYWCZLTSA-N","BRD-K01669786","","NC(=S)N\N=C\c1ncccc1N"
"5306","TRIAZOLAM","GABA benzodiazepine site receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO","","","Enzo",99.47,"BRD-K76890464-001-02-3","Withdrawn","","JOFWLTCLBGQGBO-UHFFFAOYSA-N","BRD-K76890464","","Cc1nnc2CN=C(c3ccccc3Cl)c3cc(Cl)ccc3-n12"
"5307","TRIBENOSIDE","anti-inflammatory agent, capillary stabilizing agent","","","","Prestwick",63.93,"BRD-A60294240-001-03-7","Launched","","ULLNJSBQMBKOJH-VIVFLBMVSA-N","BRD-A60294240","","CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O"
"5308","TRIBOMSALAN","","","","","Vitas-M",97.22,"BRD-K09118247-001-03-3","Preclinical","","KVSKGMLNBAPGKH-UHFFFAOYSA-N","BRD-K09118247","","Oc1c(Br)cc(Br)cc1C(=O)Nc1ccc(Br)cc1"
"5309","TRIBROMOETHANOL","analgesic agent","","","","MicroSource",0,"BRD-K69632891-001-01-3","Preclinical","","YFDSDPIBEUFTMI-UHFFFAOYSA-N","BRD-K69632891","","OCC(Br)(Br)Br"
"5310","TRIBUTYRIN","HDAC inhibitor","","","","Sigma",0,"BRD-K38969488-001-01-6","Phase 1","","UYXTWWCETRIEDR-UHFFFAOYSA-N","BRD-K38969488","","CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC"
"5311","TRICHLORMETHINE","DNA alkylating agent","","","","MicroSource",0,"BRD-K29888499-003-03-8","Preclinical","","FDAYLTPAFBGXAB-UHFFFAOYSA-N","BRD-K29888499","","ClCCN(CCCl)CCCl"
"5312","TRICHLOROETHYLENE","","","","","Sigma, MicroSource",0,"BRD-K46435528-001-05-1, BRD-K46435528-001-04-4","Preclinical","","XSTXAVWGXDQKEL-UHFFFAOYSA-N","BRD-K46435528","","ClC=C(Cl)Cl"
"5314","TRICHOSTATIN-A","HDAC inhibitor","HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","","","Selleck, Selleck",98.67,"BRD-K68202742-001-16-5, BRD-K68202742-001-13-2","Preclinical","","RTKIYFITIVXBLE-QEQCGCAPSA-N","BRD-K68202742","","C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C"
"5316","TRICIRIBINE","AKT inhibitor","AKT1, AKT2, AKT3","","","Tocris, Tocris, Selleck, Selleck",93.15,"BRD-K80431395-001-04-0, BRD-K80431395-001-08-1, BRD-K80431395-001-09-9, BRD-K80431395-001-07-3","Phase 1/Phase 2","BRD-K85975921-001-01-0","HOGVTUZUJGHKPL-HTVVRFAVSA-N","BRD-K80431395","BRD-K85975921","Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23"
"5320","TRICLOCARBAN","other antibiotic","","","","ChemDiv",97.9,"BRD-K25029121-001-05-8","Launched","","ICUTUKXCWQYESQ-UHFFFAOYSA-N","BRD-K25029121","","Clc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1"
"5321","TRICLOSAN","antibacterial agent","DNMT1","","","MicroSource",99.42,"BRD-K41731458-001-15-1","Launched","","XEFQLINVKFYRCS-UHFFFAOYSA-N","BRD-K41731458","","Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl"
"5322","TRIGONELLINE","","","","","Enzo",100,"BRD-K69231085-003-05-7","Phase 1","","WWNNZCOKKKDOPX-UHFFFAOYSA-O","BRD-K69231085","","C[n+]1cccc(c1)C(O)=O"
"5323","TRIM","","","","","Tocris",0,"BRD-K36851334-001-12-1","Preclinical","","WZBWBNCQUTXYEL-UHFFFAOYSA-N","BRD-K36851334","","FC(F)(F)c1ccccc1-n1ccnc1"
"5324","TRIMETHOQUINOL","adrenergic receptor antagonist","ADRB2, ADRB3","","","Sigma",85.22,"BRD-A56241705-003-01-2","Launched","","RGVPOXRFEPSFGH-UHFFFAOYSA-N","BRD-A56241705","","COc1cc(CC2NCCc3cc(O)c(O)cc23)cc(OC)c1OC"
"5325","TRIMETHYLOLPROPANE-TRIACRYLATE","","","","","Sigma",75.72,"BRD-K24483849-001-01-8","Preclinical","","DAKWPKUUDNSNPN-UHFFFAOYSA-N","BRD-K24483849","","CCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C"
"5326","TRIPTAN","serotonin receptor agonist","HTR1B, HTR1D","","","Sigma",0,"BRD-K19427720-001-01-6","Phase 1","","ZISSAWUMDACLOM-UHFFFAOYSA-N","BRD-K19427720","","CC(C)C(C)(C)C"
"5327","TRIPTOLIDE","RNA polymerase inhibitor","RELA","","","Selleck, Tocris",97.24,"BRD-K39484304-001-16-5, BRD-K39484304-001-14-0","Phase 3","BRD-K81258678-001-01-0","DFBIRQPKNDILPW-CIVMWXNOSA-N","BRD-K39484304","BRD-K81258678","CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O"
"5329","TROCLOSENE","","","","","MicroSource",0,"BRD-K76375510-237-01-1","Launched","","CEJLBZWIKQJOAT-UHFFFAOYSA-N","BRD-K76375510","","Cln1c(=O)[nH]c(=O)n(Cl)c1=O"
"5330","TROFINETIDE","cytokine production inhibitor","IFNG, IL6, TNF","","","Sigma",44.1,"BRD-K83502127-001-01-6","Phase 2","","JJGBXTYGTKWGAT-YUMQZZPRSA-N","BRD-K83502127","","NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"5331","TROGLITAZONE","insulin sensitizer, PPAR receptor agonist","ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3","","","Tocris, Enzo",87.12,"BRD-A13084692-001-20-7, BRD-A13084692-001-17-3","Withdrawn","","GXPHKUHSUJUWKP-UHFFFAOYSA-N","BRD-A13084692","","Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O"
"5333","TROLOX","antioxidant","","","","Enzo",76.18,"BRD-A17846016-001-13-9","Launched","","GLEVLJDDWXEYCO-UHFFFAOYSA-N","BRD-A17846016","","Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(O)=O"
"5334","TROMARIL","prostanoid receptor antagonist","","","","Enamine",99.33,"BRD-K91422571-001-01-8","Launched","","HLNLBEFKHHCAMV-UHFFFAOYSA-N","BRD-K91422571","","OC(=O)c1ccccc1NCCc1ccccc1"
"5335","TROMETAMOL","","AMD1, CANT1, DCN, NEIL1, VEGFA","","","MicroSource, Selleck",100,"BRD-K47978074-001-03-2, BRD-K47978074-001-02-4","Launched","","LENZDBCJOHFCAS-UHFFFAOYSA-N","BRD-K47978074","","NC(CO)(CO)CO"
"5337","TROPANYL-3,5-DIMETHYLBENZOATE","serotonin receptor antagonist","HTR3A, HTR3B","","","Tocris",94.98,"BRD-A84389633-001-05-7","Preclinical","","HDDNYFLPWFSBLN-UHFFFAOYSA-N","BRD-A84389633","","CN1C2CCC1CC(C2)OC(=O)c1cc(C)cc(C)c1"
"5338","TROPESIN","cyclooxygenase inhibitor","PTGS1, PTGS2","","","Sigma",99.27,"BRD-A34603619-001-01-9","Launched","","UCCJWNPWWPJKGL-UHFFFAOYSA-N","BRD-A34603619","","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(C(O)=O)c3ccccc3)c2c1"
"5339","TROVAFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","","","Tocris, Enzo",97.94,"BRD-K00494077-066-02-7, BRD-K00494077-066-01-9","Withdrawn","","WVPSKSLAZQPAKQ-CDMJZVDBSA-N","BRD-K00494077","","N[C@H]1[C@@H]2CN(C[C@H]12)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F"
"5341","TROVENTOL","","","","","MatrixSci",95.22,"BRD-A35868371-005-01-6","Phase 1","","QFWSRMACUIYPGS-UHFFFAOYSA-N","BRD-A35868371","","CCC(CO)(C(=O)OC1CC2CCC(C1)[N+]2(C)C)c1ccccc1"
"5342","TROVIRDINE","non-nucleoside reverse transcriptase inhibitor","","","","MedChemEx",96.15,"BRD-K00989047-001-01-2","Phase 1","","HOCFDYZWQYGULA-UHFFFAOYSA-N","BRD-K00989047","","Brc1ccc(NC(=S)NCCc2ccccn2)nc1"
"5343","TROXERUTIN","antioxidant","","","","Selleck, MicroSource, Selleck",90.3,"BRD-K73529671-001-02-9, BRD-K73529671-001-04-5, BRD-K73529671-001-03-7","Launched","BRD-A74160776-001-04-4, BRD-K03928833-001-01-5","IYVFNTXFRYQLRP-VVSTWUKXSA-N","BRD-K73529671","BRD-A74160776","C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O"
"5346","TRV130","opioid receptor agonist","OPRM1","","","MedChemEx",90.27,"BRD-K35626314-003-01-1","Phase 3","","DMNOVGJWPASQDL-OAQYLSRUSA-N","BRD-K35626314","","COc1ccsc1CNCC[C@]1(CCOC2(CCCC2)C1)c1ccccn1"
"5347","TRYPTANTHRIN","cyclooxygenase inhibitor","IDO1","","","Enzo",99.15,"BRD-K76973696-001-12-6","Preclinical","","VQQVWGVXDIPORV-UHFFFAOYSA-N","BRD-K76973696","","O=C1c2ccccc2-n2c1nc1ccccc1c2=O"
"5348","TTNPB","retinoid receptor agonist","RARA, RARB, RARG","","","Tocris, Selleck, Selleck",91.34,"BRD-K49685476-001-15-9, BRD-K49685476-001-14-2, BRD-K49685476-001-16-7","Phase 1","","FOIVPCKZDPCJJY-JQIJEIRASA-N","BRD-K49685476","","C\C(=C/c1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C"
"5351","TTP-22","casein kinase inhibitor","CSNK2A1","","","Tocris",98.64,"BRD-K64852730-001-01-7","Preclinical","","RAOULLCLLOGTDA-UHFFFAOYSA-N","BRD-K64852730","","Cc1ccc(cc1)-c1csc2ncnc(SCCC(O)=O)c12"
"5352","TU-2100","","","","","Vitas-M",98.81,"BRD-K44590731-001-01-7","Phase 2","","LIBAUACOIKWWKP-UHFFFAOYSA-N","BRD-K44590731","","CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc1ccccc1C(=O)OCC"
"5353","TUBASTATIN-A","HDAC inhibitor","HDAC6","","","Selleck, Selleck, Selleck",91.9,"BRD-K00627859-003-03-7, BRD-K00627859-001-07-2, BRD-K00627859-001-06-4","Preclinical","","GOVYBPLHWIEHEJ-UHFFFAOYSA-N","BRD-K00627859","","CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO"
"5356","TUCATINIB","EGFR inhibitor","ERBB2","","","MedChemEx",94.53,"BRD-K26026438-001-01-0","Phase 2","","SDEAXTCZPQIFQM-UHFFFAOYSA-N","BRD-K26026438","","Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1"
"5357","TUG-770","free fatty acid receptor agonist","FFAR1","","","MedChemEx",96.74,"BRD-K56086081-001-01-7","Preclinical","","KIZUBVPJNPVIIN-UHFFFAOYSA-N","BRD-K56086081","","OC(=O)CCc1ccc(cc1F)C#Cc1ccccc1CC#N"
"5358","TUG-891","free fatty acid receptor agonist","FFAR4","","","Tocris",97.49,"BRD-K24282351-001-01-4","Preclinical","","LPGBXHWIQNZEJB-UHFFFAOYSA-N","BRD-K24282351","","Cc1ccc(cc1)-c1ccc(F)cc1COc1ccc(CCC(O)=O)cc1"
"5359","TW-37","BCL inhibitor","BCL2, BCL2L1, MCL1","","","Selleck, Selleck",91.58,"BRD-K28360340-001-08-3, BRD-K28360340-001-05-9","Preclinical","","PQAPVTKIEGUPRN-UHFFFAOYSA-N","BRD-K28360340","","CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O"
"5361","TWS-119","glycogen synthase kinase inhibitor","GSK3B, JUN, MYC","","","Selleck, Tocris",96.31,"BRD-K94176593-001-09-4, BRD-K94176593-362-01-7","Preclinical","","VPVLEBIVXZSOMQ-UHFFFAOYSA-N","BRD-K94176593","","Nc1cccc(c1)-c1cc2c(Oc3cccc(O)c3)ncnc2[nH]1"
"5363","TXA127","angiotensin receptor agonist","","","","MedChemEx, MedChemEx",94.47,"BRD-K36040345-001-02-9, BRD-K36040345-001-01-1","Phase 2","","PVHLMTREZMEJCG-GDTLVBQBSA-N","BRD-K36040345","","CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O"
"5365","TY-52156","sphingosine 1-phosphate receptor antagonist","S1PR3","","","Tocris, MedChemEx, MedChemEx",88.43,"BRD-K66584608-001-02-1, BRD-K66584608-001-03-9, BRD-K66584608-001-01-3","Preclinical","","XONRRGIRSGNWFP-UHFFFAOYSA-N","BRD-K66584608","","CC(C)(C)C(=O)C(\NNc1ccc(Cl)cc1)=N\c1ccc(Cl)cc1"
"5368","TYLOXAPOL","NFkB pathway inhibitor","LPL, NFKB2","","","MedChemEx, Prestwick, MicroSource, MedChemEx",0,"BRD-M08959712-001-02-7, BRD-U25960968-000-01-9, BRD-U48018661-000-01-9, BRD-M08959712-001-01-9","Launched","BRD-K46156294-001-05-5, BRD-M13714491-001-01-8","MDYZKJNTKZIUSK-UHFFFAOYSA-N","BRD-M08959712","BRD-K46156294","C=O.C1CO1.CC(C)(C)CC(C)(C)c1ccc(O)cc1"
"5370","TYRPHOSTIN-AG-1296","FLT3 inhibitor","FLT3","","","Selleck, Selleck",99.83,"BRD-K76064317-001-08-1, BRD-K76064317-001-07-3","Preclinical","","QNOXYUNHIGOWNY-UHFFFAOYSA-N","BRD-K76064317","","COc1cc2ncc(nc2cc1OC)-c1ccccc1"
"5372","TYRPHOSTIN-AG-1478","EGFR inhibitor","EGFR, MAPK14","","","Selleck",98.06,"BRD-K68336408-001-10-9","Preclinical","","GFNNBHLJANVSQV-UHFFFAOYSA-N","BRD-K68336408","","COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC"
"5373","TYRPHOSTIN-AG-18","EGFR inhibitor, tyrosine kinase inhibitor","EGFR","","","Tocris, Selleck, Selleck",87.88,"BRD-K49657628-001-14-8, BRD-K49657628-001-13-0, BRD-K49657628-001-15-5","Preclinical","","VTJXFTPMFYAJJU-UHFFFAOYSA-N","BRD-K49657628","","Oc1ccc(C=C(C#N)C#N)cc1O"
"5376","TYRPHOSTIN-AG-494","EGFR inhibitor","EGFR","","","Tocris",87.72,"BRD-K34533029-001-08-5","Preclinical","","HKHOVJYOELRGMV-XYOKQWHBSA-N","BRD-K34533029","","Oc1ccc(cc1O)\C=C(/C#N)C(=O)Nc1ccccc1"
"5377","TYRPHOSTIN-AG-825","protein tyrosine kinase inhibitor","ERBB2","","","Tocris",67.33,"BRD-K87919739-001-07-5","Preclinical","","KXDONFLNGBQLTN-WUXMJOGZSA-N","BRD-K87919739","","COc1cc(\C=C(/C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O"
"5378","TYRPHOSTIN-AG-835","protein tyrosine kinase inhibitor","EGFR","","","Tocris",93.78,"BRD-K17415526-001-03-5","Preclinical","","UMGQVUWXNOJOSJ-DGGAMASNSA-N","BRD-K17415526","","C[C@H](NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N)c1ccccc1"
"5379","TYRPHOSTIN-AG-879","tyrosine kinase inhibitor","ERBB2, KDR, NTRK1","","","Selleck, Selleck",95.85,"BRD-K59469039-001-09-8, BRD-K59469039-001-08-0","Preclinical","","XRZYELWZLNAXGE-KPKJPENVSA-N","BRD-K59469039","","CC(C)(C)c1cc(cc(c1O)C(C)(C)C)\C=C(/C#N)C(N)=S"
"5381","TYRPHOSTIN-AG-99","tyrosine kinase inhibitor","EGFR","","","Tocris",96.88,"BRD-K60184833-001-05-6","Preclinical","","USOXQZNJFMKTKJ-XVNBXDOJSA-N","BRD-K60184833","","NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N"
"5382","TYRPHOSTIN-A9","protein tyrosine kinase inhibitor, tyrosine kinase inhibitor","","","","Selleck",94.87,"BRD-K40255344-001-17-6","Preclinical","","MZOPWQKISXCCTP-UHFFFAOYSA-N","BRD-K40255344","","CC(C)(C)c1cc(C=C(C#N)C#N)cc(c1O)C(C)(C)C"
"5383","U-0124","MEK inhibitor","","","","Tocris",94.09,"BRD-K63169195-001-01-5","Preclinical","","LBQNBMSPTURKGS-KQQUZDAGSA-N","BRD-K63169195","","CS\C(N)=C(C#N)\C(C#N)=C(/N)SC"
"5384","U-0126","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Selleck",93.15,"BRD-K91701654-001-03-1, BRD-K18787491-001-08-6, BRD-K91701654-001-02-3","Preclinical","BRD-M37437038-001-01-8, BRD-M92812175-001-01-7","DVEXZJFMOKTQEZ-MJZABRMRSA-N","BRD-K91701654","BRD-M37437038","N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(/N)Sc1ccccc1N"
"5385","U-0126","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Selleck",93.15,"BRD-K91701654-001-03-1, BRD-K18787491-001-08-6, BRD-K91701654-001-02-3","Preclinical","BRD-M37437038-001-01-8, BRD-M92812175-001-01-7","DVEXZJFMOKTQEZ-MJZABRMRSA-N","BRD-K91701654","BRD-M37437038","N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1N"
"5387","U-0126","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Selleck",93.15,"BRD-K91701654-001-03-1, BRD-K18787491-001-08-6, BRD-K91701654-001-02-3","Preclinical","BRD-M37437038-001-01-8, BRD-M92812175-001-01-7","DVEXZJFMOKTQEZ-JYFOCSDGSA-N","BRD-K91701654","BRD-M37437038","N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(/N)Sc1ccccc1N"
"5388","U-0126","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Selleck, Tocris, Selleck",93.15,"BRD-K91701654-001-03-1, BRD-K18787491-001-08-6, BRD-K91701654-001-02-3","Preclinical","BRD-M37437038-001-01-8, BRD-M92812175-001-01-7","DVEXZJFMOKTQEZ-JYFOCSDGSA-N","BRD-K91701654","BRD-M37437038","N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1N"
"5390","U-0521","catechol O methyltransferase inhibitor","COMT","","","SantaCruz",98.18,"BRD-K08953028-001-09-6","Preclinical","","VDQLKIBLTMPAHI-UHFFFAOYSA-N","BRD-K08953028","","CC(C)C(=O)c1ccc(O)c(O)c1"
"5391","U-104","carbonic anhydrase inhibitor","CA1, CA12, CA2, CA9","","","Selleck, Tocris",96.73,"BRD-K77867004-001-02-7, BRD-K77867004-001-03-5","Preclinical","","YJQZNWPYLCNRLP-UHFFFAOYSA-N","BRD-K77867004","","NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1"
"5393","U-18666A","oxidosqualene cyclase inhibitor","","","","Tocris",99.54,"BRD-K22025381-003-01-9","Preclinical","","DMZCCFMMPHJWQY-BKWLFHPQSA-N","BRD-K22025381","","CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1"
"5394","U-50488-(-)","opioid receptor agonist","OPRK1","","","Tocris, Tocris, Tocris",97.11,"BRD-K53532120-003-10-3, BRD-K53532120-003-11-1, BRD-K53532120-003-09-5","Preclinical","BRD-M57185017-300-01-9","VQLPLYSROCPWFF-ROUUACIJSA-N","BRD-K53532120","BRD-M57185017","CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1"
"5397","U-54494A","opioid receptor agonist","OPRK1","","","Tocris",96.38,"BRD-K20995441-001-02-5","Preclinical","","JUBNVWGVNWIXMB-SJORKVTESA-N","BRD-K20995441","","CN([C@@H]1CCCC[C@@H]1N1CCCC1)C(=O)c1ccc(Cl)c(Cl)c1"
"5398","U-75799E","growth hormone releasing factor agonist","GHSR","","","Adooq",86.33,"BRD-K77070363-001-01-5","Phase 1","","WZHKXNSOCOQYQX-FUAFALNISA-N","BRD-K77070363","","C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O"
"5399","U-99194","dopamine receptor antagonist","DRD3","","","Tocris",94.8,"BRD-K70281171-050-08-9","Preclinical","","UOLJKAPABHXFRE-UHFFFAOYSA-N","BRD-K70281171","","CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1"
"5400","UAMC-00039","dipeptidyl peptidase inhibitor","DPP4, DPP7","","","Tocris",84.99,"BRD-K38966689-300-01-5","Preclinical","","DNVZYSMOLXCOLY-HNNXBMFYSA-N","BRD-K38966689","","N[C@@H](CCNCc1ccc(Cl)cc1)C(=O)N1CCCCC1"
"5401","UB-165","acetylcholine receptor agonist","CHRNA3, CHRNA4, CHRNB2","","","Tocris, Tocris",90.79,"BRD-A14574269-051-03-0, BRD-A14574269-051-02-2","Preclinical","","TVSNVPGPFGAKPT-UHFFFAOYSA-N","BRD-A14574269","","Clc1ccc(cn1)C1=CCCC2CCC1N2"
"5403","UBP-296","glutamate receptor antagonist","GRIK1","","","Tocris",76.19,"BRD-A45499626-001-03-6","Preclinical","","UUIYULWYHDSXHL-UHFFFAOYSA-N","BRD-A45499626","","NC(Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O"
"5404","UBP-302","glutamate receptor antagonist","GRIK1","","","Tocris, Tocris, Tocris",96.2,"BRD-K79753741-001-02-5, BRD-K79753741-001-03-3, BRD-K79753741-001-01-7","Preclinical","","UUIYULWYHDSXHL-NSHDSACASA-N","BRD-K79753741","","N[C@@H](Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O"
"5407","UBP-310","glutamate receptor antagonist","GRIK1, GRIK5","","","Tocris",66.8,"BRD-K09597601-001-01-2","Preclinical","","ZTAZUCRXCRXNSU-VIFPVBQESA-N","BRD-K09597601","","Cc1cn(C[C@H](N)C(O)=O)c(=O)n(Cc2ccsc2C(O)=O)c1=O"
"5408","UC-112","XIAP inhibitor","XIAP","","","Tocris",85.21,"BRD-K73610817-001-09-7","Preclinical","","LTGLGIQQZXSLLF-UHFFFAOYSA-N","BRD-K73610817","","Oc1c(CN2CCCC2)cc(COCc2ccccc2)c2cccnc12"
"5409","UCL-2077","slow afterhyperpolarization channel blocker","","","","Tocris, Tocris",99.33,"BRD-K50325075-001-02-1, BRD-K50325075-001-03-9","Preclinical","","PQFNWDHABGBCHB-UHFFFAOYSA-N","BRD-K50325075","","C(NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1"
"5411","UF-010","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC8","","","Tocris",76.99,"BRD-K20480395-001-01-6","Preclinical","","BVQCFCYPFJOOAV-UHFFFAOYSA-N","BRD-K20480395","","CCCCNNC(=O)c1ccc(Br)cc1"
"5412","UH-232-(+)","dopamine receptor antagonist","DRD2, DRD3, DRD4, HTR1A","","","Tocris",90.44,"BRD-K66715657-050-01-0","Preclinical","","BTOJYCTUJJHANF-WMLDXEAASA-N","BRD-K66715657","","CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C"
"5413","UK-356618","metalloproteinase inhibitor","MMP13, MMP14, MMP2, MMP3, MMP9","","","Tocris",89.38,"BRD-K57011718-001-02-3","Preclinical","","JJHRUUKMPWUYIB-HVOSOHGQSA-N","BRD-K57011718","","C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCc1ccc(c(C)c1)-c1ccccc1)CC(=O)NO)C(C)(C)C)c1ccccc1"
"5414","UK-383367","Procollagen C-Endopeptidase Inhibitors","BMP1","","","Tocris, Selleck, Selleck",95.33,"BRD-K06294530-001-03-1, BRD-K06294530-001-01-5, BRD-K06294530-001-02-3","Phase 1","","ARJCBSRIPGJMAD-LLVKDONJSA-N","BRD-K06294530","","NC(=O)c1noc(n1)[C@H](CCCC1CCCCC1)CC(=O)NO"
"5417","UK-5099","monocarboxylate transporter inhibitor","SLC16A1","","","Tocris",90.92,"BRD-K19558579-001-01-0","Preclinical","","BIZNHCWFGNKBBZ-JLHYYAGUSA-N","BRD-K19558579","","OC(=O)C(=C\c1cn(-c2ccccc2)c2ccccc12)\C#N"
"5418","ULIFLOXACIN","","","","","AKSci, Ark",79.96,"BRD-A61633223-001-01-0, BRD-A61633223-001-02-8","Launched","","SUXQDLLXIBLQHW-UHFFFAOYSA-N","BRD-A61633223","","CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCNCC1"
"5420","UNBS-5162","CC chemokine receptor antagonist","","","","MedChemEx",97.44,"BRD-K30933884-001-01-0","Phase 1","","WCKZRLOUKYFJDY-UHFFFAOYSA-N","BRD-K30933884","","CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(C1=O)c23"
"5421","UNC-2327","protein arginine N-methyltransferase inhibitor","PRMT3","","","Tocris",97.06,"BRD-K60635008-001-01-5","Preclinical","","MYTRGTBDVGKKRO-UHFFFAOYSA-N","BRD-K60635008","","O=C(NCC(=O)N1CCCCC1)Nc1ccc2nnsc2c1"
"5422","UNC-3230","phosphatidyl-inositol activator","PIP5K1C","","","Tocris",96.42,"BRD-K46344388-001-01-3","Preclinical","","RZCNASHHHSKTGP-UHFFFAOYSA-N","BRD-K46344388","","NC(=O)c1nc(Nc2ccccc2)sc1NC(=O)C1CCCCC1"
"5423","UNC-926","MBT inhibitor","L3MBTL1","","","Tocris",95.92,"BRD-K22229656-003-01-5","Preclinical","","OWGLFIKZKQOYHZ-UHFFFAOYSA-N","BRD-K22229656","","Brc1cccc(c1)C(=O)N1CCC(CC1)N1CCCC1"
"5424","UNC0224","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","Tocris, Tocris",93.47,"BRD-K77428767-001-01-7, BRD-K77428767-001-02-5","Preclinical","","XIVUGRBSBIXXJE-UHFFFAOYSA-N","BRD-K77428767","","COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCCN(C)C)N1CCCN(C)CC1"
"5426","UNC0321","histone lysine methyltransferase inhibitor","EHMT2","","","MedChemEx, MedChemEx",91.24,"BRD-K74236984-001-04-8, BRD-K74236984-001-05-5","Preclinical","","AULLUGALUBVBDD-UHFFFAOYSA-N","BRD-K74236984","","COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCOCCN(C)C)N1CCCN(C)CC1"
"5428","UNC0631","histone lysine methyltransferase inhibitor","EHMT2","","","MedChemEx, MedChemEx",96.26,"BRD-K13060017-001-01-3, BRD-K13060017-001-02-1","Preclinical","","XFAXSWXKPQWHDW-UHFFFAOYSA-N","BRD-K13060017","","COc1cc2c(NC3CCN(CC4CCCCC4)CC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C"
"5430","UNC0638","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","MedChemEx, MedChemEx, Tocris",94.36,"BRD-K86856088-001-06-9, BRD-K86856088-001-07-7, BRD-K86856088-001-08-5","Preclinical","","QOECJCJVIMVJGX-UHFFFAOYSA-N","BRD-K86856088","","COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1"
"5433","UNC0642","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","MedChemEx, MedChemEx, Tocris",97.06,"BRD-K60130390-001-02-1, BRD-K60130390-001-03-9, BRD-K60130390-001-04-7","Preclinical","","RNAMYOYQYRYFQY-UHFFFAOYSA-N","BRD-K60130390","","COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)N1CCC(F)(F)CC1"
"5436","UNC0646","histone lysine methyltransferase inhibitor","EHMT2","","","MedChemEx, MedChemEx, Tocris",90.65,"BRD-K87465484-001-02-7, BRD-K87465484-001-03-5, BRD-K87465484-001-04-3","Preclinical","","OUKWLRHRXOPODD-UHFFFAOYSA-N","BRD-K87465484","","COc1cc2c(NC3CCN(CC3)C3CCCCC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C"
"5439","UNC0737","histone lysine methyltransferase inhibitor","EHMT1, EHMT2","","","SGC",82.62,"BRD-K02988401-001-01-2","Preclinical","","ATORKVYCKKBNTF-UHFFFAOYSA-N","BRD-K02988401","","COc1cc2c(nc(nc2cc1OCCCN1CCCC1)C1CCCCC1)N(C)C1CCN(CC1)C(C)C"
"5440","UNC1215","L3MBTL antagonist","L3MBTL3","","","Selleck, Selleck",93.94,"BRD-K83189926-001-03-1, BRD-K83189926-001-04-9","Preclinical","","PQOOIERVZAXHBP-UHFFFAOYSA-N","BRD-K83189926","","O=C(N1CCC(CC1)N1CCCC1)c1ccc(C(=O)N2CCC(CC2)N2CCCC2)c(Nc2ccccc2)c1"
"5442","UNC1999","histone lysine methyltransferase inhibitor","EZH2","","","Selleck, Selleck, Tocris",96.39,"BRD-K26989966-001-04-3, BRD-K26989966-001-03-5, BRD-K26989966-001-05-0","Preclinical","","DPJNKUOXBZSZAI-UHFFFAOYSA-N","BRD-K26989966","","CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2n(ncc12)C(C)C)-c1ccc(nc1)N1CCN(CC1)C(C)C"
"5445","UNC2025","MER tyrosine kinase inhibitor, FLT3 inhibitor","FLT3, MERTK","","","MedChemEx",96.41,"BRD-K91283740-003-01-6","Preclinical","","MJSHVHLADKXCML-RQNOJGIXSA-N","BRD-K91283740","","CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1"
"5446","UNC2250","MER tyrosine kinase inhibitor","MERTK","","","Selleck, Selleck",95.44,"BRD-K01773560-001-01-6, BRD-K01773560-001-02-4","Preclinical","","HSYSSKFCQHXOBP-MXVIHJGJSA-N","BRD-K01773560","","CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1"
"5448","UNC669","L3MBTL antagonist","L3MBTL1","","","Selleck, Selleck",95.32,"BRD-K21906513-001-03-2, BRD-K21906513-001-04-0","Preclinical","","CQERVFFAOOUFEQ-UHFFFAOYSA-N","BRD-K21906513","","Brc1cncc(c1)C(=O)N1CCC(CC1)N1CCCC1"
"5450","UPF-1069","PARP inhibitor","PARP2","","","Tocris, Tocris, Selleck",97.99,"BRD-K77950083-001-03-3, BRD-K77950083-001-04-1, BRD-K77950083-001-02-5","Preclinical","","JJWMRRNGWSITSQ-UHFFFAOYSA-N","BRD-K77950083","","O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1"
"5453","UPROSERTIB","AKT inhibitor","AKT1, AKT2, AKT3","","","MedChemEx",87.27,"BRD-K38332599-001-01-3","Phase 2","","AXTAPYRUEKNRBA-JTQLQIEISA-N","BRD-K38332599","","Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@H](CN)Cc1ccc(F)c(F)c1"
"5454","URACIL","","DPYD, UCKL1","","","Selleck, MicroSource",100,"BRD-K80129304-001-08-1, BRD-K80129304-001-09-9","Launched","","ISAKRJDGNUQOIC-UHFFFAOYSA-N","BRD-K80129304","","Oc1ccnc(O)n1"
"5456","URB597","FAAH inhibitor","FAAH, FAAH2, TRPA1","","","Tocris, Selleck, Selleck",80.92,"BRD-K92169341-001-12-0, BRD-K92169341-001-11-2, BRD-K92169341-001-10-4","Phase 1","","ROFVXGGUISEHAM-UHFFFAOYSA-N","BRD-K92169341","","NC(=O)c1cccc(c1)-c1cccc(OC(=O)NC2CCCCC2)c1"
"5459","URETHANE","local anesthetic","","","","MicroSource",0,"BRD-K24297741-001-05-2","Preclinical","","JOYRKODLDBILNP-UHFFFAOYSA-N","BRD-K24297741","","CCOC(N)=O"
"5460","URIC-ACID","","PYGL","","","Enamine",100,"BRD-K01295354-001-02-8","Phase 3","","LEHOTFFKMJEONL-UHFFFAOYSA-N","BRD-K01295354","","O=c1[nH]c2[nH]c(=O)[nH]c(=O)c2[nH]1"
"5461","URIDINE","dopamine receptor agonist","LSM6, TYMP","","","Selleck, Selleck",97.91,"BRD-K13050303-001-18-1, BRD-K13050303-001-17-3","Phase 2","BRD-K32566431-001-01-4","DRTQHJPVMGBUCF-XVFCMESISA-N","BRD-K13050303","BRD-K32566431","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O"
"5463","URIDINE-5'-TRIPHOSPHATE","purinergic receptor activator","P2RY11, P2RY2, P2RY4, P2RY6, UCK2","","","Sigma",0,"BRD-A89637065-001-01-0","Launched","","PGAVKCOVUIYSFO-XVFCMESISA-N","BRD-A89637065","","O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O"
"5464","URMC-099","mixed lineage kinase inhibitor","CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2","","","MedChemEx",91.98,"BRD-K66908976-001-01-8","Preclinical","","QKKIWEILHCXECO-UHFFFAOYSA-N","BRD-K66908976","","CN1CCN(Cc2ccc(cc2)-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)CC1"
"5465","URSODEOXYCHOLYLTAURINE","cholesterol inhibitor","","","","Enzo",100,"BRD-K45245728-335-01-4","Phase 2","","BHTRKEVKTKCXOH-LBSADWJPSA-N","BRD-K45245728","","C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"5466","URSOLIC-ACID","ATPase inhibitor, NFkB pathway inhibitor, STAT inhibitor","HSD11B1, PLA2G1B, PTPN1, PYGM","","","Sigma, Selleck",90.07,"BRD-K68185022-001-12-2, BRD-K68185022-001-14-8","Phase 1","BRD-A61767428-001-01-9","WCGUUGGRBIKTOS-GPOJBZKASA-N","BRD-K68185022","BRD-A61767428","C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O"
"5468","USNIACIN-(+)","MAP kinase activator","PTPN1","","","Selleck, Selleck",92.95,"BRD-A12417644-001-07-6, BRD-A12417644-001-06-8","Preclinical","BRD-A99182808-001-04-1, BRD-A99182808-001-03-3","CUCUKLJLRRAKFN-MCEAHNFKSA-N","BRD-A12417644","BRD-A99182808","CC(=O)C1C(=O)C=C2Oc3c(c(O)c(C)c(O)c3C(C)=O)[C@@]2(C)C1=O"
"5470","V-51","adrenergic receptor antagonist","","","","ChemBridge",98.78,"BRD-K75052463-001-01-4","Phase 1","","KKCOGNFFBYOKMA-UHFFFAOYSA-N","BRD-K75052463","","COc1cc(CN2CCN(CC2)c2ccc(F)cc2)cc(OC)c1OC"
"5471","VAL","","BCAT1, PCCB, VARS","","","Enzo",100,"BRD-K59424860-001-01-4","Phase 2","","KZSNJWFQEVHDMF-SCSAIBSYSA-N","BRD-K59424860","","CC(C)[C@@H](N)C(O)=O"
"5472","VALDECOXIB","cyclooxygenase inhibitor","CA12, PTGS2","","","Tocris, Selleck",98.16,"BRD-K12994359-001-19-2, BRD-K12994359-001-18-4","Withdrawn","","LNPDTQAFDNKSHK-UHFFFAOYSA-N","BRD-K12994359","","Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1"
"5474","VALNOCTAMIDE","arachidonic acid acylation inhibitor, benzodiazepine receptor agonist","","","","Sigma",61.43,"BRD-A96644976-001-01-5","Phase 3","","QRCJOCOSPZMDJY-UHFFFAOYSA-N","BRD-A96644976","","CCC(C)C(CC)C(N)=O"
"5475","VALROCEMIDE","","","","","Enamine",99,"BRD-K32804101-001-01-8","Phase 2","","RALGCAOVRLYSMA-UHFFFAOYSA-N","BRD-K32804101","","CCCC(CCC)C(=O)NCC(N)=O"
"5476","VALSPODAR","P glycoprotein inhibitor","ABCB1","","","MedChemEx, MedChemEx",43.76,"BRD-K19412342-001-01-6, BRD-K19412342-001-02-4","Phase 3","","YJDYDFNKCBANTM-QCWCSKBGSA-N","BRD-K19412342","","C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C"
"5478","VANILLIN","","ABAT, ALDH5A1","","","Selleck",93.59,"BRD-K24258499-001-05-8","Preclinical","","MWOOGOJBHIARFG-UHFFFAOYSA-N","BRD-K24258499","","COc1cc(C=O)ccc1O"
"5479","VANILLYLACETONE","","","","","Selleck, Selleck",98.97,"BRD-K33510429-001-03-1, BRD-K33510429-001-02-3","Preclinical","","OJYLAHXKWMRDGS-UHFFFAOYSA-N","BRD-K33510429","","COc1cc(CCC(C)=O)ccc1O"
"5481","VANITIOLIDE","","","","","MicroSource",92.27,"BRD-K26502378-001-07-9","Preclinical","","WQYRHRAZNNRDIA-UHFFFAOYSA-N","BRD-K26502378","","COc1cc(ccc1O)C(=S)N1CCOCC1"
"5482","VANOXERINE","dopamine uptake inhibitor","SLC6A3","","","Tocris, Tocris",96.73,"BRD-K32501161-300-07-0, BRD-K32501161-300-06-2","Phase 3","","NAUWTFJOPJWYOT-UHFFFAOYSA-N","BRD-K32501161","","Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1"
"5484","VARESPLADIB","secretory phospholipase inhibitor","PLA2G2A","","","Selleck",98.89,"BRD-K09711437-001-04-3","Phase 3","","BHLXTPHDSZUFHR-UHFFFAOYSA-N","BRD-K09711437","","CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1"
"5485","VATALANIB","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR, PDGFRB","","","Selleck, Selleck, Tocris",99.48,"BRD-K70163715-300-05-7, BRD-K70163715-300-04-0, BRD-K70163715-036-01-6","Phase 3","","YCOYDOIWSSHVCK-UHFFFAOYSA-N","BRD-K70163715","","Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1"
"5488","VBY-825","cathepsin inhibitor","CTSB, CTSL, CTSS","","","MedChemEx, MedChemEx",83.23,"BRD-K36338614-001-01-3, BRD-K36338614-001-02-1","Preclinical","","PPUXXDKQNAHHON-BJLQDIEVSA-N","BRD-K36338614","","CC[C@H](NC(=O)[C@H](CS(=O)(=O)CC1CC1)N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1"
"5490","VCH-916","HCV inhibitor","","","","MedChemEx",98.31,"BRD-K75956464-237-01-5","Phase 1","","LNYKGELUODVSNS-YSXIEMCBSA-N","BRD-K75956464","","CO[C@H]1CC[C@@H](CC1)N(C(=O)[C@H]1CC[C@H](C)CC1)c1cc(sc1C(O)=O)C1=CCCCC1"
"5491","VE-821","ATR kinase inhibitor","ATR","","","Selleck",97.3,"BRD-K26756394-001-02-2","Preclinical","","DUIHHZKTCSNTGM-UHFFFAOYSA-N","BRD-K26756394","","CS(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1ccccc1"
"5492","VE-822","ATR kinase inhibitor","ATM, ATR, MTOR, PIK3CG","","","MedChemEx, Selleck, Selleck",88.53,"BRD-K04701033-001-04-7, BRD-K04701033-001-01-3, BRD-K04701033-001-03-9","Phase 2","","JZCWLJDSIRUGIN-UHFFFAOYSA-N","BRD-K04701033","","CNCc1ccc(cc1)-c1cc(on1)-c1nc(cnc1N)-c1ccc(cc1)S(=O)(=O)C(C)C"
"5495","VELIFLAPON","leukotriene synthesis inhibitor","ALOX5AP","","","Sigma",99.55,"BRD-K12852738-001-01-2","Phase 3","","ZEYYDOLCHFETHQ-JOCHJYFZSA-N","BRD-K12852738","","OC(=O)[C@H](C1CCCC1)c1ccc(OCc2ccc3ccccc3n2)cc1"
"5496","VELIPARIB","PARP inhibitor","PARP1, PARP2","","","Selleck",96.52,"BRD-K12737986-001-01-4","Phase 3","","JNAHVYVRKWKWKQ-ZDUSSCGKSA-N","BRD-K12737986","","C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O"
"5497","VELNEPERIT","neuropeptide receptor antagonist","NPY5R","","","MedChemEx, MedChemEx",84.28,"BRD-K06357403-001-02-2, BRD-K06357403-001-01-4","Phase 2","","WGEWUYACXPEFPO-AULYBMBSSA-N","BRD-K06357403","","CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc1ccc(cn1)C(F)(F)F"
"5499","VER-155008","HSP inhibitor","HSPA1A","","","Tocris",92.19,"BRD-K32330832-001-02-8","Preclinical","","ZXGGCBQORXDVTE-UMCMBGNQSA-N","BRD-K32330832","","Nc1ncnc2n([C@@H]3O[C@H](COCc4ccc(cc4)C#N)[C@@H](O)[C@H]3O)c(NCc3ccc(Cl)c(Cl)c3)nc12"
"5500","VER-49009","HSP inhibitor","HSP90AA1","","","Selleck",97.34,"BRD-K38548312-001-01-0","Preclinical","BRD-K20177260-001-01-0","HUNAOTXNHVALTN-UHFFFAOYSA-N","BRD-K38548312","BRD-K20177260","CCNC(=O)c1[nH]nc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O"
"5501","VERBASCOSIDE","PKC inhibitor, NFkB pathway inhibitor","","","","MedChemEx",79.95,"BRD-K36201510-001-06-7","Phase 2/Phase 3","","FBSKJMQYURKNSU-ZLSOWSIRSA-N","BRD-K36201510","","C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O"
"5502","VERCIRNON","CC chemokine receptor antagonist","CCR9","","","MedChemEx",95.9,"BRD-K47929404-001-01-0","Phase 3","","JRWROCIMSDXGOZ-UHFFFAOYSA-N","BRD-K47929404","","CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)cc1C(=O)c1cc[n+]([O-])cc1"
"5503","VERINURAD","urate transporter inhibitor","SLC22A12","","","MedChemEx",98.04,"BRD-K36741660-001-01-1","Phase 2","","YYBOLPLTQDKXPM-UHFFFAOYSA-N","BRD-K36741660","","CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(O)=O"
"5504","VERUBULIN","tubulin polymerization inhibitor","TUBB","","","Key, Tocris",99.3,"BRD-K42673188-001-01-1, BRD-K42673188-003-01-7","Phase 2","","SNHCRNMVYDHVDT-UHFFFAOYSA-N","BRD-K42673188","","COc1ccc(cc1)N(C)c1nc(C)nc2ccccc12"
"5506","VESAMICOL","acetylcholinesterase inhibitor","SLC18A3","","","Tocris, Tocris",97.14,"BRD-K14765469-003-13-0, BRD-K14765469-003-12-2","Preclinical","","YSSBJODGIYRAMI-IAGOWNOFSA-N","BRD-K14765469","","O[C@@H]1CCCC[C@H]1N1CCC(CC1)c1ccccc1"
"5508","VGX-1027","tumor necrosis factor receptor antagonist","TLR4","","","Selleck",97.76,"BRD-A32269193-001-01-5","Phase 1","","MUFJHYRCIHHATF-UHFFFAOYSA-N","BRD-A32269193","","OC(=O)CC1CC(=NO1)c1ccccc1"
"5509","VICRIVIROC","CC chemokine receptor antagonist","CCR5","","","MedChemEx",97.42,"BRD-K84748119-050-01-1","Phase 3","","CNPVJJQCETWNEU-CYFREDJKSA-N","BRD-K84748119","","COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F"
"5510","VINCAMINE","adrenergic receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","","","MicroSource",93.79,"BRD-K89704198-001-12-3","Withdrawn","","RXPRRQLKFXBCSJ-HLAWJBBLSA-N","BRD-K89704198","","CC[C@@]12CCCN3CCc4c([C@H]13)n(c1ccccc41)[C@@](O)(C2)C(=O)OC"
"5511","VINPOCETINE","phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C","","","MicroSource, Tocris, Selleck",98.68,"BRD-K53318339-001-24-9, BRD-K53318339-001-23-1, BRD-K53318339-001-26-4","Launched","BRD-K25429851-001-01-5","DDNCQMVWWZOMLN-IRLDBZIGSA-N","BRD-K53318339","BRD-K25429851","CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41"
"5514","VIPADENANT","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","MedChemEx",94.33,"BRD-K56565215-001-01-9","Phase 1","","HQSBCDPYXDGTCL-UHFFFAOYSA-N","BRD-K56565215","","Cc1cc(Cn2nnc3c(nc(N)nc23)-c2ccco2)ccc1N"
"5515","VITAMIN-E","PKC inhibitor, LDL oxidation inhibitor","ALOX5, DGKA, NR1I2, PPP2CA, PPP2CB, PRKCA, PRKCB, SEC14L2, SEC14L3, SEC14L4","","","CombiBlocks",0,"BRD-K97091514-001-11-4","Phase 2/Phase 3","","GVJHHUAWPYXKBD-IEOSBIPESA-N","BRD-K97091514","","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1"
"5516","VLX-600","antitumor agent","TP53","","","Enamine",87.51,"BRD-K26122255-001-01-7","Phase 1","","CWLQNPHAUWMLEE-UHFFFAOYSA-N","BRD-K26122255","","Cc1cccc2c1[nH]c1nc(NNC(=C)c3ccccn3)nnc21"
"5517","VLX600","ubiquitin C-terminal hydrolase inhibitor","USP14","","","ChemDiv",86.93,"BRD-K89053832-001-01-0","Phase 1","","UQOSBPRTQFFUOA-NHDPSOOVSA-N","BRD-K89053832","","C\C(=N\Nc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1"
"5518","VOLASERTIB","PLK inhibitor","PLK1","","","MedChemEx, Selleck",95.76,"BRD-K69776681-001-06-1, BRD-K69776681-001-03-8","Phase 3","","SXNJFOWDRLKDSF-STROYTFGSA-N","BRD-K69776681","","CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2N(C)C1=O"
"5520","VOLINANSERIN","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C, KCNH2","","","Tocris, Cayman",98.59,"BRD-K23647661-001-03-0, BRD-K23647661-001-02-2","Phase 3","","HXTGXYRHXAGCFP-OAQYLSRUSA-N","BRD-K23647661","","COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC"
"5522","VORELOXIN","topoisomerase inhibitor","TOP2A","","","MedChemEx",93.26,"BRD-K23677682-003-01-2","Phase 3","","XZAFZXJXZHRNAQ-STQMWFEESA-N","BRD-K23677682","","CN[C@H]1CN(C[C@@H]1OC)c1ccc2c(n1)n(cc(C(O)=O)c2=O)-c1nccs1"
"5523","VOXTALISIB","mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA","","","MedChemEx",99.19,"BRD-K56291712-001-01-0","Phase 2","","RGHYDLZMTYDBDT-UHFFFAOYSA-N","BRD-K56291712","","CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O"
"5524","VP-20629","beta amyloid antagonist","PLA2G2E, SLC36A1","","","ChemDiv",99.13,"BRD-K21071223-001-02-8","Phase 1","","GOLXRNDWAUTYKT-UHFFFAOYSA-N","BRD-K21071223","","OC(=O)CCc1c[nH]c2ccccc12"
"5525","VS-4718","focal adhesion kinase inhibitor","","","","MedChemEx",98.41,"BRD-K09877029-001-01-2","Phase 1","","IGUBBWJDMLCRIK-UHFFFAOYSA-N","BRD-K09877029","","CNC(=O)c1ccccc1Nc1cc(Nc2ccc(cc2OC)N2CCOCC2)ncc1C(F)(F)F"
"5526","VT-464","cytochrome P450 inhibitor","CYP17A1","","","MedChemEx",98.44,"BRD-K72005722-001-01-2","Phase 2","","ZBRAJOQFSNYJMF-SFHVURJKSA-N","BRD-K72005722","","CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1"
"5527","VTP-27999","renin inhibitor","REN","","","MedChemEx",92.33,"BRD-K81694556-003-01-9","Phase 1","","NXWASIVXQMMPLM-ZXMXYHOLSA-N","BRD-K81694556","","CN[C@H](CNC(=O)N1CCC[C@H](C1)[C@@H](OCCNC(=O)OC)c1cccc(Cl)c1)C[C@H]1CCCOC1"
"5528","VU-0240551","potassium/chloride cotransporter inhibitor","SLC12A5","","","MedChemEx",97.16,"BRD-K27074404-001-08-4","Preclinical","","WJRWSLORVIHRNX-UHFFFAOYSA-N","BRD-K27074404","","Cc1csc(NC(=O)CSc2ccc(nn2)-c2ccccc2)n1"
"5529","VU-0364739","phospholipase inhibitor","PLD2","","","Tocris",95.98,"BRD-K93317811-003-02-2","Preclinical","","MSTXJJGAXXJCBY-UHFFFAOYSA-N","BRD-K93317811","","Fc1cccc(c1)N1CNC(=O)C11CCN(CCNC(=O)c2ccc3ccccc3c2)CC1"
"5530","VU-0422288","glutamate receptor allosteric modulator","GRM3","","","Tocris",96.47,"BRD-K68674163-001-01-7","Preclinical","","MZRLPXFGQKQHST-UHFFFAOYSA-N","BRD-K68674163","","Clc1ccc(Oc2ccc(NC(=O)c3ccccn3)cc2Cl)nc1"
"5531","VU-152100","acetylcholine receptor allosteric modulator","CHRM4","","","Tocris",93.58,"BRD-K87727457-001-01-5","Preclinical","","MDNWGCQSCGNTKH-UHFFFAOYSA-N","BRD-K87727457","","COc1ccc(CNC(=O)c2sc3nc(C)cc(C)c3c2N)cc1"
"5532","VUF10166","serotonin receptor antagonist","HTR3A, HTR3B","","","Selleck",94.56,"BRD-K11046126-001-02-0","Preclinical","","FFXVTQDGTKEXHF-UHFFFAOYSA-N","BRD-K11046126","","CN1CCN(CC1)c1nc2ccccc2nc1Cl"
"5533","VUF10460","histamine receptor agonist","HRH4","","","Tocris",96.93,"BRD-K90082312-001-01-5","Preclinical","","NIJGWJIOMPHDBP-UHFFFAOYSA-N","BRD-K90082312","","CN1CCN(CC1)c1cc(nc(N)n1)-c1ccccc1"
"5534","VUF11207","CC chemokine receptor agonist","ACKR3","","","Tocris",97.09,"BRD-A93717708-051-01-2","Preclinical","","JVRRRKAXHMGUHZ-XDJHFCHBSA-N","BRD-A93717708","","COc1cc(cc(OC)c1OC)C(=O)N(CCC1CCCN1C)C\C(C)=C\c1ccccc1F"
"5535","VU0155069","phospholipase inhibitor","PLD1","","","Tocris, Tocris",97.48,"BRD-K48535733-003-01-2, BRD-K48535733-003-02-0","Preclinical","","DRIMIUYGTDAQOX-KRWDZBQOSA-N","BRD-K48535733","","C[C@@H](CN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O)NC(=O)c1ccc2ccccc2c1"
"5537","VU0238429","acetylcholine receptor allosteric modulator","CHRM5","","","Tocris, Tocris",95.11,"BRD-K24187789-001-01-7, BRD-K24187789-001-02-5","Preclinical","","CKLGZXFOLMHCMC-UHFFFAOYSA-N","BRD-K24187789","","COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc23)cc1"
"5539","VU0357121","glutamate receptor positive allosteric modulator","GRM5","","","Selleck",97.46,"BRD-K86109159-001-02-6","Preclinical","","AHCYOTLTLQTPSU-UHFFFAOYSA-N","BRD-K86109159","","CCCCOc1ccc(cc1)C(=O)Nc1ccc(F)cc1F"
"5540","VU0360172","glutamate receptor positive allosteric modulator","GRM5","","","Tocris",77.87,"BRD-K83649660-003-03-0","Preclinical","","NEMHWVUKNWAKTM-UHFFFAOYSA-N","BRD-K83649660","","Fc1cccc(c1)C#Cc1ccc(cn1)C(=O)NC1CCC1"
"5541","VU0361737","glutamate receptor positive allosteric modulator","GRM4","","","Tocris, Tocris, Selleck",98.82,"BRD-K45462423-001-03-7, BRD-K45462423-001-04-5, BRD-K45462423-001-02-9","Preclinical","","ARYUXFNGXHNNDM-UHFFFAOYSA-N","BRD-K45462423","","COc1cc(NC(=O)c2ccccn2)ccc1Cl"
"5544","VU0364439","glutamate receptor positive allosteric modulator","GRM4","","","Tocris, Selleck",96.29,"BRD-K72687424-001-03-4, BRD-K72687424-001-02-6","Preclinical","","IXHCGJXBIHHIEF-UHFFFAOYSA-N","BRD-K72687424","","Clc1ccccc1NS(=O)(=O)c1ccc(NC(=O)c2ccccn2)cc1Cl"
"5546","VU0364770","glutamate receptor positive allosteric modulator","GRM4","","","Selleck",96.96,"BRD-K66527818-001-02-6","Preclinical","","SUYUTNCKIOLMAJ-UHFFFAOYSA-N","BRD-K66527818","","Clc1cccc(NC(=O)c2ccccn2)c1"
"5547","VU10010","acetylcholine receptor allosteric modulator","CHRM4","","","Tocris",92.95,"BRD-K12483104-001-01-2","Preclinical","","FPRULFHDSFKYBV-UHFFFAOYSA-N","BRD-K12483104","","Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCc1ccc(Cl)cc1"
"5548","VU1545","glutamate receptor positive allosteric modulator","GRM5","","","Tocris",96.37,"BRD-K48371964-001-06-5","Preclinical","","BRAZLURTFMCAHU-UHFFFAOYSA-N","BRD-K48371964","","[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1F)-c1ccccc1"
"5549","VU29","glutamate receptor potentiator","GRM5","","","Tocris",98.04,"BRD-K54783522-001-01-8","Preclinical","","KIALCSMRIHRFPL-UHFFFAOYSA-N","BRD-K54783522","","[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1)-c1ccccc1"
"5550","VU591","potassium channel blocker","KCNJ1","","","Tocris",87.5,"BRD-K72063794-003-01-0","Preclinical","","ZQPXNYLXYNRFNP-UHFFFAOYSA-N","BRD-K72063794","","[O-][N+](=O)c1ccc2nc(COCc3nc4ccc(cc4[nH]3)[N+]([O-])=O)[nH]c2c1"
"5551","VX-11E","MAP kinase inhibitor","MAPK1","","","MedChemEx",97.32,"BRD-K93725829-001-03-8","Preclinical","","WUTVMXLIGHTZJC-OAQYLSRUSA-N","BRD-K93725829","","Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(c1)C(=O)N[C@H](CO)c1cccc(Cl)c1"
"5552","VX-222","HCV inhibitor","","","","Selleck",97.92,"BRD-K70610771-001-02-9","Phase 2","","WPMJNLCLKAKMLA-UGLKCIBTSA-N","BRD-K70610771","","C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]1CC[C@H](O)CC1)c1cc(sc1C(O)=O)C#CC(C)(C)C"
"5553","VX-702","p38 MAPK inhibitor","MAPK11, MAPK12, MAPK14","","","Selleck, Selleck",93.86,"BRD-K07736136-001-04-6, BRD-K07736136-001-03-8","Phase 2","","FYSRKRZDBHOFAY-UHFFFAOYSA-N","BRD-K07736136","","NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F"
"5555","VX-745","p38 MAPK inhibitor","MAPK11, MAPK12, MAPK14","","","MedChemEx, MedChemEx, Selleck, Selleck",78.69,"BRD-K91900765-001-08-4, BRD-K91900765-001-07-6, BRD-K91900765-001-05-0, BRD-K91900765-001-06-8","Phase 2","","VEPKQEUBKLEPRA-UHFFFAOYSA-N","BRD-K91900765","","Fc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(F)c1"
"5559","VX-765","caspase inhibitor","CASP1","","","Selleck",94.98,"BRD-K26712974-001-01-5","Phase 2","","SJDDOCKBXFJEJB-QQSSDERHSA-N","BRD-K26712974","","CCO[C@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C"
"5560","W-54011","anaphylatoxin chemotactic receptor antagonist","C5AR1","","","Tocris, MedChemEx",89.3,"BRD-A00559310-003-02-9, BRD-A00559310-003-01-1","Preclinical","","DVYASSBBADJRAS-UHFFFAOYSA-N","BRD-A00559310","","COc1ccc2CCCC(C(=O)N(Cc3ccc(cc3)N(C)C)c3ccc(cc3)C(C)C)c2c1"
"5562","WALRYCIN-B","transcriptional regulatory protein WalR","","","","MedChemEx",88.74,"BRD-K01129913-001-01-5","Preclinical","","XRVMPTWWKLKLPB-UHFFFAOYSA-N","BRD-K01129913","","Cn1nc(nc2c1nc(=O)n(C)c2=O)-c1ccc(cc1)C(F)(F)F"
"5563","WAY-100635","serotonin receptor antagonist","HTR1A","","","Selleck",95.59,"BRD-K69812556-305-02-0","Phase 1","","SBPRIAGPYFYCRT-UHFFFAOYSA-N","BRD-K69812556","","COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1"
"5564","WAY-161503","serotonin receptor agonist","HTR2C","","","Tocris, Tocris",94.85,"BRD-A62021152-003-04-2, BRD-A62021152-003-03-4","Preclinical","","PHGWDAICBXUJDU-UHFFFAOYSA-N","BRD-A62021152","","Clc1cc2NC(=O)C3CNCCN3c2cc1Cl"
"5566","WAY-170523","metalloproteinase inhibitor","MMP13","","","Tocris, Tocris",97.03,"BRD-K36198571-001-02-0, BRD-K36198571-001-03-8","Preclinical","","FARMEEAGJWMFSZ-UHFFFAOYSA-N","BRD-K36198571","","Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO"
"5568","WAY-200070","estrogen receptor agonist","ERBB2, ERBB3, ERBB4, ESR2","","","Tocris, Tocris",93.82,"BRD-K08223200-001-01-1, BRD-K08223200-001-02-9","Preclinical","","BAAILVWEAXFTSF-UHFFFAOYSA-N","BRD-K08223200","","Oc1ccc(cc1)-c1nc2cc(O)cc(Br)c2o1"
"5570","WAY-207024","gonadotropin releasing factor hormone receptor antagonist","GNRHR, HRH2, TACR2","","","Tocris",95.82,"BRD-K08657056-300-01-1","Preclinical","","AVEVJMZJJJDOCI-UHFFFAOYSA-N","BRD-K08657056","","CC(C)(C)c1ccc(cc1)-c1nc2cccc(N3CCN(Cc4ccc5nccnc5c4)CC3)c2[nH]1"
"5571","WAY-208466","serotonin receptor agonist","DRD2, HTR2A, HTR2C, HTR6, HTR7","","","Tocris",96.89,"BRD-K63483542-300-01-6","Preclinical","","SFSFIDVAEMDPIP-UHFFFAOYSA-N","BRD-K63483542","","CN(C)CCn1cc(c2cccnc12)S(=O)(=O)c1cccc(F)c1"
"5572","WAY-213613","glutamate inhibitor","SLC1A2","","","Tocris, Tocris",97.19,"BRD-K96758128-001-01-8, BRD-K96758128-001-02-6","Preclinical","","BNYDDAAZMBUFRG-ZDUSSCGKSA-N","BRD-K96758128","","N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(O)=O"
"5574","WAY-316606","secreted frizzled related protein inhibitor","SFRP1","","","MedChemEx, Tocris",94.21,"BRD-K61871885-001-01-3, BRD-K61871885-003-01-9","Preclinical","","ITBGJNVZJBVPLJ-UHFFFAOYSA-N","BRD-K61871885","","FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1"
"5576","WAY-362450","FXR agonist","NR1H4","","","Selleck",91.54,"BRD-K54640016-001-04-7","Phase 1","","INASOKQDNHHMRE-UHFFFAOYSA-N","BRD-K54640016","","CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c1ccccc21)C(=O)c1ccc(F)c(F)c1"
"5577","WAY-600","mTOR inhibitor","MTOR","","","Selleck",93.96,"BRD-K85920262-001-02-1","Preclinical","","FPEIJQLXFHKLJV-UHFFFAOYSA-N","BRD-K85920262","","C(N1CCC(CC1)n1ncc2c(nc(nc12)-c1ccc2[nH]ccc2c1)N1CCOCC1)c1cccnc1"
"5578","WAY-629","serotonin receptor agonist","HTR2C","","","Tocris",66.92,"BRD-K55430733-003-02-4","Preclinical","","OIGHTPDWPMLMGT-UHFFFAOYSA-N","BRD-K55430733","","C1CCc2c(C1)n1CCNCc3cccc2c13"
"5579","WB-4101","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A","","","Tocris",96.8,"BRD-A01493904-003-12-1","Preclinical","","GYSZUJHYXCZAKI-UHFFFAOYSA-N","BRD-A01493904","","COc1cccc(OC)c1OCCNCC1COc2ccccc2O1"
"5580","WDR5-0103","histone lysine methyltransferase inhibitor","WDR5","","","Tocris",97.86,"BRD-K47726410-001-01-2","Preclinical","","ZPLBXOVTSNRBFB-UHFFFAOYSA-N","BRD-K47726410","","COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1"
"5581","WEHI-345-ANALOG","src inhibitor","","","","MedChemEx",95.92,"BRD-K55487946-001-01-3","Preclinical","","ZCZGSEXBXXYQQC-UHFFFAOYSA-N","BRD-K55487946","","Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)CNC(=O)c1ncccc1C"
"5582","WH-4-023","src inhibitor","LCK, SRC","","","Tocris",81.92,"BRD-K50199947-001-03-4","Preclinical","","NBTNHSGBRGTFJS-UHFFFAOYSA-N","BRD-K50199947","","COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(cc3)N3CCN(C)CC3)n2)c(OC)c1"
"5583","WHI-P154","JAK inhibitor","EGFR, JAK1, JAK2, JAK3","","","Selleck, Selleck, Tocris",90.22,"BRD-K07487750-001-03-3, BRD-K07487750-001-04-1, BRD-K07487750-001-05-8","Preclinical","","CBIAKDAYHRWZCU-UHFFFAOYSA-N","BRD-K07487750","","COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC"
"5586","WIKI4","Wnt pathway inhibitor, tankyrase inhibitor","TNKS2","","","MedChemEx",98.16,"BRD-K19316653-001-02-0","Preclinical","","RNUXIZKXJOGYQP-UHFFFAOYSA-N","BRD-K19316653","","COc1ccc(cc1)-n1c(SCCCN2C(=O)c3cccc4cccc(C2=O)c34)nnc1-c1ccncc1"
"5587","WIN-18446","aldehyde dehydrogenase inhibitor","ALDH1A2","","","DuPont",97.79,"BRD-K30930903-001-01-3","Preclinical","","FAOMZVDZARKPFJ-UHFFFAOYSA-N","BRD-K30930903","","ClC(Cl)C(=O)NCCCCCCCCNC(=O)C(Cl)Cl"
"5588","WIN-64338","bradykinin receptor antagonist","BDKRB2","","","Tocris, Tocris",95.81,"BRD-K22662557-300-02-5, BRD-K22662557-300-01-7","Preclinical","","UKMJWGFHXMGRNG-QLKFWGTOSA-O","BRD-K22662557","","CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N\C(NC2CCCCC2)=N\C2CCCCC2)cc1"
"5590","WISKOSTATIN","neural Wiskott-Aldrich syndrome protein inhibitor, actin related protein inhibitor","WAS, WASL","","","Tocris",91.47,"BRD-A18579359-001-04-9","Preclinical","","XUBJEDZHBUPBKL-UHFFFAOYSA-N","BRD-A18579359","","CN(C)CC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc12"
"5591","WNT-C59","porcupine inhibitor","PORCN","","","Selleck, Tocris",98.11,"BRD-K78455053-001-01-2, BRD-K78455053-001-02-0","Preclinical","","KHZOJCQBHJUJFY-UHFFFAOYSA-N","BRD-K78455053","","Cc1cc(ccn1)-c1ccc(CC(=O)Nc2ccc(cc2)-c2cccnc2)cc1"
"5593","WORTMANNIN","PI3K inhibitor","PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC","","","Selleck, Selleck",56.11,"BRD-K87343924-001-12-3, BRD-K87343924-001-15-6","Preclinical","BRD-K62662086-001-01-2,BRD-A75409952-001-12-3","QDLHCMPXEPAAMD-QAIWCSMKSA-N","BRD-K87343924","BRD-K62662086","COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O"
"5595","WP1066","STAT inhibitor","STAT3","","","Selleck, Selleck",87.63,"BRD-K05445342-001-05-3, BRD-K05445342-001-02-0","Phase 1","","VFUAJMPDXIRPKO-LQELWAHVSA-N","BRD-K05445342","","C[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1"
"5597","WP1130","deubiquitinase inhibitor","JAK2, UCHL5, USP14, USP9X","","","Selleck, Selleck",88.88,"BRD-K43644456-001-03-2, BRD-K43644456-001-04-0","Preclinical","","LIDOPKHSVQTSJY-VMEIHUARSA-N","BRD-K43644456","","CCC[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1"
"5599","WWL-113","carboxylesterase inhibitor","CES3","","","Tocris",97.33,"BRD-K49389158-001-01-3","Preclinical","","AKIIPHDGVCFVCC-UHFFFAOYSA-N","BRD-K49389158","","CCOC(=O)c1ccc(cc1)-c1ccc(OC(=O)N(C)Cc2cccc(c2)-c2ccncc2)cc1"
"5600","WWL-123","monoacylglycerol lipase inhibitor","ABHD6","","","Tocris",95.05,"BRD-K83176916-001-01-4","Preclinical","","UUJGYRHAOHORFC-UHFFFAOYSA-N","BRD-K83176916","","CN(Cc1cccc(c1)-c1ccccc1)C(=O)Oc1ccc(cc1)-c1ccc(cc1)C(N)=O"
"5601","WY-16922","histamine release inhibitor","","","","Sigma",96.26,"BRD-K43419711-001-01-4","Phase 1","","GGLRYZACPLNCKB-UHFFFAOYSA-N","BRD-K43419711","","CCOC(=O)C(=O)Nc1cccc(OC)c1C(N)=O"
"5602","WYE-125132","mTOR inhibitor","MTOR","","","Selleck",97.73,"BRD-A45498368-001-07-1","Preclinical","","QLHHRYZMBGPBJG-UHFFFAOYSA-N","BRD-A45498368","","CNC(=O)Nc1ccc(cc1)-c1nc(N2CC3CCC(C2)O3)c2cnn(C3CCC4(CC3)OCCO4)c2n1"
"5603","WYE-354","mTOR inhibitor","MTOR","","","Selleck",93.46,"BRD-K77008974-001-03-2","Preclinical","","IMXHGCRIEAKIBU-UHFFFAOYSA-N","BRD-K77008974","","COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(CC3)C(=O)OC)c2n1"
"5604","WYE-687","mTOR inhibitor","MTOR","","","Tocris",94.1,"BRD-K49900195-300-01-8","Preclinical","","VDOCQQKGPJENHJ-UHFFFAOYSA-N","BRD-K49900195","","COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(Cc4cccnc4)CC3)c2n1"
"5605","WZ-3146","EGFR inhibitor","EGFR","","","Selleck",91.78,"BRD-K73293050-001-03-1","Preclinical","","APHGZZPEOCCYNO-UHFFFAOYSA-N","BRD-K73293050","","CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)cc1"
"5606","WZ-4002","EGFR inhibitor","EGFR, ERBB2","","","Selleck, Selleck",92.97,"BRD-K72420232-001-13-1, BRD-K72420232-001-12-3","Preclinical","","ITTRLTNMFYIYPA-UHFFFAOYSA-N","BRD-K72420232","","COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1"
"5608","WZ4003","AMPK inhibitor","NUAK1, NUAK2","","","Selleck",92.13,"BRD-K45909031-001-01-5","Preclinical","","SDGJBAUIGHSMRI-UHFFFAOYSA-N","BRD-K45909031","","CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2Cl)c1"
"5609","WZ8040","EGFR inhibitor","EGFR","","","Selleck",91.07,"BRD-K81728688-001-04-4","Preclinical","","KIISCIGBPUVZBF-UHFFFAOYSA-N","BRD-K81728688","","CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Sc3cccc(NC(=O)C=C)c3)n2)cc1"
"5610","WZ811","CC chemokine receptor antagonist","CXCR4","","","Selleck",93.63,"BRD-K25359048-001-02-6","Preclinical","","KBVFRXIGQQRMEF-UHFFFAOYSA-N","BRD-K25359048","","C(Nc1ccccn1)c1ccc(CNc2ccccn2)cc1"
"5611","XALIPRODEN","serotonin receptor agonist","HTR1A","","","Tocris, Tocris",99.44,"BRD-K88358234-003-04-8, BRD-K88358234-003-05-5","Phase 3","","WJJYZXPHLSLMGE-UHFFFAOYSA-N","BRD-K88358234","","FC(F)(F)c1cccc(c1)C1=CCN(CCc2ccc3ccccc3c2)CC1"
"5613","XAMOTEROL","adrenergic receptor agonist","ADRB1","","","Tocris, Tocris, Tocris",87.58,"BRD-A59337442-051-07-9, BRD-A59337442-051-06-1, BRD-A59337442-051-05-3","Phase 3","BRD-M39942365-051-06-2, BRD-M39942365-051-07-0, BRD-M39942365-051-05-4","DXPOSRCHIDYWHW-UHFFFAOYSA-N","BRD-A59337442","BRD-M39942365","OC(CNCCNC(=O)N1CCOCC1)COc1ccc(O)cc1"
"5616","XANOMELINE","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7","","","Tocris, MedChemEx",97.8,"BRD-K72815923-034-02-0, BRD-K72815923-034-01-2","Phase 3","","JOLJIIDDOBNFHW-UHFFFAOYSA-N","BRD-K72815923","","CCCCCCOc1nsnc1C1=CCCN(C)C1"
"5618","XANTHONE","antimalarial agent","","","","Selleck",97.15,"BRD-K27135764-001-08-7","Preclinical","","JNELGWHKGNBSMD-UHFFFAOYSA-N","BRD-K27135764","","O=c1c2ccccc2oc2ccccc12"
"5619","XAV-939","tankyrase inhibitor","TNKS, TNKS2","","","Tocris, Selleck, Tocris",95.63,"BRD-K12762134-001-07-0, BRD-K12762134-001-06-2, BRD-K12762134-001-10-4","Preclinical","","KLGQSVMIPOVQAX-UHFFFAOYSA-N","BRD-K12762134","","Oc1nc(nc2CCSCc12)-c1ccc(cc1)C(F)(F)F"
"5622","XBD173","benzodiazepine receptor ligand","TSPO","","","Tocris, MedChemEx",99.75,"BRD-K45875383-001-02-0, BRD-K45875383-001-01-2","Phase 2","","NBMBIEOUVBHEBM-UHFFFAOYSA-N","BRD-K45875383","","CCN(Cc1ccccc1)C(=O)Cn1c2nc(ncc2n(C)c1=O)-c1ccccc1"
"5624","XD-14","bromodomain inhibitor","BRD2, BRD3, BRD4, BRDT","","","Tocris",87.21,"BRD-K69211575-001-01-9","Preclinical","","DPBKLIVPNYGQQG-UHFFFAOYSA-N","BRD-K69211575","","CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2CC)c1"
"5625","XE-991","potassium channel blocker","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5","","","Tocris",98.74,"BRD-K42748308-300-02-0","Preclinical","","KHJFBUUFMUBONL-UHFFFAOYSA-N","BRD-K42748308","","O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12"
"5626","XENALIPIN","","","","","Enamine",98.55,"BRD-K99506538-001-03-8","Phase 2","","IQOMYCGTGFGDFN-UHFFFAOYSA-N","BRD-K99506538","","OC(=O)c1ccccc1-c1ccc(cc1)C(F)(F)F"
"5627","XIBENOLOL","adrenergic receptor antagonist","","","","PrincetonBio",98.27,"BRD-A21446384-001-01-1","Phase 3","","RKUQLAPSGZJLGP-UHFFFAOYSA-N","BRD-A21446384","","Cc1cccc(OCC(O)CNC(C)(C)C)c1C"
"5628","XILOBAM","","","","","Enamine",88.42,"BRD-K79633074-001-01-8","Phase 1","","PAXRPWSXCPTPCA-QINSGFPZSA-N","BRD-K79633074","","CN1CCC\C1=N\C(=O)Nc1c(C)cccc1C"
"5629","XL-147","PI3K inhibitor","PIK3CA, PIK3CD, PIK3CG","","","Selleck",96.66,"BRD-K95901403-001-04-5","Phase 2","","MQMKRQLTIWPEDM-UHFFFAOYSA-N","BRD-K95901403","","Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1"
"5630","XL-647","EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR","","","MedChemEx",95.23,"BRD-K03765900-001-01-9","Phase 3","","HVXKQKFEHMGHSL-QKDCVEJESA-N","BRD-K03765900","","COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1C[C@H]2CN(C)C[C@H]2C1"
"5631","XL019","JAK inhibitor","JAK1, JAK2, JAK3","","","MedChemEx, MedChemEx, Selleck, Selleck",85.4,"BRD-K04266228-001-04-6, BRD-K04266228-001-05-3, BRD-K04266228-001-02-0, BRD-K04266228-001-03-8","Phase 1","","ISOCDPQFIXDIMS-QHCPKHFHSA-N","BRD-K04266228","","O=C(Nc1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1)[C@@H]1CCCN1"
"5635","XL228","Abl kinase inhibitor, insulin growth factor receptor inhibitor, src inhibitor","IGF1R, SRC","","","MedChemEx, MedChemEx",96.72,"BRD-K14274271-001-02-8, BRD-K14274271-001-01-0","Phase 1","","ALKJNCZNEOTEMP-UHFFFAOYSA-N","BRD-K14274271","","CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C3CC3)cc(n2)N2CCN(C)CC2)on1"
"5637","XL388","mTOR inhibitor","MTOR","","","Selleck",97.77,"BRD-K03549949-001-01-0","Preclinical","","LNFBAYSBVQBKFR-UHFFFAOYSA-N","BRD-K03549949","","Cc1c(F)c(ccc1C(=O)N1CCOc2ccc(cc2C1)-c1ccc(N)nc1)S(C)(=O)=O"
"5638","XL888","HSP inhibitor","","","","Selleck",96.96,"BRD-A03506276-001-01-5","Phase 1","","LHGWWAFKVCIILM-LAQKFSSHSA-N","BRD-A03506276","","CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O"
"5639","XMD17-109","MAP kinase inhibitor","MAPK7","","","MedChemEx, Tocris",98.26,"BRD-K48449981-001-01-9, BRD-K48449981-001-02-7","Preclinical","","XVBGRTMNFNMINE-UHFFFAOYSA-N","BRD-K48449981","","CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C3CCCC3)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1"
"5641","XMD8-92","MAP kinase inhibitor","DCLK2, MAPK7, PLK4, TNK1","","","MedChemEx, MedChemEx, Tocris",88.71,"BRD-K50387473-001-11-0, BRD-K50387473-001-09-4, BRD-K50387473-001-10-2","Preclinical","","QAPAJIZPZGWAND-UHFFFAOYSA-N","BRD-K50387473","","CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1"
"5644","XYLOSE","","","","","Selleck, Selleck",100,"BRD-K10759144-001-03-5, BRD-K10759144-001-04-3","Launched","","PYMYPHUHKUWMLA-VPENINKCSA-N","BRD-K10759144","","OC[C@@H](O)[C@H](O)[C@@H](O)C=O"
"5646","Y-11","focal adhesion kinase inhibitor","PTK2","","","Tocris",99.12,"BRD-K09317629-004-01-7","Preclinical","","SQWGHMPVSMSPNY-UHFFFAOYSA-N","BRD-K09317629","","OCC[N+]12CN3CN(CN(C3)C1)C2"
"5647","Y-134","estrogen receptor antagonist","ESR1, ESR2","","","Tocris, Tocris",93.3,"BRD-K94832621-001-02-3, BRD-K94832621-001-03-1","Preclinical","","LQEOPHGPHCWOAC-UHFFFAOYSA-N","BRD-K94832621","","CC(C)N1CCN(CC1)c1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1"
"5649","Y-26763","potassium channel activator","KCNJ8","","","Tocris",95.72,"BRD-K45117373-001-02-9","Phase 1","","IWTCFIIOUXJOOV-OLZOCXBDSA-N","BRD-K45117373","","CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N"
"5650","Y-27152","potassium channel activator","KCNJ8","","","Tocris",99.08,"BRD-K42679050-001-02-1","Phase 1","","RHFUXPCCELGMFC-UXHICEINSA-N","BRD-K42679050","","CC(=O)N(OCc1ccccc1)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N"
"5651","Y-27632","rho associated kinase inhibitor","PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2","","","Selleck, Tocris, Selleck",99.62,"BRD-K44084986-300-09-2, BRD-K44084986-300-08-4, BRD-K44084986-300-07-6","Preclinical","","IYOZTVGMEWJPKR-IJLUTSLNSA-N","BRD-K44084986","","C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1"
"5654","Y-29794","prolyl endopeptidase inhibitor","PREP","","","Tocris",64.16,"BRD-K48449073-034-02-7","Preclinical","","HAGHKJDWBDSFKC-UHFFFAOYSA-N","BRD-K48449073","","CC(C)c1ccc(C(=O)c2cccs2)c(SCCCCCCCCN(C)C)n1"
"5655","Y-320","interleukin inhibitor","IL17A","","","Selleck",93.42,"BRD-K96259238-001-01-4","Preclinical","","BWZNJVZTAWBIFG-UHFFFAOYSA-N","BRD-K96259238","","Cc1c(cnn1-c1ccc(Cl)cc1)C(=O)Nc1ccc(N2CCC(CC2)N2CCOCC2)c(c1)C#N"
"5656","Y-39983","rho associated kinase inhibitor","ROCK1, ROCK2","","","MedChemEx",97.51,"BRD-K56751279-300-01-4","Phase 2","","JTVBXQAYBIJXRP-SNVBAGLBSA-N","BRD-K56751279","","C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12"
"5657","YC-1","guanylyl cyclase activator","GUCY1A2, GUCY1A3, GUCY1B3, HIF1A","","","Tocris",93.54,"BRD-K60476892-001-16-1","Preclinical","","OQQVFCKUDYMWGV-UHFFFAOYSA-N","BRD-K60476892","","OCc1ccc(o1)-c1nn(Cc2ccccc2)c2ccccc12"
"5658","YIL-781","ghrelin receptor antagonist","GHSR","","","Tocris",79.24,"BRD-K91403886-003-01-4","Preclinical","","FRKXOBMDEXCHHD-SFHVURJKSA-N","BRD-K91403886","","CC(C)N1CCC[C@H](Cn2c(C)nc3ccc(Oc4ccc(F)cc4)cc3c2=O)C1"
"5659","YK-4-279","apoptosis inhibitor","EWSR1, FLI1","","","Tocris, MedChemEx",98.2,"BRD-A62182663-001-04-8, BRD-A62182663-001-03-0","Preclinical","","HLXSCTYHLQHQDJ-UHFFFAOYSA-N","BRD-A62182663","","COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl"
"5661","YM-155","survivin inhibitor","BIRC5","","","Selleck, MedChemEx",93.58,"BRD-K76703230-004-04-1, BRD-K76703230-004-03-3","Phase 2","BRD-U99450240-000-01-2","OTSOOHRUMBRSHZ-UHFFFAOYSA-N","BRD-K76703230","BRD-U99450240","COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C"
"5663","YM-201636","PI3K inhibitor","","","","Selleck",95.37,"BRD-K48488978-001-05-3","Preclinical","","YBPIBGNBHHGLEB-UHFFFAOYSA-N","BRD-K48488978","","Nc1ccc(cn1)C(=O)Nc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1"
"5664","YM-244769","sodium/calcium exchange inhibitor","","","","Tocris",94.4,"BRD-K52087522-300-01-2","Preclinical","","JZMLHJRKSJXARY-UHFFFAOYSA-N","BRD-K52087522","","Nc1cccc(CNC(=O)c2ccc(Oc3ccc(OCc4cccc(F)c4)cc3)nc2)c1"
"5665","YM-298198","glutamate receptor antagonist","GRM1","","","Tocris",61.48,"BRD-K59650319-003-03-3","Preclinical","","KCBXOMYXOBVLED-UHFFFAOYSA-N","BRD-K59650319","","CN(C1CCCCC1)C(=O)c1sc2nc3ccc(N)cc3n2c1C"
"5666","YM-511","aromatase inhibitor","CYP19A1","","","Tocris",98.92,"BRD-K38398115-001-01-9","Phase 2","","GGPPBTSXFROGAE-UHFFFAOYSA-N","BRD-K38398115","","Brc1ccc(CN(c2ccc(cc2)C#N)n2cnnc2)cc1"
"5667","YM-58483","calcium channel blocker","TRPC3, TRPC5, TRPM4","","","Tocris, EMDBio",99.86,"BRD-K42563464-001-02-7, BRD-K42563464-001-01-9","Preclinical","","XPRZIORDEVHURQ-UHFFFAOYSA-N","BRD-K42563464","","Cc1nnsc1C(=O)Nc1ccc(cc1)-n1nc(cc1C(F)(F)F)C(F)(F)F"
"5669","YM-750","ACAT inhibitor","SOAT1","","","Tocris",98.4,"BRD-K91716465-001-01-2","Phase 1","","FMLJREWZCZHGGW-UHFFFAOYSA-N","BRD-K91716465","","Cc1cc(C)c(NC(=O)N(Cc2ccc-3c(Cc4ccccc-34)c2)C2CCCCCC2)c(C)c1"
"5670","YM-90709","IL5 inhibitor","CSF2RB, IL5RA","","","MedChemEx, Tocris",88.31,"BRD-K06712146-001-03-8, BRD-K06712146-001-02-0","Preclinical","","HIXSPVQXXDULHS-UHFFFAOYSA-N","BRD-K06712146","","COc1cc2CC(C)(C)n3c(cc4nc5ccccc5nc34)-c2cc1OC"
"5672","YM-976","phosphodiesterase inhibitor","PDE4A","","","Tocris, Tocris",97.79,"BRD-K12932420-001-03-1, BRD-K12932420-001-02-3","Phase 1","","MNHXYNNKDDXKNP-UHFFFAOYSA-N","BRD-K12932420","","CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1"
"5674","YM022","CCK receptor antagonist","CCKBR","","","Sigma",99.62,"BRD-K09436144-001-01-7","Phase 2","","YCXFHPUBGMMWJQ-PMERELPUSA-N","BRD-K09436144","","Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)c1"
"5675","YO-01027","gamma secretase inhibitor","","","","Selleck, Tocris",96.71,"BRD-K04622161-001-02-3, BRD-K04622161-001-03-1","Preclinical","","QSHGISMANBKLQL-OWJWWREXSA-N","BRD-K04622161","","C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O"
"5677","YODA-1","piezo channel activator","PIEZO1","","","Tocris",96.08,"BRD-K88570498-001-01-9","Preclinical","","BQNXBSYSQXSXPT-UHFFFAOYSA-N","BRD-K88570498","","Clc1cccc(Cl)c1CSc1nnc(s1)-c1cnccn1"
"5678","YS-035","calcium channel blocker","","","","Tocris",96.03,"BRD-K06208435-003-08-2","Preclinical","","OXZMQFKVNVQMLI-UHFFFAOYSA-N","BRD-K06208435","","COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC"
"5679","YZ9","phosphofructokinase inhibitor","MIF, PFKFB3","","","Tocris",97.18,"BRD-K53438416-001-01-9","Preclinical","","IETDBZQIWIJQJG-UHFFFAOYSA-N","BRD-K53438416","","CCOC(=O)c1cc2ccc(O)cc2oc1=O"
"5680","Y16","rho associated kinase inhibitor","RHOA","","","MedChemEx, MedChemEx",63.43,"BRD-K81865756-001-02-5, BRD-K81865756-001-01-7","Preclinical","","ITMLWGWTDWJSRZ-PXLXIMEGSA-N","BRD-K81865756","","Cc1cccc(COc2cccc(\C=C3/C(=O)NN(C3=O)c3ccccc3)c2)c1"
"5682","ZACOPRIDE","serotonin receptor antagonist","HTR3A, HTR3B, HTR4, HTR5A","","","Tocris, Tocris",97.84,"BRD-A65615053-003-03-0, BRD-A65615053-003-02-2","Phase 2","","FEROPKNOYKURCJ-UHFFFAOYSA-N","BRD-A65615053","","COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2"
"5684","ZALDARIDE","calmodulin antagonist","CALM1","","","Tocris, Tocris",96.11,"BRD-A26032986-050-02-1, BRD-A26032986-050-03-9","Phase 3","","HTGCJAAPDHZCHL-UHFFFAOYSA-N","BRD-A26032986","","CC1(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)OCc2ccccc2-n2cccc12"
"5686","ZALTIDINE","histamine receptor antagonist","HRH2","","","MedChemEx, MedChemEx",88.8,"BRD-K12261274-001-01-6, BRD-K12261274-001-02-4","Phase 3","","GIMNAEMRNXUAQP-UHFFFAOYSA-N","BRD-K12261274","","Cc1ncc([nH]1)-c1csc(NC(N)=N)n1"
"5688","ZAMI-633","urease inhibitor","","","","PrincetonBio",0,"BRD-K11984358-001-01-3","Phase 3","","RSIPQHOWTCNEBI-UHFFFAOYSA-N","BRD-K11984358","","CCC(=O)NO"
"5689","ZAMIFENACIN","acetylcholine receptor antagonist","CHRM3","","","Tocris, Tocris",97.71,"BRD-K80451230-051-02-6, BRD-K80451230-051-03-4","Phase 3","","BDNFQGRSKSQXRI-XMMPIXPASA-N","BRD-K80451230","","C(Cc1ccc2OCOc2c1)N1CCC[C@H](C1)OC(c1ccccc1)c1ccccc1"
"5691","ZAPA","","","","","Tocris",0,"BRD-K44825564-065-01-4","Preclinical","","QEYNZJBVNYDZKZ-UPHRSURJSA-N","BRD-K44825564","","NC(=N)S\C=C/C(O)=O"
"5692","ZAPRINAST","phosphodiesterase inhibitor","GPR35, PDE1A, PDE4D, PDE5A, PDE9A","","","Tocris, Tocris, MicroSource",99.3,"BRD-K16542329-001-16-8, BRD-K16542329-001-13-5, BRD-K16542329-001-14-3","Phase 2","","REZGGXNDEMKIQB-UHFFFAOYSA-N","BRD-K16542329","","CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1"
"5695","ZARDAVERINE","phosphodiesterase inhibitor","PDE4D","","","Tocris, Tocris, Tocris",99.64,"BRD-K37561857-001-18-9, BRD-K37561857-001-17-1, BRD-K37561857-001-15-5","Phase 2","","HJMQDJPMQIHLPB-UHFFFAOYSA-N","BRD-K37561857","","COc1cc(ccc1OC(F)F)-c1ccc(=O)[nH]n1"
"5698","ZATEBRADINE","HCN channel blocker","HCN1, HCN2, HCN3, HCN4","","","Tocris, MedChemEx, MedChemEx",94.13,"BRD-K92446736-003-02-2, BRD-K92446736-003-03-0, BRD-K92446736-001-01-8","Phase 3","","KEDQCFRVSHYKLR-UHFFFAOYSA-N","BRD-K92446736","","COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC"
"5701","ZCL-278","CDC inhibitor","CDC42","","","Tocris, Selleck, Selleck",91.54,"BRD-K22829793-001-03-6, BRD-K22829793-001-02-8, BRD-K22829793-001-01-0","Preclinical","","XKZDWYDHEBCGCG-UHFFFAOYSA-N","BRD-K22829793","","Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)n1"
"5704","ZD-2079","adrenergic receptor agonist","ADRB3","","","Tocris",96.4,"BRD-K64157027-003-02-7","Phase 2","","SRBPKVWITYPHQR-KRWDZBQOSA-N","BRD-K64157027","","O[C@@H](CNCCOc1ccc(CC(O)=O)cc1)c1ccccc1"
"5705","ZD-7114","adrenergic receptor agonist","ADRB3","","","Tocris",97.54,"BRD-K28971625-003-01-4","Phase 1","","RVMBDLSFFNKKLG-SFHVURJKSA-N","BRD-K28971625","","COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1"
"5706","ZD-7155","angiotensin receptor antagonist","AGTR1","","","Tocris",97.94,"BRD-K11373525-003-02-1","Preclinical","","BFVNEYDCFJNLGN-UHFFFAOYSA-N","BRD-K11373525","","CCc1cc2N(Cc3ccc(cc3)-c3ccccc3-c3nnn[nH]3)C(=O)CCc2c(CC)n1"
"5707","ZD-7288","HCN channel blocker","HCN1, HCN2, HCN3, HCN4","","","Tocris, Tocris",97.52,"BRD-K18678457-003-03-6, BRD-K18678457-003-02-8","Phase 2","","JABSKGQQWUDVRU-UHFFFAOYSA-O","BRD-K18678457","","CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1"
"5709","ZEATIN","","","","","TimTec",96.05,"BRD-K90033078-001-08-7","Phase 1","","UZKQTCBAMSWPJD-FARCUNLSSA-N","BRD-K90033078","","C\C(CO)=C/CNc1[nH]cnc2ncnc12"
"5710","ZEBULARINE","DNA methyltransferase inhibitor","CDA, DNMT1","","","Tocris, Selleck, Selleck",71.32,"BRD-K87714311-001-02-7, BRD-K87714311-001-04-3, BRD-K87714311-001-03-5","Preclinical","BRD-K58673634-001-01-2, BRD-A01145011-001-07-1","RPQZTTQVRYEKCR-WCTZXXKLSA-N","BRD-K87714311","BRD-K58673634","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cccnc1=O"
"5713","ZIBOTENTAN","endothelin receptor antagonist","EDNRA","","","Selleck",95.3,"BRD-K31553034-001-03-0","Phase 3","","FJHHZXWJVIEFGJ-UHFFFAOYSA-N","BRD-K31553034","","COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1"
"5714","ZIMELIDINE","selective serotonin reuptake inhibitor (SSRI)","MAOA, MAOB, SLC6A4","","","Tocris",95.65,"BRD-K46914825-300-01-0","Withdrawn","","OYPPVKRFBIWMSX-SXGWCWSVSA-N","BRD-K46914825","","CN(C)C\C=C(\c1ccc(Br)cc1)c1cccnc1"
"5715","ZINDOTRINE","phosphodiesterase inhibitor","","","","Labotest",0,"BRD-K26598477-001-01-0","Phase 2","","YYHWOTFWBVRTQD-UHFFFAOYSA-N","BRD-K26598477","","Cc1cc(nn2cnnc12)N1CCCCC1"
"5716","ZK-164015","estrogen receptor antagonist","ESR1, ESR2","","","Tocris, Tocris",94.03,"BRD-K05151076-001-02-6, BRD-K05151076-001-03-4","Preclinical","","LYJSJVYJLZOMCD-UHFFFAOYSA-N","BRD-K05151076","","CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)-c1ccc(O)cc1"
"5718","ZK-200775","kainate receptor antagonist","","","","Tocris, Tocris",97.52,"BRD-K67525671-001-02-5, BRD-K67525671-001-03-3","Phase 2","","WZMQMKNCWDCCMT-UHFFFAOYSA-N","BRD-K67525671","","OP(O)(=O)Cn1c2cc(N3CCOCC3)c(cc2[nH]c(=O)c1=O)C(F)(F)F"
"5720","ZK-93423","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2","","","Tocris, Tocris",96.03,"BRD-K33882852-003-03-6, BRD-K33882852-003-02-8","Phase 3","","ALBKMJDFBZVHAK-UHFFFAOYSA-N","BRD-K33882852","","CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC"
"5722","ZK-93426","benzodiazepine receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA5","","","Tocris, Tocris",97.17,"BRD-K68392338-003-03-8, BRD-K68392338-003-02-0","Phase 1","","VMDUABMKBUKKPG-UHFFFAOYSA-N","BRD-K68392338","","CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C"
"5724","ZK811752","CC chemokine receptor antagonist","CCR1","","","Tocris, MedChemEx",100,"BRD-K91825936-001-02-0, BRD-K91825936-001-01-2","Phase 2","","XQYASZNUFDVMFH-CQSZACIVSA-N","BRD-K91825936","","C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O"
"5726","ZLN-024","AMPK activator","PRKAA1, PRKAB1, PRKAG1","","","Tocris",89,"BRD-K64103579-003-01-5","Preclinical","","KWJRSHZSULRJHE-UHFFFAOYSA-N","BRD-K64103579","","Cc1ccc(OCCSc2ncccn2)c(Br)c1"
"5727","ZLN005","","","","","Selleck",97.99,"BRD-K73073971-001-01-7","Preclinical","","LQUNNCQSFFKSSK-UHFFFAOYSA-N","BRD-K73073971","","CC(C)(C)c1ccc(cc1)-c1nc2ccccc2[nH]1"
"5728","ZM-226600","Kir6 channel (KATP) activator","","","","Tocris",95.64,"BRD-A62209527-001-04-5","Preclinical","","LJLXQHHFAKVTNP-UHFFFAOYSA-N","BRD-A62209527","","CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)c1ccccc1)C(F)(F)F"
"5729","ZM-241385","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",99.1,"BRD-K19605405-001-03-5, BRD-K19605405-001-02-7","Preclinical","","PWTBZOIUWZOPFT-UHFFFAOYSA-N","BRD-K19605405","","Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1"
"5731","ZM-306416","Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR","","","Tocris, Selleck",97.56,"BRD-K41337261-003-02-8, BRD-K41337261-001-03-0","Preclinical","","YHUIUSRCUKUUQA-UHFFFAOYSA-N","BRD-K41337261","","COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC"
"5733","ZM-323881","VEGFR inhibitor","KDR","","","Tocris, Tocris, Selleck",95.74,"BRD-K67831364-003-04-1, BRD-K67831364-003-05-8, BRD-K67831364-003-03-3","Preclinical","","NVBNDZZLJRYRPD-UHFFFAOYSA-N","BRD-K67831364","","Cc1cc(F)c(Nc2ncnc3cc(OCc4ccccc4)ccc23)cc1O"
"5736","ZM-336372","RAF inhibitor","BRAF, LCK, MAPK14, RAF1","","","Selleck, Selleck, Tocris, Tocris",92.91,"BRD-K73789395-001-09-9, BRD-K73789395-001-13-1, BRD-K73789395-001-14-9, BRD-K73789395-001-10-7","Preclinical","","PYEFPDQFAZNXLI-UHFFFAOYSA-N","BRD-K73789395","","CN(C)c1cccc(c1)C(=O)Nc1ccc(C)c(NC(=O)c2ccc(O)cc2)c1"
"5740","ZM-39923","JAK inhibitor","JAK1, JAK3","","","Tocris, Selleck, Tocris, Selleck",70.56,"BRD-K40624912-003-15-5, BRD-K40624912-003-12-2, BRD-K40624912-003-13-0, BRD-K40624912-003-14-8","Preclinical","","JSASWRWALCMOQP-UHFFFAOYSA-N","BRD-K40624912","","CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1"
"5744","ZM-447439","Aurora kinase inhibitor","AURKA, AURKB","","","Tocris, Selleck, Tocris",96.51,"BRD-K72703948-001-10-1, BRD-K72703948-001-09-3, BRD-K72703948-001-12-7","Preclinical","","OGNYUTNQZVRGMN-UHFFFAOYSA-N","BRD-K72703948","","COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1"
"5747","ZOLANTIDINE","histamine receptor antagonist","","","","Tocris",90.72,"BRD-K08996725-332-01-7","Preclinical","","KUBONGDXTUOOLM-UHFFFAOYSA-N","BRD-K08996725","","C(CNc1nc2ccccc2s1)COc1cccc(CN2CCCCC2)c1"
"5748","ZOLIMIDINE","mucus protecting agent","","","","Enamine",89.09,"BRD-K45125084-001-01-4","Launched","","VSLIUWLPFRVCDL-UHFFFAOYSA-N","BRD-K45125084","","CS(=O)(=O)c1ccc(cc1)-c1cn2ccccc2n1"
"5749","ZOMEPIRAC","prostaglandin synthesis inhibitor","PTGDR2","","","MedChemEx, Sigma, MicroSource",95.49,"BRD-K81326768-236-12-5, BRD-K81326768-236-11-7, BRD-K81326768-001-04-0","Withdrawn","","ZXVNMYWKKDOREA-UHFFFAOYSA-N","BRD-K81326768","","Cc1cc(CC(O)=O)n(C)c1C(=O)c1ccc(Cl)cc1"
"5752","ZOMETAPINE","","","","","Sigma",99.02,"BRD-K14571191-001-01-6","Phase 2","","YCWROMXNZZIJDQ-UHFFFAOYSA-N","BRD-K14571191","","Cc1nn(C)c2NCCN=C(c12)c1cccc(Cl)c1"
"5753","ZONIPORIDE","sodium/hydrogen exchanger inhibitor","SLC9A1","","","Tocris",96.95,"BRD-K43992824-300-01-0","Phase 3","","GDXBRVCQGGKXJY-UHFFFAOYSA-N","BRD-K43992824","","NC(N)=NC(=O)c1cnn(c1C1CC1)-c1cccc2ncccc12"
"5754","ZOPOLRESTAT","","","","","Sigma",99.44,"BRD-K84459715-001-01-6","Phase 2","","KODQZSCTFAQIRL-UHFFFAOYSA-N","BRD-K84459715","","OC(=O)C=C1NN(Cc2nc3cc(ccc3s2)C(F)(F)F)C(=O)c2ccccc12"
"5755","ZOSUQUIDAR","P glycoprotein inhibitor","ABCB1, ABCB4","","","Tocris, Selleck",96.07,"BRD-K70557564-305-04-4, BRD-K70557564-305-03-6","Phase 3","","IHOVFYSQUDPMCN-DBEBIPAYSA-N","BRD-K70557564","","O[C@@H](COc1cccc2ncccc12)CN1CCN(CC1)[C@@H]1c2ccccc2[C@@H]2[C@H](c3ccccc13)C2(F)F"
"5757","ZOXAZOLAMINE","myorelaxant","","","","MicroSource, Selleck",98.37,"BRD-K66353228-001-14-6, BRD-K66353228-001-13-8","Phase 2","","YGCODSQDUUUKIV-UHFFFAOYSA-N","BRD-K66353228","","Nc1nc2cc(Cl)ccc2o1"
"5759","ZSTK-474","PI3K inhibitor","PIK3CB, PIK3CD, PIK3CG","","","Selleck",98.66,"BRD-K63068307-001-08-9","Phase 1/Phase 2","","HGVNLRPZOWWDKD-UHFFFAOYSA-N","BRD-K63068307","","FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1"
"5760","Z160","N-type calcium channel blocker","CACNA2D1","","","MedChemEx",89.44,"BRD-K16037980-001-01-1","Phase 2","","VCPMZDWBEWTGNW-UHFFFAOYSA-N","BRD-K16037980","","O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1"
"5761","1,12-BESM","polyamine biosynthesis inhibitor","","","","Tocris",96.1,"BRD-K04603573-376-01-3","Phase 2","","PGMIWVSHZMWSSI-UHFFFAOYSA-N","BRD-K04603573","","CCNCCCNCCCCNCCCNCC"
"5762","1,2,3,4,5,6-HEXABROMOCYCLOHEXANE","JAK inhibitor","JAK2","","","Tocris",0,"BRD-K06817181-001-02-3","Preclinical","","QFQZKISCBJKVHI-UHFFFAOYSA-N","BRD-K06817181","","BrC1C(Br)C(Br)C(Br)C(Br)C1Br"
"5763","1,3-DIPROPYL-8-PHENYLXANTHINE","adenosine receptor antagonist","","","","Tocris",97.89,"BRD-K41853443-001-02-9","Preclinical","","CLIGSMOZKDCDRZ-UHFFFAOYSA-N","BRD-K41853443","","CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)-c1ccccc1"
"5764","1,4-BUTANEDIOL","benzodiazepine receptor agonist, gamma hydroxybutyric acid agonist","MAN1B1, PLA2G2A, PLA2G2E","","","Sigma",0,"BRD-K22346679-001-06-3","Phase 1","","WERYXYBDKMZEQL-UHFFFAOYSA-N","BRD-K22346679","","OCCCCO"
"5765","1,5-DICAFFEOYLQUINIC-ACID","","","","","AnalytiCon",0,"BRD-K53083666-001-01-0","Phase 1","","YDDUMTOHNYZQPO-PSEXTPKNSA-N","BRD-K53083666","","O[C@@H]1C[C@@](C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)\C=C\c1ccc(O)c(O)c1)C(O)=O"
"5766","1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM","","","","","BidePharm",94.41,"BRD-K88956297-003-01-9","Preclinical","","LDLCEGCJYSDJLX-UPHRSURJSA-N","BRD-K88956297","","Cl\C=C/C[N+]12CN3CN(CN(C3)C1)C2"
"5767","1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)","glutamate receptor antagonist","","","","Tocris",98.04,"BRD-A86415025-050-01-0","Preclinical","","JQWJJJYHVHNXJH-UHFFFAOYSA-N","BRD-A86415025","","C(C(N1CCCCC1)c1ccccc1)c1ccccc1"
"5768","1-(2-CHLORO-5-METHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL","","","","","Enamine",92.38,"BRD-A95802703-001-01-0","Preclinical","","NJEIOWSBPCZKTL-UHFFFAOYSA-N","BRD-A95802703","","CC(C)NCC(O)COc1cc(C)ccc1Cl"
"5769","1-ACETYL-4-METHYLPIPERAZINE","acetylcholine receptor agonist","","","","Tocris",90.28,"BRD-K96055017-003-02-7","Preclinical","","YSDBJKNOEWSFGA-UHFFFAOYSA-N","BRD-K96055017","","CN1CCN(CC1)C(C)=O"
"5770","1-AZAKENPAULLONE","glycogen synthase kinase inhibitor","CCNB1, CDK1, CDK5, GSK3B","","","Selleck",90.5,"BRD-K03273112-001-01-8","Preclinical","","NTSBZVCEIVPKBJ-UHFFFAOYSA-N","BRD-K03273112","","Brc1ccc2[nH]c-3c(CC(=O)Nc4cccnc-34)c2c1"
"5771","1-DEOXYMANNOJIRIMYCIN","alpha mannosidase inhibitor","MAN2A1","","","Tocris",100,"BRD-K89665618-003-02-5","Preclinical","","LXBIFEVIBLOUGU-KVTDHHQDSA-N","BRD-K89665618","","OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O"
"5772","1-EBIO","potassium channel activator","KCNN1, KCNN2, KCNN3, KCNN4","","","Tocris, Tocris",96.95,"BRD-K70586315-001-02-4, BRD-K70586315-001-03-2","Preclinical","","CXUCKELNYMZTRT-UHFFFAOYSA-N","BRD-K70586315","","CCn1c2ccccc2[nH]c1=O"
"5774","1-ETHYL-2-PYRROLIDONE","transdermal absorption-enhancing compound","","","","CombiBlocks",98.42,"BRD-K08288352-001-03-6","Preclinical","","ZFPGARUNNKGOBB-UHFFFAOYSA-N","BRD-K08288352","","CCN1CCCC1=O"
"5775","1-HEXADECANAL","sphingosine 1 phosphate receptor substrate","DBI, RHO","","","DuPont",0,"BRD-K35114608-001-01-7","Preclinical","","NIOYUNMRJMEDGI-UHFFFAOYSA-N","BRD-K35114608","","CCCCCCCCCCCCCCCC=O"
"5776","1-NAPHTHYL-PP1","src inhibitor","SRC","","","Tocris, Tocris",98.62,"BRD-K29542628-001-03-9, BRD-K29542628-001-04-7","Preclinical","","XSHQBIXMLULFEV-UHFFFAOYSA-N","BRD-K29542628","","CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc12"
"5778","1-OCTACOSANOL","","","","","Acros",1.71,"BRD-K03083257-001-01-6","Phase 2","","CNNRPFQICPFDPO-UHFFFAOYSA-N","BRD-K03083257","","CCCCCCCCCCCCCCCCCCCCCCCCCCCCO"
"5779","1-OCTANOL","","GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1","","","Enamine, Enamine",0,"BRD-K09338665-001-08-9, BRD-K09338665-001-07-1","Phase 2","","KBPLFHHGFOOTCA-UHFFFAOYSA-N","BRD-K09338665","","CCCCCCCCO"
"5781","1-PHENYLBIGUANIDE","serotonin receptor agonist","HTR3A, HTR3B","","","Tocris",95.79,"BRD-K31491153-003-05-9","Preclinical","","CUQCMXFWIMOWRP-UHFFFAOYSA-N","BRD-K31491153","","NC(=N)NC(=N)Nc1ccccc1"
"5782","1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME","","","","","Sigma",98.35,"BRD-A37752546-001-01-9","Preclinical","","NFONIVRMILHYLH-UHFFFAOYSA-N","BRD-A37752546","","CCCCCCCCCCCC([N+][O-])c1cc(C)ccc1O"
"5783","1S,2R-PHENYLPROPANOLAMINE","adrenergic receptor agonist","ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1","","","MicroSource",98.2,"BRD-K27853494-003-04-7","Withdrawn","","DLNKOYKMWOXYQA-VXNVDRBHSA-N","BRD-K27853494","","C[C@@H](N)[C@@H](O)c1ccccc1"
"5784","10-DEACETYLBACCATIN","antitumor agent","","","","MedChemEx, Selleck, Selleck",95.89,"BRD-K96631475-001-03-2, BRD-K96631475-001-02-4, BRD-K96631475-001-04-0","Preclinical","BRD-K61920224-001-01-8","YWLXLRUDGLRYDR-ZHPRIASZSA-N","BRD-K96631475","BRD-K61920224","CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C"
"5787","10-DEBC","AKT inhibitor","PIM1","","","Tocris, Tocris",94.57,"BRD-K70792160-003-04-6, BRD-K70792160-003-06-1","Preclinical","","GYBXAGDWMCJZJK-UHFFFAOYSA-N","BRD-K70792160","","CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc12"
"5789","10-HYDROXYCAMPTOTHECIN","topoisomerase inhibitor","TOP1","","","Selleck, Selleck",96.85,"BRD-K63784565-001-05-4, BRD-K63784565-001-06-2","Preclinical","","HAWSQZCWOQZXHI-FQEVSTJZSA-N","BRD-K63784565","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)cc4cc3Cn1c2=O"
"5791","10058-F4","c-Myc inhibitor","","","","Tocris, Selleck, Selleck",95.6,"BRD-K49460120-001-06-6, BRD-K49460120-001-05-8, BRD-K49460120-001-02-5","Preclinical","","SVXDHPADAXBMFB-JXMROGBWSA-N","BRD-K49460120","","CCc1ccc(cc1)\C=C1\SC(=S)NC1=O"
"5794","12-O-TETRADECANOYLPHORBOL-13-ACETATE","PKC activator","KCNT2, TRPV4","","","Enzo",97.9,"BRD-K68552125-001-05-3","Phase 2","","PHEDXBVPIONUQT-RGYGYFBISA-N","BRD-K68552125","","CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(CO)=C[C@H]2[C@@H]2C(C)(C)[C@]12OC(C)=O"
"5795","1400W","nitric oxide synthase inhibitor","NOS1, NOS2, NOS3","","","Tocris",89.27,"BRD-K30237152-300-02-5","Preclinical","","RODUKNYOEVZQPR-UHFFFAOYSA-N","BRD-K30237152","","CC(=N)NCc1cccc(CN)c1"
"5796","16,16-DIMETHYLPROSTAGLANDIN-E2","prostanoid receptor agonist","HPGD","","","Enzo",100,"BRD-K92301463-001-05-5","Phase 2","","QAOBBBBDJSWHMU-WMBBNPMCSA-N","BRD-K92301463","","CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O"
"5797","17-ALPHA-METHYLTESTOSTERONE","aromatase inhibitor","AR","","","MedChemEx, MedChemEx",88.24,"BRD-K84036904-001-08-8, BRD-K84036904-001-09-6","Launched","","GCKMFJBGXUYNAG-HLXURNFRSA-N","BRD-K84036904","","C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"5799","17-HYDROXYPROGESTERONE-CAPROATE","progesterone receptor agonist","AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR","","","MicroSource",97.31,"BRD-A29731977-001-04-5","Launched","","DOMWKUIIPQCAJU-JKPPDDDBSA-N","BRD-A29731977","","CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O"
"5800","17-PA","glucocorticoid receptor agonist","","","","Tocris",0,"BRD-K07395323-001-01-0","Preclinical","BRD-A34299591-001-23-2","SINAMTXBCYKFDL-WBJZGETLSA-N","BRD-K07395323","BRD-A34299591","C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC=C2c1ccccc1"
"5801","2'-C-METHYLGUANOSINE","HCV inhibitor","","","","Sigma",99.3,"BRD-K78092779-001-01-6","Preclinical","","NVKAMPJSWMHVDK-GITKWUPZSA-N","BRD-K78092779","","C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(O)nc(N)nc12"
"5802","2'-MECCPA","adenosine receptor agonist","ADORA1","","","Tocris, Tocris",95.78,"BRD-K63932022-001-01-5, BRD-K63932022-001-02-3","Preclinical","","MMPAUXMIDJWGFO-ROMFRFKVSA-N","BRD-K63932022","","C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCC3)nc(Cl)nc12"
"5804","2,3-CIS/EXO-CAMPHANEDIOL","","","","","BroadPharm",0,"BRD-K44602126-001-01-3","Phase 1","","AYEOSGBMQHXVER-DQUBFYRCSA-N","BRD-K44602126","","CC1(C)[C@@H]2CC[C@@]1(C)[C@H](O)[C@@H]2O"
"5805","2,3-CIS/EXO-PINANEDIOL","","","","","Maybridge",0,"BRD-A75263867-001-01-1","Phase 1","","MOILFCKRQFQVFS-VUMZSGCYSA-N","BRD-A75263867","","CC1(C)C2CC1[C@](C)(O)[C@H](O)C2"
"5806","2,3-DCPE","Bcl-XL downregulator","BCL2L1","","","Tocris",96.91,"BRD-K61734568-003-02-1","Preclinical","","QVEIRCZEBQRCTR-UHFFFAOYSA-N","BRD-K61734568","","OCCNCCCOc1cccc(Cl)c1Cl"
"5807","2,4-DINITROCHLOROBENZENE","thioredoxin inhibitor","TXN","","","Sigma",0,"BRD-K97833335-001-08-2","Phase 2","","VYZAHLCBVHPDDF-UHFFFAOYSA-N","BRD-K97833335","","[O-][N+](=O)c1ccc(Cl)c(c1)[N+]([O-])=O"
"5808","2,4-DINITROPHENOL","ATP synthase inhibitor","APP","","","MicroSource",98.95,"BRD-K21910317-001-12-3","Preclinical","","UFBJCMHMOXMLKC-UHFFFAOYSA-N","BRD-K21910317","","Oc1ccc(cc1[N+]([O-])=O)[N+]([O-])=O"
"5809","2,5-FURANDIMETHANOL","hemoglobin modulator","HBB","","","Key",0,"BRD-K29791386-001-01-8","Phase 2","","DSLRVRBSNLHVBH-UHFFFAOYSA-N","BRD-K29791386","","OCc1ccc(CO)o1"
"5810","2,6-DIMETHYLPIPERIDINE","","","","","MicroSource",0,"BRD-A21276153-001-01-1","Preclinical","","SDGKUVSVPIIUCF-UHFFFAOYSA-N","BRD-A21276153","","CC1CCCC(C)N1"
"5811","2-(CHLOROMETHYL)-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE","","","","","Enamine",80.5,"BRD-K46989997-001-01-8","Preclinical","","UTWSZXBGTLNPOV-UHFFFAOYSA-N","BRD-K46989997","","ClC=C1Nc2sc3CCCCc3c2C(=O)N1"
"5812","2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID","glutamate carboxypeptidase inhibitor","FOLH1","","","Tocris",84.2,"BRD-A66788520-001-01-7","Phase 1","","FNLNSQHJKVQCBP-UHFFFAOYSA-N","BRD-A66788520","","OC(=O)CCC(CCCS)C(O)=O"
"5813","2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE","serotonin receptor agonist","HTR4","","","Tocris",99.23,"BRD-K91868854-001-03-6","Preclinical","","BYHKGNWKJMGHGE-UHFFFAOYSA-N","BRD-K91868854","","C(N1CCN(CC1)c1nc2ccccc2s1)c1ccc2OCOc2c1"
"5814","2-AMINOBENZENESULFONAMIDE","carbonic anhydrase inhibitor","CA12, CA14, CA2, CA6, CA9","","","Prestwick",99.54,"BRD-K32681104-001-11-6","Preclinical","","YAZSBRQTAHVVGE-UHFFFAOYSA-N","BRD-K32681104","","Nc1ccccc1S(N)(=O)=O"
"5815","2-APB","1,4,5-trisphosphate inhibitor","TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, TRPC7, TRPM2, TRPM3, TRPM6, TRPV1, TRPV6","","","Tocris",0,"BRD-K13346085-001-04-7","Preclinical","","BLZVCIGGICSWIG-UHFFFAOYSA-N","BRD-K13346085","","NCCOB(c1ccccc1)c1ccccc1"
"5816","2-BFI","imidazoline receptor ligand","ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB","","","Tocris",97.63,"BRD-K22745370-003-02-3","Preclinical","","YTJOHEUHUVBKSB-UHFFFAOYSA-N","BRD-K22745370","","C1CN=C(N1)c1cc2ccccc2o1"
"5817","2-CHLORO-N6-CYCLOPENTYLADENOSINE","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Tocris, Tocris",98.41,"BRD-K70088346-001-02-4, BRD-K70088346-001-01-6","Preclinical","","XSMYYYQVWPZWIZ-IDTAVKCVSA-N","BRD-K70088346","","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)nc(Cl)nc12"
"5819","2-CHLOROADENOSINE","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B","","","Tocris",98.42,"BRD-K79511609-001-20-0","Preclinical","","BIXYYZIIJIXVFW-UUOKFMHZSA-N","BRD-K79511609","","Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"5820","2-CHLOROPYRAZINE","","","","","Prestwick",94.15,"BRD-K84075000-001-05-5","Preclinical","","GELVZYOEQVJIRR-UHFFFAOYSA-N","BRD-K84075000","","Clc1cnccn1"
"5821","2-CMDO","dopamine receptor antagonist","DRD2, DRD4","","","Tocris",95.69,"BRD-K92588747-051-02-7","Preclinical","","OTKUTGIVEREJLL-UHFFFAOYSA-N","BRD-K92588747","","CN1CCN(CC1)C1=Cc2ccccc2Oc2ccc(Cl)cc12"
"5822","2-CYANOPYRIMIDINE","cathepsin inhibitor","","","","Enamine",0,"BRD-K95015809-001-02-8","Preclinical","","IIHQNAXFIODVDU-UHFFFAOYSA-N","BRD-K95015809","","N#Cc1ncccn1"
"5823","2-DEOXYGLUCOSE","glycolysis inhibitor","SLC2A1, SLC2A2, SLC2A3, SLC2A4","","","Enzo",100,"BRD-K97808269-001-02-7","Phase 2","","PMMURAAUARKVCB-ZXXMMSQZSA-N","BRD-K97808269","","OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1O"
"5824","2-ETHOXYBENZOIC-ACID","analgesic agent","","","","Enamine",97.32,"BRD-K04843302-001-02-5","Phase 1","","XDZMPRGFOOFSBL-UHFFFAOYSA-N","BRD-K04843302","","CCOc1ccccc1C(O)=O"
"5825","2-ETHYL-1,3-HEXANEDIOL","","","","","Sigma, TCI",0,"BRD-A55455283-001-02-1, BRD-A55455283-001-01-3","Preclinical","","RWLALWYNXFYRGW-UHFFFAOYSA-N","BRD-A55455283","","CCCC(O)C(CC)CO"
"5827","2-FLUORO-2-DEOXY-D-GALACTOSE","","LCT","","","SantaCruz",100,"BRD-A53037300-001-01-0","Phase 1","","ZCXUVYAZINUVJD-UHFFFAOYSA-N","BRD-A53037300","","OCC1OC(O)C(F)C(O)C1O"
"5828","2-HYDROXY-4-((E)-3-(4-HYDROXYPHENYL)ACRYLOYL)-2-((2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)-6-((2S,3R,4R,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)CYCLOHEXANE-1,3,5-TRIONE","","","","","MedChemEx, MedChemEx",76.37,"BRD-A52169337-001-01-9, BRD-A52169337-001-02-7","Preclinical","","DKEZDPGUJMMUCC-MKLAZEEESA-N","BRD-A52169337","","OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1C(=O)C(C(=O)\C=C\c2ccc(O)cc2)C(=O)C(O)([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O"
"5830","2-HYDROXYETHYL-SALICYLATE","","","","","Acros",97.62,"BRD-K41866823-001-01-3","Launched","","LVYLCBNXHHHPSB-UHFFFAOYSA-N","BRD-K41866823","","OCCOC(=O)c1ccccc1O"
"5831","2-HYDROXYFLUTAMIDE","androgen receptor antagonist","AR","","","Enamine, Sigma",99.33,"BRD-K82027074-001-07-5, BRD-K82027074-001-08-3","Phase 1/Phase 2","","YPQLFJODEKMJEF-UHFFFAOYSA-N","BRD-K82027074","","CC(C)(O)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O"
"5833","2-HYDROXYSACLOFEN","GABA receptor antagonist","GABBR1, GABBR2","","","Tocris",95.2,"BRD-A27924917-001-03-3","Preclinical","","WBSMZVIMANOCNX-UHFFFAOYSA-N","BRD-A27924917","","NCC(O)(CS(O)(=O)=O)c1ccc(Cl)cc1"
"5834","2-IMINOBIOTIN","nitric oxide synthase inhibitor","NOS1, NOS2","","","BroadPharm",90.08,"BRD-K07954936-001-01-3","Phase 2","","WWVANQJRLPIHNS-ZKWXMUAHSA-N","BRD-K07954936","","OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12"
"5835","2-IODOHIPPURIC-ACID","","","","","Enamine",98.84,"BRD-K56634222-001-03-0","Preclinical","","CORFWQGVBFFZHF-UHFFFAOYSA-N","BRD-K56634222","","OC(=O)CNC(=O)c1ccccc1I"
"5836","2-IODOMELATONIN","melatonin receptor agonist","MTNR1A, MTNR1B, NQO2","","","Tocris",89.11,"BRD-K25649279-001-02-0","Preclinical","","FJDDSMSDZHURBJ-UHFFFAOYSA-N","BRD-K25649279","","COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1"
"5837","2-METHOXYESTRADIOL","hypoxia inducible factor inhibitor","COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB","","","Tocris, Selleck, Tocris",97.09,"BRD-K44408410-001-21-8, BRD-K44408410-001-22-6, BRD-K44408410-001-17-6","Phase 2","BRD-K42136116-001-01-6","CQOQDQWUFQDJMK-SSTWWWIQSA-N","BRD-K44408410","BRD-K42136116","COc1cc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2cc1O"
"5840","2-METHYL-5-HYDROXYTRYPTAMINE","serotonin receptor agonist","HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6","","","Tocris, Tocris",97.17,"BRD-K64137799-003-03-3, BRD-K64137799-003-02-5","Preclinical","","WYWNEDARFVJQSG-UHFFFAOYSA-N","BRD-K64137799","","Cc1[nH]c2ccc(O)cc2c1CCN"
"5842","2-METHYL-5-NITROPHENOL","","","","","Enamine",0,"BRD-K22327730-001-01-1","Preclinical","","UMFDLIXUUJMPSI-UHFFFAOYSA-N","BRD-K22327730","","Cc1ccc(cc1O)[N+]([O-])=O"
"5843","2-METHYLIMIDAZOLE","cholesterol inhibitor","","","","Sigma",93.95,"BRD-K68534611-001-07-8","Preclinical","","LXBGSDVWAMZHDD-UHFFFAOYSA-N","BRD-K68534611","","Cc1ncc[nH]1"
"5844","2-OCTYLDODECAN-1-OL","","","","","Sigma, Bepharm",0,"BRD-A51407134-001-02-7, BRD-A51407134-001-01-9","Preclinical","","LEACJMVNYZDSKR-UHFFFAOYSA-N","BRD-A51407134","","CCCCCCCCCCC(CO)CCCCCCCC"
"5846","2-OLEOYLGLYCEROL","glucose dependent insulinotropic receptor ligand","GPR119","","","Cayman",94.8,"BRD-K77087341-001-02-4","Phase 1","","UPWGQKDVAURUGE-KTKRTIGZSA-N","BRD-K77087341","","CCCCCCCC\C=C/CCCCCCCC(=O)OC(CO)CO"
"5847","2-OXOGLUTARIC-ACID","","OXGR1","","","Enamine",0,"BRD-K89712525-001-02-1","Preclinical","","KPGXRSRHYNQIFN-UHFFFAOYSA-N","BRD-K89712525","","OC(=O)CCC(=O)C(O)=O"
"5848","2-OXOPROPANOATE","pyruvate dehydrogenase kinase inhibitor","ABAT, AGXT2, PC, PDHB, PKLR, PKM, SLC16A1, SLC16A2, SLC16A3, SLC16A4, SLC16A5, SLC16A6, SLC16A7, SLC16A8","","","Sigma",76.6,"BRD-K86587225-236-02-5","Preclinical","","LCTONWCANYUPML-UHFFFAOYSA-N","BRD-K86587225","","CC(=O)C(O)=O"
"5849","2-PHENYLMELATONIN","melatonin receptor agonist","MTNR1A, MTNR1B","","","Tocris, Tocris",97.9,"BRD-K41869275-001-03-6, BRD-K41869275-001-02-8","Preclinical","","OFCLARYYBGKCHN-UHFFFAOYSA-N","BRD-K41869275","","COc1ccc2[nH]c(c(CCNC(C)=O)c2c1)-c1ccccc1"
"5851","2-PMDQ","adrenergic receptor antagonist","ADRA1A","","","Tocris",93.6,"BRD-A04661934-001-02-9","Preclinical","","ONSOQRPYFKDOEB-UHFFFAOYSA-N","BRD-A04661934","","O=C1Nc2ccccc2C2=NC(CN3CCN(CC3)c3ccccc3)CN12"
"5852","2-PYRIDYLETHYLAMINE","histamine receptor agonist","HRH1","","","Tocris, Tocris",97.88,"BRD-K17874705-300-03-2, BRD-K17874705-300-04-0","Preclinical","","XPQIPUZPSLAZDV-UHFFFAOYSA-N","BRD-K17874705","","NCCc1ccccn1"
"5854","2-TEDC","lipoxygenase inhibitor","ALOX12","","","Tocris",94.84,"BRD-K89072800-001-01-8","Preclinical","","KCGLTUBCAGZLHP-XYOKQWHBSA-N","BRD-K89072800","","Oc1ccc(\C=C(/C#N)C(=O)OCCc2cccs2)cc1O"
"5855","2-THIOURACIL","","","","","Selleck, MicroSource",100,"BRD-K58819470-001-04-2, BRD-K58819470-001-05-9","Preclinical","","ZEMGGZBWXRYJHK-UHFFFAOYSA-N","BRD-K58819470","","Oc1ccnc(S)n1"
"5857","20-HYDROXYECDYSONE","ecdysone receptor modulator","","","","Selleck",92.15,"BRD-K28343777-001-01-6","Preclinical","","NKDFYOWSKOHCCO-HMIIXLFTSA-N","BRD-K28343777","","CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@@H]3CC[C@]12C"
"5858","3'-FLUOROBENZYLSPIPERONE","dopamine receptor ligand","DRD2","","","Tocris, Tocris",93.86,"BRD-K45662124-050-02-3, BRD-K45662124-050-01-5","Preclinical","","DXZKTRNEOISOCA-UHFFFAOYSA-N","BRD-K45662124","","Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(Cc1cccc(F)c1)C2=O)c1ccccc1"
"5860","3,3'-DICHLOROBENZALDAZINE","glutamate receptor allosteric ligand","GRM5","","","Tocris",96.54,"BRD-K82903013-001-01-4","Preclinical","BRD-K50339813-001-01-1","XMOVWXSCYLINBJ-BEQMOXJMSA-N","BRD-K82903013","BRD-K50339813","Clc1cccc(c1)\C=N\N=C\c1cccc(Cl)c1"
"5861","3,3'-DIINDOLYLMETHANE","CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor","AR, HIF1A, IFNG, PI3","","","Enzo",87.7,"BRD-K37846922-001-09-4","Phase 3","","VFTRKSBEFQDZKX-UHFFFAOYSA-N","BRD-K37846922","","C(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12"
"5862","3,4-DCPG-(+/-)","glutamate receptor agonist","GRM8","","","Tocris",0,"BRD-A49947412-001-02-0","Preclinical","","IJVMOGKBEVRBPP-UHFFFAOYSA-N","BRD-A49947412","","NC(C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O"
"5863","3,4-DCPG-(R)","glutamate receptor antagonist","","","","Tocris",0,"BRD-K06204668-001-02-6","Preclinical","","IJVMOGKBEVRBPP-SSDOTTSWSA-N","BRD-K06204668","","N[C@@H](C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O"
"5864","3,4-DCPG-(S)","glutamate receptor agonist","GRM8","","","Tocris",0,"BRD-K86305586-001-02-3","Preclinical","","IJVMOGKBEVRBPP-ZETCQYMHSA-N","BRD-K86305586","","N[C@H](C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O"
"5865","3,5-DHPG-(S)","glutamate receptor agonist","GRM1","","","Tocris",0,"BRD-K57796080-001-03-7","Preclinical","","HOOWCUZPEFNHDT-ZETCQYMHSA-N","BRD-K57796080","","N[C@H](C(O)=O)c1cc(O)cc(O)c1"
"5866","3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE","dopamine uptake inhibitor","CHRM1, SLC6A2, SLC6A3, SLC6A4","","","Tocris",92.63,"BRD-A85216385-003-02-4","Preclinical","","MHNSOBBJZCWUGS-UHFFFAOYSA-N","BRD-A85216385","","CN1C2CCC1CC(C2)OC(c1ccc(F)cc1)c1ccc(F)cc1"
"5867","3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE","","","","","Prestwick",100,"BRD-A43598550-001-09-4","Preclinical","","QGXBDMJGAMFCBF-WRZMNKJASA-N","BRD-A43598550","","C[C@]12CCC3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O"
"5868","3-AMINO-BENZAMIDE","PARP inhibitor","PARP1","","","Selleck, Tocris",96.89,"BRD-K08703257-001-12-1, BRD-K08703257-001-13-9","Phase 2","","GSCPDZHWVNUUFI-UHFFFAOYSA-N","BRD-K08703257","","NC(=O)c1cccc(N)c1"
"5870","3-ANILINOPROPAN-1-OL","","","","","Enamine",11.05,"BRD-K49721826-001-02-7","Preclinical","","GZYBSURBYCLNSM-UHFFFAOYSA-N","BRD-K49721826","","OCCCNc1ccccc1"
"5871","3-AQC","serotonin receptor agonist","HTR3A","","","Tocris",78.92,"BRD-K38370968-050-01-3","Preclinical","","IDOXKFDPDOIUMG-UHFFFAOYSA-N","BRD-K38370968","","C=CCN1CCN(CC1)c1nc2ccccc2nc1C#N"
"5872","3-BROMO-7-NITROINDAZOLE","nitric oxide synthase inhibitor","NOS1, NOS2, NOS3","","","Tocris, Tocris",97.63,"BRD-K24689407-001-07-1, BRD-K24689407-001-06-3","Preclinical","","NFSTZPMYAZRZPC-UHFFFAOYSA-N","BRD-K24689407","","[O-][N+](=O)c1cccc2c(Br)n[nH]c12"
"5874","3-BROMOCAMPHOR","","","","","Vitas-M",0,"BRD-A62841832-001-01-1","Launched","","NJQADTYRAYFBJN-UHFFFAOYSA-N","BRD-A62841832","","CC1(C)C2CCC1(C)C(=O)C2Br"
"5875","3-BROMOPYRUVATE","hexokinase inhibitor","HK2","","","MedChemEx, MedChemEx, Enamine",0,"BRD-K92980438-001-05-8, BRD-K92980438-001-04-1, BRD-K92980438-001-03-3","Preclinical","","PRRZDZJYSJLDBS-UHFFFAOYSA-N","BRD-K92980438","","OC(=O)C(=O)CBr"
"5878","3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R)","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C","","","Tocris",85.96,"BRD-K76592088-001-02-1","Preclinical","","CHZBCZTXSTWCIG-SSDOTTSWSA-N","BRD-K76592088","","N[C@@H](C(O)=O)c1ccc(O)c(c1)C(O)=O"
"5879","3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S)","glutamate receptor antagonist","GRM1, GRM5","","","Tocris",87.81,"BRD-K61585876-001-01-0","Preclinical","","CHZBCZTXSTWCIG-ZETCQYMHSA-N","BRD-K61585876","","N[C@H](C(O)=O)c1ccc(O)c(c1)C(O)=O"
"5880","3-CPMT","dopamine reuptake inhibitor","","","","Tocris",97.29,"BRD-A51713165-003-02-6","Preclinical","","OCAXFDULERPAJM-UHFFFAOYSA-N","BRD-A51713165","","CN1C2CCC1CC(C2)OC(c1ccccc1)c1ccc(Cl)cc1"
"5881","3-DEAZAADENOSINE","adenosylhomocysteinase inhibitor","AHCY","","","Enzo",100,"BRD-A79431551-001-01-1","Phase 2","","DBZQFUNLCALWDY-JXACCQRMSA-N","BRD-A79431551","","Nc1nccc2n(cnc12)[C@@H]1O[C@H](CO)C(O)C1O"
"5882","3-DEAZANEPLANOCIN-A","histone lysine methyltransferase inhibitor","EZH2","","","Selleck, Selleck",97.43,"BRD-K77791657-001-01-1, BRD-K77791657-003-01-7","Preclinical","BRD-K55942458-001-01-7","OMKHWTRUYNAGFG-IEBDPFPHSA-N","BRD-K77791657","BRD-K55942458","Nc1nccc2n(cnc12)[C@@H]1C=C(CO)[C@@H](O)[C@H]1O"
"5884","3-DEAZAURIDINE","cytidine deaminase inhibitor","","","","AMS",99.3,"BRD-A26105646-001-06-1","Preclinical","","WIRVQQCUKDPURA-UHFFFAOYSA-N","BRD-A26105646","","OCC1OC(C(O)C1O)N1C=CC(=O)CC1=O"
"5885","3-HYDROXY-3-PHENYLPENTANAMIDE","GABA receptor modulator","","","","Enamine",96.14,"BRD-A66143912-001-01-1","Phase 1","","MOHYRCCDARWQRM-UHFFFAOYSA-N","BRD-A66143912","","CCC(O)(CC(N)=O)c1ccccc1"
"5886","3-INDOLEBUTYRIC-ACID","","B2M, HLA-A, TRAC, TRBC1","","","Selleck",97.58,"BRD-K43187796-001-02-3","Preclinical","","JTEDVYBZBROSJT-UHFFFAOYSA-N","BRD-K43187796","","OC(=O)CCCc1c[nH]c2ccccc12"
"5887","3-MATIDA","","GRM1","","","Tocris",0,"BRD-A87125127-001-02-2","Preclinical","","KOMWRBFEDDEWEP-UHFFFAOYSA-N","BRD-A87125127","","Cc1cc(sc1C(N)C(O)=O)C(O)=O"
"5888","3-METHYL-GABA","GABA aminotransferase activator","ABAT","","","Tocris",71.72,"BRD-A62890442-077-01-0","Preclinical","BRD-M64651705-077-02-0","CZGLBWZXGIAIBU-UHFFFAOYSA-N","BRD-A62890442","BRD-M64651705","CC(CN)CC(O)=O"
"5889","3-METHYLADENINE","PI3K inhibitor","PI3","","","Selleck, Selleck",86.92,"BRD-K81647657-001-04-3, BRD-K81647657-001-05-0","Preclinical","","ZPBYVFQJHWLTFB-UHFFFAOYSA-N","BRD-K81647657","","Cn1cnc(=N)c2nc[nH]c12"
"5891","3-MPPI","adrenergic receptor ligand","ADRA1A","","","Tocris",86.55,"BRD-K62581435-001-03-8","Preclinical","","AQASGOHUMGAWJJ-UHFFFAOYSA-N","BRD-K62581435","","COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4ccccc4[nH]c3c2=O)CC1"
"5892","3PO","phosphofructokinase inhibitor","PFKFB3","","","MedChemEx",92.61,"BRD-K58413118-001-01-8","Preclinical","","UOWGYMNWMDNSTL-ONEGZZNKSA-N","BRD-K58413118","","O=C(\C=C\c1cccnc1)c1ccncc1"
"5893","4,4'-DDT","","","","","SantaCruz",0,"BRD-K51799616-001-05-5","Preclinical","","YVGGHNCTFXOJCH-UHFFFAOYSA-N","BRD-K51799616","","Clc1ccc(cc1)C(c1ccc(Cl)cc1)C(Cl)(Cl)Cl"
"5894","4,4-PENTAMETHYLENEPIPERIDINE","M2 channel blocker","","","","Tocris",100,"BRD-K49545903-003-01-4","Preclinical","","LIZKZVQBLDHKCY-UHFFFAOYSA-N","BRD-K49545903","","C1CCC2(CC1)CCNCC2"
"5895","4,5,6,7-TETRABROMOBENZOTRIAZOLE","casein kinase inhibitor","AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1","","","Tocris, Tocris",97.69,"BRD-K97118047-001-03-8, BRD-K97118047-001-04-6","Preclinical","","OMZYUVOATZSGJY-UHFFFAOYSA-N","BRD-K97118047","","Brc1c(Br)c(Br)c2[nH]nnc2c1Br"
"5897","4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE","serotonin receptor antagonist","HTR2A","","","Tocris, Tocris",97.38,"BRD-K47337578-034-03-3, BRD-K47337578-034-02-5","Preclinical","","FTJXZACAQRDRNT-UHFFFAOYSA-N","BRD-K47337578","","Fc1ccc(cc1)C(=O)C1CCN(CCCCc2ccccc2)CC1"
"5899","4-ACETYL-1,1-DIMETHYLPIPERAZINIUM","acetylcholine receptor agonist","","","","Tocris",87.43,"BRD-K97019106-005-02-9","Preclinical","","MSBLMBWXUVQCDY-UHFFFAOYSA-N","BRD-K97019106","","CC(=O)N1CC[N+](C)(C)CC1"
"5900","4-AMINOHIPPURIC-ACID","","SLC22A6","","","MicroSource, Selleck, MedChemEx, Selleck, Selleck",100,"BRD-K65544384-001-15-8, BRD-K65544384-236-01-0, BRD-K65544384-236-03-6, BRD-K65544384-001-14-1, BRD-K65544384-236-02-8","Launched","","HSMNQINEKMPTIC-UHFFFAOYSA-N","BRD-K65544384","","Nc1ccc(cc1)C(=O)NCC(O)=O"
"5905","4-CARBOXY-3-HYDROXYPHENYLGLYCINE-(RS)","glutamate receptor agonist, glutamate receptor antagonist","GRM1","","","Tocris",0,"BRD-A80383043-001-03-3","Preclinical","","GXZSAQLJWLCLOX-UHFFFAOYSA-N","BRD-A80383043","","NC(C(O)=O)c1ccc(C(O)=O)c(O)c1"
"5906","4-CARBOXY-3-HYDROXYPHENYLGLYCINE-(S)","glutamate receptor agonist, glutamate receptor antagonist","GRM1, GRM2","","","Tocris",0,"BRD-K74133873-001-01-7","Preclinical","","GXZSAQLJWLCLOX-ZETCQYMHSA-N","BRD-K74133873","","N[C@H](C(O)=O)c1ccc(C(O)=O)c(O)c1"
"5907","4-CHLOROPHENYLGUANIDINE","urokinase inhibitor","PLAUR","","","Tocris",94.15,"BRD-K39160765-003-02-9","Preclinical","","ZSJNJAJDBNFVCA-UHFFFAOYSA-N","BRD-K39160765","","NC(=N)Nc1ccc(Cl)cc1"
"5908","4-CMTB","free fatty acid receptor agonist","FFAR2","","","Tocris",95.73,"BRD-A54139254-001-09-2","Preclinical","","AZYDQCGCBQYFSE-UHFFFAOYSA-N","BRD-A54139254","","CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1"
"5909","4-DAMP","cholinergic receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","","","Tocris",0,"BRD-K29313239-005-09-4","Preclinical","","HYJRTXSYDAFGJK-UHFFFAOYSA-N","BRD-K29313239","","C[N+]1(C)CCC(CC1)OC(=O)C(c1ccccc1)c1ccccc1"
"5910","4-GALACTOSYLLACTOSE","","AMY2B","","","Key",96.9,"BRD-A32796301-001-01-6","Preclinical","","FYGDTMLNYKFZSV-YXENHOCSSA-N","BRD-A32796301","","OC[C@H]1O[C@@H](O[C@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O"
"5911","4-HQN","PARP inhibitor","PARP1","","","Tocris",96.43,"BRD-K91758890-001-10-0","Preclinical","","QMNUDYFKZYBWQX-UHFFFAOYSA-N","BRD-K91758890","","Oc1ncnc2ccccc12"
"5912","4-HYDROXY-PHENAZONE","","","","","Prestwick",80.58,"BRD-K49759007-001-11-9","Preclinical","","SKVPTPMWXJSBTF-UHFFFAOYSA-N","BRD-K49759007","","Cc1c(O)c(=O)n(-c2ccccc2)n1C"
"5913","4-IBP","sigma receptor agonist","SIGMAR1","","","Tocris",98.48,"BRD-K62537556-001-02-5","Preclinical","","HELCSESNNDZLFM-UHFFFAOYSA-N","BRD-K62537556","","Ic1ccc(cc1)C(=O)NC1CCN(Cc2ccccc2)CC1"
"5914","4-IODO-L-PHENYLALANINE","","DPP4","","","Key",87.58,"BRD-K66664625-001-01-2","Preclinical","","PZNQZSRPDOEBMS-MRVPVSSYSA-N","BRD-K66664625","","N[C@H](Cc1ccc(I)cc1)C(O)=O"
"5915","4-IODO-6-PHENYLPYRIMIDINE","macrophage migration inhibiting factor inhibitor","MIF","","","Tocris",98.51,"BRD-K25690923-001-02-4","Preclinical","","ZTCJXHNJVLUUMR-UHFFFAOYSA-N","BRD-K25690923","","Ic1cc(ncn1)-c1ccccc1"
"5916","4-METHYLGENISTEIN","protein tyrosine kinase inhibitor","CYP19A1, ESRRA, ESRRB, ESRRG, FASN","","","Selleck",95.83,"BRD-K73303757-001-21-6","Preclinical","","WUADCCWRTIWANL-UHFFFAOYSA-N","BRD-K73303757","","COc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O"
"5917","4-METHYLHISTAMINE","histamine receptor agonist","HRH4","","","Tocris",90.32,"BRD-K70821460-300-02-4","Preclinical","","UGYXPZQILZRKJJ-UHFFFAOYSA-N","BRD-K70821460","","Cc1nc[nH]c1CCN"
"5918","4-MU-8C","IRE1 inhibitor","ERN1","","","Selleck",94.67,"BRD-K81316007-001-01-8","Preclinical","","RTHHSXOVIJWFQP-UHFFFAOYSA-N","BRD-K81316007","","Cc1cc(=O)oc2c(C=O)c(O)ccc12"
"5919","4-P-PDOT","melatonin receptor antagonist","MTNR1A, MTNR1B","","","Tocris, Tocris",98.79,"BRD-A67482312-001-03-4, BRD-A67482312-001-02-6","Preclinical","","RCYLUNPFECYGDW-UHFFFAOYSA-N","BRD-A67482312","","CCC(=O)NC1CC(c2ccccc2)c2ccccc2C1"
"5921","4-PHENOLSULFONIC-ACID","","","","","Acros",92.14,"BRD-K41024817-325-01-0","Preclinical","","FEPBITJSIHRMRT-UHFFFAOYSA-N","BRD-K41024817","","Oc1ccc(cc1)S(O)(=O)=O"
"5922","4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE","dopamine release inhibitor","","","","Tocris",0,"BRD-M10474530-001-03-1","Preclinical","","YYCOJKPDBCMVPP-UHFFFAOYSA-N","BRD-M10474530","","Cl.C1NCc2ccccc2C1c1ccccc1"
"5923","4-PPBP","sigma receptor ligand","SIGMAR1","","","Tocris, Tocris",96.19,"BRD-K78061844-050-02-7, BRD-K78061844-050-01-9","Preclinical","","HQGDPZPNAXRCSA-UHFFFAOYSA-N","BRD-K78061844","","C(CCc1ccccc1)CN1CCC(CC1)c1ccccc1"
"5925","4-PROPYLBENZOIC-ACID","","","","","Maybridge",0,"BRD-K42108215-001-01-5","Preclinical","","ATZHGRNFEFVDDJ-UHFFFAOYSA-N","BRD-K42108215","","CCCc1ccc(cc1)C(O)=O"
"5926","4-PYRIMIDINECARBONITRILE","","","","","Enamine",0,"BRD-K04552268-001-02-4","Preclinical","","ZIEWSZYVEDTXGH-UHFFFAOYSA-N","BRD-K04552268","","N#Cc1ccncn1"
"5927","4-TERT-BUTYLPHENOL","","","","","Enamine",0,"BRD-K06338106-001-01-4","Preclinical","","QHPQWRBYOIRBIT-UHFFFAOYSA-N","BRD-K06338106","","CC(C)(C)c1ccc(O)cc1"
"5928","4BP-TQS","nicotinic receptor agonist","CHRNA7","","","Tocris",72.37,"BRD-A18598741-001-01-2","Preclinical","","YNCXHXYZTLIZTO-UHFFFAOYSA-N","BRD-A18598741","","NS(=O)(=O)c1ccc2NC(C3CC=CC3c2c1)c1ccc(Br)cc1"
"5929","4EGI-1","protein synthesis inhibitor","EIF4E","","","Selleck, Selleck",70.43,"BRD-K52366702-001-01-6, BRD-K52366702-001-02-4","Preclinical","BRD-A42580913-001-01-2","KFRKRECSIYXARE-HYARGMPZSA-N","BRD-K52366702","BRD-A42580913","OC(=O)C(\Cc1ccccc1[N+]([O-])=O)=N\Nc1nc(cs1)-c1ccc(Cl)c(Cl)c1"
"5931","4E1RCAT","protein synthesis inhibitor","EIF4E, EIF4G1","","","Tocris, Selleck, Selleck",93.43,"BRD-K67173685-001-07-7, BRD-K67173685-001-08-5, BRD-K67173685-001-06-9","Preclinical","BRD-K56468417-001-01-2","BBQRBOIMSKMFFO-LTGZKZEYSA-N","BRD-K67173685","BRD-K56468417","OC(=O)c1ccc(cc1)N1C(=O)C(\C=C1c1ccccc1)=C\c1ccc(o1)-c1ccc(cc1)[N+]([O-])=O"
"5934","4SC-202","HDAC inhibitor","HDAC1","","","MedChemEx, MedChemEx, MedChemEx, Selleck",96.41,"BRD-K11773281-001-02-0, BRD-K11773281-001-01-2, BRD-K11773281-075-01-6, BRD-K11773281-075-02-4","Phase 1","","PRXXYMVLYKJITB-IZZDOVSWSA-N","BRD-K11773281","","Cn1cc(cn1)-c1ccc(cc1)S(=O)(=O)n1ccc(\C=C\C(=O)Nc2ccccc2N)c1"
"5938","5'-CHLORO-5'-DEOXY-ENBA-(+/-)","adenosine receptor agonist","ADORA1","","","Tocris, Tocris",95.3,"BRD-A13598753-001-01-2, BRD-A13598753-001-02-0","Preclinical","","PVJGDYDNVNCGBT-STHLEMNDSA-N","BRD-A13598753","","O[C@@H]1[C@@H](CCl)O[C@H]([C@@H]1O)n1cnc2c(NC3CC4CCC3C4)ncnc12"
"5940","5,7-DICHLOROKYNURENIC-ACID","glutamate receptor antagonist","GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Tocris, Tocris",98.43,"BRD-K60287130-001-06-5, BRD-K60287130-001-05-7","Preclinical","","BGKFPRIGXAVYNX-UHFFFAOYSA-N","BRD-K60287130","","OC(=O)c1cc(O)c2c(Cl)cc(Cl)cc2n1"
"5942","5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-8-(3-METHYL-2-BUTEN-1-YL)-2H-CHROMENE-3,4-DIONE","","","","","Sigma",62.12,"BRD-A61299447-001-01-0","Preclinical","","YHUOJWACHJLNCJ-UHFFFAOYSA-N","BRD-A61299447","","COc1ccc(cc1)C1Oc2c(CC=C(C)C)c(O)cc(O)c2C(=O)C1=O"
"5943","5-(4CHLOROPHENYL)-4-ETHYL-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE","","","","","AMS",0,"BRD-K58146797-001-01-2","Preclinical","","PXINDYJACXPZIN-UHFFFAOYSA-N","BRD-K58146797","","CCn1c(O)nnc1-c1ccc(Cl)cc1"
"5944","5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE","","","","","Berry",98.58,"BRD-K87535339-001-01-6","Preclinical","BRD-A99177285-001-01-9","TZYVRXZQAWPIAB-FCLHUMLKSA-N","BRD-K87535339","BRD-A99177285","Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)sc2c(=O)[nH]1"
"5945","5-AMINOLEVULINIC-ACID","oxidizing agent","ALAD","","","MicroSource, Selleck",100,"BRD-K57631554-003-07-0, BRD-K57631554-003-06-2","Launched","","ZGXJTSGNIOSYLO-UHFFFAOYSA-N","BRD-K57631554","","NCC(=O)CCC(O)=O"
"5947","5-BDBD","purinergic receptor antagonist","P2RX4","","","Tocris, Tocris",98.81,"BRD-K33690734-001-01-5, BRD-K33690734-001-02-3","Preclinical","","NKYMVQPXXTZHSF-UHFFFAOYSA-N","BRD-K33690734","","Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1ccccc21"
"5949","5-CARBOXAMIDOTRYPTAMINE","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","","","Tocris",90.34,"BRD-K92382976-050-01-1","Preclinical","","WKZLNEWVIAGNAW-UHFFFAOYSA-N","BRD-K92382976","","NCCc1c[nH]c2ccc(cc12)C(N)=O"
"5950","5-FLUORO-3-PYRIDYL-METHANOL","","","","","Manchester",96.92,"BRD-K73381198-001-01-1","Preclinical","","GGGJYJXAFSEWNM-UHFFFAOYSA-N","BRD-K73381198","","OCc1cncc(F)c1"
"5951","5-FP","thymidylate synthase inhibitor","TYMS","","","Maybridge, Sigma",0,"BRD-K34437622-001-06-4, BRD-K34437622-001-08-0","Phase 1","","HPABFFGQPLJKBP-UHFFFAOYSA-N","BRD-K34437622","","Oc1ncc(F)cn1"
"5953","5-HMF","","","","","Sigma, OxChem, Sigma",84.12,"BRD-K86799112-001-04-6, BRD-K86799112-001-02-0, BRD-K86799112-001-03-8","Phase 2","","NOEGNKMFWQHSLB-UHFFFAOYSA-N","BRD-K86799112","","OCc1ccc(C=O)o1"
"5956","5-HYDROXYECTOINE","","","","","Sigma",97,"BRD-K03871161-001-01-9","Preclinical","","GJSUWVXFIISKPT-WHFBIAKZSA-N","BRD-K03871161","","O[C@H]1CNC(=C)N[C@@H]1C(O)=O"
"5957","5-HYDROXYMETHYL-TOLTERODINE","acetylcholine receptor antagonist","CHRM3","","","Selleck, Selleck",89.75,"BRD-K24603946-001-02-1, BRD-K24603946-001-03-9","Phase 1","","DUXZAXCGJSBGDW-HXUWFJFHSA-N","BRD-K24603946","","CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C"
"5959","5-IODO-A-85380","acetylcholine receptor agonist","","","","Tocris, Tocris",93.6,"BRD-K90065682-300-03-4, BRD-K90065682-300-02-6","Phase 2","","RKVRGRXOYDTUEY-QMMMGPOBSA-N","BRD-K90065682","","Ic1cncc(OC[C@@H]2CCN2)c1"
"5961","5-METHYLFURMETHIODIDE","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","","","Tocris, Tocris",95.87,"BRD-K45437867-005-04-1, BRD-K45437867-005-03-3","Preclinical","","KOWVJDFMEZKDDT-UHFFFAOYSA-N","BRD-K45437867","","Cc1ccc(C[N+](C)(C)C)o1"
"5963","5-METHYLHYDANTOIN-(D)","","","","","Selleck, Selleck",0,"BRD-K06050544-001-03-1, BRD-K06050544-001-04-9","Preclinical","","VMAQYKGITHDWKL-UWTATZPHSA-N","BRD-K06050544","","C[C@H]1NC(=O)NC1=O"
"5965","5-METHYLHYDANTOIN-(L)","","","","","Prestwick",89.08,"BRD-K56033645-001-07-5","Preclinical","","VMAQYKGITHDWKL-REOHCLBHSA-N","BRD-K56033645","","C[C@@H]1NC(=O)NC1=O"
"5966","6,_7-DEHYDRO-17-ACETOXY-PROGESTERONE","steroidal progestin","","","","InterBioScreen",81.26,"BRD-K48329353-001-01-3","Preclinical","","URXWVWVPMJSAJD-KOORYGTMSA-N","BRD-K48329353","","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O"
"5967","6-AMINOCHRYSENE","transferase inhibitor","","","","Sigma",30.33,"BRD-K00656370-001-10-5","Phase 2","","KIVUHCNVDWYUNP-UHFFFAOYSA-N","BRD-K00656370","","Nc1cc2c3ccccc3ccc2c2ccccc12"
"5968","6-AMINOPENICILLANIC-ACID","","","","","Enamine",0,"BRD-K30284967-001-01-8","Preclinical","","NGHVIOIJCVXTGV-ALEPSDHESA-N","BRD-K30284967","","CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O"
"5969","6-BENZYLAMINOPURINE","purinergic receptor activator","","","","Prestwick",99.22,"BRD-K62929068-001-16-5","Preclinical","","NWBJYWHLCVSVIJ-UHFFFAOYSA-N","BRD-K62929068","","N(Cc1ccccc1)c1ncnc2nc[nH]c12"
"5970","6-CHLOROMELATONIN","melatonin receptor agonist","MTNR1A, MTNR1B","","","Tocris, Tocris",97.22,"BRD-K34663752-001-10-9, BRD-K34663752-001-09-1","Preclinical","","LUINDDOUWHRIPW-UHFFFAOYSA-N","BRD-K34663752","","COc1cc2c(CCNC(C)=O)c[nH]c2cc1Cl"
"5972","6-IODO-NORDIHYDROCAPSAICIN","TRPV antagonist","TRPV1","","","Tocris",92.2,"BRD-K49236613-001-02-3","Preclinical","","AAORACFZMYMFCG-UHFFFAOYSA-N","BRD-K49236613","","CCCCCCCCC(=O)NCc1cc(OC)c(O)cc1I"
"5973","7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE","","","","","Vitas-M",99.06,"BRD-K77756533-001-01-4","Preclinical","","HBEJFHWHFIAMAI-UHFFFAOYSA-N","BRD-K77756533","","O=C1N2CCCCC=C2Nc2ccccc12"
"5974","7-AMINOCEPHALOSPORANIC-ACID","beta lactamase inhibitor","","","","Selleck, Selleck",100,"BRD-K65377893-001-08-2, BRD-K65377893-001-07-4","Preclinical","BRD-K15457970-001-01-4","HSHGZXNAXBPPDL-HZGVNTEJSA-N","BRD-K65377893","BRD-K15457970","CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(O)=O"
"5976","7-CHLOROKYNURENIC-ACID","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C","","","Tocris, Tocris",99.07,"BRD-K84214706-001-06-5, BRD-K84214706-001-05-7","Preclinical","","UAWVRVFHMOSAPU-UHFFFAOYSA-N","BRD-K84214706","","OC(=O)c1cc(O)c2ccc(Cl)cc2n1"
"5978","7-HYDROXY-DPAT","dopamine receptor agonist","DRD2, DRD3","","","Tocris, Tocris, Tocris",89.47,"BRD-A18795974-004-08-1, BRD-A18795974-004-09-9, BRD-A18795974-004-07-3","Preclinical","","BLYMJBIZMIGWFK-UHFFFAOYSA-N","BRD-A18795974","","CCCN(CCC)C1CCc2ccc(O)cc2C1"
"5981","7-HYDROXY-PIPAT","dopamine receptor ligand","DRD3","","","Tocris",54.71,"BRD-A01295252-050-01-2","Preclinical","","RTMIJLQPWFKAFE-FPYGCLRLSA-N","BRD-A01295252","","CCCN(C\C=C\I)C1CCc2ccc(O)cc2C1"
"5982","7-HYDROXYSTAUROSPORINE","CDK inhibitor, CHK inhibitor, PKC inhibitor","CHEK1, MARK3, PDPK1","","","EMDBio",80.79,"BRD-K45293975-001-02-0","Phase 2","","PBCZSGKMGDDXIJ-KRUBCLEUSA-N","BRD-K45293975","","CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13"
"5983","7-KETO-DHEA","steroid","","","","ChemImpex",98.83,"BRD-K07785030-001-01-6","Launched","","VVSMJVQHDZUPIL-XFKPDKBWSA-N","BRD-K07785030","","CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1"
"5984","7-METHOXYTACRINE","acetylcholinesterase inhibitor","ACHE","","","Enamine",98.23,"BRD-K53156626-001-01-3","Phase 2","","APQPVVOYBLOJDY-UHFFFAOYSA-N","BRD-K53156626","","COc1ccc2nc3CCCCc3c(N)c2c1"
"5985","7-METHYLXANTHINE","adenosine receptor antagonist","","","","Sigma",100,"BRD-K41592905-001-01-6","Phase 2","","PFWLFWPASULGAN-UHFFFAOYSA-N","BRD-K41592905","","Cn1cnc2nc(O)nc(O)c12"
"5986","7-NITROINDAZOLE","nitric oxide synthase inhibitor","NOS1, NOS2, NOS3","","","Tocris, Tocris, Tocris",96.6,"BRD-K04430056-001-18-5, BRD-K04430056-236-02-1, BRD-K04430056-001-17-7","Preclinical","","PQCAUHUKTBHUSA-UHFFFAOYSA-N","BRD-K04430056","","[O-][N+](=O)c1cccc2cn[nH]c12"
"5989","8-BROMO-CAMP","PKA activator","","","","Tocris",89.36,"BRD-A09554849-236-07-6","Preclinical","","DVKQVRZMKBDMDH-UUOKFMHZSA-N","BRD-A09554849","","Nc1ncnc2n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c(Br)nc12"
"5990","8-BROMO-CGMP","PKA activator","PRKG1","","","Tocris",87.24,"BRD-A00077618-236-07-6","Preclinical","","YUFCOOWNNHGGOD-UMMCILCDSA-N","BRD-A00077618","","Nc1nc(O)c2nc(Br)n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c2n1"
"5991","8-HYDROXY-DPAT","serotonin receptor agonist","CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG","","","Tocris",93.13,"BRD-A48015106-004-08-9","Preclinical","","ASXGJMSKWNBENU-UHFFFAOYSA-N","BRD-A48015106","","CCCN(CCC)C1CCc2cccc(O)c2C1"
"5992","8-HYDROXY-PIPAT","dopamine receptor ligand","DRD2, DRD3","","","Tocris",97.35,"BRD-A60594020-034-01-1","Preclinical","","QBXHUZJZYDSLRH-RUDMXATFSA-N","BRD-A60594020","","CCCN(C\C=C\I)C1CCc2cccc(O)c2C1"
"5993","8-M-PDOT","melatonin receptor agonist","MTNR1A, MTNR1B","","","Tocris, Tocris",97.76,"BRD-A07232941-001-03-5, BRD-A07232941-001-02-7","Preclinical","","RVIGBTUDFAGRTQ-UHFFFAOYSA-N","BRD-A07232941","","CCC(=O)NC1CCc2cccc(OC)c2C1"
"5995","80841-78-7","","","","","Sigma",0,"BRD-K03044000-001-01-8","Preclinical","","QCLFSYYUWPUWQR-UHFFFAOYSA-N","BRD-K03044000","","Cc1oc(=O)oc1CCl"
"5996","9-AMINOACRIDINE","","","","","Selleck, MicroSource, Selleck",94.54,"BRD-K00535541-001-04-8, BRD-K00535541-001-05-5, BRD-K00535541-001-06-3","Preclinical","","XJGFWWJLMVZSIG-UHFFFAOYSA-N","BRD-K00535541","","Nc1c2ccccc2nc2ccccc12"
"5999","9-AMINOCAMPTOTHECIN","topoisomerase inhibitor","TOP1","","","Sigma",91.91,"BRD-K09291936-001-13-3","Phase 2","","FUXVKZWTXQUGMW-FQEVSTJZSA-N","BRD-K09291936","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc(N)c4cc3Cn1c2=O"
"6000","9-ANTHRACENECARBOXYLIC-ACID","","ANO1, CLCN1","","","Tocris",73.91,"BRD-K62607075-001-03-6","Preclinical","","XGWFJBFNAQHLEF-UHFFFAOYSA-N","BRD-K62607075","","OC(=O)c1c2ccccc2cc2ccccc12"
"6001","DESOXYCORTICOSTERONE-PIVALATE","corticosteroid agonist","NR3C2","endocrinology","Addison's disease","InterBioScreen",98.85,"BRD-K26024145-001-01-9","Launched","","VVOIQBFMTVCINR-WWMZEODYSA-N","BRD-K26024145","","CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"6002","FLUDROCORTISONE-ACETATE","","AR, NR3C1, NR3C2","endocrinology","Addison's disease, adrenogenital syndrome","MicroSource, Sigma",92.71,"BRD-K06408664-001-03-5, BRD-K06408664-001-02-7","Launched","BRD-A38749782-001-04-1","SYWHXTATXSMDSB-GSLJADNHSA-N","BRD-K06408664","BRD-A38749782","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C"
"6004","SURAMIN","DNA synthesis inhibitor","F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5","infectious disease","African trypanosomiasis, onchocerciasis","MicroSource, Tocris",96.4,"BRD-K70327167-348-13-4, BRD-K70327167-348-12-6","Launched","","FIAFUQMPZJWCLV-UHFFFAOYSA-N","BRD-K70327167","","Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O"
"6006","DONEPEZIL","acetylcholinesterase inhibitor","ACHE, HTR2A","neurology/psychiatry","Alzheimer's disease","MicroSource, Selleck",97.71,"BRD-A49160188-003-12-7, BRD-A49160188-003-11-9","Launched","","ADEBPBSSDYVVLD-UHFFFAOYSA-N","BRD-A49160188","","COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC"
"6008","TACRINE","acetylcholinesterase inhibitor","ACHE, BCHE","neurology/psychiatry","Alzheimer's disease","Selleck, Tocris, MicroSource",99.35,"BRD-K81473089-003-24-6, BRD-K81473089-003-25-3, BRD-K81473089-003-26-1","Launched","","YLJREFDVOIBQDA-UHFFFAOYSA-N","BRD-K81473089","","Nc1c2CCCCc2nc2ccccc12"
"6011","IDEBENONE","calcium channel modulator","","neurology/psychiatry, ophthalmology","Alzheimer's disease, Friedreich's ataxia, Leber hereditary optic neuropathy (LHON)","Selleck, Selleck, MicroSource",95.71,"BRD-K37516142-001-11-3, BRD-K37516142-001-09-7, BRD-K37516142-001-10-5","Launched","","JGPMMRGNQUBGND-UHFFFAOYSA-N","BRD-K37516142","","COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O"
"6014","RIVASTIGMINE","acetylcholinesterase inhibitor","ACHE, BCHE","neurology/psychiatry","Alzheimer's disease, Parkinson's Disease, senile dementia","MicroSource, Tocris, Tocris, Selleck",97.89,"BRD-K10706131-046-04-4, BRD-K10706131-046-05-1, BRD-K10706131-046-03-6, BRD-K10706131-046-02-8","Launched","","XSVMFMHYUFZWBK-NSHDSACASA-N","BRD-K10706131","","CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C"
"6018","MEMANTINE","glutamate receptor antagonist","CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A","neurology/psychiatry","Alzheimer's disease, senile dementia","Selleck, Tocris, MicroSource",100,"BRD-A79803969-003-16-1, BRD-A79803969-003-17-9, BRD-A79803969-003-18-7","Launched","","BUGYDGFZZOZRHP-UHFFFAOYSA-N","BRD-A79803969","","CC12CC3CC(C)(C1)CC(N)(C3)C2"
"6021","BENZNIDAZOLE","DNA synthesis inhibitor","","infectious disease","Chagas disease","Toronto",86.94,"BRD-K56156805-001-09-6","Launched","","CULUWZNBISUWAS-UHFFFAOYSA-N","BRD-K56156805","","[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1"
"6022","NIFURTIMOX","DNA inhibitor","","infectious disease","Chagas disease, African trypanosomiasis","Prestwick",95.98,"BRD-A00100033-001-08-9","Launched","","ARFHIAQFJWUCFH-UHFFFAOYSA-N","BRD-A00100033","","CC1CS(=O)(=O)CCN1N=Cc1ccc(o1)[N+]([O-])=O"
"6023","BUDESONIDE","glucocorticoid receptor agonist","NR3C1","gastroenterology","Crohn's disease","Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck",54.98,"BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7","Launched","BRD-A60571864-001-04-1, BRD-K17742695-001-01-1","VOVIALXJUBGFJZ-KWVAZRHASA-N","BRD-A34299591","BRD-A60571864","CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"6024","BUDESONIDE","glucocorticoid receptor agonist","NR3C1","gastroenterology","Crohn's disease","Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck",54.98,"BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7","Launched","BRD-A60571864-001-04-1, BRD-K17742695-001-01-1","VOVIALXJUBGFJZ-KWVAZRHASA-N","BRD-A34299591","BRD-A60571864","CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"6031","BUDESONIDE","glucocorticoid receptor agonist","NR3C1","gastroenterology","Crohn's disease","Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck",54.98,"BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7","Launched","BRD-A60571864-001-04-1, BRD-K17742695-001-01-1","VOVIALXJUBGFJZ-VXKMTNQYSA-N","BRD-A34299591","BRD-A60571864","CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"6032","BUDESONIDE","glucocorticoid receptor agonist","NR3C1","gastroenterology","Crohn's disease","Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck",54.98,"BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7","Launched","BRD-A60571864-001-04-1, BRD-K17742695-001-01-1","VOVIALXJUBGFJZ-VXKMTNQYSA-N","BRD-A34299591","BRD-A60571864","CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"6039","DESONIDE","glucocorticoid receptor agonist","NR3C1, PLA2G1B","gastroenterology","Crohn's disease","MicroSource, Selleck, Selleck",97.37,"BRD-K21528677-001-04-4, BRD-K21528677-001-02-8, BRD-K21528677-001-03-6","Launched","BRD-A26858303-001-02-8, BRD-K30131328-001-01-5","WBGKWQHBNHJJPZ-LECWWXJVSA-N","BRD-K21528677","BRD-A26858303","CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"6042","TRILOSTANE","3beta-hydroxy-delta5-steroid dehydrogenase inhibitor","ESR1, ESR2, HSD3B1, HSD3B2","endocrinology","Cushing's syndrome","MicroSource, MedChemEx, Selleck",99.44,"BRD-A04497688-001-05-9, BRD-A04497688-001-03-4, BRD-A04497688-001-04-2","Launched","BRD-A99644790-001-02-4, BRD-A66155091-001-01-8","RLQVKDVIBJCQGE-WDUCDQOOSA-N","BRD-A04497688","BRD-A99644790","C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O"
"6045","PASIREOTIDE","somatostatin receptor agonist","SSTR1, SSTR2, SSTR3, SSTR5","endocrinology","Cushing's syndrome, acromegaly","MedChemEx",87.58,"BRD-K59715032-362-01-4","Launched","","VMZMNAABQBOLAK-DBILLSOUSA-N","BRD-K59715032","","NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1"
"6046","AMINOGLUTETHIMIDE","glucocorticoid receptor antagonist","CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","MicroSource, Selleck, Selleck",93.51,"BRD-A25234499-001-18-3, BRD-A25234499-001-19-1, BRD-A25234499-001-17-5","Launched","","ROBVIMPUHSLWNV-UHFFFAOYSA-N","BRD-A25234499","","CCC1(CCC(=O)NC1=O)c1ccc(N)cc1"
"6049","CELIPROLOL","adrenergic receptor antagonist","ADRA2A, ADRB1, ADRB2","genetics","Ehlers-Danlos syndrome (EDS)","Prestwick",97.27,"BRD-A95602221-003-02-1","Launched","","JOATXPAWOHTVSZ-UHFFFAOYSA-N","BRD-A95602221","","CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O"
"6050","MIGLUSTAT","Glycosyl transferase inhibitor","UGCG","hematology","Gaucher disease","Enzo",100,"BRD-K33251802-001-01-3","Launched","","UQRORFVVSGFNRO-UTINFBMNSA-N","BRD-K33251802","","CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO"
"6051","ELIGLUSTAT","Glycosyl transferase inhibitor","UGCG","hematology","Gaucher disease, Gaucher disease","MedChemEx, MedChemEx",93.73,"BRD-K86410485-001-01-5, BRD-K86410485-046-01-0","Launched","BRD-M75840137-046-01-1","FJZZPCZKBUKGGU-AUSIDOKSSA-N","BRD-K86410485","BRD-M75840137","CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1"
"6053","PROCARBAZINE","monoamine oxidase inhibitor","","hematologic malignancy","Hodgkin's lymphoma","Selleck, Selleck, MedChemEx, MicroSource",47.77,"BRD-K13032584-003-19-3, BRD-K13032584-003-18-5, BRD-K13032584-003-21-9, BRD-K13032584-001-01-5","Launched","","CPTBDICYNRMXFX-UHFFFAOYSA-N","BRD-K13032584","","CNNCc1ccc(cc1)C(=O)NC(C)C"
"6057","LOMUSTINE","DNA synthesis inhibitor","STMN4","hematologic malignancy, oncology","Hodgkin's lymphoma, brain tumors","MedChemEx, MedChemEx, Selleck, Selleck, MicroSource",0,"BRD-K51768138-001-10-9, BRD-K51768138-001-09-1, BRD-K51768138-001-04-2, BRD-K51768138-001-07-5, BRD-K51768138-001-05-9","Launched","","GQYIWUVLTXOXAJ-UHFFFAOYSA-N","BRD-K51768138","","[O-][N+]N(CCCl)C(=O)NC1CCCCC1"
"6062","MECHLORETHAMINE","DNA inhibitor","","hematologic malignancy, hematology, infectious disease, oncology","Hodgkin's lymphoma, chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), polycythemia vera, mycosis, bronchogenic carcinoma","MedChemEx, Selleck, MedChemEx, MicroSource, Selleck",21.94,"BRD-K12829205-003-05-1, BRD-K12829205-003-02-8, BRD-K12829205-003-04-4, BRD-K12829205-001-04-8, BRD-K12829205-003-03-6","Launched","","HAWPXGHAZFHHAD-UHFFFAOYSA-N","BRD-K12829205","","CN(CCCl)CCCl"
"6067","CYCLOPHOSPHAMIDE","DNA alkylating agent","CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7","hematologic malignancy, oncology","Hodgkin's lymphoma, small lymphocytic lymphoma (SLL), breast cancer, neuroblastoma, Burkitt's lymphoma, multiple myeloma, chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), true histiocytic lymphoma (THL), retinoblastoma, ovarian cancer","MicroSource, Selleck, Selleck",93.6,"BRD-A09722536-002-18-0, BRD-A09722536-002-19-8, BRD-A09722536-002-17-2","Launched","","CMSMOCZEIVJLDB-UHFFFAOYSA-N","BRD-A09722536","","ClCCN(CCCl)P1(=O)NCCCO1"
"6070","VINBLASTINE","microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1","hematologic malignancy, infectious disease, oncology","Hodgkin's lymphoma, true histiocytic lymphoma (THL), mycosis, small lymphocytic lymphoma (SLL), testicular carcinoma, Kaposi sarcoma","MedChemEx, MedChemEx, MedChemEx, MicroSource, Selleck, Selleck, Tocris",96.33,"BRD-K06519765-065-01-6, BRD-K06519765-065-02-4, BRD-K06519765-001-03-7, BRD-K06519765-065-04-0, BRD-K06519765-001-02-9, BRD-K06519765-001-01-1, BRD-K06519765-065-03-2","Launched","BRD-K01188359-065-23-1, BRD-K01188359-001-03-8, BRD-A55594068-065-04-9, BRD-K01188359-001-04-6,BRD-A39708826-001-01-0, BRD-A66484359-001-01-9, BRD-K12515392-065-01-7","JXLYSJRDGCGARV-CFWMRBGOSA-N","BRD-K06519765","BRD-K01188359","CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC"
"6077","SUPLATAST","histamine release inhibitor, immunoglobulin inhibitor","","rheumatology","Kimura's disease","MedChemEx, Tocris, Selleck, MedChemEx, Selleck",36.74,"BRD-A98427211-075-06-1, BRD-A98427211-075-03-8, BRD-A98427211-075-04-6, BRD-A98427211-075-05-3, BRD-A98427211-075-02-0","Launched","","DYZJXZOQQRXDLE-UHFFFAOYSA-O","BRD-A98427211","","CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1"
"6082","AMIFAMPRIDINE","potassium channel blocker","","neurology/psychiatry","Lambert-Eaton myasthenic syndrome (LEMS)","MedChemEx",89.6,"BRD-K80262108-001-07-0","Launched","","OYTKINVCDFNREN-UHFFFAOYSA-N","BRD-K80262108","","Nc1ccncc1N"
"6083","GUANIDINE","HSP inhibitor","ALDH2, DLG4, GAMT, RNASE1","neurology/psychiatry","Lambert-Eaton myasthenic syndrome (LEMS)","Selleck, MicroSource",98.46,"BRD-K76037122-001-02-5, BRD-K76037122-001-01-7","Launched","BRD-M47712611-001-03-3, BRD-M47712611-001-04-1,BRD-M29095938-001-02-3","ZRALSGWEFCBTJO-UHFFFAOYSA-N","BRD-K76037122","BRD-M47712611","NC(N)=N"
"6085","GADOBUTROL","radiopaque medium","","radiology","MRI contrast agent","MedChemEx",100,"BRD-A67181951-001-01-2","Launched","BRD-M08398761-001-01-0","ZPDFIIGFYAHNSK-FUISWZMFSA-K","BRD-A67181951","BRD-M08398761","OCC(O)[C@@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C3)OC(=O)C2"
"6086","GADODIAMIDE","radiopaque medium","","radiology","MRI contrast agent","Selleck",100,"BRD-K38140108-002-01-2","Launched","BRD-M27076668-002-02-9","HZHFFEYYPYZMNU-UHFFFAOYSA-K","BRD-K38140108","BRD-M27076668","CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2"
"6087","GADOTERATE-MEGLUMINE","radiopaque medium","","radiology","MRI contrast agent","Sigma, TCI",97.1,"BRD-K11099631-001-08-4, BRD-K11099631-001-07-6","Launched","","WDLRUFUQRNWCPK-UHFFFAOYSA-N","BRD-K11099631","","OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1"
"6089","GADOTERIDOL","radiopaque medium","","radiology","MRI contrast agent","Kemprotec, MicroSource",86.8,"BRD-A72401848-001-02-2, BRD-A72401848-001-01-4","Launched","BRD-M87846614-001-02-9, BRD-M87846614-001-01-1","DPNNNPAKRZOSMO-UHFFFAOYSA-K","BRD-A72401848","BRD-M87846614","CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3"
"6091","BETAHISTINE","histamine receptor agonist, histamine receptor antagonist","HRH1, HRH3","neurology/psychiatry","Meniere's disease","MicroSource, Selleck",100,"BRD-K91315211-300-06-5, BRD-K91315211-300-05-7","Launched","","UUQMNUMQCIQDMZ-UHFFFAOYSA-N","BRD-K91315211","","CNCCc1ccccn1"
"6093","CINNARAZINE","calcium channel blocker","","neurology/psychiatry, gastroenterology, ophthalmology","Meniere's disease, nausea, vomiting, Cogan's syndrome","MicroSource, ChemDiv",98.16,"BRD-K07220430-001-19-2, BRD-K07220430-001-18-4","Launched","BRD-K32256916-001-04-0","DERZBLKQOCDDDZ-JLHYYAGUSA-N","BRD-K07220430","BRD-K32256916","C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1"
"6095","TASIMELTEON","melatonin receptor agonist","MTNR1A, MTNR1B","neurology/psychiatry","Non-24-Hour Sleep-Wake Disorder","Synnovator",98.42,"BRD-K62971431-001-01-9","Launched","","PTOIAAWZLUQTIO-GXFFZTMASA-N","BRD-K62971431","","CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12"
"6096","ZOLEDRONIC-ACID","bone resorption inhibitor","FDPS, GGPS1","endocrinology","Paget's disease","Selleck, Selleck",0,"BRD-K84253429-001-04-4, BRD-K84253429-001-03-6","Launched","","XRASPMIURGNCCH-UHFFFAOYSA-N","BRD-K84253429","","OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O"
"6098","ETIDRONIC-ACID","bone resorption inhibitor","ATP6V1A, PTPRS","endocrinology, orthopedics","Paget's disease, heterotopic ossification","MicroSource, Selleck, Selleck",0,"BRD-K37949327-304-06-1, BRD-K37949327-001-07-1, BRD-K37949327-001-06-3","Launched","","DBVJJBKOTRCVKF-UHFFFAOYSA-N","BRD-K37949327","","CC(O)(P(O)(O)=O)P(O)(O)=O"
"6101","BENSERAZIDE","DOPA decarboxylase inhibitor","DDC","neurology/psychiatry","Parkinson's Disease","MicroSource, Selleck",93.52,"BRD-A61194565-003-28-8, BRD-A61194565-003-27-0","Launched","","BNQDCRGUHNALGH-UHFFFAOYSA-N","BRD-A61194565","","NC(CO)C(=O)NNCc1ccc(O)c(O)c1O"
"6103","BIPERIDEN","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2","neurology/psychiatry","Parkinson's Disease","MicroSource, Selleck",97.94,"BRD-A00546892-001-02-6, BRD-A00546892-003-05-5","Launched","","YSXKPIUOCJLQIE-UHFFFAOYSA-N","BRD-A00546892","","OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1"
"6105","BUDIPINE","glutamate receptor antagonist","GRIN1","neurology/psychiatry","Parkinson's Disease","AQBioPharma",94.36,"BRD-K18324993-001-01-6","Launched","","QIHLUZAFSSMXHQ-UHFFFAOYSA-N","BRD-K18324993","","CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1"
"6106","CARAMIPHEN","cholinergic receptor antagonist","CHRM1, CHRM2","neurology/psychiatry","Parkinson's Disease","ChemDiv",87.71,"BRD-K59895502-001-01-9","Launched","","OFAIGZWCDGNZGT-UHFFFAOYSA-N","BRD-K59895502","","CCN(CC)CCOC(=O)C1(CCCC1)c1ccccc1"
"6107","CARBIDOPA","aromatic L-amino acid decarboxylase inhibitor","DDC","neurology/psychiatry","Parkinson's Disease","Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource",63.9,"BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3","Launched","BRD-A69512159-001-06-5","TZFNLOMSOLWIDK-JTQLQIEISA-N","BRD-K78712176","BRD-A69512159","C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O"
"6108","CARBIDOPA","aromatic L-amino acid decarboxylase inhibitor","DDC","neurology/psychiatry","Parkinson's Disease","Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource",63.9,"BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3","Launched","BRD-A69512159-001-06-5","TZFNLOMSOLWIDK-JTQLQIEISA-N","BRD-K78712176","BRD-A69512159","CC(Cc1ccc(O)c(O)c1)(NN)C(O)=O"
"6113","CARBIDOPA","aromatic L-amino acid decarboxylase inhibitor","DDC","neurology/psychiatry","Parkinson's Disease","Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource",63.9,"BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3","Launched","BRD-A69512159-001-06-5","TZFNLOMSOLWIDK-UHFFFAOYSA-N","BRD-K78712176","BRD-A69512159","C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O"
"6114","CARBIDOPA","aromatic L-amino acid decarboxylase inhibitor","DDC","neurology/psychiatry","Parkinson's Disease","Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource",63.9,"BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3","Launched","BRD-A69512159-001-06-5","TZFNLOMSOLWIDK-UHFFFAOYSA-N","BRD-K78712176","BRD-A69512159","CC(Cc1ccc(O)c(O)c1)(NN)C(O)=O"
"6119","ENTACAPONE","catechol O methyltransferase inhibitor","COMT","neurology/psychiatry","Parkinson's Disease","MicroSource, Selleck, Selleck",97.02,"BRD-K83636919-001-04-8, BRD-K83636919-001-05-5, BRD-K83636919-001-03-0","Launched","","JRURYQJSLYLRLN-BJMVGYQFSA-N","BRD-K83636919","","CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O"
"6122","LEVODOPA","dopamine precursor","DRD1, DRD2, DRD3, DRD4, DRD5, GPR143","neurology/psychiatry","Parkinson's Disease","Selleck, MicroSource, Selleck",92.55,"BRD-K34730807-001-17-6, BRD-K34730807-001-16-8, BRD-K34730807-001-15-0","Launched","","WTDRDQBEARUVNC-LURJTMIESA-N","BRD-K34730807","","N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O"
"6125","LISURIDE","dopamine receptor agonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6","neurology/psychiatry","Parkinson's Disease","Enzo",92.31,"BRD-K67943528-050-01-4","Launched","","BKRGVLQUQGGVSM-KBXCAEBGSA-N","BRD-K67943528","","CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34"
"6126","MELEVODOPA","dopamine precursor, dopamine receptor agonist","DDC","neurology/psychiatry","Parkinson's Disease","Vitas-M, Sigma",88.63,"BRD-A25827085-001-01-0, BRD-K18749874-003-08-9","Launched","","XBBDACCLCFWBSI-UHFFFAOYSA-N","BRD-A25827085","","COC(=O)C(N)Cc1ccc(O)c(O)c1"
"6127","MELEVODOPA","dopamine precursor, dopamine receptor agonist","DDC","neurology/psychiatry","Parkinson's Disease","Vitas-M, Sigma",88.63,"BRD-A25827085-001-01-0, BRD-K18749874-003-08-9","Launched","","XBBDACCLCFWBSI-UHFFFAOYSA-N","BRD-A25827085","","COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1"
"6128","MELEVODOPA","dopamine precursor, dopamine receptor agonist","DDC","neurology/psychiatry","Parkinson's Disease","Vitas-M, Sigma",88.63,"BRD-A25827085-001-01-0, BRD-K18749874-003-08-9","Launched","","XBBDACCLCFWBSI-ZETCQYMHSA-N","BRD-A25827085","","COC(=O)C(N)Cc1ccc(O)c(O)c1"
"6129","MELEVODOPA","dopamine precursor, dopamine receptor agonist","DDC","neurology/psychiatry","Parkinson's Disease","Vitas-M, Sigma",88.63,"BRD-A25827085-001-01-0, BRD-K18749874-003-08-9","Launched","","XBBDACCLCFWBSI-ZETCQYMHSA-N","BRD-A25827085","","COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1"
"6130","METIXENE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","neurology/psychiatry","Parkinson's Disease","Prestwick",97.52,"BRD-A33711280-003-03-1","Launched","","MJFJKKXQDNNUJF-UHFFFAOYSA-N","BRD-A33711280","","CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1"
"6131","PRAMIPEXOLE","dopamine receptor agonist","ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","neurology/psychiatry","Parkinson's Disease","Tocris, Selleck, Selleck",100,"BRD-K06388322-300-01-3, BRD-K06388322-001-07-4, BRD-K06388322-312-02-6","Launched","","FASDKYOPVNHBLU-ZETCQYMHSA-N","BRD-K06388322","","CCCN[C@H]1CCc2nc(N)sc2C1"
"6134","PROFENAMINE","butyrylcholinesterase inhibitor, cholinergic receptor antagonist","CHRM1, CHRM2, GRIN3A","neurology/psychiatry","Parkinson's Disease","MicroSource, Sigma",45.81,"BRD-A16311756-003-08-5, BRD-A16311756-003-09-3","Launched","","CDOZDBSBBXSXLB-UHFFFAOYSA-N","BRD-A16311756","","CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12"
"6136","R(-)-APOMORPHINE","dopamine receptor agonist","DRD2, HTR5A","neurology/psychiatry","Parkinson's Disease","MicroSource, Tocris, Selleck",97.34,"BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9","Launched","","VMWNQDUVQKEIOC-UHFFFAOYSA-N","BRD-A35931254","","CN1CCc2cccc-3c2C1Cc1ccc(O)c(O)c-31"
"6137","R(-)-APOMORPHINE","dopamine receptor agonist","DRD2, HTR5A","neurology/psychiatry","Parkinson's Disease","MicroSource, Tocris, Selleck",97.34,"BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9","Launched","","VMWNQDUVQKEIOC-UHFFFAOYSA-N","BRD-A35931254","","CN1CCc2cccc-3c2[C@H]1Cc1ccc(O)c(O)c-31"
"6139","R(-)-APOMORPHINE","dopamine receptor agonist","DRD2, HTR5A","neurology/psychiatry","Parkinson's Disease","MicroSource, Tocris, Selleck",97.34,"BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9","Launched","","VMWNQDUVQKEIOC-CYBMUJFWSA-N","BRD-A35931254","","CN1CCc2cccc-3c2C1Cc1ccc(O)c(O)c-31"
"6140","R(-)-APOMORPHINE","dopamine receptor agonist","DRD2, HTR5A","neurology/psychiatry","Parkinson's Disease","MicroSource, Tocris, Selleck",97.34,"BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9","Launched","","VMWNQDUVQKEIOC-CYBMUJFWSA-N","BRD-A35931254","","CN1CCc2cccc-3c2[C@H]1Cc1ccc(O)c(O)c-31"
"6142","RASAGILINE","monoamine oxidase inhibitor","BCL2, MAOB","neurology/psychiatry","Parkinson's Disease","Tocris, Selleck, MicroSource, Selleck",98.6,"BRD-K58114536-066-03-5, BRD-K58114536-066-04-3, BRD-K58114536-001-01-6, BRD-K58114536-066-02-7","Launched","BRD-K58826770-066-01-3","RUOKEQAAGRXIBM-GFCCVEGCSA-N","BRD-K58114536","BRD-K58826770","C#CCN[C@@H]1CCc2ccccc12"
"6146","SAFINAMIDE","dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor","MAOB","neurology/psychiatry","Parkinson's Disease","Selleck",97.9,"BRD-K92613113-066-02-7","Launched","","NEMGRZFTLSKBAP-LBPRGKRZSA-N","BRD-K92613113","","C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O"
"6147","SELEGILINE","monoamine oxidase inhibitor","MAOA, MAOB","neurology/psychiatry","Parkinson's Disease","MicroSource",98.41,"BRD-A28545468-003-16-6","Launched","","MEZLKOACVSPNER-UHFFFAOYSA-N","BRD-A28545468","","CC(Cc1ccccc1)N(C)CC#C"
"6148","PIRIBEDIL","dopamine receptor agonist","ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B","neurology/psychiatry","Parkinson's Disease, dizziness","Tocris",87.35,"BRD-K47936004-003-11-4","Launched","","OQDPVLVUJFGPGQ-UHFFFAOYSA-N","BRD-K47936004","","C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1"
"6149","ISTRADEFYLLINE","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","neurology/psychiatry","Parkinson's Disease, dyskinesia","MedChemEx, MedChemEx, MedChemEx, Selleck, Selleck",95.36,"BRD-K87774949-001-06-2, BRD-K87774949-001-05-4, BRD-K87774949-001-07-0, BRD-K87774949-001-03-9, BRD-K87774949-001-04-7","Launched","","IQVRBWUUXZMOPW-PKNBQFBNSA-N","BRD-K87774949","","CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O"
"6154","ROPINIROLE","dopamine receptor agonist","ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","neurology/psychiatry","Parkinson's Disease, restless leg syndrome","MicroSource, Selleck",97.67,"BRD-K15933101-003-07-9, BRD-K15933101-003-06-1","Launched","","UHSKFQJFRQCDBE-UHFFFAOYSA-N","BRD-K15933101","","CCCN(CCC)CCc1cccc2NC(=O)Cc12"
"6156","ROTIGOTINE","dopamine receptor agonist","ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A","neurology/psychiatry","Parkinson's Disease, restless leg syndrome","Tocris, MedChemEx",98.62,"BRD-K91111634-003-01-8, BRD-K91111634-001-01-2","Launched","","KFQYTPMOWPVWEJ-INIZCTEOSA-N","BRD-K91111634","","CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1"
"6158","CLOMETHIAZOLE","GABA receptor antagonist, GABA receptor modulator","GABRA1","neurology/psychiatry","Parkinson's Disease, sedative, muscle relaxant","Tocris, Enamine",94.39,"BRD-K50422030-003-02-6, BRD-K50422030-001-05-3","Launched","","PCLITLDOTJTVDJ-UHFFFAOYSA-N","BRD-K50422030","","Cc1ncsc1CCCl"
"6160","BUPHENINE","adrenergic receptor agonist","ADRB2","rheumatology","Raynaud's disease","MedChemEx, MicroSource",89.35,"BRD-A36267905-003-19-2, BRD-A36267905-003-18-4","Launched","","PTGXAUBQBSGPKF-UHFFFAOYSA-N","BRD-A36267905","","CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1"
"6162","ISOXSUPRINE","adrenergic receptor agonist","ADRB2","rheumatology, cardiology","Raynaud's disease, arteriosclerosis, Buerger's disease","MicroSource",93.61,"BRD-A16700644-003-04-4","Launched","","BMUKKTUHUDJSNZ-JRSKDTKFSA-N","BRD-A16700644","","CC(COc1ccccc1)NC(C)[C@H](O)c1ccc(O)cc1"
"6163","NICERGOLINE","adrenergic receptor antagonist","ADRA1A","rheumatology, neurology/psychiatry, cardiology, hematology","Raynaud's disease, migraine headache, atherosclerosis, thrombosis, Raynaud's disease, migraine headache, atherosclerosis, thrombosis","Tocris, MicroSource",96.16,"BRD-K76810206-001-08-1, BRD-K76810206-001-07-3","Launched","BRD-A58096341-001-01-2","YSEXMKHXIOCEJA-FVFQAYNVSA-N","BRD-K76810206","BRD-A58096341","CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13"
"6165","TIRATRICOL","thyroid hormone stimulant","THRA, THRB","endocrinology","Refetoff syndrome","Selleck, MicroSource",92.5,"BRD-K61236135-001-08-2, BRD-K61236135-001-09-0","Launched","","UOWZUVNAGUAEQC-UHFFFAOYSA-N","BRD-K61236135","","OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1"
"6167","PIMOZIDE","dopamine receptor antagonist","CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2","neurology/psychiatry","Tourette's disorder","Tocris, Selleck, Tocris, MicroSource",97.81,"BRD-K01292756-001-27-6, BRD-K01292756-001-23-5, BRD-K01292756-001-24-3, BRD-K01292756-001-25-0","Launched","","YVUQSNJEYSNKRX-UHFFFAOYSA-N","BRD-K01292756","","Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1"
"6171","ACTINOMYCIN-D","RNA polymerase inhibitor","","oncology","Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma","MedChemEx, MedChemEx",81.15,"BRD-K16547679-001-01-5, BRD-A42383464-001-06-3","Launched","","RJURFGZVJUQBHK-DCUCITLNSA-N","BRD-K16547679","","CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O"
"6172","ACTINOMYCIN-D","RNA polymerase inhibitor","","oncology","Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma","MedChemEx, MedChemEx",81.15,"BRD-K16547679-001-01-5, BRD-A42383464-001-06-3","Launched","","RJURFGZVJUQBHK-DCUCITLNSA-N","BRD-K16547679","","CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O"
"6173","ACTINOMYCIN-D","RNA polymerase inhibitor","","oncology","Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma","MedChemEx, MedChemEx",81.15,"BRD-K16547679-001-01-5, BRD-A42383464-001-06-3","Launched","","RJURFGZVJUQBHK-UHFFFAOYSA-N","BRD-K16547679","","CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O"
"6174","ACTINOMYCIN-D","RNA polymerase inhibitor","","oncology","Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma","MedChemEx, MedChemEx",81.15,"BRD-K16547679-001-01-5, BRD-A42383464-001-06-3","Launched","","RJURFGZVJUQBHK-UHFFFAOYSA-N","BRD-K16547679","","CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O"
"6175","TRIENTINE","chelating agent","CA14","metabolism","Wilson's disease","MicroSource",100,"BRD-K37111771-300-02-6","Launched","","VILCJCGEZXAXTO-UHFFFAOYSA-N","BRD-K37111771","","NCCNCCNCCN"
"6176","PENICILLAMINE-(D)","chelating agent","","metabolism, rheumatology, nephrology","Wilson's disease, rheumatoid arthritis, cystinuria","Selleck, Selleck",0,"BRD-K17518951-001-03-0, BRD-K17518951-001-04-8","Launched","","VVNCNSJFMMFHPL-VKHMYHEASA-N","BRD-K17518951","","CC(C)(S)[C@@H](N)C(O)=O"
"6178","ADENOSINE","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4","cardiology","Wolff-Parkinson-White Syndrome (WPW)","MicroSource, Selleck",96.7,"BRD-K01577834-001-15-1, BRD-K01577834-001-16-9","Launched","BRD-K63038995-001-01-4","OIRDTQYFTABQOQ-KQYNXXCUSA-N","BRD-K01577834","BRD-K63038995","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"6180","AJMALINE","sodium channel blocker","SCN5A","cardiology","Wolff-Parkinson-White Syndrome (WPW)","MicroSource",81.81,"BRD-A48300215-001-04-8","Launched","","CJDRUOGAGYHKKD-FYGXBCQKSA-N","BRD-A48300215","","CC[C@H]1C2CC3[C@@H]4N(C)c5ccccc5[C@]44C[C@@H](C2C4O)N3[C@@H]1O"
"6181","ROXATIDINE-ACETATE","histamine receptor antagonist","HRH2","gastroenterology","Zollinger-Ellison syndrome, erosive esophagitis (EE), gastroesophageal reflux disease (GERD), gastritis","MedChemEx, Selleck, MicroSource",97.97,"BRD-K81855038-003-14-7, BRD-K81855038-003-12-1, BRD-K81855038-003-13-9","Launched","","SMTZFNFIKUPEJC-UHFFFAOYSA-N","BRD-K81855038","","CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1"
"6184","VASOPRESSIN","vasopressin receptor agonist","AVPR1A, AVPR1B, AVPR2, OXTR","gastroenterology","abdominal distension","Sigma",85.73,"BRD-K73028949-001-02-8","Launched","","KBZOIRJILGZLEJ-LGYYRGKSSA-N","BRD-K73028949","","N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O"
"6185","BUTYLSCOPOLAMINE-BROMIDE","cholinergic receptor antagonist","","gastroenterology","abdominal pain","Selleck",94.79,"BRD-A53951045-004-01-6","Launched","","YBCNXCRZPWQOBR-NQNPYAFXSA-N","BRD-A53951045","","CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@@H](CO)c1ccccc1"
"6186","CAMYLOFINE-CHLORHYDRATE","","","gastroenterology","abdominal pain","Selleck, MicroSource, Selleck",96.03,"BRD-A91733352-300-03-7, BRD-A91733352-300-04-5, BRD-A91733352-300-05-2","Launched","","RYOOHIUJEJZCFT-UHFFFAOYSA-N","BRD-A91733352","","CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1"
"6189","BENZALKONIUM","Cationic surfactant","","dermatology","abrasions, superficial cuts","MicroSource",0,"BRD-K34234316-003-04-7","Launched","","VVZBFOKBSDGVGZ-UHFFFAOYSA-N","BRD-K34234316","","CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1"
"6190","ACAMPROSATE","glutamate receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5","neurology/psychiatry","abstinence from alcohol","MicroSource, Sigma",89.21,"BRD-K26262077-238-01-5, BRD-K26262077-001-01-7","Launched","BRD-M41783010-238-03-5","AFCGFAGUEYAMAO-UHFFFAOYSA-N","BRD-K26262077","BRD-M41783010","CC(=O)NCCCS(O)(=O)=O"
"6192","DISULFIRAM","aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist","ALDH2, DBH","neurology/psychiatry","abstinence from alcohol","MicroSource, Selleck, Selleck",99.04,"BRD-K32744045-001-31-2, BRD-K32744045-001-30-4, BRD-K32744045-001-34-6","Launched","","AUZONCFQVSMFAP-UHFFFAOYSA-N","BRD-K32744045","","CCN(CC)C(=S)SSC(=S)N(CC)CC"
"6195","NALTREXONE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1, SIGMAR1","neurology/psychiatry","abstinence from alcohol","MicroSource, Selleck, Selleck",93.54,"BRD-K88172511-003-21-1, BRD-K88172511-003-19-5, BRD-K88172511-003-20-3","Launched","BRD-A66559694-003-01-8","DQCKKXVULJGBQN-XFWGSAIBSA-N","BRD-K88172511","BRD-A66559694","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O"
"6198","ACETYLCYSTEINE","mucolytic agent","ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11","gastroenterology","acetaminophen overdose, hepatic injury","Selleck, MicroSource, Selleck",88.97,"BRD-K59058747-001-19-1, BRD-K59058747-001-20-9, BRD-K59058747-001-18-3","Launched","BRD-K67174965-001-02-7","PWKSKIMOESPYIA-BYPYZUCNSA-N","BRD-K59058747","BRD-K67174965","CC(=O)N[C@@H](CS)C(O)=O"
"6201","ACETYL-FARNESYL-CYSTEINE","methyltransferase inhibitor","PPARG","dermatology","acne vulgaris (AV)","Cayman, Enzo",81.86,"BRD-K79437791-001-06-5, BRD-K79437791-001-05-7","Launched","","XTURYZYJYQRJDO-BNAHBJSTSA-N","BRD-K79437791","","CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O"
"6203","ADAPALENE","retinoid receptor agonist","RARA, RARB, RARG, RXRA, RXRB, RXRG","dermatology","acne vulgaris (AV)","Tocris, Selleck, MicroSource",99.81,"BRD-K33127281-001-06-4, BRD-K33127281-001-04-9, BRD-K33127281-001-05-6","Launched","","LZCDAPDGXCYOEH-UHFFFAOYSA-N","BRD-K33127281","","COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O"
"6206","BENZOYL-PEROXIDE","oxidizing agent","","dermatology","acne vulgaris (AV)","MicroSource, Sigma",0,"BRD-K59986511-001-04-9, BRD-K59986511-001-06-4","Launched","","OMPJBNCRMGITSC-UHFFFAOYSA-N","BRD-K59986511","","O=C(OOC(=O)c1ccccc1)c1ccccc1"
"6208","FUSIDIC-ACID","bacterial 30S ribosomal subunit inhibitor","","dermatology","acne vulgaris (AV)","MicroSource",96.62,"BRD-A06935312-001-04-3","Launched","","IECPWNUMDGFDKC-FRVBXGIOSA-N","BRD-A06935312","","C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)C2[C@H](O)C[C@@H]2[C@]1(C)C[C@H](OC(C)=O)\C2=C(/CCC=C(C)C)C(O)=O"
"6209","ISOTRETINOIN","retinoid receptor agonist","RARA, RARB, RARG","dermatology","acne vulgaris (AV)","Selleck, MedChemEx, Selleck, MicroSource",51.38,"BRD-K76723084-001-25-7, BRD-K76723084-001-24-0, BRD-K76723084-001-22-4, BRD-K76723084-001-23-2","Launched","BRD-K95366153-001-02-7","SHGAZHPCJJPHSC-XFYACQKRSA-N","BRD-K76723084","BRD-K95366153","CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O"
"6213","LYMECYCLINE","bacterial 50S ribosomal subunit inhibitor","","dermatology","acne vulgaris (AV)","Prestwick",0,"BRD-A15750551-001-01-1","Launched","BRD-A58731732-001-04-5","DZTKAWPWXGIREW-UINNQTPFSA-N","BRD-A15750551","BRD-A58731732","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)C1=O"
"6214","NICOTINAMIDE","protein synthesis stimulant","BST1, LDHA, PARP1, SIRT5","dermatology","acne vulgaris (AV)","MicroSource, Selleck, Selleck",96.39,"BRD-K28912512-001-24-0, BRD-K28912512-001-25-7, BRD-K28912512-001-23-2","Launched","","DFPAKSUCGFBDDF-UHFFFAOYSA-N","BRD-K28912512","","NC(=O)c1cccnc1"
"6217","SALICYLIC-ACID","cyclooxygenase inhibitor","AKR1C1, PTGS1, PTGS2","dermatology","acne vulgaris (AV)","MicroSource",98.29,"BRD-K93632104-001-17-2","Launched","","YGSDEFSMJLZEOE-UHFFFAOYSA-N","BRD-K93632104","","OC(=O)c1ccccc1O"
"6218","RESORCINOL","phosphodiesterase inhibitor","CA12, CA14, CA2, PTGS1","dermatology","acne vulgaris (AV), eczema, psoriasis, seborrheic dermatitis","MicroSource",99.52,"BRD-K74190368-001-04-3","Launched","","GHMLBKRAJCXXBS-UHFFFAOYSA-N","BRD-K74190368","","Oc1cccc(O)c1"
"6219","MECLOCYCLINE-SULFOSALICYLATE","bacterial 50S ribosomal subunit inhibitor","","dermatology, infectious disease","acne vulgaris (AV), skin infections","MicroSource, DuPont, Selleck",82.79,"BRD-A07600638-060-05-2, BRD-A07600638-060-06-0, BRD-A07600638-060-04-5","Launched","","YKYBWGJKLYMCFI-KCDYASHQSA-N","BRD-A07600638","","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6222","NADIFLOXACIN","bacterial DNA gyrase inhibitor","","dermatology, infectious disease","acne vulgaris (AV), skin infections","MicroSource, Selleck",99.02,"BRD-A24397426-001-10-4, BRD-A24397426-001-09-6","Launched","","JYJTVFIEFKZWCJ-UHFFFAOYSA-N","BRD-A24397426","","CC1CCc2c(N3CCC(O)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O"
"6224","CIDOFOVIR","DNA polymerase inhibitor","","infectious disease","acquired immunodeficiency syndrome (AIDS), cytomegalovirus retinitis","Selleck, Selleck",100,"BRD-K96153583-001-05-1, BRD-K96153583-001-04-4","Launched","","VWFCHDSQECPREK-LURJTMIESA-N","BRD-K96153583","","Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1"
"6226","INGENOL-MEBUTATE","PKC activator","PRKCA, PRKCB, PRKCD, PRKCE, PRKCG","dermatology","actinic keratosis (AK)","MedChemEx",97.23,"BRD-K93779381-001-01-9","Launched","","VDJHFHXMUKFKET-WDUFCVPESA-N","BRD-K93779381","","C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C"
"6227","MASOPROCOL","lipoxygenase inhibitor","ALOX5","dermatology","actinic keratosis (AK)","Enzo",89.52,"BRD-A87130939-001-07-9","Launched","","HCZKYJDFEPMADG-UHFFFAOYSA-N","BRD-A87130939","","CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1"
"6228","METHYL-AMINOLEVULINATE","oxidizing agent","FCGR1A, FECH","dermatology","actinic keratosis (AK)","Enzo",0,"BRD-K01292611-003-17-8","Launched","","YUUAYBAIHCDHHD-UHFFFAOYSA-N","BRD-K01292611","","COC(=O)CCC(=O)CN"
"6229","IMIQUIMOD","interferon inducer, toll-like receptor agonist","TLR7, TLR8","dermatology, infectious disease, oncology","actinic keratosis (AK), genital warts, basal cell carcinoma (BCC)","Selleck, MicroSource, Selleck",98.69,"BRD-K26657438-001-17-8, BRD-K26657438-003-01-8, BRD-K26657438-001-15-2","Launched","","DOUYETYNHWVLEO-UHFFFAOYSA-N","BRD-K26657438","","CC(C)Cn1cnc2c(N)nc3ccccc3c12"
"6232","AMINOPENTAMIDE","acetylcholine receptor antagonist","CHRM1","gastroenterology","acute abdominal visceral spasm, hypertrophic gastritis (GHG), nausea","MicroSource",97.37,"BRD-A69917777-065-02-2","Launched","","NARHAGIVSFTMIG-UHFFFAOYSA-N","BRD-A69917777","","CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C"
"6233","TICAGRELOR","purinergic receptor antagonist","P2RY12","cardiology","acute coronary syndrome (ACS), myocardial infarction","Selleck",97.56,"BRD-K44974079-001-01-3","Launched","","OEKWJQXRCDYSHL-MGXMICMRSA-N","BRD-K44974079","","CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1"
"6234","EPTIFIBATIDE","platelet aggregation inhibitor","ITGA2B, ITGB3","cardiology","acute coronary syndrome (ACS), percutaneous coronary intervention (PCI)","Enzo",98.5,"BRD-A90547603-001-02-5","Launched","","CZKPOZZJODAYPZ-UHFFFAOYSA-N","BRD-A90547603","","NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O"
"6235","HEMIN","enzyme inducer","","hematology, cardiology","acute intermittent porphyria (AIP), hypertension, ventricular tachycardia (VT)","InterBioScreen",0,"BRD-M75036822-003-01-7","Launched","","VSTBFMUUCAUPAF-UHFFFAOYSA-N","BRD-M75036822","","[Fe+3].Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C=C)c5C)c(C=C)c4C)c(C)c3CCC(O)=O"
"6236","DEFEROXAMINE-MESYLATE","chelating agent","","hematology","acute iron intoxication, iron overload","Sigma, MicroSource, MedChemEx",95.48,"BRD-K09821361-066-24-1, BRD-K09821361-066-23-3, BRD-K09821361-066-25-8","Launched","","UBQYURCVBFRUQT-UHFFFAOYSA-N","BRD-K09821361","","CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN"
"6239","SIVELESTAT","elastase inhibitor","CELA1, ELANE","pulmonary","acute lung injury","Tocris, MedChemEx, MedChemEx",97.49,"BRD-K02152879-236-01-0, BRD-K02152879-414-02-1, BRD-K02152879-414-01-3","Launched","","BTGNGJJLZOIYID-UHFFFAOYSA-N","BRD-K02152879","","CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O"
"6242","CLOFARABINE","ribonucleotide reductase inhibitor","POLA1, POLD1, POLE, RRM1, RRM2, RRM2B","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Tocris, Tocris, Selleck",98.71,"BRD-K34022604-001-09-0, BRD-K34022604-001-06-6, BRD-K34022604-001-05-8","Launched","","WDDPHFBMKLOVOX-AYQXTPAHSA-N","BRD-K34022604","","Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F"
"6245","MERCAPTOPURINE","immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Selleck, MicroSource",100,"BRD-K91601245-001-12-0, BRD-K91601245-001-13-8","Launched","","GLVAUDGFNGKCSF-UHFFFAOYSA-N","BRD-K91601245","","S=c1[nH]cnc2nc[nH]c12"
"6247","TENIPOSIDE","topoisomerase inhibitor","TOP2A, TOP2B","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Selleck, MicroSource, Selleck",91.09,"BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2","Launched","BRD-K94631066-001-01-3","NRUKOCRGYNPUPR-QBPJDGROSA-N","BRD-K10362825","BRD-K94631066","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12"
"6248","TENIPOSIDE","topoisomerase inhibitor","TOP2A, TOP2B","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Selleck, MicroSource, Selleck",91.09,"BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2","Launched","BRD-K94631066-001-01-3","NRUKOCRGYNPUPR-QBPJDGROSA-N","BRD-K10362825","BRD-K94631066","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12"
"6250","TENIPOSIDE","topoisomerase inhibitor","TOP2A, TOP2B","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Selleck, MicroSource, Selleck",91.09,"BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2","Launched","BRD-K94631066-001-01-3","NRUKOCRGYNPUPR-OQMCATNJSA-N","BRD-K10362825","BRD-K94631066","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12"
"6251","TENIPOSIDE","topoisomerase inhibitor","TOP2A, TOP2B","hematologic malignancy","acute lymphoblastic leukemia (ALL)","Selleck, MicroSource, Selleck",91.09,"BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2","Launched","BRD-K94631066-001-01-3","NRUKOCRGYNPUPR-OQMCATNJSA-N","BRD-K10362825","BRD-K94631066","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12"
"6253","VINCRISTINE","tubulin polymerization inhibitor","TUBA4A, TUBB","hematologic malignancy","acute lymphoblastic leukemia (ALL)","MicroSource, MedChemEx, Tocris, Selleck, MedChemEx, Selleck",90.52,"BRD-K12251893-065-06-2, BRD-K12251893-065-01-3, BRD-K12251893-065-04-7, BRD-K12251893-065-05-4, BRD-K12251893-065-02-1, BRD-K12251893-065-03-9","Launched","BRD-A60414806-065-02-4, BRD-K49229349-065-01-6, BRD-K98953900-065-01-2, BRD-K49229349-065-02-4, BRD-A60578817-065-01-5","OGWKCGZFUXNPDA-CFWMRBGOSA-N","BRD-K12251893","BRD-A60414806","CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC"
"6259","AMSACRINE","topoisomerase inhibitor","KCNH2, TOP2A","hematologic malignancy","acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)","MicroSource, Enzo",95.69,"BRD-K68346641-001-02-2, BRD-K68346641-001-01-4","Launched","BRD-K98490050-001-02-6","XCPGHVQEEXUHNC-UHFFFAOYSA-N","BRD-K68346641","BRD-K98490050","COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12"
"6261","NELARABINE","DNA synthesis inhibitor, T cell inhibitor","POLA1","hematologic malignancy","acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)","Selleck",98.35,"BRD-K84466663-001-05-4","Launched","","IXOXBSCIXZEQEQ-UHTZMRCNSA-N","BRD-K84466663","","COc1nc(N)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O"
"6262","DOXORUBICIN","topoisomerase inhibitor","TOP2A","hematologic malignancy, oncology","acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Wilm's tumor, breast cancer, ovarian cancer, Hodgkin's lymphoma, bladder cancer, multiple myeloma","Selleck, Selleck, MicroSource, Tocris, Tocris, Selleck",96.83,"BRD-K92093830-003-33-2, BRD-K92093830-003-31-6, BRD-K92093830-001-05-4, BRD-K92093830-003-30-8, BRD-K92093830-003-34-0, BRD-K92093830-003-35-7","Launched","BRD-A52530684-001-02-9, BRD-K61468417-003-01-1","AOJJSUZBOXZQNB-TZSSRYMLSA-N","BRD-K92093830","BRD-A52530684","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO"
"6268","CYTARABINE","ribonucleotide reductase inhibitor","POLA1, POLB, POLD1, POLE","hematologic malignancy","acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL)","MicroSource, Selleck, Selleck",100,"BRD-K71847383-001-13-3, BRD-K71847383-001-12-5, BRD-K71847383-001-07-5","Launched","BRD-A57371185-001-04-3, BRD-K33106058-001-16-8","UHDGCWIWMRVCDJ-XVFCMESISA-N","BRD-K71847383","BRD-A57371185","Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1"
"6271","ACLARUBICIN","topoisomerase inhibitor","TOP1, TOP2A","hematologic malignancy","acute myeloid leukemia (AML)","Vitas-M, Vitas-M",24.47,"BRD-A80805100-001-02-7, BRD-A80805100-001-01-9","Launched","","USZYSDMBJDPRIF-UHFFFAOYSA-N","BRD-A80805100","","CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c2c(cc3C(=O)c4cccc(O)c4C(=O)c3c2O)C1C(=O)OC"
"6273","ENASIDENIB","isocitrate dehydrogenase inhibitor","IDH1","hematologic malignancy","acute myeloid leukemia (AML)","MedChemEx",97.55,"BRD-K70601687-001-01-3","Launched","","DYLUUSLLRIQKOE-UHFFFAOYSA-N","BRD-K70601687","","CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F"
"6274","IDARUBICIN","topoisomerase inhibitor","TOP2A","hematologic malignancy","acute myeloid leukemia (AML)","Selleck, Selleck",98.01,"BRD-K69650333-003-13-2, BRD-K69650333-003-14-0","Launched","BRD-K63126143-003-01-4","XDXDZDZNSLXDNA-TZNDIEGXSA-N","BRD-K69650333","BRD-K63126143","C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O"
"6276","IVOSIDENIB","isocitrate dehydrogenase inhibitor","IDH1","hematologic malignancy","acute myeloid leukemia (AML)","MedChemEx",96.63,"BRD-K93073858-001-01-1","Launched","","WIJZXSAJMHAVGX-DHLKQENFSA-N","BRD-K93073858","","Fc1cncc(c1)N([C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)C(=O)[C@@H]1CCC(=O)N1c1cc(ccn1)C#N"
"6277","MIDOSTAURIN","FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG","hematologic malignancy","acute myeloid leukemia (AML)","Enzo",95.95,"BRD-K13646352-001-03-8","Launched","","BMGQWWVMWDBQGC-IIFHNQTCSA-N","BRD-K13646352","","CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1"
"6278","THIOGUANINE","purine antagonist","IMPDH1, IMPDH2","hematologic malignancy","acute myeloid leukemia (AML)","Selleck, MicroSource, MicroSource",100,"BRD-K49350383-001-13-7, BRD-K49350383-001-14-5, BRD-K49350383-001-15-2","Launched","","WYWHKKSPHMUBEB-UHFFFAOYSA-N","BRD-K49350383","","Nc1nc2nc[nH]c2c(=S)[nH]1"
"6281","UBENIMEX","leukotriene synthesis inhibitor","LTA4H, RNPEP","hematologic malignancy","acute myeloid leukemia (AML)","Selleck, Tocris",91.72,"BRD-K59574735-001-11-8, BRD-K59574735-001-12-6","Launched","","VGGGPCQERPFHOB-RDBSUJKOSA-N","BRD-K59574735","","CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O"
"6283","DAUNORUBICIN","RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B","hematologic malignancy","acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL)","MicroSource, Tocris, Selleck, Selleck",90.48,"BRD-K43389675-001-02-1, BRD-K43389675-003-20-9, BRD-K43389675-003-19-1, BRD-K43389675-003-16-7","Launched","BRD-K79347022-003-01-4,BRD-A68009927-003-03-7, BRD-K91966436-003-02-3","STQGQHZAVUOBTE-VGBVRHCVSA-N","BRD-K43389675","BRD-K79347022","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O"
"6287","TRAMADOL","norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor","CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","neurology/psychiatry","acute pain, chronic pain","MicroSource",96.17,"BRD-K51033547-003-02-6","Launched","","TVYLLZQTGLZFBW-GOEBONIOSA-N","BRD-K51033547","","COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C"
"6288","TAPENTADOL","opioid receptor agonist","HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","neurology/psychiatry","acute pain, muscle pain","MicroSource, MedChemEx, MedChemEx",91.75,"BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7","Launched","","KWTWDQCKEHXFFR-FZMZJTMJSA-N","BRD-K25699529","","CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1"
"6289","TAPENTADOL","opioid receptor agonist","HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","neurology/psychiatry","acute pain, muscle pain","MicroSource, MedChemEx, MedChemEx",91.75,"BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7","Launched","","KWTWDQCKEHXFFR-FZMZJTMJSA-N","BRD-K25699529","","CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1"
"6291","TAPENTADOL","opioid receptor agonist","HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","neurology/psychiatry","acute pain, muscle pain","MicroSource, MedChemEx, MedChemEx",91.75,"BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7","Launched","","KWTWDQCKEHXFFR-SMDDNHRTSA-N","BRD-K25699529","","CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1"
"6292","TAPENTADOL","opioid receptor agonist","HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","neurology/psychiatry","acute pain, muscle pain","MicroSource, MedChemEx, MedChemEx",91.75,"BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7","Launched","","KWTWDQCKEHXFFR-SMDDNHRTSA-N","BRD-K25699529","","CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1"
"6294","TAMIBAROTENE","retinoid receptor agonist","RARA, RARB","hematologic malignancy","acute promyelocytic leukemia (APL)","Selleck",97.33,"BRD-K36627727-001-05-4","Launched","","MUTNCGKQJGXKEM-UHFFFAOYSA-N","BRD-K36627727","","CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12"
"6295","TRETINOIN","retinoid receptor agonist, retinoid receptor ligand","ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG","hematologic malignancy","acute promyelocytic leukemia (APL)","MedChemEx, Selleck, Sigma, MedChemEx, Tocris, Selleck, MicroSource",64.55,"BRD-K71879491-001-51-5, BRD-K71879491-001-44-0, BRD-K71879491-001-47-3, BRD-K71879491-001-48-1, BRD-K71879491-001-38-2, BRD-K71879491-001-37-4, BRD-K71879491-001-39-0","Launched","","SHGAZHPCJJPHSC-YCNIQYBTSA-N","BRD-K71879491","","CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O"
"6302","MITOTANE","antineoplastic agent","CYP11A1, CYP11B1, ESR1, FDX1","oncology","adrenal cortical carcinoma","MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",0,"BRD-A31204924-001-18-3, BRD-A31204924-001-14-2, BRD-A31204924-001-17-5, BRD-A31204924-001-16-7, BRD-A31204924-001-13-4","Launched","","JWBOIMRXGHLCPP-UHFFFAOYSA-N","BRD-A31204924","","ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl"
"6307","METYRAPONE","cytochrome P450 inhibitor","CYP11B1","nephrology","adrenal diagnostic agent","Tocris, MicroSource, MedChemEx",92.16,"BRD-K46862739-001-15-0, BRD-K46862739-001-13-5, BRD-K46862739-001-14-3","Launched","","FJLBFSROUSIWMA-UHFFFAOYSA-N","BRD-K46862739","","CC(C)(C(=O)c1cccnc1)c1cccnc1"
"6310","SPECTINOMYCIN","bacterial 30S ribosomal subunit inhibitor","","pulmonary","airsacculitis, chronic respiratory disease","MedChemEx, MedChemEx, Selleck, MicroSource, Selleck",68.33,"BRD-K11905747-300-11-3, BRD-K11905747-300-10-5, BRD-K11905747-300-09-7, BRD-K11905747-300-08-9, BRD-K11905747-300-12-1","Launched","BRD-K38300715-300-01-5","UNFWWIHTNXNPBV-WXKVUWSESA-N","BRD-K11905747","BRD-K38300715","CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O"
"6315","ALCAFTADINE","histamine receptor antagonist","HRH1","allergy","allergic conjunctivitis","MedChemEx",99.28,"BRD-K55991142-001-01-6","Launched","","MWTBKTRZPHJQLH-UHFFFAOYSA-N","BRD-K55991142","","CN1CCC(CC1)=C1c2ncc(C=O)n2CCc2ccccc12"
"6316","SPAGLUMIC-ACID","glutamate receptor antagonist","GRM3","allergy","allergic conjunctivitis, allergic rhinitis","Prestwick, Tocris",98.11,"BRD-K68405354-001-07-2, BRD-K68405354-001-06-4","Launched","BRD-K96659869-001-09-4","OPVPGKGADVGKTG-BQBZGAKWSA-N","BRD-K68405354","BRD-K96659869","CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"6318","DEXCHLORPHENIRAMINE","histamine receptor antagonist","","allergy, cardiology","allergic conjunctivitis, allergic rhinitis, urticaria, angioedema","MicroSource",95.84,"BRD-K39462424-050-09-8","Launched","","SOYKEARSMXGVTM-HNNXBMFYSA-N","BRD-K39462424","","CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1"
"6319","ACITAZANOLAST","mediator release inhibitor","","allergy","allergic rhinitis","LifeChem, LifeChem",96.68,"BRD-K74236708-001-01-9, BRD-K74236708-001-02-7","Launched","","VWQZJJZGISNFOE-UHFFFAOYSA-N","BRD-K74236708","","OC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1"
"6321","ACRIVASTINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","Enzo",89.65,"BRD-K50163129-001-01-4","Launched","","PWACSDKDOHSSQD-IUTFFREVSA-N","BRD-K50163129","","Cc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1"
"6322","AZATADINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","MicroSource, Selleck",91.41,"BRD-K77821588-050-01-7, BRD-K77821588-364-01-2","Launched","","SEBMTIQKRHYNIT-UHFFFAOYSA-N","BRD-K77821588","","CN1CCC(CC1)=C1c2ccccc2CCc2cccnc12"
"6324","BECLOMETHASONE","glucocorticoid receptor agonist","NR3C1, SERPINA6","allergy","allergic rhinitis","AvaChem",90.36,"BRD-A73385064-001-01-5","Launched","","NBMKJKDGKREAPL-UHFFFAOYSA-N","BRD-A73385064","","CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO"
"6325","BECLOMETHASONE-DIPROPIONATE","glucocorticoid receptor agonist","GPR97, NR3C1","allergy","allergic rhinitis","MicroSource, Selleck, Selleck",98.04,"BRD-K97810537-001-13-6, BRD-K97810537-001-12-8, BRD-K97810537-001-14-4","Launched","BRD-A11319535-001-03-6, BRD-K97429934-001-01-9,BRD-K76747609-001-02-1","KUVIULQEHSCUHY-XYWKZLDCSA-N","BRD-K97810537","BRD-A11319535","CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C"
"6328","CETIRIZINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","MicroSource, Tocris, Selleck",98.06,"BRD-A42571354-300-13-8, BRD-A42571354-300-12-0, BRD-A42571354-300-11-2","Launched","","ZKLPARSLTMPFCP-UHFFFAOYSA-N","BRD-A42571354","","OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1"
"6331","CHLORCYCLIZINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","Enzo",97.82,"BRD-A57133233-003-11-0","Launched","","WFNAKBGANONZEQ-UHFFFAOYSA-N","BRD-A57133233","","CN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1"
"6332","CICLESONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","allergy","allergic rhinitis","Enzo",98.53,"BRD-K35245662-001-01-2","Launched","","LUKZNWIVRBCLON-GXOBDPJESA-N","BRD-K35245662","","CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1"
"6333","CLEMIZOLE","HCV inhibitor","","allergy","allergic rhinitis","Tocris, MicroSource",97.9,"BRD-K04704168-003-15-0, BRD-K04704168-003-14-3","Launched","","CJXAEXPPLWQRFR-UHFFFAOYSA-N","BRD-K04704168","","Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1"
"6335","DIMETINDENE","histamine receptor antagonist, cholinergic receptor antagonist","CHRM2, HRH1","allergy","allergic rhinitis","AMS",52.79,"BRD-A54141700-001-01-5","Launched","","MVMQESMQSYOVGV-UHFFFAOYSA-N","BRD-A54141700","","CC(C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1"
"6336","DIPHENYLPYRALINE","dopamine uptake inhibitor","HRH1, SLC6A3","allergy","allergic rhinitis","MicroSource, Selleck",97.93,"BRD-K22936972-003-23-6, BRD-K22936972-003-22-8","Launched","","OWQUZNMMYNAXSL-UHFFFAOYSA-N","BRD-K22936972","","CN1CCC(CC1)OC(c1ccccc1)c1ccccc1"
"6338","FLUNISOLIDE","cytochrome P450 inhibitor","NR3C1","allergy","allergic rhinitis","MicroSource",93.61,"BRD-A65449987-001-10-4","Launched","","XSFJVAJPIHIPKU-CCRGDLLISA-N","BRD-A65449987","","CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO"
"6339","HISTAMINE","histamine receptor agonist","HRH1, HRH2, HRH3, HRH4","allergy","allergic rhinitis","Tocris, Tocris, Selleck, MicroSource, Selleck, Selleck",100,"BRD-K01674964-300-07-1, BRD-K01674964-300-10-5, BRD-K01674964-001-19-0, BRD-K01674964-300-08-9, BRD-K01674964-316-01-0, BRD-K01674964-300-06-3","Launched","BRD-U61402069-000-01-5","NTYJJOPFIAHURM-UHFFFAOYSA-N","BRD-K01674964","BRD-U61402069","NCCc1c[nH]cn1"
"6345","HOMOCHLORCYCLIZINE","antihistamine","HRH1","allergy","allergic rhinitis","Enzo",96.11,"BRD-A22769835-300-05-7","Launched","","WEUCDJCFJHYFRL-UHFFFAOYSA-N","BRD-A22769835","","CN1CCCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1"
"6346","OXATOMIDE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","Vitas-M",95.48,"BRD-K02079473-001-01-3","Launched","","BAINIUMDFURPJM-UHFFFAOYSA-N","BRD-K02079473","","O=c1[nH]c2ccccc2n1CCCN1CCN(CC1)C(c1ccccc1)c1ccccc1"
"6347","TRIPROLIDINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis","MicroSource, Tocris",98.84,"BRD-K11742128-003-23-4, BRD-K11742128-003-22-6","Launched","","CBEQULMOCCWAQT-WOJGMQOQSA-N","BRD-K11742128","","Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1"
"6349","TYMAZOLINE","","","allergy","allergic rhinitis","Sigma",53.77,"BRD-K64414150-001-01-7","Launched","","AFQQVNXTHGUXEQ-UHFFFAOYSA-N","BRD-K64414150","","CC(C)c1ccc(C)cc1OC=C1NCCN1"
"6350","PREDNISOLONE-SODIUM-PHOSPHATE","glucocorticoid receptor agonist","NR3C1","allergy, pulmonary, ophthalmology, infectious disease, rheumatology, endocrinology, neurology/psychiatry, gastroenterology, hematology","allergic rhinitis, asthma, contact dermatitis, mycosis, lupus, hypercalcemia, thyroiditis, congenital adrenal hyperplasia, multiple sclerosis, ulcerative colitis, enteritis, thrombocythemia, pneumonia, asthma, meningitis, psoriatic arthritis, rheumatoid arthritis","MicroSource",84.46,"BRD-A94523291-304-02-7","Launched","","JDOZJEUDSLGTLU-YDAVOWJHSA-N","BRD-A94523291","","C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O"
"6351","BROMPHENIRAMINE","histamine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1","allergy, otolaryngology","allergic rhinitis, common cold","MicroSource, Selleck",92.64,"BRD-A68723818-050-32-5, BRD-A68723818-050-31-7","Launched","","ZDIGNSYAACHWNL-UHFFFAOYSA-N","BRD-A68723818","","CN(C)CCC(c1ccc(Br)cc1)c1ccccn1"
"6353","PHENINDAMINE","histamine receptor antagonist","HRH1","allergy, otolaryngology","allergic rhinitis, common cold","AMS, AMS",47.35,"BRD-A33178345-001-02-2, BRD-A33178345-001-01-4","Launched","","ISFHAYSTHMVOJR-UHFFFAOYSA-N","BRD-A33178345","","CN1CCC2=C(C1)C(c1ccccc21)c1ccccc1"
"6355","CARBINOXAMINE","histamine receptor antagonist","HRH1","allergy, ophthalmology, otolaryngology, dermatology","allergic rhinitis, conjunctivitis, vasomotor rhinitis, dermatographism","MicroSource",98.35,"BRD-A29426959-050-13-2","Launched","","OJFSXZCBGQGRNV-UHFFFAOYSA-N","BRD-A29426959","","CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1"
"6356","LORATADINE","histamine receptor antagonist","HRH1","allergy, neurology/psychiatry","allergic rhinitis, itching","Tocris, MicroSource, Selleck, Tocris",99.62,"BRD-K82795137-001-28-8, BRD-K82795137-001-26-2, BRD-K82795137-001-24-7, BRD-K82795137-001-25-4","Launched","","JCCNYMKQOSZNPW-UHFFFAOYSA-N","BRD-K82795137","","CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12"
"6360","CHLORPHENAMINE","histamine receptor antagonist","HRH1, SLC6A2, SLC6A3, SLC6A4","allergy","allergic rhinitis, urticaria","Selleck",96.29,"BRD-A04553218-050-16-2","Launched","","SOYKEARSMXGVTM-UHFFFAOYSA-N","BRD-A04553218","","CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1"
"6361","CLEMASTINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","Tocris, MicroSource, Selleck, Tocris",96.36,"BRD-K30240666-051-16-7, BRD-K30240666-051-15-9, BRD-K30240666-051-13-4, BRD-K30240666-051-14-2","Launched","","YNNUSGIPVFPVBX-NHCUHLMSSA-N","BRD-K30240666","","CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1"
"6365","DESLORATADINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","MicroSource, Selleck, Selleck",91.35,"BRD-K82357231-001-18-3, BRD-K82357231-001-19-1, BRD-K82357231-001-17-5","Launched","","JAUOIFJMECXRGI-UHFFFAOYSA-N","BRD-K82357231","","Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1"
"6368","EBASTINE","histamine receptor antagonist","CYP3A4, HRH1","allergy","allergic rhinitis, urticaria","Selleck",92.12,"BRD-K13314656-001-01-0","Launched","","MJJALKDDGIKVBE-UHFFFAOYSA-N","BRD-K13314656","","CC(C)(C)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1"
"6369","FEXOFENADINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","MicroSource, Tocris, Tocris, Selleck",98.09,"BRD-A73368467-003-18-4, BRD-A73368467-003-17-6, BRD-A73368467-003-19-2, BRD-A73368467-003-16-8","Launched","","RWTNPBWLLIMQHL-UHFFFAOYSA-N","BRD-A73368467","","CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1"
"6373","LEVOCETIRIZINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","MicroSource",94.6,"BRD-K27184429-300-01-3","Launched","BRD-K18097163-300-02-6","ZKLPARSLTMPFCP-OAQYLSRUSA-N","BRD-K27184429","BRD-K18097163","OC(=O)COCCN1CCN(CC1)[C@H](c1ccccc1)c1ccc(Cl)cc1"
"6374","MEBHYDROLIN","antihistamine","","allergy","allergic rhinitis, urticaria","MicroSource",90.08,"BRD-K29713308-001-01-7","Launched","","FQQIIPAOSKSOJM-UHFFFAOYSA-N","BRD-K29713308","","CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1"
"6375","PHENIRAMINE","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","Selleck, MicroSource",98.32,"BRD-A23072235-050-17-7, BRD-A23072235-050-18-5","Launched","","IJHNSHDBIRRJRN-UHFFFAOYSA-N","BRD-A23072235","","CN(C)CCC(c1ccccc1)c1ccccn1"
"6377","RUPATADINE","histamine receptor antagonist, platelet activating factor receptor antagonist","HRH1, PTAFR","allergy","allergic rhinitis, urticaria","Selleck",91.72,"BRD-K98004573-051-02-8","Launched","","WUZYKBABMWJHDL-UHFFFAOYSA-N","BRD-K98004573","","Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1"
"6378","CYPROHEPTADINE","histamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7","allergy, otolaryngology, ophthalmology, dermatology","allergic rhinitis, vasomotor rhinitis, conjunctivitis, urticaria, dermatographism","MicroSource, Tocris, MicroSource, Selleck",98.68,"BRD-K28143534-001-02-2, BRD-K28143534-003-25-9, BRD-K28143534-003-26-7, BRD-K28143534-003-24-2","Launched","","JJCFRYNCJDLXIK-UHFFFAOYSA-N","BRD-K28143534","","CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12"
"6382","CARBARSONE","antiprotozoal agent","","infectious disease","amebiasis","MicroSource",69.44,"BRD-K94848716-001-11-6","Launched","","WWXBHTZSYYGCSG-UHFFFAOYSA-N","BRD-K94848716","","NC(=O)Nc1ccc(cc1)[As](O)(O)=O"
"6383","CHINIOFON","antiprotozoal agent","","infectious disease","amebiasis","MicroSource",95.18,"BRD-K52284881-236-02-4","Launched","","ZBJWWKFMHOAPNS-UHFFFAOYSA-N","BRD-K52284881","","Oc1c(I)cc(c2cccnc12)S(O)(=O)=O"
"6384","DILOXANIDE","protein synthesis inhibitor","","infectious disease","amebiasis","MicroSource",98.59,"BRD-K10974103-001-21-1","Launched","","BDYYDXJSHYEDGB-UHFFFAOYSA-N","BRD-K10974103","","CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1"
"6385","IODOQUINOL","antiseptic","","infectious disease","amebiasis","MicroSource",88.89,"BRD-K75855670-001-14-2","Launched","","UXZFQZANDVDGMM-UHFFFAOYSA-N","BRD-K75855670","","Oc1c(I)cc(I)c2cccnc12"
"6386","PAROMOMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","amebiasis","MicroSource, MedChemEx, Sigma, Selleck, Selleck",97.2,"BRD-K36524108-065-06-5, BRD-K36524108-065-04-0, BRD-K36524108-065-07-3, BRD-K36524108-065-05-7, BRD-K36524108-065-03-2","Launched","BRD-A20920572-065-04-7, BRD-M40700687-001-01-8, BRD-K25359791-065-01-2","UOZODPSAJZTQNH-LSWIJEOBSA-N","BRD-K36524108","BRD-A20920572","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"6391","RILUZOLE","glutamate inhibitor","KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11","neurology/psychiatry","amyotrophic lateral sclerosis (ALS)","Tocris, MicroSource, Selleck",99.88,"BRD-K21283037-003-11-2, BRD-K21283037-001-21-5, BRD-K21283037-001-20-7","Launched","","FTALBRSUTCGOEG-UHFFFAOYSA-N","BRD-K21283037","","Nc1nc2ccc(OC(F)(F)F)cc2s1"
"6394","EPERISONE","acetylcholine receptor antagonist","CYP2J2","neurology/psychiatry","amyotrophic lateral sclerosis (ALS), spasms, head injury, spinal injury","CombiBlocks",99,"BRD-A04252265-003-01-4","Launched","","SQUNAWUMZGQQJD-UHFFFAOYSA-N","BRD-A04252265","","CCc1ccc(cc1)C(=O)C(C)CN1CCCCC1"
"6395","PENTAGASTRIN","CCK receptor agonist","CCKBR","gastroenterology","anacidity diagnostic, gastric hypersecretion diagnostic, anacidity diagnostic, gastric hypersecretion diagnostic","MicroSource, Abblis",84.88,"BRD-K78789465-001-02-4, BRD-K78789465-001-01-6","Launched","BRD-K92045627-001-01-0","NEYNJQRKHLUJRU-DZUOILHNSA-N","BRD-K78789465","BRD-K92045627","CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O"
"6397","FINASTERIDE","5 alpha reductase inhibitor","AKR1D1, SRD5A1, SRD5A2","endocrinology","androgenetic alopecia","MicroSource, Selleck",98.24,"BRD-K01095011-001-15-9, BRD-K01095011-001-14-2","Launched","BRD-A83081521-001-02-3, BRD-K37882277-001-01-7","DBEPLOCGEIEOCV-WSBQPABSSA-N","BRD-K01095011","BRD-A83081521","CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C"
"6399","MINOXIDIL","KATP activator, Kir6 channel (KATP) activator, vasodilator","ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1","endocrinology","androgenetic alopecia","Tocris, MicroSource, Selleck, Sigma, Tocris",96.36,"BRD-K06902185-001-21-9, BRD-K06902185-003-01-7, BRD-K06902185-001-16-9, BRD-K06902185-001-22-7, BRD-K06902185-001-17-7","Launched","BRD-K14888893-001-14-8","ZFMITUMMTDLWHR-UHFFFAOYSA-N","BRD-K06902185","BRD-K14888893","Nc1cc(nc(N)[n+]1[O-])N1CCCCC1"
"6404","PROMESTRIENE","estrogen receptor agonist","ESR1","endocrinology","androgenetic alopecia","Carbosynth",0,"BRD-K75097983-001-01-0","Launched","","IUWKNLFTJBHTSD-AANPDWTMSA-N","BRD-K75097983","","CCCOc1ccc2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCc2c1)OC"
"6405","NANDROLONE","imidazoline receptor agonist","AR, CYP19A1, MAOA, MAOB","hematology","anemia","MedChemEx, MedChemEx",95.76,"BRD-K52080565-001-09-2, BRD-K52080565-001-10-0","Launched","","NPAGDVCDWIYMMC-IZPLOLCNSA-N","BRD-K52080565","","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O"
"6407","OXYMETHOLONE","androgen receptor agonist","AR","hematology","anemia","Selleck, Selleck",35.22,"BRD-A93291428-001-02-0, BRD-A23637604-001-04-1","Launched","BRD-A16767899-001-01-5","DLZUBMGMHUNDLF-UHFFFAOYSA-N","BRD-A93291428","BRD-A16767899","CC1(O)CCC2C3CCC4CC(=O)C(CC4(C)C3CCC12C)C=O"
"6408","OXYMETHOLONE","androgen receptor agonist","AR","hematology","anemia","Selleck, Selleck",35.22,"BRD-A93291428-001-02-0, BRD-A23637604-001-04-1","Launched","BRD-A16767899-001-01-5","DLZUBMGMHUNDLF-UHFFFAOYSA-N","BRD-A93291428","BRD-A16767899","C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@H]3CC[C@]12C)C=O"
"6409","OXYMETHOLONE","androgen receptor agonist","AR","hematology","anemia","Selleck, Selleck",35.22,"BRD-A93291428-001-02-0, BRD-A23637604-001-04-1","Launched","BRD-A16767899-001-01-5","DLZUBMGMHUNDLF-CVSXEEBHSA-N","BRD-A93291428","BRD-A16767899","CC1(O)CCC2C3CCC4CC(=O)C(CC4(C)C3CCC12C)C=O"
"6410","OXYMETHOLONE","androgen receptor agonist","AR","hematology","anemia","Selleck, Selleck",35.22,"BRD-A93291428-001-02-0, BRD-A23637604-001-04-1","Launched","BRD-A16767899-001-01-5","DLZUBMGMHUNDLF-CVSXEEBHSA-N","BRD-A93291428","BRD-A16767899","C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@H]3CC[C@]12C)C=O"
"6411","STANOZOLOL","androgen receptor agonist","AR","hematology","anemia","Prestwick",97.25,"BRD-K46791647-001-01-2","Launched","","LKAJKIOFIWVMDJ-IYRCEVNGSA-N","BRD-K46791647","","C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C"
"6412","CYANOCOBALAMIN","methylmalonyl CoA mutase stimulant, vitamin B","MMAA, MMACHC, MTHFR, MTR, MTRR, MUT","hematology, infectious disease, gastroenterology","anemia, fish tapeworm infestation, celiac disease","MicroSource, Selleck",97.22,"BRD-A18627414-001-05-6, BRD-A18627414-001-04-9","Launched","BRD-A59561452-001-01-9, BRD-M14495474-001-01-4,BRD-A97502381-001-01-3|BRD-M38660727-001-01-0","RMRCNWBMXRMIRW-WZHZPDAFSA-M","BRD-A18627414","BRD-A59561452","C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12"
"6414","ELTROMBOPAG","thrombopoietin receptor agonist","MPL","hematology, infectious disease","anemia, hepatitis C, thrombocytopenia","Selleck, Selleck, Selleck",97.73,"BRD-K40496271-396-01-1, BRD-K40496271-001-02-5, BRD-K40496271-001-03-3","Launched","","XDXWLKQMMKQXPV-HPNDGRJYSA-N","BRD-K40496271","","CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1"
"6417","PIPECURONIUM","neuromuscular blocker","CHRM2, CHRM3, CHRNA2","neurology/psychiatry","anesthetic","Kemprotec",98.54,"BRD-A21544762-303-01-5","Launched","","OWWLUIWOFHMHOQ-XUCOTFPHSA-N","BRD-A21544762","","CC(=O)OC1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1"
"6418","PRILOCAINE","local anesthetic","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","anesthetic","MicroSource, Selleck",98.67,"BRD-A53952395-003-25-1, BRD-A53952395-001-02-4","Launched","","MVFGUOIZUNYYSO-UHFFFAOYSA-N","BRD-A53952395","","CCCNC(C)C(=O)Nc1ccccc1C"
"6420","PROCAINE","HMGCR inhibitor","CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3","neurology/psychiatry","anesthetic","MicroSource, Selleck",99.21,"BRD-K24616672-003-20-1, BRD-K24616672-003-19-3","Launched","","MFDFERRIHVXMIY-UHFFFAOYSA-N","BRD-K24616672","","CCN(CC)CCOC(=O)c1ccc(N)cc1"
"6422","PROPOFOL","benzodiazepine receptor agonist","FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A","neurology/psychiatry","anesthetic","MicroSource, Enamine",76.91,"BRD-K82255054-001-15-9, BRD-K82255054-001-17-5","Launched","","OLBCVFGFOZPWHH-UHFFFAOYSA-N","BRD-K82255054","","CC(C)c1cccc(C(C)C)c1O"
"6424","PROPOXYCAINE","local anesthetic","","neurology/psychiatry","anesthetic","MicroSource",98.96,"BRD-K18250272-003-11-0","Launched","","CAJIGINSTLKQMM-UHFFFAOYSA-N","BRD-K18250272","","CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC"
"6425","PROXYMETACAINE","sodium channel blocker","SCN10A, SCN5A","neurology/psychiatry","anesthetic","MicroSource, Selleck",97.7,"BRD-K79116891-003-15-1, BRD-K79116891-003-14-4","Launched","","KCLANYCVBBTKTO-UHFFFAOYSA-N","BRD-K79116891","","CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC"
"6427","ROCURONIUM","acetylcholine receptor antagonist","CHRM2, CHRNA2, HTR3A","neurology/psychiatry","anesthetic","MicroSource, Selleck",100,"BRD-K43305603-004-03-6, BRD-K43305603-004-02-8","Launched","BRD-A40127632-004-01-8, BRD-K58951486-004-01-5","YXRDKMPIGHSVRX-OOJCLDBCSA-N","BRD-K43305603","BRD-A40127632","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1"
"6429","ROPIVACAINE","sodium channel blocker","SCN10A","neurology/psychiatry","anesthetic","Selleck",97.16,"BRD-K50938786-003-11-8","Launched","","ZKMNUMMKYBVTFN-HNNXBMFYSA-N","BRD-K50938786","","CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C"
"6430","SEVOFLURANE","membrane integrity inhibitor","ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1","neurology/psychiatry","anesthetic","Enamine, Enamine",0,"BRD-K05638300-001-02-0, BRD-K05638300-001-01-2","Launched","","DFEYYRMXOJXZRJ-UHFFFAOYSA-N","BRD-K05638300","","FCOC(C(F)(F)F)C(F)(F)F"
"6432","SUFENTANIL","opioid receptor modulator","OPRD1, OPRK1, OPRM1","neurology/psychiatry","anesthetic","MedChemEx",94.14,"BRD-K21547160-001-01-4","Launched","","GGCSSNBKKAUURC-UHFFFAOYSA-N","BRD-K21547160","","CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1"
"6433","TETRACAINE","membrane integrity inhibitor","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","anesthetic","Selleck, MicroSource",98.82,"BRD-K45071273-003-24-9, BRD-K45071273-003-25-6","Launched","","GKCBAIGFKIBETG-UHFFFAOYSA-N","BRD-K45071273","","CCCCNc1ccc(cc1)C(=O)OCCN(C)C"
"6435","THIOPENTAL","GABA receptor antagonist","CHRNA4, CHRNA7, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2","neurology/psychiatry","anesthetic","Key, MicroSource",63.17,"BRD-A72603112-236-05-7, BRD-A72603112-236-04-0","Launched","","IUJDSEJGGMCXSG-UHFFFAOYSA-N","BRD-A72603112","","CCCC(C)C1(CC)C(=O)NC(S)=NC1=O"
"6437","TILETAMINE","glutamate receptor antagonist","","neurology/psychiatry","anesthetic","MicroSource",96.29,"BRD-A30582499-003-05-1","Launched","","QAXBVGVYDCAVLV-UHFFFAOYSA-N","BRD-A30582499","","CCNC1(CCCCC1=O)c1cccs1"
"6438","TUBOCURARINE","acetylcholine receptor antagonist","ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN","neurology/psychiatry","anesthetic","MicroSource",93.49,"BRD-K99621550-300-01-8","Launched","","JFJZZMVDLULRGK-URLMMPGGSA-O","BRD-K99621550","","COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4"
"6439","XYLAZINE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","neurology/psychiatry","anesthetic","Selleck, MicroSource",99.59,"BRD-K21565985-003-02-3, BRD-K21565985-001-22-5","Launched","","BPICBUSOMSTKRF-UHFFFAOYSA-N","BRD-K21565985","","Cc1cccc(C)c1NC1=NCCCS1"
"6441","CHLOROBUTANOL","","","neurology/psychiatry","anesthetic, sedative","MicroSource, Enamine",0,"BRD-K39495750-001-01-2, BRD-K39495750-001-02-0","Launched","","OSASVXMJTNOKOY-UHFFFAOYSA-N","BRD-K39495750","","CC(C)(O)C(Cl)(Cl)Cl"
"6443","ALPRENOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, HTR1A","cardiology","angina pectoris","MicroSource",98.73,"BRD-A00993607-003-24-6","Launched","","PAZJSJFMUHDSTF-UHFFFAOYSA-N","BRD-A00993607","","CC(C)NCC(O)COc1ccccc1CC=C"
"6444","BEPRIDIL","calcium channel blocker","ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1","cardiology","angina pectoris","MicroSource, Tocris, Sigma",96.17,"BRD-A91008255-003-24-8, BRD-A91008255-003-26-3, BRD-A91008255-003-25-5","Launched","","UIEATEWHFDRYRU-UHFFFAOYSA-N","BRD-A91008255","","CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1"
"6447","BIVALIRUDIN","thrombin inhibitor","F2","cardiology","angina pectoris","MedChemEx, Key, MedChemEx",93.05,"BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5","Launched","BRD-A64231665-019-01-7","OIRCOABEOLEUMC-CPNFJSNPSA-N","BRD-K28054654","BRD-A64231665","[2H]N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O"
"6448","BIVALIRUDIN","thrombin inhibitor","F2","cardiology","angina pectoris","MedChemEx, Key, MedChemEx",93.05,"BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5","Launched","BRD-A64231665-019-01-7","OIRCOABEOLEUMC-CPNFJSNPSA-N","BRD-K28054654","BRD-A64231665","CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O"
"6450","BIVALIRUDIN","thrombin inhibitor","F2","cardiology","angina pectoris","MedChemEx, Key, MedChemEx",93.05,"BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5","Launched","BRD-A64231665-019-01-7","OIRCOABEOLEUMC-GEJPAHFPSA-N","BRD-K28054654","BRD-A64231665","[2H]N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O"
"6451","BIVALIRUDIN","thrombin inhibitor","F2","cardiology","angina pectoris","MedChemEx, Key, MedChemEx",93.05,"BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5","Launched","BRD-A64231665-019-01-7","OIRCOABEOLEUMC-GEJPAHFPSA-N","BRD-K28054654","BRD-A64231665","CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O"
"6453","IVABRADINE","HCN channel antagonist, potassium channel blocker, sodium channel blocker","HCN1, HCN3, HCN4","cardiology","angina pectoris","Selleck",96.65,"BRD-K31385749-003-01-3","Launched","","ACRHBAYQBXXRTO-NRFANRHFSA-N","BRD-K31385749","","COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC"
"6454","NICORANDIL","nitric oxide donor, potassium channel activator","KCNJ11","cardiology","angina pectoris","Tocris, MicroSource, Selleck, Selleck",93,"BRD-K97752965-001-14-9, BRD-K97752965-001-15-6, BRD-K97752965-001-13-1, BRD-K97752965-001-16-4","Launched","","LBHIOVVIQHSOQN-UHFFFAOYSA-N","BRD-K97752965","","[O-][N+](=O)OCCNC(=O)c1cccnc1"
"6458","OXYFEDRINE","adrenergic receptor agonist","","cardiology","angina pectoris","Kemprotec",94.49,"BRD-K73027814-003-01-0","Launched","","GDYUVHBMFVMBAF-LIRRHRJNSA-N","BRD-K73027814","","COc1cccc(c1)C(=O)CCN[C@@H](C)[C@H](O)c1ccccc1"
"6459","PERHEXILINE","carnitine palmitoyltransferase inhibitor","CPT1A, CPT2","cardiology","angina pectoris","MicroSource",97.96,"BRD-A19633847-050-32-1","Launched","","CYXKNKQEMFBLER-UHFFFAOYSA-N","BRD-A19633847","","C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1"
"6460","PROPATYLNITRATE","","","cardiology","angina pectoris","Sigma",0,"BRD-K56276053-001-01-8","Launched","","YZZCJYJBCUJISI-UHFFFAOYSA-N","BRD-K56276053","","CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O"
"6461","TRIMETAZIDINE","3-ketoacyl CoA thiolase inhibitor","ACAA2","cardiology","angina pectoris","MicroSource",93.14,"BRD-K88366685-300-06-0","Launched","","UHWVSEOVJBQKBE-UHFFFAOYSA-N","BRD-K88366685","","COc1ccc(CN2CCNCC2)c(OC)c1OC"
"6462","CARAZOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, cardiac arrythmia, hypertension, myocardial infarction","Cayman",95.74,"BRD-A50675490-001-01-0","Launched","","BQXQGZPYHWWCEB-UHFFFAOYSA-N","BRD-A50675490","","CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12"
"6463","ISOSORBIDE","nitric oxide stimulant","","cardiology","angina pectoris, coronary artery disease (CAD)","MedChemEx, MedChemEx, Selleck, Selleck",0,"BRD-K47178855-001-03-4, BRD-K47178855-001-02-6, BRD-K47178855-001-04-2, BRD-K47178855-001-01-8","Launched","BRD-K57344138-001-01-2","KLDXJTOLSGUMSJ-JGWLITMVSA-N","BRD-K47178855","BRD-K57344138","O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12"
"6467","ISOSORBIDE-DINITRATE","nitric oxide stimulant","GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, NPR1","cardiology","angina pectoris, coronary artery disease (CAD)","Enamine, MicroSource",0,"BRD-K55853390-001-13-2, BRD-K55853390-001-12-4","Launched","","MOYKHGMNXAOIAT-JGWLITMVSA-N","BRD-K55853390","","[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O"
"6469","ISOSORBIDE-MONONITRATE","nitric oxide stimulant","GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3","cardiology","angina pectoris, coronary artery disease (CAD)","MicroSource",97.02,"BRD-K82225283-001-03-1","Launched","","YWXYYJSYQOXTPL-SLPGGIOYSA-N","BRD-K82225283","","O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O"
"6470","BEVANTOLOL","adrenergic receptor antagonist","ADRA1A, ADRB1, ADRB2","cardiology","angina pectoris, hypertension","AKSci",94.05,"BRD-A18233884-003-02-7","Launched","","HXLAFSUPPDYFEO-UHFFFAOYSA-N","BRD-A18233884","","COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC"
"6471","NADOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, hypertension","MicroSource, Sigma",63.89,"BRD-A87606379-001-22-4, BRD-A87606379-001-23-2","Launched","","VWPOSFSPZNDTMJ-UCWKZMIHSA-N","BRD-A87606379","","CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12"
"6473","OXPRENOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","angina pectoris, hypertension, cardiac arrythmia","Selleck",95.83,"BRD-A43671941-003-11-9","Launched","BRD-U77311119-000-01-0","CEMAWMOMDPGJMB-UHFFFAOYSA-N","BRD-A43671941","BRD-U77311119","CC(C)NCC(O)COc1ccccc1OCC=C"
"6474","ICATIBANT-ACETATE","bradykinin receptor antagonist","ANPEP, BDKRB2","cardiology","angioedema","MedChemEx, MedChemEx, MedChemEx",93.99,"BRD-K63772874-001-03-0, BRD-K63772874-001-01-4, BRD-K63772874-001-02-2","Launched","","QURWXBZNHXJZBE-SKXRKSCCSA-N","BRD-K63772874","","N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O"
"6477","LCZ696","angiotensin receptor antagonist","","cardiology","angioedema, hypotension","MedChemEx, MedChemEx, MedChemEx, Selleck",61.98,"BRD-M31057929-314-01-9, BRD-M31057929-001-01-2, BRD-M31057929-385-01-9, BRD-M31057929-447-01-7","Launched","BRD-M75836831-385-01-0, BRD-M42331949-431-01-3","XTKIDERFOUYBDE-QEPKIHTBSA-N","BRD-M31057929","BRD-M75836831","CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O"
"6481","IOXILAN","radiopaque medium","","radiology","angiography","MicroSource",85.72,"BRD-A09370961-001-01-0","Launched","","UUMLTINZBQPNGF-UHFFFAOYSA-N","BRD-A09370961","","CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I"
"6482","MEGESTROL-ACETATE","progesterone receptor agonist","NR3C1, PGR","neurology/psychiatry, endocrinology","anorexia, cachexia","Selleck, Selleck, MicroSource",98.58,"BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2","Launched","BRD-K29344105-001-01-6","RQZAXGRLVPAYTJ-GQFGMJRRSA-N","BRD-K19507340","BRD-K29344105","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O"
"6484","MEGESTROL-ACETATE","progesterone receptor agonist","NR3C1, PGR","neurology/psychiatry, endocrinology","anorexia, cachexia","Selleck, Selleck, MicroSource",98.58,"BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2","Launched","BRD-K29344105-001-01-6","RQZAXGRLVPAYTJ-GQFGMJRRSA-N","BRD-K19507340","BRD-K29344105","CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O"
"6485","MEGESTROL-ACETATE","progesterone receptor agonist","NR3C1, PGR","neurology/psychiatry, endocrinology","anorexia, cachexia","Selleck, Selleck, MicroSource",98.58,"BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2","Launched","BRD-K29344105-001-01-6","RQZAXGRLVPAYTJ-VSUSFZLSSA-N","BRD-K19507340","BRD-K29344105","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O"
"6487","MEGESTROL-ACETATE","progesterone receptor agonist","NR3C1, PGR","neurology/psychiatry, endocrinology","anorexia, cachexia","Selleck, Selleck, MicroSource",98.58,"BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2","Launched","BRD-K29344105-001-01-6","RQZAXGRLVPAYTJ-VSUSFZLSSA-N","BRD-K19507340","BRD-K29344105","CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O"
"6488","RIMEXOLONE","glucocorticoid receptor agonist","NR3C1, SERPINA6","ophthalmology","anterior uveitis","Prestwick",97.27,"BRD-K31627533-001-09-5","Launched","","QTTRZHGPGKRAFB-OOKHYKNYSA-N","BRD-K31627533","","CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C"
"6489","AFOBAZOLE","anxiolytic","","neurology/psychiatry","anxiety","MedChemEx",98.16,"BRD-K37793595-003-01-7","Launched","","WWNUCVSRRUDYPP-UHFFFAOYSA-N","BRD-K37793595","","CCOc1ccc2[nH]c(SCCN3CCOCC3)nc2c1"
"6490","ETIFOXINE","GABA receptor modulator","GABRA1, GABRA2, GABRA3, GABRA5","neurology/psychiatry","anxiety","MedChemEx, MedChemEx, MedChemEx",98.68,"BRD-A60821666-003-01-2, BRD-A60821666-003-02-0, BRD-A60821666-001-01-6","Launched","","IBYCYJFUEJQSMK-UHFFFAOYSA-N","BRD-A60821666","","CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1"
"6493","MEBICAR","anxiolytic","","neurology/psychiatry","anxiety","ChemDiv",94.75,"BRD-K76606751-001-01-7","Launched","","XIUUSFJTJXFNGH-UHFFFAOYSA-N","BRD-K76606751","","CN1C2C(N(C)C1=O)N(C)C(=O)N2C"
"6494","MEPROBAMATE","","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ","neurology/psychiatry","anxiety","Enzo",91.41,"BRD-K19180152-001-02-6","Launched","","NPPQSCRMBWNHMW-UHFFFAOYSA-N","BRD-K19180152","","CCCC(C)(COC(N)=O)COC(N)=O"
"6495","OXAZEPAM","GABA benzodiazepine site receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3","neurology/psychiatry","anxiety","Enzo",98.7,"BRD-A50049929-001-01-9","Launched","","ADIMAYPTOBDMTL-UHFFFAOYSA-N","BRD-A50049929","","OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O"
"6496","TOFISOPAM","phosphodiesterase inhibitor, cytochrome P450 inhibitor","CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A","neurology/psychiatry","anxiety, abstinence from alcohol","Sigma",80.14,"BRD-K94830213-001-01-3","Launched","","LOUZDJSQOFXLAP-UHFFFAOYSA-N","BRD-K94830213","","CCC1=C(C)NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc12"
"6497","TRYPTOPHAN","serotonin receptor partial agonist","CASR, IDO1, SLC36A1, WARS, WARS2","neurology/psychiatry, gastroenterology","anxiety, bloating, constipation, fatigue, sleeplessness","MicroSource, Sigma",98.59,"BRD-K83776863-001-05-5, BRD-K83776863-001-08-9","Launched","","QIVBCDIJIAJPQS-VIFPVBQESA-N","BRD-K83776863","","N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O"
"6499","SEROTONIN","growth factor receptor activator","DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1","neurology/psychiatry","anxiety, depression, sleeplessness","Tocris, Selleck, Selleck",80.69,"BRD-K38580127-003-16-2, BRD-K38580127-003-15-4, BRD-K38580127-003-17-0","Launched","","QZAYGJVTTNCVMB-UHFFFAOYSA-N","BRD-K38580127","","NCCc1c[nH]c2ccc(O)cc12"
"6502","PHENYLPIRACETAM","noradrenaline uptake inhibitor","","neurology/psychiatry","anxiety, fatigue, depression","MedChemEx",91.32,"BRD-A65683612-001-07-7","Launched","","LYONXVJRBWWGQO-UHFFFAOYSA-N","BRD-A65683612","","NC(=O)CN1CC(CC1=O)c1ccccc1"
"6503","TAURINE","antioxidant","","neurology/psychiatry","anxiety, irritability, sleeplessness","MicroSource, Selleck",100,"BRD-K51474575-001-11-2, BRD-K51474575-001-10-4","Launched","","XOAAWQZATWQOTB-UHFFFAOYSA-N","BRD-K51474575","","NCCS(O)(=O)=O"
"6505","PHENPROBAMATE","muscle relaxant","","neurology/psychiatry","anxiety, muscle relaxant","Prestwick",98.85,"BRD-K22009844-001-12-5","Launched","","CAMYKONBWHRPDD-UHFFFAOYSA-N","BRD-K22009844","","NC(=O)OCCCc1ccccc1"
"6506","BENTAZEPAM","benzodiazepine receptor agonist","","neurology/psychiatry","anxiety, sedative, muscle relaxant","Asinex",98.21,"BRD-K89490285-001-08-1","Launched","","AIZFEOPQVZBNGH-UHFFFAOYSA-N","BRD-K89490285","","O=C1CN=C(c2c3CCCCc3sc2N1)c1ccccc1"
"6507","HYDROXYZINE","antihistamine","HRH1","neurology/psychiatry, allergy, dermatology","anxiety, urticaria, itching, dermatosis, anxiety, urticaria, itching, dermatosis","Selleck, MicroSource",96.59,"BRD-A62428732-300-06-3, BRD-A62428732-096-10-9","Launched","","ZQDWXGKKHFNSQK-UHFFFAOYSA-N","BRD-A62428732","","OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1"
"6509","AMLEXANOX","histamine receptor modulator","FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13","dental, pulmonary, ophthalmology, allergy","aphthous ulcers, asthma, conjunctivitis, allergic rhinitis","MicroSource, Tocris",99.58,"BRD-K29530284-001-06-2, BRD-K29530284-001-07-0","Launched","","SGRYPYWGNKJSDL-UHFFFAOYSA-N","BRD-K29530284","","CC(C)c1ccc2oc3nc(N)c(cc3c(=O)c2c1)C(O)=O"
"6511","BEPHENIUM-HYDROXYNAPHTHOATE","anthelmintic agent","","infectious disease","ascariasis","MicroSource, Selleck, Selleck",97.09,"BRD-K47878171-086-06-0, BRD-K47878171-086-05-2, BRD-K47878171-086-07-8","Launched","","AVWWVJUMXRXPNF-UHFFFAOYSA-N","BRD-K47878171","","C[N+](C)(CCOc1ccccc1)Cc1ccccc1"
"6514","SULBUTIAMINE","acetylcholine receptor antagonist","","neurology/psychiatry","asthenia","AKSci",97.93,"BRD-K12539416-001-01-4","Launched","","CKHJPWQVLKHBIH-GPAWKIAZSA-N","BRD-K12539416","","CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(Cc1cnc(C)nc1N)C=O)=C(\C)N(Cc1cnc(C)nc1N)C=O"
"6515","ACEFYLLINE","adenosine receptor agonist","ADORA1","pulmonary","asthma","Prestwick",97.34,"BRD-K44004064-001-07-3","Launched","","HCYFGRCYSCXKNQ-UHFFFAOYSA-N","BRD-K44004064","","Cn1c2ncn(CC(O)=O)c2c(=O)n(C)c1=O"
"6516","ALBUTEROL","adrenergic receptor agonist","ADRB1, ADRB2","pulmonary","asthma","MicroSource, Selleck",94.73,"BRD-A88254928-001-07-9, BRD-A88254928-065-04-1","Launched","","NDAUXUAQIAJITI-UHFFFAOYSA-N","BRD-A88254928","","CC(C)(C)NCC(O)c1ccc(O)c(CO)c1"
"6518","BAMBUTEROL","adrenergic receptor agonist","ADRB2, BCHE","pulmonary","asthma","MicroSource",97.14,"BRD-A17462676-003-11-6","Launched","","ANZXOIAKUNOVQU-UHFFFAOYSA-N","BRD-A17462676","","CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C"
"6519","CLORPRENALINE","adrenergic receptor agonist","ADRB1, ADRB2","pulmonary","asthma","Selleck",95.94,"BRD-A29281099-003-03-2","Launched","","SSMSBSWKLKKXGG-UHFFFAOYSA-N","BRD-A29281099","","CC(C)NCC(O)c1ccccc1Cl"
"6520","DOXOFYLLINE","adenosine receptor antagonist","ADORA1, PDE4A, PDE4B, PDE4C, PDE4D","pulmonary","asthma","Selleck, MicroSource",99.7,"BRD-K70507123-001-08-9, BRD-K70507123-001-09-7","Launched","","HWXIGFIVGWUZAO-UHFFFAOYSA-N","BRD-K70507123","","Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O"
"6522","HEXOPRENALINE","adrenergic receptor agonist","ADRB2","pulmonary","asthma","Carbosynth",79.95,"BRD-A33894669-065-01-9","Launched","","OXLZNBCNGJWPRV-UHFFFAOYSA-N","BRD-A33894669","","OC(CNCCCCCCNCC(O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1"
"6523","METHOXYPHENAMINE","adrenergic receptor agonist","","pulmonary","asthma","Sigma",98.67,"BRD-A21474126-001-01-6","Launched","","OEHAYUOVELTAPG-UHFFFAOYSA-N","BRD-A21474126","","CNC(C)Cc1ccccc1OC"
"6524","PEMIROLAST","mediator release inhibitor","HRH1","pulmonary","asthma","MedChemEx, Selleck",97.42,"BRD-K31731454-237-03-3, BRD-K31731454-237-02-5","Launched","","HIANJWSAHKJQTH-UHFFFAOYSA-N","BRD-K31731454","","Cc1cccn2c1ncc(-c1nnn[nH]1)c2=O"
"6526","PROCATEROL","adrenergic receptor agonist","ADRB2","pulmonary","asthma","Tocris, Tocris",96.33,"BRD-K78666826-003-02-4, BRD-K78666826-003-01-6","Launched","","FKNXQNWAXFXVNW-BLLLJJGKSA-N","BRD-K78666826","","CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12"
"6528","PROXYPHYLLINE","","","pulmonary","asthma","MicroSource",97.93,"BRD-A28887267-001-19-3","Launched","","KYHQZNGJUGFTGR-UHFFFAOYSA-N","BRD-A28887267","","CC(O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12"
"6529","SERATRODAST","prostanoid receptor antagonist","TBXA2R","pulmonary","asthma","MedChemEx, MedChemEx, MicroSource",87.19,"BRD-A60765580-001-03-4, BRD-A60765580-001-02-6, BRD-A60765580-001-01-8","Launched","","ZBVKEHDGYSLCCC-UHFFFAOYSA-N","BRD-A60765580","","CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O"
"6532","TIARAMIDE","anti-inflammatory agent","","pulmonary","asthma","Sigma",99.54,"BRD-K27293958-001-01-5","Launched","","HTJXMOGUGMSZOG-UHFFFAOYSA-N","BRD-K27293958","","OCCN1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O"
"6533","TRANILAST","angiogenesis inhibitor","HPGDS, HRH1","pulmonary","asthma","Selleck, Tocris, MicroSource, Selleck, Tocris",99.75,"BRD-K17849083-001-32-9, BRD-K17849083-001-34-5, BRD-K17849083-001-31-1, BRD-K17849083-001-29-5, BRD-K17849083-001-30-3","Launched","","NZHGWWWHIYHZNX-CSKARUKUSA-N","BRD-K17849083","","COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC"
"6538","TULOBUTEROL","adrenergic receptor agonist","ADRB2","pulmonary","asthma","MicroSource",97.79,"BRD-A37441042-003-04-8","Launched","","YREYLAVBNPACJM-UHFFFAOYSA-N","BRD-A37441042","","CC(C)(C)NCC(O)c1ccccc1Cl"
"6539","ZAFIRLUKAST","leukotriene receptor antagonist","CYSLTR1, CYSLTR2","pulmonary","asthma","Selleck",95.1,"BRD-K71289571-001-11-4","Launched","","YEEZWCHGZNKEEK-UHFFFAOYSA-N","BRD-K71289571","","COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C"
"6540","ZILEUTON","leukotriene synthesis inhibitor, lipoxygenase inhibitor","ALOX5","pulmonary","asthma","Selleck, Tocris, MicroSource, Selleck",92.71,"BRD-A56359832-001-13-7, BRD-A56359832-001-15-2, BRD-A56359832-001-12-9, BRD-A56359832-001-11-1","Launched","","MWLSOWXNZPKENC-UHFFFAOYSA-N","BRD-A56359832","","CC(N(O)C(N)=O)c1cc2ccccc2s1"
"6544","MONTELUKAST","leukotriene receptor antagonist","ALOX5, CYSLTR1","pulmonary, allergy","asthma, allergic rhinitis, exercise-induced bronchoconstriction (EIB)","Selleck, MicroSource, Selleck",98.68,"BRD-K69470111-236-08-9, BRD-K69470111-001-01-2, BRD-K69470111-236-09-7","Launched","","UCHDWCPVSPXUMX-TZIWLTJVSA-N","BRD-K69470111","","CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1"
"6547","TRIPELENNAMINE","histamine receptor antagonist","HRH1","pulmonary, allergy","asthma, allergic rhinitis, urticaria","MicroSource, Selleck",96.93,"BRD-K57033106-048-04-4, BRD-K57033106-003-19-7","Launched","","UFLGIAIHIAPJJC-UHFFFAOYSA-N","BRD-K57033106","","CN(C)CCN(Cc1ccccc1)c1ccccn1"
"6549","ETOFYLLINE","adenosine receptor antagonist","ADORA1","pulmonary","asthma, bronchitis","Enzo",98.82,"BRD-K83064458-001-23-0","Launched","","NWPRCRWQMGIBOT-UHFFFAOYSA-N","BRD-K83064458","","Cn1c2ncn(CCO)c2c(=O)n(C)c1=O"
"6550","AMINOPHYLLINE","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D","pulmonary","asthma, bronchitis, emphysema","Key, Selleck",97.33,"BRD-K97799481-205-02-7, BRD-K97799481-230-01-7","Launched","BRD-M53001068-230-06-8","ZFXYFBGIUFBOJW-UHFFFAOYSA-N","BRD-K97799481","BRD-M53001068","Cn1c2nc[nH]c2c(=O)n(C)c1=O"
"6552","DYPHYLLINE","adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B","pulmonary","asthma, bronchitis, emphysema","MicroSource, Selleck",99.68,"BRD-A00827783-001-24-6, BRD-A00827783-001-23-8","Launched","","KSCFJBIXMNOVSH-UHFFFAOYSA-N","BRD-A00827783","","Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O"
"6554","POTASSIUM-IODIDE","","","pulmonary","asthma, bronchitis, emphysema","Selleck, Selleck",0,"BRD-M55321172-001-03-3, BRD-M55321172-001-02-5","Launched","","KIRAUJWBCMCUBY-UHFFFAOYSA-N","BRD-M55321172","","[K].I"
"6556","FORMOTEROL","adrenergic receptor agonist","ADRB2","pulmonary","asthma, chronic obstructive pulmonary disease (COPD), bronchospasm","Tocris, Selleck, Selleck, Tocris",98.09,"BRD-K54006094-051-06-6, BRD-K54006094-051-01-7, BRD-K54006094-051-03-3, BRD-K54006094-051-02-5","Launched","BRD-M00539986-051-06-0, BRD-M00539986-051-03-7, BRD-M00539986-051-05-2, BRD-M00539986-051-04-5","BPZSYCZIITTYBL-ORAYPTAESA-N","BRD-K54006094","BRD-M00539986","COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1"
"6560","OXTRIPHYLLINE","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A","pulmonary","asthma, chronic obstructive pulmonary disease (COPD), bronchospasm","MicroSource",60.29,"BRD-K97799481-205-01-9","Launched","","ZFXYFBGIUFBOJW-UHFFFAOYSA-N","BRD-K97799481","","Cn1c2nc[nH]c2c(=O)n(C)c1=O"
"6561","SALMETEROL","adrenergic receptor agonist","ADRB2","pulmonary","asthma, chronic obstructive pulmonary disease (COPD), bronchospasm","MedChemEx, Tocris, Sigma, MedChemEx, Tocris",67.68,"BRD-A01320529-104-14-3, BRD-A01320529-104-13-5, BRD-A01320529-104-11-9, BRD-A01320529-104-12-7, BRD-A01320529-104-10-1","Launched","","GIIZNNXWQWCKIB-UHFFFAOYSA-N","BRD-A01320529","","OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1"
"6566","CROMOGLICIC-ACID","immunosuppressant","KCNMA1, S100P","pulmonary, ophthalmology, allergy, gastroenterology","asthma, conjunctivitis, urticaria, ulcerative colitis","MicroSource, Selleck",100,"BRD-K20920669-304-10-9, BRD-K20920669-304-09-1","Launched","","IMZMKUWMOSJXDT-UHFFFAOYSA-N","BRD-K20920669","","OC(COc1cccc2oc(cc(=O)c12)C(O)=O)COc1cccc2oc(cc(=O)c12)C(O)=O"
"6568","THEOPHYLLINE","adenosine receptor antagonist","","pulmonary","asthma, emphysema, bronchitis","MicroSource",98.81,"BRD-K97799481-001-16-0","Launched","","ZFXYFBGIUFBOJW-UHFFFAOYSA-N","BRD-K97799481","","Cn1c2nc[nH]c2c(=O)n(C)c1=O"
"6569","HYDROCORTISONE-PHOSPHATE","","ANXA1, NOS2, NR3C1","pulmonary, gastroenterology, hematologic malignancy, ophthalmology","asthma, nausea, vomiting, multiple myeloma, contact dermatitis, enteritis, colitis","MicroSource",79.61,"BRD-A46186775-369-02-0","Launched","","BGSOJVFOEQLVMH-QVABZINDSA-N","BRD-A46186775","","CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O"
"6570","FENSPIRIDE","bronchodilator","","pulmonary, otolaryngology","asthma, otitis, sinusitis, rhinopharyngitis, laryngitis","Selleck, MicroSource",98.6,"BRD-K26739552-003-14-7, BRD-K26739552-003-15-4","Launched","","FVNFBBAOMBJTST-UHFFFAOYSA-N","BRD-K26739552","","O=C1NCC2(CCN(CCc3ccccc3)CC2)O1"
"6572","CORTISONE-ACETATE","glucocorticoid receptor agonist","NR3C1","pulmonary, rheumatology, allergy, dermatology, ophthalmology, gastroenterology, infectious disease","asthma, rheumatoid arthritis, urticaria, osteoarthritis, psoriasis, allergic rhinitis, conjunctivitis, ulcerative colitis, meningitis","MicroSource, Selleck, Selleck",87.13,"BRD-K86161929-001-13-3, BRD-K86161929-001-11-7, BRD-K86161929-001-12-5","Launched","BRD-A54487287-001-04-7, BRD-K83872210-001-01-1","ITRJWOMZKQRYTA-RFZYENFJSA-N","BRD-K86161929","BRD-A54487287","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C"
"6575","IBUDILAST","leukotriene receptor antagonist, phosphodiesterase inhibitor","IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A","pulmonary, neurology/psychiatry","asthma, stroke","Tocris, Tocris",96.95,"BRD-K16444452-001-11-7, BRD-K16444452-001-09-1","Launched","","ZJVFLBOZORBYFE-UHFFFAOYSA-N","BRD-K16444452","","CC(C)C(=O)c1c(nn2ccccc12)C(C)C"
"6577","DRONEDARONE","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A","cardiology","atrial fibrillation (AF)","Selleck",96.35,"BRD-K05524748-003-04-4","Launched","","ZQTNQVWKHCQYLQ-UHFFFAOYSA-N","BRD-K05524748","","CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c1c(CCCC)oc2ccc(NS(C)(=O)=O)cc12"
"6578","IBUTILIDE","potassium channel blocker","CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6","cardiology","atrial fibrillation (AF)","Tocris, Selleck, Selleck",96.32,"BRD-A74391928-051-03-9, BRD-A74391928-051-01-3, BRD-A74391928-051-02-1","Launched","BRD-M56587789-051-04-6, BRD-M56587789-051-02-0, BRD-M56587789-051-03-8","ALOBUEHUHMBRLE-UHFFFAOYSA-N","BRD-A74391928","BRD-M56587789","CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1"
"6581","VERNAKALANT","potassium channel blocker","KCNA5","cardiology","atrial fibrillation (AF)","MedChemEx",97.82,"BRD-K19741547-003-01-7","Launched","","VBHQKCBVWWUUKN-KZNAEPCWSA-N","BRD-K19741547","","COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC"
"6582","SOTALOL","adrenergic receptor antagonist","ADRB1, ADRB2, KCNH2","cardiology","atrial fibrillation (AF), ventricular arrhythmias","MicroSource, Selleck, Tocris",98.92,"BRD-A33168282-003-18-0, BRD-A33168282-003-16-4, BRD-A33168282-003-17-2","Launched","","ZBMZVLHSJCTVON-UHFFFAOYSA-N","BRD-A33168282","","CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1"
"6585","PROPAFENONE","antiarrhythmic","ADRB1, ADRB2, KCNA5, KCNH2, SCN5A","cardiology","atrial fibrillation (AF), ventricular tachycardia (VT), ventricular arrhythmias","MicroSource, Selleck",96.58,"BRD-A26334849-003-23-3, BRD-A26334849-001-06-2","Launched","","JWHAUXFOSRPERK-UHFFFAOYSA-N","BRD-A26334849","","CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1"
"6587","ATOMOXETINE","norepinephrine transporter inhibitor","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD)","Selleck, Tocris, MicroSource",97.04,"BRD-K20141153-003-12-9, BRD-K20141153-003-13-7, BRD-K20141153-001-01-6","Launched","","VHGCDTVCOLNTBX-QGZVFWFLSA-N","BRD-K20141153","","CNCC[C@@H](Oc1ccccc1C)c1ccccc1"
"6590","PIMETHIXENE","antihistamine","","neurology/psychiatry, allergy","attention-deficit/hyperactivity disorder (ADHD), anxiety, sleep cycle support, allergic rhinitis","MicroSource",97.82,"BRD-K88090157-050-10-8","Launched","","NZLVRVYNQYGMAB-UHFFFAOYSA-N","BRD-K88090157","","CN1CCC(CC1)=C1c2ccccc2Sc2ccccc12"
"6591","DEXTROAMPHETAMINE","monoamine oxidase inhibitor","ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD), narcolepsy","MicroSource",85.01,"BRD-K21160401-065-01-0","Launched","","KWTSXDURSIMDCE-QMMMGPOBSA-N","BRD-K21160401","","C[C@H](N)Cc1ccccc1"
"6592","METHYLPHENIDATE","dopamine-norepinephrine reuptake inhibitor","SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD), narcolepsy","MicroSource",96.03,"BRD-A19585813-003-03-3","Launched","","DUGOZIWVEXMGBE-UHFFFAOYSA-N","BRD-A19585813","","COC(=O)C(C1CCCCN1)c1ccccc1"
"6593","CHLORAMINE-T","","","infectious disease","bacterial gill disease","MicroSource",69.13,"BRD-K93546328-236-02-8","Launched","","NXTVQNIVUKXOIL-UHFFFAOYSA-N","BRD-K93546328","","Cc1ccc(cc1)S(=O)(=O)NCl"
"6594","CEFOTIAM","bacterial cell wall synthesis inhibitor","","infectious disease","bacterial septicemia, bone and joint infections, respiratory tract infections, skin infections, urinary tract infections","Prestwick, MedChemEx",88.63,"BRD-K02275692-300-01-8, BRD-K02275692-300-02-6","Launched","","QYQDKDWGWDOFFU-IUODEOHRSA-N","BRD-K02275692","","CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O"
"6596","FLUCYTOSINE","other antifungal","DNMT1","infectious disease","bacterial septicemia, endocarditis, urinary tract infections, meningitis","MicroSource, Selleck",100,"BRD-K82143716-001-20-7, BRD-K82143716-001-19-9","Launched","","XRECTZIEBJDKEO-UHFFFAOYSA-N","BRD-K82143716","","Nc1nc(=O)[nH]cc1F"
"6598","BIAPENEM","bacterial cell wall synthesis inhibitor","","infectious disease","bacterial septicemia, pneumonia, urinary tract infections","MedChemEx, MedChemEx, Sigma, MedChemEx, Selleck, Selleck",74.7,"BRD-A80321291-001-01-6, BRD-A80321291-001-05-7, BRD-A80321291-001-04-0, BRD-A80321291-001-06-5, BRD-A80321291-001-02-4, BRD-A80321291-001-03-2","Launched","BRD-A66479836-001-03-8","MRMBZHPJVKCOMA-YJFSRANCSA-O","BRD-A80321291","BRD-A66479836","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O"
"6604","TOBRAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","bacterial septicemia, respiratory tract infections, meningitis, skin infections, urinary tract infections","MicroSource, Selleck",100,"BRD-K05619559-001-10-1, BRD-K05619559-001-12-7","Launched","BRD-K96342952-001-01-2","NLVFBUXFDBBNBW-PBSUHMDJSA-N","BRD-K05619559","BRD-K96342952","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O"
"6606","CLINDAMYCIN-PHOSPHATE","protein synthesis inhibitor","","obstetrics/gynecology","bacterial vaginosis","Selleck",100,"BRD-K27771035-001-02-5","Launched","BRD-K52542745-001-01-1","UFUVLHLTWXBHGZ-MGZQPHGTSA-N","BRD-K27771035","BRD-K52542745","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O"
"6607","SONIDEGIB","smoothened receptor antagonist","SMO","oncology","basal cell carcinoma (BCC)","Selleck, Selleck",95.51,"BRD-K19796430-001-05-6, BRD-K19796430-001-09-8","Launched","","VZZJRYRQSPEMTK-CALCHBBNSA-N","BRD-K19796430","","C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1"
"6609","VISMODEGIB","hedgehog pathway inhibitor, smoothened receptor antagonist","SMO","oncology","basal cell carcinoma (BCC)","Selleck",98.12,"BRD-K44827188-001-06-0","Launched","","BPQMGSKTAYIVFO-UHFFFAOYSA-N","BRD-K44827188","","Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O"
"6610","ALFUZOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, KCNH2","urology","benign prostatic hyperplasia (BPH)","MicroSource, Selleck",93.3,"BRD-A09056319-003-08-5, BRD-A09056319-003-07-7","Launched","","WNMJYKCGWZFFKR-UHFFFAOYSA-N","BRD-A09056319","","COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1"
"6612","DUTASTERIDE","5 alpha reductase inhibitor","SRD5A1, SRD5A2","urology","benign prostatic hyperplasia (BPH)","Selleck",97.58,"BRD-K30373883-001-02-8","Launched","BRD-K28984613-001-01-5","JWJOTENAMICLJG-QWBYCMEYSA-N","BRD-K30373883","BRD-K28984613","C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F"
"6613","NAFTOPIDIL","adrenergic receptor antagonist","ADRA1A","urology","benign prostatic hyperplasia (BPH)","Selleck, Tocris, Selleck, Selleck, Selleck, Tocris, MicroSource",99.08,"BRD-A01787639-300-09-4, BRD-A01787639-003-17-7, BRD-A01787639-300-08-6, BRD-A01787639-001-06-4, BRD-A01787639-001-08-0, BRD-A01787639-003-16-9, BRD-A01787639-001-07-2","Launched","","HRRBJVNMSRJFHQ-UHFFFAOYSA-N","BRD-A01787639","","COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1"
"6620","SILODOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D","urology","benign prostatic hyperplasia (BPH)","Selleck, Selleck",93.88,"BRD-K10906636-001-01-1, BRD-K10906636-001-02-9","Launched","","PNCPYILNMDWPEY-QGZVFWFLSA-N","BRD-K10906636","","C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F"
"6622","TAMSULOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D","urology","benign prostatic hyperplasia (BPH)","Tocris, Enzo",99.03,"BRD-K74339692-003-03-1, BRD-K74339692-001-01-9","Launched","","DRHKJLXJIQTDTD-OAHLLOKOSA-N","BRD-K74339692","","CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O"
"6624","DOXAZOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension","Tocris, MicroSource, Selleck",97.75,"BRD-A13188892-066-23-1, BRD-A13188892-066-22-3, BRD-A13188892-066-21-5","Launched","","RUZYUOTYCVRMRZ-UHFFFAOYSA-N","BRD-A13188892","","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1"
"6627","INDORAMIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension","Maybridge",92.44,"BRD-K76953762-001-08-5","Launched","","JXZZEXZZKAWDSP-UHFFFAOYSA-N","BRD-K76953762","","O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1"
"6628","TERAZOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension","Selleck, Tocris",98.12,"BRD-A22256192-310-02-8, BRD-A22256192-003-22-7","Launched","","VCKUSRYTPJJLNI-UHFFFAOYSA-N","BRD-A22256192","","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1"
"6630","CHOLIC-ACID","bile acid","ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B","gastroenterology, neurology/psychiatry, genetics","bile acid synthesis disorders, peroxisomal disorders, Zellweger syndrome","Enzo",100,"BRD-K43164539-001-11-5","Launched","","BHQCQFFYRZLCQQ-OELDTZBJSA-N","BRD-K43164539","","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C"
"6631","ALIBENDOL","antispasmodic","","gastroenterology","bile stimulation","Selleck",97.28,"BRD-K60102752-001-02-2","Launched","","UMJHTFHIQDEGKB-UHFFFAOYSA-N","BRD-K60102752","","COc1cc(CC=C)cc(C(=O)NCCO)c1O"
"6632","CYCLOVALONE","breast cancer resistance protein inhibitor","ABCG2","gastroenterology","bile stimulation","Enamine, Sigma",97.7,"BRD-K59866480-001-08-1, BRD-K59866480-001-07-3","Launched","BRD-K84397942-001-01-3","DHKKONBXGAAFTB-OTYYAQKOSA-N","BRD-K59866480","BRD-K84397942","COc1cc(ccc1O)\C=C1/CCC\C(C1=O)=C/c1ccc(O)c(OC)c1"
"6634","FENIPENTOL","choleretic agent","","gastroenterology","bile stimulation","MicroSource",0,"BRD-A66284731-001-02-0","Launched","","OVGORFFCBUIFIA-UHFFFAOYSA-N","BRD-A66284731","","CCCCC(O)c1ccccc1"
"6635","MENBUTONE","","","gastroenterology","bile stimulation","MicroSource",93.68,"BRD-K53852914-001-01-8","Launched","","FHGJSJFIQNQBCK-UHFFFAOYSA-N","BRD-K53852914","","COc1ccc(C(=O)CCC(O)=O)c2ccccc12"
"6636","LITHIUM-CITRATE","","","neurology/psychiatry","bipolar disorder, depression","MicroSource, Selleck, Selleck",0,"BRD-M41245765-001-04-2, BRD-M41245765-001-05-9, BRD-M41245765-001-03-4","Launched","BRD-M83658881-001-01-0","PTYJGLZVOMGTRG-UHFFFAOYSA-N","BRD-M41245765","BRD-M83658881","[Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O"
"6639","NITARSONE","","","dermatology","blackhead disease","MicroSource, Selleck",89.7,"BRD-K56707426-001-02-0, BRD-K56707426-001-01-2","Launched","","FUUFQLXAIUOWML-UHFFFAOYSA-N","BRD-K56707426","","O[As](O)(=O)c1ccc(cc1)[N+]([O-])=O"
"6641","VALRUBICIN","DNA inhibitor, topoisomerase inhibitor","TOP2A","oncology","bladder cancer","MedChemEx",97.11,"BRD-K72951360-001-01-4","Launched","","ZOCKGBMQLCSHFP-KQRAQHLDSA-N","BRD-K72951360","","CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1"
"6642","VINFLUNINE","microtubule inhibitor","","oncology","bladder cancer","AvaChem, Selleck",95.66,"BRD-K64120610-001-01-4, BRD-K64120610-046-01-9","Launched","BRD-K10549975-001-01-8, BRD-A52946717-045-01-7","NOSAJPUYIASWEH-USRBKURZSA-N","BRD-K64120610","BRD-K10549975","CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c1cc(OC)c(cc41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC"
"6644","CANTHARIDIN","protein phosphatase inhibitor","","dermatology","blisters","MedChemEx, MedChemEx, Sigma, Tocris",47.3,"BRD-K80684056-001-09-3, BRD-K80684056-001-06-9, BRD-K80684056-001-05-1, BRD-K80684056-001-04-4","Launched","","DHZBEENLJMYSHQ-XCVPVQRUSA-N","BRD-K80684056","","C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O"
"6648","PAMABROM","diuretic","","gastroenterology","bloating","MicroSource",0,"BRD-M67659203-001-01-9","Launched","","ATOTUUBRFJHZQG-UHFFFAOYSA-N","BRD-M67659203","","CC(C)(N)CO.Cn1c2nc(Br)[nH]c2c(=O)n(C)c1=O"
"6649","GENTAMYCIN","bacterial 50S ribosomal subunit inhibitor","HSPA8, LRP2","infectious disease, critical care","bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis","MicroSource, Sigma",0,"BRD-A89445950-001-01-6, BRD-M10279501-065-05-9","Launched","","CEAZRRDELHUEMR-VVSHQIECSA-N","BRD-A89445950","","CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1"
"6650","GENTAMYCIN","bacterial 50S ribosomal subunit inhibitor","HSPA8, LRP2","infectious disease, critical care","bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis","MicroSource, Sigma",0,"BRD-A89445950-001-01-6, BRD-M10279501-065-05-9","Launched","","CEAZRRDELHUEMR-VVSHQIECSA-N","BRD-A89445950","","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@H](CC[C@H]3N)[C@@H](C)N)[C@@H]2O)OC[C@]1(C)O.CN[C@H](C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1"
"6651","GENTAMYCIN","bacterial 50S ribosomal subunit inhibitor","HSPA8, LRP2","infectious disease, critical care","bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis","MicroSource, Sigma",0,"BRD-A89445950-001-01-6, BRD-M10279501-065-05-9","Launched","","NPEFREDMMVQEPL-YJSGWBGLSA-N","BRD-A89445950","","CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1"
"6652","GENTAMYCIN","bacterial 50S ribosomal subunit inhibitor","HSPA8, LRP2","infectious disease, critical care","bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis","MicroSource, Sigma",0,"BRD-A89445950-001-01-6, BRD-M10279501-065-05-9","Launched","","NPEFREDMMVQEPL-YJSGWBGLSA-N","BRD-A89445950","","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@H](CC[C@H]3N)[C@@H](C)N)[C@@H]2O)OC[C@]1(C)O.CN[C@H](C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1"
"6653","SECALCIFEROL","vitamin D receptor agonist","VDR","critical care","bone fracture","Enzo",81.1,"BRD-K02965577-001-03-4","Launched","","FCKJYANJHNLEEP-XRWYNYHCSA-N","BRD-K02965577","","C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C"
"6654","DANOFLOXACIN","bacterial DNA gyrase inhibitor","","pulmonary","bovine respiratory disease (BRD)","Selleck",95.15,"BRD-K45916615-066-02-5","Launched","","QMLVECGLEOSESV-RYUDHWBXSA-N","BRD-K45916615","","CN1C[C@@H]2C[C@H]1CN2c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1"
"6655","FLORFENICOL","protein synthesis inhibitor","","pulmonary","bovine respiratory disease (BRD)","MicroSource, Selleck",97.38,"BRD-A30886737-001-02-9, BRD-K11298197-001-12-0","Launched","","AYIRNRDRBQJXIF-RGURZIINSA-N","BRD-A30886737","","CS(=O)(=O)c1ccc(cc1)C(O)[C@H](CF)NC(=O)C(Cl)Cl"
"6656","FLORFENICOL","protein synthesis inhibitor","","pulmonary","bovine respiratory disease (BRD)","MicroSource, Selleck",97.38,"BRD-A30886737-001-02-9, BRD-K11298197-001-12-0","Launched","","AYIRNRDRBQJXIF-RGURZIINSA-N","BRD-A30886737","","CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl"
"6657","FLORFENICOL","protein synthesis inhibitor","","pulmonary","bovine respiratory disease (BRD)","MicroSource, Selleck",97.38,"BRD-A30886737-001-02-9, BRD-K11298197-001-12-0","Launched","","AYIRNRDRBQJXIF-NXEZZACHSA-N","BRD-A30886737","","CS(=O)(=O)c1ccc(cc1)C(O)[C@H](CF)NC(=O)C(Cl)Cl"
"6658","FLORFENICOL","protein synthesis inhibitor","","pulmonary","bovine respiratory disease (BRD)","MicroSource, Selleck",97.38,"BRD-A30886737-001-02-9, BRD-K11298197-001-12-0","Launched","","AYIRNRDRBQJXIF-NXEZZACHSA-N","BRD-A30886737","","CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl"
"6659","TILMICOSIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bovine respiratory disease (BRD)","MicroSource, Selleck",98.67,"BRD-K26634012-001-03-1, BRD-K26634012-001-04-9","Launched","BRD-K12921935-001-01-6","JTSDBFGMPLKDCD-NXYWBGGVSA-N","BRD-K26634012","BRD-K12921935","CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC"
"6661","ISOPRENALINE","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3","cardiology, pulmonary","bradycardia, heart block, asthma","Selleck, Selleck, MicroSource, Tocris",94.79,"BRD-A04322457-003-18-7, BRD-A04322457-003-15-3, BRD-A04322457-003-17-9, BRD-A04322457-003-16-1","Launched","","JWZZKOKVBUJMES-UHFFFAOYSA-N","BRD-A04322457","","CC(C)NCC(O)c1ccc(O)c(O)c1"
"6665","ABEMACICLIB","CDK inhibitor","CDK4, CDK6","oncology","breast cancer","Selleck",94.43,"BRD-K33622447-066-01-9","Launched","","UZWDCWONPYILKI-UHFFFAOYSA-N","BRD-K33622447","","CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)-c3cc(F)c4nc(C)n(C(C)C)c4c3)nc2)CC1"
"6666","ANASTROZOLE","aromatase inhibitor","CYP19A1","oncology","breast cancer","Tocris, MicroSource, Selleck",99.51,"BRD-K52172416-001-14-8, BRD-K52172416-001-11-4, BRD-K52172416-001-10-6","Launched","","YBBLVLTVTVSKRW-UHFFFAOYSA-N","BRD-K52172416","","CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N"
"6669","DIDOX","ribonucleotide reductase inhibitor","RRM1","oncology","breast cancer","MedChemEx",95.72,"BRD-K94146583-001-01-6","Launched","","QJMCKEPOKRERLN-UHFFFAOYSA-N","BRD-K94146583","","ONC(=O)c1ccc(O)c(O)c1"
"6670","DROMOSTANOLONE-PROPIONATE","androgen receptor modulator","AR","oncology","breast cancer","ANpharma",99.15,"BRD-A38706605-001-01-2","Launched","","NOTIQUSPUUHHEH-UHFFFAOYSA-N","BRD-A38706605","","CCC(=O)OC1CCC2C3CCC4CC(=O)C(C)CC4(C)C3CCC12C"
"6671","EPIRUBICIN","topoisomerase inhibitor","CHD1, TOP2A","oncology","breast cancer","MicroSource, Selleck",90.55,"BRD-K04548931-003-13-2, BRD-K04548931-003-16-5","Launched","BRD-K56844688-003-01-2","AOJJSUZBOXZQNB-VTZDEGQISA-N","BRD-K04548931","BRD-K56844688","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO"
"6673","EXEMESTANE","aromatase inhibitor","CYP19A1","oncology","breast cancer","Tocris, MicroSource, Selleck",98.07,"BRD-K33425534-001-10-9, BRD-K33425534-001-12-5, BRD-K33425534-001-11-7","Launched","BRD-A73741725-001-02-8, BRD-K93923542-001-02-7,BRD-K35247444-001-01-3","BFYIZQONLCFLEV-DAELLWKTSA-N","BRD-K33425534","BRD-A73741725","C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O"
"6676","FADROZOLE","aromatase inhibitor","CYP11B1, CYP19A1","oncology","breast cancer","SantaCruz",98.89,"BRD-A25619068-003-03-4","Launched","","CLPFFLWZZBQMAO-UHFFFAOYSA-N","BRD-A25619068","","N#Cc1ccc(cc1)C1CCCc2cncn12"
"6677","FORMESTANE","aromatase inhibitor","CYP19A1","oncology","breast cancer","Selleck, MicroSource",100,"BRD-A26503646-001-18-2, BRD-A26503646-001-16-6","Launched","BRD-A87468186-001-01-6","ZMEULISFKSVRLQ-AZXRADLDSA-N","BRD-A26503646","BRD-A87468186","C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O"
"6679","FULVESTRANT","estrogen receptor antagonist","ESR1, ESR2, GPER1","oncology","breast cancer","Tocris, MicroSource, Tocris, Selleck",97.7,"BRD-A85667082-001-10-1, BRD-A85667082-001-11-9, BRD-A85667082-001-12-7, BRD-A85667082-001-13-5","Launched","BRD-A03249105-001-02-7, BRD-A50947932-001-01-9, BRD-A03249105-001-01-9, BRD-A17828570-001-02-8,BRD-A52958897-001-01-7","VWUXBMIQPBEWFH-WCCTWKNTSA-N","BRD-A85667082","BRD-A03249105","C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31"
"6683","IXABEPILONE","microtubule stabilizing agent","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8","oncology","breast cancer","MedChemEx",98.98,"BRD-K03601870-001-01-2","Launched","","FABUFPQFXZVHFB-PVYNADRNSA-N","BRD-K03601870","","C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1"
"6684","LAPATINIB","EGFR inhibitor","EGFR, ERBB2","oncology","breast cancer","Selleck, Selleck, Selleck",97.32,"BRD-K19687926-001-10-8, BRD-K19687926-379-07-4, BRD-K19687926-001-04-1","Launched","","BCFGMOOMADDAQU-UHFFFAOYSA-N","BRD-K19687926","","CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1"
"6687","LETROZOLE","aromatase inhibitor","CYP19A1","oncology","breast cancer","Tocris, Selleck",96.85,"BRD-K88789588-001-16-4, BRD-K88789588-001-14-9","Launched","","HPJKCIUCZWXJDR-UHFFFAOYSA-N","BRD-K88789588","","N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1"
"6689","PALBOCICLIB","CDK inhibitor","CDK4, CDK6","oncology","breast cancer","Selleck, Selleck",94.04,"BRD-K51313569-001-07-8, BRD-K51313569-003-03-3","Launched","","AHJRHEGDXFFMBM-UHFFFAOYSA-N","BRD-K51313569","","CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O"
"6691","PIRARUBICIN","topoisomerase inhibitor","TOP2A","oncology","breast cancer","MedChemEx, MedChemEx, Selleck, Selleck",71.82,"BRD-K83794624-003-02-1, BRD-K83794624-003-01-3, BRD-K83794624-001-02-5, BRD-K83794624-001-03-3","Launched","","KMSKQZKKOZQFFG-YXRRJAAWSA-N","BRD-K83794624","","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO"
"6695","RIBOCICLIB","CDK inhibitor","CDK4, CDK6","oncology","breast cancer","MedChemEx, Selleck, Selleck",93.42,"BRD-K36788280-001-04-6, BRD-K36788280-001-01-2, BRD-K36788280-001-03-8","Launched","","RHXHGRAEPCAFML-UHFFFAOYSA-N","BRD-K36788280","","CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1"
"6698","TAMOXIFEN","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ","oncology","breast cancer","Tocris, Selleck, Tocris, MicroSource, Selleck",97.31,"BRD-K93754473-048-23-6, BRD-K93754473-048-18-6, BRD-K93754473-048-19-4, BRD-K93754473-048-20-2, BRD-K93754473-048-21-0","Launched","","NKANXQFJJICGDU-QPLCGJKRSA-N","BRD-K93754473","","CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1"
"6703","TESTOLACTONE","aromatase inhibitor","CYP19A1","oncology","breast cancer","MedChemEx",90.38,"BRD-K69636617-001-01-7","Launched","","BPEWUONYVDABNZ-DZBHQSCQSA-N","BRD-K69636617","","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2"
"6704","TOREMIFENE","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1","oncology","breast cancer","MicroSource, Selleck, Selleck",97.25,"BRD-K51350053-048-16-5, BRD-K51350053-048-17-3, BRD-K51350053-048-15-7","Launched","","XFCLJVABOIYOMF-QPLCGJKRSA-N","BRD-K51350053","","CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1"
"6707","CAPECITABINE","DNA synthesis inhibitor, thymidylate synthase inhibitor","TYMS","oncology","breast cancer, colorectal cancer","Selleck, Tocris, Selleck, MicroSource",97.88,"BRD-K61192372-001-05-5, BRD-K61192372-001-06-3, BRD-K61192372-001-07-1, BRD-K61192372-001-08-9","Launched","BRD-K15574380-001-01-0, BRD-A91877226-001-01-4","GAGWJHPBXLXJQN-UORFTKCHSA-N","BRD-K61192372","BRD-K15574380","CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O"
"6711","CARMOFUR","thymidylate synthase inhibitor","TYMS","oncology","breast cancer, colorectal cancer","Selleck, MicroSource, Selleck",86.52,"BRD-K11630072-001-13-2, BRD-K11630072-001-12-4, BRD-K11630072-001-11-6","Launched","","AOCCBINRVIKJHY-UHFFFAOYSA-N","BRD-K11630072","","CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O"
"6714","EVEROLIMUS","mTOR inhibitor","MTOR","oncology, neurology/psychiatry, genetics, urology","breast cancer, neuroendocrine tumors of pancreatic origin (PNET), renal cell carcinoma (RCC), subependymal giant cell astrocytoma (SEGA), tuberous sclerosis complex (TSC), renal angiomyolipoma","Selleck, Selleck",95.59,"BRD-K13514097-001-04-6, BRD-K13514097-001-05-3","Launched","BRD-K13154216-001-03-9, BRD-K13154216-001-01-3","HKVAMNSJSFKALM-GKUWKFKPSA-N","BRD-K13514097","BRD-K13154216","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO"
"6716","VINDESINE","tubulin polymerization inhibitor","TUBB, TUBB1","oncology","breast cancer, non-small cell lung cancer (NSCLC), melanoma","AvaChem",78.54,"BRD-K59753975-001-02-6","Launched","","HHJUWIANJFBDHT-KOTLKJBCSA-N","BRD-K59753975","","CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](O)[C@]1(O)C(N)=O"
"6717","DOCETAXEL","tubulin polymerization inhibitor","BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1","oncology","breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric adenocarcinoma, head and neck squamous cell carcinoma (HNSCC)","Selleck, MicroSource, Selleck",99.62,"BRD-K30577245-001-04-3, BRD-K30577245-341-01-9, BRD-K30577245-001-05-0","Launched","BRD-A05821830-001-05-6, BRD-A05821830-341-01-5, BRD-K63265447-001-07-4,BRD-A28612473-001-01-3","ZDZOTLJHXYCWBA-VCVYQWHSSA-N","BRD-K30577245","BRD-A05821830","CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C"
"6720","THIOTEPA","cytochrome P450 inhibitor","CYP2B6, CYP3A4","oncology","breast cancer, ovarian cancer, bladder cancer","MedChemEx, MicroSource, MedChemEx",77.41,"BRD-K09631521-001-12-3, BRD-K09631521-001-09-9, BRD-K09631521-001-11-5","Launched","","FOCVUCIESVLUNU-UHFFFAOYSA-N","BRD-K09631521","","S=P(N1CC1)(N1CC1)N1CC1"
"6723","NERIDRONIC-ACID","bone resorption inhibitor","FDPS","endocrinology","brittle bone disease, Paget's disease","Toronto",0,"BRD-K60212747-236-01-1","Launched","","PUUSSSIBPPTKTP-UHFFFAOYSA-N","BRD-K60212747","","NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O"
"6724","METHACHOLINE","acetylcholine receptor agonist","CHRM2, CHRM3, CHRM4","pulmonary","bronchial hyperresponsiveness diagnostic","MicroSource",98.32,"BRD-A18056626-003-22-3","Launched","","NZWOPGCLSHLLPA-UHFFFAOYSA-N","BRD-A18056626","","CC(C[N+](C)(C)C)OC(C)=O"
"6725","AMBROXOL","sodium channel blocker","CYP3A4","pulmonary","bronchitis","Tocris, MicroSource, Tocris, Selleck",97.34,"BRD-K56558538-003-12-7, BRD-K56558538-003-14-3, BRD-K56558538-003-13-5, BRD-K56558538-003-11-9","Launched","BRD-K11223672-003-05-2","JBDGDEWWOUBZPM-XYPYZODXSA-N","BRD-K56558538","BRD-K11223672","Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1"
"6729","DIRITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bronchitis","AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck",95.4,"BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6","Launched","BRD-K15706428-001-01-2, BRD-A77786295-001-01-1, BRD-A83603976-001-01-6, BRD-A44120870-001-01-6","WLOHNSSYAXHWNR-DWIOZXRMSA-N","BRD-K52756523","BRD-K15706428","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O"
"6732","DIRITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bronchitis","AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck",95.4,"BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6","Launched","BRD-K15706428-001-01-2, BRD-A77786295-001-01-1, BRD-A83603976-001-01-6, BRD-A44120870-001-01-6","WLOHNSSYAXHWNR-DWIOZXRMSA-N","BRD-K52756523","BRD-K15706428","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H](C2C)C1(C)O"
"6736","DIRITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bronchitis","AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck",95.4,"BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6","Launched","BRD-K15706428-001-01-2, BRD-A77786295-001-01-1, BRD-A83603976-001-01-6, BRD-A44120870-001-01-6","WLOHNSSYAXHWNR-GHZCURSSSA-N","BRD-K52756523","BRD-K15706428","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O"
"6739","DIRITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bronchitis","AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck",95.4,"BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6","Launched","BRD-K15706428-001-01-2, BRD-A77786295-001-01-1, BRD-A83603976-001-01-6, BRD-A44120870-001-01-6","WLOHNSSYAXHWNR-GHZCURSSSA-N","BRD-K52756523","BRD-K15706428","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H](C2C)C1(C)O"
"6743","JOSAMYCIN","bacterial 50S ribosomal subunit inhibitor","","pulmonary","bronchitis","Prestwick",90.23,"BRD-K25837718-001-03-8","Launched","","UKNSBNVKSFTZOJ-NGVXBBESSA-N","BRD-K25837718","","CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O"
"6744","METHACYCLINE","protein synthesis inhibitor","","pulmonary","bronchitis","MedChemEx, Selleck, Selleck, MicroSource",90.63,"BRD-A49035384-003-29-7, BRD-A49035384-003-28-9, BRD-A49035384-003-30-5, BRD-A49035384-003-27-1","Launched","BRD-A27249758-003-01-7","QNJKSUYWBCNWFI-KCDYASHQSA-N","BRD-A49035384","BRD-A27249758","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6748","ERDOSTEINE","mucolytic agent","","pulmonary, infectious disease","bronchitis, cough suppressant, chronic obstructive pulmonary disease (COPD), respiratory tract infections","MicroSource, Selleck, Selleck",99.06,"BRD-A05515753-001-03-2, BRD-A05515753-001-02-4, BRD-A05515753-001-04-0","Launched","","QGFORSXNKQLDNO-UHFFFAOYSA-N","BRD-A05515753","","OC(=O)CSCC(=O)NC1CCSC1=O"
"6751","ACLIDINIUM","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","pulmonary","bronchitis, emphysema, chronic obstructive pulmonary disease (COPD)","Selleck",95.22,"BRD-K74363950-004-01-0","Launched","","ASMXXROZKSBQIH-VITNCHFBSA-N","BRD-K74363950","","OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1"
"6752","CEFTIBUTEN","bacterial cell wall synthesis inhibitor","","pulmonary, otolaryngology","bronchitis, otitis, pharyngitis, tonsillitis","MicroSource, MedChemEx, MedChemEx, MedChemEx, Sigma",95.4,"BRD-K11124378-001-04-6, BRD-K11124378-335-03-0, BRD-K11124378-335-01-4, BRD-K11124378-335-02-2, BRD-K11124378-002-01-0","Launched","","UNJFKXSSGBWRBZ-BJCIPQKHSA-N","BRD-K11124378","","Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O"
"6757","GEMIFLOXACIN","bacterial DNA gyrase inhibitor","","pulmonary, infectious disease","bronchitis, pneumonia","MicroSource",94.6,"BRD-A40787240-066-04-6","Launched","","ZRCVYEYHRGVLOC-HYARGMPZSA-N","BRD-A40787240","","CO\N=C1/CN(CC1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1"
"6758","LETOSTEINE","mucolytic agent","","pulmonary, infectious disease","bronchitis, pneumonia","AKSci",96.97,"BRD-A32597168-001-03-6","Launched","","IKOCLISPVJZJEA-UHFFFAOYSA-N","BRD-A32597168","","CCOC(=O)CSCCC1NC(CS1)C(O)=O"
"6759","PIVAMPICILLIN","bacterial cell wall synthesis inhibitor","","pulmonary, infectious disease","bronchitis, pneumonia, gynecologic infections","Prestwick",38.24,"BRD-K32791151-001-04-0","Launched","","ZEMIJUDPLILVNQ-ZXFNITATSA-N","BRD-K32791151","","CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O"
"6760","EPRAZINONE","mucolytic agent","","pulmonary","bronchospasm","Selleck, Selleck",94.62,"BRD-A72212290-300-01-4, BRD-A72212290-300-02-2","Launched","","BSHWLCACYCVCJE-UHFFFAOYSA-N","BRD-A72212290","","CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1"
"6762","LEVALBUTEROL","adrenergic receptor agonist","ADRB2","pulmonary","bronchospasm","MicroSource",97.04,"BRD-K34469523-003-03-0","Launched","","NDAUXUAQIAJITI-LBPRGKRZSA-N","BRD-K34469523","","CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1"
"6763","ISOETHARINE","adrenergic receptor agonist","ADRB1, ADRB2","pulmonary","bronchospasm, asthma","Selleck, MicroSource, Selleck",94.7,"BRD-A24587114-066-21-7, BRD-A24587114-066-22-5, BRD-A24587114-066-23-3","Launched","","HUYWAWARQUIQLE-UHFFFAOYSA-N","BRD-A24587114","","CCC(NC(C)C)C(O)c1ccc(O)c(O)c1"
"6766","METAPROTERENOL","adrenergic receptor agonist","ADRB2","pulmonary","bronchospasm, asthma, bronchitis, emphysema","Selleck, MicroSource, Selleck",90.17,"BRD-A07780951-065-09-2, BRD-A07780951-001-08-9, BRD-A07780951-065-10-0","Launched","BRD-M02190957-065-05-7, BRD-M02190957-065-06-5","LMOINURANNBYCM-UHFFFAOYSA-N","BRD-A07780951","BRD-M02190957","CC(C)NCC(O)c1cc(O)cc(O)c1"
"6769","PRANLUKAST","leukotriene receptor antagonist","CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF","pulmonary","bronchospasm, asthma, bronchospasm, asthma","MedChemEx, Selleck",99.8,"BRD-K97045029-001-02-7, BRD-K97045029-001-04-3","Launched","BRD-K91497079-001-03-3,BRD-U02566398-000-01-1|BRD-K91497079-001-02-5","NBQKINXMPLXUET-UHFFFAOYSA-N","BRD-K97045029","BRD-K91497079","O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1"
"6771","TERBUTALINE","adrenergic receptor agonist","ADRB2","pulmonary","bronchospasm, bronchitis, emphysema","MedChemEx, MicroSource",93.35,"BRD-A50157456-065-21-4, BRD-A50157456-065-20-6","Launched","BRD-M79902621-065-06-7","XWTYSIMOBUGWOL-UHFFFAOYSA-N","BRD-A50157456","BRD-M79902621","CC(C)(C)NCC(O)c1cc(O)cc(O)c1"
"6773","IPRATROPIUM","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","pulmonary","bronchospasm, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema","Tocris, MicroSource, Selleck",93.93,"BRD-A47449001-004-12-9, BRD-A47449001-004-13-7, BRD-A47449001-004-14-5","Launched","BRD-A65721754-004-02-8, BRD-A96060515-004-01-6, BRD-A05352148-004-03-8","OEXHQOGQTVQTAT-BHIXFJMTSA-N","BRD-A47449001","BRD-A65721754","CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1"
"6776","SITAFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","buruli ulcer","Selleck",93.27,"BRD-K10836013-001-01-3","Launched","BRD-U60340452-000-01-3","PNUZDKCDAWUEGK-CYZMBNFOSA-N","BRD-K10836013","BRD-U60340452","N[C@@H]1CN(CC11CC1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)[C@@H]1C[C@@H]1F"
"6777","CASPOFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor, bacterial cell wall synthesis inhibitor","","infectious disease","candidemia, esophageal candidiasis, aspergillosis, fungal infection","MedChemEx, MedChemEx",51.17,"BRD-A31685486-402-01-9, BRD-A31685486-402-02-7","Launched","","JYIKNQVWKBUSNH-QPUODBGRSA-N","BRD-A31685486","","CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)c1ccc(O)cc1)[C@H](O)CCN"
"6779","CASPOFUNGIN-ACETATE","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, esophageal candidiasis, aspergillosis, peritonitis","Selleck, Selleck",79.25,"BRD-K49793107-402-03-4, BRD-K49793107-402-02-6","Launched","BRD-K49793107-001-01-8,BRD-K33838583-402-01-2","JYIKNQVWKBUSNH-JYEVSGHCSA-N","BRD-K49793107","BRD-K49793107","CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)CCN"
"6781","ANIDULAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, fungal infection, esophageal candidiasis","MedChemEx",98.03,"BRD-A75305484-001-01-3","Launched","","JHVAMHSQVVQIOT-UHFFFAOYSA-N","BRD-A75305484","","CCCCCOc1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(C)CN2C(=O)C(NC(=O)C(NC(=O)C2CC(O)CN2C(=O)C(NC1=O)C(C)O)C(O)C(O)c1ccc(O)cc1)C(C)O"
"6782","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-YABMTYFHSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6783","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-YABMTYFHSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)NC1C[C@@H](O)[C@@H](O)NC(=O)C2[C@@H](O)[C@@H](C)CN2C(=O)C(NC(=O)C(NC(=O)C2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6785","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-YABMTYFHSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6786","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-LZQXLXGFSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6787","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-LZQXLXGFSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)NC1C[C@@H](O)[C@@H](O)NC(=O)C2[C@@H](O)[C@@H](C)CN2C(=O)C(NC(=O)C(NC(=O)C2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6789","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-LZQXLXGFSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6790","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-SICPAZHLSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6791","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-SICPAZHLSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)NC1C[C@@H](O)[C@@H](O)NC(=O)C2[C@@H](O)[C@@H](C)CN2C(=O)C(NC(=O)C(NC(=O)C2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6793","MICAFUNGIN","fungal 1,3-beta-D-glucan synthase inhibitor","","infectious disease","candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","Launched","BRD-A06596811-236-02-5, BRD-A06596811-236-01-7","PIEUQSKUWLMALL-SICPAZHLSA-N","BRD-K40407248","BRD-A06596811","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O"
"6794","EPINEPHRINE","adrenergic receptor agonist, neurotransmitter","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF","cardiology, allergy, pulmonary","cardiac arrest, anaphylactic shock, asthma","Selleck, Selleck, Selleck, Selleck, Selleck, MicroSource",100,"BRD-K63126190-046-03-1, BRD-K63126190-001-05-1, BRD-K63126190-046-02-3, BRD-K63126190-001-03-6, BRD-K63126190-003-01-6, BRD-K63126190-001-04-4","Launched","","UCTWMZQNUQWSLP-VIFPVBQESA-N","BRD-K63126190","","CNC[C@H](O)c1ccc(O)c(O)c1"
"6800","EPINEPHRINE-(RACEMIC)","carbonic anhydrase activator","","cardiology, allergy, pulmonary","cardiac arrest, anaphylactic shock, asthma","Selleck, Selleck",0,"BRD-A07765530-001-06-4, BRD-A07765530-001-05-6","Launched","","UCTWMZQNUQWSLP-UHFFFAOYSA-N","BRD-A07765530","","CNCC(O)c1ccc(O)c(O)c1"
"6802","APRINDINE","voltage-gated sodium channel blocker","CALM1, SCN5A","cardiology","cardiac arrythmia","Sigma",82.34,"BRD-K53236343-003-03-7","Launched","","NZLBHDRPUJLHCE-UHFFFAOYSA-N","BRD-K53236343","","CCN(CC)CCCN(C1Cc2ccccc2C1)c1ccccc1"
"6803","HYDROQUINIDINE","antiarrhythmic","","cardiology","cardiac arrythmia","MicroSource",98.92,"BRD-A06390036-001-04-6","Launched","","LJOQGZACKSYWCH-NBGVHYBESA-N","BRD-A06390036","","CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12"
"6804","LANDIOLOL","adrenergic receptor antagonist","ADRB1","cardiology","cardiac arrythmia","AKSci",98.94,"BRD-K86436199-003-01-3","Launched","","WMDSZGFJQKSLLH-RBBKRZOGSA-N","BRD-K86436199","","CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1"
"6805","PILSICAINIDE","sodium channel blocker","SCN5A","cardiology","cardiac arrythmia","AKSci",99.35,"BRD-K83245588-001-01-4","Launched","","BCQTVJKBTWGHCX-UHFFFAOYSA-N","BRD-K83245588","","Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2"
"6806","TOCAINIDE","sodium channel blocker","SCN5A","cardiology","cardiac arrythmia","MicroSource",96.83,"BRD-A92670106-003-05-4","Launched","","BUJAGSGYPOAWEI-UHFFFAOYSA-N","BRD-A92670106","","CC(N)C(=O)Nc1c(C)cccc1C"
"6807","YOHIMBINE","adrenergic receptor antagonist","ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8","cardiology","cardiac arrythmia, bradycardia","Tocris, Selleck, MicroSource",97.72,"BRD-K35586044-003-15-4, BRD-K35586044-003-14-7, BRD-K35586044-003-16-2","Launched","BRD-A87445400-003-04-4","BLGXFZZNTVWLAY-SCYLSFHTSA-N","BRD-K35586044","BRD-A87445400","COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12"
"6810","DEXRAZOXANE","chelating agent, topoisomerase inhibitor","TOP2A, TOP2B","cardiology","cardiomyopathy","Selleck, Selleck, Tocris",94.57,"BRD-K07265709-003-05-6, BRD-K07265709-003-03-1, BRD-K07265709-003-04-9","Launched","","BMKDZUISNHGIBY-ZETCQYMHSA-N","BRD-K07265709","","C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1"
"6813","LEVOCARNITINE","","","endocrinology","carnitine deficiency","MicroSource, Selleck",100,"BRD-K59647213-001-10-5, BRD-K59647213-001-09-7","Launched","","PHIQHXFUZVPYII-ZCFIWIBFSA-O","BRD-K59647213","","C[N+](C)(C)C[C@H](O)CC(O)=O"
"6815","PIRENOXINE","AGE inhibitor","","ophthalmology","cataracts","AKSci",94.2,"BRD-K65992024-001-01-5","Launched","","OKPNYGAWTYOBFZ-UHFFFAOYSA-N","BRD-K65992024","","OC(=O)c1cc(O)c2c3nc4ccccc4oc3cc(=O)c2n1"
"6816","TAUROLIDINE","apoptosis stimulant","","infectious disease","catheter-related bloodstream infection","Sigma",0,"BRD-K98765504-001-01-5","Launched","","AJKIRUJIDFJUKJ-UHFFFAOYSA-N","BRD-K98765504","","O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1"
"6817","SODIUM-MONOFLUOROPHOSPHATE","","PYGM","dental","cavities","Selleck, MicroSource, Selleck",0,"BRD-K99308954-304-02-4, BRD-K99308954-304-03-2, BRD-K99308954-304-04-0","Launched","","DWYMPOCYEZONEA-UHFFFAOYSA-N","BRD-K99308954","","OP(O)(F)=O"
"6820","BENZYLPENICILLIN","penicillin binding protein inhibitor","","infectious disease","celluitis, meningitis, endocarditis, syphilis, pneumonia, bacterial septicemia","Selleck, MicroSource, Selleck",97.54,"BRD-K55191674-236-06-0, BRD-K55191674-237-18-3, BRD-K55191674-236-07-8","Launched","","JGSARLDLIJGVTE-MBNYWOFBSA-N","BRD-K55191674","","CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O"
"6823","DESMOPRESSIN-ACETATE","vasopressin receptor agonist","AVPR1A, AVPR1B, AVPR2, OXTR","endocrinology, urology","central diabetes insipidus, nocturnal enuresis","MedChemEx",90.07,"BRD-A49399758-015-01-8","Launched","","NFLWUMRGJYTJIN-UHFFFAOYSA-N","BRD-A49399758","","NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O"
"6824","TOCOFERSOLAN","antioxidant","","cardiology","cerebral cholesterosis","MedChemEx, MedChemEx",0,"BRD-A39830855-001-01-6, BRD-K57305459-001-01-4","Launched","BRD-U58371969-000-01-8","AOBORMOPSGHCAX-UHFFFAOYSA-N","BRD-A39830855","BRD-U58371969","CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1"
"6825","TOCOFERSOLAN","antioxidant","","cardiology","cerebral cholesterosis","MedChemEx, MedChemEx",0,"BRD-A39830855-001-01-6, BRD-K57305459-001-01-4","Launched","BRD-U58371969-000-01-8","AOBORMOPSGHCAX-UHFFFAOYSA-N","BRD-A39830855","BRD-U58371969","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1"
"6826","TOCOFERSOLAN","antioxidant","","cardiology","cerebral cholesterosis","MedChemEx, MedChemEx",0,"BRD-A39830855-001-01-6, BRD-K57305459-001-01-4","Launched","BRD-U58371969-000-01-8","AOBORMOPSGHCAX-AZAGJHQNSA-N","BRD-A39830855","BRD-U58371969","CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1"
"6827","TOCOFERSOLAN","antioxidant","","cardiology","cerebral cholesterosis","MedChemEx, MedChemEx",0,"BRD-A39830855-001-01-6, BRD-K57305459-001-01-4","Launched","BRD-U58371969-000-01-8","AOBORMOPSGHCAX-AZAGJHQNSA-N","BRD-A39830855","BRD-U58371969","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1"
"6828","CHENODEOXYCHOLIC-ACID","11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4","cardiology, gastroenterology","cerebral cholesterosis, gallstones","MicroSource, Selleck",100,"BRD-K18135438-001-14-2, BRD-K18135438-001-16-7","Launched","BRD-K43723251-001-01-5","RUDATBOHQWOJDD-BSWAIDMHSA-N","BRD-K18135438","BRD-K43723251","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"6830","FASUDIL","rho associated kinase inhibitor","PKIA, PRKACA, ROCK1, ROCK2","neurology/psychiatry","cerebral vasospasm","MicroSource, Selleck, Tocris, Tocris",98.59,"BRD-K76617868-001-05-5, BRD-K76617868-003-10-1, BRD-K76617868-003-14-3, BRD-K76617868-003-11-9","Launched","","NGOGFTYYXHNFQH-UHFFFAOYSA-N","BRD-K76617868","","O=S(=O)(N1CCCNCC1)c1cccc2cnccc12"
"6834","BROMHEXINE","mucolytic agent","","pulmonary","chest congestion","MicroSource, Selleck",93.96,"BRD-K47631482-003-07-0, BRD-K47631482-003-06-2","Launched","","OJGDCBLYJGHCIH-UHFFFAOYSA-N","BRD-K47631482","","CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1"
"6836","FUDOSTEINE","mucolytic agent","","pulmonary","chest congestion","Selleck, Selleck",100,"BRD-K54838207-001-03-8, BRD-K54838207-001-02-0","Launched","","KINWYTAUPKOPCQ-YFKPBYRVSA-N","BRD-K54838207","","N[C@@H](CSCCCO)C(O)=O"
"6838","MECYSTEINE","analgesic agent","","pulmonary","chest congestion","MicroSource",12.39,"BRD-A77473570-003-04-2","Launched","","MCYHPZGUONZRGO-UHFFFAOYSA-N","BRD-A77473570","","COC(=O)C(N)CS"
"6839","SOBREPIN","mucolytic agent","","pulmonary","chest congestion","TCI",0,"BRD-K58262380-001-01-0","Launched","","OMDMTHRBGUBUCO-BDAKNGLRSA-N","BRD-K58262380","","CC1=CC[C@H](C[C@@H]1O)C(C)(C)O"
"6840","OXYTETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","","infectious disease, urology","chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease","Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck",51.7,"BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9","Launched","BRD-A78694248-335-01-6, BRD-A56621826-001-01-3","TUEWQXNXQFRUTK-NWGWHKHOSA-N","BRD-A22740840","BRD-A78694248","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6841","OXYTETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","","infectious disease, urology","chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease","Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck",51.7,"BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9","Launched","BRD-A78694248-335-01-6, BRD-A56621826-001-01-3","TUEWQXNXQFRUTK-NWGWHKHOSA-N","BRD-A22740840","BRD-A78694248","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6848","OXYTETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","","infectious disease, urology","chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease","Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck",51.7,"BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9","Launched","BRD-A78694248-335-01-6, BRD-A56621826-001-01-3","TUEWQXNXQFRUTK-PIZKLEGOSA-N","BRD-A22740840","BRD-A78694248","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6849","OXYTETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","","infectious disease, urology","chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease","Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck",51.7,"BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9","Launched","BRD-A78694248-335-01-6, BRD-A56621826-001-01-3","TUEWQXNXQFRUTK-PIZKLEGOSA-N","BRD-A22740840","BRD-A78694248","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"6856","TETRABENAZINE","vesicular monoamine transporter inhibitor","DRD2, SLC18A1, SLC18A2","infectious disease, neurology/psychiatry","cholera, Huntington's disease","Tocris, Tocris",93.02,"BRD-K95739795-001-04-5, BRD-K95739795-001-03-7","Launched","","MKJIEFSOBYUXJB-HOCLYGCPSA-N","BRD-K95739795","","COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC"
"6858","BEZAFIBRATE","PPAR receptor agonist","PPARA, PPARD, PPARG","cardiology","cholesterol","MicroSource, Selleck",99.25,"BRD-K46018455-001-27-6, BRD-K46018455-001-26-8","Launched","","IIBYAHWJQTYFKB-UHFFFAOYSA-N","BRD-K46018455","","CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O"
"6860","LAROPIPRANT","prostanoid receptor antagonist","PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R","cardiology","cholesterol","MedChemEx",98.78,"BRD-K48894757-001-01-8","Launched","","NXFFJDQHYLNEJK-CYBMUJFWSA-N","BRD-K48894757","","CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12"
"6861","FOSTAMATINIB","SYK inhibitor","SYK","hematology","chronic immune thrombocytopenia (ITP)","Selleck, Selleck",92.92,"BRD-K85178109-001-03-1, BRD-K85178109-001-02-3","Launched","","GKDRMWXFWHEQQT-UHFFFAOYSA-N","BRD-K85178109","","COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(O)(O)=O)c4n3)n2)cc(OC)c1OC"
"6863","SEVELAMER","phosphate antagonist","","nephrology","chronic kidney disease (CKD)","Selleck, Selleck",0,"BRD-U45393375-000-01-6, BRD-M22581557-003-02-5","Launched","BRD-M22581557-003-01-7","ZNSIZMQNQCNRBW-UHFFFAOYSA-N","BRD-U45393375","BRD-M22581557","NCC=C.ClCC1CO1"
"6864","DOXERCALCIFEROL","vitamin D receptor agonist","VDR","nephrology, endocrinology","chronic kidney disease (CKD), hyperparathyroidism","Selleck, Selleck",85.38,"BRD-K82928892-001-02-5, BRD-K82928892-001-03-3","Launched","BRD-K07234650-001-01-4","HKXBNHCUPKIYDM-ZKVKAWQFSA-N","BRD-K82928892","BRD-K07234650","CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C"
"6866","PARICALCITOL","vitamin D receptor agonist","VDR","nephrology, endocrinology","chronic kidney disease (CKD), hyperthyroidism","MedChemEx",98.6,"BRD-K60585088-001-01-5","Launched","","BPKAHTKRCLCHEA-UBFJEZKGSA-N","BRD-K60585088","","C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1C[C@@H](O)C[C@H](O)C1"
"6867","FLUDARABINE","ribonucleotide reductase inhibitor","ADA, RRM1, RRM2","hematologic malignancy","chronic lymphocytic leukemia (CLL)","Tocris, Selleck, Tocris",98.32,"BRD-K66788707-001-14-3, BRD-K66788707-001-17-6, BRD-K66788707-001-15-0","Launched","BRD-K51927012-001-02-9","HBUBKKRHXORPQB-FJFJXFQQSA-N","BRD-K66788707","BRD-K51927012","Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O"
"6870","FLUDARABINE-PHOSPHATE","ribonucleotide reductase inhibitor","DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B","hematologic malignancy","chronic lymphocytic leukemia (CLL)","Selleck, MicroSource, Selleck",96.99,"BRD-K71106091-001-09-5, BRD-K71106091-001-06-1, BRD-K71106091-001-05-3","Launched","","GIUYCYHIANZCFB-FJFJXFQQSA-N","BRD-K71106091","","Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O"
"6873","IDELALISIB","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","hematologic malignancy","chronic lymphocytic leukemia (CLL)","Selleck",96.97,"BRD-K60866521-001-07-1","Launched","","IFSDAJWBUCMOAH-HNNXBMFYSA-N","BRD-K60866521","","CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1"
"6874","VENETOCLAX","BCL inhibitor","BCL2","hematologic malignancy","chronic lymphocytic leukemia (CLL)","Selleck, Adooq, Selleck",97.4,"BRD-K62391742-001-08-9, BRD-K62391742-001-09-7, BRD-K62391742-001-03-0","Launched","","LQBVNQSMGBZMKD-UHFFFAOYSA-N","BRD-K62391742","","CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1"
"6877","CHLORAMBUCIL","DNA inhibitor","","hematologic malignancy","chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma","MicroSource",94.93,"BRD-K29458283-001-29-9","Launched","","JCKYGMPEJWAADB-UHFFFAOYSA-N","BRD-K29458283","","OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl"
"6878","IBRUTINIB","Bruton's tyrosine kinase (BTK) inhibitor","BLK, BMX, BTK","hematologic malignancy","chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia (WM)","Selleck, Selleck",99.58,"BRD-K70301465-001-05-9, BRD-K70301465-001-02-6","Launched","","XYFPWWZEPKGCCK-GOSISDBHSA-N","BRD-K70301465","","Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C"
"6880","BENDAMUSTINE","DNA inhibitor","","hematologic malignancy","chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL)","Selleck, Selleck",88.19,"BRD-K17068645-003-05-9, BRD-K17068645-003-04-2","Launched","","YTKUWDBFDASYHO-UHFFFAOYSA-N","BRD-K17068645","","Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl"
"6882","BOSUTINIB","Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK","hematologic malignancy","chronic myeloid leukemia (CML)","Selleck, Tocris",99.19,"BRD-K99964838-001-11-9, BRD-K99964838-001-12-7","Launched","","UBPYILGKFZZVDX-UHFFFAOYSA-N","BRD-K99964838","","COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl"
"6884","BUSULFAN","DNA inhibitor","","hematologic malignancy","chronic myeloid leukemia (CML)","Selleck, MicroSource, Selleck",89.78,"BRD-K23204545-001-18-0, BRD-K23204545-001-16-4, BRD-K23204545-001-15-6","Launched","","COVZYZSDYWQREU-UHFFFAOYSA-N","BRD-K23204545","","CS(=O)(=O)OCCCCOS(C)(=O)=O"
"6887","HOMOHARRINGTONINE","protein synthesis inhibitor","RPL3","hematologic malignancy","chronic myeloid leukemia (CML)","Tocris",87.85,"BRD-K76674262-001-03-3","Launched","","HYFHYPWGAURHIV-JFIAXGOJSA-N","BRD-K76674262","","COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC"
"6888","NILOTINIB","Abl kinase inhibitor, Bcr-Abl kinase inhibitor","ABL1, KIT","hematologic malignancy","chronic myeloid leukemia (CML)","Selleck",98.71,"BRD-K81528515-001-13-8","Launched","","HHZIURLSWUIHRB-UHFFFAOYSA-N","BRD-K81528515","","Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F"
"6889","DASATINIB","Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1","hematologic malignancy","chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)","Selleck, Selleck",88.41,"BRD-K49328571-001-19-2, BRD-K49328571-001-15-0","Launched","","ZBNZXTGUTAYRHI-UHFFFAOYSA-N","BRD-K49328571","","Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1"
"6891","PONATINIB","Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK","hematologic malignancy","chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)","Selleck, Selleck",90.52,"BRD-K44227013-001-08-0, BRD-K44227013-001-06-4","Launched","","PHXJVRSECIGDHY-UHFFFAOYSA-N","BRD-K44227013","","CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1"
"6893","IMATINIB","Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","hematologic malignancy, oncology","chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), myelodysplastic diseases (MDS), aggressive systemic mastocytosis (ASM), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans (DFSP), gastrointestinal stromal tumors (GIST)","Selleck, Selleck, Selleck",99.23,"BRD-K92723993-001-12-5, BRD-K92723993-001-06-7, BRD-K92723993-066-22-7","Launched","","KTUFNOKKBVMGRW-UHFFFAOYSA-N","BRD-K92723993","","CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1"
"6896","HYDROXYUREA","ribonucleotide reductase inhibitor","RRM1, RRM2, RRM2B","hematologic malignancy, oncology","chronic myeloid leukemia (CML), head and neck squamous cell carcinoma (HNSCC)","Selleck, Selleck, MicroSource",98.2,"BRD-K51747290-001-15-6, BRD-K51747290-001-12-3, BRD-K51747290-001-13-1","Launched","","VSNHCAURESNICA-UHFFFAOYSA-N","BRD-K51747290","","NC(=O)NO"
"6899","ALMITRINE","neurotransmitter agonist","ATP1A1","pulmonary","chronic obstructive pulmonary disease (COPD)","AKSci",99.06,"BRD-K82677201-001-01-6","Launched","","OBDOVFRMEYHSQB-UHFFFAOYSA-N","BRD-K82677201","","Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1"
"6900","INDACATEROL","adrenergic receptor agonist","ADRB1, ADRB2","pulmonary","chronic obstructive pulmonary disease (COPD)","Selleck",95.34,"BRD-K89208535-051-01-5","Launched","","QZZUEBNBZAPZLX-QFIPXVFZSA-N","BRD-K89208535","","CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12"
"6901","VILANTEROL","adrenergic receptor agonist","ADRB2","pulmonary","chronic obstructive pulmonary disease (COPD)","MedChemEx, MedChemEx, MedChemEx, MedChemEx",54.71,"BRD-M36487418-001-05-5, BRD-M36487418-001-03-0, BRD-M36487418-001-01-4, BRD-M36487418-001-02-2","Launched","BRD-U26240578-000-01-7,BRD-M36487418-001-04-8","KLOLZALDXGTNQE-JIDHJSLPSA-N","BRD-M36487418","BRD-U26240578","OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl"
"6905","CLENBUTEROL","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3, NGF, TNF","pulmonary","chronic obstructive pulmonary disease (COPD), asthma","MicroSource",99.02,"BRD-A75726477-003-21-3","Launched","","STJMRWALKKWQGH-UHFFFAOYSA-N","BRD-A75726477","","CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1"
"6906","ROFLUMILAST","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4C, PDE4D","pulmonary","chronic obstructive pulmonary disease (COPD), bronchitis","Selleck",99.14,"BRD-K03194791-001-04-8","Launched","","MNDBXUUTURYVHR-UHFFFAOYSA-N","BRD-K03194791","","FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl"
"6907","TIOTROPIUM","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","pulmonary","chronic obstructive pulmonary disease (COPD), bronchitis, emphysema","Selleck",90.47,"BRD-K62782754-337-02-5","Launched","","LERNTVKEWCAPOY-DZZGSBJMSA-N","BRD-K62782754","","C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1"
"6908","UMECLIDINIUM","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","pulmonary","chronic obstructive pulmonary disease (COPD), bronchitis, emphysema","MedChemEx",98.3,"BRD-K46692793-004-01-8","Launched","","FVTWTVQXNAJTQP-UHFFFAOYSA-N","BRD-K46692793","","OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2"
"6909","RANOLAZINE","sodium channel blocker","SCN10A, SCN4A, SCN5A, SCN9A","cardiology","chronic stable angina","MicroSource, Tocris, Selleck, Selleck",98.48,"BRD-A97674275-001-11-8, BRD-A97674275-300-04-9, BRD-A97674275-001-10-0, BRD-A97674275-300-03-1","Launched","","XKLMZUWKNUAPSZ-UHFFFAOYSA-N","BRD-A97674275","","COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1"
"6913","NICARDIPINE","calcium channel blocker","ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B","cardiology","chronic stable angina, hypertension","Selleck, MicroSource",97.24,"BRD-A26711594-003-08-0, BRD-A26711594-003-10-6","Launched","","ZBBHBTPTTSWHBA-UHFFFAOYSA-N","BRD-A26711594","","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1"
"6915","DIOSMIN","aryl hydrocarbon receptor agonist, capillary stabilizing agent","AHR","cardiology, hematology, dermatology","chronic venous insufficiency (CVI), edema, deep vein thrombosis (DVT), statis dermatitis, heavy leg syndrome","MicroSource, Selleck, Selleck",89.84,"BRD-K94436377-001-10-2, BRD-K94436377-001-11-0, BRD-K94436377-001-12-8","Launched","BRD-K22902927-001-01-4,BRD-A35279169-001-07-8","GZSOSUNBTXMUFQ-YFAPSIMESA-N","BRD-K94436377","BRD-K22902927","COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1"
"6918","CILOSTAZOL","phosphodiesterase inhibitor","PDE3A, PDE3B","cardiology","claudication","MicroSource, Tocris, Selleck, Tocris",98.71,"BRD-K67017579-001-28-1, BRD-K67017579-001-29-9, BRD-K67017579-001-26-5, BRD-K67017579-001-27-3","Launched","","RRGUKTPIGVIEKM-UHFFFAOYSA-N","BRD-K67017579","","O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1"
"6922","LIMAPROST-ALFADEX","prostanoid receptor agonist","PTGER1","cardiology","claudication","MedChemEx, MedChemEx",93.26,"BRD-K25015158-001-01-2, BRD-K25015158-001-02-0","Launched","","OJZYRQPMEIEQFC-UAWLTFRCSA-N","BRD-K25015158","","CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O"
"6924","NAFTIDROFURYL","adrenergic receptor antagonist","","cardiology","claudication","MicroSource",92.27,"BRD-A67862938-034-14-9","Launched","","KBAFPSLPKGSANY-UHFFFAOYSA-N","BRD-A67862938","","CCN(CC)CCOC(=O)C(CC1CCCO1)Cc1cccc2ccccc12"
"6925","PENTOXIFYLLINE","phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF","cardiology","claudication","MicroSource, Selleck",99.53,"BRD-K57569181-001-27-5, BRD-K57569181-001-26-7","Launched","","BYPFEZZEUUWMEJ-UHFFFAOYSA-N","BRD-K57569181","","CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O"
"6927","CYCLANDELATE","calcium channel blocker","CACNA2D1, CES1","cardiology, rheumatology","claudication, arteriosclerosis, Raynaud's disease","MicroSource, Selleck, Selleck",96.1,"BRD-A27370296-001-03-0, BRD-A27370296-001-02-2, BRD-A27370296-001-04-8","Launched","","WZHCOOQXZCIUNC-UHFFFAOYSA-N","BRD-A27370296","","CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1"
"6930","AKLOMIDE","","","infectious disease","coccidiosis","MicroSource",98.9,"BRD-K26807903-001-04-3","Launched","","GFGSZUNNBQXGMK-UHFFFAOYSA-N","BRD-K26807903","","NC(=O)c1ccc(cc1Cl)[N+]([O-])=O"
"6931","AMPROLIUM","thiamine uptake blocker","","infectious disease","coccidiosis","Selleck, MicroSource",95.82,"BRD-K90027121-300-13-2, BRD-K90027121-003-01-7","Launched","","IPZFPROOBOUEIG-UHFFFAOYSA-N","BRD-K90027121","","CCCc1ncc(C[n+]2ccccc2C)c(N)n1"
"6933","CLOPIDOL","","","infectious disease","coccidiosis","MicroSource",95.89,"BRD-K80036624-001-04-0","Launched","","ZDPIZLCVJAAHHR-UHFFFAOYSA-N","BRD-K80036624","","Cc1nc(C)c(Cl)c(O)c1Cl"
"6934","DECOQUINATE","antiprotozoal agent","","infectious disease","coccidiosis","MicroSource, MedChemEx, Selleck, Selleck",100,"BRD-K17641316-213-01-5, BRD-K17641316-001-04-8, BRD-K17641316-001-02-2, BRD-K17641316-001-03-0","Launched","","JHAYEQICABJSTP-UHFFFAOYSA-N","BRD-K17641316","","CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC"
"6938","DINITOLMIDE","","","infectious disease","coccidiosis","MicroSource",98.55,"BRD-K93240442-001-08-4","Launched","","ZEFNOZRLAWVAQF-UHFFFAOYSA-N","BRD-K93240442","","Cc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(N)=O"
"6939","ETHOPABATE","antiprotozoal agent","","infectious disease","coccidiosis","MicroSource",97.78,"BRD-K02475039-001-01-0","Launched","","GOVWOKSKFSBNGD-UHFFFAOYSA-N","BRD-K02475039","","CCOc1cc(NC(C)=O)ccc1C(=O)OC"
"6940","LASALOCID","bacterial permeability inducer","","infectious disease","coccidiosis","MicroSource",91.23,"BRD-A72711497-236-03-8","Launched","","BBMULGJBVDDDNI-YFGMYPSKSA-N","BRD-A72711497","","CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O"
"6941","NARASIN","antiprotozoal agent","","infectious disease","coccidiosis","MicroSource",100,"BRD-A25608658-001-01-1","Launched","","VHKXXVVRRDYCIK-HNOFAURLSA-N","BRD-A25608658","","CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O"
"6942","SALINOMYCIN","","","infectious disease","coccidiosis","MicroSource, Selleck, Selleck",94.17,"BRD-A28301258-236-01-6, BRD-A28301258-001-03-0, BRD-A28301258-001-04-8","Launched","BRD-A28301258-001-05-5,BRD-A32757659-236-04-2, BRD-A98605041-001-01-5, BRD-A46641338-001-02-3","KQXDHUJYNAXLNZ-DLOCPGDYSA-N","BRD-A28301258","BRD-A28301258","CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O"
"6945","SULFAQUINOXALINE","vitamin K antagonist","","infectious disease","coccidiosis","MicroSource",92.12,"BRD-K71133585-236-14-4","Launched","","NHZLNPMOSADWGC-UHFFFAOYSA-N","BRD-K71133585","","Nc1ccc(cc1)S(=O)(=O)Nc1cnc2ccccc2n1"
"6946","TOLTRAZURIL","antiprotozoal agent","","infectious disease","coccidiosis","MicroSource, Selleck",99.46,"BRD-K64514229-001-05-2, BRD-K64514229-001-04-5","Launched","","OCINXEZVIIVXFU-UHFFFAOYSA-N","BRD-K64514229","","Cc1cc(ccc1Oc1ccc(SC(F)(F)F)cc1)-n1c(=O)[nH]c(=O)n(C)c1=O"
"6948","SULFAMERAZINE","bacterial antifolate","","infectious disease","coccidiosis, cholera","MicroSource, Selleck",98.63,"BRD-K93524252-001-24-7, BRD-K93524252-001-23-9","Launched","","QPPBRPIAZZHUNT-UHFFFAOYSA-N","BRD-K93524252","","Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1"
"6950","DOCOSANOL","lipase clearing factor inhibitor","TLR7","dental","cold sore","Selleck, Selleck, MicroSource",0,"BRD-K50050533-001-04-7, BRD-K50050533-001-02-1, BRD-K50050533-001-03-9","Launched","","NOPFSRXAKWQILS-UHFFFAOYSA-N","BRD-K50050533","","CCCCCCCCCCCCCCCCCCCCCCO"
"6953","PENCICLOVIR","DNA directed DNA polymerase inhibitor","","dental","cold sore","Selleck, MicroSource, Selleck",94.53,"BRD-K47780086-001-06-1, BRD-K47780086-001-07-9, BRD-K47780086-001-08-7","Launched","","JNTOCHDNEULJHD-UHFFFAOYSA-N","BRD-K47780086","","Nc1nc(O)c2ncn(CCC(CO)CO)c2n1"
"6956","FAMCICLOVIR","DNA polymerase inhibitor","","dental, infectious disease","cold sore, genitial herpes, shingles","MicroSource, Selleck",99.1,"BRD-K45033733-001-12-2, BRD-K45033733-001-11-4","Launched","","GGXKWVWZWMLJEH-UHFFFAOYSA-N","BRD-K45033733","","CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O"
"6958","NIFUROXAZIDE","bacterial DNA inhibitor","","gastroenterology","colitis, diarrhea","MicroSource, Selleck, Selleck",98.14,"BRD-K68188368-001-09-4, BRD-K68188368-001-08-6, BRD-K68188368-001-11-0","Launched","","YCWSUKQGVSGXJO-NTUHNPAUSA-N","BRD-K68188368","","Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O"
"6961","DOXIFLURIDINE","thymidylate synthase inhibitor","TYMS","oncology","colorectal cancer","MicroSource, Selleck",96.4,"BRD-K58262659-001-10-5, BRD-K58262659-001-09-7","Launched","BRD-A68537732-001-03-6, BRD-K83057217-001-01-2","ZWAOHEXOSAUJHY-ZIYNGMLESA-N","BRD-K58262659","BRD-A68537732","C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O"
"6963","FLOXURIDINE","DNA synthesis inhibitor","TYMS","oncology","colorectal cancer","MicroSource, Selleck",100,"BRD-A03757454-001-03-4, BRD-K47832606-001-30-1","Launched","BRD-K73088654-001-01-9","ODKNJVUHOIMIIZ-CQMSUOBXSA-N","BRD-A03757454","BRD-K73088654","OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O"
"6964","FLOXURIDINE","DNA synthesis inhibitor","TYMS","oncology","colorectal cancer","MicroSource, Selleck",100,"BRD-A03757454-001-03-4, BRD-K47832606-001-30-1","Launched","BRD-K73088654-001-01-9","ODKNJVUHOIMIIZ-CQMSUOBXSA-N","BRD-A03757454","BRD-K73088654","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O"
"6965","FLOXURIDINE","DNA synthesis inhibitor","TYMS","oncology","colorectal cancer","MicroSource, Selleck",100,"BRD-A03757454-001-03-4, BRD-K47832606-001-30-1","Launched","BRD-K73088654-001-01-9","ODKNJVUHOIMIIZ-RRKCRQDMSA-N","BRD-A03757454","BRD-K73088654","OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O"
"6966","FLOXURIDINE","DNA synthesis inhibitor","TYMS","oncology","colorectal cancer","MicroSource, Selleck",100,"BRD-A03757454-001-03-4, BRD-K47832606-001-30-1","Launched","BRD-K73088654-001-01-9","ODKNJVUHOIMIIZ-RRKCRQDMSA-N","BRD-A03757454","BRD-K73088654","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O"
"6967","FTORAFUR","thymidylate synthase inhibitor","TYMS","oncology","colorectal cancer","Selleck, Selleck",100,"BRD-K99383816-001-03-5, BRD-K99383816-001-02-7","Launched","","WFWLQNSHRPWKFK-ZCFIWIBFSA-N","BRD-K99383816","","Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O"
"6969","IRINOTECAN","topoisomerase inhibitor","TOP1, TOP1MT","oncology","colorectal cancer","Selleck, Tocris, MedChemEx, Tocris, MicroSource, Selleck, Selleck",98.48,"BRD-K08547377-001-04-4, BRD-K08547377-003-06-5, BRD-K08547377-003-07-3, BRD-K08547377-003-04-0, BRD-K08547377-003-05-7, BRD-K08547377-001-06-9, BRD-K08547377-394-03-5","Launched","BRD-K72035773-001-01-7","UWKQSNNFCGGAFS-XIFFEERXSA-N","BRD-K08547377","BRD-K72035773","CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12"
"6976","OXALIPLATIN","DNA inhibitor","","oncology","colorectal cancer","Selleck, Tocris, MicroSource, Selleck",98.79,"BRD-K78960041-001-05-7, BRD-K78960041-001-03-2, BRD-K78960041-001-07-3, BRD-K78960041-001-02-4","Launched","BRD-M78823677-034-04-0, BRD-M78823677-034-03-2, BRD-A20035137-001-01-3,BRD-M43490210-001-01-9, BRD-M78823677-034-02-4","DWAFYCQODLXJNR-BNTLRKBRSA-L","BRD-K78960041","BRD-M78823677","O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O"
"6980","SN-38","topoisomerase inhibitor","TOP1","oncology","colorectal cancer","Tocris, Tocris, Selleck",98.53,"BRD-K89561498-001-02-5, BRD-K89561498-001-03-3, BRD-K89561498-001-01-7","Launched","","FJHBVJOVLFPMQE-QFIPXVFZSA-N","BRD-K89561498","","CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12"
"6983","TIPIRACIL","thymidine phosphorylase inhibitor","TYMP","oncology","colorectal cancer","MedChemEx",92.57,"BRD-K11973162-003-01-8","Launched","","QQHMKNYGKVVGCZ-UHFFFAOYSA-N","BRD-K11973162","","Clc1c(CN2CCCC2=N)[nH]c(=O)[nH]c1=O"
"6984","5-FLUOROURACIL","thymidylate synthase inhibitor","DPYD, TYMS","oncology","colorectal cancer, breast cancer, pancreatic cancer, gastric adenocarcinoma","MicroSource, Selleck",100,"BRD-K24844714-001-25-2, BRD-K24844714-001-24-5","Launched","","GHASVSINZRGABV-UHFFFAOYSA-N","BRD-K24844714","","Fc1c[nH]c(=O)[nH]c1=O"
"6986","REGORAFENIB","FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK","oncology","colorectal cancer, gastrointestinal stromal tumors (GIST)","Selleck",97.53,"BRD-K16730910-001-07-3","Launched","","FNHKPVJBJVTLMP-UHFFFAOYSA-N","BRD-K16730910","","CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1"
"6987","MEPYRAMINE","histamine receptor antagonist","HRH1","otolaryngology, obstetrics/gynecology","common cold, menstrual pain","Selleck, MicroSource, Tocris",99.13,"BRD-K97564742-051-02-8, BRD-K97564742-050-32-7, BRD-K97564742-050-31-9","Launched","","YECBIJXISLIIDS-UHFFFAOYSA-N","BRD-K97564742","","COc1ccc(cc1)CN(CCN(C)C)c1ccccn1"
"6990","CARBETAPENTANE","acetylcholine receptor antagonist","CHRM2","otolaryngology, pulmonary","common cold, nasal congestion, bronchitis","Tocris, MicroSource",93.21,"BRD-K06181161-048-15-1, BRD-K06181161-048-16-9","Launched","","CFJMRBQWBDQYMK-UHFFFAOYSA-N","BRD-K06181161","","CCN(CC)CCOCCOC(=O)C1(CCCC1)c1ccccc1"
"6992","PREDNISONE","glucocorticoid receptor agonist","HSD11B1, NR3C1","endocrinology, rheumatology, infectious disease, dermatology, ophthalmology, hematology, gastroenterology, neurology/psychiatry","congenital adrenal hyperplasia, hypercalcemia, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, bursitis, osteoarthritis, epicondylitis, dermatomyositis, psoriasis, mycosis, conjunctivitis, anemia, ulcerative colitis, enteritis, multiple sclerosis, meningitis","Selleck, MicroSource, Selleck",95.73,"BRD-K85883481-001-22-4, BRD-K85883481-001-25-7, BRD-K85883481-001-24-0","Launched","BRD-A62525898-001-05-2, BRD-K60679745-001-01-1","XOFYZVNMUHMLCC-ZPOLXVRWSA-N","BRD-K85883481","BRD-A62525898","C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"6995","METHYLPREDNISOLONE-ACEPONATE","anti-inflammatory agent, glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, infectious disease, allergy, pulmonary, gastroenterology, dermatology, neurology/psychiatry, hematology","congenital adrenal hyperplasia, thyroiditis, hypercalcemia, rheumatoid arthritis, bursitis, epicondylitis, allergic rhinitis, asthma, ulcerative colitis, enteritis, osteoarthritis, psoriasis, multiple sclerosis, anemia","Alinda",97.13,"BRD-K24452555-001-01-7","Launched","","DALKLAYLIPSCQL-YPYQNWSCSA-N","BRD-K24452555","","CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O"
"6996","ALPROSTADIL","prostanoid receptor agonist","CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR","cardiology","congenital heart defects","Tocris, Selleck",100,"BRD-K52459643-001-15-1, BRD-K52459643-001-17-7","Launched","BRD-K73691377-001-01-6","GMVPRGQOIOIIMI-DWKJAMRDSA-N","BRD-K52459643","BRD-K73691377","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O"
"6998","AMRINONE","phosphodiesterase inhibitor","PDE3A, PDE3B, PDE4B, TNF","cardiology","congestive heart failure","MicroSource",92.25,"BRD-K45924332-001-16-8","Launched","","RNLQIBCLLYYYFJ-UHFFFAOYSA-N","BRD-K45924332","","Nc1cc(c[nH]c1=O)-c1ccncc1"
"6999","DOBUTAMINE","adrenergic receptor agonist","ADRB1, ADRB2","cardiology","congestive heart failure","Tocris, MedChemEx, Tocris, MedChemEx, Tocris",81.27,"BRD-A78322124-003-16-5, BRD-A78322124-003-18-1, BRD-A78322124-003-17-3, BRD-A78322124-003-15-7, BRD-A78322124-003-14-0","Launched","","JRWZLRBJNMZMFE-UHFFFAOYSA-N","BRD-A78322124","","CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1"
"7004","ENOXIMONE","phosphodiesterase inhibitor","PDE3A","cardiology","congestive heart failure","Sigma",92.01,"BRD-K21152241-001-07-3","Launched","","ZJKNESGOIKRXQY-UHFFFAOYSA-N","BRD-K21152241","","CSc1ccc(cc1)C(=O)c1[nH]c(O)nc1C"
"7005","LEVOSIMENDAN","calcium sensitizer","KCNJ11, KCNJ8, PDE3A, TNNC1","cardiology","congestive heart failure","Selleck, MicroSource",99.1,"BRD-K03095347-001-05-3, BRD-K03095347-001-06-1","Launched","","WHXMKTBCFHIYNQ-SECBINFHSA-N","BRD-K03095347","","C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1"
"7007","MILRINONE","phosphodiesterase inhibitor","PDE2A, PDE3A, PDE3B, PDE5A","cardiology","congestive heart failure","MicroSource, Selleck",100,"BRD-K67080878-001-16-2, BRD-K67080878-001-15-4","Launched","","PZRHRDRVRGEVNW-UHFFFAOYSA-N","BRD-K67080878","","Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N"
"7009","OLPRINONE","phosphodiesterase inhibitor","PDE3A","cardiology","congestive heart failure","MedChemEx",99.86,"BRD-K20745393-003-01-0","Launched","","JPAWFIIYTJQOKW-UHFFFAOYSA-N","BRD-K20745393","","Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N"
"7010","PIMOBENDAN","calcium sensitizer, phosphodiesterase inhibitor","PDE3A","cardiology","congestive heart failure","Selleck",97.63,"BRD-A84575140-001-02-4","Launched","","GLBJJMFZWDBELO-UHFFFAOYSA-N","BRD-A84575140","","COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C"
"7011","SACUBITRIL","neprilysin inhibitor","MME","cardiology","congestive heart failure","MedChemEx, MedChemEx",99.59,"BRD-K91456750-001-01-9, BRD-K91456750-238-01-7","Launched","BRD-M32063731-001-01-7","PYNXFZCZUAOOQC-UTKZUKDTSA-N","BRD-K91456750","BRD-M32063731","CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O"
"7013","VESNARINONE","phosphodiesterase inhibitor","KCNH2, PDE3A","cardiology","congestive heart failure","MedChemEx",88.52,"BRD-K13414800-001-01-3","Launched","","ZVNYJIZDIRKMBF-UHFFFAOYSA-N","BRD-K13414800","","COc1ccc(cc1OC)C(=O)N1CCN(CC1)c1ccc2NC(=O)CCc2c1"
"7014","DIGOXIN","ATPase inhibitor","ATP1A1","cardiology","congestive heart failure, atrial fibrillation (AF)","MicroSource",96.49,"BRD-A94756469-001-04-7","Launched","","LTMHDMANZUZIPE-QVYPYPLASA-N","BRD-A94756469","","C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C"
"7015","DESLANOSIDE","Na/K-ATPase inhibitor","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2","cardiology","congestive heart failure, cardiac arrythmia","AvaChem",98.38,"BRD-K99919177-001-01-3","Launched","","OBATZBGFDSVCJD-LALPQLPRSA-N","BRD-K99919177","","C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1"
"7016","PROSCILLARIDIN-A","","","cardiology","congestive heart failure, cardiac arrythmia","MicroSource",91.74,"BRD-A11815689-001-01-1","Launched","","MYEJFUXQJGHEQK-BACGYGAMSA-N","BRD-A11815689","","C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c2ccc(=O)oc2)C(O)C(O)[C@H]1O"
"7017","EPLERENONE","cytochrome P450 inhibitor","NR3C2","cardiology","congestive heart failure, hypertension","Selleck, Tocris, Selleck",99.75,"BRD-K19761926-001-03-6, BRD-K19761926-001-02-8, BRD-K19761926-001-04-4","Launched","BRD-K82139003-001-01-7","JUKPWJGBANNWMW-VWBFHTRKSA-N","BRD-K19761926","BRD-K82139003","COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13"
"7020","L-ARGININE","nitric oxide precursor","ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4","cardiology, neurology/psychiatry, urology, obstetrics/gynecology, otolaryngology","congestive heart failure, hypertension, coronary artery disease (CAD), claudication, senile dementia, erectile dysfunction, infertility, common cold","Selleck",100,"BRD-K76811153-003-01-3","Launched","","ODKSFYDXXFIFQN-SCSAIBSYSA-N","BRD-K76811153","","N[C@H](CCCNC(N)=N)C(O)=O"
"7021","AZELASTINE","histamine receptor antagonist","HRH1","ophthalmology","conjunctivitis","MicroSource, Selleck",96.67,"BRD-A68888262-003-16-9, BRD-A68888262-003-15-1","Launched","","MBUVEWMHONZEQD-UHFFFAOYSA-N","BRD-A68888262","","CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O"
"7023","BEPOTASTINE","histamine receptor antagonist","HRH1","ophthalmology","conjunctivitis","Selleck",90.86,"BRD-K98624455-074-02-8","Launched","","YWGDOWXRIALTES-NRFANRHFSA-N","BRD-K98624455","","OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1"
"7024","BESIFLOXACIN","bacterial DNA gyrase inhibitor","","ophthalmology","conjunctivitis","Selleck",93.81,"BRD-K10196357-003-02-0","Launched","","QFFGVLORLPOAEC-SNVBAGLBSA-N","BRD-K10196357","","N[C@@H]1CCCCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1"
"7025","BILASTINE","histamine receptor antagonist","HRH1","ophthalmology","conjunctivitis","MedChemEx",99.77,"BRD-K51937257-001-01-4","Launched","","ACCMWZWAEFYUGZ-UHFFFAOYSA-N","BRD-K51937257","","CCOCCn1c(nc2ccccc12)C1CCN(CCc2ccc(cc2)C(C)(C)C(O)=O)CC1"
"7026","CHLORTETRACYCLINE","protein synthesis inhibitor","","ophthalmology","conjunctivitis","MicroSource, Selleck, Selleck",76.26,"BRD-A25492003-003-13-3, BRD-A25492003-003-15-8, BRD-A25492003-003-14-1","Launched","BRD-A41555725-003-08-4, BRD-A25492003-001-02-0,BRD-A41555725-003-09-2","RNPLSXLZRGPQCU-WYOUFOJNSA-N","BRD-A25492003","BRD-A41555725","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"7029","EMEDASTINE","histamine receptor antagonist","HRH1","ophthalmology","conjunctivitis","Prestwick, TCI",86.56,"BRD-K15010214-364-01-9, BRD-K15010214-364-02-7","Launched","","KBUZBQVCBVDWKX-UHFFFAOYSA-N","BRD-K15010214","","CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1"
"7031","EPINASTINE","histamine receptor antagonist","ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7","ophthalmology","conjunctivitis","Selleck",95.95,"BRD-A98990573-003-01-3","Launched","","WHWZLSFABNNENI-UHFFFAOYSA-N","BRD-A98990573","","NC1=NCC2N1c1ccccc1Cc1ccccc21"
"7032","LEVOCABASTINE","histamine receptor antagonist","HRH1, NTSR2","ophthalmology","conjunctivitis","Prestwick",98.8,"BRD-K33453211-003-11-5","Launched","","ZCGOMHNNNFPNMX-KYTRFIICSA-N","BRD-K33453211","","C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1"
"7033","LOTEPREDNOL","glucocorticoid receptor agonist, phospholipase inhibitor","NR3C1","ophthalmology","conjunctivitis","Selleck, Selleck",95.55,"BRD-K39983086-001-06-1, BRD-K39983086-001-07-9","Launched","BRD-K43659793-001-01-6","DMKSVUSAATWOCU-HROMYWEYSA-N","BRD-K39983086","BRD-K43659793","CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl"
"7035","OLOPATADINE","histamine receptor antagonist","HRH1, S100A1, S100A12, S100A13, S100A2, S100B","ophthalmology","conjunctivitis","Tocris, Selleck",98.6,"BRD-K67637637-003-11-8, BRD-K67637637-003-12-6","Launched","BRD-K06625472-003-01-6","JBIMVDZLSHOPLA-LSCVHKIXSA-N","BRD-K67637637","BRD-K06625472","CN(C)CC\C=C1\c2ccccc2COc2ccc(CC(O)=O)cc12"
"7037","SULFACETAMIDE","PABA antagonist","","ophthalmology","conjunctivitis","Selleck, MicroSource",94.36,"BRD-K21520694-236-02-6, BRD-K21520694-001-21-4","Launched","","SKIVFJLNDNKQPD-UHFFFAOYSA-N","BRD-K21520694","","CC(=O)NS(=O)(=O)c1ccc(N)cc1"
"7039","MEDRYSONE","glucocorticoid receptor agonist","NR3C1","ophthalmology","conjunctivitis, episcleritis","Selleck, MicroSource",95.45,"BRD-A59014912-001-01-3, BRD-K56515112-001-21-6","Launched","BRD-A20126139-001-04-2","GZENKSODFLBBHQ-CHMAHDFQSA-N","BRD-A59014912","BRD-A20126139","C[C@H]1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C2(C)CCC(=O)C=C12"
"7040","MEDRYSONE","glucocorticoid receptor agonist","NR3C1","ophthalmology","conjunctivitis, episcleritis","Selleck, MicroSource",95.45,"BRD-A59014912-001-01-3, BRD-K56515112-001-21-6","Launched","BRD-A20126139-001-04-2","GZENKSODFLBBHQ-CHMAHDFQSA-N","BRD-A59014912","BRD-A20126139","C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)CCC(=O)C=C12"
"7041","MEDRYSONE","glucocorticoid receptor agonist","NR3C1","ophthalmology","conjunctivitis, episcleritis","Selleck, MicroSource",95.45,"BRD-A59014912-001-01-3, BRD-K56515112-001-21-6","Launched","BRD-A20126139-001-04-2","GZENKSODFLBBHQ-ILSZZQPISA-N","BRD-A59014912","BRD-A20126139","C[C@H]1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C2(C)CCC(=O)C=C12"
"7042","MEDRYSONE","glucocorticoid receptor agonist","NR3C1","ophthalmology","conjunctivitis, episcleritis","Selleck, MicroSource",95.45,"BRD-A59014912-001-01-3, BRD-K56515112-001-21-6","Launched","BRD-A20126139-001-04-2","GZENKSODFLBBHQ-ILSZZQPISA-N","BRD-A59014912","BRD-A20126139","C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)CCC(=O)C=C12"
"7043","NATAMYCIN","fungal ergosterol inhibitor","","ophthalmology, infectious disease","conjunctivitis, fungal keratosis, blepharitis","MicroSource, MedChemEx, MedChemEx, Sigma, Selleck, Selleck",91.43,"BRD-K90563805-213-01-9, BRD-K90563805-001-03-4, BRD-K90563805-001-04-2, BRD-K90563805-001-02-6, BRD-K90563805-001-05-9, BRD-K90563805-001-06-7","Launched","BRD-A00398769-213-01-5, BRD-K40312300-001-01-1, BRD-A55960065-001-01-6,BRD-A00773244-001-01-3, BRD-A55960065-001-02-4,BRD-K63692151-001-01-8","NCXMLFZGDNKEPB-FFPOYIOWSA-N","BRD-K90563805","BRD-A00398769","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7049","ANTAZOLINE","antihistamine","HRH1","ophthalmology, otolaryngology","conjunctivitis, nasal congestion","MicroSource, Tocris, Selleck",92.85,"BRD-K99300445-001-01-2, BRD-K99300445-003-21-6, BRD-K99300445-003-20-8","Launched","","REYFJDPCWQRWAA-UHFFFAOYSA-N","BRD-K99300445","","C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1"
"7052","SISOMICIN","protein synthesis inhibitor","","ophthalmology","conjunctivitis, punctate keratitis, conjunctivitis, punctate keratitis","MedChemEx, MedChemEx, AvaChem",11.93,"BRD-K71772032-001-01-3, BRD-K71772032-315-02-5, BRD-K71772032-315-01-7","Launched","BRD-M71798497-001-01-4, BRD-M47753525-343-01-2, BRD-A29840884-001-01-2","URWAJWIAIPFPJE-YFMIWBNJSA-N","BRD-K71772032","BRD-M71798497","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O"
"7055","PREDNISOLONE","glucocorticoid receptor agonist","NR3C1, NR3C2, SERPINA6","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","MicroSource, Selleck",96.97,"BRD-A27887842-001-04-0, BRD-A27887842-001-05-7","Launched","BRD-K00645576-001-01-9","OIGNJSKKLXVSLS-YDAVOWJHSA-N","BRD-A27887842","BRD-K00645576","C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO"
"7057","PREDNISOLONE-ACETATE","glucocorticoid receptor agonist","NR3C1","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","Selleck, MicroSource, Selleck",93.2,"BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4","Launched","BRD-K87234558-001-01-0","LRJOMUJRLNCICJ-JZYPGELDSA-N","BRD-K45664306","BRD-K87234558","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C"
"7058","PREDNISOLONE-ACETATE","glucocorticoid receptor agonist","NR3C1","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","Selleck, MicroSource, Selleck",93.2,"BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4","Launched","BRD-K87234558-001-01-0","LRJOMUJRLNCICJ-JZYPGELDSA-N","BRD-K45664306","BRD-K87234558","CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C"
"7060","PREDNISOLONE-ACETATE","glucocorticoid receptor agonist","NR3C1","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","Selleck, MicroSource, Selleck",93.2,"BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4","Launched","BRD-K87234558-001-01-0","LRJOMUJRLNCICJ-AUGMLKDDSA-N","BRD-K45664306","BRD-K87234558","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C"
"7061","PREDNISOLONE-ACETATE","glucocorticoid receptor agonist","NR3C1","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","Selleck, MicroSource, Selleck",93.2,"BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4","Launched","BRD-K87234558-001-01-0","LRJOMUJRLNCICJ-AUGMLKDDSA-N","BRD-K45664306","BRD-K87234558","CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C"
"7063","BISACODYL","laxative","","gastroenterology","constipation","MicroSource, Selleck",96.97,"BRD-K39987650-001-24-1, BRD-K39987650-001-23-3","Launched","","KHOITXIGCFIULA-UHFFFAOYSA-N","BRD-K39987650","","CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1"
"7065","DOCUSATE","laxative","","gastroenterology","constipation","MicroSource",60.87,"BRD-A00092689-236-03-8","Launched","","HNSDLXPSAYFUHK-UHFFFAOYSA-N","BRD-A00092689","","CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(O)(=O)=O"
"7066","LACITOL","osmosis stimulant","","gastroenterology","constipation","MicroSource, MicroSource",100,"BRD-K40787673-001-02-1, BRD-K40787673-001-01-3","Launched","BRD-A34513497-002-02-3","VQHSOMBJVWLPSR-JVCRWLNRSA-N","BRD-K40787673","BRD-A34513497","OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO"
"7068","METHYLNALTREXONE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","gastroenterology","constipation","MedChemEx",96.91,"BRD-K33732501-004-01-0","Launched","","JVLBPIPGETUEET-RESYIPQXSA-O","BRD-K33732501","","C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O"
"7069","NALOXEGOL","opioid receptor antagonist","OPRM1","gastroenterology","constipation","MedChemEx",88.98,"BRD-K41458421-034-01-6","Launched","","XNKCCCKFOQNXKV-ZRSCBOBOSA-N","BRD-K41458421","","COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC=C)c45"
"7070","PRUCALOPRIDE","serotonin receptor agonist","HTR4","gastroenterology","constipation","Selleck, Selleck",97.6,"BRD-K33681278-036-01-2, BRD-K33681278-001-02-4","Launched","","ZPMNHBXQOOVQJL-UHFFFAOYSA-N","BRD-K33681278","","COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12"
"7072","SENNOSIDE-A","glycoside agonist","","gastroenterology","constipation","MicroSource",98.1,"BRD-A30370660-001-04-1","Launched","","IPQVTOJGNYVQEO-FPJYKMGYSA-N","BRD-A30370660","","OC[C@H]1O[C@H](Oc2cccc3C([C@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O"
"7073","SODIUM-PICOSULFATE","","","gastroenterology","constipation","Selleck",91.14,"BRD-K77251551-304-02-9","Launched","","UJIDKYTZIQTXPM-UHFFFAOYSA-N","BRD-K77251551","","OS(=O)(=O)Oc1ccc(cc1)C(c1ccc(OS(O)(=O)=O)cc1)c1ccccn1"
"7074","TANNIC-ACID","PARG inhibitor","ANO1","gastroenterology","constipation","MicroSource",0,"BRD-K67392463-001-04-8","Launched","","LRBQNJMCXXYXIU-NRMVVENXSA-N","BRD-K67392463","","Oc1cc(cc(O)c1O)C(=O)Oc1cc(cc(O)c1O)C(=O)OC[C@H]1O[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1"
"7075","LUBIPROSTONE","chloride channel activator","CLCN2","gastroenterology","constipation, irritable bowel syndrome","Selleck, Selleck",98.91,"BRD-K33814251-001-01-4, BRD-K33814251-001-02-2","Launched","BRD-K58693165-001-01-7","DBVFKLAGQHYVGQ-BFYDXBDKSA-N","BRD-K33814251","BRD-K58693165","CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O"
"7077","THIRAM","","JAK2","ophthalmology","contact dermatitis","MicroSource",97.98,"BRD-K29254801-001-14-7","Launched","","KUAZQDVKQLNFPE-UHFFFAOYSA-N","BRD-K29254801","","CN(C)C(=S)SSC(=S)N(C)C"
"7078","ALGESTONE-ACETOPHENIDE","","","endocrinology","contraceptive","Prestwick",96.88,"BRD-A41774846-001-01-4","Launched","","AHBKIEXBQNRDNL-BXXPAUNWSA-N","BRD-A41774846","","CC(=O)[C@@]12OC(C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)c1ccccc1"
"7079","DESOGESTREL","progesterone receptor agonist","ESR1, PGR","endocrinology","contraceptive","Enzo",97.27,"BRD-K46061689-001-01-9","Launched","","RPLCPCMSCLEKRS-BPIQYHPVSA-N","BRD-K46061689","","CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C"
"7080","DROSPIRENONE","mineralocorticoid receptor antagonist","AR, NR3C2, PGR","endocrinology","contraceptive","Selleck, Selleck, MicroSource, Selleck",99.66,"BRD-K04394237-001-03-7, BRD-K04394237-001-04-5, BRD-K04394237-001-06-0, BRD-K04394237-001-05-2","Launched","BRD-A00938334-001-01-3, BRD-K70875526-001-01-8","METQSPRSQINEEU-HXCATZOESA-N","BRD-K04394237","BRD-A00938334","C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1"
"7084","ESTRADIOL","estrogen receptor agonist","ESR1, ESR2, GPER1, KCNMA1, NR1I2","endocrinology","contraceptive","Selleck, MicroSource, Selleck",92.44,"BRD-K18910433-001-36-6, BRD-K18910433-001-43-2, BRD-K18910433-001-42-4","Launched","BRD-A18917088-001-04-9, BRD-K60633875-001-01-0","VOXZDWNPVJITMN-ZBRFXRBCSA-N","BRD-K18910433","BRD-A18917088","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O"
"7087","ETHINYL-ESTRADIOL","estrogen receptor agonist, estrogenic hormone","ESR1, ESR2, NR1I2","endocrinology","contraceptive","Selleck, MicroSource, Selleck",91.77,"BRD-K48195008-001-17-3, BRD-K48195008-001-19-9, BRD-K48195008-001-18-1","Launched","BRD-A02367930-001-04-5, BRD-K42555202-001-01-2","BFPYWIDHMRZLRN-SLHNCBLASA-N","BRD-K48195008","BRD-A02367930","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C"
"7090","ETHYNODIOL-DIACETATE","","ESR1, PGR","endocrinology","contraceptive","Selleck, MicroSource, Selleck",99.51,"BRD-K46331928-001-06-6, BRD-K46331928-001-05-8, BRD-K46331928-001-08-2","Launched","BRD-K06056310-001-01-4","ONKUMRGIYFNPJW-KIEAKMPYSA-N","BRD-K46331928","BRD-K06056310","CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1"
"7093","ETONOGESTREL","progesterone receptor agonist","ESR1, PGR","endocrinology","contraceptive","Enzo",97.58,"BRD-A08302182-001-01-7","Launched","","GCKFUYQCUCGESZ-KIIRVTSASA-N","BRD-A08302182","","CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CC[C@@]2(O)C#C"
"7094","GESTODENE","contraceptive agent","","endocrinology","contraceptive","Selleck",95.03,"BRD-K97197005-001-03-2","Launched","BRD-K81077266-001-01-2","SIGSPDASOTUPFS-XUDSTZEESA-N","BRD-K97197005","BRD-K81077266","CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C"
"7095","LEVONORGESTREL","estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1","endocrinology","contraceptive","Tocris, Selleck, Selleck, MicroSource",98.56,"BRD-K35189033-001-28-7, BRD-K35189033-001-30-3, BRD-K35189033-001-29-5, BRD-K35189033-001-26-1","Launched","BRD-K10086084-001-02-7, BRD-K10086084-001-01-9","WWYNJERNGUHSAO-XUDSTZEESA-N","BRD-K35189033","BRD-K10086084","CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C"
"7099","LYNESTRENOL","progestogen hormone","","endocrinology","contraceptive","Prestwick, Sigma",0,"BRD-K39707084-001-04-1, BRD-K39707084-001-05-8","Launched","","YNVGQYHLRCDXFQ-XGXHKTLJSA-N","BRD-K39707084","","C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C"
"7101","MACITENTAN","endothelin receptor antagonist","EDNRA, EDNRB","endocrinology","contraceptive","Selleck, Selleck",90.02,"BRD-K48812570-001-02-3, BRD-K48812570-001-03-1","Launched","","JGCMEBMXRHSZKX-UHFFFAOYSA-N","BRD-K48812570","","CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1"
"7103","MEDROXYPROGESTERONE","progesterone receptor agonist","ESR1, PGR","endocrinology","contraceptive","MedChemEx",95.16,"BRD-K99615199-001-18-5","Launched","","FRQMUZJSZHZSGN-HBNHAYAOSA-N","BRD-K99615199","","C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12"
"7104","MEDROXYPROGESTERONE-ACETATE","progesterone receptor agonist","","endocrinology","contraceptive","Selleck, MicroSource",95.9,"BRD-A61221616-001-05-0, BRD-A61221616-001-04-3","Launched","BRD-K44848460-001-01-6","PSGAAPLEWMOORI-GDXVCIIOSA-N","BRD-A61221616","BRD-K44848460","C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12"
"7106","MESTRANOL","estrogen receptor agonist","ESR1","endocrinology","contraceptive","Selleck, MicroSource",98.35,"BRD-K31920458-001-22-8, BRD-K31920458-001-23-6","Launched","BRD-K92042497-001-01-4, BRD-A14798026-001-02-6","IMSSROKUHAOUJS-MJCUULBUSA-N","BRD-K31920458","BRD-K92042497","COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1"
"7108","NOMEGESTROL-ACETATE","progesterone receptor agonist","PGR","endocrinology","contraceptive","Prestwick",96.56,"BRD-K27351809-001-09-5","Launched","","IIVBFTNIGYRNQY-YQLZSBIMSA-N","BRD-K27351809","","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O"
"7109","NONOXYNOL-9","membrane integrity inhibitor","","endocrinology","contraceptive","MicroSource, LKT, MedChemEx",82.85,"BRD-K88625236-001-04-2, BRD-K88625236-001-07-5, BRD-K88625236-001-05-9","Launched","","FBWNMEQMRUMQSO-UHFFFAOYSA-N","BRD-K88625236","","CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1"
"7112","NORELGESTROMIN","","PGR","endocrinology","contraceptive","MedChemEx",88.48,"BRD-K42504537-001-01-6","Launched","","ISHXLNHNDMZNMC-VTKCIJPMSA-N","BRD-K42504537","","CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C"
"7113","NORETHISTERONE-ENANTHATE","contraceptive agent","","endocrinology","contraceptive","AvaChem",96.7,"BRD-K07625016-001-01-2","Launched","","APTGJECXMIKIET-WOSSHHRXSA-N","BRD-K07625016","","CCCCCCC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C"
"7114","NORETYNODREL","progestogen hormone","PGR","endocrinology","contraceptive","MicroSource",81.73,"BRD-A00758722-001-04-9","Launched","","ICTXHFFSOAJUMG-OQPPHWFISA-N","BRD-A00758722","","C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C"
"7115","NORGESTIMATE","progesterone receptor agonist","ESR1, PGR","endocrinology","contraceptive","MicroSource, Sigma",61.05,"BRD-K38041788-001-02-9, BRD-K38041788-001-01-1","Launched","BRD-A04756508-001-02-3, BRD-A75867198-001-01-9","KIQQMECNKUGGKA-NMYWJIRASA-N","BRD-K38041788","BRD-A04756508","CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(OC(C)=O)C#C"
"7117","NORGESTREL","progesterone receptor agonist","PGR","endocrinology","contraceptive","MicroSource",98.29,"BRD-A14886633-001-01-6","Launched","","WWYNJERNGUHSAO-NJTPJZBZSA-N","BRD-A14886633","","CC[C@]12CCC3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C"
"7118","ULIPRISTAL","progesterone receptor antagonist","PGR","endocrinology","contraceptive","Selleck, Selleck",91,"BRD-K64381438-001-02-0, BRD-K64381438-001-03-8","Launched","BRD-K55641198-001-01-0, BRD-K76197012-001-01-2","OOLLAFOLCSJHRE-ZHAKMVSLSA-N","BRD-K64381438","BRD-K55641198","CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12"
"7120","DIENOGEST","progesterone receptor agonist","PGR","endocrinology, obstetrics/gynecology","contraceptive, endometriosis","Selleck",92.69,"BRD-K50853363-001-02-3","Launched","BRD-K64504314-001-01-8","AZFLJNIPTRTECV-FUMNGEBKSA-N","BRD-K50853363","BRD-K64504314","C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N"
"7121","DIATRIZOIC-ACID","","","radiology","contrast agent","MicroSource",97.75,"BRD-K48247567-001-01-9","Launched","","YVPYQUNUQOZFHG-UHFFFAOYSA-N","BRD-K48247567","","CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I"
"7122","GADOPENTETIC-ACID","contrast agent","","radiology","contrast agent","Sigma",0,"BRD-K25106841-001-01-2","Launched","BRD-M44547596-002-01-7","IZOOGPBRAOKZFK-UHFFFAOYSA-K","BRD-K25106841","BRD-M44547596","OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2"
"7123","IOCETAMIC-ACID","radiopaque medium","","radiology","contrast agent","Prestwick",85.31,"BRD-A37492983-001-10-3","Launched","","GSVQIUGOUKJHRC-UHFFFAOYSA-N","BRD-A37492983","","CC(CN(C(C)=O)c1c(I)cc(I)c(N)c1I)C(O)=O"
"7124","IODIPAMIDE","radiopaque medium","ALB","radiology","contrast agent","MicroSource",99.2,"BRD-K67261995-001-11-7","Launched","","FFINMCNLQNTKLU-UHFFFAOYSA-N","BRD-K67261995","","OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(O)=O)c2I)c1I"
"7125","IODIXANOL","radiopaque medium","","radiology","contrast agent","Sigma, MicroSource",79.95,"BRD-A08660406-001-06-7, BRD-A08660406-001-05-9","Launched","","NBQNWMBBSKPBAY-UHFFFAOYSA-N","BRD-A08660406","","CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I"
"7127","IOHEXOL","radiopaque medium","","radiology","contrast agent","MicroSource",98.79,"BRD-A60217728-001-11-2","Launched","","NTHXOOBQLCIOLC-UHFFFAOYSA-N","BRD-A60217728","","CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I"
"7128","IOPAMIDOL","radiopaque medium","","radiology","contrast agent","MedChemEx",100,"BRD-K75868704-001-05-3","Launched","","XQZXYNRDCRIARQ-LURJTMIESA-N","BRD-K75868704","","C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I"
"7129","IOPODIC-ACID","","","radiology","contrast agent","Vitas-M",98.86,"BRD-K51956333-001-03-8","Launched","","YQNFBOJPTAXAKV-OMCISZLKSA-N","BRD-K51956333","","CN(C)\C=N\c1c(I)cc(I)c(CCC(O)=O)c1I"
"7130","IOPROMIDE","radiopaque medium","","radiology","contrast agent","Prestwick, Sigma",64.8,"BRD-A72075775-001-10-4, BRD-A72075775-001-11-2","Launched","","DGAIEPBNLOQYER-UHFFFAOYSA-N","BRD-A72075775","","COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I"
"7132","IOVERSOL","radiopaque medium","","radiology","contrast agent","MicroSource",97.06,"BRD-A65818372-001-05-3","Launched","","AMDBBAQNWSUWGN-UHFFFAOYSA-N","BRD-A65818372","","OCCN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I"
"7133","IOXAGLIC-ACID","radiopaque medium","","radiology","contrast agent","Prestwick",92.49,"BRD-K79124250-001-08-9","Launched","","TYYBFXNZMFNZJT-UHFFFAOYSA-N","BRD-K79124250","","CNC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c2I)c1I"
"7134","MANGAFODIPIR","contrast agent","","radiology","contrast agent","MicroSource, MedChemEx",0,"BRD-K57365211-314-01-4, BRD-K57365211-314-02-2","Launched","BRD-A81339141-314-01-6,BRD-U27874988-000-01-6","CXFKOLCMCRBYPL-UHFFFAOYSA-L","BRD-K57365211","BRD-A81339141","Cc1nc(COP(O)(O)=O)cc2CN(CC(O)=O)CCN(CC(O)=O)Cc3cc(COP(O)(O)=O)nc(C)c3O[Mn]Oc12"
"7136","METRIZAMIDE","radiopaque medium","","radiology","contrast agent","Selleck",91.39,"BRD-A45543382-001-10-0","Launched","","BAQCROVBDNBEEB-UBYUBLNFSA-N","BRD-A45543382","","CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I"
"7137","METRIZOIC-ACID","radiopaque medium","","radiology","contrast agent","Sigma, TCI",89.37,"BRD-K99241550-001-04-3, BRD-K99241550-001-03-5","Launched","","GGGDNPWHMNJRFN-UHFFFAOYSA-N","BRD-K99241550","","CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I"
"7139","PERFLUBRON","contrast agent","","radiology","contrast agent","Sigma, Oakwood",0,"BRD-K92988025-001-02-7, BRD-K92988025-001-01-9","Launched","","WTWWXOGTJWMJHI-UHFFFAOYSA-N","BRD-K92988025","","FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br"
"7141","MELDONIUM","gamma butyrobetaine hydroxylase inhibitor","BBOX1","cardiology","coronary artery disease (CAD)","LifeChem",60.9,"BRD-K79392608-335-01-8","Launched","","PVBQYTCFVWZSJK-UHFFFAOYSA-O","BRD-K79392608","","C[N+](C)(C)NCCC(O)=O"
"7142","MOLSIDOMINE","guanylate cyclase stimulant","GUCY1A3","cardiology","coronary artery disease (CAD)","MicroSource",98.74,"BRD-K63861289-001-19-6","Launched","","XLFWDASMENKTKL-UHFFFAOYSA-O","BRD-K63861289","","CCOC(=O)Nc1c[n+](no1)N1CCOCC1"
"7143","PROBUCOL","atherogenesis inhibitor","ABCA1, ABCB11, CES1","cardiology","coronary artery disease (CAD)","MicroSource, Selleck",93.74,"BRD-K72029282-001-23-8, BRD-K72029282-001-22-0","Launched","","FYPMFJGVHOHGLL-UHFFFAOYSA-N","BRD-K72029282","","CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C"
"7145","TRAPIDIL","PDGFR tyrosine kinase receptor inhibitor","PDGFRA","cardiology","coronary artery disease (CAD)","Prestwick",97.83,"BRD-K95763993-001-19-3","Launched","","GSNOZLZNQMLSKJ-UHFFFAOYSA-N","BRD-K95763993","","CCN(CC)c1cc(C)nc2ncnn12"
"7146","RAMATROBAN","prostanoid receptor antagonist","PTGDR2, TBXA2R","cardiology, pulmonary","coronary artery disease (CAD), asthma","MedChemEx",97.83,"BRD-K08586861-001-01-1","Launched","","LDXDSHIEDAPSSA-OAHLLOKOSA-N","BRD-K08586861","","OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1"
"7147","DIPYRIDAMOLE","phosphodiesterase inhibitor","ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1","cardiology","coronary artery disease (CAD), peripheral artery disease (PAD), hypertension","Selleck, Tocris, MicroSource, Selleck, Tocris",91.41,"BRD-K86301799-001-37-1, BRD-K86301799-001-39-7, BRD-K86301799-001-36-3, BRD-K86301799-001-34-8, BRD-K86301799-001-35-5","Launched","","IZEKFCXSFNUWAM-UHFFFAOYSA-N","BRD-K86301799","","OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO"
"7152","ZOTAROLIMUS","mTOR inhibitor","FKBP1A","cardiology","coronary artery restenosis","Adooq",87.25,"BRD-K46843573-001-01-9","Launched","","CGTADGCBEXYWNE-JUKNQOCSSA-N","BRD-K46843573","","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1n1cnnn1"
"7153","LOVASTATIN","HMGCR inhibitor","HDAC2, HMGCR, ITGAL, NR1I2","cardiology, endocrinology","coronary heart disease, myocardial infarction, hypercholesterolemia","Tocris, MicroSource, Selleck, Selleck, Tocris",89.65,"BRD-K09416995-001-43-1, BRD-K09416995-001-39-9, BRD-K09416995-001-44-9, BRD-K09416995-001-40-7, BRD-K09416995-001-38-1","Launched","BRD-K74251557-001-01-0","PCZOHLXUXFIOCF-BXMDZJJMSA-N","BRD-K09416995","BRD-K74251557","CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12"
"7158","ALCLOMETASONE-DIPROPIONATE","glucocorticoid receptor agonist","CYP3A4, NR3C1, SERPINA6","dermatology","corticosteroid-responsive dermatoses","Prestwick",97.41,"BRD-A17407635-001-04-0","Launched","","DJHCCTTVDRAMEH-VBIVFILRSA-N","BRD-A17407635","","CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C"
"7159","AMCINONIDE","glucocorticoid receptor agonist","ANXA1, NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource",96.95,"BRD-A36010170-001-04-0","Launched","","ILKJAFIWWBXGDU-ZYDCGBIBSA-N","BRD-A36010170","","CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C"
"7160","BETAMETHASONE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.06,"BRD-A02180903-001-04-5, BRD-K12955147-001-01-8","Launched","","UREBDLICKHMUKA-REKGUKDCSA-N","BRD-A02180903","","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"7161","BETAMETHASONE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.06,"BRD-A02180903-001-04-5, BRD-K12955147-001-01-8","Launched","","UREBDLICKHMUKA-REKGUKDCSA-N","BRD-A02180903","","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@]1(O)C(=O)CO"
"7162","BETAMETHASONE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.06,"BRD-A02180903-001-04-5, BRD-K12955147-001-01-8","Launched","","UREBDLICKHMUKA-AMDXKQBSSA-N","BRD-A02180903","","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"7163","BETAMETHASONE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.06,"BRD-A02180903-001-04-5, BRD-K12955147-001-01-8","Launched","","UREBDLICKHMUKA-AMDXKQBSSA-N","BRD-A02180903","","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@]1(O)C(=O)CO"
"7164","BETAMETHASONE-ACETATE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource",93.5,"BRD-A92177080-001-02-1","Launched","","AKUJBENLRBOFTD-DKNQJTFPSA-N","BRD-A92177080","","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O"
"7165","BETAMETHASONE-DIPROPIONATE","anti-inflammatory agent","","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",96.86,"BRD-K58148589-001-03-6, BRD-K58148589-001-02-8","Launched","BRD-A66861218-001-04-3, BRD-K95691366-001-01-3","CIWBQSYVNNPZIQ-XYWKZLDCSA-N","BRD-K58148589","BRD-A66861218","CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C"
"7167","BETAMETHASONE-VALERATE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","Selleck, MicroSource, Selleck",86.11,"BRD-K34032314-001-02-5, BRD-K34032314-001-04-1, BRD-K34032314-001-03-3","Launched","BRD-A80594172-001-04-6, BRD-K57769959-001-01-6","SNHRLVCMMWUAJD-SUYDQAKGSA-N","BRD-K34032314","BRD-A80594172","CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO"
"7170","CLOBETASOL-PROPIONATE","glucocorticoid receptor agonist","NR3C1, PLA2G1B","dermatology","corticosteroid-responsive dermatoses","Sigma, MicroSource, Selleck",98.73,"BRD-K10799896-001-24-7, BRD-K10799896-001-26-2, BRD-K10799896-001-25-4","Launched","BRD-A26095496-001-04-0, BRD-K91981767-001-01-7,BRD-K84443303-001-02-6","CBGUOGMQLZIXBE-XGQKBEPLSA-N","BRD-K10799896","BRD-A26095496","CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl"
"7173","CLOCORTOLONE-PIVALATE","steroid","NR3C1, PLA2G1B","dermatology","corticosteroid-responsive dermatoses","Prestwick",98.68,"BRD-K38003476-001-09-1","Launched","","SXYZQZLHAIHKKY-GSTUPEFVSA-N","BRD-K38003476","","C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C"
"7174","DESOXIMETASONE","glucocorticoid receptor agonist","NR3C1, PLA2G1B","dermatology","corticosteroid-responsive dermatoses","MicroSource",98.83,"BRD-A49447682-001-02-4","Launched","","VWVSBHGCDBMOOT-ZIKVJHDZSA-N","BRD-A49447682","","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO"
"7175","DIFLORASONE-DIACETATE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource",97.55,"BRD-A66869276-001-02-9","Launched","","BOBLHFUVNSFZPJ-LIRARCAYSA-N","BRD-A66869276","","C[C@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O"
"7176","FLUMETHASONE","glucocorticoid receptor agonist","NR3C1, PLA2G1B","dermatology","corticosteroid-responsive dermatoses","Selleck, MicroSource",97.76,"BRD-K61496577-001-19-4, BRD-K61496577-001-20-2","Launched","BRD-K09237689-001-01-0, BRD-A01346607-001-04-2","WXURHACBFYSXBI-GQKYHHCASA-N","BRD-K61496577","BRD-K09237689","C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"7178","FLUTICASONE-PROPIONATE","glucocorticoid receptor agonist","NR3C1, NR3C2, PGR, PLA2G4A","dermatology","corticosteroid-responsive dermatoses","Tocris, MicroSource, Selleck, Tocris",96.66,"BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5","Launched","BRD-K40517875-001-01-0","WMWTYOKRWGGJOA-CENSZEJFSA-N","BRD-K62310379","BRD-K40517875","CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF"
"7179","FLUTICASONE-PROPIONATE","glucocorticoid receptor agonist","NR3C1, NR3C2, PGR, PLA2G4A","dermatology","corticosteroid-responsive dermatoses","Tocris, MicroSource, Selleck, Tocris",96.66,"BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5","Launched","BRD-K40517875-001-01-0","WMWTYOKRWGGJOA-CENSZEJFSA-N","BRD-K62310379","BRD-K40517875","CCC(=O)O[C@@]1([C@H](C)CC2C3CC(F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF"
"7182","FLUTICASONE-PROPIONATE","glucocorticoid receptor agonist","NR3C1, NR3C2, PGR, PLA2G4A","dermatology","corticosteroid-responsive dermatoses","Tocris, MicroSource, Selleck, Tocris",96.66,"BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5","Launched","BRD-K40517875-001-01-0","WMWTYOKRWGGJOA-HLJZTEGPSA-N","BRD-K62310379","BRD-K40517875","CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF"
"7183","FLUTICASONE-PROPIONATE","glucocorticoid receptor agonist","NR3C1, NR3C2, PGR, PLA2G4A","dermatology","corticosteroid-responsive dermatoses","Tocris, MicroSource, Selleck, Tocris",96.66,"BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5","Launched","BRD-K40517875-001-01-0","WMWTYOKRWGGJOA-HLJZTEGPSA-N","BRD-K62310379","BRD-K40517875","CCC(=O)O[C@@]1([C@H](C)CC2C3CC(F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF"
"7186","HALCINONIDE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.7,"BRD-A88138582-001-04-8, BRD-K81709173-001-09-5","Launched","BRD-K64408465-001-01-9","MUQNGPZZQDCDFT-RLDTZFIDSA-N","BRD-A88138582","BRD-K64408465","CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl"
"7187","HALCINONIDE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.7,"BRD-A88138582-001-04-8, BRD-K81709173-001-09-5","Launched","BRD-K64408465-001-01-9","MUQNGPZZQDCDFT-RLDTZFIDSA-N","BRD-A88138582","BRD-K64408465","CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl"
"7188","HALCINONIDE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.7,"BRD-A88138582-001-04-8, BRD-K81709173-001-09-5","Launched","BRD-K64408465-001-01-9","MUQNGPZZQDCDFT-JNQJZLCISA-N","BRD-A88138582","BRD-K64408465","CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl"
"7189","HALCINONIDE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",97.7,"BRD-A88138582-001-04-8, BRD-K81709173-001-09-5","Launched","BRD-K64408465-001-01-9","MUQNGPZZQDCDFT-JNQJZLCISA-N","BRD-A88138582","BRD-K64408465","CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl"
"7190","HALOBETASOL-PROPIONATE","glucocorticoid receptor agonist","NR3C1, PLA2G1B","dermatology","corticosteroid-responsive dermatoses","Selleck",96.13,"BRD-K65877271-001-01-8","Launched","","BDSYKGHYMJNPAB-MUYQOBDSSA-N","BRD-K65877271","","CCC(=O)O[C@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)CCl"
"7191","HYDROCORTISONE-ACETATE","glucocorticoid receptor agonist","NR3C1, NR3C2","dermatology","corticosteroid-responsive dermatoses","MicroSource",88.6,"BRD-A65767837-001-04-4","Launched","","ALEXXDVDDISNDU-KPYZGQEZSA-N","BRD-A65767837","","CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C"
"7192","HYDROCORTISONE-VALERATE","glucocorticoid receptor agonist","","dermatology","corticosteroid-responsive dermatoses","MicroSource",88.16,"BRD-A25143711-001-02-2","Launched","","FZCHYNWYXKICIO-BXLKFAEVSA-N","BRD-A25143711","","CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO"
"7193","MOMETASONE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","Sigma",0,"BRD-K50265942-001-01-2","Launched","","QLIIKPVHVRXHRI-CXSFZGCWSA-N","BRD-K50265942","","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl"
"7194","MOMETASONE-FUROATE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",94.31,"BRD-K60640630-001-11-0, BRD-K60640630-001-10-2","Launched","BRD-A01139232-001-01-0, BRD-K28476963-001-01-8","WOFMFGQZHJDGCX-ZULDAHANSA-N","BRD-K60640630","BRD-A01139232","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl"
"7196","PRAMOXINE","topical anesthetic","","dermatology","corticosteroid-responsive dermatoses","Selleck, MicroSource",95.87,"BRD-K46523383-003-21-1, BRD-K46523383-003-22-9","Launched","","DQKXQSGTHWVTAD-UHFFFAOYSA-N","BRD-K46523383","","CCCCOc1ccc(OCCCN2CCOCC2)cc1"
"7198","TRIAMCINOLONE","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","corticosteroid-responsive dermatoses","Selleck, MicroSource, Selleck",94.01,"BRD-K77554836-001-11-6, BRD-K77554836-001-14-0, BRD-K77554836-001-13-2","Launched","BRD-A37780065-001-04-5, BRD-K97780336-001-01-9","GFNANZIMVAIWHM-OBYCQNJPSA-N","BRD-K77554836","BRD-A37780065","C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO"
"7201","TRIAMCINOLONE-ACETONIDE","glucocorticoid receptor agonist, immunosuppressant","NR3C1","dermatology","corticosteroid-responsive dermatoses","MicroSource, Selleck",95.27,"BRD-A92439610-001-04-0, BRD-A92439610-001-05-7","Launched","BRD-K41708980-001-01-6","YNDXUCZADRHECN-BPHAHLGOSA-N","BRD-A92439610","BRD-K41708980","CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"7203","HYDROCORTISONE-BUTYRATE","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses, eczema","MicroSource, Sigma",85.87,"BRD-K99199077-001-17-9, BRD-K99199077-001-16-1","Launched","BRD-A34508879-001-04-9","BMCQMVFGOVHVNG-TUFAYURCSA-N","BRD-K99199077","BRD-A34508879","CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO"
"7205","AMMONIUM-GLYCYRRHIZINATE","thrombin inhibitor","HSD11B1, HSD11B2, SLCO1B1, SLCO1B3","dermatology","cosmetic","Selleck, Selleck",97.01,"BRD-K15318383-201-01-5, BRD-K15318383-001-01-9","Launched","BRD-K70038931-001-01-2","LPLVUJXQOOQHMX-FKSWRZCVSA-N","BRD-K15318383","BRD-K70038931","C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O"
"7207","CERAMIDE","phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator","","dermatology","cosmetic","Tocris",100,"BRD-K41707108-001-05-6","Launched","","BLTCBVOJNNKFKC-QUDYQQOWSA-N","BRD-K41707108","","CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O"
"7208","CETRIMONIUM","","","dermatology","cosmetic","Selleck, MicroSource",100,"BRD-K47079459-004-04-6, BRD-K47079459-004-05-3","Launched","","RLGQACBPNDBWTB-UHFFFAOYSA-N","BRD-K47079459","","CCCCCCCCCCCCCCCC[N+](C)(C)C"
"7210","DIMETHICONE","","","dermatology","cosmetic","Sigma",0,"BRD-K26674746-001-01-4","Launched","","UQEAIHBTYFGYIE-UHFFFAOYSA-N","BRD-K26674746","","C[Si](C)(C)O[Si](C)(C)C"
"7211","DIOSMETIN","aryl hydrocarbon receptor agonist","CYP1B1","dermatology","cosmetic","Selleck",96.23,"BRD-K26862302-001-05-2","Launched","","MBNGWHIJMBWFHU-UHFFFAOYSA-N","BRD-K26862302","","COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O)cc2o1"
"7212","ISOPROPYL-MYRISTATE","","","dermatology","cosmetic","Sigma, Acros",0,"BRD-K13409143-001-02-7, BRD-K13409143-001-01-9","Launched","","AXISYYRBXTVTFY-UHFFFAOYSA-N","BRD-K13409143","","CCCCCCCCCCCCCC(=O)OC(C)C"
"7214","ISOPROPYL-PALMITATE","cosmetic moisturizer","","dermatology","cosmetic","Sigma, TCI",0,"BRD-K30758549-001-02-6, BRD-K30758549-001-01-8","Launched","","XUGNVMKQXJXZCD-UHFFFAOYSA-N","BRD-K30758549","","CCCCCCCCCCCCCCCC(=O)OC(C)C"
"7216","MALTOBIONIC-ACID","matrix metalloprotease inhibitor","","dermatology","cosmetic","CombiBlocks",97.5,"BRD-K01624185-001-05-7","Launched","","JYTUSYBCFIZPBE-AMTLMPIISA-N","BRD-K01624185","","OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O"
"7217","METHYLPARABEN","other antifungal","","dermatology","cosmetic","Enamine",0,"BRD-K78321730-001-10-8","Launched","","LXCFILQKKLGQFO-UHFFFAOYSA-N","BRD-K78321730","","COC(=O)c1ccc(O)cc1"
"7218","OXYQUINOLINE","chelating agent","METAP2","dermatology","cosmetic","MicroSource",97.72,"BRD-K66808046-065-03-7","Launched","","MCJGNVYPOGVAJF-UHFFFAOYSA-N","BRD-K66808046","","Oc1cccc2cccnc12"
"7219","PERFLUORODECALIN","","","dermatology","cosmetic","Sigma",0,"BRD-K55401595-001-01-8","Launched","","UWEYRJFJVCLAGH-UHFFFAOYSA-N","BRD-K55401595","","FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F"
"7220","RETINALDEHYDE","","","dermatology","cosmetic","SantaCruz",96.68,"BRD-K79884267-001-01-4","Launched","","NCYCYZXNIZJOKI-OVSJKPMPSA-N","BRD-K79884267","","CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=O"
"7221","TEPRENONE","mucus protecting agent","","dermatology","cosmetic","MedChemEx, MedChemEx, SantaCruz, SantaCruz",82.34,"BRD-K11510141-001-04-2, BRD-K11510141-001-03-4, BRD-K11510141-001-02-6, BRD-K11510141-001-01-8","Launched","","HUCXKZBETONXFO-NJFMWZAGSA-N","BRD-K11510141","","CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C"
"7225","TRICAPRYLIN","","","dermatology","cosmetic","MicroSource",85.71,"BRD-K24790130-001-07-1","Launched","","VLPFTAMPNXLGLX-UHFFFAOYSA-N","BRD-K24790130","","CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC"
"7226","1-HEXADECANOL","","","dermatology","cosmetic","Selleck, Selleck",0,"BRD-K37203094-001-02-5, BRD-K37203094-001-03-3","Launched","","BXWNKGSJHAJOGX-UHFFFAOYSA-N","BRD-K37203094","","CCCCCCCCCCCCCCCCO"
"7228","RETINOL","retinoid receptor ligand","ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG","dermatology","cosmetic, acne vulgaris (AV), keratosis","Sigma, MicroSource",0,"BRD-K22429181-001-15-9, BRD-K22429181-001-14-2","Launched","","FPIPGXGPPPQFEQ-OVSJKPMPSA-N","BRD-K22429181","","CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/CO"
"7230","CHLORHEXIDINE","membrane integrity inhibitor","","dermatology, infectious disease, dental","cosmetic, skin infections, gingivitis","MicroSource",97.77,"BRD-K52256627-300-06-6","Launched","","GHXZTYHSJHQHIJ-UHFFFAOYSA-N","BRD-K52256627","","Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1"
"7231","AVOBENZONE","UV blocker","TYR","dermatology","cosmetic, sunscreen lotion","MicroSource, Selleck",90.89,"BRD-K14401183-001-11-5, BRD-K14401183-001-10-7","Launched","","XNEFYCZVKIDDMS-UHFFFAOYSA-N","BRD-K14401183","","COc1ccc(cc1)C(=O)CC(=O)c1ccc(cc1)C(C)(C)C"
"7233","TAZAROTENE","retinoid receptor agonist","RARA, RARB, RARG, RXRB","dermatology","cosmetic, sunscreen lotion","Selleck",97.04,"BRD-K76841105-001-04-7","Launched","","OGQICQVSFDPSEI-UHFFFAOYSA-N","BRD-K76841105","","CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1"
"7234","BENPROPERINE","antitussive","SCN5A","pulmonary","cough suppressant","AvaChem",97.04,"BRD-A42423104-001-01-4","Launched","","JTUQXGZRVLWBCR-UHFFFAOYSA-N","BRD-A42423104","","CC(COc1ccccc1Cc1ccccc1)N1CCCCC1"
"7235","BENZONATATE","local anesthetic","SCN5A","pulmonary","cough suppressant","MicroSource",99.74,"BRD-K91699951-001-10-2","Launched","","MAFMQEKGGFWBAB-UHFFFAOYSA-N","BRD-K91699951","","CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC"
"7236","CLOFEDANOL","histamine receptor antagonist","HRH1","pulmonary","cough suppressant","Sigma",97.05,"BRD-A15687940-001-05-6","Launched","","WRCHFMBCVFFYEQ-UHFFFAOYSA-N","BRD-A15687940","","CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl"
"7237","CLOPERASTINE","antitussive","","pulmonary","cough suppressant","MicroSource",97.64,"BRD-A80908310-003-13-8","Launched","","FLNXBVJLPJNOSI-UHFFFAOYSA-N","BRD-A80908310","","Clc1ccc(cc1)C(OCCN1CCCCC1)c1ccccc1"
"7238","DEXTROMETHORPHAN","glutamate receptor antagonist, sigma receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4","pulmonary","cough suppressant","MicroSource",99.02,"BRD-K33211335-004-01-7","Launched","","MKXZASYAUGDDCJ-NJAFHUGGSA-N","BRD-K33211335","","COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1"
"7239","DIMEMORFAN","sigma receptor agonist","SIGMAR1","pulmonary","cough suppressant","Key",98.52,"BRD-K29812331-011-01-7","Launched","","KBEZZLAAKIIPFK-NJAFHUGGSA-N","BRD-K29812331","","CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C)cc31"
"7240","DROPROPIZINE","antitussive","","pulmonary","cough suppressant","MicroSource, Selleck, Selleck",95.27,"BRD-A29349577-001-23-0, BRD-A29349577-001-22-2, BRD-A29349577-001-24-8","Launched","","PTVWPYVOOKLBCG-UHFFFAOYSA-N","BRD-A29349577","","OCC(O)CN1CCN(CC1)c1ccccc1"
"7243","GUAIFENESIN","expectorant","","pulmonary","cough suppressant","MicroSource, Selleck",98.9,"BRD-A90515964-001-16-5, BRD-A90515964-001-15-7","Launched","","HSRJKNPTNIJEKV-UHFFFAOYSA-N","BRD-A90515964","","COc1ccccc1OCC(O)CO"
"7245","LEVODROPROPIZINE","antitussive","","pulmonary","cough suppressant","Selleck, Selleck",95.16,"BRD-K83551379-001-02-6, BRD-K83551379-001-01-8","Launched","BRD-K60537263-001-01-3","PTVWPYVOOKLBCG-ZDUSSCGKSA-N","BRD-K83551379","BRD-K60537263","OC[C@@H](O)CN1CCN(CC1)c1ccccc1"
"7247","LEVOPROPOXYPHENE","antitussive","OPRD1, OPRK1, OPRM1","pulmonary","cough suppressant","Prestwick",28.74,"BRD-A54635441-078-09-1","Launched","","XLMALTXPSGQGBX-UHFFFAOYSA-N","BRD-A54635441","","CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c1ccccc1"
"7248","NOSCAPINE","bradykinin receptor antagonist, tubulin polymerization inhibitor","SIGMAR1","pulmonary","cough suppressant","Selleck, MicroSource, Tocris",99.38,"BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4","Launched","BRD-K91301684-003-04-8, BRD-A51393488-003-02-7","AKNNEGZIBPJZJG-MSOLQXFVSA-N","BRD-K89237706","BRD-K91301684","COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12"
"7249","NOSCAPINE","bradykinin receptor antagonist, tubulin polymerization inhibitor","SIGMAR1","pulmonary","cough suppressant","Selleck, MicroSource, Tocris",99.38,"BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4","Launched","BRD-K91301684-003-04-8, BRD-A51393488-003-02-7","AKNNEGZIBPJZJG-MSOLQXFVSA-N","BRD-K89237706","BRD-K91301684","COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12"
"7251","NOSCAPINE","bradykinin receptor antagonist, tubulin polymerization inhibitor","SIGMAR1","pulmonary","cough suppressant","Selleck, MicroSource, Tocris",99.38,"BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4","Launched","BRD-K91301684-003-04-8, BRD-A51393488-003-02-7","AKNNEGZIBPJZJG-QZTJIDSGSA-N","BRD-K89237706","BRD-K91301684","COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12"
"7252","NOSCAPINE","bradykinin receptor antagonist, tubulin polymerization inhibitor","SIGMAR1","pulmonary","cough suppressant","Selleck, MicroSource, Tocris",99.38,"BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4","Launched","BRD-K91301684-003-04-8, BRD-A51393488-003-02-7","AKNNEGZIBPJZJG-QZTJIDSGSA-N","BRD-K89237706","BRD-K91301684","COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12"
"7254","OXELAIDIN","antitussive","","pulmonary","cough suppressant","Selleck, MicroSource, Selleck",91.86,"BRD-K17977438-048-03-2, BRD-K17977438-048-02-4, BRD-K17977438-048-04-0","Launched","BRD-M29157795-001-01-5","IQADUMSPOQKAAO-UHFFFAOYSA-N","BRD-K17977438","BRD-M29157795","CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1"
"7257","OXOLAMINE","antitussive","","pulmonary","cough suppressant","MicroSource",43.12,"BRD-K42596464-048-11-9","Launched","","IDCHQQSVJAAUQQ-UHFFFAOYSA-N","BRD-K42596464","","CCN(CC)CCc1nc(no1)-c1ccccc1"
"7258","BEXAROTENE","retinoid receptor agonist","RXRA, RXRB, RXRG","hematologic malignancy","cutaneous T-cell lymphoma (CTCL)","Selleck",98.35,"BRD-K92441787-001-04-1","Launched","","NAVMQTYZDKMPEU-UHFFFAOYSA-N","BRD-K92441787","","Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C"
"7259","ROMIDEPSIN","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","hematologic malignancy","cutaneous T-cell lymphoma (CTCL)","MedChemEx",98.84,"BRD-K61397605-001-03-4","Launched","","OHRURASPPZQGQM-GCCNXGTGSA-N","BRD-K61397605","","C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C"
"7260","VORINOSTAT","HDAC inhibitor","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9","hematologic malignancy","cutaneous T-cell lymphoma (CTCL)","Selleck, Selleck, Tocris",99.7,"BRD-K81418486-001-47-5, BRD-K81418486-001-44-2, BRD-K81418486-001-51-7","Launched","","WAEXFXRVDQXREF-UHFFFAOYSA-N","BRD-K81418486","","ONC(=O)CCCCCCC(=O)Nc1ccccc1"
"7263","TOCERANIB","protein tyrosine kinase inhibitor","FLT1, FLT3, KDR, PDGFRA, PDGFRB","oncology","cutaneous mast cell tumors, cutaneous mast cell tumors","MedChemEx, MedChemEx, MedChemEx",92.31,"BRD-K62040061-001-01-0, BRD-K62040061-011-02-7, BRD-K62040061-011-01-9","Launched","","SRSGVKWWVXWSJT-ATVHPVEESA-N","BRD-K62040061","","Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1"
"7266","ATROPINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","ophthalmology","cycloplegia, mydriasis, amblyopia","MicroSource, Selleck",97.48,"BRD-A27290375-330-01-1, BRD-A27290375-330-02-9","Launched","BRD-A93739713-065-04-3, BRD-A27290375-065-01-3,BRD-M93222215-330-02-1","RKUNBYITZUJHSG-SPUOUPEWSA-N","BRD-A27290375","BRD-A93739713","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1"
"7268","IVACAFTOR","CFTR channel potentiator","CFTR","pulmonary","cystic fibrosis","Selleck",98.82,"BRD-K52818472-001-02-2","Launched","","PURKAOJPTOLRMP-UHFFFAOYSA-N","BRD-K52818472","","CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C"
"7269","LUMACAFTOR","CFTR channel agonist","CFTR","pulmonary","cystic fibrosis","Selleck",98.26,"BRD-K69236721-001-02-7","Launched","","UFSKUSARDNFIRC-UHFFFAOYSA-N","BRD-K69236721","","Cc1ccc(NC(=O)C2(CC2)c2ccc3OC(F)(F)Oc3c2)nc1-c1cccc(c1)C(O)=O"
"7270","TEZACAFTOR","CFTR channel agonist","","pulmonary","cystic fibrosis","Selleck",96.27,"BRD-K97101532-001-02-8","Launched","","MJUVRTYWUMPBTR-MRXNPFEDSA-N","BRD-K97101532","","CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c3ccc4OC(F)(F)Oc4c3)c(F)cc2n1C[C@@H](O)CO"
"7271","ALBENDAZOLE","tubulin polymerization inhibitor","TUBA1A, TUBB, TUBB4B","infectious disease","cystic hydatid disease, parenchymal neurocysticercosis","MicroSource, Selleck",93.82,"BRD-K79131256-001-18-7, BRD-K79131256-001-17-9","Launched","","HXHWSAZORRCQMX-UHFFFAOYSA-N","BRD-K79131256","","CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1"
"7273","ALBENDAZOLE-OXIDE","anthelmintic agent","","infectious disease","cystic hydatid disease, parenchymal neurocysticercosis","Selleck",97.13,"BRD-A67060370-001-02-9","Launched","","VXTGHWHFYNYFFV-UHFFFAOYSA-N","BRD-A67060370","","CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1"
"7274","GONADORELIN","gonadotropin releasing factor hormone receptor agonist","GNRHR, GNRHR2","obstetrics/gynecology","cystic ovaries, reproductive synchrony","MedChemEx",95.93,"BRD-K96874295-015-01-0","Launched","","XLXSAKCOAKORKW-AQJXLSMYSA-N","BRD-K96874295","","CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O"
"7275","CYSTEAMINE","tissue transglutaminase inhibitor","NPY2R, SST","metabolism","cystinosis","MicroSource, Selleck, Selleck",0,"BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2","Launched","BRD-M77687198-001-11-4","UFULAYFCSOUIOV-UHFFFAOYSA-N","BRD-K92611362","BRD-M77687198","NCCS"
"7276","CYSTEAMINE","tissue transglutaminase inhibitor","NPY2R, SST","metabolism","cystinosis","MicroSource, Selleck, Selleck",0,"BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2","Launched","BRD-M77687198-001-11-4","UFULAYFCSOUIOV-UHFFFAOYSA-N","BRD-K92611362","BRD-M77687198","Cl.NCCS"
"7278","CYSTEAMINE","tissue transglutaminase inhibitor","NPY2R, SST","metabolism","cystinosis","MicroSource, Selleck, Selleck",0,"BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2","Launched","BRD-M77687198-001-11-4","OGMADIBCHLQMIP-UHFFFAOYSA-N","BRD-K92611362","BRD-M77687198","NCCS"
"7279","CYSTEAMINE","tissue transglutaminase inhibitor","NPY2R, SST","metabolism","cystinosis","MicroSource, Selleck, Selleck",0,"BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2","Launched","BRD-M77687198-001-11-4","OGMADIBCHLQMIP-UHFFFAOYSA-N","BRD-K92611362","BRD-M77687198","Cl.NCCS"
"7281","GANCICLOVIR","DNA polymerase inhibitor","","infectious disease","cytomegalovirus (CMV)","Selleck, Selleck, MicroSource",100,"BRD-K22662435-001-17-5, BRD-K22662435-001-19-1, BRD-K22662435-001-18-3","Launched","","IRSCQMHQWWYFCW-UHFFFAOYSA-N","BRD-K22662435","","Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1"
"7284","VALGANCICLOVIR","DNA synthesis inhibitor","","infectious disease","cytomegalovirus (CMV)","MicroSource, Selleck",100,"BRD-A50922295-003-05-0, BRD-A50922295-001-01-3","Launched","BRD-A08013053-003-01-2","WPVFJKSGQUFQAP-GKAPJAKFSA-N","BRD-A50922295","BRD-A08013053","CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c1nc(N)[nH]c2=O"
"7286","FOSCARNET","DNA polymerase inhibitor","","infectious disease","cytomegalovirus retinitis, acquired immunodeficiency syndrome (AIDS), virus herpes simplex (HSV)","Selleck, Selleck, MicroSource",0,"BRD-K85146014-314-05-4, BRD-K85146014-314-07-0, BRD-K85146014-314-06-2","Launched","","ZJAOAACCNHFJAH-UHFFFAOYSA-N","BRD-K85146014","","OC(=O)P(O)(O)=O"
"7289","PYRITHIONE-ZINC","ATP synthase inhibitor","KCNQ1, KCNQ2, KCNQ4, KCNQ5","dermatology","dandruff","Selleck, MicroSource, Selleck",0,"BRD-K16136380-001-03-3, BRD-K16136380-001-01-7, BRD-K16136380-001-02-5","Launched","BRD-U31911056-000-01-7, BRD-U32859412-000-01-6, BRD-U63926453-000-01-5","KTIHEFSORPLWRR-UHFFFAOYSA-L","BRD-K16136380","BRD-U31911056","O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1"
"7292","CLIMBAZOLE","enzyme inducer","","dermatology","dandruff, eczema","Selleck, MicroSource",99.56,"BRD-A61676498-001-05-8, BRD-A61676498-001-06-6","Launched","","OWEGWHBOCFMBLP-UHFFFAOYSA-N","BRD-A61676498","","CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1"
"7294","ACENOCOUMAROL","vitamin K antagonist","VKORC1","hematology","deep vein thrombosis (DVT)","MicroSource",99.56,"BRD-A65051990-001-12-9","Launched","","VABCILAOYCMVPS-UHFFFAOYSA-N","BRD-A65051990","","CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O"
"7295","ANISINDIONE","vitamin K antagonist","GGCX","hematology","deep vein thrombosis (DVT)","MedChemEx, Selleck, Vitas-M, MedChemEx, MicroSource, Selleck",89.62,"BRD-K47458712-001-22-3, BRD-K47458712-001-17-3, BRD-K47458712-001-20-7, BRD-K47458712-001-21-5, BRD-K47458712-001-18-1, BRD-K47458712-001-19-9","Launched","","XRCFXMGQEVUZFC-UHFFFAOYSA-N","BRD-K47458712","","COc1ccc(cc1)C1C(=O)c2ccccc2C1=O"
"7301","BETRIXABAN","coagulation factor inhibitor","KCNH2","hematology","deep vein thrombosis (DVT)","MedChemEx",85.59,"BRD-K45275534-001-01-3","Launched","","XHOLNRLADUSQLD-UHFFFAOYSA-N","BRD-K45275534","","COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1"
"7302","DICOUMAROL","NADPH inhibitor","CRYZ, NQO1, VKORC1","hematology","deep vein thrombosis (DVT)","MicroSource",99.51,"BRD-K82236179-213-01-0","Launched","","DOBMPNYZJYQDGZ-UHFFFAOYSA-N","BRD-K82236179","","Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12"
"7303","PHENINDIONE","vitamin K antagonist","VKORC1","hematology","deep vein thrombosis (DVT)","Selleck, MedChemEx, Selleck, MedChemEx, MicroSource, Sigma",95.63,"BRD-K70592963-001-29-0, BRD-K70592963-001-33-2, BRD-K70592963-001-27-4, BRD-K70592963-001-32-4, BRD-K70592963-001-28-2, BRD-K70592963-001-31-6","Launched","","NFBAXHOPROOJAW-UHFFFAOYSA-N","BRD-K70592963","","O=C1C(C(=O)c2ccccc12)c1ccccc1"
"7309","WARFARIN","vitamin K antagonist","VKORC1","hematology, cardiology","deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), myocardial infarction","MicroSource",99.85,"BRD-A24514565-001-09-7","Launched","","PJVWKTKQMONHTI-UHFFFAOYSA-N","BRD-A24514565","","CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O"
"7310","AGOMELATINE","melatonin receptor agonist, serotonin receptor antagonist","HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B","neurology/psychiatry","depression","Selleck",98.23,"BRD-K84698278-001-03-4","Launched","","YJYPHIXNFHFHND-UHFFFAOYSA-N","BRD-K84698278","","COc1ccc2cccc(CCNC(C)=O)c2c1"
"7311","AMITRIPTYLINE","norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin–norepinephrine reuptake inhibitor (SNRI)","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck",98.47,"BRD-K53737926-003-27-8, BRD-K53737926-003-25-2","Launched","","KRMDCWKBEZIMAB-UHFFFAOYSA-N","BRD-K53737926","","CN(C)CCC=C1c2ccccc2CCc2ccccc12"
"7313","AMOXAPINE","norepinephrine reputake inhibitor","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck, Selleck",96.84,"BRD-K02265150-001-26-5, BRD-K02265150-001-25-7, BRD-K02265150-001-27-3","Launched","","QWGDMFLQWFTERH-UHFFFAOYSA-N","BRD-K02265150","","Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1"
"7316","BUPROPION","dopamine uptake inhibitor","CHRNA3, SLC6A2, SLC6A3","neurology/psychiatry","depression","MicroSource, Tocris, Selleck",97.76,"BRD-A05186015-003-20-6, BRD-A05186015-003-21-4, BRD-A05186015-003-19-8","Launched","","SNPPWIUOZRMYNY-UHFFFAOYSA-N","BRD-A05186015","","CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1"
"7319","CITALOPRAM","selective serotonin reuptake inhibitor (SSRI)","SLC6A2, SLC6A4","neurology/psychiatry","depression","MicroSource, Enamine, Tocris, Selleck",97.27,"BRD-A47598013-004-17-8, BRD-A47598013-004-18-6, BRD-A47598013-004-16-0, BRD-A47598013-034-02-7","Launched","","WSEQXVZVJXJVFP-UHFFFAOYSA-N","BRD-A47598013","","CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1"
"7323","DESIPRAMINE","tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1","neurology/psychiatry","depression","MicroSource, Sigma",94.4,"BRD-K60762818-003-25-2, BRD-K60762818-003-26-0","Launched","","HCYAFALTSJYZDH-UHFFFAOYSA-N","BRD-K60762818","","CNCCCN1c2ccccc2CCc2ccccc12"
"7325","DESVENLAFAXINE","serotonin–norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","MicroSource, Tocris, Selleck, Selleck, Selleck, Selleck",97.16,"BRD-A98845662-036-03-7, BRD-A98845662-036-05-2, BRD-A98845662-001-02-3, BRD-A98845662-036-02-9, BRD-A98845662-001-03-1, BRD-A98845662-036-04-5","Launched","","KYYIDSXMWOZKMP-UHFFFAOYSA-N","BRD-A98845662","","CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1"
"7331","DOSULEPIN","norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4","neurology/psychiatry","depression","Prestwick",96.47,"BRD-K54759182-003-08-0","Launched","","PHTUQLWOUWZIMZ-GZTJUZNOSA-N","BRD-K54759182","","CN(C)CC\C=C1/c2ccccc2CSc2ccccc12"
"7332","EPROBEMIDE","monoamine oxidase inhibitor","MAOA","neurology/psychiatry","depression","MicroSource",96.11,"BRD-K17979676-001-01-2","Launched","","YYFGRAGNYHYWEZ-UHFFFAOYSA-N","BRD-K17979676","","Clc1ccc(cc1)C(=O)NCCCN1CCOCC1"
"7333","ISOCARBOXAZID","monoamine oxidase inhibitor","MAOA, MAOB","neurology/psychiatry","depression","Sigma, Enzo",64.59,"BRD-K93332168-001-11-5, BRD-K93332168-001-10-7","Launched","","XKFPYPQQHFEXRZ-UHFFFAOYSA-N","BRD-K93332168","","Cc1cc(no1)C(=O)NNCc1ccccc1"
"7335","LOFEPRAMINE","norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)","HTR1A, SLC6A2, SLC6A4","neurology/psychiatry","depression","Tocris, Key",46.37,"BRD-K82147103-001-02-7, BRD-K82147103-003-05-6","Launched","","SAPNXPWPAUFAJU-UHFFFAOYSA-N","BRD-K82147103","","CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1"
"7337","MIANSERIN","serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","Selleck, MicroSource, Tocris, Selleck",98.04,"BRD-A19661776-003-28-4, BRD-A19661776-003-27-6, BRD-A19661776-003-26-8, BRD-A19661776-003-25-0","Launched","","UEQUQVLFIPOEMF-UHFFFAOYSA-N","BRD-A19661776","","CN1CCN2C(C1)c1ccccc1Cc1ccccc21"
"7341","MIRTAZAPINE","adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","Tocris, MicroSource, Selleck, Tocris",98.93,"BRD-A64977602-001-16-7, BRD-A64977602-001-15-9, BRD-A64977602-001-13-4, BRD-A64977602-001-14-2","Launched","","RONZAEMNMFQXRA-UHFFFAOYSA-N","BRD-A64977602","","CN1CCN2C(C1)c1ccccc1Cc1cccnc21"
"7345","NORTRIPTYLINE","tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4","neurology/psychiatry","depression","MicroSource",98.98,"BRD-K91263825-003-21-4","Launched","","PHVGLTMQBUFIQQ-UHFFFAOYSA-N","BRD-K91263825","","CNCCC=C1c2ccccc2CCc2ccccc12"
"7346","PHENELZINE","monoamine oxidase inhibitor","ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","Sigma, MicroSource, Sigma",80.24,"BRD-K87024524-001-04-0, BRD-K87024524-065-17-7, BRD-K87024524-065-18-5","Launched","","RMUCZJUITONUFY-UHFFFAOYSA-N","BRD-K87024524","","NNCCc1ccccc1"
"7349","PIRLINDOLE","monoamine oxidase inhibitor","MAOA","neurology/psychiatry","depression","Tocris",90,"BRD-A54490543-066-11-9","Launched","","IWVRVEIKCBFZNF-UHFFFAOYSA-N","BRD-A54490543","","Cc1ccc2n3CCNC4CCCc(c34)c2c1"
"7350","PIVAGABINE","corticosteroid releasing factor receptor antagonist","CRHR1, CRHR2","neurology/psychiatry","depression","Enamine, Enamine",53.16,"BRD-K62264492-001-01-5, BRD-K62264492-001-02-3","Launched","","SRPNQDXRVRCTNK-UHFFFAOYSA-N","BRD-K62264492","","CC(C)(C)C(=O)NCCCC(O)=O"
"7352","PROTRIPTYLINE","tricyclic antidepressant","SLC6A2, SLC6A4","neurology/psychiatry","depression","MicroSource",97,"BRD-K42098891-003-20-5","Launched","","BWPIARFWQZKAIA-UHFFFAOYSA-N","BRD-K42098891","","CNCCCC1c2ccccc2C=Cc2ccccc12"
"7353","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","XGSCYTRLSDKRRZ-JQDMTEHVSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1"
"7354","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","XGSCYTRLSDKRRZ-JQDMTEHVSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1"
"7355","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","XGSCYTRLSDKRRZ-JQDMTEHVSA-N","BRD-M39350793","","CCOc1ccccc1OC(C1CNCCO1)c1ccccc1"
"7357","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-RTBURBONSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1"
"7358","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-RTBURBONSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1"
"7359","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-RTBURBONSA-N","BRD-M39350793","","CCOc1ccccc1OC(C1CNCCO1)c1ccccc1"
"7361","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-UHFFFAOYSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1"
"7362","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-UHFFFAOYSA-N","BRD-M39350793","","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1"
"7363","REBOXETINE","adrenergic receptor antagonist","SLC6A2","neurology/psychiatry","depression","Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","Launched","","CBQGYUDMJHNJBX-UHFFFAOYSA-N","BRD-M39350793","","CCOc1ccccc1OC(C1CNCCO1)c1ccccc1"
"7365","SETIPTILINE","adrenergic receptor antagonist","HRH1, HTR2A, HTR2C","neurology/psychiatry","depression","MedChemEx",96.01,"BRD-K36732695-001-01-9","Launched","","GVPIXRLYKVFFMK-UHFFFAOYSA-N","BRD-K36732695","","CN1CCC2=C(C1)c1ccccc1Cc1ccccc21"
"7366","TOLOXATONE","monoamine oxidase inhibitor","MAOA, MAOB","neurology/psychiatry","depression","Sigma",99.02,"BRD-A67182178-001-01-7","Launched","","MXUNKHLAEDCYJL-UHFFFAOYSA-N","BRD-A67182178","","Cc1cccc(c1)N1CC(CO)OC1=O"
"7367","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-BDAKNGLRSA-N","BRD-K88809146","BRD-M46777692","N[C@H]1C[C@@H]1c1ccccc1"
"7368","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-BDAKNGLRSA-N","BRD-K88809146","BRD-M46777692","N[C@@H]1C[C@H]1c1ccccc1"
"7369","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-BDAKNGLRSA-N","BRD-K88809146","BRD-M46777692","NC1C[C@H]1c1ccccc1"
"7372","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-DTWKUNHWSA-N","BRD-K88809146","BRD-M46777692","N[C@H]1C[C@@H]1c1ccccc1"
"7373","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-DTWKUNHWSA-N","BRD-K88809146","BRD-M46777692","N[C@@H]1C[C@H]1c1ccccc1"
"7374","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-DTWKUNHWSA-N","BRD-K88809146","BRD-M46777692","NC1C[C@H]1c1ccccc1"
"7377","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-IENPIDJESA-N","BRD-K88809146","BRD-M46777692","N[C@H]1C[C@@H]1c1ccccc1"
"7378","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-IENPIDJESA-N","BRD-K88809146","BRD-M46777692","N[C@@H]1C[C@H]1c1ccccc1"
"7379","TRANYLCYPROMINE","monoamine oxidase inhibitor","KDM1A, MAOA, MAOB","neurology/psychiatry","depression","Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","Launched","BRD-M46777692-003-01-9","AELCINSCMGFISI-IENPIDJESA-N","BRD-K88809146","BRD-M46777692","NC1C[C@H]1c1ccccc1"
"7382","TRAZODONE","adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck",97.98,"BRD-K70778732-003-27-5, BRD-K70778732-003-26-7","Launched","","PHLBKPHSAVXXEF-UHFFFAOYSA-N","BRD-K70778732","","Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1"
"7384","TRIMIPRAMINE","norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck",98.04,"BRD-A19195498-050-14-1, BRD-A19195498-050-13-3","Launched","","ZSCDBOWYZJWBIY-UHFFFAOYSA-N","BRD-A19195498","","CC(CN(C)C)CN1c2ccccc2CCc2ccccc12"
"7386","VILAZODONE","serotonin reuptake inhibitor","DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck, Selleck",98.4,"BRD-K58010567-003-02-2, BRD-K58010567-003-01-4, BRD-K58010567-003-03-0","Launched","","SGEGOXDYSFKCPT-UHFFFAOYSA-N","BRD-K58010567","","NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1"
"7389","VILOXAZINE","norepinephrine reuptake inhibitor","SLC6A2","neurology/psychiatry","depression","Prestwick",98.75,"BRD-A59198242-003-02-9","Launched","","YWPHCCPCQOJSGZ-UHFFFAOYSA-N","BRD-A59198242","","CCOc1ccccc1OCC1CNCCO1"
"7390","VORTIOXETINE","serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4","neurology/psychiatry","depression","MicroSource, Selleck",95.12,"BRD-K53963539-001-01-8, BRD-K53963539-004-02-0","Launched","","YQNWZWMKLDQSAC-UHFFFAOYSA-N","BRD-K53963539","","Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1"
"7392","DOXEPIN","histamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4","neurology/psychiatry","depression, anxiety","MicroSource, Tocris",98.99,"BRD-K37694030-003-12-7, BRD-K37694030-003-11-9","Launched","","ODQWQRRAPPTVAG-BOPFTXTBSA-N","BRD-K37694030","","CN(C)CC\C=C1\c2ccccc2COc2ccccc12"
"7394","MOCLOBEMIDE","monoamine oxidase inhibitor","MAOA, MAOB","neurology/psychiatry","depression, anxiety","Tocris, Selleck",94.41,"BRD-K07237224-001-20-4, BRD-K07237224-001-19-6","Launched","","YHXISWVBGDMDLQ-UHFFFAOYSA-N","BRD-K07237224","","Clc1ccc(cc1)C(=O)NCCN1CCOCC1"
"7396","TIANEPTINE","selective serotonin reuptake enhancer (SSRE)","OPRD1, OPRK1, OPRM1","neurology/psychiatry, pulmonary, gastroenterology","depression, asthma, irritable bowel syndrome","Selleck, MedChemEx, MedChemEx, MedChemEx, Selleck, Tocris",98.15,"BRD-A53077924-236-07-1, BRD-A53077924-001-02-0, BRD-A53077924-236-09-7, BRD-A53077924-001-01-2, BRD-A53077924-236-05-5, BRD-A53077924-236-06-3","Launched","","JICJBGPOMZQUBB-UHFFFAOYSA-N","BRD-A53077924","","CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O"
"7402","ADEMETIONINE","methyltransferase stimulant, phosphodiesterase inhibitor","AMD1, CBS, COMT, GNMT, MAT1A, MAT2A","neurology/psychiatry","depression, attention-deficit/hyperactivity disorder (ADHD)","MedChemEx, MedChemEx",0,"BRD-K78185697-001-02-5, BRD-K78185697-001-01-7","Launched","","MEFKEPWMEQBLKI-AIRLBKTGSA-O","BRD-K78185697","","C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12"
"7404","MAPROTILINE","norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2","neurology/psychiatry","depression, dysthymic disorder","Selleck, Tocris, MicroSource",96.89,"BRD-K25433859-003-23-9, BRD-K25433859-003-24-7, BRD-K25433859-003-25-4","Launched","","QSLMDECMDJKHMQ-UHFFFAOYSA-N","BRD-K25433859","","CNCCCC12CCC(c3ccccc13)c1ccccc21"
"7407","ESCITALOPRAM","selective serotonin reuptake inhibitor (SSRI)","ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression, generalized anxiety disorder (GAD)","MicroSource, Tocris",98.5,"BRD-K70301876-034-13-7, BRD-K70301876-034-14-5","Launched","","WSEQXVZVJXJVFP-FQEVSTJZSA-N","BRD-K70301876","","CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1"
"7409","DULOXETINE","norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)","HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression, generalized anxiety disorder (GAD), muscle pain, peripheral neuropathy","Tocris, MicroSource, Selleck",98.43,"BRD-K71103788-003-13-8, BRD-K71103788-003-12-0, BRD-K71103788-003-11-2","Launched","","ZEUITGRIYCTCEM-KRWDZBQOSA-N","BRD-K71103788","","CNCC[C@H](Oc1cccc2ccccc12)c1cccs1"
"7412","VENLAFAXINE","adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression, generalized anxiety disorder (GAD), panic disorders, social anxiety disorder","Tocris, MicroSource, Selleck",96.92,"BRD-A51714012-003-14-4, BRD-A51714012-003-13-6, BRD-A51714012-003-12-8","Launched","","PNVNVHUZROJLTJ-UHFFFAOYSA-N","BRD-A51714012","","COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1"
"7415","IMIPRAMINE","norepinephrine reputake inhibitor, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry, urology","depression, nocturnal enuresis","Selleck, MicroSource, Selleck",92.52,"BRD-K38436528-003-25-3, BRD-K38436528-003-26-1, BRD-K38436528-003-27-9","Launched","","BCGWQEUPMDMJNV-UHFFFAOYSA-N","BRD-K38436528","","CN(C)CCCN1c2ccccc2CCc2ccccc12"
"7418","FLUOXETINE","selective serotonin reuptake inhibitor (SSRI)","ANO1, HTR2B, SLC6A4","neurology/psychiatry","depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder","MicroSource, Selleck, Tocris, Tocris",98.86,"BRD-A31159102-003-30-4, BRD-A31159102-003-28-8, BRD-A31159102-003-29-6, BRD-A31159102-003-31-2","Launched","","RTHCYVBBDHJXIQ-UHFFFAOYSA-N","BRD-A31159102","","CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1"
"7422","PAROXETINE","selective serotonin reuptake inhibitor (SSRI)","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4","neurology/psychiatry","depression, obsessive compulsive disorder (OCD), generalized anxiety disorder (GAD), panic disorders, posttraumatic stress disorder, social anxiety disorder","MicroSource, Tocris, Selleck",94.73,"BRD-K37991163-003-14-2, BRD-K37991163-050-18-4, BRD-K37991163-003-13-4","Launched","","AHOUBRCZNHFOSL-YOEHRIQHSA-N","BRD-K37991163","","Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1"
"7425","SERTRALINE","selective serotonin reuptake inhibitor (SSRI)","SLC6A3, SLC6A4","neurology/psychiatry, obstetrics/gynecology","depression, obsessive compulsive disorder (OCD), panic disorders, posttraumatic stress disorder, premenstrual syndrome, social anxiety disorder","MicroSource, Tocris, Tocris, Selleck",97.77,"BRD-K82036761-003-17-9, BRD-K82036761-003-16-1, BRD-K82036761-003-19-5, BRD-K82036761-003-20-3","Launched","BRD-K70464547-003-01-2","VGKDLMBJGBXTGI-SJCJKPOMSA-N","BRD-K82036761","BRD-K70464547","CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12"
"7429","HEMATOPORPHYRIN","","","neurology/psychiatry","depression, psychosis, psychosis, depression","MedChemEx, Sigma",16.61,"BRD-A44995766-300-03-0, BRD-A44995766-001-02-6","Launched","","UJKPHYRXOLRVJJ-UHFFFAOYSA-N","BRD-A44995766","","CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(O)=O)c(CCC(O)=O)c4C)c(C)c3C(C)O"
"7431","BREXPIPRAZOLE","dopamine receptor partial agonist","DRD2","neurology/psychiatry","depression, schizophrenia","MedChemEx",94.37,"BRD-K00911143-001-01-9","Launched","","ZKIAIYBUSXZPLP-UHFFFAOYSA-N","BRD-K00911143","","O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1"
"7432","ARIPIPRAZOLE","serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7","neurology/psychiatry","depression, schizophrenia, bipolar disorder","Tocris, MicroSource, Selleck",98.35,"BRD-K70358946-001-17-3, BRD-K70358946-001-15-7, BRD-K70358946-001-14-0","Launched","","CEUORZQYGODEFX-UHFFFAOYSA-N","BRD-K70358946","","Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl"
"7435","AMIDOPYRINE","analgesic agent","","dermatology","dermatitis herpetiformis (DH)","MicroSource, Selleck, Selleck",94.77,"BRD-K12568846-001-15-3, BRD-K12568846-001-14-6, BRD-K12568846-001-16-1","Launched","","RMMXTBMQSGEXHJ-UHFFFAOYSA-N","BRD-K12568846","","CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O"
"7438","DAPSONE","bacterial antifolate","DHFR","dermatology, infectious disease","dermatitis herpetiformis (DH), leprosy","MicroSource",98.4,"BRD-K62363391-001-24-9","Launched","","MQJKPEGWNLWLTK-UHFFFAOYSA-N","BRD-K62363391","","Nc1ccc(cc1)S(=O)(=O)c1ccc(N)cc1"
"7439","ACARBOSE","glucosidase inhibitor","AMY2A, GAA, MGAM, SI","endocrinology","diabetes mellitus","Tocris, Tocris, MicroSource, Selleck",100,"BRD-K44276885-001-06-6, BRD-K44276885-001-05-8, BRD-K44276885-001-08-2, BRD-K44276885-001-07-4","Launched","BRD-A16444946-001-09-7, BRD-K01621533-001-01-1","XUFXOAAUWZOOIT-SXARVLRPSA-N","BRD-K44276885","BRD-A16444946","C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O"
"7443","ACETOHEXAMIDE","ATP channel blocker","ABCC8, KCNJ1, KCNJ10, KCNJ11","endocrinology","diabetes mellitus","MicroSource, MedChemEx",92.87,"BRD-K52960356-001-13-0, BRD-K52960356-001-15-5","Launched","","VGZSUPCWNCWDAN-UHFFFAOYSA-N","BRD-K52960356","","CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1"
"7445","ALOGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, Selleck, Selleck",93.62,"BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6","Launched","BRD-K83003151-001-03-0, BRD-K83003151-001-02-2","ZSBOMTDTBDDKMP-UHFFFAOYSA-N","BRD-A27084604","BRD-K83003151","Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O"
"7446","ALOGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, Selleck, Selleck",93.62,"BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6","Launched","BRD-K83003151-001-03-0, BRD-K83003151-001-02-2","ZSBOMTDTBDDKMP-UHFFFAOYSA-N","BRD-A27084604","BRD-K83003151","Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O"
"7448","ALOGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, Selleck, Selleck",93.62,"BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6","Launched","BRD-K83003151-001-03-0, BRD-K83003151-001-02-2","ZSBOMTDTBDDKMP-OAHLLOKOSA-N","BRD-A27084604","BRD-K83003151","Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O"
"7449","ALOGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, Selleck, Selleck",93.62,"BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6","Launched","BRD-K83003151-001-03-0, BRD-K83003151-001-02-2","ZSBOMTDTBDDKMP-OAHLLOKOSA-N","BRD-A27084604","BRD-K83003151","Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O"
"7451","ANAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MedChemEx, MedChemEx",82.68,"BRD-K05355328-001-02-9, BRD-K05355328-001-01-1","Launched","","LDXYBEHACFJIEL-HNNXBMFYSA-N","BRD-K05355328","","Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N"
"7453","CANAGLIFLOZIN","sodium/glucose cotransporter inhibitor","SLC5A1, SLC5A2","endocrinology","diabetes mellitus","MicroSource, Selleck",98.9,"BRD-K90868879-001-03-8, BRD-K90868879-001-02-0","Launched","","XTNGUQKDFGDXSJ-ZXGKGEBGSA-N","BRD-K90868879","","Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O"
"7455","CHLORPROPAMIDE","ATP channel blocker","ABCC8, KCNJ10, KCNJ11","endocrinology","diabetes mellitus","MicroSource, Selleck",98.37,"BRD-K97746869-001-27-0, BRD-K97746869-001-26-2","Launched","","RKWGIWYCVPQPMF-UHFFFAOYSA-N","BRD-K97746869","","CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1"
"7457","DAPAGLIFLOZIN","sodium/glucose cotransporter inhibitor","SLC5A1, SLC5A2","endocrinology","diabetes mellitus","Selleck, MicroSource",98,"BRD-K58160573-001-05-4, BRD-K58160573-001-04-7","Launched","BRD-K46604138-001-01-3","JVHXJTBJCFBINQ-ADAARDCZSA-N","BRD-K58160573","BRD-K46604138","CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1"
"7459","EMPAGLIFLOZIN","sodium/glucose cotransporter inhibitor","SLC5A1, SLC5A2","endocrinology","diabetes mellitus","Selleck",96.18,"BRD-K53765467-001-02-1","Launched","","OBWASQILIWPZMG-QZMOQZSNSA-N","BRD-K53765467","","OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1"
"7460","ERTUGLIFLOZIN","sodium/glucose cotransporter inhibitor","SLC5A2","endocrinology","diabetes mellitus","MedChemEx",99.59,"BRD-K10071630-001-01-0","Launched","","MCIACXAZCBVDEE-VNXMGFANSA-N","BRD-K10071630","","CCOc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1"
"7461","EXENATIDE","GLP receptor agonist","GLP1R","endocrinology","diabetes mellitus","MedChemEx",59.57,"BRD-K05505104-001-01-1","Launched","BRD-U88413610-000-01-5","HRPOQXWQRXFQTM-XWLPCZSASA-N","BRD-K05505104","BRD-U88413610","CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O"
"7462","GLICLAZIDE","ATP channel blocker, insulin secretagogue","ABCC8, VEGFA","endocrinology","diabetes mellitus","MicroSource, Selleck, Selleck",88.04,"BRD-A61154809-001-15-9, BRD-A61154809-001-16-7, BRD-A61154809-001-14-2","Launched","","BOVGTQGAOIONJV-UHFFFAOYSA-N","BRD-A61154809","","Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1"
"7465","GLIMEPIRIDE","insulin secretagogue","ABCC8, KCNJ1, KCNJ11","endocrinology","diabetes mellitus","MicroSource, Tocris, Selleck",96.93,"BRD-K34776109-001-16-6, BRD-K34776109-001-15-8, BRD-K34776109-001-14-1","Launched","","WIGIZIANZCJQQY-RUCARUNLSA-N","BRD-K34776109","","CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O"
"7468","GLIQUIDONE","sulfonylurea","ABCC8, KCNJ10, KCNJ8","endocrinology","diabetes mellitus","Selleck",94.47,"BRD-K80396088-001-12-0","Launched","","LLJFMFZYVVLQKT-UHFFFAOYSA-N","BRD-K80396088","","COc1ccc2c(c1)C(=O)N(CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C"
"7469","IPRAGLIFLOZIN-L-PROLINE","sodium/glucose cotransporter inhibitor","SLC5A2","endocrinology","diabetes mellitus","MedChemEx",98.3,"BRD-K51247865-001-01-2","Launched","","AHFWIQIYAXSLBA-RQXATKFSSA-N","BRD-K51247865","","OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(F)c(Cc2cc3ccccc3s2)c1"
"7470","LINAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, MicroSource, Selleck, Selleck",88.62,"BRD-K96550715-003-01-4, BRD-K96550715-001-03-4, BRD-K96550715-001-04-2, BRD-K96550715-001-02-6","Launched","BRD-A23155464-001-01-9","LTXREWYXXSTFRX-QGZVFWFLSA-N","BRD-K96550715","BRD-A23155464","CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1"
"7474","METFORMIN","insulin sensitizer","ACACB, PRKAB1","endocrinology","diabetes mellitus","Selleck, MicroSource, Tocris",93.76,"BRD-K79602928-003-18-1, BRD-K79602928-003-19-9, BRD-K79602928-003-21-5","Launched","","XZWYZXLIPXDOLR-UHFFFAOYSA-N","BRD-K79602928","","CN(C)C(=N)NC(N)=N"
"7477","MIGLITOL","glucosidase inhibitor","GAA, GANAB, GANC, MGAM","endocrinology","diabetes mellitus","Tocris, MicroSource, Selleck",100,"BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5","Launched","BRD-K82665349-001-01-4","IBAQFPQHRJAVAV-ULAWRXDQSA-N","BRD-K44779798","BRD-K82665349","OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO"
"7478","MIGLITOL","glucosidase inhibitor","GAA, GANAB, GANC, MGAM","endocrinology","diabetes mellitus","Tocris, MicroSource, Selleck",100,"BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5","Launched","BRD-K82665349-001-01-4","IBAQFPQHRJAVAV-ULAWRXDQSA-N","BRD-K44779798","BRD-K82665349","OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO"
"7480","MIGLITOL","glucosidase inhibitor","GAA, GANAB, GANC, MGAM","endocrinology","diabetes mellitus","Tocris, MicroSource, Selleck",100,"BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5","Launched","BRD-K82665349-001-01-4","IBAQFPQHRJAVAV-WMEPKMGJSA-N","BRD-K44779798","BRD-K82665349","OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO"
"7481","MIGLITOL","glucosidase inhibitor","GAA, GANAB, GANC, MGAM","endocrinology","diabetes mellitus","Tocris, MicroSource, Selleck",100,"BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5","Launched","BRD-K82665349-001-01-4","IBAQFPQHRJAVAV-WMEPKMGJSA-N","BRD-K44779798","BRD-K82665349","OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO"
"7483","MITIGLINIDE","insulin secretagogue","ABCC8, KCNJ10, PPARG","endocrinology","diabetes mellitus","Selleck",98.47,"BRD-K52959329-238-01-9","Launched","BRD-M71049352-238-02-2","WPGGHFDDFPHPOB-BBWFWOEESA-N","BRD-K52959329","BRD-M71049352","OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1"
"7484","NATEGLINIDE","insulin secretagogue","ABCC8, KCNJ10, KCNJ11, PPARG","endocrinology","diabetes mellitus","Tocris, MicroSource, Tocris, Selleck",98.07,"BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5","Launched","","OELFLUMRDSZNSF-BRWVUGGUSA-N","BRD-K44353683","","CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O"
"7485","NATEGLINIDE","insulin secretagogue","ABCC8, KCNJ10, KCNJ11, PPARG","endocrinology","diabetes mellitus","Tocris, MicroSource, Tocris, Selleck",98.07,"BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5","Launched","","OELFLUMRDSZNSF-BRWVUGGUSA-N","BRD-K44353683","","CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O"
"7488","NATEGLINIDE","insulin secretagogue","ABCC8, KCNJ10, KCNJ11, PPARG","endocrinology","diabetes mellitus","Tocris, MicroSource, Tocris, Selleck",98.07,"BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5","Launched","","OELFLUMRDSZNSF-ULQDDVLXSA-N","BRD-K44353683","","CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O"
"7489","NATEGLINIDE","insulin secretagogue","ABCC8, KCNJ10, KCNJ11, PPARG","endocrinology","diabetes mellitus","Tocris, MicroSource, Tocris, Selleck",98.07,"BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5","Launched","","OELFLUMRDSZNSF-ULQDDVLXSA-N","BRD-K44353683","","CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O"
"7492","PIOGLITAZONE","insulin sensitizer, PPAR receptor agonist","PPARG, TRPM3","endocrinology","diabetes mellitus","MicroSource, Tocris, Selleck, Selleck",99.54,"BRD-A48430263-003-17-2, BRD-A48430263-003-19-8, BRD-A48430263-003-16-4, BRD-A48430263-001-07-7","Launched","","HYAFETHFCAUJAY-UHFFFAOYSA-N","BRD-A48430263","","CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1"
"7496","REPAGLINIDE","insulin secretagogue","ABCC8, KCNJ11, PPARG","endocrinology","diabetes mellitus","Tocris, Tocris, MicroSource, Selleck",99.06,"BRD-K82846253-001-17-0, BRD-K82846253-001-15-4, BRD-K82846253-001-16-2, BRD-K82846253-001-14-7","Launched","","FAEKWTJYAYMJKF-QHCPKHFHSA-N","BRD-K82846253","","CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O"
"7500","SAXAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","Selleck",91.2,"BRD-A81513827-001-03-6","Launched","BRD-A82156122-001-01-9","QGJUIPDUBHWZPV-SGTAVMJGSA-N","BRD-A81513827","BRD-A82156122","N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2"
"7501","SITAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MicroSource, Selleck",92.63,"BRD-K19416115-366-02-7, BRD-K19416115-001-05-3","Launched","BRD-U27206154-000-01-9","MFFMDFFZMYYVKS-SECBINFHSA-N","BRD-K19416115","BRD-U27206154","N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F"
"7503","TENELIGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","MedChemEx",96.62,"BRD-K48068743-001-01-6","Launched","","WGRQANOPCQRCME-PMACEKPBSA-N","BRD-K48068743","","Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1"
"7504","TOLAZAMIDE","ATP channel blocker","ABCC8, KCNJ1, KCNJ10, KCNJ11","endocrinology","diabetes mellitus","Selleck, Selleck, MicroSource",97.65,"BRD-K32164935-001-29-0, BRD-K32164935-001-31-6, BRD-K32164935-001-30-8","Launched","","OUDSBRTVNLOZBN-UHFFFAOYSA-N","BRD-K32164935","","Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1"
"7507","TOLBUTAMIDE","ATP channel blocker","ABCC8, KCNJ1, KCNJ11, KCNJ8","endocrinology","diabetes mellitus","MicroSource, Selleck",98.93,"BRD-K85119730-001-28-9, BRD-K85119730-001-27-1","Launched","","JLRGJRBPOGGCBT-UHFFFAOYSA-N","BRD-K85119730","","CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1"
"7509","TRELAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","Selleck",94.03,"BRD-A88369366-001-01-7","Launched","","IWYJYHUNXVAVAA-UHFFFAOYSA-N","BRD-A88369366","","Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O"
"7510","VILDAGLIPTIN","dipeptidyl peptidase inhibitor","DPP4","endocrinology","diabetes mellitus","Selleck, Selleck",99.32,"BRD-A94993966-001-04-4, BRD-A94993966-001-05-1","Launched","","SYOKIDBDQMKNDQ-XWTIBIIYSA-N","BRD-A94993966","","OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N"
"7512","SARPOGRELATE","serotonin receptor antagonist","HTR2A, HTR2B, HTR2C","endocrinology, cardiology, rheumatology","diabetes mellitus, angina pectoris, Raynaud's disease, atherosclerosis, Buerger's disease","Tocris, MedChemEx",93.14,"BRD-A34358106-003-02-4, BRD-A34358106-003-01-6","Launched","","FFYNAVGJSYHHFO-UHFFFAOYSA-N","BRD-A34358106","","COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(O)=O)c1"
"7514","TOFOGLIFLOZIN","sodium/glucose cotransporter inhibitor","GCK","endocrinology","diabetes mellitus, diabetes mellitus","MedChemEx, MedChemEx",95.64,"BRD-K96344439-002-02-7, BRD-K96344439-002-01-9","Launched","","VWVKUNOPTJGDOB-BDHVOXNPSA-N","BRD-K96344439","","CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1"
"7516","GLIPIZIDE","sulfonylurea","ABCC8, KCNJ10, KCNJ11, PPARG","endocrinology","diabetes mellitus, hyperglycemia","MicroSource, Selleck",98.53,"BRD-K12219985-001-26-1, BRD-K12219985-001-25-3","Launched","","ZJJXGWJIGJFDTL-UHFFFAOYSA-N","BRD-K12219985","","Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1"
"7518","GLYBURIDE","ATP channel blocker, insulin secretagogue, sulfonylurea","ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1","endocrinology","diabetes mellitus, hyperglycemia","Tocris, Selleck, MicroSource, Tocris",97.94,"BRD-K36927236-001-36-7, BRD-K36927236-001-30-0, BRD-K36927236-001-32-6, BRD-K36927236-001-31-8","Launched","","ZNNLBTZKUZBEKO-UHFFFAOYSA-N","BRD-K36927236","","COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1"
"7522","VOGLIBOSE","glucosidase inhibitor","MGAM","endocrinology","diabetes mellitus, hyperglycemia","Tocris, Tocris, Selleck",100,"BRD-K66850609-001-05-8, BRD-K66850609-001-06-6, BRD-K66850609-001-07-4","Launched","BRD-K59331299-001-01-2","FZNCGRZWXLXZSZ-CIQUZCHMSA-N","BRD-K66850609","BRD-K59331299","OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O"
"7525","EPALRESTAT","aldose reductase inhibitor","AKR1B1","nephrology","diabetic nephropathy","MedChemEx, MedChemEx, Selleck, Selleck",81.25,"BRD-K98054437-001-11-5, BRD-K98054437-001-12-3, BRD-K98054437-001-09-9, BRD-K98054437-001-08-1","Launched","","CHNUOJQWGUIOLD-NFZZJPOKSA-N","BRD-K98054437","","CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1"
"7529","HEXAMINOLEVULINATE","","","radiology","diagnostic agent","MedChemEx",100,"BRD-K73753850-003-01-6","Launched","","RYQOILLJDKPETL-UHFFFAOYSA-N","BRD-K73753850","","CCCCCCOC(=O)CCC(=O)CN"
"7530","MEBROFENIN","","","radiology","diagnostic agent","Sigma",69.8,"BRD-K96691275-001-01-2","Launched","","MHPZZZZLAQGTHT-UHFFFAOYSA-N","BRD-K96691275","","Cc1cc(C)c(NC(=O)CN(CC(O)=O)CC(O)=O)c(C)c1Br"
"7531","ROSE-BENGAL","contrast agent","","radiology","diagnostic agent","SantaCruz, Acros",57.93,"BRD-K33623053-304-02-5, BRD-K33623053-304-01-7","Launched","BRD-K36163066-304-01-6","VDNLFJGJEQUWRB-UHFFFAOYSA-N","BRD-K33623053","BRD-K36163066","OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12"
"7533","ACETARSOL","","","gastroenterology","diarrhea","MicroSource, Selleck",100,"BRD-K99048103-001-19-2, BRD-K99048103-001-18-4","Launched","","ODFJOVXVLFUVNQ-UHFFFAOYSA-N","BRD-K99048103","","CC(=O)Nc1cc(ccc1O)[As](O)(O)=O"
"7535","ARSENIC-TRIOXIDE","apoptosis stimulant","AKT1, CCND1, IKBKB, JUN, MAPK1, MAPK3, TXNRD1","gastroenterology","diarrhea","MicroSource",0,"BRD-K47190141-396-01-1","Launched","","NWBBZCLIZUATJF-UHFFFAOYSA-N","BRD-K47190141","","O[AsH]O[AsH]O"
"7536","BISMUTH-SUBSALICYLATE","antacid","","gastroenterology","diarrhea","MicroSource, MedChemEx, Selleck, MedChemEx, Selleck",5.83,"BRD-K80528473-001-03-0, BRD-K80528473-001-08-9, BRD-K80528473-001-04-8, BRD-K80528473-001-07-1, BRD-K80528473-001-05-5","Launched","BRD-M10663475-001-02-8, BRD-M10663475-001-03-6","ZREIPSZUJIFJNP-UHFFFAOYSA-K","BRD-K80528473","BRD-M10663475","O[Bi]1OC(=O)c2ccccc2O1"
"7541","FIDAXOMICIN","RNA polymerase inhibitor","","gastroenterology","diarrhea","Selleck",91.8,"BRD-K57371763-001-01-7","Launched","","ZVGNESXIJDCBKN-MHDOWYNASA-N","BRD-K57371763","","CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@H](C\C=C(C)\C=C(C)[C@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@H]1O)[C@@H](C)O"
"7542","LIDAMIDINE","adrenergic receptor agonist","","gastroenterology","diarrhea","ChemDiv",93.96,"BRD-K68693535-001-03-4","Launched","","RRHJHSBDJDZUGL-UHFFFAOYSA-N","BRD-K68693535","","CNC(=N)NC(=O)Nc1c(C)cccc1C"
"7543","LOPERAMIDE","opioid receptor agonist","CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC","gastroenterology","diarrhea","Tocris, MicroSource, Selleck",98.87,"BRD-K61250553-003-30-6, BRD-K61250553-003-32-2, BRD-K61250553-003-29-8","Launched","","RDOIQAHITMMDAJ-UHFFFAOYSA-N","BRD-K61250553","","CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1"
"7546","NITAZOXANIDE","pyruvate ferredoxin oxidoreductase inhibitor","","gastroenterology","diarrhea","Selleck, MicroSource, MedChemEx, MedChemEx, Selleck",87.36,"BRD-K96471533-001-09-0, BRD-K96471533-001-08-2, BRD-K96471533-001-10-8, BRD-K96471533-001-11-6, BRD-K96471533-001-07-4","Launched","","YQNQNVDNTFHQSW-UHFFFAOYSA-N","BRD-K96471533","","CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O"
"7551","RACECADOTRIL","enkephalinase inhibitor","MME","gastroenterology","diarrhea","MicroSource, Selleck",98,"BRD-A08187463-001-12-9, BRD-A08187463-001-11-1","Launched","","ODUOJXZPIYUATO-UHFFFAOYSA-N","BRD-A08187463","","CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1"
"7553","TELOTRISTAT-ETHYL","tryptophan hydroxylase inhibitor","TPH1","gastroenterology","diarrhea","MedChemEx, MedChemEx, Selleck",99.27,"BRD-K94559059-091-03-2, BRD-K94559059-091-01-6, BRD-K94559059-091-02-4","Launched","","MDSQOJYHHZBZKA-GBXCKJPGSA-N","BRD-K94559059","","CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1"
"7556","OCTREOTIDE","somatostatin receptor agonist","SSTR1, SSTR2, SSTR3, SSTR5","gastroenterology, endocrinology, oncology","diarrhea, acromegaly, carcinoid tumors","MedChemEx, MedChemEx, MedChemEx",91,"BRD-A64173453-015-03-1, BRD-A64173453-015-02-3, BRD-A64173453-015-01-5","Launched","","DEQANNDTNATYII-UHFFFAOYSA-N","BRD-A64173453","","CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1"
"7559","FURAZOLIDONE","bacterial DNA inhibitor","","gastroenterology, infectious disease","diarrhea, enteritis, cholera","MicroSource",91.67,"BRD-K11756522-001-09-9","Launched","","PLHJDBGFXBMTGZ-WEVVVXLNSA-N","BRD-K11756522","","[O-][N+](=O)c1ccc(\C=N\N2CCOC2=O)o1"
"7560","CHLOROXINE","opioid receptor antagonist","OPRK1","gastroenterology, infectious disease, dermatology","diarrhea, inflammatory bowel disease, giardiasis, dandruff","MicroSource, Selleck, Selleck",99.48,"BRD-K17075857-001-17-6, BRD-K17075857-001-18-4, BRD-K17075857-001-16-8","Launched","","WDFKMLRRRCGAKS-UHFFFAOYSA-N","BRD-K17075857","","Oc1c(Cl)cc(Cl)c2cccnc12"
"7563","RIFAXIMIN","RNA synthesis inhibitor","NR1I2","gastroenterology","diarrhea, irritable bowel syndrome, hepatic encephalopathy (HE)","MicroSource, Selleck",94.32,"BRD-K92838188-001-01-9, BRD-K92838188-001-02-7","Launched","BRD-A62879835-001-04-2, BRD-K45512312-001-01-7","NZCRJKRKKOLAOJ-CPJOEXDVSA-N","BRD-K92838188","BRD-A62879835","CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"7565","GLUTAMINE-(L)","","CTPS1, GLUL, GPRC6A, PPAT","gastroenterology, dental, neurology/psychiatry, rheumatology","diarrhea, mucositis, muscle pain, joint pain, peptic ulcer disease (PUD), ulcerative colitis, Crohn's disease, anxiety, insomnia","Selleck, Selleck",93.22,"BRD-K83896451-001-06-7, BRD-K83896451-001-07-5","Launched","","ZDXPYRJPNDTMRX-VKHMYHEASA-N","BRD-K83896451","","N[C@@H](CCC(N)=O)C(O)=O"
"7567","ACETYLCHOLINE","acetylcholine receptor agonist","ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2","neurology/psychiatry, gastroenterology, pulmonary","drowsiness, fatigue, headache, indigestion, chest congestion","MicroSource, Selleck",100,"BRD-K82381502-003-24-9, BRD-K82381502-003-23-1","Launched","","OIPILFWXSMYKGL-UHFFFAOYSA-N","BRD-K82381502","","CC(=O)OCC[N+](C)(C)C"
"7569","ECABET","gastrin inhibitor, urease inhibitor","NOXO1","ophthalmology","dry eye syndrome","OxChem",98.28,"BRD-K03353589-236-01-4","Launched","","IWCWQNVIUXZOMJ-MISYRCLQSA-N","BRD-K03353589","","CC(C)c1cc2CC[C@H]3[C@@](C)(CCC[C@]3(C)c2cc1S(O)(=O)=O)C(O)=O"
"7570","MAZINDOL","dopamine reuptake inhibitor, selective serotonin reuptake inhibitor (SSRI)","SLC6A2, SLC6A3, SLC6A4","genetics","duchenne muscular dystrophy (DMD)","MedChemEx",96.3,"BRD-A68464583-001-02-5","Launched","","ZPXSCAKFGYXMGA-UHFFFAOYSA-N","BRD-A68464583","","OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1"
"7571","ATALUREN","CFTR channel agonist, dystrophin stimulant","DMD","genetics, pulmonary","duchenne muscular dystrophy (DMD), cystic fibrosis","Selleck",97.28,"BRD-K94830329-001-03-0","Launched","","OOUGLTULBSNHNF-UHFFFAOYSA-N","BRD-K94830329","","OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F"
"7572","BISMUTH-SUBCITRATE-POTASSIUM","","","gastroenterology","duodenal ulcer disease","Selleck, Selleck",0,"BRD-A03880619-001-01-0, BRD-A03880619-001-02-8","Launched","BRD-M47372415-001-01-8, BRD-M47372415-001-02-6","KNOSZBQOKCZXTI-UHFFFAOYSA-K","BRD-A03880619","BRD-M47372415","OC(=O)CC(O)(CC(=O)O[Bi]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O"
"7574","MISOPROSTOL","prostanoid receptor agonist","PTGER2, PTGER3, PTGER4, PTGIR","gastroenterology","duodenal ulcer disease","Sigma",99.4,"BRD-A72351335-001-04-5","Launched","","OJLOPKGSLYJEMD-URPKTTJQSA-N","BRD-A72351335","","CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC"
"7575","SUCRALFATE","antacid","EGF, FGA, FGB, FGF2, FGG","gastroenterology","duodenal ulcer disease","MicroSource",0,"BRD-M71167108-001-01-3","Launched","","DTULOKYBGCTCFP-QRLOXDDHSA-A","BRD-M71167108","","O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O"
"7576","NIZATIDINE","histamine receptor antagonist","HRH2","gastroenterology","duodenal ulcer disease, erosive esophagitis (EE), ulcerative esophagitis (UE), gastroesophageal reflux disease (GERD)","Selleck, MicroSource",93.08,"BRD-K73589491-001-12-0, BRD-K73589491-001-11-2","Launched","BRD-K46652470-001-09-1","SGXXNSQHWDMGGP-IZZDOVSWSA-N","BRD-K73589491","BRD-K46652470","CN\C(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O"
"7578","LAFUTIDINE","histamine receptor antagonist","HRH2","gastroenterology","duodenal ulcer disease, peptic ulcer disease (PUD)","Selleck",96.82,"BRD-A67516570-001-02-8","Launched","","KMZQAVXSMUKBPD-DJWKRKHSSA-N","BRD-A67516570","","O=C(CS(=O)Cc1ccco1)NC\C=C/COc1cc(CN2CCCCC2)ccn1"
"7579","CIMETIDINE","histamine receptor antagonist","HRH2, SLC29A4, SLC47A1, SLC47A2","gastroenterology, hematologic malignancy, endocrinology","duodenal ulcer disease, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), aggressive systemic mastocytosis (ASM), Zollinger-Ellison syndrome, endocrine adenoma","Tocris, Tocris, Selleck, MicroSource",99.16,"BRD-K34157611-001-21-0, BRD-K34157611-001-15-2, BRD-K34157611-001-14-5, BRD-K34157611-001-16-0","Launched","","AQIXAKUUQRKLND-UHFFFAOYSA-N","BRD-K34157611","","CN\C(NCCSCc1nc[nH]c1C)=N/C#N"
"7583","HYDROQUINONE","melanin inhibitor","TYR","dermatology","dyschromia","MicroSource, MedChemEx",49.83,"BRD-K11227669-001-07-8, BRD-K11227669-001-08-6","Launched","","QIGBRXMKCJKVMJ-UHFFFAOYSA-N","BRD-K11227669","","Oc1ccc(O)cc1"
"7585","PHTHALYLSULFATHIAZOLE","dihydropteroate synthetase inhibitor","","infectious disease, gastroenterology","dysentry, colitis","MedChemEx, MicroSource",83.45,"BRD-K64659768-001-13-6, BRD-K64659768-001-12-8","Launched","","PBMSWVPMRUJMPE-UHFFFAOYSA-N","BRD-K64659768","","OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1"
"7587","VALNEMULIN","bacterial 50S ribosomal subunit inhibitor","","infectious disease, gastroenterology","dysentry, colitis, pneumonia","Selleck",100,"BRD-K33813875-003-01-8","Launched","","LLYYNOVSVPBRGV-LWVOSLLHSA-N","BRD-K33813875","","CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@]1(C)[C@H](C)CC3"
"7588","CARBADOX","other antibiotic","","infectious disease, gastroenterology","dysentry, enteritis","MicroSource, Selleck, Selleck",99.18,"BRD-K56735750-001-06-8, BRD-K56735750-001-09-2, BRD-K56735750-001-07-6","Launched","BRD-K06386100-001-01-9","OVGGLBAWFMIPPY-WUXMJOGZSA-N","BRD-K56735750","BRD-K06386100","COC(=O)N\N=C\c1c[n+]([O-])c2ccccc2[n+]1[O-]"
"7591","TIAPRIDE","dopamine receptor antagonist","DRD2, DRD3","neurology/psychiatry","dyskinesia, abstinence from alcohol, psychosis","MicroSource",98.27,"BRD-K57432881-003-21-8","Launched","","JTVPZMFULRWINT-UHFFFAOYSA-N","BRD-K57432881","","CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O"
"7592","FENOFIBRIC-ACID","cytochrome P450 inhibitor","CLCN1, PPARA","cardiology","dyslipidemia","MicroSource",94.36,"BRD-K30213273-001-01-6","Launched","","MQOBSOSZFYZQOK-UHFFFAOYSA-N","BRD-K30213273","","CC(C)(Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1)C(O)=O"
"7593","CABAGIN","","","gastroenterology","dyspepsia","AlfaAesar",0,"BRD-K41504985-005-01-5","Launched","","YDBYJHTYSHBBAU-YFKPBYRVSA-O","BRD-K41504985","","C[S+](C)CC[C@H](N)C(O)=O"
"7594","ITOPRIDE","dopamine receptor antagonist","CHRM3, DRD2","gastroenterology, neurology/psychiatry","dyspepsia, gastroparesis, heartburn, nausea, vomiting, anorexia","MicroSource",96.72,"BRD-K96740444-001-02-1","Launched","","QQQIECGTIMUVDS-UHFFFAOYSA-N","BRD-K96740444","","COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1"
"7595","LORACARBEF","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections","Kemprotec, Prestwick",24.5,"BRD-A04915500-002-01-3, BRD-K28935038-001-02-2","Launched","","JAPHQRWPEGVNBT-MOENNCHZSA-N","BRD-A04915500","","N[C@@H](C(=O)NC1C2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1"
"7596","LORACARBEF","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections","Kemprotec, Prestwick",24.5,"BRD-A04915500-002-01-3, BRD-K28935038-001-02-2","Launched","","JAPHQRWPEGVNBT-MOENNCHZSA-N","BRD-A04915500","","N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1"
"7597","LORACARBEF","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections","Kemprotec, Prestwick",24.5,"BRD-A04915500-002-01-3, BRD-K28935038-001-02-2","Launched","","JAPHQRWPEGVNBT-UTUOFQBUSA-N","BRD-A04915500","","N[C@@H](C(=O)NC1C2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1"
"7598","LORACARBEF","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections","Kemprotec, Prestwick",24.5,"BRD-A04915500-002-01-3, BRD-K28935038-001-02-2","Launched","","JAPHQRWPEGVNBT-UTUOFQBUSA-N","BRD-A04915500","","N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1"
"7599","CEFETAMET","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","ear infections, pneumonia, otitis, sinusitis, bronchitis, urinary tract infections","Sigma",91.04,"BRD-K27798832-001-01-5","Launched","","MQLRYUCJDNBWMV-GHXIOONMSA-N","BRD-K27798832","","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"7600","PIMECROLIMUS","calcineurin inhibitor","FKBP1A, MTOR","dermatology","eczema","Selleck",90.71,"BRD-K92107055-001-01-9","Launched","BRD-K97729603-001-01-2","KASDHRXLYQOAKZ-XDSKOBMDSA-N","BRD-K92107055","BRD-K97729603","CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC"
"7601","PREDNICARBATE","phospholipase activator","NR3C1, PLA2G1B","dermatology, ophthalmology, neurology/psychiatry","eczema, contact dermatitis, itching","MicroSource",0,"BRD-A93963402-001-01-6","Launched","","FNPXMHRZILFCKX-VZWGUQLYSA-N","BRD-A93963402","","CCOC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC"
"7602","UFENAMATE","cyclooxygenase inhibitor","PTGS1, PTGS2","dermatology","eczema, dermatitis","AvaChem",98.96,"BRD-K84173274-001-01-6","Launched","","JDLSRXWHEBFHNC-UHFFFAOYSA-N","BRD-K84173274","","CCCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F"
"7603","CLOBETASONE-BUTYRATE","corticosteroid agonist","NR3C1","dermatology","eczema, psoriasis, dermatitis","Sigma",93.44,"BRD-K58810291-001-16-2","Launched","","FBRAWBYQGRLCEK-AVVSTMBFSA-N","BRD-K58810291","","CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl"
"7604","HYDROCORTISONE","glucocorticoid receptor agonist","","dermatology, neurology/psychiatry","eczema, psoriasis, seborrheic dermatitis, itching","Tocris, MicroSource, Selleck",97.33,"BRD-K93568044-001-30-4, BRD-K93568044-001-32-0, BRD-K93568044-001-31-2","Launched","BRD-A75172220-001-04-0, BRD-K97571677-001-01-9","JYGXADMDTFJGBT-VWUMJDOOSA-N","BRD-K93568044","BRD-A75172220","C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO"
"7607","AZOSEMIDE","electrolyte reabsorption inhibitor","SLC12A1, SLC12A2","cardiology","edema","AKSci",81.77,"BRD-K68770713-001-01-8","Launched","","HMEDEBAJARCKCT-UHFFFAOYSA-N","BRD-K68770713","","NS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2cccs2)cc1Cl"
"7608","METICRANE","diuretic","","cardiology","edema","Selleck, MicroSource",97.99,"BRD-K58265391-001-11-9, BRD-K58265391-001-12-7","Launched","","FNQQBFNIYODEMB-UHFFFAOYSA-N","BRD-K58265391","","Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O"
"7610","POTASSIUM-CANRENOATE","mineralocorticoid receptor antagonist","NR3C2","cardiology","edema","MicroSource, Selleck, Selleck",98.01,"BRD-K46556543-001-01-4, BRD-K46556543-237-09-7, BRD-K46556543-237-10-5","Launched","BRD-A29322418-237-04-0","PBKZPPIHUVSDNM-WNHSNXHDSA-N","BRD-K46556543","BRD-A29322418","C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O"
"7613","BUMETANIDE","solute carrier family member inhibitor","CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5","cardiology","edema, congestive heart failure","Tocris, MicroSource, Selleck",99.54,"BRD-K38197229-001-31-5, BRD-K38197229-001-29-9, BRD-K38197229-001-28-1","Launched","","MAEIEVLCKWDQJH-UHFFFAOYSA-N","BRD-K38197229","","CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O"
"7616","POLYTHIAZIDE","sodium/chloride cotransporter inhibitor","SLC12A3","cardiology, gastroenterology, rheumatology, nephrology","edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure, hypertension","Kemprotec",98.56,"BRD-A15739803-001-01-0","Launched","","CYLWJCABXYDINA-UHFFFAOYSA-N","BRD-A15739803","","CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O"
"7617","HYDROFLUMETHIAZIDE","sodium/potassium/chloride transporter inhibitor","ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3","cardiology, gastroenterology, rheumatology, nephrology","edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, chronic renal failure, acute glomerulonephritis (AGN), hypertension","MicroSource",97.64,"BRD-K36862742-001-25-6","Launched","","DMDGGSIALPNSEE-UHFFFAOYSA-N","BRD-K36862742","","NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F"
"7618","TORASEMIDE","electrolyte reabsorption inhibitor, thromboxane receptor antagonist","SLC12A1","cardiology","edema, congestive heart failure, hypertension","MicroSource, Selleck",99.36,"BRD-K30480208-001-18-5, BRD-K30480208-001-17-7","Launched","","NGBFQHCMQULJNZ-UHFFFAOYSA-N","BRD-K30480208","","CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1"
"7620","CHLOROPYRAMINE","histamine receptor antagonist","HRH1","cardiology, ophthalmology, allergy, pulmonary","edema, conjunctivitis, allergic rhinitis, asthma","MicroSource",95.27,"BRD-K83257731-003-23-5","Launched","","ICKFFNBDFNZJSX-UHFFFAOYSA-N","BRD-K83257731","","CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1"
"7621","METOLAZONE","carbonic anhydrase inhibitor","SLC12A3","cardiology","edema, hypertension","Selleck, MicroSource, Selleck",97.53,"BRD-A61793559-001-16-4, BRD-A61793559-001-15-6, BRD-A61793559-001-14-9","Launched","","AQCHWTWZEMGIFD-UHFFFAOYSA-N","BRD-A61793559","","CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O"
"7624","XIPAMIDE","carbonic anhydrase inhibitor","SLC12A3","cardiology","edema, hypertension","OxChem",99.61,"BRD-K27393415-001-01-0","Launched","","MTZBBNMLMNBNJL-UHFFFAOYSA-N","BRD-K27393415","","Cc1cccc(C)c1NC(=O)c1cc(c(Cl)cc1O)S(N)(=O)=O"
"7625","FUROSEMIDE","diuretic","CA2, GPR35, SLC12A1, SLC12A2","cardiology, rheumatology","edema, hypertension, congestive heart failure, nephrotic syndrome","Tocris, Selleck, MicroSource",99.55,"BRD-K78010432-001-24-9, BRD-K78010432-001-20-7, BRD-K78010432-001-21-5","Launched","","ZZUFCTLCJUWOSV-UHFFFAOYSA-N","BRD-K78010432","","NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl"
"7628","VANCOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","endocarditis","MicroSource, Selleck, Selleck",88.61,"BRD-K91065602-001-01-8, BRD-K91065602-003-05-5, BRD-K91065602-003-04-8","Launched","BRD-K60071190-003-01-7","MYPYJXKWCTUITO-LYRMYLQWSA-N","BRD-K91065602","BRD-K60071190","CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2"
"7631","DIFLUPREDNATE","glucocorticoid receptor agonist","NR3C1","ophthalmology","endogenous uveitis","Selleck",95.46,"BRD-K33720171-001-01-0","Launched","","WYQPLTPSGFELIB-QXNOXDERSA-N","BRD-K33720171","","CCCC(=O)O[C@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)COC(C)=O"
"7632","GESTRINONE","progesterone receptor antagonist","AR, ESR1, PGR","obstetrics/gynecology","endometriosis","Prestwick",95.29,"BRD-K97472745-001-01-8","Launched","","BJJXHLWLUDYTGC-ANULTFPQSA-N","BRD-K97472745","","CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C"
"7633","NORETHINDRONE","progesterone receptor agonist","PGR","obstetrics/gynecology","endometriosis","Selleck, MicroSource, Selleck",98.2,"BRD-K92073408-001-15-7, BRD-K92073408-001-16-5, BRD-K92073408-001-14-0","Launched","BRD-A39415247-001-11-2,BRD-A83260288-001-01-8, BRD-A39415247-001-10-4, BRD-K01123092-001-01-1","VIKNJXKGJWUCNN-XGXHKTLJSA-N","BRD-K92073408","BRD-A39415247","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C"
"7636","TIBOLONE","androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist","ESR1","obstetrics/gynecology","endometriosis","MicroSource",85,"BRD-A82522119-001-01-7","Launched","","WZDGZWOAQTVYBX-MLWZVTOESA-N","BRD-A82522119","","C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12"
"7637","DANAZOL","estrogen receptor antagonist, progesterone receptor agonist","AR, CCL2, ESR1, GNRHR, GNRHR2, PGR","obstetrics/gynecology, cardiology","endometriosis, angioedema","MicroSource",98.72,"BRD-A92537424-001-04-7","Launched","","POZRVZJJTULAOH-GSQPBCFPSA-N","BRD-A92537424","","C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C"
"7638","ATRACURIUM","acetylcholine receptor antagonist","CHRNA2","critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant","MicroSource, Selleck, Selleck",87.09,"BRD-A75935363-344-06-6, BRD-A75935363-344-07-4, BRD-A75935363-344-05-8","Launched","","YXSLJKQTIDHPOT-UHFFFAOYSA-N","BRD-A75935363","","COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC"
"7641","MIVACURIUM","acetylcholine receptor antagonist","BCHE, CHRM2, CHRM3, CHRNA2","critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant","AKSci",47.83,"BRD-A48465967-300-01-1","Launched","","ILVYCEVXHALBSC-OTBYEXOQSA-N","BRD-A48465967","","COc1cc2CC[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc3cc(OC)c(OC)c(OC)c3)[C@H](Cc3cc(OC)c(OC)c(OC)c3)c2cc1OC"
"7642","PANCURONIUM","acetylcholine receptor antagonist","CHRM2, CHRM3, CHRNA1, CHRNA2","critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant","Selleck, Selleck",100,"BRD-K50817623-303-05-7, BRD-K50817623-303-06-5","Launched","BRD-K25166838-303-01-1","GVEAYVLWDAFXET-XGHATYIMSA-N","BRD-K50817623","BRD-K25166838","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1"
"7644","LINCOMYCIN","bacterial 30S ribosomal subunit inhibitor","","gastroenterology","enteritis","Selleck, MicroSource, Selleck",94.94,"BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0","Launched","BRD-K99816398-003-01-0","OJMMVQQUTAEWLP-HZUSHKNOSA-N","BRD-K81447180","BRD-K99816398","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O"
"7645","LINCOMYCIN","bacterial 30S ribosomal subunit inhibitor","","gastroenterology","enteritis","Selleck, MicroSource, Selleck",94.94,"BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0","Launched","BRD-K99816398-003-01-0","OJMMVQQUTAEWLP-HZUSHKNOSA-N","BRD-K81447180","BRD-K99816398","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O"
"7647","LINCOMYCIN","bacterial 30S ribosomal subunit inhibitor","","gastroenterology","enteritis","Selleck, MicroSource, Selleck",94.94,"BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0","Launched","BRD-K99816398-003-01-0","OJMMVQQUTAEWLP-LPSAIEBYSA-N","BRD-K81447180","BRD-K99816398","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O"
"7648","LINCOMYCIN","bacterial 30S ribosomal subunit inhibitor","","gastroenterology","enteritis","Selleck, MicroSource, Selleck",94.94,"BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0","Launched","BRD-K99816398-003-01-0","OJMMVQQUTAEWLP-LPSAIEBYSA-N","BRD-K81447180","BRD-K99816398","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O"
"7650","SULFAMETHAZINE","PABA antagonist","","gastroenterology","enteritis, enteritis","Prestwick, MicroSource, Selleck",99.35,"BRD-K11640013-236-10-1, BRD-K11640013-001-15-8, BRD-K11640013-001-14-1","Launched","","ASWVTGNCAZCNNR-UHFFFAOYSA-N","BRD-K11640013","","Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1"
"7653","AMINOHYDROXYBUTYRIC-ACID","","","neurology/psychiatry","epilepsy","MicroSource",78.63,"BRD-A40777960-001-04-2","Launched","","YQGDEPYYFWUPGO-UHFFFAOYSA-N","BRD-A40777960","","NCC(O)CC(O)=O"
"7654","ETHOSUXIMIDE","succinimide antiepileptic","CACNA1G, CACNA1H, CACNA1I","neurology/psychiatry","epilepsy","Sigma, MicroSource",99.47,"BRD-A99633051-001-08-8, BRD-A99633051-001-07-0","Launched","","HAPOVYFOVVWLRS-UHFFFAOYSA-N","BRD-A99633051","","CCC1(C)CC(=O)NC1=O"
"7656","FELBAMATE","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","neurology/psychiatry","epilepsy","Tocris, Tocris, Selleck, Selleck",94.7,"BRD-K99107520-001-27-4, BRD-K99107520-001-24-1, BRD-K99107520-001-25-8, BRD-K99107520-001-23-3","Launched","","WKGXYQFOCVYPAC-UHFFFAOYSA-N","BRD-K99107520","","NC(=O)OCC(COC(N)=O)c1ccccc1"
"7660","METHARBITAL","GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2","neurology/psychiatry","epilepsy","Enamine",99.64,"BRD-K88143662-001-01-5","Launched","","FWJKNZONDWOGMI-UHFFFAOYSA-N","BRD-K88143662","","CCC1(CC)C(=O)NC(=O)N(C)C1=O"
"7661","PYRIDOXAL","","PDXK","neurology/psychiatry","epilepsy","Vitas-M",92.3,"BRD-K76204040-001-03-8","Launched","","RADKZDMFGJYCBB-UHFFFAOYSA-N","BRD-K76204040","","Cc1ncc(CO)c(C=O)c1O"
"7662","RETIGABINE","potassium channel activator","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5","neurology/psychiatry","epilepsy","MedChemEx",90.38,"BRD-K89917372-001-01-2","Launched","","PCOBBVZJEWWZFR-UHFFFAOYSA-N","BRD-K89917372","","CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N"
"7663","STIRIPENTOL","GABA uptake inhibitor","GABRA3","neurology/psychiatry","epilepsy","Sigma",0,"BRD-A72441487-001-05-7","Launched","","IBLNKMRFIPWSOY-FNORWQNLSA-N","BRD-A72441487","","CC(C)(C)C(O)\C=C\c1ccc2OCOc2c1"
"7664","VALPROMIDE","epoxide hydolase inhibitor","","neurology/psychiatry","epilepsy","Sigma",60.96,"BRD-K54698528-001-01-2","Launched","","OMOMUFTZPTXCHP-UHFFFAOYSA-N","BRD-K54698528","","CCCC(CCC)C(N)=O"
"7665","LAMOTRIGINE","serotonin receptor antagonist, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","epilepsy, bipolar disorder","MicroSource, Selleck",99.52,"BRD-K93460210-001-23-7, BRD-K93460210-001-22-9","Launched","","PYZRQGJRPPTADH-UHFFFAOYSA-N","BRD-K93460210","","Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl"
"7667","TOPIRAMATE","carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist","CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","epilepsy, migraine headache","Tocris, Tocris, MicroSource, Selleck",100,"BRD-K29653726-001-16-7, BRD-K29653726-001-14-2, BRD-K29653726-001-15-9, BRD-K29653726-001-13-4","Launched","","KJADKKWYZYXHBB-XBWDGYHZSA-N","BRD-K29653726","","CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1"
"7671","DIVALPROEX-SODIUM","benzodiazepine receptor agonist","ALDH5A1","neurology/psychiatry","epilepsy, seizures","Selleck, Selleck, Sigma",65.88,"BRD-K41260949-236-20-0, BRD-K41260949-236-19-2, BRD-K41260949-001-18-2","Launched","BRD-M19962486-236-03-2, BRD-M19962486-236-02-4","NIJJYAXOARWZEE-UHFFFAOYSA-N","BRD-K41260949","BRD-M19962486","CCCC(CCC)C(O)=O"
"7674","FOSPHENYTOIN","sodium channel blocker","SCN5A","neurology/psychiatry","epilepsy, seizures","AKSci, CombiBlocks",94.91,"BRD-K53809807-304-01-6, BRD-K53809807-304-02-4","Launched","","XWLUWCNOOVRFPX-UHFFFAOYSA-N","BRD-K53809807","","OP(O)(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1"
"7676","PHENACEMIDE","sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","epilepsy, seizures","MicroSource",99.38,"BRD-K40905133-001-04-9","Launched","","XPFRXWCVYUEORT-UHFFFAOYSA-N","BRD-K40905133","","NC(=O)NC(=O)Cc1ccccc1"
"7677","DICLAZURIL","antiprotozoal agent","","infectious disease","equine protozoal myeloencephalitis (EPM)","MicroSource, Selleck",98.14,"BRD-A06426627-001-04-3, BRD-A06426627-001-03-5","Launched","","ZSZFUDFOPOMEET-UHFFFAOYSA-N","BRD-A06426627","","Clc1ccc(cc1)C(C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O"
"7679","AVANAFIL","phosphodiesterase inhibitor","PDE5A","urology","erectile dysfunction","Selleck, MicroSource",92.35,"BRD-K65781196-001-03-0, BRD-K65781196-001-04-8","Launched","","WEAJZXNPAWBCOA-INIZCTEOSA-N","BRD-K65781196","","COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl"
"7681","LINSIDOMINE","nitric oxide donor","","urology","erectile dysfunction","EMDBio, Cayman",94.73,"BRD-K86344238-003-04-6, BRD-K86344238-003-03-8","Launched","BRD-K72922393-003-15-2","XZYRDNUZENBYFI-UHFFFAOYSA-N","BRD-K86344238","BRD-K72922393","Nc1c[n+](no1)N1CCOCC1"
"7683","MIRODENAFIL","phosphodiesterase inhibitor","PDE5A","urology","erectile dysfunction","MedChemEx",97.2,"BRD-K82967685-300-01-2","Launched","","MIJFNYMSCFYZNY-UHFFFAOYSA-N","BRD-K82967685","","CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1"
"7684","VARDENAFIL","phosphodiesterase inhibitor","PDE5A, PDE6G, PDE6H","urology","erectile dysfunction","MicroSource, Selleck",99.24,"BRD-K13926615-003-03-3, BRD-K13926615-394-02-8","Launched","","SECKRCOLJRRGGV-UHFFFAOYSA-N","BRD-K13926615","","CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1"
"7686","VORICONAZOLE","cytochrome P450 inhibitor","CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1","infectious disease","esophageal candidiasis, aspergillosis, skin infections","Selleck, MicroSource, Selleck",99.42,"BRD-K06557128-001-08-8, BRD-K06557128-001-07-0, BRD-K06557128-001-06-2","Launched","","BCEHBSKCWLPMDN-MGPLVRAMSA-N","BRD-K06557128","","C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F"
"7689","FLUCONAZOLE","sterol demethylase inhibitor","CYP51A1","infectious disease","esophageal candidiasis, meningitis","MicroSource, Sigma, Selleck",97.95,"BRD-K05977355-001-19-0, BRD-K05977355-001-23-2, BRD-K05977355-001-18-2","Launched","","RFHAOTPXVQNOHP-UHFFFAOYSA-N","BRD-K05977355","","OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F"
"7692","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NQTDYLQESA-N","BRD-K21656326","BRD-K82677637","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7694","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NQTDYLQESA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7695","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NQTDYLQESA-N","BRD-K21656326","BRD-K82677637","C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7696","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NQTDYLQESA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7697","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VHFLTRTASA-N","BRD-K21656326","BRD-K82677637","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7699","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VHFLTRTASA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7700","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VHFLTRTASA-N","BRD-K21656326","BRD-K82677637","C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7701","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VHFLTRTASA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7702","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VNGPISPUSA-N","BRD-K21656326","BRD-K82677637","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7704","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VNGPISPUSA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7705","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VNGPISPUSA-N","BRD-K21656326","BRD-K82677637","C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7706","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-VNGPISPUSA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7707","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NSTZTQKZSA-N","BRD-K21656326","BRD-K82677637","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7709","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NSTZTQKZSA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7710","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NSTZTQKZSA-N","BRD-K21656326","BRD-K82677637","C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7711","NYSTATIN","fungal ergosterol inhibitor","","infectious disease","esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","Launched","BRD-K82677637-001-01-0, BRD-K33243830-001-01-6","VQOXZBDYSJBXMA-NSTZTQKZSA-N","BRD-K21656326","BRD-K82677637","C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O"
"7712","ETHANOLAMINE-OLEATE","immunostimulant","F12, FABP4, FFAR1, FFAR4, PLD2","gastroenterology","esophageal varices","MicroSource",0,"BRD-M75061779-001-01-2","Launched","","KGWDUNBJIMUFAP-KVVVOXFISA-N","BRD-M75061779","","NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O"
"7713","ALTRENOGEST","progestogen hormone","PGR","endocrinology","estrus","MicroSource, Selleck",100,"BRD-K14619660-001-02-3, BRD-K14619660-001-01-5","Launched","BRD-A27554692-001-02-1","VWAUPFMBXBWEQY-IVAOSVALSA-N","BRD-K14619660","BRD-A27554692","C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C"
"7715","BENZTROPINE-MESYLATE","acetylcholine receptor antagonist","CHRM1, HRH1, SLC6A3","neurology/psychiatry","extrapyramidal symptoms (EPS), Parkinson's Disease","Selleck",97.24,"BRD-K48061146-066-01-7","Launched","","GIJXKZJWITVLHI-RTBURBONSA-N","BRD-K48061146","","CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1"
"7716","POLYMYXIN-B-SULFATE","bacterial permeability inducer","","ophthalmology","eye infection","MicroSource",59.7,"BRD-A08641215-065-04-8","Launched","","WQVJHHACXVLGBL-UHFFFAOYSA-N","BRD-A08641215","","CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O"
"7717","FLUOROMETHOLONE","glucocorticoid receptor agonist","NR3C1","ophthalmology","eye inflammation","MicroSource",98.58,"BRD-A13133631-001-04-0","Launched","","FAOZLTXFLGPHNG-KXWDGVDDSA-N","BRD-A13133631","","C[C@H]1CC2C3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)C2(C)C=CC(=O)C=C12"
"7718","FLUOROMETHOLONE-ACETATE","","NR3C1","ophthalmology","eye inflammation","Selleck, Selleck",97.54,"BRD-K02528732-001-01-6, BRD-K02528732-001-02-4","Launched","","YRFXGQHBPBMFHW-SBTZIJSASA-N","BRD-K02528732","","C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12"
"7720","NEPAFENAC","cyclooxygenase inhibitor","PTGS1, PTGS2","ophthalmology","eye inflammation","Selleck",97.8,"BRD-K04112579-001-07-0","Launched","","QEFAQIPZVLVERP-UHFFFAOYSA-N","BRD-K04112579","","NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N"
"7721","NAPHAZOLINE","adrenergic receptor agonist","ADRA1A, ADRA2A","ophthalmology","eye irritation","Selleck, MicroSource",98.84,"BRD-K77641333-003-26-3, BRD-K77641333-003-27-1","Launched","","CNIIGCLFLJGOGP-UHFFFAOYSA-N","BRD-K77641333","","C(C1=NCCN1)c1cccc2ccccc12"
"7723","TETRAHYDROZOLINE","adrenergic receptor agonist","","ophthalmology","eye irritation","Selleck, MicroSource",97.32,"BRD-A28856712-003-25-2, BRD-A28856712-003-26-0","Launched","","BYJAVTDNIXVSPW-UHFFFAOYSA-N","BRD-A28856712","","C1CN=C(N1)C1CCCc2ccccc12"
"7725","EFLORNITHINE","ornithine decarboxylase inhibitor","ARG2, ODC1","dermatology","facial hair reduction","Enzo",100,"BRD-A96292436-003-16-1","Launched","","VLCYCQAOQCDTCN-UHFFFAOYSA-N","BRD-A96292436","","NCCCC(N)(C(F)F)C(O)=O"
"7726","TAFAMIDIS-MEGLUMINE","transthyretin amyloid inhibitor","TTR","neurology/psychiatry","familial amyloid polyneuropathy (FAP)","MedChemEx",99.69,"BRD-K23728141-001-01-2","Launched","","TXEIIPDJKFWEEC-UHFFFAOYSA-N","BRD-K23728141","","OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1"
"7727","OXYCLOZANIDE","","","infectious disease","fascioliasis","MicroSource",95.82,"BRD-K07283971-001-01-3","Launched","BRD-K13017451-001-01-6","JYWIYHUXVMAGLG-UHFFFAOYSA-N","BRD-K07283971","BRD-K13017451","Oc1c(Cl)cc(Cl)cc1NC(=O)c1c(O)c(Cl)cc(Cl)c1Cl"
"7728","ADRAFINIL","adrenergic receptor agonist","","neurology/psychiatry","fatigue","MedChemEx, MedChemEx",96.69,"BRD-A90926615-001-02-7, BRD-A90926615-001-01-9","Launched","","CGNMLOKEMNBUAI-UHFFFAOYSA-N","BRD-A90926615","","ONC(=O)CS(=O)C(c1ccccc1)c1ccccc1"
"7730","QUERCETIN","polar auxin transport inhibitor","ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1","neurology/psychiatry, allergy","fatigue, allergic rhinitis, drowsiness","Tocris, Selleck, Selleck, Selleck, Selleck",93.07,"BRD-K97399794-001-15-3, BRD-K97399794-001-14-6, BRD-K97399794-335-05-6, BRD-K97399794-001-16-1, BRD-K97399794-335-06-4","Launched","","REFJWTPEDVJJIY-UHFFFAOYSA-N","BRD-K97399794","","Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O"
"7735","CAFFEINE","adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3","neurology/psychiatry","fatigue, drowsiness, fatigue, drowsiness","MicroSource",99.15,"BRD-K02404261-001-16-7","Launched","","RYYVLZVUVIJVGH-UHFFFAOYSA-N","BRD-K02404261","","Cn1cnc2n(C)c(=O)n(C)c(=O)c12"
"7736","DOMPERIDONE","dopamine receptor antagonist","DRD2, DRD3","infectious disease","fescue toxicosis","Tocris, MicroSource, Selleck",97.24,"BRD-K38305202-001-17-4, BRD-K38305202-001-18-2, BRD-K38305202-001-16-6","Launched","","FGXWKSZFVQUSTL-UHFFFAOYSA-N","BRD-K38305202","","Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1"
"7739","IBUPROXAM","cyclooxygenase inhibitor, prostaglandin inhibitor","ALOX5","endocrinology, rheumatology, neurology/psychiatry","fever, joint inflammation, pain relief","Enzo",80.93,"BRD-A40940854-001-01-1","Launched","","BYPIURIATSUHDW-UHFFFAOYSA-N","BRD-A40940854","","CC(C)Cc1ccc(cc1)C(C)C(=O)NO"
"7740","DIPYROCETYL","chelating agent","","endocrinology, neurology/psychiatry","fever, pain relief","MicroSource",46.15,"BRD-K47608922-001-04-7","Launched","","NYIZXMGNIUSNKL-UHFFFAOYSA-N","BRD-K47608922","","CC(=O)Oc1cccc(C(O)=O)c1OC(C)=O"
"7741","METHYL-SALICYLATE","","","endocrinology, neurology/psychiatry","fever, pain relief","Enamine",0,"BRD-K10103010-001-01-1","Launched","","OSWPMRLSEDHDFF-UHFFFAOYSA-N","BRD-K10103010","","COC(=O)c1ccccc1O"
"7742","PROPACETAMOL","cyclooxygenase inhibitor","PTGS2","endocrinology, neurology/psychiatry","fever, pain relief","AKSci",94.37,"BRD-K54496168-003-01-2","Launched","","QTGAJCQTLIRCFL-UHFFFAOYSA-N","BRD-K54496168","","CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1"
"7743","SODIUM-SALICYLATE","prostanoid receptor antagonist","ASIC3, PTGS1, PTGS2","endocrinology, neurology/psychiatry","fever, pain relief","Selleck, MicroSource",98.74,"BRD-K93632104-001-19-8, BRD-K93632104-001-18-0","Launched","BRD-M30512773-001-05-5, BRD-M30512773-001-06-3","YGSDEFSMJLZEOE-UHFFFAOYSA-N","BRD-K93632104","BRD-M30512773","OC(=O)c1ccccc1O"
"7745","ZALTOPROFEN","cyclooxygenase inhibitor","","endocrinology, neurology/psychiatry","fever, pain relief","Selleck",97.2,"BRD-A00578795-001-04-3","Launched","","MUXFZBHBYYYLTH-UHFFFAOYSA-N","BRD-A00578795","","CC(C(O)=O)c1ccc2Sc3ccccc3C(=O)Cc2c1"
"7746","DEMECLOCYCLINE","bacterial 30S ribosomal subunit inhibitor","","endocrinology, infectious disease, ophthalmology, urology","fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, cholera, syphilis, listeria, anthrax, actinomycosis, tularemia, brucellosis","MicroSource, MedChemEx, MedChemEx, Selleck",63.01,"BRD-A34145622-003-22-8, BRD-A34145622-003-23-6, BRD-A34145622-003-24-4, BRD-A34145622-003-25-1","Launched","BRD-A50207110-003-01-8","JHOHXJYRVSLQCB-AMESULRKSA-N","BRD-A34145622","BRD-A50207110","CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"7750","MINOCYCLINE","bacterial 30S ribosomal subunit inhibitor","ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA","endocrinology, infectious disease, ophthalmology, urology","fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, tularemia, cholera, brucellosis","MedChemEx, Sigma, MicroSource, Selleck, Selleck",93.08,"BRD-A69651145-003-11-4, BRD-A69651145-003-10-6, BRD-A69651145-003-07-2, BRD-A69651145-003-08-0, BRD-A69651145-003-09-8","Launched","BRD-A05311824-003-01-1","ZZZRUAITSXLWBH-CSYJEMQYSA-N","BRD-A69651145","BRD-A05311824","CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C"
"7755","AMINOCAPROIC-ACID","plasminogen activator inhibitor","LPA, PLAT, PLG","hematology","fibrinolytic bleeding","Selleck, MicroSource, Selleck",100,"BRD-K64931368-001-14-1, BRD-K64931368-003-01-4, BRD-K64931368-001-13-3","Launched","","SLXKOJJOQWFEFD-UHFFFAOYSA-N","BRD-K64931368","","NCCCCCC(O)=O"
"7758","MILNACIPRAN","serotonin–norepinephrine reuptake inhibitor (SNRI)","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4","rheumatology","fibromyalgia","MicroSource, Selleck",97.86,"BRD-A15202882-003-02-7, BRD-K02227374-003-07-1","Launched","","GJJFMKBJSRMPLA-UHFFFAOYSA-N","BRD-A15202882","","CCN(CC)C(=O)C1(CC1CN)c1ccccc1"
"7759","MILNACIPRAN","serotonin–norepinephrine reuptake inhibitor (SNRI)","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4","rheumatology","fibromyalgia","MicroSource, Selleck",97.86,"BRD-A15202882-003-02-7, BRD-K02227374-003-07-1","Launched","","GJJFMKBJSRMPLA-UHFFFAOYSA-N","BRD-A15202882","","CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c1ccccc1"
"7760","MILNACIPRAN","serotonin–norepinephrine reuptake inhibitor (SNRI)","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4","rheumatology","fibromyalgia","MicroSource, Selleck",97.86,"BRD-A15202882-003-02-7, BRD-K02227374-003-07-1","Launched","","GJJFMKBJSRMPLA-HIFRSBDPSA-N","BRD-A15202882","","CCN(CC)C(=O)C1(CC1CN)c1ccccc1"
"7761","MILNACIPRAN","serotonin–norepinephrine reuptake inhibitor (SNRI)","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4","rheumatology","fibromyalgia","MicroSource, Selleck",97.86,"BRD-A15202882-003-02-7, BRD-K02227374-003-07-1","Launched","","GJJFMKBJSRMPLA-HIFRSBDPSA-N","BRD-A15202882","","CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c1ccccc1"
"7762","DIETHYLCARBAMAZINE","lipoxygenase inhibitor","ALOX5, PTGS1","infectious disease","filariasis","MicroSource",99.23,"BRD-K45542189-048-22-1","Launched","","RCKMWOKWVGPNJF-UHFFFAOYSA-N","BRD-K45542189","","CCN(CC)C(=O)N1CCN(C)CC1"
"7763","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","VRKHYMXTJQCIND-UHFFFAOYSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)NCCCCC1NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CCCN)NC1=O)C(C)CC"
"7764","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","VRKHYMXTJQCIND-UHFFFAOYSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC"
"7765","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","VRKHYMXTJQCIND-UHFFFAOYSA-N","BRD-A49374018","BRD-A21002158","CCC(C)[C@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C1CN=C(S1)[C@H](N)C(C)C)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)C(C)CC"
"7766","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","CLKOFPXJLQSYAH-RNHDWVCBSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)NCCCCC1NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CCCN)NC1=O)C(C)CC"
"7767","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","CLKOFPXJLQSYAH-RNHDWVCBSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC"
"7768","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","CLKOFPXJLQSYAH-RNHDWVCBSA-N","BRD-A49374018","BRD-A21002158","CCC(C)[C@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C1CN=C(S1)[C@H](N)C(C)C)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)C(C)CC"
"7769","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","RHKCFWGPEDXSNT-IGRZHKPHSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)NCCCCC1NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CCCN)NC1=O)C(C)CC"
"7770","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","RHKCFWGPEDXSNT-IGRZHKPHSA-N","BRD-A49374018","BRD-A21002158","CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC"
"7771","BACITRACIN","bacterial cell wall synthesis inhibitor","A2M, IDE","infectious disease","first-aid antibiotic","MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","Launched","BRD-A21002158-001-01-6","RHKCFWGPEDXSNT-IGRZHKPHSA-N","BRD-A49374018","BRD-A21002158","CCC(C)[C@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C1CN=C(S1)[C@H](N)C(C)C)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)C(C)CC"
"7772","BACITRACIN-ZINC","bacterial cell wall synthesis inhibitor","","infectious disease","first-aid antibiotic","Selleck, MedChemEx, Selleck",37.33,"BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0","Launched","BRD-M97113494-001-02-7, BRD-M36533492-001-01-4","NKULICGUDKGGRL-SVBGOZHZSA-L","BRD-A06016120","BRD-M97113494","CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC"
"7773","BACITRACIN-ZINC","bacterial cell wall synthesis inhibitor","","infectious disease","first-aid antibiotic","Selleck, MedChemEx, Selleck",37.33,"BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0","Launched","BRD-M97113494-001-02-7, BRD-M36533492-001-01-4","NKULICGUDKGGRL-SVBGOZHZSA-L","BRD-A06016120","BRD-M97113494","[Zn++].CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC1=O)[C@H](C)CC"
"7775","BACITRACIN-ZINC","bacterial cell wall synthesis inhibitor","","infectious disease","first-aid antibiotic","Selleck, MedChemEx, Selleck",37.33,"BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0","Launched","BRD-M97113494-001-02-7, BRD-M36533492-001-01-4","UCRLQOPRDMGYOA-BWBYNRQYSA-N","BRD-A06016120","BRD-M97113494","CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC"
"7776","BACITRACIN-ZINC","bacterial cell wall synthesis inhibitor","","infectious disease","first-aid antibiotic","Selleck, MedChemEx, Selleck",37.33,"BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0","Launched","BRD-M97113494-001-02-7, BRD-M36533492-001-01-4","UCRLQOPRDMGYOA-BWBYNRQYSA-N","BRD-A06016120","BRD-M97113494","[Zn++].CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC1=O)[C@H](C)CC"
"7778","GRAMICIDIN","bacterial permeability inducer","","infectious disease","first-aid antibiotic","MicroSource",65.47,"BRD-A52977603-001-01-2","Launched","","ZWCXYZRRTRDGQE-UHFFFAOYSA-N","BRD-A52977603","","CC(C)CC(NC(=O)C(C)NC(=O)CNC(=O)C(NC=O)C(C)C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCCO"
"7779","NEOMYCIN-SULFATE","bacterial 30S ribosomal subunit inhibitor","","infectious disease","first-aid antibiotic","Selleck, MicroSource",0,"BRD-K71013094-065-05-3, BRD-K71013094-326-03-4","Launched","BRD-A93778806-065-02-3, BRD-A93490927-326-01-7","PGBHMTALBVVCIT-VCIWKGPPSA-N","BRD-K71013094","BRD-A93778806","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"7781","NITROFURAZONE","bacterial DNA inhibitor","","infectious disease","first-aid antibiotic","Selleck, MicroSource",98.77,"BRD-K79092138-001-10-2, BRD-K79092138-001-11-0","Launched","","IAIWVQXQOWNYOU-FPYGCLRLSA-N","BRD-K79092138","","NC(=O)N\N=C\c1ccc(o1)[N+]([O-])=O"
"7783","MAFENIDE","carbonic anhydrase inhibitor","CA12, CA14, CA2, CA4, CA6, CA9","infectious disease","first-aid antibiotic, skin infections","MicroSource",100,"BRD-K30649484-003-13-7","Launched","","TYMRLRRVMHJFTF-UHFFFAOYSA-N","BRD-K30649484","","NCc1ccc(cc1)S(N)(=O)=O"
"7784","BENZETHONIUM","sodium channel blocker","SCN10A","infectious disease","first-aid antiseptic","MicroSource, Selleck",99.48,"BRD-K72723676-003-17-8, BRD-K72723676-003-16-0","Launched","","SIYLLGKDQZGJHK-UHFFFAOYSA-N","BRD-K72723676","","CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1"
"7786","BENZOCAINE","sodium channel blocker","SCN10A","infectious disease","first-aid antiseptic","MicroSource, Selleck",99.51,"BRD-K75466013-001-14-4, BRD-K75466013-001-13-6","Launched","","BLFLLBZGZJTVJG-UHFFFAOYSA-N","BRD-K75466013","","CCOC(=O)c1ccc(N)cc1"
"7788","CHLOROCRESOL","ryanodine receptor activator","","infectious disease","first-aid antiseptic","MicroSource, Selleck, Selleck",94.58,"BRD-K89056082-001-07-7, BRD-K89056082-001-06-9, BRD-K89056082-001-08-5","Launched","","CFKMVGJGLGKFKI-UHFFFAOYSA-N","BRD-K89056082","","Cc1cc(O)ccc1Cl"
"7791","MERBROMIN","antiseptic","","infectious disease","first-aid antiseptic","MicroSource",0,"BRD-K21771665-304-04-2","Launched","","OHCFGBLQZMYRTR-UHFFFAOYSA-M","BRD-K21771665","","O[Hg]c1c(O)c(Br)cc2c(-c3ccccc3C(O)=O)c3cc(Br)c(=O)cc3oc12"
"7792","LUFENURON","chitin inhibitor","","infectious disease","flea control","MicroSource",97.07,"BRD-A71774530-001-05-9","Launched","","PWPJGUXAGUPAHP-UHFFFAOYSA-N","BRD-A71774530","","FC(C(F)(F)F)C(F)(F)Oc1cc(Cl)c(NC(=O)NC(=O)c2c(F)cccc2F)cc1Cl"
"7793","NITENPYRAM","","","infectious disease","flea control","Selleck",93.18,"BRD-K47887731-001-01-4","Launched","","CFRPSFYHXJZSBI-DHZHZOJOSA-N","BRD-K47887731","","CCN(Cc1ccc(Cl)nc1)C(\NC)=C\[N+]([O-])=O"
"7794","SELAMECTIN","nematocide","","infectious disease","flea control","MicroSource",95.85,"BRD-A58564983-001-04-6","Launched","","AFJYYKSVHJGXSN-XUCDQRGXSA-N","BRD-A58564983","","CO[C@H]1CC(O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4C(=N/O)\C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(CC[C@H](C)[C@H](O2)C2CCCCC2)C5)[C@]34O)O[C@@H](C)C1O"
"7795","COPANLISIB","PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG","hematologic malignancy","follicular lymphoma","MedChemEx, MedChemEx",97.22,"BRD-K24666289-001-02-3, BRD-K24666289-001-04-9","Launched","","PZBCKZWLPGJMAO-UHFFFAOYSA-N","BRD-K24666289","","COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12"
"7797","ACRIFLAVINE","hypoxia inducible factor inhibitor","HIF1A","infectious disease","fungal infection","Sigma",32.92,"BRD-M87138257-003-01-1","Launched","","BCBIBQWDFMQRSJ-UHFFFAOYSA-O","BRD-M87138257","","Nc1ccc2cc3ccc(N)cc3nc2c1.C[n+]1c2cc(N)ccc2cc2ccc(N)cc12"
"7798","ACRIFLAVINIUM","hypoxia inducible factor inhibitor","HIF1A","infectious disease","fungal infection","MicroSource",37.65,"BRD-K97874492-003-12-3","Launched","","XSIOKTWDEOJMGG-UHFFFAOYSA-O","BRD-K97874492","","C[n+]1c2cc(N)ccc2cc2ccc(N)cc12"
"7799","ACRISORCIN","other antifungal","","infectious disease","fungal infection","MicroSource",61.47,"BRD-M49658242-001-04-1","Launched","","YZODJQFXMFEJRM-UHFFFAOYSA-N","BRD-M49658242","","CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12"
"7800","AMPHOTERICIN-B","membrane permeability enhancer","","infectious disease","fungal infection","Selleck, MicroSource, MedChemEx, Selleck",74.84,"BRD-K27352494-001-03-6, BRD-K27352494-001-04-4, BRD-K27352494-001-05-1, BRD-K27352494-001-06-9","Launched","BRD-A75647097-001-03-3, BRD-K94561406-001-01-1, BRD-K82702594-001-02-5,BRD-K69849489-001-01-1","APKFDSVGJQXUKY-INPOYWNPSA-N","BRD-K27352494","BRD-A75647097","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O"
"7804","CERULENIN","fatty acid synthase inhibitor","FASN","infectious disease","fungal infection","Enzo",41.25,"BRD-K52075040-001-09-7","Launched","","GVEZIHKRYBHEFX-NQQPLRFYSA-N","BRD-K52075040","","C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O"
"7805","CHLORMIDAZOLE","fungal lanosterol demethylase inhibitor","","infectious disease","fungal infection","MicroSource",94.26,"BRD-K60443845-001-08-6","Launched","","WNAQOLSMVPFGTE-UHFFFAOYSA-N","BRD-K60443845","","Cc1nc2ccccc2n1Cc1ccc(Cl)cc1"
"7806","CHLORQUINALDOL","other antibiotic","","infectious disease","fungal infection","Selleck, MicroSource",96.93,"BRD-K90374350-001-09-2, BRD-K90374350-001-10-0","Launched","","GPTXWRGISTZRIO-UHFFFAOYSA-N","BRD-K90374350","","Cc1ccc2c(Cl)cc(Cl)c(O)c2n1"
"7808","LANOCONAZOLE","sterol demethylase inhibitor","","infectious disease","fungal infection","AKSci",96.68,"BRD-A54275602-001-01-0","Launched","","ZRTQSJFIDWNVJW-WYMLVPIESA-N","BRD-A54275602","","Clc1ccccc1C1CS\C(S1)=C(\C#N)n1ccnc1"
"7809","LIRANAFTATE","fungal squalene epoxidase inhibitor","","infectious disease","fungal infection","Selleck",97.22,"BRD-K35775715-001-03-1","Launched","","VPHPQNGOVQYUMG-UHFFFAOYSA-N","BRD-K35775715","","COc1cccc(n1)N(C)C(=S)Oc1ccc2CCCCc2c1"
"7810","PIROCTONE-OLAMINE","","","infectious disease","fungal infection","MicroSource",0,"BRD-A96510685-213-03-7","Launched","BRD-M95050869-001-01-2","OIQJEQLSYJSNDS-UHFFFAOYSA-N","BRD-A96510685","BRD-M95050869","CC(Cc1cc(C)cc(=O)n1O)CC(C)(C)C"
"7811","CARBENDAZIM","microtubule inhibitor, tubulin polymerization inhibitor","TP53, TUBB","infectious disease","fungicide","Sigma",98.32,"BRD-K12906202-001-06-2","Launched","","TWFZGCMQGLPBSX-UHFFFAOYSA-N","BRD-K12906202","","COC(=O)Nc1nc2ccccc2[nH]1"
"7812","MONOCTANOIN","","","gastroenterology","gallstones","Sigma, Sigma",84.6,"BRD-A48938994-001-15-8, BRD-A48938994-001-14-1","Launched","","GHBFNMLVSPCDGN-UHFFFAOYSA-N","BRD-A48938994","","CCCCCCCC(=O)OCC(O)CO"
"7814","URSODIOL","nuclear factor erythroid derived, like (NRF2) activator","NR1H4","gastroenterology","gallstones","MicroSource, Selleck",100,"BRD-K15697815-001-15-4, BRD-K15697815-001-16-2","Launched","BRD-K87300616-001-01-9","RUDATBOHQWOJDD-UZVSRGJWSA-N","BRD-K15697815","BRD-K87300616","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C"
"7816","GIMERACIL","dihydropyrimidine dehydrogenase inhibitor","DPYD","oncology","gastric adenocarcinoma","Selleck, Selleck",98.28,"BRD-K35687421-001-02-5, BRD-K35687421-001-03-3","Launched","","ZPLQIPFOCGIIHV-UHFFFAOYSA-N","BRD-K35687421","","Oc1cc(=O)[nH]cc1Cl"
"7818","BETAZOLE","histamine receptor agonist","HRH2","gastroenterology","gastric hypersecretion diagnostic","Prestwick",97.19,"BRD-K20075662-300-04-0","Launched","","JXDFEQONERDKSS-UHFFFAOYSA-N","BRD-K20075662","","NCCc1cc[nH]n1"
"7819","REVAPRAZAN","potassium-competitive acid antagonist","ATP4A","gastroenterology","gastritis","AvaChem",0,"BRD-A51497544-001-01-4","Launched","","LECZXZOBEZITCL-UHFFFAOYSA-N","BRD-A51497544","","CC1N(CCc2ccccc12)c1nc(Nc2ccc(F)cc2)nc(C)c1C"
"7820","TROXIPIDE","glucosamine synthetase stimulant","","gastroenterology","gastroesophageal reflux disease (GERD)","Selleck, Selleck",91.33,"BRD-A68589262-001-04-3, BRD-A68589262-001-05-0","Launched","","YSIITVVESCNIPR-UHFFFAOYSA-N","BRD-A68589262","","COc1cc(cc(OC)c1OC)C(=O)NC1CCCNC1"
"7822","ESOMEPRAZOLE","ATPase inhibitor","ATP4A","gastroenterology","gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease (PUD)","Selleck, Selleck, MicroSource",98.67,"BRD-K61443506-236-02-0, BRD-K61443506-239-01-6, BRD-K61443506-237-01-0","Launched","BRD-A55962179-236-02-5, BRD-M04732511-239-09-6,BRD-A55962179-239-02-9, BRD-A55962179-239-01-1","SUBDBMMJDZJVOS-DEOSSOPVSA-N","BRD-K61443506","BRD-A55962179","COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C"
"7825","RABEPRAZOLE","ATPase inhibitor, gastrin inhibitor","ATP4A","gastroenterology","gastroesophageal reflux disease (GERD), duodenal ulcer disease, Zollinger-Ellison syndrome","MicroSource, MedChemEx, Sigma, Sigma",98.9,"BRD-A39390670-236-09-9, BRD-A39390670-236-10-7, BRD-A39390670-236-12-3, BRD-A39390670-236-11-5","Launched","","YREYEVIYCVEVJK-UHFFFAOYSA-N","BRD-A39390670","","COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C"
"7829","DEXLANSOPRAZOLE","ATPase inhibitor","ATP4A, ATP4B","gastroenterology","gastroesophageal reflux disease (GERD), erosive esophagitis (EE)","MicroSource, Selleck, Selleck",95.4,"BRD-K05900209-001-02-6, BRD-K05900209-001-01-8, BRD-K05900209-001-03-4","Launched","","MJIHNNLFOKEZEW-RUZDIDTESA-N","BRD-K05900209","","Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1"
"7832","PANTOPRAZOLE","ATPase inhibitor","ATP4A","gastroenterology","gastroesophageal reflux disease (GERD), erosive esophagitis (EE), Zollinger-Ellison syndrome","MicroSource, MedChemEx, SantaCruz",99.89,"BRD-A22380646-001-05-6, BRD-A22380646-236-06-6, BRD-A22380646-236-05-8","Launched","BRD-A75848474-236-01-6","IQPSEEYGBUAQFF-UHFFFAOYSA-N","BRD-A22380646","BRD-A75848474","COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC"
"7835","OMEPRAZOLE-MAGNESIUM","proton pump inhibitor","ATP4A, ATP4B","gastroenterology","gastroesophageal reflux disease (GERD), heartburn","Vitas-M",98.99,"BRD-A56892734-001-09-4","Launched","","KWORUUGOSLYAGD-UHFFFAOYSA-N","BRD-A56892734","","COc1ccc2n([Mg]n3c(nc4cc(OC)ccc34)S(=O)Cc3ncc(C)c(OC)c3C)c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C"
"7836","PEFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","infectious disease, urology","gastrointestinal infections, urethritis, gonorrhea, urinary tract infections","MicroSource, Selleck",98.47,"BRD-K55034111-066-17-1, BRD-K55034111-066-16-3","Launched","","FHFYDNQZQSQIAI-UHFFFAOYSA-N","BRD-K55034111","","CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(C)CC1"
"7838","ABAMECTIN","benzodiazepine receptor agonist","GABBR1, GABBR2","infectious disease","gastrointestinal parasites","MicroSource",61,"BRD-A25579302-001-04-8","Launched","","RRZXIRBKKLTSOM-ONDMGMIHSA-N","BRD-A25579302","","CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C"
"7839","FLUBENDAZOLE","tubulin polymerization inhibitor","TUBB","infectious disease","gastrointestinal parasites","MicroSource, Selleck",97.49,"BRD-K86003836-001-10-5, BRD-K86003836-001-09-7","Launched","BRD-K99928247-001-01-0","CPEUVMUXAHMANV-UHFFFAOYSA-N","BRD-K86003836","BRD-K99928247","COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1"
"7841","MOXIDECTIN","chloride channel antagonist","","infectious disease","gastrointestinal parasites","MicroSource",92.02,"BRD-K61988078-001-01-2","Launched","","YZBLFMPOMVTDJY-CBYMMZEQSA-N","BRD-K61988078","","CO\N=C1\C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@@H]([C@H]1C)C(\C)=C\C(C)C"
"7842","TETRAMISOLE","immunostimulant","","infectious disease","gastrointestinal parasites","MicroSource, Selleck",99.58,"BRD-A46393198-003-16-6, BRD-A46393198-003-15-8","Launched","","HLFSDGLLUJUHTE-UHFFFAOYSA-N","BRD-A46393198","","C1CN2CC(N=C2S1)c1ccccc1"
"7844","PRAZIQUANTEL","anthelmintic agent","","infectious disease","gastrointestinal parasites, cystic hydatid disease, schistosomiasis","Selleck, MicroSource",99.62,"BRD-A21858158-001-22-7, BRD-A21858158-001-23-5","Launched","","FSVJFNAIGNNGKK-UHFFFAOYSA-N","BRD-A21858158","","O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1"
"7846","FENBENDAZOLE","tubulin polymerization inhibitor","TUBB","infectious disease","gastrointestinal parasites, gastrointestinal roundworms","Selleck, MicroSource",98.69,"BRD-K51318897-001-14-6, BRD-K51318897-001-15-3","Launched","","HDDSHPAODJUKPD-UHFFFAOYSA-N","BRD-K51318897","","COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1"
"7848","DORAMECTIN","","","infectious disease","gastrointestinal roundworms","MicroSource",96.39,"BRD-A16350940-001-01-9","Launched","","QLFZZSKTJWDQOS-CYHFSSRLSA-N","BRD-A16350940","","CO[C@H]1C[C@H](OC2[C@H](C)OC(C[C@@H]2OC)O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(C5)O[C@H](C5CCCCC5)[C@@H](C)C=C2)[C@]34O)O[C@@H](C)[C@@H]1O"
"7849","PIPERAZINE","benzodiazepine receptor agonist","GABRB3","infectious disease","gastrointestinal roundworms","MicroSource",100,"BRD-K13249881-001-02-3","Launched","","GLUUGHFHXGJENI-UHFFFAOYSA-N","BRD-K13249881","","C1CNCCN1"
"7850","PYRANTEL","nicotinic receptor agonist","","infectious disease","gastrointestinal roundworms, gastrointestinal roundworms","Sigma",97.74,"BRD-K82118441-001-03-7","Launched","","WLJNZVDCPSBLRP-UHFFFAOYSA-N","BRD-K82118441","","OC(=O)c1cc2ccccc2c(Cc2c(O)c(cc3ccccc23)C(O)=O)c1O"
"7851","TIABENDAZOLE","angiogenesis inhibitor","","infectious disease","gastrointestinal roundworms, hookworm","Selleck, MicroSource",99.12,"BRD-K77695569-001-29-2, BRD-K77695569-001-30-0","Launched","","WJCNZQLZVWNLKY-UHFFFAOYSA-N","BRD-K77695569","","c1nc(cs1)-c1nc2ccccc2[nH]1"
"7853","EPRINOMECTIN","benzodiazepine receptor agonist","","infectious disease","gastrointestinal roundworms, lungworms","MicroSource",92.46,"BRD-A91366704-001-01-9","Launched","","ZKWQQXZUCOBISE-WIDYHQJMSA-N","BRD-A91366704","","CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C"
"7854","IVERMECTIN","benzodiazepine receptor agonist","CHRNA7, GABRB3, GLRA3, P2RX7","infectious disease","gastrointestinal roundworms, lungworms, cattle grubs, mites, lice, horn flies","Tocris, MicroSource, Selleck, Selleck",94.01,"BRD-K85554912-001-05-5, BRD-K85554912-001-08-9, BRD-K85554912-001-06-3, BRD-K85554912-001-07-1","Launched","BRD-M44211600-001-01-6, BRD-A48570745-001-02-9, BRD-K71544586-001-01-6","AZSNMRSAGSSBNP-XPNPUAGNSA-N","BRD-K85554912","BRD-M44211600","CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2"
"7858","CLORSULON","glycolysis inhibitor","","infectious disease","gastrointestinal roundworms, lungworms, liver flukes, lice, mites","MicroSource, Selleck",99.05,"BRD-K97521363-001-16-1, BRD-K97521363-001-15-3","Launched","","QOVTVIYTBRHADL-UHFFFAOYSA-N","BRD-K97521363","","Nc1cc(C(Cl)=C(Cl)Cl)c(cc1S(N)(=O)=O)S(N)(=O)=O"
"7860","SUNITINIB","FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET","oncology","gastrointestinal stromal tumors (GIST), renal cell carcinoma (RCC), neuroendocrine tumors of pancreatic origin (PNET)","Selleck, MedChemEx, Selleck, Tocris",94.01,"BRD-K42828737-044-10-8, BRD-K42828737-001-03-3, BRD-K42828737-044-09-0, BRD-K42828737-044-12-4","Launched","","WINHZLLDWRZWRT-ATVHPVEESA-N","BRD-K42828737","","CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C"
"7864","METOCLOPRAMIDE","dopamine receptor antagonist, serotonin receptor antagonist","CHRM1, DRD2, HTR3A, HTR3B, HTR4","gastroenterology","gastroparesis, nausea, vomiting","MicroSource",98.56,"BRD-K75641298-003-25-0","Launched","","TTWJBBZEZQICBI-UHFFFAOYSA-N","BRD-K75641298","","CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC"
"7865","ALFAXALONE","chloride channel agonist, benzodiazepine receptor agonist","GABBR1","neurology/psychiatry","general anaesthetic","Prestwick",98.88,"BRD-K41445866-001-18-8","Launched","","DUHUCHOQIDJXAT-OLVMNOGESA-N","BRD-K41445866","","CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C"
"7866","ETOMIDATE","GABA receptor modulator","ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ","neurology/psychiatry","general anaesthetic","MicroSource, Selleck, Tocris",95.99,"BRD-K55055802-001-09-4, BRD-K55055802-001-10-2, BRD-K55055802-001-08-6","Launched","BRD-A54880345-001-20-9","NPUKDXXFDDZOKR-LLVKDONJSA-N","BRD-K55055802","BRD-A54880345","CCOC(=O)c1cncn1[C@H](C)c1ccccc1"
"7869","HALOTHANE","glutamate receptor antagonist","ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO","neurology/psychiatry","general anaesthetic","MicroSource, MedChemEx",0,"BRD-A20550616-001-02-9, BRD-A20550616-001-03-7","Launched","","BCQZXOMGPXTTIC-UHFFFAOYSA-N","BRD-A20550616","","FC(F)(F)C(Cl)Br"
"7871","ISOFLURANE","inhaled anaesthetic","ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9","neurology/psychiatry","general anaesthetic","Sigma, Enamine",0,"BRD-A31564021-001-02-6, BRD-A31564021-001-01-8","Launched","","PIWKPBJCKXDKJR-UHFFFAOYSA-N","BRD-A31564021","","FC(F)OC(Cl)C(F)(F)F"
"7873","METHOXYFLURANE","membrane permeability inhibitor","ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1","neurology/psychiatry","general anaesthetic","Sigma, MatrixSci",0,"BRD-K06152156-001-02-6, BRD-K06152156-001-01-8","Launched","","RFKMCNOHBTXSMU-UHFFFAOYSA-N","BRD-K06152156","","COC(F)(F)C(Cl)Cl"
"7875","BUSPIRONE","serotonin receptor agonist","DRD2, HTR1A","neurology/psychiatry","generalized anxiety disorder (GAD)","Tocris, MicroSource, Selleck",99.45,"BRD-K93461745-003-24-3, BRD-K93461745-003-25-0, BRD-K93461745-003-23-5","Launched","","QWCRAEMEVRGPNT-UHFFFAOYSA-N","BRD-K93461745","","O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1"
"7878","OPIPRAMOL","sigma receptor agonist","","neurology/psychiatry","generalized anxiety disorder (GAD)","Prestwick",97.22,"BRD-K43786866-300-02-3","Launched","","YNZFUWZUGRBMHL-UHFFFAOYSA-N","BRD-K43786866","","OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1"
"7879","DIAZEPAM","benzodiazepine receptor agonist","ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO","neurology/psychiatry","generalized anxiety disorder (GAD), abstinence from alcohol, hallucinosis, tremors","Enzo",99.35,"BRD-K16508793-001-05-9","Launched","","AAOVKJBEBIDNHE-UHFFFAOYSA-N","BRD-K16508793","","CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1"
"7880","TANDOSPIRONE","serotonin receptor agonist","HTR1A","neurology/psychiatry","generalized anxiety disorder (GAD), dysthymic disorder","Tocris, MedChemEx",98.71,"BRD-K65904673-003-01-0, BRD-K65904673-001-01-4","Launched","","CEIJFEGBUDEYSX-FZDBZEDMSA-N","BRD-K65904673","","O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)c1ncccn1"
"7882","AMITRAZ","adrenergic receptor agonist","ADRA1A, ADRA2A","infectious disease","generalized demodicosis","MicroSource",0.09,"BRD-K33335792-001-04-0","Launched","","QXAITBQSYVNQDR-ZIOPAAQOSA-N","BRD-K33335792","","CN(\C=N\c1ccc(C)cc1C)\C=N\c1ccc(C)cc1C"
"7883","PODOPHYLLOTOXIN","microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB","infectious disease","genital warts","MicroSource",94.65,"BRD-K47869605-001-32-0","Launched","","YJGVMLPVUAXIQN-XVVDYKMHSA-N","BRD-K47869605","","COc1cc(cc(OC)c1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)c2cc3OCOc3cc12"
"7884","AZASETRON","serotonin receptor antagonist","HTR3A, HTR3B","infectious disease","genitial herpes","Selleck",98.4,"BRD-A44133049-003-07-8","Launched","","WUKZPHOXUVCQOR-UHFFFAOYSA-N","BRD-A44133049","","CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2"
"7885","TALIPEXOLE","adrenergic receptor agonist, dopamine receptor agonist","ADRA2A, DRD2, HTR3A","infectious disease","genitial herpes","MedChemEx, MedChemEx, MedChemEx, Enzo",84.52,"BRD-K75615183-300-04-7, BRD-K75615183-300-05-4, BRD-K75615183-300-06-2, BRD-K75615183-300-03-9","Launched","","DHSSDEDRBUKTQY-UHFFFAOYSA-N","BRD-K75615183","","Nc1nc2CCN(CC=C)CCc2s1"
"7889","ACYCLOVIR","DNA polymerase inhibitor","PNP","infectious disease","genitial herpes, shingles, chicken pox","Tocris, MicroSource, Tocris, Selleck, Selleck",100,"BRD-K32318651-001-26-0, BRD-K32318651-001-23-7, BRD-K32318651-001-22-9, BRD-K32318651-001-21-1, BRD-K32318651-001-24-5","Launched","","MKUXAQIIEYXACX-UHFFFAOYSA-N","BRD-K32318651","","Nc1nc2n(COCCO)cnc2c(=O)[nH]1"
"7894","METHOTREXATE","dihydrofolate reductase inhibitor","DHFR","oncology, hematologic malignancy, dermatology, rheumatology","gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis","Selleck, Selleck, Tocris, MicroSource",98.9,"BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9","Launched","","FBOZXECLQNJBKD-ZDUSSCGKSA-N","BRD-K59456551","","CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"7897","METHOTREXATE","dihydrofolate reductase inhibitor","DHFR","oncology, hematologic malignancy, dermatology, rheumatology","gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis","Selleck, Selleck, Tocris, MicroSource",98.9,"BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9","Launched","","FBOZXECLQNJBKD-ZDUSSCGKSA-N","BRD-K59456551","","CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O"
"7898","METHOTREXATE","dihydrofolate reductase inhibitor","DHFR","oncology, hematologic malignancy, dermatology, rheumatology","gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis","Selleck, Selleck, Tocris, MicroSource",98.9,"BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9","Launched","","FBOZXECLQNJBKD-UHFFFAOYSA-N","BRD-K59456551","","CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"7901","METHOTREXATE","dihydrofolate reductase inhibitor","DHFR","oncology, hematologic malignancy, dermatology, rheumatology","gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis","Selleck, Selleck, Tocris, MicroSource",98.9,"BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9","Launched","","FBOZXECLQNJBKD-UHFFFAOYSA-N","BRD-K59456551","","CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O"
"7902","MEPACRINE","cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B, PLA2G4A, PLA2G6, PLCL1","infectious disease","giardiasis","Selleck, MicroSource, Selleck",95.48,"BRD-A45889380-300-06-3, BRD-A45889380-300-07-1, BRD-A45889380-300-08-9","Launched","","GPKJTRJOBQGKQK-UHFFFAOYSA-N","BRD-A45889380","","CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12"
"7905","TINIDAZOLE","antiprotozoal agent","","infectious disease, obstetrics/gynecology","giardiasis, amebiasis, bacterial vaginosis, trichomoniasis","Selleck, MicroSource, Selleck",98.57,"BRD-K89125793-001-25-2, BRD-K89125793-001-26-0, BRD-K89125793-001-27-8","Launched","","HJLSLZFTEKNLFI-UHFFFAOYSA-N","BRD-K89125793","","CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O"
"7908","EUCALYPTOL","acetylcholinesterase inhibitor","ACHE","dental","gingivitis","MicroSource, AMS",0,"BRD-K29996876-001-10-1, BRD-K29996876-001-09-3","Launched","BRD-K15671046-001-03-6","WEEGYLXZBRQIMU-UHFFFAOYSA-N","BRD-K29996876","BRD-K15671046","CC12CCC(CC1)C(C)(C)O2"
"7910","CETYLPYRIDINIUM","","","dental","gingivitis, mouth inflammation","MicroSource, Selleck, Selleck",98.97,"BRD-K87700323-003-05-1, BRD-K87700323-003-04-4, BRD-K87700323-003-06-9","Launched","","NEUSVAOJNUQRTM-UHFFFAOYSA-N","BRD-K87700323","","CCCCCCCCCCCCCCCC[n+]1ccccc1"
"7913","ACECLIDINE","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","ophthalmology","glaucoma","Selleck, MicroSource, Selleck",100,"BRD-A32673558-003-03-9, BRD-A32673558-001-02-5, BRD-A32673558-003-04-7","Launched","BRD-A80567352-003-02-4","WRJPSSPFHGNBMG-UHFFFAOYSA-N","BRD-A32673558","BRD-A80567352","CC(=O)OC1CN2CCC1CC2"
"7916","ACETAZOLAMIDE","carbonic anhydrase inhibitor","AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7","ophthalmology","glaucoma","MicroSource",97.61,"BRD-K43457670-001-27-8","Launched","","BZKPWHYZMXOIDC-UHFFFAOYSA-N","BRD-K43457670","","CC(=O)Nc1nnc(s1)S(N)(=O)=O"
"7917","ISOFLUROPHATE","cholinesterase inhibitor","ACHE, BCHE","ophthalmology","glaucoma","Sigma, Sigma",0,"BRD-K56575995-001-03-0, BRD-K56575995-001-02-2","Launched","","MUCZHBLJLSDCSD-UHFFFAOYSA-N","BRD-K56575995","","CC(C)OP(F)(=O)OC(C)C"
"7919","ETHOXZOLAMIDE","carbonic anhydrase inhibitor","CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9","ophthalmology, gastroenterology","glaucoma, duodenal ulcer disease","MicroSource, Selleck",96.7,"BRD-K18131774-001-18-4, BRD-K18131774-001-17-6","Launched","","OUZWUKMCLIBBOG-UHFFFAOYSA-N","BRD-K18131774","","CCOc1ccc2nc(sc2c1)S(N)(=O)=O"
"7921","DICLOFENAMIDE","carbonic anhydrase inhibitor","CA1, CA12, CA2, CA4, CA7","ophthalmology, neurology/psychiatry","glaucoma, epilepsy","Selleck",98.21,"BRD-K71499074-001-12-9","Launched","","GJQPMPFPNINLKP-UHFFFAOYSA-N","BRD-K71499074","","NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O"
"7922","PILOCARPINE","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","ophthalmology, cardiology","glaucoma, hypertension","Tocris, MicroSource, Tocris, Selleck",99.14,"BRD-K85090592-003-20-2, BRD-K85090592-008-22-7, BRD-K85090592-003-19-4, BRD-K85090592-003-18-6","Launched","","QCHFTSOMWOSFHM-WPRPVWTQSA-N","BRD-K85090592","","CC[C@H]1[C@@H](Cc2cncn2C)COC1=O"
"7926","APRACLONIDINE","adrenergic receptor agonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C","ophthalmology","glaucoma, intraocular pressure","Ark",85.91,"BRD-K38911213-003-01-6","Launched","","IEJXVRYNEISIKR-UHFFFAOYSA-N","BRD-K38911213","","Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1"
"7927","BUNAZOSIN","adrenergic receptor antagonist","ADRA1A","ophthalmology","glaucoma, intraocular pressure","Enamine",97.77,"BRD-K35034482-001-01-8","Launched","","RHLJLALHBZGAFM-UHFFFAOYSA-N","BRD-K35034482","","CCCC(=O)N1CCCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1"
"7928","DIPIVEFRINE","adrenergic receptor agonist","ACHE, ADRA1A, ADRA2A, ADRB2, BCHE","ophthalmology","glaucoma, intraocular pressure","Prestwick",94.37,"BRD-A47494775-003-11-3","Launched","","OCUJLLGVOUDECM-UHFFFAOYSA-N","BRD-A47494775","","CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1"
"7929","METHAZOLAMIDE","carbonic anhydrase inhibitor","CA1, CA12, CA14, CA2, CA4, CA7","ophthalmology","glaucoma, intraocular pressure","MicroSource, Selleck, Selleck",98.57,"BRD-K13356952-001-26-9, BRD-K13356952-001-25-1, BRD-K13356952-001-27-7","Launched","","FLOSMHQXBMRNHR-UHFFFAOYSA-N","BRD-K13356952","","CC(=O)N=c1sc(nn1C)S(N)(=O)=O"
"7932","LEVOBUNOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","ophthalmology","glaucoma, ocular hypertension","Prestwick, Enzo",99.36,"BRD-K31812033-003-11-0, BRD-K31812033-003-10-2","Launched","","IXHBTMCLRNMKHZ-LBPRGKRZSA-N","BRD-K31812033","","CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12"
"7934","RIPASUDIL","rho associated kinase inhibitor","ROCK1, ROCK2","ophthalmology","glaucoma, ocular hypertension","MedChemEx",98.73,"BRD-K53814070-310-01-3","Launched","","QSKQVZWVLOIIEV-NSHDSACASA-N","BRD-K53814070","","C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12"
"7935","BIFEMELANE","acetylcholine release enhancer","MAOA, MAOB","ophthalmology, neurology/psychiatry","glaucoma, senile dementia","Tocris, Tocris",95.87,"BRD-K18779551-003-08-6, BRD-K18779551-003-07-8","Launched","","QSQQPMHPCBLLGX-UHFFFAOYSA-N","BRD-K18779551","","CNCCCCOc1ccccc1Cc1ccccc1"
"7937","TEMOZOLOMIDE","DNA alkylating agent","MGMT","oncology","glioblastoma, astrocytoma","Tocris, Tocris, Selleck, MicroSource",97.56,"BRD-K32107296-001-20-1, BRD-K32107296-001-15-1, BRD-K32107296-001-14-4, BRD-K32107296-001-16-9","Launched","","BPEGJWRSRHCHSN-UHFFFAOYSA-N","BRD-K32107296","","Cn1nnc2c(ncn2c1=O)C(N)=O"
"7941","FLEROXACIN","topoisomerase inhibitor","","infectious disease, gastroenterology","gonorrhea, enteritis, diarrhea, respiratory tract infections","Selleck, Selleck",99.55,"BRD-K61717546-001-04-3, BRD-K61717546-001-05-0","Launched","","XBJBPGROQZJDOJ-UHFFFAOYSA-N","BRD-K61717546","","CN1CCN(CC1)c1c(F)cc2c(c1F)n(CCF)cc(C(O)=O)c2=O"
"7943","CEFTRIAXONE","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology","gonorrhea, pneumonia, otitis, skin infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, surgical prophylaxis","MicroSource, MedChemEx",85.48,"BRD-K96734425-324-01-5, BRD-K96734425-304-01-7","Launched","BRD-K38010979-324-03-7","VAAUVRVFOQPIGI-SPQHTLEESA-N","BRD-K96734425","BRD-K38010979","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(=O)c(O)nn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"7945","BENZBROMARONE","chloride channel blocker","ABCC1","rheumatology","gout","MicroSource, Selleck",96.2,"BRD-K11717138-001-30-3, BRD-K11717138-001-29-5","Launched","","WHQCHUCQKNIQEC-UHFFFAOYSA-N","BRD-K11717138","","CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1"
"7947","CINCHOPHEN","analgesic agent","","rheumatology","gout","Selleck, MicroSource",99.45,"BRD-K72915123-001-17-3, BRD-K72915123-001-18-1","Launched","","YTRMTPPVNRALON-UHFFFAOYSA-N","BRD-K72915123","","OC(=O)c1cc(nc2ccccc12)-c1ccccc1"
"7949","LESINURAD","uric acid diuretic","SLC22A12","rheumatology","gout","MedChemEx",85.07,"BRD-K75024268-001-01-0","Launched","","FGQFOYHRJSUHMR-UHFFFAOYSA-N","BRD-K75024268","","OC(=O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12"
"7950","SULFINPYRAZONE","uricosuric blocker","ABCC1, ABCC2, FPR1, SLC22A12","rheumatology","gout","MicroSource",97.57,"BRD-A36217750-001-16-3","Launched","","MBGGBVCUIVRRBF-UHFFFAOYSA-N","BRD-A36217750","","O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1"
"7951","COLCHICINE","microtubule inhibitor","GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8","rheumatology, endocrinology","gout, fever","MicroSource, Tocris",96.57,"BRD-K00259736-001-16-4, BRD-K00259736-001-18-0","Launched","BRD-A46684810-001-12-9","IAKHMKGGTNLKSZ-INIZCTEOSA-N","BRD-K00259736","BRD-A46684810","COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC"
"7953","TOPIROXOSTAT","xanthine oxidase inhibitor","XDH","rheumatology, nephrology","gout, hyperuricemia","MedChemEx",99.78,"BRD-K77561571-001-01-1","Launched","","UBVZQGOVTLIHLH-UHFFFAOYSA-N","BRD-K77561571","","N#Cc1cc(ccn1)-c1n[nH]c(n1)-c1ccncc1"
"7954","ALLOPURINOL","xanthine oxidase inhibitor","XDH","rheumatology, urology","gout, kidney stones","Selleck, MicroSource, Selleck",100,"BRD-K86307448-001-19-1, BRD-K86307448-001-17-5, BRD-K86307448-001-16-7","Launched","","OFCNXPDARWKPPY-UHFFFAOYSA-N","BRD-K86307448","","O=c1[nH]cnc2[nH]ncc12"
"7957","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-MRUMTBQISA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7958","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-MRUMTBQISA-N","BRD-A01603276","BRD-U46375448","NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)C1O"
"7959","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-MRUMTBQISA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7962","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-CJMFXXNZSA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7963","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-CJMFXXNZSA-N","BRD-A01603276","BRD-U46375448","NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)C1O"
"7964","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-CJMFXXNZSA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7967","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-RMDFUYIESA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7968","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-RMDFUYIESA-N","BRD-A01603276","BRD-U46375448","NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)C1O"
"7969","AMIKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","Launched","BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9","LKCWBDHBTVXHDL-RMDFUYIESA-N","BRD-A01603276","BRD-U46375448","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O"
"7972","APRAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",0,"BRD-K36062294-001-04-0","Launched","","XZNUGFQTQHRASN-XYPKRARZSA-N","BRD-K36062294","","CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O"
"7973","BALOFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck",97.5,"BRD-A47790386-001-02-8, BRD-A47790386-001-03-6","Launched","","MGQLHRYJBWGORO-UHFFFAOYSA-N","BRD-A47790386","","CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1"
"7975","BEKANAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, MicroSource",100,"BRD-K73425385-001-01-9, BRD-K73425385-065-04-8","Launched","BRD-K47908102-001-01-9","SKKLOUVUUNMCJE-FQSMHNGLSA-N","BRD-K73425385","BRD-K47908102","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"7977","CARBENICILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MedChemEx, MicroSource, Selleck, MedChemEx, Selleck",0,"BRD-A13078313-304-09-9, BRD-A13078313-304-06-5, BRD-A13078313-304-05-7, BRD-A13078313-304-08-1, BRD-A13078313-304-07-3","Launched","","FPPNZSSZRUTDAP-UWFZAAFLSA-N","BRD-A13078313","","CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O"
"7982","CEFMENOXIME","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",85.33,"BRD-A20839672-003-01-5","Launched","","HJJDBAOLQAWBMH-ODCIPOBUSA-N","BRD-A20839672","","CO\N=C(\C(=O)NC1C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"7983","CEFMINOX","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","Key",83.7,"BRD-K77073709-435-01-2","Launched","","JSDXOWVAHXDYCU-VXSYNFHWSA-N","BRD-K77073709","","CO[C@]1(NC(=O)CSC[C@@H](N)C(O)=O)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"7984","CEFOPERAZONE","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck",95.7,"BRD-K02292852-001-04-7, BRD-K02292852-001-02-1","Launched","BRD-A73079885-001-01-1","GCFBRXLSHGKWDP-XCGNWRKASA-N","BRD-K02292852","BRD-A73079885","CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSc4nnnn4C)=C(N3C2=O)C(O)=O)c2ccc(O)cc2)C(=O)C1=O"
"7986","CEFORANIDE","penicillin binding protein inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource, AvaChem",90.8,"BRD-K37848908-001-06-4, BRD-K37848908-001-05-6","Launched","BRD-A38738672-001-01-3","SLAYUXIURFNXPG-CRAIPNDOSA-N","BRD-K37848908","BRD-A38738672","NCc1ccccc1CC(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CC(O)=O)=C(N2C1=O)C(O)=O"
"7988","CEFPIRAMIDE","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource, Sigma, MedChemEx",86.38,"BRD-K92872987-001-02-9, BRD-K92872987-001-01-1, BRD-K92872987-236-03-9","Launched","BRD-A39975020-001-01-9","PWAUCHMQEXVFJR-PMAPCBKXSA-N","BRD-K92872987","BRD-A39975020","Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1"
"7991","CEFPIROME","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","ChemImpex",91.01,"BRD-K56542719-065-01-4","Launched","","DKOQGJHPHLTOJR-PUIFZAHNSA-O","BRD-K56542719","","CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3cccc4CCCc34)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"7992","CEFSULODIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MedChemEx, MedChemEx, Sigma, MicroSource",29.68,"BRD-K03907181-236-06-8, BRD-K03907181-236-05-0, BRD-K03907181-236-04-3, BRD-K03907181-236-07-6","Launched","BRD-A86462796-236-04-8","SYLKGLMBLAAGSC-QLVMHMETSA-O","BRD-K03907181","BRD-A86462796","NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1"
"7996","CEFUROXIME","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MedChemEx, MedChemEx, MicroSource",86.53,"BRD-K02733959-236-06-9, BRD-K02733959-236-05-1, BRD-K02733959-236-07-7","Launched","BRD-A76746748-236-04-5","JFPVXVDWJQMJEE-IZRZKJBUSA-N","BRD-K02733959","BRD-A76746748","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1"
"7999","CHLORAMPHENICOL-SODIUM-SUCCINATE","protein synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",31.43,"BRD-K25209357-236-01-2","Launched","","LIRCDOVJWUGTMW-ZWNOBZJWSA-N","BRD-K25209357","","O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+]([O-])=O"
"8000","COLISTIMETHATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck",0,"BRD-A13668387-319-04-7, BRD-A44942307-405-01-9","Launched","","JGZYUDARLHNRKM-UHFFFAOYSA-N","BRD-A13668387","","CCC(C)C1NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNCS(O)(=O)=O)NC1=O)C(C)O)NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)CCCCC(C)C)C(C)O)C(C)CC"
"8001","COLISTIMETHATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck",0,"BRD-A13668387-319-04-7, BRD-A44942307-405-01-9","Launched","","JGZYUDARLHNRKM-UHFFFAOYSA-N","BRD-A13668387","","CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O"
"8002","COLISTIMETHATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck",0,"BRD-A13668387-319-04-7, BRD-A44942307-405-01-9","Launched","","XDJYMJULXQKGMM-KFZDXBANSA-N","BRD-A13668387","","CCC(C)C1NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNCS(O)(=O)=O)NC1=O)C(C)O)NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)CCCCC(C)C)C(C)O)C(C)CC"
"8003","COLISTIMETHATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck",0,"BRD-A13668387-319-04-7, BRD-A44942307-405-01-9","Launched","","XDJYMJULXQKGMM-KFZDXBANSA-N","BRD-A13668387","","CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O"
"8004","COLISTIN","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MedChemEx, MedChemEx",65.4,"BRD-A18924964-065-01-5, BRD-A18924964-065-02-3","Launched","","YKQOSKADJPQZHB-QNPLFGSASA-N","BRD-A18924964","","CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O"
"8006","COLISTIN-B-SULFATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","Enzo",46.42,"BRD-A36456202-001-01-3","Launched","","KNIWPHSUTGNZST-INRBSFJCSA-N","BRD-A36456202","","CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O"
"8007","COLISTIN-SULFATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck, Selleck",55.02,"BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9","Launched","BRD-M52026403-001-01-6,BRD-U87151157-000-01-1, BRD-M52026403-001-02-4,BRD-M87664656-343-01-3","VCRYFUBRFYUNTM-UHFFFAOYSA-N","BRD-A45201156","BRD-M52026403","CCC(C)C1NC(=O)C(NC(=O)C(CCN)NC(=O)C(CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC1=O)C(C)O)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)CCCCC(C)C)C(C)O)C(C)CC"
"8008","COLISTIN-SULFATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck, Selleck",55.02,"BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9","Launched","BRD-M52026403-001-01-6,BRD-U87151157-000-01-1, BRD-M52026403-001-02-4,BRD-M87664656-343-01-3","VCRYFUBRFYUNTM-UHFFFAOYSA-N","BRD-A45201156","BRD-M52026403","CC(C)CCCCC(=O)N[C@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)C(C)C)[C@@H](C)O"
"8010","COLISTIN-SULFATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck, Selleck",55.02,"BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9","Launched","BRD-M52026403-001-01-6,BRD-U87151157-000-01-1, BRD-M52026403-001-02-4,BRD-M87664656-343-01-3","MEOTUCBFWIQPRL-UPDVJOSMSA-N","BRD-A45201156","BRD-M52026403","CCC(C)C1NC(=O)C(NC(=O)C(CCN)NC(=O)C(CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC1=O)C(C)O)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)CCCCC(C)C)C(C)O)C(C)CC"
"8011","COLISTIN-SULFATE","bacterial permeability inducer","","infectious disease","gram-negative bacterial infections","MicroSource, Selleck, Selleck",55.02,"BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9","Launched","BRD-M52026403-001-01-6,BRD-U87151157-000-01-1, BRD-M52026403-001-02-4,BRD-M87664656-343-01-3","MEOTUCBFWIQPRL-UPDVJOSMSA-N","BRD-A45201156","BRD-M52026403","CC(C)CCCCC(=O)N[C@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)C(C)C)[C@@H](C)O"
"8013","DIBEKACIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",0,"BRD-K48427910-001-01-1","Launched","","JJCQSGDBDPYCEO-XVZSLQNASA-N","BRD-K48427910","","NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1"
"8014","KANAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","MedChemEx, MedChemEx, MicroSource",0,"BRD-K08327065-065-05-0, BRD-K08327065-065-04-3, BRD-K08327065-065-06-8","Launched","BRD-A53533407-065-04-9","SBUJHOSQTJFQJX-NOAMYHISSA-N","BRD-K08327065","BRD-A53533407","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O"
"8017","MARBOFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck, MicroSource",99.41,"BRD-K71926323-001-14-6, BRD-K71926323-001-12-0, BRD-K71926323-001-13-8","Launched","","BPFYOAJNDMUVBL-UHFFFAOYSA-N","BRD-K71926323","","CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O"
"8020","MICRONOMICIN","protein synthesis inhibitor","","infectious disease","gram-negative bacterial infections","AvaChem",0,"BRD-K18552138-001-01-8","Launched","","DNYGXMICFMACRA-XHEDQWPISA-N","BRD-K18552138","","CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1"
"8021","NETILMICIN","protein synthesis inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource, MedChemEx, Selleck, Selleck",100,"BRD-A59825838-315-02-5, BRD-A59825838-326-01-4, BRD-A59825838-315-03-3, BRD-A59825838-315-04-1","Launched","BRD-M29626677-343-03-4, BRD-A79774694-315-01-6,BRD-M03948854-343-01-1, BRD-A79774694-315-02-4,BRD-M53946149-343-02-7","CIDUJQMULVCIBT-OHMMYJSPSA-N","BRD-A59825838","BRD-M29626677","CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O"
"8025","PIPEMIDIC-ACID","topoisomerase inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",90.96,"BRD-K08999871-213-01-5","Launched","","JOHZPMXAZQZXHR-UHFFFAOYSA-N","BRD-K08999871","","CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCNCC1"
"8026","RIBOSTAMYCIN-SULFATE","bacterial 30S ribosomal subunit inhibitor","P4HB","infectious disease","gram-negative bacterial infections","MicroSource",0,"BRD-A03826781-065-03-6","Launched","","NSKGQURZWSPSBC-VCUPSGBRSA-N","BRD-A03826781","","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"8027","RUFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",97.36,"BRD-K62374253-001-07-8","Launched","","NJCJBUHJQLFDSW-UHFFFAOYSA-N","BRD-K62374253","","CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O"
"8028","SISOMICIN-SULFATE","bacterial 30S ribosomal subunit inhibitor","","infectious disease","gram-negative bacterial infections","MicroSource",0,"BRD-A68997559-065-04-5","Launched","","URWAJWIAIPFPJE-JYERGDCNSA-N","BRD-A68997559","","CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O"
"8029","TICARCILLIN","lactamase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6","Launched","BRD-A91757199-304-01-9, BRD-A91757199-304-02-7, BRD-A91757199-001-01-1","OHKOGUYZJXTSFX-KZFFXBSXSA-N","BRD-K29229654","BRD-A91757199","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O"
"8031","TICARCILLIN","lactamase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6","Launched","BRD-A91757199-304-01-9, BRD-A91757199-304-02-7, BRD-A91757199-001-01-1","OHKOGUYZJXTSFX-KZFFXBSXSA-N","BRD-K29229654","BRD-A91757199","CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O"
"8033","TICARCILLIN","lactamase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6","Launched","BRD-A91757199-304-01-9, BRD-A91757199-304-02-7, BRD-A91757199-001-01-1","OHKOGUYZJXTSFX-IRHHVTTKSA-N","BRD-K29229654","BRD-A91757199","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O"
"8035","TICARCILLIN","lactamase inhibitor","","infectious disease","gram-negative bacterial infections","Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6","Launched","BRD-A91757199-304-01-9, BRD-A91757199-304-02-7, BRD-A91757199-001-01-1","OHKOGUYZJXTSFX-IRHHVTTKSA-N","BRD-K29229654","BRD-A91757199","CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O"
"8037","TOSUFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","gram-negative bacterial infections","Prestwick, TCI",98.13,"BRD-A41450521-003-02-7, BRD-A41450521-075-10-8","Launched","","WUWFMDMBOJLQIV-UHFFFAOYSA-N","BRD-A41450521","","NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F"
"8039","ENROFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","gram-negative bacterial infections, gram-negative bacterial infections","MicroSource, Selleck",96.46,"BRD-K76534306-001-22-7, BRD-K76534306-001-21-9","Launched","","SPFYMRJSYKOXGV-UHFFFAOYSA-N","BRD-K76534306","","CCN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1"
"8041","MEZLOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-negative bacterial infections, gram-positive bacterial infections","Selleck, Selleck",88.63,"BRD-K45114938-236-02-6, BRD-K45114938-236-01-8","Launched","BRD-K53064842-236-01-9","YPBATNHYBCGSSN-ZJOBFFGXSA-N","BRD-K45114938","BRD-K53064842","CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)c3ccccc3)C(=O)N2[C@@H]1C(O)=O"
"8043","CEFALONIUM","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","MicroSource",0,"BRD-K15514357-001-05-6","Launched","","FMZXNVLFJHCSAF-DNVCBOLYSA-O","BRD-K15514357","","NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc2cccs2)C3=O)C(O)=O)cc1"
"8044","CEFATHIAMIDINE","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","AKSci",68.39,"BRD-K63835048-001-01-0","Launched","","JYXACOFERDBGGQ-RHSMWYFYSA-N","BRD-K63835048","","CC(C)N\C(SCC(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)=N/C(C)C"
"8045","CEFETAMET-PIVOXIL","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","AvaChem, AKSci, MedChemEx",87.11,"BRD-K21372554-001-01-1, BRD-K21372554-003-01-7, BRD-K21372554-003-02-5","Launched","","DASYMCLQENWCJG-XUKDPADISA-N","BRD-K21372554","","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1"
"8048","CEFONICID","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","MicroSource, MedChemEx, MedChemEx",83.1,"BRD-K34058848-304-03-1, BRD-K34058848-304-02-3, BRD-K34058848-304-01-5","Launched","BRD-A65872513-304-01-7","DYAIAHUQIPBDIP-AXAPSJFSSA-N","BRD-K34058848","BRD-A65872513","O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1"
"8051","CLOFOCTOL","protein synthesis inhibitor","","infectious disease","gram-positive bacterial infections","Selleck, MicroSource",97.9,"BRD-K02900412-001-11-3, BRD-K02900412-001-12-1","Launched","","HQVZOORKDNCGCK-UHFFFAOYSA-N","BRD-K02900412","","CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1"
"8053","CLOXACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","MicroSource, Selleck, Selleck",94.98,"BRD-K01244426-236-12-1, BRD-K01244426-323-07-7, BRD-K01244426-323-08-5","Launched","BRD-K23933163-323-01-9","LQOLIRLGBULYKD-JKIFEVAISA-N","BRD-K01244426","BRD-K23933163","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl"
"8056","DICLOXACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","MicroSource, Selleck, Selleck",87.83,"BRD-K05673000-236-12-1, BRD-K05673000-323-13-5, BRD-K05673000-323-12-7","Launched","BRD-K59843513-323-01-4","YFAGHNZHGGCZAX-JKIFEVAISA-N","BRD-K05673000","BRD-K59843513","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl"
"8059","HEXACHLOROPHENE","potassium channel activator","GLUD1, SDHD","infectious disease","gram-positive bacterial infections","MicroSource",98.49,"BRD-K99792991-001-34-9","Launched","","ACGUYXCXAPNIKK-UHFFFAOYSA-N","BRD-K99792991","","Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl"
"8060","ISOCONAZOLE","fungal lanosterol demethylase inhibitor","CYP17A1","infectious disease","gram-positive bacterial infections","Selleck",98.55,"BRD-A93353767-008-02-2","Launched","","MPIPASJGOJYODL-UHFFFAOYSA-N","BRD-A93353767","","Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1"
"8061","NAFCILLIN","bacterial cell wall synthesis inhibitor","CYP1A2, CYP3A4, SLC22A6","infectious disease","gram-positive bacterial infections","Selleck, MicroSource, Selleck",96.54,"BRD-K18574842-323-11-6, BRD-K18574842-236-17-7, BRD-K18574842-323-10-8","Launched","BRD-K96812051-323-01-2","GPXLMGHLHQJAGZ-JTDSTZFVSA-N","BRD-K18574842","BRD-K96812051","CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O"
"8064","TEICOPLANIN-A2-3","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections","Selleck, Selleck",9.36,"BRD-K96571715-001-01-4, BRD-U59360347-000-01-3","Launched","","FHBQKTSCJKPYIO-UBGUEUOASA-N","BRD-K96571715","","CC(C)CCCCCCCC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H]1NC(=O)[C@@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl"
"8065","TYLOSIN","protein synthesis inhibitor","","infectious disease, gastroenterology","gram-positive bacterial infections, colitis","MicroSource, Selleck",94.95,"BRD-K37753391-046-02-4, BRD-K37753391-046-03-2","Launched","BRD-K90749417-046-01-8","WBPYTXDJUQJLPQ-VMXQISHHSA-N","BRD-K37753391","BRD-K90749417","CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC"
"8067","AZLOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Selleck, MicroSource, Selleck",85.42,"BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9","Launched","BRD-A95218818-236-05-4, BRD-A95218818-001-01-1, BRD-A46717658-236-03-3","JTWOMNBEOCYFNV-NFFDBFGFSA-N","BRD-K60663764","BRD-A95218818","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O"
"8068","AZLOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Selleck, MicroSource, Selleck",85.42,"BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9","Launched","BRD-A95218818-236-05-4, BRD-A95218818-001-01-1, BRD-A46717658-236-03-3","JTWOMNBEOCYFNV-NFFDBFGFSA-N","BRD-K60663764","BRD-A95218818","CC1(C)SC2C(NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2C1C(O)=O"
"8071","AZLOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Selleck, MicroSource, Selleck",85.42,"BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9","Launched","BRD-A95218818-236-05-4, BRD-A95218818-001-01-1, BRD-A46717658-236-03-3","JTWOMNBEOCYFNV-MPXNVAGNSA-N","BRD-K60663764","BRD-A95218818","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O"
"8072","AZLOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Selleck, MicroSource, Selleck",85.42,"BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9","Launched","BRD-A95218818-236-05-4, BRD-A95218818-001-01-1, BRD-A46717658-236-03-3","JTWOMNBEOCYFNV-MPXNVAGNSA-N","BRD-K60663764","BRD-A95218818","CC1(C)SC2C(NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2C1C(O)=O"
"8075","BACAMPICILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Sigma, MedChemEx",81.26,"BRD-A41698174-003-13-8, BRD-A41698174-003-11-2, BRD-A41698174-003-12-0","Launched","BRD-A10481343-003-03-3","PFOLLRNADZZWEX-FFGRCDKISA-N","BRD-A41698174","BRD-A10481343","CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O"
"8078","FLUCLOXACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, dermatology, gastroenterology","gram-positive bacterial infections, tonsillitis, sinusitis, pneumonia, eczema, endocarditis, meningitis, enteritis, bacterial septicemia","Prestwick, Sigma",78.07,"BRD-K27871792-001-01-8, BRD-K27871792-236-01-0","Launched","BRD-A13650332-236-09-6","UIOFUWFRIANQPC-JKIFEVAISA-N","BRD-K27871792","BRD-A13650332","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(F)cccc1Cl"
"8080","CLADRIBINE","adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B","hematologic malignancy","hairy cell leukemia","Selleck",98.23,"BRD-K93034159-001-25-8","Launched","","PTOAARAWEBMLNO-KVQBGUIXSA-N","BRD-K93034159","","Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1"
"8081","PENTOSTATIN","adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA","hematologic malignancy","hairy cell leukemia","MedChemEx, Enzo",86.61,"BRD-K91543828-001-02-0, BRD-A17154931-001-01-5","Launched","","FPVKHBSQESCIEP-JQCXWYLXSA-N","BRD-K91543828","","OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2[C@H](O)CNC=Nc12"
"8082","PENTOSTATIN","adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA","hematologic malignancy","hairy cell leukemia","MedChemEx, Enzo",86.61,"BRD-K91543828-001-02-0, BRD-A17154931-001-01-5","Launched","","FPVKHBSQESCIEP-JQCXWYLXSA-N","BRD-K91543828","","OC[C@H]1O[C@H](CC1O)n1cnc2[C@H](O)CNC=Nc12"
"8083","PENTOSTATIN","adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA","hematologic malignancy","hairy cell leukemia","MedChemEx, Enzo",86.61,"BRD-K91543828-001-02-0, BRD-A17154931-001-01-5","Launched","","FPVKHBSQESCIEP-FUZJYRNYSA-N","BRD-K91543828","","OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2[C@H](O)CNC=Nc12"
"8084","PENTOSTATIN","adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA","hematologic malignancy","hairy cell leukemia","MedChemEx, Enzo",86.61,"BRD-K91543828-001-02-0, BRD-A17154931-001-01-5","Launched","","FPVKHBSQESCIEP-FUZJYRNYSA-N","BRD-K91543828","","OC[C@H]1O[C@H](CC1O)n1cnc2[C@H](O)CNC=Nc12"
"8085","NIMORAZOLE","bacterial DNA inhibitor","","oncology","head and neck squamous cell carcinoma (HNSCC)","MedChemEx",96.86,"BRD-K79145628-001-05-5","Launched","","MDJFHRLTPRPZLY-UHFFFAOYSA-N","BRD-K79145628","","[O-][N+](=O)c1cncn1CCN1CCOCC1"
"8086","TEMOPORFIN","radical formation stimulant","","oncology","head and neck squamous cell carcinoma (HNSCC)","MedChemEx",85.6,"BRD-K63712959-001-01-8","Launched","","LYPFDBRUNKHDGX-UHFFFAOYSA-N","BRD-K63712959","","Oc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2"
"8087","DIPHENHYDRAMINE","histamine receptor antagonist","HRH1","neurology/psychiatry","headache","MicroSource, Selleck",98.11,"BRD-K47278471-003-26-3, BRD-K47278471-003-25-5","Launched","","ZZVUWRFHKOJYTH-UHFFFAOYSA-N","BRD-K47278471","","CN(C)CCOC(c1ccccc1)c1ccccc1"
"8089","ISOMETHEPTENE-MUCATE","","ADRA1A, SLC18A2","neurology/psychiatry","headache","Prestwick",81.13,"BRD-A64743628-001-01-5","Launched","BRD-M48029916-001-06-6,BRD-M59543297-001-05-3","XVQUOJBERHHONY-UHFFFAOYSA-N","BRD-A64743628","BRD-M48029916","CNC(C)CCC=C(C)C"
"8090","METHYSERGIDE","serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry","headache","Tocris",61.35,"BRD-K35941380-050-27-9","Launched","","KPJZHOPZRAFDTN-ZRGWGRIASA-N","BRD-K35941380","","CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34"
"8091","CHLOROGENIC-ACID","antioxidant","SLC37A4","neurology/psychiatry, pulmonary, allergy","headache, chest congestion, allergic rhinitis","Selleck, Selleck",95.33,"BRD-K47114202-001-14-6, BRD-K47114202-001-15-3","Launched","BRD-K46579573-001-01-9","CWVRJTMFETXNAD-JUHZACGLSA-N","BRD-K47114202","BRD-K46579573","O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)C(O)=O"
"8093","ETHENZAMIDE","analgesic agent","","neurology/psychiatry, endocrinology, otolaryngology","headache, fever, common cold","MicroSource",99.07,"BRD-K88308881-001-06-8","Launched","","SBNKFTQSBPKMBZ-UHFFFAOYSA-N","BRD-K88308881","","CCOc1ccccc1C(N)=O"
"8094","ASPIRIN","cyclooxygenase inhibitor","AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53","neurology/psychiatry, endocrinology, dental","headache, fever, toothache, muscle pain","Tocris, MicroSource, Selleck, Selleck",99.34,"BRD-K11433652-001-23-8, BRD-K11433652-001-17-0, BRD-K11433652-001-16-2, BRD-K11433652-001-18-8","Launched","","BSYNRYMUTXBXSQ-UHFFFAOYSA-N","BRD-K11433652","","CC(=O)Oc1ccccc1C(O)=O"
"8098","IBUPROFEN","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology, otolaryngology, obstetrics/gynecology, endocrinology, dental","headache, muscle pain, rheumatoid arthritis, backache, common cold, menstrual pain, fever, toothache","MicroSource, Selleck",99.41,"BRD-A17655518-001-24-4, BRD-A17655518-001-23-6","Launched","","HEFNNWSXXWATRW-UHFFFAOYSA-N","BRD-A17655518","","CC(C)Cc1ccc(cc1)C(C)C(O)=O"
"8100","BUTALBITAL","GABA receptor antagonist","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2","neurology/psychiatry","headache, muscle relaxant","Prestwick",98.11,"BRD-K71350836-001-02-4","Launched","","UZVHFVZFNXBMQJ-UHFFFAOYSA-N","BRD-K71350836","","CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O"
"8101","ETILEFRINE","adrenergic receptor agonist","ADRA1A, ADRB1","neurology/psychiatry, otolaryngology, endocrinology, pulmonary","headache, nasal congestion, fever, cough suppressant, common cold","Prestwick",88.17,"BRD-A09925278-003-05-6","Launched","","SQVIAVUSQAWMKL-UHFFFAOYSA-N","BRD-A09925278","","CCNCC(O)c1cccc(O)c1"
"8102","FAMOTIDINE","histamine receptor antagonist","HRH2","gastroenterology","heartburn","Selleck, MicroSource",99.08,"BRD-K00673382-001-17-1, BRD-K00673382-001-18-9","Launched","","XUFQPHANEAPEMJ-UHFFFAOYSA-N","BRD-K00673382","","NC(N)=Nc1nc(CSCC\C(N)=N/S(N)(=O)=O)cs1"
"8104","LANSOPRAZOLE","ATPase inhibitor","ATP4A, ATP4B","gastroenterology","heartburn","MicroSource, Tocris, Selleck",98.97,"BRD-A49172652-001-28-9, BRD-A49172652-001-27-1, BRD-A49172652-001-26-3","Launched","","MJIHNNLFOKEZEW-UHFFFAOYSA-N","BRD-A49172652","","Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1"
"8107","OMEPRAZOLE","ATPase inhibitor","ATP4A, CLCN2","gastroenterology","heartburn","Selleck, MicroSource, Tocris, Selleck",99.07,"BRD-A55962179-001-24-7, BRD-A55962179-001-23-9, BRD-A55962179-001-22-1, BRD-A55962179-001-21-3","Launched","","SUBDBMMJDZJVOS-UHFFFAOYSA-N","BRD-A55962179","","COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C"
"8111","RANITIDINE","histamine receptor antagonist","HRH2","gastroenterology","heartburn","Selleck, Selleck, Tocris, MicroSource",97.81,"BRD-K70505054-003-11-6, BRD-K70505054-003-13-2, BRD-K70505054-003-14-0, BRD-K70505054-003-12-4","Launched","BRD-K14204120-003-20-6","VMXUWOKSQNHOCA-UKTHLTGXSA-N","BRD-K70505054","BRD-K14204120","CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O"
"8115","TRANEXAMIC-ACID","antifibrinolytic, plasminogen activator inhibitor","PLG","hematology","hemophilia","MedChemEx, MedChemEx, MicroSource, Selleck, Selleck",97,"BRD-K15014948-001-11-1, BRD-K15014948-001-10-3, BRD-K15014948-213-01-3, BRD-K15014948-001-09-5, BRD-K15014948-001-12-9","Launched","BRD-K79165417-001-01-7","GYDJEQRTZSCIOI-LJGSYFOKSA-N","BRD-K15014948","BRD-K79165417","NC[C@H]1CC[C@@H](CC1)C(O)=O"
"8120","ADRENALONE","adrenergic receptor agonist","ADRA1A","hematology","hemorrhage","Selleck, MicroSource",91.31,"BRD-K82343404-003-02-4, BRD-K82343404-003-03-2","Launched","","PZMVOUYYNKPMSI-UHFFFAOYSA-N","BRD-K82343404","","CNCC(=O)c1ccc(O)c(O)c1"
"8122","CARBAZOCHROME","","","hematology","hemorrhage","Selleck",93.38,"BRD-A11070335-236-02-1","Launched","","OZCACMPSTYQSMM-SDQBBNPISA-N","BRD-A11070335","","CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O"
"8123","CARBETOCIN","oxytocin receptor agonist","OXTR","hematology","hemorrhage","MedChemEx",93.12,"BRD-K56107812-001-01-7","Launched","","NSTRIRCPWQHTIA-DTRKZRJBSA-N","BRD-K56107812","","CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O"
"8124","ETAMSYLATE","haemostatic agent","","hematology","hemorrhage","Selleck, Selleck",98.66,"BRD-K71055333-224-05-8, BRD-K71055333-224-06-6","Launched","","IKQCSJBQLWJEPU-UHFFFAOYSA-N","BRD-K71055333","","Oc1ccc(O)c(c1)S(O)(=O)=O"
"8126","LEVONORDEFRIN","vasodilator","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, SLC6A2","hematology","hemorrhage","Sigma, MicroSource",0,"BRD-K02976377-001-08-2, BRD-K02976377-001-07-4","Launched","","GEFQWZLICWMTKF-CDUCUWFYSA-N","BRD-K02976377","","C[C@H](N)[C@H](O)c1ccc(O)c(O)c1"
"8128","NIMODIPINE","calcium channel blocker","AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2","hematology","hemorrhage","MicroSource, Selleck, Tocris",93.03,"BRD-A58048407-001-20-4, BRD-A58048407-001-17-0, BRD-A58048407-001-18-8","Launched","","UIAGMCDKSXEBJQ-UHFFFAOYSA-N","BRD-A58048407","","COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C"
"8131","SOMATOSTATIN","somatostatin receptor agonist","OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5","hematology","hemorrhage","Key",82.44,"BRD-K14681867-001-01-6","Launched","","NHXLMOGPVYXJNR-ATOGVRKGSA-N","BRD-K14681867","","C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N"
"8132","MESNA","antioxidant","","urology","hemorrhagic cystitis","Selleck, Selleck, MicroSource",92.74,"BRD-K49954789-001-03-7, BRD-K49954789-001-01-1, BRD-K49954789-001-02-9","Launched","BRD-M40783228-001-16-8, BRD-M40783228-001-14-3, BRD-M40783228-001-15-0","ZNEWHQLOPFWXOF-UHFFFAOYSA-N","BRD-K49954789","BRD-M40783228","OS(=O)(=O)CCS"
"8135","ARGATROBAN","thrombin inhibitor","F2","hematology","heparin-induced thrombocytopenia (HIT)","Tocris, Selleck",97.13,"BRD-A48261811-001-07-3, BRD-A48261811-001-08-1","Launched","BRD-A10012892-001-01-9","KXNPVXPOPUZYGB-IOVMHBDKSA-N","BRD-A48261811","BRD-A10012892","C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1cccc2CC(C)CNc12"
"8137","MALOTILATE","protein synthesis stimulant","","gastroenterology","hepatic cirrhosis","Selleck",96.64,"BRD-K97884852-001-05-4","Launched","","YPIQVCUJEKAZCP-UHFFFAOYSA-N","BRD-K97884852","","CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1"
"8138","SILIBININ","cytochrome P450 inhibitor","ALOX5","gastroenterology","hepatic cirrhosis","Selleck, MicroSource, Selleck",97.75,"BRD-K80353138-001-13-9, BRD-K80353138-001-12-1, BRD-K80353138-001-16-2","Launched","BRD-K47267049-001-01-6","SEBFKMXJBCUCAI-HKTJVKLFSA-N","BRD-K80353138","BRD-K47267049","COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O"
"8141","NEOMYCIN","bacterial 30S ribosomal subunit inhibitor","CXCR4","gastroenterology, infectious disease","hepatic encephalopathy (HE), intra-abdominal infections","MedChemEx, Sigma, MedChemEx, Selleck",0,"BRD-K71013094-326-02-6, BRD-K71013094-001-02-5, BRD-K71013094-326-01-8, BRD-K71013094-065-04-6","Launched","BRD-M08953053-001-01-9, BRD-A35132579-065-01-1","PGBHMTALBVVCIT-VCIWKGPPSA-N","BRD-K71013094","BRD-M08953053","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"8145","ADEFOVIR","DNA polymerase inhibitor","","infectious disease","hepatitis B","AKSci, Sigma",99.1,"BRD-K77484724-001-02-0, BRD-K77484724-001-03-8","Launched","","SUPKOOSCJHTBAH-UHFFFAOYSA-N","BRD-K77484724","","Nc1ncnc2n(CCOCP(O)(O)=O)cnc12"
"8147","ADEFOVIR-DIPIVOXIL","DNA polymerase inhibitor","","infectious disease","hepatitis B","Selleck, Selleck",86.36,"BRD-K96159438-001-07-1, BRD-K96159438-001-06-3","Launched","","WOZSCQDILHKSGG-UHFFFAOYSA-N","BRD-K96159438","","CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C"
"8149","CLEVUDINE","DNA polymerase inhibitor","","infectious disease","hepatitis B","Selleck",94.05,"BRD-K18948558-001-01-9","Launched","","GBBJCSTXCAQSSJ-AZRUVXNYSA-N","BRD-K18948558","","Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2F)c(=O)[nH]c1=O"
"8150","ENTECAVIR","DNA replication inhibitor, nucleoside reverse transcriptase inhibitor","","infectious disease","hepatitis B","Selleck",99.22,"BRD-K08206212-002-01-0","Launched","","QDGZDCVAUDNJFG-FXQIFTODSA-N","BRD-K08206212","","Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)C3=C)c2[nH]1"
"8151","PROPAGERMANIUM","interferon receptor agonist, CCR agonist","CCR2","infectious disease","hepatitis B","Sigma",0,"BRD-K53382462-001-02-0","Launched","","XEABSBMNTNXEJM-UHFFFAOYSA-N","BRD-K53382462","","OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O"
"8152","TELBIVUDINE","DNA polymerase inhibitor","TK2","infectious disease","hepatitis B","Selleck",93.99,"BRD-K15976406-001-03-3","Launched","","IQFYYKKMVGJFEH-CSMHCCOUSA-N","BRD-K15976406","","Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O"
"8153","PHOSPHATIDYLCHOLINE","","PCTP","infectious disease, dermatology, gastroenterology, cardiology, obstetrics/gynecology","hepatitis B, hepatitis C, eczema, gallbladder disease, cholesterol, premenstrual syndrome","Selleck, Selleck",0,"BRD-U51753822-000-01-1, BRD-A10131665-001-02-0","Launched","BRD-M44205332-065-01-8","JLPULHDHAOZNQI-ZTIMHPMXSA-O","BRD-U51753822","BRD-M44205332","CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC"
"8154","BOCEPREVIR","HCV inhibitor","CMA1, CTSA, CTSF, CTSK, CTSL, CTSS","infectious disease","hepatitis C","MedChemEx, MedChemEx, MedChemEx",82.09,"BRD-A09735281-001-03-3, BRD-A09735281-001-02-5, BRD-A09735281-001-04-1","Launched","","LHHCSNFAOIFYRV-DOVBMPENSA-N","BRD-A09735281","","CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C"
"8157","DACLATASVIR","HCV inhibitor","","infectious disease","hepatitis C","Selleck",94.53,"BRD-K82861010-001-02-5","Launched","","FKRSSPOQAMALKA-CUPIEXAXSA-N","BRD-K82861010","","COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C"
"8158","DASABUVIR","HCV inhibitor","","infectious disease","hepatitis C","MedChemEx",91.31,"BRD-K02943813-001-01-9","Launched","","NBRBXGKOEOGLOI-UHFFFAOYSA-N","BRD-K02943813","","COc1c(cc(cc1C(C)(C)C)-n1ccc(=O)[nH]c1=O)-c1ccc2cc(NS(C)(=O)=O)ccc2c1"
"8159","ELBASVIR","HCV inhibitor","","infectious disease","hepatitis C","MedChemEx",95.63,"BRD-K09735259-001-01-3","Launched","","BVAZQCUMNICBAQ-PZHYSIFUSA-N","BRD-K09735259","","COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc2-c3cc4cc(ccc4n3[C@@H](Oc2c1)c1ccccc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C"
"8160","LEDIPASVIR","HCV inhibitor","","infectious disease","hepatitis C","MedChemEx",94.99,"BRD-K05446112-001-01-8","Launched","","VRTWBAAJJOHBQU-KMWAZVGDSA-N","BRD-K05446112","","COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1ncc([nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C"
"8161","OMBITASVIR","HCV inhibitor","","infectious disease","hepatitis C","MedChemEx, MedChemEx",96.54,"BRD-K11072003-001-02-4, BRD-K11072003-001-01-6","Launched","","PIDFDZJZLOTZTM-KHVQSSSXSA-N","BRD-K11072003","","COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1"
"8163","PARITAPREVIR","HCV inhibitor","","infectious disease","hepatitis C","MedChemEx",97.16,"BRD-K89920762-001-01-4","Launched","","UAUIUKWPKRJZJV-QPLHLKROSA-N","BRD-K89920762","","Cc1cnc(cn1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)Oc1nc2ccccc2c2ccccc12)C(=O)NS(=O)(=O)C1CC1"
"8164","RIBAVIRIN","antiviral","ADK, ENPP1, IMPDH1, IMPDH2, NT5C2","infectious disease","hepatitis C","Tocris, Selleck, MicroSource",100,"BRD-K60369935-001-17-5, BRD-K60369935-001-18-3, BRD-K60369935-001-15-9","Launched","BRD-K94397152-001-01-6","IWUCXVSUMQZMFG-AFCXAGJDSA-N","BRD-K60369935","BRD-K94397152","NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O"
"8167","SIMEPREVIR","HCV inhibitor","CYP1A2, CYP3A4","infectious disease","hepatitis C","MedChemEx",98.75,"BRD-A68493689-001-01-9","Launched","","JTZZSQYMACOLNN-SNWGISBASA-N","BRD-A68493689","","COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C"
"8168","SOFOSBUVIR","RNA polymerase inhibitor","","infectious disease","hepatitis C","MedChemEx",98.52,"BRD-K05674516-001-02-5","Launched","","TTZHDVOVKQGIBA-YBSJRAAASA-N","BRD-K05674516","","CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1"
"8169","TELAPREVIR","HCV inhibitor","CTSA, PGR","infectious disease","hepatitis C","Selleck, Selleck",85.93,"BRD-K72912098-001-03-1, BRD-K72912098-001-02-3","Launched","BRD-K83470352-001-01-2","BBAWEDCPNXPBQM-GDEBMMAJSA-N","BRD-K72912098","BRD-K83470352","CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1"
"8171","MIRIPLATIN","DNA synthesis inhibitor","","oncology","hepatocellular carcinoma (HCC)","MedChemEx, MedChemEx",0,"BRD-M78068755-001-02-0, BRD-M78068755-001-01-2","Launched","","BGIHRZPJIYJKAZ-UHFFFAOYSA-N","BRD-M78068755","","[Pt++].NC1CCCCC1N.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O"
"8173","RONIDAZOLE","antiprotozoal agent","","infectious disease","histomoniasis, dysentry","MicroSource, Selleck",99.46,"BRD-K94266545-001-24-1, BRD-K94266545-001-23-3","Launched","","PQFRTXSWDXZRRS-UHFFFAOYSA-N","BRD-K94266545","","Cn1c(COC(N)=O)ncc1[N+]([O-])=O"
"8175","BETAINE","nitric oxide donor","","metabolism","homocystinuria","MicroSource",0,"BRD-K12014493-001-02-2","Launched","BRD-M80997309-001-09-2","KWIUHFFTVRNATP-UHFFFAOYSA-O","BRD-K12014493","BRD-M80997309","C[N+](C)(C)CC(O)=O"
"8176","PYRANTEL-PAMOATE","neuromuscular blocker","","infectious disease","hookworm, tapeworm","MedChemEx, MedChemEx, MicroSource",94.32,"BRD-K20672254-096-06-7, BRD-K20672254-046-05-4, BRD-K20672254-096-03-4","Launched","","YSAUAVHXTIETRK-AATRIKPKSA-N","BRD-K20672254","","CN1CCCN=C1\C=C\c1cccs1"
"8179","ABACAVIR","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Selleck, MicroSource",98.81,"BRD-K17443395-065-03-0, BRD-K17443395-065-01-4, BRD-K17443395-065-02-2","Launched","BRD-M55852627-065-01-7, BRD-M42309903-065-03-5, BRD-A95032015-065-01-2","MCGSCOLBFJQGHM-SCZZXKLOSA-N","BRD-K17443395","BRD-M55852627","Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1"
"8182","AMPRENAVIR","HIV protease inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",95.63,"BRD-K47827687-001-02-2","Launched","","YMARZQAQMVYCKC-OEMFJLHTSA-N","BRD-K47827687","","CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1"
"8183","ATAZANAVIR","HIV protease inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",97.57,"BRD-K09757388-065-04-0","Launched","","AXRYRYVKAWYZBR-GASGPIRDSA-N","BRD-K09757388","","COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C"
"8184","COBICISTAT","cytochrome P450 inhibitor","CYP3A4, CYP3A43, CYP3A5, CYP3A7","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",95.36,"BRD-K51040301-001-02-1","Launched","","ZCIGNRJZKPOIKD-CQXVEOKZSA-N","BRD-K51040301","","CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1"
"8185","DARUNAVIR","HIV protease inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",98.7,"BRD-K84986517-001-01-8","Launched","BRD-M22677129-001-01-6","CJBJHOAVZSMMDJ-HEXNFIEUSA-N","BRD-K84986517","BRD-M22677129","CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1"
"8186","DELAVIRDINE","non-nucleoside reverse transcriptase inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Sigma, MedChemEx, Enzo",95.35,"BRD-K34068325-066-04-5, BRD-K34068325-066-02-9, BRD-K34068325-066-03-7, BRD-K34068325-066-01-1","Launched","","WHBIGIKBNXZKFE-UHFFFAOYSA-N","BRD-K34068325","","CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1"
"8190","DIDANOSINE","nucleoside reverse transcriptase inhibitor","PNP","infectious disease","human immunodeficiency virus (HIV-1)","Selleck, Selleck",99.4,"BRD-K99063460-001-13-1, BRD-K99063460-001-12-3","Launched","","BXZVVICBKDXVGW-NKWVEPMBSA-N","BRD-K99063460","","OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12"
"8192","DOLUTEGRAVIR","HIV integrase inhibitor","CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",91.66,"BRD-K36386086-001-01-1","Launched","","RHWKPHLQXYSBKR-BONVTDFDSA-N","BRD-K36386086","","C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12"
"8193","EFAVIRENZ","HIV protease inhibitor","CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Enzo",98.9,"BRD-K40758068-001-08-2","Launched","","XPOQHMRABVBWPR-ZDUSSCGKSA-N","BRD-K40758068","","FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1"
"8194","ELVITEGRAVIR","HIV integrase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",94.69,"BRD-K54472332-001-03-4","Launched","","JUZYLCPPVHEVSV-LJQANCHMSA-N","BRD-K54472332","","COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C"
"8195","EMTRICITABINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",96.41,"BRD-K61452026-001-04-6","Launched","","XQSPYNMVSIKCOC-NTSWFWBYSA-N","BRD-K61452026","","Nc1nc(=O)n(cc1F)[C@@H]1CS[C@H](CO)O1"
"8196","ETRAVIRINE","non-nucleoside reverse transcriptase inhibitor","CYP2C19, CYP2C9, CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",92.21,"BRD-K74717603-001-02-2","Launched","","PYGWGZALEOIKDF-UHFFFAOYSA-N","BRD-K74717603","","Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N"
"8197","FOSAMPRENAVIR","HIV protease inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","MedChemEx",93.28,"BRD-K59110290-238-01-7","Launched","","MLBVMOWEQCZNCC-OEMFJLHTSA-N","BRD-K59110290","","CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1"
"8198","INDINAVIR","HIV protease inhibitor","CYP3A4, CYP3A5, CYP3A7","infectious disease","human immunodeficiency virus (HIV-1)","Enzo",97.93,"BRD-K33226500-001-01-0","Launched","","CBVCZFGXHXORBI-PXQQMZJSSA-N","BRD-K33226500","","CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12"
"8199","LOPINAVIR","HIV protease inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",98.22,"BRD-K99451608-001-07-3","Launched","","KJHKTHWMRKYKJE-SUGCFTRWSA-N","BRD-K99451608","","CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1"
"8200","MARAVIROC","CC chemokine receptor antagonist","CCR5","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Selleck",95.18,"BRD-A04352665-001-06-1, BRD-A04352665-001-05-3","Launched","","GSNHKUDZZFZSJB-ILVMPNSOSA-N","BRD-A04352665","","CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1"
"8202","NELFINAVIR","HIV protease inhibitor","CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7","infectious disease","human immunodeficiency virus (HIV-1)","Enzo",98.14,"BRD-K74117820-066-10-8","Launched","","QAGYKUNXZHXKMR-HKWSIXNMSA-N","BRD-K74117820","","Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C"
"8203","NEVIRAPINE","non-nucleoside reverse transcriptase inhibitor","CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5","infectious disease","human immunodeficiency virus (HIV-1)","MicroSource, Selleck",99.37,"BRD-K15502390-001-20-9, BRD-K15502390-001-19-1","Launched","","NQDJXKOVJZTUJA-UHFFFAOYSA-N","BRD-K15502390","","Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1"
"8205","RALTEGRAVIR","HIV integrase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck, Selleck",94.8,"BRD-K05658747-001-02-9, BRD-K05658747-001-03-7","Launched","","CZFFBEXEKNGXKS-UHFFFAOYSA-N","BRD-K05658747","","Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C"
"8207","RIFABUTIN","protein synthesis inhibitor","HSP90AA1, HSP90B1","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",94.51,"BRD-K30563334-001-02-9","Launched","","AZFBLLCNOQPJGJ-NYGPAKPVSA-N","BRD-K30563334","","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(c(O)c3C)c(O)c(NC(=O)\C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c1=NC3(CCN(CC(C)C)CC3)N=c21"
"8208","RILPIVIRINE","non-nucleoside reverse transcriptase inhibitor","NR1I2, SCN10A","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",93.71,"BRD-K06240250-001-01-6","Launched","","YIBOMRUWOWDFLG-ONEGZZNKSA-N","BRD-K06240250","","Cc1cc(\C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1"
"8209","RITONAVIR","HIV protease inhibitor","CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7","infectious disease","human immunodeficiency virus (HIV-1)","Selleck",98.16,"BRD-K51485625-001-08-4","Launched","","NCDNCNXCDXHOMX-XGKFQTDJSA-N","BRD-K51485625","","CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1"
"8210","SAQUINAVIR","HIV protease inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Enzo",98.75,"BRD-K09963420-066-12-5, BRD-A26690767-066-01-9","Launched","","QWAXKHKRTORLEM-UGJKXSETSA-N","BRD-K09963420","","CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1"
"8211","SAQUINAVIR","HIV protease inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Enzo",98.75,"BRD-K09963420-066-12-5, BRD-A26690767-066-01-9","Launched","","QWAXKHKRTORLEM-UGJKXSETSA-N","BRD-K09963420","","CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1"
"8212","SAQUINAVIR","HIV protease inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Enzo",98.75,"BRD-K09963420-066-12-5, BRD-A26690767-066-01-9","Launched","","QWAXKHKRTORLEM-LINFGICFSA-N","BRD-K09963420","","CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1"
"8213","SAQUINAVIR","HIV protease inhibitor","CYP3A4","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Enzo",98.75,"BRD-K09963420-066-12-5, BRD-A26690767-066-01-9","Launched","","QWAXKHKRTORLEM-LINFGICFSA-N","BRD-K09963420","","CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1"
"8214","STAVUDINE","DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Tocris, Selleck, MicroSource",98.42,"BRD-K93880783-001-27-4, BRD-K93880783-001-28-2, BRD-K93880783-001-26-6","Launched","BRD-A06317634-001-10-2","XNKLLVCARDGLGL-JGVFFNPUSA-N","BRD-K93880783","BRD-A06317634","Cc1cn([C@@H]2O[C@H](CO)C=C2)c(=O)[nH]c1=O"
"8217","TIPRANAVIR","HIV protease inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","MedChemEx, MedChemEx",88.06,"BRD-A10039652-001-02-0, BRD-A10039652-001-01-2","Launched","","MYXACKZCYFKMTE-JETRDCLMSA-N","BRD-A10039652","","CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1"
"8219","ZALCITABINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1)","Selleck, MicroSource",100,"BRD-K85925969-001-16-6, BRD-K85925969-001-17-4","Launched","","WREGKURFCTUGRC-POYBYMJQSA-N","BRD-K85925969","","Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1"
"8221","ZIDOVUDINE","nucleoside reverse transcriptase inhibitor","TERT","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)","Selleck, MicroSource",99.36,"BRD-K72903603-001-24-4, BRD-A33692381-001-01-9","Launched","","HBOMLICNUCNMMY-XLPZGREQSA-N","BRD-K72903603","","Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O"
"8222","ZIDOVUDINE","nucleoside reverse transcriptase inhibitor","TERT","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)","Selleck, MicroSource",99.36,"BRD-K72903603-001-24-4, BRD-A33692381-001-01-9","Launched","","HBOMLICNUCNMMY-XLPZGREQSA-N","BRD-K72903603","","Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O"
"8223","ZIDOVUDINE","nucleoside reverse transcriptase inhibitor","TERT","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)","Selleck, MicroSource",99.36,"BRD-K72903603-001-24-4, BRD-A33692381-001-01-9","Launched","","HBOMLICNUCNMMY-UHFFFAOYSA-N","BRD-K72903603","","Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O"
"8224","ZIDOVUDINE","nucleoside reverse transcriptase inhibitor","TERT","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)","Selleck, MicroSource",99.36,"BRD-K72903603-001-24-4, BRD-A33692381-001-01-9","Launched","","HBOMLICNUCNMMY-UHFFFAOYSA-N","BRD-K72903603","","Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O"
"8225","LAMIVUDINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B","MicroSource, Selleck",96.67,"BRD-A02309928-001-04-1, BRD-K02992638-001-11-8","Launched","","JTEGQNOMFQHVDC-UHFFFAOYSA-N","BRD-A02309928","","Nc1ccn(C2CSC(CO)O2)c(=O)n1"
"8226","LAMIVUDINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B","MicroSource, Selleck",96.67,"BRD-A02309928-001-04-1, BRD-K02992638-001-11-8","Launched","","JTEGQNOMFQHVDC-UHFFFAOYSA-N","BRD-A02309928","","Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1"
"8227","LAMIVUDINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B","MicroSource, Selleck",96.67,"BRD-A02309928-001-04-1, BRD-K02992638-001-11-8","Launched","","JTEGQNOMFQHVDC-NKWVEPMBSA-N","BRD-A02309928","","Nc1ccn(C2CSC(CO)O2)c(=O)n1"
"8228","LAMIVUDINE","nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B","MicroSource, Selleck",96.67,"BRD-A02309928-001-04-1, BRD-K02992638-001-11-8","Launched","","JTEGQNOMFQHVDC-NKWVEPMBSA-N","BRD-A02309928","","Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1"
"8229","TENOFOVIR","HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), hepatitis B","Selleck, MicroSource, Selleck",100,"BRD-K15891719-001-05-1, BRD-K15891719-213-01-1, BRD-K15891719-001-04-4","Launched","","SGOIRFVFHAKUTI-ZCFIWIBFSA-N","BRD-K15891719","","C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O"
"8232","TENOFOVIR-DISOPROXIL","nucleoside reverse transcriptase inhibitor","CYP1A2","infectious disease","human immunodeficiency virus (HIV-1), hepatitis B","Selleck, Selleck",95.24,"BRD-K61868322-051-06-4, BRD-K61868322-050-01-7","Launched","","JFVZFKDSXNQEJW-CQSZACIVSA-N","BRD-K61868322","","CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C"
"8234","RIBOSTAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)","MedChemEx, Bosche",73.8,"BRD-K55188888-065-01-2, BRD-A86073102-001-01-6","Launched","","NSKGQURZWSPSBC-VVPCINPTSA-N","BRD-K55188888","","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"8235","RIBOSTAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)","MedChemEx, Bosche",73.8,"BRD-K55188888-065-01-2, BRD-A86073102-001-01-6","Launched","","NSKGQURZWSPSBC-VVPCINPTSA-N","BRD-K55188888","","NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(O)C2O)C(N)C(O)C1O"
"8236","RIBOSTAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)","MedChemEx, Bosche",73.8,"BRD-K55188888-065-01-2, BRD-A86073102-001-01-6","Launched","","NSKGQURZWSPSBC-UHFFFAOYSA-N","BRD-K55188888","","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O"
"8237","RIBOSTAMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)","MedChemEx, Bosche",73.8,"BRD-K55188888-065-01-2, BRD-A86073102-001-01-6","Launched","","NSKGQURZWSPSBC-UHFFFAOYSA-N","BRD-K55188888","","NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(O)C2O)C(N)C(O)C1O"
"8238","SPIRONOLACTONE","mineralocorticoid receptor antagonist","AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG","endocrinology, cardiology, gastroenterology, rheumatology","hyperaldosteronism, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, hypertension, hypokalemia","Tocris, MicroSource, Selleck, Selleck",98.19,"BRD-K90027355-001-16-6, BRD-K90027355-001-19-0, BRD-K90027355-001-20-8, BRD-K90027355-001-13-3","Launched","BRD-A97808748-001-03-8, BRD-A71422083-001-15-5,BRD-K30171400-001-01-2","LXMSZDCAJNLERA-ZHYRCANASA-N","BRD-K90027355","BRD-A97808748","CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12"
"8242","CARGLUMIC-ACID","carbamoyl phosphate synthase activator","CPS1","metabolism","hyperammonemia","MicroSource",100,"BRD-K60240222-001-01-4","Launched","","LCQLHJZYVOQKHU-VKHMYHEASA-N","BRD-K60240222","","NC(=O)N[C@@H](CCC(O)=O)C(O)=O"
"8243","PAMIDRONATE","bone resorption inhibitor","FDPS","endocrinology, oncology, hematologic malignancy","hypercalcemia, Paget's disease, breast cancer, multiple myeloma","Selleck, Selleck",0,"BRD-K58513245-304-03-5, BRD-K58513245-304-02-7","Launched","","WRUUGTRCQOWXEG-UHFFFAOYSA-N","BRD-K58513245","","NCCC(O)(P(O)(O)=O)P(O)(O)=O"
"8245","DEXAMETHASONE","glucocorticoid receptor agonist","ANXA1, NOS2, NR0B1, NR3C1, NR3C2","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Tocris, Selleck, Tocris",96.19,"BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7","Launched","BRD-A27572786-001-01-2, BRD-K45192137-001-01-1, BRD-A27572786-001-02-0","UREBDLICKHMUKA-QCYOSJOCSA-N","BRD-A10188456","BRD-A27572786","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"8246","DEXAMETHASONE","glucocorticoid receptor agonist","ANXA1, NOS2, NR0B1, NR3C1, NR3C2","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Tocris, Selleck, Tocris",96.19,"BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7","Launched","BRD-A27572786-001-01-2, BRD-K45192137-001-01-1, BRD-A27572786-001-02-0","UREBDLICKHMUKA-QCYOSJOCSA-N","BRD-A10188456","BRD-A27572786","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"8249","DEXAMETHASONE","glucocorticoid receptor agonist","ANXA1, NOS2, NR0B1, NR3C1, NR3C2","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Tocris, Selleck, Tocris",96.19,"BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7","Launched","BRD-A27572786-001-01-2, BRD-K45192137-001-01-1, BRD-A27572786-001-02-0","UREBDLICKHMUKA-CXSFZGCWSA-N","BRD-A10188456","BRD-A27572786","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"8250","DEXAMETHASONE","glucocorticoid receptor agonist","ANXA1, NOS2, NR0B1, NR3C1, NR3C2","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Tocris, Selleck, Tocris",96.19,"BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7","Launched","BRD-A27572786-001-01-2, BRD-K45192137-001-01-1, BRD-A27572786-001-02-0","UREBDLICKHMUKA-CXSFZGCWSA-N","BRD-A10188456","BRD-A27572786","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
"8253","DEXAMETHASONE-ACETATE","glucocorticoid receptor agonist","","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Selleck",97.02,"BRD-K47635719-001-21-1, BRD-K47635719-001-20-3","Launched","BRD-A93424738-001-04-8, BRD-K40063336-001-01-8","AKUJBENLRBOFTD-RPRRAYFGSA-N","BRD-K47635719","BRD-A93424738","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O"
"8255","DEXAMETHASONE-SODIUM-PHOSPHATE","glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, MicroSource",95.47,"BRD-A79380603-304-02-4, BRD-A83802939-304-04-2","Launched","","VQODGRNSFPNSQE-REKGUKDCSA-N","BRD-A79380603","","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O"
"8256","DEXAMETHASONE-SODIUM-PHOSPHATE","glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, MicroSource",95.47,"BRD-A79380603-304-02-4, BRD-A83802939-304-04-2","Launched","","VQODGRNSFPNSQE-REKGUKDCSA-N","BRD-A79380603","","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O"
"8257","DEXAMETHASONE-SODIUM-PHOSPHATE","glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, MicroSource",95.47,"BRD-A79380603-304-02-4, BRD-A83802939-304-04-2","Launched","","VQODGRNSFPNSQE-QCYOSJOCSA-N","BRD-A79380603","","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O"
"8258","DEXAMETHASONE-SODIUM-PHOSPHATE","glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, MicroSource",95.47,"BRD-A79380603-304-02-4, BRD-A83802939-304-04-2","Launched","","VQODGRNSFPNSQE-QCYOSJOCSA-N","BRD-A79380603","","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O"
"8259","METHYLPREDNISOLONE","glucocorticoid receptor agonist","NR3C1","endocrinology, rheumatology, dermatology, infectious disease, allergy, hematology, neurology/psychiatry, gastroenterology","hypercalcemia, thyroiditis, ankylosing spondylitis, bursitis, osteoarthritis, psoriatic arthritis, seborrheic dermatitis, mycosis, allergic rhinitis, psoriasis, anemia, multiple sclerosis, ulcerative colitis, enteritis","Tocris, Selleck, MicroSource",95.49,"BRD-K35240538-001-24-7, BRD-K35240538-001-25-4, BRD-K35240538-001-26-2","Launched","BRD-K99443616-001-01-3, BRD-A53176877-001-04-3","VHRSUDSXCMQTMA-PJHHCJLFSA-N","BRD-K35240538","BRD-K99443616","C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12"
"8262","METHYLPREDNISOLONE-SODIUM-SUCCINATE","glucocorticoid receptor agonist","","endocrinology, rheumatology, dermatology, pulmonary, allergy, infectious disease, ophthalmology, gastroenterology, hematology, neurology/psychiatry","hypercalcemia, thyroiditis, osteoarthritis, rheumatoid arthritis, seborrheic dermatitis, asthma, allergic rhinitis, shingles, conjunctivitis, ulcerative colitis, enteritis, anemia, multiple sclerosis, mycosis","MicroSource",85.4,"BRD-A45044890-236-02-3","Launched","","IMBXEJJVJRTNOW-RCSGDJEUSA-N","BRD-A45044890","","C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12"
"8263","LOMITAPIDE","microsomal trigylceride transfer protein inhibitor","MTTP","endocrinology","hypercholesterolemia","MedChemEx",91.88,"BRD-K92213669-001-01-3","Launched","","MBBCVAKAJPKAKM-UHFFFAOYSA-N","BRD-K92213669","","FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c2ccccc2-c2ccc(cc2)C(F)(F)F)c2ccccc2-c2ccccc12"
"8264","FLUVASTATIN","HMGCR inhibitor","HMGCR","endocrinology, cardiology","hypercholesterolemia, congenital heart defects","Selleck, MicroSource, Tocris, Selleck",97.47,"BRD-K66296774-236-11-3, BRD-K66296774-001-07-9, BRD-K66296774-236-12-1, BRD-K66296774-236-10-5","Launched","BRD-M74726084-304-01-9","FJLGEFLZQAZZCD-MCBHFWOFSA-N","BRD-K66296774","BRD-M74726084","CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12"
"8268","SIMVASTATIN","HMGCR inhibitor","HMGCR, ITGB2","endocrinology, cardiology, neurology/psychiatry","hypercholesterolemia, coronary heart disease, myocardial infarction, stroke, hyperlipidemia","Tocris, Selleck, MicroSource, Tocris, Selleck",91.31,"BRD-K22134346-001-28-0, BRD-K22134346-001-24-9, BRD-K22134346-001-22-3, BRD-K22134346-001-21-5, BRD-K22134346-001-30-6","Launched","BRD-K94986873-001-01-4","RYMZZMVNJRMUDD-HGQWONQESA-N","BRD-K22134346","BRD-K94986873","CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12"
"8273","FENOFIBRATE","PPAR receptor agonist","MMP25, PPARA","endocrinology","hypercholesterolemia, hypertriglyceridemia","Tocris, MicroSource, Selleck",99.56,"BRD-K50388907-001-32-0, BRD-K50388907-001-30-4, BRD-K50388907-001-29-6","Launched","","YMTINGFKWWXKFG-UHFFFAOYSA-N","BRD-K50388907","","CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1"
"8276","PRAVASTATIN","HMGCR inhibitor","HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Tocris, MicroSource, Tocris, Selleck",95.56,"BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9","Launched","BRD-K31447894-236-01-0","TUZYXOIXSAXUGO-PZAWKZKUSA-N","BRD-K60511616","BRD-K31447894","CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12"
"8277","PRAVASTATIN","HMGCR inhibitor","HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Tocris, MicroSource, Tocris, Selleck",95.56,"BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9","Launched","BRD-K31447894-236-01-0","TUZYXOIXSAXUGO-PZAWKZKUSA-N","BRD-K60511616","BRD-K31447894","CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12"
"8280","PRAVASTATIN","HMGCR inhibitor","HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Tocris, MicroSource, Tocris, Selleck",95.56,"BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9","Launched","BRD-K31447894-236-01-0","TUZYXOIXSAXUGO-XYLZAPOUSA-N","BRD-K60511616","BRD-K31447894","CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12"
"8281","PRAVASTATIN","HMGCR inhibitor","HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Tocris, MicroSource, Tocris, Selleck",95.56,"BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9","Launched","BRD-K31447894-236-01-0","TUZYXOIXSAXUGO-XYLZAPOUSA-N","BRD-K60511616","BRD-K31447894","CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12"
"8284","MIFEPRISTONE","glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR","endocrinology","hyperglycemia, diabetes mellitus","Tocris, MicroSource, Selleck, Selleck, Tocris",90.12,"BRD-K37270826-001-29-2, BRD-K37270826-001-31-8, BRD-K37270826-001-27-6, BRD-K37270826-001-30-0, BRD-K37270826-001-26-8","Launched","BRD-A79939557-001-01-7, BRD-K46504237-001-01-5","VKHAHZOOUSRJNA-GCNJZUOMSA-N","BRD-K37270826","BRD-A79939557","CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C"
"8289","ACIPIMOX","cholesterol inhibitor","HCAR2","endocrinology","hyperlipidemia","Tocris, MicroSource, Selleck",98.26,"BRD-K63736853-001-06-3, BRD-K63736853-001-04-8, BRD-K63736853-001-03-0","Launched","","DJQOOSBJCLSSEY-UHFFFAOYSA-N","BRD-K63736853","","Cc1cnc(c[n+]1[O-])C(O)=O"
"8292","CIPROFIBRATE","PPAR receptor agonist","PPARA","endocrinology","hyperlipidemia","MicroSource, Selleck",96.78,"BRD-A49358627-001-14-6, BRD-A49358627-001-13-8","Launched","","KPSRODZRAIWAKH-UHFFFAOYSA-N","BRD-A49358627","","CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O"
"8294","NICERITROL","NAD precursor","","endocrinology","hyperlipidemia","Kemprotec",97.86,"BRD-K11256763-001-01-5","Launched","","KUEUWHJGRZKESU-UHFFFAOYSA-N","BRD-K11256763","","O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1"
"8295","PITAVASTATIN","HMGCR inhibitor","HMGCR","endocrinology","hyperlipidemia","Tocris, Selleck",96.25,"BRD-K75958547-238-02-8, BRD-K75958547-238-01-0","Launched","BRD-M62817595-238-02-0, BRD-M62817595-238-01-2","VGYFMXBACGZSIL-MCBHFWOFSA-N","BRD-K75958547","BRD-M62817595","O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O"
"8297","CLOFIBRATE","PPAR receptor agonist","LPL, PPARA","endocrinology, cardiology","hyperlipidemia, cholesterol","MicroSource, Selleck, Selleck",99.05,"BRD-K45252063-001-13-6, BRD-K45252063-001-14-4, BRD-K45252063-001-12-8","Launched","","KNHUKKLJHYUCFP-UHFFFAOYSA-N","BRD-K45252063","","CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1"
"8300","GEMFIBROZIL","lipoprotein lipase activator","LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1","endocrinology, cardiology","hyperlipidemia, coronary heart disease","Selleck, MicroSource",97.18,"BRD-K11129031-001-26-7, BRD-K11129031-001-27-5","Launched","","HEMJJKBWTPKOJG-UHFFFAOYSA-N","BRD-K11129031","","Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1"
"8302","ROSUVASTATIN","HMGCR inhibitor","HMGCR","endocrinology, cardiology","hyperlipidemia, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, atherosclerosis","MicroSource, Selleck",93.46,"BRD-K82941592-238-03-7, BRD-K82941592-238-04-5","Launched","BRD-M41627219-238-01-7","BPRHUIZQVSMCRT-VEUZHWNKSA-N","BRD-K82941592","BRD-M41627219","CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O"
"8304","EZETIMIBE","cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1","endocrinology, metabolism","hyperlipidemia, hypercholesterolemia, sitosterolemia","MicroSource, Adooq, Selleck, Selleck",96.2,"BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2","Launched","BRD-K32180660-001-01-6","OLNTVTPDXPETLC-OJVMETQDSA-N","BRD-A41519720","BRD-K32180660","OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1"
"8305","EZETIMIBE","cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1","endocrinology, metabolism","hyperlipidemia, hypercholesterolemia, sitosterolemia","MicroSource, Adooq, Selleck, Selleck",96.2,"BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2","Launched","BRD-K32180660-001-01-6","OLNTVTPDXPETLC-OJVMETQDSA-N","BRD-A41519720","BRD-K32180660","O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1"
"8308","EZETIMIBE","cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1","endocrinology, metabolism","hyperlipidemia, hypercholesterolemia, sitosterolemia","MicroSource, Adooq, Selleck, Selleck",96.2,"BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2","Launched","BRD-K32180660-001-01-6","OLNTVTPDXPETLC-XPWALMASSA-N","BRD-A41519720","BRD-K32180660","OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1"
"8309","EZETIMIBE","cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1","endocrinology, metabolism","hyperlipidemia, hypercholesterolemia, sitosterolemia","MicroSource, Adooq, Selleck, Selleck",96.2,"BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2","Launched","BRD-K32180660-001-01-6","OLNTVTPDXPETLC-XPWALMASSA-N","BRD-A41519720","BRD-K32180660","O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1"
"8312","CHLORMADINONE-ACETATE","5 alpha reductase inhibitor","PGR","endocrinology","hypermenorrhea, amenorrhea, oligomenorrhea, polymenorrhea","MicroSource",99.74,"BRD-A01593789-001-03-1","Launched","","QMBJSIBWORFWQT-GDMUWPLKSA-N","BRD-A01593789","","CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O"
"8313","FALECALCITRIOL","vitamin D receptor agonist","VDR","endocrinology","hyperparathyroidism","MedChemEx, MedChemEx",89.51,"BRD-K08251020-001-02-8, BRD-K08251020-001-01-0","Launched","","XPYGGHVSFMUHLH-UUSULHAXSA-N","BRD-K08251020","","C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"8315","MAXACALCITOL","vitamin D receptor agonist","VDR","endocrinology","hyperparathyroidism","MedChemEx",95.36,"BRD-K81332461-001-01-4","Launched","","DTXXSJZBSTYZKE-OXMAATCFSA-N","BRD-K81332461","","[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H]"
"8316","CINACALCET","calcium channel activator","CASR","endocrinology, nephrology, oncology","hyperparathyroidism, chronic kidney disease (CKD), parathyroid carcinoma, hypercalcemia","Selleck",98.6,"BRD-K73838513-003-05-5","Launched","","VDHAWDNDOKGFTD-MRXNPFEDSA-N","BRD-K73838513","","C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12"
"8317","SAPROPTERIN","phenylalanine 4-hydroxylase stimulant","NOS3, PAH, TH, TPH1","metabolism","hyperphenylalaninemia (HPA)","Cayman, Cayman, Cayman",84.77,"BRD-K36859431-300-04-9, BRD-K36859431-300-03-1, BRD-K36859431-300-02-3","Launched","","FNKQXYHWGSIFBK-RPDRRWSUSA-N","BRD-K36859431","","C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1"
"8320","CABERGOLINE","dopamine receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7","endocrinology","hyperprolactinemia","Tocris, Enzo",94.48,"BRD-K86882815-001-05-7, BRD-K86882815-001-03-2","Launched","BRD-K34586087-001-01-7","KORNTPPJEAJQIU-KJXAQDMKSA-N","BRD-K86882815","BRD-K34586087","CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1"
"8322","QUINAGOLIDE","dopamine receptor agonist","DRD2","endocrinology","hyperprolactinemia","MedChemEx",90.35,"BRD-K02995728-003-01-9","Launched","","GDFGTRDCCWFXTG-ZIFCJYIRSA-N","BRD-K02995728","","CCCN1C[C@H](C[C@@H]2Cc3c(O)cccc3C[C@@H]12)NS(=O)(=O)N(CC)CC"
"8323","BROMOCRIPTINE","dopamine receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7","endocrinology, neurology/psychiatry","hyperprolactinemia, Parkinson's Disease, acromegaly","Tocris, MicroSource, Tocris",93.48,"BRD-K14496212-066-03-0, BRD-K14496212-066-04-8, BRD-K14496212-066-02-2","Launched","BRD-A80151636-066-04-8","OZVBMTJYIDMWIL-AYFBDAFISA-N","BRD-K14496212","BRD-A80151636","CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C"
"8326","ALACEPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","Key",98.51,"BRD-K51784806-001-01-6","Launched","","FHHHOYXPRDYHEZ-COXVUDFISA-N","BRD-K51784806","","C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O"
"8327","ALISKIREN-HEMIFUMARATE","renin inhibitor","REN","cardiology","hypertension","Tocris, MicroSource, Selleck",95.42,"BRD-K30020243-051-04-1, BRD-K30020243-051-02-5, BRD-K30020243-051-03-3","Launched","BRD-M18497616-051-03-6, BRD-K30020243-001-01-2,BRD-M18497616-051-02-8","UXOWGYHJODZGMF-QORCZRPOSA-N","BRD-K30020243","BRD-M18497616","COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC"
"8330","ALTHIAZIDE","diuretic","","cardiology","hypertension","MicroSource",99.56,"BRD-A56675431-001-12-3","Launched","","VGLGVJVUHYTIIU-UHFFFAOYSA-N","BRD-A56675431","","NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl"
"8331","AZELNIDIPINE","calcium channel blocker","CACNA1C","cardiology","hypertension","MedChemEx, Selleck, Selleck",91.33,"BRD-A01098288-001-06-0, BRD-A01098288-001-04-5, BRD-A01098288-001-02-9","Launched","","ZKFQEACEUNWPMT-UHFFFAOYSA-N","BRD-A01098288","","CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1"
"8334","AZILSARTAN","angiotensin receptor antagonist","AGTR1, AGTR2","cardiology","hypertension","Tocris, Selleck",97.15,"BRD-K81074237-001-03-1, BRD-K81074237-001-02-3","Launched","","KGSXMPPBFPAXLY-UHFFFAOYSA-N","BRD-K81074237","","CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1"
"8336","AZILSARTAN-MEDOXOMIL","angiotensin receptor antagonist","AGTR1, AGTR2","cardiology","hypertension","Selleck, MicroSource, Selleck",92.61,"BRD-K25723200-001-03-5, BRD-K25723200-237-01-9, BRD-K25723200-001-02-7","Launched","","QJFSABGVXDWMIW-UHFFFAOYSA-N","BRD-K25723200","","CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1"
"8339","BARNIDIPINE","calcium channel blocker","","cardiology","hypertension","AKSci",92.07,"BRD-K78781788-003-01-9","Launched","","VXMOONUMYLCFJD-DHLKQENFSA-N","BRD-K78781788","","COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1"
"8340","BENAZEPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","MicroSource, Tocris, Tocris, Selleck",98.78,"BRD-K49807096-003-16-3, BRD-K49807096-003-15-5, BRD-K49807096-003-17-1, BRD-K49807096-003-14-8","Launched","","XPCFTKFZXHTYIP-PMACEKPBSA-N","BRD-K49807096","","CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O"
"8344","BENDROFLUMETHIAZIDE","sodium/potassium/chloride transporter inhibitor","CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3","cardiology","hypertension","MicroSource, Selleck",98.28,"BRD-A80017228-001-25-7, BRD-A80017228-001-24-0","Launched","","HDWIHXWEUNVBIY-UHFFFAOYSA-N","BRD-A80017228","","NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F"
"8346","BENIDIPINE","calcium channel blocker","CACNA1C, CACNA1G","cardiology","hypertension","Selleck, Selleck",97.05,"BRD-K97181463-003-02-9, BRD-K97181463-003-01-1","Launched","","QZVNQOLPLYWLHQ-ZEQKJWHPSA-N","BRD-K97181463","","COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1"
"8348","BISOPROLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension","MicroSource, Tocris, Selleck, Selleck",95.41,"BRD-A89175223-051-14-8, BRD-A89175223-051-15-5, BRD-A89175223-051-13-0, BRD-A89175223-051-16-3","Launched","BRD-M21493215-051-04-3","VHYCDWMUTMEGQY-UHFFFAOYSA-N","BRD-A89175223","BRD-M21493215","CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1"
"8352","CADRALAZINE","adrenergic receptor antagonist","","cardiology","hypertension","Key",57.47,"BRD-A78134170-001-01-3","Launched","","QLTVVOATEHFXLT-UHFFFAOYSA-N","BRD-A78134170","","CCOC(=O)NNc1ccc(nn1)N(CC)CC(C)O"
"8353","CHLOROTHIAZIDE","diuretic","CA1, CA2, CA4, SLC12A3","cardiology","hypertension","MicroSource, Selleck",95.43,"BRD-K88682005-001-16-6, BRD-K88682005-001-15-8","Launched","","JBMKAUGHUNFTOL-UHFFFAOYSA-N","BRD-K88682005","","NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O"
"8355","CILNIDIPINE","calcium channel blocker","CACNA1B","cardiology","hypertension","Selleck, Tocris, Tocris, Selleck",95.59,"BRD-A02743701-001-04-4, BRD-A02743701-001-03-6, BRD-A02743701-001-06-9, BRD-A02743701-001-02-8","Launched","BRD-A07875874-001-03-2","KJEBULYHNRNJTE-DHZHZOJOSA-N","BRD-A02743701","BRD-A07875874","COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1"
"8359","CLEVIPREX","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1S","cardiology","hypertension","Selleck",96.26,"BRD-A01563671-001-02-7","Launched","","KPBZROQVTHLCDU-UHFFFAOYSA-N","BRD-A01563671","","CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC"
"8360","CLOPAMIDE","sodium/chloride cotransporter inhibitor","","cardiology","hypertension","Selleck",98.21,"BRD-A85651701-001-19-7","Launched","","LBXHRAWDUMTPSE-UHFFFAOYSA-N","BRD-A85651701","","CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O"
"8361","CYCLOTHIAZIDE","glutamate receptor modulator","CA1, CA2, CA4, FXYD2, GRIA1, GRIA2, GRIA3, GRIA4, SLC12A3","cardiology","hypertension","Tocris, MicroSource, Sigma, DuPont, Tocris",65.61,"BRD-A38675539-001-13-5, BRD-A38675539-001-11-9, BRD-A38675539-001-14-3, BRD-A38675539-001-12-7, BRD-A38675539-001-10-1","Launched","BRD-A38639147-001-17-6","BOCUKUHCLICSIY-UHFFFAOYSA-N","BRD-A38675539","BRD-A38639147","NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl"
"8366","DEBRISOQUIN","adrenergic neuron blocker","SLC6A2","cardiology","hypertension","PrincetonBio, MicroSource",80.31,"BRD-K80419150-001-02-4, BRD-K80419150-065-03-7","Launched","","JWPGJSVJDAJRLW-UHFFFAOYSA-N","BRD-K80419150","","NC(=N)N1CCc2ccccc2C1"
"8368","DELAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","AKSci",94.88,"BRD-K00573984-003-01-5","Launched","","WOUOLAUOZXOLJQ-MBSDFSHPSA-N","BRD-K00573984","","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(O)=O)C1Cc2ccccc2C1"
"8369","DESERPIDINE","angiotensin converting enzyme inhibitor","ACE, SLC18A2","cardiology","hypertension","Key, AKSci",96.99,"BRD-K29462201-001-02-7, BRD-K29462201-001-01-9","Launched","","CVBMAZKKCSYWQR-WCGOZPBSSA-N","BRD-K29462201","","CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1"
"8371","ENALAPRILAT","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","MicroSource, MedChemEx, Selleck, MedChemEx, Selleck",83.84,"BRD-K99447003-335-03-3, BRD-K99447003-335-05-8, BRD-K99447003-335-02-5, BRD-K99447003-335-06-6, BRD-K99447003-335-04-1","Launched","","LZFZMUMEGBBDTC-QEJZJMRPSA-N","BRD-K99447003","","C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O"
"8376","EPOPROSTENOL","prostacyclin analog","P2RY12, PTGER1, PTGER4, PTGIR, PTGIS","cardiology","hypertension","Enzo",36.41,"BRD-K64054020-001-03-5","Launched","","KAQKFAOMNZTLHT-OZUDYXHBSA-N","BRD-K64054020","","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O"
"8377","EPROSARTAN","angiotensin receptor antagonist","AGTR1","cardiology","hypertension","Selleck, Selleck",99.15,"BRD-K67977190-066-02-3, BRD-K67977190-066-03-1","Launched","","OROAFUQRIXKEMV-LDADJPATSA-N","BRD-K67977190","","CCCCc1ncc(\C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O"
"8379","FELODIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2","cardiology","hypertension","Tocris, MicroSource, Selleck",98.85,"BRD-A30815329-001-12-1, BRD-A30815329-001-10-5, BRD-A30815329-001-08-9","Launched","","RZTAMFZIAATZDJ-UHFFFAOYSA-N","BRD-A30815329","","CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC"
"8382","FENOLDOPAM","dopamine receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5","cardiology","hypertension","MicroSource, Tocris",94.55,"BRD-A50684349-066-11-7, BRD-A50684349-003-02-9","Launched","","TVURRHSHRRELCG-UHFFFAOYSA-N","BRD-A50684349","","Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12"
"8384","GUANABEN-ACETATE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","cardiology","hypertension","Tocris, Selleck, MicroSource, Selleck",95.27,"BRD-K62736196-015-10-2, BRD-K62736196-015-09-4, BRD-K62736196-015-13-6, BRD-K62736196-015-11-0","Launched","BRD-K56800335-015-04-9","WDZVGELJXXEGPV-YIXHJXPBSA-N","BRD-K62736196","BRD-K56800335","NC(=N)N\N=C\c1c(Cl)cccc1Cl"
"8388","GUANADREL","adrenergic inhibitor","SLC6A2","cardiology","hypertension","MicroSource",100,"BRD-A14262390-065-01-8","Launched","","HPBNRIOWIXYZFK-UHFFFAOYSA-N","BRD-A14262390","","NC(=N)NCC1COC2(CCCCC2)O1"
"8389","GUANETHIDINE","adrenergic inhibitor","SLC6A2","cardiology","hypertension","MicroSource, Selleck",100,"BRD-K62676709-001-01-9, BRD-K62676709-065-05-5","Launched","BRD-M18219129-065-04-2","ACGDKVXYNVEAGU-UHFFFAOYSA-N","BRD-K62676709","BRD-M18219129","NC(=N)NCCN1CCCCCCC1"
"8391","GUANFACINE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","cardiology","hypertension","MicroSource, MicroSource, Tocris",100,"BRD-K32830106-003-21-2, BRD-K32830106-001-02-6, BRD-K32830106-003-20-4","Launched","","INJOMKTZOLKMBF-UHFFFAOYSA-N","BRD-K32830106","","NC(=N)NC(=O)Cc1c(Cl)cccc1Cl"
"8394","HYDRALAZINE","vasodilator","AOC3, P4HA1","cardiology","hypertension","MicroSource, MedChemEx, Selleck, Selleck",87.04,"BRD-K82103381-003-07-8, BRD-K82103381-003-09-4, BRD-K82103381-003-06-0, BRD-K82103381-003-08-6","Launched","","RPTUSVTUFVMDQK-UHFFFAOYSA-N","BRD-K82103381","","NNc1nncc2ccccc12"
"8398","ISRADIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2","cardiology","hypertension","Tocris, MicroSource, Selleck, Tocris",97.4,"BRD-A90799790-001-20-7, BRD-A90799790-001-19-9, BRD-A90799790-001-16-5, BRD-A90799790-001-17-3","Launched","","HMJIYCCIJYRONP-UHFFFAOYSA-N","BRD-A90799790","","COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C"
"8402","KETANSERIN","serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2","cardiology","hypertension","MicroSource, Tocris, Selleck",98.5,"BRD-K49671696-046-01-8, BRD-K49671696-045-08-5, BRD-K49671696-001-05-4","Launched","","FPCCSQOGAWCVBH-UHFFFAOYSA-N","BRD-K49671696","","Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1"
"8405","LABETALOL","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2","cardiology","hypertension","MicroSource",95.95,"BRD-A07440155-003-25-4","Launched","","SGUAFYQXFOLMHL-UHFFFAOYSA-N","BRD-A07440155","","CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O"
"8406","LACIDIPINE","calcium channel blocker","CACNA1C","cardiology","hypertension","Selleck",95.57,"BRD-K43586850-001-02-9","Launched","","GKQPCPXONLDCMU-CCEZHUSRSA-N","BRD-K43586850","","CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1\C=C\C(=O)OC(C)(C)C)C(=O)OCC"
"8407","LERCANIDIPINE","calcium channel blocker","CACNA2D1, CACNG1","cardiology","hypertension","Sigma",98.03,"BRD-A18992208-003-02-7","Launched","","ZDXUKAKRHYTAKV-UHFFFAOYSA-N","BRD-A18992208","","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1"
"8408","MANIDIPINE","calcium channel blocker","CACNA1C, CACNA1D","cardiology","hypertension","MicroSource, Selleck, Selleck, Selleck",98.86,"BRD-A90695733-001-07-4, BRD-A90695733-300-02-1, BRD-A90695733-001-06-6, BRD-A90695733-001-08-2","Launched","","ANEBWFXPVPTEET-UHFFFAOYSA-N","BRD-A90695733","","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1"
"8412","MECAMYLAMINE","acetylcholine receptor antagonist","CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7","cardiology","hypertension","MicroSource",100,"BRD-A20119038-003-07-8","Launched","","IMYZQPCYWPFTAG-UHFFFAOYSA-N","BRD-A20119038","","CNC1(C)C2CCC(C2)C1(C)C"
"8413","METHYLDOPA","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C, DDC","cardiology","hypertension","Selleck, Selleck, Tocris, MicroSource",100,"BRD-K48578705-001-17-6, BRD-K48578705-001-14-3, BRD-K48578705-001-15-0, BRD-K48578705-001-16-8","Launched","","CJCSPKMFHVPWAR-JTQLQIEISA-N","BRD-K48578705","","C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O"
"8417","METHYLDOPATE","","","cardiology","hypertension","Prestwick",0,"BRD-K82259334-003-02-7","Launched","","SVEBYYWCXTVYCR-LBPRGKRZSA-N","BRD-K82259334","","CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1"
"8418","METIROSINE","tyrosine hydroxylase inhibitor","TH","cardiology","hypertension","Enamine",85.79,"BRD-K83766205-001-03-8","Launched","","NHTGHBARYWONDQ-JTQLQIEISA-N","BRD-K83766205","","C[C@](N)(Cc1ccc(O)cc1)C(O)=O"
"8419","MOEXIPRIL","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology","hypertension","Tocris, Selleck, Selleck",93.18,"BRD-K34441861-003-06-2, BRD-K34441861-003-05-4, BRD-K34441861-003-07-0","Launched","","UWWDHYUMIORJTA-HSQYWUDLSA-N","BRD-K34441861","","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O"
"8422","MOXONIDINE","imidazoline receptor agonist","ADRA2A, ADRA2B, ADRA2C","cardiology","hypertension","Tocris, Tocris, Selleck",96.96,"BRD-K77771411-003-10-7, BRD-K77771411-003-12-3, BRD-K77771411-001-12-7","Launched","","WPNJAUFVNXKLIM-UHFFFAOYSA-N","BRD-K77771411","","COc1nc(C)nc(Cl)c1NC1=NCCN1"
"8425","NEBIVOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension","Tocris, Tocris, Selleck, MicroSource",94.76,"BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2","Launched","","KOHIRBRYDXPAMZ-YHBROIRLSA-N","BRD-K04956647","","O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1"
"8428","NEBIVOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension","Tocris, Tocris, Selleck, MicroSource",94.76,"BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2","Launched","","KOHIRBRYDXPAMZ-YHBROIRLSA-N","BRD-K04956647","","OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1"
"8429","NEBIVOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension","Tocris, Tocris, Selleck, MicroSource",94.76,"BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2","Launched","","KOHIRBRYDXPAMZ-UHFFFAOYSA-N","BRD-K04956647","","O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1"
"8432","NEBIVOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension","Tocris, Tocris, Selleck, MicroSource",94.76,"BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2","Launched","","KOHIRBRYDXPAMZ-UHFFFAOYSA-N","BRD-K04956647","","OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1"
"8433","NISOLDIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNB2","cardiology","hypertension","MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",86.15,"BRD-A84465106-001-05-3, BRD-A84465106-001-09-5, BRD-A84465106-001-08-7, BRD-A84465106-001-03-8, BRD-A84465106-001-06-1","Launched","","VKQFCGNPDRICFG-UHFFFAOYSA-N","BRD-A84465106","","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C"
"8438","NITRENDIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4","cardiology","hypertension","Tocris, MicroSource, Selleck, Tocris",97.81,"BRD-A02006392-001-19-8, BRD-A02006392-001-17-2, BRD-A02006392-001-15-6, BRD-A02006392-001-16-4","Launched","","PVHUJELLJLJGLN-UHFFFAOYSA-N","BRD-A02006392","","CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC"
"8442","OLMESARTAN","angiotensin receptor antagonist","AGTR1","cardiology","hypertension","Tocris, MedChemEx, MicroSource, MedChemEx",95.2,"BRD-K83144676-001-09-5, BRD-K83144676-001-08-7, BRD-K83144676-001-06-1, BRD-K83144676-001-07-9","Launched","","VTRAEEWXHOVJFV-UHFFFAOYSA-N","BRD-K83144676","","CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O"
"8446","OLMESARTAN-MEDOXOMIL","angiotensin receptor antagonist","AGTR1","cardiology","hypertension","MicroSource, Tocris, Selleck",95.9,"BRD-K78485176-001-07-8, BRD-K78485176-001-09-4, BRD-K78485176-001-06-0","Launched","","UQGKUQLKSCSZGY-UHFFFAOYSA-N","BRD-K78485176","","CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1"
"8449","PARGYLINE","monoamine oxidase inhibitor","MAOA, MAOB","cardiology","hypertension","MicroSource",99.36,"BRD-K83597974-003-22-2","Launched","","DPWPWRLQFGFJFI-UHFFFAOYSA-N","BRD-K83597974","","CN(CC#C)Cc1ccccc1"
"8450","PEMPIDINE","ganglionic blocker","","cardiology","hypertension","MicroSource",52.72,"BRD-K71075093-045-14-7","Launched","","XULIXFLCVXWHRF-UHFFFAOYSA-N","BRD-K71075093","","CN1C(C)(C)CCCC1(C)C"
"8451","PENBUTOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, HTR1A, HTR1B","cardiology","hypertension","MicroSource",90.41,"BRD-K55705469-065-01-0","Launched","","KQXKVJAGOJTNJS-HNNXBMFYSA-N","BRD-K55705469","","CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1"
"8452","PENTOLINIUM","cholinergic receptor antagonist","CHRNA10, CHRNA3, CHRNA4, CHRNB4","cardiology","hypertension","Prestwick, Acros",97.01,"BRD-K44942604-346-04-7, BRD-K44942604-346-05-4","Launched","","XSBSKEQEUFOSDD-UHFFFAOYSA-N","BRD-K44942604","","C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1"
"8454","PINACIDIL","ATP channel activator, potassium channel activator","ABCC8, ABCC9","cardiology","hypertension","Selleck, MicroSource",98.87,"BRD-A43882281-001-14-8, BRD-A43882281-001-15-5","Launched","","IVVNZDGDKPTYHK-UHFFFAOYSA-N","BRD-A43882281","","CC(N\C(Nc1ccncc1)=N\C#N)C(C)(C)C"
"8456","PINDOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B","cardiology","hypertension","Selleck, Tocris, MicroSource",97.25,"BRD-A97701745-001-14-5, BRD-A97701745-001-15-2, BRD-A97701745-001-16-0","Launched","","JZQKKSLKJUAGIC-UHFFFAOYSA-N","BRD-A97701745","","CC(C)NCC(O)COc1cccc2[nH]ccc12"
"8459","PRAZOSIN","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7","cardiology","hypertension","Tocris, MicroSource, Selleck, Tocris",98.79,"BRD-K49111258-003-30-5, BRD-K49111258-003-29-7, BRD-K49111258-003-27-1, BRD-K49111258-003-28-9","Launched","","IENZQIKPVFGBNW-UHFFFAOYSA-N","BRD-K49111258","","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1"
"8463","QUINETHAZONE","thiazide diuretic","CA1, CA2, SLC12A1, SLC12A2, SLC12A3","cardiology","hypertension","MicroSource",98.85,"BRD-A59303141-001-10-4","Launched","","AGMMTXLNIQSRCG-UHFFFAOYSA-N","BRD-A59303141","","CCC1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O"
"8464","RAMIPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","MicroSource, Tocris, Selleck",98.06,"BRD-K89348303-001-14-7, BRD-K89348303-001-16-2, BRD-K89348303-001-17-0","Launched","BRD-K01296542-001-01-1","HDACQVRGBOVJII-JBDAPHQKSA-N","BRD-K89348303","BRD-K01296542","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O"
"8467","RESERPINE","vesicular monoamine transporter inhibitor","SLC18A1, SLC18A2","cardiology","hypertension","Selleck, Tocris, Selleck, MicroSource",88.29,"BRD-K95921201-001-15-3, BRD-K95921201-001-13-8, BRD-K95921201-001-12-0, BRD-K95921201-001-14-6","Launched","","QEVHRUUCFGRFIF-MDEJGZGSSA-N","BRD-K95921201","","CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1"
"8471","RILMENIDINE","adrenergic receptor agonist, imidazoline receptor agonist","ADRA2A","cardiology","hypertension","Tocris, Selleck",88.74,"BRD-K01638814-051-16-8, BRD-K01638814-011-01-4","Launched","BRD-M62162320-051-04-6","CQXADFVORZEARL-UHFFFAOYSA-N","BRD-K01638814","BRD-M62162320","C1CC1C(NC1=NCCO1)C1CC1"
"8473","RIOCIGUAT","guanylate cyclase stimulant","GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3","cardiology","hypertension","MedChemEx",99.03,"BRD-K84783599-001-01-0","Launched","","WXXSNCNJFUAIDG-UHFFFAOYSA-N","BRD-K84783599","","COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12"
"8474","SILDENAFIL","phosphodiesterase inhibitor","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3","cardiology","hypertension","Tocris, MicroSource, Selleck",99.19,"BRD-K79759585-048-07-1, BRD-K79759585-048-04-8, BRD-K79759585-048-03-0","Launched","","BNRNXUUZRGQAQC-UHFFFAOYSA-N","BRD-K79759585","","CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1"
"8477","TADALAFIL","phosphodiesterase inhibitor","PDE11A, PDE5A","cardiology","hypertension","MicroSource, Selleck",98.74,"BRD-K93645900-001-12-1, BRD-K93645900-001-11-3","Launched","","WOXKDUGGOYFFRN-IIBYNOLFSA-N","BRD-K93645900","","CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O"
"8479","TALINOLOL","adrenergic receptor antagonist","ADRB1","cardiology","hypertension","Cayman",90.03,"BRD-A94276798-001-01-4","Launched","","MXFWWQICDIZSOA-UHFFFAOYSA-N","BRD-A94276798","","CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1"
"8480","TELMISARTAN","angiotensin receptor antagonist","AGTR1, PPARG","cardiology","hypertension","MicroSource, Tocris, Selleck",99.08,"BRD-K73999723-001-11-3, BRD-K73999723-001-13-9, BRD-K73999723-001-10-5","Launched","","RMMXLENWKUUMAY-UHFFFAOYSA-N","BRD-K73999723","","CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C"
"8483","URAPIDIL","adrenergic receptor antagonist","HTR1A","cardiology","hypertension","MicroSource, Selleck, Tocris",97.01,"BRD-K73196317-003-15-5, BRD-K73196317-003-13-0, BRD-K73196317-003-14-8","Launched","","ICMGLRUYEQNHPF-UHFFFAOYSA-N","BRD-K73196317","","COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1"
"8486","VERAPAMIL","calcium channel blocker","CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4","cardiology","hypertension","Selleck, MicroSource",97.04,"BRD-A09533288-003-29-6, BRD-A09533288-003-31-2","Launched","","SGTNSNPWRIOYBX-UHFFFAOYSA-N","BRD-A09533288","","COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC"
"8488","ZOFENOPRIL-CALCIUM","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","MedChemEx",99.29,"BRD-K46654563-238-01-0","Launched","BRD-M85357167-001-01-2","IAIDUHCBNLFXEF-MNEFBYGVSA-N","BRD-K46654563","BRD-M85357167","C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@H](C[C@H]1C(O)=O)Sc1ccccc1"
"8489","DROXIDOPA","norepinephrine precursor","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH","cardiology, neurology/psychiatry","hypertension, Parkinson's Disease","Selleck, Selleck",100,"BRD-K20372197-001-02-3, BRD-K20372197-001-03-1","Launched","","QXWYKJLNLSIPIN-JGVFFNPUSA-N","BRD-K20372197","","N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O"
"8491","ATENOLOL-(+/-)","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension, angina pectoris","Tocris, MicroSource",85.31,"BRD-A20239487-001-24-9, BRD-A20239487-001-25-6","Launched","","METKIMKYRPQLGS-UHFFFAOYSA-N","BRD-A20239487","","CC(C)NCC(O)COc1ccc(CC(N)=O)cc1"
"8493","DILTIAZEM","calcium channel blocker","CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5","cardiology","hypertension, angina pectoris","Tocris, MicroSource, Selleck, Tocris",99.25,"BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0","Launched","","HSUGRBWQSSZJOP-RTWAWAEBSA-N","BRD-K24023109","","COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O"
"8494","DILTIAZEM","calcium channel blocker","CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5","cardiology","hypertension, angina pectoris","Tocris, MicroSource, Selleck, Tocris",99.25,"BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0","Launched","","HSUGRBWQSSZJOP-RTWAWAEBSA-N","BRD-K24023109","","COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O"
"8497","DILTIAZEM","calcium channel blocker","CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5","cardiology","hypertension, angina pectoris","Tocris, MicroSource, Selleck, Tocris",99.25,"BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0","Launched","","HSUGRBWQSSZJOP-UHFFFAOYSA-N","BRD-K24023109","","COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O"
"8498","DILTIAZEM","calcium channel blocker","CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5","cardiology","hypertension, angina pectoris","Tocris, MicroSource, Selleck, Tocris",99.25,"BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0","Launched","","HSUGRBWQSSZJOP-UHFFFAOYSA-N","BRD-K24023109","","COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O"
"8501","PROPRANOLOL","adrenergic receptor antagonist","","cardiology, neurology/psychiatry","hypertension, angina pectoris, migraine headache","MicroSource, Selleck, Tocris",97.75,"BRD-A10070317-003-30-9, BRD-A10070317-003-28-3, BRD-A10070317-003-29-1","Launched","","AQHHHDLHHXJYJD-UHFFFAOYSA-N","BRD-A10070317","","CC(C)NCC(O)COc1cccc2ccccc12"
"8504","METOPROLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension, angina pectoris, myocardial infarction","Tocris, MicroSource, Selleck",98.88,"BRD-A03623303-046-15-0, BRD-A03623303-045-09-5, BRD-A03623303-046-14-3","Launched","BRD-M45038741-045-02-7, BRD-M45038741-046-05-8","IUBSYMUCCVWXPE-UHFFFAOYSA-N","BRD-A03623303","BRD-M45038741","COCCc1ccc(OCC(O)CNC(C)C)cc1"
"8507","QUINAPRILAT","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, angioedema","MicroSource",0,"BRD-K42317111-001-01-7","Launched","","FLSLEGPOVLMJMN-YSSFQJQWSA-N","BRD-K42317111","","C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O"
"8508","CLONIDINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","cardiology, neurology/psychiatry","hypertension, attention-deficit/hyperactivity disorder (ADHD)","MicroSource, Tocris, Selleck",99.61,"BRD-K98530306-003-18-3, BRD-K98530306-003-17-5, BRD-K98530306-003-16-7","Launched","","GJSURZIOUXUGAL-UHFFFAOYSA-N","BRD-K98530306","","Clc1cccc(Cl)c1N=C1NCCN1"
"8511","GALLOPAMIL","L-type calcium channel blocker","ATP2A2","cardiology","hypertension, cardiac arrythmia","Enzo",97.61,"BRD-A52922642-001-03-7","Launched","","XQLWNAFCTODIRK-UHFFFAOYSA-N","BRD-A52922642","","COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC"
"8512","OUABAIN","ATPase inhibitor","ATP1A1","cardiology","hypertension, cardiac arrythmia","Tocris, MicroSource, Selleck",96.12,"BRD-K33277808-001-01-2, BRD-K33277808-331-01-3, BRD-K33277808-001-02-0","Launched","BRD-A68930007-331-01-6, BRD-A68930007-001-04-9,BRD-K92158972-331-01-3","LPMXVESGRSUGHW-VGFRVVOQSA-N","BRD-K33277808","BRD-A68930007","C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O"
"8515","NILVADIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2","cardiology","hypertension, cerebral artery occlusion","Selleck, Selleck",90.2,"BRD-A84687895-001-03-2, BRD-A84687895-001-04-0","Launched","","FAIIFDPAEUKBEP-UHFFFAOYSA-N","BRD-A84687895","","COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N"
"8517","AMLODIPINE","calcium channel blocker","CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1","cardiology","hypertension, chronic stable angina, vasospastic angina, coronary artery disease (CAD)","MicroSource, Tocris, Selleck, Tocris, Selleck, Selleck",92.46,"BRD-A22032524-074-09-9, BRD-A22032524-074-07-3, BRD-A22032524-001-03-5, BRD-A22032524-074-10-7, BRD-A22032524-074-06-5, BRD-A22032524-001-05-0","Launched","","HTIQEAQVCYTUBX-UHFFFAOYSA-N","BRD-A22032524","","CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC"
"8523","AMILORIDE","sodium channel blocker","AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2","cardiology","hypertension, congestive heart failure","MicroSource, Selleck, Selleck, Tocris",99.74,"BRD-K97181089-003-24-7, BRD-K97181089-310-06-3, BRD-K97181089-003-22-1, BRD-K97181089-003-23-9","Launched","","XSDQTOBWRPYKKA-UHFFFAOYSA-N","BRD-K97181089","","NC(=N)NC(=O)c1nc(Cl)c(N)nc1N"
"8527","CANDESARTAN","angiotensin receptor antagonist","AGTR1","cardiology","hypertension, congestive heart failure","Tocris, Selleck, MicroSource",98.75,"BRD-K84091759-001-10-5, BRD-K84091759-001-07-1, BRD-K84091759-001-08-9","Launched","","HTQMVQVXFRQIKW-UHFFFAOYSA-N","BRD-K84091759","","CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"8530","CANDESARTAN-CILEXTIL","angiotensin receptor antagonist","AGTR1, AGTR2","cardiology","hypertension, congestive heart failure","MicroSource, Selleck",98.51,"BRD-A65671304-001-08-3, BRD-A65671304-001-07-5","Launched","","GHOSNRCGJFBJIB-UHFFFAOYSA-N","BRD-A65671304","","CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"8532","CILAZAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, congestive heart failure","Selleck",97,"BRD-K65518078-002-01-1","Launched","","HHHKFGXWKKUNCY-GBESFXJTSA-N","BRD-K65518078","","CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O"
"8533","CYCLOPENTHIAZIDE","thiazide diuretic","","cardiology","hypertension, congestive heart failure","Prestwick",99.7,"BRD-A41250306-001-11-7","Launched","","BKYKPTRYDKTTJY-UHFFFAOYSA-N","BRD-A41250306","","NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl"
"8534","FOSINOPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, congestive heart failure","Selleck, Selleck",97.48,"BRD-A51382177-236-03-0, BRD-A51382177-236-04-8","Launched","","BIDNLKIUORFRQP-AJTMIRJTSA-N","BRD-A51382177","","CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C"
"8536","HYDROCHLOROTHIAZIDE","thiazide diuretic","CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3","cardiology","hypertension, congestive heart failure","Selleck, MicroSource",98.34,"BRD-K13078532-001-27-6, BRD-K13078532-001-28-4","Launched","","JZUFKLXOESDKRF-UHFFFAOYSA-N","BRD-K13078532","","NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl"
"8538","IMIDAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, congestive heart failure","Selleck",97.71,"BRD-K34332569-001-01-3","Launched","","KLZWOWYOHUKJIG-CWRNSKLLSA-N","BRD-K34332569","","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O"
"8539","INDAPAMIDE","thiazide diuretic","KCNE1, KCNQ1, SLC12A3","cardiology","hypertension, congestive heart failure","MicroSource, Selleck",96.25,"BRD-A95869247-001-26-9, BRD-A95869247-001-25-1","Launched","","NDDAHWYSQHTHNT-UHFFFAOYSA-N","BRD-A95869247","","CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O"
"8541","SODIUM-NITROPRUSSIDE","nitric oxide donor","","cardiology","hypertension, congestive heart failure","MicroSource, Selleck, Selleck",0,"BRD-K48526231-304-02-8, BRD-K48526231-304-03-6, BRD-K48526231-236-01-4","Launched","BRD-U32870953-000-01-8","WTISQLWAPBSCSF-UHFFFAOYSA-N","BRD-K48526231","BRD-U32870953","[O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N"
"8544","VALSARTAN","angiotensin receptor antagonist","AGTR1","cardiology","hypertension, congestive heart failure","MicroSource, Tocris, Selleck",99.42,"BRD-K45158365-001-11-4, BRD-K45158365-001-12-2, BRD-K45158365-001-10-6","Launched","","ACWBQPMHZXGDFX-QFIPXVFZSA-N","BRD-K45158365","","CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O"
"8547","QUINAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, congestive heart failure, angioedema","MicroSource, Selleck, Selleck",93.01,"BRD-K72222507-003-16-8, BRD-K72222507-003-15-0, BRD-K72222507-003-17-6","Launched","","JSDRRTOADPPCHY-HSQYWUDLSA-N","BRD-K72222507","","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O"
"8550","LISINOPRIL","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology, endocrinology","hypertension, congestive heart failure, diabetes mellitus","Selleck, MicroSource, Selleck",100,"BRD-K67966701-001-10-8, BRD-K67966701-001-11-6, BRD-K67966701-001-12-4","Launched","","RLAWWYSOJDYHDC-BZSNNMDCSA-N","BRD-K67966701","","NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O"
"8553","TEMOCAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology, nephrology","hypertension, congestive heart failure, diabetic nephropathy, coronary artery disease (CAD)","Selleck",97.25,"BRD-K10784860-003-02-3","Launched","","FIQOFIRCTOWDOW-BJLQDIEVSA-N","BRD-K10784860","","CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)c1cccs1"
"8554","ETACRYNIC-ACID","sodium/potassium/chloride transporter inhibitor","ATP1A1, SLC12A1","cardiology, gastroenterology, nephrology, rheumatology","hypertension, congestive heart failure, edema, hepatic cirrhosis, chronic renal failure, nephrotic syndrome","MicroSource",98.7,"BRD-K63630713-001-25-8","Launched","","AVOLMBLBETYQHX-UHFFFAOYSA-N","BRD-K63630713","","CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl"
"8555","FIMASARTAN","angiotensin receptor antagonist","AGTR1","cardiology","hypertension, congestive heart failure, hypertension, congestive heart failure","MedChemEx, MedChemEx",89.33,"BRD-K21586122-001-02-7, BRD-K21586122-001-01-9","Launched","BRD-K76786967-001-01-7","AMEROGPZOLAFBN-UHFFFAOYSA-N","BRD-K21586122","BRD-K76786967","CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"8557","ENALAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, congestive heart failure, left ventricular systolic dysfunction (LVSD)","Selleck, MicroSource",94.83,"BRD-K57545991-050-23-1, BRD-K57545991-050-24-9","Launched","","GBXSMTUPTTWBMN-XIRDDKMYSA-N","BRD-K57545991","","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O"
"8559","CAPTOPRIL","angiotensin converting enzyme inhibitor","ACE, LTA4H, MMP2, MMP9","cardiology, endocrinology, nephrology","hypertension, congestive heart failure, myocardial infarction, diabetes mellitus, diabetic nephropathy","MicroSource, Selleck, Selleck",100,"BRD-K54529596-001-25-5, BRD-K54529596-001-26-3, BRD-K54529596-001-28-9","Launched","BRD-K96855766-001-01-9","FAKRSMQSSFJEIM-RQJHMYQMSA-N","BRD-K54529596","BRD-K96855766","C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O"
"8562","BOPINDOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3, HTR1A, HTR1B","cardiology","hypertension, coronary artery disease (CAD)","Enzo",91.96,"BRD-A07563059-035-01-3","Launched","","UUOJIACWOAYWEZ-UHFFFAOYSA-N","BRD-A07563059","","Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1"
"8563","IRBESARTAN","angiotensin receptor antagonist","AGTR1, JUN, SLC10A1","cardiology, nephrology","hypertension, diabetic nephropathy","MicroSource, Selleck",98.6,"BRD-K60038276-001-09-0, BRD-K60038276-001-08-2","Launched","","YOSHYTLCDANDAN-UHFFFAOYSA-N","BRD-K60038276","","CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"8565","LOSARTAN","angiotensin receptor antagonist","AGTR1","cardiology, nephrology","hypertension, diabetic nephropathy","MicroSource, Tocris, Selleck, Pharmeks",97.85,"BRD-K76205745-001-06-6, BRD-K76205745-237-19-9, BRD-K76205745-237-16-5, BRD-K76205745-237-18-1","Launched","","PSIFNNKUMBGKDQ-UHFFFAOYSA-N","BRD-K76205745","","CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1"
"8569","BENZTHIAZIDE","carbonic anhydrase inhibitor","CA1, CA12, CA2, CA4, CA9, SLC12A3","cardiology","hypertension, edema","MicroSource, Selleck",99.29,"BRD-K21450440-001-14-6, BRD-K21450440-001-13-8","Launched","","NDTSRXAMMQDVSW-UHFFFAOYSA-N","BRD-K21450440","","NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O"
"8571","METHYCLOTHIAZIDE","chloride reabsorption inhibitor","CA1, CA2, CA4, SLC12A1, SLC12A3","cardiology","hypertension, edema","Selleck",97.93,"BRD-A95340155-001-09-7","Launched","","CESYKOGBSMNBPD-UHFFFAOYSA-N","BRD-A95340155","","CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O"
"8572","PIRETANIDE","glucocorticoid receptor agonist","SLC12A1, SLC12A2","cardiology","hypertension, edema","Prestwick",99.31,"BRD-K87990216-001-10-2","Launched","","UJEWTUDSLQGTOA-UHFFFAOYSA-N","BRD-K87990216","","NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O"
"8573","TRICHLORMETHIAZIDE","chloride channel blocker","ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3","cardiology","hypertension, edema","Selleck, MicroSource, Selleck",100,"BRD-A28940325-001-23-2, BRD-A28940325-001-24-0, BRD-A28940325-001-25-7","Launched","","LMJSLTNSBFUCMU-UHFFFAOYSA-N","BRD-A28940325","","NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl"
"8576","CHLORTHALIDONE","carbonic anhydrase inhibitor","CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3","cardiology, gastroenterology, rheumatology, nephrology","hypertension, edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure","MicroSource",98.01,"BRD-A26384407-001-25-1","Launched","","JIVPVXMEBJLZRO-UHFFFAOYSA-N","BRD-A26384407","","NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12"
"8577","L-CITRULLINE","nitric oxide stimulant","ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6","cardiology, urology","hypertension, erectile dysfunction","Vitas-M",100,"BRD-A12237696-001-04-2","Launched","","RHGKLRLOHDJJDR-UHFFFAOYSA-N","BRD-A12237696","","NC(CCCNC(N)=O)C(O)=O"
"8578","BUPRANOLOL","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology, ophthalmology","hypertension, glaucoma","Enamine, Enamine",96.59,"BRD-A48420483-001-01-5, BRD-A48420483-001-02-3","Launched","","HQIRNZOQPUAHHV-UHFFFAOYSA-N","BRD-A48420483","","Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1"
"8580","MOPROLOL","adrenergic receptor antagonist","","cardiology, ophthalmology, neurology/psychiatry","hypertension, glaucoma, anxiety","LifeChem",95.27,"BRD-A51747092-003-03-0","Launched","","LFTFGCDECFPSQD-UHFFFAOYSA-N","BRD-A51747092","","COc1ccccc1OCC(O)CNC(C)C"
"8581","TRANDOLAPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, myocardial infarction","MicroSource",96.92,"BRD-A32505112-001-04-4","Launched","","VXFJYXUZANRPDJ-UPUXWEDPSA-N","BRD-A32505112","","CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O"
"8582","PERINDOPRIL","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension, myocardial infarction, coronary artery disease (CAD)","MicroSource, Selleck",95.89,"BRD-K92731339-227-04-9, BRD-K92731339-227-05-6","Launched","BRD-A19924402-227-01-0,BRD-A47830685-227-02-1","IPVQLZZIHOAWMC-QXKUPLGCSA-N","BRD-K92731339","BRD-A19924402","CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC"
"8584","PHENOXYBENZAMINE","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB2, CALM1","cardiology, endocrinology","hypertension, pheochromocytoma","MedChemEx, Selleck, MedChemEx, Selleck",0,"BRD-A67799922-003-28-6, BRD-A67799922-003-26-0, BRD-A67799922-003-29-4, BRD-A67799922-003-27-8","Launched","","QZVCTJOXCFMACW-UHFFFAOYSA-N","BRD-A67799922","","CC(COc1ccccc1)N(CCCl)Cc1ccccc1"
"8588","AROTINOLOL","adrenergic receptor antagonist","ADRB3","cardiology, neurology/psychiatry","hypertension, tremors","AKSci",96.65,"BRD-A28044053-001-01-7","Launched","","BHIAIPWSVYSKJS-UHFFFAOYSA-N","BRD-A28044053","","CC(C)(C)NCC(O)CSc1nc(cs1)-c1ccc(s1)C(N)=O"
"8589","NOREPINEPHRINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2","cardiology, allergy, neurology/psychiatry","hypertension, urticaria, headache, seasonal affective disorder","Selleck, Selleck, MicroSource",100,"BRD-K87349682-347-02-0, BRD-K87349682-347-03-8, BRD-K87349682-001-04-9","Launched","","SFLSHLFXELFNJZ-QMMMGPOBSA-N","BRD-K87349682","","NC[C@H](O)c1ccc(O)c(O)c1"
"8592","ACEBUTOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","cardiology","hypertension, ventricular arrhythmias","MicroSource, Selleck",98.29,"BRD-A29260609-003-26-0, BRD-A29260609-003-25-2","Launched","","GOEMGAFJFRBGGG-UHFFFAOYSA-N","BRD-A29260609","","CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O"
"8594","CARBIMAZOLE","antithyroid agent","TPO","endocrinology","hyperthyroidism","Selleck, MicroSource, Selleck",86.2,"BRD-K87156652-001-11-9, BRD-K87156652-001-12-7, BRD-K87156652-001-13-5","Launched","","CFOYWRHIYXMDOT-UHFFFAOYSA-N","BRD-K87156652","","CCOC(=O)n1ccn(C)c1=S"
"8597","METHIMAZOLE","antithyroid agent","TPO","endocrinology","hyperthyroidism","Selleck, MicroSource",100,"BRD-K54416256-001-18-1, BRD-K54416256-001-19-9","Launched","","PMRYVIKBURPHAH-UHFFFAOYSA-N","BRD-K54416256","","Cn1cc[nH]c1=S"
"8599","METHYLTHIOURACIL","","","endocrinology","hyperthyroidism","MicroSource, Selleck",100,"BRD-K11900042-001-14-4, BRD-K11900042-001-13-6","Launched","","HWGBHCRJGXAGEU-UHFFFAOYSA-N","BRD-K11900042","","Cc1cc(=O)[nH]c(=S)[nH]1"
"8601","PROPYLTHIOURACIL","thyroid peroxidase inhibitor","DIO1, TPO","endocrinology","hyperthyroidism, Grave's disease, goiter","MicroSource, Selleck",97.48,"BRD-K48168960-001-19-2, BRD-K48168960-001-18-4","Launched","","KNAHARQHSZJURB-UHFFFAOYSA-N","BRD-K48168960","","CCCc1cc(=O)[nH]c(=S)[nH]1"
"8603","CLINOFIBRATE","lipase clearing factor inhibitor","LPL","endocrinology","hypertriglyceridemia","Selleck",94.72,"BRD-A90625545-001-02-0","Launched","","BMOVQUBVGICXQN-UHFFFAOYSA-N","BRD-A90625545","","CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(OC(C)(CC)C(O)=O)cc1)C(O)=O"
"8604","ETOFIBRATE","PPAR receptor agonist","PPARA","endocrinology","hypertriglyceridemia","Selleck",95.38,"BRD-K49338325-001-03-4","Launched","","XXRVYAFBUDSLJX-UHFFFAOYSA-N","BRD-K49338325","","CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1"
"8605","ICOSAPENT","platelet aggregation inhibitor","ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1","endocrinology","hypertriglyceridemia","Enzo",87.46,"BRD-K47192521-001-05-4","Launched","","JAZBEHYOTPTENJ-JLNKQSITSA-N","BRD-K47192521","","CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O"
"8606","NIACIN","NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT","endocrinology","hypertriglyceridemia","Selleck, Selleck, MicroSource",91.85,"BRD-K60237333-001-28-9, BRD-K60237333-001-26-3, BRD-K60237333-001-27-1","Launched","","PVNIIMVLHYAWGP-UHFFFAOYSA-N","BRD-K60237333","","OC(=O)c1cccnc1"
"8609","MOSAPRIDE","serotonin receptor agonist","HTR4","gastroenterology","hypertrophic gastritis (GHG), gastroesophageal reflux disease (GERD), dyspepsia, irritable bowel syndrome","Tocris, Selleck",98.7,"BRD-A39052811-048-12-8, BRD-A39052811-048-11-0","Launched","","YPELFRMCRYSPKZ-UHFFFAOYSA-N","BRD-A39052811","","CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1"
"8611","FEBUXOSTAT","xanthine oxidase inhibitor","XDH","nephrology","hyperuricemia","Tocris, MicroSource, Selleck",98.36,"BRD-K48367671-001-07-5, BRD-K48367671-001-06-7, BRD-K48367671-001-05-9","Launched","","BQSJTQLCZDPROO-UHFFFAOYSA-N","BRD-K48367671","","CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O"
"8614","PROBENECID","uricosuric blocker","PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1","nephrology, rheumatology","hyperuricemia, gout","Tocris, MicroSource, Selleck",98.66,"BRD-K95237249-001-27-3, BRD-K95237249-001-26-5, BRD-K95237249-001-25-7","Launched","","DBABZHXKTCFAPX-UHFFFAOYSA-N","BRD-K95237249","","CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O"
"8617","FLIBANSERIN","serotonin receptor agonist","DRD4, HTR1A, HTR2A","neurology/psychiatry","hypoactive sexual desire disorder","MedChemEx",96.14,"BRD-K33637378-001-01-7","Launched","","PPRRDFIXUUSXRA-UHFFFAOYSA-N","BRD-K33637378","","FC(F)(F)c1cccc(c1)N1CCN(CCn2c3ccccc3[nH]c2=O)CC1"
"8618","CALCITRIOL","vitamin D receptor agonist","VDR","endocrinology, orthopedics","hypocalcemia, hypoparathyroidism, osteoporosis","Selleck, Selleck, Selleck",96.4,"BRD-K27316855-001-13-3, BRD-K27316855-001-15-8, BRD-K27316855-001-19-0","Launched","BRD-K28731095-001-01-7","GMRQFYUYWCNGIN-NKMMMXOESA-N","BRD-K27316855","BRD-K28731095","C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"8621","ESTRADIOL-CYPIONATE","estrogen receptor agonist","ESR1","endocrinology","hypoestrogenism, menopause","MicroSource",92.4,"BRD-A91452556-001-04-0","Launched","","UOACKFBJUYNSLK-OCTSOESTSA-N","BRD-A91452556","","C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1"
"8622","DEXTROSE","","","endocrinology","hypoglycemia","Selleck",96.3,"BRD-K51431759-001-02-9","Launched","","GZCGUPFRVQAUEE-SLPGGIOYSA-N","BRD-K51431759","","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O"
"8623","DIAZOXIDE","potassium channel activator","ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3","endocrinology","hypoglycemia","Tocris, MicroSource, Tocris",99.38,"BRD-K73109821-001-22-7, BRD-K73109821-001-20-1, BRD-K73109821-001-19-3","Launched","","GDLBFKVLRPITMI-UHFFFAOYSA-N","BRD-K73109821","","CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1"
"8626","FLUOXYMESTERONE","androgen receptor modulator","AR, ESR1, NR3C1, PRLR","endocrinology","hypogonadism","Enzo",96.41,"BRD-K24255045-001-05-3","Launched","","YLRFCQOZQXIBAB-RBZZARIASA-N","BRD-K24255045","","C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C"
"8627","TESTOSTERONE","androgen receptor agonist","AR","endocrinology","hypogonadism","MicroSource",86.8,"BRD-A55393291-001-09-9","Launched","","MUMGGOZAMZWBJJ-PPORCNLBSA-N","BRD-A55393291","","C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O"
"8628","TESTOSTERONE-ENANTHATE","androgen receptor agonist","AR","endocrinology","hypogonadism","Enzo",84.92,"BRD-K89657519-001-01-8","Launched","","VOCBWIIFXDYGNZ-IXKNJLPQSA-N","BRD-K89657519","","CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"8629","TESTOSTERONE-UNDECANOATE","androgen receptor agonist","AR","endocrinology","hypogonadism","MedChemEx",88.78,"BRD-K70650177-001-01-7","Launched","","UDSFVOAUHKGBEK-CNQKSJKFSA-N","BRD-K70650177","","CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"8630","TRIAMTERENE","sodium channel blocker","SCNN1A, SCNN1B, SCNN1D, SCNN1G","endocrinology, cardiology","hypokalemia, hypertension, edema","MicroSource, Selleck",99.47,"BRD-K92049597-001-20-8, BRD-K92049597-001-19-0","Launched","","FNYLWPVRPXGIIP-UHFFFAOYSA-N","BRD-K92049597","","Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1"
"8632","CONIVAPTAN","vasopressin receptor antagonist","AVPR1A, AVPR2","endocrinology","hyponatremia","Selleck",98.26,"BRD-K37385792-003-02-1","Launched","","IKENVDNFQMCRTR-UHFFFAOYSA-N","BRD-K37385792","","Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1"
"8633","MOZAVAPTAN","vasopressin receptor antagonist","AVPR1A, AVPR1B, AVPR2","endocrinology","hyponatremia","Selleck",97.07,"BRD-A31095847-001-02-3","Launched","","WRNXUQJJCIZICJ-UHFFFAOYSA-N","BRD-A31095847","","CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12"
"8634","TOLVAPTAN","vasopressin receptor antagonist","AVPR1A, AVPR2","endocrinology, cardiology, gastroenterology","hyponatremia, congestive heart failure, hepatic cirrhosis","Tocris, Selleck",98.54,"BRD-A82035391-001-03-5, BRD-A82035391-001-02-7","Launched","","GYHCTFXIZSNGJT-UHFFFAOYSA-N","BRD-A82035391","","Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1"
"8636","ERGOCALCIFEROL","vitamin analog","VDR","endocrinology, orthopedics","hypoparathyroidism, rickets, hypophosphatemia","MicroSource, Sigma, Selleck, Selleck",79.58,"BRD-K56155962-001-15-4, BRD-K56155962-001-12-1, BRD-K56155962-001-16-2, BRD-K56155962-001-11-3","Launched","BRD-A87199639-001-04-4, BRD-K05243578-001-01-6","MECHNRXZTMCUDQ-RKHKHRCZSA-N","BRD-K56155962","BRD-A87199639","CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C"
"8640","GEPEFRINE","adrenergic receptor agonist","","cardiology","hypotension","Sigma",84.77,"BRD-A04447196-001-01-8","Launched","","WTDGMHYYGNJEKQ-UHFFFAOYSA-N","BRD-A04447196","","CC(N)Cc1cccc(O)c1"
"8641","HEPTAMINOL","vasoconstrictor","","cardiology","hypotension","MicroSource",100,"BRD-A32988684-003-08-7","Launched","","LREQLEBVOXIEOM-UHFFFAOYSA-N","BRD-A32988684","","CC(N)CCCC(C)(C)O"
"8642","MEPHENTERMINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3","cardiology","hypotension","MicroSource",93.01,"BRD-K18194590-065-08-0","Launched","","RXQCGGRTAILOIN-UHFFFAOYSA-N","BRD-K18194590","","CNC(C)(C)Cc1ccccc1"
"8643","METARAMINOL","adrenergic receptor agonist","ADRA1A","cardiology","hypotension","MicroSource, Selleck, Selleck",95.01,"BRD-K96253961-046-04-9, BRD-K96253961-046-05-6, BRD-K96253961-046-03-1","Launched","","WXFIGDLSSYIKKV-RCOVLWMOSA-N","BRD-K96253961","","C[C@H](N)[C@H](O)c1cccc(O)c1"
"8646","METHOXAMINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D","cardiology","hypotension","Selleck, MicroSource",97.81,"BRD-A39189014-003-21-9, BRD-A39189014-003-22-7","Launched","","WJAJPNHVVFWKKL-UHFFFAOYSA-N","BRD-A39189014","","COc1ccc(OC)c(c1)C(O)C(C)N"
"8648","MIDODRINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D","cardiology","hypotension","MicroSource",96.09,"BRD-A79981887-003-16-4","Launched","","PTKSEFOSCHHMPD-UHFFFAOYSA-N","BRD-A79981887","","COc1ccc(OC)c(c1)C(O)CNC(=O)CN"
"8649","TERLIPRESSIN","vasopressin receptor agonist","AVPR1A, AVPR1B, AVPR2","cardiology","hypotension","Key",86.38,"BRD-K73451719-001-01-2","Launched","","BENFXAYNYRLAIU-QSVFAHTRSA-N","BRD-K73451719","","NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O"
"8650","PHYSOSTIGMINE","cholinesterase inhibitor","ACHE, BCHE","cardiology, neurology/psychiatry, ophthalmology, gastroenterology","hypotension, Alzheimer's disease, glaucoma, gastroparesis","MicroSource",86.09,"BRD-K25650355-065-02-0","Launched","","PIJVFDBKTWXHHD-HIFRSBDPSA-N","BRD-K25650355","","CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1"
"8651","EPHEDRINE","adrenergic receptor agonist","ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2","cardiology, pulmonary, neurology/psychiatry, endocrinology","hypotension, asthma, narcolepsy, obesity","MicroSource",97.68,"BRD-K45014108-003-01-8","Launched","","KWGRBVOPPLSCSI-WPRPVWTQSA-N","BRD-K45014108","","CN[C@@H](C)[C@H](O)c1ccccc1"
"8652","EPHEDRINE-(RACEMIC)","adrenergic receptor agonist","ADRA1A, ADRA2A","cardiology, pulmonary, neurology/psychiatry, endocrinology","hypotension, asthma, narcolepsy, obesity","MicroSource",97.69,"BRD-A54236247-003-04-3","Launched","","KWGRBVOPPLSCSI-UHFFFAOYSA-N","BRD-A54236247","","CNC(C)C(O)c1ccccc1"
"8653","LIOTHYRONINE","thyroid hormone stimulant","THRA, THRB","endocrinology","hypothyroidism, myxedema coma","MicroSource, Selleck, Selleck",87.3,"BRD-K89152108-236-06-8, BRD-K89152108-236-05-0, BRD-K89152108-236-07-6","Launched","","AUYYCJSJGJYCDS-LBPRGKRZSA-N","BRD-K89152108","","N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O"
"8656","NINTEDANIB","FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","pulmonary","idiopathic pulmonary fibrosis (IPF)","Selleck, Selleck",90.8,"BRD-K49075727-001-09-3, BRD-K49075727-001-08-5","Launched","","XZXHXSATPCNXJR-ZIADKAODSA-N","BRD-K49075727","","COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1"
"8658","PIRFENIDONE","TGF beta receptor inhibitor","FURIN, TNF","pulmonary","idiopathic pulmonary fibrosis (IPF)","Selleck, Tocris",97.6,"BRD-K96862998-001-14-8, BRD-K96862998-001-15-5","Launched","","ISWRGOKTTBVCFA-UHFFFAOYSA-N","BRD-K96862998","","Cc1ccc(=O)n(c1)-c1ccccc1"
"8660","PIDOTIMOD","interferon receptor agonist, interleukin receptor agonist","","infectious disease","immune adjuvant","MicroSource, Selleck",92.63,"BRD-K44442813-001-12-9, BRD-K44442813-001-11-1","Launched","","UUTKICFRNVKFRG-WDSKDSINSA-N","BRD-K44442813","","OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1"
"8662","MUPIROCIN","isoleucyl-tRNA synthetase inhibitor","","infectious disease","impetigo","MicroSource, MedChemEx, Selleck",93.41,"BRD-K15262564-001-14-3, BRD-K15262564-001-15-0, BRD-K15262564-001-16-8","Launched","BRD-K25394084-001-01-0","MINDHVHHQZYEEK-HBBNESRFSA-N","BRD-K15262564","BRD-K25394084","C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O"
"8665","RETAPAMULIN","protein synthesis inhibitor","","infectious disease","impetigo","Selleck",100,"BRD-K33082088-001-03-3","Launched","BRD-K17930269-001-01-8","STZYTFJPGGDRJD-NHUWBDDWSA-N","BRD-K33082088","BRD-K17930269","C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C"
"8666","CLOMIFENE","estrogen receptor antagonist","ESR1","obstetrics/gynecology","infertility","MicroSource, Selleck, Selleck",94.27,"BRD-K29950728-048-17-4, BRD-K29950728-048-16-6, BRD-K29950728-048-18-2","Launched","","GKIRPKYJQBWNGO-QPLCGJKRSA-N","BRD-K29950728","","CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1"
"8669","DYDROGESTERONE","progesterone receptor agonist","PGR","obstetrics/gynecology","infertility","MicroSource, Selleck, Selleck",98.97,"BRD-K68620903-001-11-4, BRD-K68620903-001-10-6, BRD-K68620903-001-09-8","Launched","BRD-A86597857-001-01-1, BRD-K27038879-001-01-0","JGMOKGBVKVMRFX-HQZYFCCVSA-N","BRD-K68620903","BRD-A86597857","CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C"
"8672","PROGESTERONE","progesterone receptor agonist","CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5","obstetrics/gynecology, endocrinology","infertility, amenorrhea","MicroSource, Selleck",97.71,"BRD-K64994968-001-32-5, BRD-K64994968-001-33-3","Launched","BRD-A67479912-001-03-4, BRD-K37762555-001-01-4","RJKFOVLPORLFTN-LEKSSAKUSA-N","BRD-K64994968","BRD-A67479912","CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C"
"8674","AMINOSALICYLATE","cyclooxygenase inhibitor","ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2","gastroenterology","inflammatory bowel disease, ulcerative colitis","MicroSource, Selleck, Selleck",97.87,"BRD-K80267133-001-17-7, BRD-K80267133-001-18-5, BRD-K80267133-001-19-3","Launched","BRD-M65097687-001-19-1, BRD-M65097687-001-18-3, BRD-M65097687-001-20-9","WUBBRNOQWQTFEX-UHFFFAOYSA-N","BRD-K80267133","BRD-M65097687","Nc1ccc(C(O)=O)c(O)c1"
"8677","ARBIDOL","cytochrome P450 inhibitor","CYP3A4","infectious disease","influenza A virus infection","MedChemEx, Selleck, MedChemEx, Selleck",80.95,"BRD-K73881242-003-06-1, BRD-K73881242-003-02-0, BRD-K73881242-003-04-6, BRD-K73881242-003-03-8","Launched","","KCFYEAOKVJSACF-UHFFFAOYSA-N","BRD-K73881242","","CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12"
"8681","MOROXYDINE","antiviral","","infectious disease","influenza A virus infection","MicroSource, Selleck",100,"BRD-K57291914-003-10-2, BRD-K57291914-003-09-4","Launched","","KJHOZAZQWVKILO-UHFFFAOYSA-N","BRD-K57291914","","NC(=N)NC(=N)N1CCOCC1"
"8683","OSELTAMIVIR-CARBOXYLATE","neuraminidase inhibitor","","infectious disease","influenza A virus infection","MedChemEx",85.81,"BRD-K93767137-001-01-1","Launched","","NENPYTRHICXVCS-YNEHKIRRSA-N","BRD-K93767137","","CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O"
"8684","OSELTAMIVIR-PHOSPHATE","neuraminidase inhibitor","CES1, NEU1, NEU2","infectious disease","influenza A virus infection","Selleck, Selleck, MicroSource",93.88,"BRD-K76011241-011-02-5, BRD-K76011241-001-02-6, BRD-K76011241-001-01-8","Launched","BRD-U75584406-000-01-6","VSZGPKBBMSAYNT-RRFJBIMHSA-N","BRD-K76011241","BRD-U75584406","CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1"
"8687","PERAMIVIR","neuraminidase inhibitor","","infectious disease","influenza A virus infection","Selleck, Selleck",85.33,"BRD-K00519864-341-02-5, BRD-K00519864-341-03-3","Launched","","XRQDFNLINLXZLB-CKIKVBCHSA-N","BRD-K00519864","","CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O"
"8689","RIMANTADINE","antiviral, RNA synthesis inhibitor","","infectious disease","influenza A virus infection","MicroSource, Selleck",100,"BRD-A75479906-003-11-1, BRD-A75479906-001-02-4","Launched","","UBCHPRBFMUDMNC-UHFFFAOYSA-N","BRD-A75479906","","CC(N)C12CC3CC(CC(C3)C1)C2"
"8691","ZANAMIVIR","neuraminidase inhibitor","NEU2","infectious disease","influenza A virus infection","Selleck, Selleck",100,"BRD-K23067689-001-03-9, BRD-K23067689-001-02-1","Launched","BRD-K75153898-001-01-5","ARAIBEBZBOPLMB-UFGQHTETSA-N","BRD-K23067689","BRD-K75153898","CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O"
"8693","AMANTADINE","glutamate receptor antagonist","DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A","infectious disease, neurology/psychiatry","influenza A virus infection, Parkinson's Disease","MicroSource, Selleck",100,"BRD-K70330367-003-08-7, BRD-K70330367-003-07-9","Launched","","DKNWSYNQZKUICI-UHFFFAOYSA-N","BRD-K70330367","","NC12CC3CC(CC(C3)C1)C2"
"8695","TILORONE","interferon inducer","","infectious disease, gastroenterology, neurology/psychiatry","influenza A virus infection, diarrhea, hepatitis B, multiple sclerosis, urinary tract infections, virus herpes simplex (HSV), hepatitis C","MicroSource",86.28,"BRD-K34568562-001-04-3","Launched","","MPMFCABZENCRHV-UHFFFAOYSA-N","BRD-K34568562","","CCN(CC)CCOc1ccc2-c3ccc(OCCN(CC)CC)cc3C(=O)c2c1"
"8696","ESZOPICLONE","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO","neurology/psychiatry","insomnia","MicroSource",98.3,"BRD-K29220403-001-10-8","Launched","","GBBSUAFBMRNDJC-INIZCTEOSA-N","BRD-K29220403","","CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1"
"8697","RAMELTEON","melatonin receptor agonist","MTNR1A, MTNR1B","neurology/psychiatry","insomnia","MicroSource, Selleck",98.49,"BRD-K28761891-001-10-1, BRD-K28761891-001-09-3","Launched","","YLXDSYKOBKBWJQ-LBPRGKRZSA-N","BRD-K28761891","","CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12"
"8699","SUVOREXANT","orexin receptor antagonist","HCRTR1, HCRTR2","neurology/psychiatry","insomnia","Selleck",99.04,"BRD-K94293891-001-01-3","Launched","","JYTNQNCOQXFQPK-MRXNPFEDSA-N","BRD-K94293891","","C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1"
"8700","ZALEPLON","benzodiazepine receptor agonist","GABRA1, GABRB1, GABRG2, TSPO","neurology/psychiatry","insomnia","MicroSource",99.85,"BRD-K92657060-001-05-7","Launched","","HUNXMJYCHXQEGX-UHFFFAOYSA-N","BRD-K92657060","","CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N"
"8701","ZOLPIDEM","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3","neurology/psychiatry","insomnia","MicroSource",98.52,"BRD-K44876623-001-03-7","Launched","","ZAFYATHCZYHLPB-UHFFFAOYSA-N","BRD-K44876623","","CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1"
"8702","5-HYDROXYTRYPTOPHAN","neurotransmitter","SLC36A1, SLC36A2","neurology/psychiatry","insomnia","Selleck, Selleck",97.09,"BRD-A73930134-001-02-2, BRD-A73930134-001-03-0","Launched","","LDCYZAJDBXYCGN-UHFFFAOYSA-N","BRD-A73930134","","NC(Cc1c[nH]c2ccc(O)cc12)C(O)=O"
"8704","ETIZOLAM","benzodiazepine receptor agonist","GABRA1","neurology/psychiatry","insomnia, anxiety","MedChemEx",99.78,"BRD-K68232413-001-01-2","Launched","","VMZUTJCNQWMAGF-UHFFFAOYSA-N","BRD-K68232413","","CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl"
"8705","PHENYL-SALICYLATE","antiseptic","","urology","interstitial cystitis (IC)","Enamine",0,"BRD-K44091963-001-01-5","Launched","","ZQBAKBUEJOMQEX-UHFFFAOYSA-N","BRD-K44091963","","Oc1ccccc1C(=O)Oc1ccccc1"
"8706","FINAFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease, pulmonary","intra-abdominal infections, chronic obstructive pulmonary disease (COPD), cystic fibrosis","SantaCruz",93.21,"BRD-K98384930-003-01-5","Launched","","FYMHQCNFKNMJAV-HOTGVXAUSA-N","BRD-K98384930","","OC(=O)c1cn(C2CC2)c2c(C#N)c(N3C[C@@H]4NCCO[C@H]4C3)c(F)cc2c1=O"
"8707","PIPERACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia","MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck",96.3,"BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7","Launched","BRD-K67009182-236-01-6","IVBHGBMCVLDMKU-GXNBUGAJSA-N","BRD-K86873305","BRD-K67009182","CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O"
"8710","PIPERACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia","MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck",96.3,"BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7","Launched","BRD-K67009182-236-01-6","IVBHGBMCVLDMKU-GXNBUGAJSA-N","BRD-K86873305","BRD-K67009182","CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O"
"8713","PIPERACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia","MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck",96.3,"BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7","Launched","BRD-K67009182-236-01-6","IVBHGBMCVLDMKU-UVIOZBFDSA-N","BRD-K86873305","BRD-K67009182","CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O"
"8716","PIPERACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia","MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck",96.3,"BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7","Launched","BRD-K67009182-236-01-6","IVBHGBMCVLDMKU-UVIOZBFDSA-N","BRD-K86873305","BRD-K67009182","CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O"
"8719","CLINDAMYCIN-PALMITATE","bacterial 50S ribosomal subunit inhibitor","","infectious disease","intra-abdominal infections, skin infections, pneumonia, peritonitis, gynecologic infections","Selleck",100,"BRD-A76672327-003-02-0","Launched","","OYSKUZDIHNKWLV-UHFFFAOYSA-N","BRD-A76672327","","CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)Cl"
"8720","ERTAPENEM","bacterial cell wall synthesis inhibitor","","infectious disease","intra-abdominal infections, skin infections, pneumonia, urinary tract infections, gynecologic infections, postpartum endomyometritis","SantaCruz, SantaCruz",0,"BRD-A40472231-304-01-7, BRD-A40472231-304-02-5","Launched","","JUZNIMUFDBIJCM-YZLSNGRKSA-N","BRD-A40472231","","C[C@@H](O)C1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)Nc3cccc(c3)C(O)=O)=C(N2C1=O)C(O)=O"
"8722","DORIPENEM","bacterial cell wall synthesis inhibitor","DPEP1","infectious disease","intra-abdominal infections, urinary tract infections, pyelonephritis","Sigma, MedChemEx, MedChemEx, Selleck, Selleck",42.28,"BRD-K45319714-002-02-7, BRD-K45319714-002-04-3, BRD-K45319714-002-03-5, BRD-K45319714-002-05-0, BRD-K45319714-002-01-9","Launched","BRD-K20901660-002-03-3","AVAACINZEOAHHE-VFZPANTDSA-N","BRD-K45319714","BRD-K20901660","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O"
"8727","AVIBACTAM","beta lactamase inhibitor","","infectious disease","intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis","MedChemEx, MedChemEx, MedChemEx",100,"BRD-K85882401-323-01-5, BRD-K85882401-236-01-9, BRD-K85882401-236-02-7","Launched","","NDCUAPJVLWFHHB-UHNVWZDZSA-N","BRD-K85882401","","NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O"
"8730","MANNITOL-D","diuretic","","neurology/psychiatry, ophthalmology, gastroenterology","intracranial pressure, intraocular pressure, constipation","MicroSource, Selleck",100,"BRD-K66035042-001-11-9, BRD-K30374899-001-09-3","Launched","","FBPFZTCFMRRESA-JGWLITMVSA-N","BRD-K66035042","","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"8731","MANNITOL-D","diuretic","","neurology/psychiatry, ophthalmology, gastroenterology","intracranial pressure, intraocular pressure, constipation","MicroSource, Selleck",100,"BRD-K66035042-001-11-9, BRD-K30374899-001-09-3","Launched","","FBPFZTCFMRRESA-JGWLITMVSA-N","BRD-K66035042","","OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"8732","MANNITOL-D","diuretic","","neurology/psychiatry, ophthalmology, gastroenterology","intracranial pressure, intraocular pressure, constipation","MicroSource, Selleck",100,"BRD-K66035042-001-11-9, BRD-K30374899-001-09-3","Launched","","FBPFZTCFMRRESA-KVTDHHQDSA-N","BRD-K66035042","","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"8733","MANNITOL-D","diuretic","","neurology/psychiatry, ophthalmology, gastroenterology","intracranial pressure, intraocular pressure, constipation","MicroSource, Selleck",100,"BRD-K66035042-001-11-9, BRD-K30374899-001-09-3","Launched","","FBPFZTCFMRRESA-KVTDHHQDSA-N","BRD-K66035042","","OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO"
"8734","CARBACHOL","cholinergic receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2","ophthalmology","intraocular pressure","MicroSource, Selleck",100,"BRD-K75037734-003-14-7, BRD-K75037734-003-13-9","Launched","","VPJXQGSRWJZDOB-UHFFFAOYSA-O","BRD-K75037734","","C[N+](C)(C)CCOC(N)=O"
"8736","DEMECARIUM","acetylcholinesterase inhibitor","ACHE, BCHE","ophthalmology","intraocular pressure, glaucoma","Prestwick",94.41,"BRD-K51471001-303-04-7","Launched","","RWZVPVOZTJJMNU-UHFFFAOYSA-N","BRD-K51471001","","CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc1cccc(c1)[N+](C)(C)C"
"8737","DORZOLAMIDE","carbonic anhydrase inhibitor","CA1, CA12, CA14, CA2, CA4, CA7","ophthalmology","intraocular pressure, glaucoma","Selleck",90.38,"BRD-K71075609-003-01-0","Launched","","IAVUPMFITXYVAF-POYBYMJQSA-N","BRD-K71075609","","CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O"
"8738","LEVOBETAXOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma","Selleck",94.07,"BRD-K43883465-003-01-5","Launched","","NWIUTZDMDHAVTP-KRWDZBQOSA-N","BRD-K43883465","","CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1"
"8739","BETAXOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck",96.12,"BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6","Launched","","NWIUTZDMDHAVTP-UHFFFAOYSA-N","BRD-A02759312","","CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1"
"8744","BETAXOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck",96.12,"BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6","Launched","","NWIUTZDMDHAVTP-UHFFFAOYSA-N","BRD-A02759312","","COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC"
"8745","BETAXOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck",96.12,"BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6","Launched","","YXSLJKQTIDHPOT-LJCJQEJUSA-N","BRD-A02759312","","CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1"
"8750","BETAXOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck",96.12,"BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6","Launched","","YXSLJKQTIDHPOT-LJCJQEJUSA-N","BRD-A02759312","","COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC"
"8751","BIMATOPROST","prostanoid receptor agonist","AKR1C3, PTGER1, PTGER3, PTGFR","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","Selleck",95.82,"BRD-A45153512-001-01-0","Launched","","AQOKCDNYWBIDND-GCYMYIANSA-N","BRD-A45153512","","CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(O)CCc1ccccc1"
"8752","BRIMONIDINE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","Tocris, Tocris, Tocris, Selleck, Selleck",99,"BRD-K68264559-001-14-2, BRD-K68264559-045-02-4, BRD-K68264559-001-13-4, BRD-K68264559-045-03-2, BRD-K68264559-045-04-0","Launched","BRD-M06829359-001-01-4, BRD-M06829359-001-02-2","XYLJNLCSTIOKRM-UHFFFAOYSA-N","BRD-K68264559","BRD-M06829359","Brc1c(NC2=NCCN2)ccc2nccnc12"
"8757","BRINZOLAMIDE","carbonic anhydrase inhibitor","CA1, CA12, CA14, CA2, CA4, CA5A, CA7","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Selleck",99.04,"BRD-K74913225-001-14-0, BRD-K74913225-001-12-4, BRD-K74913225-001-13-2","Launched","BRD-A82599487-001-01-9","HCRKCZRJWPKOAR-JTQLQIEISA-N","BRD-K74913225","BRD-A82599487","CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O"
"8760","CARTEOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","MedChemEx",98.62,"BRD-A42167015-003-10-2","Launched","","LWAFSWPYPHEXKX-UHFFFAOYSA-N","BRD-A42167015","","CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12"
"8761","CIMETROPIUM","acetylcholine receptor antagonist","CHRM1","gastroenterology","irritable bowel syndrome","Sigma",93.27,"BRD-A99899486-004-01-9","Launched","","QVVOZYKELHAIPX-WVHCHWADSA-N","BRD-A99899486","","C[N+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"8762","DICYCLOVERINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","irritable bowel syndrome","MicroSource, Selleck",100,"BRD-K68507560-003-25-3, BRD-K68507560-003-24-6","Launched","","CURUTKGFNZGFSE-UHFFFAOYSA-N","BRD-K68507560","","CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1"
"8764","ELUXADOLINE","opioid receptor modulator","OPRD1, OPRK1, OPRM1","gastroenterology","irritable bowel syndrome","MedChemEx",94.62,"BRD-K39560679-001-01-1","Launched","","QFNHIDANIVGXPE-FNZWTVRRSA-N","BRD-K39560679","","COc1ccc(CN([C@@H](C)c2ncc([nH]2)-c2ccccc2)C(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(N)=O)cc1C(O)=O"
"8765","MEBEVERINE","acetylcholine receptor antagonist","CHRM1","gastroenterology","irritable bowel syndrome","MicroSource",95.24,"BRD-A09467419-003-22-4","Launched","","VYVKHNNGDFVQGA-UHFFFAOYSA-N","BRD-A09467419","","CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1"
"8766","OTILONIUM","acetylcholine receptor antagonist","CACNA1C","gastroenterology","irritable bowel syndrome","Selleck",98.47,"BRD-K85337334-004-02-6","Launched","","NQHNLNLJPDMBFN-UHFFFAOYSA-O","BRD-K85337334","","CCCCCCCCOc1ccccc1C(=O)Nc1ccc(cc1)C(=O)OCC[N+](C)(CC)CC"
"8767","PINAVERIUM","T-type calcium channel blocker","CACNA1C","gastroenterology","irritable bowel syndrome","Prestwick",98.24,"BRD-A70998768-004-01-1","Launched","","DDHUTBKXLWCZCO-GFUWAVFVSA-N","BRD-A70998768","","COc1cc(Br)c(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)cc1OC"
"8768","TREPIBUTONE","cholinergic receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology","irritable bowel syndrome","AvaChem",97.79,"BRD-K37543758-001-01-3","Launched","","YPTFHLJNWSJXKG-UHFFFAOYSA-N","BRD-K37543758","","CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(O)=O"
"8769","TRIMEBUTINE","opioid receptor agonist","OPRD1, OPRK1, OPRM1","gastroenterology","irritable bowel syndrome","MicroSource, Selleck",93.92,"BRD-A92630576-050-24-1, BRD-A92630576-001-02-0","Launched","","LORDFXWUHHSAQU-UHFFFAOYSA-N","BRD-A92630576","","CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1"
"8771","LINACLOTIDE","guanylate cyclase activator","GUCY2C","gastroenterology","irritable bowel syndrome, constipation","MedChemEx",0,"BRD-A55468767-001-01-1","Launched","","KXGCNMMJRFDFNR-IURAOCFRSA-N","BRD-A55468767","","C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2"
"8772","ALVERINE","muscle relaxant","HTR1A","gastroenterology","irritable bowel syndrome, diverticular disease","MicroSource, Selleck",94.35,"BRD-K89055274-048-23-5, BRD-K89055274-048-22-7","Launched","","ZPFXAOWNKLFJDN-UHFFFAOYSA-N","BRD-K89055274","","CCN(CCCc1ccccc1)CCCc1ccccc1"
"8774","KETOTIFEN","histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor","HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD","neurology/psychiatry","itching","Tocris, MicroSource, Selleck",98.24,"BRD-K28936863-051-32-2, BRD-K28936863-051-33-0, BRD-K28936863-051-31-4","Launched","","ZCVMWBYGMWKGHF-UHFFFAOYSA-N","BRD-K28936863","","CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12"
"8777","THONZYLAMINE","antihistamine","","neurology/psychiatry","itching","MicroSource",91.69,"BRD-K88405679-003-03-1","Launched","","GULNIHOSWFYMRN-UHFFFAOYSA-N","BRD-K88405679","","COc1ccc(CN(CCN(C)C)c2ncccn2)cc1"
"8778","NEDOCROMIL","histamine receptor antagonist","CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR","neurology/psychiatry, ophthalmology","itching, conjunctivitis","MedChemEx, MedChemEx, MedChemEx",91.97,"BRD-K64716392-001-02-1, BRD-K64716392-001-01-3, BRD-K64716392-001-03-9","Launched","","RQTOOFIXOKYGAN-UHFFFAOYSA-N","BRD-K64716392","","CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O"
"8781","LIDOCAINE","histamine receptor agonist","EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry, dermatology, hematology","itching, eczema, hemorrhage","Selleck, MicroSource",99.22,"BRD-K52662033-001-19-0, BRD-K52662033-003-21-2","Launched","","NNJVILVZKWQKPM-UHFFFAOYSA-N","BRD-K52662033","","CCN(CC)CC(=O)Nc1c(C)cccc1C"
"8783","RIBOFLAVIN","vitamin B2","BLVRB, RFK","gastroenterology","jaundice","MicroSource, Selleck, Selleck",91.09,"BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5","Launched","","AUNGANRZJHBGPY-MBNYWOFBSA-N","BRD-K70246307","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C"
"8784","RIBOFLAVIN","vitamin B2","BLVRB, RFK","gastroenterology","jaundice","MicroSource, Selleck, Selleck",91.09,"BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5","Launched","","AUNGANRZJHBGPY-MBNYWOFBSA-N","BRD-K70246307","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C"
"8786","RIBOFLAVIN","vitamin B2","BLVRB, RFK","gastroenterology","jaundice","MicroSource, Selleck, Selleck",91.09,"BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5","Launched","","AUNGANRZJHBGPY-SCRDCRAPSA-N","BRD-K70246307","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C"
"8787","RIBOFLAVIN","vitamin B2","BLVRB, RFK","gastroenterology","jaundice","MicroSource, Selleck, Selleck",91.09,"BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5","Launched","","AUNGANRZJHBGPY-SCRDCRAPSA-N","BRD-K70246307","","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C"
"8789","DEFLAZACORT","glucocorticoid receptor agonist","NR3C1","rheumatology","joint inflammation","Selleck",91.86,"BRD-K96006502-001-02-6","Launched","BRD-K94177716-001-01-1","FBHSPRKOSMHSIF-NADGHRDBSA-N","BRD-K96006502","BRD-K94177716","CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C"
"8790","NIFLUMIC-ACID","cyclooxygenase inhibitor","ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9","rheumatology, neurology/psychiatry","joint pain, muscle pain","MicroSource, Selleck",97.55,"BRD-K98763141-001-30-8, BRD-K98763141-001-29-0","Launched","","JZFPYUNJRRFVQU-UHFFFAOYSA-N","BRD-K98763141","","OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F"
"8792","SUXIBUZONE","cyclooxygenase inhibitor","","rheumatology, neurology/psychiatry","joint pain, muscle pain","Selleck, MicroSource",97.83,"BRD-K78815826-001-13-8, BRD-K78815826-001-14-6","Launched","","ONWXNHPOAGOMTG-UHFFFAOYSA-N","BRD-K78815826","","CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1"
"8794","MECLOFENAMIC-ACID","cyclooxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2","rheumatology, neurology/psychiatry, endocrinology","joint pain, muscle pain, rheumatoid arthritis, primary dysmenorrhea (PD)","MicroSource",98.55,"BRD-K50398167-236-22-7","Launched","","SBDNJUWAMKYJOX-UHFFFAOYSA-N","BRD-K50398167","","Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl"
"8795","RUTIN","antioxidant, capillary stabilizing agent, nitric oxide scavenger","AKR1C3","rheumatology, otolaryngology, gastroenterology, neurology/psychiatry, allergy","joint pain, nasal congestion, constipation, irritability, allergic rhinitis","MicroSource, Selleck, Selleck",91.2,"BRD-K20482099-001-11-0, BRD-K20482099-001-09-4, BRD-K20482099-001-10-2","Launched","BRD-A76747559-001-03-1, BRD-K22924152-001-01-4","IKGXIBQEEMLURG-NVPNHPEKSA-N","BRD-K20482099","BRD-A76747559","C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O"
"8798","TIOPRONIN","chelating agent, reducing agent","","urology","kidney stones","MedChemEx, Sigma, Selleck, MicroSource, Selleck",91.45,"BRD-A85295731-001-06-4, BRD-A85295731-001-05-6, BRD-A85295731-001-02-3, BRD-A85295731-001-03-1, BRD-A85295731-001-04-9","Launched","","YTGJWQPHMWSCST-UHFFFAOYSA-N","BRD-A85295731","","CC(S)C(=O)NCC(O)=O"
"8803","DINOPROST","prostacyclin analog","PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R","obstetrics/gynecology","labor induction","Enzo",100,"BRD-K81672972-001-03-1","Launched","","PXGPLTODNUVGFL-YNNPMVKQSA-N","BRD-K81672972","","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O"
"8804","DROTAVERINE","phosphodiesterase inhibitor","CACNA1C, PDE4A","obstetrics/gynecology","labor induction","Vitas-M, Enamine",88.7,"BRD-K14658796-001-01-0, BRD-K14658796-003-01-6","Launched","","OMFNSKIUKYOYRG-DEDYPNTBSA-N","BRD-K14658796","","CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC"
"8806","OXYTOCIN","oxytocin receptor agonist","AVPR1A, AVPR1B, AVPR2, OXTR","obstetrics/gynecology","labor induction","Sigma, MedChemEx",84.04,"BRD-K25243230-001-01-2, BRD-K25243230-001-02-0","Launched","BRD-A80365673-001-01-1","XNOPRXBHLZRZKH-DSZYJQQASA-N","BRD-K25243230","BRD-A80365673","CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O"
"8808","VALETHAMATE","acetylcholine receptor antagonist","CHRM1, CHRM4, CHRM5","obstetrics/gynecology","labor induction","Sigma",90.39,"BRD-A56613951-004-01-1","Launched","","UPPMZCXMQRVMME-UHFFFAOYSA-N","BRD-A56613951","","CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1"
"8809","MILTEFOSINE","membrane integrity inhibitor","PLA2G1B","infectious disease","leishmaniasis","MicroSource",92.47,"BRD-A31811760-001-06-7","Launched","","PQLXHQMOHUQAKB-UHFFFAOYSA-O","BRD-A31811760","","CCCCCCCCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C"
"8810","SODIUM-STIBOGLUCONATE","tyrosine phosphatase inhibitor","PTPN6, TOP1","infectious disease","leishmaniasis","Enzo",0,"BRD-A60786380-412-01-5","Launched","","RPOBPHCDIPHDQL-UHFFFAOYSA-L","BRD-A60786380","","OCC(O)C1O[Sb]2(O)(O[Sb]34(O)OC(C(O)CO)C(O3)C(O4)C(O)=O)OC1C(O2)C(O)=O"
"8811","ACEDAPSONE","","","infectious disease","leprosy","MicroSource",77.47,"BRD-K97417064-001-02-4","Launched","","AMTPYFGPPVFBBI-UHFFFAOYSA-N","BRD-K97417064","","CC(=O)Nc1ccc(cc1)S(=O)(=O)c1ccc(NC(C)=O)cc1"
"8812","CLOFAZIMINE","GK0582 inhibitor","","infectious disease","leprosy","MicroSource, Selleck, Selleck",86.22,"BRD-K56614220-001-19-0, BRD-K56614220-001-18-2, BRD-K56614220-001-21-6","Launched","","WDQPAMHFFCXSNU-BGABXYSRSA-N","BRD-K56614220","","CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1"
"8815","MALATHION","cholinesterase inhibitor","ACHE, BCHE","infectious disease","lice","MedChemEx, MicroSource, MedChemEx",78.47,"BRD-A01976766-001-06-8, BRD-A01976766-001-04-3, BRD-A01976766-001-07-6","Launched","","JXSJBGJIGXNWCI-UHFFFAOYSA-N","BRD-A01976766","","CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC"
"8818","PERMETHRIN","","SCN1A","infectious disease","lice","MedChemEx, MicroSource, Sigma",0,"BRD-A25366096-001-09-9, BRD-A25366096-001-07-3, BRD-A25366096-001-08-1","Launched","","RLLPVAHGXHCWKJ-UHFFFAOYSA-N","BRD-A25366096","","CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1"
"8821","PHENOTHRIN","","","infectious disease","lice","MicroSource, Selleck",76.28,"BRD-A22106989-001-06-8, BRD-A22106989-001-05-0","Launched","","SBNFWQZLDJGRLK-UHFFFAOYSA-N","BRD-A22106989","","CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C"
"8823","PIPERONYL-BUTOXIDE","cytochrome P450 inhibitor","","infectious disease","lice","MicroSource",88.86,"BRD-K76452401-001-03-6","Launched","","FIPWRIJSWJWJAI-UHFFFAOYSA-N","BRD-K76452401","","CCCCOCCOCCOCc1cc2OCOc2cc1CCC"
"8824","ERYTHROMYCIN","NFkB pathway inhibitor","MLNR","infectious disease","listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","MicroSource, MicroSource, Selleck, Selleck",88.23,"BRD-K63550407-001-12-7, BRD-K63550407-028-04-7, BRD-K63550407-001-13-5, BRD-K63550407-001-14-3","Launched","BRD-K05127550-001-02-1, BRD-K05127550-001-03-9,BRD-A20485507-001-01-2","ULGZDMOVFRHVEP-RWJQBGPGSA-N","BRD-K63550407","BRD-K05127550","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O"
"8828","ERYTHROMYCIN-ESTOLATE","bacterial 50S ribosomal subunit inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1","infectious disease","listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","MicroSource",0,"BRD-K39746403-084-04-9","Launched","","TYQXKHPOXXXCTP-CSLYCKPJSA-N","BRD-K39746403","","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O"
"8829","ERYTHROMYCIN-ETHYLSUCCINATE","cytochrome P450 inhibitor, protein synthesis inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1","infectious disease","listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","MicroSource, Selleck, Selleck",93.05,"BRD-K51677086-001-12-0, BRD-K51677086-001-13-8, BRD-K51677086-001-14-6","Launched","BRD-K13846766-001-01-8","NSYZCCDSJNWWJL-YXOIYICCSA-N","BRD-K51677086","BRD-K13846766","CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C"
"8832","CLOSANTEL","chitinase inhibitor, NFkB pathway inhibitor","","infectious disease","liver flukes","MicroSource, Selleck, Selleck, Selleck",99.14,"BRD-A19952358-001-11-3, BRD-A19952358-236-01-6, BRD-A19952358-001-10-5, BRD-A19952358-001-12-1","Launched","","JMPFSEBWVLAJKM-UHFFFAOYSA-N","BRD-A19952358","","Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O"
"8836","ARTICAINE","local anesthetic","","neurology/psychiatry","local anesthetic","Selleck",90.48,"BRD-A70514680-003-11-2","Launched","","QTGIAADRBBLJGA-UHFFFAOYSA-N","BRD-A70514680","","CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC"
"8837","BUTACAINE","local anesthetic","","neurology/psychiatry","local anesthetic","MicroSource, Selleck",95.48,"BRD-K99622919-001-23-0, BRD-K99622919-001-22-2","Launched","","HQFWVSGBVLEQGA-UHFFFAOYSA-N","BRD-K99622919","","CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1"
"8839","CHLOROPROCAINE","sodium channel blocker","ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3","neurology/psychiatry","local anesthetic","Enamine",88.33,"BRD-K86864073-001-01-1","Launched","","VDANGULDQQJODZ-UHFFFAOYSA-N","BRD-K86864073","","CCN(CC)CCOC(=O)c1ccc(N)cc1Cl"
"8840","CINCHOCAINE","sodium channel blocker","CALM1, SCN10A, SCN5A","neurology/psychiatry","local anesthetic","MicroSource, Selleck",96.87,"BRD-K99121711-003-20-5, BRD-K99121711-003-19-7","Launched","","PUFQVTATUTYEAL-UHFFFAOYSA-N","BRD-K99121711","","CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1"
"8842","DIMETHISOQUIN","local anesthetic","","neurology/psychiatry","local anesthetic","Prestwick",95.73,"BRD-K73391359-003-10-2","Launched","","XNMYNYSCEJBRPZ-UHFFFAOYSA-N","BRD-K73391359","","CCCCc1cc2ccccc2c(OCCN(C)C)n1"
"8843","DYCLONINE","sodium channel blocker","SCN10A, SCN5A","neurology/psychiatry","local anesthetic","Selleck, MedChemEx, MicroSource, Selleck, MedChemEx",93.29,"BRD-K72259270-003-25-6, BRD-K72259270-003-27-2, BRD-K72259270-003-24-9, BRD-K72259270-003-23-1, BRD-K72259270-003-26-4","Launched","","BZEWSEKUUPWQDQ-UHFFFAOYSA-N","BRD-K72259270","","CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1"
"8848","FOMOCAINE","voltage-gated sodium channel modulator","","neurology/psychiatry","local anesthetic","ChemDiv",96.22,"BRD-K44942188-001-09-1","Launched","","CVHGCWVMTZWGAY-UHFFFAOYSA-N","BRD-K44942188","","C(CN1CCOCC1)Cc1ccc(COc2ccccc2)cc1"
"8849","HEXYLCAINE","sodium channel blocker","SCN10A, SCN5A","neurology/psychiatry","local anesthetic","Prestwick",96.16,"BRD-A97730597-003-11-5","Launched","","DKLKMKYDWHYZTD-UHFFFAOYSA-N","BRD-A97730597","","CC(CNC1CCCCC1)OC(=O)c1ccccc1"
"8850","MEPIVACAINE","potassium channel blocker, sodium channel blocker","SCN10A","neurology/psychiatry","local anesthetic","MicroSource, Selleck",97.82,"BRD-A03216249-003-24-3, BRD-A03216249-003-23-5","Launched","","INWLQCZOYSRPNW-UHFFFAOYSA-N","BRD-A03216249","","CN1CCCCC1C(=O)Nc1c(C)cccc1C"
"8852","OXETHAZAINE","local anesthetic","","neurology/psychiatry","local anesthetic","MicroSource, Selleck",94.7,"BRD-K56940463-001-14-6, BRD-K56940463-001-13-8","Launched","","FTLDJPRFCGDUFH-UHFFFAOYSA-N","BRD-K56940463","","CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1"
"8854","OXYBUPROCAINE","local anesthetic","SCN10A","neurology/psychiatry","local anesthetic","MicroSource, Selleck, Selleck",94.35,"BRD-K04185004-003-12-7, BRD-K04185004-003-11-9, BRD-K04185004-003-13-5","Launched","","CMHHMUWAYWTMGS-UHFFFAOYSA-N","BRD-K04185004","","CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC"
"8857","PHENACAINE","local anesthetic","","neurology/psychiatry","local anesthetic","MPBio",99.16,"BRD-K81092066-311-01-6","Launched","","QXDAEKSDNVPFJG-UHFFFAOYSA-N","BRD-K81092066","","CCOc1ccc(NC(C)=Nc2ccc(OCC)cc2)cc1"
"8858","BENFOTIAMINE","antioxidant","AGER","rheumatology","lumbago","MicroSource, Selleck, Selleck",93.58,"BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9","Launched","","BTNNPSLJPBRMLZ-GHRIWEEISA-N","BRD-K07359318","","C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)c1ccccc1"
"8859","BENFOTIAMINE","antioxidant","AGER","rheumatology","lumbago","MicroSource, Selleck, Selleck",93.58,"BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9","Launched","","BTNNPSLJPBRMLZ-GHRIWEEISA-N","BRD-K07359318","","C\C(N(Cc1cnc(C)nc1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)c1ccccc1"
"8861","BENFOTIAMINE","antioxidant","AGER","rheumatology","lumbago","MicroSource, Selleck, Selleck",93.58,"BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9","Launched","","BTNNPSLJPBRMLZ-LGMDPLHJSA-N","BRD-K07359318","","C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)c1ccccc1"
"8862","BENFOTIAMINE","antioxidant","AGER","rheumatology","lumbago","MicroSource, Selleck, Selleck",93.58,"BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9","Launched","","BTNNPSLJPBRMLZ-LGMDPLHJSA-N","BRD-K07359318","","C\C(N(Cc1cnc(C)nc1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)c1ccccc1"
"8864","OXFENDAZOLE","anthelmintic agent","","infectious disease","lungworms, tapeworm, gastrointestinal roundworms","MicroSource, Selleck",97.28,"BRD-A33447119-001-11-6, BRD-A33447119-001-10-8","Launched","","BEZZFPOZAYTVHN-UHFFFAOYSA-N","BRD-A33447119","","COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1"
"8866","ANECORTAVE-ACETATE","angiogenesis inhibitor","","ophthalmology","macular degeneration","InterBioScreen",96.76,"BRD-A53566267-001-01-9","Launched","","YUWPMEXLKGOSBF-SQIVGGFUSA-N","BRD-A53566267","","CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C"
"8867","VERTEPORFIN","photosensitizing agent","","ophthalmology","macular degeneration","MedChemEx, Tocris, Selleck, Cayman, Selleck",69.27,"BRD-K81849500-001-07-7, BRD-K81849500-001-06-9, BRD-K81849500-001-02-8, BRD-K81849500-001-05-1, BRD-K81849500-001-01-0","Launched","","YTZALCGQUPRCGW-ZSFNYQMMSA-N","BRD-K81849500","","COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC"
"8872","LUTEIN","antioxidant","","ophthalmology","macular degeneration, cataracts, retinitis pigmentosa (RP)","Sigma, AKSci",0,"BRD-K16742848-001-02-6, BRD-K16742848-001-01-8","Launched","","KBPHJBAIARWVSC-RGZFRNHPSA-N","BRD-K16742848","","CC(\C=C\C=C(C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C"
"8874","AMODIAQUINE","histamine receptor agonist","HNMT","infectious disease","malaria","Prestwick, MicroSource",98.24,"BRD-K91290917-336-05-3, BRD-K91290917-300-01-8","Launched","BRD-K73443792-300-04-9","OVCDSSHSILBFBN-UHFFFAOYSA-N","BRD-K91290917","BRD-K73443792","CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O"
"8876","ARTEMETHER","antimalarial agent","ATP1A1","infectious disease","malaria","MicroSource, Selleck, MedChemEx, MedChemEx, Selleck",0,"BRD-K39621635-001-09-7, BRD-K39621635-001-08-9, BRD-K39621635-001-07-1, BRD-K39621635-001-05-5, BRD-K39621635-001-06-3","Launched","BRD-A45966947-001-02-8, BRD-K17916327-001-02-5, BRD-K12393844-001-01-8","SXYIRMFQILZOAM-HVNFFKDJSA-N","BRD-K39621635","BRD-A45966947","CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3"
"8881","ARTEMISININ","DNA synthesis inhibitor","CYP2B6","infectious disease","malaria","Tocris, MicroSource, Tocris, Selleck",100,"BRD-K13112821-001-14-1, BRD-K13112821-001-18-2, BRD-K13112821-001-16-6, BRD-K13112821-001-17-4","Launched","BRD-K27678847-001-06-1, BRD-K01715490-001-01-2","BLUAFEHZUWYNDE-NNWCWBAJSA-N","BRD-K13112821","BRD-K27678847","C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4"
"8885","ARTEMOTIL","","","infectious disease","malaria","MedChemEx, AKSci, MedChemEx",0,"BRD-K96006160-001-03-7, BRD-K96006160-001-01-1, BRD-K96006160-001-02-9","Launched","","NLYNIRQVMRLPIQ-XQLAAWPRSA-N","BRD-K96006160","","CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3"
"8888","ARTESUNATE","DNA synthesis inhibitor","","infectious disease","malaria","MicroSource, Selleck",100,"BRD-K54634444-001-05-9, BRD-K54634444-001-04-2","Launched","BRD-K17944737-001-02-1, BRD-K65768634-001-01-1","FIHJKUPKCHIPAT-AHIGJZGOSA-N","BRD-K54634444","BRD-K17944737","C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4"
"8890","CHLORPROGUANIL","dihydrofolate reductase inhibitor","DHFR","infectious disease","malaria","AMS",97.75,"BRD-K25494650-003-01-8","Launched","","ISZNZKHCRKXXAU-UHFFFAOYSA-N","BRD-K25494650","","CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1"
"8891","DIHYDROARTEMISININ","antimalarial agent","","infectious disease","malaria","Selleck, MicroSource",94.91,"BRD-K62213621-001-01-6, BRD-K62213621-001-02-4","Launched","BRD-K45089490-001-02-8,BRD-K11421397-001-01-9, BRD-A82452087-001-02-3","BJDCWCLMFKKGEE-ISOSDAIHSA-N","BRD-K62213621","BRD-K45089490","C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4"
"8893","HALOFANTRINE","antimalarial agent","KCNH2, KCNN4","infectious disease","malaria","Enzo",89.55,"BRD-A51964809-003-12-6","Launched","","FOHHNHSLJDZUGQ-UHFFFAOYSA-N","BRD-A51964809","","CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(ccc12)C(F)(F)F"
"8894","HYDROXYCHLOROQUINE","antimalarial agent","TLR7, TLR9","infectious disease","malaria","MicroSource, Sigma",98.39,"BRD-A99117172-065-04-0, BRD-A99117172-065-05-7","Launched","","XXSMGPRMXLTPCZ-UHFFFAOYSA-N","BRD-A99117172","","CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12"
"8896","LUMEFANTRINE","antimalarial agent","ATP1A1","infectious disease","malaria","MedChemEx, Enamine, MedChemEx",58.57,"BRD-A05926236-001-04-6, BRD-A05926236-001-05-3, BRD-A05926236-001-03-8","Launched","BRD-A58804007-001-01-4","DYLGFOYVTXJFJP-MYYYXRDXSA-N","BRD-A05926236","BRD-A58804007","CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12"
"8899","MEFLOQUINE","adenosine receptor antagonist, hemoglobin antagonist","ADORA2A, HBA1","infectious disease","malaria","MicroSource",88.97,"BRD-A89585551-003-16-6","Launched","","XEEQGYMUWCZPDN-UHFFFAOYSA-N","BRD-A89585551","","OC(C1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F"
"8900","PIPERAQUINE-PHOSPHATE","antimalarial agent","","infectious disease","malaria","AKSci",96.15,"BRD-K27382019-418-01-9","Launched","","UCRHFBCYFMIWHC-UHFFFAOYSA-N","BRD-K27382019","","Clc1ccc2c(ccnc2c1)N1CCN(CCCN2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1"
"8901","PRIMAQUINE","antimalarial agent, DNA inhibitor","KRT7, NQO2","infectious disease","malaria","Selleck, MicroSource",89.83,"BRD-A55913614-316-08-8, BRD-A55913614-316-09-6","Launched","","INDBQLZJXZLFIT-UHFFFAOYSA-N","BRD-A55913614","","COc1cc(NC(C)CCCN)c2ncccc2c1"
"8903","PROGUANIL","dihydrofolate reductase inhibitor","DHFR","infectious disease","malaria","MicroSource",92.08,"BRD-K28183345-003-11-4","Launched","","SSOLNOMRVKKSON-UHFFFAOYSA-N","BRD-K28183345","","CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1"
"8904","PYRIMETHAMINE","dihydrofolate reductase inhibitor","DHFR, SLC47A1","infectious disease","malaria","Tocris, Selleck, Tocris, MicroSource",99.69,"BRD-K88429204-001-38-5, BRD-K88429204-001-33-6, BRD-K88429204-001-34-4, BRD-K88429204-001-35-1","Launched","","WKSAUQYGYAYLPV-UHFFFAOYSA-N","BRD-K88429204","","CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1"
"8908","QUININE","hemozoin biocrystallization inhibitor","GP9, KCNB2, KCNN4, SLC29A4","infectious disease","malaria","Selleck, MicroSource",93.42,"BRD-K07940445-310-02-9, BRD-K48278478-001-01-2","Launched","BRD-K99257182-310-01-6","LOUPRKONTZGTKE-WZBLMQSHSA-N","BRD-K07940445","BRD-K99257182","COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1"
"8909","QUININE","hemozoin biocrystallization inhibitor","GP9, KCNB2, KCNN4, SLC29A4","infectious disease","malaria","Selleck, MicroSource",93.42,"BRD-K07940445-310-02-9, BRD-K48278478-001-01-2","Launched","BRD-K99257182-310-01-6","LOUPRKONTZGTKE-WZBLMQSHSA-N","BRD-K07940445","BRD-K99257182","COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1"
"8910","QUININE","hemozoin biocrystallization inhibitor","GP9, KCNB2, KCNN4, SLC29A4","infectious disease","malaria","Selleck, MicroSource",93.42,"BRD-K07940445-310-02-9, BRD-K48278478-001-01-2","Launched","BRD-K99257182-310-01-6","LOUPRKONTZGTKE-AFHBHXEDSA-N","BRD-K07940445","BRD-K99257182","COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1"
"8911","QUININE","hemozoin biocrystallization inhibitor","GP9, KCNB2, KCNN4, SLC29A4","infectious disease","malaria","Selleck, MicroSource",93.42,"BRD-K07940445-310-02-9, BRD-K48278478-001-01-2","Launched","BRD-K99257182-310-01-6","LOUPRKONTZGTKE-AFHBHXEDSA-N","BRD-K07940445","BRD-K99257182","COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1"
"8912","QUININE-ETHYL-CARBONATE","","","infectious disease","malaria","MicroSource",92.37,"BRD-K97028990-001-04-4","Launched","","NSBRKSWSLRQPJW-FRMGNDQPSA-N","BRD-K97028990","","CCOC(=O)O[C@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccc(OC)cc12"
"8913","SULFADOXINE","dihydropteroate synthase inhibitor","","infectious disease","malaria","MicroSource, Selleck",96.8,"BRD-K55250441-001-13-0, BRD-K55250441-001-12-2","Launched","","PJSFRIWCGOHTNF-UHFFFAOYSA-N","BRD-K55250441","","COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC"
"8915","WR99210","dihydrofolate reductase inhibitor","TYMS","infectious disease","malaria","Sigma",98.92,"BRD-K45973863-001-01-4","Preclinical","","MJZJYWCQPMNPRM-UHFFFAOYSA-N","BRD-K45973863","","CC1(C)N=C(N)N=C(N)N1OCCCOc1cc(Cl)c(Cl)cc1Cl"
"8916","CHLOROQUINE","antimalarial agent","GSTA2, MRGPRX1, TLR9, TNF","infectious disease","malaria, amebiasis","MicroSource, Selleck, Selleck",96.54,"BRD-A91699651-316-10-9, BRD-A91699651-316-09-1, BRD-A91699651-316-11-7","Launched","","WHTVZRBIWZFKQO-UHFFFAOYSA-N","BRD-A91699651","","CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12"
"8919","QUINIDINE","sodium channel blocker","KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4","infectious disease, cardiology","malaria, atrial fibrillation (AF), ventricular arrhythmias","MicroSource",87.9,"BRD-K59632282-052-03-1","Launched","","LOUPRKONTZGTKE-LHHVKLHASA-N","BRD-K59632282","","COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1"
"8920","SULFADIAZINE","bacterial antifolate","","infectious disease, ophthalmology","malaria, meningitis, urinary tract infections, conjunctivitis, trachoma, chancroid","Enamine, Selleck, MicroSource",99.24,"BRD-K32273377-001-17-9, BRD-K32273377-001-15-3, BRD-K32273377-001-16-1","Launched","","SEEPANYCNGTZFQ-UHFFFAOYSA-N","BRD-K32273377","","Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1"
"8923","SULFAMETOPYRAZINE","PABA antagonist","","infectious disease","malaria, urinary tract infections, respiratory tract infections","Enamine",96.63,"BRD-K17205817-001-06-1","Launched","","KXRZBTAEDBELFD-UHFFFAOYSA-N","BRD-K17205817","","COc1nccnc1NS(=O)(=O)c1ccc(N)cc1"
"8924","CEPHAPIRIN","bacterial cell wall synthesis inhibitor","","obstetrics/gynecology","mastitis","MicroSource, Selleck",85.45,"BRD-K49880111-236-09-2, BRD-K49880111-236-10-0","Launched","BRD-K25085912-236-01-4","UQLLWWBDSUHNEB-CZUORRHYSA-N","BRD-K49880111","BRD-K25085912","CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc1ccncc1)C2=O)C(O)=O"
"8926","HETACILLIN","bacterial cell wall synthesis inhibitor","","obstetrics/gynecology","mastitis","MicroSource",26.47,"BRD-A27828834-237-04-4","Launched","","DXVUYOAEDJXBPY-HCYBMXRASA-N","BRD-A27828834","","CC1(C)S[C@@H]2C(N3C(=O)[C@H](NC3(C)C)c3ccccc3)C(=O)N2[C@H]1C(O)=O"
"8927","NOVOBIOCIN","bacterial DNA gyrase inhibitor","","obstetrics/gynecology","mastitis","Selleck, MicroSource, Selleck",89.03,"BRD-K85307935-236-10-3, BRD-K85307935-236-09-5, BRD-K85307935-236-08-7","Launched","","YJQPYGGHQPGBLI-KGSXXDOSSA-N","BRD-K85307935","","CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C"
"8930","THIOSTREPTON","FOXM1 inhibitor, protein synthesis inhibitor","FOXM1","obstetrics/gynecology","mastitis","MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",96.6,"BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7","Launched","BRD-A89819812-001-02-8, BRD-A86083681-001-01-4, BRD-A91347104-001-01-5, BRD-A89819812-001-01-0,BRD-A51799737-001-01-0","NSFFHOGKXHRQEW-DVRIZHICSA-N","BRD-A20697603","BRD-A89819812","CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O"
"8931","THIOSTREPTON","FOXM1 inhibitor, protein synthesis inhibitor","FOXM1","obstetrics/gynecology","mastitis","MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",96.6,"BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7","Launched","BRD-A89819812-001-02-8, BRD-A86083681-001-01-4, BRD-A91347104-001-01-5, BRD-A89819812-001-01-0,BRD-A51799737-001-01-0","NSFFHOGKXHRQEW-DVRIZHICSA-N","BRD-A20697603","BRD-A89819812","CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O"
"8935","THIOSTREPTON","FOXM1 inhibitor, protein synthesis inhibitor","FOXM1","obstetrics/gynecology","mastitis","MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",96.6,"BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7","Launched","BRD-A89819812-001-02-8, BRD-A86083681-001-01-4, BRD-A91347104-001-01-5, BRD-A89819812-001-01-0,BRD-A51799737-001-01-0","NSFFHOGKXHRQEW-AIHSUZKVSA-N","BRD-A20697603","BRD-A89819812","CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O"
"8936","THIOSTREPTON","FOXM1 inhibitor, protein synthesis inhibitor","FOXM1","obstetrics/gynecology","mastitis","MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",96.6,"BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7","Launched","BRD-A89819812-001-02-8, BRD-A86083681-001-01-4, BRD-A91347104-001-01-5, BRD-A89819812-001-01-0,BRD-A51799737-001-01-0","NSFFHOGKXHRQEW-AIHSUZKVSA-N","BRD-A20697603","BRD-A89819812","CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O"
"8940","MASITINIB","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor","FGFR3, KIT, PDGFRA, PDGFRB","dermatology","mastocytoma","Selleck, Selleck",92.11,"BRD-K71035033-001-08-9, BRD-K71035033-001-07-1","Launched","","WJEOLQLKVOPQFV-UHFFFAOYSA-N","BRD-K71035033","","CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1"
"8942","CABOZANTINIB","RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET","oncology","medullary thyroid cancer (MTC)","Selleck, Tocris",99.07,"BRD-K51544265-001-04-2, BRD-K51544265-001-06-7","Launched","","ONIQOQHATWINJY-UHFFFAOYSA-N","BRD-K51544265","","COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC"
"8944","VANDETANIB","EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA","oncology","medullary thyroid cancer (MTC)","Selleck",97.69,"BRD-K77625799-001-07-7","Launched","","UHTHHESEBZOYNR-UHFFFAOYSA-N","BRD-K77625799","","COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1"
"8945","FOLIC-ACID","folate receptor ligand","FOLR2, FOLR3, SLC19A1, SLC46A1","hematology","megaloblastic anemia","MicroSource",89.21,"BRD-K18673820-001-15-5","Launched","","OVBPIULPVIDEAO-LBPRGKRZSA-N","BRD-K18673820","","Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1"
"8946","VITAMIN-B12","","","hematology","megaloblastic anemia","AKSci",97.81,"BRD-A75369945-001-01-2","Launched","BRD-M28180999-001-01-2","FMCRMSOQAVOHRD-WZHZPDAFSA-M","BRD-A75369945","BRD-M28180999","C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12"
"8947","COBIMETINIB","MEK inhibitor","","oncology","melanoma","MedChemEx",91.15,"BRD-K03390685-001-01-7","Launched","","BSMCAPRUBJMWDF-KRWDZBQOSA-N","BRD-K03390685","","OC1(CN(C1)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[C@@H]1CCCCN1"
"8948","DABRAFENIB","RAF inhibitor","BRAF, LIMK1, NEK11, RAF1, SIK1","oncology","melanoma","Selleck, MedChemEx, Selleck",98.14,"BRD-K09951645-001-11-8, BRD-K09951645-001-08-4, BRD-K09951645-001-06-8","Launched","","BFSMGDJOXZAERB-UHFFFAOYSA-N","BRD-K09951645","","CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F"
"8951","FOTEMUSTINE","thioredoxin inhibitor","TXNRD1","oncology","melanoma","MedChemEx, MedChemEx",36.92,"BRD-A62893078-001-02-3, BRD-A62893078-001-01-5","Launched","","YAKWPXVTIGTRJH-UHFFFAOYSA-N","BRD-A62893078","","CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)[N+][O-]"
"8953","TRAMETINIB","MEK inhibitor","MAP2K1, MAP2K2","oncology","melanoma","Selleck, MedChemEx, Selleck, Selleck",94.67,"BRD-K12343256-001-18-8, BRD-K12343256-001-14-7, BRD-K12343256-001-11-3, BRD-K12343256-001-08-9","Launched","","LIRYPHYGHXZJBZ-UHFFFAOYSA-N","BRD-K12343256","","CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O"
"8957","VEMURAFENIB","RAF inhibitor","BRAF, RAF1","oncology","melanoma","Selleck, MedChemEx, Selleck",98.74,"BRD-K56343971-001-14-8, BRD-K56343971-001-12-2, BRD-K56343971-001-10-6","Launched","","GPXBXXGIAQBQNI-UHFFFAOYSA-N","BRD-K56343971","","CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F"
"8960","DACARBAZINE","DNA alkylating agent","PGD, POLA2","oncology, hematologic malignancy","melanoma, Hodgkin's lymphoma","MicroSource, Selleck",98.92,"BRD-K35520305-001-17-7, BRD-K35520305-001-16-9","Launched","","FDKXTQMXEQVLRF-ZHACJKMWSA-N","BRD-K35520305","","CN(C)\N=N\c1[nH]cnc1C(N)=O"
"8962","CHLORAMPHENICOL","bacterial 50S ribosomal subunit inhibitor","CD55","infectious disease, endocrinology","meningitis, fever, cholera","MicroSource, Selleck",99.59,"BRD-K08111712-001-16-7, BRD-K08111712-001-14-2","Launched","BRD-K22969690-001-04-2","WIIZWVCIJKGZOK-RKDXNWHRSA-N","BRD-K08111712","BRD-K22969690","OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O"
"8964","CHLORAMPHENICOL-PALMITATE","protein synthesis inhibitor","","infectious disease, endocrinology","meningitis, fever, cholera","MicroSource",89.74,"BRD-K96424892-001-02-9","Launched","","PXKHGMGELZGJQE-UKILVPOCSA-N","BRD-K96424892","","CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O"
"8965","SULFISOXAZOLE-ACETYL","folic acid antagonist","","infectious disease, otolaryngology","meningitis, urinary tract infections, otitis, trachoma","MicroSource",56.69,"BRD-K84810336-001-01-9","Launched","BRD-K05009775-001-02-0","JFNWFXVFBDDWCX-UHFFFAOYSA-N","BRD-K84810336","BRD-K05009775","CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1"
"8966","DEHYDROEPIANDROSTERONE-SULFATE","androgen receptor agonist, estrogen receptor agonist","AR, ESR1, ESR2","endocrinology","menopause","Sigma",99.5,"BRD-K15360631-325-01-4","Launched","","CZWCKYRVOZZJNM-USOAJAOKSA-N","BRD-K15360631","","C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)OS(O)(=O)=O)[C@@H]1CCC2=O"
"8967","DIENESTROL","estrogen receptor agonist","ESR1","endocrinology","menopause","MicroSource",90.26,"BRD-K95309561-001-24-7","Launched","","NFDFQCUYFHCNBW-SCGPFSFSSA-N","BRD-K95309561","","C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C"
"8968","QUINESTROL","estrogen receptor agonist","ESR1","endocrinology","menopause","MicroSource",99.34,"BRD-A16439188-001-01-1","Launched","","PWZUUYSISTUNDW-BOSQQAFTSA-N","BRD-A16439188","","C[C@]12CCC3C(CCc4cc(OC5CCCC5)ccc34)C1CC[C@@]2(O)C#C"
"8969","NORETHINDRONE-ACETATE","progesterone receptor agonist","","endocrinology, orthopedics, obstetrics/gynecology","menopause, osteoporosis, vaginal atrophy","MicroSource",98.25,"BRD-A09349126-001-10-7","Launched","","IMONTRJLAWHYGT-FJMAIUEKSA-N","BRD-A09349126","","CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@]12C)C#C"
"8970","CHLOROTRIANISENE","estrogenic hormone","ESR1, ESR2","endocrinology, oncology","menopause, prostate cancer","Prestwick",98.18,"BRD-K27062708-001-23-1","Launched","","BFPSDSIWYFKGBC-UHFFFAOYSA-N","BRD-K27062708","","COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1"
"8971","ESTRADIOL-ACETATE","estrogen receptor agonist","ESR1","endocrinology, obstetrics/gynecology","menopause, vaginal atrophy","Sigma",96.27,"BRD-K53319039-001-01-8","Launched","","FHXBMXJMKMWVRG-SLHNCBLASA-N","BRD-K53319039","","CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1"
"8972","ESTRIOL","estrogen receptor agonist","ESR1, ESR2","endocrinology, obstetrics/gynecology, infectious disease","menopause, vaginal atrophy, urinary tract infections","MicroSource, Selleck, MicroSource, Selleck",88.19,"BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9","Launched","BRD-A18620900-001-05-2, BRD-K03411175-001-01-8","PROQIPRRNZUXQM-ZXXIGWHRSA-N","BRD-K17016787","BRD-A18620900","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O"
"8974","ESTRIOL","estrogen receptor agonist","ESR1, ESR2","endocrinology, obstetrics/gynecology, infectious disease","menopause, vaginal atrophy, urinary tract infections","MicroSource, Selleck, MicroSource, Selleck",88.19,"BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9","Launched","BRD-A18620900-001-05-2, BRD-K03411175-001-01-8","PROQIPRRNZUXQM-ZXXIGWHRSA-N","BRD-K17016787","BRD-A18620900","CC12CCC3C(CCc4cc(O)ccc34)C1C[C@H](O)[C@@H]2O"
"8976","ESTRIOL","estrogen receptor agonist","ESR1, ESR2","endocrinology, obstetrics/gynecology, infectious disease","menopause, vaginal atrophy, urinary tract infections","MicroSource, Selleck, MicroSource, Selleck",88.19,"BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9","Launched","BRD-A18620900-001-05-2, BRD-K03411175-001-01-8","PROQIPRRNZUXQM-WRECPOHLSA-N","BRD-K17016787","BRD-A18620900","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O"
"8978","ESTRIOL","estrogen receptor agonist","ESR1, ESR2","endocrinology, obstetrics/gynecology, infectious disease","menopause, vaginal atrophy, urinary tract infections","MicroSource, Selleck, MicroSource, Selleck",88.19,"BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9","Launched","BRD-A18620900-001-05-2, BRD-K03411175-001-01-8","PROQIPRRNZUXQM-WRECPOHLSA-N","BRD-K17016787","BRD-A18620900","CC12CCC3C(CCc4cc(O)ccc34)C1C[C@H](O)[C@@H]2O"
"8980","RALTITREXED","thymidylate synthase inhibitor","FPGS, TYMS","oncology","mesothelioma","Selleck, Selleck",93.68,"BRD-K89839824-001-06-1, BRD-K89839824-001-05-3","Launched","","IVTVGDXNLFLDRM-HNNXBMFYSA-N","BRD-K89839824","","CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O"
"8982","DIMERCAPROL","chelating agent","","neurology/psychiatry","metal toxicity","Sigma, MicroSource",0,"BRD-A56152450-001-03-8, BRD-A56152450-001-02-0","Launched","","WQABCVAJNWAXTE-UHFFFAOYSA-N","BRD-A56152450","","OCC(S)CS"
"8984","DIMERCAPTOSUCCINIC-ACID","chelating agent","DNMT1","neurology/psychiatry","metal toxicity","AlfaAesar, AlfaAesar",0,"BRD-K88701661-001-03-7, BRD-K88701661-001-02-9","Launched","","ACTRVOBWPAIOHC-XIXRPRMCSA-N","BRD-K88701661","","OC(=O)[C@@H](S)[C@@H](S)C(O)=O"
"8986","ETHYLENEDIAMINETETRAACETIC-ACID","PKC inhibitor","","neurology/psychiatry","metal toxicity","MicroSource",100,"BRD-K82603084-408-01-1","Launched","","KCXVZYZYPLLWCC-UHFFFAOYSA-N","BRD-K82603084","","OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O"
"8987","METHYLENE-BLUE","guanylyl cyclase inhibitor, nitric oxide production inhibitor","ACHE","hematology","methemoglobinemia","MicroSource, MedChemEx",47.14,"BRD-K16406336-311-02-0, BRD-K54770538-003-14-6","Launched","","RBTBFTRPCNLSDE-UHFFFAOYSA-N","BRD-K16406336","","CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C"
"8988","METHYLENE-BLUE","guanylyl cyclase inhibitor, nitric oxide production inhibitor","ACHE","hematology","methemoglobinemia","MicroSource, MedChemEx",47.14,"BRD-K16406336-311-02-0, BRD-K54770538-003-14-6","Launched","","RBTBFTRPCNLSDE-UHFFFAOYSA-N","BRD-K16406336","","CN(C)c1ccc2nc3ccc(cc3sc2c1)=[N+](C)C"
"8989","TOLONIUM","","","hematology","methemoglobinemia","MicroSource",48.61,"BRD-K94882685-003-09-2","Launched","","RQNADZJRELIICT-UHFFFAOYSA-N","BRD-K94882685","","CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1"
"8990","FUMAGILLIN","methionine aminopeptidase inhibitor","METAP2","infectious disease","microsporidiosis","MedChemEx, MedChemEx, Enzo",86.8,"BRD-A99367815-001-04-9, BRD-A99367815-001-03-1, BRD-A99367815-001-01-5","Launched","","NGGMYCMLYOUNGM-ZVVCMXCESA-N","BRD-A99367815","","CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O"
"8993","ALMOTRIPTAN","serotonin receptor agonist","HTR1B, HTR1D","neurology/psychiatry","migraine headache","MicroSource, Selleck",93.42,"BRD-K67601717-001-03-8, BRD-K67601717-037-02-4","Launched","","WKEMJKQOLOHJLZ-UHFFFAOYSA-N","BRD-K67601717","","CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12"
"8995","BUCLIZINE","histamine receptor antagonist","CHRM1, HRH1","neurology/psychiatry","migraine headache","Key",99.32,"BRD-A91444184-300-01-9","Launched","","MOYGZHXDRJNJEP-UHFFFAOYSA-N","BRD-A91444184","","CC(C)(C)c1ccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)cc1"
"8996","DIHYDROERGOTAMINE","serotonin receptor agonist","ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7","neurology/psychiatry","migraine headache","Tocris, MicroSource, Tocris",97.15,"BRD-K72166146-066-06-2, BRD-K72166146-066-05-4, BRD-K72166146-066-04-7","Launched","","LUZRJRNZXALNLM-JGRZULCMSA-N","BRD-K72166146","","CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O"
"8999","ELETRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7","neurology/psychiatry","migraine headache","Tocris, Selleck, MicroSource, Tocris",97.64,"BRD-K30652337-004-03-9, BRD-K30652337-004-01-3, BRD-K30652337-001-01-9, BRD-K30652337-004-02-1","Launched","","PWVXXGRKLHYWKM-LJQANCHMSA-N","BRD-K30652337","","CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12"
"9003","ERGOTAMINE","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2","neurology/psychiatry","migraine headache","MicroSource",25.51,"BRD-A43227343-046-01-4","Launched","","XCGSFFUVFURLIX-WSHJXIHDSA-N","BRD-A43227343","","CN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)C3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O"
"9004","FROVATRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D","neurology/psychiatry","migraine headache","Sigma",91.96,"BRD-K08255599-365-01-1","Launched","","XPSQPHWEGNHMSK-SECBINFHSA-N","BRD-K08255599","","CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O"
"9005","LOMERIZINE","calcium channel blocker","CACNA1B, SCN5A","neurology/psychiatry","migraine headache","MicroSource, Selleck",97.88,"BRD-K62858456-001-01-8, BRD-K62858456-300-01-4","Launched","","JQSAYKKFZOSZGJ-UHFFFAOYSA-N","BRD-K62858456","","COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC"
"9007","NARATRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F","neurology/psychiatry","migraine headache","Selleck, Selleck",88.86,"BRD-K61337602-003-03-9, BRD-K61337602-003-02-1","Launched","","AMKVXSZCKVJAGH-UHFFFAOYSA-N","BRD-K61337602","","CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1"
"9009","PIZOTIFEN","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C","neurology/psychiatry","migraine headache","Selleck, MicroSource",98.76,"BRD-K75958195-037-08-6, BRD-K75958195-037-09-4","Launched","","FIADGNVRKBPQEU-UHFFFAOYSA-N","BRD-K75958195","","CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12"
"9011","RIZATRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F","neurology/psychiatry","migraine headache","Selleck, Tocris, MicroSource, Selleck",93.99,"BRD-K75699339-057-09-9, BRD-K75699339-057-10-7, BRD-K75699339-057-08-1, BRD-K75699339-057-07-3","Launched","","ULFRLSNUDGIQQP-UHFFFAOYSA-N","BRD-K75699339","","CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12"
"9015","SUMATRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7","neurology/psychiatry","migraine headache","MicroSource, Tocris, Tocris, Selleck",95.83,"BRD-K50938287-001-09-0, BRD-K50938287-036-13-8, BRD-K50938287-036-16-1, BRD-K50938287-036-12-0","Launched","","KQKPFRSPSRPDEB-UHFFFAOYSA-N","BRD-K50938287","","CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1"
"9019","TOLFENAMIC-ACID","cyclooxygenase inhibitor, prostanoid receptor antagonist","","neurology/psychiatry","migraine headache","MicroSource, Selleck",98.71,"BRD-K50133271-001-18-7, BRD-K50133271-001-17-9","Launched","","YEZNLOUZAIOMLT-UHFFFAOYSA-N","BRD-K50133271","","Cc1c(Cl)cccc1Nc1ccccc1C(O)=O"
"9021","ZOLMITRIPTAN","serotonin receptor agonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F","neurology/psychiatry","migraine headache","Tocris, MicroSource, Selleck",95.65,"BRD-K54314721-001-11-0, BRD-K54314721-001-10-2, BRD-K54314721-001-09-4","Launched","","ULSDMUVEXKOYBU-ZDUSSCGKSA-N","BRD-K54314721","","CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12"
"9024","FLUNARIZINE","calcium channel blocker","CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1","neurology/psychiatry, cardiology","migraine headache, vertigo, peripheral artery disease (PAD)","Tocris, Selleck, MicroSource, Tocris",97.81,"BRD-K29582677-300-11-4, BRD-K29582677-300-08-0, BRD-K29582677-300-10-6, BRD-K29582677-300-09-8","Launched","","SMANXXCATUTDDT-QPJJXVBHSA-N","BRD-K29582677","","Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1"
"9028","DIMENHYDRINATE","histamine receptor antagonist","HRH1","neurology/psychiatry, gastroenterology","motion sickness, nausea, vomiting","MicroSource, MedChemEx, MedChemEx",59.15,"BRD-M98649031-001-08-6, BRD-M98649031-001-10-2, BRD-M98649031-001-09-4","Launched","","NFLLKCVHYJRNRH-UHFFFAOYSA-N","BRD-M98649031","","Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1"
"9031","SCOPOLAMINE","acetylcholine receptor antagonist","","neurology/psychiatry, gastroenterology","motion sickness, vomiting, nausea","Selleck, MicroSource, Tocris",98.87,"BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2","Launched","BRD-A62035778-004-03-6","STECJAGHUSJQJN-FWXGHANASA-N","BRD-K89923877","BRD-A62035778","CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9032","SCOPOLAMINE","acetylcholine receptor antagonist","","neurology/psychiatry, gastroenterology","motion sickness, vomiting, nausea","Selleck, MicroSource, Tocris",98.87,"BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2","Launched","BRD-A62035778-004-03-6","STECJAGHUSJQJN-FWXGHANASA-N","BRD-K89923877","BRD-A62035778","CN1[C@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9034","SCOPOLAMINE","acetylcholine receptor antagonist","","neurology/psychiatry, gastroenterology","motion sickness, vomiting, nausea","Selleck, MicroSource, Tocris",98.87,"BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2","Launched","BRD-A62035778-004-03-6","STECJAGHUSJQJN-AQGHMYMLSA-N","BRD-K89923877","BRD-A62035778","CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9035","SCOPOLAMINE","acetylcholine receptor antagonist","","neurology/psychiatry, gastroenterology","motion sickness, vomiting, nausea","Selleck, MicroSource, Tocris",98.87,"BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2","Launched","BRD-A62035778-004-03-6","STECJAGHUSJQJN-AQGHMYMLSA-N","BRD-K89923877","BRD-A62035778","CN1[C@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9037","EMORFAZONE","antiinflammatory agent, cyclooxygenase inhibitor","","dental","mouth inflammation","Sigma",99.42,"BRD-K90629600-001-01-4","Launched","","URJQOOISAKEBKW-UHFFFAOYSA-N","BRD-K90629600","","CCOc1c(cnn(C)c1=O)N1CCOCC1"
"9038","BENZYDAMINE","prostanoid receptor antagonist","","dental, otolaryngology","mouth inflammation, throat inflammation","MicroSource, Selleck",98.35,"BRD-K28542495-003-13-5, BRD-K28542495-003-12-7","Launched","","CNBGNNVCVSKAQZ-UHFFFAOYSA-N","BRD-K28542495","","CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12"
"9040","CARFILZOMIB","proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9","hematologic malignancy","multiple myeloma","Selleck",95.76,"BRD-K15179879-001-03-2","Launched","","BLMPQMFVWMYDKT-NZTKNTHTSA-N","BRD-K15179879","","CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"
"9041","IXAZOMIB","proteasome inhibitor","","hematologic malignancy","multiple myeloma","Selleck",93.99,"BRD-K78659596-001-03-9","Launched","","MXAYKZJJDUDWDS-LBPRGKRZSA-N","BRD-K78659596","","CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O"
"9042","IXAZOMIB-CITRATE","proteasome inhibitor","","hematologic malignancy","multiple myeloma","Selleck",92.47,"BRD-A66419424-001-02-4","Launched","","YTXSYWAKVMZICI-PVCZSOGJSA-N","BRD-A66419424","","CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(O)=O)(O1)C(O)=O"
"9043","MELPHALAN","DNA alkylating agent, DNA inhibitor","","hematologic malignancy","multiple myeloma","MicroSource, MicroSource",93.38,"BRD-K87827419-001-16-8, BRD-K87827419-001-14-3","Launched","","SGDBTWWWUNNDEQ-LBPRGKRZSA-N","BRD-K87827419","","N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O"
"9045","PANOBINOSTAT","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9","hematologic malignancy","multiple myeloma","Selleck, MedChemEx, MedChemEx, Selleck",81.65,"BRD-K02130563-001-12-2, BRD-K02130563-001-15-5, BRD-K02130563-001-14-8, BRD-K02130563-001-11-4","Launched","","FPOHNWQLNRZRFC-ZHACJKMWSA-N","BRD-K02130563","","Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1"
"9049","POMALIDOMIDE","angiogenesis inhibitor, tumor necrosis factor production inhibitor","CRBN, PTGS2, TNF","hematologic malignancy","multiple myeloma","Selleck",96.64,"BRD-A12994259-001-02-1","Launched","","UVSMNLNDYGZFPF-UHFFFAOYSA-N","BRD-A12994259","","Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12"
"9050","BORTEZOMIB","NFkB pathway inhibitor, proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA","hematologic malignancy","multiple myeloma, mantle cell lymphoma (MCL)","MedChemEx, Selleck, Selleck, Selleck, Selleck",97.62,"BRD-K88510285-001-18-6, BRD-K88510285-001-17-8, BRD-K88510285-001-25-1, BRD-K88510285-001-22-8, BRD-K88510285-001-11-1","Launched","BRD-K50691590-001-05-5, BRD-K50691590-001-02-2","GXJABQQUPOEUTA-RDJZCZTQSA-N","BRD-K88510285","BRD-K50691590","CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O"
"9055","LENALIDOMIDE","anticancer agent","CDH5, CRBN, PTGS2, TNF, TNFSF11","hematologic malignancy","multiple myeloma, mantle cell lymphoma (MCL), myelodysplastic diseases (MDS)","Selleck",98.9,"BRD-A17883755-001-06-1","Launched","","GOTYRUGSSMKFNF-UHFFFAOYSA-N","BRD-A17883755","","Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O"
"9056","DALFAMPRIDINE","potassium channel blocker","KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2","neurology/psychiatry","multiple sclerosis","Tocris, MicroSource",97.14,"BRD-K22482860-001-20-6, BRD-K22482860-001-21-4","Launched","","NUKYPUAOHBNCPY-UHFFFAOYSA-N","BRD-K22482860","","Nc1ccncc1"
"9058","DIMETHYL-FUMARATE","nuclear factor erythroid derived, like (NRF2) activator","KEAP1","neurology/psychiatry","multiple sclerosis","MicroSource, Selleck, Selleck",97.66,"BRD-K31111078-001-04-2, BRD-K31111078-001-05-9, BRD-K31111078-001-03-4","Launched","","LDCRTTXIJACKKU-ONEGZZNKSA-N","BRD-K31111078","","COC(=O)\C=C\C(=O)OC"
"9061","FINGOLIMOD","immunosuppressant, sphingosine phosphate receptor agonist","S1PR1, S1PR5","neurology/psychiatry","multiple sclerosis","Selleck, Selleck",95.28,"BRD-K88025533-003-04-1, BRD-K88025533-003-03-3","Launched","","KKGQTZUTZRNORY-UHFFFAOYSA-N","BRD-K88025533","","CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1"
"9063","TERIFLUNOMIDE","dihydroorotate dehydrogenase inhibitor","DHODH","neurology/psychiatry","multiple sclerosis","Selleck, Tocris, Selleck",99.84,"BRD-A42699921-001-02-8, BRD-A42699921-001-04-4, BRD-A42699921-001-03-6","Launched","","NABQBYDEMLGCEO-UHFFFAOYSA-N","BRD-A42699921","","CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F"
"9066","MITOXANTRONE","topoisomerase inhibitor","TOP2A","neurology/psychiatry, oncology, hematologic malignancy","multiple sclerosis, prostate cancer, acute myeloid leukemia (AML)","MicroSource, Selleck, Selleck",96.64,"BRD-K21680192-300-15-1, BRD-K21680192-300-16-9, BRD-K21680192-300-14-4","Launched","","KKZJGLLVHKMTCM-UHFFFAOYSA-N","BRD-K21680192","","OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12"
"9069","BACLOFEN","benzodiazepine receptor agonist","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8","neurology/psychiatry","multiple sclerosis, spasms","MicroSource",0,"BRD-A84174873-003-07-4","Launched","","KPYSYYIEGFHWSV-UHFFFAOYSA-N","BRD-A84174873","","NCC(CC(O)=O)c1ccc(Cl)cc1"
"9070","METAXALONE","muscle relaxant","","neurology/psychiatry","muscle pain","MicroSource",99.54,"BRD-A94709349-001-08-3","Launched","","IMWZZHHPURKASS-UHFFFAOYSA-N","BRD-A94709349","","Cc1cc(C)cc(OCC2CNC(=O)O2)c1"
"9071","ORPHENADRINE","acetylcholine receptor antagonist","GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2","neurology/psychiatry","muscle pain","MicroSource, Selleck",98.55,"BRD-A53576514-048-14-3, BRD-A53576514-048-13-5","Launched","","QVYRGXJJSLMXQH-UHFFFAOYSA-N","BRD-A53576514","","CN(C)CCOC(c1ccccc1)c1ccccc1C"
"9073","BUTORPHANOL-(+)-TARTRATE","opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1","neurology/psychiatry, gastroenterology","muscle pain, headache, abdominal pain","Enzo",97.38,"BRD-K42417338-045-01-9","Launched","BRD-M74255273-001-01-2","IFKLAQQSCNILHL-QHAWAJNXSA-N","BRD-K42417338","BRD-M74255273","Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1"
"9074","BENDAZAC","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain","Key",97.29,"BRD-K19515365-001-02-6","Launched","","BYFMCKSPFYVMOU-UHFFFAOYSA-N","BRD-K19515365","","OC(=O)COc1nn(Cc2ccccc2)c2ccccc12"
"9075","ETOFENAMATE","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain","MedChemEx",97.04,"BRD-K73541271-001-03-6","Launched","","XILVEPYQJIOVNB-UHFFFAOYSA-N","BRD-K73541271","","OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F"
"9076","FENTIAZAC","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain","Prestwick",92.65,"BRD-K16077845-001-06-1","Launched","","JIEKMACRVQTPRC-UHFFFAOYSA-N","BRD-K16077845","","OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1"
"9077","CAPSAICIN","TRPV agonist","CFTR, TRPV1","neurology/psychiatry, rheumatology","muscle pain, rheumatoid arthritis","Tocris, MicroSource",95.04,"BRD-K50590187-001-19-9, BRD-K50590187-001-20-7","Launched","","YKPUWZUDDOIDPM-SOFGYWHQSA-N","BRD-K50590187","","COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O"
"9079","GLUCOSAMINE","glycosylated protein precursor","IFNG, IL1B, MMP9, NFKB2, TNF","neurology/psychiatry, rheumatology","muscle pain, rheumatoid arthritis, joint pain, backache","MicroSource",100,"BRD-K29918010-003-04-1","Launched","","MSWZFWKMSRAUBD-QZABAPFNSA-N","BRD-K29918010","","N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O"
"9080","ALCURONIUM","muscle relaxant","CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7","neurology/psychiatry","muscle relaxant","Prestwick",89.64,"BRD-A84907376-300-03-8","Launched","","MUQUYTSLDVKIOF-CNCPGNHZSA-N","BRD-A84907376","","OC\C=C1/C[N@+]2(CC=C)CC[C@@]34[C@@H]2C[C@@H]1\C1=C\N2C5[C@]6(CC[N@@+]7(CC=C)C\C(=C/CO)[C@H](C[C@@H]67)\C5=C\N(C31)c1ccccc41)c1ccccc21"
"9081","CARISOPRODOL","acetylcholine receptor antagonist","CYP2C19","neurology/psychiatry","muscle relaxant","MicroSource",100,"BRD-A99939097-001-24-2","Launched","","OFZCIYFFPZCNJE-UHFFFAOYSA-N","BRD-A99939097","","CCCC(C)(COC(N)=O)COC(=O)NC(C)C"
"9082","CHLORZOXAZONE","bacterial 30S ribosomal subunit inhibitor","KCNMA1, KCNN4","neurology/psychiatry","muscle relaxant","MicroSource, Selleck",100,"BRD-K98174813-001-18-0, BRD-K98174813-001-17-2","Launched","","TZFWDZFKRBELIQ-UHFFFAOYSA-N","BRD-K98174813","","Clc1ccc2oc(=O)[nH]c2c1"
"9084","DECAMETHONIUM","acetylcholine receptor agonist","ACHE, CHRNA2","neurology/psychiatry","muscle relaxant","MicroSource, Selleck",99.47,"BRD-K49783248-303-08-4, BRD-K49783248-303-07-6","Launched","","MTCUAOILFDZKCO-UHFFFAOYSA-N","BRD-K49783248","","C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C"
"9086","GALLAMINE-TRIETHIODIDE","acetylcholine receptor antagonist","ACHE, CHRM2, CHRNA1, CHRNA2","neurology/psychiatry","muscle relaxant","Selleck, MicroSource, Selleck",98.46,"BRD-K43106192-320-09-2, BRD-K43106192-320-10-0, BRD-K43106192-320-11-8","Launched","","OZLPUNFFCJDMJD-UHFFFAOYSA-N","BRD-K43106192","","CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC"
"9089","MEPHENESIN","muscle relaxant","","neurology/psychiatry","muscle relaxant","MicroSource",99.05,"BRD-A55469827-001-07-4","Launched","","JWDYCNIAQWPBHD-UHFFFAOYSA-N","BRD-A55469827","","Cc1ccccc1OCC(O)CO"
"9090","METHOCARBAMOL","muscle relaxant","CA1","neurology/psychiatry","muscle relaxant","Selleck, MicroSource",99.36,"BRD-A31521121-001-25-6, BRD-A31521121-001-26-4","Launched","","GNXFOGHNGIVQEH-UHFFFAOYSA-N","BRD-A31521121","","COc1ccccc1OCC(O)COC(N)=O"
"9092","METOCURINE","acetylcholine receptor antagonist","CHRM2, CHRNA2","neurology/psychiatry","muscle relaxant","Specs",96.67,"BRD-K16484091-001-01-1","Launched","","JFXBEKISTKFVAB-AJQTZOPKSA-N","BRD-K16484091","","COc1ccc2C[C@@H]3c4c(CC[N+]3(C)C)cc(OC)c(OC)c4Oc3ccc(C[C@H]4c5cc(Oc1c2)c(OC)cc5CC[N+]4(C)C)cc3"
"9093","PRIDINOL","muscle relaxant","","neurology/psychiatry","muscle relaxant","Selleck, MicroSource",98.23,"BRD-K17565903-066-22-3, BRD-K17565903-066-23-1","Launched","","RQXCLMGKHJWMOA-UHFFFAOYSA-N","BRD-K17565903","","OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1"
"9095","SUCCINYLCHOLINE-CHLORIDE","","CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10","neurology/psychiatry","muscle relaxant","Sigma, DuPont, Selleck, Selleck",66.78,"BRD-K45497762-336-03-2, BRD-K45497762-300-01-2, BRD-K45497762-336-01-6, BRD-K45497762-336-02-4","Launched","","AXOIZCJOOAYSMI-UHFFFAOYSA-N","BRD-K45497762","","C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C"
"9099","THIOCOLCHICOSIDE","GABA receptor antagonist","GABRA1, GABRB2, GABRG2, GLRA1, GLRB","neurology/psychiatry","muscle relaxant","Prestwick",96.58,"BRD-K26619122-001-02-1","Launched","","LEQAKWQJCITZNK-AXHKHJLKSA-N","BRD-K26619122","","COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2CC[C@H](NC(C)=O)c3cc(=O)c(SC)ccc3-c2c1OC"
"9100","VECURONIUM","acetylcholine receptor antagonist","CHRNA2","neurology/psychiatry","muscle relaxant","MicroSource, Selleck",96.73,"BRD-K20168442-004-07-1, BRD-K20168442-004-06-3","Launched","BRD-A82463680-004-02-5, BRD-K07365190-004-01-7","BGSZAXLLHYERSY-XQIGCQGXSA-N","BRD-K20168442","BRD-A82463680","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1"
"9102","CISATRACURIUM","acetylcholine receptor antagonist","CHRNA2","neurology/psychiatry, critical care","muscle relaxant, endotracheal intubation","Selleck",64.92,"BRD-K17498618-344-03-4","Launched","","YXSLJKQTIDHPOT-LJCJQEJUSA-N","BRD-K17498618","","COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC"
"9103","TOLPERISONE","voltage-gated sodium channel blocker","CYP2C19, CYP2D6","neurology/psychiatry, infectious disease, rheumatology, cardiology","muscle relaxant, multiple sclerosis, encephalomyelitis, ankylosing spondylitis, atherosclerosis, Raynaud's disease","MicroSource, Selleck",97.96,"BRD-A27732521-003-08-3, BRD-A27732521-003-07-5","Launched","","FSKFPVLPFLJRQB-UHFFFAOYSA-N","BRD-A27732521","","CC(CN1CCCCC1)C(=O)c1ccc(C)cc1"
"9105","CHLORPHENESIN","muscle relaxant","","neurology/psychiatry","muscle relaxant, sedative","Enamine, Sigma",98.16,"BRD-A92262698-001-01-7, BRD-A92262698-001-02-5","Launched","","MXOAEAUPQDYUQM-UHFFFAOYSA-N","BRD-A92262698","","OCC(O)COc1ccc(Cl)cc1"
"9107","ETHAVERINE","calcium channel blocker","","neurology/psychiatry","muscle relaxant, spasms","MicroSource",99.19,"BRD-K36756879-003-08-7","Launched","","ZOWYFYXTIWQBEP-UHFFFAOYSA-N","BRD-K36756879","","CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC"
"9108","AMBENONIUM","cholinesterase inhibitor","ACHE","neurology/psychiatry","myasthenia gravis","Tocris",93.62,"BRD-K11292736-300-02-8","Launched","","OMHBPUNFVFNHJK-UHFFFAOYSA-P","BRD-K11292736","","CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl"
"9109","EDROPHONIUM","acetylcholinesterase inhibitor","ACHE, BCHE","neurology/psychiatry","myasthenia gravis","MicroSource",98.99,"BRD-K81128206-003-24-4","Launched","","VWLHWLSRQJQWRG-UHFFFAOYSA-O","BRD-K81128206","","CC[N+](C)(C)c1cccc(O)c1"
"9110","MESTINON","cholinesterase inhibitor","ACHE, BCHE","neurology/psychiatry","myasthenia gravis","MicroSource, Selleck",98.82,"BRD-K69688083-004-23-1, BRD-K69688083-004-22-3","Launched","","RVOLLAQWKVFTGE-UHFFFAOYSA-N","BRD-K69688083","","CN(C)C(=O)Oc1ccc[n+](C)c1"
"9112","NEOSTIGMINE","acetylcholinesterase inhibitor","ACHE","neurology/psychiatry","myasthenia gravis","Selleck, Selleck, MicroSource",95.35,"BRD-K18922609-004-24-9, BRD-K18922609-004-22-3, BRD-K18922609-004-23-1","Launched","","ALWKGYPQUAPLQC-UHFFFAOYSA-N","BRD-K18922609","","CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C"
"9115","FLUTRIMAZOLE","sterol demethylase inhibitor","","infectious disease","mycosis","SantaCruz",99.39,"BRD-A00218260-001-03-4","Launched","","QHMWCHQXCUNUAK-UHFFFAOYSA-N","BRD-A00218260","","Fc1ccc(cc1)C(c1ccccc1)(c1ccccc1F)n1ccnc1"
"9116","DAPIPRAZOLE","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D","ophthalmology","mydriasis","AvaChem",99.76,"BRD-K33133047-001-01-8","Launched","","RFWZESUMWJKKRN-UHFFFAOYSA-N","BRD-K33133047","","Cc1ccccc1N1CCN(CCc2nnc3CCCCn23)CC1"
"9117","HYDROXYAMPHETAMINE","trace amine associated receptor agonist","TAAR1","ophthalmology","mydriasis","MicroSource",97.66,"BRD-A80871782-004-06-9","Launched","","GIKNHHRFLCDOEU-UHFFFAOYSA-N","BRD-A80871782","","CC(N)Cc1ccc(O)cc1"
"9118","TROPICAMIDE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","ophthalmology","mydriasis diagnostic, cycloplegia diagnostic","Tocris, Tocris, MicroSource, Selleck",99.63,"BRD-A79672927-001-22-3, BRD-A79672927-001-19-9, BRD-A79672927-001-20-7, BRD-A79672927-001-18-1","Launched","","BGDKAVGWHJFAGW-UHFFFAOYSA-N","BRD-A79672927","","CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1"
"9122","CYCLOPENTOLATE","acetylcholine receptor antagonist","CHRM1","ophthalmology","mydriasis, cycloplegia","MicroSource",94.68,"BRD-A77291778-003-22-0","Launched","","SKYSRIRYMSLOIN-UHFFFAOYSA-N","BRD-A77291778","","CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1"
"9123","DECITABINE","DNA methyltransferase inhibitor","DNMT1, DNMT3A","hematologic malignancy, hematology","myelodysplastic diseases (MDS), anemia, chronic myeloid leukemia (CML)","Tocris, Tocris, Selleck",100,"BRD-K79254416-001-24-2, BRD-K79254416-001-22-6, BRD-K79254416-001-21-8","Launched","","XAUDJQYHKZQPEU-KVQBGUIXSA-N","BRD-K79254416","","Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1"
"9126","AZACITIDINE","DNA methyltransferase inhibitor","DNMT1, DNMT3A","hematologic malignancy, hematology","myelodysplastic diseases (MDS), anemia, chronic myelomonocytic leukemia (CMMoL)","MicroSource, Selleck, Tocris",100,"BRD-K03406345-001-21-1, BRD-K03406345-001-27-8, BRD-K03406345-001-24-5","Launched","BRD-K55026842-001-01-4","NMUSYJAQQFHJEW-KVTDHHQDSA-N","BRD-K03406345","BRD-K55026842","Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1"
"9129","RUXOLITINIB","JAK inhibitor","JAK1, JAK2, JAK3, TYK2","hematologic malignancy, hematology","myelofibrosis, polycythemia vera","Selleck",96.54,"BRD-K53972329-001-07-0","Launched","BRD-K19601669-001-02-7","HFNKQEVNSGCOJV-OAHLLOKOSA-N","BRD-K53972329","BRD-K19601669","N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12"
"9130","PRASUGREL","purinergic receptor antagonist","P2RY12","cardiology","myocardial infarction, acute coronary syndrome (ACS)","Selleck, MedChemEx, Selleck, MedChemEx",83.3,"BRD-A83029242-001-06-1, BRD-A83029242-001-08-7, BRD-A83029242-001-05-3, BRD-A83029242-001-07-9","Launched","","DTGLZDAWLRGWQN-UHFFFAOYSA-N","BRD-A83029242","","CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F"
"9134","PAPAVERINE","phosphodiesterase inhibitor","PDE10A, PDE4B, PDE5A","cardiology, hematology, gastroenterology","myocardial infarction, angina pectoris, pulmonary embolism (PE), colitis, vascular spasm","MicroSource",99.78,"BRD-K15567136-003-27-2","Launched","","XQYZDYMELSJDRZ-UHFFFAOYSA-N","BRD-K15567136","","COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC"
"9135","CARVEDILOL","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA","cardiology","myocardial infarction, hypertension","Tocris, MicroSource, MicroSource, Tocris, Selleck",93.97,"BRD-A10977446-001-17-0, BRD-A10977446-001-14-7, BRD-A10977446-011-01-3, BRD-A10977446-001-13-9, BRD-A10977446-001-12-1","Launched","","OGHNVEJMJSYVRP-UHFFFAOYSA-N","BRD-A10977446","","COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12"
"9140","VORAPAXAR","thrombin receptor antagonist","F2R","cardiology","myocardial infarction, peripheral artery disease (PAD)","Adooq",98.32,"BRD-K93442924-001-03-4","Launched","","ZBGXUVOIWDMMJE-QHNZEKIYSA-N","BRD-K93442924","","CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c2ccc(cn2)-c2cccc(F)c2)C1"
"9141","TIROFIBAN","platelet aggregation inhibitor, structural glycoprotein antagonist","ITGA2B, ITGB3","cardiology","myocardial infarction, refactory angina","Enzo",97.97,"BRD-K37872686-003-01-9","Launched","","COKMIXFXJJXBQG-NRFANRHFSA-N","BRD-K37872686","","CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O"
"9142","CLOPIDOGREL","purinergic receptor antagonist","P2RY12","cardiology, neurology/psychiatry","myocardial infarction, stroke, peripheral artery disease (PAD), acute coronary syndrome (ACS)","Selleck, MicroSource, Selleck",99.2,"BRD-K27721098-065-10-2, BRD-K27721098-065-09-4, BRD-K27721098-065-08-6","Launched","","GKTWGGQPFAXNFI-HNNXBMFYSA-N","BRD-K27721098","","COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl"
"9145","REGADENOSON","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","radiology","myocardial perfusion imaging (MPI)","Enzo",98.94,"BRD-A78341343-001-01-6","Launched","","LZPZPHGJDAGEJZ-SMDQVTJXSA-N","BRD-A78341343","","CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1"
"9146","LEVOTHYROXINE","thyroid hormone stimulant","THRA, THRB","endocrinology","myxedema coma","Selleck, MicroSource, Selleck, Sigma",96.14,"BRD-K30685142-001-16-2, BRD-K30685142-001-15-4, BRD-K30685142-001-14-7, BRD-K30685142-001-17-0","Launched","","XUIIKFGFIJCVMT-LBPRGKRZSA-N","BRD-K30685142","","N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O"
"9150","SODIUM-OXYBATE","benzodiazepine receptor agonist","GABRB1, HCAR1, SLC52A2","neurology/psychiatry","narcolepsy","MicroSource",90.06,"BRD-K82166906-236-02-8","Launched","","SJZRECIVHVDYJC-UHFFFAOYSA-N","BRD-K82166906","","OCCCC(O)=O"
"9151","OXYMETAZOLINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C","otolaryngology","nasal congestion","Tocris, MicroSource, Selleck",99.39,"BRD-K16195444-003-25-2, BRD-K16195444-003-26-0, BRD-K16195444-003-24-5","Launched","","WYWIFABBXFUGLM-UHFFFAOYSA-N","BRD-K16195444","","Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C"
"9154","TUAMINOHEPTANE","","","otolaryngology","nasal congestion","MicroSource",100,"BRD-A19958636-065-04-4","Launched","","VSRBKQFNFZQRBM-UHFFFAOYSA-N","BRD-A19958636","","CCCCCC(C)N"
"9155","XYLOMETAZOLINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","otolaryngology, allergy","nasal congestion, allergic rhinitis","MicroSource, Selleck",98.38,"BRD-K08356259-003-24-7, BRD-K08356259-003-23-9","Launched","","HUCJFAOMUPXHDK-UHFFFAOYSA-N","BRD-K08356259","","Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C"
"9157","PROPYLHEXEDRINE","adrenergic receptor agonist","SLC18A2, TAAR1","otolaryngology, endocrinology, allergy","nasal congestion, fever, allergic rhinitis","PrincetonBio",76.33,"BRD-A35667010-001-01-8","Launched","","JCRIVQIOJSSCQD-UHFFFAOYSA-N","BRD-A35667010","","CNC(C)CC1CCCCC1"
"9158","PHENYLEPHRINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D","otolaryngology, gastroenterology, cardiology","nasal congestion, hemorrhoids, hypotension","Selleck, Selleck, MicroSource",93.38,"BRD-K73381542-003-22-6, BRD-K73381542-003-24-2, BRD-K73381542-003-23-4","Launched","","SONNWYBIRXJNDC-VIFPVBQESA-N","BRD-K73381542","","CNC[C@H](O)c1cccc(O)c1"
"9161","ALIZAPRIDE","dopamine receptor antagonist","DRD2","gastroenterology","nausea","Selleck",97.32,"BRD-A03061970-003-07-3","Launched","","KSEYRUGYKHXGFW-UHFFFAOYSA-N","BRD-A03061970","","COc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C"
"9162","CLEBOPRIDE","dopamine receptor antagonist","ACHE, DRD2","gastroenterology","nausea","Prestwick",99.18,"BRD-K17294426-050-12-3","Launched","","BVPWJMCABCPUQY-UHFFFAOYSA-N","BRD-K17294426","","COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1"
"9163","THIETHYLPERAZINE","dopamine receptor antagonist","DRD1, DRD2, DRD4","gastroenterology","nausea","Prestwick",91.84,"BRD-K69600043-328-05-5","Launched","","XCTYLCDETUVOIP-UHFFFAOYSA-N","BRD-K69600043","","CCSc1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1"
"9164","APREPITANT","tachykinin antagonist","TACR1","gastroenterology","nausea, vomiting","Selleck",96.84,"BRD-K65170927-001-01-6","Launched","","ATALOFNDEOCMKK-OCCQLPPTSA-N","BRD-K65170927","","C[C@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F"
"9165","DOLASETRON","serotonin receptor antagonist","HTR3A","gastroenterology","nausea, vomiting","Tocris, Enzo",99.45,"BRD-K28029915-066-03-3, BRD-K28029915-001-02-2","Launched","BRD-K37792492-066-01-0,BRD-A03259768-066-01-9, BRD-K34008116-001-01-7","UKTAZPQNNNJVKR-YXSUXZIUSA-N","BRD-K28029915","BRD-K37792492","O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12"
"9167","DROPERIDOL","dopamine receptor antagonist","ADRA1A, DRD2, DRD3, DRD4, HTR2A","gastroenterology","nausea, vomiting","MicroSource, Selleck",94.72,"BRD-K97158071-001-18-1, BRD-K97158071-001-17-3","Launched","","RMEDXOLNCUSCGS-UHFFFAOYSA-N","BRD-K97158071","","Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O"
"9169","FOSAPREPITANT-DIMEGLUMINE","tachykinin antagonist","TACR1","gastroenterology","nausea, vomiting","MedChemEx, MedChemEx, Selleck, Selleck",78.2,"BRD-K23848629-401-05-2, BRD-K23848629-401-04-5, BRD-K23848629-401-02-9, BRD-K23848629-401-03-7","Launched","","BARDROPHSZEBKC-OITMNORJSA-N","BRD-K23848629","","C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F"
"9173","GRANISETRON","serotonin receptor antagonist","HTR3A","gastroenterology","nausea, vomiting","MicroSource, Selleck",97.08,"BRD-A10967948-003-06-3, BRD-A10967948-003-05-5","Launched","","MFWNKCLOYSRHCJ-UHFFFAOYSA-N","BRD-A10967948","","CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12"
"9175","NETUPITANT","tachykinin antagonist","TACR1","gastroenterology","nausea, vomiting","MedChemEx",97.52,"BRD-K97428065-001-01-2","Launched","","WAXQNWCZJDTGBU-UHFFFAOYSA-N","BRD-K97428065","","CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1"
"9176","ONDANSETRON","serotonin receptor antagonist","HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1","gastroenterology","nausea, vomiting","Selleck, Selleck, MicroSource",99.41,"BRD-A19736161-003-14-7, BRD-A19736161-001-05-9, BRD-A19736161-001-06-7","Launched","","FELGMEQIXOGIFQ-UHFFFAOYSA-N","BRD-A19736161","","Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C"
"9179","PALONOSETRON","serotonin receptor antagonist","HTR3A","gastroenterology","nausea, vomiting","Selleck",97.7,"BRD-K08924299-003-06-1","Launched","","CPZBLNMUGSZIPR-NVXWUHKLSA-N","BRD-K08924299","","O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]1CN2CCC1CC2"
"9180","PROCHLORPERAZINE","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4","gastroenterology","nausea, vomiting","Tocris, Selleck, MicroSource, Selleck",93,"BRD-K19352500-332-09-4, BRD-K19352500-332-07-8, BRD-K19352500-070-12-4, BRD-K19352500-332-08-6","Launched","","WIKYUJGCLQQFNW-UHFFFAOYSA-N","BRD-K19352500","","CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1"
"9184","BROMOPRIDE","dopamine receptor antagonist","DRD2","gastroenterology","nausea, vomiting, gastroesophageal reflux disease (GERD)","MicroSource",96.6,"BRD-K73642618-001-13-3","Launched","","GIYAQDDTCWHPPL-UHFFFAOYSA-N","BRD-K73642618","","CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC"
"9185","RAMOSETRON","serotonin receptor antagonist","HTR3A","gastroenterology","nausea, vomiting, irritable bowel syndrome","MedChemEx",99.58,"BRD-K85046107-003-01-2","Launched","","NTHPAPBPFQJABD-LLVKDONJSA-N","BRD-K85046107","","Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc12"
"9186","MECLIZINE","constitutive androstane receptor (CAR) agonist","HRH1, NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Tocris, Selleck, MicroSource",97.63,"BRD-A50311610-300-11-2, BRD-A50311610-300-09-6, BRD-A50311610-300-10-4","Launched","","OCJYIGYOJCODJL-UHFFFAOYSA-N","BRD-A50311610","","Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1"
"9189","TROPISETRON","serotonin receptor antagonist","GLRA1, GLRA2, GLRB, HTR3A, HTR4","gastroenterology","nausea, vomiting, nausea, vomiting","Tocris, Selleck",98.6,"BRD-K50866992-003-09-5, BRD-K50866992-003-10-3","Launched","BRD-M19407551-300-01-6, BRD-A79226577-003-19-3","ZNRGQMMCGHDTEI-ITGUQSILSA-N","BRD-K50866992","BRD-M19407551","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c1c[nH]c2ccccc12"
"9191","CYCLIZINE","histamine receptor modulator","HRH1, SULT1E1","gastroenterology, neurology/psychiatry","nausea, vomiting, vertigo, motion sickness","MicroSource, Selleck",99.27,"BRD-K79501723-001-04-6, BRD-K79501723-300-01-8","Launched","","UVKZSORBKUEBAZ-UHFFFAOYSA-N","BRD-K79501723","","CN1CCN(CC1)C(c1ccccc1)c1ccccc1"
"9193","TILUDRONATE","bone resorption inhibitor, osteoclast inhibitor","ATP6V1A, MMP2, PTPN1","orthopedics","navicular syndrome","Enzo",100,"BRD-K10845183-304-01-6","Launched","","DKJJVAGXPKPDRL-UHFFFAOYSA-N","BRD-K10845183","","OP(O)(=O)C(Sc1ccc(Cl)cc1)P(O)(O)=O"
"9194","BROMANTAN","dopamine reuptake inhibitor, serotonin reuptake inhibitor","","neurology/psychiatry","neurasthenia","Enamine, Enamine",86.43,"BRD-K86358349-001-01-2, BRD-K86358349-001-02-0","Launched","","LWJALJDRFBXHKX-UHFFFAOYSA-N","BRD-K86358349","","Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1"
"9196","IOBENGUANE","antineoplastic agent","","oncology, cardiology, endocrinology","neuroblastoma, congestive heart failure, pheochromocytoma","Prestwick, Axon",98.26,"BRD-K43860855-065-10-1, BRD-K43860855-065-11-9","Launched","","PDWUPXJEEYOOTR-UHFFFAOYSA-N","BRD-K43860855","","NC(=N)NCc1cccc(I)c1"
"9198","CYTISINE","acetylcholine receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4","neurology/psychiatry","nicotinism","MicroSource, Tocris, Selleck, Selleck",98.23,"BRD-K74186897-001-13-2, BRD-K74186897-001-11-6, BRD-K74186897-001-10-8, BRD-K74186897-001-12-4","Launched","BRD-A55579717-001-04-0","ANJTVLIZGCUXLD-DTWKUNHWSA-N","BRD-K74186897","BRD-A55579717","O=c1cccc2[C@H]3CNC[C@H](C3)Cn12"
"9202","PIXANTRONE","topoisomerase inhibitor","TOP2A","hematologic malignancy","non-Hodgkin lymphoma (NHL)","MedChemEx, MedChemEx",53.02,"BRD-K48304345-332-02-4, BRD-K48304345-332-01-6","Launched","","PEZPMAYDXJQYRV-UHFFFAOYSA-N","BRD-K48304345","","NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12"
"9204","URACIL-MUSTARD","DNA synthesis inhibitor","","hematologic malignancy","non-Hodgkin lymphoma (NHL)","MedChemEx, MedChemEx, Sigma",69.59,"BRD-K10180294-001-07-3, BRD-K10180294-001-06-5, BRD-K10180294-001-04-0","Launched","","IDPUKCWIGUEADI-UHFFFAOYSA-N","BRD-K10180294","","Oc1ncc(N(CCCl)CCCl)c(O)n1"
"9207","CARMUSTINE","DNA alkylating agent, DNA inhibitor","GSR","hematologic malignancy, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, multiple myeloma, glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma","MicroSource",0,"BRD-K36234266-001-09-8","Launched","","DLGOEMSEDOSKAD-UHFFFAOYSA-N","BRD-K36234266","","[O-][N+]N(CCCl)C(=O)NCCCl"
"9208","BLEOMYCIN","DNA synthesis inhibitor","LIG1, LIG3","hematologic malignancy, pulmonary, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma","Selleck, Selleck, MedChemEx, MicroSource",51.47,"BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3","Launched","","OYVAGSVQBOHSSS-NHOVFDEISA-O","BRD-A42083487","","C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C"
"9210","BLEOMYCIN","DNA synthesis inhibitor","LIG1, LIG3","hematologic malignancy, pulmonary, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma","Selleck, Selleck, MedChemEx, MicroSource",51.47,"BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3","Launched","","OYVAGSVQBOHSSS-NHOVFDEISA-O","BRD-A42083487","","CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(N)=O)NCC(N)C(N)=O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C"
"9212","BLEOMYCIN","DNA synthesis inhibitor","LIG1, LIG3","hematologic malignancy, pulmonary, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma","Selleck, Selleck, MedChemEx, MicroSource",51.47,"BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3","Launched","","OYVAGSVQBOHSSS-UHFFFAOYSA-O","BRD-A42083487","","C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C"
"9214","BLEOMYCIN","DNA synthesis inhibitor","LIG1, LIG3","hematologic malignancy, pulmonary, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma","Selleck, Selleck, MedChemEx, MicroSource",51.47,"BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3","Launched","","OYVAGSVQBOHSSS-UHFFFAOYSA-O","BRD-A42083487","","CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(N)=O)NCC(N)C(N)=O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C"
"9216","PLERIXAFOR","CC chemokine receptor antagonist","ACKR3, CCR4, CXCR4","hematologic malignancy","non-Hodgkin lymphoma (NHL), multiple myeloma","MedChemEx, Selleck, MedChemEx, Selleck",97.85,"BRD-K33240821-001-06-2, BRD-K33240821-001-03-9, BRD-K33240821-400-02-5, BRD-K33240821-001-05-4","Launched","","YIQPUIGJQJDJOS-UHFFFAOYSA-N","BRD-K33240821","","C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1"
"9220","AFATINIB","EGFR inhibitor","EGFR, ERBB2, ERBB4","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, Selleck, Selleck",99.28,"BRD-K66175015-332-01-6, BRD-K66175015-001-13-2, BRD-K66175015-001-09-0","Launched","","ULXXDDBFHOBEHA-CWDCEQMOSA-N","BRD-K66175015","","CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1"
"9223","ALECTINIB","ALK tyrosine kinase receptor inhibitor","ALK, MET","oncology","non-small cell lung cancer (NSCLC)","Selleck, Selleck",98.17,"BRD-K11267252-001-06-9, BRD-K11267252-001-04-4","Launched","","KDGFLJKFZUIJMX-UHFFFAOYSA-N","BRD-K11267252","","CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1"
"9225","BRIGATINIB","ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, MedChemEx",93.49,"BRD-K56981171-001-02-8, BRD-K56981171-001-01-0","Launched","","AILRADAXUVEEIR-UHFFFAOYSA-N","BRD-K56981171","","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1"
"9227","CERITINIB","ALK tyrosine kinase receptor inhibitor","ALK, FLT3, IGF1R, INSR, TSSK1B","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, MedChemEx, Selleck, Selleck",95.07,"BRD-K22149900-001-06-2, BRD-K22149900-001-05-4, BRD-K22149900-001-03-9, BRD-K22149900-001-01-3","Launched","","VERWOWGGCGHDQE-UHFFFAOYSA-N","BRD-K22149900","","CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1"
"9231","CRIZOTINIB","ALK tyrosine kinase receptor inhibitor","ALK, MET","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, Selleck, Selleck",89.1,"BRD-K78431006-001-15-1, BRD-K78431006-001-10-2, BRD-K78431006-001-11-0","Launched","","KTEIFNKAUNYNJU-GFCCVEGCSA-N","BRD-K78431006","","C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl"
"9234","ETOPOSIDE","topoisomerase inhibitor","TOP2A, TOP2B","oncology","non-small cell lung cancer (NSCLC)","Selleck, Tocris, MedChemEx, MicroSource, Selleck, Tocris",99.86,"BRD-K37798499-001-18-1, BRD-K37798499-001-24-9, BRD-K37798499-001-25-6, BRD-K37798499-001-27-2, BRD-K37798499-001-22-3, BRD-K37798499-001-21-5","Launched","BRD-A33280134-001-04-7, BRD-K36186323-001-01-8, BRD-A26175277-001-02-9,BRD-A35357953-001-01-5","VJJPUSNTGOMMGY-MRVIYFEKSA-N","BRD-K37798499","BRD-A33280134","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12"
"9240","GEFITINIB","EGFR inhibitor","EGFR","oncology","non-small cell lung cancer (NSCLC)","Selleck, Tocris, Selleck, Tocris",99.54,"BRD-K64052750-001-22-5, BRD-K64052750-001-17-5, BRD-K64052750-001-16-7, BRD-K64052750-001-23-3","Launched","","XGALLCVXEZPNRQ-UHFFFAOYSA-N","BRD-K64052750","","COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1"
"9244","ICOTINIB","EGFR inhibitor","EGFR","oncology","non-small cell lung cancer (NSCLC)","Selleck",96.95,"BRD-K31698212-001-02-9","Launched","","QQLKULDARVNMAL-UHFFFAOYSA-N","BRD-K31698212","","C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1"
"9245","OSIMERTINIB","EGFR inhibitor","EGFR","oncology","non-small cell lung cancer (NSCLC)","MedChemEx",87.75,"BRD-K42805893-001-04-9","Launched","","DUYJMQONPNNFPI-UHFFFAOYSA-N","BRD-K42805893","","COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C)c2ccccc12"
"9246","VINORELBINE","tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, MedChemEx, Enzo",77.38,"BRD-K04269837-346-01-8, BRD-K69280563-346-01-7, BRD-K69280563-001-01-8","Launched","","GBABOYUKABKIAF-IELIFDKJSA-N","BRD-K04269837","","CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC"
"9247","VINORELBINE","tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8","oncology","non-small cell lung cancer (NSCLC)","MedChemEx, MedChemEx, Enzo",77.38,"BRD-K04269837-346-01-8, BRD-K69280563-346-01-7, BRD-K69280563-001-01-8","Launched","","GBABOYUKABKIAF-IELIFDKJSA-N","BRD-K04269837","","CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC"
"9249","PEMETREXED","dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS","oncology","non-small cell lung cancer (NSCLC), mesothelioma","Key, Selleck, MedChemEx, MedChemEx, Selleck, MicroSource",87.62,"BRD-K32842773-434-01-8, BRD-K32842773-304-04-7, BRD-K32842773-304-05-4, BRD-K32842773-380-01-3, BRD-K32842773-304-06-2, BRD-K32842773-304-03-9","Launched","BRD-M17920320-304-01-2, BRD-M18147244-437-01-2, BRD-K55395145-304-01-5","WBXPDJSOTKVWSJ-ZDUSSCGKSA-N","BRD-K32842773","BRD-M17920320","Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1"
"9255","ERLOTINIB","EGFR inhibitor","EGFR, NR1I2","oncology","non-small cell lung cancer (NSCLC), pancreatic cancer","Selleck, Selleck",99.27,"BRD-K70401845-001-15-7, BRD-K70401845-003-09-6","Launched","","AAKJLRGGTJKAMG-UHFFFAOYSA-N","BRD-K70401845","","COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC"
"9257","AMFEPRAMONE","adrenergic receptor agonist","SLC6A2, SLC6A3","endocrinology","obesity","Prestwick",97.41,"BRD-A37288617-003-02-2","Launched","","XXEPPPIWZFICOJ-UHFFFAOYSA-N","BRD-A37288617","","CCN(CC)C(C)C(=O)c1ccccc1"
"9258","LORCASERIN","serotonin receptor agonist","HTR2A, HTR2B, HTR2C","endocrinology","obesity","Selleck",95.01,"BRD-K55013654-003-02-3","Launched","","XTTZERNUQAFMOF-QMMMGPOBSA-N","BRD-K55013654","","C[C@H]1CNCCc2ccc(Cl)cc12"
"9259","CLOMIPRAMINE","serotonin transporter (SERT) inhibitor","GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","MicroSource, Tocris, Selleck",92.56,"BRD-K52989797-003-28-0, BRD-K52989797-003-27-2, BRD-K52989797-003-26-4","Launched","","GDLIGKIOYRNHDA-UHFFFAOYSA-N","BRD-K52989797","","CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12"
"9262","FLUVOXAMINE","selective serotonin reuptake inhibitor (SSRI)","SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","MicroSource, Tocris, Selleck",93.31,"BRD-K53517854-050-21-4, BRD-K53517854-050-20-6, BRD-K53517854-051-01-4","Launched","","CJOFXWAVKWHTFT-XSFVSMFZSA-N","BRD-K53517854","","COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN"
"9265","ARMODAFINIL","adrenergic receptor agonist","SLC6A3","pulmonary, neurology/psychiatry","obstructive sleep apnea, narcolepsy, shift work disorder (SWD)","MicroSource",93.1,"BRD-K87278688-001-01-0","Launched","","YFGHCGITMMYXAQ-LJQANCHMSA-N","BRD-K87278688","","NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1"
"9266","MODAFINIL","adrenergic receptor agonist","ADRA1B, SLC6A3","pulmonary, neurology/psychiatry","obstructive sleep apnea, shift work disorder (SWD)","MicroSource",48.32,"BRD-A16332958-001-09-9","Launched","","YFGHCGITMMYXAQ-UHFFFAOYSA-N","BRD-A16332958","","NC(=O)CS(=O)C(c1ccccc1)c1ccccc1"
"9267","LATANOPROST","prostanoid receptor agonist","PTGFR","ophthalmology","ocular hypertension, glaucoma","Enzo",98.27,"BRD-K10961822-001-05-1","Launched","","GGXICVAJURFBLW-CEYXHVGTSA-N","BRD-K10961822","","CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1"
"9268","TIMOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","ocular hypertension, glaucoma","MicroSource, Tocris, Selleck",97.45,"BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8","Launched","","BLJRIMJGRPQVNF-SNVBAGLBSA-N","BRD-K30421593","","CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1"
"9269","TIMOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","ocular hypertension, glaucoma","MicroSource, Tocris, Selleck",97.45,"BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8","Launched","","BLJRIMJGRPQVNF-SNVBAGLBSA-N","BRD-K30421593","","CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1"
"9271","TIMOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","ocular hypertension, glaucoma","MicroSource, Tocris, Selleck",97.45,"BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8","Launched","","BLJRIMJGRPQVNF-JTQLQIEISA-N","BRD-K30421593","","CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1"
"9272","TIMOLOL","adrenergic receptor antagonist","ADRB1, ADRB2","ophthalmology","ocular hypertension, glaucoma","MicroSource, Tocris, Selleck",97.45,"BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8","Launched","","BLJRIMJGRPQVNF-JTQLQIEISA-N","BRD-K30421593","","CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1"
"9274","TRAVOPROST","prostanoid receptor agonist","PTGFR","ophthalmology","ocular hypertension, glaucoma","Enzo",95.41,"BRD-K23976833-001-01-0","Launched","","MKPLKVHSHYCHOC-AHTXBMBWSA-N","BRD-K23976833","","CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc1cccc(c1)C(F)(F)F"
"9275","AMOROLFINE","membrane integrity inhibitor","","infectious disease","onychomycosis","Selleck, MicroSource",96.04,"BRD-A37390343-003-02-7, BRD-A37390343-003-03-5","Launched","","MQHLMHIZUIDKOO-AYHJJNSGSA-N","BRD-A37390343","","CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1"
"9277","CICLOPIROX","membrane integrity inhibitor","ATP1A1","infectious disease","onychomycosis","MicroSource, Selleck, Selleck, Sigma, Selleck, Selleck",84.85,"BRD-K13044802-213-21-5, BRD-K13044802-001-02-4, BRD-K13044802-001-03-2, BRD-K13044802-213-25-6, BRD-K13044802-213-24-9, BRD-K13044802-213-20-7","Launched","","SCKYRAXSEDYPSA-UHFFFAOYSA-N","BRD-K13044802","","Cc1cc(C2CCCCC2)n(O)c(=O)c1"
"9283","EFINACONAZOLE","lanosterol demethylase inhibitor","CYP51A1","infectious disease","onychomycosis","MedChemEx",92.45,"BRD-A30774155-001-01-2","Launched","","NFEZZTICAUWDHU-IKJXHCRLSA-N","BRD-A30774155","","C[C@@H](N1CCC(=C)CC1)C(O)(Cn1cncn1)c1ccc(F)cc1F"
"9284","TAVABOROLE","leucyl-tRNA synthetase inhibitor","","infectious disease","onychomycosis","MedChemEx, MedChemEx",91.53,"BRD-K76713213-001-02-1, BRD-K76713213-001-01-3","Launched","","LFQDNHWZDQTITF-UHFFFAOYSA-N","BRD-K76713213","","OB1OCc2cc(F)ccc12"
"9286","ITRACONAZOLE","cytochrome P450 inhibitor","CYP51A1","infectious disease","onychomycosis, histoplasmosis, blastomycosis, aspergillosis","MicroSource, Selleck, Selleck",89.77,"BRD-A23067620-300-01-3, BRD-A23067620-001-04-1, BRD-A23067620-001-03-3","Launched","","VHVPQPYKVGDNFY-ZPGVKDDISA-N","BRD-A23067620","","CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O"
"9289","FLUORESCEIN","","SLC22A6","ophthalmology","ophthalmology diagnostic","MicroSource",95.86,"BRD-K21913543-001-02-4","Launched","","GNBHRKFJIUUOQI-UHFFFAOYSA-N","BRD-K21913543","","Oc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccccc23)c1"
"9290","LOFEXIDINE","adrenergic receptor agonist","ADRA2A","neurology/psychiatry","opioid withdrawal","Selleck, MicroSource",97.02,"BRD-A02990301-003-05-8, BRD-A02990301-003-06-6","Launched","","KSMAGQUYOIHWFS-UHFFFAOYSA-N","BRD-A02990301","","CC(Oc1c(Cl)cccc1Cl)C1=NCCN1"
"9292","MYCOPHENOLATE-MOFETIL","dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2","transplant","organ rejection","Tocris, MicroSource, Selleck",95.21,"BRD-K92428153-001-07-7, BRD-K92428153-001-05-1, BRD-K92428153-001-04-4","Launched","","RTGDFNSFWBGLEC-SYZQJQIISA-N","BRD-K92428153","","COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1"
"9295","MYCOPHENOLIC-ACID","dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2","transplant","organ rejection","Tocris, MicroSource, Selleck, Tocris",98.39,"BRD-K63750851-001-22-3, BRD-K63750851-001-20-7, BRD-K63750851-001-18-1, BRD-K63750851-001-19-9","Launched","","HPNSFSBZBAHARI-RUDMXATFSA-N","BRD-K63750851","","COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O"
"9299","TACROLIMUS","calcineurin inhibitor","FKBP1A","transplant","organ rejection","MedChemEx, MicroSource, Selleck",97.24,"BRD-K69608737-001-08-6, BRD-K69608737-001-10-2, BRD-K69608737-001-09-4","Launched","BRD-A96754982-001-01-4, BRD-K54509797-001-01-5","QJJXYPPXXYFBGM-LFZNUXCKSA-N","BRD-K69608737","BRD-A96754982","CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC"
"9302","SIROLIMUS","mTOR inhibitor","FGF2, FKBP1A, MTOR","transplant, pulmonary","organ rejection, lymphangioleiomyomatosis","Selleck, MedChemEx, MicroSource, Selleck",95.67,"BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5","Launched","BRD-K79988249-001-01-6","QFJCIRLUMZQUOT-HPLJOQBZSA-N","BRD-K84937637","BRD-K79988249","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O"
"9304","SIROLIMUS","mTOR inhibitor","FGF2, FKBP1A, MTOR","transplant, pulmonary","organ rejection, lymphangioleiomyomatosis","Selleck, MedChemEx, MicroSource, Selleck",95.67,"BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5","Launched","BRD-K79988249-001-01-6","QFJCIRLUMZQUOT-HPLJOQBZSA-N","BRD-K84937637","BRD-K79988249","COC1CC(CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O"
"9306","SIROLIMUS","mTOR inhibitor","FGF2, FKBP1A, MTOR","transplant, pulmonary","organ rejection, lymphangioleiomyomatosis","Selleck, MedChemEx, MicroSource, Selleck",95.67,"BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5","Launched","BRD-K79988249-001-01-6","QFJCIRLUMZQUOT-XWBLMERNSA-N","BRD-K84937637","BRD-K79988249","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O"
"9308","SIROLIMUS","mTOR inhibitor","FGF2, FKBP1A, MTOR","transplant, pulmonary","organ rejection, lymphangioleiomyomatosis","Selleck, MedChemEx, MicroSource, Selleck",95.67,"BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5","Launched","BRD-K79988249-001-01-6","QFJCIRLUMZQUOT-XWBLMERNSA-N","BRD-K84937637","BRD-K79988249","COC1CC(CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O"
"9310","CYCLOSPORINE","calcineurin inhibitor","ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3","transplant, rheumatology, dermatology","organ rejection, rheumatoid arthritis, psoriasis","Selleck, Selleck",98.93,"BRD-K13533483-001-16-2, BRD-K13533483-001-17-0","Launched","BRD-K03152136-001-01-6, BRD-A11864475-001-02-5","PMATZTZNYRCHOR-CGLBZJNRSA-N","BRD-K13533483","BRD-K03152136","CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C"
"9312","PRALIDOXIME","acetylcholinesterase inhibitor","ACHE, BCHE","critical care","organophosphate poisoning","MicroSource, MicroSource, MedChemEx",96.7,"BRD-K84281997-003-09-2, BRD-K84281997-066-03-2, BRD-K84281997-003-08-4","Launched","BRD-K61327230-003-13-9","JBKPUQTUERUYQE-UHFFFAOYSA-O","BRD-K84281997","BRD-K61327230","C[n+]1ccccc1\C=N\O"
"9315","POSACONAZOLE","sterol demethylase inhibitor","CYP3A4","infectious disease","oropharyngeal candidiasis","Selleck, Selleck",87.29,"BRD-K06222852-001-05-7, BRD-K06222852-001-03-2","Launched","","RAGOYPUPXAKGKH-XAKZXMRKSA-N","BRD-K06222852","","CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@@H]3CO[C@](Cn4cncn4)(C3)c3ccc(F)cc3F)cc2)c1=O"
"9317","URIDINE-TRIACETATE","","","nephrology","orotic aciduria","Bepharm",96.02,"BRD-K18323388-001-01-1","Launched","","AUFUWRKPQLGTGF-FMKGYKFTSA-N","BRD-K18323388","","CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)n1ccc(=O)[nH]c1=O"
"9318","ACEMETACIN","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis","MicroSource, Selleck",98.86,"BRD-K67563174-001-17-6, BRD-K67563174-001-16-8","Launched","","FSQKKOOTNAMONP-UHFFFAOYSA-N","BRD-K67563174","","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1"
"9320","CARPROFEN","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis","Selleck, MicroSource",98.54,"BRD-A17411484-001-10-1, BRD-A17411484-001-11-9","Launched","","PUXBGTOOZJQSKH-UHFFFAOYSA-N","BRD-A17411484","","CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21"
"9322","DERACOXIB","cyclooxygenase inhibitor","PTGS2","rheumatology","osteoarthritis","MicroSource",99.74,"BRD-K68558722-001-04-0","Launched","","WAZQAZKAZLXFMK-UHFFFAOYSA-N","BRD-K68558722","","COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F"
"9323","DIACEREIN","interleukin inhibitor","IL1B","rheumatology","osteoarthritis","MicroSource, Selleck, Selleck",95.35,"BRD-K69122748-001-10-1, BRD-K69122748-001-09-3, BRD-K69122748-001-11-9","Launched","","TYNLGDBUJLVSMA-UHFFFAOYSA-N","BRD-K69122748","","CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O"
"9326","FIROCOXIB","cyclooxygenase inhibitor","PTGS2","rheumatology","osteoarthritis","MicroSource",99.46,"BRD-K09090523-001-02-1","Launched","","FULAPETWGIGNMT-UHFFFAOYSA-N","BRD-K09090523","","CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(cc1)S(C)(=O)=O"
"9327","GRAPIPRANT","prostaglandin inhibitor","PTGER4","rheumatology","osteoarthritis","MedChemEx",96.45,"BRD-K62050508-001-01-0","Launched","","HZVLFTCYCLXTGV-UHFFFAOYSA-N","BRD-K62050508","","CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1"
"9328","HYALURONIC-ACID","","C1QBP, CD44, HABP2, HAPLN1, HAPLN3, HAPLN4, HMMR, ICAM1, NCAN, VCAN","rheumatology, urology","osteoarthritis, interstitial cystitis (IC)","Sigma",0,"BRD-K59788572-236-01-3","Launched","","WCDDVEOXEIYWFB-VXORFPGASA-N","BRD-K59788572","","CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O"
"9329","NIMESULIDE","cyclooxygenase inhibitor","LTF, PLA2G2E, PTGS1, PTGS2","rheumatology, obstetrics/gynecology","osteoarthritis, menstrual pain","MicroSource, Tocris, Selleck",99.29,"BRD-K76775527-001-30-2, BRD-K76775527-001-29-4, BRD-K76775527-001-28-6","Launched","","HYWYRSMBCFDLJT-UHFFFAOYSA-N","BRD-K76775527","","CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O"
"9332","ETODOLAC","cyclooxygenase inhibitor","PTGS1, PTGS2, RXRA","rheumatology","osteoarthritis, rheumatoid arthritis","Selleck, MicroSource",99.16,"BRD-A74667430-001-25-1, BRD-A74667430-001-23-6","Launched","BRD-K36911961-001-01-6","NNYBQONXHNTVIJ-UHFFFAOYSA-N","BRD-A74667430","BRD-K36911961","CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12"
"9334","MELOXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis, rheumatoid arthritis","MicroSource, Sigma, Selleck",99.09,"BRD-A84174393-236-07-1, BRD-A84174393-323-07-7, BRD-A84174393-001-34-3","Launched","","ZAHQBPYQBHTECE-UHFFFAOYSA-N","BRD-A84174393","","CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O"
"9337","OXAPROZIN","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis, rheumatoid arthritis","MicroSource, Selleck",99.41,"BRD-K25394294-001-14-9, BRD-K25394294-001-13-1","Launched","","OFPXSFXSNFPTHF-UHFFFAOYSA-N","BRD-K25394294","","OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1"
"9339","PIROXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis, rheumatoid arthritis","Tocris, Selleck, MicroSource",99.2,"BRD-A57382968-001-28-2, BRD-A57382968-001-27-4, BRD-A57382968-001-29-0","Launched","","MNSCVRXKDINXEY-UHFFFAOYSA-N","BRD-A57382968","","CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O"
"9342","SASAPYRINE","NFkB pathway inhibitor","PTGS1, PTGS2","rheumatology","osteoarthritis, rheumatoid arthritis","MicroSource, Selleck",97.73,"BRD-K48892307-001-05-8, BRD-K48892307-001-04-1","Launched","","WVYADZUPLLSGPU-UHFFFAOYSA-N","BRD-K48892307","","OC(=O)c1ccccc1OC(=O)c1ccccc1O"
"9344","SULINDAC","cyclooxygenase inhibitor","AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2","rheumatology","osteoarthritis, rheumatoid arthritis, ankylosing spondylitis","Tocris, Selleck, MicroSource, Selleck",95.9,"BRD-A13946108-001-17-1, BRD-A13946108-001-16-3, BRD-A13946108-001-18-9, BRD-A13946108-001-19-7","Launched","","MLKXDPUZXIRXEP-MFOYZWKCSA-N","BRD-A13946108","","CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O"
"9348","CELECOXIB","cyclooxygenase inhibitor","CA12, PDPK1, PTGS2","rheumatology, endocrinology","osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, primary dysmenorrhea (PD)","Tocris, MicroSource, Selleck",99.47,"BRD-K02637541-001-22-2, BRD-K02637541-001-18-0, BRD-K02637541-001-17-2","Launched","","RZEKVGVHFLEQIL-UHFFFAOYSA-N","BRD-K02637541","","Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F"
"9351","LORNOXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology, neurology/psychiatry","osteoarthritis, sciata","Selleck, MicroSource",97.64,"BRD-A90551241-001-09-0, BRD-A90551241-001-10-8","Launched","","QOFQTBTZCJVITI-UHFFFAOYSA-N","BRD-A90551241","","CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O"
"9353","ALENDRONATE","bone resorption inhibitor","ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS","orthopedics","osteoporosis","Selleck, MicroSource, Selleck",0,"BRD-K75527158-360-06-4, BRD-K75527158-360-05-6, BRD-K75527158-360-04-9","Launched","","OGSPWJRAVKPPFI-UHFFFAOYSA-N","BRD-K75527158","","NCCCC(O)(P(O)(O)=O)P(O)(O)=O"
"9356","IBANDRONATE","bone resorption inhibitor","FDPS","orthopedics","osteoporosis","MicroSource, Selleck, Selleck",0,"BRD-K08681769-323-04-5, BRD-K08681769-323-05-2, BRD-K08681769-323-03-7","Launched","","MPBVHIBUJCELCL-UHFFFAOYSA-N","BRD-K08681769","","CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O"
"9359","IPRIFLAVONE","bone resorption inhibitor","","orthopedics","osteoporosis","MicroSource, Selleck",98.07,"BRD-K93618743-001-21-0, BRD-K93618743-001-20-2","Launched","","SFBODOKJTYAUCM-UHFFFAOYSA-N","BRD-K93618743","","CC(C)Oc1ccc2c(c1)occ(-c1ccccc1)c2=O"
"9361","MENATETRENONE","bone resorption inhibitor","","orthopedics","osteoporosis","Sigma",48.49,"BRD-K75864342-001-14-2","Launched","","DKHGMERMDICWDU-GHDNBGIDSA-N","BRD-K75864342","","CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O"
"9362","MINODRONIC-ACID","bone resorption inhibitor","FDPS, GGPS1","orthopedics","osteoporosis","AKSci, AvaChem",0,"BRD-K89337853-001-01-1, BRD-K89337853-001-02-9","Launched","","VMMKGHQPQIEGSQ-UHFFFAOYSA-N","BRD-K89337853","","OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O"
"9364","RISEDRONATE","osteoclast inhibitor","FDPS","orthopedics, endocrinology","osteoporosis, Paget's disease","Selleck, MicroSource, Selleck, Selleck, Selleck",0,"BRD-K05185389-236-05-1, BRD-K05185389-236-04-4, BRD-K05185389-001-02-6, BRD-K05185389-001-03-4, BRD-K05185389-236-03-6","Launched","","IIDJRNMFWXDHID-UHFFFAOYSA-N","BRD-K05185389","","OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O"
"9369","LASOFOXIFENE","selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","MedChemEx, MedChemEx",98.71,"BRD-M93148412-001-02-6, BRD-M93148412-001-01-8","Launched","","INEHJXCWEVNEDZ-LUDNRVPPSA-N","BRD-M93148412","","O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1"
"9371","RALOXIFENE","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","MicroSource, Tocris, Tocris, Selleck",98.21,"BRD-K63828191-003-34-7, BRD-K63828191-003-33-9, BRD-K63828191-003-35-4, BRD-K63828191-003-32-1","Launched","","GZUITABIAKMVPG-UHFFFAOYSA-N","BRD-K63828191","","Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1"
"9375","CLODRONIC-ACID","bone resorption inhibitor","SLC25A4, SLC25A5, SLC25A6","orthopedics, endocrinology, hematologic malignancy","osteoporosis, hyperparathyroidism, hypercalcemia, multiple myeloma","Selleck, Selleck",0,"BRD-K72542090-304-02-4, BRD-K72542090-304-03-2","Launched","","ACSIXWWBWUQEHA-UHFFFAOYSA-N","BRD-K72542090","","OP(O)(=O)C(Cl)(Cl)P(O)(O)=O"
"9377","BAZEDOXIFENE","selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, endocrinology","osteoporosis, menopause","Selleck, Selleck, Tocris",92.53,"BRD-K90195324-003-02-5, BRD-K90195324-003-03-3, BRD-K90195324-015-01-1","Launched","","UCJGJABZCDBEDK-UHFFFAOYSA-N","BRD-K90195324","","Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12"
"9380","ESTROPIPATE","estrogen receptor agonist","ESR1, ESR2","orthopedics, endocrinology, obstetrics/gynecology","osteoporosis, menopause, vaginal atrophy, hypoestrogenism","MicroSource",97.6,"BRD-A22143024-231-03-8","Launched","","JKKFKPJIXZFSSB-GUZDXLFXSA-N","BRD-A22143024","","C[C@]12CCC3C(CCc4cc(OS(O)(=O)=O)ccc34)C1CCC2=O"
"9381","STRONTIUM-RANELATE","bone formation stimulant, bone resorption inhibitor","CASR","orthopedics, rheumatology","osteoporosis, osteoarthritis","MedChemEx, Selleck, LKT, Selleck",0,"BRD-K83146339-001-02-4, BRD-K83146339-001-03-2, BRD-K83146339-001-04-0, BRD-K83146339-001-05-7","Launched","BRD-K88014802-001-01-9,BRD-M65265990-001-02-2, BRD-M65265990-001-03-0, BRD-K88014802-001-02-7,BRD-K83146339-001-01-6","XXUZFRDUEGQHOV-UHFFFAOYSA-J","BRD-K83146339","BRD-K88014802","O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N"
"9385","LEUCOVORIN","folate receptor ligand","TYMS","oncology","osteosarcoma","Selleck, Selleck, MicroSource",97.3,"BRD-A75919782-399-02-6, BRD-A75919782-399-03-4, BRD-A75919782-238-08-3","Launched","","VVIAGPKUTFNRDU-ABLWVSNPSA-N","BRD-A75919782","","Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1"
"9388","CIPROFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","otolaryngology","otitis","MicroSource, Selleck, Selleck",98.2,"BRD-K04804440-001-09-5, BRD-K04804440-001-13-7, BRD-K04804440-001-08-7","Launched","","MYSWGUAQZAJSOK-UHFFFAOYSA-N","BRD-K04804440","","OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O"
"9391","CLAVULANATE","beta lactamase inhibitor","","otolaryngology","otitis","MicroSource, AvaChem",0,"BRD-K94250879-235-03-9, BRD-K94250879-001-01-9","Launched","","HZZVJAQRINQKSD-PBFISZAISA-N","BRD-K94250879","","OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O"
"9393","ALTRETAMINE","DNA synthesis inhibitor","","oncology","ovarian cancer","MicroSource, Selleck",99.9,"BRD-K67043667-001-26-4, BRD-K67043667-001-25-6","Launched","","UUVWYPNAQBNQJQ-UHFFFAOYSA-N","BRD-K67043667","","CN(C)c1nc(nc(n1)N(C)C)N(C)C"
"9395","CARBOPLATIN","DNA alkylating agent, DNA inhibitor","","oncology","ovarian cancer","Selleck, Tocris, MicroSource, Selleck",0,"BRD-K90947825-001-05-0, BRD-K90947825-001-02-7, BRD-K90947825-001-03-5, BRD-K90947825-001-04-3","Launched","BRD-M80278122-318-03-3, BRD-K64763651-001-01-1, BRD-K11626735-318-08-7, BRD-M80278122-318-02-5","YAYRGNWWLMLWJE-UHFFFAOYSA-L","BRD-K90947825","BRD-M80278122","N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1"
"9399","OLAPARIB","PARP inhibitor","PARP1, PARP2","oncology","ovarian cancer","Selleck, Selleck",98.64,"BRD-K02113016-001-19-6, BRD-K02113016-001-15-4","Launched","","FDLYAMZZIXQODN-UHFFFAOYSA-N","BRD-K02113016","","Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1"
"9401","TREOSULFAN","DNA synthesis inhibitor","","oncology","ovarian cancer","MedChemEx, MedChemEx",0,"BRD-K20902145-001-01-2, BRD-K20902145-001-02-0","Launched","","YCPOZVAOBBQLRI-WDSKDSINSA-N","BRD-K20902145","","CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O"
"9403","PACLITAXEL","tubulin polymerization inhibitor","BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1","oncology","ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC)","Tocris, MicroSource, Selleck, Selleck, Tocris",98.1,"BRD-K62008436-001-25-4, BRD-K62008436-001-22-1, BRD-K62008436-001-18-9, BRD-K62008436-001-23-9, BRD-K62008436-001-24-7","Launched","BRD-A28746609-001-13-1, BRD-A28746609-001-11-5, BRD-A63610676-001-14-1, BRD-A28746609-001-10-7","RCINICONZNJXQF-MZXODVADSA-N","BRD-K62008436","BRD-A28746609","CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1"
"9408","GEMCITABINE","ribonucleotide reductase inhibitor","CMPK1, RRM1, RRM2, TYMS","oncology","ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), pancreatic cancer","MedChemEx, Selleck, Tocris, Selleck",100,"BRD-K15108141-001-08-2, BRD-K15108141-001-06-6, BRD-K15108141-003-04-7, BRD-K15108141-003-05-4","Launched","BRD-K67681739-003-01-4, BRD-K11238904-003-01-9","SDUQYLNIPVEERB-QPPQHZFASA-N","BRD-K15108141","BRD-K67681739","Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1"
"9412","AMFENAC","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","Selleck",96.17,"BRD-K82122102-323-01-1","Launched","","SOYCMDCMZDHQFP-UHFFFAOYSA-N","BRD-K82122102","","Nc1c(CC(O)=O)cccc1C(=O)c1ccccc1"
"9413","AMPIROXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","MedChemEx, MedChemEx, MicroSource, Selleck, Selleck",78.57,"BRD-A39172021-001-14-5, BRD-A39172021-001-13-7, BRD-A39172021-001-10-3, BRD-A39172021-001-09-5, BRD-A39172021-001-11-1","Launched","","LSNWBKACGXCGAJ-UHFFFAOYSA-N","BRD-A39172021","","CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1"
"9418","CLONIXIN-LYSINATE","cyclooxygenase inhibitor","","neurology/psychiatry","pain relief","Prestwick, Sigma",86.5,"BRD-M63173034-001-02-8, BRD-M63173034-001-03-6","Launched","","CVNFYQCHAWFYQI-ZSCHJXSPSA-N","BRD-M63173034","","NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O"
"9420","EPIRIZOLE","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","Prestwick",98.14,"BRD-K39339537-001-21-0","Launched","","RHAXSHUQNIEUEY-UHFFFAOYSA-N","BRD-K39339537","","COc1cc(C)nn1-c1nc(C)cc(OC)n1"
"9421","FLOCTAFENINE","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","Carbosynth",99.43,"BRD-A23418262-001-01-5","Launched","","APQPGQGAWABJLN-UHFFFAOYSA-N","BRD-A23418262","","OCC(O)COC(=O)c1ccccc1Nc1ccnc2c(cccc12)C(F)(F)F"
"9422","FLUPIRTINE","glutamate receptor antagonist","ADRA2A, KCNQ1, KCNQ2","neurology/psychiatry","pain relief","Selleck, Tocris, MedChemEx, MedChemEx, Selleck",85.76,"BRD-K50720187-051-03-1, BRD-K50720187-001-02-8, BRD-K50720187-050-09-0, BRD-K50720187-050-08-2, BRD-K50720187-051-02-3","Launched","","JUUFBMODXQKSTD-UHFFFAOYSA-N","BRD-K50720187","","CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N"
"9427","LEVOMENTHOL","","OPRK1, TRPA1, TRPM8, TRPV3","neurology/psychiatry","pain relief","MicroSource, Sigma, Sigma",32.51,"BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0","Launched","","NOOLISFMXDJSKH-KXUCPTDWSA-N","BRD-K50329370","","CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O"
"9428","LEVOMENTHOL","","OPRK1, TRPA1, TRPM8, TRPV3","neurology/psychiatry","pain relief","MicroSource, Sigma, Sigma",32.51,"BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0","Launched","","NOOLISFMXDJSKH-KXUCPTDWSA-N","BRD-K50329370","","CC(C)C1CCC(C)CC1O"
"9430","LEVOMENTHOL","","OPRK1, TRPA1, TRPM8, TRPV3","neurology/psychiatry","pain relief","MicroSource, Sigma, Sigma",32.51,"BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0","Launched","","NOOLISFMXDJSKH-UHFFFAOYSA-N","BRD-K50329370","","CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O"
"9431","LEVOMENTHOL","","OPRK1, TRPA1, TRPM8, TRPV3","neurology/psychiatry","pain relief","MicroSource, Sigma, Sigma",32.51,"BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0","Launched","","NOOLISFMXDJSKH-UHFFFAOYSA-N","BRD-K50329370","","CC(C)C1CCC(C)CC1O"
"9433","LOXOPROFEN","cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGS2","neurology/psychiatry","pain relief","MicroSource, MedChemEx",98.61,"BRD-A43082555-001-02-9, BRD-A43082555-001-01-1","Launched","BRD-A18039798-001-01-9","YMBXTVYHTMGZDW-UHFFFAOYSA-N","BRD-A43082555","BRD-A18039798","CC(C(O)=O)c1ccc(CC2CCCC2=O)cc1"
"9435","MABUPROFEN","cyclooxygenase inhibitor","","neurology/psychiatry","pain relief","Enamine",91.14,"BRD-A93683007-001-01-9","Launched","","JVGUNCHERKJFCM-UHFFFAOYSA-N","BRD-A93683007","","CC(C)Cc1ccc(cc1)C(C)C(=O)NCCO"
"9436","MEPTAZINOL","opioid receptor agonist","BCHE","neurology/psychiatry","pain relief","Tocris, Selleck, Selleck",94.08,"BRD-A02710418-003-13-4, BRD-A02710418-003-12-6, BRD-A02710418-003-11-8","Launched","","JLICHNCFTLFZJN-UHFFFAOYSA-N","BRD-A02710418","","CCC1(CCCCN(C)C1)c1cccc(O)c1"
"9439","MORNIFLUMATE","anti-inflammatory agent","","neurology/psychiatry","pain relief","AKSci",97.89,"BRD-K38938675-001-01-4","Launched","","LDXSPUSKBDTEKA-UHFFFAOYSA-N","BRD-K38938675","","FC(F)(F)c1cccc(Nc2ncccc2C(=O)OCCN2CCOCC2)c1"
"9440","NALBUPHINE","opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1","neurology/psychiatry","pain relief","MicroSource, Enzo",91.8,"BRD-K66404838-001-02-4, BRD-K66404838-310-01-1","Launched","BRD-A92651262-003-04-7","NETZHAKZCGBWSS-CEDHKZHLSA-N","BRD-K66404838","BRD-A92651262","O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45"
"9442","NEFOPAM","cyclooxygenase inhibitor","","neurology/psychiatry","pain relief","Selleck, MicroSource",98.6,"BRD-A78877355-003-11-9, BRD-A78877355-001-03-0","Launched","","RGPDEAGGEXEMMM-UHFFFAOYSA-N","BRD-A78877355","","CN1CCOC(c2ccccc2)c2ccccc2C1"
"9444","NIFENAZONE","analgesic agent","","neurology/psychiatry","pain relief","Selleck, MicroSource",99.25,"BRD-K47407372-001-16-3, BRD-K47407372-001-17-1","Launched","","BRZANEXCSZCZCI-UHFFFAOYSA-N","BRD-K47407372","","Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C"
"9446","PARECOXIB","cyclooxygenase inhibitor","LTF","neurology/psychiatry","pain relief","MedChemEx",99.02,"BRD-K13800121-001-01-5","Launched","","TZRHLKRLEZJVIJ-UHFFFAOYSA-N","BRD-K13800121","","CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1"
"9447","PHENAZONE","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","MicroSource, Selleck",99.14,"BRD-K46937689-001-15-0, BRD-K46937689-001-14-3","Launched","","VEQOALNAAJBPNY-UHFFFAOYSA-N","BRD-K46937689","","Cc1cc(=O)n(-c2ccccc2)n1C"
"9449","PIKETOPROFEN","cyclooxygenase inhibitor","","neurology/psychiatry","pain relief","Enamine",93.58,"BRD-A85548292-001-01-8","Launched","","ASFKKFRSMGBFRO-UHFFFAOYSA-N","BRD-A85548292","","CC(C(=O)Nc1cc(C)ccn1)c1cccc(c1)C(=O)c1ccccc1"
"9450","PRANOPROFEN","cyclooxygenase inhibitor","","neurology/psychiatry","pain relief","MicroSource, Selleck, Selleck",98.99,"BRD-A64610707-001-04-4, BRD-A64610707-001-03-6, BRD-A64610707-001-05-1","Launched","","TVQZAMVBTVNYLA-UHFFFAOYSA-N","BRD-A64610707","","CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1"
"9453","PROGLUMETACIN","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry","pain relief","AKSci",0,"BRD-A19458515-001-01-2","Launched","","PTXGHCGBYMQQIG-UHFFFAOYSA-N","BRD-A19458515","","CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1"
"9454","TALNIFLUMATE","cyclooxygenase inhibitor","CLCA1","neurology/psychiatry","pain relief","Tocris, Tocris",93.24,"BRD-A98378129-001-02-2, BRD-A98378129-001-03-0","Launched","","ANMLJLFWUCQGKZ-UHFFFAOYSA-N","BRD-A98378129","","FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1"
"9456","PARACETAMOL","cyclooxygenase inhibitor","FAAH, PTGS1, PTGS2, TRPV1","neurology/psychiatry, endocrinology","pain relief, fever","Tocris, MicroSource, Tocris",95,"BRD-K41524689-001-25-0, BRD-K41524689-001-23-5, BRD-K41524689-001-22-7","Launched","","RZVAJINKPMORJF-UHFFFAOYSA-N","BRD-K41524689","","CC(=O)Nc1ccc(O)cc1"
"9459","RAMIFENAZONE","cyclooxygenase inhibitor","","neurology/psychiatry, endocrinology","pain relief, fever","Key, MicroSource",80.52,"BRD-K85333151-001-01-3, BRD-K85333151-003-13-4","Launched","","XOZLRRYPUKAKMU-UHFFFAOYSA-N","BRD-K85333151","","CC(C)Nc1c(C)n(C)n(-c2ccccc2)c1=O"
"9461","SALICYLAMIDE","analgesic agent","","neurology/psychiatry, endocrinology","pain relief, fever","MicroSource",98.74,"BRD-K81130846-001-17-4","Launched","","SKZKKFZAGNVIMN-UHFFFAOYSA-N","BRD-K81130846","","NC(=O)c1ccccc1O"
"9462","NAPROXEN","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology, dental, otolaryngology, endocrinology","pain relief, rheumatoid arthritis, headache, toothache, backache, muscle pain, common cold, fever","Selleck, Tocris, Selleck, MicroSource",99.66,"BRD-K59197931-236-22-9, BRD-K59197931-236-21-1, BRD-K59197931-236-20-3, BRD-K59197931-001-04-5","Launched","","CMWTZPSULFXXJA-VIFPVBQESA-N","BRD-K59197931","","COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O"
"9466","BENTIROMIDE","","HPN","gastroenterology","pancreas diagnostic agent","Selleck, Selleck",93.46,"BRD-K58794715-001-01-8, BRD-K58794715-001-02-6","Launched","","SPPTWHFVYKCNNK-FQEVSTJZSA-N","BRD-K58794715","","OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1"
"9468","STREPTOZOTOCIN","DNA alkylating agent","SLC2A2","oncology","pancreatic cancer","Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris",83.34,"BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4","Launched","BRD-A25576662-001-02-2","ZSJLQEPLLKMAKR-GKHCUFPYSA-N","BRD-K34411947","BRD-A25576662","CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O"
"9470","STREPTOZOTOCIN","DNA alkylating agent","SLC2A2","oncology","pancreatic cancer","Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris",83.34,"BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4","Launched","BRD-A25576662-001-02-2","ZSJLQEPLLKMAKR-GKHCUFPYSA-N","BRD-K34411947","BRD-A25576662","CN([N+][O-])C(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O"
"9475","STREPTOZOTOCIN","DNA alkylating agent","SLC2A2","oncology","pancreatic cancer","Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris",83.34,"BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4","Launched","BRD-A25576662-001-02-2","ZSJLQEPLLKMAKR-FEQHFJGESA-N","BRD-K34411947","BRD-A25576662","CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O"
"9477","STREPTOZOTOCIN","DNA alkylating agent","SLC2A2","oncology","pancreatic cancer","Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris",83.34,"BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4","Launched","BRD-A25576662-001-02-2","ZSJLQEPLLKMAKR-FEQHFJGESA-N","BRD-K34411947","BRD-A25576662","CN([N+][O-])C(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O"
"9482","MITOMYCIN-C","DNA alkylating agent, DNA synthesis inhibitor","","oncology","pancreatic cancer, gastric adenocarcinoma","MicroSource",99.49,"BRD-A48237631-001-04-8","Launched","","NWIBSHFKIJFRCO-CPKMXBGFSA-N","BRD-A48237631","","CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O"
"9483","2-DEOXY-2-{[METHYL(NITROSO)CARBAMOYL]AMINO}HEXOSE","","","oncology, endocrinology","pancreatic cancer, hypoglycemia","Labotest",0,"BRD-A55902763-001-01-3","Preclinical","","AGRCPNMCOXLKFO-UHFFFAOYSA-N","BRD-A55902763","","CN([N+][O-])C(=O)NC(C=O)C(O)C(O)C(O)CO"
"9484","CAMOSTAT-MESILATE","protease inhibitor","PRSS1","gastroenterology","pancreatitis","Tocris, Selleck",96.31,"BRD-K43806473-066-03-9, BRD-K43806473-066-02-1","Launched","","XASIMHXSUQUHLV-UHFFFAOYSA-N","BRD-K43806473","","CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1"
"9486","GABEXATE","serine protease inhibitor","PRSS1, TPSAB1","gastroenterology","pancreatitis","MedChemEx, Selleck, MedChemEx, Selleck, Tocris",85.7,"BRD-K59256312-066-17-3, BRD-K59256312-066-13-2, BRD-K59256312-066-16-5, BRD-K59256312-066-15-7, BRD-K59256312-066-14-0","Launched","","YKGYIDJEEQRWQH-UHFFFAOYSA-N","BRD-K59256312","","CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1"
"9491","DEXPANTHENOL","","","gastroenterology","paralytic ileus","MicroSource, MicroSource",89.9,"BRD-K71210479-001-05-5, BRD-A59413292-001-08-2","Launched","","SNPLKNRPJHDVJA-ZETCQYMHSA-N","BRD-K71210479","","CC(C)(CO)[C@@H](O)C(=O)NCCCO"
"9492","DEXPANTHENOL","","","gastroenterology","paralytic ileus","MicroSource, MicroSource",89.9,"BRD-K71210479-001-05-5, BRD-A59413292-001-08-2","Launched","","SNPLKNRPJHDVJA-ZETCQYMHSA-N","BRD-K71210479","","CC(C)(CO)C(O)C(=O)NCCCO"
"9493","DEXPANTHENOL","","","gastroenterology","paralytic ileus","MicroSource, MicroSource",89.9,"BRD-K71210479-001-05-5, BRD-A59413292-001-08-2","Launched","","SNPLKNRPJHDVJA-UHFFFAOYSA-N","BRD-K71210479","","CC(C)(CO)[C@@H](O)C(=O)NCCCO"
"9494","DEXPANTHENOL","","","gastroenterology","paralytic ileus","MicroSource, MicroSource",89.9,"BRD-K71210479-001-05-5, BRD-A59413292-001-08-2","Launched","","SNPLKNRPJHDVJA-UHFFFAOYSA-N","BRD-K71210479","","CC(C)(CO)C(O)C(=O)NCCCO"
"9495","TRIHEXYPHENIDYL","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","neurology/psychiatry","parkinsonism","MicroSource",96.17,"BRD-A48180038-003-24-3","Launched","","HWHLPVGTWGOCJO-UHFFFAOYSA-N","BRD-A48180038","","OC(CCN1CCCCC1)(C1CCCCC1)c1ccccc1"
"9496","PROCYCLIDINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","parkinsonism, Parkinson's Disease, akathisia, dystonia","Selleck, MicroSource",96.66,"BRD-A31800922-003-24-4, BRD-A31800922-003-25-1","Launched","","WYDUSKDSKCASEF-UHFFFAOYSA-N","BRD-A31800922","","OC(CCN1CCCC1)(C1CCCCC1)c1ccccc1"
"9498","IBUPROFEN-LYSINE","cyclooxygenase inhibitor","PTGS1, PTGS2","cardiology","patent ductus arteriosus (PDA)","Selleck, Selleck",0,"BRD-M64062803-001-03-9, BRD-M64062803-001-02-1","Launched","","IHHXIUAEPKVVII-ZSCHJXSPSA-N","BRD-M64062803","","NCCCC[C@H](N)C(O)=O.CC(C)Cc1ccc(cc1)C(C)C(O)=O"
"9500","THIAMPHENICOL","bacterial 50S ribosomal subunit inhibitor","","infectious disease","pelvic inflammatory disease","MicroSource, Selleck",98.69,"BRD-K79711234-001-18-3, BRD-K79711234-001-17-5","Launched","","OTVAEFIXJLOWRX-NXEZZACHSA-N","BRD-K79711234","","CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl"
"9502","AZITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","MLNR","infectious disease","pelvic inflammatory disease, pneumonia","Tocris, MicroSource, Selleck, Selleck",100,"BRD-K74501079-001-17-3, BRD-K74501079-001-15-7, BRD-K74501079-335-01-9, BRD-K74501079-001-18-1","Launched","BRD-A37438244-335-01-2, BRD-K73794685-001-01-5","MQTOSJVFKKJCRP-BICOPXKESA-N","BRD-K74501079","BRD-A37438244","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O"
"9506","ACEGLUTAMIDE","","","gastroenterology","peptic ulcer disease (PUD)","MicroSource",100,"BRD-K13619941-213-01-8","Launched","","KSMRODHGGIIXDV-YFKPBYRVSA-N","BRD-K13619941","","CC(=O)N[C@@H](CCC(N)=O)C(O)=O"
"9507","ANISOTROPINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","Selleck",96.04,"BRD-A06771424-004-01-7","Launched","","XGGHHHBGPSNXFE-XYPWUTKMSA-N","BRD-A06771424","","CCCC(CCC)C(=O)OC1C[C@@H]2CC[C@H](C1)[N+]2(C)C"
"9508","GLYCOPYRROLATE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","gastroenterology","peptic ulcer disease (PUD)","MicroSource",98.36,"BRD-A81233518-004-16-1","Launched","","ANGKOCUUWGHLCE-UHFFFAOYSA-N","BRD-A81233518","","C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1"
"9509","IRSOGLADINE","phosphodiesterase inhibitor","PDE4A","gastroenterology","peptic ulcer disease (PUD)","Tocris, Tocris, Selleck",99.31,"BRD-K74195153-050-12-1, BRD-K74195153-050-13-9, BRD-K74195153-001-04-1","Launched","","ATCGGEJZONJOCL-UHFFFAOYSA-N","BRD-K74195153","","Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl"
"9512","MEPENZOLATE","acetylcholine receptor antagonist","CHRM1, CHRM3","gastroenterology","peptic ulcer disease (PUD)","MicroSource, Selleck",99.17,"BRD-A62421304-004-18-9, BRD-A62421304-004-17-1","Launched","","GKNPSSNBBWDAGH-UHFFFAOYSA-N","BRD-A62421304","","C[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1"
"9514","METHSCOPOLAMINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","Selleck, MicroSource, Selleck",98.54,"BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6","Launched","BRD-K05224916-004-01-1","LZCOQTDXKCNBEE-IKIFYQGPSA-N","BRD-K48619321","BRD-K05224916","C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9515","METHSCOPOLAMINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","Selleck, MicroSource, Selleck",98.54,"BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6","Launched","BRD-K05224916-004-01-1","LZCOQTDXKCNBEE-IKIFYQGPSA-N","BRD-K48619321","BRD-K05224916","C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1"
"9517","METHSCOPOLAMINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","Selleck, MicroSource, Selleck",98.54,"BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6","Launched","BRD-K05224916-004-01-1","LZCOQTDXKCNBEE-RUTJIGONSA-N","BRD-K48619321","BRD-K05224916","C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1"
"9518","METHSCOPOLAMINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","Selleck, MicroSource, Selleck",98.54,"BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6","Launched","BRD-K05224916-004-01-1","LZCOQTDXKCNBEE-RUTJIGONSA-N","BRD-K48619321","BRD-K05224916","C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1"
"9520","OXYPHENCYCLIMINE","cholinergic receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","peptic ulcer disease (PUD)","MicroSource",97.02,"BRD-A58193911-003-18-7","Launched","","DUDKAZCAISNGQN-UHFFFAOYSA-N","BRD-A58193911","","CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)c1ccccc1"
"9521","OXYPHENONIUM","cholinergic receptor antagonist","CHRM1","gastroenterology","peptic ulcer disease (PUD)","MicroSource",92.38,"BRD-A14208071-004-19-8","Launched","","GFRUPHOKLBPHTQ-UHFFFAOYSA-N","BRD-A14208071","","CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1"
"9522","PIRENZEPINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","gastroenterology","peptic ulcer disease (PUD)","MicroSource",98.27,"BRD-K89375097-300-08-8","Launched","","RMHMFHUVIITRHF-UHFFFAOYSA-N","BRD-K89375097","","CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1"
"9523","PROPANTHELINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology","peptic ulcer disease (PUD)","MicroSource",80.23,"BRD-K90885812-004-24-2","Launched","","VVWYOYDLCMFIEM-UHFFFAOYSA-N","BRD-K90885812","","CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc12)C(C)C"
"9524","SOFALCONE","mucus protecting agent","CBR1","gastroenterology","peptic ulcer disease (PUD)","Cayman",97.31,"BRD-K01039503-001-01-2","Launched","","GFWRVVCDTLRWPK-KPKJPENVSA-N","BRD-K01039503","","CC(C)=CCOc1ccc(\C=C\C(=O)c2ccc(OCC=C(C)C)cc2OCC(O)=O)cc1"
"9525","SULMETOZINE","gastrin inhibitor","GAST","gastroenterology","peptic ulcer disease (PUD)","Vitas-M",96.89,"BRD-K29570907-001-07-3","Launched","","MVOUIYUWRXPNKD-UHFFFAOYSA-N","BRD-K29570907","","COc1cc(cc(OC)c1OC)C(=S)N1CCOCC1"
"9526","VONOPRAZAN","potassium-competitive acid antagonist","ATP4A","gastroenterology","peptic ulcer disease (PUD)","Selleck, Selleck",88.52,"BRD-K32768103-051-02-6, BRD-K32768103-051-03-4","Launched","","BFDBKMOZYNOTPK-UHFFFAOYSA-N","BRD-K32768103","","CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1"
"9528","HYOSCYAMINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology, urology, neurology/psychiatry, allergy","peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis","MicroSource, Selleck",97.93,"BRD-K40530731-001-11-6, BRD-K40530731-001-10-8","Launched","BRD-A78303415-001-04-3, BRD-A97674763-001-01-8","RKUNBYITZUJHSG-FXUDXRNXSA-N","BRD-K40530731","BRD-A78303415","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c1ccccc1"
"9530","ENOXOLONE","gap junction modulator","HSD11B1","gastroenterology, otolaryngology","peptic ulcer disease (PUD), common cold","MicroSource, Selleck",99.76,"BRD-K96137854-001-18-9, BRD-K96137854-001-17-1","Launched","BRD-A20200672-001-05-5, BRD-K80535353-001-01-4","MPDGHEJMBKOTSU-YKLVYJNSSA-N","BRD-K96137854","BRD-A20200672","C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O"
"9532","REBAMIPIDE","free radical scavenger","FPR1","gastroenterology","peptic ulcer disease (PUD), gastritis","MicroSource, Selleck",98.72,"BRD-A15909516-001-07-4, BRD-A15909516-001-06-6","Launched","","ALLWOAVDORUJLA-UHFFFAOYSA-N","BRD-A15909516","","OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1"
"9534","ISOPROPAMIDE-IODIDE","acetylcholine receptor antagonist","CHRM3, CHRM4","gastroenterology","peptic ulcer disease (PUD), gastrointestinal acidosis","MicroSource",97.23,"BRD-K14127446-005-22-7","Launched","","JTPUMZTWMWIVPA-UHFFFAOYSA-O","BRD-K14127446","","CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C"
"9535","CLIDINIUM","acetylcholine receptor antagonist","CHRM1, CHRM3","gastroenterology","peptic ulcer disease (PUD), irritable bowel syndrome, enterocolitis","MicroSource",99.37,"BRD-A46066006-004-22-6","Launched","","HOOSGZJRQIVJSZ-UHFFFAOYSA-N","BRD-A46066006","","C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c1ccccc1)c1ccccc1"
"9536","METHANTHELINE","acetylcholine receptor antagonist","CHRM1, HRH2","gastroenterology, neurology/psychiatry, urology","peptic ulcer disease (PUD), irritable bowel syndrome, pancreatitis, dyskinesia, neurogenic bladder","Prestwick",53.05,"BRD-K09859624-004-10-4","Launched","","GZHFODJQISUKAY-UHFFFAOYSA-N","BRD-K09859624","","CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc12"
"9537","CARBENOXOLONE","11-beta hydroxysteroid dehydrogenase inhibitor","GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3","gastroenterology, dental","peptic ulcer disease (PUD), mouth inflammation","Selleck, MicroSource, Selleck",94.39,"BRD-A29700858-304-03-4, BRD-A29700858-304-02-6, BRD-A29700858-304-01-8","Launched","BRD-A25216804-304-01-4, BRD-A98702003-304-04-8, BRD-A25216804-304-02-2","OBZHEBDUNPOCJG-SOJSWMKXSA-N","BRD-A29700858","BRD-A25216804","CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O"
"9540","TRIDIHEXETHYL","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology, ophthalmology","peptic ulcer disease (PUD), nystagmus","Prestwick",94,"BRD-A22152765-003-10-0","Launched","","NPRHVSBSZMAEIN-UHFFFAOYSA-N","BRD-A22152765","","CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c1ccccc1"
"9541","DOXYCYCLINE","metalloproteinase inhibitor","MMP8","dental","periodontitis","MicroSource, Selleck, Selleck, Selleck, Selleck",99,"BRD-A08545410-003-06-0, BRD-A08545410-003-08-6, BRD-A08545410-311-01-8, BRD-A08545410-311-03-4, BRD-A08545410-003-07-8","Launched","BRD-A36632888-003-01-6, BRD-M28128163-312-01-2,BRD-M68646745-311-09-6, BRD-M28128163-312-03-8","VXVNYCRICCVPTD-MULYGRJNSA-N","BRD-A08545410","BRD-A36632888","C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12"
"9546","DOXYCYCLINE-HYCLATE","bacterial 30S ribosomal subunit inhibitor","","dental","periodontitis","MedChemEx",0,"BRD-M28128163-003-01-7","Launched","","OQQMRKYWJNJBBI-AIDNFEPSSA-N","BRD-M28128163","","CCO.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12"
"9547","BELINOSTAT","HDAC inhibitor","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9","hematologic malignancy","peripheral T-cell lymphoma (PTCL)","Selleck",94.73,"BRD-K17743125-001-08-4","Launched","","NCNRHFGMJRPRSK-MDZDMXLPSA-N","BRD-K17743125","","ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc1ccccc1"
"9548","PRALATREXATE","dihydrofolate reductase inhibitor","DHFR, TYMS","hematologic malignancy","peripheral T-cell lymphoma (PTCL)","Selleck",94.33,"BRD-A74914197-001-02-9","Launched","","OGSBUKJUDHAQEA-WMCAAGNKSA-N","BRD-A74914197","","Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1"
"9549","BUFLOMEDIL","adrenergic receptor antagonist, calcium channel blocker","ADRA1A","cardiology","peripheral artery disease (PAD)","Selleck, MicroSource",98.69,"BRD-K19462402-003-23-8, BRD-K19462402-003-24-6","Launched","","OWYLAEYXIQKAOL-UHFFFAOYSA-N","BRD-K19462402","","COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1"
"9551","BUPIVACAINE","sodium channel blocker","KCNA5, PTGER1, SCN10A, SCN4A","neurology/psychiatry","peripheral nerve block, caudal epidural block, lumbar epidural block","MicroSource, Selleck",98.95,"BRD-A01636364-003-15-1, BRD-A01636364-003-14-4","Launched","","LEBVLXFERQHONN-UHFFFAOYSA-N","BRD-A01636364","","CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C"
"9553","LEVOCARNITINE-PROPIONATE","carnitine palmitoyltransferase inhibitor","CRAT","neurology/psychiatry, endocrinology","peripheral neuropathy, carnitine deficiency","MedChemEx",61.9,"BRD-K84366268-003-01-0","Launched","","UFAHZIUFPNSHSL-MRVPVSSYSA-O","BRD-K84366268","","CCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C"
"9554","PREGABALIN","voltage-gated calcium channel ligand","CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8","neurology/psychiatry, rheumatology","peripheral neuropathy, seizures, fibromyalgia, postherpetic neuralgia","MicroSource, MedChemEx",97.97,"BRD-K66786476-003-01-9, BRD-K66786476-001-01-3","Launched","","AYXYPKUFHZROOJ-ZETCQYMHSA-N","BRD-K66786476","","CC(C)C[C@H](CN)CC(O)=O"
"9556","PHENOL","","CA1, CA12, CA14, CA2, CA4, CA9","otolaryngology","pharyngitis","Sigma",0,"BRD-K76549667-001-04-6","Preclinical","","ISWSIDIOOBJBQZ-UHFFFAOYSA-N","BRD-K76549667","","Oc1ccccc1"
"9557","HEXETIDINE","local anesthetic","","otolaryngology, infectious disease, dental, gastroenterology","pharyngitis, meningitis, laryngitis, gingivitis, ulcerative colitis","MicroSource, MedChemEx, MedChemEx",25.25,"BRD-A18605525-001-12-4, BRD-A18605525-001-13-2, BRD-A18605525-001-14-0","Launched","","DTOUUUZOYKYHEP-UHFFFAOYSA-N","BRD-A18605525","","CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1"
"9560","CEFPODOXIME","bacterial cell wall synthesis inhibitor","","otolaryngology, infectious disease, pulmonary","pharyngitis, pneumonia, bronchitis, gonorrhea, skin infections, urinary tract infections, sinusitis, tonsillitis","Key, MicroSource",49.13,"BRD-A34205213-001-03-9, BRD-A34205213-001-04-7","Launched","BRD-A87387433-001-03-5","LTINZAODLRIQIX-FBXRGJNPSA-N","BRD-A34205213","BRD-A87387433","COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)OC(C)OC(=O)OC(C)C"
"9562","CEFUROXIME-AXETIL","bacterial cell wall synthesis inhibitor","","otolaryngology","pharyngitis, tonsillitis, otitis, sinusitis","Sigma, MicroSource",56.52,"BRD-A22303829-001-01-6, BRD-A22303829-001-02-4","Launched","BRD-A36322567-001-02-4","KEJCWVGMRLCZQQ-YJBYXUATSA-N","BRD-A22303829","BRD-A36322567","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)c1ccco1"
"9564","CEFPROZIL","bacterial cell wall synthesis inhibitor","","otolaryngology, infectious disease, pulmonary","pharyngitis, tonsillitis, otitis, sinusitis, respiratory tract infections, skin infections, bronchitis","MicroSource, Selleck, MedChemEx, Selleck",76.4,"BRD-K24871708-001-01-4, BRD-K24871708-002-03-8, BRD-K24871708-002-04-6, BRD-K24871708-002-02-0","Launched","BRD-A85137183-001-03-8","WDLWHQDACQUCJR-ZAMMOSSLSA-N","BRD-K24871708","BRD-A85137183","C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O"
"9568","CLARITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","CYP3A4","otolaryngology, pulmonary, infectious disease","pharyngitis, tonsillitis, sinusitis, bronchitis, pneumonia, skin infections, otitis","MicroSource, Selleck",100,"BRD-K49668410-001-16-2, BRD-K49668410-001-18-8","Launched","BRD-K16762525-001-01-6","AGOYDEPGAOXOCK-KCBOHYOISA-N","BRD-K49668410","BRD-K16762525","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC"
"9570","PHENTOLAMINE","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","endocrinology, cardiology","pheochromocytoma, hypertension","Selleck, MicroSource, Selleck, Enzo",99.38,"BRD-K90333595-066-17-9, BRD-K90333595-003-21-4, BRD-K90333595-066-16-1, BRD-K90333595-003-22-2","Launched","","MRBDMNSDAVCSSF-UHFFFAOYSA-N","BRD-K90333595","","Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1"
"9574","MEBENDAZOLE","tubulin polymerization inhibitor","TUBA1A, TUBB, TUBB4B","infectious disease","pinworm, whipworm, hookworm, ascariasis","MicroSource",96.72,"BRD-K77987382-001-13-2","Launched","","OPXLLQIJSORQAM-UHFFFAOYSA-N","BRD-K77987382","","COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1"
"9575","ATOVAQUONE","mitochondrial electron transport inhibitor","DHODH","infectious disease","pneumonia","MicroSource, Selleck",97.44,"BRD-A19795905-001-08-0, BRD-A19795905-001-07-2","Launched","","UYFLKEIEOREOFC-KWRXGGKWSA-N","BRD-A19795905","","Clc1ccc(cc1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)c2ccccc2C1=O"
"9577","PENTAMIDINE","anti-pneumocystis agent","TRDMT1","infectious disease","pneumonia","MicroSource, Selleck",98.99,"BRD-K13183738-317-10-2, BRD-K13183738-300-02-5","Launched","","XDRYMKDFEDOLFX-UHFFFAOYSA-N","BRD-K13183738","","NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1"
"9579","TAZOBACTAM","beta lactamase inhibitor","","infectious disease","pneumonia","MicroSource",96.32,"BRD-A18611368-001-01-5","Launched","","LPQZKKCYTLCDGQ-KTOWXAHTSA-N","BRD-A18611368","","C[C@]1(Cn2ccnn2)C(N2C(CC2=O)S1(=O)=O)C(O)=O"
"9580","TELITHROMYCIN","bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","infectious disease","pneumonia","MicroSource, Cayman",81.67,"BRD-A94008949-001-01-9, BRD-K82240271-001-01-8","Launched","","LJVAJPDWBABPEJ-FXVGUYRBSA-N","BRD-A94008949","","CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC"
"9581","TELITHROMYCIN","bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","infectious disease","pneumonia","MicroSource, Cayman",81.67,"BRD-A94008949-001-01-9, BRD-K82240271-001-01-8","Launched","","LJVAJPDWBABPEJ-FXVGUYRBSA-N","BRD-A94008949","","CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC"
"9582","TELITHROMYCIN","bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","infectious disease","pneumonia","MicroSource, Cayman",81.67,"BRD-A94008949-001-01-9, BRD-K82240271-001-01-8","Launched","","LJVAJPDWBABPEJ-PNUFFHFMSA-N","BRD-A94008949","","CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC"
"9583","TELITHROMYCIN","bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","infectious disease","pneumonia","MicroSource, Cayman",81.67,"BRD-A94008949-001-01-9, BRD-K82240271-001-01-8","Launched","","LJVAJPDWBABPEJ-PNUFFHFMSA-N","BRD-A94008949","","CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC"
"9584","CEFDITOREN-PIVOXIL","bacterial cell wall synthesis inhibitor","","infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, skin infections, tonsillitis, pharyngitis","MicroSource, Selleck, Selleck",88.24,"BRD-K72167406-001-04-7, BRD-K72167406-001-02-1, BRD-K72167406-001-03-9","Launched","BRD-A39056513-001-04-6, BRD-K05878591-001-01-2","AFZFFLVORLEPPO-UVYJNCLZSA-N","BRD-K72167406","BRD-A39056513","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1"
"9587","FAROPENEM","lactamase inhibitor","","infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, skin infections, urinary tract infections, sinusitis","Astatech",98.06,"BRD-A49622760-001-01-9","Launched","","HGGAKXAHAYOLDJ-UHFFFAOYSA-N","BRD-A49622760","","CC(O)C1C2SC(C3CCCO3)=C(N2C1=O)C(O)=O"
"9588","TROLEANDOMYCIN","protein synthesis inhibitor","","infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, tonsillitis, sinusitis","MicroSource",100,"BRD-A24297246-001-03-9","Launched","","LQCLVBQBTUVCEQ-RFHKDOLOSA-N","BRD-A24297246","","CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O"
"9589","PENICILLIN-V-POTASSIUM","bacterial cell wall synthesis inhibitor","","infectious disease","pneumonia, ear infections, skin infections, throat infections, cholera, scarlet fever","MicroSource",90.16,"BRD-K43966364-237-04-8","Launched","","BPLBGHOLXOTWMN-MBNYWOFBSA-N","BRD-K43966364","","CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(O)=O"
"9590","SULFAMETHOXAZOLE","PABA antagonist","","infectious disease, gastroenterology","pneumonia, enteritis, urinary tract infections","MicroSource, Selleck",98.94,"BRD-K28494619-001-28-2, BRD-K28494619-001-27-4","Launched","","JLKIGFTWXXRPMT-UHFFFAOYSA-N","BRD-K28494619","","Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1"
"9592","TEBIPENEM","bacterial cell wall synthesis inhibitor","CNR1","infectious disease, otolaryngology","pneumonia, otitis","Selleck",94.38,"BRD-K06900071-001-01-2","Launched","","SNUDIPVBUUXCDG-MXYBEHONSA-N","BRD-K06900071","","C[C@@H](O)[C@@H]1[C@@H]2[C@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C"
"9593","ISEPAMICIN","protein synthesis inhibitor","","infectious disease","pneumonia, peritonitis","Carbosynth, Sigma",95.5,"BRD-K74759733-001-01-9, BRD-K74759733-065-01-4","Launched","","UDIIBEDMEYAVNG-ZKFPOVNWSA-N","BRD-K74759733","","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O"
"9595","PAZUFLOXACIN","topoisomerase inhibitor","","infectious disease","pneumonia, peritonitis, bacterial septicemia","MicroSource",97.79,"BRD-K66412701-066-01-6","Launched","","XAGMUUZPGZWTRP-ZETCQYMHSA-N","BRD-K66412701","","C[C@H]1COc2c(c(F)cc3c2n1cc(C(O)=O)c3=O)C1(N)CC1"
"9596","CEFTIOFUR","bacterial cell wall synthesis inhibitor","","infectious disease","pneumonia, respiratory tract infections","MicroSource, Selleck, Selleck",93.8,"BRD-K82960980-003-01-9, BRD-K82960980-003-03-5, BRD-K82960980-003-02-7","Launched","BRD-K75097379-003-01-8, BRD-K15436267-003-01-6, BRD-K21017401-003-02-1","ZBHXIWJRIFEVQY-IHMPYVIRSA-N","BRD-K82960980","BRD-K75097379","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"9599","LEVOFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","infectious disease, otolaryngology, pulmonary, urology","pneumonia, sinusitis, bronchitis, skin infections, prostatitis, urinary tract infections, pyelonephritis, anthrax, plague","MicroSource, Selleck",97.7,"BRD-K09471561-001-18-2, BRD-K09471561-001-20-8","Launched","BRD-K88565300-001-01-7","GSDSWSVVBLHKDQ-JTQLQIEISA-N","BRD-K09471561","BRD-K88565300","C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O"
"9601","LINEZOLID","bacterial 50S ribosomal subunit inhibitor","MAOA, MAOB","infectious disease","pneumonia, skin infections","Tocris, MicroSource, Selleck",98.39,"BRD-K66876909-001-15-9, BRD-K66876909-001-12-6, BRD-K66876909-001-11-8","Launched","","TYZROVQLWOKYKF-ZDUSSCGKSA-N","BRD-K66876909","","CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1"
"9604","CEFACLOR","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology","pneumonia, skin infections, urinary tract infections, respiratory tract infections, tonsillitis, pharyngitis","Selleck, MicroSource, Selleck",89.07,"BRD-K20338176-001-18-5, BRD-K20338176-001-17-7, BRD-K20338176-001-16-9","Launched","","QYIYFLOTGYLRGG-GPCCPHFNSA-N","BRD-K20338176","","N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1"
"9607","CEFDINIR","bacterial cell wall synthesis inhibitor","MPO","infectious disease, otolaryngology, pulmonary","pneumonia, tonsillitis, pharyngitis, bronchitis, skin infections, otitis, sinusitis","MicroSource, Selleck, Selleck",87.42,"BRD-K15766189-001-09-8, BRD-K15766189-001-10-6, BRD-K15766189-001-08-0","Launched","","RTXOFQZKPXMALH-GHXIOONMSA-N","BRD-K15766189","","Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O"
"9610","IMIPENEM","bacterial cell wall synthesis inhibitor","","infectious disease","pneumonia, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections, endocarditis","MicroSource, Sigma",0,"BRD-K23200955-002-01-5, BRD-K23200955-002-02-3","Launched","","ZSKVGTPCRGIANV-ZXFLCMHBSA-N","BRD-K23200955","","C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O"
"9612","CEFEPIME","bacterial cell wall synthesis inhibitor","","infectious disease","pneumonia, urinary tract infections, skin infections, intra-abdominal infections","MicroSource",96.32,"BRD-A12077521-003-01-5","Launched","","HVFLCNVBZFFHBT-FSJBWODESA-O","BRD-A12077521","","CO\N=C(\C(=O)NC1C2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"9613","BEMEGRIDE","chemoreceptor agonist","GABRA1","critical care","poison antidote","Selleck",90.86,"BRD-K14993104-001-05-9","Launched","","ORRZGUBHBVWWOP-UHFFFAOYSA-N","BRD-K14993104","","CCC1(C)CC(=O)NC(=O)C1"
"9614","FOMEPIZOLE","alcohol dehydrogenase inhibitor","ADH1A, ADH1B, ADH1C, AKR1A1, CAT","critical care","poison antidote","MicroSource, MicroSource",98.99,"BRD-K56810756-003-07-7, BRD-K56810756-001-03-0","Launched","","RIKMMFOAQPJVMX-UHFFFAOYSA-N","BRD-K56810756","","Cc1cn[nH]c1"
"9616","SODIUM-NITRITE","nitric oxide donor","","critical care","poison antidote, cyanide poisoning","Selleck, Selleck",0,"BRD-K61230716-236-02-7, BRD-K61230716-236-03-5","Launched","","KYHRXPHIUFTLNH-UHFFFAOYSA-N","BRD-K61230716","","[O-][N+][O-]"
"9618","OBIDOXIME","cholinesterase reactivator","ACHE","critical care, neurology/psychiatry","poison antidote, nerve gas poisoning","Vitas-M",100,"BRD-K33588785-001-01-9","Launched","","HIGRLDNHDGYWQJ-UHFFFAOYSA-P","BRD-K33588785","","O\N=C\c1cc[n+](COC[n+]2ccc(cc2)\C=N\O)cc1"
"9619","PIPOBROMAN","DNA alkylating agent","","hematology","polycythemia vera, thrombocythemia","MicroSource, MedChemEx, MedChemEx",81.16,"BRD-K15656090-001-04-0, BRD-K15656090-001-06-5, BRD-K15656090-001-07-3","Launched","","NJBFOOCLYDNZJN-UHFFFAOYSA-N","BRD-K15656090","","BrCCC(=O)N1CCN(CC1)C(=O)CCBr"
"9622","LACTULOSE","laxative","","gastroenterology","portal-systemic encephalopathy (PSE)","MicroSource",100,"BRD-K77258318-001-04-6","Launched","","JCQLYHFGKNRPGE-FCVZTGTOSA-N","BRD-K77258318","","OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O"
"9623","ALVIMOPAN","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","gastroenterology","postoperative ileus","MedChemEx",97.74,"BRD-K07857022-002-01-1","Launched","","UPNUIXSCZBYVBB-JVFUWBCBSA-N","BRD-K07857022","","C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1"
"9624","ERGONOVINE","adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E","hematology","postpartum hemorrhage (PPH)","MicroSource",95.17,"BRD-A26387268-050-04-4","Launched","","WVVSZNPYNCNODU-FWXSHLFISA-N","BRD-A26387268","","CC(CO)NC(=O)C1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34"
"9625","METHYLERGOMETRINE","dopamine receptor antagonist, serotonin receptor antagonist","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C","hematology, neurology/psychiatry","postpartum hemorrhage (PPH), migraine headache","Tocris, MicroSource",91.71,"BRD-K34685430-050-11-7, BRD-K34685430-050-12-5","Launched","","UNBRKDKAWYKMIV-QWQRMKEZSA-N","BRD-K34685430","","CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34"
"9627","FENIGAM","benzodiazepine receptor agonist","GABBR1, GABBR2","neurology/psychiatry","posttraumatic stress disorder, anxiety, depression","Enamine",92.36,"BRD-A66920069-001-01-3","Launched","","DAFOCGYVTAOKAJ-UHFFFAOYSA-N","BRD-A66920069","","NCC(CC(O)=O)c1ccccc1"
"9628","DAPOXETINE","selective serotonin reuptake inhibitor (SSRI)","HTR1A, HTR1B, HTR2C, SLC6A4","urology","premature ejaculation (PE)","Selleck",98.79,"BRD-K51579475-003-02-4","Launched","","USRHYDPUVLEVMC-FQEVSTJZSA-N","BRD-K51579475","","CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1"
"9629","ALLYLESTRENOL","steroidal progestin","ESR1, PGR, SLC6A9","obstetrics/gynecology","premature labor","ChemImpex",0,"BRD-K12872829-001-01-0","Launched","","ATXHVCQZZJYMCF-XUDSTZEESA-N","BRD-K12872829","","C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)CC=C"
"9630","RITODRINE","adrenergic receptor agonist","ADRB2","obstetrics/gynecology","premature labor","Selleck, Selleck, MicroSource",98.11,"BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5","Launched","","IOVGROKTTNBUGK-SJKOYZFVSA-N","BRD-K14003026","","C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1"
"9632","RITODRINE","adrenergic receptor agonist","ADRB2","obstetrics/gynecology","premature labor","Selleck, Selleck, MicroSource",98.11,"BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5","Launched","","IOVGROKTTNBUGK-SJKOYZFVSA-N","BRD-K14003026","","CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1"
"9633","RITODRINE","adrenergic receptor agonist","ADRB2","obstetrics/gynecology","premature labor","Selleck, Selleck, MicroSource",98.11,"BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5","Launched","","IOVGROKTTNBUGK-UHFFFAOYSA-N","BRD-K14003026","","C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1"
"9635","RITODRINE","adrenergic receptor agonist","ADRB2","obstetrics/gynecology","premature labor","Selleck, Selleck, MicroSource",98.11,"BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5","Launched","","IOVGROKTTNBUGK-UHFFFAOYSA-N","BRD-K14003026","","CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1"
"9636","CETRORELIX","gonadotropin releasing factor hormone receptor antagonist","GNRHR, LHCGR","endocrinology","premature luteinizing hormone surges","Sigma",97.29,"BRD-K76315403-015-02-5","Launched","","SBNPWPIBESPSIF-MHWMIDJBSA-N","BRD-K76315403","","CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O"
"9637","OBETICHOLIC-ACID","FXR agonist","NR1H4","gastroenterology","primary biliary cholangitis","Selleck",67.62,"BRD-A75838038-001-01-4","Launched","","ZXERDUOLZKYMJM-UHFFFAOYSA-N","BRD-A75838038","","CCC1C(O)C2C3CCC(C(C)CCC(O)=O)C3(C)CCC2C2(C)CCC(O)CC12"
"9638","MEFENAMIC-ACID","cyclooxygenase inhibitor","KCNQ1, PTGS1, PTGS2, TRPM3","endocrinology","primary dysmenorrhea (PD)","MicroSource, Selleck",99.01,"BRD-K92778217-001-32-7, BRD-K92778217-001-31-9","Launched","","HYYBABOKPJLUIN-UHFFFAOYSA-N","BRD-K92778217","","Cc1cccc(Nc2ccccc2C(O)=O)c1C"
"9640","NIRAPARIB","PARP inhibitor","PARP1","oncology","primary peritoneal cancer (PPC)","MedChemEx, MedChemEx",95.87,"BRD-K54955827-001-02-2, BRD-K54955827-001-01-4","Launched","","PCHKPVIQAHNQLW-CQSZACIVSA-N","BRD-K54955827","","NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)[C@@H]1CCCNC1"
"9642","ABIRATERONE","androgen biosynthesis inhibitor","CYP11B1, CYP17A1","oncology","prostate cancer","Selleck",92.23,"BRD-K50071428-001-03-3","Launched","BRD-K00111504-001-01-9","GZOSMCIZMLWJML-VJLLXTKPSA-N","BRD-K50071428","BRD-K00111504","C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1"
"9643","ABIRATERONE-ACETATE","androgen biosynthesis inhibitor","CYP17A1","oncology","prostate cancer","Selleck, Selleck",98.65,"BRD-K24048528-001-01-7, BRD-K24048528-001-02-5","Launched","BRD-K16133773-001-01-9","UVIQSJCZCSLXRZ-UBUQANBQSA-N","BRD-K24048528","BRD-K16133773","CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c4cccnc4)[C@@H]3CC=C2C1"
"9645","APALUTAMIDE","androgen receptor antagonist","","oncology","prostate cancer","Selleck",97.61,"BRD-K91308639-001-02-7","Launched","","HJBWBFZLDZWPHF-UHFFFAOYSA-N","BRD-K91308639","","CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F"
"9646","BICALUTAMIDE","androgen receptor antagonist","AR","oncology","prostate cancer","Tocris, MicroSource, Selleck",98.74,"BRD-A29485665-001-14-4, BRD-A29485665-001-12-8, BRD-A29485665-001-11-0","Launched","","LKJPYSCBVHEWIU-UHFFFAOYSA-N","BRD-A29485665","","CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F"
"9649","CABAZITAXEL","microtubule inhibitor","TUBA4A, TUBB, TUBB1","oncology","prostate cancer","Selleck",96.88,"BRD-K06858286-001-01-3","Launched","","BMQGVNUXMIRLCK-VCPXPHFHSA-N","BRD-K06858286","","CO[C@@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@@H](OC(=O)c3ccccc3)[C@@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C"
"9650","CYPROTERONE","androgen receptor antagonist","AR","oncology","prostate cancer","MicroSource",54.15,"BRD-A48103086-001-04-2","Launched","","DUSHUSLJJMDGTE-AVWUXPBGSA-N","BRD-A48103086","","CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@]12C"
"9651","CYPROTERONE-ACETATE","androgen receptor antagonist","ADORA1, AR","oncology","prostate cancer","MicroSource, Sigma, Selleck",94.11,"BRD-K41141507-001-17-0, BRD-K41141507-001-15-4, BRD-K41141507-001-16-2","Launched","BRD-A95207036-001-04-4, BRD-K59573506-001-01-8","UWFYSQMTEOIJJG-FDTZYFLXSA-N","BRD-K41141507","BRD-A95207036","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O"
"9654","DEGARELIX","gonadotropin releasing factor hormone receptor antagonist","GNRHR","oncology","prostate cancer","MedChemEx",96.07,"BRD-A88562598-001-01-7","Launched","","MEUCPCLKGZSHTA-UHFFFAOYSA-N","BRD-A88562598","","CC(C)CC(NC(=O)C(Cc1ccc(NC(N)=O)cc1)NC(=O)C(Cc1ccc(NC(=O)C2CC(=O)NC(=O)N2)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O"
"9655","ENZALUTAMIDE","androgen receptor antagonist","AR","oncology","prostate cancer","Selleck",95.96,"BRD-K56851771-001-06-8","Launched","","WXCXUHSOUPDCQV-UHFFFAOYSA-N","BRD-K56851771","","CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F"
"9656","ESTRAMUSTINE","DNA alkylating agent","ESR1, ESR2, MAP1A, MAP2","oncology","prostate cancer","MicroSource",94.83,"BRD-A70858459-001-01-7","Launched","","FRPJXPJMRWBBIH-ZZSVNSIZSA-N","BRD-A70858459","","C[C@]12CCC3C(CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)C1CC[C@@H]2O"
"9657","ESTRAMUSTINE-PHOSPHATE","DNA synthesis inhibitor, microtubule inhibitor","ESR1, ESR2, MAP1A, MAP2","oncology","prostate cancer","Enzo",93.37,"BRD-K00077635-304-01-2","Launched","","ADFOJJHRTBFFOF-RBRWEJTLSA-N","BRD-K00077635","","C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O"
"9658","FLUTAMIDE","androgen receptor antagonist","AHR, AR","oncology","prostate cancer","Tocris, MicroSource, Selleck",99.28,"BRD-K28307902-001-23-3, BRD-K28307902-001-21-7, BRD-K28307902-001-20-9","Launched","","MKXKFYHWDHIYRV-UHFFFAOYSA-N","BRD-K28307902","","CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O"
"9661","FOSFESTROL","synthetic estrogen","ESR1, ESR2","oncology","prostate cancer","MatrixSci",0,"BRD-K20801936-001-01-9","Launched","","NLORYLAYLIXTID-ISLYRVAYSA-N","BRD-K20801936","","CC\C(c1ccc(OP(O)(O)=O)cc1)=C(\CC)c1ccc(OP(O)(O)=O)cc1"
"9662","LEUPROLIDE","gonadotropin releasing factor hormone receptor agonist","GNRHR","oncology","prostate cancer","Sigma",93.87,"BRD-K26323068-001-01-8","Launched","","GFIJNRVAKGFPGQ-LIJARHBVSA-N","BRD-K26323068","","CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1"
"9663","NILUTAMIDE","androgen receptor antagonist","AR","oncology","prostate cancer","MicroSource, Tocris",99.22,"BRD-K23566484-001-15-1, BRD-K23566484-001-14-4","Launched","","XWXYUMMDTVBTOU-UHFFFAOYSA-N","BRD-K23566484","","CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O"
"9665","GOSERELIN-ACETATE","gonadotropin releasing factor hormone receptor agonist","GNRHR, LHCGR","oncology, obstetrics/gynecology","prostate cancer, breast cancer, endometriosis","Enzo",97.19,"BRD-K99504665-001-01-2","Launched","","BLCLNMBMMGCOAS-URPVMXJPSA-N","BRD-K99504665","","CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O"
"9666","TRIPTORELIN","gonadotropin releasing factor hormone receptor agonist","GNRHR","oncology, endocrinology, obstetrics/gynecology","prostate cancer, breast cancer, precocious puberty, endometriosis, myoma, gender dysphoria","Enzo",93.55,"BRD-K62685538-001-01-7","Launched","","VXKHXGOKWPXYNA-PGBVPBMZSA-N","BRD-K62685538","","CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O"
"9667","ESTRADIOL-VALERATE","estrogen receptor agonist","ESR1","oncology, endocrinology, obstetrics/gynecology","prostate cancer, hypoestrogenism, menopause, vaginal atrophy","MicroSource, Selleck",96.27,"BRD-K66766661-001-19-2, BRD-K66766661-001-20-0","Launched","BRD-A39747742-001-04-3, BRD-K12790232-001-01-5","RSEPBGGWRJCQGY-RBRWEJTLSA-N","BRD-K66766661","BRD-A39747742","CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C"
"9669","ORNIDAZOLE","antiprotozoal agent","","infectious disease","protozoan infection","MicroSource, Selleck, Selleck",92.96,"BRD-A42759514-001-20-5, BRD-A42759514-001-21-3, BRD-A42759514-001-19-7","Launched","","IPWKIXLWTCNBKN-UHFFFAOYSA-N","BRD-A42759514","","Cc1ncc(n1CC(O)CCl)[N+]([O-])=O"
"9672","SECNIDAZOLE","acetylcholinesterase inhibitor, microtubule inhibitor","","infectious disease","protozoan infection","Selleck, Selleck, MicroSource",99.58,"BRD-A70083328-001-22-7, BRD-A70083328-001-24-3, BRD-A70083328-001-23-5","Launched","","KPQZUUQMTUIKBP-UHFFFAOYSA-N","BRD-A70083328","","CC(O)Cn1c(C)ncc1[N+]([O-])=O"
"9675","ACITRETIN","retinoid receptor agonist","RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3","dermatology","psoriasis","Selleck, Selleck",96.4,"BRD-K62012036-001-14-4, BRD-K62012036-001-13-6","Launched","","IHUNBGSDBOWDMA-AQFIFDHZSA-N","BRD-K62012036","","COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C"
"9677","ANTHRALIN","DNA synthesis inhibitor","","dermatology","psoriasis","MedChemEx, MicroSource, MedChemEx",0,"BRD-K04725460-001-12-1, BRD-K04725460-001-10-5, BRD-K04725460-001-11-3","Launched","","NUZWLKWWNNJHPT-UHFFFAOYSA-N","BRD-K04725460","","Oc1cccc2Cc3cccc(O)c3C(=O)c12"
"9680","CALCIPOTRIOL","vitamin D receptor agonist","VDR","dermatology","psoriasis","Tocris, MedChemEx, MedChemEx",92.24,"BRD-K56429665-001-07-0, BRD-K56429665-001-09-6, BRD-K56429665-002-01-1","Launched","","LWQQLNNNIPYSNX-UROSTWAQSA-N","BRD-K56429665","","C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"9683","DITHRANOL","DNA synthesis inhibitor","","dermatology","psoriasis","Sigma",0,"BRD-K51807679-001-06-8","Launched","","YUTJCNNFTOIOGT-UHFFFAOYSA-N","BRD-K51807679","","Oc1cccc2cc3cccc(O)c3c(O)c12"
"9684","METHOXSALEN","DNA synthesis inhibitor","CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4","dermatology","psoriasis","Selleck, MicroSource",99.46,"BRD-K63430059-001-16-4, BRD-K63430059-001-17-2","Launched","","QXKHYNVANLEOEG-UHFFFAOYSA-N","BRD-K63430059","","COc1c2occc2cc2ccc(=O)oc12"
"9686","TACALCITOL","vitamin D receptor agonist","VDR","dermatology","psoriasis, chapped lips","MedChemEx",93.56,"BRD-K73237276-001-01-0","Launched","","BJYLYJCXYAMOFT-RSFVBTMBSA-N","BRD-K73237276","","CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"9687","PSORALEN","","MAOA, MAOB","dermatology","psoriasis, eczema, vitiligo","Specs",91.19,"BRD-K47264279-001-08-9","Launched","","ZCCUUQDIBDJBTK-UHFFFAOYSA-N","BRD-K47264279","","O=c1ccc2cc3ccoc3cc2o1"
"9688","APREMILAST","phosphodiesterase inhibitor","PDE4A, PDE4B, PDE4C, PDE4D","dermatology, rheumatology","psoriasis, psoriatic arthritis","Selleck",93.31,"BRD-K93208532-001-02-5","Launched","","IMOZEMNVLZVGJZ-QGZVFWFLSA-N","BRD-K93208532","","CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O"
"9689","UREA","hydroxy radical formation stimulant","ARG1, CA2, CTNNB1","dermatology","psoriasis, xerosis cutis, ichthyosis vulgaris, eczema, keratosis, dermatitis","MicroSource",97.73,"BRD-K88052444-001-08-8","Launched","","XSQUKJJJFZCRTK-UHFFFAOYSA-N","BRD-K88052444","","NC(N)=O"
"9690","ACETOPHENAZINE","dopamine receptor antagonist","DRD1, DRD2","neurology/psychiatry","psychosis","MicroSource",85.87,"BRD-K42938903-332-01-1","Launched","BRD-K92986184-050-01-7","WNTYBHLDCKXEOT-UHFFFAOYSA-N","BRD-K42938903","BRD-K92986184","CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(CCO)CC3)c2c1"
"9691","AMPEROZIDE","dopamine receptor antagonist","FAAH, HTR2A","neurology/psychiatry","psychosis","Enzo",98.96,"BRD-K52397688-003-06-4","Launched","","NNAIYOXJNVGUOM-UHFFFAOYSA-N","BRD-K52397688","","CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1"
"9692","CLOROTEPINE","dopamine receptor antagonist, adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6","neurology/psychiatry","psychosis","Sigma",99.23,"BRD-A19053834-050-09-5","Launched","","XRYLGRGAWQSVQW-UHFFFAOYSA-N","BRD-A19053834","","CN1CCN(CC1)C1Cc2ccccc2Sc2ccc(Cl)cc12"
"9693","CLOTIAPINE","","","neurology/psychiatry","psychosis","Enzo",98.82,"BRD-K10990317-001-04-5","Launched","","KAAZGXDPUNNEFN-UHFFFAOYSA-N","BRD-K10990317","","CN1CCN(CC1)C1=Nc2ccccc2Sc2ccc(Cl)cc12"
"9694","MELPERONE","dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A","neurology/psychiatry","psychosis","Tocris, Tocris",96.46,"BRD-K92984783-003-05-7, BRD-K92984783-003-06-5","Launched","","DKMFBWQBDIGMHM-UHFFFAOYSA-N","BRD-K92984783","","CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1"
"9696","AMISULPRIDE","dopamine receptor antagonist","DRD2, DRD3, HTR2A, HTR7","neurology/psychiatry","psychosis, bipolar disorder, schizophrenia","Selleck, Tocris",94.44,"BRD-A60197193-001-13-8, BRD-A60197193-001-14-6","Launched","","NTJOBXMMWNYJFB-UHFFFAOYSA-N","BRD-A60197193","","CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC"
"9698","TRIFLUPROMAZINE","dopamine receptor antagonist","CHRM1, CHRM2, DRD1, DRD2, HTR2B","neurology/psychiatry, gastroenterology","psychosis, nausea, vomiting","MicroSource, Selleck",96.33,"BRD-K63675182-003-23-6, BRD-K63675182-003-22-8","Launched","","XSCGXQMFQXDFCW-UHFFFAOYSA-N","BRD-K63675182","","CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F"
"9700","LEVOMEPROMAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C","neurology/psychiatry, gastroenterology","psychosis, schizophrenia, bipolar disorder, nausea, insomnia","Prestwick, Sigma",96.44,"BRD-K35559145-050-08-5, BRD-K35559145-001-01-3","Launched","","VRQVVMDWGGWHTJ-CQSZACIVSA-N","BRD-K35559145","","COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1"
"9702","ACT-132577","endothelin receptor antagonist","EDNRA, EDNRB","pulmonary","pulmonary arterial hypertension (PAH)","MedChemEx, MedChemEx, MedChemEx",80.39,"BRD-K34843150-001-03-0, BRD-K34843150-001-02-2, BRD-K34843150-001-01-4","Launched","","DKULOVKANLVDEA-UHFFFAOYSA-N","BRD-K34843150","","NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1"
"9705","AMBRISENTAN","endothelin receptor antagonist","EDNRA, EDNRB","pulmonary","pulmonary arterial hypertension (PAH)","Selleck",97.47,"BRD-K41185545-001-02-3","Launched","","OUJTZYPIHDYQMC-LJQANCHMSA-N","BRD-K41185545","","COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1"
"9706","BOSENTAN","endothelin receptor antagonist","EDNRA, EDNRB","pulmonary","pulmonary arterial hypertension (PAH)","Selleck",97.9,"BRD-K74763371-002-04-0","Launched","","GJPICJJJRGTNOD-UHFFFAOYSA-N","BRD-K74763371","","COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1"
"9707","ILOPROST","platelet aggregation inhibitor, prostanoid receptor agonist","PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R","pulmonary","pulmonary arterial hypertension (PAH)","MedChemEx",50.79,"BRD-A45664787-001-04-8","Launched","","HIFJCPQKFCZDDL-ACWOEMLNSA-N","BRD-A45664787","","CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O"
"9708","HOMATROPINE","acetylcholine receptor antagonist","CES1, CHRM1","ophthalmology","pupil dilation","MicroSource, Selleck",93.54,"BRD-A74975734-004-10-7, BRD-A74975734-004-09-9","Launched","BRD-A09539288-004-04-4, BRD-A35196708-004-01-9","ZTVIKZXZYLEVOL-MCOXGKPRSA-N","BRD-A74975734","BRD-A09539288","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c1ccccc1"
"9710","AXITINIB","PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, FLT1, FLT4, KDR, PLK4","oncology","renal cell carcinoma (RCC)","Selleck, Selleck, Selleck, Adooq, Tocris",96.08,"BRD-K29905972-001-10-5, BRD-K29905972-001-08-9, BRD-K29905972-001-06-3, BRD-K29905972-001-11-3, BRD-K29905972-001-12-1","Launched","","RITAVMQDGBJQJZ-FMIVXFBMSA-N","BRD-K29905972","","CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1"
"9715","TEMSIROLIMUS","mTOR inhibitor","MTOR","oncology","renal cell carcinoma (RCC)","Selleck",90.63,"BRD-K42898655-001-01-8","Launched","","CBPNZQVSJQDFBE-SREVRWKESA-N","BRD-K42898655","","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO"
"9716","PAZOPANIB","KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3","oncology","renal cell carcinoma (RCC), soft tissue sarcoma (STS)","Selleck, Selleck",98.32,"BRD-K74514084-003-09-2, BRD-K74514084-001-03-9","Launched","","CUIHSIWYWATEQL-UHFFFAOYSA-N","BRD-K74514084","","CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1"
"9718","SORAFENIB","FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET","oncology","renal cell carcinoma (RCC), thyroid cancer, hepatocellular carcinoma (HCC)","Selleck, Selleck",98.3,"BRD-K23984367-075-15-2, BRD-K23984367-001-07-5","Launched","","MLDQJTXFUGDVEO-UHFFFAOYSA-N","BRD-K23984367","","CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1"
"9720","AZATHIOPRINE","dehydrogenase inhibitor","HPRT1, IMPDH1, PPAT","transplant, rheumatology","renal homotransplantation, rheumatoid arthritis","Tocris, MicroSource, Selleck",98.13,"BRD-K32821942-001-22-1, BRD-K32821942-001-21-3, BRD-K32821942-001-20-5","Launched","","LMEKQMALGUDUQG-UHFFFAOYSA-N","BRD-K32821942","","Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O"
"9723","AMIFOSTINE","reducing agent","ALPPL2, ENPP1","nephrology","renal toxicity","MicroSource",0,"BRD-K73947551-001-04-4","Launched","","JKOQGQFVAUAYPM-UHFFFAOYSA-N","BRD-K73947551","","NCCCNCCSP(O)(O)=O"
"9724","BETAMIPRON","panipenem uptake inhibitor","","nephrology","renal toxicity","MicroSource, Selleck",96.24,"BRD-K82142815-001-19-1, BRD-K82142815-001-18-3","Launched","","CWXYHOHYCJXYFQ-UHFFFAOYSA-N","BRD-K82142815","","OC(=O)CCNC(=O)c1ccccc1"
"9726","LEVALLORPHAN","opioid antagonist","CHRNA2, OPRM1","pulmonary","respiratory depression","Enzo",93.45,"BRD-K30634073-046-01-0","Launched","","OZYUPQUCAUTOBP-QXAKKESOSA-N","BRD-K30634073","","Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1"
"9727","NALMEFENE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","pulmonary","respiratory depression","Tocris, Selleck",96.81,"BRD-K68407436-003-02-7, BRD-A72767275-003-01-6","Launched","","WJBLNOPPDWQMCH-MBPVOVBZSA-N","BRD-K68407436","","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=C)CC[C@@]35O"
"9728","NALMEFENE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","pulmonary","respiratory depression","Tocris, Selleck",96.81,"BRD-K68407436-003-02-7, BRD-A72767275-003-01-6","Launched","","WJBLNOPPDWQMCH-MBPVOVBZSA-N","BRD-K68407436","","Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O"
"9729","NALMEFENE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","pulmonary","respiratory depression","Tocris, Selleck",96.81,"BRD-K68407436-003-02-7, BRD-A72767275-003-01-6","Launched","","WJBLNOPPDWQMCH-UHFFFAOYSA-N","BRD-K68407436","","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=C)CC[C@@]35O"
"9730","NALMEFENE","opioid receptor antagonist","OPRD1, OPRK1, OPRM1","pulmonary","respiratory depression","Tocris, Selleck",96.81,"BRD-K68407436-003-02-7, BRD-A72767275-003-01-6","Launched","","WJBLNOPPDWQMCH-UHFFFAOYSA-N","BRD-K68407436","","Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O"
"9731","NALOXONE","opioid receptor antagonist","CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4","pulmonary","respiratory depression","Selleck, Selleck, Tocris, MicroSource",87.7,"BRD-K67511046-003-16-9, BRD-K67511046-003-14-4, BRD-K67511046-003-15-1, BRD-K67511046-001-02-3","Launched","BRD-A23195370-003-01-4","UZHSEJADLWPNLE-GRGSLBFTSA-N","BRD-K67511046","BRD-A23195370","Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O"
"9735","PRALIDOXIME-CHLORIDE","acetylcholinesterase inhibitor","ACHE, BCHE","pulmonary","respiratory depression","Sigma",97.1,"BRD-K24221957-003-01-6","Launched","","MHOAUIZFSQGCNM-UHFFFAOYSA-N","BRD-K24221957","","C[n+]1ccccc1C[N+][O-]"
"9736","DOXAPRAM","potassium channel blocker","KCNK3, KCNK9","pulmonary, neurology/psychiatry","respiratory depression, central nervous system depression, acute hypercapnia (AHC)","MicroSource, Selleck",97.8,"BRD-A46179541-311-03-8, BRD-A46179541-311-02-0","Launched","BRD-A47978079-003-01-9","XFDJYSQDBULQSI-UHFFFAOYSA-N","BRD-A46179541","BRD-A47978079","CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1"
"9738","COLFOSCERIL-PALMITATE","pulmonary surfactant","","pulmonary","respiratory distress syndrome (RDS)","Sigma, Acros",0,"BRD-A95886749-001-04-3, BRD-A95886749-001-03-5","Launched","","KILNVBDSWZSGLL-KXQOOQHDSA-O","BRD-A95886749","","CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC"
"9740","GARENOXACIN","topoisomerase inhibitor","TOP2A","infectious disease","respiratory tract infections","MedChemEx",96.9,"BRD-K77038618-356-01-3","Launched","","NJDRXTDGYFKORP-LLVKDONJSA-N","BRD-K77038618","","C[C@H]1NCc2cc(ccc12)-c1ccc2c(c1OC(F)F)n(cc(C(O)=O)c2=O)C1CC1"
"9741","CEFOTAXIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, bone and joint infections, pelvic inflammatory disease, intra-abdominal infections, skin infections, bone and joint infections, meningitis, urinary tract infections, bacterial septicemia, gynecologic infections","MedChemEx, MicroSource, MedChemEx, Sigma",95.77,"BRD-K78364995-236-18-3, BRD-K78364995-236-19-1, BRD-K78364995-236-17-5, BRD-K78364995-236-16-7","Launched","BRD-K99586414-236-04-9","GPRBEKHLDVQUJE-QSWIMTSFSA-N","BRD-K78364995","BRD-K99586414","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"9745","MIDECAMYCIN","protein synthesis inhibitor","","infectious disease","respiratory tract infections, ear infections, skin infections","AvaChem",0,"BRD-K68822425-001-01-6","Launched","","DMUAPQTXSSNEDD-QALJCMCCSA-N","BRD-K68822425","","CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C"
"9746","AMPICILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, meningitis, bacterial septicemia, endocarditis, urinary tract infections, gastrointestinal infections","MedChemEx, Selleck, MicroSource, Selleck, MedChemEx, Sigma, Selleck, Selleck",84.41,"BRD-K68432770-236-24-9, BRD-K68432770-236-21-5, BRD-K68432770-236-20-7, BRD-K68432770-236-19-9, BRD-K68432770-236-23-1, BRD-K68432770-236-22-3, BRD-K68432770-341-07-2, BRD-K68432770-341-05-6","Launched","BRD-K94927753-341-01-3","AVKUERGKIZMTKX-NJBDSQKTSA-N","BRD-K68432770","BRD-K94927753","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O"
"9754","CEPHALEXIN","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology","respiratory tract infections, otitis, skin infections, bone and joint infections, genitourinary tract infections","MedChemEx, MedChemEx, Sigma, Selleck, MicroSource, Selleck",75.26,"BRD-K90733503-001-08-7, BRD-K90733503-001-07-9, BRD-K90733503-001-06-1, BRD-K90733503-001-09-5, BRD-K90733503-001-10-3, BRD-K90733503-001-05-3","Launched","BRD-K64997193-001-01-0, BRD-A37536726-001-04-2","ZAIPMKNFIOOWCQ-UEKVPHQBSA-N","BRD-K90733503","BRD-K64997193","CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O"
"9760","CEFRADINE","bacterial cell wall synthesis inhibitor","CYP3A4","infectious disease, otolaryngology","respiratory tract infections, otitis, skin infections, urinary tract infections, tonsillitis, pharyngitis, pneumonia","MedChemEx, MedChemEx",65.46,"BRD-K13797099-001-02-9, BRD-K13797099-001-01-1","Launched","","RDLPVSKMFDYCOR-UEKVPHQBSA-N","BRD-K13797099","","CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O"
"9762","CLINDAMYCIN","protein synthesis inhibitor","","infectious disease","respiratory tract infections, pneumonia, skin infections, gynecologic infections, intra-abdominal infections, bacterial septicemia, bone and joint infections","MicroSource, Selleck, Selleck",100,"BRD-K23586533-003-01-6, BRD-K23586533-001-03-6, BRD-K23586533-003-02-4","Launched","BRD-A23034328-003-09-1, BRD-A43673346-001-01-1,BRD-A52252998-001-01-3, BRD-A43673346-003-01-7,BRD-A52252998-003-01-9","KDLRVYVGXIQJDK-AWPVFWJPSA-N","BRD-K23586533","BRD-A23034328","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O"
"9765","TETRACYCLINE","bacterial 30S ribosomal subunit inhibitor","PRNP","infectious disease, dermatology","respiratory tract infections, pneumonia, skin infections, urinary tract infections, acne vulgaris (AV), plague, psittacosis","MedChemEx, Selleck, Selleck, MedChemEx, MicroSource, Sigma",76.62,"BRD-A34788695-003-13-6, BRD-A34788695-003-08-6, BRD-A34788695-003-10-2, BRD-A34788695-003-14-4, BRD-A34788695-003-09-4, BRD-A34788695-003-12-8","Launched","BRD-A78253580-003-01-1","MUHBBHLZPHKTTR-GWFFGYACSA-N","BRD-A34788695","BRD-A78253580","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O"
"9771","OFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","infectious disease, otolaryngology, gastroenterology, endocrinology","respiratory tract infections, sinusitis, skin infections, bone and joint infections, intra-abdominal infections, diarrhea, fever, urinary tract infections","MicroSource, Selleck",98.67,"BRD-A24228527-213-01-9, BRD-A24228527-001-31-5","Launched","","GSDSWSVVBLHKDQ-UHFFFAOYSA-N","BRD-A24228527","","CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O"
"9773","CEFTAZIDIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis","Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",74,"BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4","Launched","BRD-A73933229-396-01-8","ORFOPKXBNMVMKC-DWVKKRMSSA-O","BRD-K52117081","BRD-A73933229","CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O"
"9777","CEFTAZIDIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis","Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",74,"BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4","Launched","BRD-A73933229-396-01-8","ORFOPKXBNMVMKC-DWVKKRMSSA-O","BRD-K52117081","BRD-A73933229","CC(C)(O\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O"
"9779","CEFTAZIDIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis","Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",74,"BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4","Launched","BRD-A73933229-396-01-8","ORFOPKXBNMVMKC-KZBLUZIOSA-O","BRD-K52117081","BRD-A73933229","CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O"
"9783","CEFTAZIDIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis","Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",74,"BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4","Launched","BRD-A73933229-396-01-8","ORFOPKXBNMVMKC-KZBLUZIOSA-O","BRD-K52117081","BRD-A73933229","CC(C)(O\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O"
"9785","CEFODIZIME","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, skin infections, gonorrhea","AKSci, Kemprotec",73.75,"BRD-K22641081-001-01-0, BRD-K22641081-304-01-8","Launched","BRD-A42969929-001-01-9, BRD-K72150952-304-01-5","XDZKBRJLTGRPSS-BGZQYGJUSA-N","BRD-K22641081","BRD-A42969929","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1"
"9787","LOMEFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","infectious disease","respiratory tract infections, urinary tract infections","Selleck, MicroSource",98.31,"BRD-A75850590-003-09-8, BRD-A75850590-213-01-0","Launched","","ZEKZLJVOYLTDKK-UHFFFAOYSA-N","BRD-A75850590","","CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12"
"9789","CEFTIZOXIM","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, skin infections, bone and joint infections, meningitis","MedChemEx, MedChemEx, Enzo",88.85,"BRD-K04301924-236-03-2, BRD-K04301924-236-02-4, BRD-K04301924-236-01-6","Launched","","NNULBSISHYWZJU-LLKWHZGFSA-N","BRD-K04301924","","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1"
"9792","CEFOXITIN","bacterial cell wall synthesis inhibitor","","infectious disease","respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections","MedChemEx, MedChemEx, MicroSource",98.36,"BRD-K70976396-236-27-8, BRD-K70976396-236-26-0, BRD-K70976396-236-25-2","Launched","","WZOZEZRFJCJXNZ-ZBFHGGJFSA-N","BRD-K70976396","","CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O"
"9795","ROXITHROMYCIN","bacterial 50S ribosomal subunit inhibitor","ABCB1, MLNR","infectious disease","respiratory tract infections, urinary tract infections, skin infections","MicroSource, Selleck",99.06,"BRD-K38684403-001-04-7, BRD-K38684403-001-05-4","Launched","BRD-K58211978-001-01-5","RXZBMPWDPOLZGW-XMRMVWPWSA-N","BRD-K38684403","BRD-K58211978","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O"
"9797","GABAPENTIN-ENACARBIL","adrenergic receptor agonist","CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8","neurology/psychiatry","restless leg syndrome, postherpetic neuralgia","AdvChemBlocks",89.16,"BRD-A86665761-001-01-1","Launched","","TZDUHAJSIBHXDL-UHFFFAOYSA-N","BRD-A86665761","","CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1"
"9798","ATIPAMEZOLE","adrenergic receptor antagonist","","neurology/psychiatry","reverse sedative","Tocris, MedChemEx",99.36,"BRD-K39252998-003-02-3, BRD-K39252998-003-01-5","Launched","","HSWPZIDYAHLZDD-UHFFFAOYSA-N","BRD-K39252998","","CCC1(Cc2ccccc2C1)c1cnc[nH]1"
"9800","TOLAZOLINE","adrenergic receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2","neurology/psychiatry","reverse sedative","MicroSource, Selleck",98.11,"BRD-K46211610-003-26-7, BRD-K46211610-003-25-9","Launched","","JIVZKJJQOZQXQB-UHFFFAOYSA-N","BRD-K46211610","","C(C1=NCCN1)c1ccccc1"
"9802","ACTARIT","interleukin receptor agonist","","rheumatology","rheumatoid arthritis","MicroSource",96.94,"BRD-K33483813-001-10-0","Launched","","MROJXXOCABQVEF-UHFFFAOYSA-N","BRD-K33483813","","CC(=O)Nc1ccc(CC(O)=O)cc1"
"9803","ALCLOFENAC","cyclooxygenase inhibitor","PTGS1","rheumatology","rheumatoid arthritis","Sigma",96.73,"BRD-K47492008-001-02-7","Launched","","ARHWPKZXBHOEEE-UHFFFAOYSA-N","BRD-K47492008","","OC(=O)Cc1ccc(OCC=C)c(Cl)c1"
"9804","AURANOFIN","NFkB pathway inhibitor","IKBKB, PRDX5, TRPA1","rheumatology","rheumatoid arthritis","MedChemEx, Selleck, MedChemEx",73.57,"BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3","Launched","BRD-U68276368-000-01-4, BRD-A28431708-001-01-5, BRD-K63171558-001-01-2","IRPYFWIZKIOHQN-XTZHGVARSA-N","BRD-K73841932","BRD-U68276368","CCP(CC)(CC)[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O"
"9805","AURANOFIN","NFkB pathway inhibitor","IKBKB, PRDX5, TRPA1","rheumatology","rheumatoid arthritis","MedChemEx, Selleck, MedChemEx",73.57,"BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3","Launched","BRD-U68276368-000-01-4, BRD-A28431708-001-01-5, BRD-K63171558-001-01-2","IRPYFWIZKIOHQN-XTZHGVARSA-N","BRD-K73841932","BRD-U68276368","CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O"
"9807","AURANOFIN","NFkB pathway inhibitor","IKBKB, PRDX5, TRPA1","rheumatology","rheumatoid arthritis","MedChemEx, Selleck, MedChemEx",73.57,"BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3","Launched","BRD-U68276368-000-01-4, BRD-A28431708-001-01-5, BRD-K63171558-001-01-2","AUJRCFUBUPVWSZ-XTZHGVARSA-M","BRD-K73841932","BRD-U68276368","CCP(CC)(CC)[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O"
"9808","AURANOFIN","NFkB pathway inhibitor","IKBKB, PRDX5, TRPA1","rheumatology","rheumatoid arthritis","MedChemEx, Selleck, MedChemEx",73.57,"BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3","Launched","BRD-U68276368-000-01-4, BRD-A28431708-001-01-5, BRD-K63171558-001-01-2","AUJRCFUBUPVWSZ-XTZHGVARSA-M","BRD-K73841932","BRD-U68276368","CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O"
"9810","AUROTHIOGLUCOSE","PKC inhibitor","PRKCI","rheumatology","rheumatoid arthritis","MicroSource",0,"BRD-A89825407-001-01-8","Launched","","XHVAWZZCDCWGBK-BMZZJELJSA-M","BRD-A89825407","","OC[C@H]1OC(S[Au])[C@H](O)[C@@H](O)[C@@H]1O"
"9811","BUCILLAMINE","immunosuppressant","","rheumatology","rheumatoid arthritis","Kemprotec, AKSci",96.91,"BRD-K24697665-001-02-2, BRD-K24697665-001-01-4","Launched","","VUAFHZCUKUDDBC-BYPYZUCNSA-N","BRD-K24697665","","CC(C)(S)C(=O)N[C@@H](CS)C(O)=O"
"9813","IGURATIMOD","cyclooxygenase inhibitor, NFkB pathway inhibitor","PTGS2","rheumatology","rheumatoid arthritis","MedChemEx",96.01,"BRD-K15426076-001-01-2","Launched","","ANMATWQYLIFGOK-UHFFFAOYSA-N","BRD-K15426076","","CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1"
"9814","LEFLUNOMIDE","dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor","AHR, DHODH, PTK2B","rheumatology","rheumatoid arthritis","MicroSource, Tocris, Selleck",94.48,"BRD-K78692225-001-24-5, BRD-K78692225-001-23-7, BRD-K78692225-001-22-9","Launched","","VHOGYURTWQBHIL-UHFFFAOYSA-N","BRD-K78692225","","Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F"
"9817","LOBENZARIT","immunosuppressant","","rheumatology","rheumatoid arthritis","AKSci",98.34,"BRD-K55847762-304-01-7","Launched","","UGDPYGKWIHHBMB-UHFFFAOYSA-N","BRD-K55847762","","OC(=O)c1ccccc1Nc1cc(Cl)ccc1C(O)=O"
"9818","TIAPROFENIC-ACID","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis","Prestwick, Sigma",94.01,"BRD-A72988804-001-10-3, BRD-A72988804-001-11-1","Launched","","GUHPRPJDBZHYCJ-UHFFFAOYSA-N","BRD-A72988804","","CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1"
"9820","TOFACITINIB","JAK inhibitor","JAK1, JAK2, JAK3, TYK2","rheumatology","rheumatoid arthritis","Selleck, Selleck, Tocris",98.2,"BRD-K31283835-001-08-4, BRD-K31283835-048-04-4, BRD-K31283835-048-03-6","Launched","BRD-K36280065-001-01-1, BRD-K36280065-048-01-2","UJLAWZDWDVHWOW-YPMHNXCESA-N","BRD-K31283835","BRD-K36280065","C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N"
"9823","INDOMETHACIN","cyclooxygenase inhibitor","GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1","rheumatology, orthopedics","rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, bursitis, tendinitis","Tocris, MicroSource, Selleck",99.45,"BRD-K57222227-001-29-3, BRD-K57222227-001-30-1, BRD-K57222227-001-28-5","Launched","","CGIGDMFJXJATDK-UHFFFAOYSA-N","BRD-K57222227","","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1"
"9826","ACECLOFENAC","prostanoid receptor antagonist","PTGS2","rheumatology","rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, periarthritis, lumbago, ischiadynia","MicroSource",98.5,"BRD-K68538666-001-12-3","Launched","","MNIPYSSQXLZQLJ-UHFFFAOYSA-N","BRD-K68538666","","OC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl"
"9827","TEPOXALIN","cyclooxygenase inhibitor, lipoxygenase inhibitor","ALOX5","rheumatology, orthopedics","rheumatoid arthritis, hip dysplasia","MicroSource, Toronto",97.32,"BRD-K89714990-001-01-5, BRD-K89714990-001-02-3","Launched","","XYKWNRUXCOIMFZ-UHFFFAOYSA-N","BRD-K89714990","","COc1ccc(cc1)-n1nc(CCC(=O)N(C)O)cc1-c1ccc(Cl)cc1"
"9829","FELBINAC","cyclooxygenase inhibitor","CTSL","rheumatology, neurology/psychiatry","rheumatoid arthritis, muscle pain","MicroSource",99.79,"BRD-K91740057-001-19-8","Launched","","QRZAKQDHEVVFRX-UHFFFAOYSA-N","BRD-K91740057","","OC(=O)Cc1ccc(cc1)-c1ccccc1"
"9830","NONIVAMIDE","TRPV agonist","TRPV1","rheumatology, neurology/psychiatry","rheumatoid arthritis, muscle pain","MicroSource",92,"BRD-K05907307-001-07-1","Launched","","RGOVYLWUIBMPGK-UHFFFAOYSA-N","BRD-K05907307","","CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1"
"9831","AMTOLMETIN-GUACIL","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","OxChem",94.69,"BRD-K70924353-001-01-2","Launched","","CWJNMKKMGIAGDK-UHFFFAOYSA-N","BRD-K70924353","","COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C"
"9832","DIFLUNISAL","prostanoid receptor antagonist","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","MicroSource",98.97,"BRD-K22031190-001-23-6","Launched","","HUPFGZXOMWLGNK-UHFFFAOYSA-N","BRD-K22031190","","OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F"
"9833","DROXICAM","cyclooxygenase inhibitor","PTGS1","rheumatology","rheumatoid arthritis, osteoarthritis","Ark, Sigma",0,"BRD-K17219082-001-01-1, BRD-K17219082-001-02-9","Launched","","OEHFRZLKGRKFAS-UHFFFAOYSA-N","BRD-K17219082","","CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O"
"9835","FENOPROFEN","prostaglandin inhibitor","PTGS1, PTGS2, SLC5A8","rheumatology","rheumatoid arthritis, osteoarthritis","Selleck, MicroSource, Selleck",99.05,"BRD-A81129465-001-04-6, BRD-A81129465-001-03-8, BRD-A81129465-238-01-0","Launched","BRD-U45213318-000-01-6, BRD-M61246020-238-04-4","RDJGLLICXDHJDY-UHFFFAOYSA-N","BRD-A81129465","BRD-U45213318","CC(C(O)=O)c1cccc(Oc2ccccc2)c1"
"9838","FLURBIPROFEN-(+/-)","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","Tocris, MicroSource",98.21,"BRD-A86044036-001-26-5, BRD-A86044036-001-27-3","Launched","","SYTBZMRGLBWNTM-UHFFFAOYSA-N","BRD-A86044036","","CC(C(O)=O)c1ccc(c(F)c1)-c1ccccc1"
"9840","FLURBIPROFEN-(S)-(+)","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","Selleck, Selleck",99.2,"BRD-K69907333-001-07-2, BRD-K69907333-001-10-6","Launched","","SYTBZMRGLBWNTM-JTQLQIEISA-N","BRD-K69907333","","C[C@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1"
"9842","KETOPROFEN","cyclooxygenase inhibitor","CXCR1, PTGS1, PTGS2, SLC5A8","rheumatology","rheumatoid arthritis, osteoarthritis","Selleck, MicroSource",99.39,"BRD-A97739905-001-25-7, BRD-A97739905-001-26-5","Launched","","DKYWVDODHFEZIM-UHFFFAOYSA-N","BRD-A97739905","","CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1"
"9844","NABUMETONE","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","MicroSource, Selleck",99.57,"BRD-K65146499-001-27-9, BRD-K65146499-001-26-1","Launched","","BLXXJMDCKKHMKV-UHFFFAOYSA-N","BRD-K65146499","","COc1ccc2cc(CCC(C)=O)ccc2c1"
"9846","TOLMETIN","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology","rheumatoid arthritis, osteoarthritis","Selleck, MicroSource",98.68,"BRD-K82562631-325-04-7, BRD-K82562631-236-04-6","Launched","","UPSPUYADGBWSHF-UHFFFAOYSA-N","BRD-K82562631","","Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C"
"9848","TENOXICAM","cyclooxygenase inhibitor","PTGS1, PTGS2","rheumatology, orthopedics","rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, periarthritis","MicroSource, Selleck",98.19,"BRD-A22844106-001-26-0, BRD-A22844106-001-25-2","Launched","","OTGJPAOGHQFBMI-UHFFFAOYSA-N","BRD-A22844106","","CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O"
"9850","DICLOFENAC","cyclooxygenase inhibitor","AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A","rheumatology, neurology/psychiatry","rheumatoid arthritis, osteoarthritis, migraine headache","MicroSource, Selleck, Selleck, Selleck",99.61,"BRD-K08252256-236-33-8, BRD-K08252256-237-02-1, BRD-K08252256-224-02-9, BRD-K08252256-236-32-0","Launched","","DCOPUUMXTXDBNB-UHFFFAOYSA-N","BRD-K08252256","","OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl"
"9854","MOFEZOLAC","cyclooxygenase inhibitor","PTGS1","rheumatology, orthopedics","rheumatoid arthritis, osteoporosis","Sigma",99.58,"BRD-K49372556-001-04-1","Launched","","DJEIHHYCDCTAAH-UHFFFAOYSA-N","BRD-K49372556","","COc1ccc(cc1)-c1noc(CC(O)=O)c1-c1ccc(OC)cc1"
"9855","CYCLOSPORIN-A","calcineurin inhibitor","PPP3CA","rheumatology, dermatology","rheumatoid arthritis, psoriasis","Tocris, MicroSource",99.52,"BRD-A69815203-001-07-6, BRD-A69815203-001-08-4","Launched","","PMATZTZNYRCHOR-IMVLJIQESA-N","BRD-A69815203","","CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C"
"9857","ETORICOXIB","cyclooxygenase inhibitor","PTGS2","rheumatology","rheumatoid arthritis, psoriatic arthritis, osteoarthritis, gout, ankylosing spondylitis","MedChemEx",99.25,"BRD-K54770957-001-04-3","Launched","","MNJVRJDLRVPLFE-UHFFFAOYSA-N","BRD-K54770957","","Cc1ccc(cn1)-c1ncc(Cl)cc1-c1ccc(cc1)S(C)(=O)=O"
"9858","PYRITINOL","","","rheumatology, neurology/psychiatry","rheumatoid arthritis, senile dementia","MicroSource",96.46,"BRD-K82181219-001-04-3","Launched","","SIXLXDIJGIWWFU-UHFFFAOYSA-N","BRD-K82181219","","Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O"
"9859","DIHYDROTACHYSTEROL","vitamin analog","VDR","orthopedics, endocrinology","rickets, hypocalcemia, osteomalacia","Sigma",0,"BRD-A34455052-001-01-8","Launched","","ILYCWAKSDCYMBB-ZJGOHBTISA-N","BRD-A34455052","","CC(C)C(C)\C=C\C(C)C1CCC2C1(C)CCC\C2=C/C=C1\CC(O)CCC1C"
"9860","GRISEOFULVIN","tubulin polymerization inhibitor","KRT12","infectious disease","ringworm, tinea pedis","MicroSource, Selleck",95.44,"BRD-K08273968-001-16-6, BRD-K08273968-001-19-0","Launched","BRD-K12423485-001-01-7","DDUHZTYCFQRHIY-RBHXEPJQSA-N","BRD-K08273968","BRD-K12423485","COc1cc(OC)c(Cl)c2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)c12"
"9862","AZELAIC-ACID","tyrosinase inhibitor","AKR1D1, SRD5A2, TYR","dermatology","rosacea","MicroSource",97.8,"BRD-K08976401-001-18-5","Launched","","BDJRBEYXGGNYIS-UHFFFAOYSA-N","BRD-K08976401","","OC(=O)CCCCCCCC(O)=O"
"9863","METRONIDAZOLE","DNA inhibitor","CYP2C9, CYP3A4","dermatology","rosacea","Selleck, MicroSource",99.43,"BRD-K52020312-001-25-0, BRD-K52020312-001-26-8","Launched","","VAOCPAMSLUNLGC-UHFFFAOYSA-N","BRD-K52020312","","Cc1ncc(n1CCO)[N+]([O-])=O"
"9865","CROTAMITON","antipruritic","","infectious disease","scabies","MicroSource",85.06,"BRD-K57179821-001-15-4","Launched","","DNTGGZPQPQTDQF-XBXARRHUSA-N","BRD-K57179821","","CCN(C(=O)\C=C\C)c1ccccc1C"
"9866","LINDANE","","GABRB1, GLRA1, GLRA2, GLRA3, GLRB","infectious disease","scabies","MedChemEx, MedChemEx, MicroSource",0,"BRD-K93814253-001-06-8, BRD-K93814253-001-05-0, BRD-K93814253-001-04-3","Launched","","JLYXXMFPNIAWKQ-GNIYUCBRSA-N","BRD-K93814253","","Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl"
"9869","HYCANTHONE","RNA synthesis inhibitor","","infectious disease","schistosomiasis","MicroSource",86.83,"BRD-K50406511-001-26-0","Launched","","MFZWMTSUNYWVBU-UHFFFAOYSA-N","BRD-K50406511","","CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12"
"9870","NIRIDAZOLE","phosphofructokinase inhibitor","","infectious disease","schistosomiasis","Prestwick",94.95,"BRD-K53123955-001-10-5","Launched","","RDXLYGJSWZYTFJ-UHFFFAOYSA-N","BRD-K53123955","","[O-][N+](=O)c1cnc(s1)N1CCNC1=O"
"9871","BENPERIDOL","dopamine receptor antagonist","DRD2","neurology/psychiatry","schizophrenia","Prestwick",88.46,"BRD-K79425933-001-09-3","Launched","","FEBOTPHFXYHVPL-UHFFFAOYSA-N","BRD-K79425933","","Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O"
"9872","BLONANSERIN","dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A","neurology/psychiatry","schizophrenia","Selleck",90.29,"BRD-K25943794-001-02-3","Launched","","XVGOZDAJGBALKS-UHFFFAOYSA-N","BRD-K25943794","","CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1"
"9873","BROMPERIDOL","dopamine receptor antagonist","DRD2","neurology/psychiatry","schizophrenia","MicroSource",98.85,"BRD-K78643075-001-11-6","Launched","","RKLNONIVDFXQRX-UHFFFAOYSA-N","BRD-K78643075","","OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Br)cc1"
"9874","CARIPRAZINE","dopamine receptor antagonist","DRD2, DRD3","neurology/psychiatry","schizophrenia","MedChemEx",97.64,"BRD-K57764956-001-02-8","Launched","","KPWSJANDNDDRMB-QAQDUYKDSA-N","BRD-K57764956","","CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1"
"9875","CLOZAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia","MicroSource, Selleck, Tocris, Selleck",95.42,"BRD-K37289225-001-36-4, BRD-K37289225-001-34-9, BRD-K37289225-001-35-6, BRD-K37289225-001-37-2","Launched","","QZUDBNBUXVUHMW-UHFFFAOYSA-N","BRD-K37289225","","CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12"
"9879","FLUPHENAZINE","dopamine receptor antagonist","CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7","neurology/psychiatry","schizophrenia","MicroSource",95.33,"BRD-K55127134-300-11-2","Launched","","PLDUPXSUYLZYBN-UHFFFAOYSA-N","BRD-K55127134","","OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1"
"9880","FLUPHENAZINE-DECANOATE","dopamine receptor antagonist","DRD2, HTR1B, HTR4","neurology/psychiatry","schizophrenia","AKSci",59.41,"BRD-K27898013-001-01-4","Launched","","VIQCGTZFEYDQMR-UHFFFAOYSA-N","BRD-K27898013","","CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1"
"9881","FLUSPIRILENE","dopamine receptor antagonist","CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A","neurology/psychiatry","schizophrenia","Enzo",91.79,"BRD-K77947974-001-16-3","Launched","","QOYHHIBFXOOADH-UHFFFAOYSA-N","BRD-K77947974","","Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1"
"9882","HALOPERIDOL-DECANOATE","psychoactive drug","DRD2, DRD3, DRD4, HTR2A","neurology/psychiatry","schizophrenia","Key",99.05,"BRD-K80859331-001-01-5","Launched","","GUTXTARXLVFHDK-UHFFFAOYSA-N","BRD-K80859331","","CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1"
"9883","ILOPERIDONE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7","neurology/psychiatry","schizophrenia","Selleck",97.56,"BRD-K48722833-001-07-6","Launched","","XMXHEBAFVSFQEX-UHFFFAOYSA-N","BRD-K48722833","","COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O"
"9884","LOXAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","schizophrenia","MicroSource, Selleck",98.55,"BRD-K39915878-036-25-1, BRD-K39915878-036-24-4","Launched","","XJGVXQDUIWGIRW-UHFFFAOYSA-N","BRD-K39915878","","CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12"
"9886","LURASIDONE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7","neurology/psychiatry","schizophrenia","Selleck",97.97,"BRD-K51143828-003-03-1","Launched","","PQXKDMSYBGKCJA-CVTJIBDQSA-N","BRD-K51143828","","O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12"
"9887","MESORIDAZINE","dopamine receptor antagonist","DRD2, HTR2A","neurology/psychiatry","schizophrenia","MicroSource, Selleck, Selleck",90.35,"BRD-A14395271-074-17-8, BRD-A14395271-074-16-0, BRD-A14395271-074-18-6","Launched","","SLVMESMUVMCQIY-UHFFFAOYSA-N","BRD-A14395271","","CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O"
"9890","MOLINDONE","dopamine receptor antagonist","CHRM1, DRD2, HRH1, HTR1A, HTR2A","neurology/psychiatry","schizophrenia","MicroSource",98.2,"BRD-A65280694-003-13-7","Launched","","KLPWJLBORRMFGK-UHFFFAOYSA-N","BRD-A65280694","","CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12"
"9891","NEMONAPRIDE","dopamine receptor antagonist","DRD2, DRD3, DRD4","neurology/psychiatry","schizophrenia","Tocris, Tocris",96.75,"BRD-M80207679-001-02-3, BRD-M80207679-001-01-5","Launched","","QCYCDKUNJFKYEI-ZVWWNKPMSA-N","BRD-M80207679","","CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C"
"9893","PALIPERIDONE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C","neurology/psychiatry","schizophrenia","Selleck, Selleck, MicroSource",96.4,"BRD-A99888680-001-05-3, BRD-A99888680-001-03-8, BRD-A99888680-001-04-6","Launched","BRD-K00665454-001-01-4, BRD-K00665454-001-02-2","PMXMIIMHBWHSKN-UHFFFAOYSA-N","BRD-A99888680","BRD-K00665454","Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12"
"9896","PENFLURIDOL","T-type calcium channel blocker","CACNA1G","neurology/psychiatry","schizophrenia","MicroSource, Selleck",93.21,"BRD-K15409150-001-07-4, BRD-K15409150-001-05-8","Launched","","MDLAAYDRRZXJIF-UHFFFAOYSA-N","BRD-K15409150","","OC1(CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(Cl)c(c1)C(F)(F)F"
"9898","PIPAMPERONE","dopamine receptor antagonist","DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A","neurology/psychiatry","schizophrenia","MicroSource",89.65,"BRD-K26801045-001-02-9","Launched","","AXKPFOAXAHJUAG-UHFFFAOYSA-N","BRD-K26801045","","NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1"
"9899","PIPERACETAZINE","dopamine receptor antagonist","","neurology/psychiatry","schizophrenia","MicroSource",94.04,"BRD-K16277217-001-10-9","Launched","","BTFMCMVEUCGQDX-UHFFFAOYSA-N","BRD-K16277217","","CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCC(CCO)CC3)c2c1"
"9900","PROMAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C","neurology/psychiatry","schizophrenia","MedChemEx, MicroSource",94.85,"BRD-K06980535-003-26-7, BRD-K06980535-003-25-9","Launched","","ZGUGWUXLJSTTMA-UHFFFAOYSA-N","BRD-K06980535","","CN(C)CCCN1c2ccccc2Sc2ccccc12"
"9902","SPIPERONE","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7","neurology/psychiatry","schizophrenia","Tocris, MicroSource",96.07,"BRD-K55468218-003-02-8, BRD-K55468218-001-26-1","Launched","","DKGZKTPJOSAWFA-UHFFFAOYSA-N","BRD-K55468218","","Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1"
"9904","THIOPROPERAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A","neurology/psychiatry","schizophrenia","Prestwick",77.82,"BRD-K08619574-334-05-4","Launched","","VZYCZNZBPPHOFY-UHFFFAOYSA-N","BRD-K08619574","","CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1"
"9905","THIOTHIXENE","dopamine receptor antagonist","DRD1, DRD2, HRH1, HTR2A","neurology/psychiatry","schizophrenia","MicroSource",92.31,"BRD-K97309399-001-09-4","Launched","","GFBKORZTTCHDGY-UFWORHAWSA-N","BRD-K97309399","","CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C/CCN3CCN(C)CC3)c2c1"
"9906","TRIFLUOPERAZINE","dopamine receptor antagonist","ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1","neurology/psychiatry","schizophrenia","Selleck, MicroSource, Selleck",96.64,"BRD-K89732114-300-15-4, BRD-K89732114-300-14-7, BRD-K89732114-300-13-9","Launched","","ZEWQUBUPAILYHI-UHFFFAOYSA-N","BRD-K89732114","","CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1"
"9909","ZOTEPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4","neurology/psychiatry","schizophrenia","Prestwick",97.88,"BRD-K64557645-001-02-4","Launched","","HDOZVRUNCMBHFH-UHFFFAOYSA-N","BRD-K64557645","","CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc12"
"9910","HALOPERIDOL","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1","neurology/psychiatry","schizophrenia, Tourette's disorder","Tocris, Selleck, MicroSource",99.67,"BRD-K67783091-003-07-7, BRD-K67783091-001-25-3, BRD-K67783091-001-26-1","Launched","","LNEPOXFFQSENCJ-UHFFFAOYSA-N","BRD-K67783091","","OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1"
"9913","CYAMEMAZINE","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C, HTR7","neurology/psychiatry","schizophrenia, anxiety","Sigma",87.23,"BRD-A42881122-001-01-1","Launched","","SLFGIOIONGJGRT-UHFFFAOYSA-N","BRD-A42881122","","CC(CN(C)C)CN1c2ccccc2Sc2ccc(cc12)C#N"
"9914","ASENAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder","Tocris, Tocris, Selleck",95.05,"BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3","Launched","BRD-M82363962-001-01-0","VSWBSWWIRNCQIJ-HUUCEWRRSA-N","BRD-K95260951","BRD-M82363962","CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21"
"9915","ASENAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder","Tocris, Tocris, Selleck",95.05,"BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3","Launched","BRD-M82363962-001-01-0","VSWBSWWIRNCQIJ-HUUCEWRRSA-N","BRD-K95260951","BRD-M82363962","CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21.CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21"
"9917","ASENAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder","Tocris, Tocris, Selleck",95.05,"BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3","Launched","BRD-M82363962-001-01-0","QGBIWSABMNWWNB-FGYPTBLJSA-N","BRD-K95260951","BRD-M82363962","CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21"
"9918","ASENAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder","Tocris, Tocris, Selleck",95.05,"BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3","Launched","BRD-M82363962-001-01-0","QGBIWSABMNWWNB-FGYPTBLJSA-N","BRD-K95260951","BRD-M82363962","CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21.CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21"
"9920","CHLORPROTHIXENE","dopamine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C","neurology/psychiatry","schizophrenia, bipolar disorder","Selleck, MicroSource, Selleck",97.83,"BRD-K36207157-001-07-0, BRD-K36207157-001-09-6, BRD-K36207157-001-08-8","Launched","BRD-K59058766-003-21-9, BRD-K59058766-001-01-5","WSPOMRSOLSGNFJ-AUWJEWJLSA-N","BRD-K36207157","BRD-K59058766","CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12"
"9923","OLANZAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder","MicroSource, Tocris, Selleck, Selleck",95.27,"BRD-K18895904-001-16-1, BRD-K18895904-001-19-5, BRD-K18895904-001-15-3, BRD-K18895904-001-17-9","Launched","","KVWDHTXUZHCGIO-UHFFFAOYSA-N","BRD-K18895904","","CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12"
"9927","PEROSPIRONE","dopamine receptor antagonist, serotonin receptor antagonist","DRD2, DRD3, DRD4","neurology/psychiatry","schizophrenia, bipolar disorder","Prestwick, AKSci",98.77,"BRD-K85503079-001-01-0, BRD-K85503079-001-02-8","Launched","","FBVFZWUMDDXLLG-HDICACEKSA-N","BRD-K85503079","","O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12"
"9929","QUETIAPINE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2","neurology/psychiatry","schizophrenia, bipolar disorder","MicroSource, Tocris, Selleck",98.67,"BRD-K68867920-001-11-0, BRD-K68867920-051-12-3, BRD-K68867920-051-11-5","Launched","BRD-M66874015-051-04-2, BRD-M66874015-051-02-6","URKOMYMAXPYINW-UHFFFAOYSA-N","BRD-K68867920","BRD-M66874015","OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12"
"9932","ZIPRASIDONE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4","neurology/psychiatry","schizophrenia, bipolar disorder","MicroSource, Selleck",94.98,"BRD-K29582115-066-01-2, BRD-K29582115-003-03-1","Launched","","MVWVFYHBGMAFLY-UHFFFAOYSA-N","BRD-K29582115","","Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12"
"9934","ZUCLOPENTHIXOL","dopamine receptor antagonist","ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A","neurology/psychiatry","schizophrenia, bipolar disorder","Prestwick",97.19,"BRD-K28761384-300-01-0","Launched","","WFPIAZLQTJBIFN-DVZOWYKESA-N","BRD-K28761384","","OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1"
"9935","RISPERIDONE","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7","neurology/psychiatry","schizophrenia, bipolar disorder, irritability","MicroSource, Selleck",98.34,"BRD-K53857191-001-22-7, BRD-K53857191-001-21-9","Launched","","RAPZEAPATHNIPO-UHFFFAOYSA-N","BRD-K53857191","","Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12"
"9937","FLUPENTIXOL","dopamine receptor antagonist","ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A","neurology/psychiatry","schizophrenia, depression","Enzo",93.69,"BRD-K70487031-001-02-8","Launched","","NJMYODHXAKYRHW-DVZOWYKESA-N","BRD-K70487031","","OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1"
"9938","PERPHENAZINE","dopamine receptor antagonist","CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7","neurology/psychiatry, gastroenterology","schizophrenia, nausea, vomiting","MicroSource, MedChemEx, Sigma",87.72,"BRD-K10995081-001-26-1, BRD-K10995081-001-28-7, BRD-K10995081-001-27-9","Launched","","RGCVKNLCSQQDEP-UHFFFAOYSA-N","BRD-K10995081","","OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1"
"9941","CHLORPROMAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5","neurology/psychiatry, gastroenterology, hematology, infectious disease","schizophrenia, nausea, vomiting, acute intermittent porphyria (AIP), tetanus","MicroSource, Selleck, Selleck",97.33,"BRD-K89997465-001-10-3, BRD-K89997465-003-43-0, BRD-K89997465-003-44-8","Launched","","ZPEIMTDSQAKGNT-UHFFFAOYSA-N","BRD-K89997465","","CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12"
"9944","LEVOSULPIRIDE","dopamine receptor antagonist","CA1, CA12, CA7, DRD2, DRD3","neurology/psychiatry, gastroenterology, urology","schizophrenia, psychosis, anxiety, vertigo, dyspepsia, irritable bowel syndrome, premature ejaculation (PE)","Tocris, Selleck, Tocris",98.1,"BRD-K51671335-001-12-2, BRD-K51671335-001-09-8, BRD-K51671335-001-10-6","Launched","","BGRJTUBHPOOWDU-NSHDSACASA-N","BRD-K51671335","","CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O"
"9947","SULPIRIDE","dopamine receptor antagonist","","neurology/psychiatry","schizophrenia, schizophrenia","Tocris, Tocris, MicroSource",98.91,"BRD-A55272860-001-16-1, BRD-A55272860-001-14-6, BRD-A55272860-001-15-3","Launched","BRD-A10715913-001-04-6","BGRJTUBHPOOWDU-UHFFFAOYSA-N","BRD-A55272860","BRD-A10715913","CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O"
"9950","HALOFUGINONE","collagenase inhibitor","COL1A1, MMP2","rheumatology","scleroderma","EMDBio",95.58,"BRD-K54247840-004-01-3","Launched","","LVASCWIMLIKXLA-CABCVRRESA-N","BRD-K54247840","","O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O"
"9951","POTASSIUM-P-AMINOBENZOATE","","","rheumatology, urology","scleroderma, dermatomyositis, Peyronie's disease","MicroSource",92.96,"BRD-K58497451-237-10-7","Launched","","ALYNCZNDIQEVRV-UHFFFAOYSA-N","BRD-K58497451","","Nc1ccc(cc1)C(O)=O"
"9952","ASCORBIC-ACID","antioxidant","ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE","endocrinology","scurvy","MedChemEx, MedChemEx, Selleck, Sigma, Selleck, MicroSource",100,"BRD-A85242401-001-11-5, BRD-A85242401-001-10-7, BRD-A85242401-001-05-7, BRD-A85242401-001-09-9, BRD-A85242401-001-07-3, BRD-A85242401-001-12-3","Launched","BRD-A08112603-001-04-5","KRGQEOSDQHTZMX-IGCYCDGOSA-N","BRD-A85242401","BRD-A08112603","OC[C@H](O)[C@H]1OC(=O)C(=O)C1O"
"9958","FLUOCINOLONE-ACETONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","MicroSource, MicroSource, Selleck",97.54,"BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8","Launched","BRD-A77824596-001-04-0, BRD-K95627890-001-01-2","FEBLZLNTKCEFIT-VSXGLTOVSA-N","BRD-K94353609","BRD-A77824596","CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"9959","FLUOCINOLONE-ACETONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","MicroSource, MicroSource, Selleck",97.54,"BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8","Launched","BRD-A77824596-001-04-0, BRD-K95627890-001-01-2","FEBLZLNTKCEFIT-VSXGLTOVSA-N","BRD-K94353609","BRD-A77824596","CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C"
"9961","FLUOCINOLONE-ACETONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","MicroSource, MicroSource, Selleck",97.54,"BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8","Launched","BRD-A77824596-001-04-0, BRD-K95627890-001-01-2","WJOHZNCJWYWUJD-UUTDCOIBSA-N","BRD-K94353609","BRD-A77824596","CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"9962","FLUOCINOLONE-ACETONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","MicroSource, MicroSource, Selleck",97.54,"BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8","Launched","BRD-A77824596-001-04-0, BRD-K95627890-001-01-2","WJOHZNCJWYWUJD-UUTDCOIBSA-N","BRD-K94353609","BRD-A77824596","CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C"
"9964","KETOCONAZOLE","sterol demethylase inhibitor","AR, CYP19A1, CYP21A2, KCNA10","dermatology","seborrheic dermatitis","Selleck, Tocris, Selleck, MicroSource",95.89,"BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9","Launched","","XMAYWYJOQHXEEK-OZXSUGGESA-N","BRD-K29113274","","CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1"
"9967","KETOCONAZOLE","sterol demethylase inhibitor","AR, CYP19A1, CYP21A2, KCNA10","dermatology","seborrheic dermatitis","Selleck, Tocris, Selleck, MicroSource",95.89,"BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9","Launched","","XMAYWYJOQHXEEK-OZXSUGGESA-N","BRD-K29113274","","CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1"
"9968","KETOCONAZOLE","sterol demethylase inhibitor","AR, CYP19A1, CYP21A2, KCNA10","dermatology","seborrheic dermatitis","Selleck, Tocris, Selleck, MicroSource",95.89,"BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9","Launched","","XMAYWYJOQHXEEK-NASUQTAISA-N","BRD-K29113274","","CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1"
"9971","KETOCONAZOLE","sterol demethylase inhibitor","AR, CYP19A1, CYP21A2, KCNA10","dermatology","seborrheic dermatitis","Selleck, Tocris, Selleck, MicroSource",95.89,"BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9","Launched","","XMAYWYJOQHXEEK-NASUQTAISA-N","BRD-K29113274","","CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1"
"9972","FLUOCINONIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6, SMO","dermatology","seborrheic dermatitis, eczema","Selleck",93.28,"BRD-K57886322-001-16-6","Launched","BRD-K68865937-001-01-6","WJOHZNCJWYWUJD-IUGZLZTKSA-N","BRD-K57886322","BRD-K68865937","CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C"
"9973","ACEPROMAZINE","dopamine receptor antagonist","ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A","neurology/psychiatry","sedative","MicroSource",90.02,"BRD-K37814297-050-09-6","Launched","","NOSIYYJFMPDDSA-UHFFFAOYSA-N","BRD-K37814297","","CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(C)=O"
"9974","AFLOQUALONE","acetylcholine receptor antagonist","","neurology/psychiatry","sedative","AKSci",97.87,"BRD-K69247067-001-01-8","Launched","","VDOSWXIDETXFET-UHFFFAOYSA-N","BRD-K69247067","","Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O"
"9975","ALIMEMAZINE","histamine receptor agonist","HRH1","neurology/psychiatry","sedative","MicroSource",80.57,"BRD-A49225603-045-10-0","Launched","","ZZHLYYDVIOPZBE-UHFFFAOYSA-N","BRD-A49225603","","CC(CN(C)C)CN1c2ccccc2Sc2ccccc12"
"9976","AZAPERONE","dopamine receptor antagonist","DRD2, DRD3","neurology/psychiatry","sedative","MicroSource, Selleck, Selleck",98.29,"BRD-K45861246-001-14-2, BRD-K45861246-001-13-4, BRD-K45861246-001-15-9","Launched","","XTKDAFGWCDAMPY-UHFFFAOYSA-N","BRD-K45861246","","Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1"
"9979","DETOMIDINE","adrenergic receptor agonist","ADRA2A","neurology/psychiatry","sedative","Selleck",98.34,"BRD-K77597856-003-02-5","Launched","","RHDJRPPFURBGLQ-UHFFFAOYSA-N","BRD-K77597856","","Cc1cccc(Cc2c[nH]cn2)c1C"
"9980","DOXYLAMINE","histamine receptor antagonist","CHRM1, HRH1","neurology/psychiatry","sedative","MicroSource, Selleck",98.3,"BRD-A44008656-036-25-8, BRD-A44008656-036-24-1","Launched","","HCFDWZZGGLSKEP-UHFFFAOYSA-N","BRD-A44008656","","CN(C)CCOC(C)(c1ccccc1)c1ccccn1"
"9982","FLUMAZENIL","benzodiazepine receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ","neurology/psychiatry","sedative","Tocris, MicroSource, Selleck, Tocris",99.3,"BRD-K98769987-001-25-2, BRD-K98769987-001-23-7, BRD-K98769987-001-21-1, BRD-K98769987-001-22-9","Launched","","OFBIFZUFASYYRE-UHFFFAOYSA-N","BRD-K98769987","","CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21"
"9986","MEDETOMIDINE","adrenergic receptor agonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","neurology/psychiatry","sedative","Selleck, Tocris, Tocris",98.61,"BRD-A21607826-003-04-4, BRD-A21607826-003-06-9, BRD-A21607826-003-05-1","Launched","","CUHVIMMYOGQXCV-UHFFFAOYSA-N","BRD-A21607826","","CC(c1c[nH]cn1)c1cccc(C)c1C"
"9989","THIAMYLAL","glutamate receptor antagonist","GABRA1, KCNJ11, KCNJ8","neurology/psychiatry","sedative","MicroSource",52.77,"BRD-A23970436-236-04-2","Launched","","XLOMZPUITCYLMJ-UHFFFAOYSA-N","BRD-A23970436","","CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O"
"9990","TRIMETOZINE","sedative","","neurology/psychiatry","sedative","MicroSource",99.51,"BRD-K53220666-001-02-6","Launched","","XWVOEFLBOSSYGM-UHFFFAOYSA-N","BRD-K53220666","","COc1cc(cc(OC)c1OC)C(=O)N1CCOCC1"
"9991","PROMETHAZINE","histamine receptor antagonist","ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A","neurology/psychiatry, allergy","sedative, allergic rhinitis","MedChemEx, MicroSource",88.98,"BRD-A46335897-003-27-8, BRD-A46335897-003-26-0","Launched","","PWWVAXIEGOYWEE-UHFFFAOYSA-N","BRD-A46335897","","CC(CN1c2ccccc2Sc2ccccc12)N(C)C"
"9993","BARBITAL","sedative","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2","neurology/psychiatry","sedative, seizures","MicroSource",98.75,"BRD-K83359602-001-02-3","Launched","","FTOAOBMCPZCFFF-UHFFFAOYSA-N","BRD-K83359602","","CCC1(CC)C(=O)NC(=O)NC1=O"
"9994","BECLAMIDE","anticonvulsant","","neurology/psychiatry","sedative, seizures","MicroSource",96.76,"BRD-K44824027-001-02-1","Launched","","JPYQFYIEOUVJDU-UHFFFAOYSA-N","BRD-K44824027","","ClCCC(=O)NCc1ccccc1"
"9995","BRIVARACETAM","voltage-gated sodium channel blocker","SV2A","neurology/psychiatry","seizures","MedChemEx, MedChemEx",94.2,"BRD-K00634421-001-02-8, BRD-K00634421-001-01-0","Launched","","MSYKRHVOOPPJKU-BDAKNGLRSA-N","BRD-K00634421","","CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1"
"9997","CARBAMAZEPINE","carboxamide antiepileptic","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Tocris, MicroSource, Selleck",99.2,"BRD-K71799949-001-38-0, BRD-K71799949-001-36-4, BRD-K71799949-001-35-6","Launched","","FFGPTBGBLSHEPO-UHFFFAOYSA-N","BRD-K71799949","","NC(=O)N1c2ccccc2C=Cc2ccccc12"
"10000","CLOBAZAM","GABA benzodiazepine site receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ","neurology/psychiatry","seizures","Enzo",98.93,"BRD-K52408781-001-02-8","Launched","","CXOXHMZGEKVPMT-UHFFFAOYSA-N","BRD-K52408781","","CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)CC1=O"
"10001","ESLICARBAZEPINE-ACETATE","sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","MedChemEx",99.86,"BRD-K61237927-001-01-7","Launched","","QIALRBLEEWJACW-INIZCTEOSA-N","BRD-K61237927","","CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc12"
"10002","ETHOTOIN","hydantoin antiepileptic","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","MicroSource, AMS",97.23,"BRD-A30205217-001-11-2, BRD-A30205217-001-12-0","Launched","","SZQIFWWUIBRPBZ-UHFFFAOYSA-N","BRD-A30205217","","CCN1C(=O)NC(C1=O)c1ccccc1"
"10004","LACOSAMIDE","collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Enzo",98.58,"BRD-K68232650-001-02-2","Launched","","VPPJLAIAVCUEMN-GFCCVEGCSA-N","BRD-K68232650","","COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1"
"10005","LEVETIRACETAM","calcium channel blocker","CACNA1B, SCN1A, SV2A","neurology/psychiatry","seizures","Selleck, Tocris, MicroSource, Selleck",95.46,"BRD-K49404994-001-11-7, BRD-K49404994-001-13-3, BRD-K49404994-001-10-9, BRD-K49404994-001-09-1","Launched","","HPHUVLMMVZITSG-LURJTMIESA-N","BRD-K49404994","","CC[C@H](N1CCCC1=O)C(N)=O"
"10009","MEPHENYTOIN","hydantoin antiepileptic","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","MicroSource",98.67,"BRD-A83937277-001-10-5","Launched","","GMHKMTDVRCWUDX-UHFFFAOYSA-N","BRD-A83937277","","CCC1(NC(=O)N(C)C1=O)c1ccccc1"
"10010","METHSUXIMIDE","T-type calcium channel binder","CACNA1G, CACNA1H, CACNA1I","neurology/psychiatry","seizures","MicroSource",99.54,"BRD-A57592049-001-01-6","Launched","","AJXPJJZHWIXJCJ-UHFFFAOYSA-N","BRD-A57592049","","CN1C(=O)CC(C)(C1=O)c1ccccc1"
"10011","OXCARBAZEPINE","sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","MicroSource, Selleck, Selleck",95.44,"BRD-K04196797-001-24-4, BRD-K04196797-001-23-6, BRD-K04196797-001-25-1","Launched","","CTRLABGOLIVAIY-UHFFFAOYSA-N","BRD-K04196797","","NC(=O)N1c2ccccc2CC(=O)c2ccccc12"
"10014","PARAMETHADIONE","anticonvulsant","CACNA1G, CACNA1H, CACNA1I","neurology/psychiatry","seizures","MicroSource, Enamine",15,"BRD-A22128695-001-02-6, BRD-A22128695-001-03-4","Launched","","VQASKUSHBVDKGU-UHFFFAOYSA-N","BRD-A22128695","","CCC1(C)OC(=O)N(C)C1=O"
"10016","PERAMPANEL","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","neurology/psychiatry","seizures","MedChemEx",99.4,"BRD-K41438959-001-01-7","Launched","","PRMWGUBFXWROHD-UHFFFAOYSA-N","BRD-K41438959","","O=c1c(cc(cn1-c1ccccc1)-c1ccccn1)-c1ccccc1C#N"
"10017","PHENSUXIMIDE","succinimide antiepileptic","CACNA1G, CACNA1H, CACNA1I","neurology/psychiatry","seizures","MicroSource",98.87,"BRD-A18043272-001-09-9","Launched","","WLWFNJKHKGIJNW-UHFFFAOYSA-N","BRD-A18043272","","CN1C(=O)CC(C1=O)c1ccccc1"
"10018","PHENYTOIN","hydantoin antiepileptic","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Selleck, MicroSource, Selleck",99.77,"BRD-K55930204-236-23-5, BRD-K55930204-236-24-3, BRD-K55930204-001-20-9","Launched","","CXOFVDLJLONNDW-UHFFFAOYSA-N","BRD-K55930204","","O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1"
"10021","PRIMIDONE","GABA receptor antagonist","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Selleck, Tocris, MicroSource",99.02,"BRD-K32247306-001-27-8, BRD-K32247306-001-28-6, BRD-K32247306-001-29-4","Launched","","DQMZLTXERSFNPB-UHFFFAOYSA-N","BRD-K32247306","","CCC1(C(=O)NCNC1=O)c1ccccc1"
"10024","RUFINAMIDE","voltage-gated sodium channel blocker","GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Selleck",98.35,"BRD-K20079257-001-09-6","Launched","","POGQSBRIGCQNEG-UHFFFAOYSA-N","BRD-K20079257","","NC(=O)c1cn(Cc2c(F)cccc2F)nn1"
"10025","TIAGABINE","GABA uptake inhibitor","SLC6A1","neurology/psychiatry","seizures","Tocris, Enzo",95.06,"BRD-K60160658-003-12-0, BRD-K60160658-003-11-2","Launched","","PBJUNZJWGZTSKL-MRXNPFEDSA-N","BRD-K60160658","","Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C"
"10027","TRIMETHADIONE","oxazolidine antiepileptic","CACNA1G, CACNA1H, CACNA1I","neurology/psychiatry","seizures","MicroSource, MedChemEx, MedChemEx, Sigma",12.34,"BRD-K16606819-001-10-1, BRD-K16606819-001-13-5, BRD-K16606819-001-12-7, BRD-K16606819-001-11-9","Launched","","IRYJRGCIQBGHIV-UHFFFAOYSA-N","BRD-K16606819","","CN1C(=O)OC(C)(C)C1=O"
"10031","VALPROIC-ACID","HDAC inhibitor","ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures","Selleck, EMDBio, MicroSource, Enzo, Tocris",96.83,"BRD-K41260949-236-15-0, BRD-K41260949-236-18-4, BRD-K41260949-236-16-8, BRD-K41260949-236-17-6, BRD-K41260949-236-21-8","Launched","","NIJJYAXOARWZEE-UHFFFAOYSA-N","BRD-K41260949","","CCCC(CCC)C(O)=O"
"10036","ZONISAMIDE","sodium channel blocker, T-type calcium channel blocker","CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry","seizures, epilepsy","Tocris, Tocris, Selleck",98.12,"BRD-K48300629-001-17-8, BRD-K48300629-001-14-5, BRD-K48300629-001-13-7","Launched","","UBQNRHZMVUUOMG-UHFFFAOYSA-N","BRD-K48300629","","NS(=O)(=O)Cc1noc2ccccc12"
"10039","CLONAZEPAM","GABA benzodiazepine site receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO","neurology/psychiatry","seizures, panic disorders","MicroSource",96.01,"BRD-K38183498-001-02-0","Launched","","DGBIGWXXNGSACT-UHFFFAOYSA-N","BRD-K38183498","","[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1"
"10040","VIGABATRIN","GABA aminotransferase inhibitor","ABAT, GABBR1, SLC32A1","neurology/psychiatry","seizures, spasms","MicroSource",0,"BRD-A07893380-213-01-7","Launched","","PJDFLNIOAUIZSL-UHFFFAOYSA-N","BRD-A07893380","","NC(CCC(O)=O)C=C"
"10041","GALANTAMINE","acetylcholinesterase inhibitor","ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG","neurology/psychiatry","senile dementia","Tocris, MicroSource",98.59,"BRD-K49481516-004-18-3, BRD-K49481516-001-01-5","Launched","","ASUTZQLVASHGKV-JDFRZJQESA-N","BRD-K49481516","","COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24"
"10043","PIRACETAM","acetylcholine receptor agonist","GRIA1, GRIA2, GRIA3, GRIA4","neurology/psychiatry","senile dementia","Selleck, MicroSource",100,"BRD-K19456237-001-26-8, BRD-K19456237-001-27-6","Launched","","GMZVRMREEHBGGF-UHFFFAOYSA-N","BRD-K19456237","","NC(=O)CN1CCCC1=O"
"10045","MECLOFENOXATE","nootropic agent","","neurology/psychiatry","senile dementia, Alzheimer's disease","MicroSource",87.92,"BRD-K10314788-003-12-7","Launched","","XZTYGFHCIAKPGJ-UHFFFAOYSA-N","BRD-K10314788","","CN(C)CCOC(=O)COc1ccc(Cl)cc1"
"10046","SILVER-SULFADIAZINE","PABA antagonist","","critical care","sepsis","Sigma, Enzo",99.7,"BRD-K68379918-001-01-1, BRD-K68379918-001-02-9","Launched","BRD-M11664367-001-01-8","UEJSSZHHYBHCEL-UHFFFAOYSA-N","BRD-K68379918","BRD-M11664367","Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1"
"10048","BRIVUDINE","DNA directed DNA polymerase inhibitor","","infectious disease","shingles","TCI",95.52,"BRD-A63675168-001-01-6","Launched","","ODZBBRURCPAEIQ-GIANCMQGSA-N","BRD-A63675168","","OC[C@H]1O[C@H](CC1O)n1cc(\C=C\Br)c(=O)[nH]c1=O"
"10049","VALACICLOVIR","DNA polymerase inhibitor","","infectious disease","shingles, virus herpes simplex (HSV)","MicroSource, Selleck",97.83,"BRD-K46435977-003-12-9, BRD-K46435977-003-11-1","Launched","","HDOVUKNUBWVHOX-QMMMGPOBSA-N","BRD-K46435977","","CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O"
"10051","MOXIFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","otolaryngology, pulmonary, infectious disease","sinusitis, bronchitis, pneumonia, skin infections, intra-abdominal infections","MicroSource, Selleck",92.59,"BRD-K66615216-003-14-8, BRD-K66615216-003-13-0","Launched","","FABPRXSRWADJSP-MEDUHNTESA-N","BRD-K66615216","","COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1"
"10053","FAROPENEM-MEDOXOMIL","lactamase inhibitor","","otolaryngology, infectious disease, pulmonary","sinusitis, pneumonia, bronchitis, skin infections, urinary tract infections","MedChemEx, MedChemEx, MedChemEx",82.42,"BRD-K59045783-001-03-7, BRD-K59045783-001-02-9, BRD-K59045783-001-01-1","Launched","","JQBKWZPHJOEQAO-DVPVEWDBSA-N","BRD-K59045783","","C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C"
"10056","CEVIMELINE","acetylcholine receptor agonist","CHRM1, CHRM3","rheumatology","sjogren's syndrome","Tocris",97.85,"BRD-M98279124-300-01-1","Launched","","YMMKDPCCYMGDHD-JWGPUQBJSA-N","BRD-M98279124","","C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1"
"10057","MEDRONIC-ACID","bone resorption inhibitor","","radiology","skeletal imaging agent","Sigma",98.4,"BRD-K94072573-001-09-9","Launched","","MBKDYNNUVRNNRF-UHFFFAOYSA-N","BRD-K94072573","","OP(O)(=O)CP(O)(O)=O"
"10058","MEQUINOL","","TYR","dermatology","skin depigmentation","MicroSource, Selleck, Selleck",99.23,"BRD-K45216060-001-10-0, BRD-K45216060-001-09-2, BRD-K45216060-001-11-8","Launched","","NWVVVBRKAWDGAB-UHFFFAOYSA-N","BRD-K45216060","","COc1ccc(O)cc1"
"10061","MONOBENZONE","melanin inhibitor","TYR","dermatology","skin depigmentation","Selleck, MicroSource, Sigma, Selleck",77.12,"BRD-K54262262-001-11-6, BRD-K54262262-001-10-8, BRD-K54262262-001-12-4, BRD-K54262262-001-09-0","Launched","","VYQNWZOUAUKGHI-UHFFFAOYSA-N","BRD-K54262262","","Oc1ccc(OCc2ccccc2)cc1"
"10065","CHLOROXYLENOL","ATP synthase inhibitor","","infectious disease","skin infections","MicroSource",95.32,"BRD-K17223896-001-10-0","Launched","","OSDLLIBGSJNGJE-UHFFFAOYSA-N","BRD-K17223896","","Cc1cc(O)cc(C)c1Cl"
"10066","DALBAVANCIN","bacterial cell wall synthesis inhibitor","PNLIP","infectious disease","skin infections","MedChemEx",68.91,"BRD-K30177383-001-01-0","Launched","","KGPGQDLTDHGEGT-SZUNQUCBSA-N","BRD-K30177383","","CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2"
"10067","ENILCONAZOLE","sterol demethylase inhibitor","CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2","infectious disease","skin infections","MicroSource",98.23,"BRD-A11776908-065-01-5","Launched","","PZBPKYOVPCNPJY-UHFFFAOYSA-N","BRD-A11776908","","Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1"
"10068","ORITAVANCIN","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections","MedChemEx",92.37,"BRD-A33352494-316-01-6","Launched","","VHFGEBVPHAGQPI-UHFFFAOYSA-N","BRD-A33352494","","CNC(CC(C)C)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(OC5CC(C)(N)C(O)C(C)O5)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(NCc3ccc(cc3)-c3ccc(Cl)cc3)C(O)C(C)O1)c(Cl)c2"
"10069","SULBACTAM-PIVOXIL","beta lactamase inhibitor","","infectious disease","skin infections","AvaChem",85.23,"BRD-A63431791-001-01-9","Launched","","OHPVYKXTRACOSQ-UHFFFAOYSA-N","BRD-A63431791","","CC(C)(C)C(=O)OCOC(=O)C1N2C(CC2=O)S(=O)(=O)C1(C)C"
"10070","TEDIZOLID","bacterial 50S ribosomal subunit inhibitor","","infectious disease","skin infections","MedChemEx",98.73,"BRD-K59436580-001-01-7","Launched","","XFALPSLJIHVRKE-GFCCVEGCSA-N","BRD-K59436580","","Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](CO)OC1=O"
"10071","TEDIZOLID-PHOSPHATE","protein synthesis inhibitor","","infectious disease","skin infections","MedChemEx, Annova, MedChemEx",94.69,"BRD-K89121095-001-02-5, BRD-K89121095-304-01-5, BRD-K89121095-001-01-7","Launched","","QCGUSIANLFXSGE-GFCCVEGCSA-N","BRD-K89121095","","Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O"
"10074","MOXALACTAM","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis","MedChemEx, MicroSource, Selleck, Selleck",0,"BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7","Launched","","JWCSIUVGFCSJCK-LIUKBUMOSA-N","BRD-K40831222","","CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10075","MOXALACTAM","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis","MedChemEx, MicroSource, Selleck, Selleck",0,"BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7","Launched","","JWCSIUVGFCSJCK-LIUKBUMOSA-N","BRD-K40831222","","CO[C@]1(NC(=O)C(C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10078","MOXALACTAM","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis","MedChemEx, MicroSource, Selleck, Selleck",0,"BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7","Launched","","JWCSIUVGFCSJCK-CAVRMKNVSA-N","BRD-K40831222","","CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10079","MOXALACTAM","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis","MedChemEx, MicroSource, Selleck, Selleck",0,"BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7","Launched","","JWCSIUVGFCSJCK-CAVRMKNVSA-N","BRD-K40831222","","CO[C@]1(NC(=O)C(C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10082","AMOXICILLIN","penicillin binding protein inhibitor","CYP2C19, SLC15A1, SLC15A2, SLC22A6","infectious disease, gastroenterology","skin infections, duodenal ulcer disease, gonorrhea, ear infections, throat infections, genitourinary tract infections, respiratory tract infections","MedChemEx, MicroSource, Selleck, Selleck, Selleck, Selleck",96.19,"BRD-K55044200-236-03-1, BRD-K55044200-001-16-1, BRD-K55044200-236-02-3, BRD-K55044200-236-04-9, BRD-K55044200-001-15-3, BRD-K55044200-001-14-6","Launched","BRD-K08635111-001-04-8, BRD-K39234907-236-01-9, BRD-K58632460-001-01-7","LSQZJLSUYDQPKJ-NJBDSQKTSA-N","BRD-K55044200","BRD-K08635111","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O"
"10088","DAPTOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, endocarditis","Selleck, Selleck",89.99,"BRD-K94358652-001-03-9, BRD-K94358652-001-02-1","Launched","BRD-K25021320-001-01-3","DOAKLVKFURWEDJ-QAMDLYIKSA-N","BRD-K94358652","BRD-K25021320","CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2ccccc2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O"
"10090","HEXYLRESORCINOL","local anesthetic","TYR","infectious disease","skin infections, first-aid antiseptic","MicroSource",98.8,"BRD-K99946902-001-07-5","Launched","","WFJIVOKAWHGMBH-UHFFFAOYSA-N","BRD-K99946902","","CCCCCCc1ccc(O)cc1O"
"10091","SULBACTAM","beta lactamase inhibitor","","infectious disease","skin infections, intra-abdominal infections, gynecologic infections","Selleck, Selleck, MicroSource, Selleck",98.41,"BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9","Launched","BRD-K85679373-001-01-1, BRD-K85679373-236-01-3","FKENQMMABCRJMK-RITPCOANSA-N","BRD-K44133266","BRD-K85679373","CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O"
"10093","SULBACTAM","beta lactamase inhibitor","","infectious disease","skin infections, intra-abdominal infections, gynecologic infections","Selleck, Selleck, MicroSource, Selleck",98.41,"BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9","Launched","BRD-K85679373-001-01-1, BRD-K85679373-236-01-3","FKENQMMABCRJMK-RITPCOANSA-N","BRD-K44133266","BRD-K85679373","CC1(C)C(N2[C@@H](CC2=O)S1(=O)=O)C(O)=O"
"10095","SULBACTAM","beta lactamase inhibitor","","infectious disease","skin infections, intra-abdominal infections, gynecologic infections","Selleck, Selleck, MicroSource, Selleck",98.41,"BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9","Launched","BRD-K85679373-001-01-1, BRD-K85679373-236-01-3","FKENQMMABCRJMK-LWOQYNTDSA-N","BRD-K44133266","BRD-K85679373","CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O"
"10097","SULBACTAM","beta lactamase inhibitor","","infectious disease","skin infections, intra-abdominal infections, gynecologic infections","Selleck, Selleck, MicroSource, Selleck",98.41,"BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9","Launched","BRD-K85679373-001-01-1, BRD-K85679373-236-01-3","FKENQMMABCRJMK-LWOQYNTDSA-N","BRD-K44133266","BRD-K85679373","CC1(C)C(N2[C@@H](CC2=O)S1(=O)=O)C(O)=O"
"10099","MEROPENEM","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, intra-abdominal infections, meningitis","Selleck, Key, Selleck, MicroSource",23.73,"BRD-K01612348-001-12-2, BRD-K01612348-001-11-4, BRD-K01612348-001-13-0, BRD-K01612348-001-14-8","Launched","BRD-A18115130-001-03-0, BRD-A18115130-001-02-2, BRD-A53925737-001-01-9","DMJNNHOOLUXYBV-PQTSNVLCSA-N","BRD-K01612348","BRD-A18115130","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O"
"10103","CEFTAROLINE-FOSAMIL","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, pneumonia","GLSyntech",63.93,"BRD-K37252028-349-01-8","Launched","","ZCCUWMICIWSJIX-XHNDKCDBSA-O","BRD-K37252028","","CCO\N=C(\C(=O)N[C@H]1[C@H]2SCC(Sc3nc(cs3)-c3cc[n+](C)cc3)=C(N2C1=O)C(O)=O)c1nsc(NP(O)(O)=O)n1"
"10104","TIGECYCLINE","bacterial 30S ribosomal subunit inhibitor","","infectious disease","skin infections, pneumonia, intra-abdominal infections","Selleck, MedChemEx, MedChemEx, Selleck, Sigma, MedChemEx, MicroSource",26.42,"BRD-A34462049-001-09-3, BRD-A34462049-001-14-3, BRD-A34462049-001-13-5, BRD-A34462049-001-15-0, BRD-A34462049-001-11-9, BRD-A34462049-001-12-7, BRD-A34462049-001-08-5","Launched","BRD-A08915912-001-01-3","CGZOGNUFXMNYEI-UDUHKTKDSA-N","BRD-A34462049","BRD-A08915912","CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C"
"10111","CEFCAPENE-PIVOXIL","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, pneumonia, urinary tract infections","Sigma, AKSci, Astatech",90.61,"BRD-K27515606-311-02-8, BRD-K27515606-311-01-0, BRD-K27515606-003-01-3","Launched","","WVPAABNYMHNFJG-QDVBXLKVSA-N","BRD-K27515606","","CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1"
"10114","FLUDROXYCORTIDE","glucocorticoid receptor agonist","NR3C1, SERPINA6","infectious disease, dermatology","skin infections, psoriasis","MicroSource",97.06,"BRD-A49765801-001-04-1","Launched","","POPFMWWJOGLOIF-KYSSJFEUSA-N","BRD-A49765801","","CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO"
"10115","CEPHRADINE","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, respiratory tract infections, urinary tract infections","MicroSource",5.47,"BRD-A90807417-001-04-5","Launched","","RDLPVSKMFDYCOR-MHSSMOFYSA-N","BRD-A90807417","","CC1=C(N2C(SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O"
"10116","CEPHALOTHIN","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, surgical prophylaxis","MicroSource",92.86,"BRD-K28210218-236-08-1","Launched","","XIURVHNZVLADCM-IUODEOHRSA-N","BRD-K28210218","","CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1cccs1)C2=O)C(O)=O"
"10117","DIFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","skin infections, urinary tract infections","Selleck, MicroSource",97.01,"BRD-K73923631-003-01-1, BRD-K73923631-003-02-9","Launched","","NOCJXYPHIIZEHN-UHFFFAOYSA-N","BRD-K73923631","","CN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1"
"10119","CEFAMANDOLE","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, urinary tract infections, respiratory tract infections","Sigma, MicroSource",32.02,"BRD-K27130738-236-14-1, BRD-K27130738-236-15-8","Launched","BRD-A23933379-236-04-9","OLVCFLKTBJRLHI-AXAPSJFSSA-N","BRD-K27130738","BRD-A23933379","Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](O)c1ccccc1)C2=O)C(O)=O"
"10121","CEFAMANDOLE-NAFATE","bacterial cell wall synthesis inhibitor","","infectious disease","skin infections, urinary tract infections, respiratory tract infections","MedChemEx, MedChemEx, MicroSource",43.32,"BRD-K17903788-236-01-9, BRD-K17903788-236-02-7, BRD-K17903788-236-03-5","Launched","BRD-A02439449-236-04-8","RRJHESVQVSRQEX-SUYBPPKGSA-N","BRD-K17903788","BRD-A02439449","Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](OC=O)c1ccccc1)C2=O)C(O)=O"
"10124","ENBUCRILATE","","","dermatology","skin lacerations, tissue adhesive","Ark",0,"BRD-K66918327-001-01-3","Launched","","JJJFUHOGVZWXNQ-UHFFFAOYSA-N","BRD-K66918327","","CCCCOC(=O)C(=C)C#N"
"10125","ALLANTOIN","cosmetic","","dermatology","skin protectant","MicroSource",97.81,"BRD-A96407378-001-15-1","Launched","","POJWUDADGALRAB-UHFFFAOYSA-N","BRD-A96407378","","NC(=O)NC1NC(=O)NC1=O"
"10126","DIHYDROXYACETONE","","","dermatology","skin protectant","Sigma",0,"BRD-K18637542-001-01-7","Launched","","RXKJFZQQPQGTFL-UHFFFAOYSA-N","BRD-K18637542","","OCC(=O)CO"
"10127","ECAMSULE-TRIETHANOLAMINE","","","dermatology","skin protectant, sunscreen lotion","MicroSource",92.57,"BRD-A47953250-001-01-7","Launched","","HEAHZSUCFKFERC-AXPXABNXSA-N","BRD-A47953250","","CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/c1ccc(cc1)\C=C1\C2CCC(CS(O)(=O)=O)(C1=O)C2(C)C"
"10128","BUCLADESINE","adenosine receptor agonist, cAMP stimulant","PRKACA","dermatology","skin ulcer","Tocris, MicroSource, Tocris",98.02,"BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0","Launched","","CJGYSWNGNKCJSB-YVLZZHOMSA-N","BRD-A94624445","","CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC"
"10129","BUCLADESINE","adenosine receptor agonist, cAMP stimulant","PRKACA","dermatology","skin ulcer","Tocris, MicroSource, Tocris",98.02,"BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0","Launched","","CJGYSWNGNKCJSB-YVLZZHOMSA-N","BRD-A94624445","","CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC"
"10131","BUCLADESINE","adenosine receptor agonist, cAMP stimulant","PRKACA","dermatology","skin ulcer","Tocris, MicroSource, Tocris",98.02,"BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0","Launched","","CJGYSWNGNKCJSB-ZBSNKJFMSA-N","BRD-A94624445","","CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC"
"10132","BUCLADESINE","adenosine receptor agonist, cAMP stimulant","PRKACA","dermatology","skin ulcer","Tocris, MicroSource, Tocris",98.02,"BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0","Launched","","CJGYSWNGNKCJSB-ZBSNKJFMSA-N","BRD-A94624445","","CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC"
"10134","MELATONIN","melatonin receptor agonist, nitric oxide synthase inhibitor","ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB","neurology/psychiatry","sleep cycle support","Tocris, Tocris, Selleck",95.68,"BRD-K97530723-001-20-9, BRD-K97530723-001-24-1, BRD-K97530723-001-19-1","Launched","","DRLFMBDRBRZALE-UHFFFAOYSA-N","BRD-K97530723","","COc1ccc2[nH]cc(CCNC(C)=O)c2c1"
"10137","TOPOTECAN","topoisomerase inhibitor","TOP1, TOP1MT","oncology","small cell lung cancer, cervical cancer","Selleck, MedChemEx, MicroSource, Key, MedChemEx, Selleck",76.92,"BRD-K55696337-003-22-8, BRD-K55696337-003-25-1, BRD-K55696337-003-21-0, BRD-K55696337-003-23-6, BRD-K55696337-003-24-4, BRD-K55696337-003-20-2","Launched","","UCFGDBYHRUNTLO-QHCPKHFHSA-N","BRD-K55696337","","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O"
"10143","AMRUBICIN","topoisomerase inhibitor","TOP2A, TOP2B","oncology","small cell lung cancer, small cell lung cancer","MedChemEx, MedChemEx",74.78,"BRD-K13843533-001-02-5, BRD-K13843533-001-01-7","Launched","","VJZITPJGSQKZMX-XDPRQOKASA-N","BRD-K13843533","","CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c2C1"
"10145","LOBELINE","acetylcholine receptor antagonist","CHRNA10, CHRNA9, SLC18A2","neurology/psychiatry","smoking cessation","MedChemEx, MicroSource, Tocris, Sigma, MedChemEx",65.76,"BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3","Launched","BRD-M82226456-065-01-7","MXYUKLILVYORSK-HBMCJLEFSA-N","BRD-K66206289","BRD-M82226456","CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1"
"10146","LOBELINE","acetylcholine receptor antagonist","CHRNA10, CHRNA9, SLC18A2","neurology/psychiatry","smoking cessation","MedChemEx, MicroSource, Tocris, Sigma, MedChemEx",65.76,"BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3","Launched","BRD-M82226456-065-01-7","MXYUKLILVYORSK-HBMCJLEFSA-N","BRD-K66206289","BRD-M82226456","CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c1ccccc1"
"10150","LOBELINE","acetylcholine receptor antagonist","CHRNA10, CHRNA9, SLC18A2","neurology/psychiatry","smoking cessation","MedChemEx, MicroSource, Tocris, Sigma, MedChemEx",65.76,"BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3","Launched","BRD-M82226456-065-01-7","MXYUKLILVYORSK-UHFFFAOYSA-N","BRD-K66206289","BRD-M82226456","CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1"
"10151","LOBELINE","acetylcholine receptor antagonist","CHRNA10, CHRNA9, SLC18A2","neurology/psychiatry","smoking cessation","MedChemEx, MicroSource, Tocris, Sigma, MedChemEx",65.76,"BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3","Launched","BRD-M82226456-065-01-7","MXYUKLILVYORSK-UHFFFAOYSA-N","BRD-K66206289","BRD-M82226456","CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c1ccccc1"
"10155","NICOTINE","acetylcholine receptor agonist","CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1","neurology/psychiatry","smoking cessation","Selleck, MicroSource, Selleck",98.55,"BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5","Launched","","SNICXCGAKADSCV-UHFFFAOYSA-N","BRD-A93695607","","CN1CCCC1c1cccnc1"
"10156","NICOTINE","acetylcholine receptor agonist","CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1","neurology/psychiatry","smoking cessation","Selleck, MicroSource, Selleck",98.55,"BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5","Launched","","SNICXCGAKADSCV-UHFFFAOYSA-N","BRD-A93695607","","CN1CCC[C@H]1c1cccnc1"
"10158","NICOTINE","acetylcholine receptor agonist","CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1","neurology/psychiatry","smoking cessation","Selleck, MicroSource, Selleck",98.55,"BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5","Launched","","SNICXCGAKADSCV-JTQLQIEISA-N","BRD-A93695607","","CN1CCCC1c1cccnc1"
"10159","NICOTINE","acetylcholine receptor agonist","CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1","neurology/psychiatry","smoking cessation","Selleck, MicroSource, Selleck",98.55,"BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5","Launched","","SNICXCGAKADSCV-JTQLQIEISA-N","BRD-A93695607","","CN1CCC[C@H]1c1cccnc1"
"10161","VARENICLINE","acetylcholine receptor agonist","CHRNA3, CHRNA4, CHRNA6, CHRNA7","neurology/psychiatry","smoking cessation","Selleck",91.17,"BRD-A86216746-046-02-6","Launched","","JQSHBVHOMNKWFT-UHFFFAOYSA-N","BRD-A86216746","","C1C2CNCC1c1cc3nccnc3cc21"
"10162","ADIPHENINE","acetylcholine receptor antagonist","CHRNA1","neurology/psychiatry","spasms","MicroSource, Selleck",94.95,"BRD-K60907894-003-23-5, BRD-K60907894-003-22-7","Launched","","JGOAIQNSOGZNBX-UHFFFAOYSA-N","BRD-K60907894","","CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1"
"10164","CYCLOBENZAPRINE","adrenergic receptor agonist, serotonin receptor agonist","HTR2A","neurology/psychiatry","spasms","MicroSource",97.11,"BRD-K42348709-003-13-1","Launched","","JURKNVYFZMSNLP-UHFFFAOYSA-N","BRD-K42348709","","CN(C)CCC=C1c2ccccc2C=Cc2ccccc12"
"10165","DIPHEMANIL","acetylcholine receptor antagonist","CHRM3","neurology/psychiatry","spasms","Selleck",96.64,"BRD-K93441486-067-12-8","Launched","","LCTZPQRFOZKZNK-UHFFFAOYSA-N","BRD-K93441486","","C[N+]1(C)CCC(CC1)=C(c1ccccc1)c1ccccc1"
"10166","DROFENINE","","","neurology/psychiatry","spasms","MicroSource",93.04,"BRD-A22267103-003-13-1","Launched","","AGJBLWCLQCKRJP-UHFFFAOYSA-N","BRD-A22267103","","CCN(CC)CCOC(=O)C(C1CCCCC1)c1ccccc1"
"10167","FENOVERINE","acetylcholine receptor antagonist","","neurology/psychiatry","spasms","Vitas-M",94.91,"BRD-K77564118-001-03-1","Launched","","UBAJTZKNDCEGKL-UHFFFAOYSA-N","BRD-K77564118","","O=C(CN1CCN(Cc2ccc3OCOc3c2)CC1)N1c2ccccc2Sc2ccccc12"
"10168","FLOPROPIONE","serotonin receptor antagonist","HTR1A","neurology/psychiatry","spasms","MicroSource, Selleck",98.95,"BRD-K43383936-001-05-2, BRD-K43383936-001-04-5","Launched","","PTHLEKANMPKYDB-UHFFFAOYSA-N","BRD-K43383936","","CCC(=O)c1c(O)cc(O)cc1O"
"10170","MOXAVERINE","phosphodiesterase inhibitor","","neurology/psychiatry","spasms","Innovapharm",99.2,"BRD-K12742203-003-01-7","Launched","","MYCMTMIGRXJNSO-UHFFFAOYSA-N","BRD-K12742203","","CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1"
"10171","PIPENZOLATE","cholinergic receptor antagonist","CHRM1","neurology/psychiatry","spasms","Selleck, MicroSource",97.76,"BRD-A53561827-004-22-3, BRD-A53561827-004-23-1","Launched","","WPUKUEMZZRVAKZ-UHFFFAOYSA-N","BRD-A53561827","","CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1"
"10173","PIPERIDOLATE","acetylcholine receptor antagonist","CHRM1","neurology/psychiatry","spasms","MicroSource",98.09,"BRD-A97479839-003-13-3","Launched","","KTHVBAZBLKXIHZ-UHFFFAOYSA-N","BRD-A97479839","","CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1"
"10174","TIQUIZIUM","acetylcholine receptor antagonist","","neurology/psychiatry","spasms","AKSci",97.14,"BRD-K77552740-004-01-0","Launched","","ZGSDGGRVFIYKKE-OXQOHEQNSA-N","BRD-K77552740","","C[N@+]12CCCC[C@@H]1CCC(C2)=C(c1cccs1)c1cccs1"
"10175","TIZANIDINE","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C, NISCH","neurology/psychiatry","spasms","Tocris, Tocris, Selleck",98.81,"BRD-K06335600-003-20-7, BRD-K06335600-003-22-3, BRD-K06335600-003-19-9","Launched","","XFYDIVBRZNQMJC-UHFFFAOYSA-N","BRD-K06335600","","Clc1ccc2nsnc2c1NC1=NCCN1"
"10178","DANTROLENE","calcium channel blocker","RYR1, RYR3","neurology/psychiatry, endocrinology","spasms, malignant hyperthermia (MH)","MicroSource, Tocris",97.08,"BRD-K81272440-236-13-5, BRD-K81272440-236-12-7","Launched","","OZOMQRBLCMDCEG-VIZOYTHASA-N","BRD-K81272440","","[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1"
"10180","LEVOMENOL","","","neurology/psychiatry, infectious disease","spasms, skin infections","Sigma",0,"BRD-K62751771-001-01-3","Launched","","RGZSQWQPBWRIAQ-CABCVRRESA-N","BRD-K62751771","","CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1"
"10181","IMIDAFENACIN","acetylcholine receptor antagonist","CHRM1, CHRM3","neurology/psychiatry","spasms, spasms","MedChemEx, MedChemEx",97.97,"BRD-K29626940-001-01-5, BRD-K29626940-001-02-3","Launched","","SQKXYSGRELMAAU-UHFFFAOYSA-N","BRD-K29626940","","Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1"
"10183","TALTIRELIN","thyrotropin releasing hormone receptor agonist","TRHR","neurology/psychiatry","spinocerebellar ataxia","MedChemEx",86.52,"BRD-K93869735-001-01-1","Launched","","LQZAIAZUDWIVPM-SRVKXCTJSA-N","BRD-K93869735","","CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O"
"10184","HYDROXYPROGESTERONE","progesterone receptor agonist","PGR","obstetrics/gynecology","spontaneous preterm birth","MicroSource",95.14,"BRD-A39791822-001-05-1","Launched","","DBPWSSGDRRHUNT-AYUYWISESA-N","BRD-A39791822","","CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C"
"10185","ROSE-BENGAL-LACTONE","coloring agent","","ophthalmology","staining agent","CombiBlocks",73.73,"BRD-K36163066-304-02-4","Launched","","IICCLYANAQEHCI-UHFFFAOYSA-N","BRD-K36163066","","Oc1c(I)cc2c(Oc3c(I)c(O)c(I)cc3C22OC(=O)c3c2c(Cl)c(Cl)c(Cl)c3Cl)c1I"
"10186","OXACILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","staphylococcal infections","Selleck, Selleck, MicroSource",98.27,"BRD-K96786677-323-02-0, BRD-K96786677-323-03-8, BRD-K96786677-236-02-4","Launched","BRD-K71213463-323-01-4, BRD-A66481418-236-04-0","UWYHMGVUTGAWSP-JKIFEVAISA-N","BRD-K96786677","BRD-K71213463","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1"
"10189","INOSITOL-HEXANICOTINATE","","","dermatology, cardiology, rheumatology, neurology/psychiatry","statis dermatitis, claudication, Raynaud's disease, hypertension, insomnia, atherosclerosis, restless leg syndrome, schizophrenia, psoriasis, acne vulgaris (AV)","AKSci",89.29,"BRD-K82800842-001-01-9","Launched","","MFZCIDXOLLEMOO-GYSGTQPESA-N","BRD-K82800842","","O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1"
"10190","LORAZEPAM","benzodiazepine receptor agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO","neurology/psychiatry","status epilepticus","Enzo",98.57,"BRD-A11990600-001-03-4","Launched","","DIWRORZWFLOCLC-UHFFFAOYSA-N","BRD-A11990600","","OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O"
"10191","BUTYLPHTHALIDE","potassium channel antagonist","KCNK2","neurology/psychiatry","stroke","MedChemEx",94.43,"BRD-A59378440-001-01-3","Launched","","HJXMNVQARNZTEE-UHFFFAOYSA-N","BRD-A59378440","","CCCCC1OC(=O)c2ccccc12"
"10192","EDARAVONE","nootropic agent","BCL2","neurology/psychiatry","stroke","MedChemEx, MedChemEx, MicroSource, Selleck, Tocris, Selleck",65.37,"BRD-K35458079-001-34-9, BRD-K35458079-001-33-1, BRD-K35458079-001-29-9, BRD-K35458079-001-31-5, BRD-K35458079-001-28-1, BRD-K35458079-001-27-3","Launched","","QELUYTUMUWHWMC-UHFFFAOYSA-N","BRD-K35458079","","CC1=NN(C(=O)C1)c1ccccc1"
"10198","NIZOFENONE","ion channel antagonist","","neurology/psychiatry","stroke","AKSci",99.4,"BRD-K84011460-051-01-7","Launched","","WZGBZLHGOVJDET-UHFFFAOYSA-N","BRD-K84011460","","CCN(CC)Cc1nccn1-c1ccc(cc1C(=O)c1ccccc1Cl)[N+]([O-])=O"
"10199","OZAGREL","thromboxane synthase inhibitor","TBXAS1","neurology/psychiatry","stroke","Selleck, Selleck, Tocris",96.99,"BRD-K53061490-003-13-9, BRD-K53061490-001-02-6, BRD-K53061490-003-14-7","Launched","","SHZKQBHERIJWAO-AATRIKPKSA-N","BRD-K53061490","","OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1"
"10202","PROPENTOFYLLINE","adenosine reuptake inhibitor, phosphodiesterase inhibitor","PDE1A","neurology/psychiatry","stroke","Enzo",95.57,"BRD-K59273480-001-10-6","Launched","","RBQOQRRFDPXAGN-UHFFFAOYSA-N","BRD-K59273480","","CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12"
"10203","VINBURNINE","adrenergic receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","stroke","Enzo",98.61,"BRD-K40227168-001-12-9","Launched","","WYJAPUKIYAZSEM-MOPGFXCFSA-N","BRD-K40227168","","CC[C@@]12CCCN3CCc4c([C@H]13)n(C(=O)C2)c1ccccc41"
"10204","CITICOLINE","membrane permeability enhancer, glutathione transferase stimulant","ACHE, SLC1A2","neurology/psychiatry, ophthalmology","stroke, Alzheimer's disease, senile dementia, Parkinson's Disease, attention-deficit/hyperactivity disorder (ADHD), glaucoma","TargetMol, MicroSource, Cayman",99.5,"BRD-A91728607-001-01-8, BRD-A91728607-396-01-2, BRD-A91728607-236-11-9","Launched","BRD-A74441166-396-01-6","RZZPDXZPRHQOCG-OJAKKHQRSA-O","BRD-A91728607","BRD-A74441166","C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(N)nc1=O"
"10207","ATOSIBAN","oxytocin receptor antagonist","AVPR1A, AVPR1B, AVPR2, OXTR","neurology/psychiatry, cardiology, endocrinology","stroke, angina pectoris, myocardial infarction, hyperlipidemia","MedChemEx, MedChemEx, MedChemEx",75.28,"BRD-A85261566-001-02-5, BRD-A85261566-001-03-3, BRD-A85261566-001-01-7","Launched","","VWXRQYYUEIYXCZ-AVTFEHRISA-N","BRD-A85261566","","CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1"
"10210","ATORVASTATIN","HMGCR inhibitor","AHR, DPP4, HMGCR","neurology/psychiatry, cardiology","stroke, heart attack","Tocris, MicroSource, Selleck",97.04,"BRD-K69726342-238-03-2, BRD-K69726342-001-03-4, BRD-K69726342-238-02-4","Launched","BRD-M94983326-238-03-6, BRD-M94983326-238-02-8","XUKUURHRXDUEBC-KAYWLYCHSA-N","BRD-K69726342","BRD-M94983326","CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1"
"10213","TRIFLUSAL","cyclooxygenase inhibitor, platelet aggregation inhibitor, thromboxane synthase inhibitor","NFKB1, NOS2, PDE10A, PTGS1","neurology/psychiatry, cardiology","stroke, myocardial infarction, atrial fibrillation (AF)","MedChemEx, MedChemEx, Selleck, MedChemEx, Selleck",94.75,"BRD-K71696703-001-08-7, BRD-K71696703-001-11-1, BRD-K71696703-001-07-9, BRD-K71696703-001-09-5, BRD-K71696703-001-06-1","Launched","","RMWVZGDJPAKBDE-UHFFFAOYSA-N","BRD-K71696703","","CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F"
"10218","EDOXABAN","coagulation factor inhibitor","F10","neurology/psychiatry, hematology, cardiology","stroke, pulmonary embolism (PE), systemic embolism, deep vein thrombosis (DVT), atrial fibrillation (AF)","Selleck",95.16,"BRD-K29322660-001-01-9","Launched","","HGVDHZBSSITLCT-KMFMINBZSA-N","BRD-K29322660","","CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](C1)NC(=O)c1nc2CCN(C)Cc2s1"
"10219","RIVAROXABAN","coagulation factor inhibitor","F10","neurology/psychiatry, hematology, cardiology","stroke, systemic embolism, atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE)","MicroSource, Selleck",96.48,"BRD-K37130656-001-03-8, BRD-K37130656-001-04-6","Launched","BRD-A50033377-001-02-8","KGFYHTZWPPHNLQ-AWEZNQCLSA-N","BRD-K37130656","BRD-A50033377","Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O"
"10221","APIXABAN","coagulation factor inhibitor","F10","neurology/psychiatry, hematology, cardiology","stroke, systemic embolism, pulmonary embolism (PE), atrial fibrillation (AF), deep vein thrombosis (DVT)","Selleck, MicroSource",99.06,"BRD-K67121414-001-02-5, BRD-K67121414-001-03-3","Launched","","QNZCBYKSOIHPEH-UHFFFAOYSA-N","BRD-K67121414","","COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O"
"10223","DABIGATRAN","thrombin inhibitor","F2","neurology/psychiatry, hematology","stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)","MedChemEx, Selleck, MedChemEx, Selleck",77.34,"BRD-K38168441-001-04-5, BRD-K38168441-001-02-9, BRD-K38168441-001-05-2, BRD-K38168441-001-03-7","Launched","","YBSJFWOBGCMAKL-UHFFFAOYSA-N","BRD-K38168441","","Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1"
"10227","DABIGATRAN-ETEXILATE","thrombin inhibitor","F2","neurology/psychiatry, hematology","stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)","MicroSource, Selleck",92.78,"BRD-K57041787-066-01-1, BRD-K57041787-001-02-6","Launched","","KSGXQBZTULBEEQ-UHFFFAOYSA-N","BRD-K57041787","","CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1"
"10229","OXIBENDAZOLE","tubulin polymerization inhibitor","TUBB, TUBB4B","infectious disease","strongyles","MicroSource, Selleck",96.34,"BRD-K52075715-001-07-5, BRD-K52075715-001-06-7","Launched","","RAOCRURYZCVHMG-UHFFFAOYSA-N","BRD-K52075715","","CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1"
"10231","DEOXYCHOLIC-ACID","biliverdin reductase A activator, G protein-coupled receptor agonist","EFTUD1, FPR1, GPBAR1","endocrinology","submental fat","Enzo",100,"BRD-K41170226-001-13-8","Launched","","KXGVEGMKQFWNSR-LLQZFEROSA-N","BRD-K41170226","","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C"
"10232","KINETIN","cell division inducer","","dermatology","sunburn","Selleck",97.88,"BRD-K65667145-001-14-0","Launched","","QANMHLXAZMSUEX-UHFFFAOYSA-N","BRD-K65667145","","C(Nc1ncnc2[nH]cnc12)c1ccco1"
"10233","BEMOTRIZINOL","","","dermatology","sunscreen lotion","MicroSource",0,"BRD-A92974210-396-01-0","Launched","","XVAMCHGMPYWHNL-UHFFFAOYSA-N","BRD-A92974210","","CCCCC(CC)COc1ccc(c(O)c1)-c1nc(nc(n1)-c1ccc(OCC(CC)CCCC)cc1O)-c1ccc(OC)cc1"
"10234","CINOXATE","","","dermatology","sunscreen lotion","Enamine",95.2,"BRD-K17828029-001-01-5","Launched","","CMDKPGRTAQVGFQ-RMKNXTFCSA-N","BRD-K17828029","","CCOCCOC(=O)\C=C\c1ccc(OC)cc1"
"10235","DIETHYLTOLUAMIDE","ionotropic receptor IR40a activator","","dermatology","sunscreen lotion","MicroSource",98.89,"BRD-K94080537-001-09-7","Launched","","MMOXZBCLCQITDF-UHFFFAOYSA-N","BRD-K94080537","","CCN(CC)C(=O)c1cccc(C)c1"
"10236","ISOPENTYL-4-METHOXYCINNAMATE","","","dermatology","sunscreen lotion","Enamine",0,"BRD-K37851352-001-01-0","Launched","","UBNYRXMKIIGMKK-RMKNXTFCSA-N","BRD-K37851352","","COc1ccc(cc1)\C=C\C(=O)OCCC(C)C"
"10237","LISADIMATE","topical sunscreen agent","","dermatology","sunscreen lotion","Sigma",78.91,"BRD-A76533773-001-01-9","Launched","","WHQOKFZWSDOTQP-UHFFFAOYSA-N","BRD-A76533773","","Nc1ccc(cc1)C(=O)OCC(O)CO"
"10238","OCTINOXATE","","","dermatology","sunscreen lotion","MicroSource",95.81,"BRD-K19972289-001-01-4","Launched","","YBGZDTIWKVFICR-NRMKIYEFSA-N","BRD-K19972289","","CCCC[C@@H](CC)COC(=O)\C=C\c1ccc(OC)cc1"
"10239","OCTISALATE","","","dermatology","sunscreen lotion","MicroSource",98.81,"BRD-K95161686-001-02-8","Launched","","FMRHJJZUHUTGKE-GFCCVEGCSA-N","BRD-K95161686","","CCCC[C@@H](CC)COC(=O)c1ccccc1O"
"10240","OCTOCRYLENE","","","dermatology","sunscreen lotion","MicroSource",98.2,"BRD-K39023557-001-01-7","Launched","","FMJSMJQBSVNSBF-LJQANCHMSA-N","BRD-K39023557","","CCCC[C@@H](CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1"
"10241","OXYBENZONE","lipase inhibitor","LIPE","dermatology","sunscreen lotion","MicroSource",98.13,"BRD-K59037100-001-14-7","Launched","","DXGLGDHPHMLXJC-UHFFFAOYSA-N","BRD-K59037100","","COc1ccc(C(=O)c2ccccc2)c(O)c1"
"10242","PHENYLBENZIMIDAZOLE-SULFONIC-ACID","","","dermatology","sunscreen lotion","Vitas-M",92.52,"BRD-K02729857-001-01-9","Launched","","UVCJGUGAGLDPAA-UHFFFAOYSA-N","BRD-K02729857","","OS(=O)(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1"
"10243","SULISOBENZONE","","","dermatology","sunscreen lotion","MicroSource, ChemBridge",98.83,"BRD-K38602774-001-03-2, BRD-K38602774-002-01-4","Launched","BRD-K59265707-001-01-8","CXVGEDCSTKKODG-UHFFFAOYSA-N","BRD-K38602774","BRD-K59265707","COc1cc(O)c(cc1S(O)(=O)=O)C(=O)c1ccccc1"
"10245","3-(4-METHYLBENZYLIDENE)CAMPHOR","endocrine disruptor","","dermatology","sunscreen lotion","AlfaAesar",98.91,"BRD-A55464252-001-01-2","Launched","","HEOCBCNFKCOKBX-KAMYIIQDSA-N","BRD-A55464252","","Cc1ccc(cc1)\C=C1\C2CCC(C)(C1=O)C2(C)C"
"10246","BENZYL-BENZOATE","lipase inhibitor","LIPE","allergy","sweet itch","MicroSource, MedChemEx, Sigma",0,"BRD-K52072429-001-10-3, BRD-K52072429-001-12-9, BRD-K52072429-001-11-1","Launched","","SESFRYSPDFLNCH-UHFFFAOYSA-N","BRD-K52072429","","O=C(OCc1ccccc1)c1ccccc1"
"10249","MORANTEL","acetylcholine receptor agonist","","infectious disease","tapeworm","MicroSource",55.48,"BRD-K71454870-048-06-3","Launched","","NVEPPWDVLBMNMB-SNAWJCMRSA-N","BRD-K71454870","","CN1CCCN=C1\C=C\c1sccc1C"
"10250","NICLOSAMIDE","DNA replication inhibitor, STAT inhibitor","STAT3","infectious disease","tapeworm","MicroSource, Selleck",97.63,"BRD-K35960502-001-20-0, BRD-K35960502-001-19-2","Launched","","RJMUSRYZPJIFPJ-UHFFFAOYSA-N","BRD-K35960502","","Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O"
"10252","TRICLABENDAZOLE","microtubule inhibitor","DNMT1","infectious disease","tapeworm","MicroSource, Selleck",97.58,"BRD-K81916719-001-14-7, BRD-K81916719-001-13-9","Launched","","NQPDXQQQCQDHHW-UHFFFAOYSA-N","BRD-K81916719","","CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1"
"10254","PLICAMYCIN","alcohol dehydrogenase inhibitor","","oncology, endocrinology","testicular carcinoma, Paget's disease, hypercalcemia","Enzo",59.72,"BRD-K36368047-001-01-7","Launched","","CFCUWKMKBJTWLW-BGLFSJPPSA-N","BRD-K36368047","","CO[C@@H]([C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O"
"10255","DACTINOMYCIN","RNA polymerase inhibitor","POLR2A","oncology","testicular carcinoma, Wilm's tumor, rhabdomyosarcoma, Ewing's sarcoma, gestational trophoblastic disease (GTD)","MicroSource",77.87,"BRD-K70578146-001-06-7","Launched","","RJURFGZVJUQBHK-IIXSONLDSA-N","BRD-K70578146","","CC(C)[C@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O"
"10256","IFOSFAMIDE","DNA alkylating agent","CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1","oncology, urology","testicular carcinoma, hemorrhagic cystitis","MicroSource, Selleck",100,"BRD-A67097164-001-18-7, BRD-A67097164-001-17-9","Launched","","HOMGKSMUEGBAAB-UHFFFAOYSA-N","BRD-A67097164","","ClCCNP1(=O)OCCCN1CCCl"
"10258","CISPLATIN","DNA alkylating agent, DNA synthesis inhibitor","XIAP","oncology","testicular carcinoma, ovarian cancer, bladder cancer","Selleck, Tocris, MicroSource, Selleck",0,"BRD-K69172251-001-11-3, BRD-K69172251-001-09-7, BRD-K69172251-001-10-5, BRD-K69172251-001-08-9","Launched","BRD-K33494261-407-01-2, BRD-K01228321-318-04-3","DQLATGHUWYMOKM-UHFFFAOYSA-L","BRD-K69172251","BRD-K33494261","N[Pt](N)(Cl)Cl"
"10262","ETOPOSIDE-PHOSPHATE","topoisomerase inhibitor","TOP2A","oncology","testicular carcinoma, small cell lung cancer","ChemImpex",94.37,"BRD-K72533376-001-01-2","Launched","","LIQODXNTTZAGID-OCBXBXKTSA-N","BRD-K72533376","","COc1cc(cc(OC)c1OP(O)(O)=O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12"
"10263","DIHYDROTESTOSTERONE","androgen receptor agonist","AR, HSD17B1","neurology/psychiatry, endocrinology","tetany, hypoparathyroidism","MedChemEx",99.31,"BRD-K22525962-001-05-0","Launched","","NVKAWKQGWWIWPM-ABEVXSGRSA-N","BRD-K22525962","","C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O"
"10264","THIAMINE","vitamin B","SLC19A2, SLC19A3, TPK1","metabolism","thiamine deficiency","Selleck, MicroSource",96.41,"BRD-K95785345-300-14-8, BRD-K95785345-300-15-5","Launched","","JZRWCGZRTZMZEH-UHFFFAOYSA-N","BRD-K95785345","","Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N"
"10266","ANAGRELIDE","phosphodiesterase inhibitor","PDE3A","hematology, hematologic malignancy","thrombocythemia, myeloproliferative neoplasms","MicroSource, Selleck, Selleck",98.12,"BRD-K62200014-003-11-3, BRD-K62200014-001-02-6, BRD-K62200014-003-10-5","Launched","","OTBXOEAOVRKTNQ-UHFFFAOYSA-N","BRD-K62200014","","Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl"
"10269","AVATROMBOPAG","thrombopoietin receptor agonist","MPL","hematology","thrombocytopenia","MedChemEx",95.01,"BRD-K68544925-001-01-1","Launched","","OFZJKCQENFPZBH-UHFFFAOYSA-N","BRD-K68544925","","OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1"
"10270","INDOBUFEN","cyclooxygenase inhibitor, platelet aggregation inhibitor","PTGS1, PTGS2","hematology","thrombosis","AKSci",99.21,"BRD-A16296925-001-01-3","Launched","","AYDXAULLCROVIT-UHFFFAOYSA-N","BRD-A16296925","","CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O"
"10271","PICOTAMIDE","thromboxane receptor antagonist, thromboxane synthase inhibitor","TBXA2R","hematology","thrombosis","Prestwick",99.78,"BRD-K67277431-002-10-5","Launched","","KYWCWBXGRWWINE-UHFFFAOYSA-N","BRD-K67277431","","COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1"
"10272","DEXTRAN","","","hematology, critical care","thrombosis, hypovolemia","ANpharma",100,"BRD-K67117832-001-01-9","Launched","","FZWBNHMXJMCXLU-BLAUPYHCSA-N","BRD-K67117832","","OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O"
"10273","PHENPROCOUMON","vitamin K antagonist","VKORC1","hematology","thrombosis, pulmonary embolism (PE)","Abblis",97.47,"BRD-A49838158-001-01-1","Launched","","DQDAYGNAKTZFIW-UHFFFAOYSA-N","BRD-A49838158","","CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O"
"10274","TICLOPIDINE","purinergic receptor antagonist","P2RY12","hematology, neurology/psychiatry","thrombosis, stroke","MicroSource, Selleck",98.54,"BRD-K00603606-003-24-0, BRD-K00603606-003-23-2","Launched","","PHWBOXQYWZNQIN-UHFFFAOYSA-N","BRD-K00603606","","Clc1ccccc1CN1CCc2sccc2C1"
"10276","LENVATINIB","FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR","oncology","thyroid cancer","Selleck",98.78,"BRD-K39974922-001-04-3","Launched","","WOSKHXYHFSIKNG-UHFFFAOYSA-N","BRD-K39974922","","COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O"
"10277","PROTIRELIN","thyrotropin releasing hormone receptor agonist","TRHR","radiology","thyroid function diagnostic","MicroSource",96.18,"BRD-A16997652-001-02-3","Launched","","XNSAINXGIQZQOO-UHFFFAOYSA-N","BRD-A16997652","","NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1"
"10278","DIFTALONE","cyclooxygenase inhibitor","","endocrinology","thyroiditis","Vitas-M",98.16,"BRD-K80076813-001-08-8","Launched","","CXSJGNHRBWJXEA-UHFFFAOYSA-N","BRD-K80076813","","O=C1N2Cc3ccccc3C(=O)N2Cc2ccccc12"
"10279","BENZOIC-ACID","food preservative","DAO, HRSP12, PRDX5, RAB9A","infectious disease","tinea pedis","MicroSource, Selleck, Selleck",98.16,"BRD-K53397409-001-12-3, BRD-K53397409-001-11-5, BRD-K53397409-001-13-1","Launched","","WPYMKLBDIGXBTP-UHFFFAOYSA-N","BRD-K53397409","","OC(=O)c1ccccc1"
"10282","HALOPROGIN","other antifungal","","infectious disease","tinea pedis","Prestwick",98.19,"BRD-K13238168-001-02-0","Launched","","CTETYYAZBPJBHE-UHFFFAOYSA-N","BRD-K13238168","","Clc1cc(Cl)c(OCC#CI)cc1Cl"
"10283","SERTACONAZOLE","sterol demethylase inhibitor","","infectious disease","tinea pedis","Selleck",98.39,"BRD-A95939040-001-01-2","Launched","BRD-U65696040-000-01-2","JLGKQTAYUIMGRK-UHFFFAOYSA-N","BRD-A95939040","BRD-U65696040","Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1"
"10284","ZINC-UNDECYLENATE","other antifungal","","infectious disease","tinea pedis","MicroSource",0,"BRD-K13330768-001-01-1","Launched","BRD-K86452172-410-01-8","YMCOHQVWOBMDCZ-UHFFFAOYSA-L","BRD-K13330768","BRD-K86452172","C=CCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCC=C"
"10285","TOLNAFTATE","fungal squalene epoxidase inhibitor","","infectious disease","tinea pedis, tinea corporis","MicroSource, Selleck",99.91,"BRD-K44273375-001-25-0, BRD-K44273375-001-24-3","Launched","","FUSNMLFNXJSCDI-UHFFFAOYSA-N","BRD-K44273375","","CN(C(=S)Oc1ccc2ccccc2c1)c1cccc(C)c1"
"10287","UNDECYLENIC-ACID","other antifungal","","infectious disease","tinea pedis, tinea corporis","MicroSource, MedChemEx",25.82,"BRD-K19189338-001-03-2, BRD-K19189338-001-05-7","Launched","","FRPZMMHWLSIFAZ-UHFFFAOYSA-N","BRD-K19189338","","OC(=O)CCCCCCCCC=C"
"10289","BIFONAZOLE","sterol demethylase inhibitor","CYP2B6","infectious disease","tinea pedis, tinea cruris","MicroSource, Selleck",98.98,"BRD-A94543220-001-24-7, BRD-A94543220-001-23-9","Launched","","OCAPBUJLXMYKEJ-UHFFFAOYSA-N","BRD-A94543220","","c1cn(cn1)C(c1ccccc1)c1ccc(cc1)-c1ccccc1"
"10291","BUTENAFINE","fungal squalene epoxidase inhibitor","SQLE","infectious disease","tinea pedis, tinea cruris, tinea corporis","Selleck",97.73,"BRD-K90630139-003-05-9","Launched","","ABJKWBDEJIDSJZ-UHFFFAOYSA-N","BRD-K90630139","","CN(Cc1ccc(cc1)C(C)(C)C)Cc1cccc2ccccc12"
"10292","LULICONAZOLE","sterol demethylase inhibitor","","infectious disease","tinea pedis, tinea cruris, tinea corporis","Selleck",92.75,"BRD-K71058253-001-01-9","Launched","","YTAOBBFIOAEMLL-REQDGWNSSA-N","BRD-K71058253","","Clc1ccc([C@@H]2CS\C(S2)=C(\C#N)n2ccnc2)c(Cl)c1"
"10293","NAFTIFINE","fungal squalene epoxidase inhibitor","SQLE","infectious disease","tinea pedis, tinea cruris, tinea corporis","MicroSource, Selleck",98.83,"BRD-K74141488-003-11-2, BRD-K74141488-003-10-4","Launched","","OZGNYLLQHRPOBR-DHZHZOJOSA-N","BRD-K74141488","","CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12"
"10295","OXICONAZOLE","bacterial cell wall synthesis inhibitor","","infectious disease","tinea pedis, tinea cruris, tinea corporis","MicroSource",98.63,"BRD-K56104152-008-04-1","Launched","","QRJJEGAJXVEBNE-HKOYGPOVSA-N","BRD-K56104152","","Clc1ccc(CO\N=C(/Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1"
"10296","SULCONAZOLE","sterol demethylase inhibitor","","infectious disease","tinea pedis, tinea cruris, tinea corporis","Selleck, MicroSource",99.7,"BRD-A70649075-008-29-0, BRD-A70649075-008-30-8","Launched","","AFNXATANNDIXLG-UHFFFAOYSA-N","BRD-A70649075","","Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1"
"10298","TERBINAFINE","fungal squalene epoxidase inhibitor","SQLE","infectious disease","tinea pedis, tinea cruris, tinea corporis","MicroSource, Selleck, Selleck",98.49,"BRD-K68132782-003-14-6, BRD-K68132782-003-13-8, BRD-K68132782-001-03-3","Launched","","DOMXUEMWDBAQBQ-WEVVVXLNSA-N","BRD-K68132782","","CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12"
"10301","ECONAZOLE","lanosterol demethylase inhibitor, sterol demethylase inhibitor","CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5","infectious disease","tinea pedis, tinea cruris, tinea corporis, tinea versicolor, cutaneous candidiasis","Selleck, MicroSource",99.93,"BRD-A51820102-008-27-1, BRD-A51820102-008-28-9","Launched","","LEZWWPYKPKIXLL-UHFFFAOYSA-N","BRD-A51820102","","Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1"
"10303","CAROVERINE","glutamate receptor antagonist, calcium channel blocker","","neurology/psychiatry","tinnitus","Sigma",86.74,"BRD-K65900713-003-01-0","Launched","","GVZONAHBJMFJOW-UHFFFAOYSA-N","BRD-K65900713","","CCN(CC)CCN1C(=O)C(Nc2ccccc12)=Cc1ccc(OC)cc1"
"10304","EUGENOL","androgen receptor antagonist","AR","dental","toothache","MicroSource",92.11,"BRD-K32977963-001-05-0","Launched","","RRAFCDWBNXTKKO-UHFFFAOYSA-N","BRD-K32977963","","COc1cc(CC=C)ccc1O"
"10305","SPIRAMYCIN","bacterial 50S ribosomal subunit inhibitor","","infectious disease","toxoplasmosis, soft tissue infection","MicroSource, Selleck, Selleck",84.38,"BRD-A67305656-001-03-1, BRD-A67305656-001-02-3, BRD-A67305656-001-01-5","Launched","BRD-K14716343-001-04-8, BRD-K77056640-001-01-9,BRD-K14716343-001-06-3, BRD-K35824922-001-01-0","ACTOXUHEUCPTEW-YJTMPVKHSA-N","BRD-A67305656","BRD-K14716343","CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C"
"10308","DEFERASIROX","chelating agent","CYP3A4","hematology","transfusional hemosiderosis, thalassemia, iron overload","Selleck",97.73,"BRD-K97010173-001-04-1","Launched","","BOFQWVMAQOTZIW-UHFFFAOYSA-N","BRD-K97010173","","OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O"
"10309","DEFERIPRONE","chelating agent","UGT1A6","hematology","transfusional hemosiderosis, thalassemia, iron overload","MicroSource, Selleck",95.65,"BRD-K06878038-001-18-6, BRD-K06878038-001-17-8","Launched","","TZXKOCQBRNJULO-UHFFFAOYSA-N","BRD-K06878038","","Cc1c(O)c(=O)ccn1C"
"10311","BEDAQUILINE","ATPase inhibitor","","infectious disease","tuberculosis","MedChemEx, MedChemEx, MedChemEx",92.56,"BRD-K90817094-001-05-9, BRD-K90817094-001-02-6, BRD-K90817094-001-03-4","Launched","","QUIJNHUBAXPXFS-XLJNKUFUSA-N","BRD-K90817094","","COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12"
"10314","CAPREOMYCIN","protein synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, MedChemEx",100,"BRD-A33801468-065-04-1, BRD-A31362467-065-01-3","Launched","","JNIIDKODPGHQSS-OQLLNIDSSA-N","BRD-A33801468","","NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC1=O)=C/NC(N)=O)C1CCNC(=N)N1"
"10315","CAPREOMYCIN","protein synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, MedChemEx",100,"BRD-A33801468-065-04-1, BRD-A31362467-065-01-3","Launched","","JNIIDKODPGHQSS-OQLLNIDSSA-N","BRD-A33801468","","CC1NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=C/NC(N)=O)C1CCNC(=N)N1"
"10316","CAPREOMYCIN","protein synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, MedChemEx",100,"BRD-A33801468-065-04-1, BRD-A31362467-065-01-3","Launched","","FRXNXDHFQYZYNA-MHWRWJLKSA-N","BRD-A33801468","","NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC1=O)=C/NC(N)=O)C1CCNC(=N)N1"
"10317","CAPREOMYCIN","protein synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, MedChemEx",100,"BRD-A33801468-065-04-1, BRD-A31362467-065-01-3","Launched","","FRXNXDHFQYZYNA-MHWRWJLKSA-N","BRD-A33801468","","CC1NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=C/NC(N)=O)C1CCNC(=N)N1"
"10318","CYCLOSERINE-(D)","bacterial cell wall synthesis inhibitor","GRIN1","infectious disease","tuberculosis","MedChemEx, MicroSource, Selleck, MedChemEx, Selleck",0,"BRD-K87226815-001-21-3, BRD-K87226815-001-17-1, BRD-K87226815-001-18-9, BRD-K87226815-001-20-5, BRD-K87226815-001-19-7","Launched","BRD-K53226837-001-08-4","DYDCUQKUCUHJBH-UWTATZPHSA-N","BRD-K87226815","BRD-K53226837","N[C@@H]1CONC1=O"
"10323","DELAMANID","bacterial cell wall synthesis inhibitor","","infectious disease","tuberculosis","Adooq",97.31,"BRD-K17480742-001-01-1","Launched","","XDAOLTSRNUSPPH-XMMPIXPASA-N","BRD-K17480742","","C[C@]1(COc2ccc(cc2)N2CCC(CC2)Oc2ccc(OC(F)(F)F)cc2)Cn2cc(nc2O1)[N+]([O-])=O"
"10324","ETHAMBUTOL","bacterial cell wall synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, Selleck",100,"BRD-K93231391-300-06-4, BRD-K93231391-300-05-6","Launched","","AEUTYOVWOVBAKS-UWVGGRQHSA-N","BRD-K93231391","","CC[C@@H](CO)NCCN[C@@H](CC)CO"
"10326","ETHIONAMIDE","mycolic synthesis inhibitor","","infectious disease","tuberculosis","MicroSource, Selleck",98.1,"BRD-K51207550-001-23-0, BRD-K51207550-001-22-2","Launched","","AEOCXXJPGCBFJA-UHFFFAOYSA-N","BRD-K51207550","","CCc1cc(ccn1)C(S)=N"
"10328","ISONIAZID","FABI inhibitor","CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","infectious disease","tuberculosis","Selleck, MicroSource",100,"BRD-K87202646-001-32-6, BRD-K87202646-001-33-4","Launched","","QRXWMOHMRWLFEY-UHFFFAOYSA-N","BRD-K87202646","","NNC(=O)c1ccncc1"
"10330","PASINIAZID","cyclooxygenase inhibitor","","infectious disease","tuberculosis","MicroSource, Selleck",93.93,"BRD-K87202646-061-05-6, BRD-K87202646-061-04-9","Launched","","QRXWMOHMRWLFEY-UHFFFAOYSA-N","BRD-K87202646","","NNC(=O)c1ccncc1"
"10332","PERCHLOZONE","","","infectious disease","tuberculosis","Vitas-M",99.35,"BRD-K86435560-001-01-0","Launched","","QTSJJDIDTYFLFC-UHFFFAOYSA-N","BRD-K86435560","","NC(=S)NN=Cc1ccncc1"
"10333","PHENYL-AMINOSALICYLATE","","","infectious disease","tuberculosis","MicroSource",99.55,"BRD-K73157543-001-04-1","Launched","","DNVVZWSVACQWJE-UHFFFAOYSA-N","BRD-K73157543","","Nc1ccc(C(=O)Oc2ccccc2)c(O)c1"
"10334","PROTIONAMIDE","","","infectious disease","tuberculosis","MicroSource, Selleck",94.39,"BRD-K75360161-001-18-0, BRD-K75360161-001-17-2","Launched","","VRDIULHPQTYCLN-UHFFFAOYSA-N","BRD-K75360161","","CCCc1cc(ccn1)C(S)=N"
"10336","PYRAZINAMIDE","fatty acid synthase inhibitor","FASN","infectious disease","tuberculosis","Selleck, MicroSource",98.54,"BRD-K28667793-001-27-3, BRD-K28667793-001-28-1","Launched","","IPEHBUMCGVEMRF-UHFFFAOYSA-N","BRD-K28667793","","NC(=O)c1cnccn1"
"10338","RIFAPENTINE","RNA polymerase inhibitor","CYP2C8, CYP2C9, CYP3A4","infectious disease","tuberculosis","Selleck, MedChemEx, Selleck",71.91,"BRD-K28346421-001-08-4, BRD-K28346421-001-07-6, BRD-K28346421-001-06-8","Launched","BRD-K55889443-001-03-4, BRD-K42569090-001-01-8, BRD-K62325629-001-01-0","WDZCUPBHRAEYDL-GZAUEHORSA-N","BRD-K28346421","BRD-K55889443","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10341","STREPTOMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","tuberculosis","Selleck, Selleck, MicroSource",94.3,"BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7","Launched","BRD-K91768078-330-01-5,BRD-M30124979-326-01-1, BRD-K91768078-330-02-3,BRD-M87628937-326-02-2","UCSJYZPVAKXKNQ-HZYVHMACSA-N","BRD-K07166362","BRD-K91768078","CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O"
"10343","STREPTOMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","tuberculosis","Selleck, Selleck, MicroSource",94.3,"BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7","Launched","BRD-K91768078-330-01-5,BRD-M30124979-326-01-1, BRD-K91768078-330-02-3,BRD-M87628937-326-02-2","UCSJYZPVAKXKNQ-HZYVHMACSA-N","BRD-K07166362","BRD-K91768078","CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O"
"10344","STREPTOMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","tuberculosis","Selleck, Selleck, MicroSource",94.3,"BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7","Launched","BRD-K91768078-330-01-5,BRD-M30124979-326-01-1, BRD-K91768078-330-02-3,BRD-M87628937-326-02-2","UCSJYZPVAKXKNQ-HUOHZKRVSA-N","BRD-K07166362","BRD-K91768078","CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O"
"10346","STREPTOMYCIN","bacterial 30S ribosomal subunit inhibitor","","infectious disease","tuberculosis","Selleck, Selleck, MicroSource",94.3,"BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7","Launched","BRD-K91768078-330-01-5,BRD-M30124979-326-01-1, BRD-K91768078-330-02-3,BRD-M87628937-326-02-2","UCSJYZPVAKXKNQ-HUOHZKRVSA-N","BRD-K07166362","BRD-K91768078","CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O"
"10347","VIOMYCIN","protein synthesis inhibitor","","infectious disease","tuberculosis","Prestwick",39.8,"BRD-A42379279-065-03-8","Launched","","GXFAIFRPOKBQRV-IKZNKTFNSA-N","BRD-A42379279","","NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)C1C[C@H](O)N=C(N)N1"
"10348","RIFAMYCIN","DNA directed RNA polymerase inhibitor","SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1","infectious disease","tuberculosis, leprosy","AvaChem",2.86,"BRD-K38512030-001-01-7","Launched","","HJYYPODYNSCCOU-ODRIEIDWSA-N","BRD-K38512030","","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10349","RIFAMPIN","RNA polymerase inhibitor","NR1I2, SLCO1A2, SLCO1B1, SLCO1B3","infectious disease","tuberculosis, meningitis","Selleck, MicroSource, Selleck",89.01,"BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9","Launched","BRD-K66218091-001-01-2, BRD-K56156786-001-01-6","JQXXHWHPUNPDRT-WLSIYKJHSA-N","BRD-K01507359","BRD-K66218091","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10350","RIFAMPIN","RNA polymerase inhibitor","NR1I2, SLCO1A2, SLCO1B1, SLCO1B3","infectious disease","tuberculosis, meningitis","Selleck, MicroSource, Selleck",89.01,"BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9","Launched","BRD-K66218091-001-01-2, BRD-K56156786-001-01-6","JQXXHWHPUNPDRT-WLSIYKJHSA-N","BRD-K01507359","BRD-K66218091","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10352","RIFAMPIN","RNA polymerase inhibitor","NR1I2, SLCO1A2, SLCO1B1, SLCO1B3","infectious disease","tuberculosis, meningitis","Selleck, MicroSource, Selleck",89.01,"BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9","Launched","BRD-K66218091-001-01-2, BRD-K56156786-001-01-6","JQXXHWHPUNPDRT-OUBGVEFFSA-N","BRD-K01507359","BRD-K66218091","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10353","RIFAMPIN","RNA polymerase inhibitor","NR1I2, SLCO1A2, SLCO1B1, SLCO1B3","infectious disease","tuberculosis, meningitis","Selleck, MicroSource, Selleck",89.01,"BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9","Launched","BRD-K66218091-001-01-2, BRD-K56156786-001-01-6","JQXXHWHPUNPDRT-OUBGVEFFSA-N","BRD-K01507359","BRD-K66218091","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C"
"10355","NITISINONE","hydroxyphenylpyruvate dioxygenase inhibitor","HPD","metabolism","tyrosinemia","MedChemEx, Enzo",87.67,"BRD-K01109406-001-04-5, BRD-K01109406-001-03-7","Launched","","OUBCNLGXQFSTLU-UHFFFAOYSA-N","BRD-K01109406","","[O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F"
"10357","BALSALAZIDE","cyclooxygenase inhibitor","ALOX5, PPARG, PTGS1, PTGS2","gastroenterology","ulcerative colitis","MicroSource",97.52,"BRD-K41410256-304-02-2","Launched","","IPOKCKJONYRRHP-UHFFFAOYSA-N","BRD-K41410256","","OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O"
"10358","OLSALAZINE","cyclooxygenase inhibitor","IFNG, TPMT","gastroenterology","ulcerative colitis","Selleck, MicroSource",98.41,"BRD-K57853941-304-02-5, BRD-K57853941-304-03-3","Launched","","QQBDLJCYGRGAKP-FOCLMDBBSA-N","BRD-K57853941","","OC(=O)c1cc(ccc1O)\N=N\c1ccc(O)c(c1)C(O)=O"
"10360","SULFASALAZINE","cyclooxygenase inhibitor","ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1","gastroenterology","ulcerative colitis","Tocris, MicroSource, Selleck",97.78,"BRD-K10670311-001-17-1, BRD-K10670311-001-15-5, BRD-K10670311-001-14-8","Launched","","NCEXYHBECQHGNR-QZQOTICOSA-N","BRD-K10670311","","OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1"
"10363","COUMARIN","vitamin K antagonist","CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6","gastroenterology, pulmonary","ulcerative colitis, asthma, celiac disease","MicroSource, Selleck",99.45,"BRD-K23913458-001-20-7, BRD-K23913458-001-19-9","Launched","","ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","BRD-K23913458","","O=c1ccc2ccccc2o1"
"10365","MENADIONE","mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1","gastroenterology, neurology/psychiatry, dermatology, rheumatology","ulcerative colitis, diarrhea, headache, varicose veins, rheumatoid arthritis","Selleck, Selleck, MicroSource",98.17,"BRD-K78126613-001-27-7, BRD-K78126613-001-29-3, BRD-K78126613-001-28-5","Launched","","MJVAVZPDRWSRRC-UHFFFAOYSA-N","BRD-K78126613","","CC1=CC(=O)c2ccccc2C1=O"
"10368","MESALAZINE","cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2","gastroenterology","ulcerative colitis, inflammatory bowel disease","Selleck, MicroSource, Selleck",90.1,"BRD-K28849549-001-13-4, BRD-K28849549-001-12-6, BRD-K28849549-001-11-8","Launched","","KBOPZPXVLCULAV-UHFFFAOYSA-N","BRD-K28849549","","Nc1ccc(O)c(c1)C(O)=O"
"10371","CORTISONE","glucocorticoid receptor agonist","NR3C1","gastroenterology, rheumatology, dermatology","ulcerative colitis, rheumatoid arthritis, psoriasis, joint inflammation, eczema","MicroSource",93.59,"BRD-A62731508-001-05-8","Launched","","MFYSYFVPBJMHGN-BDQMTFAOSA-N","BRD-A62731508","","C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO"
"10372","PHENYLBUTYRATE","HDAC inhibitor","HDAC1","metabolism","urea cycle disorders","MicroSource, Tocris, Selleck, Tocris",97.03,"BRD-K67102207-236-08-5, BRD-K67102207-236-07-7, BRD-K67102207-236-06-9, BRD-K67102207-236-10-1","Launched","","OBKXEAXTFZPCHS-UHFFFAOYSA-N","BRD-K67102207","","OC(=O)CCCc1ccccc1"
"10376","NALFURAFINE","opioid receptor agonist","OPRK1, OPRM1","nephrology","uremic pruritus","MedChemEx",97.5,"BRD-K89272869-003-01-8","Launched","","XGZZHZMWIXFATA-UEZBDDGYSA-N","BRD-K89272869","","CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)\C=C\c1ccoc1"
"10377","CHLOROPHYLLIN","","","urology","urinary incontinence","Adooq",5.35,"BRD-K23728266-001-01-1","Preclinical","","OYINILBBZAQBEV-UWJYYQICSA-N","BRD-K23728266","","CCc1c(C)c2cc3[nH]c(cc4nc([C@@H](CCC(O)=O)[C@@H]4C)c(CC(O)=O)c4nc(cc1[nH]2)c(C)c4C(O)=O)c(C)c3C=C"
"10378","DARIFENACIN","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","urology","urinary incontinence","MicroSource, Selleck",95.96,"BRD-K95773607-004-04-6, BRD-K95773607-004-03-8","Launched","BRD-K95773607-001-03-4,BRD-A01118042-004-01-8","HXGBXQDTNZMWGS-RUZDIDTESA-N","BRD-K95773607","BRD-K95773607","NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1"
"10380","FESOTERODINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","urology","urinary incontinence","Selleck, Selleck",88.03,"BRD-K46731503-050-01-8, BRD-K46731503-051-04-0","Launched","","DCCSDBARQIPTGU-HSZRJFAPSA-N","BRD-K46731503","","CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1OC(=O)C(C)C)C(C)C"
"10382","MIRABEGRON","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","urology","urinary incontinence","Selleck, Selleck",95.25,"BRD-K47949423-001-02-3, BRD-K47949423-001-03-1","Launched","","PBAPPPCECJKMCM-IBGZPJMESA-N","BRD-K47949423","","Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1"
"10384","OXYBUTYNIN","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","urology","urinary incontinence","MicroSource, Selleck, Selleck",95.56,"BRD-A65013509-003-24-4, BRD-A65013509-001-02-4, BRD-A65013509-003-23-6","Launched","","XIQVNETUBQGFHX-UHFFFAOYSA-N","BRD-A65013509","","CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1"
"10387","PROPIVERINE","acetylcholine receptor antagonist","CHRM1","urology","urinary incontinence","Sigma",97.84,"BRD-K91244729-003-01-3","Launched","","QPCVHQBVMYCJOM-UHFFFAOYSA-N","BRD-K91244729","","CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1"
"10388","FLAVOXATE","acetylcholine receptor antagonist","CHRM1, CHRM2","urology","urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis","Selleck",96.85,"BRD-K47639036-003-06-6","Launched","","SPIUTQOUKAMGCX-UHFFFAOYSA-N","BRD-K47639036","","Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1"
"10389","SOLIFENACIN-SUCCINATE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","urology","urinary incontinence, urinary frequency","MicroSource, Selleck",97.36,"BRD-K24723746-001-01-1, BRD-K24723746-036-02-5","Launched","","FBOUYBDGKBSUES-VXKWHMMOSA-N","BRD-K24723746","","O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1"
"10391","TOLTERODINE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","urology","urinary incontinence, urinary frequency","Tocris, Selleck, Selleck",90.63,"BRD-K54316499-046-06-0, BRD-K54316499-046-05-2, BRD-K54316499-046-04-5","Launched","","OOGJQPCLVADCPB-HXUWFJFHSA-N","BRD-K54316499","","CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C"
"10394","TROSPIUM","acetylcholine receptor antagonist","CHRM1","urology","urinary incontinence, urinary frequency","Selleck",97.42,"BRD-K69469734-003-02-5","Launched","","OYYDSUSKLWTMMQ-JKHIJQBDSA-N","BRD-K69469734","","OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(c1ccccc1)c1ccccc1"
"10395","BETHANECHOL","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","urology","urinary retention","MicroSource, Selleck, Selleck",100,"BRD-A99833829-003-26-3, BRD-A99833829-003-27-1, BRD-A99833829-003-25-5","Launched","","NZUPCNDJBJXXRF-UHFFFAOYSA-O","BRD-A99833829","","CC(C[N+](C)(C)C)OC(N)=O"
"10398","ACETOHYDROXAMIC-ACID","urease inhibitor","MMP12","infectious disease","urinary tract infections","MicroSource",0,"BRD-K21615095-001-08-4","Launched","","RRUDCFGSUDOHDG-UHFFFAOYSA-N","BRD-K21615095","","CC(=O)NO"
"10399","CINOXACIN","topoisomerase inhibitor","","infectious disease","urinary tract infections","MicroSource, Selleck",93.53,"BRD-K14704277-001-23-4, BRD-K14704277-001-22-6","Launched","","VDUWPHTZYNWKRN-UHFFFAOYSA-N","BRD-K14704277","","CCn1nc(C(O)=O)c(=O)c2cc3OCOc3cc12"
"10401","FLUMEQUINE","topoisomerase inhibitor","","infectious disease","urinary tract infections","MicroSource, Selleck",98.1,"BRD-A69777949-001-25-9, BRD-A69777949-001-24-2","Launched","","DPSPPJIUMHPXMA-UHFFFAOYSA-N","BRD-A69777949","","CC1CCc2cc(F)cc3c2n1cc(C(O)=O)c3=O"
"10403","FOSFOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections","Selleck, MicroSource",100,"BRD-K81101512-234-01-9, BRD-A10652366-238-04-1","Launched","BRD-K48461310-234-01-3","YMDXZJFXQJVXBF-STHAYSLISA-N","BRD-K81101512","BRD-K48461310","C[C@@H]1O[C@@H]1P(O)(O)=O"
"10404","FOSFOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections","Selleck, MicroSource",100,"BRD-K81101512-234-01-9, BRD-A10652366-238-04-1","Launched","BRD-K48461310-234-01-3","YMDXZJFXQJVXBF-STHAYSLISA-N","BRD-K81101512","BRD-K48461310","CC1OC1P(O)(O)=O"
"10405","FOSFOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections","Selleck, MicroSource",100,"BRD-K81101512-234-01-9, BRD-A10652366-238-04-1","Launched","BRD-K48461310-234-01-3","YMDXZJFXQJVXBF-UHFFFAOYSA-N","BRD-K81101512","BRD-K48461310","C[C@@H]1O[C@@H]1P(O)(O)=O"
"10406","FOSFOMYCIN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections","Selleck, MicroSource",100,"BRD-K81101512-234-01-9, BRD-A10652366-238-04-1","Launched","BRD-K48461310-234-01-3","YMDXZJFXQJVXBF-UHFFFAOYSA-N","BRD-K81101512","BRD-K48461310","CC1OC1P(O)(O)=O"
"10407","METHENAMINE","bacterial DNA inhibitor","","infectious disease","urinary tract infections","Selleck, MicroSource",100,"BRD-K30114692-001-15-9, BRD-K30114692-001-16-7","Launched","","VKYKSIONXSXAKP-UHFFFAOYSA-N","BRD-K30114692","","C1N2CN3CN1CN(C2)C3"
"10409","NALIDIXIC-ACID","bacterial DNA gyrase inhibitor","","infectious disease","urinary tract infections","MicroSource, Selleck",97.94,"BRD-K47886988-001-22-2, BRD-K47886988-001-21-4","Launched","","MHWLWQUZZRMNGJ-UHFFFAOYSA-N","BRD-K47886988","","CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12"
"10411","NITROXOLINE","cathepsin inhibitor","METAP2","infectious disease","urinary tract infections","MedChemEx, MicroSource",62.54,"BRD-K97534525-001-24-3, BRD-K97534525-001-23-5","Launched","","RJIWZDNTCBHXAL-UHFFFAOYSA-N","BRD-K97534525","","Oc1ccc([N+]([O-])=O)c2cccnc12"
"10413","ORBIFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease","urinary tract infections","MicroSource, Selleck, Selleck",99.48,"BRD-K63001556-001-08-8, BRD-K63001556-001-10-4, BRD-K63001556-001-09-6","Launched","BRD-K68153448-001-01-9","QIPQASLPWJVQMH-DTORHVGOSA-N","BRD-K63001556","BRD-K68153448","C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1"
"10416","PHENAZOPYRIDINE","local anesthetic","SCN1A","infectious disease","urinary tract infections","Selleck, MicroSource, Selleck",96.12,"BRD-K76304753-003-19-5, BRD-K76304753-003-20-3, BRD-K76304753-003-21-1","Launched","","QPFYXYFORQJZEC-FOCLMDBBSA-N","BRD-K76304753","","Nc1ccc(\N=N\c2ccccc2)c(N)n1"
"10419","ROSOXACIN","topoisomerase inhibitor","","infectious disease","urinary tract infections","Accela",98.05,"BRD-K49841478-001-01-6","Launched","","XBPZXDSZHPDXQU-UHFFFAOYSA-N","BRD-K49841478","","CCn1cc(C(O)=O)c(=O)c2ccc(cc12)-c1ccncc1"
"10420","SULFACHLORPYRIDAZINE","bacterial antifolate","","infectious disease","urinary tract infections","MicroSource",98.26,"BRD-K32021043-001-14-3","Launched","","XOXHILFPRYWFOD-UHFFFAOYSA-N","BRD-K32021043","","Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)nn1"
"10421","SULFAFURAZOLE","bacterial antifolate","","infectious disease","urinary tract infections","Tocris, MicroSource, Selleck",97.76,"BRD-K50859149-001-18-7, BRD-K50859149-001-19-5, BRD-K50859149-001-17-9","Launched","","NHUHCSRWZMLRLA-UHFFFAOYSA-N","BRD-K50859149","","Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C"
"10424","SULFAGUANIDINE","bacterial antifolate","","infectious disease","urinary tract infections","MicroSource, Selleck, Selleck",100,"BRD-K45086103-001-15-5, BRD-K45086103-001-14-8, BRD-K45086103-001-16-3","Launched","","BRBKOPJOKNSWSG-UHFFFAOYSA-N","BRD-K45086103","","NC(=N)NS(=O)(=O)c1ccc(N)cc1"
"10427","SULFAMETER","dihydrofolate reductase inhibitor","DHFR","infectious disease","urinary tract infections","Selleck, MicroSource",98.75,"BRD-K87492696-001-15-7, BRD-K87492696-001-16-5","Launched","","GPTONYMQFTZPKC-UHFFFAOYSA-N","BRD-K87492696","","COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1"
"10429","SULFAMETHIZOLE","bacterial antifolate","","infectious disease","urinary tract infections","MicroSource, Selleck",93.08,"BRD-K31682896-001-24-0, BRD-K31682896-001-23-2","Launched","","VACCAVUAMIDAGB-UHFFFAOYSA-N","BRD-K31682896","","Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1"
"10431","SULFAMONOMETHOXINE","bacterial antifolate","","infectious disease","urinary tract infections","MicroSource",97.68,"BRD-K14116214-001-09-6","Launched","","WMPXPUYPYQKQCX-UHFFFAOYSA-N","BRD-K14116214","","COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1"
"10432","SULFAMOXOLE","PABA antagonist","","infectious disease","urinary tract infections","Sigma, SantaCruz",70.9,"BRD-K19742012-001-02-3, BRD-K19742012-001-01-5","Launched","","CYFLXLSBHQBMFT-UHFFFAOYSA-N","BRD-K19742012","","Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C"
"10434","SULFAPHENAZOLE","dihydropteroate synthetase inhibitor","DHPS","infectious disease","urinary tract infections","MicroSource",90.33,"BRD-K10671814-001-14-8","Launched","","QWCJHSGMANYXCW-UHFFFAOYSA-N","BRD-K10671814","","Nc1ccc(cc1)S(=O)(=O)Nc1ccnn1-c1ccccc1"
"10435","PRULIFLOXACIN","bacterial DNA gyrase inhibitor","","infectious disease, pulmonary, gastroenterology","urinary tract infections, bronchitis, diarrhea","MicroSource, MedChemEx",79.74,"BRD-A92341659-001-03-2, BRD-A92341659-001-04-0","Launched","BRD-A96891111-001-01-8","PWNMXPDKBYZCOO-UHFFFAOYSA-N","BRD-A92341659","BRD-A96891111","CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1"
"10437","MIOCAMYCIN","other antibiotic","","infectious disease","urinary tract infections, chlamydia","AvaChem",92.27,"BRD-K30764557-001-01-5","Launched","","GQNZGCARKRHPOH-RQIKCTSVSA-N","BRD-K30764557","","CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(C)=O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](OC(C)=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C"
"10438","TRIMETHOPRIM","dihydrofolate reductase inhibitor","DHFR, TYMS","infectious disease, gastroenterology","urinary tract infections, ear infections, diarrhea","MicroSource, Selleck",98.69,"BRD-K07208025-001-31-3, BRD-K07208025-001-29-7","Launched","","IEDVJHCEMCRBQM-UHFFFAOYSA-N","BRD-K07208025","","COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC"
"10440","ENOXACIN","topoisomerase inhibitor","TOP2A","infectious disease","urinary tract infections, gonorrhea","MicroSource, Selleck, Selleck",89.69,"BRD-K78113049-001-16-2, BRD-K78113049-001-15-4, BRD-K78113049-001-17-0","Launched","","IDYZIJYBMGIQMJ-UHFFFAOYSA-N","BRD-K78113049","","CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1"
"10443","NORFLOXACIN","bacterial DNA gyrase inhibitor","TOP2A","infectious disease, urology","urinary tract infections, gonorrhea, prostatitis","Selleck, Selleck, MicroSource",98.57,"BRD-K11196887-001-22-0, BRD-K11196887-001-20-4, BRD-K11196887-001-21-2","Launched","","OGJPXUAPXNRGGI-UHFFFAOYSA-N","BRD-K11196887","","CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1"
"10446","AMDINOCILLIN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, gram-negative bacterial infections","Sigma",61.16,"BRD-K41051431-001-02-4","Launched","","BWWVAEOLVKTZFQ-ISVUSNJMSA-N","BRD-K41051431","","CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(O)=O"
"10447","CARUMONAM","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, gram-negative bacterial infections","Sigma",97.4,"BRD-K71026158-304-01-0","Launched","","UIMOJFJSJSIGLV-JNHMLNOCSA-N","BRD-K71026158","","NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O"
"10448","PIVMECILLINAM","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, gram-negative bacterial infections","Sigma, Prestwick, MedChemEx",95.37,"BRD-K67100011-001-01-8, BRD-K67100011-003-06-3, BRD-K67100011-003-07-1","Launched","","NPGNOVNWUSPMDP-UTEPHESZSA-N","BRD-K67100011","","CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O"
"10451","CEFIXIME","bacterial cell wall synthesis inhibitor","","infectious disease, otolaryngology, pulmonary","urinary tract infections, otitis, pharyngitis, tonsillitis, gonorrhea, bronchitis","Sigma, MedChemEx, Enzo",93.65,"BRD-K71059170-341-02-5, BRD-K71059170-001-12-4, BRD-K71059170-001-11-6","Launched","","OKBVVJOGVLARMR-QSWIMTSFSA-N","BRD-K71059170","","Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O"
"10454","NITROFURANTOIN","DNA inhibitor","","infectious disease","urinary tract infections, pyelonephritis","MedChemEx, MedChemEx, MicroSource",83.96,"BRD-K76927775-001-13-4, BRD-K76927775-001-11-8, BRD-K76927775-001-10-0","Launched","","NXFQHRVNIOXGAQ-YCRREMRBSA-N","BRD-K76927775","","[O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1"
"10457","AZTREONAM","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, respiratory tract infections, bacterial septicemia, skin infections, intra-abdominal infections, gynecologic infections","MicroSource, Selleck, Selleck",90.6,"BRD-K62607865-236-02-4, BRD-K62607865-001-09-7, BRD-K62607865-236-01-6","Launched","BRD-K36547807-001-03-2, BRD-K41270709-001-01-7","WZPBZJONDBGPKJ-VEHQQRBSSA-N","BRD-K62607865","BRD-K36547807","C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O"
"10460","CEFOTETAN","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, respiratory tract infections, skin infections, gynecologic infections, chlamydia, intra-abdominal infections, bone and joint infections, surgical prophylaxis","MicroSource",88.4,"BRD-A78723049-001-01-2","Launched","","SRZNHPXWXCNNDU-PGEKIEPBSA-N","BRD-A78723049","","CO[C@]1(NC(=O)C2SC(S2)=C(C(N)=O)C(O)=O)C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10461","CEFMETAZOLE","bacterial cell wall synthesis inhibitor","","infectious disease","urinary tract infections, skin infections","MedChemEx, MedChemEx, MicroSource",89.48,"BRD-K48470486-236-11-6, BRD-K48470486-236-10-8, BRD-K48470486-236-12-4","Launched","BRD-A97040294-236-04-6","SNBUBQHDYVFSQF-HIFRSBDPSA-N","BRD-K48470486","BRD-A97040294","CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O"
"10464","CEFAZOLIN","bacterial cell wall synthesis inhibitor","PON1","infectious disease","urinary tract infections, skin infections, bacterial septicemia, endocarditis, surgical prophylaxis, bone and joint infections","MedChemEx, MicroSource, MedChemEx",87.37,"BRD-K99750640-236-20-3, BRD-K99750640-236-18-7, BRD-K99750640-236-19-5","Launched","","MLYYVTUWGNIJIB-BXKDBHETSA-N","BRD-K99750640","","Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1"
"10467","CEFADROXIL","bacterial cell wall synthesis inhibitor","SLC15A1, SLC15A2, SLC22A6, SLC22A8","infectious disease, otolaryngology","urinary tract infections, skin infections, tonsillitis, pharyngitis","MicroSource",87.28,"BRD-A56858165-001-04-4","Launched","","BOEGTKLJZSQCCD-HUFXEGEASA-N","BRD-A56858165","","CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O"
"10468","MIZOLASTINE","histamine receptor antagonist","HRH1","allergy","urticaria, allergic rhinitis","Selleck",98.43,"BRD-K21884483-001-03-7","Launched","","PVLJETXTTWAYEW-UHFFFAOYSA-N","BRD-K21884483","","CN(C1CCN(CC1)c1nc2ccccc2n1Cc1ccc(F)cc1)c1nccc(=O)[nH]1"
"10469","TRIMEPRAZINE","histamine receptor ligand, histamine receptor antagonist","HRH1","allergy, neurology/psychiatry, pulmonary","urticaria, itching, cough suppressant","Sigma",0,"BRD-M58473998-046-01-0","Launched","","QVKSGMJGGSXIQM-UHFFFAOYSA-N","BRD-M58473998","","CC(CN(C)C)CN1c2ccccc2Sc2ccccc12.CC(CN(C)C)CN1c2ccccc2Sc2ccccc12"
"10470","HOMATROPINE-METHYLBROMIDE","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","ophthalmology","uveal tract inflammation","MicroSource",96.2,"BRD-A43999749-004-04-1","Launched","","WKWOJBUWWZTUQV-JWMHWRSXSA-N","BRD-A43999749","","C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1"
"10471","OSPEMIFENE","selective estrogen receptor modulator (SERM)","ESR1, ESR2","obstetrics/gynecology, endocrinology","vaginal atrophy, dyspareunia, menopause","Selleck",99.9,"BRD-K44184170-001-01-7","Launched","","LUMKNAVTFCDUIE-VHXPQNKSSA-N","BRD-K44184170","","OCCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1"
"10472","ESCIN","nitric oxide synthase stimulant","","dermatology","varicose veins","MicroSource",34.56,"BRD-A90796352-001-04-7","Launched","","AXNVHPCVMSNXNP-LGWBRZJHSA-N","BRD-A90796352","","C\C=C(\C)C(=O)O[C@@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)C5CC[C@@]34C)C2CC1(C)C"
"10473","POLIDOCANOL","local anesthetic","","dermatology","varicose veins","Sigma",97.44,"BRD-K35798650-001-01-4","Launched","","ONJQDTZCDSESIW-UHFFFAOYSA-N","BRD-K35798650","","CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO"
"10474","SODIUM-TETRADECYL-SULFATE","","PROC, PROS1","dermatology","varicose veins, varicose veins","MicroSource, AlfaAesar",100,"BRD-A55664972-236-02-6, BRD-K84544951-236-01-0","Launched","","GROJOWHVXQYQGN-UHFFFAOYSA-N","BRD-A55664972","","CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O"
"10475","SODIUM-TETRADECYL-SULFATE","","PROC, PROS1","dermatology","varicose veins, varicose veins","MicroSource, AlfaAesar",100,"BRD-A55664972-236-02-6, BRD-K84544951-236-01-0","Launched","","GROJOWHVXQYQGN-UHFFFAOYSA-N","BRD-A55664972","","CCCCCCCCCCCCCCOS(O)(=O)=O"
"10476","SODIUM-TETRADECYL-SULFATE","","PROC, PROS1","dermatology","varicose veins, varicose veins","MicroSource, AlfaAesar",100,"BRD-A55664972-236-02-6, BRD-K84544951-236-01-0","Launched","","URLJMZWTXZTZRR-UHFFFAOYSA-N","BRD-A55664972","","CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O"
"10477","SODIUM-TETRADECYL-SULFATE","","PROC, PROS1","dermatology","varicose veins, varicose veins","MicroSource, AlfaAesar",100,"BRD-A55664972-236-02-6, BRD-K84544951-236-01-0","Launched","","URLJMZWTXZTZRR-UHFFFAOYSA-N","BRD-A55664972","","CCCCCCCCCCCCCCOS(O)(=O)=O"
"10478","NIFEDIPINE","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3","cardiology","vasospastic angina, chronic stable angina","MedChemEx, MedChemEx, Tocris, Selleck, MicroSource, Selleck",96.3,"BRD-K96354014-001-29-4, BRD-K96354014-001-27-8, BRD-K96354014-001-15-3, BRD-K96354014-001-21-1, BRD-K96354014-001-17-9, BRD-K96354014-001-14-6","Launched","","HYIMSNHJOBLJNT-UHFFFAOYSA-N","BRD-K96354014","","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC"
"10484","AMIODARONE","potassium channel blocker","ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2","cardiology","ventricular arrhythmias","MicroSource, Selleck, Selleck",91.22,"BRD-K17561142-003-33-3, BRD-K17561142-003-35-8, BRD-K17561142-003-32-5","Launched","","IYIKLHRQXLHMJQ-UHFFFAOYSA-N","BRD-K17561142","","CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1"
"10487","MORACIZINE","sodium channel blocker","SCN5A","cardiology","ventricular arrhythmias","Prestwick",99.39,"BRD-K21548250-003-19-1","Launched","","FUBVWMNBEHXPSU-UHFFFAOYSA-N","BRD-K21548250","","CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN3CCOCC3)c2c1"
"10488","DOPAMINE","dopamine receptor agonist","DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4","cardiology, neurology/psychiatry","ventricular arrhythmias, depression, headache, tremors","MicroSource, Selleck, Selleck",100,"BRD-K43887077-003-26-3, BRD-K43887077-003-27-1, BRD-K43887077-003-25-5","Launched","","VYFYYTLLBUKUHU-UHFFFAOYSA-N","BRD-K43887077","","NCCc1ccc(O)c(O)c1"
"10491","BRETYLIUM","norepinephrine inhibitor","ATP1A1","cardiology","ventricular arrhythmias, ventricular fibrillation (VF), ventricular tachycardia (VT)","Sigma, MicroSource",49.99,"BRD-K49669424-075-19-2, BRD-K49669424-001-01-6","Launched","","AAQOQKQBGPPFNS-UHFFFAOYSA-N","BRD-K49669424","","CC[N+](C)(C)Cc1ccccc1Br"
"10493","MEXILETINE","sodium channel blocker","AHR, SCN4A, SCN5A","cardiology","ventricular arrhythmias, ventricular tachycardia (VT)","MicroSource, Tocris, Tocris, Selleck",98.76,"BRD-A64092382-003-18-3, BRD-A64092382-003-17-5, BRD-A64092382-003-19-1, BRD-A64092382-003-16-7","Launched","","VLPIATFUUWWMKC-UHFFFAOYSA-N","BRD-A64092382","","CC(N)COc1c(C)cccc1C"
"10497","NIFEKALANT","potassium channel blocker","","cardiology","ventricular arrhythmias, ventricular tachycardia (VT)","Prestwick",94.25,"BRD-K32311154-001-01-0","Launched","","OEBPANQZQGQPHF-UHFFFAOYSA-N","BRD-K32311154","","Cn1c(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)cc(=O)n(C)c1=O"
"10498","PROCAINAMIDE","sodium channel blocker","DNMT1, SCN5A","cardiology","ventricular arrhythmias, ventricular tachycardia (VT)","MicroSource",97.98,"BRD-K75089421-003-24-5","Launched","","REQCZEXYDRLIBE-UHFFFAOYSA-N","BRD-K75089421","","CCN(CC)CCNC(=O)c1ccc(N)cc1"
"10499","ETHACIZIN","anticonvulsant","","cardiology","ventricular tachycardia (VT), Wolff-Parkinson-White Syndrome (WPW)","Vitas-M",97.41,"BRD-K10667240-001-01-7","Launched","","PQXGNJKJMFUPPM-UHFFFAOYSA-N","BRD-K10667240","","CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1"
"10500","FLECAINIDE","sodium channel blocker","KCNA5, KCNA7, SCN4A, SCN5A","cardiology","ventricular tachycardia (VT), atrial fibrillation (AF), ventricular arrhythmias","Tocris, MicroSource, Tocris",96.6,"BRD-A09472452-015-26-7, BRD-A09472452-015-23-4, BRD-A09472452-015-22-6","Launched","","DJBNUMBKLMJRSA-UHFFFAOYSA-N","BRD-A09472452","","FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1"
"10503","ESMOLOL","adrenergic receptor antagonist","ADRB1","cardiology","ventricular tachycardia (VT), hypertension","Selleck",95.59,"BRD-A07395371-003-10-0","Launched","","AQNDDEOPVVGCPG-UHFFFAOYSA-N","BRD-A07395371","","COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1"
"10504","DISOPYRAMIDE","sodium channel blocker","CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A","cardiology","ventricular tachycardia (VT), ventricular arrhythmias","MicroSource, Selleck",97.94,"BRD-A29734509-011-13-6, BRD-A29734509-011-12-8","Launched","","UVTNFZQICZKOEM-UHFFFAOYSA-N","BRD-A29734509","","CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C"
"10506","LODOXAMIDE","histamine receptor antagonist","","ophthalmology","vernal keratoconjunctivitis (VKC)","Prestwick",94.05,"BRD-K66937583-001-01-2","Launched","","RVGLGHVJXCETIO-UHFFFAOYSA-N","BRD-K66937583","","OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N"
"10507","ACETYL-L-LEUCINE","","","neurology/psychiatry","vertigo","MicroSource",100,"BRD-K27406233-001-07-7","Launched","","WXNXCEHXYPACJF-ZETCQYMHSA-N","BRD-K27406233","","CC(C)C[C@H](NC(C)=O)C(O)=O"
"10508","DIPHENIDOL","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","vertigo","Enamine",99.63,"BRD-K01663662-003-20-2","Launched","","OGAKLTJNUQRZJU-UHFFFAOYSA-N","BRD-K01663662","","OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1"
"10509","BENZYL-ALCOHOL","local anesthetic","","infectious disease","virus herpes simplex (HSV)","MicroSource, Sigma",0,"BRD-K98494274-001-03-6, BRD-K98494274-001-05-1","Launched","","WVDDGKGOMKODPV-UHFFFAOYSA-N","BRD-K98494274","","OCc1ccccc1"
"10511","EDOXUDINE","DNA directed DNA polymerase inhibitor","","infectious disease","virus herpes simplex (HSV)","MicroSource",98.02,"BRD-K86892782-001-17-0","Launched","BRD-A62505706-001-04-9","XACKNLSZYYIACO-DJLDLDEBSA-N","BRD-K86892782","BRD-A62505706","CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O"
"10512","IDOXURIDINE","DNA directed DNA polymerase inhibitor","","infectious disease","virus herpes simplex (HSV)","Selleck, MicroSource",98.08,"BRD-K76634210-001-12-1, BRD-K76634210-001-14-7","Launched","BRD-A85439007-001-01-6","XQFRJNBWHJMXHO-RRKCRQDMSA-N","BRD-K76634210","BRD-A85439007","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O"
"10514","TRIFLURIDINE","DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor","TYMS","infectious disease","virus herpes simplex (HSV)","Selleck, Tocris, MicroSource, Selleck",96.52,"BRD-K03243820-001-23-8, BRD-K03243820-001-24-6, BRD-K03243820-001-25-3, BRD-K03243820-001-22-0","Launched","BRD-A64485570-001-12-8, BRD-A64485570-001-11-0","VSQQQLOSPVPRAZ-RRKCRQDMSA-N","BRD-K03243820","BRD-A64485570","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F"
"10518","GABAPENTIN","calcium channel blocker","ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","infectious disease, neurology/psychiatry","virus herpes simplex (HSV), shingles, seizures, restless leg syndrome","Selleck, MicroSource, Selleck",100,"BRD-K62737565-001-09-5, BRD-K62737565-001-10-3, BRD-K62737565-003-02-6","Launched","","UGJMXCAKCUNAIE-UHFFFAOYSA-N","BRD-K62737565","","NCC1(CC(O)=O)CCCCC1"
"10521","DENOTIVIR","antiviral","","infectious disease","virus herpes simplex (HSV), skin infections","Vitas-M",98.5,"BRD-K01773083-001-01-4","Launched","","ZPBLNADJHWHOEP-UHFFFAOYSA-N","BRD-K01773083","","Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1"
"10522","VIDARABINE","antiviral","ADA","infectious disease","virus herpes simplex (HSV), varicella-zoster virus (VZV)","MicroSource, Selleck",98.16,"BRD-K72093121-001-17-1, BRD-K72093121-001-16-3","Launched","","OIRDTQYFTABQOQ-UHTZMRCNSA-N","BRD-K72093121","","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O"
"10524","PYRIDOXINE","vitamin B","DDC, PDXK","metabolism","vitamin B6 deficiency","MicroSource, Selleck",100,"BRD-K14349461-001-04-4, BRD-K14349461-003-13-1","Launched","","LXNHXLLTXMVWPM-UHFFFAOYSA-N","BRD-K14349461","","Cc1ncc(CO)c(CO)c1O"
"10526","ALFACALCIDOL","vitamin D receptor agonist","CYP27B1, VDR","endocrinology","vitamin D deficiency","Selleck, MedChemEx, Selleck",91.26,"BRD-K49522529-001-02-9, BRD-K49522529-001-01-1, BRD-K49522529-001-03-7","Launched","BRD-K92644009-001-02-6, BRD-K84280765-001-01-5","OFHCOWSQAMBJIW-AVJTYSNKSA-N","BRD-K49522529","BRD-K92644009","CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C"
"10529","CHOLECALCIFEROL","","VDR","endocrinology","vitamin D deficiency","MicroSource, Selleck, Selleck",92.35,"BRD-K62779383-001-08-9, BRD-K62779383-001-07-1, BRD-K62779383-001-05-5","Launched","BRD-A56749456-001-04-3, BRD-K32793810-001-01-5","QYSXJUFSXHHAJI-YRZJJWOYSA-N","BRD-K62779383","BRD-A56749456","CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C"
"10532","ALPHA-TOCHOPHEROL","antioxidant","","endocrinology","vitamin E deficiency","MicroSource",65.25,"BRD-A82892199-001-04-1","Launched","","GVJHHUAWPYXKBD-UHFFFAOYSA-N","BRD-A82892199","","CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1"
"10533","ALPHA-TOCHOPHERYL-ACETATE","antioxidant","","endocrinology","vitamin E deficiency","MicroSource",93.36,"BRD-A61850409-001-10-7","Launched","","ZAKOWWREFLAJOT-UHFFFAOYSA-N","BRD-A61850409","","CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(C)=O)c(C)c(C)c2O1"
"10534","PHYTONADIONE","","BGLAP, GGCX","hematology","vitamin K deficiency, anticoagulation reversal","MicroSource, Sigma",2.14,"BRD-K76661572-001-07-6, BRD-K76661572-001-08-4","Launched","","MBWXNTAXLNYFJB-NKFFZRIASA-N","BRD-K76661572","","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O"
"10536","TRIOXSALEN","DNA synthesis inhibitor","","dermatology","vitiligo, eczema","MicroSource",97.99,"BRD-K54790157-001-15-5","Launched","","FMHHVULEAZTJMA-UHFFFAOYSA-N","BRD-K54790157","","Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1"
"10537","MAROPITANT","neurokinin receptor antagonist","TACR1","gastroenterology","vomiting","MedChemEx",97.11,"BRD-K76594255-001-01-6","Launched","","OMPCVMLFFSQFIX-CONSDPRKSA-N","BRD-K76594255","","COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C"
"10538","TRIMETHOBENZAMIDE","histamine receptor antagonist","DRD2","gastroenterology","vomiting, nausea, gastroenteritis","MicroSource",98.53,"BRD-K34415467-003-13-0","Launched","","FEZBIKUBAYAZIU-UHFFFAOYSA-N","BRD-K34415467","","COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1"
"10539","BUTOCONAZOLE","bacterial cell wall synthesis inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource, Selleck",99.34,"BRD-A16665823-001-02-0, BRD-A16665823-008-12-4","Launched","","SWLMUYACZKCSHZ-UHFFFAOYSA-N","BRD-A16665823","","Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1"
"10541","CANDICIDIN","fungal ergosterol inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource",0,"BRD-A37348498-015-01-4","Launched","","HYIZCDMXFDRDFE-RTQJASBYSA-N","BRD-A37348498","","CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(O[C@@H]2O[C@H](C)[C@H](O)[C@@H](O)[C@@H]2N)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)c1ccc(N)cc1"
"10542","FENTICONAZOLE","bacterial cell wall synthesis inhibitor","","infectious disease","vulvovaginal candidiasis","Selleck",98.76,"BRD-A33697453-008-02-4","Launched","","ZCJYUTQZBAIHBS-UHFFFAOYSA-N","BRD-A33697453","","Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1"
"10543","SULFANILAMIDE","carbonic anhydrase inhibitor","CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4","infectious disease","vulvovaginal candidiasis","MicroSource, Selleck",100,"BRD-K02594908-001-16-4, BRD-K02594908-001-15-6","Launched","","FDDDEECHVMSUSB-UHFFFAOYSA-N","BRD-K02594908","","Nc1ccc(cc1)S(N)(=O)=O"
"10545","TERCONAZOLE","sterol demethylase inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource, Kemprotec",94.91,"BRD-K86204871-001-16-2, BRD-K07400595-001-02-7","Launched","","BLSQLHNBWJLIBQ-OZXSUGGESA-N","BRD-K86204871","","CC(C)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1"
"10546","TERCONAZOLE","sterol demethylase inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource, Kemprotec",94.91,"BRD-K86204871-001-16-2, BRD-K07400595-001-02-7","Launched","","BLSQLHNBWJLIBQ-OZXSUGGESA-N","BRD-K86204871","","CC(C)N1CCN(CC1)c1ccc(OC[C@@H]2CO[C@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1"
"10547","TERCONAZOLE","sterol demethylase inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource, Kemprotec",94.91,"BRD-K86204871-001-16-2, BRD-K07400595-001-02-7","Launched","","BLSQLHNBWJLIBQ-ZEQKJWHPSA-N","BRD-K86204871","","CC(C)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1"
"10548","TERCONAZOLE","sterol demethylase inhibitor","","infectious disease","vulvovaginal candidiasis","MicroSource, Kemprotec",94.91,"BRD-K86204871-001-16-2, BRD-K07400595-001-02-7","Launched","","BLSQLHNBWJLIBQ-ZEQKJWHPSA-N","BRD-K86204871","","CC(C)N1CCN(CC1)c1ccc(OC[C@@H]2CO[C@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1"
"10549","CLOTRIMAZOLE","cytochrome P450 inhibitor, imidazoline receptor ligand","CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8","infectious disease","vulvovaginal candidiasis, oropharyngeal candidiasis","Tocris, MicroSource, Selleck",98.93,"BRD-K15916496-001-29-5, BRD-K15916496-001-27-9, BRD-K15916496-001-26-1","Launched","","VNFPBHJOKIVQEB-UHFFFAOYSA-N","BRD-K15916496","","Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1"
"10552","TRICHLOROACETIC-ACID","","","dermatology","warts","Enamine, Enamine",0,"BRD-K42090719-001-07-3, BRD-K42090719-001-06-5","Launched","","YNJBWRMUSHSURL-UHFFFAOYSA-N","BRD-K42090719","","OC(=O)C(Cl)(Cl)Cl"
"10554","OXANDROLONE","androgen receptor agonist","AR","endocrinology","weight-gain aid","MedChemEx",100,"BRD-K92467929-001-01-1","Launched","","QSLJIVKCVHQPLV-PEMPUTJUSA-N","BRD-K92467929","","C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C"
"10555","ROXARSONE","antiprotozoal agent","","endocrinology","weight-gain aid","MicroSource",98.02,"BRD-K22685337-001-13-4","Launched","","XMVJITFPVVRMHC-UHFFFAOYSA-N","BRD-K22685337","","Oc1ccc(cc1[N+]([O-])=O)[As](O)(O)=O"
"10556","ZILPATEROL","adrenergic receptor agonist","ADRB2","endocrinology","weight-gain aid","Cayman",97.26,"BRD-K42816473-001-01-0","Launched","","ZSTCZWJCLIRCOJ-AAEUAGOBSA-N","BRD-K42816473","","CC(C)N[C@H]1CCn2c(O)nc3cccc([C@@H]1O)c23"
"10557","ORLISTAT","lipase inhibitor","CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP","endocrinology","weight-loss aid","MicroSource, Tocris, Selleck",100,"BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2","Launched","","AHLBNYSZXLDEJQ-GWMMUDDPSA-N","BRD-K94062100","","CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O"
"10558","ORLISTAT","lipase inhibitor","CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP","endocrinology","weight-loss aid","MicroSource, Tocris, Selleck",100,"BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2","Launched","","AHLBNYSZXLDEJQ-GWMMUDDPSA-N","BRD-K94062100","","CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O"
"10560","ORLISTAT","lipase inhibitor","CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP","endocrinology","weight-loss aid","MicroSource, Tocris, Selleck",100,"BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2","Launched","","AHLBNYSZXLDEJQ-FWEHEUNISA-N","BRD-K94062100","","CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O"
"10561","ORLISTAT","lipase inhibitor","CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP","endocrinology","weight-loss aid","MicroSource, Tocris, Selleck",100,"BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2","Launched","","AHLBNYSZXLDEJQ-FWEHEUNISA-N","BRD-K94062100","","CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O"
"10563","PHENTERMINE","dopamine uptake inhibitor, serotonin reuptake inhibitor","MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4","endocrinology","weight-loss aid","Prestwick",96.96,"BRD-K96319534-003-03-9","Launched","","DHHVAGZRUROJKS-UHFFFAOYSA-N","BRD-K96319534","","CC(C)(N)Cc1ccccc1"
"10564","LIRAGLUTIDE","GLP receptor agonist","GLP1R","endocrinology","weight-loss aid, diabetes mellitus","MedChemEx",83.15,"BRD-A48274390-001-01-8","Launched","","YSDQQAXHVYUZIW-UHFFFAOYSA-N","BRD-A48274390","","CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O"
"10565","ACEXAMIC-ACID","5 alpha reductase inhibitor","GAST","dermatology","wound healing","MicroSource",100,"BRD-K72215350-001-06-5","Launched","","WDSCBUNMANHPFH-UHFFFAOYSA-N","BRD-K72215350","","CC(=O)NCCCCCC(O)=O"
"10566","PIDOLIC-ACID","","ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA","dermatology","xerosis cutis","MicroSource",92.71,"BRD-K57313110-001-06-8","Launched","","ODHCTXKNWHHXJC-VKHMYHEASA-N","BRD-K57313110","","OC(=O)[C@@H]1CCC(=O)N1"
"10567","AMMONIUM-LACTATE","","HCAR1","dermatology","xerosis cutis, ichthyosis vulgaris","MicroSource",0,"BRD-M29182745-001-01-4","Launched","","RZOBLYBZQXQGFY-UHFFFAOYSA-N","BRD-M29182745","","N.CC(O)C(O)=O"
"10568","TIOCONAZOLE","sterol demethylase inhibitor","CYP51A1","infectious disease","yeast infection","MicroSource, Selleck",98.01,"BRD-A33084557-001-07-4, BRD-A33084557-001-06-6","Launched","","QXHHHPZILQDDPS-UHFFFAOYSA-N","BRD-A33084557","","Clc1sccc1COC(Cn1ccnc1)c1ccc(Cl)cc1Cl"
"10570","MICONAZOLE","bacterial cell wall synthesis inhibitor","KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5","infectious disease, neurology/psychiatry","yeast infection, itching","Tocris, Selleck, Selleck, MicroSource",99.92,"BRD-A82396632-008-30-8, BRD-A82396632-001-16-2, BRD-A82396632-008-28-2, BRD-A82396632-008-29-0","Launched","","BYBLEWFAAKGYCD-UHFFFAOYSA-N","BRD-A82396632","","Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1"
